Contact Us

 Contact Us
 Careers
 Services
 About Us
 Home
News
Monthly Archives
Patent lawyer held in Goa for duping film writer of Rs 45 lakh

(V Narayan , 17-Dec-2018 , The Times Of India)
Police also seized the fake rubber stamps and signatures of the Controller General of Patents (Ministry of
Commerce and Industry) from Intellectual Property Rights office that he used to dupe people. Cheddha
has been booked for cheating and forgery. He is in police custody till December 21. More...
Patent applications by female innovators to get faster clearance: Draft rules

(PTI , 16-Dec-2018 , Financial Express)
A patent application filed by a female innovator will be examined expeditiously with a view to promoting
women entrepreneurship in the country, as per a DIPP proposal. More...
N-E varsity researchers patent process to treat industrial waste

(Rahul Karmakar , 16-Dec-2018 , The Hindu)
Three researchers from the North-Eastern Hill University (NEHU) based in Meghalaya capital Shillong
have patented a fast, energy-efficient and low-cost process for treatment and bio-detoxification of
industrial effluents contaminated with harmful azo-dye. More...
DRL will have to wait to sell Suboxone generic in US, says US Court
(TNN , 12-Dec-2018 , The Times Of India)
In a setback of sorts for city-based pharma major Dr Reddy’s Laboratories (DRL), a US appeals court
has asked it to wait for some more time before it can begin selling its generic version of Indivior Plc’s
Suboxone Film drug, which is used to treat opioid addiction. More...
DIPP floats draft patent rules

(PTI , 10-Dec-2018 , The Economic Times)
The commerce and industry ministry has floated a draft to amend the existing patent rules with a view
to further streamline examination of applications. More...
What exactly are geographical indications and who can apply for GI status?
(Latha Nair , 9-Dec-2018 , Business Standard)
Latha Nair, partner at K&S Partners, examines what constitutes a GI tag and what the gaps in the Indian
GI law are More...
India granted 86 per cent of total patents to foreigners in 2017: UN

(BusinessToday.In , 04-Dec-2018 , Business Today)
India granted 86 per cent (10,675) of the total patents to foreigners as compared to 14 per cent (1,712)
awarded to entities and individuals based in India. More...
Number of patents granted by India shot up by 50% in 2017: UN

(IANS , 4-Dec-2018 , The Tribune)
The number of patents granted by India shot up by 50 per cent in 2017, keeping up a trend of steep
increases, according to the UN's World Intellectual Property Organisation (WIPO). More...
Opinion | Incentivizing private sector R&D in India

(Gaurav S. Ghosh , 26-Nov-2018 , Livemint)
The Indian government has tried to implement the increasingly popular patent box policy but hasn’t
quite got it right. More...
Govt to launch initiative to boost intellectual property in defence sector: Top official
(PTI , 24-Nov-2018 , The Times Of India)
Seeking to "significantly enhance" the country's design capabilities in the defense segment, the
government will next week launch a new initiative to boost the quantum of intellectual property in the
sector, a top official said on Saturday. More...
Activists irked by RCEP talks over pharma patents

(Rupali Mukherjee | TNN , 15-Nov-2018 , The Times Of India)
Public health activists and patient groups have raised serious concerns over intellectual property (IP)
provisions in the ongoing negotiations of the Regional Comprehensive Economic Partnership (RCEP),
charging Japan and South Korea of pushing a TRIPS-plus regime that would expand and extend
monopolies for pharma MNCs, and undermine generic competition. More...
'Simmba' movie infringes its trademark, claims a beverage co in HC

The Delhi High Court has sought Rohit Shetty Picturez' response to a plea alleging that its movie
'Simmba',Ranveer Singh and Sara Ali Khan, infringes the trademark of a beverage company. More...
Suven Life gets product patents from Australia, Hong Kong

(PTI , 13-Nov-2018 , The Economic Times)
Suven LifeNSE -6.71 % Sciences Tuesday said it has been granted a product patent each by Australia
and Hong Kong for a new chemical entity (NCE) for the treatment of disorders associated with neuro-
degenerative diseases. More...
LG files patent for a phone with four rear cameras

(Shweta Ganjoo New Delhi , 31-Oct-2018 , India Today)
LG is likely to retain the 3.5mm jack in its upcoming smartphone More...
Johnson & Johnson loses cancer drug patent, Indian firms eye US market
(Sohini Das | Mumbai , 31-Oct-2018 , Business Standard)
Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga More...
Universities and patents

(Feroz Ali , 31-Oct-2018 , The Hindu)
The ambitious goal set by India’s IPR Policy rests on how universities embrace patents More...
ShareChat drags Bytedance to court over copyright row

( Venkat Ananth , ET Bureau , 31-Oct-2018 , The Economic Times)
The Delhi High Court on Tuesday ordered Chinese content giant Bytedance to desist from using
“ShareChat” as an ad-word on Google. More...
Copyright violation case: Nitish Kumar told to record evidence via video conference today
(Express News Service | New Delhi , 31-Oct-2018 , The Indian Express)
Atul Kumar Singh, a former senior JNU scholar-turned-politician, has alleged that a book published by
Patna-based Asian Development Research Institute and endorsed by the Bihar CM, was a plagiarised
version of his research project. More...
No copyright on Patel community: Court

(TNN , 31-Oct-2018 , The Times Of India)
Patel is a community name and one cannot have a trademark right over this word. More...
Indian start-ups file 909 patent applications last year, compared to 61 in 2016
(Priyanka Golikeri , 31-Oct-2018 , Zee Business)
Data from the Department of Industrial Policy & Promotion (DIPP) reveals that Indian start-ups filed 909
patent applications last year, as compared to a mere 61 in 2016. More...
Number of GI registrations from T.N. dwindles

(Sanjay Vijayakumar , 29-Oct-2018 , The Hindu)
The number of registrations of the Geographical Indication (GI) tag for products from Tamil Nadu has
dwindled in recent years, according to data from the Geographical Indications Registry. More...
KAU embarks on a mission to rejuvenate hill garlic

( E.M. Manoj , 28-Oct-2018 , The Hindu)
‘Malai poondu’ or hill garlic grown on the hills of Kanthalloor and Vattavada areas of Idukki district of
Kerala are known for its unique flavour, pungency, taste, medicinal properties and longer shelf life .
More...
326 products registered as geographical indication so far

(PTI , 23-Oct-2018 , The Economic Times)
As many as 326 products such as Kancheepuram silk saree, Alphonso Mango, Nagpur Orange and
Kolhapuri Chappal have been registered as geographical indications (GI) so far, according to government
data. More...
ZEE patents immersive tech platform for home entertainment

(Gaurav Laghate , ET Bureau , 23-Oct-2018 , The Economic Times)
Imagine being able to smell the food that’s been cooked on a cookery show or the perfume of the
protagonist of a daily soap and being able to order it online with a click of a button. More...
'Take patent to avoid wastage of resource’

Hard work put in by researchers can lead to wastage of resources and become subject to duplication if it
is not patented in the market, said Pradip Ingle, Hingna unit head of Maarashtra Centre for
Entrepreneurship Development (MCED) on Saturday. More...
Indian researchers develop skin gel that will protect farmers from pesticides
(Snehal Fernandes , 19-Oct-2018 , Hindustan Times)
A team from the Institute for Stem Cell Biology and Regenerative Medicine (inStem) have
formulated/created and patented the gel. More...
Bihar's 'Shahi Litchi' Gets Geographical Indication Tag

(All India | Indo-Asian News Service , 18-Oct-2018 , NDTV)
The famous Shahi litchi, which is famous for its sweet, juicy, unique flavour and aroma, is mostly grown
in Muzaffarpur and neighbouring districts including East Champaran, Vaishali, Samastipur and
Begusarai. More...
Walmart seeks patent for drones to deliver products

(Sajan C Kumar | Chennai , 9-Oct-2018 , Financial Express)
Walmart, in the patent application, said in a modern retail environment, there is a need to improve the
customer service and one aspect of that is delivery of products. More...
Taking steps to cut time to grant patents, trade marks: DIPP Secretary
India is taking several steps, including hiring more manpower and increasing use of technology, to
reduce time for granting patents and trade marks, a top government official said Monday. More...
Study shows low IPR awareness in India

(Neetu Chandra Sharma , 8-Oct-2018 , Livemint)
Around 35% respondents were not aware about Intellectual Property Rights, according to a new study
More...
Protect intellectual property rights: V-C

Protection of intellectual property rights is a must for universities as it ensures safety of research work
carried out by students, said SP Kane, vice-chancellor of Nagpur University on Saturday. More...
Setback for Mahindra in US as court denies motion for injunction in infringement case
(Arushi Kotecha , 06-Oct-2018 , Livemint)
The court denied M&M motion on grounds that it “cannot show that they are likely to succeed on merits
of their claim” More...
Alphonso mangoes get Geographical Indication tag

(TIMESOFINDIA.COM , 5-Oct-2018 , The Times Of india)
Alphonso mangoes from Ratnagiri, Sindhudurg and other adjoining areas in Maharashtra have finally got
the Geographical Indication (GI) tag from the government on Friday. More...
Fiji fights to trademark 'Bula'; time for India to think about Namaste?
(ET Bureau , 1-Oct-2018 , The Economic Times)
A country can take only so much bula-ing. Considering its national greeting ‘Bula’ has been trademarked
in the US no less than 42 times before, the spirited reaction of the Fijian government to the 43rd one by
a chain of bars that also serve a version of its national drink kava, is not surprising. More...
IPR policy reduces pendency of intellectual property applications: DIPP Secy

(PTI , 26-Sep-2018 , The Economic Times)
There has been a significant reduction in pendency of intellectual property applications, including patents
and trademarks, with the adoption of the national IPR policy, a top government official has said. More...
After a slump, IIT-B witnesses 8 per cent hike in patent application

( Priyanka Sahoo | Mumbai , 23-Sep-2018 , The Indian Express)
Over the last five years, the institute has filed 109 patents on an average every year, the highest being
143 in 2015-16. More...
Funding for research and innovation is improving: Clarivate Analytics

(Sudhir Chowdhary , 12-Sep-2018 , Financial Express)
Clarivate Analytics accelerates the pace of innovation by providing insights and analytics to clients
around the world, enabling them to discover, protect and commercialise new ideas, faster. More...
Say cheers to Kutchhi dates wine!

(Nimesh Khakhariya | tnn , 12-Sep-2018 , The Times Of India)
State’s prohibition and excise department has granted registration to their brand and the company is
planning to make to make the wine available in liquor shops by the end of this month. More...
Sohan Lal Commodity Management applies for a patent

( Sutanuka Ghosal , ET Bureau , 11-Sep-2018 , The Economic Times)
Sohan Lal Commodity Management (SLCM), India’s leading agri services solutions provider with
operations across India & Myanmar has applied for a patent with the India Patent Office. More...
Man held for allegedly violating copyright law
(Staff Reporter , 10-Sep-2018 , The Hindu)
The police on Sunday arrested a printing press owner for allegedly printing and selling foreign and
Indian novels without obtaining the copyrights. More...
Study shows low IPR awareness in India

(Neetu Chandra Sharma , 09-Sep-2018 , Livemint)
Around 35% respondents were not aware about Intellectual Property Rights, according to a new study
More...
GI tag fails to boost Kalamkari sales

( By Anirudh Chakravarthy , 08-Sep-2018 , The New Indian Express)
Even after Kalamkari art form got Geographical Indication (GI) tag in 2013, artisans are struggling to
sell their products. More...
Government seeks Geographical Indication tag for ‘Odisha Rasagola’

( By Express News Service , 08-Sep-2018 , The New Indian Express)
The State Government has submitted the required documents seeking Geographical Indication (GI) tag
for ‘Odisha Rasagola’ in February this year. More...
Intellectual property and agriculture: The world’s only IP Act that recognises rights of
breeders, farmers
(Kumble Vinod Prabhu & Rakesh Chandra Agrawal , 6-Sep-2018 , The Indian Express)
How the Vajpayee-led government in the late-1990s navigated through the WTO’s TRIPS agreement to
craft a one-of-its-kind plant varieties protection law. More...
Mumbai: Andhericha Raja gets a trademark certificate, finally

(Anagha Sawant , 03-Sep-2018 , DNA)
This year, the city-based Azad Nagar Sarvajanik Utsav Samiti in Andheri has finally got a trademark for
its Ganesh idol, Andhericha Raja. According to the mandal members, they have received a trademark
certificate from the government of India for the name 'Andhericha Raja'. More...
Storm in a coffee mug: Starbucks versus Sardarbuksh

( Rasul Bailay , ET Bureau , 30-Aug-2018 , The Economic Times)
Ever been to a Sardarbuksh for a coffee? More...
Patent infringement complaint filed by Fiat in US: M&M

(PTI , 29-Aug-2018 , THe Times Of India)
Mahindra & Mahindra (M&M) today said a patent violation complaint has been filed against the home
grown utility vehicles major by Fiat Chrysler Automobile US, LLC, at US-based International Trade
Commission (ITC) More...
Chindia, Now Trademark It
( Rajay Verma , 22-Aug-2018 , The Economic Times)
India’s emergence as Asia’s third-largest economy and favourable demographics has helped it attract
FDI and trade from various quarters. More...
A withering climate for agricultural innovation

(Puneeta Arora Bhagirath Choudhary , 21-Aug-2018 , Business Line)
The Centre needs to clarify its stance on protection of naturally occurring plant varieties and man-made
gene sequences More...
GSK Pharma to pare brands to 20 in India, bring new products into country
(Sohini Das | Mumbai , 20-Aug-2018 , Business Standard)
The company will launch brand extensions whenever needed and focus on bringing in patented product
More...
Patent Applications: Bigger team, faster processing on the cards

(ANJALI MARAR | Pune , 14-Aug-2018 , The Indian Express)
In comparison to international standards, where a patent is awarded in three years, in India it can take
anywhere between five and eight years, one of the main reasons being manpower shortage to scan the
patent applications piling up. More...
Patent Applications: Bigger team, faster processing on the cards

(ANJALI MARAR | Pune , 14-Aug-2018 , The Indian Express)
In comparison to international standards, where a patent is awarded in three years, in India it can take
anywhere between five and eight years, one of the main reasons being manpower shortage to scan the
patent applications piling up. More...
Ministry, HUL clash over use of Ayush trademark

(Ratna Bhushan, Sagar Malviya , ET Bureau , 14-Aug-2018 , The Economic Times)
The Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy, or Ayush, has asked
the Controller General of Patents, Designs and Trade Marks not to register the acronym as a trademark.
More...
August 14, 1968: Patents Bill to Joint Select Committee

(14-Aug-2018 , The Hindu)
The Lok Sabha to-day [August 13, New Delhi] decided to refer to a Joint Select Committee the
comprehensive Bill to amend and consolidate the law relating to patents. More...
Public health TRIPS at WTO

(Anil K Kanungo | New Delhi , 14-Aug-2018 , Financial Express)
TRIPS must be monitored closely, both in countries with strong generic industries and those relying on
imports of generic substitutes. More...
US FDA drug import plans hold promise for Indian pharma
(13-Aug-2018 , The Pharma Letter)
The doors appear to be opening. In what is being seen as a major positive for the Indian pharma
industry, the US Food and Drug Administration is working on an action plan to import drugs. More...
‘The magic rice that needs no cooking’ from Assam gets GI tag
(Tora Agarwala | Guwahati , 10-Aug-2018 , The Indian Express)
From the warriors of the Ahom kingdom then to the farmers of lower Assam now, the ‘magic’ Boka saul
— which recently got a GI tag — has been a breakfast staple for centuries now. More...
Pfizer to lose patent of drug Viagra, Indian companies gear up with copycat versions
(Himani Chandna ThePrint , 7-Aug-2018 , Hindustan Times)
Pfizer’s patent for the formulation of Viagra, used to treat impotence in men, ends in the US in 2020.
More...
Kerala Agriculture University to pitch cases of a gram, bean for GI tag

(A Satish Express News Service , 7-Aug-2018 , The New Indian Express)
This is the second year of cultivation and the funding is done by the Scheduled Tribe Development
Department. More...
Novartis restrains local pharma Cos from making patented diabetes drug
(TNN , 06-Aug-2018 , The Times Of India)
The Swiss multinational pharmaceutical company Novartis has obtained court orders restraining five
city-based pharma companies from manufacturing its patented drug for diabetes. More...
HC restrains firm from using ‘Limeroad’ trademark

(PTI Feeds , 5-Aug-2018 , India.com)
The Delhi High Court has restrained a firm from using the trademark 'Limeroad', observing that prima
facie it is a case of infringement, fraud and cheating. More...
DowDuPont ‘defers’ field trials to seek sale of GM corn seed in India

(Mayank Bhardwaj and Neha Dasgupta, Reuters , 4-Aug-2018 , Livemint)
DowDuPont has told India it is putting off trials needed for approval to sell a GM variety of corn, taking a
cue from US rival Monsanto that has pulled a similar application due to intellectual property concerns
More...
Famous Kadaknath chicken meat from Jhabua of MP gets Geographical Indication tag
(PTI , 02-Aug-2018 , Financial Express)
The famous Kadaknath chicken meat from Jhabua district of Madhya Pradesh has now got a
Geographical Indication (GI) tag. More...
AstraZeneca-DRL patent case: Fate of Rs 2.35 bn drug to be decided today
(Sohini Das | Mumbai , 31-Jul-2018 , Business Standard)
AstraZeneca has dragged Dr Reddy's Laboratories to the court to protect its blood clot inhibitor drug
Brilinta from generic competition More...
Govt’s drug price caps may trigger showdown with US

(Rupali Mukherjee , 31-Jul-2018 , The Times Of India)
US pharma biggies are at the receiving end of the Donald Trump administration’s ire due to rising drug
prices in that country, and this may cause anxiety for the Indian government as well as domestic generic
companies. More...
Get Geographical Indication tags for Indori Poha, Mawa jalebi: EXIM tells Madhya Pradesh
government
(PTI , 29-Jul-2018 , Financial Express)
A Geographical Indication is a sign used on products that have a specific geographical origin and possess
qualities or a reputation that are due to that origin. More...
Flautist designs hybrid musical instrument; applies for patent

( K Rathna Express News Service , 27-Jul-2018 , The New Indian Express)
An engineer from the city has created a one-of-a-kind musical instrument that combines the Veena and
the flute. Vinayak S Honnavar is also More...
KitKat’s four-finger shape can’t be trademarked, rules E.U. court

(AP , 25-Jul-2018 , The Hindu)
That will come as a relief to lovers of a Norwegian chocolate bar, the Kvikk Lunsj, that has a similar
shape, More...
Patently flawed: India must allow foreign universities to boost Indian research
( TOI Editorials , 25-Jul-2018 , The Times Of India)
In statistics that show Indian research in poor light, the number of patents filed by a single US firm in
India in 2016-17 was more than double of all applications filed by top laboratories in the country,
including 50 labs under DRDO, more than 40 labs in IISc, 23 IITs and six research facilities under Isro.
More...
AstraZeneca sues DRL on patent

(Prabha Raghavan, Vikas Dandekar , 24-Jul-2018 , The Economic Times)
AstraZeneca has filed a lawsuit in the Delhi High Court against Indian drug maker Dr Reddy’s
Laboratories to block it from launching generic versions of Brilinta, its blockbuster medicine for heart
ailments. More...
SC restrains educational institute from using DPS trademark

(PTI Feeds , 24-Jul-2018 , India.com)
The Supreme Court today restrained an educational institute from using the ‘DPS’ trademark of the Delhi
Public School. More...
One US firm files 135% more patents in India than all top labs together
(Chethan Kumar , 24-Jul-2018 , The Times Of India)
The number of patents filed by a US firm in India in 2016-17was more than double of all patent
applications from 50 labs under DRDO, more than 40 labs in IISc, 38 labs under CSIR, 31 NITs, 23 IITs
and six major research facilities under Isro. More...
From trademark row to export duty, here are the key court orders
(M J Antony , 23-Jul-2018 , Business Standard)
There is no exclusive right to the word 'Malabar', the Supreme Court has stated in a trademark dispute
between two firms that sell biryani rice. More...
Bombay High Court: Don't use any trademark resembling Pro Kabaddi League
(Mustafa Plumber , 23-Jul-2018 , DNA)
The Bombay High Court has restrained organisers of Pro Rajasthan Kabbadi league, from using a
trademark deceptively similar to the popular, 'Pro Kabaddi League'. More...
Maharashtra gets 474 patents, highest in India

( Express News Service | Mumbai , 21-Jul-2018 , The Indian Express)
However, patents granted in fields such as Agriculture Engineering, Food and Microbiology remain low at
24, 105 and 108 respectively. More...
Awareness on patent rights among scholars in govt varsities stressed

(THE HANS INDIA , 20-Jul-2018 , THE HANS INDIA)
Research is the basic task to innovate new ideas in the universe. In such kind of exercises, Andhra
Pradesh State Universities and colleges have been lagging behind when compared to private universities
in the state. More...
Philips wins patent battle in Delhi HC

(PTI , 19-Jul-2018 , India Today)
New Delhi, Jul 17 (PTI) Dutch electronic major Philips has won a major legal battle here with the Delhi
High Court ruling that it has a patent right over a channel decoding technology used for DVD video
playback function in a DVD player which was infringed upon by two domestic manufacturers. More...
Meril may get relief on price cap for its stent

(Teena Thacker , 18-Jul-2018 , Livemint)
Meril has developed MeRes100, which it claims is the country’s first locally made bioresorbable vascular
scaffold, or naturally dissolving stent for clearing blockages in arteries More...
BSE building at Dalal Street gets trademark

(PTI , 17-Jul-2018 , The Times Of India)
Leading stock exchange BSE today said it has secured a trademark for its iconic building Phiroze
Jeejeebhoy Towers at Dalal Street in Mumbai. More...
As Chandamama firm goes bust, rare copies, key patents lie locked up in Mumbai building
( Khushboo Narayan | Mumbai , 16-Jul-2018 , The Indian Express)
Geodesic Ltd and its top officials are now under the scanner of the Economic Offences Wing of the
Mumbai Police, Enforcement Directorate and the Income Tax department for tax evasion and alleged
siphoning and laundering of $125 million (Rs 812 crore). More...
India raises trade deficit issue with China at WTO

(Kirtika Suneja , 15-Jul-2018 , The Economic Times)
India has flagged concerns of its large trade deficit with China, visa restrictions for Indian professionals
and the challenges faced in exporting IT services, meat, rice and medicines to Beijing at the World Trade
Organization (WTO). More...
Gennova Bio gets US drug patent to treat brain clots

Decks have been cleared for a more affordable stroke treatment — developed by domestic company
Gennova Bio pharmaceuticals. More...
West Bengal trademark battle over biriyani leaves ‘Malabar’ amused

(Dhinesh Kallungal Express News Service , 14-Jul-2018 , The New Indian Express)
There can be no right to the exclusive commercial use of the word ‘Malabar’, said the SC in a trademark
battle between two companies to use the particular nomenclature for the sale of Biriyani rice. More...
Sun Pharma in focus after unit files patent case against German firm
(Capital Market , 11-Jul-2018 , Business Standard)
Sun Pharmaceutical Industries said that its wholly-owned subsidiary, DUSA Pharmaceuticals, filed trade
secret misappropriation and tortious interference claims in an ongoing patent infringement lawsuit
against Biofrontera Inc., Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG in
the United States District Court for the District of Massachusetts. More...
Drug regulator orders recall of Novartis’s painkiller diclofenac

(Teena Thacker , 11-Jul-2018 , Livemint)
Drug controller general of India (DCGI )cancels licence for diclofenac sold by Novartis after concerns
raised by a health ministry panel More...
Samsung ‘Galaxy Watch’ name confirmed by trademark registration

(Tech Desk | New Delhi , 11-Jul-2018 , The Indian Express)
Samsung has filed a trademark for a new smartwatch, dubbed the 'Galaxy Watch', with the South
Korea's patent office. More...
Global Innovation Index ranks India the 57th most innovative nation
(Hari Pulakkat , ET Bureau , 11-Jul-2018 , The Economic Times)
The Global Innovation Index (GII) has ranked India as the 57th most innovative nation in the world.
More...
Patent challenge to hepatitis-C medicines
(Our Special Correspondent , 11-Jul-2018 , The Telegraph)
Patients' rights advocates in India on Tuesday filed two oppositions in the Indian patent office,
challenging patent claims by the US pharmaceutical company Gilead Sciences for its medicines
sofosbuvir and velpatasvir, used to treat hepatitis-C infections. More...
Two pre-grant patent oppositions filed on Gilead’s Hepatitis C medicines

(PT Jyothi Datta , 10-Jul-2018 , Business Line)
The Delhi Network of Positive People has filed two pre-grant oppositions at the Indian Patent Office
(Mumbai) challenging “additional” patent claims made by the US drugmaker Gilead Sciences on its
hepatitis C medicines sofosbuvir and velpatasvir. More...
India sees huge surge in Intellectual Property rights applications

(Mudit Kapoor , 09-Jul-2018 , Business Today)
Trademarks, copyrights and patent registrations have seen growth of 236 per cent, 233 per cent and 41
per cent respectively since 2016. More...
Meerut scissors struggle to cut through Chinese competition

(S Raju S Raju Hindustan Times, Lucknow , 09-Jul-2018 , Hindustan Times)
GI Tag Product Buyers demanding local high quality product at the price of Chinese scissors, say
manufacturers. More...
Lightweight ‘sadmridangam’ finally gets patent

( K.A. Shaji , 09-Jul-2018 , The Hindu)
The improvised 5-kg instrument was designed by percussion maestro Kuzhalmannam Ramakrishnan
More...
Supreme Court to hear appeals on Monsanto patent issue on July 18

(Indu Bhan | New Delhi , 7-Jul-2018 , Financial Express)
The Supreme Court on Friday sought response from Monsanto Technology and others on an appeal by
Nuziveedu Seeds. More...
Patent filing low in AP state

(THE HANS INDIA , 7-Jul-2018 , THE HANS INDIA )
On an average, 350 patents are being filed in the state, which is lower compared to other states in the
country, said BK Sahu, Manager and In-charge, NRDC-TISC & IPFC, Visakhapatnam. More...
Nagaland: The world’s ‘easiest’ musical instrument seeks a patent

( Tora Agarwala | Guwahati , 7-Jul-2018 , The Indian Express)
Dimapur-based Moa and Arenla Subong make music by humming into a self-made bamboo instrument,
the notes of which transcend musical genres and geographical borders. More...
India keeps a close watch as US and China trade blows
(Asit Ranjan Mishra, Reuters , 06-Jul-2018 , Livemint)
Beijing blames Washington for ‘largest-scale trade war’ as both sides slap tit-for-tat tariffs More...
Jaipur to have WIPO support centre

(Santosh Patnaik , 06-Jul-2018 , The Hindu)
‘Accessing patent database to become easier with country’s fourth TISC’ More...
Parag Milk buys ColoPlus patent from ColoPlus AB

(Sapna Agarwal , 06-Jul-2018 , Livemint)
The patent works on Colostrum, the first milk of the cow after giving birth, which helps it to retain its
goodness and is said to be equivalent to that of a mother’s first milk More...
Patent eco-system gets a boost in Rajasthan

(TNN , 5-Jul-2018 , The Times Of India)
An institutional agreement was signed last week between Rajasthan Council of Science and Technology
and CIPAM under department of industrial policy and promotion (DIPP)has approved Technology &
Innovation Support Centre (TISC) at Rajasthan Council of S&T (RAJCOST). More...
India becomes a part of global copyright treaties

(dna Correspondent , 5-Jul-2018 , DNA)
India will be now be a part of global treaties on copyright, cheering authors, producers and performers,
who upload their works on the digital space. More...
Cabinet nod to India joining world intellectual property treaties

(IANS | New Delhi , 04-Jul-2018 , Business Standard)
The Cabinet on Wednesday approved India's accession to the World Intellectual Property Organisation
(WIPO) Copyright Treaty, and WIPO Performers and Phonograms Treaty (WPPT) extending copyright
coverage to the internet and digital spheres, IT Minister Ravi Shankar Prasad said. More...
Suven Life gets product patents from India, S. Korea and Singapore
(04-Jul-2018)
Suven Life Sciences today said it has been granted a product patent by India, Singapore, South Korea
and Israel each for a new chemical entity (NCE) used in treatment of disorders associated with
neurodegenerative diseases. More...
Mridangam maestro Kuzhalmannam Ramakrishnan receives patent for designing new version
of instrument
(Express News Service , 04-Jul-2018 , The New Indian Express)
Kuzhalmannam Ramakrishnan has named the instrument made of steel and fibre 'Sadmridangam' and it
hardly weighs 5 kg. More...
HUL raises stakes in battle against trademark violation
(Maulik Vyas , 3-Jul-2018 , Livemint)
Hindustan Unilever has sued rivals aggressively to prevent the usage of similar logos to save its brands
More...
Ready2Innovate exhibition gives thrust on inventions

Everything, from herbal chocolates and eco-friendly plates to waste management system and air
purifiers, was on display at an exhibition on the theme of environment, organized at Rajiv Gandhi
Institute of Intellectual Property Management (RGIIPM) at its auditorium on Saturday. More...
India's profile in global medical fraternity: Rich in research, poor in patents

( Richa Sharma and Kanu Sarda , 01-Jul-2018 , The New Indian Express)
A government study has admitted that Indian researchers focus only on publishing research findings
rather than filing patents and reaping financial benefits. More...
An ‘IAM’ or intellectual asset management strategy is the need of the hour: Patent expert
Rodney D Ryder
Lack of understanding of intellectual property protection and its benefits/utilities are among the key
reasons why Indian researchers do not get their innovations patented, he says. More...
A denied patent stands between farmers and GM cotton

(Harish Damodaran | New Delhi , 28-Jun-2018 , The Indian Express)
The more immediate consequence of the resultant uncertainty on the intellectual property rights (IPR)
protection regime for GM technology, though, would be felt on herbicide-tolerant or HT cotton. More...
Experts stress on integrating Intellectual Property Rights in govt policies

(dna Correspondent , 27-Jun-2018 , DNA)
Integrating Intellectual Property Rights (IPR) with government policies and adopting the right strategies
are keys to make the country an IP leader, experts said at an orientation programme on National IPR
Policy on Tuesday. More...
Navara IP rights sought for preventing biopiracy: farmer

(Special Correspondent , 27-Jun-2018 , The Hindu)
Chittur-based farmer P. Narayanan Unny has said his bid to seek Intellectual Property (IP) rights over
conservation of the nearly extinct traditional rice variety Navara under the Protection of Plant Variety
and Farmers Right Act, 2001 (PPVFR Act) is for protecting the native species from biopiracy. More...
India must focus on IP creation, commercialisation: ICRIER report

(Our Bureau , 26-Jun-2018 , Business Line)
‘Lack of funds for research a major concern’ More...

India a weak innovator, but potential exists: EU official
(PTI , 26-Jun-2018 , The Times Of India)
India is weak in innovation but has the potential to improve its position with increase in investments in
research, an European Union official said today. More...
Top seed industry official quits over IPR concerns on GM crops

(Sayantan Bera , 26-Jun-2018 , Livemint)
National Seed Association of India director general Kalyan Goswami has resigned due to differences with
NSAI president M. Prabhakar Rao over IPR of GM crops More...
Dr Reddy's loses patent case with Eli Lilly over Alimta

(PTI , 24-Jun-2018 , The Economic Times)
Dr Reddys Laboratories Limited has lost a legal battle with Eli Lilly and Company in a patent litigation on
Alimta (pemetrexed for injection), a drug used for treatment of various types of cancer, in USA. More...
Bihar’s Shahi litchi grown extensively in Muzaffarpur may soon have GI tag
(FE Online , 23-Jun-2018 , Financial Express)
The popular Shahi litchi which grows extensively across many north Bihar districts may soon get itself
the Geographical Indications (GI) tag. More...
Suresh Prabhu asks officials to prepare policy to set up GI stalls at airports

Commerce and Industry Minister Suresh Prabhu on Saturday directed officials to prepare a policy to set
up stalls of GI products at all the airports of the country. More...
Why Intellectual Property Rights as security for loans is correct in legal terms
(ET CONTRIBUTORS , 20-Jun-2018 , The Economic Times)
Recently the Supreme Court has ruled that a trademark cannot be assigned to a bank by a borrower
who has defaulted on the loan. In the case of Canara Bank vs NG Subbaraya Setty, the Supreme Court
held that assignment of a trademark — EENADU — for agarbattis, as a security for a loan outstanding is
against the Trademarks Act and the Banking Regulation Act. More...
Bangladesh’s bulk drugs policy may hurt Indian exports

(Teena Thacker , 19-Jun-2018 , Livemint)
Bangladesh has announced a corporate tax holiday bulk drug, or API, makers till 2032, and many other
incentives to encourage local pharma manufacturing More...
India stands against a patently unjust proposal at WIPO meet

(PT Jyothi Datta , 18-Jun-2018 , Business Line)
Proposed tweak of ‘patents treaty’ may affect sovereign rights of small countries More...
India to oppose planned patents rule
(Rema Nagarajan , 16-Jun-2018 , The Times Of India)
An effort by the World Intellectual Property Organisation (WIPO) to bring in a new rule that would allow
countries to delegate the functions of their patents office to another country or international organisation
has set alarm bells ringing among many developing countries and activists working on access to
medicines. More...
KVIC moves HC against Fabindia over use of 'khadi' trademark

(DNA Web Team , 16-Jun-2018 , DNA)
The Khadi and Village Industries Commission (KVIC) has petitioned the Bombay High Court against
Fabindia for "illegally" using its trademark "charkha" and selling apparel with the "khadi" tag. More...
West Bengal secures registration of ‘Biswa Bangla’ trademark

(Arkamoy Dutta Majumdar , 10-Jun-2018 , Livemint)
With the West Bengal government finally securing the registration of the Biswa Bangla trademark, it will
now look to adapt it for use by various departments More...
‘Lack of reviewers, training time reason for fewer patent credits to Indians’
(ANJALI MARAR | Pune , 06-Jun-2018 , The Indian Express)
While Indian researchers are often questioned about having ‘fewer’ patents to their credit than their
international counterparts, the problem appears to be that of availability of fewer reviewers to check the
huge number of patent applications filed every year in India. More...
The Indian copyright row that created literary history

( Soutik Biswas , India correspondent , 31-May-2018 , BBC News)
In March 1949, the government in India's southern state of Tamil Nadu acquired the work of one of
India's greatest poets. It was the first time in the world that the state had taken over the copyright of a
writer and put his writings in the public domain. More...
India pitches for WTO talks on checking theft of traditional knowledge

(PTI , 30-May-2018 , The Economic Times)
India today pitched for reviving negotiations at World Trade Organization on issues related to prevention
of theft of traditional knowledge such as Ayurveda and naturopathy. More...
Bengal’s Chau mask acquires GI fame

(Shiv Sahay Singh , 30-May-2018 , The Hindu)
The Chau mask of Purulia, the wooden mask of Kushmandi, the Patachitra, the Dokras of Bengal, and
Madhurkathi (a kind of mat) have been presented with the Geographical Indication (GI) tag by the
Geographical Indication Registry and Intellectual Property India. More...
AP Tourism looks forward to GI tag with Putareku

(TNN , 29-May-2018 , The Times of India)
Principal secretary of Andhra Pradesh Tourism Development Corporation Mukesh Kumar Meena held a
review meeting on Tuesday and directed the officials to promote the state’s delicacies by attaining
geographical indication (GI) tag for them. More...
Balbharati makes licence must to access its copyright material
(Alifiya Khan | Pune , 29-May-2018 , The Indian Express)
On March 9 this year, Balbharati had issued notices in several newspapers that in order to curb
commercialisation of education, they would make licence mandatory to access all material found in
Balbharati books from standard I to XII. More...
Dr. Reddy’s arm files patent infringement lawsuit

(Special Correspondent , 26-May-2018 , The Hindu)
Promius Pharma LLC, a wholly owned subsidiary of Dr. Reddy’s Laboratories, has filed a lawsuit for
patent infringement in a US court against Perrigo UK FINCO Limited Partnership, Perrigo Israel
Pharmaceuticals Ltd. and Taro Pharmaceuticals. More...
Patent protection: What Monsanto can learn from Tesla's instance

(Shalini Bhutani | The Wire , 25-May-2018 , Business Standard)
Monsanto not only needs to let go of its patents, but also move away from GM products to more
sustainable technologies More...
Patents and patent trolling in America

(Varghese K. George , 20-May-2018 , The Hindu)
Some time next month, the U.S. Patent and Trademark Office will issue patent number 10 million.
More...
Five Years After The Indian Supreme Court’s Novartis Verdict

(Patralekha Chatterjee , 20-May-2018 , Intellectual Property Watch)
On 1 April 2013, in a packed room inside India’s Supreme Court, a magnificent building in Indo-British
architectural style, two judges delivered a verdict that impacted the national and global conversation
about patents and patients. More...
HomeOpinion Picking your pharma right: Why alienate US with stent regulations or
compulsory licensing? Picking your pharma right: Why alienate US with stent regulations or
compulsory licensing?
(The Financial Express , 16-May-2018 , Financial Express)
While the two countries have traditionally sparred on the intellectual property rights (IPR) regime in the
pharmaceuticals sector, India must learn the right lessons from the US President Donald Trump’s
warnings over the weekend. More...
Reward innovation
( Ashish Bharadwaj, Punkhuri Chawla , 13-May-2018 , The Hindu)
A robust intellectual property rights (IPR) framework, with suitable enforcement systems, is critical to
support India’s efforts to be a global leader in innovation and competitiveness. More...
Barclays seeks patents around e-currency tech

(Sanjay Vijayakumar , 13-May-2018 , The Hindu)
Filings with India’s Patent Office refer to transactions in digital currency, related security mechanisms
More...
Bengaluru gets first Geographical Indication-based products store

(TNN , 11-May-2018 , The Times Of India)
he city has got a unique store which endorses some of the Geographical Indication (GI) products such as
Channapatna toys and Devanahalli pomelo among others. More...
Xiaomi sued by Coolpad for alleged patent infringement ahead of IPO

(Reuters | Hong Kong , 11-May-2018 , The Indian Express)
Xiaomi last week filed its IPO plans, which could be the largest listing globally in almost four years.
More...
Study Finds Rise In Use Of India’s Section 3(d) Against Pharma Primary Patents
(Adithi Koushik for Intellectual Property Watch , 11-May-2018 , Intellectual Property Rights)
Access to affordable medicines is one of the most pressing policy issues globally. More...
Supreme Court rejects Monsanto plea on seed patent order

(Priyanka Mittal , 07-May-2018 , Livemint)
Supreme Court refused to stay a Delhi HC order which held that plant varieties, seeds cannot be
patented under Indian law and that royalties would be decided by a specialized panel of agriculture
ministry More...
Supreme Court to hear Monsanto plea over GM cotton patents

( Madhvi Sally , ET Bureau , 5-May-2018 , The Economic Times)
Monsanto’s appeal against the invalidation of its patent on Bt cotton seed variety Bollgard II will be
heard by the Supreme Court on May 7 in a case that will have far-reaching impact on India’s intellectual
property (IP) regime. More...
Patent for Water Purifying Antibacterial Film Granted to Hyderabad University Scientists
(Nirupa Vatyam , 04-May-2018 , The Times Of India)
A patent for developing ‘Nanoparticle Embedded Polymer Film for Antibacterial Application’ has been
granted to the faculty and research scholars of the University of Hyderabad (UoH). More...
R&D in agri-biotech to be hit after court order on Bt cotton patent: Seed bodies
(Press Trust of India | New Delhi , 04-May-2018 , Business Standard)
Seed industry bodies FSII and AAI have expressed disappointment over a court order dismissing US-
biotech major Monsanto's plea to enforce patent for its BT cotton seeds in India, saying this may cause
"irreparable damage" to agri and crop-biotech research while depriving farmers from new farm
technologies. More...
Sabyasachi Mukherjee moves against plagiarism

(Sohini Dey , 04-May-2018 , Livemint)
With over 700 copyrighted designs, Sabyasachi Mukherjee’s eponymous couture label has become
India’s first fashion house to win the National Intellectual property Award More...
Monsanto Appeals To Supreme Court Over Genetically Modified Cotton Patents

(World | Reuters , 04-May-2018 , NDTV)
The Delhi High Court on April concurred with Indian seed company Nuziveedu Seeds Ltd (NSL), which
argued that the Patent Act does not allow Monsanto any patent cover for its genetically modified cotton
seeds More...
R&D in agri-biotech to be hit after court order on Bt cotton patent: Seed bodies
Seed industry bodies FSII and AAI have expressed disappointment over a court order dismissing US-
biotech major Monsanto's plea to enforce patent for its BT cotton seeds in India, saying this may cause
"irreparable damage" to agri and crop-biotech research while depriving farmers from new farm
India has made progress in protecting IPRs: US expert

(IANS , 03-May-2018 , The Times of India)
India has made a "lot of progress" in producing specialists in intellectual property and in developing new
protections and laws dealing with related issues, a US expert said here on Thursday. More...
India opposes US proposal to penalise China for IPR violation

(Amiti Sen , 03-May-2018 , Business Line)
At dispute-settlement body meeting, 8 countries tell US to follow WTO rules More...
Innovate in India: The country cannot afford to wait any longer for a robust intellectual
property rights regime
(Ritesh Kumar Singh , 03-May-2018 , Firstpost)
India’s Minister of Commerce & Industry, Suresh Prabhu, recently remarked that the Indian
pharmaceutical industry should focus on future opportunities in healthcare, both within and outside the
country. More...
Protect patents: on revoking Monsanto’s Bollgard-2 patent

(Priyanka Pulla , 3-May-2018 , The Hindu)
The Delhi HC’s judgment revoking Monsanto’s Bollgard-2 patent is troubling More...
GI tag and branding boost demand for Mattu Gulla brinjal

(AJ Vinayak , 01-May-2018 , Business Line)
Efforts by a set of growers — assisted by Nabard financially, and a private university in the form of
marketing interventions — have helped boost the prospects of ‘Mattu Gulla’ (a brinjal variety) with
geographical indication (GI) tag in Udupi district of Karnataka. More...
Why India may not be able to ignore USTR’s 2018 Special 301 report
(PT Jyothi Datta , 01-May-2018 , Business Line)
Amended statute allows for US action plan for each market on the ‘priority watch list’ More...
Fewer women researchers file for patents globally: Study

(ANJALI MARAR | Pune , 30-Apr-2018 , The Indian Express)
The World Intellectual Property Day is observed on April 26 and the programme was held in Pune on
Friday. More...
WTO: India, China warn US on ‘unilateral’ trade moves

(D. Ravi Kanth , 29-Apr-2018 , Livemint)
Several countries voice concern, say US measures could trigger full-blown trade war More...
India continues to figure in US' intellectual property priority watch list

(Kirtika Suneja , 28-Apr-2018 , The Economic Times)
India continues to figure in the US’ Priority Watch List that identifies trade barriers to US companies due
to intellectual property (IP) laws of other countries More...
India again on US priority watch list on intellectual property protection

(Press Trust of India, Washington , 27-Apr-2018 , Hindustan Times)
India remains on the list for longstanding challenges in its IP framework and lack of sufficient
improvements, particularly with respect to patents, copyrights, trade secrets, and enforcement. More...
The elephant in the Patent Office

(Feroz Ali, Roshan John , 28-Apr-2018 , The Hindu)
Over the last few years the Indian Patent Office (IPO) has been focussing on granting patents
expeditiously and reducing the backlog of pending applications. More...
Big positive for India: Dramatic rise in disposal of IPR applications, says DIPP
(PTI | New Delhi , 27-Apr-2018 , Financial Express)
There is a "dramatic" improvement in examination and disposal of IPR applications with the commerce
and industry ministry taking steps to strengthen the intellectual property rights regime. More...
Healthcare: India mustn’t give in to US policy pressure

(K.M Gopakumar , 27-Apr-2018 , Business Line)
India is an almost permanent name on the Priority Watch List due to its development-friendly IP laws.
More...
Rampant evergreening in Indian pharma industry

(Feroz Ali,Sudarsan Rajagopal , 27-Apr-2018 , Livemint)
Pharmaceutical companies commonly used legal argument, as opposed to demonstrating proof of

therapeutic efficacy, to overcome anti-evergreening objections More...
Patent inventions for financial gains: Kumar
(TNN , 27-Apr-2018 , The Times Of India)
India’s contribution to intellectual property rights (IPR) is not significant given the fact that the people
are either reluctant, are not aware or not willing to get patent for the inventions they made, said
divisional commissioner Anoop Kumar on Thursday. More...
Family support is key to get IPR, says Padma Shri winner

(Keyur Dhandeo , 27-Apr-2018 , DNA)
Support of family members is one of the most critical reasons to encourage women to own Intellectual
Property, said local women who have filed for patents. According to estimates, 28% of patents filed in
India have at least one women as a contributor, but in Gujarat, the share is estimated at 10%. More...
Google secures Indian patent for image identification

(Sajan C Kumar | Chennai , 27-Apr-2018 , Financial Express)
Google claims the method includes identifying the named entity, retrieving images associated with the
entity and performing face-detection on the retrieved images to detect faces in the retrieved images,
where a face detection was performed using a face-detection algorithm More...
India’s patent office is being too lenient on pharma patents

( Vikas Dandekar , 26-Apr-2018 , ET Prime)
Research shows the error rate in grant of pharma patents is as high as 72%. In many cases, patent
claims are made even without clinical-trial data. More...
Lionel Messi scores in trademark tussle in EU court

(Reuters , 26-Apr-2018 , The Indian Express)
Argentine football player Lionel Messi may register his name as a trademark for sports equipment and
clothing, the EU's second highest court said. More...
India may face pressure to cut duties on 90% of goods traded with China
RCEP is a comprehensive free trade agreement including goods, services, investment, competition and
intellectual property rights between the 10 ASEAN countries and its six free trade agreement partners-
Australia, China, India, Japan, Korea and New Zealand. More...
Killer jeans maker drags Levi’s to court over design infringement

(Maulik Vyas , 24-Apr-2018 , Livemint)
Kewal Kiran Clothing, the maker of ‘Killer’ jeans has taken Levi’s owner Levi Strauss (India) Pvt. Ltd to
court for the alleged infringement of its registered design More...
Court sides with human in copyright fight over monkey selfie

(AP | San Francisco , 24-Apr-2018 , The Indian Express)
A US appeals court on Monday favored humans over animals in a novel copyright lawsuit filed over a
series of entertaining selfies taken by a monkey with a toothy grin. More...
78% of drug patent grants in India for marginal improvements, says study
(Joe C Mathew New Delhi , 24-Apr-2018 , Business Today)
Majority of pharmaceutical drug patents granted by India might have skipped elaborate scrutiny, an
analysis of patent grants by a team of researchers and patent lawyers reveals. More...
India: Bihar earns 3 GI Tags for Agricultural Products - Katarni Rice, Zardalu Mango and
Magahi Paan
(SS Rana & Co , 24-Apr-2018 , Lexology)
On March 28, 2018, State of Bihar earned 3 exclusive Geographical Indication Tag for agricultural
products namely, Katarni Rice, Zardalu Mango and Magahi Paan. More...
Scissors, wet grinders and soap: GI tags you might not have known about
(Society , 24-Apr-2018 , The Hindu)
Here are some of the lesser known items that have bagged the GI tag recently More...
Now, only mangoes from Konkan to be called Hapus

(Eeshanpriya M S , 20-Apr-2018 , Hindustan Times)
The registry of GI, Mumbai, rejected individual applications filed by four producers of Alphonso mangoes
in Konkan to patent their produce as Hapus. More...
Indian Pharma Inc shifts to high gear in filing patents

(Nandita Vijay , 19-Apr-2018 , Pharmabiz)
Indian pharma is thinking beyond generics and is investing considerably in developing new drugs and
filing patents. More...
Cancellation of Monsanto’s patent over Bt cotton by Delhi HC: Ensuring agricultural security
(Ashok Jha , 19-Apr-2018 , Financial Express)
Interestingly, it was not only the seed companies of Andhra Pradesh, but almost all others, along with
the National Seeds Association of India, that backed this action. More...
GI tag for Allagadda stone carvings

(Special Correspondent , 18-Apr-2018 , The Hindu)
Allagadda, one of the important stone carving centres in Andhra Pradesh, has been issued Geographical
Indication (GI) registration certificate by the GI Registry, Chennai. More...
Adilabad Dokra and Warangal Durries get GI tag

(: FE Bureau | Hyderabad , 18-Apr-2018 , Financial Express)
The Technology Centre of CII has facilitated State Handicrafts Development Corporation towards the
registrations of Adilabad Dokra and Warangal Durries as Geographical Indications. More...
CNN wins trademark battle with Indian media firm
US cable and satellite television giant CNN has won a trademark battle with media firm GNN India
Limited after taking it to court for using a similar logo. More...
CNN wins trademark battle with Indian media firm

US cable and satellite television giant CNN has won a trademark battle with media firm GNN India
Limited after taking it to court for using a similar logo. More...
FICCI seeks amendment in Form 27 & patent law to facilitate commercialisation of patented
product & ease of doing business
(Laxmi Yadav, Mumbai , 16-Apr-2018 , Pharmabiz)
The Federation of Indian Chambers of Commerce and Industry (FICCI) has urged the patent office to
amend Form 27 and update Patent Rules in line with international best practices so as to befit emerging
technological fields, make commercialization of patented invention more easier and facilitate ease of
doing business. More...
NSE studying technical, legal aspects of SGX’s India futures

(Jayshree P. Upadhyay , 16-Apr-2018 , Livemint)
Bypassing the NSE ban, SGX has introduced new products India equity derivative products that mimic
the Nifty futures and options and use the closing Nifty price to settle the new contracts More...
India may move WTO if US denies preferential treatment to exports

India could approach the dispute settlement body of the World Trade Organization (WTO) if the US
denies it preferential benefits in retaliation for the barriers Washington claims its exports face here.
More...
U.S. wants patent form recall

( Vidya Krishnan , 14-Apr-2018 , The Hindu)
Submission on interpretation of a domestic patent law raises eyebrows More...
Bye bye, Bt cotton, indeed any GM crop

(Sunil Jain , 13-Apr-2018 , Financial Express)
Indeed, they will also impact patents by locals such as Deepak Pental whose GM mustard is awaiting
government approval —since Pental’s research was funded by the government-created National Dairy
Development Board that spearheaded India’s milk revolution, though, he may not be interested in a
patent. More...
The Delhi High Court order on patenting on GM traits is confidence-shattering

( Vivian Fernandes | New Delhi , 12-Apr-2018 , Financial Express)
In a setback to Mahyco Monsanto Biotech, a division bench of the Delhi High Court has held that it
cannot patent its genetically-modified Bollgard I and Bollgard II technologies and the Plant Breeders’
Rights Act will apply. More...
EU-India FTA: MSF raises concerns about IP provisions’ effect on generic medicines
(Teena Thacker , 12-Apr-2018 , Livemint)
A draft of the EU-India free trade pact pushes for proposals from the EU that would impose higher
standards of IP protection and enforcement on India than required by the WTO More...
Patent enforcement: Delhi High Court tosses Monsanto plea

(FE Bureau | New Delhi , 12-Apr-2018 , Financial Express)
The Delhi High Court on Wednesday disallowed a plea by American agricultural biotechnology giant
Monsanto to enforce its patent for its genetically modified (Bt) cotton seed varieties ‘Bollgard’ and the
widely used ‘Bollgard II’ in India. More...
Protect India's Generic Medicines and Patent Laws: MSF to the European Commission
(Aradhna Wal , 12-Apr-2018 , News18.com)
According to the MSF, the EU is proposing an ambitious enforcement mechanism for IP rights that will
drag to court even third party procurers of generic drugs, such as MSF itself that supplies affordable
drugs to low income countries around the world. More...
Delhi High Court dismisses Monsanto plea to enforce BT cotton seed patent
(Madhvi Sally , 11-Apr-2018 , The Economic Times)
The Delhi High Court on Wednesday said MonsantoNSE -1.16 % Technologies’ patents on Bt cotton seed
varieties Bollgard and Bollgard II were not valid and dismissed its claims against Nuziveedu Seeds on
this count, a finding that will likely have far-reaching consequences for the agriculture sector. More...
Pharma associations from India, America and Japan seek amendment to Sec 146 of Patents
Act for working of patents
Leading pharmaceutical organisations from India and abroad have sought amendment to Section 146 of
the Patents Act, 1970 to ensure that patent working disclosures under that section complement other
provisions of India’s patent laws and foster ongoing efforts to increase the ease of doing business in
India. More...
Patents and protecting public health

(Prabha Sridevan, Srividhya Ragavan , 10-Apr-2018 , The Hindu)
A new chapter on the access to medication debate in India began when Shamnad Basheer filed a public
interest litigation before the Delhi High Court. More...
Indian Pharmaceutical Alliance urges govt to effectively use patent law to safeguard public
health
The Indian Pharmaceutical Alliance (IPA), a representative body of 20 research-based pharmaceutical

companies in India, has called on the government to effectively use public health safeguards in Indian
Patents Act. More...
Delhi HC stops infringement of Patanjali trademark
(PTI , 08-Apr-2018 , The New Indian Express)
The Delhi High Court has restrained four ayurveda firms and a trust from manufacturing, selling or
advertising any goods or services bearing the mark or word 'Patanjali', the registered trademark of yoga
guru Ramdev's company. More...
Madhya Pradesh to get GI tag for Kadaknath chicken meat by July end
(Ankur Sirothia , 08-Apr-2018 , The Times Of India)
Madhya Pradesh is just a step away from getting the Geographical Indication (GI) tag for Kadaknath, the
all-black fowl reared by tribal communities. More...
Amazon's Prime, Echo hit trademark hurdles

(Digbijay Mishra , 7-Apr-2018 , The Times Of India)
Amazon is facing in India what Apple encountered in China - a trademark hurdle for its top brands.
More...
19 states implemented startup policies: Commerce ministr

(PTI , 06-Apr-2018 , The Times Of India)
As many as 19 state governments have implemented startup policies with a view to promote budding
entrepreneurs in the country, the commerce and industry ministry today said. More...
Indivior files patent lawsuits against Dr Reddy’s, others

( FE Bureau | Hyderabad , 06-Apr-2018 , Financial Express)
Indivior PLC said its US subsidiary Indivior Inc has filed patent lawsuits against Dr Reddy’s, Actavis, Par,
Alvogen and Teva for infringement of a US patent related to their respective proposed generic versions
of the company’s Suboxone sublingual film product. More...
Time to revive India-EU trade pact

( Prachi Priya and Ritesh Singh , 06-Apr-2018 , The Indian Express)
That explains India’s strong opposition to the proposal. Moreover, India doesn’t allow patenting of
incremental innovation in old drugs, often termed as ever-greening. Miffed by MNCs frequently serving
arbitration notices on India for hefty compensation, New Delhi’s model act on investment protection has
introduced several changes that are not to the liking of the European Commission, such as the removal
of MFN clause and narrower scope of national treatment or exclusion of tax disputes from the purview of
investment protection. More...
Patent experts call on govt to amend Form 27 for 'working of patents' more precise and
transparent
As per provisions of Patents Act, 1970, Form 27 is required to be filed by patentees, within three months
of calendar year to declare working of the patented invention granted in India. Form 27 requires to
declare if the patent is worked in India - whether manufactured in India or imported in India and if
imported, the country of origin, the quantity and the value of goods relating to the patented invention.
While for goods manufactured in India, normally the sales annual figures are declared, as regards
imports, the declared value is often vague and non-uniform. Value declaration can be free on board
(FOB) or cost insurance and freight (CIF) value or Landed value or very often, similar to manufactured
goods, the value of imports declared are also as gross domestic sales value or based on MRP. For both
manufactured in India as well as for imported into India, it is advisable that the figures declared in value
terms are better expressed in terms of gross sale value in Indian rupees, said patent expert Dr.
Gopakumar G. Nair. More...
Not short-term and not alone: Roche chief on India plan

(PT Jyothi Datta , 04-Apr-2018 , Business Line)
MNC drug-maker to tailor offerings to different pricing and tech needs of States More...
Chlorophile: No conflict between PPVFR Act & Patents Act

( Vivian Fernandes | New Delhi , 4-Apr-2018 , Financial Express)
Kumble Vinod Prabhu, who is at the helm of the Protection of Plant Varieties and Farmers’ Rights
Authority (PPVFRA), says that, in GM tech, a trait or an expression can’t be patented, but the GM
process, the resultant event and even the gene sequence may be patented. More...
Wood bank to solve raw material crunch for Kondapalli toymakers

The government will now set up wood banks to preserve this craft which has not only brought fame to
the state but also has a geographical indication. More...
Pendency of patent applications down to 1.72 lakh

(PTI , 02-Apr-2018 , The Economic Times)
Pendency of patent applications at the examination stage has come down to 1.72 lakh as of February
end this year on account of measures such as hiring of manpower and use of IT, the government said
today. More...
Innovate more, create patents in India: PM Modi to students at Hackathon

(Pankaj Doval , 30-Mar-2018 , The Times Of India)
Prime Minister Narendra Modi on Friday said that the “innovation quotient of nations” will determine
their progress and emphasised on the need for greater research and innovation in the country. More...
Govt not using patent law effectively: Pharma body

(TNN , 20-Mar-2018 , The Times Of India)
The Indian Pharmaceutical Alliance, an association of 20 top Indian pharma companies that account for
80% of the country’s exports and 46% of the domestic market, has submitted a report to the
government that says that public health safeguards in the patent law were not being used effectively.
More...
US company files case against Meerut hotel for trademark infringement; court orders FIR
(Ishita Bhatia , 20-Mar-2018 , The Times Of India)
A US-based multinational company, 7-Eleven – which operates a convenience store chain with 61,000
stores around the world – filed a case against a Meerut hotel running under the name ‘7-Eleven
Restaurant and Party Place’ with the same logo and mark in a local court here for trademark
infringement. More...
Govt not using patent law effectively: Pharma body

The Indian Pharmaceutical Alliance, an association of 20 top Indian pharma companies that account for
80% of the country’s exports and 46% of the domestic market, has submitted a report to the
government that says that public health safeguards in the patent law were not being used effectively.
More...
NPPA must balance access with innovation

(Ashish Bharadwaj , 20-Mar-2018 , Livemint)
The World Health Organisation (WHO) revealed last year that several countries that are poorer than
India allocated and disbursed significantly more funds to their health sectors. More...
View: How India can play the role of consensus builder at the high table of global trade
(ET CONTRIBUTORS , 19-Mar-2018 , The Economic Times)
The ‘mini-ministerial’ of over 25 leading trading nations gathering in New Delhi this week, at the
invitation of Union commerce and industry minister Suresh Prabhu, is supposed to find a way out of the
deadlock at the last ministerial meeting of the World Trade Organisation (WTO), held in Buenos Aires in
December 2017. More...
Madhya Pradesh loses GI tag claim for Basmati; India may ask Pakistan to check farming
(New Delhi , 19-Mar-2018 , Financial Express)
The Geographical Indication Registry has dismissed Madhya Pradesh's plea for its inclusion in the
Basmati growing region. More...
Bone of contention: Madhya Pradesh, Chhattisgarh at war over chicken breed Kadaknath
(PTI , 18-Mar-2018 , The Economic Times)
The two neighbouring states have filed applications with the Geographical Indication registry office in
Chennai to obtain the 'GI tag' for this black-winged chicken variety. More...
Notice to Bengal over GI tag for ‘Rosogolla’

(Staff Reporter , 18-Mar-2018 , The Hindu)
The Geographical Indication (GI) Registry has issued a notice to the West Bengal State Food Processing
and Horticulture Development Corporation, asking why the GI recognition given to ‘Banglar Rosogolla’
not be withdrawn. More...
Counterfeit market in India worth over Rs 40,000 crore: ASPA

(IANS , 18-Mar-2018 , Th Economic Times)
"We are going to make a very modern Intellectual Property Rights (IPR) era in India and that would lead
to creating people investing into the brand and that will lead to a knowledge economy which in turn will
make India a far better place and developed place," he said. More...
Amitabh Bachchan rails against 60-year copyright rule, calls it ‘rubbish’

(Indo Asian News Service, Mumbai , 17-Mar-2018 , Hindustan Times)
On his blog, Amitabh Bachchan questioned how individual property could become public property.
More...
Lack of requisite infrastructure and sponsorship hinder innovation in research in Indian
pharma industry: Ajay Bhargava
(Nandita Vijay, Bengaluru , 17-Mar-2018 , Pharmabiz)
Indian pharma industry despite being one of the fast-growing sectors lacks requisite infrastructure and
sponsorship, and these factors act as a hindrance for the innovators, said Ajay Bhargava, Partner,
Khaitan & Co. More...
Why it is in India’s Best Interests to have a Strong World Trade Organisation

(Prabhash Ranjan , 17-Mar-2018 , The Wire)
In other words, even if prices increase, there are regulatory tools available in the Indian patent law such
as issuance of compulsory licenses that could address this problem as it happened in the case of Natco v
Bayer. More...
Origiin IP Solutions sees opposition and revocation of patent important for pharma industry
(Nandita Vijay, Bengaluru , 17-Mar-2018 , The Pharmabiz)
Origiin IP Solutions sees that the opposition and revocation of a patent is of great significance for the
pharma industry. More...
Madhya Pradesh loses basmati war, fails to get GI tag

(A Subramani , 16-Mar-2018 , The Times Of India)
Madhya Pradesh’s bid to get geographical indication (GI) tag for its basmati rice and join an elite
‘basmati league’ failed, as the nation’s GI registry rejected its claim as being the original and unique
basmati growing region. More...
Textiles ministry pitches for GI tag for more Bengali sarees

(PTI , 16-Mar-2018 , The Hindu)
So far, only three types of sarees from West Bengal — Baluchari, Santipur and Dhaniakhali have
obtained the GI tags. More...
Intricacies in grant of life form patents explained

(THE HANS INDIA , 16-Mar-2018 , THE HANS INDIA)
The Chair Professor, MHRD, IPR Chair, National Law School of India University, Bengaluru, Prof T
Ramakrishna, highlighted the divergent facets, including copy right protection in the era of digitalisation
and trade mark protection under the aegis of Madrid protocol. More...
Time to explore the licence to make new TB drugs more accessible

(Leena Menghaney , 16-Mar-2018 , Business Line)
A ‘government use’ licence for bedaquiline and delamanid will encourage generic production and supply
to India’s TB Control Program while reserving them for public health use Getty Images More...
Plan for timely grant of patents in works: Prabhu

(PTI Feeds , 15-Mar-2018 , India.com)
Commerce and Industry Minister Suresh Prabhu today said he has directed the ministry to formulate a
plan to grant patents at the earliest. More...
Johnson & Johnson , Mylan propose ways to cut TB drugs prices in India
(Prabha Raghavan , 15-Mar-2018 , The Economic Times)
The talks coincide with increasing calls from health activists for India to grant compulsory licences for
delamanid and bedaquiline so that domestic companies can make generic versions of the potentially life-
saving drugs at much cheaper rates. More...
US pursues India at WTO, widening trade offensive’s Asia focus

(AFP , 15-Mar-2018 , Livemint)
US takes action at WTO against Indian export subsidies as Washington’s intensifying trade offensive
moved to encompass India and China. More...
Micromax to take global patent licence from Ericsson

( Gulveen Aulakh , ET Bureau , 14-Mar-2018 , The Economic Times)
Home-bred handset maker Micromax Informatics will take a global patent licence from Ericsson, under
which it will pay royalties to the Swedish telecom gear maker on every phone it sells in India and
overseas that uses 2G or 3G technology. More...
India's leadership in cost-efficient generics is unchallenged: Sanjiv Kaul

(Abhineet Kumar , 14-Mar-2018 , Business Standard)
Price erosion has been in excess of 15 per cent last year and will perhaps be at similar levels this year
due to sales channel consolidation, says Kaul More...
An urgent prescription
( K. Srinath Reddy & Shaktivel Selvaraj , 14-Mar-2018 , The Hindu)
Much of this growth took place after India opted for process patenting over product patenting in 1970.
More...
Government mulling giving patent registrations quickly, says Suresh Prabhu

( IANS | New Delhi , 13-Mar-2018 , Financial Express)
The Indian government will soon unveil a plan for issue of patent registrations in the shortest possible
time towards further streamlining the Intellectual Property Rights (IPR) regime in the country,
Commerce Minister Suresh Prabhu said on Tuesday. More...
Patient groups want faster approval for low cost generic TB drugs
(Joe C Mathew New Delhi , 13-Mar-2018 , Business Today)
In a joint letter, the health organisations, people living with HIV and the TB community in India and
across the world -- representing those affected by DR-TB -- wanted India to permit local production of
two new patented TB drugs by issuing a compulsory license 'on grounds of public non-commercial' use
to overcome the patent restrictions. More...
BT 3 cotton seeds banned by govt, so farmers now buying them online

(BS Web Team , 13-Mar-2018 , Business Standard)
Indian farmers have been planting Bollgard II variety till now whose yields have hit a plateau and the
government has not approved Bollgard 3 seeds yet More...
DIPP likely to dispose of 2 lakh pending patent applications in 2 yrs

(PTI , 12-Mar-2018 , The Times Of India)
The department of industrial policy and promotion (DIPP) is taking several steps including hiring more
manpower as it hopes to dispose of over 2 lakh pending patent applications in two years, an official
today said. More...
109 startups have received funding under Fund of Funds: Chaudhary

(PTI , 12-Mar-2018 , The Times Of India)
More than 100 startups in the country have received funding under the government's Fund of Funds
(FFS) corpus with catalysed investment of Rs 517.92 crore, Parliament was informed today. More...
Goldman Sachs issues notice to Jaipur-based Bitman Sachs for trademark violation
( Sachin Dave , ET Bureau , 10-Mar-2018 , The Economic Times)
Goldman Sachs has sent a notice to Jaipur-based Bitman Sachs, which runs a cryptocurrency exchange,
accusing it of infringing intellectual property rights and violating trademark norms owing to what the US
firm said were similarities in the name. More...
Donald Trump’s trade war may extend to IPR ‘violators’

(Asit Ranjan Mishra , 9-Mar-2018 , Livemint)
Though China is likely to be the main target of any IPR-related sanctions by the US, it may also spell
trouble for India More...
Price crash ahead? Key diabetes, cancer drugs to go off-patent in India

(Sohini Das | Ahmedabad , 07-Mar-2018 , Business Standard)
The development is likely to trigger launch of generic versions by Indian drug majors; this would be a
great relief to patients as prices might come down by 25% or so More...
Have an innovative idea? Get patent with help of Allinov

( lRathna K | Express News Service , 07-Mar-2018 , The New Indian Express)
Allinnov Research and Development, Mysuru, has several patents for its innovation products. More...
Torrent gets favourable order against Otsuka's patent application

(Gireesh Babu | Chennai , 7-Mar-2018 , Business Standard)
The order is latest among the several battles both the companies took on related to the drug
aripiprazole and its various forms More...
Cipla's U-turn: Happily ever after?

( Vikas Dandekar , 1-Mar-2018 , The Economic Times)
One of the most radical changes in the Indian pharma industry over the last decade has been the shift in
the go-to-market strategies of leading players. More...
US pharma concerns on IP rights and compulsory licensing in India

(28-Feb-2018 , The Pharma Letter)
Continuing its tirade against some developed and developing countries, the US drugmakers lobby group
Pharmaceutical Research and Manufacturers of America (PhRMA) has urged the office of the US Trade
Representative (USTR) to take immediate action to address serious market access and intellectual
property (IP) barriers in 19 overseas markets, including India, reports The Pharma Letter’s India
correspondent. More...
Two years on, IPAB Chennai Bench resumes hearing

(Sanjay Vijayakumar , 27-Feb-2018 , The Hindu)
After a gap of nearly two years, the Chennai bench of the Intellectual Property Appellate Board (IPAB)
has started hearing cases, much to the relief of the industry. More...
Ashok Leyland gets patent for tech to help improve fuel economy
(Sajan C Kumar , 17-Feb-2018 , Financial Express)
Hinduja flagship commercial vehicle major Ashok Leyland has been granted a patent for its invention
related to a technology for real-time road slope estimation, which could be used in predictive systems
for improving fuel economy of vehicles. More...
IIT Kharagpur law school starts cell to extend legal help

(Express News Service | Kolkata , 15-Feb-2018 , The Indian Express)
The cell will also provide assistance on cyber issues, in the protection of indigenous crafts, and other
areas where its expertise in intellectual property rights will be needed. More...
Delhi HC stays interim licence granted to internet firm to broadcast Saregama, T-Series music
(PTI , 14-Feb-2018 , The New Indian Express)
The Delhi High Court has put on hold the interim licence granted by the copyright office to an internet
broadcasting firm to communicate online the sound recordings of music labels Saregama and T-Series.
More...
US Trade Representative asked to place India on its priority watch list

(PTI , 14-Feb-2018 , Financial Express)
An American business advocacy group has asked US Trade Representative to continue to place India on
its priority watch list, alleging that there is strong evidence that New Delhi has not made sufficient
efforts to protect Intellectual Property Rights holders' interests. More...
Nepal logo relief for Darjeeling Tea

(Vivek Chhetri , 12-Feb-2018 , The Telegraph)
Nepal has decided to give a distinct trademark to its orthodox tea - a move that is expected to put an
end to the practice of the Nepal brew being passed off as Darjeeling Tea. More...
Agrochemicals leading patent activities for Agri sector: Study
(ANI , 09-Feb-2018 , The Hans India)
During 2014-2017, the India Patent Office received 5,448 patent applications from the agriculture
sector, majority of which were filed in the agrochemicals segment (biocides, pesticides, herbicides, pest
repellents), according to a recent Study conducted by Einfolge, a Patent and Market Research
Organisation. More...
A balancing act
(Vyshali Karthikeyan, Bengaluru , 9-Feb-2018 , The Hindu)
Indian patent laws have rightly been made stringent to avoid patents from lasting forever (“Biologics,
patents and drug prices”, Feb. 8) More...
Indivior files lawsuit against Dr Reddy’s for infringing on US patents

(FE Bureau | Hyderabad , 9-Feb-2018 , The Financial Express)
UK-based Indivior on Thursday said its US unit Indivior has filed lawsuits against Dr Reddy's
Laboratories, Actavis Generics, Par Pharmaceutical, Alvogen Pharmaceutical and Teva Pharmaceutical
Industries for infringing on US patents for the company's Suboxone sublingual film product. More...
Indian Pharmaceutical Alliance appeals to USTR to remove India from Priority Watch List
(Ramesh Shankar, Mumbai, , 9-Feb-2018 , Pharmabiz)
The Indian Pharmaceutical Alliance, which consists of 20 pharmaceutical companies which collectively
account for about 85 per cent of private sector investment on pharmaceutical research and development
in India, has appealed to the USTR to remove India from the USTR Priority Watch List. More...
India improves ranking in US Chamber's intellectual property index

(Joe C Mathew New Delhi , 08-Feb-2018 , Business Today)
A US lobby group which ranks countries on the basis of its intellectual property friendliness to innovation
based global corporations has improved India's position in its current year's ranking. More...
IP reforms not enough to push India out of US’ watch list

( Kirtika Suneja , 08-Feb-2018 , The Economic Times)
India's reforms to reduce patent pendency and expedite trademark backlogs are unlikely to steer it out
of the US' Priority Watch List even this year as legacy issues of compulsory licensing and curbs on patent
eligibility weigh heavily on its intellectual property regime, a senior official of the US Chamber of
Commerce said. More...
‘Copyright is a tool for movie producers’

(TNN , 9-Feb-2018 , The Times Of India)
Three popular local cable TV channels in Tirupur were recently booked for telecasting new movies
without obtaining rights. More...
Biologics, patents and drug prices

( Feroz Ali & Sudarsan Rajagopal , 8-Feb-2018 , The Hindu)
India’s rejection of secondary patents has kept blockbuster medicines affordable for many More...
‘India’s IPR policy will drive a new focus on empowering domestic innovators’
(Nayanima Basu , 07-Feb-2018 , Business Line)
Issues like curbs on patent eligibility, compulsory licensing need to be addressed: Global Innovation
Policy Centre’s V-P More...
Goa needs IPR panel, says expert

Goa will benefit from an intellectual property rights (IPR) facilitation centre in order to protect
intellectual property of people in the state, said T Ramakrishna, professor of law and chair (IPR),
National Law School of India University, Bengaluru. More...
'Shikari Shambu' copyright: Amar Chitra Katha moves Bombay High Court against Kerala
producer
(PTI , 7-Feb-2018 , The New Indian Express)
Publishing house Amar Chitra Katha (ACK) has filed a suit in the Bombay High Court against a Kerala-
based film producer for allegedly infringing the name of its famous storybook character "Shikari
Shambu" without permission. More...
Issue of investment allowance, weighted deduction unaddressed in Budget 2018: Experts

(Nandita Vijay, Bengaluru, , 7-Feb-2018 , Pharmabiz)
Another ask by the industry was in relation to patent box regime. More...
Rasagola battle in Orissa HC

( Correspondent , 06-Feb-2018 , The Hindu)
Petitioners urge court to direct State to stake claim to GI tag More...
Patents filings prove Indian start-ups are no longer copycats

(Rajesh Kurup , 06-Feb-2018 , Business Line)
Firms with patent plans have a better chance of getting funds, say analysts More...
‘Easy availability of antibiotics led to India’s TB epidemic’

(Gauree Malkarnekar , 3-Feb-2018 , The Times Of India)
India made a big mistake in making antibiotics freely available over the counter. This allowed antibiotics
overuse, leading to rising cases of drug-resistant tuberculosis in India, 1993 Nobel laureate Richard J
Roberts said here. More...
Make pharmaceutical patents work in the public interest

(Shamnad Basheer , 02-Feb-2018 , Business Line)
A Delhi High Court case shines a light on why public disclosure on working a patent is critical for
compulsory licensing and public health More...
Delhi court upholds Daiichi Sankyo claim on ex-Ranbaxy owners
(AKIRA HAYAKAWA, Nikkei staff writer , 2-Feb-2018 , Asian Review)
The Japanese drugmaker awarded $550m in damages More...
CBI books senior patent official, predecessor for demanding bribe

(Siddharth Prabhakar , 01-Feb-2018 , The Times Of India)
The anti-corruption branch of the CBI has booked a senior official in the Chennai office of Controller
General of Patents, Designs and Trade Marks and his predecessor for demanding bribes to give patents
to a private company. More...
Samsung sliding phone revealed in a new patent

(Staff , 01-Feb-2018 , BGR India)
But it’s not the usual sliding phone you’d instinctively think of! More...
McDonald’s plea against NCLT show cause premature, observes Delhi HC

(PTI , 01-Feb-2018 , Livemint)
McDonald’s India had asked CPRL not to use its brand system, trademark, designs and associated
intellectual property among other things, within 15 days of the termination notice. More...
India takes five years to look at patent applications, reveals economic survey
(Snehal Fernandes , 30-Jan-2018 , The Hindustan Times)
During financial year 2016-2017, there were only 132 examiners for all patent applications across the
country. More...
US copyright board boosts songwriters’ music streaming fees

(AP | San Francisco , 29-Jan-2018 , The Indian Express)
The US' National Music Publishers Association have raise the royalty fees that music streaming services
will have to pay publishers, songwriters and artists for every song. More...
Omkar Speciality receives patent for process of Alkali Metal Iodide products
( Business Economy , 29-Jan-2018 , United News Of India)
Omkar Speciality Chemicals one of the leading players in the manufacturing of Speciality Chemicals and
Veterinary APIs said that company has been granted patent by Intellectual Property India, The
Government of India Patent Office, for Alkali Metal Iodide products. More...
Sugarcane vinegar process gets PAU patent

(TNN , 25-Jan-2018 , The Times Of India)
Punjab Agricultural University (PAU) has been granted patent on "A fermentation process for preparation
of concentrated sugarcane vinegar" by the Indian Patent Office, government of India, New Delhi. More...
Patanjali accuses Kalpamrit Ayurveda of copyright violations, drags Ramdev's ex-partner to

Delhi HC
(Rasul Bailay , 25-Jan-2018 , The Economic Times)
In a Baba versus Baba case, Baba Ramdev's Patanjali Ayurved has dragged a firm launched by his
former partner Swami Karamveer to Delhi High Court for allegedly violating its trademark and
copyrights. More...
KAU bid to get patent for fertiliser from human hair

(Shafeeq Alingal | Express News Service , 24-Jan-2018 , The New Indian Express)
In a recent development, the KAU approached the Inter University Centre for Intellectual Property Rights
Studies of Cusat seeking steps to get patent for the product. More...
LG patent shows foldable phone that turns into a tablet

( Tech Desk | New Delhi , 23-Jan-2018 , The Indian Express)
LG's patent shows a device similar to a book that can be opened and closed, transforming the phone into
a tablet. More...
US appeals court upholds ruling invalidating Johnson & Johnson patent on arthritis drug
(Reuters , 23-Jan-2018 , CNBC)
An appeals court affirmed a previous ruling that a Johnson & Johnson patent covering the active
ingredient in Remicade was invalid because it was based on an obvious concept. More...
Karnataka’s only technological varsity earns no patent in 19 yrs

(Rashmi Belur , 20-Jan-2018 , The New Indian Express)
It has been 19 years since its inception, and the earnings of Visvesvaraya Technological University
(VTU), Belagavi, Karnataka, has remained zero. More...
Bars beware! Some famous cocktails are trademarked

(Suresh Kumar , 19-Jan-2018 , The Times Of India)
We might have heard people fond of cocktails saying, "One cannot buy happiness, but can make a
cocktail, and that's kind of same thing." But have you ever wondered that even such cocktails are
protected under trademark rights and infringing them might cost a fortune? More...
Patent suit: Sun Pharma reaches settlement with Ironwood Pharmaceuticals and Allergan
Sun Pharma announced its wholly owned subsidiaries have reached an agreement with Ironwood
Pharmaceuticals and Allergan to resolve the patent litigation regarding submission of an Abbreviated
New Drug Application (ANDA) for a generic version of Linzess (Linaclotide capsules) in the US. More...
Start-ups likely to create 5 lakh jobs

(Special Correspondent , 18-Jan-2018 , The Hindu)
Government-aided industries must purchase at least 10% of their requirements from start-ups. Besides,
100% reimbursement of stamp and registration duty in the first phase and 50% in the second,
concession of up to Rs. 2 lakh for an Indian patent and Rs. 10 lakh for an international patent,
government reimbursement of up to 80% of the amount spent on quality testing, and payment of SGST
from the State government, are other features. More...
Sun Pharma will be watched after settling patent litigation for generic
(Capital Market , 17-Jan-2018 , Business Standard)
Sun Pharmaceutical Industries announced that its wholly-owned subsidiaries have reached an
agreement with Ironwood Pharmaceuticals, Inc. and Allergan plc (together known as the companies) to
resolve the patent litigation regarding submission of an Abbreviated New Drug Application (ANDA) for a
generic version of Linzess (Linaclotide capsules) in the US. More...
‘Fake’ council case: Patna HC dismisses CBI plea

A division bench of the Patna high court on Tuesday upheld the single bench order to the CBI to
investigate into the allegations against a fake institution named Medical Council of Patent Medicine of
Bhojpur. More...
‘Expect India’s rank to improve in global IP index’

(PTI , 16-Jan-2018 , The Hindu Business Line)
India’s rank may improve in the international intellectual property index this year with the introduction
of national IPR policy adding to its systemic efficiency, a top official at the Global Innovation Policy
Center said today. More...
In 19 years, Visvesvaraya Technological University earns nothing from patents

( Rashmi Belur | Express News Service , 16-Jan-2018 , The New Indian Express)
It has been 19 years, and the Visvesvaraya Technological University (VTU), Belagavi, the only Technical
University of the state, has not earned a single rupee from patents since its inception. More...
Brief case: Test for foreign trademarks, Tisco claims river water, and more
(M J Antony , 15-Jan-2018 , Business Standard)
Territorial test for foreign trademarks More...
LG trademarks ‘Icon’ smartphone and ‘Iconic’ smartwatch, could launch in 2019

(Tech Desk | New Delhi , 14-Jan-2018 , The Indian Express)
The Icon and Iconic could be part of LG's next-generation of devices, as the South Korean company
trademarked several new names with the United States Patent and Trademark Office (USPTO). More...
GI tag for ‘Gulbarga Tur Dal’ in a month

(Staff Reporter , 10-Jan-2018 , The Hindu)
The Kalaburagi red gram, “Gulbarga Tur Dal”, which is known internationally for its superior quality, will
soon be added to the list of Karnataka producers with the Geographical Indication (GI) tag. More...
India 2nd largest contributor to IBM's over 9,000 patents in 2017

(PTI , 09-Jan-2018 , The Economic Times)
Tech giant IBM today said it received 9,043 patents in 2017, with India accounting for over 800 patents
making the country the second highest contributor to the record tally. More...
Want to Protect Your Invention? Here’s All You Need to Know About Getting a Patent in India
(LawRato , 09-Jan-2018 , The Better India)
A patent is a legal protection given to a person so that the invention can be made available to the public.
More...
Family contests GI tag for Aranmula mirror, says their formula was leaked
(Shenoy Karun | TNN , 4-Jan-2018 , The Times Of India)
The geographical indication (GI) of Aranmula mirror — the first product from Kerala to receive the tag in
2005 — has been contested by a family that claims to have developed its technology. More...
Pfizer’s patent for children’s pneumonia vaccine challenged in India

(The ID Staff , 4-Jan-2018 , Indus Dictum )
India’s High Court in Delhi has moved to February 2018 the final decision on allowing Pfizer to be the
only pharmaceutical company selling pneumococcal conjugate vaccine (PCV 13) to the Indian
government, a plan that was contested by ‘Doctors without Borders’, an international humanitarian
group providing medical aid. More...
Kerala sees bright future in GI tagging

(Shenoy Karun | TNN , 4-Jan-2018 , The Times Of India)
Kerala has great potential in GI tagging agricultural and manufactured products. More...
Indian pharma will continue to stare at single digit growth: ICRA

(DIVYA RAJAGOPAL , 03-Jan-2018 , The Economic Times)
The growth trajectory for Indian pharmaceutical industry is likely to be moderate on back of slowing
growth from US given the relatively moderate proportion of large size drugs going off patent, increased
competition leading to price erosion in low-to--mid-teens, generic adoption reaching saturation levels
and, regulatory overhang along with base effect catching up, rating agency wrote in its research report.
More...
Dip in pharma exports due to shifting of manufacturing bases, market consolidation:

Government
Shifting of manufacturing bases to overseas markets by certain domestic companies and absence of
blockbuster drugs going off-patent are some of reasons for dip in India's pharmaceutical exports,
Parliament was informed today. More...
First for forest produce, GI tag for Nilambur teak

(T Ramavarman , 1-Jan-2018 , The Times Of India)
Nilambur teak, known internationally for its superior timber quality and appearance has been accorded
the Geographical Indication (GI) status by the GI registry, Chennai. More...
Protect the marketplace of ideas

(30-Dec-2017 , The New Indian Express)
A group of journalists recently moved the Bombay High Court against an order by a CBI court last
month, which barred the media from reporting on the trial in the Sohrabuddin Sheikh encounter case.
More...
Indian pharma sees traction in novel biologics

(Sohini Das | Ahmedabad , 28-Dec-2017 , Business Standard)
Saldanha said, “Today, we have seven novel drugs and three specialty drugs in our research and
development pipeline, and the company enjoys a strong position in IP (intellectual property) leadership
and global footprint for rapid market penetration.” More...
2.32 lakh patent applications pending with patent office

Over 2.32 lakh patent applications were pending with the Indian Patent Office as on November 30,
How India rejects bad patents

( Feroz Ali & Sudarsan Rajagopal , 26-Dec-2017 , The Hindu)
In 2005, India made some remarkable amendments to the Indian Patents Act of 1970, to keep
medicines affordable in the country. More...
India, South Korea may hold joint IPRs through trade pact
( Kirtika Suneja , ET Bureau , 26-Dec-2017 , The Economic Times)
With South Korean companies establishing themselves as big players in India, the two countries plan to
jointly hold intellectual property rights (IPRs) in areas of manufacturing, energy and healthcare. More...
Uttarakhand to apply for patent of wonder herb after DRDO unit validates medicinal
properties
(Seema Sharma , 25-Dec-2017 , The Times Of India)
Uttarakhand government has decided to apply for intellectual property rights (IPR) of wonder herb,
Kasani (cichorium intybus), after Defence Institute of Bio-Energy Research (DIBER), a unit of the DRDO,
scientifically corroborated medicinal properties of the plant which is believed to be helpful in treatment
of diabetes, asthma, blood pressure, liver and kidney diseases. More...
Fooya! founder in patent war over digital vaccine with US pharma giant
(Press Trust of India , 25-Dec-2017 , Business Line)
Fooya! founder and inventor of ‘digital vaccine’ technology Bhargav Sri Prakash has run into a trademark
war with $5-billion pharma giant Moderna Therapeutics. More...
Morepen gets US FDA marketing clearance for its bulk drug montelukast sodium
(Our Bureau, Mumbai , 20-Dec-2017 , Pharmabiz)
Morepen Laboratories, a Rs.580 crore plus pharma major, has received marketing authorisation from US
FDA for a bulk drug/API montelukast sodium. This gives Morepen an entry into the Rs.2,000 crore US
market for montelukast. More...
Mylan, Natco take early lead with enhanced safety profile generic drug for Hepatitis B
( E Kumar Sharma New Delhi , 19-Dec-2017 , Business Today)
Two companies, one a global major, Mylan and the other, Hyderabad-headquartered niche pharma
product-maker Natco Pharma, have taken an early lead in launching generic version of Tenofovir
Alafenamide, TAF, 25 mg, a once-daily tablet for the treatment of chronic hepatitis B in adults. More...
SC rejects Toyota plea for ‘Prius’ trademark

(Dhananjay Mahapatra , 19-Dec-2017 , The Times Of India)
Japanese automobile major Toyota lost a legal battle in the Supreme Court for exclusive trademark
rights over 'Prius', the name under which it had launched its first mass produced hybrid car in Japan in
1997 and in the UK, Australia and the US in 2000-2001. More...
Natco Pharma launches Hepatitis B medicine

(THE HANS INDIA , 18-Dec-2017 , THE HANS INDIA )
Natco Pharma has launched a generic version of Tenofovir Alafenamide, a drug used for treating chronic
Hepatitis B. More...
Indian drugmakers making inroads into new CNS treatments

(18-Dec-2017 , The Pharma Letter)
The patents are valid through 2029 and 2033 respectively. More...
Kamat Hotels (India) wins the trade mark case against ROHL
(P Krishna Kumar , 15-Dec-2017 , BizIndia.com)
In a major legal victory for Kamat Hotels (India) Ltd., and a loss of face for the Royal Orchid Hotels
Limited (ROHL) in a long drawn legal battle, the Supreme Court today while disposing of a Special Leave
Petition (SLP) filed by ROHL has upheld the Madras High Court order of February 11, 2015 restraining
them from using the trade mark/logo which is same or similar to that of ‘Orchid’, a brand promoted by
Kamat Hotels. More...
No Relief For Toyota From Supreme Court In The Prius Matter.

( Adheesh Nargolkar, Shailendra Bhandare and Sourav Dan , 14-Dec-2017 , Mondaq)
the Supreme Court of India (Supreme Court) has affirmed the order of the Division Bench of the Delhi
High Court (Division Bench) permitting the use of the mark PRIUS by Prius Auto. More...
India seeks global checks on patenting neem, yoga

(Sidhartha | TNN , 13-Dec-2017 , The Times Of India)
The government on Wednesday moved in to check patenting of products using genetic resources such as
neem, haldi, aamla or even bhaang, as well as illegal rights over traditional knowledge such as yoga and
ayurveda. More...
GI tag plea reaches Chennai

(Anwesha Ambaly , 12-Dec-2017 , The Telegraph)
A religious outfit from the state on Monday reached Chennai to seek the geographical indication (GI) tag
for the Jagannath Rasagolla. More...
Suven gets product patent for cognitive disorders
(PTI , 11-Dec-2017 , Business Line)
Suven Life Sciences has secured a product patent each from India and the US for the treatment of
disorders associated with neurodegenerative diseases. More...
Automakers, seeking Silicon Valley tech in vehicle systems, land in patent wars
(Bloomberg , 08-Dec-2017 , The Indian Express)
Top automakers are now entering patent battles, as they try to enable their vehicles with cutting-edge
technology features being provided by Silicon Valley companies. More...
After Rosogolla, Bengal plans GI tags for Kalonunia, Randhunipagal rice

(Sutanuka Ghosal , 08-Dec-2017 , The Economic Times)
Close on the heels of getting GI ( geographical indication) for Rosogolla, West Bengal government is all
geared up to apply for tags for Kalonunia and Randhunipagal varieties of rice More...
WTO meet in Buenos Aires a litmus test for Suresh Prabhu

(D. Ravi Kanth , 8-Dec-2017 , Livemint)
Much would depend on how commerce minister Suresh Prabhu forcefully articulates India’s positions
during the closed-door meetings in Buenos Aires More...
Precision medicine: Zuckerberg backs Indian-origin scientist with formula to jolt drug market
( Ananya Borgohain , ET Onlin , 07-Dec-2017 , The Economic Times)
Butte says that several of the drug candidates are going through the patent process at present. More...
Suven gets product patent from Eurasia, Norwa

(06-Dec-2017 , Business Line)
Suven Life Sciences has secured a product patent each from Eurasia and Norway for the treatment of
disorders associated with neurodegenerative diseases. More...
India to flood the US market with generic HIV medication

(Ari Altstedter , 05-Dec-2017 , BusinessDay)
Among the coconut plantations and beaches of South India, a factory the size of 35 football fields is
preparing to churn out billions of generic pills for HIV patients and flood the US market with the low-cost
copycat medicines. More...
Osho: Can the name of an India-born spiritual guru become a European trademark?
(Abhay Vaidya , 05-Dec-2017 , Hindustan Times)
‘OSHO’ brand ruling in a European court has split the worldwide followers of the India-born spiritual guru
once again. More...
FDA approves Mylan/Biocon Herceptin biosimilar

(05-Dec-2017 , Pharmaphorum)
The FDA has approved Mylan and Biocon’s biosimilar of Roche’s Herceptin (trastuzumab) breast cancer
drug after a delay because of manufacturing issues. More...
No patent for yoga means world has gained from it: Suresh Prabhu
Cautioning against knowledge being the exclusive preserve of a few, Union Commerce Minister Suresh
Prabhu today made the point that yoga benefits the whole world since the practice has not been
patented. More...
In race for Basmati GI tag, Telugu states not in picture

(U Sudhakar Reddy , 4-Dec-2017 , The Times Of India)
After awarding Geographical Indication (GI) tag for rosogolla to West Bengal, the Geographical
Indication Registry in Chennai has decided to deliver a verdict in the next 15 days on Madhya Pradesh's
claim for inclusion of certain districts in the Basmati rice GI tag. More...
Media licensing, Intellectual Property Rights: Experts bat for ‘clearer picture’
(ANI , 03-Dec-2017 , The New Indian Express)
Deliberations on protection and licensing laws in the field of Intellectual Property Rights (IPR) in India
and initiatives required by the government to address the problems being faced by content producers
were held at a one-day workshop on ‘Innovation, Intellectual Property and Role of Licensing: A
Technology Driven Initiative towards Make in India.' More...
GI Joynagarer Moa to make its debut in city malls in December

(Monotosh Chakraborty , 29-Nov-2017 , The Times Of India)
Years have passed since the quintessential winter delicacy of Bengal, Joynagarer Moa, won the coveted
geographical indication tag. More...
India: IPR Exchange India: A Business Case For IPR

(Monika Shailesh Singh & Associates , 28-Nov-2017 , mondaq)
Intellectual property is the outcome of human genius, creativity and the power of imagination. IP relates
to inventions, new designs, brands and artistic works. More...
From food to crop, Karnataka tops GI table with 39 products

(ManuAiyappa Kanathanda , 28-Nov-2017 , The Times Of India)
Karnataka leads the list of states that have claimed geographical indications for products, with 39
tagged items, ranging from Mysore silk and Dharwad pedha to Coorg green cardamom and Appemidi
mango. More...
Balancing patents and drug prices

(Ashish Bharadwaj , 27-Nov-2017 , Livemint)
We must achieve a balance between the current and future needs of patients and the timely introduction
of existing and new pharmaceutical drugs. More...
Locked out, without a GI tag
(Jupi Gogoi , 27-Nov-2017 , The Hindu)
he law of Geographical Indications (GIs) is linked to the terroir, that is the quality of a product is
essentially attributable to the territory where the product originates from. GIs support local production
and are an important economic tool for the uplift of rural and tribal communities. More...
Here's a list of India's geographical indication tagged products

( G Seetharaman, ET Bureau , 26-Nov-2017 , The Economic Times)
A geographical indication (GI) map of India, from the moirang phee of Manipur to the blue pottery of
Rajasthan, from Pochampalli ikat to the papier-mâché of Kashmir. More...
West Bengal rural polls: Clad in trademark sari, ‘Mamata’ takes to stage
(Ravik Bhattacharya | Kolkata , 25-Nov-2017 , The Indian Express)
We also have an actor playing Narendra Modi,” said Samanta More...
India's mindset that sees global trade as threat is a hurdle for US cos: GIPC
(Patrick Kilbride, Vice-President, International Intellectual Property at GIPC , 20-Nov-2017 ,
moneycontrol.com)
Global Intellectual Property Center (GIPC), a part of US Chamber of Commerce, the trade lobby group of
US which advocates for implementation of strong intellectual property (IP) standards globally, recently
said it sees a protectionist mindset among Indian political leadership and inadequate enforcement of
which hampers the growth of Indo-US trade. More...
India: Unmerited Pfizer patent on pneumonia vaccine limits access for children
(Médecins Sans Frontières , 20-Nov-2017)
Pfizer does not deserve the patent it was granted in August on its pneumonia vaccine, said Médecins
Sans Frontières (MSF). MSF is set to argue tomorrow in the High Court of Delhi, India that it should be
overturned because the patent doesn’t meet the standards laid out in India’s Patents Act. More...
Facebook seeks India patent intelligently augmenting electronic messages

(Gireesh Babu | Chennai , 16-Nov-2017 , Business Standard)
In a patent application the company claims that the invention is related to electronic communications
More...
Odisha govt wakes up to GI tag for Kandhamal turmeric

( Odisha Sun Times Bureau , 16-Nov-2017 , Odisha Sun Times)
Odisha government is planning to apply for geographical indication (GI) tag status for ‘Kandhamal
Haladi’ (turmeric). More...
Suven gets patents on neurological molecule

(THE HANS INDIA , 16-Nov-2017 , THE HANS INDIA)
Suven Life Sciences has been granted a patent each from Hong Kong and the US and two from India for
treatment of disorders associated with neurodegenerative diseases. More...
Suven shares gain 4% after getting patents from HK, India, US
Suven Life Sciences today ended 4 per cent higher, following which the market capitalisation of the
company improved by Rs 94 crore after announcement of receiving patents from Hong Kong, India, the
US on neurological molecule. More...
Now, Odisha to move Geographical Indication registry seeking tag for Rasagola
(PTI | Bhubaneswar , 15-Nov-2017 , The Indian Express)
While West Bengal government claimed that it was invented in the state by Nabin Chandra Das in 1868,
Odisha claimed the sweet was first served at the 12th-century Lord Jagannath temple in Puri. More...
India, EU hold discussions on proposed free trade agreement

Senior officials of India and European Union (EU) today held discussions on the long-stalled free trade
pact and expressed willingness to address issues in a time-bound manner, the department of commerce
said today. More...
With GI tag, Bengal retains rosogulla: Here’s why Odisha may not be happ
(Nandini Rathi | New Delhi , 14-Nov-2017 , The Indian Express)
Many food historians, such as Chitrita Banerjee, have corroborated the fact that prior to the 18th
century, there is no documented evidence of chhena anywhere in India. More...
DRL launches anti-cancer drug in US market

(PTI , 14-Nov-2017 , The New Indian Express)
Clolar is a registered trademark of Genzyme Corporation, it said. More...
Troikaa-Novartis Diclofenac row: Govt seeks panel’s report in 15 days

(Teena Thacker , 10-Nov-2017 , Livemint)
Troikaa has alleged that Themis Medicare manufactured a version of 75ml Diclofenac injection with 1ml
Transcutol to avoid infringement of Troikaa’s patent. More...
Anna University to host India's 2nd tech and innovation centre

(Ranjani Ayyar , 10-Nov-2017 , The Times Of India)
A vaccine for filariasis, a footboard accident prevention system and a microgripper to be used in nuclear
research -these are just a few among the many patents that are filed through the Centre for Intellectual
Property Rights, Anna University . More...
K&S Partners sees grant of patent can directly affect access to life-saving medicines
(Nandita Vijay, Bengaluru , 10-Nov-2017 , Pharmabiz)
K&S Partners, the Intellectual Property Attorneys, is of the view that the grant of a patent can directly
affect access to life-saving medicines. More...
DIPP inks pact with Anna University to set up tech support centre
( PTI , 08-Nov-2017 , The New Indian Express)
The Department of Industrial Policy and Promotion (DIPP) today said it has signed an agreement with
Anna University to set up a Technology and Innovation Support Center (TISC) in Chennai. More...
US price-fixing case: Indian drug companies can ill afford this reputation dent
(PT Jyothi Datta , 08-Nov-2017 , Business Line)
It looks worse than it actually is in a business sense,” says Mark Pohl, an attorney with Pharmaceutical
Patent Attorneys (New Jersey), a law firm that represents drug-makers. More...
Pharma industry faces hypocrisy charge over patents

(David Crow in New York , 1-Nov-2017 , The Financial Times)
When Allergan transferred patents protecting a $1.5bn eye drug to a Native American tribe last month in
an attempt to shield the medicine from generic rivals, the drugmaker enlisted one of the main industry
lobby groups to quell the howls of protest from patients and politicians. More...
Pfizer expects broad interest for consumer health business

(Reuters , 31-Oct-2017 , The Times of India)
Supply problems related to sterile injectable products acquired in Pfizer's purchase of Hospira, along
with steep declines in sales of off-patent products, contributed to an 11 percent drop in third quarter
revenue from the Essential Health unit to $5.05 billion. More...
Innovative breast cancer early warning system developed by Chennai firm

( IANS , 31-Oct-2017 , The New Indian Express)
llumina 360, a robot-assisted breast cancer early warning system developed by a city-based medical
technology firm, can help in early detection of tumours through thermal imaging and be a boon in
tackling the disease that is fast spreading in India, an official said. More...
AHF: Big Pharma Must Slash Exorbitant Sofosbuvir Prices for Hep C Patients
(31-Oct-2017 , Business Wire)
On the eve of the World Hepatitis Summit 2017 in Sao Paulo, AIDS Healthcare Foundation (AHF)
demands that Gilead lower the price of its lifesaving drug Sofosbuvir, an essential treatment for patients
living with hepatitis C virus (HCV). More...
Patent office takes one more step towards being transparent and user friendly
(RNA IP Attorneys , 31-Oct-2017 , Lexology)
The Indian Patent Office will now publish in the weekly journal information about list of patent
applications for which First Examination Report (FER) has been issued. More...
Rayagada seeks GI tag for Dongria shawl

(Express News Service , 31-Oct-2017 , The New Indian Express)
Rayagada district administration will seek help of the Handloom, Science and Technology departments to
get geographical indication (GI) tag for Kapdaganda, the prestigious shawl of Dongria Kondh tribe.
More...
Cancer-drug setback sends Merck shares down again

(Lewis Krauskopf , 30-Oct-2017 , The Times Of India)
The drugmaker said that the cost of a June cyber attack that temporarily crippled manufacturing coupled
with lower sales of off-patent products caused its third-quarter revenue to fall 2 percent to $10.33
billion, even as Keytruda sales topped $1 billion for the first time. More...
Khadi trademark: Why Modi govt is so worried about protecting this IP

(Carol Goyal & Sandeep Goyal , 30-Oct-2017 , Business Standard)
In recent days, the use of the KHADI trademark by a German company Khadi Naturprodukte GbR has
got the Indian government very worried More...
Health ministry can invoke provision of Patent Act to reduce cost of procurement of Prevnar
13 under UIP: says Dr Nair
(Laxmi Yadav, Mumbai , 30-Oct-2017 , Pharmabiz)
Even though the Indian patent office has granted Pfizer a patent for Prevnar 13 pneumonia vaccine
making it unaffordable for many, the Union health ministry can invoke government use provision under
section 100 and 101 of Patent Act to designate an Indian vaccine manufacturer to manufacture the life
saving vaccine exclusively for government use which will be distributed through government channel,
said noted patent expert Dr Gopakumar G Nair. More...
Govt moves to finalize methodology to fix prices of new drugs

(Teena Thacker , 30-Oct-2017 , Livemint)
The government is considering doing away with the present practice of deciding a new price for each
applicant of ‘new drug’ More...
ICMR releases Handbook on IPR & Technology Transfer to step up awareness among
scientists
(Ramesh Shankar, Mumbai , 30-Oct-2017 , Pharmabiz)
The Indian Council of Medical Research (ICMR) has released the Handbook on Intellectual Property
Rights & Technology Transfer which will help increase awareness among ICMR scientists to help them
protect all new knowledge before publication. More...
Pneumonia vaccine case traces the fine line on public health

(PT Jyothi Datta , 27-Oct-2017 , Business Line)
The legal battle that brews over Pfizer’s pneumococcal vaccine in India is set to create a benchmark of
sorts for vaccines in the arena of public health. More...
At testy trade meet, US presses India on imbalance, wants more market access
(Yashwant Raj Hindustan Times, Washington , 27-Oct-2017 , Hindustan Times)
Both sides paint different picture of meeting, with delegation led by Suresh Prabhu calling the interaction
positive while the Americans said their side “expressed concerns” More...
India-US lock horns on market access, H-1B visas at trade forum
(Asit Ranjan Mishra , 27-Oct-2017 , Livemint)
The issues of IP rights, prices of medical devices and India-US trade deficit also came to the fore during
the 11th US-India trade policy forum in Washington Thursday More...
Govt initiatives & MCI norms along with patent expiry & affordability would propel sale of
generic drugs in India: Prof Mohan
(Nandita Vijay, Bengaluru , 27-Oct-2017 , Pharmabiz)
From Union government initiatives, Medical Council of India (MCI) norms to patent expiry and
affordability are all expected to spur the prescriptions of generic drugs in the country, said Prof S Mohan,
director, PES College of Pharmacy. More...
Nobody has patent over romance genre: Irrfan K

( PTI , 26-Oct-2017 , The New Indian Express)
Actor Irrfan Khan has said that he always wanted to explore the romance genre which he believes is not
a "patented" property of any actor. More...
Nagaland gets patent rights for Naga King Chilli

(Manash Pratim Gohain , 25-Oct-2017 , The Times Of India)
The Nagaland government has finally won the patent rights for the "Naga King Chilli. More...
Trump admin urged to press India on IP protection,market

(PTI , 25-Oct-2017 , The New Indian Express)
Ahead of the India-US Trade Policy Forum meeting, an influential business advocacy group today asked
the Trump Administration to press India to address issues that limit market access or undermine the
competitiveness of US industries. More...
'India, EU not considering scaled-down version of trade pact'

(Special Correspondent , 25-Oct-2017 , The Hindu)
Even as India and the European Union (EU) are yet to finalise a date for re-launching their Free Trade
Agreement (FTA) negotiations stalled since 2013, both the sides are not considering inking a scaled
down version of the pact with a view to somehow expedite the conclusion of the talks by lowering
ambition, according to an EU official. More...
Government ensured Monsanto business came to a halt and illegal copies of its seed have
flooded market
( Sunil Jain , 24-Oct-2017 , The Financial Express)
Since Monsanto had told GEAC of illegal seeds over a decade ago, but no action was taken to stop this,
it is difficult to argue India is much better than China in terms of IPR theft. More...
Innovators, not pirates

(Ashok Gulati , Siraj Hussain , 23-Oct-2017 , The Indian Express)
India must curb intellectual property rights violations, like the one on herbicide tolerant Bt cotton, in
order to become an innovation hub. More...
India, US trade policy forum meet in Washington on October 25

(PTI | New Delhi , 22-Oct-2017 , The Indian Express)
Issues including visa, greater market access for goods and intellectual property rights are expected to
figure in the trade policy forum (TPF) meeting between India and the US on October 25 in Washington,
an official said. More...
Allergan ruling casts doubt on tribal patent strategy

(Reuters , 18-Oct-2017 , The Times Of India)
A U.S. judge's ruling on Monday invalidating Allergan Plc's patents on its blockbuster $1.5 billion dry-eye
medicine, Restasis, has cast doubt on the company's novel strategy to enlist a Native American tribe to
help shield those patents from challenge by generic drugmakers, legal experts said. More...
India on radar as Trump aims for cheaper drugs?

(TNN & Agencies , 18-Oct-2017 , The Times Of India)
United States President Donald Trump has promised to bring the cost of prescription drugs in the
country "way down" and let other countries pay more for these medicines. More...
India-EU FTA: chief negotiators to meet mid-November

(PTI , 17-Oct-2017 , The New Indian Express)
Chief negotiators for the proposed India-EU free trade agreement will meet in New Delhi next month to
discuss the way forward for the resumption of the long-stalled talks over it. More...
India's Andhra Pradesh investigates planting of Monsanto's unapproved GM cotton

(Mayank Bhardwaj , 17-Oct-2017 , Business Insider)
One of India's biggest cotton-growing states has formed a panel to investigate how 15 percent of the
state's cotton acreage has been planted with a non-approved genetically modified strain developed by
Monsanto and may bring criminal charges. More...
Allergan's latest drug wheeze has bad side-effects

(Robert Cyran , 17-Oct-2017 , The Times Of India)
The firm's stock fell as much as 5 percent on Monday after a judge invalidated a key medication's
intellectual property and called the company's plan to use a Native American tribe to protect the patents
a "ploy." More...
MSF Challenges Patent to Pfizer Pneumococcal Vaccine

(TIS Staffer , 16-Oct-2017 , India Saga )
Médecins Sans Frontières/Doctors Without Borders India has filed a petition before the High Court of
Delhi to overturn the patent granted on the pneumococcal conjugate vaccine (PCV) to the US
pharmaceutical corporation Pfizer. More...
Dilip De gets copyright for his phablet art

A year after Creators Project (CP) -- launched by Intel and Vice Media to celebrate creativity --
recognised art collector Dilip De for his breakthrough in using a smartphone and stylus to create art, he
has secured copyright registrations of his paintings in this "new school of art" from the Union commerce
& industry ministry. More...
BlackBerry CEO says patent plans on track after departures

(Alastair Sharp , 16-Oct-2017 , The Times Of India)
BlackBerry Ltd Chief Executive John Chen said on Monday the company's strategy for generating
licensing revenue from its patent portfolio remains on track following the recent departures of two
people from the team negotiating deals. More...
NSL to pursue intellectual property litigation with Monsanto

(Mayank Bhardwaj | Reuters | New Delhi , 16-Oct-2017 , Business Standard)
Monsanto is yet to settle the dispute with Sri Rama Agri Genetics, Amar Biotech and NSL along with two
group companies, Prabhat Agri Biotech and Pravardhan Seeds More...
Left holds patent for outside support: Sitaram Yechury

(Manoj C G | New Delhi , 14-Oct-2017 , The Indian Express)
Sources in CPI(M) said Yechury is of the view that without an electoral alliance or front, CPI(M) should
seek the cooperation of non-Left secular parties to defeat the BJP More...
Panacea Biotec, MSF India oppose Pfizer’s pneumonia vaccine patent

(Teena Thacker , 14-Oct-2017 , Livemint)
Panacea Biotec files a review petition with the patent office seeking revocation of the patent given to
Pfizer; MSF India moves Delhi high court to overturn patent More...
BlackBerry patent licensing director says he has left company

(Alastair Sharp , 14-Oct-2017 , The Times Of India)
A key attorney executing BlackBerry Ltd's patent licensing strategy has left the company, the second
recent departure from the team tasked with making money from the Canadian company's intellectual
property. More...
Indian Patent Act achieved balance between drug innovators & public health: Dr BR
Jagashetty
(Nandita Vijay, Bengaluru, , 13-Oct-2017 , Pharmabiz)
Indian Patent Act maintains a balance between the interest of the inventor of a drug and public health,
said Dr BR Jagashetty, former National Adviser (Drugs Control) to MoHFW and CDSCO and former
Karnataka state drugs controller. More...
Indigenous clean energy technologies showcased

The event focused on various topics, including CEERI's solar tree technology and CSIR-NCL's patent
protected biodiesel technology, that are being piloted in Japan & US. More...
India-EU summit signals progress but no big results
(ET CONTRIBUTORS , 12-Oct-2017 , The Economic Times)
Jean-Claude Juncker, the European Commission president, has described the EU and India as natural
partners. More...
India renews commitment to WTO’s Doha agenda ahead of crucial meet

(FE Bureau | New Delhi , 12-Oct-2017 , The Financial Express)
India has reiterated its commitment towards a successful conclusion of the 2001 Doha Development
Agenda and other issues of interest to developing countries at an informal gathering ahead of the next
WTO ministerial More...
Tata Steel acquiring intellectual property rights from mining major Rio Tinto
(Rakhi Mazumdar , 11-Oct-2017 , The Economic Times)
Tata Steel could reduce the cost of making steel by 20% with the company acquiring intellectual
property rights (IPR) for a technology from global metals and mining major, Rio Tinto More...
Suven spurts over 7% on securing product patent

(Our Bureau , 10-Oct-2017 , Business Line)
Shares of Suven Life Sciences surged over 7 per cent in Tuesday's trade as the company has received a
patent from New Zealand for a drug used for the treatment of neuro-degenerative diseases. More...
Malaysian CL on Hep C drug reignites discussion in India

(PT Jyothi Datta , 09-Oct-2017 , Business Line)
Last month, Malaysia issued a compulsory licence (CL) on multinational drugmaker Gilead's Hepatitis C
drug Sofosbuvir for government use. More...
Amazon files patent for deploying exclusive drones in India

(Gireesh Babu | Chennai , 9-Oct-2017 , Business Standard)
Firm says the proposed drones can also be used to identify other such objects, along with aircraft, plying
within Indian skies More...
Patents allow increasing number of people access to cheaper medicines

(Jonathan Berger and Achal Prabhala , 9-Oct-2017 , Business Day)
Instead of impeding treatment roll-out, draft intellectual property law will stir up competition and cut
prices More...
AP govt seeks legitimising cultivation of herbicide-tolerant GM cotton

(B Dasarath Reddy | Hyderabad , 08-Oct-2017 , Business Standard)
A group of Indian seed companies have also been engaged in legal battle with Monsanto over trait value
among other patent-related claims More...
Honda Motor files patents for invention on automatic transmission vehicles
Company has filed two applications, one for gear shift control device, another for a transmission control
device for automatic transmission More...
India-EU FTA talks expected to move forward in next few days

(PTI , 06-Oct-2017 , The Press Trust of India)
European Commission President Jean-Claude Juncker today expressed hope that talks on free trade
agreement (FTA) between EU and India will move forward in the next few days. More...
Experts see value of pharma patents in India can encourage research for novel drugs
(Nandita Vijay, Bengaluru, , 6-Oct-2017 , Pharmabiz)
The growing value of pharmaceutical patents in India has led to a paradigm-shift in the country’s strong
research initiatives for novel drugs and innovative technology, according to experts. More...
Omkar Speciality soars after receiving patent

(Capital Market , 04-Oct-2017 , Business Standard)
Omkar Speciality Chemicals rose 12.29% to Rs 85 at 14:52 IST on BSE after the company said it was
granted patent for process for terminal Dihaloalkane. More...
BlackBerry's patent strategy head exits, joins health tech firm - sources
The man who was leading BlackBerry Ltd's efforts to make money from its patent portfolio has left to
join a health technology company, two sources with knowledge of the move said on Monday. More...
Holding: Allergan exposes patent-reform quackery

The $70 bln drugmaker's fishy deal with Native Americans may impede a U.S. tribunal from cracking
down on such rights. More...
Free trade talks with EFTA grouping hit IPR, services wall
(Amiti Sen , 25-Sep-2017 , Business Line)
Switzerland insists on intellectual property commitments beyond TRIPS More...
Suven Life Science gets neuro patent from India, Japan

(PTI , 25-Sep-2017 , Business Line)
The patents are valid till 2027 and 2032, respectively. More...
Patent, trademark filings have risen sharply: DIPP

(Our Bureau , 22-Sep-2017 , Business Line)
After the Department of Industrial Policy and Promotion (DIPP) streamlined and installed processes,
patent and trademark filing has risen sharply. In FY16, there was a jump of almost 35 per cent in
trademark filings; in FY18, there is almost a 6 per cent jump, said Rajiv Aggarwal, Joint Secretary, DIPP.
More...
US offers to host trade policy forum with India next month

(Amiti Sen , 22-Sep-2017 , Business Line)
The US is also keen to discuss IPR issues and nudge India to make its patent laws more favourable for
patent holders by going beyond its commitment made in the global TRIPS (Agreement on Trade-Related
Aspects of Intellectual Property Rights) agreement. More...
Nokia set to get sales boost after smartphone patent ruling

(Reuters | Helsinki (finland) , 18-Sep-2017 , The Indian Express)
We believe that this award confirms the quality of Nokia’s patent portfolio. More...
How pharma firms stretch their patents

((New Delhi edition) , 17-Sep-2017 , The Times of India)
Medicines are a big business, and a highly profitable one at that, but the key to maintaining super profits
is to keep your patents alive for as long as possible. Leading pharma companies do it in a number of fair
and unfair ways, an article in Statnews points out. More...
Indivior in battle to protect opioid treatment from rivals

(Alex Ralph , 16-Sep-2017 , The Times)
A British drugs company reliant on sales of a treatment for opioid addiction has started legal action
against competitors seeking approval for generic versions. More...
Setback for Dr Reddy’s Labs, Mylan, others as Indivior files patent suits over Suboxone
(FE Bureau | Hyderabad , 16-Sep-2017 , The Financial Express)
US-based Indivior has filed patent lawsuits against the generic rivals like Dr Reddy’s Laboratories,
Actavis, Par, Alvogen, Teva and Mylan for an alleged infringement of patents relating to their respective
proposed generic versions of Suboxone. More...
Dr Reddy's Lab slides after reports of Indivior filing patent lawsuits

(Capital Market , 15-Sep-2017 , Business Standard)
Dr Reddy's Laboratories dropped 1.83% to Rs 2,207.75 at 14:00 IST on BSE after report suggested that
Indivior Plc., the UK drug firm has filed patent lawsuits against the company, Teva and Mylan. More...
West Bengal government eyes GI tag for Kolkatti jewellery

(Sutanuka Ghosal , 15-Sep-2017 , The Economic Times)
For Aishwarya Rai in Tagore’s Chokher Bali, the late Rituparno Ghosh had chosen ageless Bengali
jewellery that burnished the allure of the widowed Binodini in the eyes of the married landlord,
Mahendra. More...
Strong IP standards can lead to innovation, which, in turn, can lead to jobs and growth
(Hemal Shah , 14-Sep-2017 , The Economic Times)
When it comes to promoting innovation, India is already taking the lead among emerging economies.
More...
US asks India to open market, address trade imbalance

( PTI | Washington , 13-Sep-2017 , Financial Express)
The US today asked India to open its market for American firms and address the rising trade imbalance
between the two countries while taking steps to protect intellectual property rights. More...
U.S. tribal patent deal could have big impact on generic drug market
(Reuters , 12-Sep-2017 , Business Standard)
A groundbreaking deal between Allergan Plc and a Native American tribe to shield the company's patents
in administrative proceedings could also be used be to protect them from challenges in federal court,
legal experts said, potentially dealing a blow to generic competition. More...
Patent to Pfizer could delay Indian vaccines for pneumonia

(Abhineet Kumar & Aneesh Phadnis | Mumbai , 12-Sep-2017 , Business Standard)
The vaccine, called PCV13 and marketed as Prevnar13, provides protection against 13 strains of
streptococcus pneumoniae bacteria More...
Amit Shah asks business organisations to focus on obtaining patents

(Rishi Sankhla , 11-Sep-2017 , The Indian Wire)
Amit Shah said Indian companies should focus on obtaining patents and creating their own IPR so that
the wealth created remains in India. More...
Demonetisation, GST fostered trademark protection awareness in India

(Virendra Singh Rawat | Lucknow , 10-Sep-2017 , Business Standard)
Huge qualitative improvement seen in filing of trademark applications by firms, says senior official
More...
Amit Shah urges Indian firms to focus on IPR, patents

(ET Bureau , 10-Sep-2017 , The Economic Times)
BJP president Amit Shah said Indian companies and business organisations should focus on obtaining
patents and creating their own Intellectual Property Rights so that the wealth created by them remains
within the country. More...
Allergan in patent deal with Mohawk tribe over eye drug

(Reuters , 8-Sep-2017 , The Times Of India)
Drugmaker's shares up 1.7 pct at $231.89 More...
Facebook seeks patent for innovation tailored to recognise gestures

(Gireesh Babu | Chennai , 8-Sep-2017 , Business Standard)
Objects to be tracked using light detection device More...

Need to develop IPR in aerospace sector: Air Force Vice Chief S B Deo
India is "lazy" in developing intellectual property rights in the aerospace sector and will be at the mercy
of foreign manufacturers if it does not work on indigenous technologies, a top Air Force official said
today. More...
India grants patent to Pfizer’s anti-pneumonia drug

(Rupali Mukherjee , 7-Sep-2017 , The Times Of India)
Hopes for improved access to an affordable pneumococcal vaccine that safeguards both children and
adults from pneumonia, has suffered a major blow in the wake of the Indian patent office granting a
patent to the US drug major Pfizer, for its PCV13 product, marketed as Prevnar13 More...
Dr Reddy’s launches 2 drugs in US mkt

(THE HANS INDIA , 7-Sep-2017 , THE HANS INDIA)
City-based Dr Reddy's Laboratories Limited announced on Wednesday that it has launched anti-
depressant, Bupropion Hydrochloride Extended Release Tablets, 150 mg and 300 mg, as well as muscle
relaxant drug Metaxalone in the US. More...
Trade mark protection a must, says official

( Special Correspondent , 6-Sep-2017 , The Hindu)
Trade mark protection is a must as per Madrid Protocol to protect Intellectual Property Rights, said R.A.
Tiwari, Deputy Registrar of Trade Marks and GI (Intellectual Property Office (IPO), Government of
India). More...
Startups get 80% rebate on patent fee

(Ruchika Chitravanshi , 5-Sep-2017 , The Times Of India)
More domestic and foreign startups will now be able to access the fast-track mechanism for filing
patents, which will drastically cut down the time taken to obtain these rights. More...
Centre launches social media campaign to promote Indian GIs

(IANS | New Delhi , 5-Sep-2017 , The Indian Express)
The initiative, designed to make more people aware about the importance of Intellectual property rights,
has been launched under the aegis of the Department of Industrial Policy and Promotion (DIPP), a
Commerce Ministry statement said here. More...
CIPAM-DIPP launches social media campaign to promote Geographical Indications

The Cell for IPR Promotions & Management (CIPAM) under the aegis of Department of Industrial Policy
and Promotion (DIPP), Ministry of Commerce and Industry, has launched a social media campaign to
promote Indian Geographical Indications (GIs) with #LetsTalkIP which is an ongoing movement initiated
by CIPAM to make more people aware about the importance of Intellectual Property Rights. More...
Startups get 80% rebate on patent fee

(Ruchika Chitravanshi , 5-Sep-2017 , The Economic Times)
More domestic and foreign startups will now be able to access the fast-track mechanism for filing
patents, which will drastically cut down the time taken to obtain these rights. More...
Indian-origin Vasant Narasimhan to head $48 billion pharma giant Novartis

(Aneesh Phadnis | Mumbai , 5-Sep-2017 , Business Standard)
At present, he holds the post of global head of drug development and chief medical officer More...
Suresh Prabhu at Commerce Ministry: 5 points that make new minister’s task tough
(Banikinkar Pattanayak | New Delhi , 04-Sep-2017 , The Financial Express)
At the same time, India has to resist pressure from developed countries for going beyond TRIPS (Trade-
Related Aspects of Intellectual Property Rights) and IT agreement, and including e-commerce on the
WTO agenda. More...
DIPP launches social media campaign to promote GIs

(Press Trust of India | New Delhi , 04-Sep-2017 , Business Standard)
Cell for IPR Promotions and Management (CIPAM) has launched a social media campaign to promote
Indian Geographical Indications to make more people aware about the importance of intellectual
property rights (IPRs), the commerce and industry ministry said today. More...
U.S. court rules in favour of Dr. Reddy’s in patent litigation

(Special Correspondent , 1-Sep-2017 , The Hindu)
Overrules Indivior’s infringment claim on proposed generic version of Suboxone More...
My legal victory is in deference to producers as a fraternity’, says Rajiv Rai after winning a
copyright battle
(Subhash K Jha , 1-Sep-2017 , DNA)
Says Rajiv Rai, who has just won a copyright battle More...
Switzerland for early India-EFTA pact

( Special Correspondent , 1-Sep-2017 , The Hindu)
The early conclusion of the proposed Free Trade Agreement(FTA) between India and European Free
Trade Association (EFTA) as well as an investment protection framework would boost economic ties
between the two sides, said Switzerland President Doris Leuthard on Friday. More...
India’s public health and the looming threat of US pharma giants

(D. Ravi Kanth , 30-Aug-2017 , Livemint)
India has an opportunity to squash criticism to squash criticism of global health pressure groups by
issuing a compulsory licence to Pfizer vaccine. Otherwise, it would be seen as ready to genuflect to the
diktats of American lobbies More...
GI tag sought for Bengal’s lightweight gold jewellery

(Our Bureau , 30-Aug-2017 , Business Line)
The lightweight traditional gold jewellery of Bengal, popularly known as ‘Kolkati’, might soon bag a GI
(geographical indication) tag. More...
Chicken and veg offerings to replace IKEA's trademark beef and pork meatballs in India
(Rasul Bailay , 30-Aug-2017 , The Economic Times)
The world's biggest furniture retailer IKEA is also a top restaurateur, and its characteristically Swedish
menu helps sustain the stamina of shoppers at the giant DIY stores. More...
Medecins Sans Frontieres to legally challenge Pfizer’s patent on pneumonia vaccine

(Teena Thacker , 29-Aug-2017 , Livemint)
Medecins Sans Frontieres also raises the matter with the government, urging it to issue a compulsory
licence for Pfizer’S pneumonia vaccine More...
Mersal becomes the first south Indian movie to get trademarked

(M Suganth , 29-Aug-2017 , The Times Of India)
Only recently, Vijay's Mersal became the first south Indian movie to get an emoji on Twitter. More...
India grants Pfizer patent for pneumonia vaccine

India has granted Pfizer a patent for Prevnar 13 pneumonia vaccine, in spite of opposition from the
heath group Médecins Sans Frontières (MSF) More...
Eisai Pharma introduces anti-epileptic drug at India-specific price

The drug is priced at less than one dollar a tablet as compared to $12 to $15 in the United States and
Europe More...
In praise of branded generics: breaking some myths

(Abhay Pandey, V.T. Bharadwaj , 23-Aug-2017 , Livemint)
Arguments against branded generics are built on emotions rather than facts—making them very social
media friendly—but maybe not reflecting reality More...
Government to ensure protection of film, music intellectual property rights: Nirmala

Sitharaman
(PTI , 22-Aug-2017 , The New Indian Express)
Commerce and Industry Minister Nirmala Sitharaman today said the government will ensure protection
of intellectual property rights of film and music industry as any kind of piracy is "absolutely
unacceptable". More...
Piracy, copyright violation sources of terror funding: Rajnath Singh

(PTI | New Delhi , 22-Aug-2017 , The Indian Express)
Delivering a keynote speech during the 'National Workshop on Enforcement of Intellectual Property
Rights', Singh asked agencies like the police and the customs department "not (to) take lightly" these
violations as they have direct links with public safety and security of the country. More...
Draft pharma policy to further ease of doing business & Make in India programmes
(Laxmi Yadav, Mumbai , 21-Aug-2017 , Pharmabiz)
The draft Pharmaceutical Policy proposed by the Department of Pharmaceuticals (DoP), if accepted,
would significantly contribute to furthering Prime Minister's key initiatives-- ease of doing business in the
pharmaceutical sector and Make in India programme. More...
Suven Life Sciences gets product patents for neurodegenerative drug

(PTI , 17-Aug-2017 , Livemint)
Suven Life Sciences has been granted a patent each by Europe, Japan and New Zealand for a drug used
in the treatment of neurodegenerative diseases More...
Draft pharma policy dilutes powers of pricing regulator

(Aesha Datta , 17-Aug-2017 , Business Line)
The NPPA cannot revise the price of a drug once fixed, nor cap the prices of in-patent medicines More...
India-Sweden MoU on IPRs to benefit SMEs: Govt

(Rituparna Kakati , 17-Aug-2017 , SME Times)
The Union Cabinet on Wednesday approved an Memorandum of Understanding (MoU) between India and
Sweden that seeks to spread awareness about best practices in the field among small and medium
enterprises (SMEs), stated an official release. More...
Patent granted in record 113 days, down from 6 yrs

(Rupali Mukherjee , 16-Aug-2017 , The Times Of India)
Patent offices in India, traditionally known to be long-winding and tardy, are witnessing a major
overhaul. More...
Spices Board and J&K government to work for GI tag for Kashmir saffron
(ET Bureau , 16-Aug-2017 , The Economic Times)
Spices Board has teamed up with the Jammu and Kashmir government to boost production and improve
value addition of saffron for its consumption and trading in both domestic and international markets.
More...
Motorola could launch smartphone with self-healing screen: Report

(Tech Desk | New Delhi , 16-Aug-2017 , The Indian Express)
A patent first spotted by SlashGear shows that Motorola has designed a self-healing technology, which
would detect a crack in the display and notify the user. More...
Cabinet clears India, Sweden MoU signing on intellectual property right cooperation
( PTI , 16-Aug-2017 , The New Indian Express)
The Union Cabinet today cleared MoU signing between India and Sweden on intellectual property right
(IPR) cooperation, aimed at benefiting entrepreneurs, investors and businesses. More...
Granules, Hetero in patent battle with Takeda Pharma

(M SOMASEKHAR , 15-Aug-2017 , Business Line)
Global drug major Takeda Pharmaceuticals has dragged two Indian drug firms — Granules India and
Hetero Drugs — to court over charges of patent infringement of its drug to treat Gout and Familial
Mediterranean Fever. More...
Can a stronger IPR regime hurt India's push for generics?

(Sayan Ghosal , 13-Aug-2017 , Business Standard)
Such move will cause more litigation over patents, having impact on local manufacturers: Critics More...
Patent Battle Over Breast Cancer Drug: Roche Withdraws Its SLP Against Delhi High Court’s
Approval To Biosimilars.
(Live Law News Network , 13-Aug-2017 , LiveLaw)
Swiss Pharma major, Roche has withdrawn its Special Leave Petition filed in the Supreme Court against
the Delhi High Court’s March 3 decision, rejecting its challenge to the grant of approval to drug
companies, Biocon and Mylan, to use product data f... More...
Patent Battle Over Breast Cancer Drug: Roche Withdraws Its SLP Against Delhi High Court’s
Approval To Biosimilars
(Live Law News Network , 13-Aug-2017 , LiveLaw)
Swiss Pharma major, Roche has withdrawn its Special Leave Petition filed in the Supreme Court against
the Delhi High Court’s March 3 decision, rejecting its challenge to the grant of approval to drug
companies, Biocon and Mylan, to use product data f... More...
Move from patented drugs to generics, says Economic Survey Volume-2

(Veena Mani | New Delhi , 12-Aug-2017 , Business Standard)
Healthcare activists believe such a move would break the corporate-doctor nexus More...
Economic Survey says India faces health care challenges on multiple fronts
(Neetu Chandra Sharma , 12-Aug-2017 , Livemint)
The patent drugs and medicine providers in India are large players, enjoy a monopoly position, and so
make excess profits at the cost of the consumer. More...
IPR laws will help Ericsson grow in India

(Varun Aggarwal , 09-Aug-2017 , Business Line)
Despite getting entangled in legal cases against Indian handset manufacturers over licensing issues of
its IPR, Ericsson is confident that Indian Intellectual Property Rights laws will help the company grow in
India. In an interview with BusinessLine, Dina Kallay, Head of Antitrust (IPR, Americas & Asia-Pacific) at
Ericsson, talked about how the new Fair, Reasonable, and Non-Discriminatory (FRAND) licensing will
unleash the deployment of 5G in India. More...
Hilsa fish now a cerified unique product of Bangladesh
(TIMESOFINDIA.COM , 09-Aug-2017 , The Times Of India)
Hilsa fish has been accorded geographical identification (GI), which has tagged the fish as a Bangladeshi
product More...
Post Startup India, 2,200 ventures get DIPP stamp

(Ruchika Chitravanshi , 8-Aug-2017 , The Times Of India)
Over 2,196 new ventures have been recognised by the Department of Industrial Policy and Promotion
(DIPP) since the launch of Startup India, easing patent filing and credit availability for them. More...
Health ministry warns on rushed implementation of generics plan

The health ministry says the prime minister’s idea of pushing generics should be implemented carefully
to ensure the right quantity and quality of medicines are available More...
Delhi High Court imposes Rs 20,000 cost on Nitish Kumar in copyright case
(PTI , 04-Aug-2017 , The New Indian Express)
The Delhi High Court has dismissed Bihar Chief Minister Nitish Kumar's plea to delete his name as a
defendant from a lawsuit on copyright violation filed by a former JNU scholar-turned-politician, and
imposed a cost of Rs 20,000 on him. More...
Kolkata scientist develops non-invasive device to detect anaemia and more

(Sumati Yengkhom , 4-Aug-2017 , The Times Of India)
A city-based scientist has developed a device that will detect anaemia, jaundice and oxygen level in a
fraction of a second without using a needle. More...
Anju Modi, Anita Dongre patent their collections, lawyer says designers are finally becoming
aware of copyright laws
(Divya Kaushik | TNN , 3-Aug-2017 , The Times Of India)
Due steps have been taken to protect our IP. More...
GI tag need of the hour, feel Chirala silk weavers

( S. Murali , 2-Aug-2017 , The Hindu)
Inheritors of the centuries-old legacy say it will add value to their product and increase visibility More...
Odisha govt to approach CTTC to file GI tag for rasagolla

(Minati Singha , 02-Aug-2017 , The Times Of India)
Odisha government has decided to approach the Central Tool room and Training Centre (CTTC) for filing
application seeking Geographical Indication (GI) tag for Odisha's popular sweet dish Rasagolla. More...
International evidence suggests we understand, embrace and protect intellectual property

rights
(Ashish Bharadwaj & Punkhuri Chawla , 2-Aug-2017 , Financial Express)
International evidence suggests we understand, embrace and protect IPRs More...
PU hikes revenue share of inventors

The Panjab University Board of Finance has approved a new formula for the sharing of revenue from
intellectual property rights (IPR). More...
Medicines in India likely to be costlier due to RCEP trade pact

(Jyotsna Singh , 2-Aug-2017 , DNA)
However, the key issues holding the final text of these negotiations don’t seem to be getting resolved.
More...
Toilet Ek Prem Katha makers argue in copyright case

(IANS | Jaipur , 31-Jul-2017 , The Indian Express)
A local court here on Monday heard in part the arguments in a case of violation of the Copyright Act by
makers of Akshay Kumar starrer Toilet: Ek Prem Katha. More...
Income earned from registered patents is taxed at a concessional rate

(Parizad Sirwalla , 31-Jul-2017 , Livemint)
If the patent is registered under the Patents Act, 1971, a concessional tax rate could be claimed under
section 115BBF of the Income Tax Act, 1961 More...
India’s proposed Intellectual Property Exchange could help determine quality of patents
(Ashish Bharadwaj and Punkhuri Chawla , 31-Jul-2017 , Hindustan Times)
Several firms in telecommunication, especially SMEs and startups, that have struggled to pay desired
royalties to use essential patents can build new and expand existing IP portfolios, which can facilitate
cross-licensing deals with other patent holders More...
Trade policy forum meeting between India, US unlikely to be held this year
(Asit Ranjan Mishra , 31-Jul-2017 , Livemint)
The annual India-US trade policy forum meeting may not be held this year, amid a growing feeling in the
US that such high-level talks have not delivered intended results More...
Compulsory licence must to make drugs affordable

(Rohit P.S. , 30-Jul-2017 , The Hindu)
His leaks in 2016 had set the tone for protests against the Regional Comprehensive Economic
Partnership (RCEP). More...
No logic in extending length of patents

(Feroz Ali, Roshan John , 28-Jul-2017 , Livemint)
Granting a longer term for pharmaceutical patents will result in delays in the entry of generic versions
and could adversely affect access to medicines More...
Rohit Bal becomes the first designer to patent and copyright his entire collection
(Shashi Sunny , 28-Jul-2017 , The Economic Times)
Designer Rohit Bal hosted an intimate Kashmiri wazwan (ceremonial feast) for his close friends, home-
cooked by his personal chef, Phoolchand, in New Delhi recently. More...
What’s at stake in Hyderabad

( Feroz Ali , 28-Jul-2017 , The Hindu)
India must counter Japan’s U.S.-style pressure at the RCEP talks and ensure affordable generic
medicines More...
IMA registers its trademark for allopathic doctors

(Express News Service | Mumbai , 28-Jul-2017 , The Indian Express)
The IMA is now raising awareness about the trademark, a red cross with Dr written at the centre,
amongst patients and the medical community. More...
Thaana Serndha Kootam song Naana Thaana: This song featuring Suriya is a trademark
Anirudh Ravichander track
(Ashameera Aiyappan | Chennai , 28-Jul-2017 , The Indian Express)
Naana Thaana Veena Pona, a fun single track from Suriya’s Thaana Serndha Kootam was launched on
Thursday on the music streaming platform Saavn. More...
India Innovation Growth Programme 2.0 top winners announced

(ANI , 26-Jul-2017 , Outlook)
The winners from the University Challenge and Open Innovation Challenge of the India Innovation
Growth Programme 20 (IIGP 20) were announced in New Delhi today Over 1300 applications for
innovative ideas across social and industrial sectors were received More...
Toilet Ek Prem Katha: Court demands a reply from makers in copyright case
(IANS | Jaipur , 26-Jul-2017 , The Indian Express)
The makers of actor Akshay Kumar's Toilet: Ek Prem Katha have been asked by the local court to file a
reply to the charge of violation of the Copyright Act by July 31. More...
Microsoft patent reveals 'Surface Microsoft patent reveals Surface Phone coming soon'
coming soon
(IANS , 25-Jul-2017 , India Today)
Even though Microsoft has reported a fall in Surface PC line and Windows phones revenues, the
Redmond-based tech giant is aiming for new devices called "Surface Phones" and has made its patent
public. More...
A Trade Deal Could Hit Affordable & Generic Medicines in India. Here’s What You Need to
Know
( Doctors Without Borders / Médecins Sans Frontières (MSF) , 25-Jul-2017 , The BetterIndia)
Ironically, the venue is the city of Hyderabad – the hub of the Indian generic industry – which will host
the intellectual property (IP) negotiations that seek to curb the ability of Indian manufacturers to deliver
lifesaving medicines to the world. More...
India: Section 3(D) Of The Patents Act, 1970 (As Amended): A Deeming Provision!
(Dinesh Kumar Sharma LexOrbis , 24-Jul-2017 , mondaq)
Ambiguous and inconsistent standards regarding interpretation of Section 3(d) of the Patents Act, 1970,
as amended by the Patents (Amendment) Act, 2005, a provision peculiar to Indian law, has remained a
key issue in India. More...
Patents boost to offset weak networks for Nokia

(Reuters , 24-Jul-2017 , The Times Of India)
Telecoms gear maker Nokia is likely to see a boost to quarterly earnings on Thursday from a recent
patent licensing deal with Apple that offsets weak demand in its main equipment business from network
operators. More...
Facebook working on a modular smartphone, reveals patent

(Tech Desk | New Delhi , 23-Jul-2017 , The Indian Express)
Facebook may be working on a smartphone that could be modular in nature. More...
Suven Life secures neuro drug patent from Australia

(PTI , 21-Jul-2017 , The Economic Times)
Suven Life SciencesBSE 0.35 % has been granted a patent from Australia for a drug used in the
treatment of disorders associated with neurodegenerative diseases. More...
India Copyright Board and IPAB to merge completely by year-end: Official

(PTI , 22-Jul-2017 , The New Indian Express)
The copyright board and the intellectual property appellate board (IPAB) is in the process of merging
and will be fully functional by the end of this year, a senior government official said here today. More...
Roche's new breast cancer drug that could cut treatment time denied patent
(Gireesh Babu | Chennai , 21-Jul-2017 , Business Standard)
Roche has filed for a patent for its new drug formulation meant for subcutaneous administration More...
Pfizer shares downgraded because Viagra patent is expiring later this year
(Tae Kim , 21-Jul-2017 , CNBC)
The firm believes the drugmaker will suffer from the patent expirations of its key drugs such as Viagra
and Lyrica in the next 18 months. More...
Pfizer nears patent cliff, Credit Suisse downgrades to "neutral"

Pfizer flat early Thurs as Credit Suisse downgrades to neutral from outperform, lowers PT to $36 from
$38 More...
Emergent Biosolutions to acquire Raxibacumab from GSK
Emergent Biosolutions to acquire Raxibacumab, an FDA-approved Anthrax monoclonal antibody, from

GSK More...
Course correction in place before WTO meeting: India

(D. Ravi Kanth , 20-Jul-2017 , Livemint)
Nirmala Sitharaman says there is a genuine ‘course correction’ in place for delivering results on
mandated issues at the WTO’s 11th ministerial meeting in December More...
Now, IPR on law varsity's curricula

(Debasish Konar , 20-Jul-2017 , The Times Of India)
NUJS will launch a year-long postgraduate diploma course on intellectual property rights (IPR) this
month.Professor P Ishwara Bhat, VC of NUJS, said it's the first university in eastern India to offer such a
course since demand for IPR is on the rise. More...
Unfair or abusive? IPR rhetoric in India must be echoed by CCI

(Avirup Bose, CCI , 20-Jul-2017 , Financial Express)
India’s IPR rhetoric needs to be echoed by Competition Commission of India. More...
DIPP inks pact with a Punjab institute to set up TISC

The Department of Industrial Policy and Promotion (DIPP) today signed a pact with a Punjab state
council to set up Technology and Innovation Support Centre (TISC). More...
ASG advises Centre to clarify law over cotton seed prices

(Dilip Kumar Jha | Mumbai , 13-Jul-2017 , Business Standard)
Existing deadlock renders future investments in the sector uncertain, say industry players More...
Kumar Vishwas offers to pay Rs 32 after Amitabh Bachchan sends copyright infringement
notice
(TIMESOFINDIA.COM , 12-Jul-2017 , The Times of India)
Actor Amitabh Bachchan sent a legal notice to AAP leader Kumar Vishwas, accusing him of "copyright
infringement" for unauthorised use of a poem penned by his late father, the poet Harivansh Rai
Bachchan, in a video paying tribute to renowned Hindi poets. More...
Indian doctors get US patent for hair regrowth

(THE HANS INDIA , 11-Jul-2017 , THE HANS INDIA )
Indian plastic surgeon, Dr Debraj Shome and Cosmetic dermatologist, Dr Rinky Kapoor, have just been
awarded a US patent for a molecule - QR 678 - that treats hair loss in patients, injected intradermally
into an affected area of the scalp of the patient. The molecule stimulates hair follicles and promotes hair
growth. More...
Robots set to become integral part of Indian hospitals' surgery rooms in future
(Laxmi Yadav, Mumbai , 10-Jul-2017 , Pharmabiz)
With the rise in demand for minimal invasive surgeries in the country, surgical robots are set to become
integral part of surgery rooms of Indian hospitals in coming years. More...
Wisconsin Indian tribe challenges Oneida Nation trademarks

(Greg Mason , 9-Jul-2017 , Times Telegram)
The Oneida Indian Nation called it “unfortunate, but not surprising” that a Wisconsin-based Oneida
Indian tribe would challenge the Nation’s trademark rights. More...
Uber-Alphabet legal tussle over patent escalates

( Indo-Asian News Service , 9-Jul-2017 , India.com)
Uber views these depositions as critical information to determining Alphabet's motivation behind the
lawsuit and whether it was simply a tactic to delay the development of its self-driving vehicle
technology. More...
Pattern on Mother Teresa sari now a registered trademark

(Jayanta Gupta , 6-Jul-2017 , Times of India)
The characteristic blue and white stripes that the world associates with Mother Teresa can no longer be
used either on attire or items of stationery without the permission of the Missionaries of Charity. The
unique pattern is now a registered trademark with the government of India's Trade Marks Registry. Any
violation can invite prosecution. More...
GST: CGST won’t apply on items not registered under trademark law
(05-Jul-2017 , Live Mint)
The finance ministry on Wednesday said that 5% central goods and services tax (CGST) will not apply
on products that are not registered under the Trade Marks Act. More...
Xiaomi to acquire key Nokia patents

(05-Jul-2017 , The Economic Times )
NEW DELHI: In a strategic move, Chinese tech major Xiaomi and Finnish mobile phone manufacturer
Nokia on Wednesday signed an agreement for business collaboration and patent licencing where Xiaomi
will acquire key patent assets from Nokia. More...
India: Compulsory License Of Copyright Work

(N. Mahabir , 03-Jul-2017 , Mondaq)
Copyright is the monopoly granted in exchange or as a quid pro quo for disclosure of work. More...
India may get Intellectual Property Exchange soon

(Jyotika Sood, Priyanka Mittal , 3-Jul-2017 , Livemint)
The Intellectual Property Exchange will enable individuals and commercial entities both in India and
overseas to buy and sell IP rights across various sectors More...
Government eases process to seek CRI patents, revised norms out
(PTI | New Delhi , 02-Jul-2017 , The Indian Express)
The Office of the Controller General of Patents, Designs, and Trade Marks (CGPDTM) came out with
revised guidelines on June 30 for examination of CRIs as there were concerns on the general rules
released in February last year More...
India Patent Office reissues norms for software patenting

(PTI , 30-Jun-2017 , India Today)
The Indian Patent Office has again issued guidelines on examination of computer-related inventions
(CRIs) such as software programmes. More...
USFDA’s off-patent drugs list may not offer much to Indian firms
(Isha Trivedi , 29-Jun-2017 , Livemint)
USFDA’s list of off-patent branded drugs, published to encourage competition for their generic versions,
is unlikely to offer much to Indian pharmaceutical firms More...
Chennai office rejects Tencent's patent application for online ads

(Gireesh Babu | Chennai , 28-Jun-2017 , Business Standard)
Says Tencent's method is a mere software application, and hence is not patentable More...
US turns screws on India over patent laws

(Nayanima Basu , 27-Jun-2017 , Business Line)
Big-ticket investments by the US could hinge on India taking positive steps on this front More...
Intellectual property: Why India has a long way to go in reforming IPR policy
(Ajay Batra , 27-Jun-2017 , The Financial Express)
An intellectual property (IP)-intensive skilled worker earns 40% premium than her peers who either
serve products or services from IPR-sensitive industries in the developed economies of the US and EU.
More...
For innovation’s sake

(Patrick Kilbride , 26-Jun-2017 , The Indian Express)
Working together, the US and Indian governments have the opportunity to begin bilateral relationships
afresh and move forward in the global economy together. More...
In Mumbai, Taj Palace gets a trademark

(Lalatendu Mishra , 25-Jun-2017 , The Hindu)
India’s Trade Mark Registry has assigned an image trademark to Mumbai’s Taj Mahal Palace hotel.
More...
What Narendra Modi may offer in exchange for Donald Trump’s goodwill
(D. Ravi Kanth , 24-Jun-2017 , Livemint)
The deliverables demanded by the US include further concessions on the intellectual property front, such
as TRIPS-plus (Trade-Related Aspects of Intellectual Property Rights) commitments and market access
for several health-related products, technologies and other hi-tech items. More...
MSF urges Modi to withstand US pressure to change India's IP laws

(Joe C Mathew New Delhi , 23-Jun-2017 , Business Today)
Medicines Sans Frontiers (MSF) has urged India to withstand U.S. pressure to change its drug regulatory
and patent system as it could result in millions of people in the U.S. and around the world losing their
lifeline of affordable medicines. More...
Poly Medicure wins patent battle against B. Braun over IV catheters

(Urvashi Valecha , 23-Jun-2017 , Business Line)
Domestic medical devices maker Poly Medicure has won a patent battle against German major B. Braun
Melsungen on IV catheters. More...
DIPP forms six groups for preparing new industrial policy

(PTI , 21-Jun-2017 , The New Indian Express)
The commerce and industry ministry has constituted six groups for preparing a framework for the
country's new industrial policy that includes taxation, MSME and innovation, among others. More...
Image trademark for Taj Mumbai: Smart or senseless?

(Sandeep Goyal & Carol Goyal , 21-Jun-2017 , Business Standard)
Indian hotels took the precaution of protecting goodwill of the hotel as a means of good governance
More...
GI tag for 100 agricultural products a distant dream

(Vikram Sharma Tribune News Service , 21-Jun-2017 , The Tribune )
The government’s claim to bring 100 agricultural products of the state under geographical indication
(GI) to avoid misbranding of unique local products has fallen flat as the process is yet to start. More...
Low wages push this art of hand-woven saris to the brink

(Snehlata Shrivastav | TNN , 20-Jun-2017 , The Times Of India)
The Karvat Kathi sari from Vidarbha's Bhandara and Nagpur districts have got a Geographical Indication
(GI) tag and bagged national and international recognition, thanks to the efforts of the Maharashtra
State Handloom Corporation Ltd (MSHC). More...
114-year-old Taj Palace becomes first Indian building to get trademark

(Reeba Zachariah & Vipashana V K , 19-Jun-2017 , The Times of India)
This makes the 114-year-old building the first in the country to get such a registration. More...
Nissan seeks autonomous vehicle patents in India

(Sanjay Vijayakumar , 18-Jun-2017 , The Hindu)
The technology will help a car sense road conditions More...
IIT scientists present India's first 5G patent before global body

(Vishwa Mohan | TNN , 16-Jun-2017 , The Times Of India)
With India gearing up for the commercial roll out of 5G (high speed fifth generation of wireless
networks) by 2020, scientists at IIT Hyderabad and Centre of Excellence in Wireless Technology
(CEWiT), an R&D society under IIT Madras, have tabled the country's first 5G patent before an
international body that defines the global cellular radio standards for different generations of wireless
network. More...
Promoting innovation: Moving towards a better intellectual property regime

(VK Unni, Professor, IIM Calcutta , 15-Jun-2017 , Financial Express)
The economic growth of a country is heavily dependent on the culture of innovation and creativity that it
has developed. Systematic implementation of innovative ideas results in the availability of better goods
and services, which, in turn, benefit consumers. More...
Suven secures product patents from US, Australia

(Swati Rathor , 13-Jun-2017 , The Times Of India)
City-based pharma player Suven Life Sciences Ltd (Suven) on Tuesday announced that it has been
granted one product patent each by Australia and the US corresponding to new chemical entities (NCEs)
for the treatment of disorders associated with neurodegenerative diseases. More...
US Supreme Court to rule on legality of patent review system

(Reuters , 13-Jun-2017 , The Financial Express)
The U.S. Supreme Court agreed on Monday to decide whether a federal administrative process
frequently used by technology companies to ward off patent infringement lawsuits violates the
constitutional rights of patent owners. More...
Fate of pending ‘slaughter’ patents hangs in balance

New cattle trade rules cast shadow over ‘patentability’ of devices, processes More...
Gufic Bio: Patent wins may keep it healthy

(05-Jun-2017 , Business Line)
Gufic Biosciences has received two patent certificates from the Intellectual Property India. More...
Facebook seeks India payment system patent

Facebook has sought an Indian patent for its electronic payment system enabled through messaging.
More...
Amazon files patent application in India for tech related to drone safety
This comes as the e-commerce major is working on Amazon Prime Air More...
Will GM mustard be able to survive the challenges ahead after approval?

(HARI PULAKKAT , 01-Jun-2017 , The Economic Times)
Balwinder Singh Kang had been a farmer for over three decades. He cultivates cotton, wheat, vegetables
and mustard at Hanumangarh in Rajasthan, but the mustard crop had been troublesome for him in
recent times. More...
New twist in fight over patent on cancer drug

(Rupali Mukherjee , 01-Jun-2017 , The Times Of India)
The fight for a patent on a steeply-priced wonder drug, Xtandi (enzalutamide) used in prostate cancer
has taken an interesting turn, with a clutch of civil society organisations including Union for Affordable
Cancer treatment, and Health Global Access Project, urging University of California to withdraw its case
and cease efforts to obtain a patent in India. More...
Drug costs: Patent delinkage no panacea

(: Nilanjan Banik and Philip Stevens , 01-Jun-2017 , Financial Express)
Leaving drug development to the public sector will not help improve access to medicines; rather, it could
impede it. More...
MSF fears some provisions in India-EFTA trade talks will erode India’s ability to supply
generic drugs across developing world
(Ramesh Shankar, Mumbai , 31-May-2017 , Pharmabiz)
Even as trade talks between India and the European Free Trade Association (EFTA) countries of
Switzerland, Norway, Iceland and Liechtenstein resume in Liechtenstein, the international medical
humanitarian organisation Médecins Sans Frontières (MSF) has expressed concern over some of the
provisions in the Free Trade Agreement (FTA) which will erode India’s ability to produce and supply
generic medicines for people across the developing world. More...
Civil society organizations ask University of California to withdraw efforts to obtain patent on
prostate cancer drug enzalutamide in India
A group of 56 civil society organizations, the Union for Affordable Cancer Treatment and academic
experts have called upon Janet Napolitano, the president of the University of California, and the Board of
Regents to withdraw efforts to obtain a patent on the prostate cancer drug enzalutamide (brand name
Xtandi) in India as the grant of a patent on enzalutamide in India would prevent generic competitors
from supplying the drug at an affordable price, both in India and in other countries where there is no
patent, or where Astellas has abused its patent rights by charging prices that are excessive and create
access barriers for this important drug. More...
Facebook seeks to up-end digital payment market

(Gireesh Babu | Chennai , 26-May-2017 , Business Standard)
Facebook's entry into digital payments could spark an upheaval in the segment in India More...
Tracing feni's footsteps, cashew candy too seeks GI nod

(Nida Sayed , 24-May-2017 , The Times of India)
With feni being granted Geographical Indication (GI) status a few years ago, the ICAR-Central Coastal
Agricultural Research Institute (CCARI) is in the process of acquiring an identical status for its “cashew
candy” - a dry fruit that they have manufactured from the fruit’s apple. More...
RCEP deliberations: Negotiations for service sector getting tighter, slower, says Nirmala
Sitharaman
(ENS Economic Bureau | New Delhi , 24-May-2017 , The Indian Express)
There is some kind of a campaign going on that India probably has agreed to something that will restrict
the movement of generic drugs and as a result, India may have to suffer. More...
Tur dal origins found in India, to aid patent bid

(Syed Akbar , 24-May-2017 , The Times Of India)
Tur dal, an essential ingredient in Indian kitchens, is `desi', and its origins are somewhere in Madhya
Pradesh. More...
Cropping Monsanto’s patent rights

( Vivian Fernandes | New Delhi , 24-May-2017 , The Indian Express)
The agriculture ministry is not reconciled to the grip which Monsanto has on the Indian cottonseed
industry owing to the immense preference for its patented, genetically-modified (GM) bollworm-
resistance traits. More...
Nepal tea steals Darjeeling’s flavour

(Sovon Manna , 24-May-2017 , The Times Of India)
"This high quantity of deceptively similar-looking but cheaper variety is passed off as GI-registered
Darjeeling to unsuspecting Indian and overseas consumers. More...
ANALYSIS-Patent plaintiffs see way around U.S. Supreme Court ruling

(Reuters , 24-May-2017 , DNA)
Corporations are cheering a U.S. Supreme Court decision limiting where they can be sued for patent
infringement, but some intellectual property lawyers say loopholes in the ruling likely mean lawsuits will
continue to be filed in plaintiff-friendly jurisdictions. More...
Nokia settles patent dispute with Apple, signs new collaboration deal
( Reuters , 23-May-2017 , The Indian Express)
Nokia has settled its patent dispute with Apple and signed a business collaboration deal with the US
giant More...
Chitkara University ranked 4th among top Indian universities for filing 46 patents
(ANI , 18-May-2017 , DNA)
Chitkara University ranking is published on Page 20 of the Indian Patents annual report 2015-16. More...
GM crops: Centre fires salvo against patents, says Monsanto is lying on BT cotton seeds
(FE Bureau | New Delhi , 17-May-2017 , Financial Express)
Even as the government stance on giving a nod to GM mustard remains unclear, it has mounted a fresh
salvo against GM crops, the patents granted to them and the royalties associated with such patents.
More...
Humour: To counter Kapil Mishra, Kejribawal applies for patent over drama
(Vikram Bhalla , 16-May-2017 , The Times Of India)
Delhi CM (Critic Minister) today checkmated Kapil Mishra and all future rebel MLAs by applying for patent
over drama. More...
Two women among four new high court judges

(Abhinav Garg , 16-May-2017 , The Times of India)
The Delhi high court on Monday achieved the rare distinction of having 10 women judges out of a total
working strength of 38. More...
TVS bags patent for hybrid drive system in two-wheelers

(THE HANS INDIA , 16-May-2017 , The Hans India)
The Chennai patent office has finally awarded TVS a patent for a power propulsion system for a hybrid
two-wheeler. More...
Google gets big boost in India, awarded patent for system to spot good and bad phrases
(Sajan C Kumar | New Delhi , 13-May-2017 , Financial Express)
Search engine major Google has been granted an Indian patent for an invention related to an
informational retrieval system that uses phrases to index, search, rank and describe documents in the
document collection. The system is adapted to identify phrases that have sufficiently frequent and
distinguished usage to indicate that they are valid or good […] More...
India’s IPR policy a good first step, needs to address gaps, says US industry
(PTI | Washington , 13-May-2017 , Financial Express)
India’s national intellectual property regime (IPR) policy announced a year ago is a "good first step", but
the country needs to address the gaps in it to attract more foreign direct investment and global talent, a
US industry representative said today. More...
Mysuru startup rolls out 25 patents in just 18 months, more to come

( Vincent D’Souza | Express News Service , 11-May-2017 , The Indian Express)
Twenty-five patents in a span of 18 months and many more in the pipeline. This is not Japan’s Shunpei
Yamazaki or Australia’s Kia Silverbrook who hold nearly 10,000 patents each, but a start-up founded by
a few youngsters from Mysuru. More...
Bt cotton: Centre to soon allow commercial use of 3 locally made varieties

(Sanjeeb Mukherjee | New Delhi , 11-May-2017 , Business Standard)
The three variants are expected to be priced lower than current ones; seeds would be reusable. More...
Apple gets iTunes-like Indian patent for media programme
(Sajan C Kumar | Chennai , 11-May-2017 , The Financial Express)
Apple has been granted an Indian patent for a media management program, akin to its own iTunes,
which will help viewers enjoy graphical interface while browsing through multiple browsers. More...
US decision to keep India in its watchlist on IPRs is unilateral; move not recognised by India:
Nirmala Sitharaman
(Banikinkar Pattanayak , 10-May-2017 , The Indian Express)
Commerce and industry minister Nirmala Sitharaman says the US decision to keep India in its priority
watchlist on intellectual property rights (IPRs) is a unilateral move that India doesn't recognise. More...
An analysis of generic medicines in India

(Gudipati Rajendera Kumar , 09-May-2017 , THE HANS INDIA)
Generic medicines in India have received a new impetus with Prime Minister Modi himself advocating the
usage of these medicines. Doctors will now be required to prescribe generic formulations of medicines,
as opposed to specific brands. More...
Govt pushes for patent to revive the dying legacy of Kolhapuri chappals
(Dipti Singh | Mumbai , 10-May-2017 , The Indian Express)
The profit margins for Lokare and Satpute’s workshop have shrunk from 40 per cent and 35 per cent a
month to just 10-15 per cent, the two claim. More...
MIT engineer receives patent for invention

The Indian Patent Office has granted patent to an invention by Raghunath Manohar of Manipal Institute
of Technology (MIT), a constituent of Manipal University. More...
TVS Motor gets patent for a hybrid two-wheeler with an unusual drive setup
(FE Online , 08-May-2017 , The Financial Express)
After almost a decade of TVS Motor Company filing a request for patent of a hybrid scooter, the
company has received it from the Chennai Patent Office More...
Getting Narendra Modi’s generic medicines policy right

(Tanoubi Ngangom , 8-May-2017 , Livemint)
The poorly managed documentation practices of Indian generics firms featured as the primary criticism
flagged by foreign regulatory authorities. More...
After Banaganapalle Mangoes, state to pitch four more crops for GI tag
(Manish M | TNN , 6-May-2017 , The Times Of India)
With the Banaganapalle mangoes getting GI (Geographical Indication) registration tag recently, the
horticulture department is gearing up to pitch four more horticultural crops for the tag. More...
Hyundai gets India patent for cost-effective molding crash pad

Hyundai had filed the patent application in 2008 at the Delhi patent office. More...
Pharma companies file 15% of patents in India: Report

(Viswanath Pilla Moneycontrol News , 05-May-2017 , MoneyControl)
Around 15 percent of the total 1.3 lakh patents filed in India from 2013 to 2015 was contributed by the
pharmaceutical industry, according to report by Clarivate Analytics More...
India needs to address IPR, tax issues for ease-of-doing- business: US diplomat
(PTI , 5-May-2017 , The Financial Express)
To improve ease-of-doing-business, India must address issues like protection of intellectual property
rights and rationalise taxes and tariffs, a senior US diplomat said here today. More...
Andhra Pradesh’s Banganapalle mango gets Geographical Indication tag

(Yunus Y. Lasania , 5-May-2017 , Livemint)
The Banganapalle mango has got a Geographical Indication (GI) tag, making Andhra Pradesh the
proprietor of the variety know for its sweetness More...
IPAB tottering without head, tech members

(A Subramani , 3-May-2017 , The Times Of India)
It is a first anniversary any self-respecting statutory body would strive to forget. Come May 13, the
Intellectual Property Appellate Board (IPAB) will complete one year without a regular chairman. More...
Patent issues challenging, but India’s IPR regime balanced and neutral: Monica Magnusson
(Danish Khan , 02-May-2017 , The Economic Times)
It is becoming increasingly challenging for Ericsson to deal with handset companies over fair, reasonable
and non-discriminatory (FRAND) terms and conditions to license its standard-essential patents (SEPs)
around technologies like 2G and 3G among others, said Monica Magnusson, VP of IPR Policy and
Communication at IPR & Licensing at Ericson. More...
Manipal Institute of Technology engineer receives patent for his invention

(Kevin Mendonsa , 02-May-2017 , The Times Of India)
The Indian patent office has granted patent to the invention of Raghunath Manohar of Manipal Institute
of Technology, Manipal University. More...
A robust IPR regime is necessary for growth

(Ashish Bharadwaj , 2-May-2017 , Livemint)
Innovators and entrepreneurs must trust the patent system for intellectual property rights (IPR) if they
are to embark on risky innovation gambles More...
India protests ‘unparliamentary’ remarks by US delegate at WTO

(D Ravi Kanth , 01-May-2017 , Livemint)
An American delegate at the WTO described certain procedural concerns raised by India as being
‘synonymous with their national identity to be obstructionist’ More...
U.S. to probe Japanese, German automakers over alleged patent violations

(Reuters Tokyo , 01-May-2017 , Hindustan Times)
The USITC listed 25 companies in the probe, including BMW, Honda Motor Co Ltd, Toyota Motor Corp,
along with Japanese parts suppliers Aisin Seiki Co Ltd and Denso Corp. More...
US retains India under intellectual property rights priority watch list

(Asit Ranjan Mishra , 29-Apr-2017 , Livemint)
US says despite positive statements and initiatives upon which the Modi administration has embarked,
the pace of reform has not matched high-level calls to foster innovation More...
Govt's aim is to make IPR policy more efficient: Nirmala Sitharaman

(BS B2B Bureau | New Delhi , 28-Apr-2017 , Business Standard)
India's IPR policy is TRIPS compliant and forward looking, says the Minister of Commerce & Industry
More...
Wait time for patent examination to be cut to 18 months by March 2018

(Subhayan Chakraborty | New Delhi , 28-Apr-2017 , Business Standard)
Current wait time for patents is at 48 months More...
Commerce and Industry Minister says mindset of the government is to make IPR(Intellectual
Property Rights) policy more efficient
(MJPS , 27-Apr-2017 , Business Standard)
Commerce and Industry Minister says mindset of the government is to make IPR(Intellectual Property
Rights) policy more efficient More...
Not many people in India know why they should protect innovative ideas’
People in India are not aware about the benefits of protecting their innovative ideas, which is the reason
for the low rate of filing patents in the country, said R Muthukumar, CEO of DexPatent Trichy, during an
interaction with students at National Institute of Technology (NIT-T) held as part of World Intellectual
Property (IP) day on Wednesday. More...
Facebook gets patent for tech to provide user-profile data to third party
(Sajan C Kumar , 27-Apr-2017 , The Financial Express)
India's patent office has granted a patent to Mark Zuckerberg-led Facebook for an invention relating to a
method for providing a third party the access to user-profile data maintained by the social network
website More...
Science fairs can wait; get your finding patented first

(TOI , 26-Apr-2017 , The Times Of India)
On World Intellectual Property Day, colleges should sensitise students on protecting ideas & innovations
More...
Seed firm appeals against HC order upholding Monsanto patent

(PTI , 26-Apr-2017 , DNA)
Hyderabad-based Nuziveedu seeds today moved the Delhi High Court against its single judge order
rejecting its claim that US-based agro major Monsanto was incorrectly granted patent for BT cotton
seeds. More...
Science fairs can wait; get your finding patented first

One of the biggest problems intellectual and creative circles in Tamil Nadu suffer from is a lack of basic
awareness about intellectual property rights. More...
Innovate in India, IPR is the key

(ET Bureau , 26-Apr-2017 , The Economic Times)
All are Indo-American innovations that are making a difference in people's lives. More...
Varanasi based NGO gets National Intellectual Property Award

(Binay Singh , 25-Apr-2017 , The Times Of India)
A city based NGO Human Welfare Association (HWA) has been selected as a winner of National
Intellectual Property (IP) Award for the year 2017 in the category of "top individual/organisation for best
facilitation of registration of GI and promotion of registered GI in India. More...
Can India innovate? Fact is that even successful Indian startups are often modelled on
Western businesses
(RK Mishra , 25-Apr-2017 , The Times Of India)
India is the top region for innovation in Asia, as per a recent report. This might seem like excellent
news, till we ask how much of this innovation is truly Indian? According to the Patent Office, over 70%
of the patents filed in the country are by MNCs. Indian companies and academia share the remaining
30%. Currently, we rank 66th on the Global Innovation Index list. That places us 41 places behind
China. More...
Intellectual Property: Government extends IP protection scheme for startups till 2020
(ENS Economic Bureau | New Delhi , 25-Apr-2017 , The Indian Express)
Startups covered under SIPP will not be required to obtain certificate of an eligible business from the
Inter-Ministerial Board of Certification More...
GI tag for Ratnagiri & Devgad alphonso to keep fakes at bay

(Aishwarya Upadhye , 21-Apr-2017 , The Times Of India)
No longer will fruit vendors trick people into buying any mango by passing it off as Ratnagiri or Devgad
alphonso. More...
H1B visa talks: In first round, India, US fail to find solution, issue set to linger
(Banikinkar Pattanayak | New Delhi , 21-Apr-2017 , The Financial Express)
While assistant USTR Mark Linscott headed the US team for the talks, the Indian side was led by
additional secretary in the commerce ministry Anup Wadhawan. More...
After India, I-MAK files legal challenge against Gilead’s hepatitis C drug sofosbuvir in China
(Ramesh Shankar, Mumbai , 21-Apr-2017 , Pharmabiz)
Close on the heels of filing four patent challenges in India, two on daclatasvir, one on velpatasvir and
another on sofosbuvir, the international NGO-- Initiative for Medicines, Access & Knowledge (I-MAK), in
association with other NGOs, has filed a legal challenge against Gilead’s remaining patent for the
hepatitis C medicine sofosbuvir in China. More...
India sees high patent growth: Report

India recorded the highest growth of 26 per cent in terms of published patents during 2013-15 in Asia, a
report said. More...
India logs highest growth among Asian peers in published patents for 2013-15: Report
(Viswanath Pilla , 19-Apr-2017 , MoneyControl)
According to a report Clarivate Analytics, polymers and plastics, computing, pharmaceuticals and
telecommunications were the top 4 sectors that contribute about two-thirds of total patents filed in
India. More...
Indian handmade carpets may get government trademark

The government is developing standards and a trademark to reinforce India’s position as the top source
of handmade carpets and ensure that products comply with quality benchmarks. More...
Patent awaited for self-defense device

Patent for a cost-effective self-defence device for women featuring embedded hardware and software
application, developed by an alumnus of Velalar College of Engineering and Technology, Erode, is going
through accelerated clearance process, having qualified under the Startup India Action Plan of the Union
Ministry of Commerce and Industry launched by Prime Minister Narendra Modi last year. More...
Genomic boost to protect Assam's muga silkworm

(IANS | Kolkata , 17-Apr-2017 , Business Standard)
A "snapshot" of the muga silkworm genome decoded by Indian scientists offers vital clues for imparting
disease-resistance to help conserve the economically important insect which spins the distinctive golden
yellow fabric synonymous with Assam. More...
Modi says govt will bring law to push doctors to prescribe generic medicines
(Saubhadra Chatterji , 17-Apr-2017 , Hindustan Times)
Making medicines cheaper is a politically sensitive issue in India. More...

Trademarks by foreign firms doubled in 2015-16: Report
Trademark applications in the country filed by foreign companies have doubled to 15,670 in 2015-16,
reflecting renewed interest in Indian market. More...
NIT-T to set up task force on patent filing

(C. Jaisankar , 13-Apr-2017 , The Hindu)
Stating that it was a team effort that eventually put National Institute of Technology-T (NIT-T) on top of
National Institutional Ranking Framework (NIRF) 2017 among 31 NITs and 11th among all engineering
institutions in the country, Mini Shaji Thomas, Director, NIT-T, said that it would shift the focus on
patent filing and generating revenue from patents. More...
New site to guide young inventors applying for patents

(Ankita Bhatkhande , 10-Apr-2017 , DNA)
Website is set to be launched on April 26, which is celebrated as the World Intellectual Property Day
More...
TVS, Tata Motors, Bosch, M&M top ‘innovators list’ in Motown

(Nandini Sen Gupta , 08-Apr-2017 , The Times of India)
TVS Motor, Tata Motor, Bosch and Mahindra & Mahindra top the list of R&D-led innovators in the
automobile industry in India though the sector as a whole comes in at 7th position in terms of patents
published, lower than food and fermentation. More...
India not leveraging R&D benefits

(Apurva Venkat | Bengaluru , 8-Apr-2017 , Business Standard)
Advantages are not being leveraged fully mainly because of lack of funds, say experts. More...
MP Dhananjay Mahadik seeks patent for Kolhapuri chappal

The Kolhapuri chappal makers are awaiting approval for patenting of the product since the last five
years. More...
Undergraduate student at Jipmer files patent

A third year MBBS student at Jipmer has filed his first patent for an innovation targeted towards helping
stroke and comatose patients. More...
The case by Star India and Vijay TV challenging the jurisdiction of the Telecom Regulatory
Authority of India in the matter of tariff orders took a surprising turn when the two judges --
Justice S Nagamuthu and Justice Anita Sumanth recused themselves from the case and
referred it to the chief justice for being referred to another bench.
(indiantelevision.com Team , 4-Apr-2017 , Indian Television)
The case by Star India and Vijay TV challenging the jurisdiction of the Telecom Regulatory Authority of
India in the matter of tariff orders took a surprising turn when the two judges -- Justice S Nagamuthu
and Justice Anita Sumanth recused themselves from the case and referred it to the chief justice for
being referred to another bench.dramatic-turn-as-judges-withdraw-170404 More...
Google announces ‘Pax’ for cross-licensing of Android patents

(Tech Desk | New Delhi , 4-Apr-2017 , The Indian Express)
Google has announced Pax, a new licensing agreement group for patents across Android devices More...
Malaysian PM Najib Razak pushes for conclusion of trade deal

(Elizabeth Roche , 4-Apr-2017 , Livemint)
India and Malaysia sign business pacts worth about $36 billion during Najib Razak’s visit More...
Nellore's Udayagiri wooden cutlery gets Geographical Identification tag

(PATHRI RAJASEKHAR , 4-Apr-2017 , DECCAN CHRONICLE)
Geographical indication indicates products which come from a specific region. More...
Indian co faces HC ire for infringing Bridgestone trademark

(PTI , 03-Apr-2017 , India Today)
Two top officials of an Indian tyre company had to spend a night in jail and directed by the Delhi High
Court to shell out Rs 35 lakh for infringing the trademark of Japanese tyre maker Bridgestone. More...
India’s bilateral relationship with major powers

(THE HANS INDIA , 3-Apr-2017 , THE HANS INDIA )
Recently, all founding nations of TPP met barring USA with presence of China. More...
India in a bind as Russia, China plan investment facilitation talks

(D. Ravi Kanth , 3-Apr-2017 , Livemint)
New Delhi piqued as negotiations will be almost on lines of its proposal on trade facilitation for services
More...
Udayagiri wooden cutlery to get GI Tag

(THE HANS INDIA , 1-Apr-2017 , THE HANS INDIA)
After Venkatagiri sari achieved GI tag in 2009, now it is the turn of exquisite and excellent craft in the
district, Udayagiri Wooden Cutlery to get the GI (Geographical Indication) tag. More...
MSF files patent challenge on hepatitis C drug sofosbuvir with European Patent Office
(Ramesh Shankar, Mumbai , 31-Mar-2017 , Pharmabiz)
Even as four cases challenging patent on hepatitis C drugs sofosbuvir, velpatasvir and daclatasvir are
pending in Indian Patent Office, the international medical humanitarian organisation Médecins Sans
Frontières (MSF) has filed a patent challenge on sofosbuvir with the European Patent Office (EPO) in an
effort to increase access to affordable hepatitis C treatment. More...
Monsanto loses trademark infringement suit against Nuziveedu Seeds
(India Infoline News Service | Mumbai , 29-Mar-2017 , India Infoline News Service)
Monsanto Technology LLC’s trademark infringement suit against Nuziveedu Seed Limited has been
dismissed by the Delhi High Court on Tuesday. More...
Suven Life gets product patent for neuro-degenerative molecule

(PTI , 28-Mar-2017 , Business Line)
Suven Life Sciences has received one product patent from New Zealand for its molecule to be used in
the treatment of neuro-degenerative diseases. More...
Copyright watchers back Illaiyaraaja; industry says it complies with rule

(Bindu D Menon , 24-Mar-2017 , Business Line)
Is music maestro and composer IIaiyaraaja right in sending a legal notice to singers SP
Balasubrahmanyam (SPB), Chitra and Charan over performing of his compositions? More...
The compulsive patent hoarding disorder

( Feroz Ali, Shweta Mohandas , 24-Mar-2017 , The Hindu)
The current model of commercialisation does not work for publicly funded research More...
Honda Motor makes India an export hub. Read how

(24-Mar-2017 , The Economic Times)
To that end, HMC has started registering in the country intellectual property rights (IPR) of its
technology for two-wheelers, a move that would help retain India as the lead market for the parent
company over the next decade. More...
Centre considering stringent Intellectual Property Rights regime: I&B secretary

(PTI | Mumbai , 21-Mar-2017 , The Indian Express)
He said the ministry was in talks with the Department of Industrial Policy and Promotion (DIPP) on the
implementation of a new national IPR policy. More...
TVS Motor's bikes to get new antilock brake system with grant of patent
(Gireesh Babu , 21-Mar-2017 , Business Standard)
TVS Motor has bagged a patent for its antilock brake system (ABS) for motorcycles. The new system
helps to overcome the problems, defects and drawbacks encountered in the previous models. The
company is currently using the ABS technology in its high-end motorcycle TVS Apache, in collaboration
with German component manufacturer Continental Corporation. More...
Ilaiyaraaja's rights tune splits IPR experts

(Ranjani Ayyar , 21-Mar-2017 , The Times of India)
When he ruled the Tamil film music world, all of Ilaiyaraaja's time and energy went into conjuring up
tunes and background music. More...
Government aims to make India a global Biotech Hub by 2020
(Business Wire India , 20-Mar-2017 , Business Line)
The Biotechnology Industry Research Assistance Council (BIRAC) celebrated its 5th Foundation Day on
Monday in New Delhi. More...
Lilly loses a heated patent row with the Canadian government

(17-Mar-2017)
An international tribunal sided against Eli Lilly in a closely watched claim that the drug maker brought
against the Canadian government over its right to set patent laws. More...
Lilly loses a heated patent row with the Canadian government

(ED Silverman , 17-Mar-2017 , Statnews)
An international tribunal sided against Eli Lilly in a closely watched claim that the drug maker brought
against the Canadian government over its right to set patent laws. More...
Indra Nooyi-led PepsiCo gets Indian patent for wonder beverage preservative system
(Sajan C Kumar | Chennai , 17-Mar-2017 , The Financial Express)
Many food and beverage products include chemical preservatives to extend the shelf life of the product
by inhibiting the growth of spoilage microorganisms such as mold, yeast and bacteria. More...
Ip Environment In India - An Insight Of Opportunities And Threats

(Monika Shailesh , 16-Mar-2017 , mondaq)
India is believed to have an incredible potential to become one of the world's leading markets and hub
for the innovation, research and development. Intellectual property industry is assessed to have a huge
growth potential in the current Indian and Global context. Intellectual Property Rights (IPRs) unarguably
are emerging as a strategic business tool for any business organization to enhance its competitiveness.
More...
Amazon has an idea for delivery drones with robotic wings and legs to help them land
(Arjun Kharpal , 16-Mar-2017 , CNBC)
Amazon has been awarded two patents in which it outlines propellers with robotic adjustable wingtips
and legs that act as landing gears to help drones touch down on uneven surfaces. More...
U.S. trade nominee for ‘aggressive’ steps on IP

(Varghese K George , 16-Mar-2017 , The Hindu)
IPRs have been a bone of contention between U.S., India More...
Adidas trademark war means three stripes and you’re out

(Kim Bhasin , 16-Mar-2017 , Livemint)
Almost everything Adidas makes has the three stripes, and the company wages a constant war to snuff
out anyone who dares use something similar More...
India wants intl legal regime to protect traditional knowledge
(PTI , 15-Mar-2017 , DNA)
India wants an effective legal international regime to stop misappropriation and reckless patenting of
traditional knowledge like healing properties of neem and turmeric. More...
US court favours Aurobindo in patent case on cough & cold drug

(Dasarath Reddy | Hyderabad , 15-Mar-2017 , Business Standard)
The court has scheduled a five-day bench trial beginning April 17 to deliver a final judgment More...
Delhi HC bars Cipla from selling Novartis’ respiratory drug

(Priyanka Mittal / Isha Trivedi , 10-Mar-2017 , Livemint)
Delhi high court bars Cipla from selling copies of Novartis respiratory drug Onbrez in India, upholding
the patents held by the swiss drug maker More...
Inside Views: Patent Data – The Modern Investor’s Crystal Ball

( Sirena Rubinoff , 10-Mar-2017 , Intellectual Property Watch)
What if there was a crystal ball that could tell you where and when to invest your money? It sounds like
science fiction, but engineers at MIT have actually developed a formula that can predict future events in
tech development. The formula is based on a combination of big data from patent applications and
smart analytics which, when put together, can estimate how fast a technology is advancing. More...
No GI tag for Hyderabadi biriyani, applicant fails to provide supports

(PTI , 09-Mar-2017 , DNA)
The 'Hyderabadi Biryani' has failed to secure the Geographical Indications tag as the applicant for it
could not prove the historical origin and data relating to the delectable dish with supporting documents,
according to the GI registry in Chennai. More...
Balanced prescription
(09-Mar-2017 , Business Line)
The Delhi HC ruling on Nexavar upholds the compulsory licensing principle More...
Firms allowed to export patented drugs

(Akanksha Jain , 9-Mar-2017 , The Hindu)
The Delhi High Court on Wednesday allowed two Indian pharmaceutical companies — Natco and Alembic
— to export generic versions of German drug major Bayer’s patented invention Sorafenib, used in
treatment of kidney cancer, and Rivaroxaban, which is a blood thinner, for research and development
purposes. More...
India Inc can now register trademark as ‘well-known’

(Lubna Kably , 8-Mar-2017 , The Times Of India)
In a significant development, the Trade Mark Rules 2017 — which were notified on March 6 — permit
companies to apply for their trademark to be recognised as a 'well-known' one. More...
Cadila's US subsidiary settles case with US company
(Rupali Mukherjee , 07-Mar-2017 , The Times Of India)
Cadila Healthcare and its US subsidiary Zydus Pharmaceuticals announced that they have finalized an
agreement with Supernus Pharmaceuticals, Inc, to settle all outstanding patent litigation related to
Trokendi XR (topiramate) extended-release capsules. More...
India, China team up against West’s pressure on drug patent norms

(AMITI SEN , 06-Mar-2017 , Business Line)
Brazil, S Africa also on board; seek WTO parleys on UN report suggesting stricter IPR regime More...
HC seeks reason for denial of prostrate cancer drug patent

(PTI Feeds , 05-Mar-2017 , India.com)
The Delhi High Court has asked the Centre to explain on what basis the Indian patent office has rejected
the application by the Regents of University of California seeking a pat More...
Samsung trademarks ‘Infinity Display’ for the Galaxy S8: Report

( Tech Desk , 05-Mar-2017 , The Indian Express)
Samsung has already announced an event on March 29 in New York where it makes the Galaxy S8 and
Galaxy S8+ official. More...
Intellectual property rights: Patent grants jump by nearly half

(Surbhi Prasad , 3-Mar-2017 , The Financial Express)
The easing of the procedures for appraisal/grant of intellectual property rights (IPRs), announced in May
2016, has resulted in far quicker disposal of applications and reduced the backlog substantially. More...
Bitcoin ‘creator’ races to patent technology with fugitive gambling tycoon

(Byron Kaye, Jeremy Wagstaff , 02-Mar-2017 , Livemint)
Craig Wright, who claims to be bitcoin’s creator, is working with a fugitive online gambling entrepreneur
to file scores of patents relating to Bitcoin and blockchain More...
The weak ‘I’ in India; country underperforms on innovation, investment and competition
(The Financial Express , 2-Mar-2017 , The Financial Express)
Last month, the US Chamber released the fifth edition of the International Intellectual Property (IP)
Index, which benchmarks IP standards in 45 economies around the world. More...
US investors still concerned over compulsory licensing in India

(NAYANIMA BASU , 01-Mar-2017 , Business Line)
Section 3(d) of the Indian Patents Act prevents ever-greening of patents unless it differs significantly in
properties with regard to efficacy More...
U.S. appeals court tosses patent verdict against Apple

(Reuters , 01-Mar-2017 , The Times Of India)
A federal appeals court has thrown out a jury verdict that had originally required Apple Inc to pay $533
million to Smartflash LLC, a technology developer and licenser that claimed Apple's iTunes software
infringed its data storage patents. More...
Copyright case against Rangoon

(23-Feb-2017 , The Times Of India)
Its director Vishal Bhardwaj is defending allegations that the film's swashbuckling 1940s movie star
character is copyright violation of 'Fearless Nadia' a stunt actor of the 1930s and '40s. More...
Patent office hopes to halve backlog by March 2018

(Shishir Arya | TNN , 23-Feb-2017 , The Times Of India)
With the appointment of 460 examiners, the office of Controller General of Patents is aiming to reduce
the backlog by over half till March 2018. More...
From Trump, the nationalist, a trail of global trademarks

(Danny Hakim & Sui-Lee Wee , 22-Feb-2017 , Business Standard)
Trump has cast himself as the anti-globalist president but as a businessman, it's a different story More...
US law makers non-committal on rethink of H-1B visa norms

(AMITI SEN , 22-Feb-2017 , Business Line)
Ask India to make patent laws stricter. More...
Bajaj Electricals renews trademark license agreement with Morphy Richards for next five year
(Tejal Yerunkar , 21-Feb-2017 , Zee Business)
Bajaj Electricals announced on Tuesday of extending its trademark license agreement for the next five
years with the UK-based electrical appliances company Morphy Richards starting from April 25 this year.
More...
Healthcare, patient groups oppose hep-C drug patents

(Rupali Mukherjee | TNN , 21-Feb-2017 , The Times Of India)
Healthcare aid and patient groups have come together in patent courts to fight against "abusive
strategies" of Big Pharma to ensure access to affordable treatment in hepatitis C. More...
India discusses H1B visa, IPR issues with US lawmakers

(PTI, New Delhi , 21-Feb-2017 , Hindustan Times)
India on Monday discussed several issues, including the proposed restrictions on H1B visa programme
and intellectual property rights (IPRs), with visiting US lawmakers. More...
HomeIndustry Mark Zuckerberg’s Facebook gets patent in India for creating relationship-
based content Mark Zuckerberg’s Facebook gets patent in India for creating relationship-
based content
(Sajan C Kumar | Chennai | , 21-Feb-2017 , The Financial Express)
The social networking major will provide database for storing relationship info More...
Indian Government To Discuss H-1B Visa Issues With US Lawmakers Today

(Press Trust of India , 21-Feb-2017 , NDTV)
The meeting comes at a time when the new Trump administration in the US is proposing an overhaul of
the popular H-1B visa regime, raising concerns among Indian IT firms. More...
Domestic pharmaceutical firms seek removal of India from USTR list of weak IPR regimes
(Dibyajyoti Bhattacharjee , 17-Feb-2017 , The Financial Express)
The Indian Pharmaceutical Alliance (IPA), which comprises top-notch domestic drug companies, has
dispatched a letter to the United States Trade Representative (USTR), making a strong case for removal
of India from its Priority Watch List (PWL) on intellectual property rights (IPR) in its 2017 edition. More...
Dr Reddy’s gets unfavourable patent ruling

(ENS Economic Bureau | Hyderabad , 17-Feb-2017 , The Indian Express)
The injection is used to help prevent nausea and vomiting due to chemotherapy. More...
Patents expiry to boost agrochemical firms' sales, profit

(Ashish Kulshrestha , 16-Feb-2017 , The Economic Times)
Indian agro-chemical firms are preparing to launch dozens of new products over the next few years that
could significantly boost their sales and profits as molecules worth over $4.1 billion (over Rs 26,000
crore) are going off patent by 2020. Of this, nearly $1.6 billion (over Rs 10,000 crore) worth molecules
are going off patent by end of current year itself. More...
India defends IP rights despite threats from US pharma lobby groups

(Divya Rajagopal , 16-Feb-2017 , The Economic Times)
A week after the US Chamber of Commerce released its Global Intellectual Property Report that named
India among worst countries in terms of IP rights, the commerce ministry has stood its ground by asking
those discontented with the country’s IP regime to take up the issue at multilateral trade channels.
More...
Apple patent reveals fingerprint scanner built inside iPhone display

(Tech Desk , 16-Feb-2017 , The Indian Express)
The next iPhone could have no home button and a screen that scans the fingerprints, a newly published
patent has revealed. More...
Dr Reddy’s hits fresh 52-week low after patent infringement confirmation

(ETMarkets.com , 16-Feb-2017 , The Economic Times)
Shares of Dr Reddy’s Laboratories hit fresh 52-week low of Rs 2,803.50 in early trade on Thursday after
the United States District Court for the District of New Jersey issued its opinion regarding Helsinn
Healthcare’s patent infringement claims against Dr Reddy’s Laboratories proposed palonosetron product.
More...
Time to Break in India
(Shamnad Basheer , 16-Feb-2017 , The Hindu)
There is no point in hitching our bandwagon to what will soon be an obsolete patent game. We must
think through alternative innovation incentives such as prizes and open source formats More...
India defends IP rights despite threats from US pharma lobby groups

(PTI , 15-Feb-2017 , The Economic Times)
India's Intellectual Property Rights regime has consistently fallen short of international best practices
and the recent steps taken by the country under the IPR policy remain "merely aspirational", the US
Chambers of Commerce has said. More...
Major setback for Aurobindo, Mylan wins patent case

In a major setback for homegrown pharma player Aurobindo Pharma, US-based pharma bahemoth
Mylan has won a court ruling in a patent case in a US district court as a result of which Aurobindo will
have to stop selling Isosulfan Blue in the US market. More...
Healthcare and patient groups oppose patents on crucial hepatitis C drugs

(Rupali Mukherjee , 15-Feb-2017 , The Times Of India)
Healthcare aid and patient groups have come together in patent courts to fight against ``abusive
strategies'' of Big Pharma, to ensure access to affordable treatment in hepatitis C. More...
Indian & MNC pharma cos scout for qualified pharmacy graduates & post graduates to work in
regulatory depts
(Nandita Vijay, Bengaluru, , 15-Feb-2017 , Pharmabiz)
Regulatory departments of domestic and multinational companies in the country along with and drug
control departments and start-up enterprises are scouting for qualified pharmacy graduates and post
graduates, said Dr. Shenaz Khaleeli, founder and technical director, PharmaLeaf India. More...
US pharma sector demands keeping India in patent violator list

(Lalit K Jha , 14-Feb-2017 , Livemint)
American pharma sector asks US Trade Representative to continue to keep India on its priority watch list
claiming that the environment on the ground remains ‘challenging’ More...
Hepatitis C Patent Challenges In India, Argentina To Allow Generic Production

( CATHERINE SAEZ , 14-Feb-2017 , INTELLECTUAL PROPERTY WATCH)
Resistance to high prices for hepatitis C drugs is ongoing as five new challenges against patents have
been filed in India and Argentina, according to sources. More...
Maintaining a tricky balance on IPR

(Livemint , 14-Feb-2017 , Livemint)
India must strengthen its intellectual property rights infrastructure without giving in to US pressure to
do away with the flexibility granted by WTO regulations. More...
Agriculture department to adapt Union Budget proposals
(Salim Joseph , 14-Feb-2017 , The Times Of India)
The state agriculture department is gearing up to take the Union Budget proposals 'in the right
perspective and dovetail the schemes to give maximum benefits to farmers in the state'. More...
‘Violation of copyright’: Bombay High Court restrains release of translated edition of

Bhagavad Gita
(Radhika Ramaswamy | Mumbai , 14-Feb-2017 , The Financial Express)
The Bhaktivedanta Book Trust told the court that they hold the copyright of Srimad Bhagvatam. More...
Indian Pharmaceutical Alliance demands exclusion of India from USTR Priority Watch List
(Laxmi Yadav, Mumbai , 14-Feb-2017 , Pharmabiz)
In a move aimed at removal of India from the USTR Priority Watch List, Indian Pharmaceutical Alliance
(IPA) has filed its submission to the USTR for 2017 Special 301 Review citing in support several actions
taken by the government for improving the IPR environment and enforcement.. More...
PM Narendra Modi’s Make-in-India is facing the IPR drag

(Santosh Tiwari , 13-Feb-2017 , The Financial Express)
India’s poor 43/45 rank in global IP index of the US Chamber of Commerce’s Global Intellectual Property
Center is worrisome, and India must attune its handling of the Intellectual Property issues to the global
standards. More...
Generic drugs
(THE HANS INDIA , 11-Feb-2017 , THE HANS INDIA )
The Central government is targeting launch of 3,000 Pradhan Mantri Bhartiya Janaushadhi Kendras
(PMBJKs) to sell generic drugs across the country March 2017. More...
Domestic drug makers ask US to remove India from IP watch list

(Aneesh Phadnis | Mumbai , 10-Feb-2017 , Business Standard)
Pharma body moves USTR, says no cases of compulsory licensing or patent revocation in last two years
More...
Indian pharma asks US to exclude India from list of IPR offenders

( PB Jayakumar , 10-Feb-2017 , Business Today)
The Indian pharmaceutical industry has urged the Office of the United States Trade Representative
(USTR), to remove India from its Priority Watch List (PWL) of countries having lax patent laws, which
harm interests of the US drug companies. More...
HC dismisses Sun Pharma's plea against Mylan on Oxaliplatin trademark case

(Sayan Ghosal & Veena Mani | New Delhi , 10-Feb-2017 , Business Standard)
Delhi High Court allows companies to approach bench after IPAB order More...
TPP is dead, but its legacy lives on
(Arjun Jayadev , 10-Feb-2017 , The Hindu)
The Trans-Pacific Partnership was dead long before Donald Trump signed his executive order. But its
damaging aspects, like stringent IP provisions, have just migrated to other agreements More...
Education: India’s innovation agenda is a work-in-progress

(Avirup Bose | New Delhi , 10-Feb-2017 , The Financial Express)
Most of India’s science and technology universities do not have a former IPR policy to sync R&D efforts.
Lack of IPR awareness, formal technology transfer, and licensing policies ensures that results of new
R&D efforts are quickly disseminated; this results in loss of patentability and commercial use. More...
India has the potential to become a leader among innovative economies

(Mark Elliot , 10-Feb-2017 , The Economic Times)
The next life-saving medical treatment, the next groundbreaking technology, the next fashion icon, the
next hit book, song and movie: all could be made in India. More...
Intellectual Property index: India remains near bottom

(SPECIAL CORRESPONDENT , 09-Feb-2017 , The Hindu)
India remains near the bottom in an international Intellectual Property (IP) index by being ranked 43rd
out of 45 countries, according to a report by the U.S. Chamber of Commerce’s Global Intellectual
Property Center (GIPC). More...
MNC pharma lobby pushes for single drug authority here

(C R Sukumar , 9-Feb-2017 , The Economic Times)
Alobby group of multinational pharmaceutical companies (MNCs) is pushing for replacing statebased
multiple drug authorities with a single body for more effective protection of intellectual property (IP) and
patents. More...
Commercial disputes: How India’s bid to make farmers self-sufficient is being harmed by
policy aberrations
(Ram Kaundiya , 9-Feb-2017 , The Financial Express)
Without any doubt India needs to apply modern science and technology in agriculture if it has to move
farmers from a position of distress to a point of prosperity and become self-sufficient in the times to
come, and in fighting climate change. More...
India ranks 43rd out of 45 nations in IP environment:

India continues to languish near the bottom in an international intellectual property index, ranking 43rd
out of 45 global economies, according to a report by the US Chamber of Commerce's Global Intellectual
Property Center (GIPC). More...
India continues to fall behind others on patent protection, says US Chamber of Commerce
(Kirtika Suneja , 08-Feb-2017 , The Economic Times)
India continues to lag behind other emerging economies when it comes to protection of intellectual
property and ranks near the bottom of the pack for fifth year in a row, as per the International IP Index
prepared by the US Chamber of Commerce. More...
India says ‘cheers’ to new varieties of grapes

( Banikinkar Pattanayak | New Delhi , 7-Feb-2017 , The Indian Express)
Established foreign companies are learnt to be looking for upfront payment, as they fear their rights
over patented grape varieties may not be well protected in India. More...
Patent reveals Intel working on a curved 2-in-1 laptop

A new patent has revealed, which shows Intel might be working on the hybrid notebook with an
innovative design. More...
A health boost for Indian pharma sector

(A G Rajmohan , 06-Feb-2017 , THE HANS INDIA )
It has been a long established fact that pharmaceutical sector plays an important role in ensuring a
robust health sector in any country. More...
US companies seek "fair play" in India

Asserting that US businesses continue to face an "evolving array" of tariff and non-tariff barriers in
India, a group of 20 eminent American business organisations and industry groups in a letter to
Congressional leadership have sought a "fair play" for them in the huge Indian market. More...
Mihidana, sitabhog win sweet glory with geographical indication tag

(Ajanta Chakraborty , 1-Feb-2017 , The Times Of India)
As Burdwan's sitabhog and mihidana made it to the finishing line of the coveted GI (geographical
indication) tag, an enthused Bengal government sought similar honours for dokra of Bengal, Bengal
patachitra, Purulia Chhau and Kushumandi wooden masks and madurkathi. More...
Samsung files trademark for ‘Gear Fit Pro’; hints at a new wearable device
Samsung may be looking to add a new wearable device, dubbed the 'Gear Fit Pro'. More...
Indian pharma industry fears tougher US stance on IP

(Aneesh Phadnis & Reuters | Mumbai , 1-Feb-2017 , Business Standard)
Prices of patented drugs are lower in Canada, United Kingdom and Australia in comparison to the US
More...
Surveying ideas for India Surveying ideas for India

( Arvind Subramanian , 1-Feb-2017 , The Indian Express)
Economic reforms are not, or not just, about overcoming vested interests; they are increasingly about
shared narratives on problems and solutions. Economic Survey builds on this idea. More...
IIT-Kharagpur and State Bank of India develop a customised portal for intellectual property
(Somdatta Basu | TNN , 31-Jan-2017 , The Times Of India)
Indian Institute of Technology, Kharagpur and State Bank of India are collaborating to develop a
customized portal for launching 'Intellectual Property Development as a service' (IPDaas) for Intellectual
Property Rights generation. Mr. Mrutyunjay Mahapatra, Deputy Managing Director and CIO of SBI
launched this project today at IIT-Kharagpur. More...
Natco partner clears one patent hurdle for US generic launch

(BS Reporter | Hyderabad , 31-Jan-2017 , Business Standard)
This is for the generic version of a popular drug for multiple sclerosis, Copaxone 40 mg More...
Suven Life gets patent for anti-neuro degenerative drug

Drug firm Suven Life Sciences has been granted a patent by the US for a drug to cure neuro-
degenerative diseases. More...
HC allows Indian firm to export drug in which Bayer has patent

In a setback to German pharma major 'Bayer', Delhi High Court has suspended its order restraining an
Indian drug company from manufacturing and selling overseas an erectile dysfunction medicine, the
patent for which was held by the foreign company More...
Hilleman Labs gets global patents on simplifed oral cholera vaccine

(PT JYOTHI DATTA , 27-Jan-2017 , Business Line)
It is an entirely new design, says Davinder Gill, Chief Executive of Hilleman Laboratories, explaining the
innovation behind their oral cholera vaccine that has received global patents in different countries.
More...
Innovate In India: A strong intellectual property framework is critical to making India the
world’s pharmacy
(Rajiv Kumar , 27-Jan-2017 , The Times Of India)
A robust intellectual property (IP) rights framework encourages investment in innovation and promotes
the development of new product and processes. More...
Experts call for strengthening of intellectual rights protection

(JULIUS BIZIMUNGU , 27-Jan-2017 , The New Times)
Members of the judiciary from the East African Community partner states have called for more efforts to
strengthen Intellectual Property Rights (IPR) protection in the region. More...
Apple expands fight over patent licensing, sues Qualcomm

(IANS , 26-Jan-2017 , The Economic Times)
Taking its legal fight against the US chip-maker Qualcomm global, Apple has filed two complaints in
Chinese courts alleging that Qualcomm's patent-licensing practices amount to extortion. More...
Assam’s rice wine qualifies for GI registration

(IANS , 25-Jan-2017 , Eastern Mirror)
The “Judima” traditional rice wine, a popular alcoholic beverage of Assam’s Dimasa tribe — and an
integral part of the community’s social and cultural life — is a fit candidate for geographical indication
(GI) registration, a don at New Delhi’s Indian Law Institute says. More...
Suven Life gets patent for neuro-degenerative drug

Drug firm Suven Life Sciences has been granted a patent by Australia for a drug used in the treatment
of neuro-degenerative diseases. More...
Hero XF3R patent images leaked; India launch soon

(Anoop Menon , 23-Jan-2017 , India.com)
The Hero XF3R concept was first seen at the 2016 Auto Expo as a design concept. More...
FDA roadblock to city start-up’s innovation

(Rohit P.S. , 23-Jan-2017 , The Hindu)
The quick-testing device for antibiotic resistance can be launched only after approval from the US
agency More...
Intellectual property: GST expected to deal with dual taxation in time, but clarity needed in
interim
(Rajeev Dimri , 21-Jan-2017 , The Financial Express)
GST is expected to deal with the dual taxation issue over time, but there has to be clarity in the interim
More...
Merck Settles With Bristol-Meyers, Ono Over Cancer-Drug Patent

(Anne Steele , 20-Jan-2017 , The Wall Street Journal)
Merck & Co. will pay $625 million plus royalties on Keytruda sales to Bristol-Myers Squibb Co. and Ono
Pharmaceutical Co. to settle a suit alleging the cancer drug violates their patent for a method of
harnessing the body’s immune system to fight cancer. Bristol and Ono filed suit in federal court in
Delaware in 2014, the same day that Merck received U.S. Food and Drug Administration approval to
market Keytruda as a treatment for the deadly skin cancer melanoma. More...
Play the new copyright act

(Rajeev Shukla , 20-Jan-2017 , The Indian Express)
Singers, composers are denied their due as music companies profiteer More...
Two-wheeler riders mobile phone problem: TVS Motor gets patent for solution
(Sajan C Kumar | Chennai , 20-Jan-2017 , The Financial Express)
The Chennai-based auto major TVS Motor on Thursday got patent for its invention related to a cellphone
ring detecting device which will come handy for riders of two-wheelers while on the move. More...
Govt should reduce over dependence on Chinese imports of pharma raw materials
(Rahul Patni , 19-Jan-2017 , The Economic Times)
The expectations of the country from Budget 2017 has gained significance and momentum in light of the
disruption caused in the Indian economy by the demonetisation scheme, albeit for a short term. More...
Paul McCartney files lawsuit against Sony/ATV over copyright

( Associated Press , 19-Jan-2017 , The New Indian Express)
Paul McCartney says he wants his music to get back to where it once belonge. More...
The Paytm-Paypal dispute

(Roger Mendonca , 18-Jan-2017 , Business Today)
One of the most significant changes the Modi Government's demonetization scheme has brought about
in India, is an economy struggling to veer towards cashless transactions. More...
From 5 to 22 Geographical Indication tags, Uttar Pradesh comes a long way

(Binay Singh , 18-Jan-2017 , The Times Of India)
UP's journey of getting Geographical Indication (GI) tags for its exclusive products that made a modest
beginning during Mayawati's regime, took a big leap when Akhilesh government came to power. More...
To ensure success of Startup India, Digital India, regulators must encourage innovation
(Avirup Bose , 17-Jan-2017 , The Financial Express)
They should help facilitate emergence of new industrial ideas along with regulation. More...
The needle has moved for Start-up India

(CHITRA NARAYANAN , 15-Jan-2017 , Business Line)
The campaign has to put on running shoes and become speed-up India More...
Nokia could be developing a foldable smartphone, hints patent

(Tech Desk , 15-Jan-2017 , The Indian Express)
The patent for a “Foldable device” - which was filed in 2013 - features a device that resembles a pocket
mirror. More...
Relief for US firm in trademark dispute

(STAFF REPORTER , 14-Jan-2017 , The Hindu)
The Delhi High Court on Thursday set aside an arbitration award by which an IT company registered in
the US was denied relief against an Indian company using its trademark. More...
Innovators and patent holders
(Achuthsankar S. Nair , 13-Jan-2017 , The Hindu)
J.P. Subramonya Iyer was one of the early patent holders in erstwhile Travancore. More...
US firms want more clarity in India's tax policies: Official

American companies are keen on investing in India but they want to see improvement in business
climate like clarity in tax policies and streamlining of "complex" regulations, a top Obama administration
official has said. More...
US Biotech Industry Head To India’s Modi: Follow Our IP Practices, Get ‘Tidal Wave’ Of
Investment
(WILLIAM NEW , 13-Jan-2017 , INTELLECTUAL PROPERTY WATCH)
IP-Watch is a non-profit independent news service, and subscribing to our service helps support our
goals of bringing more transparency to global IP and innovation policies. More...
Research key to idea’s uniqueness: Expert

Before any new invention can be patented, extensive research must be done to ensure the idea is
unique, said patent and trademark attorney Bindu Sharma in her key note address at the national
seminar on intellectual property rights (IPR) and importance of patents to boost research, on Monday.
More...
India should adopt global IPR laws: Intellectuals at Gujarat Global Summit
At the 'Genes, Gene Editing and the New Biotechnology,' seminar at the Vibrant Gujarat Global Summit,
James Greenwood, president and CEO Biotechnology Innovation Organizations, said that if India joined
the global intellectual property rights regime, the biotech industry would see a tidal wave of expansion.
More...
IP protection, access to capital key to India's biotech wave

(Press Trust of India | Gandhinagar , 11-Jan-2017 , Business Standard)
Intellectual property protection and access to capital are two challenges facing a new wave of biotech
innovation and investment in India, according to James Greenwood, President and CEO of Biotechnology
Innovation Organization (BIO). More...
India likely to remain under ‘priority watch list’ in US IPR report

(NAYANIMA BASU , 11-Jan-2017 , Business Line)
India will continue to be under pressure for having an “ineffectual” intellectual property rights (IPR) and
patents regime even under the Donald Trump administration, which is perceived to be India-friendly.
More...
IBM tops US patent list, Indian inventors contribute 658

(Press Trust of India | New York , 10-Jan-2017 , Business Standard)
IBM inventors were granted more than 22 patents per day in 2016. More...
Implementation of Indo-Japan free trade agreement needs to be expedited: Nirmala
Sitharaman
(PTI | New Delhi , 10-Jan-2017 , The Financial Express)
The pace of implementation of Indo-Japan free trade agreement needs to be further enhanced in order
to exploit the huge potential of the pact, Commerce and Industry Minister Nirmala Sitharaman said
today. More...
DPS World Foundation files settlement proposal for trademark

(PTI | New Delhi , 06-Jan-2017 , The Indian Express)
The bench asked DPS society to file its response on the proposal of settlement and fixed the matter for
hearing on January 10. More...
India rejects T-Mobile patent for mobile terminals invention

(Sajan C Kumar | Chennai , 6-Jan-2017 , The Indian Express)
India's patent office has rejected an application by German telecom major T-Mobile International AG
seeking a patent for an invention related to a method for optimising the operational times and cell
exchange performances of mobile terminals. More...
Russia's Goznak gets patent for counterfeit protection of bank notes

(Gireesh Babu | Chennai , 05-Jan-2017 , Business Standard)
Goznak is among the eight firms that have bagged contracts to supply currency paper to India in 2017
More...
India sees rise in patent filings by 2% during April-November

(Express News Service , 5-Jan-2017 , The New Indian Express)
The number of patents filed by Indians across the country have increased by about two per cent to
8,273 during the April-November this financial with government taking steps to promote Intellectual
Property Rights (IPR). More...
Foreign Filing Permission: Indian Patent System Perspective

(Khurana And Khurana , 05-Jan-2017 , Mondaq)
Different countries having regard to National Security Considerations and with the intent of having a
check on the defence and atomic energy related inventions, have different restrictions in place. More...
ECE student gets US patent for BCI device

In a major achievement, Muttukuri Rajasekhar, a final year Electronics and Communication Engineering
(ECE) student of SRKR Engineering College, has got the US patent for his Brain Computer Interface
(BCI) device. More...
Biotech firms form patent alliance over interference proceeding against CRISPR patent
application
(Steve Brachmann , 05-Jan-2017 , IPWatchDog)
In mid-December, medical and business news outlets alike were reporting on the formation of a patent
licensing alliance among biotech firms and a leading research university. More...
China’s Alibaba sues vendors over selling counterfeits

(AFP | Beijing , 05-Jan-2017 , The Indian Express)
The shopping site said this was the first time an e-commerce giant had taken a counterfeiter to court in
the world's second-largest economy. More...
Protection of intellectual property rights

(Henry J. Schumacher , 04-Jan-2017 , Business Mirror)
The Philippines has shown great improvement in the past years in terms of intellectual-property rights
(IPR) protection, as highlighted by its removal from the United States watchlist of trading partners with
grave IPR infringements. More...
Launch of IPR Enforcement Toolkit for Police and IPR Awareness Campaign for Children
(Delhi , 04-Jan-2017 , Business Standard)
Launch of IPR Enforcement Toolkit for Police and IPR Awareness Campaign for Children More...
Telangana, AP tops in filing patents

(Sribala Vadlapatla , 4-Jan-2017 , The Times Of India)
When it comes to filing patents, the twin states of Telangana and Andhra Pradesh are way ahead of
competition, but experts say most of inventions have little or no commercial value. More...
Event organisers to pay royalty to use copyrighted songs: Delhi HC

(Press Trust of India | New Delhi , 3-Jan-2017 , Business Standard)
Under arrangement, organisers have to inform 3 societies about copyrighted work to be used More...
Foreigners dominate Indian patents

(3-Jan-2017 , Times of India)
Around 80% of the more-than 43,000 domestic product and process patents have been secured by
foreign entities - many of them global technology giants like Qualcomm, Samsung and Philips. More...
PayPal Accuses Paytm of Trademark Infringement in India

(Rahul Vijh , 02-Jan-2017 , IPWatchDog)
On November 18, 2016, Paypal Inc. filed an objection at the Indian Trademark Office accusing Paytm,
an Indian mobile wallet company, of trademark infringement. The objection comes at the heels of the
recent windfall made by the latter on account of a cash-strapped nation moving rapidly towards a
cashless normal. More...
TVS gets patent for auto hybrid transmission system

(Sajan C Kumar , 29-Dec-2016 , The Financial Express)
Giving a major fillip to its innovation-packed product line-up, Chennai-based auto major TVS Motor Co
has been granted an Indian patent for automatic hybrid transmission (AHT) system for two-wheelers.
More...
Delhi High Court restrains three copyright societies from issuing licences
(PTI | New Delhi , 28-Dec-2016 , The Indian Express)
The Delhi High Court restrained the societies from granting licences to play music and songs of various
artists in public till April 24 next year. More...
India-EFTA trade deal talks to be held in January

With India and the European Free Trade Association (EFTA) members resuming talks for the long-stalled
proposed free trade agreement last month, senior officials of the four-nation bloc will visit here in
January to iron out differences related with the pact. More...
Who owns blockchain? Goldman, BofA amass patents for coming wars
(Bloomberg , 28-Dec-2016 , Livemint)
In the headlong rush to revolutionize modern finance, blockchain enthusiasts are overlooking one
potentially costly problem: their applications, built on open-source code, may actually belong to
someone else. More...
Backdoor patents could hurt patients

(SRIVIDHYA RAGAVAN MOUSHAMI JOSHI , 27-Dec-2016 , Business Line)
Extending data ‘exclusivity’ for a drug after clinical trials, thereby shutting out competition, is not a good
idea More...
Apple pulls Nokia-owned Withings devices from stores in patent fight

(DNA WEB TEAM | , 26-Dec-2016 , DNA)
The Cupertino tech giant has expunged all mentions of the brand from its online stores in retaliation for
a patent infringement lawsuit filed by Nokia. More...
India, US must exchange wish lists to iron out issues: IACC

(PTI | New Delhi , 26-Dec-2016 , The Indian Express)
Broad contours of the wish lists should include amicable settlement of IPR issues leading to earliest
conclusion of a bilateral investment treaty (BIT), totalisation agreement, a sound legal framework to
expeditiously settle disputes, settlement of issues emanating from non-tariff measures and importantly,
a fast solution to nagging visa problems. More...
India drops initial objections, clears Google Technology patent to improve mobile phone out
of service response
(Sajan C Kumar | Chennai , 24-Dec-2016 , The Financial Express)
Google has secured Indian patent for an invention relating to techniques for the mobile phones to
improve responses to out-of-service conditions. More...
Start-up accuses Amazon of using its brand name to drive traffic

(PRIYANKA PANI , 23-Dec-2016 , Business Line)
Chennai-based Flintobox files legal notice against the e-commerce giant More...
GM technology: Trait fee war between Monsanto and Indian seed firms intensifies
(Harish Damodaran | New Delhi , 22-Dec-2016 , The Indian Express)
Monsanto has sublicensed its BG-II Bt technology — which was granted an Indian patent in February
2008 – to 49 companies More...
Nokia sues Apple for infringing 32 patents

(Helsinki , PTI , 22-Dec-2016 , DNA)
Nokia filed a lawsuit against Apple claiming that the company has infringed on a number of its patents.
More...
Who owns blockchain? Goldman, Bank of America amass patents for coming wars
(Olga Kharif , 21-Dec-2016 , Livemint)
Some of the biggest names in business, from Goldman Sachs to Bank of America , have quietly patented
some of the most promising blockchain technologies More...
China: Court fines firms for using BMW-like trademark

(Reuters | Shanghai , 20-Dec-2016 , The Indian Express)
The ruling is the latest win for a large foreign firm in China, a sign that courts are taking trademark
infringement more seriously. More...
Parentlane applies for patent on "GrowthCheck"

(Press Trust of India , 19-Dec-2016 , Business Standard)
Parentlane, a mobile technology company that focuses on early-child development and parenting, has
filed a patent application in India for its recently launched feature - GrowthCheck - which will measure
the overall development of children between 0-8 years, considered to be the most critical phase when
90 per cent of brain development happens. More...
Parentlane applies for patent on "GrowthCheck"

(19-Dec-2016 , business standard)
Parentlane, a mobile technology company that focuses on early-child development and parenting, has
filed a patent application in India for its recently launched feature - GrowthCheck - which will measure
the overall development of children between 0-8 years, considered to be the most critical phase when
90 per cent of brain development happens. More...
PayPal files copyright infringement against Paytm, says similar colour scheme used in logo
(Express Web Desk , 19-Dec-2016 , The Indian Express)
In the notice served against the mobile wallet company, PayPal has described how Paytm used the "two-
tone blue colour scheme" that is also part of PayPal's colour scheme. More...
Merck wins record $2.5 billion patent verdict against Gilead

(Bloomberg , 17-Dec-2016 , The Economic Times)
Gilead Sciences was told by a federal jury to pay $2.54 billion to MerckBSE 1.42 % & Co. for using a
patented invention as the basis for its blockbuster drugs for the potentially deadly liver disease hepatitis
C — the biggest patent-infringement verdict in US history More...
Nintendo Switch patent hints at possible VR headset support

(Tech Desk , 16-Dec-2016 , The Indian Express)
A patent filed by Nintendo with the US Patent Office shows prospects of a VR headset compatibility with
the gaming console More...
Pharmexcil, AIDCOC to organize symposium on 'IPR & Regulatory Perspective for Pharma &
Biotech' on Dec 17 at IPC
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) in association with the All India
Drugs Control Officers' Confederation (AIDCOC) is organizing a symposium on 'Intellectual Property
Rights (IPR) and Regulatory Perspective for Pharma & Biotech Sectors' on December 17, 2016 at Andhra
University, Visakhapatnam, A.P. More...
Sonata Software gets patent for mobility platform

(OUR BUREAU , 15-Dec-2016 , Business Line)
Sonata Software has been granted a patent for enabling users to be notified across web, SMS, email and
in-app push notifications. More...
Donald Trump's vow to end TPP affects India’s trade talks

(Kirtika Suneja, ET Bureau , 14-Dec-2016 , The Economic Times)
It aims to cover goods, services, investment, competition, economic and technical cooperation, dispute
settlement and intellectual property rights. More...
Supreme Court declines to hear biologic drug patent fight

(Brendan Pierson | WASHINGTON , 13-Dec-2016 , Reuters)
The U.S. Supreme Court on Monday declined to hear a case over whether companies that make copycat
versions of biologic drugs must wait six months after winning federal approval before bringing them to
the market. More...
Indian Trade Marks Registry to widen its doors for recording “well known” marks
(RNA IP Attorneys - Ranjan Narula , 12-Dec-2016 , Lexology)
The role of recordation of well-known marks varies across jurisdictions. More...
The new patents regime

(12-Dec-2016 , Business Standard )
The government’s attempt to expedite the process of granting patents by hiring more application
examiners and digitising the procedures is a welcome move. The need for reforms in this field has long
been felt to remove, or at least tone down, the taint the country’s intellectual property administration
has acquired due to unduly long delays and lack of transparency in clearing patent applications. More...
Apple iPhone patents reveal virtual buttons, and a foldable device: Report
Apple patents indicate the company could be working on a new iPhone design with virtual buttons and
Touch sensors More...
Issues of access and ‘fair use’ in new High Court copyright judgment
(Aneesha Mathur , 12-Dec-2016 , The Indian Express)
Delhi HC has ruled there’ll be no cap on how much of a book can be photocopied, so long as course
demands it. What are the implications for the publishing industry? More...
Dindigul leather gets into Geographical Indication Registry

(SPECIAL CORRESPONDENT , 11-Dec-2016 , The Hindu)
Leather industry in Dindigul received a shot in the arm on Saturday when the user certificate issued to
the Geographical Indication Registry for ‘East India Leather’ was handed over to representatives of
Dindigul Tanners’ Association at a function here on Saturday. More...
HC restores publishers’ copyright suit

(Akanksha Jain , 10-Dec-2016 , The Hindu)
The Delhi High Court on Friday restored for trial the dispute whether photocopying study material was a
violation of copyright while allowing Delhi University’s Rameshwari Photocopy Service to continue with
preparing course packs for the time being. More...
Delhi HC verdict on publishers’ plea in DU photocopy case likely today

(Priyanka Mittal , 9-Dec-2016 , Livemint)
The single judge order if set aside will be a game changer for the applicability of Indian copyright law in
education cases and would shift focus to the interest of publishers. More...
India lags behind in leveraging intellectual property rights: CBEC Chief Najib Shah
(08-Dec-2016 , Buissness Standard)
"India has been a little behind, perhaps,in leveraging in IPR and it has become an impediment," Shah
said addressing an event on 'Illicit cross-border trade in goods: impact on economy and consumers'
organised by industry body Ficci. More...
Finance Ministry set to boost start-up operations in India; here’s how

(Devendra Raghav , 7-Dec-2016 , The Financial Express)
The Make-in-India initiative was launched to encourage national as well as multinational companies to
manufacture in India. More...
Intellectual property vs competition law

(Shamnad Basheer , 7-Dec-2016 , Livemint)
The competition cure may well be worse than the patent plague that it was meant to heal More...
US Supreme Court sides with Samsung in $399 million patent case by Apple
( Reuters , 06-Dec-2016 , DNA)
The court overruled an appeals court judgement, directing the South Korean company to pay Apple US
$399 million in compensation. More...
Delhi HC reserves verdict on foreign publishers plea in book photocopy case

(05-Dec-2016 , DNA)
The Delhi High Court on Monday reserved its judgement on a petition by leading foreign publishers
against a single judge verdict allowing sale of photocopies of textbooks published by them by a shop
located at the Delhi University (DU) campus. More...
Delhi HC reserves verdict on publishers’ appeal in photocopy case

The HC reserved judgement on a plea brought by publishers against an order allowing a photocopy shop
in the DU campus to sell course packs using material published by them More...
Apple could be working on circular smartwatch, hints patent

Apple could be working on a smartwatch with a circular display, according to its recent patent filing
More...
Experts welcome India's denial of patent to prostrate cancer drug, Xtandi

(Laxmi Yadav , 1-Dec-2016 , Pharmabiz)
The Indian Patent Office's denial of patent for life-saving prostrate cancer drug, Xtandi (enzalutamide)
has been welcomed by patent experts in the country, who say it will open up avenues for generic drugs
costing less than half the price. In India, prostrate cancer is the second most common cancer in males
as per the Indian Council of Medical Research (ICMR) and various state cancer registries. On November
10, India's patent office revoked the patent application filed by University of California in 2007. The
University had discovered the drug. The patent on blockbuster cancer drug, Xtandi which is marketed by
Japan's Astella Pharma, was opposed by Fresenius Kabi in 2012, and by Mumbai-based BDR Pharma in
2013. Indian Pharmaceutical Alliance, an organisation of 20 research based Indian drug companies also
opposed the grant of patent. More...
No copyright over our judgments: SC

(Dhananjay Mahapatra , 24-Nov-2016 , Times of India)
NEW DELHI: For long, a couple of firms had a virtual monopoly over printing judgments of the Supreme
Court in book format and selling it to advocates, institutions and others. So much so that one of them
claimed copyright over the manner in which it edited and published the judgments. . More...
‘Per capita patent filings, research applications very low in India’

(OUR BUREAU , 23-Nov-2016 , Business Line)
China tops in patent applications, followed by US, Japan More...
India – patent challenges and compulsory licensing

(23-Nov-2016 , The PharmaLetter)
Even as Astellas Pharma (TYO; 4502) and Pfizer (NYSE: PFE) have received the green signal on a
supplemental New Drug Application from the US Food and Drug Administration for Xtandi (enzalutamide)
to treat advanced prostate cancer, the Indian patent office has denied Xtandi a patent, opening up the
market to generic versions of the drug, reports More...
China top innovator with 1 million patent requests in year: UN

(Stephanie Nebehay , 23-Nov-2016 , Livemint)
Chinese innovators filed most of their patent applications in electrical engineering, which includes
telecoms, followed by computer technology and semiconductors More...
IIT Madras patent filings increase by 33%

(T E Narasimhan | Chennai , 22-Nov-2016 , Business Standard)
Approval for international patents doubled to 15 during the year 2015-16 More...
‘CRI guidelines may impact the innovation ecosystem’

(TANVEER KAUR , 21-Nov-2016 , Business Line)
The “CRI Guidelines” for examination of computer-related inventions (CRI), published by the Indian
Patent Office (IPO) on February 19 are currently under review. While some have supported it, there has
been criticism from various stakeholders. More...
Preserving a rare medicinal rice variety

(K. A. SHAJI , 18-Nov-2016 , The Hindu)
It was only last week Palakkad-based marketing executive-turned farmer P. Narayanan Unni was invited
to present a paper on how he conserved Kerala’s nearly extinct medicinal rice variety, Navara, in an
organic way at a global conference on best practices in agri-food innovation. More...
Bangladesh registers Jamdani as first GI product

(Press Trust of India | Dhaka , 17-Nov-2016 , Business Standard)
Bangladesh today registered Jamdani, one of the world's finest and classic Muslin craft, as its first
Geographical Indication (GI) product, a move that will help in branding the product in the international
market. More...
Increasing the period of surveillance data may delay entry of generic drugs: Commerce
secretary Rita Teotia
(Abantika Ghosh | New Delhi , 15-Nov-2016 , The Indian Express)
Commerce secretary Rita Teotia echoes the views of the industry in a letter to the health ministry.
More...
272 products registered as geographical indication so far

(PTI , 14-Nov-2016 , India Today)
As many as 272 products such as Sangli raisins, Banaras metal repousse craft and Beed custard apple
have been registered as geographical indications since September 2003, according to a government
data. More...
Interplay Of Section 63 And Section 64 Of Indian Patent Act, 1970
(Khurana and Khurana , 14-Nov-2016 , mondaq)
What is the effect of surrender proceedings on the ongoing opposition/ revocation proceedings? More...
Bayer gets over compulsory licence

(Divya Rajagopal , 14-Nov-2016 , The Economic Times)
German chemicals and life sciences company Bayer has gotten over its brush with India’s intellectual
property rights policy and is now looking for a bigger slice of the market, according to a senior executive
of the company. More...
Bayer to set up active ingredients plant for agrochemicals in Vapi

(Rakesh Rao | Mumbai , 11-Nov-2016 , Business Standard)
The German company will invest Euro 30 million for the new plant in Vapi, where it recently opened a
global formulation technology laboratory More...
India, US lock horns over intellectual property at WTO

(AMITI SEN , 11-Nov-2016 , Business Line)
US criticises UN report, says it ‘distracts rather than benefits’ More...
Grant of patents during Apr-Oct up 21.5 pc

(Press Trust of India | New Delhi , 11-Nov-2016 , Business Standard)
With the commerce and industry ministry taking steps to streamline the procedures, grant of patents
during April-October this fiscal year has increased by 21.5 per cent. More...
Bayer group hints at continuing crop research in India

(Rajesh Bhayani | Mumbai , 11-Nov-2016 , Business Standard)
Bayer group is setting up a new plant at Vapi in Gujarat with €30-million fresh investments More...
Patent denied, price of prostate cancer drug may go down

(Rupali Mukherjee , 10-Nov-2016 , The Times Of India)
The Indian Patent Office has denied a patent to Xtandi (Enzalutamide), a steeplypriced wonder drug
used in prostate cancer, on the pre-grant opposition filed by a clutch of entities, including Mumbai-based
BDR Pharma, drug company Fresenius Kabi and Indian Pharmaceutical Alliance. More...
Trump’s anti-tariff stance on drug import cheers companies

(Himani Chandna, New Delhi , 10-Nov-2016 , Hindustan Times)
Donald Trump’s win in the US presidential elections may create a new set of opportunities for Indian
generic drug makers More...
Samsung’s new patent hints at a foldable smartphone

(Tech Desk , 10-Nov-2016 , The Indian Express)
A new patent application by Samsung suggests that the company is working on a foldable smartphone
design More...
Govt taking steps to expedite patent applications

The commerce and industry ministry is taking several steps including hiring more people and training
them to reduce the time and pendency of patents and trademark applications, an official said today.
More...
Pfizer gets process patents for Enbrel despite Mylan & Biocon opposition
(Sajan C Kumar | Chennai , 9-Nov-2016 , The Financial Express)
US pharmaceutical giant Pfizer has received a shot in the arm with the company securing two Indian
process patents related to its blockbuster drug Etanercept, marketed under the brand name Enbrel in
countries like the US. More...
GI Registry holds meeting to decide on GI tag for Basmati rice from Madhya Pradesh
(Gireesh Babu | Chennai , 09-Nov-2016 , Business Standard)
Madhya Pradesh farmers and APEDA met the registry to put forward their arguments More...
British appliance company Dyson headed for Indian market by 2017

(Tech Desk , 08-Nov-2016 , The Indian Express)
Dyson has recently announced that he has applied for a business licence to patent and sell his products
for the first time in India More...
Indian Pharma Exporters & The World of P-MEC-Collector’s Edition

(8-Nov-2016 , Chemical Weekly)
Indian Pharma Exporters & The World of P-MEC-Collector’s Edition: Key highlights More...
India, Britain sign MoUs on IPR, ease of doing business

(IANS , 07-Nov-2016 , The Economic Times)
India and Britain on Monday signed memoranda of understanding (MoUs) on intellectual property rights
(IPR) and ease of doing business following delegation-level talks led by Prime Ministers Narendra Modi
and Theresa May here. More...
Experts stress on importance of trademark protection

(TNN , 6-Nov-2016 , The Times Of India)
Indian companies have only recently realized the importance of brandname and trademark protection.
More...
Glaxo wins battle for GSK trademark

(Prabha Raghavan , 04-Nov-2016 , The Economic Times)
British drug maker GlaxoSmithKline has secured a crucial victory in a three-year court battle over its
trademark rights with a Hyderabad company which used the same acronym. More...
Bonita India slaps legal notice on Milton over IPR infringement

Consumer goods major Bonita India has slapped a legal notice on Milton over alleged infringement of
intellectual property rights (IPR). More...
Delhi HC turns 50: Five landmark intellectual property rights rulings

(Priyanka Mittal , 2-Nov-2016 , Livemint)
Delhi HC has helped shape intellectual property law by interpreting various facets of the trademark,
copyright, patent laws and coming up with innovative solutions More...
GI: POOR MAN’S INTELLECTUAL PROPERTY RIGHTS

(Makhan Saikia , 29-Oct-2016 , The Pioneer)
To ensure the protection of the Geographical Indication (GI) in India, the Government, along with
various other civil society organisations and the NGOs, must keep a close watch on the registration of
GIs. More...
Hardware clause makes software patenting difficult

(VENKATESH GANESH , 28-Oct-2016 , Business Line)
Revised norms say patent can be granted only when there is combination of software and hardware
More...
Decision to amend IP law to give ‘cinnamon’ GI protection hailed

(28-Oct-2016 , Mirror Business)
The country’s cinnamon industry stakeholders yesterday hailed the Cabinet’s decision to amend the
Intellectual Property Act of 2003 to enable ‘Ceylon Cinnamon’ to obtain Geographical Indications (GI)
locally, and be included in a GI register. More...
Patents in India needs a culture of investment in software innovation, says BSA

(ANI | New Delhi , 27-Oct-2016 , Business Standard)
The Software Alliance, advocate for the global software industry before governments and in the
international marketplace, supports the objectives of important initiatives like Digital India and Start-up
India, depend on harnessing the power of innovation to achieve their goals and concerned with the
current CRI policy. More...
Indian Patent Office to create awareness programme for new IPR policy
(BS B2B Bureau | New Delhi , 25-Oct-2016 , Business Standard)
The aim of the new policy is to provide IP protection in India to the innovator in a reasonable period of
time without much problems, says O P Gupta, Controller General of Patents More...
India should strengthen IPR laws to increase trade with America: US Envoy
(ANI , 25-Oct-2016 , Sify News)
In order to increase trade between United States and India, the government should strengthen its
existing Intellectual Property Right laws otherwise many of the American companies with their new
developed ideas and technology would not be able to invest in the Indian market, said a senior diplomat
of U.S. posted in India. More...
Software patent: TCS plea for protection of invention on technical documents rejected
(Sajan C Kumar , 25-Oct-2016 , The Financial Express)
In yet another instance of saying no to exclusivity for innovations in software development, the
country's patent office has rejected a patent application by Tata Consultancy Services (TCS) seeking
protection to its claimed invention relating to organisation and development of technical documents,
with few defects, minimal effort and less cost. More...
Rocky bail: It's patent HC fallacy, says state

(25-Oct-2016 , Times of India)
PATNA: The Supreme Court will hear on Friday the Bihar government's appeal seeking cancellation of
bail granted to JD(U) MLC Manorama Devi's son Rocky Yadav, who allegedly shot dead Aditya Sachdeva,
a student, for overtaking his SUV with a small car. More...
Detailed annual plan on spreading awareness about new IPR Policy soon: Controller General
of Patents
(Capital Market , 24-Oct-2016 , Business Standard)
Need to strengthen existing IPR related systems & mechanisms: NRDC chairman More...
Walmart sues cookware maker for ‘using’ name

(Rasul Bailay , 24-Oct-2016 , The Economic Times)
American retailer Walmart has dragged a local firm, Yash Enterprises, to the Delhi High Court for
allegedly selling cookware products under the supermarket chain’s brand name. More...
India to US: Will not tighten IPR rules beyond TRIPS mandate
(OUR BUREAU , 20-Oct-2016 , Business Line)
Commerce Minister Nirmala Sitharaman demands food safety clearance mechanism during talks with US
Trade Representative More...
Patents on software: India’s CRI guidelines create impractical situation

(Ashish Bharadwaj , 20-Oct-2016 , The finanacial express)
India’s CRI guidelines create an impractical situation, which makes patentability of software possible
only if the inventor also invents a new hardware More...
Karnataka fares better than most states on innovation front

(Mihika Basu | Bangalore Mirror Bureau , 20-Oct-2016 , The Times Of India)
The number of patents filed is usually an indication of the amount of innovation being done by a
particular institution and is also linked to the growth of a nation. More...
3G, 4G, now 5G: India takes early call
(Surabhi Agarwal, ET Bureau , 20-Oct-2016 , The Economic Times)
A research team commissioned by the government to work on 5G technology has already filed 100
patents so far — of which around 10 have already been granted. More...
Nirmala Sitharaman calls for push to India’s IPR activities

(19-Oct-2016 , The Financial Express)
Commerce and Industry Minister Nirmala Sitharaman on Wednesday said that Indias intellectual
property rights (IPR)-related activities need great traction. Sitharaman was speaking at the launch of
the logo of Cell for IPR Promotion & Management (CIPAM). More...
India still has impediments to FDI in some retail, finance areas, rues USTR
(NAYANIMA BASU/ AMITI SEN , 19-Oct-2016 , Business Line)
Washington will continue dialogue with India on IPR issues, says Michael Froman More...
CSIR wants labs to stop random filing of patents

(Akshaya Mukul , 19-Oct-2016 , Times of India)
NEW DELHI: The Council of Scientific & Industrial Research (CSIR) has sent out a stern message to its
38 laboratories to avoid indiscriminate filing of Indian and foreign patents. In order to "inculcate
responsible behaviour" CSIR has decided that "henceforth 25% of expenses incurred on prosecution and
maintenance of Indian patents and up to 50% of expenses on foreign patents will be borne by the
laboratories". CSIR director-general Girish Sahni has told laboratories "if they succeed in licensing,
headquarter will give you a matching grant". . In a strongly worded letter to lab heads, Sahni said
"patents are just filed for the sake of filing without any techno-commerical and legal evaluation". He told
them that even choice of countries where patents are being filed is "ad-hoc without any logic". For
instance, he said, majority of patents are "biodata" patents. More...
E-commerce in India: Amazon gets patent for system to manage data centres
(Sajan C Kumar | Chennai , 19-Oct-2016 , The Financial Express)
Amazon Technologies Inc, subsidiary of e-commerce giant Amazon.com Inc, has secured an Indian
patent relating to a system for efficiently managing data centres by streamlining the processing of
applications generated out of multiple computing systems. More...
Copyright as exception
(Shamnad Basheer , 19-Oct-2016 , The Indian Express)
Free competition and access to knowledge have been the default legal norm for many a nation. More...
Ceat develops puncture-safe tyres for bikes; files patent

(Subhayan Chakraborty | New Delhi , 18-Oct-2016 , Business Standard)
With the US going into its Presidential elections in November, both governments are being cautious
More...
Patent office calls meeting to make things user-friendly

(Press Trust of India | New Delhi , 18-Oct-2016 , Business Standard)
The Indian Patent Office has decided to hold meetings with stakeholders here and in Mumbai to take
feedback on making examination and processing more user-friendly. More...
US health departments wants Ayurveda cures for cancer documented

(FE Online , 18-Oct-2016 , The Financial Express)
The US department of health and human services' premier National Institutes of Health (NIH) and
National Cancer Institute (NCI) have expressed interest in documenting ayurveda's success stories in
treating cancer. More...
Epidemics among most pressing health security issues today: K. Vijay Raghavan
(Arijit Paladhi , 18-Oct-2016 , Livemint)
Epidemics of emerging infectious diseases are a significant and growing threat to life, health and
prosperity, says K. Vijay Raghavan, chairperson of CEPI’s interim board More...
India, US trade ministers to meet on October 20 as part of Trade Policy Forum

(PTI | New Delhi , 17-Oct-2016 , The Financial Express)
Visa, customs cooperation, greater market access for goods and intellectual property rights are the key
issues that will be discussed during the trade policy forum (TPF) meeting between India and the US on
October 20. More...
US health department wants ayurveda cures for cancer documented

(Chethan Kumar | , 17-Oct-2016 , The Times Of India)
In a major fillip to India's efforts to globalise ayurveda and other traditional medicines, the US
department of health and human services' premier National Institutes of Health (NIH) and National
Cancer Institute (NCI) have expressed interest in documenting ayurveda's success stories in treating
cancer. More...
Healthcare in India: From innovation to action

(Ratna Devi | New Delhi , 17-Oct-2016 , The Financial Express)
Patient access to life-changing healthcare needs innovative medicines and collective effortRatna Devi |
New Delhi More...
GM crops: How to plant the future

(C D Mayee , 17-Oct-2016 , The Economic Times)
The government must listen to industry associations and experts who have been criticising the cotton
price control and compulsory licensing notification More...
Start-ups: Indian entrepreneurs’ focus on short-term gains turns them into laggards
( Rajeev Banduni | New Delhi , 17-Oct-2016 , The Financial Express)
Indian entrepreneurs’ focus on short-term gains has led to a rise in the number of start-ups that simply
mirror the technology of mature, established companies More...
India-US trade relationship to grow: US Trade Representative Michael Froman

Describing the reforms undertaken by the Indian government as "work in progress", a top Obama
Administration official has linked the growth in bilateral trade between the two countries to India
opening up and liberalising its economy. More...
Mylan discontinues its pursuit to patent process to prepare anti impotence drug
Company filed application for novel process for preparation of Sildenafil Citrate, the active ingredient of
Pfizer's Viagra More...
Pfizer loses appeal in UK patent case over use of Lyrica drug for pain
(Reuters | London , 13-Oct-2016 , The Financial Express)
Pfizer suffered a setback in Britain on Thursday when the Court of Appeal in London ruled against it in a
patent case over the use of its $5 billion-a-year drug Lyrica for pain relief. More...
Bangladesh’s Jamdani textiles to get global patent

(7-Oct-2016 , India Live Today)
Dhakai Jamdani, one of Bangladesh’s finest muslin textiles, is set to be registered this month as the
country’s first Geographical Indication (GI) product, a media report said on Thursday. Senior Secretary
of the Industries Ministry M. Mosharraf Hossain Bhuiyan made the disclosure while addressing the 56th
annual meeting of the World Intellectual Property Organization (WIPO) in Geneva on Tuesday, according
to a message received here on Thursday. More...
Copy-wrongs and the invisible subsidy

(Satish Deshpande , 7-Oct-2016 , The Indian Express)
Academic publishers challenged the right of Indian students to photocopied texts. Their suit shows how
much they themselves benefitted from the intellectual commons. More...
Fake copyright site infuriates Indian government

(Simon Sharwood , 7-Oct-2016 , The Register)
India's government has issued a warning to users of www.copyright.in, which it says is “creating a false
impression that it is the official website of the copyright registration office in India and inviting
applications for protection of the various works i.e. literary, artistic, dramatic, musical, sound recording
and cinematographic films along with its evidences.” More...
India’s pharma competitiveness rank drops

(Arijit Paladhi , 06-Oct-2016 , Livemint)
India scores low on almost all metrics except for partial step-ups on two counts: scientific capabilities
and infrastructure, and clinical research conditions and framework More...
Rameshwari Photocopy case: Delhi HC to hear publisher’s appeal tomorrow

(Priyanka Mittal , 5-Oct-2016 , Livemint)
The publishers have challenged a Delhi HC ruling, which allowed Rameshwari Photocopy Service to sell
photocopies of textbooks and course materials to students More...
It’s time for new swadeshi battle
( Navdanya Trust , 5-Oct-2016 , The Asian Age)
The Industrial Revolution brought with it colonialism. Colonies of cotton, indigo, opium (and other)
plantations were installed, to feed the machines of the Industrial “Revolution” — patented machines,
built by patented machines. More...
The battle over Bt cotton

(SHAMNAD BASHEER , 4-Oct-2016 , The Hindu)
While Monsanto and Indian seed companies spar, more worrying is the confused lawmaking
underpinning regulation of patents More...
India, US companies to fight in Supreme Court over Exide trademark

(Samanwaya Rautray , 3-Oct-2016 , The Economic Times)
The protracted legal battle over who can use the ExideBSE 2.70 % brand name to sell automobile
batteries in the Indian market has reached the Supreme Court. But for now, US-based Exide
Technologies will not be able to use the name in any manner in this country to either promote the brand
or the company. More...
Students question IIT-B’s intellectual property rule, but alumni give it a thumbs up
(Shreya Bhandary , 03-Oct-2016 , Hindustan Times)
While the IP policy is similar across all IITs as well as the Massachusetts Institute of Technology (MIT),
royalty sharing models have differed, claimed students. More...
With 3 surface transport patents in US, Rivigo takes road less travelled
(Biswarup Gooptu , 3-Oct-2016 , The Economic Times)
Surface transport logistics provider Rivigo has filed for three patents in the US for algorithms created by
it, making it a rare instance of an Indian startup seeking to do so, given the country's poor record in
developing and protecting intellectual property. More...
Government approves India-Singapore MoU to boost innovation, technological advancement

(PTI , 28-Sep-2016 , The Indian Express)
The MoU will enable India to exchange experiences in the innovation and IP ecosystems that will
substantially benefit entrepreneurs, investors and businesses on both sides. More...
India: Smell Marks: The New Rage In Trademarks

(Intepat IP Services Pvt Ltd , 28-Sep-2016 , Mondaq)
The ever increasing competition in the business world compels corporations and businesses to be
distinct; to stand out in order to garner a larger consumer base. Apart from huge investments in
advertising and attractive offers, the prime mode that they adopt is by way of trademarks. More...
Cabinet approves India-Singapore agreement on industrial property rights

(IANS , 28-Sep-2016 , The Economic Times)
NEW DELHI: The Union Cabinet on Wednesday approved an agreement between India and Singapore on
industrial property cooperation that is expected to enhance bilateral activities in Industrial Property
Rights of patents, trademarks and industrial designs. More...
Affordable drugs: India stand justified

(28-Sep-2016 , Deccan Herald)
Just about two years ago, when the Supreme Court had rejected the claims of Bayer against grant of
compulsory licence by India Patent Office to the Hyderabad-based Natco Pharma for manufacture and
sale of cancer fighting drug Sorafenib at Rs 8,800 per person per year against Rs 33.60 lakh by the
multi-national firm, an impression was sought to be created by the global firms as if India was
disincentivising research and development (R&D). More...
NGO opposes NSAI views on patent laws

(26-Sep-2016 , Times of India)
New Delhi, Sep 26 (IANS) Opposing the views of National Seeds Association of India (NSAI) on biotech
traits patenting rules, an NGO promoting agriculture biotechnology on Monday approached the Union
Agriculture Ministry seeking its intervention. More...
On the right to photocopy

(S. Sivakumar, Lisa P. Lukose , 26-Sep-2016 , The Hindu)
On September 16, the Delhi High Court dismissed the copyright infringement petition filed by three
international publishers against a photocopy shop located in the Delhi University premises (The
Chancellor, Masters and Scholars of the University of Oxford v. Rameshwari Photocopy Services). The
court ruled that making course packs for suggested reading for students by photocopying portions of
various prescribed reference books does not violate the copyright of the publishers. More...
DIPP Drags the Dasatinib Compulsory License Drama: A situation of “extreme urgency”?
(Pankhuri Agarwal , 24-Sep-2016 , Spicy IP)
As our readers may recall, in January 2013, the Ministry of Health and Family Welfare (MoH) had
recommended that DIPP declare that a compulsory license (CL) should be granted, under section 92 of
the Patents Act, 1970, for three exorbitantly priced anti-cancer drugs – Bristol-Myers Squibb’s Dasatinib
(or Sprycel) and Ixabepilone (or Ixempra) and Roche’s Trastuzumab (or Herceptin). Two of these three
cases were dropped as Roche allowed its patent on Herceptin to lapse (presumably to avoid the license)
and MoH raised safety concerns regarding Ixabepilone. Regarding Dasatinib (used for treatment of
chronic myelogenous leukemia or CML), DIPP had asked a series of questions to MoH including whether
the probability of 0.001% occurrence of CML with no alarming increase could be categorised as national
emergency or extreme urgency under section 92. In May 2015, MoH sent its point wise reply stating,
among other things, that since Dasatanib was required by 40% of all CML cases, it certainly constituted
a situation of ‘extreme urgency’. More than a year has elapsed since then, but it seems that the DIPP is
yet to decide on the matter. More...
Govt seeks views on pricing patented drugs

(Arijit Paladhi , 23-Sep-2016 , Livemint)
Institutions involved in discussions include commerce ministry, DIPP, health ministry, department of
pharmaceuticals and the national pharmaceutical pricing authority More...
Welspun India: will patent help in recovery?

(23-Sep-2016 , Business Line)
Welspun India has secured an “interactive textile article and augmented reality system” patent. More...
Copyright lessons
(Business Standard Editorial Comment | New Delhi , 22-Sep-2016 , Business Standard)
It's the textbook publishers who need to be proactive More...
Delhi high court virtually busts ‘property’ rhetoric in the IPR narrative
(SHAMNAD BASHEER , 22-Sep-2016 , DNA)
In a momentous decision, the Delhi high court has ruled that the making of course packs for the purpose
of study was well within the bounds of the law and did not amount to copyright infringement. More...
Government plans to create patent sharing regime

(Moulishree Srivastava | Mumbai , 22-Sep-2016 , Business Standard)
It aims to transfer technology from research and development labs to companies that can then take it to
market, while protecting rights of innovators More...
Breaking News: Setback with a silver lining- The Supreme Court in IPRS v Aditya Pandey &
Ors.
(Vasundhara Majithia , 22-Sep-2016 , Spicy IP)
In 2012, the Division bench of the Delhi High Court, in the matter of IPRS v Aditya Pandey & Ors.
dismissed IPRS’s appeal against the order of a Single Judge who had held that radio stations etc., who
were broadcasting/communicating ‘sound recordings’ were required to pay royalty only to the owner of
the sound recording and not to the owner of the lyrics or the musical works which had been incorporated
into the sound recordings. More...
Seed companies say Monsanto spreading falsehoods on patent rights

(KVL Akshay , 22-Sep-2016 , The Economic Times)
Indian seed companies have accused US major MonsantoBSE 0.16 % of deliberately spreading
falsehoods on patents and claiming patent rights on seeds and plant varieties. More...
Hyperlinking Can Amount to Copyright Infringement, Rules CJEU

(Rahul Bajaj , 21-Sep-2016 , Spicy IP)
In a development that could have several far-reaching ramifications for the free flow of information in
cyberspace in Europe and beyond, the Court of Justice for the European Union (“CJEU”) ruled earlier this
month that linking to infringing material could amount to copyright infringement in some cases. More...
63 Moons Technologies to commercialise its IPRs

(T E Narasimhan | Chennai , 21-Sep-2016 , Business Standard)
Management says company continues to face challenging and hostile environment More...
Novartis gets Indian patent for skin cancer drug Tafinlar

(Sajan C Kumar | Chennai , 21-Sep-2016 , The Financial Express)
Swiss pharma major Novartis AG has secured an Indian patent for its skin cancer drug Tafinlar, used in
the treatment of metastatic melanoma- the most serious and life-threatening type of skin cancer that is
associated with low survival rates. More...
Copyright and copy-making
(21-Sep-2016 , The Hindu)
The Delhi High Court verdict that photocopying portions of academic publications to make course packs
for students does not amount to copyright infringement has been interpreted by many as a victory for
the wider public interest of ensuring affordable access to quality educational material. More...
US Supreme Court to take up less sensitive IP cases over important yet’politically sensitive’
matters
( Reuters | Washington , 21-Sep-2016 , The Indian Express)
In addition to intellectual property cases, the Supreme court could soon take up a trademark battle that
pits an Asian-American rock band and the Washington Redskins football team. More...
Lupin caught in legal tussle over 'patent infringement'

(Veena Mani | New Delhi , 20-Sep-2016 , Business Standard)
Horizon decided to take legal action after Lupin filed an abbreviated new drug application (Anda) for a
generic version of Pennsaid More...
Skype gets patent for know-how on faster communication system

Text and video chat app Skype, now owned by Microsoft Corporation, has secured an Indian patent for
an invention relating to a system and method for minimising the load on a message server, which in
turn could facilitate faster communication. More...
Counterview – The DU Photocopy case – How wide should educational use exceptions be in
the age of photocopier machines?
(Prashant Reddy , 19-Sep-2016 , Spicy IP)
“Copyright, specially in literary works, is thus not an inevitable, divine, or natural right that confers on
authors the absolute ownership of their creations. It is designed rather to stimulate activity and progress
in the arts for the intellectual enrichment of the public. Copyright is intended to increase and not to
impede the harvest of knowledge. It is intended to motivate the creative activity of authors and
inventors in order to benefit the public.” More...
India should become society of design and innovation: Amitabh Kant

(BS B2B Bureau | New Delh , 19-Sep-2016 , Business Standard)
IT companies and manufacturing companies need to work together to create a disruptive culture for
creating globally competitive designs, says NITI Aayog CEO More...
34 startups avail rebate on patent fee: DIPP

(PTI , 19-Sep-2016 , India Today)
As many as 34 startups have so far availed the benefits under a government scheme to obtain patents
with 80 per cent fee rebate, the Department of Industrial Policy and Promotion (DIPP) said today.
More...
Geographical Indication tag sought for Boka Chaul
(TNN , 19-Sep-2016 , The Times Of India)
The coveted Geographical Indication (GI) tag is being sought for indigenous Boka Chaul that can be
consumed directly without cooking. More...
IIT-Madras is patent king

(Express News Service , 18-Sep-2016 , The Sunday Standard)
The Indian Institute of Technology-Madras (IIT-M) has filed applications for, and secured, the most
number of patents among the country’s premier educational institutes. More...
Delhi HC adjourns hearing on patent challenge to US pharma giant Gilead's controversial

hepatitis C drug, sofosbuvir to Nov 22
(Ramesh Shankar, Mumbai , 17-Sep-2016 , Pharmabiz)
The Delhi High Court (HC) has adjourned hearing on patent challenge to US Pharmaceutical major
Gilead's controversial hepatitis C drug, sofosbuvir. More...
Copyright is not a divine right: Delhi HC

(Abhinav Garg , 17-Sep-2016 , The Times Of India)
Observing that "copyright is not a divine right", the Delhi high court on Friday allowed Delhi University to
issue photocopies of major textbooks published by leading publishers. More...
University copying books for teaching is not copyright violation: Delhi HC

(AKANKSHA JAIN , 16-Sep-2016 , The Hindu)
Delhi University photocopy shop allowed to resume business as court dismisses suits initiated by three
international publishing giants. More...
Ensure genuine innovation in drug patents: UN panel

(D. Ravi Kanth , 15-Sep-2016 , Livemint)
Committee urges governments to use ‘flexibilities’ accorded to them in the World Trade Organization’s
TRIPS agreement More...
India files plaint at WTO against US

India has moved the World Trade Organization's dispute settlement system, complaining about subsidy
provided by eight US states in the renewable energy sector. The development is seen as a retaliation to
the American complaint at the multilate. More...
Google withdraws application for social network-related patent

(BS Reporter | Chennai , 12-Sep-2016 , Business Standard)
After Google abandoned its application, the Patent Office refused the same on grounds of outstanding
objections More...
India, EFTA to resume talks on proposed FTA in September

(PTI | New Delhi , 09-Sep-2016 , The Indian Express)
Two-way trade between India and EFTA stood at USD 24.5 billion in 2014-15 as against USD 22.1 billion
in 2013-14. More...
Centre claims Monsanto's immunity under patents Act is misleading

(Sanjeeb Mukherjee | New Delhi , 9-Sep-2016 , Business Standard)
The Centre has challenged Mahyco Monsanto Biotech's claim that trait value is governed by the Indian
Patents Act, 1970 More...
Suven secures 3 product patents in Canada, Europe and Hong Kong

(Swati Rathor , 08-Sep-2016 , The Times Of India)
Hyderabad-based pharma player Suven Life Sciences Ltd (Suven) on Thursday informed the bourses
that it has secured one product patent each from Canada, Europe and Hong Kong. More...
MIC Electronics gets patent for LED DigiPoster, bags order from Railways
(V RISHI KUMAR , 07-Sep-2016 , Business Line)
MIC Electronics Ltd has announced it has secured a patent for its LED DigiPoster, which the company
maintains is a next generation digital display technology for various applications across the world. The
patent is valid up to the year 2028. More...
Soligenix receives US patent for new composition of matter for dusquetide analogs
(Princeton, New Jersey , 07-Sep-2016 , Pharmabiz)
Soligenix, Inc., a late-stage biopharmaceutical company, has received the United States Patent Office
(USPTO) patent entitled "Peptides for Treating and Preventing Immune-Related Disorders, Including
Treating and Preventing Infection by Modulating Innate Immunity." More...
Music streaming services welcome govt's clarification on Statutory Licensing

The government on Monday issued an "office memorandum" clarifying that internet was covered under
the Statutory Licensing (SL) provision 31(D) of the Copyright Act 2013. More...
NPCI is attempting to get a patent for its UPI technology

National Payments Corporation of India has applied for a patent for its Unified Payments Interface (UPI)
technology that was launched in April of this year and went live last month. More...
US patent office rules in favour of Mylan: Natco Pharma

(Viswanath Pilla , 02-Sep-2016 , Livemint)
Natco Pharma says US patent office ruled in Mylan’s favour by striking down a patent related to Teva
Pharmaceutical Industries drug Copaxone More...
Uttarakhand HC stays Rakesh Roshan's arrest in copyright violation case

(IANS , 31-Aug-2016 , The New Indian Express)
The Uttarakhand High Court has stayed the arrest of Bollywood producer-director Rakesh Roshan till
September 19, an official said on Wednesday. More...
Sinha cites tech demand since Mahabharata era, seeks Indian IP

(Press Trust of India | New Delhi , 30-Aug-2016 , Business Standard)
Pitching for developing indigenous technology, Telecom Minister Manoj Sinha today invoked
Mahabharata saying the quest for communication tools began when blind king Dhritrashtra sought to
know war proceedings from afar through Sanjay, who was known to have divine vision. More...
Incentivise intellectual property: How to strike right balance

(Vinod Dhall | , 30-Aug-2016 , The Indian Express)
The govt should set broad guidelines on principles that standard-setting bodies may keep in mind
More...
India’s Monsanto clash is bad news for innovators

(Mihir Sharma , 30-Aug-2016 , Livemint)
What’s happened to Monsanto could happen to any foreign company and any innovator. Once that
realization sinks in, India will pay the heavier price More...
For innovation’s sake

(Patrick Kilbride , 30-Aug-2016 , The Indian Express)
Strong intellectual property rights infrastructure will help Indian industry. More...
Patent booster for Omkar Speciality

(29-Aug-2016 , Business Line)
Shares of Omkar Speciality Chemicals will be in demand on Tuesday, as it has received a patent licence
from the Centre. More...
New Offices, Strategic Plan, GIs, Oversight Among Focus Of WIPO Committee
(CATHERINE SAEZ , 29-Aug-2016 , INTELLECTUAL PROPERTY WATCH)
The choice of hosting countries for new WIPO external offices and the Medium Term Strategic Plan 2016-
2021 are among the hottest subjects of the week, according to several regional groups speaking at the
opening today of the World Intellectual Property Organization Program and Budget Committee. More...
Odisha government gears up to apply for GI tag for 'Odishara Rasagola'

(Minati Singha , 28-Aug-2016 , The Times Of India)
Amidst tug of war over the origin of Rasagola with West Bengal, Odisha government has shown
promptness to apply for Geographical Indication (GI) status for 'Odishara Rasagola' on the basis of
evidences available with the state. More...
Monsanto stops release of new Bt cotton tech

(JACOB KOSHY , 26-Aug-2016 , The Hindu)
Seed technology major Monsanto says it is suspending plans to introduce an upgraded version of its
genetically modified cotton in India because of uncertainty in the “business and regulatory environment”
More...
The new war on piracy

(LAWRENCE LIANG , 25-Aug-2016 , The Hindu)
The punitive rhetoric underlying the warning about accessing torrent websites addresses only one axis of
the debate. It would be more accurate to see piracy as a global pricing problem More...
Geographical indication: Battle over Basmati

(Milind Ghatwai , Harish Damodaran , Divya Goyal , 25-Aug-2016 , The Indian Express)
The GI tag is used to identify various kinds of goods including Darjeeling tea, Kanchipuram silk saree
and Kolhapuri chappal. More...
Natco Pharma upbeat over US Patent Office's ruling on two of Copaxone patents
(BS Reporter | Hyderabad , 25-Aug-2016 , Business Standard)
In August 2014, Mylan had filed the abbreviated new drug application for multiple sclerosis drug
Copaxone 40 mg/ml with the US FDA More...
Govt will suggest states to frame own IPR policies

(Subhayan Chakraborty| New Delhi , 24-Aug-2016 , Business Standard)
To promote innovation and giving a boost to state economies More...
Rossogolla inches forward as sitabhog, mihidana strive for GI tag

(Jhimli Mukherjee Pandey , 22-Aug-2016 , The Times Of India)
As Daniels came to judgement over rasogolla, Bengal's pride sat right in the middle of the room, quite
nonchalant of the goings on. Beside her sat her cousins, sitabhog and mihidana and rice specimens
Tulaipanji and Gobindobhog. More...
West Bengal seeks geographical indication tag for handicrafts

(Tasmayee Laha Roy , 22-Aug-2016 , The Economic Times)
The West Bengal State Council of Science and Technology is seeking GI recognition for various
handicrafts which are unique in character and have the potential to be marketed nationally and
internationally. More...
Solvay files patent infringement lawsuit against Molycorp

(BS B2B Bureau | Brussels, Belgium , 19-Aug-2016 , Business Standard)
Lawsuit has been filed with respect to the patent covering certain high surface-area ceric oxides and
catalysts for purifying automotive exhaust gases More...
Spread awareness on patent rights

(PTI , 19-Aug-2016 , The Times Of India)
There is a need to create awareness about Intellectual Property Rights (IPR) among various
stakeholders, said a senior official from the the Defence Research and Development Organisation,
adding that DRDO had taken efforts to improve the standard and importance of IPR in new fields.
More...
Need to create awareness about IPR stressed

(Press Trust of India | Coimbatore , 18-Aug-2016 , Business Standard)
A senior DRDO official today stresed the need to create awareness about Intellectual Property Rights
among various stakeholders and said they had taken efforts to improve the standard and importance of
IPR in new fields. More...
Devas falsely claimed to have IPR of hybrid technology: CBI

(PTI | New Delh , 18-Aug-2016 , The Indian Express)
The agency alleged that while the company was set up on December 17, 2004, it entered the deal with
Antrix, commercial arm of ISRO, on January 28, 2005. More...
'High on innovation, city can own more patents'

The city has a huge potential for successfully applying for more intellectual property rights (IPR) as it
has the second highest number of technology business incubators (TBI) in the country, the member
secretary of department of science and technology, Government of India, H K Mittal, said. More...
Bengal handicrafts to get new fillip with GI tags

(PTI , 16-Aug-2016 , The Hindu)
GI tags applications made for seven handicraft products. More...
Madhya Pradesh may spoil India’s basmati GI party

(Madhvi Sally & Kirtika Suneja , 16-Aug-2016 , The Economic Times)
The basmati industry is up in arms against the Madhya Pradesh government which wants the registrar of
geographical indications (GI) to include it as a certified grown area. Experts say the move will impact
India's position in the global trade and wash away all victories against the worldwide infringements on
basmati. More...
GI benefits: MP demands inclusion of 13 districts in ‘basmati-growing geography’

(Sandip Das | New Delhi , 15-Aug-2016 , The Financial Express)
Six months after the Geographical Indications (GI) tag was given to basmati rice, allowing exclusive
rights to farmers of 77 districts on the Indo-Gangetic Plain to grow this long-grained aromatic rice,
Madhya Pradesh has filed a fresh demand for inclusion of the state's 13 districts in the “traditionally
basmati-growing geography” which could entitle them to the GI benefits. More...
Clause for evergreening of patents dropped from RCEP: Nirmala Sitharaman

A patent on the new form would give the innovator company a 20-year monopoly on the drug More...
Shaping Standard Essential Patents policy

(Vaibhav Choukse , 8-Aug-2016 , The Financial Express)
The government must ensure that standard essential technologies are accessible on FRAND terms.
More...
Inventors to get their due with IPR policy

(Express News Service , 8-Aug-2016 , The New Indian Express)
The Central government approved its first Intellectual Property Rights Policy (IPR) earlier this year and
the legal fraternity in Chennai has welcomed it with open arms. More...
Patent registration: Indore city lags far behind

(Meenakshi Sharma , 6-Aug-2016 , The Times Of India)
"Most of the applications received by department for patent registration come from youngsters of tier-II
cities of the country, such as Pune, Nagpur etc, while cities of Madhya Pradesh are far behind in the
race," said a top official from the department of industrial policy and promotion on sidelines of an
industry event on Friday. More...
New intellectual propertypolicy, a catalyst for development

(OUR BUREAU , 6-Aug-2016 , Business Line)
The National IPR Policy announced in May will bring about a vibrant intellectual policy ecosystem, which
will in turn speed up economic, social and cultural development, said Justice M Jaichandran of Madras
High Court. More...
Cities in MP lag far behind in patent registration

Patent is one of forms of intellectual property rights that also include copyrights, trademarks, industrial
designs and trade secrets /confidential information. More...
Centre’s flagship initiatives likely to get additional funds

(ARUN S , 3-Aug-2016 , The Hindu)
National industrial corridors, ‘Make In India,’ ‘Start-up India’ and the national Intellectual Property
Rights (IPR) policy may get a major fillip later this year in terms of additional Budgetary allocation.
More...
US judge rejects $625.6 million patent ruling against Apple

(Reuters , 02-Aug-2016 , The Times Of India)
A federal judge has thrown out a verdict requiring Apple to pay VirnetX Holding Corp $625.6 million for
infringing four patents relating to internet security technology, causing VirnetX's share price to plunge.
More...
Over 1 lakh patents filed since 2013

(Dharani Thangavelu, Sharan Poovanna , 2-Aug-2016 , Livemint)
Patents by Indian citizens or organizations account for 39,318 while the number is 1,05,742 for foreign
nationals and organizations More...
Knowledge of patent laws a must, says Joint Collector
(STAFF REPORTER , 2-Aug-2016 , The Hindu)
The Federation of Telangana and Andhra Pradesh Chambers of Commerce and Industry (FAPTCCI)
organised an awareness meeting on the Intellectual Property Rights (IPR) and copyright laws at Hotel
DR Uthama here on Monday. More...
73 percent of patent requests in India filed by foreigners

(Chethan Kumar , 01-Aug-2016 , The Times Of India)
In 2016-17, some 12,442 patent applications filed and 9,194 (74%) are from foreigners More...
Ethypharm receives patent for crush resistant oxycodone

The invention prevents accidental intake, misuse and unlawful diversion of the medicine More...
MSU researchers get patent to develop biodegradable polymer

M S University researchers have developed a process of making polymer like rubber using organic fillers,
which recently got patent. More...
MSF and Pfizer battle over patent application for life-saving pneumonia vaccine
(Prabha Raghavan , 29-Jul-2016 , The Economic Times)
Medecins Sans Frontieres, also known as Doctors Without Borders, on Friday argued against US drug
giant Pfizer's application to patent its pneumonia vaccine at the Indian patent office. More...
Lupin in talks with Japan's Astellas, Shionogi to buy their off-patent drug brands
(Vikas Dandekar , 27-Jul-2016 , The Economic Times)
LupinBSE -1.30 %, India's third-largest drugmaker, is in talks with Japan's Astellas and Shionogi to buy
the off-patent medicine brands they have separately put on the block, two people aware of the
development said. More...
Income from IPR transfer can’t be taxed in India if ownership outside country: HC
(Indu Bhan | New Delhi , 27-Jul-2016 , The Indian Express)
The Delhi High Court has held that the income arising from transfer of intangible assets like intellectual
property rights (IPR), including brands... More...
If IPR owner is abroad, its transfer cannot be taxed in India: Delhi HC

(Shreeja Sen , 26-Jul-2016 , Livemint)
The Delhi high court ruled that transfer of intellectual property rights (IPR) whose owners are not based
in India could not be taxed in the country More...
India rejects 955 pharma patent applications in last 3 years

(Press Trust of India | New Delhi , 25-Jul-2016 , Business Standard)
Nirmala Sitharaman said there was a slowdown in exports from SEZs because of reasons like withdrawal
of exemptions of minimum alternate tax More...
Compulsory licensing is very critical to original patent holder: Dr Malathi Lakshmikumaran

(Nandita Vijay, Bengaluru , 22-Jul-2016 , Pharmabiz)
Compulsory licensing is a practice critical to patent holders in pharmaceutical industry. More...
Samsung hits back at China's Huawei with patent suit

(AFP , 22-Jul-2016 , Zee News)
South Korea's Samsung Electronics said on Friday it had filed a patent infringement suit in China against
Huawei, adding fuel to a growing legal battle between the rival smartphone makers. More...
US indicts owner of Kickass Torrents for copyright infringement

(Reuters , 21-Jul-2016 , The Indian Express)
One of the domains operated by KAT, Kat.cr, was the 70th most popular website in the world according
to Alexa More...
Canadian firm Island Labs denied patent on concoction for hair growth
A Canadian company has been denied patent for a hair and scalp medical formulation by the
government after the Ministry of Science and Technology opposed the application on the ground that it
was part of traditional Indian medicine. More...
Diluted patent laws will spike drug price: experts

(SPECIAL CORRESPONDENT , 15-Jul-2016 , The Hindu)
Drug prices in India are likely to escalate if the government dilutes patent laws under pressure from
monopoly companies in the West, Intellectual Property Rights (IPR) experts participating in a meeting
here have warned. More...
India-EU FTA chief negotiators to meet today

(FE Bureau | New Delhi , 15-Jul-2016 , The Financial Express)
The meeting is important as it comes barely a week after Britain’s business minister Sajid Javid called on
India’s commerce and industry minister Nirmala Sitharaman and discussed the possibility of a trade pact
between the two countries, post-Brexit. More...
India may offer tariff cut in goods at trade summit

(Asit Ranjan Mishra , 14-Jul-2016 , Live Mint)
New Delhi: India has agreed to show flexibility in Regional Comprehensive Economic Partnership (RCEP)
negotiations and offer further tariff cuts in goods if other member countries agree to a higher level of
commitment in trade in investment and services. More...
India-EU talks over free trade agreement in the offing

(Elizabeth Roche , 14-Jul-2016 , Live Mint)
New Delhi: India and the European Union (EU) are expected to sit down for talks on how to move
forward their long dragging free trade agreement (FTA) in the next few days. More...
US move to negotiate in small groups creates chaos at WTO

(D. Ravi Kanth , 14-Jul-2016 , Live Mint)
Geneva: Attempts by the US to force so-called plurilateral initiatives with a small group of countries
instead of pursuing larger multilateral agreements are causing “negotiating chaos” at the World Trade
Organization (WTO), according to several trade officials. More...
High Court stops two Indian firms from infringing Toyota trademarks
DELHI High Court has restrained two Indian auto spare parts manufacturers from infringing on the
trademarks like Prius and Innova of Japanese car-maker Toyota and directed them to pay Rs 10 lakh as
damages to the auto giant for "knowingly and intentionally" using its brands to earn "undue profits".
More...
‘Section 3(d) of Indian Patents Act stifles innovation’

(NAYANIMA BASU , 14-Jul-2016 , Business Line)
National IPR Policy falls short on specifics, says GIPC’s Kalpana Reddy More...
Kanchipuram silks to cost more as silver shoots up

(ET Bureau , 11-Jul-2016 , The Economic Times)
Expect a price shock if you are in the market for a Kanchipuram silk sari. As prices of raw silk and silver
have shot up, sellers are considering when, not whether, to hike prices. More...
Patent Office refuses patent to Italian research firm Indena to treat mucositis
Also rejects a pre-grant opposition filed by a scientist while considering application More...
Zydus inks pact with Medicines Patent Pool for Hepatitis-C drug
(Press Trust of India | New Delhi , 7-Jul-2016 , Business Standard)
The agreement sub-licences Zydus to produce and sell daclatasvir in 112 low and middle income
countries More...
Awareness about intellectual property rights is rising in India

(Sheo S Jaiswal , 06-Jul-2016 , The Times of India)
The Confederation of Indian Industry (CII) in association with the department of industrial policy and
promotion (DIPP) on Wednesday organized a workshop on intellectual property right (IPR) awareness
and national intellectual property right policy at SIDCUL in Haridwar. More...
Suven Life Sciences gets patent for neuro-degenerative drug

Drug firm Suven Life Sciences has been granted a patent from Europe and two product patents from
Eurasia for a drug used in the treatment of neuro-degenerative diseases. More...
Pooja Bhatt fixing copyright issues for 'Cabaret' release

(IANS , 28-Jun-2016 , The Times of India)
Addressing the delay in the release of Richa Chadha-starrer "Cabaret" -- which has already suffered two
postponements in its release date, filmmaker Pooja Bhatt has said some copyright issues are being fixed
before the movie gets "a dignified release". More...
TIPCU to tackle online piracy

(SPECIAL CORRESPONDENT , 25-Jun-2016 , The Hindu)
The initiative is said to be first of its kind in the country More...
Seizing India’s Innovation Opportunity

(GUEST AUTHOR , 24-Jun-2016 , Business Insider)
A lot can change in two years - or not. The world has weathered an economic crisis and has come
together through to tackle poverty, hunger, disease, and global terror. More...
Why India’s patent law is more secure at WTO than in bilateral engagements
(Sanjiv Shankaran , 23-Jun-2016 , The Times of India)
The allegations made by Subramanian Swamy about finance ministry’s chief economic advisor Arvind
Subramanian’s deposition in US a few years ago about India’s patent laws is important, but for a
different reason. More...
Australian 'Bitcoin founder' quietly bidding for patent empire

(Reuters | Sydney/Singapore , 21-Jun-2016 , Business Standard)
Since February, Craig Wright has filed over 50 patent applications in Britain through EITC Holdings
More...
IBM patents Google Glass-like night vision eyewear

(IANS , 19-Jun-2016 , The Economic Times)
US tech giant IBM has patented an eye wear like Google Glass that will have red-eyed night vision
capabilities, a media report said. More...
Decathlon gets patent for invention related to bicycle

The invention helps in making bicycle riding a better experience in tough terrains More...
Patent office caps fast-track requests

(SPECIAL CORRESPONDENT , 18-Jun-2016 , The Hindu)
The number of applications have been limited to 1,000 More...

Apple iPhones found to have violated Chinese rival's patent
(Bloomberg , 17-Jun-2016 , The Economic Times)
Apple Inc. violated the design patents of a Chinese device maker and may have to halt sales of its latest
iPhones in Beijing, the city's intellectual property authority ruled, handing the US company its latest
setback in a pivotal market. More...
Apple iPhones found to have violated Chinese rival's patent

(Bloomberg , 17-Jun-2016 , The Economic Times)
Apple Inc. violated the design patents of a Chinese device maker and may have to halt sales of its latest
iPhones in Beijing, the city's intellectual property authority ruled, handing the US company its latest
setback in a pivotal market. More...
TCS, Wipro lead patent charge

(TE RAJA SIMHAN , 16-Jun-2016 , Business Line)
File over 500 patents each in 2015-16; Infosys disappoints with just nine More...
TVS Motor gets patent for a new gearshift assembly

(TE Narasimhan | Chennai , 16-Jun-2016 , Business Standard)
The invention talks about putting switch or switches on the handlebar to shift gear in a SMT vehicle
More...
India warned against pitfalls in ASEAN trade agreement

(VIDYA KRISHNAN , 15-Jun-2016 , The Hindu)
As talks for a Regional Comprehensive Economic Partnership (RCEP) — a regional trade agreement
among the 10 ASEAN countries — continue in Auckland, Médecins Sans Frontières (MSF) has warned
India that it will no more remain ‘the pharmacy of the developing world’ if the proposals in the pact are
adopted. More...
Suven gets patent for CNS molecules from Canada, Hong Kong
Drug firm Suven Life Sciences has received a patent each from Canada and Hong Kong for molecules to
be developed as drugs for treatment of various central nervous system (CNS) disorders. More...
If India signs RCEP, it will not be the 'pharmacy of the world': MSF
(VIDYA KRISHNAN , 14-Jun-2016 , The Hindu)
The RCEP is a regional trade agreement being negotiated between the 10 ASEAN countries currently in
Auckland. More...
Large margin of improvement for Indian IPR regime: European Patent Office
(13-Jun-2016 , DNA)
Seeing a "very large margin of improvement" for the IPR regime in India, the European Patent Office
(EPO) has offered to expand its cooperation with the country in this regard. EPO President Benoit
Battistelli also said that India has all the elements to become a great player in IP (Intellectual Property)
space with a vast talent pool of well-qualified people and its huge knowledge economy. More...
Why you just can’t have a one-size-fits-all IPR policy

(sushila ravindranath , 13-Jun-2016 , The Financial Express)
The National IPR (Intellectual Property Rights) policy was released on May 11. This 38-page document
will give directions to the government to promote ‘creative and innovative India’. Questions have been
raised in some quarters about the need for a new policy now, as extensive legislation has been passed
amending patent, copyright, trademark and design laws. Was the report released because of the Prime
Minister’s US trip? Will it play into the pharmaceutical lobby? More...
Patent office issues guidelines for startups

(10-Jun-2016 , The Economic Times)
Indian Patent Office has issued guidelines for facilitators and startups with respect to filling and
processing of applications for patent, designs and trade marks aiming to encourage budding
entrepreneurs and boost innovation. More...
India has not claimed IPR on Yoga, PM Modi tells US lawmakers

(PTI , 9-Jun-2016 , The Times of India)
Observing that there are over 30 million practitioners of Yoga in America, Prime Minister Narendra Modi
on Wednesday told members of the US Congress that India has not yet claimed IPR on Yoga. More...
Uttarakhand tejpatta (sweet bay leaf) gets GI tag

(Shivani Saxena , 06-Jun-2016 , The Times of India)
The famed Uttarakhand tejpatta, a popular spice used extensively in the hilly cuisine, has been awarded
a geographical indication (GI) certificate by the Chennai-based Geographical Indications Registry,
making it the first product indigenous to the state to have made it to the GI list which features 261
products from across the country. More...
Devgad Alphonso growers' two-year wait for patent may end on Monday
(DNA CORRESPONDENT , 6-Jun-2016 , DNA)
Devgad Alphonso growers are eagerly waiting for a hearing, which might grant them the Geographical
Indication (GI)-related rights. More...
Don’t confuse patents with innovation

(EBEN MOGLEN / MISHI CHOUDHARY , 05-Jun-2016 , Business Line)
Our IPR policy fails to recognise that sharing knowledge, as in the case of open source software, spurs
creativity More...
Seven agriculture products get GI tag

(Anandi Mishra , 4-Jun-2016 , The Times of India)
Seven agricultural products of the state were issued the Geographical Identification (GI) mark this week.
More...
Xiaomi’s Microsoft patent buy-up is part of its global push
(Bruce Einhorn , 03-Jun-2016 , Livemint)
Microsoft finding in Xiaomi a ready buyer for its patents is a sign of growing importance Chinese
companies, trying to be global brands, now put on intellectual property More...
Rise in patents from India for essential drugs may hurt affordable treatment
(Rupali Mukherjee , 03-Jun-2016 , The Times of India)
Increase in patents on essential medicines in India will jeopardise supply of affordable treatment , not
only in the country, but also in developing nations. More...
How India patent will help Volkswagen cut production cost

(Sajan C Kumar | Bengaluru , 3-Jun-2016 , The Indian Express)
The country's patent office has granted a Indian patent to German automobile major Volkswagen Group
for its invention relating to a uniform communication system involving different control devices of a
vehicle which in turn is said to reduce the cost of production of a motor vehicle. More...
A policy without intellectual clarity

(SRIVIDHYA RAGAVAN , 2-Jun-2016 , Business Line)
The IP policy is all for turning knowledge into IP assets, not realising that public access and equity are
central to creativity More...
FIR against hotel for copyright violation of Bollywood songs

(Express News Service , 1-Jun-2016 , The Indian Express)
The police said the alleged infringement came to light as N Gopalkrishnan, the firm’s general manager,
was present at the party. - More...
US Supreme Court rejects patent appeal over Cubicin drug

(Reuters , 31-May-2016 , The Financial Express)
The US Supreme Court on Tuesday rejected Cubist Pharmaceuticals Inc's bid to revive four patents for
its antibiotic drug Cubicin, paving the way for rival Hospira Inc to introduce a generic version as soon as
this year. More...
CII establishes three IPR facilitation centres

The Confederation of Indian Industry (CII), in association with the Ministry of Micro, Small and Medium
Enterprises, has established Intellectual Property Rights Facilitation Centres (IPFC) in Indore, Mysuru
and Gandhinagar. More...
Strike a balance between access to data and data theft

(Sayan Ghosal , 29-May-2016 , Business Standard)
Indian data protection laws have been the subject of much debate and concern in recent times with the
advent of e-commerce platforms and cyber technology in the nation More...
Yahoo secures Indian patent for invention to classify image
(Sajan C Kumar | Chennai | , 27-May-2016 , The Indian Express)
Numerous situations exist where a system treats a photo differently from a graphic; thus it would be
desirable for the system to know if a particular digital image is a photo or graphic More...
Huawei sues Samsung over patent infringements

(Reuters , 25-May-2016 , The Times of India)
Huawei Technologies Co Ltd on Wednesday said it sued Samsung Electronics Co Ltd claiming
infringement of smartphone patents, the Chinese firm's first intellectual property challenge against the
world's top mobile maker. More...
Patently a missed opportunity

( Achal Prabhala, Sudhir Krishnaswamy , 25-May-2016 , The Hindu)
India’s first IPR policy trots out the worn western fairy tale that more IP means innovation, and
encourages the pointless privatisation of indigenous knowledge More...
Suven Life Sciences gets patent for neurodegenerative medicine in Australia, Eurasia, Israel &
USA
(Our Bureau, Mumbai , 23-May-2016 , Pharmabiz)
Suven Life Sciences Ltd (Suven) announced that it has secured product patents in Australia, Eurasia,
Israel and USA to its new chemical entities (NCE’s) for CNS therapy through mechanism of action – H3
Inverse agonist and these patents are valid until 2032, 2030, 2031 and 2032 respectively. More...
'TRIPS sets the floor for IP-led innovation

(Patrick Kilbride , 22-May-2016 , Business Standard)
The US Chamber looked to the announcement of the final National Intellectual Property Rights Policy as
the beginning of a new era, with a re-commitment to a strong intellectual property policy framework.
More...
Standing up to patent bullying

(B. Vinod Kumar , 22-May-2016 , The Hindu)
India is at the centre of the world's generic drug production as it is one of the few countries with the
technical capacity to produce raw materials. More...
Google patent glues pedestrians to self-driving cars

(AFP , 21-May-2016 , The Economic Times)
Google on Thursday had a fresh US patent for a sticky coating that could be applied to self-driving cars
so pedestrians stick instead of bouncing off when hit. More...
New IPR policy aims for ‘Creative India: Innovative India’ but few kinks remain
(Indu Bhan , 20-May-2016 , The Indian Express)
But there are a few kinks, like the lack of nuance in its IP creation vision. More...
Colombia's government is giving pharmaceutical giant Novartis a few weeks to lower prices
on a popular cancer drug or see its monopoly on production of the medicine broken and
competition thrown open to generic rivals
(Joshua Goodman & Linda Johnson , 18-May-2016 , USNews)
Colombia's government is giving pharmaceutical giant Novartis a few weeks to lower prices on a popular
cancer drug or see its monopoly on production of the medicine broken and competition thrown open to
generic rivals. More...
Government opens special channel to speed up patent grant process

(Asit Ranjan Mishra , 18-May-2016 , Livemint)
The government, in a first, aims to process patent applications within 6 to 12 months as against the
normal route which takes 5 to 7 years More...
India introduces cheaper & faster patent registration for startups

(ET Bureau , 18-May-2016 , The Economic Times)
Startups from the world over will now be able to register patents in India faster and at much lower costs
under a 'tatkal (instant)' option offered under the latest amended patent rules. More...
Intellectually promising
(17-May-2016 , Business Line)
The new IPR policy is reformist, but misses the big picture More...
Global legal experts urge Indian government to strongly protect IPR

(IANS | New Delhi , 17-May-2016 , Business Standard)
A few days after India got its new National Intellectual Property Rights (IPR) Policy to safeguard
commercial interests arising from creativity, legal experts urged the government to fortify obligations to
protect IPR and strengthen commitments to enforce laws against counterfeiting and piracy. More...
India must resist pressure to amend its patent laws

(17-May-2016 , DNA)
There is external pressure to evolve a patent regime that would prevent affordable drugs from reaching
the needy. More...
Centre to speed up patent examination for start-ups, India first filers

(Our Bureau , 17-May-2016 , Business Line)
The Centre is introducing a facility for speeding up the examination of patents for start-ups and for
applicants who choose India as the competent authority for international searching or preliminary
examination. More...
Ashok Leyland gets patent for lightweight composite articles for auto industry
(Gireesh Babu | Chennai , 17-May-2016 , Business Standard)
The composite articles are suitable for making structures for use in automobile, aerospace industries
More...
Now, a ‘tatkal’ system to expedite patent examination
Aim is to reduce the period from 5-7 years to 18 months by March 2018. More...
Intellectual Property Rights: New policy may power R&D, national growth
(Anil Sasi , 17-May-2016 , The Indian Express)
The announcement of the new IPR policy has been a much sought after reform considering the
unfavourable regulatory environment prevalent in the country. The new policy is expected to encourage
the IPR regime, making it more efficient. More...
Wockhardt chief Habil Khorakiwala backs fast tracking of drug patents

(Aneesh Phadnis | Mumbai , 17-May-2016 , Business Standard)
New IPR policy unveiled last week aims to simplify and expedite patent application processes More...
Microsoft fails to get patent for e-mail management system

(Sajan C Kumar , 17-May-2016 , The Indian Express)
The patent office rejected Microsoft’s application on the grounds that the subject matter was not
patentable as it fell under Section 3 (k) of the Indian Patent act, 1970 More...
Intellectual Property Rights policy to help commercialise patents, copyrights: Government

(PTI | , 16-May-2016 , The Economic Times)
The Intellectual Property Rights (IPR) policy will not only incentivise entrepreneurship and innovation in
the country, but will aid in the conversion of copyrights and patents for commercial use, Commerce
Minister Nirmala Sitharaman said today. More...
Gilead Sciences withdraws writ petition in support of consolidating hearings over patent
rights
(Vikas Dandekar , 16-May-2016 , The Economic Times)
US drug maker Gilead Sciences withdrew a writ petition it filed in Delhi High Court in support of
consolidating hearings over patent rights of its Hepatitis C drug sofosbuvir at the Kolkata Patent Office.
More...
IPR policy to promote R&D, bring down waiting period: Nirmala Sitharaman
(PTI | New Delhi , 15-May-2016 , The Indian Express)
The total number of patent applications and trademark registration requests pending as on February 1
were 2,37,029 and 5,44,171, respectively. More...
Gilead patent on sofosbuvir a setback for health groups, but they vow to fight on
(Rupali Mukherjee , 12-May-2016 , The Times Of India)
A day after US company Gilead was granted a patent on hepatitis C medicine, sofosbuvir, patient groups
and companies are planning to challenge it. More...
India has 1.92 lakh active researchers, 2.37 lakh pending patents
(Chethan Kumar , 11-May-2016 , The Times Of India)
As of April 2016, India has 1.92 lakh active researchers with 14% of them being women, but Indian
patent offices have 2.37 lakh patent applications pending. More...
India wary of EU seizing drug shipments under new law

May move WTO; in talks with bloc More...
Patent not to affect hepatitis C drug price in India: Gilead Sciences Inc
(PTI , 11-May-2016 , The Economic Times )
US-based pharmaceuticals firm Gilead Sciences Inc today said prices of its hepatitis C drug Sovaldi will
not be impacted by granting of patent to it by the country's patent office. More...
50% drop in patents filed by Biotechnoloy department: Parliamentary Committee

(PTI , 10-May-2016 , DNA)
According to the report, patent filing is one of the major indicators of the scientific achievements of the
department. More...
Gilead’s $1,000 pill gets patent in India

(Rupali Mukherjee , 10-May-2016 , The Times of India)
In what could be a major setback for access to treatment in high-burden countries, the Indian Patent
Office on Monday granted a patent to Gilead Pharmasset on Sovaldi (sofosbuvir), its blockbuster drug for
hepatitis C, for which the company charges $1,000 per pill in the US. More...
TVS secures patent for air-injection system to improve fuel economy

(Sajan C Kumar | Chennai , 10-May-2016 , The Indian Express)
The air-injection system, capable of reducing exhaust emission, is meant to provide the benefit of
improved fuel economy by reducing fuel supply during deceleration. More...
Groupon sues 'once-great' IBM over patent

(Reuters | , 10-May-2016 , The Economic Times)
The online marketplace Groupon Inc has sued IBM Corp, accusing it of infringing a patent related to
technology that helps businesses solicit customers based on the customers' locations at a given
moment. More...
Nasa releases 56 patent technologies for public use

(Zee News Bureau , 09-May-2016 , Zee News)
If you are a techno geek or someone who keep a close eye on latest technological developments then
then here's a bonanza offer for you! More...
Facebook wins trademark case in China
(IANS , 09-May-2016 , The Indian Express)
Along with other social media platforms like Twitter, Facebook is currently blocked to nearly 700 million
internet users in China. More...
Former employees of Serum Institute of India booked for stealing vaccine info
(PTI , 9-May-2016 , The Financial Express)
Two former employees of the Serum Institute of India here have been booked for breach of trust for
allegedly stealing confidential information about a vaccine and filing for patent on behalf of their present
employer, police said today. More...
Start-ups should understand Intellectual Property

(8-May-2016 , The Hindu Business Line)
There is a need to develop product-based technologies, for which patents can be obtained, according to
Ramesh Loganathan, President of HYSEA and Vice-President of Progress Software Dev Pvt Ltd. He was
speaking at a seminar organised on Intellectual Property Rights (IPR) management, organised by the
Confederation of India Industry (CII) in association with the Department of Electronics & IT (DeitY),
Government of India. More...
IT bigwigs, startups spar over software patents

Battle lines are drawn in the technology industry over software patents as the bigwigs and startups spar
over allowing patenting of software More...
BusinessLine twenty years ago today: Patent laws: New govt. to have hands full
The next Union Government, whatever its composition may be, would find itself in a spot over the
proposed amendments to the country’s patent laws as a group of Parliamentarians, cutting across party
lines, have resolved to fight the move tooth and na9il. More...
Indian mobile handset companies facing might of tech patent holders. Here’s what they
should do
(5-May-2016 , The Financial Express)
The Indian Cellular Association (ICA) views the debate between patent owners and implementers as a
non-issue. More...
Needless pressure to change copyright laws

(DEVIKA AGARWAL RADHIKA AGARWAL , 4-May-2016 , Business Line)
RCEP’s position should be resisted. India must take a tough stand on digital rights else internet users
will find the going rough More...
Needless pressure to change copyright laws

(DEVIKA AGARWAL RADHIKA AGARWAL , 4-May-2016 , Business Line)
RCEP’s position should be resisted. India must take a tough stand on digital rights else internet users
will find the going rough More...
Apple loses Chinese lawsuit over iPhone trademark
(AP Beijing , 04-May-2016 , The Indian Express)
Apple loses legal battle with Chinese handbag company over iPhone trademark. More...
385 Indian applications for trademark registration in FY16

(04-May-2016 , The Economic Times)
The World Intellectual Property Organisation (WIPO) received only 385 applications from the Indian
entrepreneurs aspiring to have their trademarks registered globally during the year 2015-16. More...
India needs more tie-ups to boost pharma sector

(Nilanjan Banik and Philip Stevens , 04-May-2016 , The Financial Express)
Local pharmaceutical firms have to focus on creating new medicines instead of simply manufacturing
copies of those invented elsewhere More...
Nvidia settles patent battle with Samsung

Graphics chip maker Nvidia Corp announced a settlement of a patent dispute with Samsung Electronics
Co Ltd, hours before a US trade agency was due to rule on a complaint that could have blocked
importation of some of Nvidia's products. More...
Broadband body questions need for discussion paper on patents

(Gulveen Aulakh, ET Bureau , 02-May-2016 , The Economic Times)
A broadband forum consisting of companies such as Bharti Airtel Vodafone, Qualcomm, Ericsson and
Intel, has questioned the government's move to float a discussion paper on standard essential patents
(SEPs), saying that issues raised including fixing of royalty rates and position on legal injunctions have
already been discussed and incorporated in the Intellectual Property Rights (IPR) policy back in 2014.
More...
Patent of Ayurvedic system of medicine

(Delhi , 02-May-2016 , Business Standard)
Under the Agreement on Trade Related Intellectual Property Rights (TRIPS Agreement) to which India is
committed, every country is required to accord to the nationals of other members, treatment which is no
less favourable than it accords to its own nationals with regard to the protection of intellectual property.
More...
India on US watch list for harsh IP law

(SPECIAL CORRESPONDENT , 30-Apr-2016 , The Hindu)
India remained on the ‘Priority Watch List’ of the United States Trade Representative’s (USTR) “Special
301 Report”, for using legal tools to protect generic competition and access to affordable medicines.
More...
Tata Motors gets patent for auto stop-start control system

(Sajan C Kumar | Chenna , 30-Apr-2016 , The Financial Express)
Tata Motors in the patent application submitted that the invention will be a solution to save the fuel
wasted when idling at traffic signals by automatically switching off the engine when the vehicle is
stopped. More...
Thyrocare IPO gets subscribed 73 times

(Ankit Doshi , 30-Apr-2016 , Livemint)
Retail investors and high net-worth individual investors bid for 8.45 times and 225.3 times the number
of shares reserved for them in IPO, respectively More...
Won't yield to pressure on IPR: Sitharaman

She termed the US’ Special 301 Report as a unilateral measure to create pressure to enhance IPR
protection beyond the TRIPS agreement. More...
India has more than 200,000 pending patent applications

( Joe C Mathew , 26-Apr-2016 , Business Today)
Indian patent office has set up four subject specific patent examination groups in its Delhi, Chennai,
Kolkata and Mumbai branches to streamline and speed up the handling of patent applications. More...
India won't succumb to any pressure on IPR issues: Nirmala Sitharaman

India today said its intellectual property rights regime is fully in compliance with global norms and the
country will not succumb to "any pressure from any where" to modify it. More...
DIPP looks to reduce delays in clearing intellectual property applications

DIPP secretary Ramesh Abhishek says the department had set a target of lowering the time taken to
clear pending IPR applications from the current five to seven years to 18 months by March 2018 More...
Ericsson fails India patent bid for mobile altitude determination

(Sajan C Kumar , 26-Apr-2016 , The Financial Express)
Swedish major Telefonaktiebolaget LM Ericsson (Ericsson), one of the world’s largest wireless telecom-
equipment provider, has been denied an Indian patent for an 'invention' that defines altitude
determination method in a cellular communication system. More...
Centre steps in to expedite patent approvals

The government is taking measures to reduce the time to examine patent applications for clearing them
at the earliest, Ramesh Abhishek, Secretary, Department of Industrial Policy and Promotion (DIPP)
measures said. More...
US ‘Special 301’ process on IPR a unilateral measure: Nirmala Sitharaman

(PTI | New Delhi | , 26-Apr-2016 , The Financial Express)
India today accused the US of taking "unilateral measure" to pressurise countries to accept Intellectual
Property Rights (IPR) protection beyond WTO obligations. More...
Govt wants to cut patent examination time to 18 months from 5-7 years
(PTI , 25-Apr-2016 , DNA)
For this, the government has hired more examiners and DIPP is taking several other initiatives. More...
Patent attorneys await clarifications on govt's start-up IP scheme

(Gireesh Babu | Chennai , 25-Apr-2016 , Business Standard)
Clarity required on fee structure, procedures to follow in filing IP More...
The importance of IP rights for innovation

(Richard R. Verma , 25-Apr-2016 , Livemint)
Protecting intellectual property of our innovators ensures future generations will enjoy art forms as rich,
diverse and creative as those we enjoy today More...
Secretive' patent talks is worrying generic drug activists

(ARADHNA WAL , 25-Apr-2016 , DNA)
As a round of massive free trade talks kick off on April 25, civil society groups have raised alarm after a
leaked documents showed proposals that would make access to generic medicines far tougher than
Bitter pill I More...
Patent your innovations, claim authority

(Subra Mani , 24-Apr-2016 , The Times of India)
Be authority of your own innovations by claiming patents for them - this was Intellectual Property
Appellate Board (IPAB) chief's World IPR Day message to students. More...
IT firms yet to take patent benefit

(TNN , 22-Apr-2016 , The Times of India)
Even though the AP IT policy promises reimbursement for filing patent costs up to Rs 5 lakh, IT
companies are yet to utilise the benefit offered by the state government. According to a senior IT
official, not even a single IT company utilised the benefit in the state. More...
Monitoring patents critical to develop more innovative products & to stay ahead of
competition: Origiin IP Solutions CEO
(Nandita Vijay, Bengaluru , 23-Apr-2016 , Pharmabiz)
For pharma companies monitoring patents is extremely critical to develop more innovative products and
also to stay ahead of competition, avoid duplication of work and giving right direction to R&D, according
to Bindu Sharma, patent attorney and chief executive officer, Origiin IP Solutions LLP, Bengaluru.
More...
Apple patents hybrid wired/wireless headphones

(TOI Tech , 22-Apr-2016 , The Times of India)
Technology giant Apple has filed a new patent application for a wireless hybrid headphone system.
More...
GI expert bags intellectual property award

His is a story of an undying spirit and a fight against all odds to achieve a weighty goalsomething you've
set your heart on. More...
Trademark Office's Bid to Clear Backlog Hits a Block

(Maulik Vyas , 20-Apr-2016 , The Economic Times)
The patent and trademark office's apparent drive to clear its backlog of applications has hit a legal
roadblock, with the Tatas and a group of intellectual property attorneys dragging it to court. More...
US think tank launches India-US trade initiative

A top US think-tank has launched an India-US trade initiative aimed to strengthen economic ties and
meet the two countries' bilateral trade target of $500 billion. More...
Patent box regime: Time for a market-oriented approach

(Sanjay Kumar , 20-Apr-2016 , The Financial Express)
The new patent box regime, despite its limited scope and a tentative beginning, will no doubt address
multiple market failures More...
TCS to appeal against verdict in intellectual property rights case

(Bloomberg , 18-Apr-2016 , Livemint)
A federal grand jury in Wisconsin ordered Tata Consultancy Services and Tata America International
Corporation to pay $940 million More...
Roche sues Intas Pharma over Mircera anaemia drug patent

(Vikas Dandekar , 18-Apr-2016 , The Economic Times)
Swiss biotechnology giant Roche has sued Ahmedabad-based drug maker Intas Pharmaceuticals in Delhi
High Court, alleging infringement of its patent rights over Mircera, an injectable brand used to treat
patients with anaemia in chronic kidney-related ailments. More...
Gufic Private Limited and Anr. Versus Vasu Healthcare Limited

(Shan Kohli , 17-Apr-2016 , SpicyIP)
There are few greater joys in the life of an IP enthusiast than reading an eloquent, nuanced and pithy
judgment of Justice Gautam Patel of the Bombay High Court. His recent judgment in the case of Gufic
Private Limited and Anr. Versus Vasu Healthcare Limited (Notice of Motion No. 399 of 2013 in Suit No.
164 of 2013 decided on 28.03.2016) is another excellent example of why he has been consistently
ranked as one of the world’s 50 most influential IP thinkers. More...
Global outlook on Indian IPR changing for better

(IANS , 12-Apr-2016 , THE HANS INDIA)
Take strong steps to encourage innovation Convictions needed in cases counterfeiting Empower more
courts to award damages New policy must incentivise patent filing More...
Apple’s new patent could kill traditional keyboards

(HT Correspondent, Hindustan Times , 11-Apr-2016 , Hindustan Times)
A new patent filed by Apple suggests that traditional keyboards might be replaced by a touchpad which
uses pressure-sensitive technology and haptic feedback More...
Geographical Indications have the potential to be India’s growth engine

(Anil K Kanungo , 11-Apr-2016 , The Financial Express)
The recent overall slowdown in India’s exports possibly calls for a re-examination of policies essential to
propel India’s foreign trade. More...
CSIR Features in the Thomson Reuters Top 50 Indian Innovator Companies and Research
Organizations for the Year 2015
(Delhi , 06-Apr-2016 , Business Standard)
CSIR Features in the Thomson Reuters Top 50 Indian Innovator Companies and Research Organizations
for the Year 2015 More...
Start-ups could benefit from Madrid route of trademark filing: Survey

(Sajan C Kumar | Chennai , 6-Apr-2016 , The Financial Express)
Report finds India Inc is showing ‘indifference’ to Madrid Protocol when it comes to trademark
registration even as firms attribute the ‘lethargy’ to non-awareness of Madrid procedures, cost disadvan-
tages, and non-interest in overseas operations More...
Delhi HC stays 193,908 orders issued by trademarks registry

(Apurva Vishwanath , 6-Apr-2016 , Livemint)
A group had moved the court alleging the trademark registry cancelled an unusually high number of
trademark applications without issuing notices More...
India should join TPP to maintain trade advantages in generics: Patent experts
India which has stronghold in manufacture and export of generic drugs globally could lose its trade
advantages in generics if it does not join US-led trade pact Trans Pacific Partnership Agreement (TTP),
involving twelve Pacific Rim countries and concerning duty free trade, reduced tariffs and mutual
regulatory recognition to members, according to patent experts. More...
Patent office set to be rechristened

( FE Bureau , 5-Apr-2016 , The Financial Express)
The Controller General of Patents Designs and Trademarks, which oversees the implementation of
patents, designs and trademark laws, will soon be rechristened as the Controller General of Intellectual
Property Rights, a senior government official said on Monday. More...
USIBC team to push for ‘stronger’ IPRs
(ARUN S , 03-Apr-2016 , The Hindu)
USIBC will also push for India and the U.S. to expedite a Bilateral Investment Treaty. More...
Novartis refused patent for anti-hypertension drug combination

The patent for the triple drug combination was filed in 2007 at the Chennai patent office More...
Justin Timberlake sued for alleged copyright infringement

(PTI , 1-Apr-2016 , The Indian Express)
Justin Timberlake is being accused of stealing one of his songs from Cirque du Soleil. More...
India denies Vertex patent on cystic fibrosis drug Orkambi

(Phil Taylor , 1-Apr-2016 , PMLive)
The Indian Patent Office has refused a patent to Vertex Pharma for its cystic fibrosis therapy Orkambi,
saying the drug is not novel. More...
Govt needs 'intensive marketing campaign' for trademark

(PTI , 31-Mar-2016 , The Times of India)
Government should carry out an intensive marketing for Madrid System to encourage trademark
registrations as part of its 'Make in India' campaign, a study by IIM-Bangalore has suggested. More...
GlaxoSmithKline promises reduced drug patents to help world's poor

(By Reuters , 31-Mar-2016 , The Economic Times)
GlaxoSmithKline is to adopt a graduated approach to patenting its medicines, depending on the wealth
of different countries, in order to make drugs more affordable in the developing world. More...
Strong regulatory ecosystem vital for safeguarding IPR if M and E industry has to grow in the
international market
(Indiantelevision.com Team , 31-Mar-2016 , IndianTelevision)
The subject of intellectual property rights and piracy keep coming up at the FICCI FRAMES year after
year and appeals are made by creative artistes for stringent measures to check this. More...
HC upholds CCI jurisdiction over patent matters

(Deepak Patel , 31-Mar-2016 , Business Standard)
In a huge win for the Competition Commission of India (CCI), the Delhi High Court on Wednesday
upheld its jurisdiction to investigate patent-related competition matters. The regulator would now be
able to freely investigate and pass orders in the cases filed by Micromax and Intex against Ericsson,
alleging abuse of dominance in the market of technology patents. More...
India, EU Leaders Touch On IPR, Innovation, ICTs, Pharmaceuticals

(INTELLECTUAL PROPERTY WATCH , 30-Mar-2016 , Intellectual Property Watch)
The leaders of India and the European Union today in Brussels discussed a wide range of topics including
intellectual property rights – including geographical indications – innovation, digital issues, and health
and pharmaceuticals. More...
Govt. draws flak for decision to allow U.S.- trained patent examiners
(VIDYA KRISHNAN , 30-Mar-2016 , The Hindu)
Humanitarian aid organisation Médecins Sans Frontières (Doctors Without Borders) has questioned the
Indian government’s decision to have patent officers trained by the United States Patent & Trademark
Office after the recent controversy over compulsory licensing. More...
Patent Office rejects divisional patent application of Wyeth

(BS Reporter , 30-Mar-2016 , Business Standard)
The Patent Office has refused to proceed with a divisional patent application of Wyeth, now part of
Pfizer, for an invention as the claims are within the claims of parent application. This comes at a time
when some patient groups and others has been alleging that the divisional patent provisions are used by
the patent owners to extend the patent life. More...
Why India lags in innovation

(D. Ravi Kanth , 29-Mar-2016 , Livemint)
International patent applications filed from India dropped to 1,423 last year—as compared to Japan’s
44,235, China’s 29,846 and South Korea’s 14,626 in the same period More...
Johnson & Johnson receives patent for multifocal contact lens designs
(BS Reporter , 28-Mar-2016 , Business Standard)
Johnson & Johnson Vision Care Inc has received patent in India for multifocal contact lens designs, for
contact lens for the aged especially patients with presbyopia. More...
‘Strong patent regime the only way to boost drug innovation’

(Aesha Datta , 27-Mar-2016 , business line)
Janssen, the pharmaceutical arm of multinational Johnson & Johnson, has been in the news for many
reasons – right and wrong. Its new ‘miracle’ tuberculosis (TB) drug Bedaquiline was introduced in India
this week as part of the government’s programme for treating multi and extensive drug resistant TB.
More...
GE, Boeing, Honeywell back India on patents

(Dilasha Seth | New Delhi , 26-Mar-2016 , Business Standard)
Most representations have acknowledged improvement in India's IPR regime under PM Narendra Modi
More...
Patent dispute: Gilead ordered to pay Merck $200 m

(REUTERS , 25-Mar-2016 , Business Line)
A US federal jury on Thursday ordered Gilead Sciences Inc to pay Merck & Co $200 million in damages
for infringing two Merck patents related to a lucrative cure for hepatitis C. More...
Govt won't dilute stance to waive patent rights
(TNN , 24-Mar-2016 , The Times of India)
The government has ruled out any dilution in its stance on granting compulsory licences, or waiving
patent rights in case of a public health emergency, saying it is open to using flexibility provided under
international laws. More...
India has right to grant compulsory licences under WTO: Government

The government today said every member of the WTO, including India, has the right to grant
compulsory licences (CL) and also decide the grounds for issuing them. More...
US top court agrees to hear Samsung-Apple patent fight

(Reuters , 21-Mar-2016 , The Indian Express)
US Supreme Court agreed to hear Samsung's appeal of what it contends were excessive penalties for
copying the patented designs of the iPhone More...
Verdict likely in Ericsson’s patent infringement case, 20 more pleas in FDC case
(Apurva Vishwanath , 21-Mar-2016 , Livemint)
Today’s significant legal developments would cover the areas of advertising, pharma and telecom More...
Standing up to patent bullying

(SRIVIDHYA RAGAVAN , 21-Mar-2016 , The Hindu)
The Modi government must stop engaging U.S. bureaucrats as patent consultants and instead showcase
the Indian patent statute as an exemplar for a balanced regime. More...
Should software be patented in a country of over a billion people?

(VENKATESH GANESH , 18-Mar-2016 , Business Line)
Investors who see India as a software powerhouse will need to start focussing on the brewing issue of
software patents which has opened up new wounds. More...
Why has MSF chosen India to challenge Pfizer's patent on a pneumonia vaccine
(ARADHNA WAL , 18-Mar-2016 , DNA)
International not-for-profit Medecins Sans Frontieres (MSF) has taken on US pharma giant Pfizer,
challenging the latter's patent for a pneumonia vaccine priced at $100 a vial, in the Indian Patent Office.
More...
US No. 1 in international patent filings; Huawei filed most in 2015: WIPO

(TOI Tech , 17-Mar-2016 , The Times of India)
America continued its lead in international patents filings in 2015 with 57,385 international patent
applications, according to World Intellectual Property Organization (WIPO). More...
Startup India may be non-starter if patent office has its way
(Prathiba M Singh , 17-Mar-2016 , The Economic Times)
The government's major initiative announced by Prime Minister Narendra Modi on January 16 has
prepared the ground for an innovation-friendly atmosphere in the country. More...
Apple loses video streaming patent case

(Reuters , 17-Mar-2016 , The Times of India)
A German court has ruled against Apple in a case over video streaming patents, handing Kudelski's
OpenTV unit a victory in its ongoing intellectual property licensing campaign against major technology
companies. More...
Global patent applications from India drop to 1,423 in 2015: report

The US continued to dominate the world of innovation and inventions by filing 57,385 international
patent applications last year More...
Court rules against Apple in video streaming patent case

(REUTERS , 17-Mar-2016 , IBN Live)
A German court has ruled against Apple Inc in a case over video streaming patents, handing Kudelski's
OpenTV unit a victory in its ongoing intellectual property licensing campaign against major technology
companies. More...
Making India GI brand conscious

(LATHA R. NAIR , 17-Mar-2016 , The Hindu)
The current Indian legal framework for geographical indications needs to be strengthened to address
quality control and consumer expectations. More...
Doctors Without Borders challenges Pfizer's pneumonia vaccine patent in India

(BS B2B Bureau | Mumbai , 15-Mar-2016 , Business Standard)
With this, MSF or Doctors Without Borders, which claims Pfizer vaccine is highly priced, has become the
first medical organisation to challenge a vaccine (biosimilar) patent in India. More...
Amazon seeks patent for buying items using selfies instead of passwords
(AFP , 15-Mar-2016 , The Economic Times)
Online retail colossus Amazon is seeking a US patent on using selfies -- instead of passwords -- for
shopping when using smartphones. More...
Patents over patients

(Shamnad Basheer , 14-Mar-2016 , The Indian Express)
Government privileges the private over the public, preferring trade to health More...
MSF files pre-grant patent opposition against Pfizer's pneumococcal conjugate vaccine
The international medical humanitarian organisation Médecins Sans Frontières (MSF) has filed a 'patent
opposition' in India to prevent US pharmaceutical company Pfizer from getting a patent for the
pneumococcal conjugate vaccine (PCV13), so that more affordable versions can become available to
developing countries and humanitarian organisations. More...
Doctors Without Borders opposes Pfizer’s pneumonia vaccine patent in India

(Viswanath Pilla , 12-Mar-2016 , Livemint)
MSF is challenging this patent to ensure manufacturers planning to produce the pneumonia vaccine do
not face patent barriers while launching more affordable versions More...
Patent office: Filing of further divisional applications creates uncertainty over patent
(Sajan C Kumar | Chennai , 12-Mar-2016 , The Indian Express)
The Mumbai patent office says that such ‘uncertainty’ is against public interest and it also results in
abuse of the provisions of the Indian Patent Act More...
Why should we not revoke Bollgard II patent, Centre asks Mahyco Monsant
(KV KURMANATH , 10-Mar-2016 , Business Line)
Govt acts on a letter from farmers’ union on bollworm developing resistance to technology More...
India said to mull taking EU to WTO over threat to drug exports

(Shruti Srivastava , 10-Mar-2016 , Livemint)
European Union’s stricter trademark rules could stop exports of some generic drugs via the bloc to
markets such as Latin America More...
Over 2 lakh patent applications pending with govt: Nirmala

(Press Trust of India | New Delhi , 09-Mar-2016 , Business Standard)
As many as 2.37 lakh patent applications are pending with the government, mainly due to shortage of
manpower, Parliament was informed today. More...
Gilead Solvaldi Case Reveals Patent-Health Fissures In India

(PATRALEKHA CHATTERJEE , 9-Mar-2016 , INTELLECTUAL PROPERTY WATCH)
Are patient groups, health activists and manufacturers of low-cost generic drugs always on the same
page? Do India’s generic companies think alike? More...
India 'privately' against patent-overriding drug permits: USIBC

Indian government has "privately reassured" industry lobby group US-India Business Council that the
country would not invoke 'compulsory licensing' for commercial purposes that could allow local
drugmakers to make cheaper products by overriding patents of big global players. More...
Monsanto patent under cloud as Bt cotton prone to pink bollworm

(Vivek Deshpande | Nagpur , 8-Mar-2016 , The Indian Express)
Keshav Raj Kranthi, said that he had been consulted by the Union Agriculture Ministry on whether the
pink bollworm had developed resistance to Bt cotton grown in India — to which he had given an
affirmative reply. More...
US-based company stirs up trademark dispute against Houzify

(Aditi Shrivastava & Shashwati Shankar , 8-Mar-2016 , The Economic Times)
Facebook has removed the business page of Indian home interior startup Houzify without warning or
consultation, based on an alleged trademark infringement case by a US company called Houzz,
according to its CEO Gunaseelan Radhakrishnan. More...
75 MILLION COPYRIGHT TAKEDOWN REQUESTS RECEIVED BY GOOGLE

(HARIKIRAN ANAND , 8-Mar-2016 , The Indian Republic)
75 million copyright takedown requests received by Google More...
Eli Lilly bats for a favourable patent regime in India

(Shine Jacob , 07-Mar-2016 , Livemint)
Eli Lilly wants a more favourable patent regime that ‘rewards innovation’ and would welcome an open
dialogue from the government in this respect More...
Money laundering: Trade patents, a new tool for bringing back black money
(Sachin Dave , 2-Mar-2016 , Economic Times)
People who own patents in India are suddenly in demand - in many cases not because of the value of
their inventions that may be worthless, but as a conduit to launder money . More...
Lower tax on patent income to boost R&D

(Rupali Mukherjee , 2-Mar-2016 , Times of India )
The Budget has introduced a special 'royalty tax' which lowers the effective rate of tax on income earned
from patents. The objective is to encourage indigenous research and development, and to make India an
innovation hub. The benefit will be available across knowledge-based sectors of the economy, including
pharmaceuticals. More...
Farmers seek patent seed varieties

Farmers from North Maharashtra, especially Nashik, have demanded that the government must supply
patent varieties of seeds to boost their yield. More...
Apple patents detachable wireless earbuds

(TOI Tech , 01-Mar-2016 , The Times of India)
Here's the very latest on iPhone 7 rumours. According to a report in Apple Insider, the next iPhone may
come with "magnetically detachable wireless earbuds." T More...
Budget 2016: Steps to encourage domestic patent regime proposed

In order to encourage R&D in India, Finance Minister Arun Jaitley today proposed a special patent
regime under which 10 per cent tax on income will be charged on commercial exploitation of patents
developed and registered in India. More...
Hearing on Gilead's patent for hepatitis C drug, sofosbuvir, begins at patent office
(Ramesh Shankar, Mumbai , 29-Feb-2016 , Pharmabiz)
The much awaited patent challenge hearing on US pharmaceutical company Gilead Sciences' patent
application for hepatitis C drug sofosbuvir began in Indian Patent Office in Delhi which will have major
implications for millions of people waiting for affordable access to a life-saving hepatitis C drug. More...
Tata Motors fails to get patent for ‘follow-me-home’

(Sajan C Kumar | Chennai , 27-Feb-2016 , The Indian Express)
The Mumbai patent office, which took up the application, refused to buy the auto company’s argument
that the electronic control unit of the vehicle has been modified to facilitate the follow-me-home
headlamp flashing feature More...
Samsung Wins Appeal in Patent Dispute with Apple

( Reuters , 27-Feb-2016 , The New Indian Express)
A U.S. appeals court on Friday overturned a $120 million jury verdict against Samsung, finally handing
the South Korean smartphone maker a significant win in its longstanding patent feud with top rival
Apple. More...
IPR integral part of flagship Indian projects like Make in India, Digital India
India's "robust" IPR regime is an integral part of flagship projects like Make in India and Digital India
which is encouraging foreign companies to invest and establish their manufacturing, R&D and
outsourcing bases in the country, a senior Indian diplomat said. More...
Patent challenge hearing on Gilead hepatitis C drug sofosbuvir starts in India

(India Infoline News Service | Mumba , 26-Feb-2016 , IIFL)
Protesters living with hepatitis C and HIV rallied outside the Delhi patent office, urging the officials not to
cave in to pressure on the Indian government to blindly and speedily grant patents to multinational drug
companies. More...
A prudent decision
(OPINION » EDITORIAL , 26-Feb-2016 , The Hindu)
In this process, the patent office, called the Office of the Controller General of Patents, Designs & Trade
Marks, effectively reversed an August 2015 guideline that had triggered the ambiguity in the first place.
More...
Patents Office rolls back guidelines allowing patenting for software, hailed as victory for
startups
(Neha Alawadhi , 24-Feb-2016 , The Economic Times)
The Patent Office's decision to roll back its guidelines that allowed software patents in India is being
hailed as a big win for domestic startups, which will not have to worry about expensive patent litigation
that can potentially stifle innovation in the country. More...
Government to unveil IPR policy in a fortnight
(ARUN S , 23-Feb-2016 , The Hindu)
Cabinet Secretariat held meeting on Feb 22 to fine-tune the Policy; Cabinet note circulated among 29
ministries for suggestions. More...
India not to allow software patents

(BS Reporter | Bengaluru , 23-Feb-2016 , Business Standard)
Globally, patents favour large MNCs that can afford the high cost of filing patents and not startups,
hence the decision on India's part More...
Intellectual property rights: when it’s broken, fix it!

(Arun Maira , 23-Feb-2016 , Livemint)
We need affordable medicines and we need more innovation. It’s time to reinvent the patents regime
More...
Make in India runs into high royalty fee hurdle

(M Rajendran, Hindustan Times, New Delh , 23-Feb-2016 , Hindustan Times)
High patent royalty fees charged by foreign technology firms are fast emerging a major hurdle for
India’s ambitions of turning into a global mobile manufacturing hub. More...
No patent if invention lies only in computer programme, says Indian Patent Office
(BS REPORTER | Chennai , 22-Feb-2016 , Business Standard)
The Patent Office issues fresh guideline related to Computer Related Inventions (CRI) to bring in
uniformity in examining patent claims More...
USPTO grants patent for TapImmune's next-generation vaccine technology, PolyStart

(Jacksonville, Florida, Monday , 22-Feb-2016 , Pharmabiz)
TapImmune, Inc. (TPIV), a clinical-stage immuno-oncology company specializing in the development of

innovative peptide and nucleic acid-based immunotherapeutic vaccines for the treatment of cancer,
including metastatic cancer, announced that it has received a Notice of Allowance from the US Patent
and Trademark Office (USPTO) for its patent application entitled, “A chimeric nucleic acid molecule with
non-AUG initiation sequences.” More...
USIBC seeks to protect India’s IPR status

(VARGHESE K GEORGE , 21-Feb-2016 , The Hindu)
Dr. Aghi’s submission lists of a series of measures by the Indian government under Narendra Modi that
he said strengthened IP regime in the country. More...
GM gets favourable order from Patent Office for its vehicle diagnostics system
(BS Reporter | Chennai , 21-Feb-2016 , Business Standard)
The system is to help the owner to manage the vehicle health More...
The rationale of India’s drug policy
(Jayachandran/Mint , 18-Feb-2016 , Livemint)
The government’s price control mechanisms have not been optimal More...
Andhra Pradesh accuses Monsanto of abusing Indian Patents Act through JV

(Banikinkar Pattanayak | New Delhi , 18-Feb-2016 , The Financial Express)
Rao cautioned that if such a step isn’t taken, farmers will be required to pay ‘high royalty on a
technology which has lost its economic value’ More...
Everything that is wrong with the world’s cheapest smartphone

(Pranav Dixit, Hindustan Times, New Delhi , 18-Feb-2016 , Hindustan Times)
The Freedom 251 may be the world’s cheapest smart phone but the device released by Noida-based
Ringing Bells is riddled with problems, including a possible copyright infringement of Apple’s iconic
iPhone, HT has found. More...
Google refused patent for ‘invention’ on obsolete data

(Sajan C Kumar | Chennai , 18-Feb-2016 , The Financial Express)
The Indian patent office has refused to grant a patent to Google for its claimed invention relating to a
system for efficiently identifying and removing obsolete data from the database of a directory
information provider. More...
Nadiad whiz-kid gets three patents in his name

(Piyush Mishra , 18-Feb-2016 , The Times of India)
A final year engineering student of Nadiad has made a record of sorts. More...
Relief for MP’s Basmati farmers as Court nixes Apeda’s opposition

(R BALAJI , 17-Feb-2016 , Business Line)
Court asks Madhya Pradesh to proceed with applying for GI Registration of Basmati More...
MP govt moves Madras HC against IPAB order on Basmati GI tag

The Court asked APEDA not to take action against Basmati farmers in MP pending disposal of petition,
says counsel More...
PhRMA concerned over Sect 3(d) of India’s Patents Act as it fears other emerging markets
may emulate it as a model
The Pharmaceutical Research and Manufacturers of America (PhRMA) continues to flog India for what it
termed as a 'Generally weak IP environment' in the country and has expressed concern over Section
3(d) of India’s Patents Act as it fears that other emerging markets may emulate it as a model. More...
Stronger IP measures will be a boon for Indian start-ups
(PATRICK KILBRIDE , 12-Feb-2016 , DNA)
TRIPS is an important starting point, but it is far from representing an international best practice when it
comes to implementing an IP framework that nurtures domestic innovation and fosters national
competitiveness in the global marketplace. More...
AIISH seeks patent for two innovations

(SHANKAR BENNUR , 12-Feb-2016 , The Hindu)
The Mysuru-based All India Institute of Speech and Hearing (AIISH), a premier institute in
communication disorders, has developed iCry, a software for infant cry analysis, which will identify
whether a newborn is suffering from any abnormality. More...
Patient challenges patent on two key HIV drugs

(Rupali Mukherjee , 11-Feb-2016 , The Times of India)
A patient suffering with HIV has opposed patent applications for two important HIV medicines,
dolutegravir and cabotegravir, thwarting an attempt by ViiV Healthcare (a joint venture by Pfizer and
GlaxoSmithKline) to obtain monopoly rights on the drugs, in India. More...
Give Pakistani rice the Basmati tag

(Business Standard Editorial Comment | New Delhi , 11-Feb-2016 , Business Standard)
Rejection by India based on some petty procedural grounds seems unfair More...
India near bottom of intellectual property index

(NATIONAL BUREAU , 11-Feb-2016 , The Hindu)
India remains at the bottom of the Index for the fourth year in a row, according to the GIPC report
More...
India, RCEP members to discuss trade pact in Brunei starting February 15

(BS Reporter | New Delhi , 11-Feb-2016 , Business Standard)
The Regional Comprehensive Economic Partnership is a trade deal that aims to cover goods, services,
investments, economic and technical cooperation, competition and intellectual property rights More...
India ranks 37 on USCC’s Intellectual Property Index

(Shreeja Sen , 11-Feb-2016 , Livemint)
The index painted a grim picture of India, which scored 7.05, lower than last year’s 7.23 More...
Patent protection in India remains outside of international best practices

(OUR BUREAU , 10-Feb-2016 , Business Line)
Country ranked 37th among 38 countries in the IP index released by US Chamber of Commerce More...
US pharma body calls for stronger protection of intellectual property rights in India
(Shine Jacob , 10-Feb-2016 , Livemint)
PhRMA says India has not increased investment in this critical area, leaving public healthcare spending
at a very low level of approximately 1% of GDP More...
US pharma body slams Indian patent regime

(Rupali Mukherjee , 9-Feb-2016 , The Times of India)
Criticizing India's "weak" intellectual property rights (IPR) regime, PhRMA (Pharmaceutical Research and
Manufacturers of America), which represents leading pharma and biotech companies in the US, has
suggested India remain on the Priority Watch List in the 2016 Special 301 Report. More...
Enact safeguards on cultivation of GM crops

(9-Feb-2016 , DNA)
Without setting up an independent regulator with statutory backing, the Centre’s attempts to expedite
genetically modified crop cultivation are bound to fail More...
Basmati rice gets GI tag in 7 Indian states: Geographical indicators in India

(INDIATODAY.IN , 08-Feb-2016 , INDIA TODAY)
The world is full of beautiful places and each one has something unique about it. People tend to relate
things to the places they originated in. More...
Genetically modified crops: the way forward

(Shyamal Banerjee/Mint , 8-Feb-2016 , Livemint)
The government must be transparent and address understandable fears More...
The pill that costs $9,000 in US sells for $70 in India

(Rema Nagarajan , 07-Feb-2016 , The Times of India)
India's generic industry has been producing many such life-saving medicines at a fraction of the global
price More...
Order on GI tag for basmati likely today

(SPECIAL CORRESPONDENT , 5-Feb-2016 , The Hindu)
The much-awaited order in a dispute between parties, including the Madhya Pradesh government, over
granting Geographical Indications (GI) tag for basmati rice, is expected to be delivered by the
Intellectual Property Appellate Board (IPAB) here on Friday. More...
Protecting India’s trade interests

(SHAILJA SINGH , 5-Feb-2016 , The Hindu)
Only a cohesive trade policy approach on the international and domestic front will help the country
mitigate projected losses from the Trans-Pacific Partnership agreement. More...
Compulsory licensing in manufacturing may slow investments: EU

(ARUN S , 5-Feb-2016 , The Hindu)
The U.S. had also sought clarity from India regarding the CL decision-making process More...
GlaxoSmithKline arm gets patent nod for pneumonia vaccine
Company argues composition is new and provides an improved technical effect More...
Andhra Pradesh to centre: invoke compulsory licence or cancel Bt cotton patent

(Sayantan Bera, Shreeja Sen , 4-Feb-2016 , Livemint)
AP agriculture minister, in a letter dated 1 February to Nirmala Sitharaman, accused Monsanto of

abusing its monopoly position in the genetically modified Bt cotton seed market More...
Indian firm develops Zika vaccine candidates

(Y. MALLIKARJUN , 03-Feb-2016 , The Hindu)
Hyderabad-based Bharat Biotech has filed for global patent of two vaccine candidates - a recombinant
vaccine and an inactivated vaccine - for Zika virus. More...
Nokia's patent deal with Samsung puts off investors, hits shares
(Reuters | Helsinki , 2-Feb-2016 , Business Standard)
Nokia said it had settled a lengthy patent dispute with South Korea's Samsung on Monday, but investors
were disappointed by the financial terms of the deal. More...
Trans-Pacific pact may impact exports

(NATIONAL BUREAU , 2-Feb-2016 , The Hindu)
The Trans-Pacific Partnership (TPP), or the mega-regional free trade pact led by the U.S. and including
11 other Asia-Pacific countries, is likely to indirectly impact India’s exports in several industrial sectors
such as textiles, plastics, leather, clothing, cotton and yarn, besides the country’s regime on investment,
labour standards, intellectual property rights (IPR), government procurement and State-owned
enterprises (SOE), according to Commerce Minister Nirmala Sitharaman. More...
EU’s trademark law: India fears pharma exports will be hit

(AMITI SEN , 31-Jan-2016 , Business Line)
New Delhi not convinced by EU’s clarification; terms law unwarranted More...
Support needed for filing of patents and their protection

(STAFF REPORTER , 30-Jan-2016 , The Hindu)
Intellectual Property Rights (IPR) attorneys Ashok Ram Kumar and M. Vijay Kumar said a sizable
quantum of intellectual property emanates from Indian universities and research institutes but it was not
well protected and commercialised due to gaps in industry linkages. More...
Chinese patent ecosystem progressive

(V. RAGHAVENDRA , 30-Jan-2016 , The Hindu)
China has the world’s largest number of patent filings, as it encourages ‘utility model’ or ‘petty’ patents.
More...
IIT-Roorkee scientists patent low-cost biofuel tech
(Tapan Susheel , 29-Jan-2016 , The Times of India)
Scientists at the Indian Institute of Technology, Roorkee (IIT-R) have achieved remarkable success in
generating low-cost biofuel using a perennial weed, Kans grass. More...
SC agrees to hear Cipla’s plea against La Roche

(TNN , 28-Jan-2016 , The Times of India)
The Supreme Court on Wednesday admitted a plea of generic drug manufacturer Cipla Ltd challenging
the Delhi high court order holding it guilty of infringing Swiss pharma company Hoffmann-La Roche's
patent over lung cancer drug Erlotinib. More...
CommMin starts inter-ministerial talks on WTO decisions

The Commerce Ministry has begun an inter-ministerial exercise to assess implications of the decisions
taken at the WTO's Nairobi meeting and find out the extent to which India can liberalise tariff regime,
especially with regard to the farm sector. More...
Delhi HC extends stay on transfer of commercial IP right cases

(Priyanka Mittal , 27-Jan-2016 , Livemint)
The transfer of commercial IP right cases to district courts was brought to a halt on 3 December under
an interim order passed by a high court bench More...
Ethypharm receives patent for invention related to orally disintegrating pain killer, in India
(BS Reporter | Chennai , 27-Jan-2016 , Business Standard)
The Patent Office accepted the argument of the company that its invention addresses a specific problem
related to degradation of oxycodone More...
Google files patent for drone “delivery receptacle”

(Reuters, San Francisco , 27-Jan-2016 , Hindustan Times)
Google’s secretive drone delivery project could include a component designed to store packages
securely. More...
India plans own FTA template to counter zero tariff formula

(Asit Ranjan Mishra , 27-Jan-2016 , Livemint)
India’s proposal is born out of concerns that the zero tariff formula may become the benchmark for all
future trade talks More...
Qualcomm denied patent on e-coupon distribution tech

Qualcomm Inc, US-based semiconductor company that designs and markets wireless telecommunication
products globally, has been denied an Indian patent... More...
India spikes 220 foreign patent bids on desi drugs
(Chethan Kumar , 26-Jan-2016 , The Times of India)
US company filed an application before the European Patent Registers on May 28, 2010, seeking patent
for a medicinal formulation to control lipid levels. More...
DRDO’s patent technology now with Pune start-up firm

(Sushant Singh New Delhi , 25-Jan-2016 , The Indian Express)
CuTi technology is patent protected by DRDO and the Pune-based start-up has been granted an
exclusive license to manufacture More...
India, Australia miss free trade pact deadline

(SUHASINI HAIDAR, ARUN S. , 21-Jan-2016 , The Hindu)
Talks were stuck due to several issues related to market access in services and goods More...
Indian drug firms dip into patent pool for Hep C drug
(OUR BUREAU , 20-Jan-2016 , Business Line)
To make generic versions of Bristol-Myers Squibb’s daclatasvir More...
Cipla, Emcure, Hetero and Natco Pharma join patent pool for new Hepatitis C drug Daclatavir
(DIVYA RAJAGOPAL, , 20-Jan-2016 , The Economic Times)
CiplaBSE 0.08 %, Emcure, Hetero and Natco PharmaBSE 4.47 % have received the license for Bristol
Myers Squibb' Hepatitis C drug Daclatavir under the Geneve based Medicines Patent Pool (MPP). More...
India rejects licence plea for AstraZeneca's antidiabetic drug

(PTI , 20-Jan-2016 , moneycontrol)
The Indian patent office has rejected Hyderabad-based Lee Pharma's application for a compulsory
licence on AstraZeneca's anti-diabetic medicine saxagliptin sold under the brand name Onglyza. More...
De Beers group firm initiates legal suit against competitor

(Dilip Kumar Jha | Mumbai , 20-Jan-2016 , Business Standard)
The development assumes significance Ila might face damages worth millions of dollars More...
FICCI announces online certificate course on intellectual property

( Rajiv Kr. Choudhry , 20-Jan-2016 , SpicyIP)
Registrations are open for Online Certificate Course on Intellectual Property (IP), May – July 2013 being
conducted by Federation of Indian Chambers of Commerce and Industry (FICCI). More...
Counterfeits to hurt India's manufacturing sector: A report

(BS B2B Bureau | New Delhi , 19-Jan-2016 , Business Standard)
Illicit market in seven select manufacturing sectors led to a loss of Rs 39,239 crore during 2014, says a
FICCI report More...
Startup India: Challenges galore on funding, patent and IPR fronts

(SURABHI , 19-Jan-2016 , Business Line)
First generation entrepreneurs across the country are applauding the government’s efforts to recognise
their business ventures under the banner of Start-Up India, but for most challenges of funding, patents
and creation of intellectual property remain. More...
Patent Office refuses divisional patent for GSK Biologicals' vaccine

(BS Reporter | Chennai , 19-Jan-2016 , Business Standard)
The application was related to a novel formulation comprising a combination of a cancer antigen or a
derivative More...
A strict FDA, competition may slow pharma growth; export may halve to 8 per cent by 2020:
Study
(Prabha Raghavan, ET Bureau , 19-Jan-2016 , The Economic Times)
Tighter scrutiny of Indian manufacturing sites by US drug regulators, increased competition and weaker
currencies in key markets such as Africa and Russia are likely to slow down the growth of Indian
pharmaceutical exports over the next four years, says a new study. More...
Firm owned by Gujarati faces patent lawsuit

(PTI , 17-Jan-2016 , The Times of India)
A synthetic diamond manufacturing company owned by a Gujarati diamantaire is facing litigation from
De Beers subsidiary, Element Six Technologies Ltd, for alleged infringement of its patents related to
synthetic diamond material production. More...
National IPR policy to give fillip to economic growth: Ram Vilas Paswan
The government is drawing up the contours of a national Intellectual Property Rights (IPR) policy and its
implementation will provide an impetus to growth, Union Minister Ram Vilas Paswan said today. More...
Patent Office refuses divisional application of Merck's antibiotic

The application lacked distinct invention from parent application, the Patent Officer said More...
UN agency to help India bolster IP enforcement

(AMITI SEN , 14-Jan-2016 , Business Line)
The World Intellectual Property Organisation (WIPO) plans to strengthen cooperation with India to help
improve enforcement of intellectual property laws in the country. More...
Only 8 patents granted to Panjab University inventors since 2007

(Meghna Malik | Chandigarh , 13-Jan-2016 , The Indian Express)
According to the data from the Centre for Industry Institute Partnership Programme (CIIPP) at PU, only
eight patents have been granted to inventors from the varsity since 2007. More...
Abraxis denied patent for combination of Taxane

The company filed the patent application for combinations, modes of administration of therapeutic
agents and the combination therapy More...
Duplicate GI products hampering niche market: Textile Min

(PTI , 13-Jan-2016 , moneycontrol)
According to the statement, this is hampering the niche market of these handloom products affecting
their goodwill adversely and shrinking their market value due to encroachment on their registered
geographical indications. More...
How patent delays are threatening 'Make In India'

(IndiaSpend Team | Bengaluru , 12-Jan-2016 , Business Standard)
Years-long delays in approving patents could undermine the innovation critical to the 'Make in India'
campaign's success More...
TVS Motor backs out of patent row

The invention was novel as well as simple-a self-locating ignition lock assembly which comprises a lock
body with a key slot for the ignition key, with a plate made of a fluorescent substance that absorbs light
energy during the day and render itself fluorescent at night More...
Govt & industry anxious on TPP & TTIP which could impact manufacture & supply of drugs to
12 Pacific Rim nations
(Nandita Vijay, Bengaluru , 11-Jan-2016 , Pharmabiz)
The Union government and the Indian pharma industry are now concerned about the regulatory and
trade challenges coming in with the implementation of the Trans-Pacific Partnership (TPP) and the
Transatlantic Trade and Investment Partnership (TIPP) which was reached on October 5, 2015 after 7
years of negotiations by the 12 Pacific Rim countries that include US, Australia, Brunei, Canada, Chile,
Japan, Malaysia, Mexico, New Zealand, Peru, Singapore and Vietnam. More...
Script Lacks the Selvaraghavan Trademark

(Malini Mannath , 11-Jan-2016 , The New Indian Express)
Among the New Year releases, this was the film expected with anticipation. More...
StatsGuru: Tracking what hinders research in India

(Business Standard , 10-Jan-2016 , Business Standard)
At the Indian Science Congress, Prime Minister Narendra Modi called for a revival of research in India.
More...
Don’t tamper with patent laws

(A SRINIVAS , 08-Jan-2016 , Business Line)
The Centre is needlessly apologetic about our IPR laws. More...
Suven Life shares gain on patent rights in foreign countries

Suven Life SciencesBSE 0.70 % shares rose over 1 per cent after the drug firm got patent rights in
foreign countries for a neuro-degenerative drug. More...
History on India's Side, Not Pakistan, on Basmati GI Tag'

With a tussle over getting a Geographical Indication tag for Basmati rice on, as Pakistan had laid claims
over the origins of the variety of rice grown here, an RSS mouthpiece article termed the neighbouring
country’s “illegible claim” as one of the unfinished agendas of partition. More...
India needs to catch up on R&D

(Business Standard | New Delhi , 04-Jan-2016 , Business Standard)
China is ahead of us on several parameters like spending on R&D and patent applications filed More...
Apple Patent Tips Plans for Money Transfer via iMessage

(Manish Singh , 04-Jan-2016 , NDTV)
Apple may soon allow users to send money to their friends using iMessage and a number of other
means. More...
No respite for Big Pharma on patents

(Banikinkar Pattanayak , 30-Dec-2015 , The Financial Express)
Dilution of Section 3(d), compulsory licensing unlikely despite US concerns More...
Mobikwik files patent for power wallet platform that integrates with payment platform of
retailers
(Surabhi Agarwal , 30-Dec-2015 , The Economic Times)
New-age payment companies seem to be taking the lead when it comes to filing for patents. More...
Employees in the US assign all patent rights

(Mark Flynn , 30-Dec-2015 , The Financial TImes)
Sir, Thank you for publishing the excellent article on Shuji Nakamura’s renowned contributions to light-
emitting diode technology (“Bright idea pioneer shining a light on innovation in Japan”, Business Life,
December 29). More...
Suven Life secures two new patents

(THE HANS INDIA , 30-Dec-2015 , THE HANS INDIA)
City-based Suven Life Sciences has been granted a patent each by Europe and Macau for drug used in
the treatment of disorders associated with neurodegenerative diseases. More...
US court asks Indian company to pay $100000 for using pirated software
(PTI , 29-Dec-2015 , The Times of India)
An Indian textile company has agreed to pay a penalty of $100,000 (or Rs 66 lakhs) to settle charges of
using pirated software that gave it competitive advantages over American businesses. More...
Suven Life gets patent for neurodegenerative drug

Suven LifeBSE 0.71 % Sciences has been granted a patent each by Europe and Macau for drug used in
the treatment of disorders associated with neurodegenerative diseases. More...
Govt. to amend patent rules

(PRADEESH CHANDRAN , 29-Dec-2015 , The Hindu)
The centre is in the process of bringing out a new national policy for IPR More...
Cisco Wins US Patent Dispute Over Wi-Fi Technology

(Reuters , 29-Dec-2015 , NDTV)
Cisco Systems Inc did not infringe a patent holding company's wi-fi technology, a US appeals court ruled
on Monday, reversing a near $64-million (roughly Rs. 424 crores) judgment against the networking
equipment maker in the long-running patent dispute. More...
Intellectual property rights attorneys slam proposed amendments in patent rules

(A Subramani , 28-Dec-2015 , The Times of India)
few key proposed amendments in the patent rules, such as limiting adjournments to just three and
restricting the right to file patent applications only to patent attorneys and not all regular lawyers, have
come in for criticism from an association of IPR attorneys. More...
Abbott unit’s divisional patent application for drug rejected in India

The country's patent office has rejected a divisional patent application by AbbVie Biotechnology Ltd, the
biopharmaceutical arm of US-based Abbott Laboratories... More...
Patent office puts norms for computer inventions on hold

The norms aim to provide uniform, consistent guidelines More...
Patent Office keeps Novartis Vaccines' application under temporarily refusal

(BS Reporter | Chennai , 25-Dec-2015 , Business Standard)
Order is liable to change in accordance with the direction of the divisional patent issue pending with the
Calcutta High Court More...
Apple seeks $180 million morefrom Samsung in patent battle
(REUTERS , 25-Dec-2015 , The Hindu)
In a case that has come to epitomise the global smartphone war, Apple and Samsung have more battles
ahead. More...

Drug firm Suven Life Sciences has been granted a patent each by Europe, Hong Kong, Japan, Macau,
ARIPO and South Korea for a drug used in the treatment of neuro-degenerative diseases. More...
Celgene settles Revlimid patent litigation with Natco Pharma

(Viswanath Pilla , 24-Dec-2015 , Livemint)
The deal provides Natco with the certainty of a generic Revlimid launch in the US as well as a billion-
dollar windfall. More...
WTO gets strict over patent extension

(TNN , 24-Dec-2015 , The Times of India)
The government on Wednesday said WTO member countries have agreed to "prevent evergreening" of
patents in pharmaceuticals, a move that will help the entry of generic medicines into the market by
ensuring that Big Pharma does not tweak the composition of drugs to extend the validity of a patent.
More...
Celgene to allow sale of generic Revlimid before patent expiry

(Reuters , 23-Dec-2015 , Business Standard)
Celgene Corp said it would allow the sale of a generic version of its flagship multiple myeloma drug,
Revlimid, in the United States more than a year before the drug's patent expires. More...
Patent files damaged

(SANGEETHA KANDAVEL , 23-Dec-2015 , The Hindu)
The recent floods have destroyed some key trademark and patent files at the Trade Marks Registry,
Intellectual Property Office in Guindy. More...
Ericsson ends patent feud with Apple, signs new licence deal
(Reuters | Stockholm , 22-Dec-2015 , The Indian Express)
Swedish mobile telecom gear maker Ericsson said it had signed a patent licence deal with Apple Inc,
sending its shares up much as 8 per cent. More...
Twitter patents drone that adds photos in your tweets

(IANS , 22-Dec-2015 , The Times of India)
Drones capable of taking photos and videos controlled by tweets and sharing them through users'
accounts may soon change the way people use social media, according to media reports. More...
Ericsson signs patent deal with Apple, shares soar

(Reuters Stockholm , 22-Dec-2015 , India Today)
Swedish mobile telecom gear maker Ericsson said it had signed a patent license deal with Apple Inc over
technology that helps smartphones and tablets connect to mobile networks, sending its shares up much
as 8 per cent. More...
Glenmark settles patent litigation

(Press Trust Of India | New Delhi , 22-Dec-2015 , Business Standard)
Glenmark Pharmaceuticals on Monday announced a patent litigation settlement with Forest Laboratories
and Royalty Pharma Collection Trust over anti-depressant drug Savella. More...
Patent files damaged

(SANGEETHA KANDAVEL , 22-Dec-2015 , The Hindu)
The recent floods have destroyed some key trademark and patent files at the Trade Marks Registry,
Intellectual Property Office in Guindy. More...
Indian Patent Office puts on hold guidelines for patenting software

(Krithika Krishnamurthy , 22-Dec-2015 , The Economic Times)
India's patent office has put on hold guidelines that would have allowed patenting of software, a move
being hailed as a big win for domestic startups. More...
Demand for GI tag to Jeypore cashew

Cashew nut producers of Odisha have demanded Geographical Indication (GI) status for Jeypore cashew
produced in Koraput district. More...
Ericsson, Apple settle litigation, sign patent license deal

(Reuters , 21-Dec-2015 , The Times of India)
Swedish telecom equipment maker Ericsson said it has signed a patent license agreement with Apple Inc
but did not specify how much it would earn from the deal. More...
Seed companies demand withdrawal of govt order regulating cotton seed MRP
(Jayashree Bhosale , 21-Dec-2015 , The Economic Times)
ABLE-AG is an association of 13 leading technology provider, seed and biotechnology companies focused
on research. More...
Koraput farmers seek GI tag for cashew nut

Bhubaneswar: Cashew nut producers of Odisha have demanded Geographical Indication (GI) status for
Jeypore cashew produced in Koraput district. More...
Lack of IPR protection poses barriers for companies to sell and compete globally: Victoria A.
Espinel
(Ankush Kumar , 17-Dec-2015 , The Financial Express)
Protection and enforcement of intellectual property specifically for software is supremely important.
More...
Revised guidelines for software patents put on hold

(Sadhana Chathurvedula , 17-Dec-2015 , Livemint)
Revised draft guidelines allows the patenting of software on technical advancement, sparking concern
from start-ups and software product lobbies like iSpirt and Software Freedom Law Center More...
AstraZeneca seeks hearing with patent controller regarding Lee Pharma's CL application
(Gireesh Babu | Chennai , 16-Dec-2015 , Business Standard)
Delhi High Court had earlier issued an order granting permanent injunction in favour of AstraZeneca
More...
India should protect patent over its native species

(NAHLA NAINAR , 16-Dec-2015 , The Hindu)
As awareness of the medicinal value of Indian plants goes up globally, more should be done by the
Government to protect the nation’s biodiversity, according to Appu Rathinavelu, Executive Director,
Rumbaugh Goodwin Institute for Cancer Research, Nova Southeastern University, U.S. More...
National policy suggests use of intellectual property rights as collateral to raise funds
(Ruchika Chitravanshi , 16-Dec-2015 , The Economic Times)
In a potentially big boost to innovation, the country's first Intellectual Property Rights (IPR) policy has
proposed securitisation of innovation rights, allowing them to be used as collateral to raise funds for
their commercial development. More...
Industry-academia collaboration on patents at nascent stage in India: report

(Nikita Mehta , 15-Dec-2015 , Livemint)
A Thomson Reuters report shows that only 0.4% of the patents have been a result of collaboration
between industry and academia More...
Natco settles patent case with Gilead

The Natco Pharma on Monday said it has, along with its partner Alvogen, settled the patent infringement
suit with Gilead Sciences Inc. and others over Tamiflu in a US court. More...
Samsung Takes Apple Patent Case to US Supreme Court

(Agence France-Presse , 15-Dec-2015 , NDTV)
Samsung, on the losing end of a massive smartphone patent lawsuit, appealed on Monday to the US
Supreme Court in hopes of overturning a ruling that it pay $548 million to rival Apple. More...
Samsung set to unseat IBM in US patent wars

(Harriet Taylor , 14-Dec-2015 , CNBC)
Samsung is on track to unseat IBM as the number one company when it comes to winning U.S. utility
patents. More...
China drives global patent applications to new high

(AFP | Geneva , 14-Dec-2015 , Business Standard)
China accounted for nearly a third of the world's patent applications last year, once again driving strong
global growth, despite a sharp decrease in industrial design filings, the UN said today. More...
India defends most red lines in Paris pact

(Nitin Sethi | Paris , 14-Dec-2015 , Business Standard)
Manages to create differentiation between developed and developing world in almost all elements
More...
Apple 'Self-Healing Elastomer' Patent Hints at Waterproof iPhone

(Manish Singh , 14-Dec-2015 , NDTV)
Apple has been granted a patent that puts further weight to rumours of an upcoming waterproof iPhone.
More...
Taylor Swift trying to patent ‘1989’, title of her novel

(PTI , 13-Dec-2015 , The Indian Express)
Taylor Swift has apparently filed trademark applications for five phrases including "Swiftmas," "Blank
Space," "And I'll Write Your Name," "A Girl Named Girl" and "1989". More...
Japanese co loses diabetes drug patent bid

(Rupali Mukherjee , 12-Dec-2015 , The Times of India)
In good news for patients, a multinational drug firm's efforts to claim monopoly rights on a new diabetes
drug, teneligliptin, have been thwarted, with the patent office rejecting the application of Japan's
Mitsubishi Pharma Corporation. More...
Suven Life Sciences gets patent for neuro-degenerative drug

Drug firm Suven Life Sciences has been granted a patent each by Eurasia, Europe, Israel and Macau for
a drug used in the treatment of neuro-degenerative diseases. More...
India Plans to Streamline Intellectual Property Rights Process

( SURYATAPA BHATTACHARYA , 11-Dec-2015 , The Wall Street Journal)
Government is drafting legislation to create new intellectual-property courts and simplify drug-patent
applications More...
FreeCharge files patent for alternative to One-Time-Password

(Surabhi Agarwal , 10-Dec-2015 , The Times of India)
In what is perhaps the first sign of new age Indian companies waking up to the potential of patents,
Snapdeal-owned digital payments firm FreeCharge has indigenously developed an alternative to the SMS
based one-time-password and has already filed a patent for the technology. More...
India R&D accounted for 9% of global patents in 2015: Cisco

echnology giant Cisco today said its research and development team in India accounted for nine per cent
of the total 1,100 patents issued to the US-based company this year. More...
The Weeknd sued for copyright infringement over ‘The Hills'

The Weeknd has been served with a copyright infringement lawsuit over his hit song "The Hills". More...
The Weeknd sued for copyright infringement over ‘The Hills'

The Weeknd has been served with a copyright infringement lawsuit over his hit song "The Hills". More...
India-US narrow down differences on climate pact

(G. ANANTHAKRISHNAN , 10-Dec-2015 , The Hindu)
India's IPR import bill highlights the importance of technology transfer to fight climate change without
rigid Intellectual Property Rights restrictions. More...
Verdict corner: The case for shifting of IPR cases

(Indu Bhan , 10-Dec-2015 , The Financial Express)
Legal fraternity including IPR experts are all united in the fight against the transfer of pending IPR cases
More...
FreeCharge's patent filing for alternative to OTP a wake up call for other companies
(Surabhi Agarwal , 10-Dec-2015 , The Economic Times)
In what is perhaps the first sign of new age Indian companies waking up to the potential of patents,
Snapdeal-owned digital payments firm FreeCharge has indigenously developed an alternative to the SMS
based one-time-password and has already filed a patent for the technology. More...
Steps Afoot to List Tirur Betel in GI Registry

(Dhinesh Kallungal , 10-Dec-2015 , The New Indian Express)
The sagging fortune of Tirur betel leaves aka ‘Tirur Paan’ is set to revive with the authorities completing
the formalities for listing it in the Geographical Indications Registry of India. More...
Google files patent for needle-free blood draw device

(TOI Tech , 09-Dec-2015 , The Times of India)
Google Life Sciences has filed a patent for a needle-free blood draw device with US Patent and
Trademark Office (USPTO). The patent is being seen as the latest addition to its growing list of projects
in the fields of medtech and healthcare. More...
Google patent hints at device that could draw blood without needles
Google has filed a patent that could allow for blood to be drawn without needles, and the patent is
available online More...
Google’s latest patent allows for device to draw blood without needles
Google has filed a patent that could allow for blood to be drawn without needles, and the patent is
available online More...
Google needle-free blood draw patent: A blood-sucking smartwatch for blood test
(India.com News Desk , 06-Dec-2015 , India.com)
The needle-free blood draw system works by sending a surge of gas into a barrel containing a micro-
particle that pierces the skin. More...
Grant of wrong patents prevented by TDKL in 220 cases till date

(04-Dec-2015 , Business Standard)
The Ministry of AYUSH has established Traditional Knowledge Digital Library (TKDL) in collaboration with
Council for Scientific & Industrial Research (CSIR) for prevention of grant of patents on non-original
inventions by International Patent Offices like European Patent office, United States Patent & Trademark
office, Japan Patent office etc. on Indian Systems of Medicine such as Ayurveda, Unani, and Siddha.
More...
HC stays the transfer of pending IPR cases to lower courts

Sanjay Ghosh, representing the high court, submitted that the order is likely to be replaced by a law in
the winter session of Parliament More...
TPP likely to impact patent regime: Panel

A government think tank on Thursday said the Trans-Pacific Partnership (TPP), which will create the
world's largest free-trade pact, is unlikely to impact India's trade significantly and warned that joining
the new framework would have adverse impact on the country's patent regime, especially access to
medicines. More...
Stay on transfer of IPR cases to district courts

(Aneesha Mathur New Delhi , 4-Dec-2015 , The Indian Express)
The Asian Patents Attorney's Association in a plea filed before the high court however has argued that
cases arising out of the statutes relating to IPR were "protected" under the Commercial Courts
Ordinance 2015. More...
Patents filed not enough, says DIPP Secy

(BS Reporter | New Delhi , 3-Dec-2015 , Business Standard)
Businesses as well as government institutions need to step up filing patents to safeguard their
intellectual property rights (IPR), said Amitabh Kant, secretary, Department of Industrial Policy and
Promotion (DIPP), on Wednesday. More...
Micromax-Ericsson patent row: Bailable warrants against founders

(Indu Bhan | New Delhi | , 3-Dec-2015 , The Financial Express)
Micromax was not only offender in the patent case filed by Ericsson. More...
Bid to restore Channapatna craft to its original glory

(RANJANI GOVIND , 3-Dec-2015 , The Hindu)
The traditional wooden toy-and-doll craft, with perfected lacquer-ware of Channapatna (on the
Bengaluru-Mysuru highway), may be protected by a geographical indication (GI) tag but today a crisis
stares the industry in the face. More...
IPR policy to help India become innovative: Govt

The national Intellectual Property Rights (IPR) policy being prepared by government will help India
become an innovative economy over the next 10 years, a top official said today. More...
Now GI tag for black clay pottery of Nizamabad

(Manish Raj , 2-Dec-2015 , The Times of India)
The Geographical Indication (GI) registry in the city has provided the GI tag to black clay pottery of
Nizamabad in Azamgarh district of Uttar Pradesh. More...
2.46 lakh patent applications pending due to manpower shortage

About 2.46 lakh patent applications and 5.32 lakh trademark registrations are pending with the
government due to shortage of manpower, Parliament was informed today. More...
Cipla infringing Roche’s patent in lung cancer drug, says Delhi HC - See more at:
http://indianexpress.com/article/business/companies/cipla-infringing-roches-patent-in-
lung-cancer-drug-says-delhi-hc/#sthash.bsn7k8oe.dpuf
(Aneesha Mathur , 28-Nov-2015 , The Indian Express)
Delhi HC refused to issue any injunction against Cipla restraining it from manufacturing the medicine,
after observing that the life of the patent granted to Roche was ending in March 2016. More...
IRCTC slaps notice on Travelkhana for 'copyright violation'

(Sudheer Pal Singh| New Delhi , 28-Nov-2015 , Business Standard)
According to IRCTC, the similarity of the applications is likely to create the impression that the source of
the apps is same or that there exists an association between the two companies More...
Breather for India's compulsory licence seekers as WTO group extends moratorium on IP
violation
(Kirtika Suneja , 27-Nov-2015 , The Economic Times)
In a relief to Indian manufacturers seeking compulsory licences, a committee of the WTO has decided to
shield intellectual property from a mechanism through which one WTO member can challenge the other's
IP related policies even if there is no rules infringement. More...
Burger King locked in trademark cases with food joints of similar names
(Rasul Bailay & Ratna Bhushan, , 26-Nov-2015 , The Economic Times)
Burger King has a whopper of a headache on its plate. Even before the world's second-largest burger
chain made its India debut a year ago, it has been locked in trademark cases in India - from a small
pushcart called Mr Singh Burger King to joints in malls with deceptively similar names or logos. More...
Supreme Court: Gods, religious texts can’t be trademarked

(Utkarsh Anand , 25-Nov-2015 , The Indian Express)
The court added that an entity, wanting to register the ‘Ramayan’ as a trademark, would have to add
another word or symbol as suffix or prefix. More...
Patents India
(24-Nov-2015 , The Financial Express )
Need to synchronise laws with those of the United States More...
Patent registration: Centre plans cutting approval time to 15 months from 5-6 yrs
(Shruti Srivastava , 23-Nov-2015 , The Indian Express)
As many as 2,26,339 patent applications were pending as on July 31, 2015, due to shortage of
professionals, according to the government data. More...
Patent process to be speeded up

(DHNS , 23-Nov-2015 , Deccan Herald)
The Central government has proposed a set of modifications in the existing patent rules, seeking to
expedite the lengthy process of granting of patents in India. More...
Dr Reddy’s sues AstraZeneca over purple colour of Nexium generic

(Vikas Dandekar , 20-Nov-2015 , The Economic Times)
Hyderabad-based drug maker Dr Reddy's has filed a lawsuit in a US court against Anglo-Swedish drug
giant AstraZenecaBSE -1.06 % alleging material breach of a settlement agreement that had released the
company from any liability in connection with generic versions of Nexium, the blockbuster drug used to
treat heartburns and gastric ulcers. More...
US, Switzerland back out of disputed norm in patent law

(D. Ravi Kanth , 20-Nov-2015 , Livemint)
Both nations agree not to introduce norm for pharma products at WTO for two more years until end-
2017 More...
Suzuki Motor secures patent for fuel efficiency

The auto major filed application for patent titled ‘Control apparatus for a generator of a vehicle’ in 2009
More...
Indian in US convicted for selling counterfeit cigarettes

(Press Trust of India | Washington , 18-Nov-2015 , Business Standard)
An Indian national has pleaded guilty to the charges of selling counterfeit cigarettes in the United States.
More...
India needs predictable IPR regime: Novartis

A "highly predictable" IPR regime is needed for the pharma industry in India to develop to the level of
the US or Europe, a senior executive of Swiss drug major Novartis said today. More...
Taken remedial actions at two plants in Maharashtra: Drug firm Novartis

Drug firm NovartisBSE -1.83 % today said it has taken remedial action at its two plants in Western India
which had received a warning letter from the US health regulator and expects the manufacturing facility
to returm to normal functioning soon. More...
Get a Patent, Get 3-yr Cheap Loan!

(Dileep V Kumar , 17-Nov-2015 , The New Indian Express)
Giving wings to the entrepreneurial dreams of student innovators, the Kerala Startup Mission (KSUM)
will soon come out with a Patent Support Scheme, allowing student entrepreneurs to avail interest
subsidy on bank loans taken for patented projects. More...
Comprehensive policy on IPRs being finalised: PM Modi

Prime Minister Narendera Modi has assured business leaders here that India will soon come out with a
comprehensive national intellectual property rights (IPR) policy. More...
GSFC gets patent for Gujcon nylon products

State-run Gujarat State Fertilizers & Chemicals Ltd informed that it has received a process patent for its
Gujcon products range under Nylon-6 that will improve the quality of roads and building infrastructure.
More...
Tata Global Beverages fails to get patent for herbal tea

The patent office has refused to grant a patent to Tata Global Beverages (formerly known as Tata Tea)
for its 'invention' regarding a process for preparation of flavoured herbal tea. More...
Merck & Co to expand in India, favourable IPR ruling encourages co to invest more
(Vikas Dandekar, , 6-Nov-2015 , The Economic Times)
Merck & Co. wants to expand its presence in India, building on what the $42-billion US pharmaceutical
giant calls a "responsible pricing strategy" and heartened by a recent intellectual property rights ruling in
its favour. More...
India catching up with China in patented products

(T.V. SIVANANDAN , 6-Nov-2015 , The Hindu)
Executive council member of the Visvesvaraya Technological University, V.D. Mytri, an expert on
Intellectual Property Rights (IPR), has said that India was catching up with China in getting patents for
various products and innovations and in another decade would surpass it. More...
Pressure over patent laws

(Ashima Sahni, , 6-Nov-2015 , The Hindu)
There is no doubt that India — often called the pharmacy of the world — has played an important role in
improving the lives of people from the poor African countries by providing affordable drugs. More...
Column: DCGI doesn’t infringe Indian patent laws

(Anand Grover , 5-Nov-2015 , The Financial Express)
It is neither authorised by the law to assess patent issues nor does it have the institutional competence
for this More...
Strengthening IP policies will fuel India's growth, development

India's modest improvement in the World Bank's "Doing Business Index" this year, along with the Bank's
projection that the economy will continue to experience merely moderate growth, were not the boosts
that Indian officials hoped for. More...
Apeda says can’t include MP for Basmati GI tag

The Basmati Growers Association from Pakistan also challenged the Apeda move in the IPAB claiming
that Basmati is a name for a slender, aromatic and long grain variety of rice grown in the specific
geographical area at the foothills of the Himalayas in Pakistan. More...
ESDS Software gets US patent for its cloud tech

(RAJESH KURUP , 04-Nov-2015 , Business Line)
ESDS Software Solution has been awarded a patent for its cloud computing technology by the US patent
office, making it first Indian company to be recognised in this space. More...
Notice to Centre Over Appointment of Patents Registrar

( Express News Service , 4-Nov-2015 , The New Indian Express)
he High Court on Tuesday issued notice to the Union government on public interest litigation (PIL)
seeking directions to remove IAS officer Rajiv Aggarwal as Registrar and Controller of General Patents,
Designs and Trademarks. More...
Plea on IBL's IPR to be heard on December 10
(03-Nov-2015 , Zee News)
BAI has recently announced that they will conduct the 2nd edition of IBL in January 2016 on their own.
More...
Draft patent rules propose quick clearance, greater clarity

Under ‘expedited examination’ provision, the examiner must complete report within 2 months More...
Investigators get tips on combating counterfeiting, piracy

An interactive session was organised here for police and other investigating officers on combating
counterfeiting and piracy. More...
Govt proposes patent rule changes to boost ease of doing business

(FE Bureau | New Delhi , 30-Oct-2015 , The Financial Express)
The government on Thursday proposed amendments to the rules under the Patents Act to streamline
the application process, as part of its efforts to improve the ease of doing business in India. More...
Column: Drug licensing must recognise patents

(Uttam Gupta | October , 30-Oct-2015 , The Financial Express)
Once patent-linkage gets embedded in our law, cheap drugs won’t get market entry More...
Colgate-Palmolive gets patent right for a powered toothbrush

(BS Reporter | Chennai , 26-Oct-2015 , Business Standard)
There is a need in the art for a powered toothbrush with increased effectiveness, says the company in
claims More...
Shell companies' patents to come under domestic tax net on adoption of BEPS
(Sachin Dave , 23-Oct-2015 , The Economic Times)
Technologies that are developed in India but their patents registered in tax havens may come under the
domestic tax net from the next financial year, when the country is expected to adopt a new world
standard aimed at preventing abuse of double taxation avoidance agreements. More...
Leaked draft only an input to national IPR policy: Amitabh Kant

Industry secretary says that the final policy will be in place in next 30 to 45 days More...
Karnataka Pips TN to Post on Patents

(Jonathan Ananda , 15-Oct-2015 , The New Indian Express)
Patents. Those innocuous bits of rubber stamped paper that make the difference between making
yourself a million dollar invention or making an invention that earns someone else a million dollars
More...
US varsity cites two Indians' work in $862 million patent case against Apple
(Chidanand Rajghatta , 15-Oct-2015 , The Times of India)
Gurindar Sohi and T N Vijaykumar are not names that will leap out of your latest iPhones as you gush
over the performance of Apple's much-coveted devices. More...
Apple may face $400 million in damages over university patent case
(Reuters, New York , 15-Oct-2015 , Hindustan Times)
The disputed patent relates to technology found in several of Apple’s phone models, including it’s latest
releases. More...
India opposes proposed European Trademark rules

India fears provision will be used to seize low-cost generic drugs headed for African and Latin American
nations More...
Apple loses patent lawsuit to University of Wisconsin, faces $862 mn in damages

(Reuters , 14-Oct-2015 , The Economic Times)
Apple Inc could be facing up to $862 million in damages after a US jury on Tuesday found the iPhone
maker used technology owned by the University of Wisconsin-Madison's licensing arm without
permission in chips found in many of its most popular devices. More...
Dr.Reddy’s and Helsinn settles patent litigation for anti-nausea Aloxi injection
(Viswanath Pilla , 13-Oct-2015 , Livemint)
The settlement will allow Dr. Reddy’s to market the generic version of Aloxi in the US on 30 September
2018 or earlier under certain circumstances More...
Samsung patent case: Nvidia to seek review of US judge’s determination

(ALKA KSHIRSAGAR , 13-Oct-2015 , Business Line)
In the next step in the patent infringement lawsuit against Samsung, Nvidia will seek a review by the six
commissioners of the US International Trade Commission (ITC) on what the judge determined, and
confirm the judgment of the US Patents Office. More...

Drug firm Suven LifeBSE 0.83 % Sciences has been granted patent by Australia, China, Europe, South
Korea and the US for a drug used in the treatment of neuro-degenerative diseases. More...
Indian drug makers engineer hepatitis C cocktails impossible in West

(Ketaki Gokhale, Caroline Chen , 9-Oct-2015 , Livemint)
Generic drug makers are working on a one-pill cocktail of the ingredients in Daklinza and Sovaldi that
could compete with blockbuster Gilead drugs More...
Glenmark loses anti-diabetes drugs' patent battle to Merck

(Press Trust of India | New Delhi , 8-Oct-2015 , Business Standard)
However while granting the injunction, the high court did not say anything about sale of existing stock
More...
Apple Inc gets India patent for compact antenna in mobile phones
The patent filing mentioned Zhang Zhijun, a Chinese citizen, and Caballero Ruben, a Canadian citizen, as
the inventors. More...
International politics and IPR

(Dr R Saha , 07-Oct-2015 , Express Pharma)
The recent WTO’s Trade Policy Review (TPR) in respect of India has put to rest any misgivings about the
robustness of India’s IPR regime particularly related to laws and the judicial system. More...
STALEMATE ON PRICING PATENTED DRUGS

(P A Francis , 06-Oct-2015 , Pharmabiz)
The policy of price control in pharmaceutical industry continues to remain partial and unfair to patients
in India as large number of expensive patented drugs still remain outside the purview of Drug Price
Control Order. Indian Patent Act was amended in 2005 almost after 35 years of its notification allowing
product patent to new drugs and pharmaceuticals. More...
Patent blitz likely to pay off for Arrow Coated products; shares jumped 3000% in 2 years
(Jwalit Vyas, ET Bureau , 6-Oct-2015 , The Economic Times)
ET Intelligence Group: The shares of Arrow Coated Products have spiralled 3000 per cent — from Rs 15
to Rs 490 — in the past two years with the company beginning to 'monetise' its patents. More...
Modi's Valley hug sparks swadeshi talk

(Sujit John & Shilpa Phadnis , 6-Oct-2015 , The Times of India)
This includes the issue of net neutrality , on which the government is seen to be waffling, and the
guidelines issued by the Indian Patent Office declaring that software is patentable in India. More...
Congress dismisses RSS claim against Rahul as 'patent lie'

Congress today dismissed as a "patent lie" a report in the RSS mouthpiece, which claimed that party
vice-president Rahul Gandhi drew daily parliamentary allowance despite being absent from the House
during his 56-day sabbatical earlier this year. More...
Cipher, Ranbaxy settle patent litigation with Actavis

(05-Oct-2015 , The Times of India)
Cipher Pharma Inc, along with partners Ranbaxy - a Sun Pharma firm - and Galephar Pharmaceutical
Research, has entered into a patent litigation settlement with Actavis over generic version of Absorica, a
drug used to treat acne. More...
Cipher, Ranbaxy settle patent litigation with Actavis

(05-Oct-2015 , The Times of India)
Cipher Pharma Inc, along with partners Ranbaxy - a Sun Pharma firm - and Galephar Pharmaceutical
Research, has entered into a patent litigation settlement with Actavis over generic version of Absorica, a
drug used to treat acne. More...
PM Narendra Modi wants delays in patent grants to be history

Prime Minister Narendra Modi has slammed the delays in approving patent and trademark applications
and asked for a reduction in paperwork for speedier clearances - a major gripe for global investors who
often raise concerns about the enforcement of intellectual property rights in India. More...
PM Narendra Modi wants delays in patent grants to be history

(2-Oct-2015 , The Economic Times)
Prime Minister Narendra Modi has slammed the delays in approving patent and trademark applications
and asked for a reduction in paperwork for speedier clearances - a major gripe for global investors who
often raise concerns about the enforcement of intellectual property rights in India. More...
Microsoft and Google call truce in patent wars

(PTI, San Francisco , 2-Oct-2015 , Hindustan Times)
After years of tussle over devices, applications and services, technology titans Microsoft and Google
have announced their agreement over ending all patent infringement litigation against each other.
More...
Has the US diluted pressure on India’s IP regime?

(DG SHAH , 2-Oct-2015 , Business Line)
India should keep its patent dialogue alive with America, while protecting its interests More...
Why Bengal, Odisha’s claim to rasgulla is not ‘rational’

(Zia Haq, Hindustan Times, New Delhi , 2-Oct-2015 , Hindustan Times)
Both states have staked claim to India’s most iconic snack -- a syrupy, spongy ball -- and are now
reportedly preparing to acquire a Geographical Indication (GI) for it, which is essentially about putting a
legal stamp of origin on the rasgulla. More...
Google, Microsoft resolve global patent feud over smartphones, Xbox

(Susan Decker, Dina Bass , 1-Oct-2015 , Livemint)
Google, Microsoft to drop about 20 lawsuits in US and Germany More...
Facebook ‘copyright’ declaration again? It’s a hoax and let Jon Oliver explain that
(Tech Desk , 1-Oct-2015 , The Indian Express)
On Facebook, one popular scam that keeps resurfacing every year is a 'legal'-sounding message which
aims to 'protect' users content. Sadly it remains a giant fraud More...
West Bengal Submits Application for Rosogolla Geographical Indication Tag

(All India | Indo-Asian News Service , 30-Sep-2015 , NDTV)
West Bengal has submitted the application for a (Geographical Indication) GI tag for the rosogolla to
stake claim on the sugary delicacy and beat Odisha, a minister said. More...
G20 should consider a new, more fair intellectual property rights regime
(SA Aiyar in Swaminomics , 30-Sep-2015 , The Economic Times)
Cynics say that G20 meetings are a complete waste of time. More...
Alstom allowed to appeal against rejection of its patent application

(Manish Raj , 28-Sep-2015 , The Times of India)
Showing a little leniency towards appeals that are delayed but have valid reasons, the Intellectual
Property Appellate Tribunal (IPAB) has said the term "sufficient cause" should be analyzed "liberally"
when appeals are filed with a little delay in judicial forums. More...
Patent Office refuses application for Genentech's cancer drug

While Glenmark and others filed pre-grant opposition, all parties told patent office they do not want to
pursue the case More...
Modi in US: PM meets media magnates; promises protection to Intellectual Property Rights
(PTI , 25-Sep-2015 , The Indian Express)
Presenting India as a technology-driven society, Prime Minister Narendra Modi today pledged protection
to Intellectual Property Rights (IPR) as he met top executives of major media and communication
companies. More...
Patent office rejects Google invention on improving online ads with audio
Google has also informed the patent office about its new-found disinterest in the subject matter, just
barely a month after it appeared for a hearing to push the application. More...
Can India & America take Gilead-IPA model further?

(Ashok Malik , 24-Sep-2015 , The Economic Times)
As Prime Minister Narendra Modi begins his second trip to the United States, the bilateral relationship
between New Delhi and Washington, DC looks remarkably different from the summer of 2014. More...
US judge rules copyright for ‘Happy Birthday’ song invalid

(Reuters , 23-Sep-2015 , The Indian Express)
In order to make his ruling, US District Judge George H. King had to delve into the song's long and
complicated history. More...
US industry waiting to hear PM Narendra Modi's stand on Intellectual Property Rights

(Dipanjan Roy Chaudhury , 22-Sep-2015 , The Economic Times)
The US industry will wait to hear the Narendra Modi government's stand on protection of Intellectual
Property Rights when PM meets business leaders in New York and Silicon Valley this week. More...
Dr Reddy's, BioMarin settle Kuvan patent suit

(Agencies , 22-Sep-2015 , The Times of India)
The Californiabased BioMarin Pharmaceutical has entered into a settlement agreement with Dr Reddy's
Laboratories to resolve patent litigation in the US regarding Kuvan, the former's 100mg oral tablets.
More...
Verdict corner: Aligning India’s patent law with global standards

(Indu Bhan , 18-Sep-2015 , The Financial Express)
The country is emerging as a jurisdiction where customised patent prosecution strategies must be
followed More...
Patent Office refuses application for AcelRX's Nanotab Sufentanil

Application failed to pass the test of Section 3(d) More...
Trademark for Pokkali rice

(SPECIAL CORRESPONDENT , 16-Sep-2015 , The Hindu)
The Indian Council of Agricultural Research-Krishi Vigyan Kendra attached to the Central Marine
Fisheries Research Institute here has registered a trademark Jaiva Pokkali at the Chennai trademark
registry to be leased free to groups of pokkali farmers, who wish to use the trademark on their produce.
More...
Onbrez case: Delhi High Court reserves decision on Novartis-Cipla patent dispute
(Vikas Dandekar , 16-Sep-2015 , The Economic Times)
A division bench of the Delhi High Court has reserved its decision on a high-profile patent case that
pitted Swiss drug maker Novartis against Cipla over its respiratory drug brand Onbrez. More...
Revival of FTA talks on agenda for Merkel visit

(Huma Siddiqui | New Delh , 16-Sep-2015 , The Financial Express)
With German Chancellor Angela Merkel set to visit India early October, the two countries are working to
take up several issues... More...
Hope that IPR policy of India contains commitment to legal rights of patent: US
The US business community has hoped that the much-anticipated intellectual property rights (IPR)
policy of India contains a principled commitment to the legal rights of patent, copyright, and trademark
holders. More...
IPR policy contains commitment to legal rights of patent: US

(Press Trust of India | Washington , 15-Sep-2015 , Business Standard)
Under the current administration, political attitudes toward IP seem to have improved, it said More...
Spicy insight: Curcumin database to preclude false patent claims

(IANS , 15-Sep-2015 , The Economic Times)
Indian scientists have created the world's first comprehensive open database on curcumin - the star
therapeutic component of the golden Indian spice turmeric and a hot favourite with researchers across
the globe -- to foster innovation and generate public awareness. More...
Revised patent norms for software could impact tech start-ups

(Sadhana Chathurvedula , 15-Sep-2015 , Livemint)
Revised guidelines say software that demonstrates a technical application or improves hardware may
also be patented, widening the scope of patents More...
IPA, Natco withdraw opposition to Gilead's drug

We wanted to tell the big pharma that IPA is not unreasonable and we are not blindly following an idea,
said IPA More...
Patent Controller to hear Lee Pharma’s plea on compulsory licence for diabetes drug
(AMITI SEN , 11-Sep-2015 , Business Line)
CL application was prima facie rejected by the Patent Office in August More...
CFTRI to file patent for bottled sugar cane juice

(V. RAGHAVENDRA , 11-Sep-2015 , The Hindu)
The Central Food Technological Research Institute (CFTRI), Mysore, is in advanced stages of filing patent
for bottled sugarcane juice, for which it has developed preservation and packaging technologies. More...
Suven Life gets patents for neurodegenerative drug

Biopharma firm Suven Life SciencesBSE 2.35 % today said it has been granted one patent each in 5
nations, including China and Israel, for a drug used in the treatment of neurodegenerative diseases.
More...
More steps required to make India investment friendly: CII

(Press Trust of India | Washington , 10-Sep-2015 , Business Standard)
More steps needs to be taken to make India an investment friendly destination as there is a long way to
go, a top leader of an association of Indian businesses has said here in the US. More...
Patent for Ayurveda Anti-rabies Medicine
(Express Features , 10-Sep-2015 , The Indian Express)
A traditional ayurveda practitioner from Kozhikode got patent for his herbal composition which has
proved effective against Rhabdovirus. More...
Pfizer's arthritis drug application gets rejected by Indian patent office again
(PTI , 8-Sep-2015 , DNA)
The Intellectual Property Appellate Board (IPAB) in October last year set aside an order by the patent
office which rejected Pfizer's patent for a new formula of the drug and directed it to re-consider the
application. More...
Free Software activists against changes to patent norms

(OUR BUREAU , 07-Sep-2015 , Business Line)
he Free Software Movement of India (FSMI) has alleged that the new Guidelines for Examination of
Computer Related Inventions are illogical. More...
Pfizer’s patent claim for Xeljanz dismissed

(Vikas Dhoot , 7-Sep-2015 , The Economic Times)
The Indian Patent Office has denied American drugmaker PfizerBSE -0.82 % patents for certain isomers
and stereoisomers of tofacitinib, a product it markets globally as Xeljanz for the treatment of rheumatoid
arthritis, in the latest example of a foreign company finding it difficult to patent incremental innovations
in the country. More...
Recent guidelines from Indian Patent Office will stifle innovation: Software product lobbies
(Vishal Dutta & Krithika Krishnamurthy , 7-Sep-2015 , The Economic Times)
The Indian Patent Office's recent guidelines, declaring that software and business methods are
patentable in India, has set off alarm bells across the software product industry. More...
Pfizer’s patent application for arthritis drug rejected

(Sajan C Kumar , 4-Sep-2015 , The Financial Express)
In a setback to US drug major Pfizer, the country’s patent office has rejected for the second time, the
patent application for its rheumatoid arthritis treatment drug Tofacitinib in India. More...
HC notice to govt over MNCs' patent disclosure

(Rupali Mukherjee , 2-Sep-2015 , The Times of India)
MUMBAI: In a development that could have major ramifications on intellectual property cases in
pharmaceutical and technology sectors, the Delhi high court issued a notice to the government on
Tuesday in a PIL (public interest litigation) filed by IP expert Shamnad Basheer. More...
Invention spree: 24% jump in patents at IIT-Bombay in five years

(Apoorva Puranik , 01-Sep-2015 , Hindustan Times)
Students at Indian Institute of Technology, Bombay (IIT-B), are on an invention spree, with patents for
inventions like solar-powered fluid heaters, speech decoding systems and a user-friendly map of
Mumbai’s rail system jumping by more than 24% this year. More...
Bt cotton: Govt admits Monsanto never had patent in India

(Shishir Arya , 26-Aug-2015 , The Times of India )
Nagpur: Thirteen years after US multinational Monsanto launched Bt cotton seeds in the country, the
government has woken up to the fact that the first version of the genetically modified crop was not
patented in India. Monsanto ended up earning huge royalties on the Bt seeds even without a patent,
changing the economics of cotton farming in India. More...
Eli Lilly fails to get Indian patent for drug to treat alcohol addiction
(Sajan C Kumar , 21-Aug-2015 , The Financial Express)
The Indian patent office has refused to entertain an application by US-based pharma major Eli Lilly and
company for a patent on an invention regarding a drug compound of kappa opioid receptor, used for the
treatment of disorders associated with alcohol dependency. More...
India rejects Lee Pharma’s compulsory licence plea

(Ruchika Chitravanshi , 18-Aug-2015 , The Economic Times)
India has decided against giving the compulsory licence for Anglo-Swedish drugmaker AstraZeneca's key
antidiabetes compound Saxagliptin sought by Hyderabad based Lee Pharma. More...
Camson’s patent filing may attract attention

Camson Bio Technologies has filed for patent for its discovery of Natural Fertilizer, a product derived
from microbial extracts. More...
U.S. patent for MIT engineer’s device

(SPECIAL CORRESPONDENT , 17-Aug-2015 , The Hindu)
aghunath Manohar, deputy engineer in the advanced material testing laboratory of Mechanical
Engineering, Manipal Institute of Technology (MIT), Manipal University received a U.S. patent for his
invention, Marking Gauge. More...
Protecting IPR regime will bring new medicines

(13-Aug-2015 , Hindustan Times)
Protecting intellectual property will help bring new solutions for rare diseases and new medicines, to
save and improve lives. More...
In the forefront of fight against bio-piracy

(TNN , 13-Aug-2015 , The Times of India)
It has been proven beyond doubt, with literature and other records as evidence, that India has always
been a treasure trove of medicinal knowledge. More...
Copycats beware! Amul now has trademark protection

(VIRENDRA PANDIT , 12-Aug-2015 , Business Line)
No one will be able to use the name, logos or fonts of the dairy product brand More...
India, US to hold key commercial dialogue next month

(PTI , 12-Aug-2015 , The Times of India)
India and the US will hold first-ever high-level strategic and commercial dialogue next month in
Washington focusing on areas such as ease of doing business and smart cities with an aim to boost
investment and raise bilateral trade five-fold to US $ 500 billion annually. More...
Interim injunction on Audi: In battle for ‘TT’ trademark, garment firm wins round 1 against
German auto giant
(Aneesha Mathur , 12-Aug-2015 , The Indian Express)
The Delhi High Court, in an order on July 21, has issued an ex-parte interim injunction restraining Audi
from using the name ‘TT’ as a brand name. More...
Bengaluru Court stops Pearson's Indian arm from infringing on New Rubric Solutions' IP
rights
(Evelyn Fok , 12-Aug-2015 , The Economic Times)
The Bengaluru City Court has restrained global educational corporation Pearson's Indian subsidiary from
infringing on the intellectual property (IP) of Bengaluru-based education startup New Rubric Solutions.
More...
BMW checking whether Google’s Alphabet violates its trademark

(Reuters, Frankfurt , 12-Aug-2015 , The Indian Express)
BMW on Tuesday said it was looking into whether Google infringed any trademark rights after it set up a
new company called Alphabet More...
Two Gurgaon schools accused of misusing ‘DPS’ name, get notices

(Sandali Tiwari Gurgaon , 12-Aug-2015 , The Indian Express)
The education department has sent notices to two schools running under the popular chain, the Delhi
Public School (DPS), in Gurgaon. More...
Joynagarer Moya wins G I tag

(Jhilmil Mukherjee Pandey , 11-Aug-2015 , The Times of India)
Here's a first from the world of Bengali sweets. More...
Comic characters to give you lessons in IPR

(Timsy Jaipuria , 11-Aug-2015 , Hindustan Times)
Imagine reading the adventures of your favourite comic characters, flying over houses, brandishing
swords or triumphing over evil, and, learning about intellectual property rights (IPR). More...
Celebrating traditional treasures of GI handloom products

(Abhijit Das , 11-Aug-2015 , The Financial Express)
The Geographical Indication tag can be used effectively as a marketing tool for enhancing sales and
raising incomes of weavers More...
T-Series has filed a criminal complaint against Mahesh Bhupathi's Blue Whale Motion Pictures
on multiple counts
(IANS , 10-Aug-2015 , The Indian Express)
T-Series has filed a criminal complaint against Mahesh Bhupathi's Blue Whale Motion Pictures on multiple
counts. More...
Over 1500 yogic asanas shortlisted to thwart patenting by fgn MNCs, individuals
(PTI , 09-Aug-2015 , The Times of India)
In a move that will help thwart attempts by foreign MNCs and individuals to get patents and trademark
on ancient yoga techniques, the government has shortlisted over 1500 asanas and videographed over
250, classifying them as "traditional knowledge" of the country. More...
Explaining the intellectual

(K. SUBRAMANIAN , 8-Aug-2015 , The Hindu)
This book expands the boundaries of intellectual property rights to include not just economy but also
arts, culture and heritage More...
India's Intellectual Property Spend Up by 57 Percentage in 4 Years

(Express News Service , 08-Aug-2015 , The New Indian Express)
A 6.9 billion dollars was the cost Indian companies had to dish out as intellectual property (IP) royalty in
the year 2013. This steep figure accounted for almost 18 per cent of the nations’ Foreign Direct
Investment (FDI) that year, said former Supreme Court judge, Justice AR Lakshmanan. More...
India to unveil new IPR policy in two months

(Elizabeth Roche , 08-Aug-2015 , Livemint)
Indian firms have done well in following intellectual property rights laws despite complaints from some
quarters, says Amitabh Kant More...
India's first e-flora database developed

(IANS | Kolkata , 08-Aug-2015 , Business Standard)
The Botanical Survey of India (BSI) has developed the first open-access online database of India's floral
diversity to document over 18,000 flowering plant species in an effort at boosting digitisation and
conservation of endangered ones. More...
Need to strike 'careful balance' in Intellectual Property Rights related cases: CCI
(PTI , 7-Aug-2015 , DNA)
As it probes cases related to intellectual property rights (IPR), CCI chairman Ashok Chawla on Friday
said its intervention in such matters would be "cautious and balanced" to ensure that incentive for
innovation is not undermined. More...
India files 34.4 patents as regards to per million people:Government

(PTI , 05-Aug-2015 , The Economic Times)
India registers 34.4 patents in regards to per million people as compared to other developed countries,
the government today said. More...
Get States into the IPR policy loop

(AJAY BATRA , 05-Aug-2015 , Business Line)
Beyond the Centre, there is a lack of awareness on how to create an ecosystem that spurs inventiveness
More...
India Foils UK Firm's Bid to Patent Use of Turmeric, Pine Bark and Tea
(ANI , 04-Aug-2015 , The New Indian Express)
India has foiled British firm Pangaea Laboratories Limited's bid to patent the use of turmeric, pine bark
and tea for treating hair loss. More...
No local plant registered with PPVFR authority

The Protection of Plant Varieties and Famers' Rights Act 2001 (PPVFR Act) is considered landmark
legislation for protection of intellectual property rights of plants and seeds conserved by local farmers
while keeping within WTO agreements. More...
German drug maker Merck KGaA finds Indian market promising for its pharma, consumer
health business
Merck KGaA, the family-controlled $12.5-billion German drug maker, has identified India as one of its
key markets under aglobal expansion strategy, amplified with forecasts that the economy could be equal
or even outpace China over time. More...
Startups, SMEs tardy in protecting patents

(LUBNA KABLY , 03-Aug-2015 , The Times of India)
A startup recently found to its dismay that the patent created by its employee was not owned by it. The
founders were unaware that under the Indian Patent Act, 1970, the inventor of the patent is the 'first
owner'. More...
Geographical indication identifies product's place of origin

Geographical indication (GI) of goods is a sign used for products that originate either from a particular
country or a specific location in a country. More...
Mudhi to be promoted globally

(Minati Singha , 3-Aug-2015 , The Times of India)
The humble 'mudhi', a popular snack of Odias, will soon satiate global taste buds. More...
India foils UK dermaceutical company's bid to patent ayurvedic mix for hair loss
India has once again successfully foiled an attempt by a major European major dermaceutical company
to take patent on a medicinal composition containing turmeric, pine bark and green tea for treating hair
loss. More...
Future sustainability is key to strong brand value

(RAMNATH SUBBU, LALATENDU MISHRA , 02-Aug-2015 , The Hindu)
The business of brands is highly competitive and today traditional global brands that straddled the space
for years are confronting the emerging digital media, which is asking a lot of questions. The U.K.-based
Brand Finance is a leading player in the global measurement and valuation of brands, and in a chat with
The Hindu, Brand Finance CEO, David Haigh spoke about the impact of the economy on brands, the
changing paradigm and tips on what Indian brands must do to break into the big league. Edited
excerpts: More...
Patent Office refuses Eli Lilly's application for anti-cancer drug

(BS Reporter | Chennai , 31-Jul-2015 , Business Standard)
The Patent Office has refused to grant patent for a crystalline form of Eli Lilly's cancer drug Pemetrexed,
in favour of the pre-grant opposition filed by three pharma firms - Fresenius Kabi Oncology Ltd, Cipla Ltd
and Glenmark Pharmaceuticals Ltd. More...
2.26 lakh patent applications pending due to manpower shortage: Govt

(PTI , 31-Jul-2015 , Livemint)
Nirmala Sitharaman said a number of patent applications are lying pending with the govt for due to
shortage of professionals More...
Samsung can halt Smartflash patent infringement trial

(Reuters , 31-Jul-2015 , India Today)
Samsung Electronics Co Ltd, which faced a trial on patent infringement in a lawsuit brought by patent
holder Smartflash LLC, can halt the proceedings while the Smartflash patents are scrutinized for their
validity by the U.S. Patent and Trademark Office, a U.S. appeals court ruled on Thursday. More...
Google gets Indian patent

(Sajan C Kumar | Chennai , 31-Jul-2015 , The Financial Express)
Google has secured an Indian patent for an invention regarding a method and system for transferring
annotations associated with video files. More...
Samsung can halt Smartflash patent infringement trial, says US appeals court
(Reuters , 30-Jul-2015 , The Economic Times)
Samsung Electronics Co Ltd, which faced a trial on patent infringement in a lawsuit brought by patent
holder Smartflash LLC, can halt the proceedings while the Smartflash patents are scrutinized for their
validity by the US Patent and Trademark Office, a US appeals court ruled on Thursday. More...
High Court rejects AstraZeneca’s diabetes drug plea

The Delhi High Court has dismissed AstraZeneca's plea to block Hyderabad based Lee Pharma from
making copies of its anti-diabetes drug Onglyza and left it for the patent office to decide whether to
grant a compulsory licence for the medicine. More...
India, US on a collision course over e-commerce, IP norms

The US wants rule of no customs duty on e-tail to continue; India not in favour of preparing any
recommendations More...
Govt to finalise national IPR policy in 3-4 months: Official

(Press Trust of India | Mumbai , 29-Jul-2015 , Business Standard)
The Centre is likely to finalise the policy on intellectual property rights (IPR) in the next 3-4 months and
will come out with clarification on FDI in the e-commerce space, a senior government official said today.
More...
US court rejects Glenmark's patent plea for Finacea

(Press Trust of India | New York , 28-Jul-2015 , Business Standard)
Drug firm Glenmark's generic skin care drug that was under patent litigation infinges patent of Bayer, a
US court has ruled. More...
Google to curb patent trolls by offering them for free

(IndiaToday.in New Delhi , 26-Jul-2015 , India Today)
Patent trolls can prove to be a grave block in the evolution of technology. More...
Colgate fails to secure patent for flexible dome toothbrush

(Sajan C Kumar | Chennai | , 25-Jul-2015 , The Financial Express)
Rejecting the application, the patent office based in New Delhi said Colgate-Palmolive’s claims lack
novelty and inventive step More...
India granted patent to treat incurable disease in Malaysia

(IBNS , 24-Jul-2015 , New Kerela)
Indian medical innovation has come to the forefront with the Human Embryonic Stem Cell technology
developed by Dr Geeta Shroff at Nutech Mediworld being granted the 66th patent in Malaysia for the
treatment of various medical conditions. More...
Nutech gets patent to treat incurable diseases in Malaysia

(Press Trust of India | Mumbai , 24-Jul-2015 , Business Standard)
A technology developed by Nutech Mediworld, the first facility in the world to provide human embryonic
stem cell therapy, has been granted the 66th patent in Malaysia for the treatment of various medical
conditions. More...
Amul trademark to get global shield

(Sidhartha , 24-Jul-2015 , The Times of India)
Amul is joining the league of global brands such as Coca-Cola, Kodak, Wimbledon and Viagra to get a
"well-known" trademark, ensuring unparalleled protection not just in India but across the world. More...
India rejects Swiss drug maker Roche Patent claims on Valcyte again
(ET Now , 24-Jul-2015 , The Economic Times)
Indian authorities have for the second time rejected Swiss drug maker Roche's patent claims on
valganciclovir, or Valcyte, used to treat an eye infection affecting acquired immune deficiency syndrome
(AIDS) patients. More...
India IPR Policy Update: Final Draft Circulated

(WILLIAM NEW , 23-Jul-2015 , INTELLECTUAL PROPERTY WATCH)
The final draft of India’s national intellectual property policy has been circulated for inter-ministerial
consultation and will be sent to the Cabinet for approval after receiving comments, the Ministry of
Commerce and Industry said this week. More...
Google patents new way to archive, search your ‘real-life experiences

(Tech Desk , 23-Jul-2015 , The Indian Express)
Google patent could make your real-life experiences searchable via a device like say the Google Glass.
More...
DIPP lays down norms on use of 'Make in India' logo

The Department of Industrial Policy and Promotion (DIPP) has come up with detailed guidelines for the
use of 'Make in India' logo by various ministries, departments, states, private authorities and electronic
media, among others. More...
India must keep patent laws for manufacture of cheap generic drugs
(Leena Menghaney , 22-Jul-2015 , Hindustan Times)
Recently, trade ministers from 10 Asean countries, India, China, Japan, Australia, New Zealand and
South Korea gathered to negotiate a deal on the Regional Comprehensive Economic Partnership (RCEP)
trade agreement. More...
India's IPR Policy to fully protect patents: Nirmala Sitharaman

(BS B2B Bureau , 21-Jul-2015 , Business Standard)
The final draft of the National IPR Policy has been circulated for inter-ministerial consultation and is
likely to be put up to the Union Cabinet for approval soon More...
IPR policy draft under inter-ministerial consultation, final version to be moved to the Cabinet
soon
The much-awaited National Intellectual Property Rights (IPR) policy will be moved to the Cabinet soon
after incorporating inputs from various departments, commerce and industry minister Nirmala
Sitharaman said on Monday. More...
IPR is a means, not an end
(Eben Moglen and Mishi Choudhary , 19-Jul-2015 , The Financial Express)
The Indian government is preparing the National Intellectual Property Rights (IPR) Policy as a presumed
base for the unleashing of Indian creativity that will drive... More...
India’s pharmaceutical patent law may face new hurdle

The norm calls for applying non-violation complaints to the World Trade Organization’s trade-related
intellectual property rights agreement More...
CSIR cites ancient texts to foil MNC’s patent plea

(Vishwa Mohan , 17-Jul-2015 , The Times of India)
India has cited ancient texts in foiling an attempt by US-based consumer goods giant Colgate-Palmolive
to patent a mouthwash formula containing herb extracts. More...
The curious case of Indian innovation

(Avirup Bose , 15-Jul-2015 , The Financial Express)
The govt should join India Inc in patronising research and training in codified frugal-engineering
practices and brand it as a globally-relevant business methodology More...
Delhi HC stays order restraining Lupin from using disputed trademark

(Priyanka Mittal , 14-Jul-2015 , Livemint)
The court stayed an earlier order restraining Lupin from using the trademark LUCYNTA for its medicines
More...
Compulsory license application may prove to be test for Modi govt

(Reghu Balakrishnan , 14-Jul-2015 , Livemint)
The reason for the industry’s keen anticipation of the decision is because the govt had assured
protection of IP rights to multinational pharmaceutical firms operating in India More...
Wipro aims to increase rate of patent filing

(PTI , 12-Jul-2015 , Zee News)
Country's third largest software services firm Wipro aims to significantly increase its rate of patent filing
over the next three years. More...
Lee Pharma files compulsory license application for diabetes management drug Saxagliptin
(Ramesh Shankar, Mumbai , 09-Jul-2015 , Pharmabiz)
The Hyderabad-based pharmaceutical company, Lee Pharma Limited, has filed a compulsory license (CL)
application for the patent covering AstraZeneca’s diabetes management drug Saxagliptin. More...
GI dispute : Patiala growers join legal tussle at IPAB

(BS Reporter | Chennai , 08-Jul-2015 , Business Standard)
The association says the GI should be allowed based on the geographical area where basmati grows
naturally More...
AstraZeneca not importing enough of diabetes drug: Lee Pharma

The move was a sign of the evolution of compulsory licensing in India, say experts More...
Abbott Biotech allowed to appeal against cancellation of patent for Humira drug
(Sajan C Kumar , 07-Jul-2015 , The Financial Express)
The Intellectual Property Appellate Board (IPAB) on Tuesday allowed US pharma major Abbott
Biotechnology to file an appeal against the order that cancelled the patent for its Humira drug, touted to
be a blockbuster medicine for treating severe forms of arthritis. The patent was cancelled on a review
petition by Glenmark Pharmaceutical. More...
Youth bags patent for music instrument

(Shounak Ghosal , 7-Jul-2015 , The Times of India)
A young pakhawaj player from the city outskirts has bagged a patent for creating a percussion-melody
instrument where sound or note is produced by leather and metal string fitted in tension. More...
Patent to CSIR's iodising agent

he Intellectual Property Appellate Board (IPAB) has directed the Patent Office to grant a patent to the
national R&D organisation Council of Scientific & Industrial Research (CSIR) for a novel iodising agent
finding its use in iodised salt. More...
Indian company seeks compulsory nod for MNC’s drug

(Rupali Mukherjee , 6-Jul-2015 , The Times of India)
A little-known Hyderabad-based pharma company has filed an application with the Patent Office to
manufacture saxagliptin, a diabetes drug patented and marketed in the country by MNC AstraZeneca.
More...
Delhi High Court upholds BMS’ patent for cancer drug Dasatinib
(DIVYA RAJAGOPAL , 6-Jul-2015 , The Economic Times)
The Delhi High Court has upheld the patent of US-based Bristol Myers Squibs (BMS) for Dasatinib,
dashing the hopes of a local company to sell a generic version of the cancer drug and providing some
relief to multinational drugmakers who are up in arms against India's patent laws. More...
Coke Studio 'Rangabati...' Tunes on Copyright Notice

Telecast of remix version of Sambalpuri folk song ‘Rangabati, rangabati...’ on Coke Studio programme of
MTV on Sunday even after legal notices were issued to the Coca Cola company, singers and music
composer of the remix, has left the copyright owners of the original song shocked. More...
Suven Life Sciences gets patents from Israel, South Africa and Japan for neurological drug
Drug firm Suven Life Sciences today said it has been granted a patent each by Israel, Japan and South
Africa for a drug used to treat neuro-degenerative diseases. More...
EU, India aim to resume stalled FTA talks in August

(Asit Ranjan Mishra , 30-Jun-2015 , Livemint)
Commerce secretary says this is the best time to conclude the deal to give a boost to textile and leather
exports More...
Is weak IP law enforcement in India a deterrent to Indian industry and innovators?

(Anant Kataria , 29-Jun-2015 , The Economic Times)
IP laws or the intellectual property system plays a pivotal role in framing industrial, trade and financial
policies, for scientific and technological development of any country. More...
TAKE Solutions secures patent for clinical data standardization process

(Sindhu Hariharan , 25-Jun-2015 , The Times of India)
TAKE Solutions -- a Chennai-based global business technology solutions provider -- has been awarded a
patent by the United States Patent and Trademark Office ( USPTO) for its clinical data standardization
process. More...
Govt research body’s claim for constipation drug patent rejected

(Sajan C Kumar | Chennai , 25-Jun-2015 , The Financial Express)
The country’s patent office has refused to entertain a claim by the Central Council for Research in Unani
Medicine (CCRUM), for a patent on a process for the preparation of a herbal drug composition to treat
constipation. More...
India, Japan to sign pact on increasing IP cooperation

(PTI , 25-Jun-2015 , Business Standard)
The Memorandum of Cooperation will be signed between the Department of Industrial Policy and
Promotion and the Japan Patent Office More...
Recent developments in intellectual property laws in India- Part 2

(Diljeet Titus & Rai S Mittal , 23-Jun-2015 , The Economic Times)
Besides to the most recent developments, in order to bring progressive changes towards a free market
society, rapid liberalization of international trade practices and demonstrating its commitments to the
WTO under the Trade Related Intellectual Property Rights Agreement (TRIPS), the Government of India
undertook a series of steps, to conform India IP legislation to acceptable international standards. More...
Bengaluru-based IT firms lead patent hunt

(Madhumathi D. S. , 22-Jun-2015 , The Hindu)
Karnataka has surged ahead in the number of patents filed in 2013-14 with Bengaluru-based Samsung
R&D Institute (84); Infosys (83); Wipro Ltd (59); Samsung India Software Operations Pvt. Ltd. (66) top
filers from among infotech companies. More...
A Short History Lesson on Patent Policy
(Robert Taylor , 21-Jun-2015 , IP DogWatch)
To avert serious and lasting damage to our innovation ecosystem and our most promising young
companies, it may be helpful to consider some history that appears to have been forgotten. More...
US court rejects Teva’s Copaxone patent plea

(TNN , 20-Jun-2015 , The Times Of India)
In a major booster for city-based Natco Pharma, the US Court of Appeals for the Federal Circuit has
again struck down Israeli pharma giant Teva Pharmaceutical Industries Ltd's Copaxone patent, paving
the way for Natco Pharma to manufacture the copycat version of the drug subject to the United States
Food And Drug Administration (USFDA) nod. More...
Call to Patent State's Knowledge

(Express News Service , 20-Jun-2015 , The Indian Express)
Kerala High Court Judge Justice V Chitambaresh on Friday said that though the State had a huge
knowledge-base, processes, products and brands - ranging from Ayurveda to traditional knowledge -
many of them were yet to be patented. More...
Snapdeal faces Heat for Misusing Nalli's Trademark, Photos

(Express News Service , 18-Jun-2015 , The New Indian Express)
Iconic saree retailer Nalli Chinnasami Chetty has initiated legal action against leading e-commerce giant
Snapdeal.com for ‘dishonestly’ using their trademark and brand on the site. More...
The Reason the Statue of Liberty Has Its Own Patent

(Kelsey Campbell-Dollaghan-, Gawker Media , 18-Jun-2015 , Gizmodo)
Liberty Enlightening the World. That's the title of patent #USD11023 granted to one Auguste Bartholdi
on February 18, 1879. You might know it better as the Statue of Liberty. More...
Cipla, BMS settles patent dispute

(BS Reporter | Chennai , 17-Jun-2015 , Business Standard)
Parties seek confidentiality of the terms of settlement More...
India’s patent regime should not change – Cipla CEO

(Zeba Siddiqui , 17-Jun-2015 , Reuters)
Cipla Ltd, founded in 1935 by scientist Khwaja Abdul Hamied, is among India’s oldest pharmaceutical
companies. More...
IPFACE, Gopakumar Nair Associates & others to organise seminar on recent developments in
patent law on June 20 in Pune
(OUR BUREAU , 16-Jun-2015 , Pharmabiz)
The Intellectual Property Facilitation Center (IPFACE), Venture Center & IP Group, NCL Innovations,
Gnanlex Hermeneutics and Gopakumar Nair Associates to organise a one day seminar on current themes
in pharma patenting with an aim to overview and insights on recent developments in patent law and
practice of relevance to the pharma industry and research More...
Nokia, LG join hands; inks smartphone patent license

(PTI , 16-Jun-2015 , The Financial Express)
LG Electronics will soon embed technologies developed by Nokia in its smartphones as the Korean firm
has agreed to take a royalty-bearing smartphone patent license from the Finnish telecom gear maker.
More...
Generic Mistake
(The Financial Express , 16-Jun-2015 , The Financial Express)
The push for generics in prescriptions will harm pharma companies and ultimately patients More...
Doctors Without Borders urges PM Modi not to change patent rules

(BS B2B Bureau | New Delhi , 15-Jun-2015 , Business Standard)
MSF has launched global campaign, Hands Off!, urging India to take strong stand against the pressure
from MNCs to change India's patent laws that would severely restrict production of generics. More...
'Biased? India has a balanced pharma patent regime'

(Soumonty Kanungo , 15-Jun-2015 , daily news and analysis)
India has a balanced pharmaceutical patent regime in place because it needs to hold the rights and
interest of a wide section of consumers who are in need of free medicines, according to Frederick
Abbott, professor of international law at the Florida State University. More...
Eureka Forbes denied patent for Aquasure after Hindustan Unilever’s opposition
(Sajan C Kumar | Chennai , 13-Jun-2015 , The Financial Express)
The patent office has rejected an application by Eureka Forbes for a patent for its flagship iron removal
water purifier, Aquasure, on grounds of lack of inventive step and insufficient disclosure. More...
India’s patent law may face legal hurdle at WTO

(D. Ravi Kanth , 12-Jun-2015 , Livemint)
Potential challenge from US, Switzerland over provision which defines inventions could hurt Indian drug
makers More...
India to resist Japan and South Korea

(Dilasha Seth , 12-Jun-2015 , The Economic Times)
India will resist a push by Japan and South Korea for stringent patent legislation at the eighth round of
negotiations for Regional Comprehensive Economic Partnership (RCEP), according to a senior official.
More...
Decoding Myths & Facts about Patents

(Anant Kataria , 12-Jun-2015 , moneycontrol)
A patent is a legal property granted by the government that confers a right for a limited period to
anyone who makes an invention of a product or process that meets the conditions of novelty, non-
obviousness and industrial use. More...
Opto Circuits subsidiary wins patent case against US firm

(BS Reporter | Bengaluru , 9-Jun-2015 , Business Standard)
To get Rs 147 crore towards loss of royalty from Zoll LifeCor More...
Cipla's Stempeutics gets process patent for Stempeucel from Japan

Drug major CiplaBSE -2.49 % today said its JV firm Stempeutics Research has received process patent
from the Japan Patent Office for novel stem cell drug Stempeucel aimed at treatment of critical limb
ischemia (CLI). More...
With FTA talks set to start, EU seeks to tap Indian middle class
( D. Ravi Kanth , 8-Jun-2015 , Livemint)
EU director general for trade Jean-Luc Demarty wants more access for the bloc’s automobiles and wines
More...
Seeds of doubt: Monsanto never had Bt cotton patent

(Shishir Arya & Snehlata Shrivastav , 8-Jun-2015 , The Times Of India)
Fourteen years after US multinational Monsanto brought the genetically modified (GM) Bt Cotton
(Bollgard) to India, there is no clarity on the discovery having ever been patented in the country. More...
Intellectual property vital to make in India

(Ifftikhar Gilani , 6-Jun-2015 , DNA)
US ambassador to India Richard Verma has liked the success of "Make in India" to not only permitting...
More...
Relief for Natco Pharma as Chennai patent office rejects US firm’s application for cancer drug
(Sajan C Kumar , 06-Jun-2015 , The Financial Express)
The Chennai patent office has rejected an application by US-based Abraxis BioScience related to a new
composition for Paclitaxel, an anti-cancer drug marketed under the trade name Abraxane, citing lack of
novelty and inventive step. More...
US co Abraxis denied patent on cancer drug

The Indian Patent Office has refused a patent on US firm Abraxis BioSciences' anti-cancer drug
Abraxane, paving the way for generic companies to launch affordable versions in the domestic market.
More...
India’s import regime still complex: WTO

(ENS Economic Bureau , 3-Jun-2015 , The Indian Express)
India continues to have a very complex import regime, notwithstanding the steps taken by it to
streamline customs procedures, a World Trade Organization (WTO) report has said. The country has,
however, taken a slew of steps to modernise its intellectual property rights regime, the report said.
More...
India’s average import tariffs up marginally in 4 years: WTO review

(OUR BUREAU , 02-Jun-2015 , Business Line)
Trade policy review report does not fault India on its patent regime More...
We are not under pressure from the US on IPR: Nirmala Sitharaman

( Asit Ranjan Mishra , 2-Jun-2015 , Livemint)
The trade balance with China is definitely adverse and it is growing, and this cannot be sustained, says
commerce minister Sitharaman More...
US Supreme Court Rules Against Cisco in Patent Infringement Fight

(Reuters , 27-May-2015 , NDTV)
The U.S. Supreme Court on Tuesday ruled against Cisco Systems Inc over a patent infringement claim
the tech giant is fighting. More...
Basmati rice to get IPR protection as exporters support Centre’s view

( Sandip Das | Chennai , 26-May-2015 , The Financial Express)
Chennai-based Intellectual Property Appellate Board is slated to hear the claims of all the parties for
three consecutive days from July 8 for granting GI certification to Basmati rice More...
Smartphone 'Cold War' seen in Asian moves on patent licensingm the tech giant is fighting.
(Susan Decker, Ian King & Jungah Lee , 26-May-2015 , Business Standard)
New antitrust policies and the clampdown on patents might weaken the ability of Apple, Microsoft and
Qualcomm to compete in China and other countries More...
Pfizer gets IPAB breather on Zeldox patent

In a reprieve to US-based pharma major Pfizer Inc, the Intellectual Property Appellate Board (IPAB) has
set aside an order.. More...
Smartphone ‘cold war’ seen in Asian moves on patent licensing

( Susan Decker | Ian King | Jungah Lee , 26-May-2015 , Livemint)
Asian regulators were spurred by the smartphone wars, in which tech giants battled over billions of
dollars on four continents for more than four years More...
Google to patent 'creepy' internet toys for homes

(PTI , 24-May-2015 , DNA)
Google has filed a patent for internet-connected creepy-looking teddy bears and bunny rabbits which
could keep a watchful eye on children, eavesdrop on anything we say and control smart home
appliances More...
Chennai patent office rejects Merck arm’s plea for female contraceptive
NV Organon has failed to secure a patent in India for its invention on a female contraceptive kit More...
Suven Life Sciences gets patents for neurodegenerative drug

(PTI , 22-May-2015 , Zee News)
Neurodegenerative diseases include Alzheimer's, Schizophrenia and Parkinson's. More...
Columns Letters India’s IPR environment is maturing

(Ajay Batra , 22-May-2015 , Business Line)
Legal systems are in place, landmark judgments have been pronounced, and next-gen policies are being
evolved More...
Tech startups plan to secure key intellectual property rights

(Biswarup Gooptu, ET Bureau , 21-May-2015 , The Economic Times)
Technology startups mindful of the need to protect key intellectual property in the fiercely competitive
Indian startup industry where employees are often poached by rivals will have to ensure they lock the
stable doors before the horses bolt. More...
Draft policy on patents stresses enforcement, independence

(Arun S | New Delhi , 21-May-2015 , The Financial Express)
National IPR policy is aimed at boosting PM Narendra Modi’s pet ‘Make in India’ and ‘Digital India’
initiatives. More...
Godzilla creator sues US studio, alleges copyright violation

(Associated Press | Yuri Kageyama , 20-May-2015 , The Indian Express)
Japanese movie studio Toho Co. said on Wednesday, it is suing Voltage Pictures and a director in a
lawsuit complaining that promotions of an upcoming film infringe on its copyright to Godzilla. More...
Novo Nordisk, Baxter clash over haemophilia drug patent

(Reuters , 20-May-2015 , The Economic Times)
Novo Nordisk on Wednesday rejected claims by Baxter International that its drug used substances
developed by the US rival, following the launch this week of a US investigation into possible patent
Strong IPR regime can only entice companies to invest in India: Swiss minister
(BS B2B Bureau | New Delhi , 19-May-2015 , Business Standard)
Johann Schneider Ammann, Swiss economic affairs minister, urges Indian government to remove the
difficulties faced by pharma companies in testing and marketing facilities More...
Mixed decision for Samsung appeal in Apple patent case
(PTI , 19-May-2015 , DNA)
A US appeals court on Monday upheld most elements of the blockbuster patent case in which Samsung
was found to have violated Apple iPhone patents, but invalidated some of the damages More...
Wyeth denied patent for cancer drug

The patent office order came in response to a pre-grant opposition filed by Fresenius Kabi Oncology,
which alleged that the ‘invention’ was publicly known in India before the priority date of Wyeth’s claim
More...
Defending India’s IPR

(C.R.L. NARASIMHAN , 17-May-2015 , The Hindu)
India’s IPR regime, never in the background, has come under sharp focus recently for a variety of
reasons. More...
Patent Office rejects Novartis' patent claim on diabetes drug

(BS B2B Bureau | Mumbai , 16-May-2015 , Business Standard)
The company was refused a patent for a modified release formulation of its diabetes drug, Vildagliptin,
which it markets under the brand name of Galvus More...
SC bars Glenmark from selling copies of Merck diabetes drugs

(Shreeja Sen , 15-May-2015 , Livemint)
The court has, however, allowed Glenmark to continue to sell existing inventory More...
Tata Group to double patent base in three years to 4,000

(Megha Mandavia & Devina Sengupta , 14-May-2015 , The Economic Times)
Tata Group plans to double its patent base to more than 4000 in the next three years as it pushes
through innovation in the century old conglomerate, its first chief technology officer (CTO) Gopichand
Katragadda said. More...
Suven Life Sciences gets patents for neurological drug

With these new patents, Suven has a total of 16 granted patents from Europe and 17 from Hong Kong
More...
India should not give way on IPR

(Ravi Kanth , 12-May-2015 , Livemint)
The Indian industrial and economic policy elite must not succumb to pressures from Washington and
Brussels More...
Patent office rejects J&J arm’s plea for HIV drug intermediate
In a setback to US consumer health behemoth Johnson & Johnson, India’s patent office has rejected an
application... More...
Protection against piracy: 'Bombay Velvet' producers move HC

(Meeta Pillai , 10-May-2015 , The New Indian Express)
Producers of upcoming Bollywood crime drama "Bombay Velvet" have moved the Delhi High Court
seeking a restraint on local cable operators and websites from showing or providing online access to
pirated versions of the Ranbir Kapoor, Anushka Sharma starrer movie. More...
India Rejects US Report on Intellectual Property as Unilateral

(IANS , 9-May-2015 , The New Indian Express)
India has rejected the US' annual report on intellectual property rights (IPR) and patents, describing it
as a "unilateral" action "inconsistent" with global trading rules, against the backdrop of its earlier
announcement on bringing a national IPR policy by early 2015, parliament was told on Friday. More...
Ericsson takes patent fight against Apple to Europe

(Reuters , 8-May-2015 , The Times Of India)
Swedish mobile telecom equipment maker Ericsson has filed lawsuits in Germany, Britain and the
Netherlands against Apple over technology licence payments. More...
Patent pressures
(OPINION » EDITORIAL , 7-May-2015 , The Hindu)
In its 2015 Special 301 Report on Intellectual Property Rights, the office of the United States Trade
Representative (USTR) has retained India in its “Priority Watch List”, noting however that bilateral
engagement between the two countries on IPR concerns had increased over the past year. More...
US lambasts India on IPR, trade policies

(Nayanima Basu | New Delhi , 7-May-2015 , Business Standard)
USITC initiates fresh round of investigations More...
Chinese company ZTE among world's top patent holders

(PTI , 7-May-2015 , The Times Of India)
China's leading telecom equipment manufacturer, ZTE Corp, was ranked third globally in patent
applications, the company said citing the World Intellectual Property Organization (WIPO). More...
Will Real IP Policy Stand up?

(Shamnad Basheer , 6-May-2015 , Indian Express)
Government has been speaking in two tongues on intellectual property. More...
IPR Policy to be Guided by National Interest

( The New Indian Express , 6-May-2015 , The New Indian Express)
Reacting to the US Trade Representative’s Special 301 report that placed India yet again on the ‘priority
watch list’ of countries with an “unfavourable” Intellectual Property Rights (IPR) regime, Commerce and
Industry Minister Nirmala Sitharaman has said India’s IPR policy will not be formulated under any
country’s pressure but will be guided by its national interest. More...
Software needs a stronger IPR regime

(VIPIN AGARWAL , 6-May-2015 , Business Line)
In the past few decades, India has emerged as a major hub for innovation in product research and
development across sectors. More...
US Welcomes India's Intellectual Property Policy

(PTI , 6-May-2015 , The New Indian Express)
The US pharma sector has welcomed India's recent moves on intellectual property, including bringing
out a draft policy and sustained engagement, while regretting the consistent barriers posed by the
country's pharma sector to US companies. More...
India fully aligned with international IPR, will safeguard its own interests, says Nirmala
Sitharaman
(Dilasha Seth & Soma Das, ET Bureau , 4-May-2015 , The Economic Times)
India is fully aligned with international intellectual property rights standards and "there is no need for
anyone to question us", Commerce and Industry Minister Nirmala Sitharaman said, rebuffing a US report
released last week that questions India's IP policies More...
India will not respond under pressure on IPR issues

(AMITI SEN , 3-May-2015 , Business Line)
The IPR policy to keep national interest in mind, says Nirmala Sitharaman More...
USTR’s praise of Modi’s remarks worries pharma companies

(Sushmi Dey , 2-May-2015 , The Times Of India)
The United States' appreciation of Prime Minister Narendra Modi's remarks on intellectual property rights
(IPR) has stirred concerns among the public health groups as well as the domestic drug manufacturing
industry. More...
Talks on India-European Free Trade Association pact stuck over IPR issues
The negotiations between the European Free Trade Association and India over a free trade pact are
stuck due to intellectual property rights issues but the Swiss government is hopeful that talks could soon
resume. More...
US names India, China as partners that fail to protect intellectual property rights, hurt
economy
(AFP , 1-May-2015 , IBN Live)
The United States on Thursday kept India and China on its Priority Watch List of trading partners that
fail to protect intellectual property rights (IPR), hurting the economy. More...
Coimbatore college’s novel windmill blade design wins patent
(Adarsh Jain , 30-Apr-2015 , The Times Of India)
Students and staff of Park College of Engineering and Technology here in the city have been awarded
patent by the Indian Patent Office for designing a low-speed windmill blade. More...
International seed day: farmers promote use of patent-free seeds

(R. Krishna Kumar , 27-Apr-2015 , The Hindu)
The movement against monopoly of patented seeds is gaining traction in the State, with hundreds of
activist-farmers forming a loose network to propagate the use of indigenous crops and promote the use
of patent-free seeds. More...
National IPR Policy still awaited

( Nayanima Basu | New Delhi , 27-Apr-2015 , Business Standard)
November draft proposals had drawn flak; DIPP formulation ready but Cabinet nod yet to come; clashing
concerns on pharma sector a key area More...
Innovation needs protection

(Richard R. Verma , 26-Apr-2015 , LiveMint)
India and the US share a mutual interest in encouraging innovation and safeguarding intellectual
property rights More...
IPAB dismisses UK firm's plea to remove trademark Hypnos of Indian firm

(BS Reporter | Chennai , 24-Apr-2015 , Business Standard)
Appellate Board said UK-based Hypnos Ltd, which supplies beds to the British Royal Family, failed to
prove international reputation spill over to India More...
USIBC concludes pharmaceutical & biologics mission to India

(Our Bureau, Mumbai , 24-Apr-2015 , Pharmabiz)
The US-India Business Council (USIBC) concluded its pharmaceutical & biologics executive mission to
Hyderabad and New Delhi recently. More...
Peps wins intellectual property case against UK brand

(Press Trust of India | New Delhi , 24-Apr-2015 , Business Standard)
Spring mattress company Peps Industries today said it has won an intellectual property rights case
against a UK brand for using Hypnos brand name in the Indian market. More...
India must align patent laws with global standards to boost trade: PM Narendra Modi
Batting for opening of sectors such as legal and finance to foreign players, Prime Minister Narendra Modi
on Thursday asked the services industry to overcome its fears, asserting that India is globally
competitive and suggesting that the country could become a hub for global arbitration with some
changes in legislation. More...
Despite GI tag, Kora silk has no takers
The congested lanes of Thiruvallur Street, located near Alangombu and Sirumugai, 40km from
Coimbatore, echo the rhythmic sounds of wooden panels as weavers operate the loom, creating colorful
designs on Saris adorned by millions of Indians across the country More...
Stempeutics gets process patent on novel product in China

(PT Jyothi Datta , 22-Apr-2015 , Business Line)
Even as it awaits regulatory approvals in India on its novel product targeting a limb disorder,
Stempeutics Research has crossed a milestone in China with this product. More...
Apple wins voice recognition patent case in China

(PTI , 22-Apr-2015 , The Times of India)
US tech giant Apple has won a case relating to patent on voice recognition technology in China over a
Chinese government agency and a Shanghai technology company. More...
Dr Reddy’s in a legal tangle over patent

(Trushna Udgirkar , 15-Apr-2015 , mydigitalfc.com)
Sanofi Aventis has sued Dr. Reddy’s Laboratories which wanted to make a generic version of their
patented product Jevtana More...
India examines WTO option over EU drug suspension order

(EP News Bureau-Mumbai , 15-Apr-2015 , Express Pharma)
The European Medicines Agency (EMA) had in January suspended a number of medicines approved for
sale in the EU More...
Fears over EU plan for strict drug patent regime

(Sushmi Dey , 14-Apr-2015 , The Times Of India)
As Prime Minister Narendra Modi and German Chancellor Markel are set to discuss the India-EU free
trade agreement, public health groups and Indian pharmaceutical companies are concerned that the
European Commission may push for stringent patent regime for cheaper medicines manufactured at
home. More...
Mylan settles Viagra patent litigation with Pfizer

(Reuters , 14-Apr-2015 , Yahoo)
Drugmaker Mylan N.V said it settled a patent litigation with Pfizer Inc related to Viagra, paving the way
for the launch of the drug's generic version in the United States once approved. More...
Industrialist wins patent battle against nephew

(Sunil Baghel , 12-Apr-2015 , Mumbai Mirror)
Dr Keki Hormusji Gharda's nephew Darius Kavasmaneck had moved the high court saying his uncle
shouldn't be allowed to create rights on patents owned by him as their company had spent Rs 180 crore
between 2001 and 2010 on research and development. More...
Kerala's Ayurveda Patent Cell's work infructuous: CAG
The traditional Ayurvedic knowledge in Kerala remain unprotected as the literature digitised by the
state's 'Patent Cell' has not been included in the database of the Centre's TKDL, a CAG report has said.
More...
Google’s patent to put an end to TV, film spoilers online

(PTI , 12-Apr-2015 , The Financial Express)
Search giant Google has been granted a patent for a system that would spot and hide spoilers about TV
shows, books and movies from a user’s social media feeds until they are up to date. More...
Azamgarh black clay pottery in race to get GI tag

The unique black clay pottery of Nizamabad in Azamgarh district may soon join the league of
Geographical Indication (GI) tagged products. More...
India, EU to discuss FTA on April 13 in Hannover

(Nayanima Basu | New Delhi , 11-Apr-2015 , Business Standard)
EU to push for higher car emission standards More...
US Patent Office revokes elements of podcasting patent

(Reuters , 11-Apr-2015 , The Times Of India)
The US Patent Office revoked key elements of a Texas company's patent, which the firm deployed in
high-profile legal actions to claim ownership over a method for distributing podcasts and video episodes
on the internet. More...
Better intellectual property values luring Indian startups abroad

(Evelyn Fok & Varun Aggarwal , 10-Apr-2015 , The Economic Times)
Prime Minister Narendra Modi says Make in India. More...
Natco takes patent blitz honed in India to US pharma market

Natco expects to be among the first to win regulatory approval for its Copaxone generic, with sales
anticipated to start in the next six months More...
Court questions Google on patent values in Microsoft case

A US appeals court appeared skeptical on Wednesday toward Google's bid to charge Microsoft a high
royalty rate to use some of the internet search provider's Motorola Mobility patents. More...
Modi visit will energise India-EU FTA talks: João Cravinho

( Nayanima Basu | New Delhi , 09-Apr-2015 , Business Standard)
Interview with Ambassador of the European Union to India More...
India to soon finalise Doha round work programme

(Press Releases , 09-Apr-2015 , ZeeBiz)
India will soon finalise its work programme which will be discussed as part of the long-pending agenda
of Doha round of talks at the next WTO meet in Nairobi in December, a Commerce Ministry official said
on Thursday. More...
IndiaFilings Launches 30 Minute Online Trademark Filing Service

(Chennai, Tamil Nadu , 8-Apr-2015 , Business Wire India)
IndiaFilings.com a leading website that helps Entrepreneurs start and manage a business has launched
30 Minute Online Trademark Filing service. More...
Pharma companies dominate 2014 list of Indian firms filing for global patents
(Rupali Mukherjee , 04-Apr-2015 , The Times Of India)
Led by companies such as Ranbaxy, Wockhardt and Hetero, the pharma sector dominates the list of top
Indian filers under the Patent Cooperation Treaty (PCT) in 2014, seeking protection internationally for
their inventions. More...
ICT and ONGC Energy receives patent for process to generate hydrogen from water
(BS B2B Bureau | Mumbai , 6-Apr-2015 , Business Standard)
The patent, granted by US Patent and Trademark Office, holds the potential to open up new vista for
generation of hydrogen from water on commercial scale in a sustainable manner in the coming years
More...
IPL opening ceremony's music copyright issue settled

(IANS , 06-Apr-2015 , Hindustan Times)
The row between an official body that works to protect the rights of artists and the organisers of the
Indian Premier League's (IPL) opening ceremony over payment of fees for music usage at the
programme was resolved ahead of the event on Tuesday. More...
India's GI List Gets Longer with 20 New Products

(Express News Service , 5-Apr-2015 , The New Indian Express)
Wooden lacquer wear and toys from Prime Minister Narendra Modi’s Varanasi, Bengaluru rose onion,
Naga tree tomato, Mizo chilli, Makrana marble from Rajasthan, Nendran banana from Kerala and Meerut
scissors - the Geographical Indications (GI) Registry has just got longer. More...
After a decade: why we need to protect Section 3(d) of the patent law
(Anand Grover , 03-Apr-2015 , Business Line)
For affordable medicines; to ensure only true innovations are rewarded with patent protection More...
HC Restrains Centre From Appointing Babus in Copyright Board

( IANS , 3-Apr-2015 , The New Indian Express)
The Madras High Court has restrained the Centre from appointing any bureaucrat as chairman or
member of the Copyright Board and directed that its earlier order on appointments in quasi-judicial
boards be followed. More...
Procter & Gamble fails to secure patent for smart sanitary napkin in India
Procter & Gamble (P&G), which manufactures ‘Whisper’, has failed to secure a patent in India for an
invention regarding a sanitary napkin that claims to signal the wearer indications on its status. More...
Spurt in number of IPR applicants from state

(Laxmi Ajai Prasanna , 2-Apr-2015 , The Hindu)
Kerala State Council for Science, Technology and Environment (KSCSTE) has constituted a new advisory
committee on intellectual property rights (IPR) and has issued an order in this regard. More...
Research activity up in India, but patents are hard to come by

(Adarsh Jain , 2-Apr-2015 , The Times Of India)
More research may be happening in academic institutions and industries now than ever before, but the
quality of the research remains questionable. More...
Nendran Banana gets GI tag

(R. Sivaraman , 1-Apr-2015 , The Hindu)
Bangalore Rose Onion has also received the status More...
Compulsory licensing hit India’s image:Hetero Pharma

(DIVYA RAJAGOPAL , 31-Mar-2015 , The Economic Times)
In what is seen as a contrarian stand adopted by an Indian drug maker over intellectual property (IP),
Hyderabadbased Hetero Pharma said that the country has lost nearly $10 billion worth of investment by
not respecting IP norms. More...
Nine north-eastern Indian products gets geographical indication registr

(Bikash Singh , 30-Mar-2015 , The Economic Times)
The organic and exotic agricultural produce of Northeast India got leg up with as many as nine products
accorded geographical indication (GI) registry. More...
Boeing patents Star Wars-style force field technology

US aviation giant Boeing has been granted a patent for a Star Wars-style 'force field' technology that
would protect vehicles from nearby explosions. More...
Corrosion of WTO’S mandate

WTO has done well as custodian of the multilateral trading system, but there have been a few ‘corrosive’
developments, as well as positive ones More...
Rasabale and Mattu brinjal losing ground

(Niranjan Kaggere, Bangalore Mirror Bureau , 30-Mar-2015 , Bangalore Mirror)
While diseases affect the banana variety, seawater flooding has nearly wiped out the brinjal crop More...
Nine north-eastern Indian products gets geographical indication registry

( Bikash Singh , 30-Mar-2015 , The Economic Times)
The organic and exotic agricultural produce of Northeast India got leg up with as many as nine products
accorded geographical indication (GI) registry. More...
Pakistan Farmers Challenge GI tag for Basmati rice

(Express News Service , 30-Mar-2015 , The New Indian Express)
The Intellectual Properties Appellate Board (IPAB), Chennai, has adjourned to July 8 the hearing on an
application filed by a Pakistan-based farmers organisation challenging the grant of geographical
indication (GI) tag for Basmati rice to certain Indian areas in the himalayan foothills spread between
Punjab and Uttar Pradesh. More...
Motorola found guilty of patent infringement

Patent holding company Intellectual Ventures's second crack at holding Motorola Mobility liable for using
its technology without permission partially succeeded after a US jury in Delaware found Motorola
infringed a patent on multimedia text messaging. More...
SC stays HC order against Glenmark in patent case

(Amit Choudhary , 26-Mar-2015 , The Economic Times)
The Supreme Court on Wednesday stayed a Delhi high court order restraining Glenmark Pharmaceuticals
from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met for allegedly infringing the
patent rights of US drug major Merck Sharp and Dohme (MSD). More...
Facebook’s patent application rejected

(Our Bureau , 24-Mar-2015 , Business Line)
The patent office has refused to entertain Facebook’s application for patent to the “method and
apparatus for an application crawler” that is used to search the Web for files, including texts and videos.
More...
Don't dilute Patent Act

(Ashwani Mahajan , 24-Mar-2015 , Deccan Herald)
Recent visit of US President Barak Obama to New Delhi has been boasted as a major breakthrough in
Indian diplomacy. More...
Open Invention Network calls Indian companies to join

(Evelyn Fok , 24-Mar-2015 , The Economic Times)
Open Invention Network, a community promoting open source innovation and patent non-aggression in
Linux, is reaching out to Indian companies to join its shared patent pool. More...
Big Pharma drives innovation in pain therapy development, despite declining patent
applications
(EP News Bureau-Mumbai , 23-Mar-2015 , Express Pharma)
Patent applications for pain treatments between 2008 and 2012 were dominated by Big Pharma,
including Sanofi, Novartis and Merck & Co More...
Indian Court Sides with Merck in Patent Dispute

(Michael Mezher , 23-Mar-2015 , Regulatory Focus)
A prominent court in India has issued an interim injunction, overturning a previous ruling, in favor of US
drug maker Merck in a patent dispute with Glenmark Pharmaceuticals over an active ingredient used in
two of Merck's diabetes medicines, Januvia and Janumet. More...
Exclusive: Leaked Oppo patent reveals bezelless screen tech

(News , 22-Mar-2015 , GSMArena)
Curved displays seems to be the craze right now and even more so, after Samsung set the tone with the
Galaxy Note edge. More...
Curved displays seems to be the craze right now and even more so, after Samsung set the
tone with the Galaxy Note edge.
(Press Trust of India | New Delhi , 22-Mar-2015 , Business Standard)
India needs to check high patent royalty payments demanded by foreign firms and bring them in line
with rates allowed by China and the US to ensure that its efforts to develop a robust local mobile
manufacturing base are not derailed, says a report. More...
India remains bit player, China marches ahead in patent filings

India registered an increase of 5.6% in patent filings during 2013-14, while China notched up a rise of
18.7% More...
Government seeds stronger IP protection with agrochemicals

(Arun S , 20-Mar-2015 , The Financial Express)
While the move would benefit global chemical giants like Bayer, Syngenta, BASF, Dow, Monsanto and
DuPont, it is also seen as a precursor to similar exclusivity for pharmaceutical majors. More...
Patents are like nuclear weapons: Vivek Wadhwa

(ET Bureau , 20-Mar-2015 , The Economic Times)
Vivek Wadhwa, Indian-American tech entrepreneur and academician is an outspoken advocate of

abolishing software patents in the US. More...
India remains bit player, China marches ahead in patent filings

India registered an increase of 5.6% in patent filings during 2013-14, while China notched up a rise of
18.7% More...
Chennai accounts for 17,000 of the 45,000 patent pleas in India

(Special Correspondent , 20-Mar-2015 , The Hindu)
Nearly 45,000 patent applications are filed in India in a year; of them, 17,000 are filed from Chennai,
said R.Devan, Deputy Controller of Patents and Designs, Patents Office, Chennai here on Wednesday
More...
ndia's new patent laws bulldoze domestic industry, appease foreign firms
(K Yatish Rajawat , 19-Mar-2015 , First Post)
Sometimes a small sentence answers a lot of questions. For instance, Nirmala Sitharaman in reply to a
question in the Rajya Sabha yesterday said that the draft Indian Patent policy is almost ready. More...
India, Pharmacy to the Developing World, Must Honor IP Rights

(Dr. Kristina Lybecker , 18-Mar-2015 , IPWATCH DOG)
The United States and India are locked in a vitriolic debate over intellectual property rights in the
pharmaceutical sector. More...
HC to govt: Can Delhi get IP tribunal bench?

(Rupali Mukherjee , 18-Mar-2015 , The Times of India)
Clearance and disposal of trademark and patent disputes may soon get a leg up. The Delhi high court
has directed the government to look into the feasibility of setting up a permanent bench of the
Intellectual Property Appellate Board (IPAB) tribunal in the capital. This would ensure the smooth
functioning of the tribunal and help in the timely and effective disposal of trademark and patent cases,
according to legal experts. More...
USFDA plans to shift to an incentive based from a penalty based audits

(Soma Das , 18-Mar-2015 , The Economic Times)
In a marked departure from its approach to dealing with Indian pharmaceuticals companies, the US drug
regulator would now incentivize those adopting a culture of quality in addition to its usual practice of
pulling up those for manufacturing lapses, a top US Food and Drug Administration (FDA) official
currently on a visit to India told ET. More...
IPAB impleads MP farmer body in basmati GI tag plea

(Manish Raj , 18-Mar-2015 , The Times Of India)
There is quite another facet distinctive of the aromatic, slender and long-grained Basmati rice,apart from
its delectable presence in cuisines across the country. It continues to be mired in a legal wrangle.
More...
Apple did not infringe wireless patents: Jury

A federal jury in Texas on March 16 said Apple Inc did not infringe five wireless technology patents
owned by Canadian patent licensing firm Conversant Intellectual Property Management Inc. More...
Patent Office refuses Wockhardt's application related to osteoarthritis drug
(BS Reporter | Chennai , 17-Mar-2015 , Business Standard)
The company claimed that its invention shows at least 25% reduction in soft stool effect as compared to
other drugs More...
Suven Life shares zoom 20 per cent on getting patent for drug
Shares of Suven Life Sciences soared 20 per cent today as the company has been granted a patent each
by the US and New Zealand for a drug used in the treatment of neuro-degenerative diseases. More...
IPR/patent issues: US calls for stock taking, India says wait

(AMITI SEN , 12-Mar-2015 , Business Line)
Washington unhappy with India’s unwillingness to change IP laws More...
High court raises bar for intellectual property forums, sets new rules
Cutting to size the role of bureaucrats in appointment of members and chiefs of statutory boards that
decide patent, trademark and other related disputes, the Madras high court on Tuesday quashed
existing selection criteria and ordered the reconstitution of the search committee to choose members of
such boards. More...
Certain provisions in Trademarks Act unconstitutional: Madras High Court

Madras High Court today declared as unconstitutional a sub-section of by More...
Hewlett-Packard patents invalidated in ServiceNow case

A federal judge in California has invalidated four Hewlett-Packard Co patents for being too abstract,
marking a setback in the company's patent infringement lawsuit against competitor ServiceNow Inc.
More...
IP Appellate Board upholds Wockhardt’s petition for relief in diabetes drug patent row
(OUR BUREAU , 11-Mar-2015 , Business Line)
The Intellectual Property Appellate Board (IPAB) on Wednesday ordered that Wockhardt need not
produce any additional documents for evidence in a patent case against Novartis AG relating to an anti-
diabetes drug. More...
UT court stays sale, transfer of copyrights of 'Dolly ki Doli' movie

(Ajay Sura,TNN , 11-Mar-2015 , The Times Of India)
A Chandigarh court on Tuesday stayed the sale or transfer of the copyrights of movie 'Dolly ki Doli' after
a petition was filed alleging that the producers of the film had violated the Copyright Act. More...
German co’s patent for asthma drug revoked
India's Patent Office has revoked a patent on asthma drug, Spiriva (tiotropium bromide monohydrate)
held by German major Boehringer Ingelheim on an opposition filed by generic company, Cipla. More...
Former Google executive Lee confirmed to lead U.S. patent office

(Andrew Chung , 10-Mar-2015 , Reuters)
The U.S. Senate on Monday confirmed former Google Inc (GOOGL.O) executive Michelle Lee to head the
U.S. Patent and Trademark Office, a position that has been vacant for more than two years. More...
Govt working to wrest Khadi trademark from German firm

Government is working in tandem with the Khadi and Village Industries Commission (KVIC) to expedite
the process of de-registering 'Khadi' trademark in the European Union by a German company,
Suven Life secures One (1) Product Patent each in Eurasia and Israel
(Capital , 09-Mar-2015 , Business Standard)
For NCEs developed as therapeutic agents for major depressive disorder More...
Patent office refuses patent for tosylate salt form of Bayer's sorafenib
(Gireesh Bbau | Chennai , 09-Mar-2015 , Business Standard)
Bayer's sorafenib drug Nexavar was the first to have a compulsory license in India More...
Patent for modified poultry feed

Panjab University (PU) has been granted a patent by Technology Information, Forecasting and
Assessment Council (TIFAC) for an invention entitled 'A Modified Poultry Feed for Production of Eggs'.
More...
Patent controller issues draft guidelines for search & examination of patent applications
The Controller General of Patents, Designs and Trademarks (CGPDTM) of India has issued draft
guidelines for search and examination of patent applications. More...
Faster patent approvals on anvil for firms making in India

(Apoorva, Vidya Krishnan , 09-Mar-2015 , Livemint)
Patent applicants could soon jump the queue and fast-track to production if the views of an official panel
take the form of law More...
Will Indian generic pharma players live up to their billing?

(Rajabahadur V Arcot , 09-Mar-2015 , Deccan Herald)
Compared with many other industries in the country, save for the software industry, the Indian
pharmaceutical sector’s performance has been impressive and its future secure. More...
Suven Life up 5%, gets product patent in Eurasia & Israel

(Moneycontrol Bureau , 09-Mar-2015 , moneycontrol.com)
Shares of Suven Life Sciences (Suven) climbed 5 percent intraday Monday on getting product patent
each in Eurasia and Israel. More...
EU expected to reach out to India to restart FTA talks

(Elizabeth Roche , 8-Mar-2015 , Livemint)
Both sides may have lost an opportunity to give a push to talks, with Narendra Modi dropping plans to
visit Brussels during a visit to Europe next month More...
KAU bid to get GI tag for Marayoor sandal

(K. Santhosh , 8-Mar-2015 , The Hindu)
The Department of Wood Science of Kerala Agricultural University (KAU) has taken the initiative for
securing forest certification and registration of Geographical Indication for Marayoor sandal. More...
India is not being victimised: Meir Pugatch

(Sudipto Dey , 8-Mar-2015 , Business Standard)
Continuing its dismal run for the third year, India was ranked second from bottom among 30 countries
in the third edition of the annual international IP index brought out by the US Chamber of Commerce's
Global Intellectual Property Center (GIPC). More...
Patent law firms look to tap demand from startups

(Vishal Dutta , 5-Mar-2015 , The Economic Times)
Intellectual property rights (IPR) law firms have spotted a new business opportunity in the growing
number of start-ups in the country that could be at risk from both competitors and impersonators.
More...
Ilaiyaraaja irked with copyright infringement of his songs

(IANS , 5-Mar-2015 , The Times Of India)
Maestro Illayaraja, who has the rights to all the songs that he has composed in over 1,000 films, says
it's illegal for television channels and radio stations to play them without paying him. More...
Patent law firms look to tap demand from startups

(Vishal Dutta, ET Bureau , 5-Mar-2015 , The Economic Times)
Intellectual property rights (IPR) law firms have spotted a new business opportunity in the growing
number of startups in the country that could be at risk from both competitors and impersonators.
More...
Trademark Through this App

(Express News Service , 5-Mar-2015 , The New Indian Express)
IndiaFilings.com a leading online portal launched India’s first mobile application for company
registration, trademark registration and tax registration. The mobile app was released by K Rosaiah,
Governor of Tamil Nadu. More...
Apple's Claims of Phone Patent Harm by Samsung Make Judges Wary

(Reuters , 5-Mar-2015 , NDTV)
Apple Inc told a U.S. appeals court on Wednesday that rival Samsung Electronics Co Ltd should be
barred from selling products that infringe on its smartphone patents, but the judges were sceptical.
More...
Bengaluru based Stempeutics Research has been granted a US process patent for its stem-
cell based drug Stempeucel by the United States Patent and Trademarks Office.
(Peerzada Abrar, ET Bureau , 04-Mar-2015 , The Economic Times)
Bengaluru based Stempeutics Research has been granted a US process patent for its stem-cell based
drug Stempeucel by the United States Patent and Trademarks Office. More...
Huawei Bumps Up Patent Portfolio as 5G Era Draws Near: CEO

China's Huawei Technologies, the world's second-biggest maker of network gear, is beefing up its patent
portfolio ahead of 5G, the next generation of mobile equipment, its chief executive said on Tuesday.
More...
Huawei Bumps Up Patent Portfolio as 5G Era Draws Near: CEO

China's Huawei Technologies, the world's second-biggest maker of network gear, is beefing up its patent
portfolio ahead of 5G, the next generation of mobile equipment, its chief executive said on Tuesday.
More...
Indian firm challenges Apple over ‘iPhone’ brand

(Anupam Saxena,TOI Tec , 03-Mar-2015 , The Times Of India)
Apple is getting aggressive in India with the company reportedly setting a target to double iPhone sales
and increasing focus on e-commerce. More...
IPAB sets aside order against Cima Labs' painkiller for cancer
The Assistant Controller shall consider the matter afresh More...
Natco Pharma ties up with Gilead on hepatitis C drug

(Bloomberg , 3-Mar-2015 , The Times Of India)
Natco Pharma Ltd., the Indian drugmaker that had challenged Gilead Sciences Inc.'s patent claims on a
blockbuster hepatitis C treatment in the Asian country, said it signed a licensing agreement with the US
company for the drug. More...
India-US ties still problematic
(Nayanima Basu | New Delhi , 03-Mar-2015 , Business Standard)
While merchandise trade grew at a sluggish 0.47% in FY14, Washington remains concerned about
India's IPR laws More...
IP Department hopes to see GI certification for every province in three years

(PETCHANET PRATRUANGKRAI , 3-Mar-2015 , The Nation)
THE Intellectual Property Department plans to extend its "one geographical indication, one province"
scheme to all provinces within three years to boost development of localised products and income for
local people. More...
The Legal Implications Of Medicinal Marijuana As A Geographical Indication For Jamaica

(Marsha Cadogan , 2-Mar-2015 , IP-Watch)
The EU-Cariforum Economic Partnership Agreement between Caricom countries and the European Union,
facilitated interest in, and led to the subsequent enactment of geographical indication (GI) legislation in
most Caricom countries, including Jamaica. More...
Ericsson sues Apple for patent infringement

(Reuters , 28-Feb-2015 , The Times Of India)
Swedish mobile telecom gear maker Ericsson is suing Apple Inc for patent infringement after Apple
refused Ericsson's offer to have a court determine fair licensing terms, Ericsson said on Friday. More...
Qualifying norms for start-up patent subsidy scheme now relaxed

(Anita Babu , 26-Feb-2015 , Business Standard)
Many technology start-ups and small and medium enterprises could benefit from a government initiative
that provides financial assistance to file global patents, as the Centre has eased the qualifying norms.
More...
No proposal to change patent law

(Press Trust of India , 25-Feb-2015 , Business Standard)
"There is no proposal to amend patent law... There is no proposal to anything to do with Indian Patent
Act," Commerce and Industry Minister Nirmala Sitharaman said while replying to questions in the Rajya
Sabha. More...
First Traditional Healer in State Set to Get Patent

(Archana Ravi , 24-Feb-2015 , The New Indian Express)
Shahul Hamid is all set to become the first traditional healer with a patent, if everything goes as
planned. More...
Verdict in trademark row delivered 6 years after order is reserved

(A Subramani , 22-Feb-2015 , The Times Of India)
Even by the snail pace of Indian judicial machinery, delivering a verdict six years after reserving the
order is a big delay, indeed. More...
Experts come ouExperts come out against draft National IPR policyt against draft National
IPR policy
(G. KRISHNAKUMAR , 22-Feb-2015 , The Hindu)
The draft prepared by the Centre’s IPR Think Tank has failed to address many pertinent questions
regarding intellectual property More...
Xiaomi to take legal action against websites selling its phones illegally
(Gulveen Aulakh , 21-Feb-2015 , The Economic Times)
Xiaomi will be taking legal action against websites selling its phones illegally and infringing on the
company's trademark in India where the Chinese handset maker has an ongoing patent dispute with
Ericsson. More...
Microsoft, ZTE do not infringe InterDigital patents: Court

InterDigital, a patent licensing firm, lost an infringement fight on Wednesday as a US appeals court ruled
that wireless phones made by Nokia, since purchased by Microsoft, and ZTE do not infringe on
InterDigital patents. More...
Apple patents VR headset for iPhone

(AFP , 18-Feb-2015 , The Times Of India)
Apple has been awarded a patent on a headset that could let iPhones be part of augmented or virtual
reality displays. More...
Samsung to pay $15.7 million for patent infringements

(IndiaToday.in New Delhi , 16-Feb-2015 , India Today)
Samsung has been dragged to the court for patent issues yet again. More...
Suven gets patent for neurodegenerative drug in 4 countries

(16-Feb-2015 , DNA)
Pharmaceutical firm Suven Life Sciences has been granted one patent each by Australia, Canada, Japan
and New Zealand for its drug used in treatment of neurodegenerative diseases. More...
Big Pharma groupings urges US to ask India to change its IPR policies
(Soma Das , 12-Feb-2015 , The Economic Times)
Big Pharma groupings have urged the US government to keep nudging India to change its policies on
intellectual property rights, which they claim don't conform to global norms. More...
Delhi HC stays release of ‘Badmashiyaan’

(PTI , 11-Feb-2015 , Livemint)
The release has been stayed on Multi Screen Media’s plea alleging copyright infringement by the movie’s
producers More...
Ten-fold rise in patent applications, says Nasscom
(OUR BUREAU , 10-Feb-2015 , Business Line)
Frontline IT companies have seen a 10-fold increase in the number of patent applications made over the
last five years, an indication of the growing push towards automation and higher margin offerings.
More...
Microsoft, Samsung settle dispute over patents

Microsoft and Samsung Electronics Co Ltd have settled a contract dispute over patent royalties, though
terms of the settlement are confidential, Microsoft said in a statement on Monday. More...
IBM sues Priceline for patent infringement

IBM filed a lawsuit against Priceline Group, accusing it of infringing four IBM patents in running its travel
and dining websites. More...
New policies, other IP reforms could improve India's IP score: Meir Pugatch
(Jyotindra Dubey , 10-Feb-2015 , Business Today)
The US Chamber of Commerce's Global Intellectual Property Center released the third annual edition of
its International IP Index 2015 two days ago. More...
Venus Remedies scrip surges over 13% on patent win

Shares of pharmaceutical firm Venus Remedies Ltd today surged over 13 per cent after the company
secured Indian product patent for an antibiotic research product, Vancoplus. More...
IBM Sues Priceline for Patent Infringement

(MARIA ARMENTAL , 09-Feb-2015 , The Wall Street Journal)
International Business Machines Corp. is suing Priceline Group Inc., claiming the online travel giant built
its business on IBM’s inventions and owes it billions of dollars in royalties. More...
India may finally usher in pharma data protection

(Arun S , 9-Feb-2015 , The Financial Express)
Patent linkage would ensure patent controllers and drug regulators coordinate so that a generic versions
of a patented product are not approved by the latter during the term of a patent. More...
Indian drug cos worried about patent regime changes

(PT Jyothi Datta , 08-Feb-2015 , Business Line)
Seek clarification on US trade representative’s testimony that India has committed to address IP issues
that concern America More...
US has secured commitments from India on IPR, claims Michael Froman
(Soma Das & Dilasha Seth , 5-Feb-2015 , The Economic Times)
A remark tucked away in the top US trade official's testimony before American lawmakers, stating that
the US has secured commitments from India on intellectual property rights, has alarmed Indian
drugmakers and public health activists. More...
Global Intellectual Property Index: India's dismal run continues

(BS Reporter | New Delhi , 5-Feb-2015 , Business Standard)
India continues its dismal run in Global Intellectual Property Index score, occupying the 29th position
among 30 countries. More...
India ranked second last in Intellectual Property Index

(ET Bureau , 04-Feb-2015 , The Economic Times)
India has improved its rank marginally on the intellectual property (IP) index released by the US
Chamber of Commerce on Wednesday. More...
HC asks patent office to review Gilead's case

The Delhi high court has sent the decision of patent refusal for US firm Gilead's hepatitis C drug, Sovaldi,
back to the patent office on procedural grounds. More...
Samsung patent showcases new dual-edged screen design

(2-Feb-2015 , GSM Arena)
With MWC 2015 closing in fast all eyes are on manufacturers to usher forth their new device lineups.
Samsung's next flagship S device - the Galaxy S6 has long been in the rumor mill and is still expected to
make its first appearance at the Barcelona venue this year. More...
Patent application refused to Wockhardt for skin care drug

(Gireesh Babu | Chennai , 01-Feb-2015 , Business Standard)
It was refused because the drug was found incapable of industrial application More...
Delhi high court sets aside order on Gilead’s Sovaldi patent

(Apoorva & Vidya Krishnan Mail Me | Vidya Krishnan , 31-Jan-2015 , Livemint)
The Controller General of Patents, Designs and Trademarks had rejected a patent to the US drug maker
for the hepatitis C drug More...
Patent dispute: Novartis objects to Wockhardt filing fresh documents

Swiss pharma company Novartis has raised objections to Wockhardt filing additional documents in a
revocation petition by the latter against the former’s patent for anti-diabetes drug Vildagliptin. More...
Coffee Board to monetise ‘Coffees of India’ logos

(Vishwanath Kulkarni , 29-Jan-2015 , Business Line)
Exporters, traders, roasters and curers displaying the ‘Coffees of India’ and the other regional/speciality
coffee trademarks on their packages will now have to seek the Coffee Board’s permission to do so and
pay a fee for using each logo. More...
International health activists criticise President Obama’s attempts to undermine India's IPR
(Ramesh Shankar, Mumbai , 29-Jan-2015 , Pharmabiz)
US President Barack Obama’s comments during the India-US CEO Forum in New Delhi on Monday
January 26 with Indian Prime Minister Narendra Modi have drawn harsh criticism from international
health activists. More...
Did PM concede to the US on IP and patents?

(Rema Nagarajan , 28-Jan-2015 , The Times of India)
Reports of Prime Minister Narendra Modi telling a conclave of Indian and US corporate chiefs that India
was ready to accept suggestions made by a joint working group with the United States on intellectual
property rights has led to howls of protest and accusations of Indian selling out and bending to US
interests. More...
US having a good dialogue with India on intellectual property issues: Mike Froman
The United States is having a good dialogue with the new Indian Government on issues related to
intellectual property (IP), a top Obama Administration trade official told lawmakers. More...
Demand for geographical indication status: This time for Gulbarga toor
(Harish Damodaran | Gulbarga , 28-Jan-2015 , Indian Express)
After Dehraduni basmati, Darjeeling tea and Malabar pepper, it is the turn of pulses millers and traders
in this Northeast Karnataka district to seek geographical indication (GI) status for “Gulbarga toor”.
More...
Patent row no hurdle for Gilead Pharma’s Sovaldi launch

US drug maker Gilead Pharma says that the recent decision by the patent office, which rejected patent
for one of its molecules, does not impact its India plans. More...
Will Modi give up India's intellectual property stand just to please Obama?
(G Pramod Kumar , 28-Jan-2015 , First Post)
Amidst the feel-good roadshow of Barrack Obama and Narendra Modi and the promise of $ 4 billion
American investment, something critical to the survival of India and the rest of the developing world
went under the radar - continuing pressure by America to dilute India’s intellectual property regime that
saves the lives of millions of people in India and elsewhere. More...
Pfizer earnings slip on loss of drug patent exclusivity

(AFP , 27-Jan-2015 , The Economic Times)
Pfizer reported Tuesday that revenues and profits fell again in the fourth quarter of 2014 as the drug
maker continued to suffer from the loss of exclusive rights to various treatments. More...
Japan’s Sharp, Coimbatore’s Sharp Ind told to settle trademark row amicably
(Our Bureau , 27-Jan-2015 , Business Line)
Japan’s entertainment electronics and consumer durables major Sharp Corporation and the Coimbatore-
based water pumps manufacturer Sharp Industries are expected to settle a trademark dispute between
them amicably. More...
Promote Indian drugs, US health groups urge Obama

(Sushmi Dey , 27-Jan-2015 , The Times of India)
Leading US health groups including AVAC, Oxfam America, amfAR, Health Global Access Project (GAP),
TAG (Treatment Action Group)and others have written to Barack Obama urging him to support India in
providing "high-quality, low-cost generic medicines essential for health care around the world". More...
CEOs from India, US brainstorm Intellectual Property Right, piracy among other issues
(PTI , 26-Jan-2015 , DNA)
ssues related with intellectual property rights, including piracy of films and software, figured prominently
during the India-US CEO Forum in New Delhi attended by Prime Minister Narendra Modi and US
President Barack Obama. More...
Ready to Accept India-US Panel's IPR Suggestions: PM Modi

(Reuters , 26-Jan-2015 , NDTV)
Prime Minister Narendra Modi on Monday said the government is ready to accept suggestions made by a
joint working group with the United States on intellectual property rights (IPR). More...
Modi pledges open business environment, Obama raises IPR issue at US-India Business
Summit
(IndiaToday.in/New Delhi , 26-Jan-2015 , India Today)
Prime Minister Narendra Modi on Monday said the state should be driven by policies which should be
consistent so as to draw more investments, while revealing US investments in India jumped by 50 per
cent in the first six months of his government. More...
CEOs from India, US brainstorm Intellectual Property Right, piracy among other issues
(PTI , 26-Jan-2015 , DNA)
Issues related with intellectual property rights, including piracy of films and software, figured
prominently during the India-US CEO Forum in New Delhi attended by Prime Minister Narendra Modi and
US President Barack Obama. More...
India, US to enhance engagement on intellectual property rights issues

India and the US today agreed to enhance their engagement on intellectual property rights, a vexed
issue between the two countries. More...
World backs India against ‘bully’ US

Apprehensive of the US exerting pressure on India to dilute the public health safeguards in its patent
laws, organizations from across the world have signed a global petition supporting India's patent law and
urging India to stand strong in the face of " US bullying". More...
India's patent laws under threat?

Setting up of a bilateral mechanism on intellectual property (IP) rights through the US-India trade policy
forum and the new draft national IP policy championing IP as the only way to promote innovation have
raised apprehensions among health activists that India might concede ground on IP during President
Obama's visit. More...
US 'threats' to Patent Act irks RSS outfit

(Suvojit Bagchi , 23-Jan-2015 , The Hindu)
Only days before President Barack Obama’s visit, Swadeshi Jagran Manch (SJM), the powerful economic
wing of the Rashtriya Swayamsevak Sangh, has objected to the United States’ “threats” to India’s
domestic policies on Intellectual Property Right (IPR). More...
Govt may negotiate price of drugs before market entry

(Sushmi Dey , 23-Jan-2015 , The Times of India)
The government may negotiate prices of patented medicines with their manufacturers before allowing
pharmaceutical companies to launch them in India. More...
HC seeks Centre reply on Gilead plea for patent of Hep C drug

Delhi High Court has sought the Government's response on US-based pharma firm Gilead Sciences Inc's
plea challenging rejection of its patent application for its Hepatitis C drug, sofosbuvir, marketed under
the brand name Sovaldi. More...
Setback to Natco pharma; US Supreme Court sends Teva patent case to Federal Circuit
(TNN , 22-Jan-2015 , The Economic Times)
In a setback to homegrown pharma player Natco, the US Supreme Court has sent back the patent case
related to Teva's multiple sclerosis drug Copaxone for a review by the Federal Circuit, which hears
appeals in patent, trademark and trade-related matters. More...
Blow for Natco, Mylan as US Supreme Court remands patent case

(fe Bureau , 22-Jan-2015 , The Financial Express)
The US Supreme Court has sent back to a federal Circuit Court a patent case over the multiple sclerosis
treatment drug, Copaxone. More...
‘Obama visit will pressurize India to alter patent law to suit US interests’
(Rema Nagarajan , 21-Jan-2015 , The Times of India)
US President Barack Obama's visit has set alarms bells ringing among those working to improve access
to medicines. More...
Medical charity warns India over patent rules
(AFP , 21-Jan-2015 , Medical Express)
Doctors without Borders on Wednesday warned the Indian government not to bow to US pressure to
amend patent regulations that allow millions access to affordable medicines, ahead of a visit by
President Barack Obama. More...
Natco slumps; US court rules for Teva in drug patent case

(Reuters , 21-Jan-2015 , The Economic Times)
The US Supreme Court on Tuesday ruled Teva Pharmaceutical Industries can still benefit from patent
protection for top-selling multiple sclerosis drug Copaxone More...
GRANTING OF UNDESERVING PATENTS

(P A Francis , 20-Jan-2015 , Pharmabiz)
There has been a steady increase in disputes between Indian drug companies and the multinationals
over the grant of patents in the country ever since the Indian Patent Act was amended in 2005. More...
Global Patents Reflect Advances in Connected and Self-Driving Cars

Technology advances in telematics and driver assistance systems are gathering steam as the enablers of
future connected and self-driving cars, according to an analysis of global patent applications released
Monday. More...
Hindustan Aeronautics’ patent filings see 10-fold rise in 3 years

(Huma Siddiqui , 19-Jan-2015 , The Financial Express)
State-owned Hindustan Aeronautics (HAL) is enriching its patents repository fast. More...
Patented medicine
(Dr. Srinivasan Nagarajan, Sydney, Australia , 19-Jan-2015 , The Hindu)
As a professional adviser on IP matters in Australia, I agree with the main thrust of the article, “Patented
medicine and affordability” (Dec.22, 2014). More...
Patents are scourge on software industry, says Vishal Sikka

Terming patents as a "scourge" on the software industry, Infosys CEO Vishal Sikka has said his company
is "rethinking" its approach on the subject. More...
Xiaomi bolsters its patent portfolio across globe as it fights patent battle in India
(ANI , 16-Jan-2015 , DNA)
Beset with a patent battle in India over its smartphones, Xiaomi is now trying to bolster its patent
portfolio in China and elsewhere. More...
India’s refuses patent to Gilead for its drug Sovaldi

(DIVYA RAJAGOPAL, , 16-Jan-2015 , The Economic Times)
India's patent office has refused a patent to US drugmaker Gilead for its blockbuster drug Sovaldi on the
grounds that the molecules and compounds of the drug were "known" elements. More...
IPR won't be part of model law on fake drugs, says UN arm

(Soma Das , 16-Jan-2015 , The Economic Times)
The UN agency for drug control has assured India and the other BRICS nations that it will steer clear of
intellectual property rights matters while drafting a model law to combat fraudulent drugs. More...
Monaco can't trademark 'Monaco', EU court rules

(AFP , 15-Jan-2015 , Zee News)
Monaco cannot register its own name as a trademark because the principality is too well known on
account of its royal family and Formula One race, an EU court ruled Thursday. More...
It’s time to ratchet up India’s IP stance

(Chirantan Chatterjee , 15-Jan-2015 , Hindustan Times)
NE implies that unlike an encrypted code in a software, ideas unless protected through intellectual
property (IP) are difficult to exclude from being used by others. NR in ideas gives rise to increasing
returns (IR). More...
Government taking steps to reduce patent backlog: Kant

(Nayanima Basu | New Delhi , 15-Jan-2015 , Business Standard)
Human resources in the IP office has not kept pace with the increase in filings More...
Patent filing sees unprecedented surge worldwide: WIPO

(Ragini Verma , 14-Jan-2015 , Livemint)
In 2012, 2.35 million patent applications, 6.58 million trademark class applications and 1.22 million
design applications were filed worldwide, says Gurry More...
Cipla moves HC against bar on sale of generic drug

Cipla has filed an appeal in the Delhi high court against a recent order which restrained it from selling its
generic version of Novartis drug Onbrez in the domestic market. The matter is expected to come up for
a hearing on Wednesday. More...
India suffers from an unpredictable regulatory environment: John Castellani

(Nayanima Basu & Digbijay Mishra | New Delhi , 13-Jan-2015 , Business Standard)
The IPR think-tank has the critical task of developing a national IPR Policy that will advance the new
government’s goals of fostering a spirit of innovation, entrepreneurship and growth in research and
development (R&D). More...
Trademark registry to look at claim of biryani eatery in Chennai

(Manish Raj , 12-Jan-2015 , The Times Of India)
It was an order in decidedly poor taste. Rapping the assistant registrar of the trademark registry in the
city for passing an order with "total non-application of mind", the Intellectual Property Appellate Board
asked it to consider afresh a trademark application by a biriyani eatery in Dindigul. More...
Bristol-Myers Squibb, Natco Pharma settle patent dispute

The dispute was over the patent of Hepatitis B drug entecavir More...
India, US agree to restart talks on bilateral investment treaty

(Sachin Parashar , 12-Jan-2015 , The Times Of India)
India and the US have reaffirmed commitment to the long-pending Bilateral Investment Treaty with PM
Narendra Modi on Sunday conveying to visiting secretary of state John Kerry that New Delhi was
prepared to hold early talks for the same. More...
IBM again tops lists of US patent recipients

(IANS | New Delhi , 12-Jan-2015 , Business Standard)
IBM has received a record 7,534 patents in 2014 -- marking the 22nd consecutive year that the
company topped the annual list of US patent recipients, a company statement said here Monday. More...
Delhi HC stops Cipla’s generic drug sales

(Rupali Mukherjee , 10-Jan-2015 , The Times Of India)
In a move which may be a dampener for patients suffering from lung and respiratory diseases, the Delhi
high court has decided in favour of drug MNC Novartis, restraining generic firm Cipla from selling its
affordable version of respiratory drug Onbrez in the domestic market. More...
10 northeast products to get GI tag

Ten horticulture products from the northeast are set to get the much-coveted geographical indication
(GI) tag by March this year. More...
Glenmark wins patent row but says has no plans to launch produc
(E. Kumar Sharma , 09-Jan-2015 , Business Today)
The excitement was arguably more in the media than in the company or the analysts tracking it. More...
Glenmark Pharma wins patent suit against Abbott; stock gains

(ECONOMICTIMES.COM , 8-Jan-2015 , The Economic Times)
Shares of Glenmark Pharma moved higher in early trade after the company won patent suit against US
pharma major Abbott Biotechnology. More...
GI mark for basmati delayed as MP cos, farmers oppose APEDA

( Gireesh Babu & T E Narasimhan | Chennai , 07-Jan-2015 , Business Standard)
Apeda representatives said GI registration should be seen from a "national interest" perspective, as
Pakistan also is claiming rights over Basmati More...
Facebook Copyright Post Just a Hoax
(IANS , 07-Jan-2015 , The New Indian Express)
If you have received a Facebook copyright post in your news feed warning about your private
photographs and content, just ignore it. More...
Indian government plans to establish dynamic and balanced IPR policy

(India Correspondent , 07-Jan-2015 , The Pharma Letter)
Even as US President Barack Obama is slated to be the chief guest at India's Republic Day Parade on
January 26, action has revved up behind the scenes with the readying of the draft of the national
Intellectual Property Rights policy, reports The Pharma Letter’s India correspondent. More...
Tamil Nadu leads in ensuring GI protection in India

(C.H. Unnikrishnan , 7-Jan-2015 , Livemint)
Uttar Pradesh and Maharashtra were joint second in geographical indication protection; Goa and Punjab
claimed the least with two each More...
New IPR policy focuses on utility patents

First draft stresses the need to create new law that can facilitate the patenting of innovative utilitarian
inventions More...
Patent Office sets aside earlier order granting patent to Abbott's Humira
It had earlier granted patent without considering pre-grant opposition of Glenmark Pharma More...
Apple patent could lead to truly flexible iPhone

(Lance Whitney , 06-Jan-2015 , CNet)
The device described in the patent would use flexible materials for the display, housing, circuit boards
and batteries. More...
Patent Office revokes the patent of Roche's osteoporosis drug Bonviva

Decision comes in a post-grant opposition filed by Cipla, and following an order from IPAB. More...
Apple gets patent for 'stylus-designed smart pen'

(ANI , 01-Jan-2015 , The Times Of India)
Tech giant Apple has been granted a patent for a stylus design of a smart pen capable of detecting hand
movements that enables translation into digital line drawings and text, adding into the list of their new
innovations. More...
Microsoft sues Indian company for technical support scam
(Yoshita Singh , 31-Dec-2014 , Livemint)
Microsoft’s filed a civil lawsuit for unfair and deceptive business practices and trademark infringement
against C-Cubed Solutions More...
Suven Life surges on securing three product patents

(SI Reporter | Mumbai , 30-Dec-2014 , Business Standard)
The company secured three product patents one each in Eurasia, Japan and Mexico. More...
SIMI, IM trademark on pipe bomb

(Rajiv Kalkod , 30-Dec-2014 , The Times Of India)
The improvised explosive device that went off on Church Street on Sunday night fits the bill of a typical
'pipe bomb', the go-to detonator of the Indian Mujahideen and the Students' Islamic Movement of India.
More...
India-US panel: Access to medicines may be under threat

( Dr Gopal Dabade , 29-Dec-2014 , Deccan Herald)
Medicines when used appropriately can save lives. More...
Foreign pharma cos won 77% of all patents in last 10 years

(PTI , 28-Dec-2014 , Business Line)
India issued 4,614 drug patents between January 2005 and December 2014, of which 3,575 were given
to foreign drug makers More...
Chugai Pharma wins first instance patent infringement lawsuit for Oxarol ointment
(Tokyo , 26-Dec-2014 , Pharmabiz)
Chugai Pharmaceutical, one of Japan’s leading research-based pharmaceutical companies with strengths
in biotechnology products, announced that the Tokyo District Court (Civil affairs No. 29, Chief Judge
Kazuhide Shimasue) has granted Chugai an overall victory for the first instance demanding the
suspension of patent infringement of the manufacturing process patent owned by Chugai (Patent No.
3310301) related to Oxarol Ointment 25 µg/g, a treatment drug for keratosis including psoriasis vulgaris
(Oxarol ointment) . More...
IPR must be a subject in law colleges, IITs and IIMs: Draft national policy
(hananjay Mahapatra , 26-Dec-2014 , The Times Of India)
Intellectual property rights may soon become one of the key courses in the education system as the IPR
Think Tank, in its draft national policy, has recommended that it be made a compulsory subject in all law
colleges, National Institute of Fashion Technology, agriculture universities and management institutes.
More...
Micromax vs OnePlus: Delhi High Court lifts ban on OnePlus One, but case far from over
(Express News Service , 25-Dec-2014 , Indian Express)
The Delhi High Court on Wednesday granted relief to mobile company OnePlus by lifting the ban
imposed on the sales of its mobile phones by a single judge bench on December 16. More...
Micromax vs OnePlus: Delhi High Court lifts ban on OnePlus One, but case far from over
The Delhi High Court on Wednesday granted relief to mobile company OnePlus by lifting the ban
imposed on the sales of its mobile phones by a single judge bench on December 16. More...
US ITC to Investigate Samsung's Patent Infringement Case Against Nvidia

(Hitesh Arora , 25-Dec-2014 , NDTV)
Samsung's infringement case against Nvidia over semiconductor-related patents will now be investigated
by the US International Trade Commission. More...
Patent issue won't affect our product launches: Xiaomi India head Manu Jain
(Gulveen Aulakh , 24-Dec-2014 , The Economic Times)
Xiaomi says it needs to be prepared to face obstacles such as the patent infringement allegation it is
fighting in India as it grows at a break-neck pace, already becoming the largest smartphone maker at
home in China and the No. 3 globally. More...
Role of IPR immense in knowledge economy

When compared to China, India is way behind in filing Intellectual Property Rights applications, says
GSIB director. More...
40 years ago... And now: Cipla: The crusader for affordable drugs takes the patent battle to
MNCs
(Dev Chatterjee , 24-Dec-2014 , Business Standard)
In 1935, when Khwaja Abdul Hamied set up Cipla in Central Mumbai to manufacture medicines in India,
few could have predicted that in the next few decades the company would take on the world's mightiest
multinationals on patents and produce low-cost drugs for the world's extreme poor. More...
Claris Lifesciences confirms patent challenge for its generic version of PROPOFOL in USA
(COMPANY NEWS , 24-Dec-2014 , Livemint)
Claris Lifesciences has filed an Abbreviated New Drug Application (ANDA) for Propofol for Injection, 10
mg/ml with the US Food and Drug Administration (USFDA) with a Paragraph IV certification. More...
AstraZeneca files patent case against Aurobindo Pharma

(fe Bureau | Hyderabad , 24-Dec-2014 , Financial Express)
AstraZeneca has filed a patent infringement case against Aurobindo Pharma and Aurobindo Pharma
USA… More...
Patented medicine and affordability

(C. R. L. Narasimhan , 22-Dec-2014 , The Hindu)
India’s ongoing efforts at safeguarding its intellectual property rights (IPRs) have been facing challenges
from different directions. More...
Copyright Not for Making CDs: Piracy Cell
( Siva Sekaran , 21-Dec-2014 , The New Indian Express)
Using the copyright acquired for a feature film, no one can reproduce it in the form of CDs/DVDs evading
the particulars to be included as per Section 52 A of the Cinematograph Act, the Video Piracy Cell has
said in a counter affidavit before Madras HC, last week. More...
Govt studying options as Novartis-Cipla patent dispute moves to court

(Amiti Sen , 18-Dec-2014 , Business Line)
Cipla has requested the Centre to revoke Novartis’ patent on respiratory drug Onbrez More...
215 products registered as geographical indication: Govt

(Press Trust of India | New Delhi , 19-Dec-2014 , Business Standard)
As many as 215 products were registered as geographical indication (GI) till December 15, 2014,
government said today. More...
TM Registry Ordered to Examine Plea

The Intellectual Property Appellate Board (IPAB) has directed the TRADE Marks Registry to consider the
petition of a US based multi-national company, E I Du Pont De Nemours and Company, that has
challenged the trademark ‘Nomex’, registered by a pharmaceutical firm in Mumbai. More...
A doc’s call against patent overdose

(PT Jyothi Datta , 15-Dec-2014 , Business Line)
Public health groups have a supportive voice in American surgeon-author Atul Gawande in their fight to
break “secondary patents” that drug companies seek on existing medicines. More...
A doc’s call against patent overdose

(PT Jyothi Datta , 15-Dec-2014 , Business Line)
Public health groups have a supportive voice in American surgeon-author Atul Gawande in their fight to
break “secondary patents” that drug companies seek on existing medicines. More...
Government may not act on Cipla’s patent plea

(Sidhartha , 15-Dec-2014 , The Times Of India)
In a setback to Cipla, the homegrown generics medicine company, the government has so far found
little merit in its plea for waiver and cancellation of patent rights for five drugs over which Novartis has
exclusive rights. More...
Obama administration content with Modi govt taking 'baby steps' to improving country's
weak IPR laws
(Nayanima Basu | New Delhi , 15-Dec-2014 , Business Standard)
Obama administration content with Modi govt taking 'baby steps' to improving country's weak IPR laws
More...
India-led BRICS opposes UN arm’s move on model drug law
(Soma Das , 15-Dec-2014 , The Economic Times)
India has spearheaded a move by BRICS countries to oppose a United Nations agency's move to float
without consultations with member states a model law on fraudulent drugs that has raised fears of
genuine generic drugs getting disrupted. More...
India-led BRICS opposes UN arm’s move on model drug law

(Soma Das , 15-Dec-2014 , The Economic Times)
India has spearheaded a move by BRICS countries to oppose a United Nations agency's move to float
without consultations with member states a model law on fraudulent drugs that has raised fears of
genuine generic drugs getting disrupted. More...
Apple Just Patented An Idea That Steve Jobs Would Have Hated
(Sam Colt | Business Insider , 14-Dec-2014 , Yahoo)
Apple recently filed a patent for a stylus that Steve Jobs would've hated. More...
Xiaomi's India ban exposes wider patent risks

(Reuters , 14-Dec-2014 , The Times Of India)
The court order that banned Chinese mobile maker Xiaomi from selling its phones in India has halted its
breakneck expansion into the world's fastest growing major smartphone market and could be just the
start of a string of patent challenges. More...
US closes out-of-cycle review of India's trade and patent policies

(HT Correspondent, Washington, , 14-Dec-2014 , Hindustan Times )
The United States Trade Representative (USTR) has announced closure of the out-of-cycle review of
India’s trade and intellectual property rights practices, noting the progress made in recent months.
More...
SHOT IN ARM FOR DESI COS, PATIENTS

SC order to boost access to medicines More...
US concludes OCR of India's intellectual property policies

(Press Trust of India | Washington , 13-Dec-2014 , Business Standard)
Citing positive steps taken by the new Indian government in addressing America's concerns on
intellectual property (IP) rights, the US has concluded its Out-of-Cycle Review of India's intellectual
property policies. More...
Protecting patents will boost innovation in India

(RANJANA SMETACEK , 12-Dec-2014 , Business Line)
This is also essential to meet the healthcare challenges facing the country More...
Google, YouTube face patent suit in Germany
Technology company Max Sound said it filed a lawsuit against Google and YouTube in Germany earlier
this month, alleging infringement of a video-streaming patent. More...
Max Sound files patent suit against Google, YouTube in Germany

(Reuters , 12-Dec-2014 , The Economic Times)
Technology company Max Sound Corp said it filed a lawsuit against Google Inc and YouTube in Germany
earlier this month, alleging infringement of a video-streaming patent. More...
Agriculture department starts Geographical Indication process for Lasalgaon onions

Onions from Lasalgaon will get the Geographical Indication (GI) tag soon as the agricultural department
of the state has started the process to grant the special status to the commodity produced in the
district. More...
Delhi HC stops sale of Xiaomi phones over patent case

(PTI , 11-Dec-2014 , Livemint)
The court restrained Xiaomi from making, assembling, importing or offering for sale its devices which
are infringing the patents of Ericsson More...
Will India, US Bridge Divide Over Intellectual Property Rights?

( Patralekha Chatterjee , 10-Dec-2014 , Intellectual Property Watch)
There is an uptick in India-United States relations. More...
India assumes frontline position in battles over intellectual property rights

(Amy Kazmin , 10-Dec-2014 , Financial Times)
As their cities grow more polluted, more people in India grapple with respiratory difficulties. More...
UN Office on Drugs and Crime scheduled to meet to firm up model law

(Dilasha Seth & Soma Das , 8-Dec-2014 , The Economic Times)
A United Nations agency is scheduled to hold two days of closed-door meetings in Vienna starting
Monday to firm up a model law prescribing harsh penalties for 'falsified' drug-related crimes, reviving
fears about seizures of Indian-made generics similar to those made by the European Union in 2008.
More...
Cisco Systems sues rival Arista for patent infringement

Network equipment maker Cisco Systems Inc filed two lawsuits against Arista Networks Inc, accusing
the smaller rival of copying its networking technologies. More...
Keryx Biopharma receives US patent for Auryxia covering orally administrable forms
(New York , 6-Dec-2014 , Pharmabiz)
Keryx Biopharmaceuticals, a company focused on bringing innovative therapies to market for patients
with renal disease, announced that the US Patent and Trademark Office issued US Patent No. 8,901,349.
More...
Burger King in trademark soup

(BS Reporter | New Delhi , 6-Dec-2014 , Business Standard)
Burger King has about 13,000 outlets across the world and has had a trademark registration in India
since 1979, which has been renewed by the company More...
Patent protection, a key issue for foreign hybrid seed companies

(TOMOJIT BASU , 05-Dec-2014 , Business Line)
With demand for hybrid seeds growing across the developing world for characteristics ranging from
drought- and pest-resistance to higher yield, the protection of technology that goes into making is
becoming a key issue for developers, usually large companies such as Monsanto, DuPont and Bayer.
More...
Brands cry foul over counterfeit products on e-commerce sites like Flipkart, Snapdeal,
Amazon & others
(ET Bureau , 3-Dec-2014 , The Economic Times)
Consumer brands and channel partners are turning the heat on India's online retailers, accusing them of
not only undercutting prices but also encouraging the sale of counterfeit goods by sellers of dubious
origins on their sites. More...
New Google Glass Patent Tips Successor Will Feature Slimmer Profile
(Ketan Pratap , 03-Dec-2014 , NDTV)
Reports have started to emerge about Google's next-generation Glass wearable. On Monday, a report
suggested that the Google Glass successor will be powered by an Intel chip. More...
Cipla, Meda sue Apotex in US over nasal spray patent

(Our Bureau , 03-Dec-2014 , Business Line)
Swedish drug-maker Meda Pharmaceuticals Inc and India’s Cipla have sued Canadian pharmaceutical
company Apotex in the US Federal District Court in Delaware to enforce their patents covering nasal
spray Dymista. More...
Govt moves to protect 'khadi' trademark

(Sidhartha , 3-Dec-2014 , The Times Of India)
Hit by trademark infringement in Europe, the Khadi and Village Industries Commission (KVIC) has
moved to quickly register 'khadi' as a 'wordmark' to check against further violation. More...
Public interest groups urge DIPP's IPR Think Tank not to revisit India’s Patent Act
(Ramesh Shankar, Mumbai , 3-Dec-2014 , Pharmabiz)
A large number of patient groups, public interest organisations including MSF, treatment providers and
academia world-wide have urged the newly constituted IPR Think Tank not to revisit or challenge
democratically-determined and legally-consistent intellectual property rules introduced under India’s
Patent Act. More...
India, Japan spar over higher intellectual property standards

(Nayanima Basu , 2-Dec-2014 , Business Standard)
India and Japan locked horns over a higher standard in intellectual property rights, with a special focus
on the pharmaceutical sector, at the negotiations for a Regional Comprehensive Economic Partnership.
More...
IPAB asks UK-based bed maker and Indian firm to explore settlement
Hypnos claims to be the supplier of beds and upholstery for Royal Family and Royal Household in Britain.
More...
Panel to draft intellectual property policy riddled with conflict of interest

(Rema Nagarajan , 1-Dec-2014 , The Times Of India)
Increased focus on India's intellectual property and patent law has put the spotlight on the IP think tank
set up by the Department of Industrial Policy and Promotion (DIPP). More...
CSIR files patent for leather tanning tech breakthrough

(PTI , 30-Nov-2014 , Zee News)
The CSIR has filed a patent for its breakthrough in leather tanning technology that does not require
water. More...
If US had a patent law like ours, they would discover many more drugs: Anand Grover
(Rema Nagarajan , 30-Nov-2014 , The Times Of India)
India's intellectual property (IP) law has been hailed as one of the most progressive for safeguarding
public interest, and several nations like Argentina, the Philippines and Brazil are looking to learn from it.
More...
Government files for ‘Make in India’ trademark

(Nishtha Grover | New Delhi , 28-Nov-2014 , The Asian Age)
In order to prevent the misuse of the “Make In India” phrase and the symbol, the government has filed
for the trademark of the much celebrated phrase. More...
Intel wants government to strengthen protection for trade secrets under IPR policy
(Dilasha Seth , 28-Nov-2014 , The Economic Times)
Intel, the world's largest manufacturer of computer chips, has called on the Indian government to
strengthen protection for Trade secrets under the intellectual property rights policy, raising concerns
that the current regime is not strong enough. More...
Differences on intellectual property rights between India and US widen

(Asit Ranjan Mishra , 28-Nov-2014 , Livemint)
US disappointed at the stature of joint working group; India insists the group is important to resolve
bilateral issues More...
Patent expiries valued at $170 bn set Indian pharma to accelerate its complex generic
programmes
Indian pharmaceutical industry will now be able to make further inroads and garner a fair share of the
global MARKET opportunity as blockbuster drugs valued at $170 billion are set to come off the patents.
More...
Affordable healthcare is beyond compulsory licenses, US tells India

(Nayanima Basu | New Delhi , 26-Nov-2014 , Business Standard)
The discussion took place under the much-awaited India-US Trade Policy Forum More...
India to US: Tech companies violating copyright law

(Sidhartha,TNN , 26-Nov-2014 , The Times Of India)
For years, the US has blamed lax policing in countries such as India for a boost to piracy. More...
U.S. raises protection to firms in India, IPR issues

(Puja Mehra , 26-Nov-2014 , The Hindu)
Both countries to explore enhanced market access to farm products More...
India, US Trade Policy Forum meets after four years

Both sides have set a target of achieving $500 bn worth of trade in goods and services from the present
$100 bn More...
Modi urged to stand up to US pressure to change patent law

(Rema Nagarajan , 25-Nov-2014 , The Times of India)
US Trade Representative meeting high-ranking Indian officials during his India visit is worrying public
health activists that he will pressurise the government to weaken India's patent law which is seen to be
pro-public health, with in-built safeguards that prevent pharma companies from getting extensions on
patents by tweaking existing molecules and claiming them to be innovation. More...
India needs to look at IPR norms more closely: USTR Froman

Raising concerns that issues related to Intellectual Property Rights (IPR) were impeding their bilateral
trade, the US today asked India to look more closely at its IPR norms and address this problem
mutually. More...
US urges India to toughen patent laws to draw investors

(AFP , 25-Nov-2014 , The Economic Times)
A top US trade envoy urged India on Tuesday to strengthen its drug and other intellectual property laws,
saying such a move is needed to draw vital investment to spur a sputtering economy. More...
Indian company receives US patent for Alzheimer treating med

(Saswati Mukherjee , 24-Nov-2014 , The Times of India)
BCM-95, the patented turmeric extract formulation from Arjuna Natural Extracts Ltd has received a US
patent (US Patent No. 8859020) for a composition for the treatment of Alzheimers disease comprising
curcuminoid mixture and added essential oil of turmeric. More...
Arjuna Natural Extracts bags turmeric patent from US

(ET Bureau , 24-Nov-2014 , The Economic Times)
Arjuna Natural Extracts, a leading domestic manufacturer and exporter of botanical extracts, has said it
has been granted a US patent related to a turmeric extract used for treatment of Alzheimer's disease.
More...
Indian industry not taking advantage of IPR

(IANS | Kolkata , 24-Nov-2014 , Business Standard)
Due to lack of awareness on Intellectual Property Rights (IPR), the Indian industry is lagging behind in
exploiting benefits of registering and protecting trademarks internationally, an official said here Monday.
More...
US trade rep Froman urges India to create ‘world class’ IPR regime
(Amiti Sen , 24-Nov-2014 , Business Line)
Pitching for tighter intellectual property protection in India, US Trade Representative Michael Froman has
said that the country needed to enforce a world-class IPR regime and deal with issues such as piracy,
counterfeiting, trade secrets and compulsory licensing. More...
IPR unique opportunity for 'Make in India' innovations: WIPO official

(IANS | Kolkata , 24-Nov-2014 , Business Standard)
With Intellectual Property Rights (IPR) set to "play a major role" in Prime Minister Narendra Modi's
"Make in India" campaign, Indian innovators and businesses need to opt for the Madrid System of
trademark registrations to manage their portfolios internationally, an IP official said Monday. More...
India’s patent problems

(Dipti Jain , 24-Nov-2014 , Livemint)
India’s IP administration, which was widely criticized for lack of transparency in the initial years, has
made its file movements and examination process public in just the first step More...
US industry patent lobby meeting with judges foiled

(Dilasha Seth & Soma Das , 24-Nov-2014 , The Economic Times)
Public health groups successfully prevented meetings that had been scheduled between a visiting
delegation of a US industry patent grouping and judges of the Delhi High Court and the Intellectual
Property Appellate Board last week after questioning the propriety of such discussions, people familiar
with the matter told ET. More...
National IPR policy relook: Government moves slowly
India-US talks begin today at a high level, with little progress on New Delhi's homework in the two
months since a review was to begin More...
Kerala biotech firm receives US patent for Alzheimer’s drug

(Sangeetha G. , 23-Nov-2014 , mydigitalfc.com)
Turmeric extract formulation made by Kerala-based Arjuna Natural Extracts has received a US patent for
the treatment of Alzheimers disease. More...
Ebola vaccine running into patent cover in Canada?

(Sushmi Dey , 21-Nov-2014 , The Times Of India)
A Canadian patent protection may be blocking an Ebola vaccine even as the world is struggling to stop
the spread of the deadly virus. More...
Google, Rockstar Agree to Settle Patent Litigation

(Reuters , 21-Nov-2014 , NDTV)
Google Inc has agreed to settle litigation with patent consortium Rockstar, though terms of the deal
were not disclosed in a court filing made public this week. More...
Patent row: Delhi High Court asks Micromax to pay royalty to Ericsson
(y Soma Das & Anandita Singh Mankotia , 20-Nov-2014 , The Economic Times)
The Delhi High Court has asked homegrown handset maker Micromax to pay a royalty that amounts up
to 1% of the selling price of its devices to Ericsson for using the Swedish equipment maker's patents on
technologies that are essential to manufacture the products. More...
Claims of plagiarism pile on Kollywood

(Udhav Naig , 20-Nov-2014 , The Hindu)
The Tamil film industry has aggressively fought the issue of piracy, with some degree of success. But,
the issue of plagiarism within its own ranks has not been taken seriously enough. More...
MSU to host workshop on 'Patents: concept and practice'

(Prashant Rupera , 19-Nov-2014 , The Times Of India)
The Department of Chemistry of M S University's Faculty of Science in association with the Baroda
chapter of the Indian Society for Analytical Scientists and Infinvent IP is going to organize one day
workshop on 'Patents: concept and practice' on November 29. More...
India-US trade meet on Nov 25; IPR, market access on agenda

Intellectual property rights, market access for agri products, visa matters and a boost to investments
are some of the issues that will come up for discussions during the Trade Policy Forum (TPF) meeting
between India and the US on November 25 here. More...
India-US trade meet on Nov 25; IPR, market access on agenda
Intellectual property rights, market access for agri products, visa matters and a boost to investments
are some of the issues that will come up for discussions during the Trade Policy Forum (TPF) meeting
between India and the US on November 25 here. More...
Govt’s engagement with MNCs on patent protection keeps domestic industry on edge
The government's intention to engage with multinational companies and patent lawyers to discuss
protection and enforcement of intellectual property rights in India has triggered concerns from the civil
society, local firms and those advocating affordable medicines. More...
India Divided on Whether to Break Bristol-Myers Drug Patent

(Rajesh Roy , 18-Nov-2014 , The Wall Street Journal)
The Indian government is divided about whether to break a patent on a Bristol-Myers Squibb Co.cancer
drug. More...
Campaign concerned over US-based IPOA's 'Innovation Dialog' being organised in India from
Nov 16-22
(Ramesh Shankar, Mumbai , 18-Nov-2014 , Pharmabiz)
The Campaign for Affordable Trastuzumab has expressed grave concern over the intent and purpose of
the “Innovation Dialog” being organised in India from November 16-22, 2014 by the Intellectual
Property Owners Association (IPOA), a US-based group consisting of large corporations and law firms.
More...
Foreign drug makers urge government to review IPR think tank

(Soma Das , 18-Nov-2014 , The Economic Times)
Foreign drug makers are urging the government to review the membership of a think tank it has set up
to formulate intellectual property rights (IPR) policy in the next few months, saying that it lacks
representation from innovator firms and needs to be more balanced. More...
Government holding IP conference with MNCs, their lawyers, excluding civil society,
academics
The government of India claims to seek balance of public and private interests in intellectual property
rights. More...
Life-saving drugs to show govt-fixed rates in bold red

(Sushmi Dey | New Delhi , 17-Nov-2014 , The Times of India, Mumbai.)
From January 2015, all life-saving drugs will come with a bold red strip on the pack highlighting the
price as fixed by the government and specifying if the drug is under price control. More...
Group writes to SC, HC CJs against US patent body

The Campaign for Affordable Transtuzumab, a group of individuals and organisations fighting to increase
access to medicines, has written to the chief justices of the Supreme Court and Delhi high court and to
the chairperson of the Intellectual Property Appellate Board (IPAB) expressing grave concern over the
meetings scheduled by the US lobby group Intellectual Property Owners Association (IPOA) with IPAB, a
quasi-judicial body, the Delhi HC and the offices of the Controller of Patents. More...
US stand on India's IPR regime not arm twisting: Diplomat Charles Rivkin
(DIVYA RAJAGOPAL , 15-Nov-2014 , The Economic Times)
The US will push India into giving adequate protection to intellectual property regime (IPR, a major bone
of contention between the two countries. More...
Appeal to chief justices to cancel meetings with US patent lobby

The Campaign for Affordable Transtuzumab, a group of individuals and organisations fighting to increase
access to medicines, has written to the chief justices of the Supreme Court and the Delhi Court and to
the chairperson of the Intellectual Property Appellate Board (IPAB) expressing grave concern over the
meetings scheduled by the US lobby group, Intellectual Property Owners Association (IPOA) with IPAB, a
quasi-judicial body, the Delhi High Court and the offices of the Controller of Patents. More...
A reality check on intellectual property concerns

(Moushami Joshi, Srividhya Ragavan , 15-Nov-2014 , The Hindu)
Alarms were sounded when the Indian Supreme Court rightly refused to endorse ever-greening of
patents and denied patent protection on Glivec, a drug owned by Novartis.” More...
American envoy to focus on IPR protection during his visit

(Satyanarayan Iyer , 14-Nov-2014 , Business Line)
Emphasising that intellectual property rights (IPR) protection is in the “best interests of India,” the US
Assistant Secretary of State for Economic and Business Affairs Charles Rivkin said that is will be one of
the main focus areas of his visit. More...
Why it is important for India to defend its IPR

(DG SHAH , 14-Nov-2014 , Business Line)
The Office of the United States Trade Representative (USTR) is currently engaged in the Out-of-Cycle
Review (OCR) of India’s intellectual property rights (IPR) regime, tracking its “progress” since March
2014. This article addresses the OCR and why it is important for India to defend its IPR regime. More...
Conflict of interest: US patent lobby to meet Indian judiciary, patent officials

(Rema Nagarajan , 13-Nov-2014 , The Times of India)
In a glaring instance of conflict of interest many pharmaceutical MNC representatives from the US will be
meeting members of judicial tribunals and higher judiciary and officers who are dealing with intellectual
property (IP) cases of these companies on a visit to India next week. More...
India, US IPR dialogue to begin this month

India says it will engage bilaterally through the TRADE Policy Forum but not cooperate in the review
process More...
Sun Basks in Taro After-glow

(11-Nov-2014 , The Economic Times.)
Sun Pharma's stock hit a new high of `932 on Monday on strong performance of Taro, the Israeli
company it acquired in 2010. This also pushed its latest buyout Ranbaxy Labs to a record high of
`697.50.Sun Pharma stock got listed in 1994, an issue that was oversubscribed 55 times. More...
US lobbyists lose fire ahead of trade intellectual property review

(AESHA DATTA/AMITI SEN , 10-Nov-2014 , Business Line)
The US pharmaceutical lobby seems to have become less aggressive in its efforts to make India tighten
its intellectual property norms to give more protection to their own industry. In a recent proposal sent to
the US Trade Representative (USTR), which is carrying out an investigation into India’s intellectual
property regime, the Global Intellectual Property Centre (GIPC), an arm of the US Chambers, has
refrained from talking about any sanctions against the country. The same body, however, had asked for
India to be listed as a priority country as late as April this year. More...
Sun Pharma, Ranbaxy Laboratories hit new high

(SI Reporter , 10-Nov-2014 , Business Standard)
Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories have hit their respective lifetime
high and are up over 4% each on NSE after Sun Pharma’s US subsidiary, Taro Pharmaceutical
Industries, reported a strong 49% year on year growth in net profit to $143.4 million for the quarter
ended September 2014. More...
Cautious Japan Inc Reaches Out Via Lawyers

(Deepali Gupta , 10-Nov-2014 , The Economic Times.)
Business enquiries from Japan have nearly doubled since last year but actual work has increased only 5-
10%, lawyers said. Most Japanese business houses are watching for regulatory changes to simplify
norms for control and exit clauses. More...
NRIs filed 78% of the patent pleas in India

India registered the third highest rate for patent filings by non-residents at 78% of the total
applications, ahead of China at 18%, Japan at 16% and the US at 50%, the latest data from the Indian
patent office showed. More...
US Federal Trade Commission settles first case in crackdown on 'patent trolls'

(Reuters , 06-Nov-2014 , The Economic Times)
The US Federal Trade Commission has for the first time taken action against a patent assertion entity
(PAE) under its consumer protection authority, the agency said on Thursday. More...
LG, Google strike patent-sharing

(AFP , 5-Nov-2014 , Livemint)
The deal covers patents on a ‘broad range of products and technologies” that already exist and will be
filed in the next 10 years. More...
Origiin IP considers Indian Patent Office effort to simplify analysis of patent applications a
positive move
Origiin IP Solutions views the move by the Indian Patent Office to simplify the method of analysing the
patent applications of pharma companies a positive development. More...
Kaththi gets embroiled in plagiarism controversy once again

(M Suganth , 4-Nov-2014 , The Times Of India)
The controversies around AR Murugadoss's Kaththi just refuse to die down. Minjur Gopi, who had earlier
filed a case in the Chennai City Civil Court stating that the story of the film was his, has now appealed
again to the court after it had dismissed his petition earlier in September. More...
Indra Nooyi-headed Pepsi-Co backs India's much-disputed Intellectual Property Rights

(Dilasha Seth & Soma Das , 4-Nov-2014 , The Economic Times)
US pharmaceutical companies may be gunning for India's patent regime, but New Delhi has found a
prominent MNC ally in this high-profile dispute. Indra Nooyi-headed Pepsi-Co has backed India's regime
of intellectual property rights, it said in comments to the US Trade Representative. More...
Trademark war: ‘Khadi’ registered in Germany, Spain

(Sidhartha , 4-Nov-2014 , The Times Of India)
The government's efforts to promote 'khadi' are facing a trademark hurdle with the brand having been
registered abroad, in countries such as Germany, as well as in India. More...
MNCs ,other organisations, like Pepsi, IPA back India's IP regime

Multinational organisations including PepsiCo and industry associations like IPA, have come in favour of
India's intellectual property regime, which is being reviewed by the US administration. More...
Cipla-Novartis patent row: DIPP looking into merit of case

The Commerce and Industry Ministry is looking into the merit of Cipla's demand for revocation of
patents of Swiss drug major Novartis for respiratory drug Indacaterol citing the need for public health
access. More...
Commerce Ministry Looking Into Merit of Case in Cipla-Novartis Patent Row

(Press Trust of India , 02-Nov-2014 , NDTV)
The Commerce and Industry Ministry is looking into the merit of Cipla's demand for revocation of
patents of Swiss drug major Novartis for respiratory drug Indacaterol citing the need for public health
access. More...
Roche-Cipla patent row mediation fails

(Rupali Mukherjee , 31-Oct-2014 , The Times of India)
Efforts to end the long and bitter patent tussle between domestic pharma company Cipla and
multinational Roche over a lung cancer drug have come to a naught, with the Delhi high court-appointed
mediator submitting its "failure" report in the case. More...
Johnson & Johnson may buy electrolyte drink ORS-L for Rs 700cr
(Boby Kurian, TNN , 30-Oct-2014 , The Times of India)
The world's sixth largest consumer health and pharma giant Johnson & Johnson (J&J) has emerged as a
front-runner to acquire electrolyte energy drink business of Jagdale Healthcare in a deal estimated at Rs
700 crore, people directly involved with the matter said. More...
Cipla asks government to revoke five patents held by Novartis

It also urged the government to consider COPD as an epidemic worthy of being qualified as a "public
health crisis" as it claims 50 lakh lives annually in India, which is more than the toll from HIV-AIDS,
malaria, cancer and tuberculosis. More...
Patent office eases rule for pharma companies

(C.H. Unnikrishnan , 29-Oct-2014 , Livemint)
Office drops a proposed clause that would have enforced a more stringent examination of patent
applications More...
Update on the grant of Patent to the Company

(BSE , 29-Oct-2014 , Business Line)
Omkar Speciality Chemicals Ltd has informed BSE that the Companys claim for process patent for an
Advance Intermediate namely "BENZENESELENINIC ANHYDRIDE”, having special applications in
pharmaceutical industry has been accepted by the Patents Office, Govt. of India, vide their Certificate
No. 022/11999 Patent Registration No. 263298 dated October 17, 2014. More...
The IPR stand-off

(Business Standard Editorial Comment , 28-Oct-2014 , Business Standard)
Behind India's confrontation with the US on intellectual property More...
Under US pressure, Indian government is getting its act together on IP matters

(27-Oct-2014 , The Pharma Letter)
The pressure from the US government on India seems to be working. More...
Modi’s chief economic adviser Arvind Subramanian had opposed India on IPR till recently
he man who has been appointed the chief economic adviser to the government of India Arvind
Subramanian was until recently urging the US to initiate disputes against India before the World TRADE
Organization. More...
Centre mulls trademark for Brand Khadi

(Reshmi R Dasgupta & Vijaya Rathore , 25-Oct-2014 , The Economic Times)
Finally khadi seems to be on the way to getting its due, not only on the catwalk but also officially.
More...
Govt sets up 6-member IPR think tank

(Dhananjay Mahapatra , 25-Oct-2014 , The Times Of India)
Taking into account India's dismal performance in protecting intellectual property rights over drug and
agricultural products, the Centre has formed a six-member 'think tank' to draft national IPR policy and
suggest legal means to handle undue pressure exerted by other countries on this issue. More...
Intellectual Property Rights and India's competitiveness

(Amit Kapoor , 22-Oct-2014 , The Economic Times)
Intellectual Property Rights are important from the standpoint of maintaining present as well as ensuring
future competitiveness. More...
Trademark name issue being sorted out: Abhishek Bachchan

(Arun Venugopal , 22-Oct-2014 , The Hindu)
Chennai FC, a football club in the city, had sent a legal notice to Chennayin FC, asking to desist from
using its trademark name. More...
DU to soon have policy on registration of patents

(PTI , 19-Oct-2014 , Zee News)
What research exactly is patentable? What are the legal issues involved? If the student pursues a
research using university infrastructure, is the outcome students' intellectual property? More...
Erode-based phone manufacturer claims it has challenged trademark of iPhone in IPAB

(BS Reporter | Chennai , 19-Oct-2014 , Business Standard)
The company said that it has filed a rectification application to remove the trademark of iPhone from
Indian Trademark Registry More...
Medical charity accuses US of pushing India to ease patent rules

(AFP , 18-Oct-2014 , The Economic Times)
Medical charity Medecins Sans Frontieres (MSF) on Saturday accused the United States of ratcheting up
pressure on India's new government to relax strict patent conditions which have made the country the
"world's pharmacy" More...
US complaints about India's IPR regime are bullying attempts

(Bibek Debroy , 16-Oct-2014 , The Economic Times)
If India agrees to higher standards of IPR protection than necessary, one needs to ask what India gets in
return. More...
India says will not cooperate with US on IPR regime review

(Nayanima Basu | New Delhi , 16-Oct-2014 , Business Standard)
The Government of India has told American authorities that it will not cooperate with the out-of-cycle
review (OCR) initiated by the Office of the US Trade Representative (USTR) as part of the latter’s annual
‘Special 301 Report’, on India's supposedly slack intellectual property rights (IPR) regime. More...
Patent office invites final comments on 'Revised draft guidelines for examination of patent
applications'
The Controller General of Patents, Designs and Trademarks (CGPDTM) has invited final comments and
suggestions from the stakeholders and others on “Revised draft guidelines for examination of patent
applications in the field of pharmaceuticals”. More...
US launches review of India's patent regime

(Press Trust Of India , 15-Oct-2014 , Business Standard)
The US on Tuesday launched a review of India's Intellectual Property Regime, in which the focus is to
measure the engagement that New Delhi has pursued in terms of intellectual property. More...
US to launch fresh review of India's patent regime

(Sidhartha , 14-Oct-2014 , The Times Of India)
Within days of Prime Minister Narendra Modi's return from the US, the US TRADE Representative (USTR)
has launched a fresh offensive against India's intellectual property rights (IPR) regime, a move that may
lead to the government going slow on a bilateral dialogue with Washington. More...
Pharma patent regime may get stricter, say experts

(Soumonty Kanungo , 14-Oct-2014 , DNA)
In order to boost dollar inflows in pharma sector and establish stronger IPR regime, govt may affect
patent amendments. More...
GI tag for basmati rice: Pakistan is MP’s new enemy

(Milind Ghatwai | Bhopal , 13-Oct-2014 , The Indian Express)
Madhya Pradesh which early this year celebrated a Geographical Indication (GI) tag for its basmati rice
now has a new enemy: Pakistan. More...
Patent considerations
(Patrick Kilbride , 13-Oct-2014 , The Indian Express)
Among other things, they committed to establishing an annual intellectual property (IP) working group
as a core element of the bilateral trade policy forum. More...
Pfizer wins patent for Voriconazole in India

The patent application was opposed by pharma firms including Ranbaxy Labs and Natco Pharma More...
Bose and Beats Agree to Settle Headphone Patent Dispute

(Reuters , 11-Oct-2014 , NDTV)
A high-profile patent spat over noise cancelling headphones between Bose Corp and Beats Electronics
ended on Friday with the two sides settling the case out of court. More...
Playing the frenemy card

(Viveka Roychowdhury , 10-Oct-2014 , Express Pharma)
The pricing pill looks set to choke pharmaceutical companies in India again. On October 9, barely a
fortnight after the National Pharmaceutical Pricing Authority (NPPA) withdrew its now infamous ‘internal
guidelines’, a Spicy IP blogpost reported that the All India Drug Action Network (AIDAN) had filed yet
another PIL in the Delhi High Court. The AIDAN’s PIL alleges that the NPPA’s volte face was a result of
'browbeating' by the Secretary, Department of Pharmaceuticals (DoP). The PIL reportedly refers to
internal memos where the DoP has sent an endorsed copy of its opinion on the guidelines and directed
the NPPA to withdraw them. AIDAN alleges that this amounts to ‘sabotaging the efforts of the Union
Government and the stand taken by the Union Government in their two affidavits' at 'huge financial
benefits to the pharmaceutical industries.' More...
PILs challenge NPPA decision on price cap

(Apoorva | C.H. Unnikrishnan , 10-Oct-2014 , Livemint)
Two public interest litigations (PILs) filed on Thursday in the Supreme Court and Delhi high court
challenged a 22 September decision by the National Pharmaceutical Pricing Authority (NPPA) to
withdraw internal guideline to set prices of non-essential drugs following directions from the department
of pharmaceuticals. More...
Google-Rockstar patent lawsuit goes to California court

Google Inc will fight patent holder Rockstar Consortium in a California court instead of a Texas court that
lawyers consider more friendly toward plaintiffs. More...
IPAB to take up TVS Motor’s patent appeal

The Intellectual Property Appellate Board (IPAB) will hear TVS Motor Company’s appeal against...
More...
Apple granted patent for digital newspaper

(Business Insider , 8-Oct-2014 , The Times Of India)
APPLE has been granted a patent for a flexible display that can be used as a self-updating digital
newspaper. More...
Samsung initiates arbitration against Microsoft after patent royalty lawsuit

(Nate Raymond , 7-Oct-2014 , Livemint)
The arbitration was commenced under the terms of a business collaboration agreement More...
Sri Lanka seeks cinnamon trademark

(AAP , 06-Oct-2014 , Yahoo Finance)
Ten years after the Asian tsunami devastated Sarath Kumara's cinnamon plantation in Sri Lanka, forcing
him to start over with nothing, the farmer faces a new threat from further afield. More...
The patent discord
(Feroz Ali , 06-Oct-2014 , The Financial Express)
India is probably the only country that is consciously working towards a system of open prosecution of
patents. More...
DIPP Dismisses PM Modi’s Efforts To Resolve IPR Issues, Says India’s IPR Laws TRIPS
Compliant
(Purba Das , 06-Oct-2014 , Business Insider)
In what could be a dismissal of Prime Minister Modi's efforts to resolve the US concern regarding India's
Intellectual Property Rights (IPR) laws, the Department of Industrial Policy and Promotion (DIPP) has
pointed out that there's already a committee to discuss IPR issues between the US and India. More...
Govt mulls IPR courts to fast-track cases

(Arun S , 06-Oct-2014 , The Financial Express)
The government is working on a new, comprehensive policy on intellectual property rights (IPR), which
would pave the way for setting up special IPR courts comprising experts to fast-track adjudication on
infringement cases concerning all forms of IPRs, official sources told FE. More...
Government says India’s intellectual property regime fully compliant with WTO norms
India's intellectual property regime is fully compliant with WTO norms, the government said on Friday,
two days after the two countries decided to set up a high-level working group on IPR during Prime
Minister Narendra Modi's US visit to sort out the contentious issue. More...
India’s intellectual property regime fully compliant with WTO norms: Government
India says US agrees to its stand on IPR

(BS Reporter | New Delhi , 04-Oct-2014 , Business Standard)
Says bilateral forum, mentioned in Obama-Modi statement, already exists More...
India’s intellectual property regime fully compliant with WTO norms: Government
DIPP Statement on Bilateral Mechanism for Discussing IPR Issues with USA
(3-Oct-2014 , Business Standard)
The US- India Joint Statement issued by the Prime Minister of India and the President of the United
States of America after the bilateral summit had the following reference to IPR issues Agreeing on the
need to foster innovation in a manner that promotes economic growth and job creation the leaders
committed to establish an annual high level Intellectual Property (IP) Working Group with appropriate
decision making and technical level meetings as a part of the TRADE policy forum. More...
Country's IPR regime is fully compliant with global norms: Government

Amidst the US raising concern over the country's IPR laws, government today said its intellectual
property rights regime is fully compliant with the global norms. More...
Has PM Modi bowed to US pressure on patent laws?

(Rema Nagarajan , 03-Oct-2014 , The Times Of India)
A paragraph buried in the US-India joint statement, which talks of establishing an annual high-level
Intellectual Property (IP) working group as part of the Trade Policy Forum, has made health activists
across the world apprehensive that the Modi government might be bending to US pressure to change its
patent laws. More...
Real-time online app opens India’s patent process to public eye

The public will be able to access digital updates at each stage of file movement on the patent office’s
website from September More...
Apple wins LTE patent case against WiLan

Canadian patent licensing company WiLan Inc said a US judge had ruled in favor of APPLE Inc in a
litigation case against it. More...
Online push buoys patent filings

(P. T. JYOTHI DATTA , 1-Oct-2014 , Business Line)
The Government’s efforts to encourage people to file their patent applications online seem to be paying
off. More...
Modi must resist U.S. pressure on drug patents - MSF

(NITA BHALLA , 30-Sep-2014 , Reuters)
Prime Minister Narendra Modi must not give in to U.S. pressure to change intellectual property laws
which allow India to produce generic medicines poor people can afford, the medical charity Doctors
Without Borders (MSF) said. More...
The right prescription in the IPR debate

(29-Sep-2014 , Hindustan Times)
Chief on the list will be the US TRADE Representative’s (USTR’s) requirement that India wind back parts
of its posture on patents. More...
The right prescription in the IPR debate

Chief on the list will be the US TRADE Representative’s (USTR’s) requirement that India wind back parts
of its posture on patents. More...
India’s draft rules on patenting drugs draw mixed response

(29-Sep-2014 , Livemint)
India’s latest draft rules on patenting drugs that say modifications of existing medicines can be patented
only if they show increased therapeutic value has drawn sharp reaction from international pharma
companies. More...
IPR: US expert hopes to see commitment from Modi

(Press Trust of India | New York , 28-Sep-2014 , Business Standard)
Underscoring the need to strengthen India's IP policy for creating a conducive environment for foreign
investors, a US expert has expressed hope to see a principled commitment by Prime Minister Narendra
Modi to amend country's patent laws to boost economic growth and global competitiveness. More...
NGOs call upon Modi not to commit flexibilities in Indian Patents Act during his US visit
(Ramesh Shankar , 24-Sep-2014 , Pharmabiz)
Ahead of Prime Minister Narendra Modi’s scheduled visit to the United States next week, experts and
NGOs in the pharma sector have called upon the Prime Minister not to make any legal or political
commitment that compromises flexibilities in the Indian Patents Act for facilitating access to medicines
and safeguarding public health, which is based on policies and principles approved by Indian Parliament
and is fully consistent with international laws. More...
NPPA withdraws May drug price control guideline

(C.H. Unnikrishnan , 24-Sep-2014 , Livemint)
India’s drug price regulator scrapped a May guideline giving itself sweeping powers to set the price of
non-essential medicines. The move is likely to find favour with drug companies that have protested and
also legally challenged a July order by the National Pharmaceutical Pricing Authority (NPPA) capping the
price of 108 non-essential drugs More...
BITTER PILL - Drug pricing: `Govt bowed to lobbies'

(24-Sep-2014 , The Times of India, Mumbai.)
In a move that will disappoint many patients, the government has withdrawn certain powers of the drug
pricing regulator that allowed it to cap prices of widely-prescribed anti-diabetes, cancer, tuberculosis,
HIV and cardiac medicines. The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing
“with immediate effect“ a May 29 guideline that had allowed it to put price caps on crucial drugs, to
comply with a government “direction''. More...
US raps India's IPR regime

(Rupali Mukherjee | TNN , 23-Sep-2014 , The Times of India, Mumbai.)
US has rapped India's weak intellectual property regime on the eve of Prime Minister Narendra Modi's
visit to the country , saying US companies “seek to invest“ in India, but “need transparent governance, a
fair regulatory environment, and strong legal mechanisms“ to protect their investments More...
Cipla grants patent rights in Rifaximin Complexes family to Salix Pharma

(Our Bureau, Mumbai , 19-Sep-2014 , Pharmabiz)
Cipla, a Rs.9,800 crore plus fifth largest Mumbai based pharma major, has signed an agreement with
Salix Pharmaceuticals, Inc., a US-based speciality pharmaceutical company. More...
Software patent guidelines in the offing, says official

Currently, software is not patentable under the existing Act and it needs to be registered under
copyright More...
Fresh opposition on Gilead’s Hepatitis C drug

(PT JYOTHI DATTA , 18-Sep-2014 , Business Line)
The last word is far from heard on drugmaker Gilead’s Hepatitis C drug sofosbuvir in India. More...
India sends substandard generic drugs to Africa, say researchers

(Anna Edney , 18-Sep-2014 , Livemint)
Generic drugs that some Indian companies send to African countries are lower quality than the same
medicines the companies sell at home and outside Africa, according to tests of 1,470 samples,
researchers said. More...
A strong IPR regime benefits India

(17-Sep-2014 , The Financial Express)
India’s growing population, at 1.3 billion citizens now, represents the second-largest consumer MARKET
in the world, and may soon be the largest. Its productive capacity is also growing More...
Draft Guidelines could lead to unnecessary bias against pharma patent applications: USIBC
The US-India Business Council (USIBC) has stated that the Draft 'Guidelines for Examination of Patent
Applications in the Field of Pharmaceuticals' issued recently by the Indian Patent Controller could lead to
an unnecessary bias against pharmaceutical patent applications. More...
Gilead to license Sovaldi to Indian generics drug firms Read more at:
http://www.livemint.com/Industry/no7AnbJi4dRkjJY7dn4SOI/Indian-companies-to-sign-
generic-licensing-deal-for-Hepatiti.html?utm_source=copy
The licensing agreements will allow the generic drug companies to make and sell copies of the expensive
pill for low- and middle-income countries at lower prices More...
Weaker currency, patent expiration boost for healthcare firms

(Sneha Padiyath , 15-Sep-2014 , Business Standard)
Stocks of Indian pharma companies seem to be in the pink of health as investor-interest in them rises
on the back of a weakening currency, the expiry of generic-drug patents later this year and a slew of US
FDA approvals. More...
Government to hear out US pharma companies' patent fears
(Sidhartha , 15-Sep-2014 , The Economic Times)
After months of skirmishes, the government is finally going to sit down with American pharma giants
this week to hear out their concerns, a move that comes weeks before Prime Minister Narendra Modi
leaves for the US. More...
India uses ancient texts to foil US bid to patent lotus to treat obesity
(Vanita Srivastava , 14-Sep-2014 , Hindustan Times)
The claim made by a US company on the usefulness of lotus and cowhage (a herb) for treatment of
obesity and hunger at the European Patent Office (EPO) has been foiled by India, largely because of
submission of prior art evidence from ancient Hindu texts that refutes the claim of novelty. More...
Increasing patent expiration may brighten India's export prospects: CARE Ratings
(Sanjay Pingle , 13-Sep-2014 , Pharmabiz)
CARE Ratings has pointed out that the drug patent expiry in the USA will create new opportunity for
Indian pharmaceutical industry in the coming years and the pharma industry will gain a larger foothold
in the world's generic market. More...
PM Modi's US Visit: India, US discuss WTO, visa, IPR related issues

Ahead of Prime Minister Narendra Modi's visit to the US, a senior American official today met Commerce
and Industry Nirmala Sitharaman and discussed various issues including India's stand in the WTO on the
food security issue. More...
India’s drug industry to touch $48 billion by 2018

Industry may see growth on back of patent expiry of some blockbuster drugs in US and local demand
More...
Fresh, detailed norms for drug patent filing examiners

Fresh and detailed guidelines are being put in place for examiners of drug patent filings More...
McDonald's Files Trademark Petition for 'McBrunch'

(BurgerBusiness , 11-Sep-2014 , NDTV)
McDonald's is in need of a secret weapon that will help boost sales and bring back lost customers.
More...
Novartis files lawsuit against Zydus

(Premal Balan & Sohini Das | Ahmedabad , 10-Sep-2014 , Business Standard)
Zydus is accused of infringing patents related to a drug used to treat Alzheimer's and Parkinson's
diseases More...
IPR policy on the cards to protect national interests, says Nirmala Sitharaman
India has proposed a national intellectual property rights (IPR) policy to safeguard its interests and bring
clarity to existing laws ahead of Prime Minister Narendra Modi's visit to the US this month. More...
Novartis drags DRL to US court for patent violation

(fe Bureau | The Financial Express , 09-Sep-2014 , The Indian Express)
Switzerland-based Novartis AG and Novartis Pharmaceuticals Corporation (NPC) have sued Dr Reddy’s
Laboratories in a the United States’ District Court for the District of Delaware for a patent infringement
action on the drug Gleevec. More...
Poly Medicure wins long patent battle against German pharma giant B Braun
(Soma Das , 8-Sep-2014 , The Economic Times)
Poly Medicure, an Indian medical devices firm with annual sales of just over Rs 320 crore, has won a
five-year long patent battle with Rs 40,000 crore German medical devices and pharma giant B Braun as
the European Patent Office (EPO) revoked two of the latter's patents covering features of intravenous
(IV) safety catheters. More...
India revamps intellectual property policy in face of western anger

(Amy Kazmin in New Delhi , 8-Sep-2014 , The Financial Times)
India is hiring 1,000 officials for its patent offices and has vowed to clear the backlog of all pending
applications over the next 18 months as it seeks to defend itself against western allegations that it
tramples on companies’ intellectual property rights. More...
Gitam scholars patent millet biscuits

Researchers of Gitam University's food science and technology department have successfully registered
a patent for millet rich biscuits. More...
Sun Shines on Pharma Chart, Wockhardt Dims

(Kiran Somvanshi , 5-Sep-2014 , The Economic Times.)
Mumbai-based Sun Pharma has made it to the top of the domestic drug makers' leaderboard through
overseas acquisitions and quadrupling of revenue in five years. Others like Aurobindo Pharma and
Glenmark, too, have outperformed their peers during this period. More...
Sun-Ranbaxy deal may hit fair trade: CCI

(Agencies , 05-Sep-2014 , The Times of India, Mumbai.)
Launching the first-ever public scrutiny of an M&A deal in India, the fair trade watchdog on Thursday
said it has prima facie found that the $4-billion merger of Ranbaxy Labs into rival Sun Pharma is likely to
have an “appreciable adverse impact” on competition in the market. More...
Apple loses bid for Samsung US sales ban after patent win
(Joel Rosenblatt , 28-Aug-2014 , Livemint)
A US Judge denied Apple’s bid for what the company had pitched as a narrowly tailored ban on some
older Samsung smartphone models More...
Disney patents filing reveals plan for flying puppets
Walt Disney has filed for three drone-related patents that it says could lead to an era of aerial movie
screens and larger-than-life puppets flying through the sky. More...
REVISED NORMS FOR ISSUE OF PATENTS

(P A Francis , 27-Aug-2014 , Pharmabiz)
The Section 3(d) of the amended Indian Patent Act of 2005 is a key safeguard against ever greening of
a drug patent by the inventor companies by making some incremental changes to the original molecule.
More...
Gwyneth Paltrow slapped with copyright infringement lawsuit

(Press Trust of India | Los Angeles , 27-Aug-2014 , The New Indian Express)
Gwyneth Paltrow has been slapped with a copyright infringement lawsuit over her lifestyle website Goop.
More...
Raisoni students file 70 patents in three years

(Vaibhav Ganjapure , 12-Jun-2015 , The Times Of India)
Students of GH Raisoni College of Engineering (GHRCE) made the city proud by filing 70 patents of their
research that included many public-utility ones. More...
Researchers earn patent for wooden honey box

(TNN , 23-Aug-2014 , Business Standard)
For the first time in India, two farmers, who are also researchers, have got design patent for their
wooden honey box design. Efforts are on to get process patent for the same product, as it uses a simple
method to extract honey without damaging the honeybee colony. More...
Monkey does not own selfie, rules US Copyright Office

(Express News Service | New Delhi , 22-Aug-2014 , The New Indian Express)
The copyright regulator ruled that "the Office will not register works produced by nature, animals, or
plants. More...
IPAB allows Pfizer to appeal against rejection of patent for Tofacitinib

(Gireesh Babu | Chennai , 22-Aug-2014 , Business Standard)
Patent Office rejected Pfizer's application in June, 2011, and a review application in March 27, 3014
More...
Microsoft-backed patent buyer to layoff 19% employees

Patent buyer Intellectual Ventures announced its second round of staff cuts this year, saying it will
reduce its global workforce by 19% as the firm increasingly turns to litigation to generate licensing
revenue. More...
US Patent to VIT Alumnus for Travel Aid Gizmo that Doesn't Need Internet
(V NarayanaMurthi , 20-Aug-2014 , The New Indian Express)
Imagine travelling in a long-distance train with no idea about the current location, no internet
connectivity to identify the spot through GPRS and not knowing when to alight. More...
Payyannur Pavithra Mothiram in a Geographical Indication tag ownership tussle

(P Sudhakaran , 20-Aug-2014 , The Times Of India)
Payyannur Pavithra Mothiram, a unique gold ornament with a mythical tradition has been caught up in a
battle over the Geographical Indication registration awarded to it in 2004. More...
Apple’s curved touchscreen patents hints at smartwatch

(Techradar , 20-Aug-2014 , The Times Of India)
Moto 360 will bring the first circular screen to wearables, but it looks like Apple may be looking to one-
up Motorola with a curved touchscreen. More...
Rise in ex-parte orders upset generic drugmakers' future business plans

(Soma Das , 19-Aug-2014 , The Economic Times)
A growing number of cases in the pharma sector, where courts forbid Indian drugmakers from launching
generic versions of patented drugs (ex-parte injunction, without even hearing defendants) or ask them
to furnish undertakings proclaiming that they have no plans to launch such a drug, has rattled domestic
drugmakers. More...
Govt set to revise patent norms for pharma

(Sushmi Dey | New Delhi , 19-Aug-2014 , Business Standard)
Guidelines won't replace present structure, but will let examiners adopt standard procedure in evaluating
complex applications More...
Swedish retailer Ikea locks horns over brand name with Varanasi-based fabric maker Ekaya
(Maulik Vyas , 18-Aug-2014 , The Economic Times)
Swedish retailer Ikea has objected to a Varanasi-based fabric maker's brand name 'Ekaya' on the
grounds that it can create confusion among its customers as it sounds pretty similar to its own and
urged the Registrar of Trademarks to strike it down. More...
Cipla Favours Zero Monopoly in Healthcare

(ENS Economic Bureau , 18-Aug-2014 , The New Indian Express)
Amid growing tension with the US over Intellectual Property Rights (IPR)-related issues, pharma major
Cipla said free competition, zero monopoly in healthcare and adoption of a pragmatic IPR policy will aid
growth of pharma sector. More...
BU Prof’s Patented Technique to Purify Water Could Bring Hope to Several Lives
(Bharath Joshi , 18-Aug-2014 , The New Indian Express)
Millions of children can be saved from the ill-effects of fluoride and arsenic contamination in water with
the use of a nanoparticle technology patented by a Bangalore University professor. More...
Indian drug regulator plugs quality gaps after drawing flak from USFDA
The Indian drug regulator, the Central Drugs Standard Control Organisation, is busy reforming itself and
plugging all quality gaps by organising skills development programs for its officers and inspectors to
make them more attuned to international standards. More...
India’s action in WTO

(New Delhi Times , 17-Aug-2014)
On January 1 1995 when World Trade Organization came into existence the entire economy of the world
was affected in respect of international trade because WTO framed the new global trade rules for
international trade. More...
Research lab to help fight patent war

(Shounak Ghosal , 13-Aug-2014 , The Times Of India)
A laboratory, devoted to research and document qualities of certain indigenous plants and crops that are
at the risk of being patented by multi-national companies, started rolling off EM Bypass on Tuesday.
More...
THE PATENT SETTLEMENTS

A new trend of collusion of multinational drug corporations with large Indian companies is emerging in
the Indian pharmaceutical market to overcharge essential drugs which are under patent. More...
Samsung-Apple patent war: What was it good for? Nothing

(Bloomberg , 13-Aug-2014 , The Times Of India)
The decision by Apple to scale back its patent battle with Samsung may represent more of a reboot than
a truce. More...
Delhi HC issues notice on a PIL filed by Prof. Shamnad Basheer, seeking overriding powers of
RTI Act against other Statutes and for declaring S.144 of Patent Act ultravires
(Apoorva Mandhani , 6-Aug-2014 , Live law.in)
Delhi High Court today issued notice in a Public Interest Litigation filed by Prof. Shamnad Basheer,
founder of SpicyIP and leading academician in the country, with path-breaking research in the field of
Intellectual Property Rights, praying inter alia to declare that the mechanism under the Right to
Information Act, 2005 overrides all other mechanisms under any other statute or rule for discharge of
information from public authorities to the extent of inconsistencies therein and to declare Section 144 of
the Patents Act, 1970 is ultra vires the Constitution of India. More...
Samsung, Apple drop patent disputes pending in courts outside US

(By Reuters , 06-Aug-2014 , The Economic Times.)
Samsung Electronics Co Ltd and Apple Inc said they had agreed to drop all patent litigation outside the
United States, scaling down a protracted legal battle between the smartphone rivals. The iPhone and
Galaxy handset makers issued nearly identical statements announcing the global ceasefire while vowing
to pursue ongoing litigation in the United States, which analysts say involves much bigger amounts of
potential damages More...
Apple, Samsung agree to end patent lawsuits outside US

(06-Aug-2014 , BusinessLine)
Apple and Samsung, two of the world’s top technology companies, agreed to end ongoing patent
lawsuits against each other outside of the US, the companies said in a joint statement on Wednesday.
More...
FDA chief who cracked down on erring chemists shunted out

(Prafulla Marpakwar , 6-Aug-2014 , The Times of India, Mumbai.)
Bowing to the mounting pressure of chemists and a section of multinational firms, CM Prithviraj Chavan
on Tuesday shunted out Food and Drug Administration (FDA) commissioner Mahesh Zagade on the
ground that he has completed his tenure. While no new assignment has been given to Zagade, director
of municipal administration Purushottam Bhapkar will replace him. Significantly , Bhapkar, an IAS officer
of the 1997 batch, did not complete even one year as the director. More...
CCI to scan drug patent settlements

(C.H. Unnikrishnan , 3-Aug-2014 , Livemint)
The country’s competition regulator may examine details of patent settlements being negotiated
between foreign branded medicine companies and local generic drug makers as these agreements may
restrict the access of cheaper drugs to the sick. More...
Get wonder drugs that cure hepatitis at subsidized cost, patients and doctors in Mumbai urge
health ministry
(Times News Ntework , 28-Jul-2014 , The Times of India, Mumbai.)
City patient groups, NGOs and doctors have jointly petitioned the Union health ministry to procure two
wonder drugs, which promise 90% cure for hepatitis C patients, at a subsidized cost. More...
More drug price caps soon Regulator examines prices of vaccines & medicines used in
treatment of cancer, asthma, TB & malaria
(Sushmi Dey | New Delhi , 15-Jul-2014 , Business Standard)
The government is scrutinising prices of vaccines and drugs used to treat cancer, viral infections,
asthma, tuberculosis and malaria after having slashed prices of expensive anti-diabetic and
cardiovascular medicines. More...
Bombay HC upholds IPAB order on Nexavar’s generic copy

(Khushboo Narayan, C.H Unnikrishnan , 15-Jul-2014 , livemint)
The Bombay high court on Tuesday dismissed a challenge by Bayer AG against a decision to allow drug
maker Natco Pharma Ltd to manufacture and sell a generic copy of a patent-protected cancer drug made
by the German company. More...
Pharma Cos Find New Price Controls Difficult to Swallow

(Divya Rajagopal , 15-Jul-2014 , The Economic Times.)
The drug price regulator's move to control the prices of more commonly used diabetes and heart-disease
medicines has made pharmaceutical companies furious, as they fear it would wipe out their margins just
when they seemed to recover from the previous government's decision to slash the prices of more than
300 drugs. More...
QUALITY ISSUES - Glenmark joins pharma cos setting up US plants

(15-Jul-2014 , The Times of India, Mumbai.)
With quality issues continuing to dog domestic pharma industry , more companies are de-risking their
growth strategy by setting up manufacturing facilities in the US, the world's most lucrative market. The
latest to jump on the bandwagon is Mumbaibased Glenmark Pharma, which is planning to set up a
greenfield facility to serve the US market, which has sales of generic drugs totalling $65 billion. Over the
years, leading companies like Ranbaxy , Sun Pharma and Dr Reddy's have either invested in greenfield
facilities or acquired existing plants to grow their share in the fast-growing generics business. India is
the largest supplier of generic medicines to the US, around 20% in volume and 12% in value terms,
according to IMS. More...
Diabetes, cardiac drugs to become up to 35% cheaper

(14-Jul-2014 , The Times of India, Mumbai.)
Coping with the inflation demon will become a tad easier for the burdened consumer. In a move that has
shaken the pharma industry , prices of widely-used expensive anti-diabetic and cardiac medicines will
reduce over the next few weeks by as much as 35%, with the drug pricing regulator, the National
Pharmaceutical Pricing Authority (NPPA), deciding to bring them under price control. More...
India emerges world's top consumer of antibiotics

(Kounteya.Sinha@timesgroup.com , 14-Jul-2014 , The Times of India, Mumbai.)
India has emerged as the world’s largest antibiotics consumer, with a 62% rise in use over the past
decade. ‘Global Trends in Antibiotic Consumption, 2000-2010’, a study by Princeton University scientists,
has found that worldwide antibiotic use has risen 36% in the same period, with Brics countries — Brazil,
Russia, India, China and South Africa — accounting for over three-quarters of the surge. Among 16
antibiotics groups studied, cephalosporins, broad-spectrum penicillins and fluoroquinolones accounted
for over half the increase — consumption rising 55% from 2000. More...
Merck seeks to settle patent row with Glenmark

(Rupali Mukherjee, TNN , 12-Jul-2014 , The Times of India, Mumbai.)
In the long-winding patent battle on a widely-prescribed diabetes drug, Januvia (sitagliptin),

multinational company Merck (MSD) has sought a settlement to end the dispute with generic company,
Glenmark on the blockbuster drug. Last year, US-based Merck's subsidiary in India dragged Glenmark to
court, seeking a stop on the sale of a more affordable version of its diabetes drug, Januvia, joining the
list of MNCs engaged in turf wars with generic companies in the country. More...
Google, Dropbox and other top tech companies band together to fight patent trolls
(Martyn Williams , 10-Jul-2014 , pcworld.com)
Google, Dropbox and a few other high-tech firms have come up with a new way to help defend
themselves against patent trolls. Patent trolls, or “non-practicing entities,” are companies that buy up
old patents and try to monetize them by accusing others of infringement. They usually request a one-off
licensing fee to end a lawsuit, something many companies reluctantly pay because it’s cheaper than
defending the claim. More...
Unconventional Energy Boom Drives Oil and Gas Patents to Record

(Reuters , 30-Jun-2014 , profit.ndtv.com)
A boom in the search for unconventional forms of energy such as shale gas or oil sands has led to a
record high in new oil and gas patents filed across the world, research published by Thomson Reuters'
legal business showed. More...
Copyright shocker on Thyagaraja kritis

(25-Jun-2014 , The Hindu)
A spate of copyright-violation notices issued to video channels on YouTube for uploading Carnatic music
rendition of compositions of saint Thyagaraja, has raised the hackles of musicians and fans of the art
form. More...
US company denied patent on anti-cancer drug

(Rupali Mukherjee | TNN , 24-Jun-2014 , The Times of India, Mumbai.)
The Indian Patent Office has refused a patent on US firm Abraxis BioSciences' anti-cancer drug
Abraxane, paving the way for domestic companies to launch affordable versions in the local market. The
application was refused on the grounds of the US firm's claims lacking of inventive step, not being
patentable and insufficiency, legal sources say. More...
Patent medicine
(Tarun Khanna , 23-Jun-2014 , The Economic Times.)
In the patenting literature, economists and legal scholars have focused on improving the quality of prior
art available to patent examiners and mitigating the filing and granting of patents where prior art exists
in common knowledge. More...
Mahindra to Review Tesla Patents for Applicability to its Electric Vehicles

(Press Trust of India , 22-Jun-2014 , profit.ndtv.com)
Homegrown auto major Mahindra & Mahindra, which has been developing a range of electric vehicles,
will review technology patents that American electric carmaker Tesla Motors has made free for
applicability to its products. More...
Microsoft's Android Patents Revealed for the First Time

(NDTV Correspondent , 17-Jun-2014 , gadgets.ndtv.com)
Microsoft's smartphone platform might be a distant third compared to Google's Android and Apple's iOS,
but Microsoft has been earning a significant amount of money from Android device manufacturers
through its patents, and has even sued some of these companies More...
Nissan and BMW Keen To Collaborate with Tesla

(AFP , 17-Jun-2014 , auto.ndtv.com)
Electric car-makers Nissan and BMW are keen to collaborate with rival Tesla after the US company
agreed to share its patents with competitors, the Financial Times reported today. More...
MNC drug companies like Roche, Merck Serono, Novartis see top deck reshuffle
(Divya Rajagopal , 17-Jun-2014 , The Economic Times.)
Multinational drugmakers including Roche, Merck Serono, Novartis and Bristol Myers Squibs are
witnessing top-level changes in their management in India, with their chief executives exiting the
country at a time when the Rs 72,000-crore market appears to be as challenging as it is potentially
lucrative. More...
Nirmala Sitharaman discusses intellectual property rights related issues with officials
(PTI , 17-Jun-2014 , The Economic Times.)
Amidst the US targeting India's intellectual property rights regime, Commerce and Industry Minister
Nirmala Sitharaman today discussed various IPR related issues with her officials More...
Electric car maker Tesla Motors is handing over the keys to its technology in an unusual effort
to encourage other automakers to expand beyond gasoline-burning vehicles.
(Ameya Naik , 13-Jun-2014 , auto.ndtv.com)
Tesla CEO Elon Musk revealed that the company will allow other automakers to use their patents and will
not initiate patent lawsuits against anyone who, in good faith, wants to use their technology. The
message to the world is loud and clear, that the company wants electric vehicles on the road and the
only way they see it happening is getting through to the competition and sharing expertise. More...
Roche and Cipla are ordered to mediate in a new twist on Indian IP fights.
(Eric Palmer , 13-Jun-2014 , Fierce Pharma)
Roche and Cipla are writing a new chapter in the bitter battles that have been fought by Western
drugmakers over their patents in India. They are in mediation over the patent for Roche's blockbuster
cancer fighter Tarceva, in what may be the first case to take this route. More...
Electric Car Maker Tesla Handing Over the Keys to its Technology
(Associated Press, San Francisco, California , 13-Jun-2014 , ndtv.com)
Electric car maker Tesla Motors is handing over the keys to its technology in an unusual effort to
encourage other automakers to expand beyond gasoline-burning vehicles. More...
Patent Case Against Facebook Goes to Trial in the US

(Associated Press , 12-Jun-2014 , gadgets.ndtv.com)
Facebook infringed on patents held by a Dutch computer programmer who tried to launch a similar site
called "Surfbook" more than a decade ago, according to a lawsuit heard by a federal jury Wednesday.
The civil trial was underway in U.S. District Court in Alexandria, where social media giant Facebook is
being sued by a holding company called Rembrandt Social Media. More...
Plea alleges patent process biased against Indians

Highlighting an anomaly in patent laws, a PIL filed in the Madras high court has said that while foreign
applicants are eligible for express processing of their applications, similar facility is being denied to
Indian individuals and companies, resulting in delay in awarding patent for Indian products More...
USFDA warns Sun Pharma on import ban

(Reuters , 21-May-2014 , The Times of India, Mumbai.)
Generic drugmaker Sun Pharmaceutical Industries’ response to an import ban on one of its plants lacked
“sufficient corrective actions”, the US Food and Drug Administration said in a warning letter published on
Tuesday. The FDA banned imports from Sun Pharma’s Karkhadi plant in Gujarat in March, but the
reason for the ban was not clear at that time. More...
Merck HIV Drug Strategy Seen Shielding Patent: Corporate India
(Ketaki Gokhale , 20-May-2014 , Bloomberg)
Merck & Co. (MRK) is set to sell an HIV medication in India by mid-year in partnership with local
company Cipla Ltd. (CIPLA), a strategy that may help the U.S. drugmaker protect its patent as the Asian
nation seeks cheaper generics. More...
Apple, Samsung, Google Stop Suing Each Other And Start Focusing On Patent Reform
(Cameron Fuller , 20-May-2014 , International Business Times)
With Apple, Samsung and Google calling a truce on their interlocking patent lawsuits, the money they’ll
save in legal costs and damages is now expected to go to innovation and patent reform. Good news for
consumers, bad news for patent trolls. More...
US Court Refuses to Revive Samsung Patent Case Against Apple

(Reuters , 14-May-2014 , profit.ndtv.com)
A US appeals court on Wednesday affirmed a decision by the International Trade Commission that Apple
Inc was innocent of violating three patents owned by Samsung Electronics to make its iPhones and
iPads. More...
Copyright act violated, 2 held

(Mohammed Akhef , 14-May-2014 , The Times Of India)
The crime branch of the city police on Tuesday arrested two persons under the Copyright Act for
allegedly downloading and distributing songs and movies from a mobile shop he runs. More...
Column: Get prudent with the patents law

(Pravin Anand , 13-May-2014 , The Financial Express)
To start with, India should rethink its ‘ever-greening’ argument given to justify Section 3(d) rules
More...
Defending India’s patent law

(Prabha Sridevan , 12-May-2014 , The Hindu)
No one can attack India’s well-founded Intellectual Property regime as being weak merely because a
drug that is claimed to be an invention fails the test of law More...
UK to review EU ban on Indian mangoes; IPR attorneys welcome call

(A Subramani , 11-May-2014 , The Times Of India)
Intellectual Property Rights Attorneys Association here has welcomed the British parliament's decision to
go into the controversial European Union ban on the import of mangoes from India, and go through
India's inspection process to prevent pest and insecticide presence in export materials. More...
Govt looking at incentive scheme to retain patent examiners

With the Indian Patent Office finding it difficult to retain patent examiners on Government pay-scales, a
move is underway to increase remuneration by introducing an incentive scheme. More...
Pfizer, Roche end association with US-India Business Council
(Soma Das , 9-May-2014 , The Economic Times)
Tension over intellectual property rights (IPR) between the US and India has led to cracks in the US
India Business Council (USIBC), a grouping of hundreds of companies present in both countries, to the
extent that a section of Big Pharma has chosen to end its association with the organisation seemingly in
a huff. More...
Don’t Buckle under US Pressure on IP Rights

(The New Indian Express , 8-May-2014 , The New Indian Express)
Special 301 report 2014, the US Trade Representative (USTR) has identified India as a “priority watch
country” for failure to protect intellectual property. More...
Patent institute remains non-starter after recruitment ban

(Shishir Arya , 7-May-2014 , The Times Of India)
There is jubilation over Nagpur Orange getting a geographical indication (GI) tag but a massive building
of the very department dealing in such matters, which include patents and intellectual property rights,
awaits to get a befitting status. More...
India needs to modify Intellectual Property Rights regime to attract FDI: Report
India needs to modify its Intellectual Property Rights (IPR) regime and fast-track legal system to attract
foreign investments, a report said today. More...
Cancer drug patent waiver move lifts hopes

(Shimona Kanwar , 7-May-2014 , The Times Of India)
For 60-year-old Gian Tomar, who hails from Sirmour district in Himachal Pradesh, financial crunch has
been more painful than his wife's suffering with Chronic Myelogenous Leukemia (CML), a type of blood
cancer. More...
After BMS's patent rights for Dasatinib, expensive drugs should be brought under price
control
( ET Bureau , 7-May-2014 , The Economic Times)
The health ministry has reportedly sought a waiver of drugmaker Bristol-Myers Squibb's (BMS) patent
rights for cancer drug Dasatinib, citing an emergency. More...
PDKV becomes guardian of Nagpur orange

(Shishir Arya , 07-May-2014 , The Times Of India)
As the good old Nagpuri Santra gets a special status on the basis of its geographical origin, Akola-based
Panjabrao Deshmukh Krishi Vidyapeeth (PDKV) has become the guardian of this household fruit. More...
Bayer to buy Merck arm for $14bn

(TNN , 07-May-2014 , The Times of India, Mumbai.)
Germany’s Bayer has trumped rival bidders for Merck & Co’s consumer care business in a $14.2-billion
deal, adding to a string of major cross-border deals in the healthcare industry. “This acquisition marks a
major milestone on our path towards global leadership in the attractive non-prescription medicines
business,” Bayer’s CEO Marijn Dekkers said in a statement on Tuesday. More...
India spending billions of dollars on IPR imports: ASSOCHAM

(Capital Market , 6-May-2014 , Business Standard)
India is estimated to have spent a tidy sum of over USD five billion in the fiscal 2013-14 on imports of
the intellectual property rights (IPRs) clearly negating concerns over India's IPR track record by the
countries like the US which has been threatening trade sanctions against New Delhi by putting it under
the Priority Watch List under an American trade law, an ASSOCHAM paper on IPR Imports has pointed
out. More...
US faces pressure to take India to WTO

(Sidhartha , 6-May-2014 , The Times Of India)
The US government is coming under intense pressure from lawmakers to act against India at the World
Trade Organization (WTO) for what they say are violations of patent rules. More...
Intellectual Property Rights Attorneys Association petitions British envoy over mango ban
With the British Parliament scheduled to debate EU ban on mango imports from India on May 8, the city-
based Intellectual Property Rights Attorneys Association (IPRAA) has written to the British high
Commissioner in India seeking UK's intervention in the matter. More...
Apple-Samsung jury leaves $120 million patent verdict intact

(Joel Rosenblatt , 6-May-2014 , Livemint)
The jury recalculated damages and arrived at the same grand total as three days ago More...
Government mulls cancer drug patent waiver for Dasatinib

(Sidhartha , 05-May-2014 , The Economic Times)
The health ministry has reopened the issue of waiving a global drug giant's patent rights for Dasatinib, a
cancer drug, arguing the move is needed to deal with an "emergency". More...
S wants more transparency on inter-ministerial panel on compulsory license issue

(Joseph Alexander, New Delhi , 05-May-2014 , Pharmabiz)
While keeping India in its `priority watch list’ as in the previous years, the US Trade Representative
(USTR) 2014 “Special 301 Report’ has called for greater transparency about the ongoing inter-ministerial
process that is considering over a dozen patented medicines as candidates for government- initiated
compulsory licenses. More...
Apple vs Samsung: Patents at dispute

(AP , 05-May-2014 , The Times Of India)
Apple and Samsung are suing each other in courts and trade offices around the world, each making
claims that the other copied patented mobile device features. More...
Govt mulls cancer drug patent waiver
The health ministry has reopened the issue of waiving a global drug giant's patent rights for Dasatinib, a
cancer drug, arguing the move is needed to deal with an "emergency". More...
US expects its restraint on IPR to pay off after polls

(Shastri Ramachandaran , 5-May-2014 , DNA)
The Obama administration wants American big business, especially Big Pharma, to pause before reviving
the push to prise open the Indian market. More...
India Shaken But Not Stirred by US Concerns About Patent Laws

(Sunitha Natti , 04-May-2014 , The New Indian Express)
India had a few anxious moments on April 26, when countries and companies globally observed World
Intellectual Property Day. More...
Amarin Pharma files patent infringement case against Dr Reddy's Laboratories on lipid
lowering drug, Vascepa
Dublin-based Amarin Pharma has filed a patent infringement case against Dr Reddy's Laboratories
alleging that the latter is attempting to come out with generic versions of its patented drug Vascepa.
More...
Make essential drugs affordable for all: Cipla

(PTI , 04-May-2014 , ZeeBiz)
Amid US firms' allegations of patent norm violations against Indian pharma companies, leading domestic
drug maker Cipla has said that "essential" medicines be made available to people at affordable rates and
should not be sold under "monopoly". More...
Cipla for Making Essential Drugs Affordable for All

(Press Trust of India , 4-May-2014 , profit.ndtv.com)
Amid American firms' allegations of patent norm violations against Indian pharmaceutical companies,
domestic drug maker Cipla has said that "essential" medicines should be made available to people at
affordable rates and not be sold under "monopoly". More...
Amarin files patent case against DRL on lipid lowering drug

(Press Trust of India | Hyderabad , 04-May-2014 , Business Standard)
Amarin alleges Abbreviated New Drug Application seeking to market generic version would infringe
patent of Vascepa on 16 counts More...
Drug MNCs stall generics with RTI

(Rupali Mukherjee , 03-May-2014 , The Times Of India)
A huge spurt in infringement suits (stay orders) recently against domestic drug companies highlight that
multinational firms are increasingly using the right to information (RTI) route to enforce intellectual
property and block entry of affordable generics. More...
Patent trial: US jury orders smartphone maker Samsung to pay Apple $119.6 mn
( Reuters , 3-May-2014 , The Economic Times)
A US jury on Friday ordered Samsung Electronics Co Ltd to pay $119.6 million to Apple Inc, a big loss
for the iPhone maker in the latest round of their globe-spanning mobile patent litigation. More...
US jury says Samsung, Apple both infringed patents

A US jury on Friday ordered Samsung Electronics Co Ltd to pay $119.6 million to Apple Inc, a big loss
for the iPhone maker in the latest round of their globe-spanning mobile patent litigation. More...
USTR report: Global drug makers, patient groups lock horns over Indian pharma IPR
(C.H. Unnikrishnan , 2-May-2014 , Livemint)
Report retains India on its ‘priority watch’ list of countries that are alleged violators of US patent laws.
More...
Patent relief
(Summary , 2-May-2014 , The Indian Express)
India escapes being downgraded by the US for IP violations, with a compelling self-defence. More...
Commerce secy raps US step on IPR issue

(Nayanima Basu , 2-May-2014 , Business Standard)
The Union commerce secretary has rapped the US Trade Representative’s (USTR’s) decision to retain
India on that country’s “Priority Watch” (PW) list for various perceived deficiencies in India’s intellectual
property rights (IPR) rules. More...
Column: The US IPR hypocrisy

(Biswajit Dhar , 02-May-2014 , The Financial Express)
The USTR Special 301 report on IP violations singles out India for naming and shaming More...
India won't participate in unilateral US probe on IPR

India today made it clear it will not take part in any unilateral investigation by the US on its intellectual
property rights (IPR). More...
India dodges bullet from Big Pharma in patent war

(Chidanand Rajghatta , 01-May-2014 , The Times Of India)
The Obama administration has resisted pressure from the American domestic business lobby, notably
Big Pharma, and avoided escalating a simmering trade dispute with New Delhi. More...
India invites U.S. to discuss IP, market access after polls

(Manoj Kumar, NEW DELHI , 01-May-2014 , Reuters)
India said on Thursday it would hold trade talks on intellectual property rights with the United States
after its general election, buying time to address friction over drug patents until a new government is
formed. More...
India invites US to discuss IPR

(Reuters , 1-May-2014 , The Financial Express)
US wants access to the Indian market for its own firms. More...
US-India business lobby for dialogue on IPR issues

( IANS , 01-May-2014 , The Economic Times)
As the US retained India on its Priority Watch List of ten countries with "growing concerns" about
protection of Intellectual Property Rights (IPR), a US-India business advocacy group called for a dialogue
on the issue. More...
Apple Inc. vs Samsung Electronics patent case: Jurors end day without verdict
(Associated Press | San Jose , 01-May-2014 , The Indian Express)
California jurors failed to decide a patent-infringement case involving the world's two biggest
smartphone makers. More...
India defends IPR laws, won't take part in unilateral US probe

(PTI , 01-May-2014 , ZeeBiz)
Stressing that its IPR regime complies with international laws, India on Thursday bluntly said it will not
take part in any unilateral investigation by the US on its intellectual property rights. More...
Intellectual Property Right experts flay EU ban on Indian mangoes

(A Subramani , 30-Apr-2014 , The Times Of India)
While the European Union's ban on Indian mangoes, including the famed Alphonso varieties, set to take
effect on May 1, intellectual property right (IPR) attorneys in the country are citing provisions of Free
Trade Agreements (FTAs) between EU and India and saying the former should have resolved the issue
under the WTO instead of imposing unilateral ban. More...
No downgrade but India still on US priority watch list on intellectual property rights
US trade representative says it will try to resolve ongoing concerns through bilateral engagement
More...
U.S. resists pressure to give India worst offender rating in IP review

(Krista Hughes , 30-Apr-2014 , Reuters)
The United States has resisted lobbying by U.S. drug and pharmaceutical companies to take tougher
trade action against India for its intellectual property policies, deciding against risking ties with a likely
new government in New Delhi. More...
India not in the worst IPR classification of US

(PTI , 30-Apr-2014 , Zee News)
The US on Wednesday kept India out of Priority Foreign Country list, a worst classification, and said it
will hold discussions with the next government in New Delhi on enforcement and protection of
intellectual property rights. More...
Respect for intellectual property rights leads to innovation, investment

(Aesha Datta , 30-Apr-2014 , Business Line)
Need to see how India can improve its IP system: US trade chamber official More...
Pfizer isolated in campaign against Indian patent regime, say Indian pharma alliance
(Soma Das , 30-Apr-2014 , The Economic Times)
A grouping of top domestic drugmakers, Indian Pharma Alliance, has told the government that global
pharma giant 'Pfizer Inc is getting isolated in its campaign' to push the US to 'downgrade India' to a
'priority foreign country' in a review of its intellectual property (IP) regime. More...
Europe warns Google, Samsung on phone patent abuse

(AP , 29-Apr-2014 , The Economic Times)
The European Commission moved on Tuesday to stem aggressive patent lawsuits by smartphone and
tablet makers against rivals, ruling that Motorola Mobility had broken EU law by taking such action
against Apple. More...
Novartis files injunctions against 4 cos

(Times News Ntework , 29-Apr-2014 , The Times of India, Mumbai.)
Drug MNCs are aggressively guarding their home turf and taking measures to safeguard against
competition. Novartis has filed injunctions in the Delhi high court against four generic companies
including Glenmark Generics, Cadila Healthcare, Alembic Pharma and Bajaj Healthcare, preventing them
from launching generic versions of its blockbuster anti-diabetic drug Galvus (Vildagliptin). More...
AstraZeneca rejects Pfizer’s 2nd $100bn offer

(Reuters , 29-Apr-2014 , The Times of India, Mumbai.)
US drugmaker Pfizer is working on its next move in a potential $100 billion battle for Britain’s
AstraZeneca after having two bids rejected, as deal-making grips the healthcare industry. Pfizer said on
Monday it made a 59-billion pounds ($99 billion) bid for AstraZeneca in January and had contacted its
British rival again on April 26 seeking further discussions about a takeover. More...
There is a rush for patents

(Madhumathi D. S. , 29-Apr-2014 , The Hindu)
Karnataka working on a new intellectual property policy More...
Alibaba on Patent-Buying Spree May Avoid Tech IPO Pitfall

(Susan Decker , 29-Apr-2014 , Bloomberg)
Alibaba Group Holding Ltd. is beefing up its patent holdings in the U.S., a move that may help avoid the
pitfalls that bedeviled Google Inc., Facebook Inc. and Twitter Inc. ahead of their initial public offerings.
More...
Apple, Samsung set for closing arguments in patent trial
(AP , 28-Apr-2014 , The Times Of India)
The high-stakes battle between the world's largest smartphone makers is scheduled to wrap up this
week after a month-long trial that has pulled the curtain back on just how very cutthroat the
competition is between Apple and Samsung. More...
Aurobindo Pharma in patent litigation cases in US

(PTI , 28-Apr-2014 , Livemint)
Three multinational drug makers take Aurobindo to court in separate cases More...
Apple patents technology to prevent texting and driving

(Agencies , 28-Apr-2014 , The Times Of India)
American tech giant Apple has filed a patent application for a system that aims to make texting at the
wheel impossible by blocking drivers from sending messages from cellphones. More...
HC asks Centre to reply on appointments in patents panel IPAB

The Delhi High Court on Monday sought a response from the Centre on a plea seeking quashing of
certain provisions that lay down criteria for appointment of Vice Chairman and the judicial member of
the patents' panel. More...
Govt Urged to Encourage Patents

( Express News Service - CHENNAI , 28-Apr-2014 , The New Indian Express)
Intellectual Property Rights (IPR) is the next milestone in services sector revolution that’s being
engineered by the middle class, said P Vanangamudi, Vice-Chancellor, Tamil Nadu Dr Ambedkar Law
University. More...
Apple patent lawsuit against Google revived by US appeals court

(Reuters , 28-Apr-2014 , NDTV)
A U.S. appeals court on Friday revived patent claims Apple made against Google subsidiary Motorola
Mobility that were dismissed by an Illinois court shortly before trial. More...
India strikes a balance on IPR regime

(Sudipto Dey | New Delhi , 27-Apr-2014 , Business Standard)
As India awaits the outcome of Special 301 report brought out by the office of the US Trade
Representative, an annual survey of countries with lax intellectual property rights regime, the
administration is getting ready to set its own IPR house in order. More...
New Apple patent seeks to prevent drivers from texting

American tech giant Apple has filed a patent application for a system that aims to make texting at the
wheel impossible by blocking drivers from sending messages on cell phones. More...
Step up patent awareness drive
(Our Bureau , 27-Apr-2014 , Business Line)
There is an urgent need to create IP awareness to augment domestic filing of IP applications, said
Amitabh Kant, Secretary, Department of Industrial Policy and Promotion, Ministry of Commerce and
Industry. More...
American drug major Abbott backs India’s drug patent regime

(Sidhartha , 26-Apr-2014 , The Times Of India)
The government has received support from an unexpected quarter in its battle against the US on the
intellectual property (IP) regime. More...
Ballot Petty' and 'Netamaker' Slug It out over IP Rights

(Nidheesh M K - KOCHI , 26-Apr-2014 , The New Indian Express)
It’s raining apps in Kerala as many companies in the state, both big and small, have developed
applications in Android and other platforms; so do controversies. More...
Geological Indications tag for Nagpur orange, Kannauj perfume

Intellectual Property Right (IPR) Day is observed on April 26. But the celebrations seem to have reached
India a day early. More...
U.S. envoy calls on India to engage in discussions regarding intellectual property rights
(ANI | New Delhi , 26-Apr-2014 , Business Standard)
U.S. Ambassador to India, Nancy Powell, has asked India to engage in discussions related to Intellectual
Property Rights (IPR). More...
Innovation that includes

(Shamnad Basheer , 26-Apr-2014 , The Indian Express)
The pharmaceutical industry needs to shed its archaic blockbuster model. More...
India's pharma export growth hits a 15-year low as US holds on to import curbs
(25-Apr-2014 , domian-b.com)
Hit hard by the continuing row over intellectual property rights related to generic equivalents of some
patented medicines and regulatory concerns in the West over the quality of India-made drugs,
pharmaceutical exports from the country registered the slowest growth in at least 15 years of 1.2 per
cent to $14.84 billion last fiscal. More...
India: Robin Hood of the pharma world

(Feroz Ali Khader , 25-Apr-2014 , Business Line)
India’s pro-consumer patent regime is an exciting alternative to the dominant IP model pushed by the
US More...
US envoy raises IPR, taxation issues with India
US had been extremely critical of some of India's trade and industrial policies. More...
Nude patent heels must-have fashion!

(IANS , 25-Apr-2014 , The Times of India)
Nude court shoes are storming up the fashion charts - thanks to the Duchess of Cambridge, who has
made them a must-follow trend. More...
U.S. appeals court revives an Apple patent lawsuit against Google

(Diane Bartz and Dan Levine , 25-Apr-2014 , Reuters)
A U.S. appeals court on Friday revived patent claims Apple made against Google subsidiary Motorola
Mobility that were dismissed by an Illinois court shortly before trial. More...
Not facing any significant IPR challenges in India: Abbott

(Press Trust of India | Washington , 25-Apr-2014 , Business Standard)
They added that India was an investment priority and fundamentally important to the future of the
company. More...
United States’ 1999 assurance to WTO may help India’s IPR case
(Dilasha Seth & Soma Das , 25-Apr-2014 , The Economic Times)
An undertaking given by the United States to a WTO dispute settlement panel on unilateral trade action
in 1999 may prove to be an important ammunition in New Delhi's hands if the Obama administration
takes action against India on its intellectual property regime. More...
Pfizer complains about India’s intellectual property regime again

(Soma Das , 24-Apr-2014 , The Economic Times.)
In a letter to Jaishankar, India's Ambassador to the US a copy of which was seen by ET, Pfizer's senior
vice-president for global policy and international public affairs, Justin McCarthy, has said that "a series of
regulatory initiatives and legal challenges have frayed relations between the Indian government and
global pharmaceutical firms", and urged the government to "shift from using destructive IP policy as an
access strategy" More...
Ericsson takes Intex to court over patent infringement

(Staff Reporter , 24-Apr-2014 , The Hindu)
The Swedish-based company moved the Delhi High Court last week, saying that it was taking legal
action after failing to negotiate a licence agreement with Intex for "products compliant with GSM, EDGE,
and UMTS/WCDMA standards. More...
Abbott wins patent battle against Glenmark

(BS Reporter , 23-Apr-2014 , Business Standard)
US-based Abbott Labs has won a patent battle against Glenmark Pharmaceuticals related to generic
launch of Abbott's version of anti-hypertension drug, Tarka ((trandolapril/verapamil hydrochloride).
More...
India businesses unlikely to be affected immediately

(HT Correspondent , 23-Apr-2014 , Hindustan Times )
While Novartis AG, GlaxoSmithKline and Eli Lilly are unclear about the long-term impact of deal on their
India businesses, there is unlikely to be any direct or immediate impact. More...
Glenmark Pharma drops after losing appeal to invalidate Abbott's TARKA patent
(Capital Market , 22-Apr-2014 , Business Standard)
Key benchmark indices trimmed intraday gains in early afternoon trade. More...
Samsung files 'patent-infringement' suit against Apple

(ANI , 22-Apr-2014 , Zee News)
Samsung has filed a 'patent- infringement' case against Apple saying that the American multinational
infringed the '239 patent in its iPhone through the use of FaceTime. More...
Govt prepares to battle US pressure on patents

Top officials meet amid apprehension of sanctions under US law; decide to take Washington to the World
Trade Organization if such action taken. More...
Glenmark loses patent case to Abbott; stock plunges

(R. Yegya Narayanan , 22-Apr-2014 , Business Line)
Shares of Glenmark Pharmaceuticals were down by Rs 17.45 on the BSE after the company said it has
lost its appeal to invalidate Abbott Laboratories' Tarka (trandolapril/verapamil hydrochloride) patent in a
US court. More...
Boost for Natco Pharma as Teva denied stay in Copaxone patent fight
(Lawrence Hurley , 21-Apr-2014 , Livemint)
US Supreme Court denies Teva’s request to stay ruling that favours developers of generic versions of
Copaxone. More...
We need to open up defence 100 pc to FDI: Amitabh Kant, DIPP secretary

Compulsory licensing has been over talked about. More...
India-US ties headed for rough weather over drug IP issue

(Amiti Sen , 20-Apr-2014 , Business Line)
Facing the threat of sanctions by the US for what it terms India’s lax intellectual property (IP) rules, the
Commerce Ministry is studying the possible impact on trade with the US if Washington goes ahead with
its action. More...
Patent rights meet on US concerns
(BS Reporter | New Delhi , 19-Apr-2014 , Business Standard)
Cabinet Secretary Ajit Seth will on Monday meet officials from various ministries to discuss concerns
raised by the US on India’s management of intellectual property rights (IPRs), it is learnt. More...
On Mobile settles patent infringement dispute with US firm

Mobile VAS company OnMobile has settled a patent infringement case with US-based Synchronoss
Technologies for $ 3 million or about Rs 18 crore. More...
Committee of secretaries to take up Indo-US IPR issues

(fe Bureau | New Delh , 19-Apr-2014 , The Financial Express)
A committee of secretaries, led by cabinet secretary Ajit Seth, will meet next week to discuss the issues
related to India’s intellectual property rights and the concerns raised by the US on the same. More...
Insecticides (India) gets patent for insecticide preparation process

Agrochemical firm Insecticides (India) Ltd has been granted a patent for the preparation process of a
chemical compound to control pests. More...
Apple-backed patent group Rockstar loses bid to move Google case

A US judge on Thursday rejected a request by patent consortium Rockstar to transfer patent litigation
from Google's home turf in California to Texas, according to a court ruling. More...
‘Patent laws for IT sector needs clarity’

The need for clearer regulations with regard to patents for computer-related inventions was underlined
by experts at the two-day executive programme on Strategic Intellectual Property Management for
Electronics and IT Sector, which began here today. More...
Cadila, Depomed Inc settle patent dispute

(BS Reporter | Ahmedabad , 15-Apr-2014 , Business Standard)
The settlement permits Cadila and Zydus to begin selling generic versions of Gralise More...
NSE alleges software trademark violation; sues domain registrar

( Khushboo Narayan | Malvika Joshi , 15-Apr-2014 , Livemint)
The firm drags GoDaddy and a Hyderabad-based tech firm to court over alleged copyright and
trademark infringement of its software. More...
Indian laws should not be considered discriminatory: Group

(Press Trust of India | Washington , 15-Apr-2014 , Business Standard)
Asserting that Indian patent and pharma laws falls within the bounds of what is allowed under the rules
of the World Trade Organization, a top American non-profit consumer rights advocacy group has said
Indian pharma laws should not be considered discriminatory. More...
Novartis Sues Dr Reddy's Labs Over Patent Infringement

(ENS Economic Bureau - HYDERABAD , 15-Apr-2014 , The New Indian Express)
Novartis Pharmaceuticals Corporation moved the District Court of Delaware, US against city-based Dr
Reddy’s Laboratories Ltd (DRL) for alleged infringement of its patents. More...
Cadila, Depomed settle US patent dispute on neuro pain drug Gralise

(C.H. Unnikrishnan , 15-Apr-2014 , Livemint)
Cadila can now launch its generic version of Gralise in the US soon after the expiry of Depomed’s
original patent. More...
Indian patent and pharma laws should not be considered discriminatory: Public Citizen
Asserting that Indian patent and pharma laws falls within the bounds of what is allowed under the rules
of the World Trade Organization, a top American non-profit consumer rights advocacy group has said
Indian pharma laws should not be considered discriminatory. More...
Are intellectual property and patent laws hampering innovation, research and development?
(Ruchi Kumar , 14-Apr-2014 , DNA)
With over 200,000 filings, 2013 saw the highest intellectual property applications, says UN report.
More...
FICCI discusses IPR issue with US delegation

(PTI , 14-Apr-2014 , Buisness Line)
Industry body FICCI today raised the issue of US proposal to declare India as a ‘Priority Foreign Country
for IPR violations with a visiting delegation of American companies. More...
Are intellectual property and patent laws hampering innovation, research and development?
(Ruchi Kumar , 14-Apr-2014 , DNA)
With over 200,000 filings, 2013 saw the highest intellectual property applications, says UN report.
More...
Natco moves to oppose Gilead hepatitis C drug patent

(Ramnath Subbu , 12-Apr-2014 , The Hindu)
Under India’s patent laws, a third party can dispute the validity of a pending patent application. More...
Experts highlight importance of intellectual property rights

Protecting intellectual property right is very important. More...
Natco seeks to block Gilead’s drug

(REUTERS , 11-Apr-2014 , The Times of India, Mumbai.)
Natco Pharma has formally asked the Indian patent office to deny US drug maker Gilead Sciences’ new
Hepatitis C drug Sovaldi a patent in India, a source with direct knowledge of the matter said. If
successful, the move could clear the way for the Indian company to launch a cheap generic version of
the drug. More...
Sun Pharma Refutes Allegations of Insider Trading Ahead of Ranbaxy Acquisition

(Our Bureau, Mumbai. , 10-Apr-2014 , The Economic Times.)
Sun Pharma on Wednesday refuted allegations of insider trading by Sudhir Valia, the executive director
and brother-in-law of managing director Dilip Shanghvi, in the run-up to the Ranbaxy deal. More...
SAIL encashes bank guarantees of re-rollers misusing its trademark

(ENS Economic Bureau | New Delhi , 10-Apr-2014 , The Financial Express)
Over more than a year, SAIL has been receiving tip-offs that spurious steel products bearing its
trademark have flooded marketsmarkets across the country. More...
Natco seeks to block Gilead's hepatitis C drug patent in India - source

(Zeba Siddiqui , 10-Apr-2014 , Reuters)
India's Natco Pharma Ltd (NATP.NS) has formally asked the Indian patent office to deny U.S. drugmaker
Gilead Sciences Inc's (GILD.O) new hepatitis C drug Sovaldi a patent in India, a source with direct
knowledge of the matter said. More...
SUN-RANBAXY DEAL: Pharma MNCs May Need New Prescription for Growth Here
(Divya Rajagopal , 10-Apr-2014 , The Economic Times.)
Sun Pharmaceutical’s acquisition of Ranbaxy Laboratories, the largest consolidation move in the Indian
market, may force multinational pharmaceutical companies to change their strategy considering that the
combined entity will become the country’s largest drug maker and the fifth-largest generic company in
the world. It will command a turnover of $4 billion globally, while in India it will have estimated sales of .
6,921 crore More...
ONE-ON-ONE Israel Makov | CHAIRMAN, SUN PHARMA

(Rupali Mukherjee TNN , 10-Apr-2014 , The Times of India, Mumbai.)
Admitting there are “challenges” in every acquisition, and even in this one, Sun Pharma chairman Israel
Makov expressed confidence in handling them, including the sticky FDA issue which has been plaguing
Ranbaxy over the past six years. In an interview with TOI, he said the company will reconsider whether
it wants to use the Ranbaxy brand in the US — its largest and most lucrative market, and where it has
faced a huge distrust. On the manpower front, he said the plan is to keep everyone who is good.
Excerpts… More...
D-St questions Ranbaxy spike

(Times News Ntework , 10-Apr-2014 , The Times of India, Mumbai.)
The 33% rise in Ranbaxy’s stock in just six days prior to the announcement of its merger with Sun
Pharma has come under public scrutiny, raising pressure on market regulator Sebi to dig deeper into the
trading patterns in the counter for any possible violations of securities laws. More...
Samsung should pay over $2 bln for patent infringement: Apple

(ANI | Washington , 09-Apr-2014 , Business Standard)
The figure comes from evaluating the scale of infringement, time span and the head-to-head rivalry
between Apple and Samsung More...
Rovi loses patent fight with Amazon

Rovi has lost a patent fight with Amazon.com when a federal appeals court upheld a US district judge's
ruling in favour of the world's largest online retailer. More...
Popular Ghee Brand Loses Trademark

(Express News Service - CHENNAI , 09-Apr-2014 , The New Indian Express)
The Intellectual Property Appellate Board cancelled the trademarks ‘Udhayam’ and ‘GRB’s Udhayam’ of a
popular ghee brand in the southern States in an order passed by the board on Friday. More...
Court relief on NTT Docomo’s patent plea for network tech

In a major relief to Japan-based telecommunication major NTT Docomo More...
BlackBerry wins patent lawsuit against NXP in the US

A federal jury in Florida on Monday ruled in favor of Blackberry Ltd in a lawsuit accusing the company of
infringing three patents belonging to Dutch semiconductor company NXP BV. More...
Teva's patent plea rejected in US: Natco

Hyderabad-based Natco Pharma said on Friday in a BSE filing that the US Patent and Trademark Office
has issued a final office action rejecting Israel-based Teva Pharma's application on its blockbuster drug
Copaxone. More...
US Patents rejects Teva's plea on Copaxone; Natco shares up

(ET Bureau. , 5-Apr-2014 , The Economic Times)
The US Patent and Trademark Office has rejected the application of Israel's Teva Pharmaceutical seeking
re-issue of patent for its blockbuster multiple sclerosis drug Copaxone. More...
Apple loses bid to show patent use in trial

(Bloomberg | San Jose/ California , 5-Apr-2014 , Business Standard)
Apple Inc, accusing Samsung Electronics Co of misleading jurors at the start of a $2-billion trial over
smartphone technology, lost its bid to show jurors how it uses three of five patents disputed in the case.
More...
Poll fever cure: Ragaflam, Namo tablets fly off pharmacy shelves
(Rahul Anand TNN , 5-Apr-2014 , The Times of India, Mumbai.)
As election fever grips the country, Namo and Ragaflam tablets, named after BJP’s Narendra Modi and
Congress’s Rahul Gandhi, are flying off pharmacy shelves. Neither Modi nor Rahul may have all the
answers to what ails the nation, but generic drugs named after them are certainly getting people’s
votes. More...
Biocon rejects Novartis patent accusations

(AFP , 04-Apr-2014 , Livemint)
Biocon has a reputation for respecting all valid intellectual property and intends to operate within the
applicable laws, the firm said More...
Novartis sues Biocon for patent breach

(BS Reporter | Zurich , 4-Apr-2014 , Business Standard)
According to industry estimates, Galvus, one of the best-selling medicines of Novartis, clocks Rs 200
crore of sales annually More...
Samsung: Patents Developed by Google Engineers

(AP , 03-Apr-2014 , The New Indian Express)
Samsung fired back at Apple's accusations of patent theft Tuesday, saying the South Korean tech giant
didn't write any of the Android software on its smartphones and tablets, Google did. More...
IPAB defers hearing on trademark dispute between Diageo, Khoday

Dispute is on Khoday Brewing's registration of 'Black Label' for beer More...
Lupin Approaches Cabinet Secy to Push FII Cap Proposal

(Deepshikha Sikarwar & Soma Das, New Delhi. , 3-Apr-2014 , The Economic Times.)
Lupin has approached the nation’s senior most bureaucrat, seeking his intervention to secure approval
to increase foreign institutional investor (FII) holding in the pharmaceutical major to 49% from 33%,
according to a person with knowledge of the matter. More...
Torn Records Led to Sun Plant’s Ban

(Soma Das, New Delhi , 3-Apr-2014 , The Economic Times.)
Torn documents, partially destroyed raw data showing undesirable results and unclean toilets were
among the reasons cited by the US drug regulator for the ban it imposed last month on a Gujarat based
facility of Sun Pharma, the largest Indian drugmaker by market capitalisation. More...
PE ChrysCap invests $40m in Torrent Pharma

(Rupali Mukherjee TNN , 3-Apr-2014 , The Times of India, Mumbai.)
Private equity firm ChrysCapital has invested around $40 million in drug company Torrent Pharma,
expanding its portfolio of healthcare companies and taking up the total exposure in the sector to nearly
$300 million. ChrysCapital, which has over $2.5 billion assets under management in India, will hold the
largest non-promoter stake — of around 3% — in the drug firm, sources close to the development told
TOI. More...
Novartis sues Biocon for patent infringement on Galvus

( Archana Shukla, CNBC-TV18 , 03-Apr-2014 , MoneyControl)
In yet another patent infringement battles in India, Swiss drug maker Novartis has taken Indian biotech
firm Biocon to court on anti-diabetes drug. More...
Compulsory licence for another cancer drug?

(Amiti Sen , 2-Apr-2014 , Business Line)
DIPP wants to know why generic version of Bristol-Myers Squibb’s drug is needed More...
Samsung puts 'blame' on Google in Apple patent trial

Samsung fired back at Apple's accusations of patent theft, saying the South Korean tech giant didn't
write any of the Android software on its smartphones and tablets, Google did. More...
GI tags stopped as poll code is in force

The tags help identify goods — originating from a definite territory — with special characteristics More...
Chipmaker Marvell fined $1.54 billion over patent violation

A federal judge ordered Marvell Technology to pay nearly $1.54 billion to Carnegie Mellon University for
selling billions of semi-conductors that infringed the school's two hard disk drive patents. More...
Natco Pharma, Teva Patent Row Now in US Court

(ENS Economic Bureau - HYDERABAD , 2-Apr-2014 , The New Indian Express)
Natco Pharma Ltd’s plan to sell multiple sclerosis drug Copaxone is likely to be further delayed with the
patent battle between Natco and the innovator company Teva Pharmaceutical Industries Ltd among
others, entering a new phase. More...
Apple and Samsung trade barbs as new patent trial opens

(AFP , 2-Apr-2014 , The Economic Times)
Lawyers for Apple and Samsung exchanged barbs as a major new patent trial opened Tuesday, and
debated the role of a company not even part of the case. Google. More...
Copyright Suit Against Bieber, Usher Dismissed

(AP - NORFOLK, VIRGINIA , 01-Apr-2014 , The New Indian Express)
A judge has dismissed a $10 million lawsuit that claimed Justin Bieber and Usher copied parts of a song
written by two Virginia songwriters. More...
Intellectual property office mops up 282cr despite staff crunch
Despite battling severe staff crunch and requiring critical infrastructure, the intellectual property office
has mopped up more than Rs 282 crore in revenue for 2012-13. More...
US Supreme Court to scrutinise eligibility of software for patent protection

The U.S. Supreme Court will on Monday delve into the hotly contested question of when software is
eligible for patent protection. More...
Patent trolls target US businesses, consumers ultimately foot the bill

( Heesun Wee , 31-Mar-2014 , CNBC)
Patent asserting groups that bully businesses and entrepreneurs into paying licensing fees or
settlements—as opposed to actually using the patents—are not new, especially in the technology space.
More...
In trademark battle, TN co beats US clothing giant

In another example of David trouncing Goliath, an Erode-based hosiery manufacturer has humbled a US
clothing giant by staving off a trademark infringement suit. More...
First Case: Ed Seizes Assets for Faking SAIL Trademark

(PTI - NEW DELHI , 28-Mar-2014 , The New Indian Express)
In the first case of money laundering charges being slapped for violation of the Trade Marks Act in the
country, the Enforcement Directorate has seized Rs 7 crore assets of two Chhattisgarh based firms for
allegedly fake branding of public sector SAIL. More...
Corning joins growing US firms doing business in India

(Yashwant Raj , 28-Mar-2014 , Hindustan Times)
They had heard harrowing stories about infrastructure, bad patent laws. More...
Cisco sued by Spherix for patent infringement

Spherix Inc, which buys and licenses technology patents, said it filed a lawsuit against Cisco Inc alleging
infringement of 11 patents Spherix acquired from Nortel Networks. More...
New-age zamindars
(Bhupesh Bhandari | New Delhi , 27-Mar-2014 , Business Standard)
Thanks to the regime of product patents India inherited, home-grown companies like Cipla found their
attempts to make medicines blocked by multinationals. More...
Cheaper Versions of Cancer Drug Dasatinib Will Have to Wait
(Dilasha Seth & Soma Das, New Delhi , 27-Mar-2014 , The Economic Times.)
The department of industrial policy and promotion (DIPP) has shot down a health ministry proposal to
consider a government-initiated compulsory licence (CL) for cancer drug Dasatinib on the ground that it
is unaffordable. This comes at a time when the US is reviewing India’s intellectual property regime that,
in the worst case, could lead to trade sanctions. More...
Patent opportunis
(Feroz Ali Khader , 27-Mar-2014 , The Indian Express)
India’s trailblazing balance of patent law and necessary access falls foul of an IP index released by US
companies. More...
Apple wins patent ruling against Samsung in Japan

(ANI , 26-Mar-2014 , The Times Of India)
Apple has won another legal bout against Samsung in its ongoing patent row. More...
IPAB stays revocation of Pfizer's patent on drug Detrol

Justice K N Basha says that Ranbaxy had enough time to appear and argue the matter of stay petition
More...
Patent seal on device to check vehicle pollution

(Abhijeet Patil , 26-Mar-2014 , The Times Of India)
A motor mechanic from Tardel, a non-descript village around 30km from Kolhapur, has earned the
patent for a device developed by him, which he claims can bring down fuel consumption in both two-
and four-wheelers. More...
Apple wins another legal bout against Samsung in patent row

(ANI | Washington , 26-Mar-2014 , Business Standard)
Samsung said it will analyze the decision and possibly appeal it More...
Indian generic drug firms court US off-patent market

(Pallavi Ail , 25-Mar-2014 , Financial Express)
With $32 billion worth of drugs going off patent in the next two years. More...
Plea against Gilead's patent bid

A patient group and a UK-based intellectual property law firm have together filed a patent opposition
before the Delhi Patent Office to prevent US-based pharma company Gilead from gaining protection on a
life-saving hepatitis-C drug in India. More...
IPAB to take up Wockhardt plea against Novartis

The Intellectual Property Appellate Board (IPAB) has decided to proceed with the hearing of a revocation
petition by Wockhardt against the patent of a diabetes drug of Swiss pharma major Novartis, even as a
dispute between the parties on an alleged infringement of patent of the same product is pending with
the Delhi High Court. More...
Delay in Microsoft deal may lead to more Nokia patent concessions

Nokia does not expect to close the sale of its phone business to Microsoft until April as talks with Asian
regulators drag on, it said on Monday, fuelling speculation it may have to make technology patent
concessions to get the deal done. More...
Friction over drug patents

(24-Mar-2014 , The Hindu)
Differences over intellectual property rights (IPRs) have emerged as a strong undercurrent in India’s
economic relations with the U.S. More...
India ready to discuss intellectual property rights norms at WTO if US wants: Anand Sharma
Rejecting US allegations related to intellectual property rights (IPR), India said that it is ready to discuss
the matter at WTO as it has not breached any international agreement. More...
Changes to India's patent law will impact prices of life-saving drugs

India's trade and investment policies, particularly balancing right to health with intellectual property and
public health safeguards, are being questioned in a US investigation. More...
Indian pharma sector still attractive for foreign investors

(C.H. Unnikrishnan , 23-Mar-2014 , Livemint)
Section 3(d) of India’s patent law that denies patent protection for modified forms of already known
drugs, unless they are proved to result in higher therapeutic benefits, has irked many foreign drug
makers. More...
IPAB to take up Wockhardt plea against Novartis

A patent infringement case between the two over a diabetes drug is pending with the Delhi HC. More...
Health organisations demand affordable access to oral HCV drugs; oppose patent on new
hepatitis C drug
(Our Bureau , 22-Mar-2014 , Pharmabiz)
With the availability of oral drugs promising to simplify and improve hepatitis C treatment in India, the
Delhi Network of Positive People wants the ministry of health to start rolling out treatment with the
same, for the millions of patients waiting. More...
Apple's new patent hints at stylus for iPad
(Techradar , 21-Mar-2014 , The Times Of India)
Apple's latest patent is titled simply "Input Device Having Extendable Nib," but don't let that fool you;
this may be the long-awaited iStylus. More...
Pharma firm gets FDA notice

(Maitri Porecha , 21-Mar-2014 , DNA)
Drug authority issues notices to Wockhardt’s three plants in Aurangabad and seeks explanation on poor
compliance with good manufacturing practices. More...
Quality Woes Point to a Generic Drugs Shake-out: Novartis CEO

(Ben Hirschler & Caroline Copley, Basel, Switzerland. , 21-Mar-2014 , The Economic Times.)
Recent manufacturing problems in India suggest some makers of generic drugs will struggle to compete
in the face of a rising quality bar, pointing to a likely shake-out in the low-cost sector, according to
Novartis. Chief executive Joe Jimenez said the Swiss group’s Sandoz unit — a world leader in making
cheap off-patent medicines — was well placed to thrive in an era of tougher standards. More...
Indian Data Comes in Handy for US Tirade against Sub-standard Drugs

(Our Bureau, New Delhi , 20-Mar-2014 , The Economic Times.)
About 2.3% of drugs tested by the Drug Controller General of India (DCGI) since December 2012 were
found to be sub-standard. As many as 1,123 samples were tested of which 26 failed to qualify,
according to a surveillance report prepared by the central drug regulator early this month. More...
Merck HIV drug strategy in India seen shielding patent

(Ketaki Gokhale , 20-Mar-2014 , Livemint)
Merck is set to sell an HIV medication in India by mid-year in partnership with local company Cipla
More...
US leads the world in use of compulsory licenses: KEI

While the US Government and strong American pharma sector have been up in arms against India for
issuing compulsory licence in the sector, an eminent global non-governmental organisation has said that
it is the United States which leads the world in use of compulsory licenses. More...
Google, Viacom Settle YouTube Copyright Suit

(PTI - NEW YORK , 18-Mar-2014 , The New Indian Express)
Google and Viacom announced a settlement today in a long-running lawsuit claiming the Internet giant's
YouTube video-sharing site promoted copyright infringement. More...
On intellectual property, a new strategy

(Meir Perez Pugatch , 17-Mar-2014 , The Indian Express)
India could use IP rights to take its rightful place as a leader in global innovation. More...
India undermining intellectual property: Pfizer
(PTI , 14-Mar-2014 , The Economic Times.)
Months after its patent for a cancer medication was revoked by India, American firm Pfizer has told US
lawmakers that New Delhi is undermining intellectual property by misuse of its compulsory licence
provisions. More...
Google unmasks patent accuser

(Bloomberg | Washington , 14-Mar-2014 , Business Standard)
Google Inc wanted to find out who was behind a company called Suffolk Technologies LLC that accused
the world's largest search engine's owner of using its internet-search technology without permission.
More...
FICCI lambasts US for pressurising India to increase IPR protection beyond TRIPS
(Our Bureau, Mumbai , 14-Mar-2014 , Pharmabiz)
The Federation of Indian Chambers of Commerce and Industry has taken strong exception to the effort
being made by the US to declare India as 'Priority Foreign Country' under the Special 301 provisions of
the US Trade Act of 1974. More...
US firms like Honeywell and Boeing, professors back India on patent regime
(Dilasha Seth , 14-Mar-2014 , The Economic Times)
Leading US companies such as Honeywell and Boeing, and professors of US universities have backed
India before the US by shopping-chip" More...
Drug makers pump up injectables as US patent cliff looms

(Pallavi Ail , 13-Mar-2014 , Financial Express)
Indian and foreign generic drug makers seem to focus increasingly on the relatively fast-growing
injectables segment to ramp up their revenues. More...
How to strengthen India's case on intellectual property rights

New Delhi is well within its rights to rebuff the US pharma lobby's attempt to label India a habitual
intellectual property rights offender. More...
Big Pharma still betting on "messed up" Indian drugs market

(Ben Hirschler and Zeba Siddiqui , 12-Mar-2014 , Reuters)
Global drugmakers have had a nauseous time in India's $14 billion market. More...
The thorn in India-US business ties

(Arvind Subramanian , 12-Mar-2014 , Business Standard)
As the Office of the US Trade Representative (USTR) turns its lens on India's intellectual property and
patents regime, Business Standard brings you what Arvind Subramanian, columnist and economist,
More...
Strand Lifesciences’ virtual liver gets US patent
Strand Lifesciences has received a US patent for virtual liver, which would aid the pharmaceutical
industry in understanding liver-related issues better. More...
US and India could accomplish a lot together: Obama

(Chidanand Rajghatta,TNN , 12-Mar-2014 , The Times of India)
India's new ambassador to the United States, Dr S Jaishankar, presented his credentials to President
Obama at the White House on Monday in a formal ceremony at which the American President essayed
an anodyne ''the U.S and India could accomplish a lot together,'' at a time New Delhi has largely fallen
off Washington's radar, in part because of India's pre-occupation with the general elections. More...
How to strengthen India's case on intellectual property rights

New Delhi is well within its rights to rebuff the US pharma lobby's attempt to label India a habitual
intellectual property rights offender. More...
Sun Pharma recalls batch of drug in US

(Times News Ntework , 11-Mar-2014 , The Times of India, Mumbai.)
Following Ranbaxy’s drug recall in the US, another domestic company, Sun Pharma has recalled 2,528
bottles of its generic version of diabetes drug Glumetza. More...
Indian patent laws sound, unchallenged: Drug companies tell US International Trade
Commission
The World Health Organization has strongly endorsed India's patent laws and no country, including the
United States, has challenged these laws at the WTO claiming that these infringe trade-related
intellectual property rights, Indian drugmakers have told the US International Trade Commission.
More...
Clinical trials: SC asks govt to give details on deaths

(Agencies , 11-Mar-2014 , The Times of India, Mumbai.)
he Supreme Court on Monday directed the Centre to provide details on the number of deaths and severe
adverse effects caused to people who were subjected to clinical trials. More...
Indian patent laws sound, unchallenged: Drug companies tell US International Trade
Commission
The commission, a quasi-judicial body set up by the US Congress, is investigating whether Indian
policies discriminate against American manufacturers and is due to submit its views later this year.
More...
GSK pays $1bn to up stake in Indian arm to 75% from 50.7%

GlaxoSmithKline Plc has increased its stake in its Indian pharma subsidiary, GlaxoSmithKline
Pharmaceuticals, from 50.7% to 75%, following a recent open offer. The company announced that the
subsidiary will remain publicly-listed. The offer of Rs 3,100 per share values the transaction at
approximately Rs 6,400 crore ($1 billion). More...
Cipla may put patent for new HIV drug in open access pool
(C.H. Unnirkishnan , 10-Mar-2014 , Livemint)
Cipla says product under development, doesn’t have a time frame for completion as yet More...
U.S. pharma companies benefit from large Indian generic market

(Ramnath Subbu , 9-Mar-2014 , The Hindu)
The tirade by the U.S. against India with regard to its ‘unfriendly’ business environment, particularly the
Indian pharmaceutical sector, is largely misplaced according to the Indian Pharmaceutical Alliance.
More...
A flimsy case against Indian pharma

(Mike Palmedo , 09-Mar-2014 , Business Line)
Much of the controversy surrounds flexibilities in Indian patent law designed to promote access to
generic medicines. More...
MNC buys Mangalore fisheries college's patent

(Staff Correspondent , 8-Mar-2014 , The Hindu)
In a major boost for the research capabilities of the College of Fisheries in Mangalore city, its patent on a
shrimp disease testing kit will be sold to a private multinational company for mass distribution. More...
Seed savers network formed to fight intellectual property rights by corporations

(Jayashree Nandi , 07-Mar-2014 , The Times of India)
Farmers from 15 states are all set to form a national seed savers network that will be one of the largest
repositories of seeds for crops and vegetables in India. More...
Sun Pharma Seeks to Enter Japan Via Buys, Deals

(REUTERS , 07-Mar-2014 , The Economic Times.)
Sun Pharmaceutical Industries, India’s biggest drugmaker by market value, is looking for partnerships or
acquisitions to enter Japan, an especially lucrative market for manufacturers of low-cost drugs, a senior
executive said. More...
Patent office issues draft pharma norms

The guidelines are aimed at minimizing the risk of patent litigations of the kind that Novartis AG fought
for seven years over its cancer drug Glivec. More...
U.S. fears for patents on next-generation drugs in India

( Douglas Busvine and Zeba Siddiqui , 06-Mar-2014 , Reuters)
The United States on Thursday voiced concern over protection of patents on safer and more effective
next-generation medicines in India amid fears that authorities are considering allowing more Indian
firms to make new varieties of cheap generic drugs still on patent. More...
Now, Indian industry raises its voice against US

(Nayanima Basu | New Delhi , 06-Mar-2014 , Business Standard)
High chances that US in its Special 301 report will put India as 'Priority Foreign Country' More...
Patent filing fees doubled for cos, up 60% for individuals

Invention and innovation will now cost more. More...
Targeting India’s IP laws undermines WTO’s legitimacy’

A Geneva-based inter-governmental organisation of developing countries has slammed America and

developed world countries for pressurising India over its IP (intellectual property) laws, which it alleged
undermines the legitimacy of WTO. More...
Patent attorneys demand fair deal for Indian applicants

Highlighting a major anomaly in the Indian Patents Act, 1970 which provides for fast-track award of
patent to foreign entities, attorneys specializing in patents have demanded similar facility for individuals
and companies from India as well. More...
Sharma Accuses US of Trade Protectionism

(Our Bureau, New Delhi , 5-Mar-2014 , The Economic Times,Mumbai)
Commerce and industry minister Anand Sharma on Tuesday accused the United States of protectionist
trade policies while asserting that India’s trade and intellectual property rights are compliant with the
respective multilateral regimes. More...
PSU Insurers may Stay Out of GSK Open Offe

(Dheeraj Tiwari & Soma Das, New Delhi , 5-Mar-2014 , The Economic Times,Mumbai)
State-run financial institutions Life Insurance Corporation, General Insurance Corporation of India and
Oriental Insurance are unlikely to take part in UK drug maker GlaxoSmithKline’s ongoing open offer to
shareholders of its Indian subsidiary GlaxoSmithKline Pharmaceuticals. More...
India’s IPR regime in line with global pacts: Sharma

The government on Tuesday said its laws on intellectual property were fully in line with global
agreements and rejected arguments that New Delhi had not followed global practices. More...
Sanofi files cases against Glenmark on patent infringement

French drug-maker Sanofi filed patent infringement petition against Glenmark on cardiac drug Multaq, in
the district court of Delaware, on three counts. More...
India must call the US' bluff on patents

(Arvind Panagariya , 04-Mar-2014 , Business Standard)
Apart from the deterioration of the business environment generally, which impacts both domestic and
foreign investors, retrospective taxation has figured most prominently in the media as the principal
cause of growing scepticism among foreign investors. More...
Foundation stone laid for Intellectual Property Appellate Board building in Chennai
Supreme Court judge Justice F M Ibrahim Kalifulla has laid the foundation stone for a new building of the
Intellectual Property Appellate Board (IPAB) at Kelambakkam on the outskirts of Chennai. More...
Anand Sharma accuses US of protectionism, says India's patent laws WTO compliant
(Reuters , 04-Mar-2014 , Business Standard)
Says has approached finance ministry to ease gold import curbs More...
Is the Indian patent regime weak?

(4-Mar-2014 , The Financial Express)
India's Patent Act is no weak IPR regime given its ability to scupper ever-greening bids through an
innovation filter. More...
Cadila R&D unit served closure notice over pollution

(Paul John TNN , 4-Mar-2014 , The Times of India, Mumbai.)
The Gujarat Pollution Control Board (GPCB) has issued closure notices to the research wing of pharma
major Cadila Healthcare— Zydus Research Centre (ZRC)—at Changodar on the outskirts of Ahmedabad.
The notice was issued on March 1 after the company was found allowing waste water from its
laboratories to percolate through a dead borewell into an underground aquifer. More...
Outside the patent monopolies

(Ritu Kamal , 4-Mar-2014 , The Indian Express)
India’s role in pharmaceutical patent wars has broadened access to healthcare. More...
AstraZeneca Jumps 20% on Delisting Plan

(Our Bureau, Mumbai , 4-Mar-2014 , The Economic Times,Mumbai)
British drug maker AstraZeneca’s India unit has revived its plan of delisting the company from the stock
markets, an announcement about which sent the company’s shares soaring 20% to hit the upper circuit
on the BSE on Monday. More...
Google, Samsung said to express Microsoft-Nokia concern to China

(Steven Yang , 03-Mar-2014 , Livemint)
Google, Samsung express concern that Microsoft’s bid to take over Nokia may result in higher patent
licensing fees. More...
Natco wins Indian patent dispute case

(Special Correspondent , 03-Mar-2014 , The Hindu)
Natco Pharmaceuticals, the Hyderabad-based drug manufacturer, has won a patent case against Teva
Pharmaceuticals of Israel. More...
Novartis Chief Rules out Merger with Rival Roche

(Reuters Zurich , 3-Mar-2014 , The Economic Times,Mumbai)
Swiss pharma group Novartis will work more closely with rival Roche but rules out a merger, its
chairman said in a newspaper interview on Sunday. Asked whether the two companies wanted to stay
independent, Joerg Reinhardt, who took over as Novartis chairman in August, told Swiss newspaper
SonntagsZeitung: “Absolutely.” More...
Sequoia Looks to Exit GVK Bio

(Sneha Shah , 3-Mar-2014 , The Economic Times,Mumbai)
Venture capital fund Sequoia Capital is looking to exit its seven-year-old investment in GVK Group’s GVK
Biosciences, a biotech research and development outsourcing company. The fund has appointed
investment bank Avendus to look for buyers for its 20% stake in the company, said three people with
knowledge of the development More...
Bid to get GI tag for Tirunelveli 'halwa', Tuticorin macaroons

After 'Kancheepuram Silk', 'Madurai Malli' and Coimbatore wet grinders, makers of 'Tirunelveli Halwa',
famous for its taste and long shelf-life and Tuticorin macaroons, an Indianised dish of European
macaroons, are trying to get Geographical Indication tag. More...
Innovation Incubator
(Deepshikha Punj , 3-Mar-2014 , The New Indian Express)
In 2012-13, 94 patents were filed, and Indian trademark and design and copyright registered by the
Institute, a rise of nearly 400 per cent from 2008-09, in which 19 were filed. In 2013-14, already 89
patents have been filed. More...
Tirupati laddu gets stern with imitators

Makers of clones or identically named versions of the Tirupati laddu, beware. More...
Govt cautious on cancer drug patent regimes

(Sidhartha , 1-Mar-2014 , The Times of India)
Amid heightened scrutiny of the intellectual property regime, the government has decided to tread with
caution on a compulsory licence for a cancer drug to ensure that its decision is in line with the legal
provisions. More...
Apple wins dismissal of $2.2-bn German patent suit
(Bloomberg | Berlin , 1-Mar-2014 , Business Standard)
The rulings are a blow to Munich-based patent holding company IPCom, which has sued mobile-device
makers over technology it acquired from Robert Bosch GmbH in 2007 More...
Now, Geographical Indication rights for 'Tirupati laddu'

(IANS | Hyderabad , 28-Feb-2014 , Business Standard)
Tirumala Tirupati Devasthanam (TTD), which runs the affairs of the richest Hindu temple, is enforcing
Geographical Indication (GI) rights for its famous 'Tirupati laddu'. More...
Applications for trademark on the rise

(Bindu D Menon , 28-Feb-2014 , Business Line)
The International Trademark Association (INTA) has said that the number of applications for trademark
from India is on the rise, with more companies seeking brand protection. More...
Apeda moves patent board over order on basmati rice

(Gireesh Babu | Chennai , 27-Feb-2014 , Business Standard)
The move by IPAB came amidst protests from rice producers, processors and the state govt of MP,
against the Apeda's application for registration of basmati as GI in class 30 under the Geographical
Indications of Goods (Registration & Protection) Act, More...
Apple asks Chinese court to overturn patent ruling

(AFP , 27-Feb-2014 , The Economic Times)
US technology giant Apple on Thursday asked a Beijing court to strike down a patent ruling by state
authorities, as it fights an intellectual property battle with a Chinese firm. More...
Ranbaxy Suspends Shipment of Drug Ingredients from Two Plants

(Our Bureau, New Delhi , 26-Feb-2014 , The Economic Times,Mumbai)
Gurgaon-based drugmaker Ranbaxy Laboratories on Tuesday said it has suspended all shipments of
drug ingredients produced at two of its India-based plants located at Dewas and Toansa ‘voluntarily’ to
review processes and controls. The Punjab-based Toansa facility and Madhya Pradesh-based Dewas
plant are already facing a ban from the US drug regulator on quality concerns More...
Drug Regulator Seen Failing US Quality Test

(Divya Rajagopal , 26-Feb-2014 , The Economic Times,Mumbai)
US drug regulator Margaret Hamburg’s recent visit to India has done little to clear the air about the
quality of drugs manufactured by Indian companies and one reason for this may be India’s drug
controller. There is a growing perception in the US that the drug regulator is unwilling to monitor the
quality of drugs manufactured by the local companies, said Roger Bate of Washington DC-based think
tank, the American Enterprise Institute. More...
Patent laws safe from US challenge: India

(Amiti Sen , 25-Feb-2014 , Business Line)
India has said its patent laws cannot be successfully challenged by the US either in a bilateral or
multilateral forum as they strictly comply with the intellectual property agreement of the World Trade
Organization. More...
Chinese firm awaits ruling in Apple Siri patent infringement lawsuit

(Agence France-Presse , 25-Feb-2014 , NDTV)
A Chinese company suing Apple over similarities between its product and the "Siri" personal assistant
believes its case has merit and is awaiting a court ruling, a lawyer said Tuesday. More...
US industry wants India designated Priority Foreign Country

Ramping up their anti-India campaign, an influential section of American businesses, in particular those
from the pharma and manufacturing sectors, here on Monday urged the Obama Administration to
designate India as a Priority Foreign Country. More...
India, US trade spat intensifies

(Sidhartha TNN , 25-Feb-2014 , The Times of India, Mumbai.)
Amid the ongoing trade spat, the government has advised deputy US Trade Representative Wendy
Cutler to defer her planned trip to India next month in the view of the “flux” as well as the fiscal year-
end commitments of officials. More...
US, India must stop trading petty insults over various issues
This is more substantive than the childish tantrums over cancelled or postponed visits to India of senior
US officials in the wake of India's tough stance and childish retaliations against US embassy personnel
over the US decision to prosecute Indian diplomat Devyani Khobragade. More...
India ready to take on US over patents at World Trade Organization

The government is readying for a fresh battle with the US at the World Trade Organization in the wake
of the continued pressure over its intellectual property rights regime. More...
57 farm products enjoy GI status in India

(Press Trust of India | New Delhi , 24-Feb-2014 , Business Standard)
Government has granted Geographical Indicator status to around 57 agricultural products such as
Darjeeling tea, Pokkali rice and Dharwad Pedha in the last ten years. More...
US-India trade war worsens

(Sachin Parashar TNN , 24-Feb-2014 , The Times of India, Mumbai.)
India-US ties are again under stress—this time over trade and investment. There are calls in the US for
designating India a Priority Foreign Country (PFC), the worst downgrading of status by the US Trade
Representative for inability to protect intellectual property rights. More...
India set to take on US over probe into IPR laws

(Nayanima Basu | New Delhi , 24-Feb-2014 , Business Standard)
To deny visa to trade officials planning to scrutinise country's trade & industrial practices More...
India-US ties are under stress again, this time over trade and investment
(Sachin Parashar , 23-Feb-2014 , The Times Of India)
US pharmaceutical companies like Pfizer have demanded that India amend its patents law by doing
away with section 3(d) altogether. More...
Apple, Samsung fail to reach settlement in US patent infringement case

(ANI | Washington , 23-Feb-2014 , Business Standard)
The mediator's settlement proposal to the parties was unsuccessful More...
India hardens stance against US Says Disputes Should Go To WTO, Officials To Skip Trade
Body Meet
(Sidhartha TNN , 22-Feb-2014 , The Times of India, Mumbai.)
The government is set to ask all its officials to stay away from any interaction with a delegation from the
US International Trade Commission (USITC), a quasi-judicial agency, probing the impact of India’s trade
and investment regime on the American economy in what is seen as the latest sore point in economic
ties between the two countries. More...
‘Illegal e-purchase of pharma drugs a growing concern’

(Sanjiv Shivadekar TNN , 22-Feb-2014 , The Times of India, Mumbai.)
There are growing concerns in the state food and drug administration (FDA) over Maharashtra’s gradual
rise as a hub for drugs sold overseas through illegal internet pharmacies. More...
APEDA rues delay in traditional basmati growers' protection by MP govt

(Shashikant Trivedi | Bhopal , 20-Feb-2014 , Business Standard)
Agricultural and Processed Food Products Export Development Authority (APEDA) on Thursday said that
intervention of Madhya Pradesh government will unnecessarily delay the process of protecting
"traditional" basmati rice growers of India. More...
India has to indicate its position on certain aspects of IPR: Kiran Mazumdar-Shaw
(Vidya Krishnan , 20-Feb-2014 , Livemint)
Biocon head addresses issue of US lobbies demanding trade sanctions against India if it does not take a
tough stand on intellectual property rights. More...
Ranbaxy, Teva Settle US Case Over Competition

(OUR BUREAU NEW DELHI , 20-Feb-2014 , The Economic Times,Mumbai)
Ranbaxy Laboratories, the largest India-based drugmaker, and Israeli generic drug giant Teva Pharma
have reached a settlement with the New York Attorney General, which will end a 2010 pact between the
two companies that “restricted competition” in the US market. More...
Ranbaxy, Teva settle claims in US

(Agencies , 20-Feb-2014 , The Times of India, Mumbai.)
Ranbaxy Laboratories and Israel-based Teva Pharmaceuticals have agreed to settle allegations levelled
by New York state that the two rival generic drug makers made an unlawful agreement to restrict
competition. More...
Onerous licensing regime killing legal digital music

(TNN , 20-Feb-2014 , The Times of India, Mumbai.)
Last Friday, one of four major legal music streaming services — Dhingana — shut down, leaving only
Gaana.com, Saavn, and Hungama as the remaining digital music outlets broadcasting music from India
for consumption in India and abroad. This follows another recent shutdown of Flyte, a music download
service offered by Flipkart, a company that has raised over $200 million to date. More...
India should put more resources to keep pace with global practices: de Acedo
(C.H. Unnikrishnan , 20-Feb-2014 , Livemint)
Etienne Sanz de Acedo speaks about the critical issues that India should address in the transformation
phase More...
GI Basmati: CM urges PM to step in for state's inclusion

(TNN , 20-Feb-2014 , The Times of India)
Expressing 'shock and deep dismay' over apex agency monitoring India's agricultural exports deciding to
oppose inclusion of Madhya Pradesh areas for Geographical Indication tag for basmati, chief minister
Shivraj Singh Chouhan has written to Prime Minister Manmohan Singh to intervene in state's favour.
More...
Patent error
(Shamnad Basheer , 20-Feb-2014 , The Indian Express)
In its criticism of India’s IP regime, the US takes its cue from flawed rankings. More...
‘Indian drug cos must meet US standards’

(Times News Ntework , 19-Feb-2014 , The Times of India, Mumbai.)
When US Food & Drug Administration commissioner Margaret Hamburg signed off her 9-day visit to
India on Tuesday, she praised everything Indian with a steely demand for quality. More...
Intellectual property and economic development

(Rod Hunter , 20-Feb-2014 , Business Day)
In his recent State of the Union address, US President Barack Obama reiterated his ambition to complete
the Trans-Pacific Partnership, a proposed trade agreement among the US and 11 Pacific countries.
More...
US FDA Plans to Deploy More Inspection Staff in India

(Divya Rajagopal , 19-Feb-2014 , The Economic Times, Mumbai.)
The US Food and Drug regulator said on Tuesday that it will increase the number of its inspection staff in
India. Currently, the FDA deploys 12 officials in India, which the regulatory body plans to increase by 19,
said Margaret Hamburg, Commissioner, US Food and Drug Administration in the course of an interaction
in Mumbai. More...
A FAIR GAME: RPG Life loses domain name battle
(Lubna Kably TNN , 19-Feb-2014 , The Times of India, Mumbai.)
A complaint filed by RPG Life Sciences, a pharma company that is part of the diversified RPG Group,
against the owner of the domain name ‘rpglife.com’ has been denied by an international arbitration
panel. Interestingly, the owner has now offered to sell the domain name to RPG Life. More...
Separate Copyright Office for Authors, Performers: Raju

( IANS - NEW DELHI , 19-Feb-2014 , The New Indian Express)
A separate copyright office and a permanent copyright board is being set up to provide better services to
the authors, performers and creators of various works," Raju said. More...
Indian firms under pressure on drug patent regime, as global majors mount lobbying
(Yashwant Raj and Himani Chandna Gurtoo , 19-Feb-2014 , Hindustan Times)
India is defending its patent regime more aggressively than ever before from attacks in the US that have
come to define the state of ties between the two countries lately. More...
Research funding body a growth tonic for pharma cos

(TEAM TOI , 18-Feb-2014 , The Times of India, Mumbai.)
Research and development (R&D) in innovation and technology-driven sectors is expected to get a boost
with the fi nance minister announcing the setting up of a ‘research funding organisation’ to fund projects
selected through a competitive process. More...
Success strategies for Indian pharma industry in an uncertain world

(Manish Panchal, Charu Kapoor and Mansi Mahajan , 17-Feb-2014 , Business Standard)
The Indian pharmaceutical industry is going through a period of significant volatility and uncertainty,
requiring companies to re-visit their traditional growth strategies to succeed More...
IISc professor’ virtual liver product gets patent in US

(Anshul Dhamija , 17-Feb-2014 , The Times Of India)
Strand Life Sciences, founded by professors at the Indian Institute of Science, Bangalore, was awarded a
patent in the US last week for its two-year-old virtual liver product, used by pharmaceuticals companies
across the world to test new drug toxicity in the liver. More...
Novartis puts pressure on India over patent abuse

(Andrew Ward in London and Amy Kazmin in New Delhi , 16-Feb-2014 , The Financial Times)
Novartis has urged US and European governments to “apply pressure” on India to respect intellectual
property and warned New Delhi that its stance on patents is deterring investment. More...
Geographical indication tag to Patan patola to end feud over name

(Rupam Singh Gupta , 15-Feb-2014 , The Times Of India)
The geographical indication (GI) tag to Patan patola puts an end to the conflict between the Salvi
brothers of Patan and the Rajkot weavers over the name patola. More...
Indian policy on clinical research restrictive: US pharma cos
(Press Trust of India | Washington , 15-Feb-2014 , Business Standard)
American pharma companies and their advocacy groups today rued at the alleged restrictive India
policies on clinical research, saying such policies are harming the companies. More...
India has strong legal framework to protect intellectual property rights: Boeing
(PTI , 15-Feb-2014 , The Times Of India)
Even as a section of the US' corporate sector lobbies against India over protection of intellectual
property rights, American aircraft major Boeing, On Saturday said the country has a strong legal
framework to protect such rights. More...
Doctors association slams US for pressuring India on pharma patent laws

A Geneva-based non-profit doctors association has criticised the US and its pharma lobby for exerting
pressure on India over its patent laws, saying such actions undermine the global trading system. More...
Patent troll Intellectual Ventures lays off 5% employees

Privately held patent owner Intellectual Ventures has cut about 5% of its global workforce and
"consolidated positions" in a corporate restructuring. More...
Suven Life Sciences gets patent approval from New Zealand

(14-Feb-2014 , Business Line)
Suven Life Sciences has received patent rights from New Zealand for two products More...
Time to call the US bluff on pharmaceuticals

(Shishir Asthana | Mumbai , 13-Feb-2014 , Business Standard)
While Indian drug makers are expected to adhere to norms in the US, one of their key markets, why
aren't US companies operating in India following the laws here? More...
India faces US sanction threat

India is facing multiple threats on its trade and investment policies. More...
MORE BACKING FROM BIG PHARMA

(R SRIRAM & DIVYA RAJAGOPAL MUMBAI , 13-Feb-2014 , The Economic Times,Mumbai)
The US Chamber of Commerce may think India is an inhospitable terrain for innovation, but surprisingly,
Big Pharma doesn’t agree. Merck Serono, whose pharmaceutical roots go back to 1668, has not only
become the latest global giant to support lower pricing for emerging markets and but has also opposed
incremental innovation — a favourite bugbear of the Indian government and local industry. More...
U.S. probing ‘discrimination’ in Indian trade policies
(Narayan Lakshman , 13-Feb-2014 , The Hindu)
India’s policies for regulating foreign trade and investment, particularly in the context of intellectual
property rights affecting the pharmaceutical industry, were in the crosshairs of the US Congress this
week, as a lengthy investigation was launched into whether such policies were harming the US economy
by discriminating against American firms. More...
Trade team in US to explain India’s position

(P. T. Jyothi Datta , 12-Feb-2014 , Business Line)
Indian drugmakers and IT representatives will be in Washington tomorrow, making submissions before
the US International Trade Commission to explain India’s trade policies. More...
A duel on drugs
(T S Vishwanath , 12-Feb-2014 , Business Standard)
The discussions between the SA govt and pharma giants on intellectual property policy should keep both
the needy and the inventor in mind More...
Majority of Indian IT-BPM firms at an initial stage of IP development: Report

(Rajesh Kurup , 12-Feb-2014 , Business Line)
Majority of the Indian Information Technology-Business Process Management firms are at an initial stage
of Intellectual Property rights development. More...
US FDA Refuses to Sweeten Indian Drug Cos’ Bitter Pill

(Soma Das , New Delhi , 12-Feb-2014 , The Economic Times,Mumbai)
The head of the US drug regulatory body has turned down Ranbaxy Laboratories’ plea to allow
drugmakers to continue exporting from banned manufacturing facilities while they take remedial
measures to rectify the issues flagged. More...
‘EU rules denying kids of cancer drugs’

(Kounteya Sinha TNN , 12-Feb-2014 , The Times of India, Mumbai.)
Children with cancer are being denied entry into potentially life-saving drug trials because of loopholes in
European Union regulations. Of the 28 cancer drugs which have received authorization in Europe since
2007, 26 have the potential to work on children but 14 of them have been waived from being tested on
under-18-year-olds. More...
‘Dumb Starbucks’ a TV stunt, shut down

(12-Feb-2014 , The Times of India, Mumbai.)
Long lines formed outside the shop over the weekend as word of mouth and social media attracted large
crowds. On Monday Canadian comedian Nathan Fielder, known for a Comedy Central prank show, said it
was his idea. In a “press meet” outside the shop, he said: “By adding the word ‘dumb’, we are legally
allowed to use the Starbucks name and logo. More...
Editorial: Patent problems

(12-Feb-2014 , The Financial Express)
While the agreement between the US FDA and its Indian counterpart to share information and perhaps
coordinate action is good news as both regulators will now be on the same page, the need of the day is
for the Indian regulators to be more stringent and conduct more surprise tests in the manner the FDA
does. More...
After Starbucks parody, trademark violations take center stage: Here's all you need to know
about Trademark laws
(Vishal Manve , 11-Feb-2014 , DNA)
When King, the makers of popular game, Candy Crush Saga trade-marked the word Candy, there were
protests around the world. More...
CII feels International IP Index does not give true picture of India's IP ecosystem
(ANI | New Delhi , 11-Feb-2014 , Business Standard)
Commenting on the Global Intellectual Property Centre's International IP Index 2014 which presents
India as the weakest among 25 countries, the Confederation of Indian Industry on Tuesday said the
index does not represent the true picture of India's IP ecosystem. More...
Nokia, HTC settle long-running patent battles, agree on collaboration

(ANI , 11-Feb-2014 , DNA)
Nokia and HTC have reportedly settled their long-running patent infringement battles by agreeing on a
'patent and technology collaboration' that would settle all outstanding litigation. More...
Big Pharma's profiteering protests

(Amit Gupta , 11-Feb-2014 , Business Standard)
The war against the Indian patent regime is little more than multinationals' chagrin at their inability to
exercise monopolies More...
India Raises Concerns over FDA Actions on Local Drug Companies

(Our Bureau, New Delhi , 11-Feb-2014 , The Economic Times,Mumbai)
India will issue an informal note to the US in which it will protest against the “disproportionate” action
targeting Indian pharmaceutical companies, commerce and industry minister Anand Sharma said after
his meeting with visiting US Food and Drug Administration (US FDA) chief Margaret Hamburg More...
COFFEE TIME JOKE? ‘Dumb Starbucks’: A parody cafe in LA

(Adam Withnall , 11-Feb-2014 , The Times of India, Mumbai.)
An independent coffee shop has opened up in LA using the same name, logo and store layout as any
branch of the Starbucks chain — with one crucial exception — the prefix ‘dumb’. “Dumb Starbucks” has
rocketed to social media fame by claiming to be completely legal under “parody law”, with its mysterious
owners insisting it makes “fair use” of the chain’s famous brand. More...
India faces trade action from US

(Times News Ntework , 11-Feb-2014 , The Times of India, Mumbai.)
Washington’s Retaliatory Move Aimed At Govt’s Stance On Patent Regime More...
India faces US trade action over patents

(TIMES NEWS NETWORK , 11-Feb-2014 , The Times Of India)
The US, which recently downgraded the DGCA’s safety ratings, is expected to announce traderelated
measures in what is seen as a retaliatory move against India’s recent stand on the patent regime.
More...
US challenges India's requirements for solar products in WTO

(IANS | Washington , 11-Feb-2014 , Business Standard)
In another potential blow to India-US ties after the Khobragade affair, US Monday challenged India's
domestic content requirements in Phase II of India's National Solar Mission. More...
India patent regime not about access to medicine: U.S body

(Staff Reporter , 11-Feb-2014 , The Hindu)
Representative Michael Froman set to announce a trade enforcement action tied to India, the highly
influential U.S Chamber of Commerce has lashed out at India’s recent pattern of pharma patent denials,
pointing out that the country’s actions “are not about access to medicine.” More...
US business pressure again on Indian IPR

(Nayanima Basu | New Delhi , 11-Feb-2014 , Business Standard)
Tells trade representative's office that New Delhi's already bad record got worse last year; wants action,
even as bilateral investment treaty being negotiated. More...
India, US seek to better drug-making processes

(fe Bureau , 11-Feb-2014 , The Financial Express)
No surprise checks on drug firms as US FAA and its Indian counterpart agree to coordinate in drug
making. More...
Intellectual property rights: US set to punish India

(TNN , 10-Feb-2014 , The Economic Times)
Tensions over the Khobragade episode are yet to fully dissipate, but the two sides are locking horns
again over intellectual property rights. More...
Immense opportunities await Indian pharma manufacturing industry: Study

(Peethaambaran Kunnathoor, Chennai , 10-Feb-2014 , Pharmabiz)
Immense opportunities are waiting for the Indian pharmaceutical industry, both at the domestic and at
the global level, and the future will be extremely promising with many more milestones, according to a
research study conducted by Dr G Selvaraju, former director of drugs control, Tamil Nadu for the
Vinayaka Mission University, Salem, Tamil Nadu. More...
India raises concerns over USFDA actions

(10-Feb-2014 , Hindustan Times)
The government on Monday expressed clearly to the US its growing unease over its drug regulator
USFDA’s "disproportionate penalties" on India’s generic pharmaceutical companies, many of these which
have been rattled by a string of import bans without getting sufficient opportunity to clarify details.
More...
IPA slams methodology used by US Chamber of Commerce to rank IP environment of India
(Joseph Alexander , 10-Feb-2014 , Pharmabiz)
The Indian Pharmaceutical Alliance, representing large domestic drug-makers in India, has taken
exception to the methodology that the Global Intellectual Property Centre of the US Chamber of
Commerce adopted to rank India in the recent International Intellectual Property index. More...
HTC, Nokia ink deal on patent lawsuits

(AFP | Taipei , 09-Feb-2014 , The Financial Express)
Under the deal, HTC will make payments to Nokia and the collaboration will involve HTC’s LTE patent
portfolio. More...
Trade Groups Seek More US Pressure on India over Patent Protection

(Bill Berkrot | Reuters - US Chamber of Commerce , 8-Feb-2014 , The New Indian Express)
The US Chamber of Commerce on Friday called on the government to ratchet up pressure on India over
intellectual property rights, in a move that could help prevent Indian companies from producing cheap
generic versions of medicines still under patent protection. More...
Novartis sues Dr Reddy’s Laboratories over patent infringement on cancer drug

(fe Bureau | Hyderabad , 8-Feb-2014 , The Financial Express)
The patent and Novartis' new drug application, approved by the FDA in 2001. More...
HTC, Nokia reach truce in patent dispute

(AFP , 8-Feb-2014 , The Times of India)
Taiwan's smartphone maker HTC said it has signed a patent and technology collaboration agreement
with Finnish phone giant Nokia to end all pending patent litigation between them. More...
Apple gets patent for autocorrect review system: Report

(ANI , 07-Feb-2014 , The Times Of India)
Apple has reportedly patented an autocorrect review system in which autocorrect changes are
highlighted to a user once they press the send button. More...
Cancer drug may lose patent shield

The government is studying options to issue a compulsory licence on life-saving anti-cancer drug
dasatinib, which could bring down its price by over 90%. More...
Roche sues Biocon, Mylan, DCGI over breast cancer drug

(Soma Das , 7-Feb-2014 , The Economic Times)
The Indian arm of Swiss pharma major Roche, which unexpectedly gave up its patent on it s $6 billion
breast cancer drug Herceptin in India last year, has sued Bangalore based BioconBSE 2.29 % and US
generic giant Mylan Inc in Delhi High Court for launching world's first biosimilar version of the original
drug in India. More...
Patents and Copyrights Are Not for Violation
(The New Indian Express , 7-Feb-2014 , The Times Of India)
India has for the second time in succession found itself at the bottom of the International Intellectual
Property Index issued by the US apex trade body’s Global Intellectual Property Centre. More...
Big pharma firms pushes for US action against India over patent worries
(Reuters , 06-Feb-2014 , The Economic Times)
Global pharmaceutical firms are pressuring the United States to act against India to stop more local
companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with
direct knowledge of the matter said. More...
Turning down knowledge

(Business Standard Editorial Comment , 05-Feb-2014 , Business Standard)
Troublingly, India is an outlier on intellectual property. More...
Cisco, Google sign patent-sharing agreement

Google Inc entered into a patent cross-licensing agreement with Cisco Systems Inc, the internet search
giant's second such deal in as many months. More...
India slips in rankings as slowdown hits pharma

(Rupali Mukherjee | TNN , 4-Feb-2014 , The Times of India, Mumbai.)
India has slipped from the 8th rank as forecast in 2016 to the 11th position in 2017, figures culled from
IMS Health said. The downgrade suggests that the market may not be growing at the pace projected
earlier, and has lost value due to the currency fluctuation, impacting the country’s global ranking,
experts say. More...
Mylan launches biosimilar for cancer

(TNN , 4-Feb-2014 , The Times of India, Mumbai.)
Mylan Inc, a leading generic and specialty pharmaceutical company, said that its Indian subsidiary Mylan
Pharmaceuticals has launched the world’s first trastuzumab biosimilar in India. The product, which will
be marketed under the brand name Hertraz, is a biosimilar to Roche’s Herceptin More...
Registering trademarks turns cheaper for firms

New system works on a single registration fee to be paid in India, is likely to help firms save more
money More...
Patent filing by IIT Bombay up by nearly 400%, students major contributors

(Mihika Basu , 3-Feb-2014 , The Indian Express)
In 2012-13, 94 patents were filed and Indian trademark and design and copyright registered, a rise of
nearly 400 per cent from 2008-09, when 19 were filed. More...
India's IP environment has deteriorated in last 2 years: Jasper MacSlarrow
(Sudipto Dey , 02-Feb-2014 , Business Standard)
Interview with Executive Director of International IP, Global Intellectual Property Center, US Chamber of
Commerce More...
Apple gets 'sapphire window' and pressure-sensitive display patents granted

(Robin Sinha , 31-Jan-2014 , NDTV)
Apple, a tech firm best known for its innovations, after introducing a sapphire- based fingerprint sensor
on its iPhone 5s, got one of its important patents granted by the USPTO on Thursday, detailing a cutting
and processing method for sapphire material. More...
Twitter buying 900 IBM patents to end infringement dispute

(Susan Decker , 31-Jan-2014 , Livemint)
The agreement also resolves a dispute that prompted IBM to write to Twitter last year about possible
infringement of at least three patents. More...
IPAB sets aside Patent Office's order for Roche's anti-viral drug
The Intellectual Property Appellate Board has set aside an order of Indian Patent Office, which revoked
the patent of Hoffmann-La Roche's antiviral drug Valganciclovir, branded as Valcyte, and remanded the
matter back to the patent official for fresh consideration. More...
Protecting patents: India worst in world

(Surabhi Agarwal | New Delhi , 30-Jan-2014 , Business Standard)
Ranking by arm of US Chamber of Commerce; study says all BRICS countries lack the required drive to
enforce patents; Indian law & SC rulings rapped More...
Basmati WARS
(Summary , 30-Jan-2014 , The Financial Express)
Madhya Pradesh joining the battle for geographical indications gives it a new twist More...
Doha talks will be back on track: WTO

(Times News Ntework , 29-Jan-2014 , The Times of India, Mumbai.)
The Doha Round of talks on lowering world trade barriers would resume this year, following the
successful trade talks in Bali recently:WTO More...
Venus Remedies bags US patent for painkiller injection

Venus Remedies Ltd, a research oriented global pharmaceutical company today said it has bagged a
patent from US Patent Office for Achnil, a once-a-day painkiller injection developed by Venus Medicine
Research Centre, the R&D wing of Venus Remedies. More...
Apple patents 'magnetic add-on camera lens' for iPhones
(ANI | Washington , 29-Jan-2014 , Business Standard)
The external camera lens could be attached securely to the iPhone with magnets and aligned with its
camera. More...
US Record Company Sues Vietnam Site for Copyright

(Chris Brummit | AP - HANOI , 28-Jan-2014 , The New Indian Express)
A record company that accuses a Vietnamese entertainment portal of making its songs available for free
download has filed suit in an American court against the U.S- venture capital firm which invested in the
website, seeking millions in damages for copyright violations. More...
Ericsson agrees to end patent dispute with Samsung

(Reuters | Stockholm , 28-Jan-2014 , Business Standard)
Ericsson said on Monday it had signed a cross-licensing deal with Samsung Electronics Co, ending a
long-running patent dispute and boosting fourth-quarter sales by 4.2 billion crowns. More...
Google, Samsung sign patent agreement

(Eric Pfanner | Washington , 28-Jan-2014 , Business Standard)
The deal covers existing patents as well as some that would be filed during the next 10 years. More...
GI battle: Madhya Pradesh govt puts basmati in a rice soup

(Sandip Das , 28-Jan-2014 , Indian Express)
The state has asked for inclusion in basmati rice growing zone although being outside the Indo-Gangetic
plain. More...
MSF criticises Bayer CEO's comments on CL issued by Indian patent office on Nexavar
(Ramesh Shankar , 28-Jan-2014 , Pharmabiz)
German drug major Bayer's CEO Marijn Dekkers' reported comments that “We did not develop this
medicine for Indians,” have come in for severe criticism from the international medical humanitarian
organization Médecins Sans Frontières. More...
Sanofi India stock likely to be re-rated on company's improving fundamentals

(Narendra Nathan , 27-Jan-2014 , The Economic Times)
Sanofi India is a subsidiary of Sanofi, one of the world's leading pharmaceutical companies. More...
Patented drugs face price caps

(Sidhartha , 27-Jan-2014 , The Times Of India)
After sitting on it for years, the government is finally initiating steps to regulate the price of patented
medicines and medical devices, a move that may provide relief to patients suffering from life-
threatening diseases. More...
Safeguarding your intellectual property rights
(Sakina Babwani , 27-Jan-2014 , The Economic Times)
Have you wondered what you would do if someone sells their products under your brand name or uses
the content you have written without your permission? More...
Google and Samsung Electronics, which are frequently involved in patent infringement
lawsuits but not against each other, announced that they have reached a global patent cross-
licensing agreement.
(Reuters , 27-Jan-2014 , The Times Of India)
Google and Samsung Electronics, which are frequently involved in patent infringement lawsuits but not
against each other, announced that they have reached a global patent cross-licensing agreement.
More...
IPAB directs patent office to consider Schering Corporation's application afresh

The Intellectual Property Appellate Board has directed the patent office to consider the patent
application of US-based Schering Corporation for a crystalline form of a compound for treatment of heart
related disease afresh. More...
USFDA bans Ranbaxy’s 4th plant

(Rupali Mukherjee , 25-Jan-2014 , The Times of India, Mumbai.)
India’s largest drug maker Ranbaxy faced fresh regulatory trouble due to manufacturing violations at its
fourth domestic facility, which may threaten new drug launches and jeopardize lucrative revenues from
the US, the world’s biggest pharma market. More...
Developed cancer drug for 'western patients' who could afford, not 'for Indians': Bayer's CEO
(AFP , 25-Jan-2014 , The Times Of India)
Global medical charity Medecins Sans Frontieres slammed on Friday a statement by Bayer's chief
executive that the giant German firm only developed its cancer drug Nexavar for people who could
afford the medicine, not "for Indians". More...
European office upholds 3G patent disputed by Nokia, HTC, Apple

(PTI , 25-Jan-2014 , Zee News)
The European Patent Office has upheld a narrowed version of a patent on 3G technology rejecting claims
from Nokia, HTC, Apple, Ericsson and Vodafone. More...
Nokia says Indian mobile app downloads rise 15-fold globally

Mobile handset company Nokia has seen a 15-fold increase in downloads of applications developed by
Indian companies globally on a yearly basis. More...
Google, Intellectual Ventures face off as patent trial begins

Opening statements began in patent owner Intellectual Ventures' trial against Google's Motorola Mobility
unit in a lawsuit that could be a bellwether on public opinion toward intellectual property. More...
GI tag won, hopes soar for MP’s basmati
(Milind Ghatwai | Bhopal , 24-Jan-2014 , The Indian Express)
Basmati rice, in the cultivation of which Madhya Pradesh has already taken long strides, has finally got
what it had been seeking for a long time: a geographical indication tag. More...
Qualcomm buys Palm patents from Hewlett-Packard

(AP , 24-Jan-2014 , The Times Of India)
Cellphone chip-maker Qualcomm said that it has acquired patents once owned by smartphone maker
Palm from Hewlett-Packard for an undisclosed amount. More...
Mera-vala pink
(B Desikan , 23-Jan-2014 , Business Line)
Colours, sounds, smells, gestures and moves… you can trademark them all. More...
Apple wins 'autocomplete' patent claim against Samsung

(TOI Tech & Agencies , 23-Jan-2014 , The Times Of India)
Apple has won a patent claim against Samsung, after a US Judge ruled that the South Korean
electronics giant infringed on auto complete patent owned by the iPhone maker. More...
With a GI tag in the bag, Udupi farmers cash in on rare green brinjal
(AJ Vinayak , 23-Jan-2014 , Business Line)
‘Mattu Gulla’, a special variety of green brinjal grown in Karnataka’s Udupi district for over five centuries
now, is now attracting special attention from growers. More...
HC Restrains Jubilant Co from Infringing Pidilite's Trademarks

(PTI , 23-Jan-2014 , The Indian Express)
Holding that it was a case of an infringement of copyright and passing off goods in someone else's
name, the Bombay High Court has restrained M/s Jubilant Agri & Consumer Products Ltd from using the
registered trademarks of M/s Pidilite Industries Ltd. More...
IPAB refers opposition to anti-cancer drug to patent office

Board has set aside an earlier order of Assistant Controller of Patent stating that it was passed in
'flagrant violation of principles of natural justice' More...
Merck to Bristol-Myers Face More Threats on India Drug Patents

(Ketaki Gokhale , 21-Jan-2014 , Bloomberg)
Pharmaceutical companies from Merck & Co. to Bristol-Myers Squibb Co. face fresh threats to protecting
their patents in India as a government-appointed panel prepares to evaluate more drugs for local
makers to copy. More...
Sherlock Holmes just escaped the bonds of copyright, new adventures beckon
(21-Jan-2014 , The Times Of India)
Its elementary a character in public domain cannot be appropriated as private intellectual property.
More...
Biocon’s copy of Roche breast cancer drug still expensive for India
(Naomi Kresge, Ketaki Gokhale , 21-Jan-2014 , Livemint)
Biocon will sell its version of Herceptin, which it is calling Canmab, at a 25% lower price More...
No More 'Tricky' Postures can Get a Yoga Copyright

( Wilson George Thomas - COIMBATORE , 20-Jan-2014 , The New Indian Express)
Practitioners of yoga lose no time in waxing eloquent of its antiquity. More...
IBM leads in tech patent filings in 2013

IBM has retained its patent crown in 2013, while Google climbed to No. 11 in the rankings. More...
Google set to face Intellectual Ventures in landmark patent trial

Intellectual Ventures is set to square off this week against Google Inc's Motorola Mobility unit in the first
trial that the multibillion-dollar patent-buying firm has undertaken since it was founded. More...
Unbranded generics way to cheaper cure

(Rupali Mukherjee | TNN , 18-Jan-2014 , The Times of India, Mumbai.)
Rajasthan, TN implement Model that cuts prices of branded drugs by at least 30%. More...
Patent mapping system to find more innovation

(Leslie D’Monte , 16-Jan-2014 , Livemint)
Patent maps provide visual representation of where universities, companies and other organizations are
protecting intellectual property produced by their research More...
Swarovski drops 'Crystal' mark after Indian company challenge

(Manish Raj , 17-Jan-2014 , The Economic Times)
In a letter to the Intellectual Property Appellate Board, Austrian crystal jewellery and accessories maker
Swarovski said it will not renew its trademark 'Crystal Glamour' for its clothing, footwear and headgear
More...
No copyright over yoga, pranic healing techniques: HC

(Aneesha Mathur , 15-Jan-2014 , The Indian Express)
The court has held that the expression ‘pranic healing’ cannot be monopolised as trademark by the
institute. More...
India has an impeccable Copyright Act - now it needs teeth: Javed Akhtar
(Arnab Banerjee , 15-Jan-2014 , The Times Of India)
Poet and writer Javed Akhtar is also Vice President of the Brussels-based International Confederation of
Societies of Authors and Composers (CISAC), addressing copyrights, intellectual property rights, etc.
More...
Allergan wins lawsuit against Lupin, two others over Lumigan

(Susan Decker , 14-Jan-2014 , Livemint)
The patent will prevent copies of Allergan’s Lumigan glaucoma treatment from entering the US until
2027. More...
Gujarat-based CMSCRI gets European patent for 'green plastic'

(Avinash Nair | Ahmedabad , 13-Jan-2014 , The Financial Express)
The institute developed biodegradable plastic by using a residue generated from Jatropha. More...
Why India needs to take intellectual property seriously

(Rod Hunter , 11-Jan-2014 , Business Standard)
Without reform of IP law, Indian companies - and broader economic growth - will remain stunted.
More...
Pharma companies rope in third-party advisors to deal with compliance issues

(Pallavi Ail | Mumbai , 11-Jan-2014 , The Financial Express)
Inadequate resources, coupled with rising demand, has proved to be a stumbling block for Indian
pharmaceutical companies More...
Apple did not violate Google patents: US court

The US Court of Appeals for the Federal Circuit upheld a decision by the International Trade Commission
in April that Apple did not violate a Google patent to make the popular iPhone. More...
Solvay wins two rare earth mixed oxides patent cases against HySci in China
(BS B2B Bureau | Brussels , 10-Jan-2014 , Business Nair)
Solvay has won two rare earth mixed oxides patent cases against China-based HySci (Tianjin) Specialty
Materials Co Ltd. Solvay was awarded RMB 5.6 million (Euro 0.67 million) in damages and HySci was
ordered to immediately stop the production and the sale of certain rare earth mixed oxides used in
automotive catalysts. More...
After Basmati rice, MP govt to seek patent for rare poultry breed
(Shashikant Trivedi | Bhopal , 09-Jan-2014 , Business Standard)
Farmers Welfare and Agriculture Development department will file applications for patenting breed soon.
More...
Glenmark's anti-diabetes drugs shake up Indian anti-diabetes market

Mumbai-based Glenmark Pharmaceuticals has shaken up India's Rs 3,000-crore lucrative anti-diabetes

market dominated by multinationals with its new drugs, Zitamed and Zita. More...
Pharma FDI: No Ban on Non-compete Clause

(Our Bureau, New Delhi , 09-Jan-2014 , The Economic Times,Mumbai)
The government has decided against a blanket ban on the incorporation of a ‘non-compete’ clause if an
Indian pharma company is acquired by a foreign drug company. The ban was mooted by the
Department of Industrial Policy and Promotion (DIPP) as a safeguard to ensure large scale acquisition of
Indian pharma companies does not lead to shortage of critical drugs. More...
Apple, Samsung agree to mediation in US patent fight

(Reuters | San Francisco , 9-Jan-2014 , Business Standard)
The rivals are facing a March trial date in the United States More...
Ghansal rice variety set to attain GI status

(Nikhil Deshmukh , 9-Jan-2014 , The Times Of India)
Following the footsteps of Kolhapur jaggery, the Ghansal variety of rice grown in the Ajara tehsil is set to
attain geographical indication status to preserve its aroma and peculiarity. More...
Centre to SC: No advantage in contesting US patent of wheat variety

(Utkarsh Anand , 8-Jan-2014 , The New Indian Express)
The Centre has told the Supreme Court that it was not "advantageous" to contest the United States'
patent of a wheat variety, similar to Indian Nap Hal, since the patent granted to American multinational
chemical and agricultural biotechnology corporation Monsanto had already expired in 2010. More...
Nestle's cumin extract patent bid raises hackles

(Sushmi Dey | New Delhi , 8-Jan-2014 , Business Standard)
Company claims new use for kala jeera extract, provoking alarmed campaigners here and abroad; says
reaction not based on facts More...
India sees sharp drop in patent applications

(Mihika Basu , 8-Jan-2014 , The Indian Express)
While patent filing at the Indian patent office has seen a rise of 23.97 per cent from 2007-08 to 2012-
13, assessment shows that only a meagre 22 per cent of them have been filed by Indian applicants in
2012-13. More...
Madhya Pradesh’s basmati plea may delay India’s geographical indication battle
(Sanjay Vijayakumar , 7-Jan-2014 , The Economic Times)
India's battle to protect the distinctive identity of basmati rice name, fought in part through a filing for a
geographical indication protection by state-run export registration agency Apeda, is facing a hurdle in
Madhya Pradesh. More...
Student Gets Patent for her Innovation

(Express News Service - KOCHI , 07-Jan-2014 , The New Indian Express)
An MTech student from Alappuzha has developed a sensor faucet with a sensor-controlled flow kit which
ensures that water is provided manually through the water taps in case of electronic failure. More...
Software patents: US Supreme Court needs to clear the air

(Anurag K Agarwal , 6-Jan-2014 , DNA)
Granting a patent involves three important criteria – novelty or inventive step, non-obviousness and
utility. More...
Microsoft’s Nokia deal to face China limits on patent fees

(Bloomberg , 2-Jan-2014 , The Economic Times)
Chinese mobile phone makers asked regulators to make sure Microsoft's 5.44-billion euro bid to take
over Nokia Oyj's handset business doesn't result in higher patent fees on wireless technology, said two
government officials with knowledge of the matter. More...
Health ministry sought tough laws for drugs, clinical trials.

(By PTI , 01-Jan-2014 , The Economic Times)
As India inches towards being a polio-free country, the health sector made some rapid strides in
strengthening regulations for drugs and clinical trials, and saw stronger food laws and re-establishment
of an elected medical regulator during 2013. More...
Glenmark faces patent infringement suit in US

Glenmark Pharmaceuticals has been slapped with a patent infringement case by US-based Cephalon Inc
over plans to sell generic version of leukaemia treatment drug Treanda in the American market. More...
Samsung, Apple working on patent deal: Report

(TOI Tech , 31-Dec-2013 , The Times Of India)
Arch rivals Apple and Samsung are reportedly back to the negotiating table. More...
Haleem makers vie for international geographical indication tag

(Rohit PS , 31-Dec-2013 , The Times Of India)
The savoury Haleem may soon be sold in Europe with the Hyderabadi tag proudly displayed on the
packaging if makers manage to bag an international geographical indication tag for it. More...
Naidu has Patent for Graft: Botcha

(Express News Service - HYDERABAD , 31-Dec-2013 , The New Indian Express)
Taking exception to TDP chief N Chandrababu Naidu alleging that AICC supremo Sonia Gandhi is
encouraging corruption in the country, PCC president Botcha Satyanarayana said Naidu was the
embodiment of corruption and had got ‘patent rights’ for graft. More...
PIL wants additional statutory protection for GI-tagged handicrafts

(Subra Mani , 30-Dec-2013 , The Times Of India)
While GI-tagged liquor and spirits of foreign make enjoy additional protection in India, nearly 130 Indian
handicraft products having GI status do not have such additional protection overseas, intellectual
property rights (IPR) attorneys have informed the Madras high court. More...
The cancer divide

(Gardiner Harris , 30-Dec-2013 , Livemint)
Alka Kudesia needs an expensive drug to treat her breast cancer, but refuses to tell her children for fear
they will take loans to buy the medicine and spend the rest of their lives in debt. More...
Sole right to make ‘Tirupati laddu’ will vest with TTD

(R. Sivaraman , 30-Dec-2013 , The Hindu)
Madras High Court restrains Chennai sweet stall from making and selling ‘laddus’ under a near similar
name. More...
2013: Few bitter pills, booster injections for pharma sector

(Press Trust of India , 29-Dec-2013 , NDTV)
Domestic firms coming under increased scrutiny of global regulators, resulting in Ranbaxy paying a
record $500-million fine, and drugs becoming cheaper in India thanks to a new pricing policy marked a
roller-coaster year 2013 for the pharma industry. More...
Traditional knowledge, culture can be patented

(Rupali Mukherjee , 27-Dec-2013 , The Times Of India)
Traditional Knowledge and Traditional Cultural Expression reflecting a community's cultural and social
identity, handed down generations, may soon be recognized as a form of intellectual property. More...
Google files lawsuit against Apple, Microsoft backed Rockstar patent group
(ANI , 27-Dec-2013 , Zee News)
Google has reportedly filed a lawsuit against Apple and Microsoft backed consortium Rockstar, claiming
that its patent campaign is unfairly targeting Google's Android partners and customers. More...
Govt may have to Reset Prices of Essential Drugs

(Soma Das , 24-Dec-2013 , The Economic Times,Mumbai)
Seven months into the new pharma pricing regime, the government may have to go back to the drawing
board and reset prices of essential drugs, adding to the prevailing confusion in the domestic drug
market. More...
CMIA’s summit to provide platform to patent holders

(Mohammed Akhef , 24-Dec-2013 , The Times Of India)
The Chamber of Marathwada Industries and Agriculture will organise a first-of-its-kind innovation
summit on January 7 for industries, education and service sectors to discuss ways of exploring more
opportunities. More...
New patenting norms may put India's software innovation into sleep mode
(Surabhi Agarwal | New Delhi , 24-Dec-2013 , Business Standard)
Technology experts argue the guidelines defeat the very objective of most software applications - to be
hardware agnostic and interoperable More...
Chennai Patent Office revokes Pfizer's second patent on Detrol

In yet another blow to the multinational drug companies in patent cases in India, the Chennai Patent
Office has revoked Pfizer's patent on Detrol, a drug used to manage overactive bladder symptoms.
More...
Japanese companies keen to establish telecom gear test labs in India

(Kalyan Parbat , 24-Dec-2013 , The Economic Times)
Japanese companies are keen to establish telecom gear test labs in India even as the government
prepares to invite bids from private lab operators to pave the way for local testing from July 2014.
More...
Pharma firms might resume sales of analgin-based drugs

(Sushmi Dey , 23-Dec-2013 , Business Standard)
Soon, drug makers might be able to resume the sale of analgin, the popular pain-relief drug. The Drugs
Controller General of India is considering the recommendations of its advisory body to revoke the
suspension of the sale of analgin-based medicines in the country More...
New patenting norms may put India's software innovation into sleep mode
(Surabhi Agarwal , 23-Dec-2013 , Business Standard)
Patenting of software applications could virtually become impossible in the country if the draft guidelines
on computer-related innovation come into force. The rules, the first ever for software applications in the
country, were recently issued by the patent office and mandate each new software to be "machine-
specific" and packaged with "new hardware" to qualify for a licence. Technology experts argue the
guidelines defeat the very objective of most software applications - to be hardware agnostic and
interoperable. More...
He Has the Patent to Cure Many Ills

(Shevlin Sebastian , 22-Dec-2013 , The New Indian Express)
This was Shet’s 79th patented invention in his 30-year career as an inventor. More...
Ramnad farmers seek GI tag for their ‘Madurai Malli’ plants

(Walter Scott , 21-Dec-2013 , The Hindu)
Claiming that ‘Madurai Malli’ which was recently given the coveted Geographical Indication tag, had its
origin in Ramanathapuram, farmers have urged the district administration to help them secure GI mark
also for the plants raised in the district and which produced ‘Madurai Malli.’ More...
Apple granted patent for flexible sapphire display
(TOI Tech , 20-Dec-2013 , The Times Of India)
Flexible and bendable screens are the new buzzwords in the technology industry, with all major
manufacturers readying display panels for the next generation of gadgets. More...
Hisar university issued patent to estimate multi residue in milk and milk products
(Madhvi Sally , 20-Dec-2013 , The Economic Times)
Chaudhary Charan Singh Haryana Agricultural University Hisar has been issued a patent on a technique
for estimation of multi residue in milk and milk products, announced the Vice-Chancellor, Dr K.S.
Khokhar. More...
Patent war spills over to non-cancer drugs

The turf war between Big Pharma and generic companies, which was largely restricted to exorbitantly
priced drugs for cancer and HIV, is now spilling over to chronic and lifestyle problems. More...
ZTE says India operations unaffected in Vringo patents row

( Danish Khan , 18-Dec-2013 , The Economic Times)
Chinese telecom gear maker ZTE said that the Delhi High Court has set aside the injunction sought
against the company's products by Vringo Inc. More...
Lack of awareness about GI spelling doom for many products

(Press Trust of India | Kolkata , 18-Dec-2013 , Business Standard)
Lack of awareness about the importance of geographical indicators for goods is pushing many products,
unique to India, out of business, according to the Trade Marks & GI Registry, the Intellectual Property
office of India. More...
Indian pharma company wins patent war against US firm

(Express News Service , 18-Dec-2013 , The Indian Express)
Gujarat-based La Renon Healthcare Pvt Ltd has successfully got revoked the Indian patent held by a US
firm for a proprietary probiotic formulation, named Renadyl. More...
GSK to spend $1 billion to raise stake in Indian unit

GlaxoSmithKline Plc said on Monday it plans to raise its stake in its Indian pharmaceutical unit to up to
75 per cent from 50.7 per cent through an open offer in a deal worth about 629 million pounds. More...
Presence of law to protect copyright 'not effectual': CJI

(PTI , 15-Dec-2013 , Zee News)
Observing that the revenue of conventional record labels has plunged in recent years due to copyright
infringement, Chief Justice of India P Sathasivam on Sunday said in spite of the existence of a law, its
implementation was not "effectual" as envisaged. More...
MNCs lead in patenting of both product and processes in India after change in patent law:
Origiin IP
(Nandita Vijay, Bengaluru , 14-Dec-2013 , Pharmabiz)
Origiin IP Solutions LLP has observed that there is an impressive number of foreign multinational
pharmaceutical companies which have taken a lead in patenting activities in India. More...
Nod for anti-depressant cheers Indian pharma

(BS Reporter | Mumbai , 13-Dec-2013 , Business Standard)
Five companies get US regulator's approval for Cymbalta generic More...
Seoul court rules in favour of Apple in patent row with Samsung

(ANI | Washington , 13-Dec-2013 , Business Standard)
A Seoul court has reportedly ruled that Apple did not infringe on some of Samsung's patents, in a patent
battle that has spread to multiple continents. More...
Cadila, Zydus Pharma in pact with Warner Chilcott to settle US patent issue
Warner Chilcott had lodged a suit in the Delaware federal court in 2011 seeking to stop Cadila
Healthcare and its US unit from launching a generic version of Asacol. More...
Medicines Patent Pool, BMS sign agreement to increase access to key HIV medicine
The Medicines Patent Pool, a UN-backed organisation, and pharma company Bristol-Myers Squibb have
signed a licensing agreement to increase access to a key HIV medicine, atazanavir, in 110 developing
countries, including India. More...
11 more items from Bengal identified for GI tag

After Darjeeling tea, 11 more items from West Bengal are in line to get Geographical Indication tag.
More...
HC Favours Colgate in HUL Ad Row

(Our Bureau , 12-Dec-2013 , The Economic Times,Mumbai)
The battle for supremacy in the oral care segment took another interesting turn on another turf when
market leader Colgate Palmolive obtained a favourable court order against its arch rival Hindustan
Unilever (HUL), India’s largest consumer goods company. More...
Apple Inc scores legal victory over Samsung on sales of iPhone 4S, iPhone 5 in South Korea
(Reuters , 12-Dec-2013 , The Indian Express)
Apple Inc products such as the iPhone 5, iPhone 4S and iPad2 do not violate Samsung Electronics
patents, said a Seoul judge. More...
Cadila Healthcare gains after settling patent litigation with Warner Chilcott
(Capital Market , 12-Dec-2013 , Business Standard)
Cadila Healthcare rose 2.63% to Rs 744.50 after the company said it has settled a patent litigation with
US-based Warner Chilcott Company LLC. More...
Samsung loses patent lawsuit in South Korea against Apple

(IANS , 12-Dec-2013 , Business Standard)
The three technologies under the legal dispute included those related with multi-tasking service while
writing text messages. More...
Former Google executive Michelle Lee to run US patent office

Former Google Inc executive Michelle Lee has been named deputy director of the US Patent and
Trademark Office and will run the agency until a new director is named, the agency said on Wednesday.
More...
MSME Dept Bats for IPR

( Express News Service - CUTTACK , 11-Dec-2013 , The New Indian Express)
The State MSME Department has pressed the entrepreneurs, manufacturers and producers to protect
their innovations, designs and work processes through Intellectual Property Rights. More...
Apple granted patent for curved touchscreen

(ANI , 11-Dec-2013 , The Economic Times)
Apple has been reportedly granted patent for curved touchscreen designs for smartphones and other
devices. More...
Intellectual Property Appellate Board crippled due to poor infrastructure, PIL says
(A Subramani , 10-Dec-2013 , The Times Of India)
Despite being a premier body settling disputes over intellectual property rights and trademark rows, the
Intellectual Property Appellate Board headquartered in Chennai has neither proper infrastructure nor
finance to function efficiently, said a PIL in the Madras high court. More...
No clarity on pricing, patents

(P. T. Jyothi Datta , 10-Dec-2013 , Business Line)
Interview with Pfizer India chief, Aijaz Tobaccowalla, on prospects and pitfalls of doing business in India.
More...
With most patents, China biggest intellectual property growth driver, says report
(Vanita Srivastava , 10-Dec-2013 , Hindustan Times)
China– with the highest number of patents filed and received– was the biggest driver of the intellectual
property growth in 2012, according to the World Intellectual Property Organisation. More...
Baring India sees geographical diversification driven by patent expires, rise in R&D spend as
2 emerging trends
(Nandita Vijay, Bengaluru, , 10-Dec-2013 , Pharmabiz)
Baring India, a leading private equity fund, signals that Indian pharmaceutical sector seems to suggest
two clear emerging trends. More...
Global patents for Mahindra Two Wheelers

(10-Dec-2013 , The Indian Express)
Mahindra Two Wheelers Ltd — the scooter and motorcycle making arm of Mahindra and Mahindra Ltd —
has obtained international patents for four of its indigenously developed technologies. More...
Sell drugs at govt rates, not higher prices mentioned on box, says SC
(Utkarsh Anand , 10-Dec-2013 , The Indian Express)
The Supreme Court on Monday ruled that drug manufacturers and retailers cannot sell medicines at
higher prices mentioned on the label of the boxes if the government notifies a lower rate. They must
implement the price fixed under the Drugs (Prices Control) Order (DPCO) within 15 days from the date
of notification. More...
No reprieve for drug cos in new DPCO prices

(Jayati Ghose, Indu Bhan , 10-Dec-2013 , The Financial Express.)
Reducing the leeway for drug firms to sell older stocks of price-regulated medicines in the market at
previously notified — rather than new — prices, the Supreme Court on Monday held that the firms are
liable to replace these stocks within the grace period provided by the National Pharmaceuticals Pricing
Authority (NPPA). More...
Drug retailing: SC upholds 15-day deadline for price-control rollout

(BS Reporter , 10-Dec-2013 , Business Standard)
The Supreme Court ruled on Monday that manufacturers and importers of pharmaceutical products must
implement the Drugs (Prices Control) Order within 15 days from the date of notification or receipt of the
order. More...
European Union warns Nokia not to become 'patent troll

(AP , 09-Dec-2013 , The Economic Times)
Europe's top regulator has warned Nokia not to try to become a "patent troll'' after the Finnish company
sold most of its cellphone-making business to Microsoft Corp. this year but retained its patent portfolio.
More...
India records growth in patent filings

Global patent filings in 2012 increased at its strongest rate in nearly two decades as industrial-design
registration notched its best-ever rate of growth, a report says. More...
Samsung may need to offer more to settle patent dispute: Almunia

Samsung Electronics Co Ltd will likely need to do more to settle an investigation over whether its use of
patent lawsuits against Apple Inc breached EU rules, the EU antitrust chief said on Monday. More...
Global patent growth hits 18-year high: World Intellectual Property Organization
(AFP , 09-Dec-2013 , The Economic Times)
Global patent filings grew at their fastest pace in almost two decades in 2012, with China the driving
force, the UN's intellectual property agency said Monday. More...
Patents law
(Poonam Jain , 9-Dec-2013 , The Times Of India)
Anirban Mazumdar, associate professor of law at West Bengal National University of Juridical Sciences,
on career options in patents law. More...
WTO: 5 Gains for World Trade

(9-Dec-2013 , The Economic Times,Mumbai)
Even the diehard optimist did not believe the Bali Ministerial of the World Trade Organization (WTO)
would achieve anything.The sceptics said its failure would be a nail in the coffin of multilateral attempts
at equitable trade orders, after all in its 12 years the Doha Round had nothing to show. Unexpectedly,
Bali did deliver a result.ET deciphers the gains from Bali..... More...
US Supreme Court case could mean 'death' of software patents

(Associated Press , 7-Dec-2013 , IBN Live)
The US Supreme Court decided Friday to hear an appeal of a lower court decision that a federal judge
called the "death" of software patents. More...
US House passes IT firms-backed patent bill

The US House of Representatives has approved a bill aimed at reining in "patent trolls," companies that
buy or license patents from others, then extract licensing fees or file infringement lawsuits viewed by
many as frivolous. More...
Govt may issue compulsory licences on diabetes drugs

( C.H. Unnikrishnan , 5-Dec-2013 , Livemint)
Health ministry panel may suggest compulsory licences for at least two patented drugs that are yet to
be identified. More...
India to showcase drugmaking facilities to global regulators

(Raji Reddy Kesireddy , 4-Dec-2013 , The Economic Times)
India is showcasing its best pharmaceutical manufacturing facilities to regulators from emerging
economies to counter adverse publicity the country's drug industry has endured in recent times. More...
IPAB scraps 7 trademarks of TT Industries in favour of Korean firm Tageu Tec

South Korean firm says TT Industries has not sold or marketed a single product under the impugned
marks despite obtaining registration. More...
Indian pharma seeks women part-time sales force in Tier II cities to ensure diversity,
stability in cos
(Nandita Vijay, Bengaluru , 04-Dec-2013 , Pharmabiz)
Indian pharma companies are now seeking out to employ women part time sales work force in Tier II
cities. The move comes in because the industry is seen grappling with an attrition rate of 18-20 per cent
particularly in sales and marketing. More...
J&J faulty implants: $2.5b payout in US, Indians left in lurch

(Sumitra Deb Roy , 4-Dec-2013 , The Times of India, Mumbai.)
Pharmaceutical giant Johnson & Johnson recently agreed to pay $2.5 billion (over Rs 15,000 crore) as
compensation to around 8,000 US citizens who had sued the company after being fitted with its faulty
hip implants More...
Pharma industry has a deep culture of corruption

(Chirantan Chatterje , 3-Dec-2013 , Business Line)
Circumventing 56 patents protecting a medicine to re-invent a novel process and procure a 57th one for
Eli Lilly’s drug Cefaclor had been Ranbaxy’s biggest claim to fame in the last couple of decades. But in
2013, the situation flipped in what can be termed as its summer of dirty medicine. More...
Medical Device Cos Urge Govt not to Punish All for a Quality Lapse
(Soma Das , 03-Dec-2013 , The Economic Times,Mumbai)
Cos want input providers, component suppliers to also be held responsible for a faulty device More...
Pharmaceuticals: Compulsory licensing & reasonable efforts

(Anurag K Agarwal , 02-Dec-2013 , DNA)
Globally harmonised patenting laws recognise the sovereignty of nations like India which retain the right
to compulsory licensing. More...
Govt to dissolve panel on patented drug pricing

(Sushmi Dey , 2-Dec-2013 , Business Standard)
Almost six years after forming a committee to derive a mechanism to negotiate and bring down prices of
patented medicines in the country, the government has decided to dissolve the panel and dump the
report the body submitted at the start of this year. More...
US biotech firm Kibow to enter India after favourable patent ruling

( C.H. Unnikrishnan , 2-Dec-2013 , Livemint)
Kibow has sought marketing approval for Renadyl, a biological supplement that helps kidney patients
sustain themselves without dialysis, and has already set up a local entity. More...
14 items on GI tag list

Oranges of Nagpur, paintings of Kangra, Moradabad metal craft and Kolhapur jaggery are among 14
items waiting for Geographical Indications (GI) tag. More...
Facts about the WTO

(AAP , 2-Dec-2013 , Yahoo)
The World Trade Organisation (WTO) meets for its ninth ministerial conference on the Indonesian island
of Bali this week, fighting to salvage a deal on slashing barriers to global commerce. More...
IP tribunal upholds US company’s product patent

(Our Bureau , 29-Nov-2013 , Business Line)
The Intellectual Property Appellate Board has upheld its 2009 decision to grant US-based Kibow Biotech
a patent for a probiotic dietary supplement that will augment kidney function, according to a statement
by the company. More...
India to investigate Ericsson in smartphone patent row

(Reuters | Stockholm , 28-Nov-2013 , The Financial Express)
Ericsson had sued Micromax in March 2013 for patent infringement. More...
Interview Dr. Jeremy Desai - “The pharma industry is going through a major transition”
(Sheetal Srivastava , 28-Nov-2013 , The Economic Times,Mumbai)
Dr. Jeremy Desai, president and COO of Apotex Inc. discusses with Sheetal Srivastava the future of the
pharmaceutical industry More...
Wockhardt Revenues may Dip Up to $250 m on USFDA Ban

(Divya Rajagopal , 28-Nov-2013 , The Economic Times,Mumbai)
Wockhardt may suffer an annual revenue fall of up to $250 million and its American operations may
grind to a halt after the US’s drug regulator banned the sale of medicines produced from the firm’s
Chikalthana plant in the world’s biggest pharma market. More...
KKR Set to Pick Up 35% Stake in Gland Pharma

(Arun Kumar , 28-Nov-2013 , The Economic Times,Mumbai)
At about . 1,300 crore, it will be one of the largest private equity deals in pharmaceutical sector More...
Wockhardt’s 2nd plant faces US ban

(Rupali Mukherjee , 28-Nov-2013 , The Times of India, Mumbai.)
Drug major Wockhardt suffered a huge blow on Wednesday with the US Food and Drug Administration
(FDA) banning products shipped from its key plant located at Chikalthana in Maharashtra. More...
Centre mulling new premises for Intellectual Property Appellate Board in Chennai
(Aparna Ramalingam , 27-Nov-2013 , The Times Of India)
The Union commerce ministry is in the process of setting up new premises for the Intellectual Property
Appellate Board (IPAB) here. More...
Industry to benefit from utility model for patents

(BS Reporter | Chennai , 27-Nov-2013 , Business Standard)
After the elections, Centre may bring an amendment in the 2014 sessions of the Parliament, to accept
the utility model in Indian Patent Act More...
Government mulls stricter norms for patents in pharma space

In a move that could usher in more transparency in the pharma patent landscape, the Indian Patent
Office is considering a proposal that seeks to make it mandatory for drug firms to disclose the WHO-
assigned generic names of drugs, whenever known, while applying for their patent. More...
EU lays down data protection steps for US

(27-Nov-2013 , The Economic Times)
The EU on Wednesday laid down steps Washington must take to restore trust after a huge spying
scandal, including giving EU citizens the right to US legal redress to protect personal data. More...
WTO deal teeters, some blame Indian electioneering

India may hold the key to the credibility of the World Trade Organization and to a trillion-dollar trade
deal that apparently was derailed this week, diplomats in Geneva said on Tuesday. More...
Biocon, Mylam get approval for biosimilar of cancer drug Herceptin

(C.H. Unnikrishnan , 26-Nov-2013 , Livemint)
Biocon says the biosimilar Trastuzumab will be sold in India under the brand name Canmab. More...
Sony seeks ‘SmartWig’ patent in US

(Grace Huang , 26-Nov-2013 , Livemint)
SmartWig hairpieces can be used to navigate, check blood pressure or control a slideshow and can
communicate wirelessly with another device. More...
Govt should not interfere with cross-fertilisation in Indian pharma sector

(Habil Khorakiwala , 26-Nov-2013 , The Economic Times,Mumbai)
The last 10 years in the Indian pharmaceutical industry have been characterised by many events that
led to its stellar performance. More...
The NDTV Dialogues: Why is India's healthcare in critical condition?

(Sonia Singh , 25-Nov-2013 , www.ndtv.com)
India's health parameters are amongst the worst in the world right now and a child born in India today
has less chances of survival than in Nepal or Bangladesh. On The NDTV Dialogues, Dr Srinath Reddy,
Kiran Mazumdar Shaw, Dr Binayak Sen and Dr Ashok Seth join NDTV's Sonia Singh to look at why
India's healthcare is in a critical condition. More...
Suggestion of WTO complaint irks public health workers in India

(P. T. Jyothi Datta , 25-Nov-2013 , Business Line)
A US trade lawyer’s observation on the possibility of hauling India to the World Trade Organisation, “for
violating international patent treatises”, has ruffled feathers back in India. More...
European Patent Office to slash fee to euro 5,000 by 2015

(BS Reporter | Hyderabad , 25-Nov-2013 , Business Standard)
Says lack of complete database on Indian patents slowing down patent filing by local inventors. More...
Indian health activists move to prevent Gilead’s drug patent

(Andrew Jack in London , 24-Nov-2013 , The Financial Times )
Indian health activists are seeking to prevent Gilead from patenting its new treatment for Hepatitis C in
the country in a fresh battle over affordable access to medicine. More...
Gilead’s patent application on hepatitis C drug opposed

US drug-maker Gilead Sciences’ patent application on hepatitis C drug sofosbuvir has been opposed at
the Indian Patent Office by legal group I-MAK — Initiative for Medicines, Access & Knowledge. More...
Samsung shares rise despite patent case setback

(AFP , 22-Nov-2013 , The Times Of India)
South Korean markets took in stride a US federal jury's order for Samsung to pay $290 million in
damages to Apple, with Samsung shares going up 0.69% on Friday. More...
Now, a bid to trademark ‘stem cells’

(Bindu D. Menon , 22-Nov-2013 , Business Line)
After bima (insurance) and manjal (turmeric), a company now wants to be the brand owner of the word
‘stem cell’. More...
India, EU should address regulatory problems, tariff issues

Seeking deeper co-operation with India, European Union today said both sides need to work on
eliminating tariff barriers and regulatory difficulties in their bilateral economic exchanges. More...
Creative Commons: thinking beyond copyright

(T. Ramachandran , 22-Nov-2013 , The Hindu)
Are there ways of going beyond copyright when it comes to promoting and sharing original work and
content online? Yes, think of Creative Commons, which has been relaunched in India. More...
Biocon ups generic war with nod for Roche's cancer drug clone
Two months after the Swiss innovator firm Roche threw in a surprise by announcing that it would no
longer pursue a patent on breast cancer drug Herceptin in India, it will have to brace up for generic
competition, probably much earlier than it anticipated. More...
India’s monopoly regime stops us from making many drugs here: Cipla’s Hamied
( C.H. Unnikrishnan , 22-Nov-2013 , Livemint)
Cipla’s market is not India alone and it has to go global, says Yusuf K. Hamied, who stepped down as
MD in February. More...
US Jury awards Apple $290 million in Samsung patent case

A US federal jury Thursday ordered Samsung to pay $290 million in damages to Apple in a partial retrial
of the blockbuster patent case involving the two smartphone giants. More...
Microsoft sues Acacia over smartphone patents

(Reuters , 21-Nov-2013 , The Times Of India)
Microsoft filed a lawsuit against Acacia Research, charging that Acacia broke a contract to license various
smartphone and mobile computing technologies to Microsoft. More...
US house panel passes bill targeting ‘patent trolls’

( Reurtes , 21-Nov-2013 , Livemint)
The bill requires companies filing infringement lawsuits to provide specific details on what patent is
infringed, how it is used. More...
IPAB revokes a patent of US-based Kibow Biotech

(BS Reporter | Chennai , 20-Nov-2013 , Business Standard)
The revocation petition was filed by the Indian firm after it was challenged by Kibow Biotech in the
Madras High Court. More...
Samsung sued for patent infringement

A Taiwanese electronics company said that it has filed a lawsuit against South Korean tech giant
Samsung for allegedly infringing on its optics technology patents. More...
Expiry of patent to make rheumatic drugs cheap

(Shimona Kanwar , 20-Nov-2013 , The Times Of India)
With the patent date of drugs used in the treatment of rheumatic diseases nearing its expiry, those
suffering with the crippling disease would soon be able to afford the expensive treatment. More...
When Cadbury replaced its eclairs
(Viveat Susan Pinto | Mumbai , 19-Nov-2013 , Business Standard)
Mondelez, the parent, recently, was asked to remove three of its Chocolate Eclairs label trademarks by
the Intellectual Property Appellate Board following a case lodged by rival ITC. More...
Emerging economies' trademark filings rise

(AAP , 18-Nov-2013 , Yahoo Finance)
Emerging economies have almost tripled their trademark applications over the past three decades,
underscoring the growing store they place in branding, the World Intellectual Property Organisation
says. More...
‘It’s Wholly Reasonable for India to Think About Pricing’

(Divya Rajagopal & Sagar Malviya , 18-Nov-2013 , The Economic Times,Mumbai)
Glaxo CEO Andrew Witty says MNCs need to look at things from India’s perspective. It might hurt to go
through price adjustments but there are alternative ways to have a good dialogue More...
'Superbugs may erase medical advances'

(Charlie Cooper , 18-Nov-2013 , The Times of India, Mumbai.)
Even Routine Operations Could Become Deadly 'In The Very Near Future', say Doctors. More...
Whose tribunal is it anyway?

(Justice Prabha Sridevan , 18-Nov-2013 , The Hindu)
The independence of specialist tribunals must be ensured. But this is not happening, as the functioning
of the Intellectual Property Appellate Board shows More...
WikiLeaks expose: Drug makers see red

(Sushmi Dey | New Delhi , 16-Nov-2013 , Business Standard)
Approach govt to open negotiations on generics More...
Natco wins patent war against Teva

(Fe Bureau : New Delhi/ Hyderabad , 15-Nov-2013 , The Indian Express)
Hyderabad based-Natco Pharma has won a patent battle against Israeli drug giant Teva
Pharmaceuticals, which could enable it to launch a generic version of the multiple sclerosis drug
Copaxone in the US market in 2014. More...
Emerging economies' trademark filings climb sharply: WIPO

(AFP | Geneva , 14-Nov-2013 , Business Standard)
Emerging economies have almost tripled their trademark applications over the past three decades,
underscoring the growing store they place in branding, the World Intellectual Property Organization said
today. More...
Apple wants $380 mn in patent trial with Samsung

(PTI , 14-Nov-2013 , Business Line)
Apple demanded today that Samsung Electronics pay it $380 million for copying vital iPhone and iPad
features, as a billion-dollar patent fight between the world’s two biggest smartphone makers resumed in
a Silicon Valley courtroom. More...
Jury selection starts in Samsung-Apple patent trial

(DPA , 13-Nov-2013 , Business Line)
Smartphone giants Apple and Samsung renewed their US court battle on Tuesday in a trial to determine
damages for Samsung’s violation of Apple’s iPhone and iPad patents. More...
Ignorance to blame for basmati setback

Indian inventors lack the knowledge of patenting and hence lose out to international competitors.
More...
Government rejects BDR Pharma's CL application for anti-cancer drug

The government has rejected a compulsory licensing application by BDR Pharmaceuticals to manufacture
the generic version of patented anti-cancer drug 'Dasatinib', a decision that is seen as evidence that IP
rules prevail in India. More...
Rakesh Roshan to pursue Krrish 3 copyright violation case

(Geety Sahgal , 9-Nov-2013 , The Indian Express)
Rakesh Roshan is a relieved man that the Bombay HC did not entertain an appeal by Uday Singh Rajput.
More...
Reliance Telecom's domain name plea rejected

(LUBNA KABLY , 8-Nov-2013 , The Times Of India)
The company filed a complaint against the domain name holder with World Intellectual Property
Organisation (WIPO), an international arbitration service provider for settlement of domain name
disputes. More...
Cadbury loses battle with ITC over Chocolate Eclairs

(Sanjay Vijayakumar , 07-Nov-2013 , The Times Of India)
After Kellogg's and Bata, it is now the turn of Cadbury to lose a trademark for non-use, 'eclairs' in this
case, leaving experts intrigued as to why the chocolate maker couldn't come up with enough evidence of
its use when asked in a court. More...
Apple patents tech for tracking homes via iPhone

(ANI , 06-Nov-2013 , The Times Of India)
Apple has reportedly patented a technology that would allow users to track certain events in their home
while they are commuting back home or away for a holiday. More...
It’s strategies sans frontiers in pharma patent filings

(Pallavi Ail , 6-Nov-2013 , The Financial Express)
Despite seemingly strict criteria, pharmaceutical patents are not that hard to come by in India More...
Takeda drags DRL to US court for infringement

(ENS Economic Bureau - HYDERABAD , 6-Nov-2013 , The Indian Express )
Japanese pharma major Teijin Ltd and Takeda Pharmaceutical USA Inc together dragged city-based Dr
Reddy’s Laboratories Ltd (DRL) to a US court allegedly for infringing their patent. More...
Japan's Eisai to launch breast cancer drug in India

(DIVYA RAJAGOPAL , 6-Nov-2013 , The Economic Times)
Japan's Eisai Pharma, a 741 billion yen ( Rs 46,439-crore) pharma major, is slated to launch in India its
novel anti-cancer drug Eribulin, sold under the brand name of Halaven, as part of its strategy to expand
its presence in the emerging markets. More...
Strong patent regime needed for GM crops, says MoS Tariq Anwar
Congress 2013 began here Tuesday with union Minister of State for Agriculture Tariq Anwar calling for a
strong patent regime to regulate genetically modified (GM) crops in the country. More...
In patent fight, IBM's arsenal dwarfs Twitter's

International Business Machines Corp's patent demand against Twitter Inc as it approaches an initial
public offering highlights how few patents the social media company possesses compared with the
established tech players. More...
GI tag: applications filed for eight articles

(Special Correspondent , 05-Nov-2013 , The Hindu)
Applications have been submitted for getting Geographical Indication (GI) tag for eight articles,
according to P.Sanjai Gandhi, Geographical Indication (GI) Attorney and Additional Government Pleader.
More...
Samsung extends patent licence deal with Nokia

Finland's Nokia said Samsung Electronics has extended a phone patent licence agreement between the
two companies for five years. More...
BDR’s compulsory licence bid for MNC cancer drug rejected

(Rupali Mukherjee , 31-Oct-2013 , The Times OF India)
India's second compulsory licensing application filed by domestic company BDR Pharma on dasatinib, an
anti-cancer drug patented by Bristol-Myers Squibb, has been rejected by the Indian Patent Office,
denying millions of patients access to the affordable version at a fraction of the cost of the patented one.
More...
Nokia wins mobile patent judgment in UK against HTC
Finnish telecoms group Nokia scored another victory on Wednesday in its patent battle against Taiwan-
based rival HTC Corporation with a British court ruling in its favour over mobile telecoms technology.
More...
IPAB refuses use of trademark 'Sony' by India's AB Textiles

The IPAB came down heavily on the decision of the deputy registrar in refusing the Japanese firm's
opposition and allowing the textile firm to register the trade mark. More...
IPAB refuses use of TM 'Sony' by Indian firm

(Gireesh Babu , 28-Oct-2013 , Business Standard)
Sides with Sony Corp in trademark case. More...
Samsung files patent to rival Google Glass

(26-Oct-2013 , DNA)
The South Korean firm's patent, filed on March 8, shows that it is working on a device it calls 'Sports
Glasses' that are likely its response to Google's Internet-connected eyewear. More...
Getting IP owners to blow the whistle can check piracy

Containing infringement of intellectual property rights and piracy will require efforts to educate people
about its impact. More...
Samsung files patent to rival Google Glass

(ANI , 26-Oct-2013 , DNA)
The South Korean firm's patent, filed on March 8, shows that it is working on a device it calls 'Sports
Glasses' that are likely its response to Google's Internet-connected eyewear. More...
GIPC urges India to strengthen IP laws to utilize its vast knowledge pool and create more
jobs
(Our Bureau , 25-Oct-2013 , Pharmabiz)
The US Chamber of Commerce’s Global Intellectual Property Centre has urged India to encourage
innovation in the country and strengthen its Intellectual Property laws to utilize its vast knowledge pool
and create more jobs. More...
Emerging markets like Brazil, South Africa initiate reforms in patent laws in line with India’s
IP policy
Days before the Supreme Court ruled that Novartis’ cancer drug Glivec is not a new invention good
enough to be granted patent in April, a top executive of Pfizer had told a US Congress sub-committee,
“India’s action reverberates far beyond its borders.” More...
US pharma firms lobby to protect patents in India
(Amiti Sen , 23-Oct-2013 , Business Line)
US pharma majors are putting pressure on the Government to stop issuing permits to domestic
companies for making low-priced copies of patented life saving drugs. More...
India yet to seriously take up loopholes in new EU regulation on customs enforcement

(Joseph Alexander, New Delhi , 22-Oct-2013 , Pharmabiz)
India is yet to seriously take up with the European Union the alleged loopholes in the recent EU
regulation on customs enforcement of intellectual property rights even as the public interest groups
claimed that the new regulation was nothing better than the original one of 2003 that led to the seizure
of Indian generic drugs and could pose serious hurdles again for Indian industry. More...
'India has failed to recognise IP rights;deterring investors'

A US trade body has asked India to spur innovation and strengthen its intellectual property laws, saying
failure to recognise IP rights was dissuading investors and keeping Indian economy in a logjam. More...
?'India is committing selective genocide in healthcare'

(Rema Nagarajan , 20-Oct-2013 , The Times Of India)
The recent release of the documentary Fire in the Blood has revived the debate on whether patents
block access to life-saving medicines. More...
When patents, not patients, matter more

(Narayan Lakshman , 19-Oct-2013 , The Hindu)
Neither the long-term health of their clientele nor the affordability or true effectiveness of a drug
matches profit-making as a motivator for drug companies. More...
PGI for patent cell to market research

(Shimona Kanwar , 19-Oct-2013 , The Times Of India)
In a recent open house the PGI faculty sought the director's permission to allow their medical research
to be translated into marketable commodities for affordable healthcare. More...
Samsung offers to stop patent lawsuits in Europe

(AP , 18-Oct-2013 , The Times Of India)
Samsung Electronics has offered not to launch any patent lawsuits over key mobile telephone
technology in Europe for the coming five years, in hopes of avoiding a fine from the European
Commission. More...
Samsung offers concessions to EU in patent case

(AP , 17-Oct-2013 , The Times Of India)
The European Commission is calling for comments or objections to a proposal by Samsung to end one
type of patent dispute over mobile telephones in Europe for the coming five years. More...
Invention to detect fake currency gets US patent
(Laxmi Ajai Prasanna , 15-Oct-2013 , The Times Of India)
Rarely though there is a 400 per cent increase in counterfeit currency circulation in the country
according to the national financial intelligence unit. More...
Nokia India tax dispute: India to discuss case WTO cooperation with Finland
(fe Bureau , 15-Oct-2013 , Financial Express)
Nokia's dispute with Indian tax authorities is likely to figure in a high level bilateral meeting. More...
New Ferrari revealed in patent images

(Autocar India , 14-Oct-2013 , Hindustan Times)
Several official illustrations, which appeared online after being submitted for design registration, show
the new Ferrari in detail. More...
Madras HC sets aside IPAB order in Enercon GmbH patent case

Court has directed IPAB to look at maintainability of petition filed by Indian partner and submit its
decision within two months. More...
Samsung gadgets to face US import ban over Apple patent row

(ANI , 09-Oct-2013 , Business Standard)
Apple won a case at the US International Trade Commission that found Samsung had infringed the two
patents. More...
US patents granted to inventions to contain suicide bombers

(Bloomberg , 7-Oct-2013 , The Economic Times)
Among the recently granted US patents is an invention to contain suicide bombers, technology that
prevents you from getting shot, and a way to rest in peace. More...
Indian pharma majors step up R&D spend by 19.7% in 2012-13

(Sanjay Pingle, Mumbai , 7-Oct-2013 , Pharmabiz)
Expenditures on Research & Development by 30 leading Indian pharmaceutical companies have gone up
significantly by 19.7 per cent during the year ended March 2013 over the previous year. More...
The right cure for pharma frauds

(KPMG , 06-Oct-2013 , Business Line)
Drugs estimated at $116 billion are going off-patent in the next five years. More...
Kalanamak rice, ‘Buddha’s gift’, awarded GI tag

(Manish Raj , 4-Oct-2013 , The Times Of India)
If you think Basmati rice, a subject of many patent battles, is the best, here is Kalanamak rice More...
Ispat Nigam Limited eyes patent route to consolidate position

(Manish , 03-Oct-2013 , The Times Of India)
State-run steel major Rashtriya Ispat Nigam Limited which expects to complete its 6.3 million tonnes
per annum expansion plan soon, now also aims to strengthen its research and development wing to
consolidate its position in the steel industry. More...
India's IPR regime - Moving beyond the myths of US pharma

(Hemant Krishan Singh & Aman Raj Khanna , 03-Oct-2013 , Business Standard)
It is time for the Indian government to address the growing trust deficit with foreign pharmaceutical
manufacturers on the question of IPRs and improve the enforcement of patent protection. More...
US, EU irked by India’s compulsory licence plan for green technologies

(Amiti Sen , 02-Oct-2013 , Business Line)
The US and the EU have raised strong objections to India’s decision to allow compulsory licensing in the
green technology sector. More...
Restricting FDI in pharma may prove counter-productive

(Subir Roy | Kolkata , 1-Oct-2013 , Business Standard)
One way India can ensure supply of cheap generics is by reviving the half-dead state-owned pharma
companies. More...
Patent battles healthy for pharma

(Rajeshwari Hariharan , 30-Sep-2013 , DNA)
The Indian pharma space has seen a number of battles between innovators and generic companies —
the Novartis war and Merck-Glenmark being one of the recent ones. More...
‘Patan Patola’ gets GI registration

(R. Sivaraman , 30-Sep-2013 , The Hindu)
Patan Patola a double-sided saree from Gujarat and a favourite of Congress president Sonia Gandhi has
got recognition from Geographical Indication Registry. More...
Nilambur teak to get geographical indication tag soon

(T P Nijish , 30-Sep-2013 , The Times Of India)
Nilambur teak will soon become the first forest resource from India to get GI (geographical indication)
tag of World Trade Organisation. More...
Patent battles healthy for pharma

(Rajeshwari Hariharan , 30-Sep-2013 , DNA)
The Indian pharma space has seen a number of battles between innovators and generic companies the
Novartis war and Merck - Glenmark being one of the recent ones More...
TN distillery stopped from brewing French Cognac
(Express News Service - CHENNAI , 30-Sep-2013 , The New Indian Express)
The Madras High Court has restrained a firm in the State from manufacturing and selling a branded
liquor saying the brand name ‘French Cognac’ enjoyed Geographical Indication protection and that it
exclusively belonged to a French company. More...
Indian pharma market isn’t going to be that rosy

(Ramnath Subbu , 29-Sep-2013 , The Hindu)
Glenn Saldanha, Chairman & Managing Director, spoke to The Hindu on a range of issues in the
pharmaceutical industry. More...
DRL would infringe on Lunesta patent: US court

(Press Trust Of India : Hyderabad , 28-Sep-2013 , The Indian Express)
The United States Court of Appeals for the Federal Circuit has ruled that Dr Reddy's Laboratories Ltd
would infringe on the patent of Sunovion Pharmaceuticals blockbuster drug Lunesta. More...
New ordinance against piracy

However, the Copyright (Amendment) Act 2012, which came into force in July 2012 following the
President's assent, has the provision for punishment up to two years along with a fine for dealing in fake
cassettes, CDs and DVDs. More...
Samsung moves to appease EU on Apple patent fight

(AFP , 27-Sep-2013 , The Economic Times)
South Korea's Samsung has answered accusations by Brussels that the company abused its dominant
market position by taking out unfair injunctions against rival Apple, the European Commission said on
Friday. More...
Dr Reddy’s loses insomnia drug patent case in US court

A US Court of Appeals has ruled that Dr Reddy’s Laboratories Ltd infringed on the patent of insomnia
drug Lunesta of Sunovion Pharmaceuticals. More...
Obama to raise industry concerns at patent regime in India with Singh

(BS Reporter | New Delhi , 27-Sep-2013 , Business Standard)
Alliance for Free Trade with India today urged the US President to 'stand up for the American industry'.
More...
Tech giants fear spread of patent wars to Europe

(Danny Hakim , 27-Sep-2013 , Business Standard)
The European headquarters of Google Inc in Dubin, Ireland. Google is concerned about a proposed
change in the European Union's patent court system. More...
Japan fines Apple for patent infringement
(IANS - TOKYO , 26-Sep-2013 , The New Indian Express)
Saito filed an application with Tokyo Customs for an injunction against iPod imports for the patent
infringement in 2007, said the report. More...
Refrain aggressive buying of large-cap pharma firms: G Chokkalingam, Centrum Wealth

Management
(ET Now , 26-Sep-2013 , The Economic Times)
G Chokkalingam: I am nervous on very large-cap pharma companies because ever since the courts have
revoked patent for pharma companies, we have seen a lot of qualitative restriction, especially from the
US for Indian pharma companies. More...
Forest files patent suits against Lupin, Ranbaxy and others

(Press Trust of India | New Delhi , 26-Sep-2013 , Business Standard)
Joint lawsuits have been filed in the Court for the District of Delaware. More...
Cautious moves
(Sujay Mehdudia , 26-Sep-2013 , The Hindu)
Governments should safeguard public interests while negotiating Free Trade Agreements, says a CUTS
study. More...
US wants MNCs to have right to sue India abroad

Most bilateral investment treaties include a broad definition of investment, covering just every aspect
from financial transactions to intellectual property to any form of asset, Dhar added. More...
Suven Life Sciences gains after securing three product patents

Suven Life Sciences rose 2.29% to Rs 44.65 at 11:13 IST on BSE after the company said it has secured
three product patents corresponding to the new chemical entities for the treatment of disorders
associated with Neurodegenerative diseases. More...
Samsung, LG end patent dispute over display tech

(AFP , 24-Sep-2013 , The Times Of India)
South Korean electronic giants Samsung and LG have agreed to end a year-long battle over display
technology patents that spawned a series of lawsuits. More...
HTC violates Nokia's patents: US judge

HTC Corporation infringed on two Nokia patents in making its mobile telephones and tablets, a judge
said in a preliminary ruling issued on Monday for the US International Trade Commission. More...
Kerala man gets US patent for device that generates power 'anywhere, anytime'
(Indo-Asian News Service , 24-Sep-2013 , NDTV)
MC David, a 57-year-old amateur magician from Kerala, has secured a US patent for an invention that
generates electricity "anywhere, anytime". More...
Samsung, LG end patent dispute on display technology

South Korean electronic giants Samsung and LG have agreed to end a year-long battle over display
technology patents that spawned a series of lawsuits. More...
Dr Reddy's plunges nearly 2% on patent infringement suit

(ECONOMIC TIMES.COM , 23-Sep-2013 , The Economic Times)
Dr Reddy's Laboratories Ltd plunged as much as 1.85 per cent in a weak market on Monday, after
Genzyme Corporation, a fully-owned subsidiary of drug major Sanofi-Aventis, filed a suit against Dr.
Reddy's Laboratories. More...
Pharmaceutical Price Regulation - Is the government being two-faced?

(DNA/Saurav Datta , 23-Sep-2013 , ZeeNews)
Pharmaceutical Prices Regulation- the government’s deception needs to be called out. More...
Genzyme Corporation files patent infringement suit against DRL

Genzyme Corporation, a fully-owned subsidiary of drug major Sanofi-Aventis, has filed a suit against Dr.
Reddy's Laboratories alleging that the Indian drug maker infringed patents of its blockbuster cancer drug
Mozobil on three counts. More...
Watson Laboratories send patent challenge notice to Ranbaxy for acne drug
Drug firm Ranbaxy Laboratories has said its US arm has received a notice from Watson Laboratories Inc,
challenging the patent of acne treatment drug Absorica. More...
Ranbaxy to contest US pharma company to protect drug patent

Ranbaxy Laboratories Inc, the US-based wholly-owned subsidiary of Ranbaxy Laboratories Ltd, has
received a Paragraph IV Certification Notice of filing from Watson Laboratories Inc of an Abbreviated
New Drug Application to the US Food and Drug Administration for a generic version of Absoric
(isotretinoin capsules), the company said in an official statement on Thursday. More...
Teva drug copy to boost Natco Pharma sales

(Bloomberg , 19-Sep-2013 , Livemint)
Natco says sales will jump 62% in two years once it starts selling generic version of Copaxone to treat
multiple sclerosis More...
Princeton Sues Princeton for a Share of Its Patent Millions
(David Voreacos and Susan Decker , 19-Sep-2013 , Business Week)
More than three decades ago, Princeton University professor Edward Taylor invented the compound that
became the anticancer drug Alimta. More...
Are Indian pharma companies being victimised by US FDA?

(Shishir Asthana | Mumbai , 17-Sep-2013 , Business Standard)
US FDA has increased its focus on Indian pharma cos but is it deliberate. More...
In pursuit of geographical indication tag

(S M Arun , 17-Sep-2013 , The Times Of India)
Geographical Indication tag has been sought for four products Erode turmeric, Salem mango, Hosur rose
and Namakkal makkal stone work that have a distinctive character compared to similar products from
other parts of the state. More...
Nagpur firm's drug developed for crop protection gets US patent

(Press Trust Of India | Ahmedabad , 16-Sep-2013 , Business Standard)
He claimed that this drug can reduce use of pesticides to the tune of Rs 50,000 cr. More...
US drug regulator red flags Ranbaxy, Strides

(HT Correspondent , 16-Sep-2013 , Hindustan Times)
The US drug regulator has blacklisted Ranbaxy Laboratories’ Mohali plant, its third factory to face such
an import ban, dealing a body blow to the company’s reputation and bringing its share prices crashing
by 30.3% on Monday. More...
India's War On Intellectual Property Rights May Bring With It A Body Count
(16-Sep-2013 , Forbes)
Last month, drug maker Roche withdrew its patents for the breast-cancer drug Herceptin in India — and
thus gave tacit approval to other companies to make low-cost generic versions of the drug. More...
Foreign drug makers won 77% of all patents in last 3 years

India issued 1,001 drug patents between April 2010 and March 2013, of which 771 were given to foreign
drug makers. More...
Amended Patents Act: Of medicines and increased back-room activities

(P. T. Jyothi Datta , 15-Sep-2013 , Business Line)
Multinational pharmaceutical companies such as Novartis have been major beneficiaries of India’s patent
regime. More...
Indian pharma draws more scrutiny as US exports rise

(Reuters | Mumbai , 14-Sep-2013 , Business Standard)
India produces nearly 40% of generic drugs and over-the-counter products and 10% of finished dosages
in the US. More...
Petition against trademark on temple dismissed

(Express News Service - KOCHI , 13-Sep-2013 , The New Indian Express)
The Kerala High Court on Thursday dismissed a plea against a decision by the Controller General of
Patents, Designs and Trademarks granting certificate of trademark on the picture of the deity at Attukal
Devi Temple and the description that the temple is the ‘Sabarimala of women.’ More...
Who used my Ajinomoto, the real maker asks

(Viveat Susan Pinto | Mumbai , 13-Sep-2013 , Business Standard)
The latter is a registered trademark of Ajinomoto Co Inc, a Japanese food ingredients major, which has
been operating in the domestic market for the last 10 years. More...
Interesting turn in Dasatinib patent war

The BMS affidavit is an attempt ``to mislead the court through false information'', when the order by
the Patent Office has not been communicated officially, yet. This may influence the court decision,
Andreya Fernandes of the law firm said. More...
BDR Pharmaceuticals plea for compulsory licence on cancer drug rejected

(DIVYA RAJAGOPAL , 12-Sep-2013 , The Economic Times)
The Indian Patent Office has rejected Mumbai-based BDR Pharmaceuticals application for compulsory
licence on cancer drug Dasatinib according to an affidavit filed by Bristol Myers Squibb, the patent holder
for the drug. More...
Apple, Google back in court over mobile phone patent lawsuit

(Diane Bartz , 12-Sep-2013 , Reuters)
Apple and Google subsidiary Motorola Mobility on Wednesday squared off in court over whether a judge
should reopen a lawsuit in which the companies accuse one another of illegally using patented mobile
phone technology. More...
ApplGoogle back in court over mobile phone patent lawsuit

(Reuters , 12-Sep-2013 , The Economic Times)
Apple and Google subsidiary Motorola Mobility on Wednesday squared off in court over whether a judge
should reopen a lawsuit in which the companies accuse one other of illegally using their patented mobile
phone technology. More...
Samsung sued by Dyson over patent violation

British manufacturer Dyson said it had begun legal action against Samsung Electronics, to protect
against what it claims is a "cynical rip off" by the Korean group of the British firm's patented technology.
More...
Wockhardt stock soars on patent row settlement
(Sushmi Dey | New Delhi , 11-Sep-2013 , Business Standard)
Deal allows drug major to sell generic version of Neudexta from 2026. More...
Mylan will not shy away from pursuing ‘frivolous’ patents

(P. T. Jyothi Datta , 11-Sep-2013 , Business Line)
Multinational drug-maker Mylan has hinted that it is willing to get its hands dirty in India, even if this
meant pursuing frivolous or invalid patents to bring in less-expensive generic medicines. More...
Panel backs compulsory licence on cancer drug

(Vidya Krishnan , 11-Sep-2013 , Livemint)
If the DIPP approves the recommendation, it will be India’s second compulsory licence. More...
Siddhivinayak Temple trust moves to patent ' Mahaprasad'

(DNA , 11-Sep-2013 , Zee News)
The Siddhivinayak Temple Trust proposes to patent the mahaprasad laddus that it sells to devotees, who
visit the city’s most popular shrine to Lord Ganesh. More...
Losing ground to Big Pharma, bit by BIT

(Prabhash Ranjan/ Deepak Raju , 6-Sep-2013 , The Hindu)
India needs to revisit its bilateral investment treaties programme to ensure that multilateral gains on
patents are not lost. More...
Microsoft wins jury trial over Google’s patent licensing

(Bloomberg , 5-Sep-2013 , Livemint)
The jury in Seattle acts in its first day of deliberations and awards Microsoft about $14.5 million in
damages: reports More...
Salim-Javed settle with producers over copyright of Zanjeer

(PTI , 4-Sep-2013 , DNA)
Under section 38(3)(c) of the Act, a court can grant permanent injunction in cases where the defendant
invades plaintiff's right, and the invasion is such that compensation in money would not afford adequate
relief. More...
Roche had lost patent on breast cancer drug, Herceptin in Europe earlier
Multinational pharmaceutical company Roche which decided to drop monopoly rights on its blockbuster
breast cancer drug, Herceptin in India, had lost the same patent in Europe earlier More...
Patent lies and convenient truths

(Shamnad Basheer , 4-Sep-2013 , The Hindu)
The attempt by U.S. pharma majors to falsely depict India as an under-protector of intellectual property
smacks of hypocrisy More...
Why Nokia didn't sell patents to Microsoft

Nokia may have sold its handset business to Microsoft, but by hanging on to its valuable patent
portfolio, the Finnish company could also get a big future payoff at the expense of Android phone
makers. More...
Nokia patent move may mean big payoff post Microsoft

(Dan Levine , 4-Sep-2013 , Reuters)
Nokia may have sold its handset business to Microsoft Corp but by hanging on to its valuable patent
portfolio the Finnish company could also get a big future payoff at the expense of Android phone
makers. More...
Kolkata doctors patent neem extract to fight cancer

(Prithvijit Mitra , 3-Sep-2013 , The Times Of India)
A neem extract, which fortifies the immune system and helps fight cancer, has been patented by the
Chittaranjan National Cancer Research Institute. More...
Cost cutting: Silicon Valley patent office shelved

(AP , 02-Sep-2013 , The Times Of India)
Silicon Valley's high-tech firms are fighting what they consider a deeply personal federal cut this
summer that shelves a planned patent office in this innovation-fueled region. More...
Exhibition of Bengal sarees, handicrafts begins

An exhibition of exquisite and exclusive handicrafts and handloom creations from West Bengal is on here
in the run up to the Durga Puja. More...
Indian patent law doesn't discriminate against US companies: IPA

(Soma Das, ET Bureau , 29-Aug-2013 , The Economic Times)
India's intellectual property policy doesn't discriminate against US firms, Indian Pharma Alliance (IPA)
representing major domestic drugmakers has told Pfizer's Intellectual Property chief Counsel Roy
Waldron. More...
Indian patent regime a thorn in the flesh of global drug makers: Arun Narasani
(Nandita Vijay, Bengaluru , 29-Aug-2013 , Pharmabiz)
Brain League IP Services and Origin IP Solutions LLP have expressed that India needs to be taken
seriously by global pharma majors when it comes to revoking of patents. More...
Govt refutes Novartis' allegations on patents

(PTI , 28-Aug-2013 , ZeeNews)
Tearing into the allegations made by Novartis on India's 'discriminatory' patent practices, the
government has said global firms, including the Swiss drug major, have benefited more from the
country's rules cornering over 80 percent of the patents granted. More...
Patent regime not discriminatory, India tells Novartis

(Special Correspondent , 28-Aug-2013 , The Hindu)
Commerce Secretary S. R. Rao has asserted that global firms, including Swiss drug major Novartis AG,
have benefited more from the country’s rules. More...
More companies take to trademarks

An increasing number of Indian companies are registering their trademarks. More...
Chennai region has the highest number of patents filed in India

(Express News Service - CHENNAI , 28-Aug-2013 , Indian Express)
Chennai region has the highest number of patents filed in India and it accounts for 30 to 35 per cent of
the total patents filed last year, according to Chaitanya Prasad, controller general of patents, designs,
trademarks and registrar of geographical indications. More...
Right prescription for pharma

(S. Srinivasan , 28-Aug-2013 , Business Line)
The Parliamentary Standing Committee report is correct in recommending a cautious approach to FDI in
pharma. More...
Applications for registering trademark increasing 12% annually

(Press Trust of India | Chennai , 27-Aug-2013 , Business Standard)
The Controller General of Patents, Designs and Trademarks under the Commerce Ministry has received
over 1.94 lakh applications from industries for registering their trademarks in the last fiscal and it is
growing at 12% annually, a top official said today. More...
RCI getting ready to patent its technology

(Jatinder Kaur Tur , 27-Aug-2013 , The Times Of India)
Research Centre Imarat is all set to go for patenting of its products and technologies, its director G
Satheesh Reddy said during the organization's silver jubilee celebrations. More...
Dictionary words in software patent guidelines puzzle industry

(C.H. Unnikrishnan | Leslie D’Monte , 26-Aug-2013 , Livemint)
Terms not defined in draft guidelines on patents for computer-related inventions leaves room for
misinterpretation. More...
Techie's plastic-to-fuel device passes patent office tests

(Manish Raj, TNN , 26-Aug-2013 , The Times Of India)
Is necessity the mother of invention? Well, not always. More...
Indian Pharmaceutical Alliance slams US over charges on Indian patent law

Indian Pharmaceutical Alliance has contested US allegations that India's patent Act is discriminatory and
said America can go to WTO's dispute settlement mechanism if such is the case. More...
IPA slams US over charges on Indian patent law

Says, America can go to WTO's dispute settlement mechanism More...
Microsoft, Motorola set for second round of trial over patents

(Bill Rigby | Dan Levine , 25-Aug-2013 , Livemint)
The argument between the companies is just one facet of a wide-ranging global patent war surrounding
smartphone and Internet technology. More...
Patent litigation case: Apple, Samsung do not have to disclose profit details
(Reuters , 24-Aug-2013 , The Indian Express)
Apple Inc and Samsung Electronics Co Ltd do not have to make public the financial details submitted to
a US court during high-profile patent litigation, a federal appeals panel ruled on Friday. More...
Judge upholds $1.17 billion patent verdict against Marvell

(Bernard Vaughan , 24-Aug-2013 , Yahoo News)
A federal judge on Friday upheld a $1.17 billion award a jury imposed on chipmaker Marvell Technology
Group Ltd for infringing two patents held by Carnegie Mellon University. More...
Google buys patents from Apple Inc product manufacturer Hon Hai
(Reuters : San Francisco , 24-Aug-2013 , The Indian Express)
Taiwan's Hon Hai Precision Industry said it sold Google Inc part of a patent portfolio involving the
superimposition of virtual images on real-world photos. More...
Ratlami Sev all set to get global recognition

(Vivek Trivedi, Daily News & Analysis , 23-Aug-2013 , Daily Bhaskar)
Ratlami Sev renowned for its unique crispiness and non-staining quality is all set to attain global
recognition as an application has been filed for receiving Geographical Indication certification for this
product. More...
Individual cases to dictate MNC drug cos’ approach to patents

(DIVYA RAJAGOPAL , 22-Aug-2013 , The Economic Times)
Swiss drug maker Roche's move to give up its India patent for anti-cancer drug Herceptin is unlikely to
set a precedent for multinational drug manufacturers, a lobby group of MNC drug manufacturers said.
More...
Compulsory Licenses and “Statements of Working” in India
(Michael Lin , 21-Aug-2013 , IPWatchDog)
This brief note provides an update of the quickly-changing Compulsory License and Statement of
Working situations in India. More...
Serum, Univ of Pune bag US patent for new vaccine adjuvant from Ashwagandha
(Nandita Vijay, Bengaluru , 21-Aug-2013 , Pharmabiz)
Serum Institute of India and the Interdisciplinary School of Health Sciences, University of Pune’s work
leading to an innovative product and technology using Ashwagandha or Withania somnifera as vaccine
adjuvant has received the US patent. More...
1.58 lakh patent applications pending for examination: Govt

As many as 1.58 lakh patent applications are pending for examination before the government due to
manpower shortage, Parliament was informed on Tuesday. More...
AOL patent sale case dismissed

A federal judge on Monday dismissed a lawsuit accusing AOL and some of its executives of fraud for
repurchasing 14.8 million shares in 2011 without disclosing that the company would sell a $1 billion
portfolio of patents to Microsoft months later More...
IPAB revokes one more patent of Aloys Wobben in a petition of Enercon India
(BS Reporter | Chennai , 18-Aug-2013 , Business Standard)
This is the fourth patent of Wobben the Appellate Board revokes since the beginning of June this year.
More...
Novartis lashes out at India for not respecting IPR

(PTI , 18-Aug-2013 , Business Line)
Hitting out at India’s way of dealing with Intellectual Property Rights issues, drug major Novartis has
said India is losing investments in research and development from MNCs to China due to lack of an
ecosystem that fosters innovation. More...
Cipla chief calls for ‘obligatory’ drug licensing

The Chairman of pharmaceutical firm Cipla has asked the Indian government to push for ‘obligatory
licensing’ of drugs to improve access to essential medicines in the Third World. More...
Roche's patent pain to be Biocon's gain

(Reghu Balakrishnan , 17-Aug-2013 , Business Standard)
Indian firm to soon launch copycat of anti-breast-cancer drug. More...

Swiss drug major Roche to drop anti-cancer drug Herceptin patent in India
(DIVYA RAJAGOPAL , 16-Aug-2013 , The Economic Times)
Swiss drug major Roche has decided not to pursue its patent for anti-cancer drug Herceptin, the patent
which had come up for extension till 2019, paving the way for generic drug makers to manufacture this
drug. More...
No hostile climate for US-based companies: Nirupama Rao

In the op-ed,'India honors not dishonors patent laws', Rao said the most prominently cited example of
alleged patent infringement is actually a case study in patent protection. More...
No plans to restore Herceptin patent in India, says Roche

Move marks change in strategy by Roche, which was otherwise aggressive in protecting patents More...
Panel for FDI ban in pharma companies

(Mahendra Singh , 14-Aug-2013 , The Times Of India)
A Parliamentary panel has recommended a ban on foreign direct investment in existing pharmaceutical
companies, a suggestion which is going to provide ammunition to the commerce and industry ministry
that has been opposing the entry of overseas players that are acquiring stakes in Indian drug
manufacturers. More...
Roche misses renewal deadline, loses Herceptin patent in India

If Roche does not restore the patent in six months, manufacturers can legally produce the drug in the
country More...
Sudarshan Chemicals wins UK patent case

(Dileep Athavale , 13-Aug-2013 , The Times Of India)
The High Court of UK has exonerated Pune-based pigments and performance colorant manufacturer
Sudarshan Chemicals in a patent-related appeal raised by German chemicals major Clariant Produkte
(Deutschland) and awarded costs and damages for wrongful threats to Sudarshan. More...
Ajanta Pharma succeeds in revoking 2 Allergan patents

(Our Bureau, Mumbai , 12-Aug-2013 , Pharmabiz)
In yet another landmark victory to the Indian patent scenario, Ajanta Pharma, a specialty focused
pharmaceutical formulation company, emerged successful in revoking two composition patents of
Allergan Inc. used for eye-related treatments. More...
iWar and Peace

(Reynolds Holding , 12-Aug-2013 , Business Standard)
Apple appeal may bring smartphone patent ceasefire More...

Drug companies seek PM role in new pricing enforcement
(Soma Das , 12-Aug-2013 , The Economic Times)
Top domestic drugmakers have urged the prime minister's office to intervene in the manner the new
drug pricing control order is being implemented, complaining that 'all sections of the pharmaceutical
industry are frustrated'. More...
Sun Pharma to pay Rs 2,517 crore to settle patent suit

Drug firm Sun Pharmaceutical Industries has said it will pay its dues of Rs 2,517.41 crore soon as part of
settlement agreement with Wyeth(now a division of Pfizer Inc.) and Altana Pharma AG (now known as
Takeda GmbH). More...
Apple wins patent fight against Samsung

(ANI , 11-Aug-2013 , DNA)
As the ITC has sent the findings to President Barack Obama to be reviewed within 60 days and if he
gives his veto, Samsung might as well be out of the US market. More...
New vaccine adjuvant from 'Ashwagandha' gets US patent

(Vishwas Kothari , 10-Aug-2013 , The Times Of India)
The US patent office has granted patent to an innovative industry-academia research project that has
led to a new vaccine adjuvant extracted from ' Ashwagandha', also known as Indian Ginseng, a
medicinal plant used in Ayurveda as an immunity enhancer. More...
Sun Pharma posts R1,276 cr Q1 loss on patent settlement

(ENS Economic Bureau , 10-Aug-2013 , The Indian Express)
India's largest pharmaceutical firm by market capitalisation, Sun Pharmaceutical Industries, on Friday
reported a net loss of Rs 1,276.1 crore for the April-June quarter, resulting from an exceptional charge
on account of the settlement in a patent infringement litigation related to generic versions of Protonix.
More...
IPAB revokes two patents of Allergan's ophthalmic drugs

(BS Reporter | Chennai , 09-Aug-2013 , Business Standard)
The Intellectual Property Appellate Board has revoked two patents related to two ophthalmic drugs of
US-based Allergan Inc, finding that the claimed inventions were obvious. More...
Allergan loses patents for two drugs

(R. Sivaraman , 09-Aug-2013 , The Hindu)
Ajantha Pharma alleged that the patent was obtained on false representation More...
India revokes patents on Allergan eye drugs Ganfort and Combigan

(Reuters , 9-Aug-2013 , The Economic Times)
India revoked patents on two of Allergan Inc's eye drugs on Thursday, the latest in a series of
intellectual property setbacks suffered by Western drugmakers. More...
Apple vs Google: Court ruling revives patent case
A US appeals court ruled that Apple should be able to renew its arguments at the International Trade
Commission that Google's Motorola Mobility unit violated two patents relating to the iPhone. More...
Javed Akhtar's on a copyright mission

(Subhash K Jha , 6-Aug-2013 , DNA)
After taking up the issue of copyright and royalty rights for Bollywood writers, Akhtar now wants to
highlight cross-border copyright infringement More...
Low IPR awareness costing Indian SMEs heavily

(Komal Amit Gera | Chandigarh , 05-Aug-2013 , Business Standard)
All states in India now have patent facilitation centres and SMEs need to consult them to find out how
they can benefit from them More...
Kolkota Patent Office denies reports of partly revoking patent to Roche’s cancer drug
(Our Bureau, New Delhi , 05-Aug-2013 , Pharmabiz)
Patent authorities in India have denied reports that India had partly revoked patent granted to Roche for
its breast cancer drug herceptin. More...
Patent Office clarifies action on Roche application

Says drug-maker ignored opportunities to be heard. More...
Roche lost Herceptin patent due to procedural problems

(Vidya Krishnan , 4-Aug-2013 , Livemint)
Health ministry says patent for the breast cancer drug had lapsed due to procedural delays on the part
of the Swiss company. More...
India partly revokes Roche cancer drug patent

India has partly revoked patents granted to Roche Holding AG for its breast cancer drug Herceptin, a
spokesman for the drugmaker confirmed on Sunday. More...
Apple import veto risks undermining patent protection push

(James Politi , 04-Aug-2013 , CNBC)
President Barack Obamas move to overturn a looming import ban on older iPhone and iPad models
favoring Apple over Samsung in a long running legal battle risks undermining the US administration's
aggressive push for stricter intellectual property regimes around the world. More...
GSK’s breast cancer drug patent upheld till 2019
The Intellectual Property Appellate Board has upheld a patent granted on the original compound
(lapatinib) of GSK's breast cancer drug, Tykerb, which ensures monopoly rights on the drug till 2019 in
the domestic market. More...
Organic kaipad rice set to get pride of place

(Byju Aryad | ENS - KOCHI , 02-Aug-2013 , The New Indian Express)
Kaipad, a rice variety from the state, will soon receive a Geographical Indications tag. More...
IPAB upholds patent on basic compound of GSK's breast cancer drug

The Intellectual Property Appellate Board (IPAB) has upheld a patent granted on the original compound
(lapatinib) of GSK's breast cancer drug, Tykerb, which ensures monopoly rights on the drug till 2019 in
the domestic market. More...
In desi Viagra market, companies fight over names

(Manish Raj , 2-Aug-2013 , The Times Of India)
Kamagra Silagra, Edegra, Penegra, Zenegra the complete list can fill reams. More...
Delhi HC reserves verdict on MSD-Glenmark drug patent row

(PTI , 01-Aug-2013 , Livemint)
US firm had earlier appealed against the order refusing to restrain Glenmark from manufacturing Zita
and Zita-Met. More...
India Asks U.S. To Stiffen Their Own Laws on Patent Regime

(SiliconIndia , 01-Aug-2013 , SiliconIndia)
For some time now the U.S. government was criticizing India’s laws on intellectual property rules.
More...
GI tag for Nagpur orange, Dharmavaram saris

(Sharath S. Srivatsa , 1-Aug-2013 , The Hindu)
The juicy Nagpur orange, the famous tribal Warli art, Dharmavaram saris and Kerala’s Kaipad rice have
been cleared for inclusion in Geographical Indications registry in the country. More...
India asks US to tighten patent regime to curb misuse

(Amiti Sen , 31-Jul-2013 , Business Standard)
Our intellectual property rules are in compliance with global rules, says Govt. More...
Mirna Therapeutics Announces Important Expansion of microRNA Patent Portfolio

(AUSTIN, Texas--(BUSINESS WIRE) , 30-Jul-2013 , Yahoo)
U.S. Patent and Trademark Office Allows microRNA Mimic Composition of Matter Patent. More...
Patents are not just about pharma
(RISHIKESHA T. KRISHNAN , 30-Jul-2013 , Business Line)
Innovators in IT and other sectors need protection as well. More...
Obama’s recent orders on ‘patent trolls’ could impact biotech cos more than pharma cos
(Nandita Vijay , 30-Jul-2013 , Pharmabiz)
Intellectual Property has been a strategic tool for business advantage in the developed regions for quite
a while now. More...
Natco Pharma up 20% post US ruling on Copaxone patent case

(29-Jul-2013 , Money Control)
We are pleased to announce the US Court of Appeals for the Federal Circuit ruling, reversing a district
court's finding related to Teva's US patent for Copaxone," Natco said in its filing More...
Domestic IPR: Dependence on imported equipment proves costly

(T. E. Raja Simhan , 28-Jul-2013 , Business Line)
Large-scale dependence on imported equipment deprived the Indian telecom industry from developing
its own Intellectual Property Rights. More...
Small Indian retailer locked in trademark fight with Gap

(Abhaya Srivastava , 28-Jul-2013 , Livemint)
In March, the owners of Green the Gap were slapped with a legal notice by Gap asking them to change
their name within 14 days. More...
New techs to drive patent filings in India

(BS Reporter | Hyderabad , 26-Jul-2013 , Business Standard)
Patent filings in India would be more and more driven by new technologies, which are either kept secret
or patented. In line with this, there will be a big shift towards protection of innovation rather than just
granting the patents, said Chaitanya Prasad, Controller General of Patents, Design and Trade Marks,
Indian Patent Office. More...
S. Africa group writes to USTR in support of Indian drugs

(P. T. Jyothi Datta , 25-Jul-2013 , Business Line)
As India’s intellectual property protection policy comes under intense criticism in the United States a
pro-health group, South Africa’s Treatment Action Campaign, has come out in support of the Indian
generic drugs industry. More...
Google buys speech rec patents from SR Tech

(Richard Chirgwin , 24-Jul-2013 , The Register)
A company established last year to negotiate royalties from patents filed by previously low-profile
individuals from Cincinnati has vaulted into public eye courtesy of Google, which has bought rights to
two of its patents. More...
Natco drops Albupax launch despite overcoming patent, safety hurdles
(C.H. Unnikrishnan , 23-Jul-2013 , Livemint)
While Natco has been unable to launch its biosimilar version of the breast cancer drug, three other firms
have introduced theirs. More...
Price control, IP Act & regulatory framework: Revisiting some imp issues about Indian
pharma
(Ramesh Adige , 23-Jul-2013 , The Economic Times)
Pricing of patented medicines, though, continues to evade an equitable solution and discussions are
ongoing. More...
UCB drags 15 cos to court for patent violation

(fe Bureau : Hyderabad , 23-Jul-2013 , The Financial Express)
Belgium-based UCB Inc, a global biopharmaceutical company focusing on central nervous system and
immunology treatment and research, has filed separate patent infringement cases against as many as
15 drug makers in a Delaware court to prevent generic drug makers such as Ranbaxy, Aurobindo, Sun
Pharma, Glenmark, Sandoz, Glenmark, Watson from entering the market with versions of its epilepsy
treatment drug Vimpat. More...
Health ministry ups ante against patents

(Sidhartha , 23-Jul-2013 , The Times Of India)
The health ministry has asked for a cancellation of patent to Trastuzumab a medicine which treats a
form of breast cancer using a rarest of the rare provision in the Indian Patents Act. More...
UCB files cases against Ranbaxy, Aurobindo, Glenmark, Sun Pharma, others on patent issue
UCB, a global biopharma company, alongwith others has filed separate cases against as many as 15
drug makers, including India's Ranbaxy, Aurobindo, Zydus, Sun PharmaBSE -1.08 %, GlenmarkBSE
0.83 % and Alembic Pharmaceuticals for allegedly infringing its patented drug Vimpat. More...
Forgotten email patent holder pings Chennai

(Karthikeyan Hemalatha , 19-Jul-2013 , The Times Of India)
He has a patent for email and is fighting to be recognized for it. More...
The growing trust deficit in India

(Pramath Raj Sinha , 18-Jul-2013 , Livemint)
The recent Merck Sharp and Dohme vs Glenmark case highlights an important regulatory gap between
Indias drug licensing authorities and its patent offices. More...
Mylan says court dismisses some of Teva's patent claims on MS drug

(Pallavi Ail in Bangalore and Bill Berkrot in New York , 17-Jul-2013 , Reuters)
A federal court in New York ruled that Mylan Incs generic application for a multiple sclerosis drug has not
infringed some of Teva Pharmaceutical Industries patents Mylan said. More...
IPAB lays rules for granting of interim orders

(Sruthisagar Yamunan - CHENNAI , 16-Jul-2013 , The New Indian Express)
In a major judgement that has come as a respite to patent law practitioners in the country, the
Intellectual Property Appellate Board has asserted that it indeed had powers to grant interim orders on
applications and has framed guidelines to be followed for issuing the same. More...
NGOs call upon Indian govt to reject US pressure on economic policies including CL on life-
saving drugs
A coalition of over 75 civil society groups in the country, under the banner of Forum Against Free Trade
Agreements in India, has called upon prime minister Dr Manmohan Singh to review its forthcoming
economic engagements with the USA, and to reject pressure from the US government and business
lobby groups on India’s economic policies, including its recent decision to allow compulsory licensing for
life-saving drugs. More...
Glenmark Pharma inches up after confirming patent fight for a generic in US

(Capital Market , 15-Jul-2013 , Business Standard)
The announcement was made after market hours on Friday, 12 July 2013. More...
India has weak intellectual property rules: Michael Froman

(Nayanima Basu | New Delhi , 15-Jul-2013 , Business Standard)
Michael Froman, who was appointed the US Trade Representative on June 21, is President Barack
Obama's principal advisor, negotiator and spokesperson on international trade and investment issues.
More...
SMS, RTI potent tools of drug companies fighting patent battle

(Soma Das, ET Bureau , 15-Jul-2013 , The Economic Times)
As patent wars heat up in the pharma space, mobile phone messages and Right to Information filings
have emerged as potent weapons in the hands of multinationals keen to delay competition from low-cost
generic versions of their patented products in India. More...
US visa is non-tariff barrier for IT, says FM

(BS Reporter | Washington , 13-Jul-2013 , Business Standard)
He said Indian law affirms intellectual property rights and the process of granting compulsory licence
and patent registration were World Trade Organisation-compliant and subject to judicial review. More...
Chidambaram tells US India respects IPRs

(Arun Kumar | IANS - WASHINGTON , 12-Jul-2013 , The New Indian Express)
Chidambaram stressed the "importance of India becoming a manufacturing hub for meeting its own
domestic needs and for rebalancing the global economy". More...
Glenmark confirms patent challenge for its generic versions of VIMPAT in the US Court
( Vishal Dutta, ET Bureau , 12-Jul-2013 , The Economic Times)
Mumbai-based Glenmark Generics Ltd confirms that it has filed Abbreviated New Drug Applications for
Lacosamide tablets and oral solution with the US drug authorities with a Paragraph IV certification for
the Orange-Book listed patent. More...
US welcomes India's decision on PMA, express concerns over IPR

(Press Trust of India | Washington , 12-Jul-2013 , Business Standard)
Welcoming the recent Indian decision to put a hold on its policy of Preferential Market Access the United
States has expressed its concern over continued investment climate in India and its policies related to
Intellectual Property Regime. More...
Metro planning to patent indigenous electrical design

(Rumu Banerjee , 12-Jul-2013 , The Times Of India)
It was lack of space at the upcoming Chirag Dilli Metro station that made Delhi Metro think up an
indigenous electrical solution it is now planning to patent. More...
US to probe China's Sany Heavy for alleged patent infringement

The US International Trade Commission will launch a probe into Sany Heavy Industry Co Ltd after
Manitowoc Co Inc accused China's biggest maker of construction equipment of infringing its crawler
crane patents. More...
Visa issues, patents to dominate India-US trade talks

(Amiti Sen , 11-Jul-2013 , Business Line)
While concerns on visa restrictions for Indian professionals top the country’s agenda in the India-US
high-level bilateral trade talks that started on Thursday, Commerce Minister Anand Sharma will also
make a case for allowing LNG exports to India and the need to finalise a social security agreement that
would save over $1 billion of annual contributions made by temporary Indian workers. More...
Monsantos climate-resilient crop patent claims rejected

(Sanjay Vijayakumar , 10-Jul-2013 , The Economic Times)
India's patent appeals board has denied Monsanto a patent for a genetically-engineered method of
increasing climate resilience in plants. More...
Anand Sharma defends India’s IP Law at Indo-French CEOs meet

Commerce and industry minister Anand Sharma defended India's intellectual property regime in his
address at the Indo-French CEOs forum in Paris on Monday. More...
Monsanto’s climate-resilient crop patent claims rejected

(Sanjay Vijayakumar , 10-Jul-2013 , The Economic Times)
India's patent appeals board has denied Monsantoa patent for a genetically-engineered method of
increasing climate resilience in plants. More...
Generic Pharma Association study says patent settlements netted $25.5 bn in savings for US
health system
(Our Bureau, Mumbai , 10-Jul-2013 , Pharmabiz)
Generic pharmaceuticals launched prior to patent expiration due to a patent settlement helped the US
health system save $25.5 billion from 2005-2012 and brought generic medicines to market on average
81 months sooner than patent expiry, according to a new analysis conducted for the Generic
Pharmaceutical Association by the IMS Institute for Healthcare Informatics. More...
Falling standards of pharma companies is industry's big bane: GV Prasad, Chairman, Dr

Reddy’s Lab
(CR Sukumar & Raji Reddy Kesireddy , 10-Jul-2013 , The Economic Times)
The pharmaceutical industry is facing pressure from regulators in the US because companies have
allowed standards to decline, the head of one of India's biggest drug makers has said. More...
The Holy Grail of new drug development

(Professor of Corporate Strategy and Policy at IIM-B, Jugaad to Systematic Innovation: The Challenge
for India. , 9-Jul-2013 , Business Line)
Pioneering Indian pharmaceutical companies started on the journey of new drug development in the
early 1990s when India announced its decision to sign the WTO agreement and bring in a product patent
regime in drugs from January 1 2005. More...
SSWL soars on bagging patent for semi-full face wheels

(SI Reporter | Mumbai , 9-Jul-2013 , Business Standard)
The patent is for the company's innovative design concept in semi-full face wheels. More...
Trademark registration goes global from Monday

(A Subramani , 07-Jul-2013 , The Times Of India)
Come Monday, the Madrid Protocol for a single window trademark registration for 90 member-countries
will come into operation. More...
Protect innovation to secure growth

(Ron Somers , 6-Jul-2013 , Business Standard)
There are grave concerns about intellectual property protection in India. More...
US patent for Gujarat weed that gives IQ high

(Tushar Prabhune , 07-Jul-2013 , The Times Of India)
Sounds unbelievable, but the humble seaweed growing in abundance along Gujarat's 1,600-km coastline
can yield a health drink that boosts brain functioning and increases immunity. More...
Venus Remedies surges after Japan grants patent for 'Elores'

(SI Reporter | Mumbai , 03-Jul-2013 , Business Standard)
The company is expecting to launch this product in Japanese market by end of 2015. More...
EU threat to Indian farmers
(K P Prabhakaran Nair , 3-Jul-2013 , The New Indian Express)
The protective cover given to the EU products under the Geographical Indication tag with over 3,000
registered GIs, of which 130 are for dairy products, will make things worse for Indian dairy products.
More...
Apple's Siri in China court over alleged patent infringement

(Agence France-Presse , 03-Jul-2013 , NDTV)
A case against US technology giant Apple brought by a Chinese firm for alleged patent infringement in
its digital personal assistant "Siri" has begun in a Shanghai court, state media said on Wednesday.
More...
Apple applies for 'iWatch' trademark in Japan

(Associated Press - TOKYO , 3-Jul-2013 , The New Indian Express)
Apple Inc. has applied for a trademark in Japan for "iWatch" as rumors suggest it may be developing a
smart wristwatch. More...
IP environment deteriorating in India: US pharma industry

(Press Trust of India | Washington , 2-Jul-2013 , Business Standard)
India however maintained that the India Patent Act was in accordance with the TRIPS Agreement & the
Paris Convention. More...
US ups its pressure on India over generics industry

(Regulatory , 01-Jul-2013 , PMLive)
Follows complaints from Pfizer about the country’s patent laws. More...
Patent Fight Short Circuits 'Laser Peg' Toy Plan

(Ashley Lagzial , 30-Jun-2013 , CNBC)
It took several years for inventor Jon Capriola to get his toy to market. More...
Indian varsities account for 5% of patents

(DNA Correspondent , 27-Jun-2013 , DNA)
Universities in India are not only gradually upgrading their innovation radars, but are also increasingly
filing patent applications on innovations. More...
Sun, Merck sign patent licensing agreement for Januvia

(Archana Shukla ,CNBC-TV18 , 27-Jun-2013 , MoneyControl)
Merck Sharp & Dhome and Sun Pharma, who have a co-marketing tie up for Merck's diabetes drug
Januvia, have now included a patent licensing agreement in their arrangement in a bid to strengthen
their case. More...
Apple loses bid to add Galaxy S4 to Samsung patent lawsuit
(Bloomberg , 27-Jun-2013 , Livemint)
Judge rules that adding another product to the Apple-Samsung patent lawsuit is a tax on the court’s
resources More...
India ready to discuss patent policies with U.S. lawmakers

(PTI , 26-Jun-2013 , The Hindu)
Asserting that the Indian Patents Act related to pharmaceutical products is not discriminatory against
foreign companies, Indian Ambassador to the United States, Nirupama Rao, offered lawmakers
concerned to discuss the issue for the sake of long-term bilateral and strategic partnership between the
two countries. More...
Intellectual Property creation witnessing steady growth in India: Report

The country's contribution to Intellectual Property creation is witnessing a steady growth, however,
investments in R&D and patent activities in the country are still relatively slow when compared to
developed nations, a report says. More...
WIPO reaches agreement on treaty for blind

(Pankaj Mishra , 26-Jun-2013 , Livemint)
India has 63 million visually impaired people, of whom about 8 million are blind, according to WHO
More...
GI Tag: Varanasi-Mau-Bhadohi leading in UP

(Saurabh Gupta , 26-Jun-2013 , SME Times)
Varanasi, Bhadohi and Mau clusters, the three very renowned districts of Uttar Pradesh, are now having
the Geographical Indications tag. More...
India ready to discuss patent policies with US lawmakers: Nirupama Rao

Asserting that the Indian Patents Act related to pharmaceutical products is not discriminatory against
foreign companies, the Indian ambassador to the United States, Nirupama Rao, offered concerned
lawmakers to discuss the issue for the sake of long-term bilateral and strategic partnership between the
two countries. More...
NPPA formula for fixing ceiling prices of essential drugs under new DPCO confusing
(Ramesh Shankar, Mumbai , 26-Jun-2013 , Pharmabiz)
Even as the drug price regulator NPPA has started fixing ceiling prices of 348 essential drugs as per the
new DPCO 2013, confusion prevails over the formula being used by the NPPA for calculation of ceiling
prices as the industry says that it is contrary to the formula specified in the NPPP 2012 and the DPCO
2013. More...
Merck Sharp and Dohme Corporation gets relief on diabetes drug patent row
The Delhi high court has restrained an Indian pharmaceutical company from launching its diabetes drug
allegedly having identical molecule and derivative salt of the patented drug manufactured by US
drugmaker Merck Sharp and Dohme Corporation. More...
Shilpa Medicare in pact with medicines patent pool for entering HIV space
(P. T. Jyothi Datta , 26-Jun-2013 , Business Line)
The United Nations-backed Medicines Patent Pool, Shilpa Medicare and Gilead Sciences have entered
into an agreement to increase the access to medicines for HIV/AIDS treatment. More...
Breakingviews - India should take U.S. pharma complaints seriously

(Katrina Hamlin , 25-Jun-2013 , Reuters)
U.S. drug giants are once again pushing for stronger patent protection in India. Their arguments may be
transparently self-serving - but there are still good reasons for India to take note. More...
India counters US over patents

(Sidhartha , 25-Jun-2013 , The Times Of India)
The government has taken on the United States, defending its intellectual property regime, and has
gone to the extent of suggesting that Washington could draw from the Indian experience in checking
frivolous patents. More...
Court upholds Apple’s $ 625 mn patent victory

(DPA , 25-Jun-2013 , Business Line)
The US Supreme Court yesterday upheld lower court rulings that cleared Apple of three patent violations
that carried fines of 625 million dollars. More...
Google patents photo-capturing walking stick

(ANI , 24-Jun-2013 , The Times Of India)
Google has got its new invention, a walking stick that takes pictures whenever it hits the ground,
patented. More...
European wines seek geographical indication tag with India proposing a steep duty cut
(ET Bureau , 24-Jun-2013 , The Economic Times)
Popular European wine brands are making a beeline for geographical indication registration in India.
More...
US Secretary of state's complex task in today's talks

(Jyoti Malhotra | Toronto , 24-Jun-2013 , Business Standard)
US Admn seems divided on supporting India membership in APEC; Afghan and trade issues also to come
up. More...
Intas settles patent litigation with Hoffmann-La Roche for capecitabine tablet
(Vishal Dutta , 24-Jun-2013 , The Economic Times)
Ahmedabad-based drug maker Intas Pharmaceuticals Ltd and its US-based wholly owned subsidiary
Accord Healthcare Inc. has entered into a settlement and license agreement with Hoffmann-La Roche
Inc. to resolve pending patent litigation on XELODA Tablets. More...
Developed markets turn spotlight on generic drug settlements

(Ravi Ananthanarayanan , 23-Jun-2013 , Livemint)
Increasing scrutiny poses uncertainty for Indian generic firms, adding to the list of uncertainties for
investors. More...
India pushes back against US industry's charges

(Indira Kannan | Toronto , 21-Jun-2013 , Business Standard)
Just ahead of the next round of the strategic dialogue with the United States, the Indian government is
pushing back against allegations from American industry groups that it engages in discriminatory trade
practices and does not respect global intellectual property standards More...
Patent justice
The U.S Supreme Courts landmark ruling that DNA segments are a product of nature and hence not
patent-eligible has worldwide significance because it settles the controversial issue of patenting human
genes in the one jurisdiction where it has come to matter the most. More...
FTC is said to plan inquiry of frivolous patent lawsuits

(Edward Wyatt, The New York Times , 20-Jun-2013 , NDTV)
The chairwoman of the Federal Trade Commission is expected on Thursday to recommend a sweeping
investigation of "patent trolls," companies that buy large portfolios of technology patents and use them
to sue software designers and makers of products like smartphones and tablet computers, people
briefed on the inquiry said. More...
Zydus infringed Takeda Pharma's patent : US court

(Sohini Das | Ahmedabad , 20-Jun-2013 , Business Standard)
Zydus Pharmaceutical USA, a subsidiary of Ahmedabad-based Cadila Healthcare, has lost a patent
infringement suit in the US. More...
The patent truth

(Ritu Kamal , 20-Jun-2013 , The Indian Express)
The US Supreme Court's judgment on gene patents is fair to patients. More...
Ranbaxy, 8 other companies fined Rs 1,000 crore

EU antitrust regulators on Wednesday imposed fines totalling 146 million euros (Rs 1,150 crore) on nine
global drugmakers, including Ranbaxy, for blocking the supply of cheaper versions of Danish company
Lundbeck's antidepressant drug citalopram. More...
Dr Reddy’s sued for infringement of thyroid injection patent

U.S. drug maker AbbVie filed petition in U.S. court More...
IIT-D scholars patent prosthetic limb guided by good leg

(Naveed Iqbal , 19-Jun-2013 , The Indian Express)
Two young scientists from IIT-Delhi have received a provisional patent for the prototype of a prosthetic
limb that will enable amputees to walk "without having to drag their leg". More...
Drug price control formula leaves companies shaky, cos approach pharma department
(Soma Das , 19-Jun-2013 , The Economic Times)
The government's interpretation of 'brand' while fixing price caps of essential drugs has prompted
leading domestic manufacturers to approach the pharma department and seek a halt to immediate
implementation of the new drug price control order. More...
In India, copycat drug firms get off lightly compared with US

(Jayati Ghose , 18-Jun-2013 , The Indian Express)
Indian drug major Sun Pharmaceutical Industries last week agreed to pay $550 million to New York-
based Pfizer as part of an out-of-court settlement of the Protonix patent infringement lawsuit. More...
Copyright issue plagues Shah Rukh Khan’s Om Shanti Om

(MAYURA JANWALKAR , 18-Jun-2013 , The Indian Express)
Nearly six years after the movie's release, Ajay Monga — claiming to be the original script writer of the
Shah Rukh Khan-Deepika Padukone starrer Om Shanti Om, that released in November 2007 — has
sought restoration of a suit he had filed earlier alleging infringement of his copyright. More...
Venus Remedies gets patent for Potentox from Mexico

(PTI , 17-Jun-2013 , Business Line)
Venus Remedies Limited, a research-based global pharmaceutical company, has received patent from
Mexico for its novel antibiotic product Potentox. More...
US Supreme Court's judgment on gene patents is neither ethical nor logical

(Noah Feldman , 17-Jun-2013 , The Economic Times)
Can you patent genes? In Association for Molecular Pathology vs Myriad Genetics, the US Supreme Court
answered this imponderable question with a split decision you can't if they are naturally occurring and
you've simply discovered the gene but if you've crafted a synthetic gene you've invented it and you can
keep the patent. More...
J&J’s Depuy Synthes Wins $16 Million in Patent Case

(Phil Milford , 16-Jun-2013 , Bloomberg)
Johnson & Johnsons DePuy Synthes unit, a maker of artificial spinal repair products, won $16 million in
damages from Globus Medical Inc. More...
Patent body dismisses HUL's appeal on hair-conditioner

(T E Narasimhan , 15-Jun-2013 , Business Standard)
The Intellectual Property Appellate Board has dismissed an appeal by fast-moving consumer goods
company Hindustan Unilever Ltd for recognising the company's patent claim for a hair-conditioning
agent. More...
Now, licence to play copyrighted music in public places

( Express News Service - BANGALORE , 15-Jun-2013 , The New Indian Express)
Next time you hear your favourite song playing at a bar, restaurant or even an airplane remember that
the shopowner might well be in contravention of the Copyright Act of 1957 which makes it mandatory
for public establishments playing copyrighted music to procure a public performance licence. More...
Patent ruling a boost to genetic research

(The New Indian Express , 15-Jun-2013 , The New Indian Express)
The US Supreme Courts ruling that DNA in the human genome is a “product of nature” that cannot be
patented is of great significance. More...
'Happy Birthday' song in court over copyrights issue

(PTI , 14-Jun-2013 , The Indian Express)
The beloved 120-year-old ditty 'Happy birthday to you' is in court over copyright issues after a
documentary film company filed a USD 5 million lawsuit to bring the popular song into public domain.
More...
GI certificate for Toda embroidery formally handed over to tribals

Toda tribal representatives on Thursday formally received a Geographical Indication certificate for their
unique embroidery, which is known for its striking colours. More...
Pfizer’s India patents, revenue grow despite adverse testimony

(C.H. Unnikrishnan , 14-Jun-2013 , Livemint)
Firm says India’s patent regime protectionist, but has been one of the top patent winners in pharma in
the country. More...
US court says human genes cannot be patented

(AP , 14-Jun-2013 , The Times Of India)
The US Supreme Court ruled on Thursday that companies cannot patent parts of naturally-occurring
human genes, a decision with the potential to profoundly affect the emerging and lucrative medical and
biotechnology industries. More...
Sun Pharma sues Novartis in US court

(Sushmi Dey | New Delhi , 13-Jun-2013 , Business Standard)
Demands rights to Gleevec generic before Novartis' patent expires More...
Sun to pay Pfizer, Takeda Rs 3K cr over Protonix patent

(Ashish K Tiwari , 13-Jun-2013 , DNA)
Sun Pharmaceutical Industries will pay as much as Rs 3,178 crore this year as its share of the
settlement reached with US-based Pfizer Inc and Japans Takeda Pharma in the case of patent
infringement relating to generic Protonix a blockbuster acid reflux medicine. More...
Eastern Mills in carpet city Bhadohi has loose ends to tie up as IKEA bolsters link
(Nivedita Mookerji | Bhadohi (near Varanasi) , 13-Jun-2013 , Business Standard)
The group, which started supplying to the global retail major four years ago, is seeing winds of change
at its factories. More...
Goa government seeks geographical indication status for azulejos, crochet, coconut craft
(Anisha Francis , 13-Jun-2013 , The Times Of India)
The office of the development commissioner for handicrafts has sought GI status for three handicraft
items they claim are unique to Goa—azulejos crochet and the centuries-old handicraft of coconut
carving. More...
Sun Pharma in action after reaching settlement on patent lawsuit

(Capital Market , 13-Jun-2013 , Business Standard)
Sun Pharmaceutical Industries after market hours on Wednesday, 12 June 2013 announced that it
together with its subsidiaries, has settled an ongoing litigation pending in the United States District
Court, District of New Jersey regarding Sun Pharma subsidiary's generic pantoprazole. More...
A Strategy for Combating Patent Trolls

(CHARLES E. SCHUMER , 12-Jun-2013 , The Wall Street Journal)
With so many weak patents being used just to get a payoff, it's time to make patents stronger. More...
Patents must balance profit with social cost

(The New Indian Express , 12-Jun-2013 , The New Indian Express)
The US Supreme Court’s verdict on a rather unique case, which seeks to answer the question if human
genes can be patented, will soon be available. More...
India needs to show the world it respects intellectual property rights: Kiran Mazumdar-Shaw
India needs to show the world that it respects intellectual property rights if it wants global
pharmaceutical firms to invest in India, according to Biocon Chairman and Managing Director Kiran
Mazumdar-Shaw. More...
Is it all right for firms like Myriad Genetics to patent genes?

(Hari Pulakkat , 10-Jun-2013 , The Economic Times)
The US Supreme Court will rule on Monday on a case challenging some patents by Myriad Genetics, a
company that offers predictive genetictesting services for breast cancer More...
New US biz centre to boost ties with Indian SMEs

(Vijay C Roy | Chandigarh , 10-Jun-2013 , Business Standard)
ABC's activities will include dissemination of catalogues of US and Indian products to potential buyers,
and staging of workshops and seminars on topics ranging from trade and finance to IPR. More...
Copy right?
(Shubashree Desikan , 09-Jun-2013 , The Hindu)
With the publishers taking up the case against course packs, students have also jumped into the fray to
represent their side. More...
Tata Motors moves court against trademark infringement

(Press Trust of India , 09-Jun-2013 , Business Standard)
Tata Motors has filed a complaint before a Delhi court alleging infringement of its trademark and
copyright by unknown persons manufacturing and marketing spurious ancillary automobile products
under its name. More...
Delhi University students impleaded on copyright row

(Shubashree Desikan , 9-Jun-2013 , The Hindu)
With the publishers taking up the case against course packs, students have also jumped into the fray to
represent their side. More...
Google files 'facial password' patent to increase Android security

(ANI , 7-Jun-2013 , DNA)
It says examples of the requests that might be made include, a frown, a tongue protrusion, an open-
mouth smile, a forehead wrinkle, an eyebrow movement. More...
Motorola settles patent dispute with TiVo

Motorola Mobility said that it has reached a settlement with digital video recording pioneer TiVo ahead of
a patent trial that was to start in a Texas court next week. More...
Google files 'facial password' patent to increase Android security

(ANI , 07-Jun-2013 , DNA)
It says examples of the requests that might be made include, a frown, a tongue protrusion, an open-
mouth smile, a forehead wrinkle, an eyebrow movement. More...
US lawmakers express concern over Indian economic policies

(PTI , 7-Jun-2013 , The Indian Express)
US lawmakers and some top business organisations of the country have alleged that the "restrictive"
and "protectionist" policies of India is hampering bilateral trade, an issue said to be of deep concern for
the Obama administration. More...
Apathy leaves tangaliya in tangles

(Rupam Singh Gupta , 7-Jun-2013 , The Times Of India)
It has been almost four years since tangaliya, a 700-year-old indigenous craft of Saurashtra, got the
geographical indication tag. More...
Mumbai firm loses Maggi trademark to Nestle

(Sruthisagar Yamunan - CHENNAI , 6-Jun-2013 , The New Indian Express)
The Intellectual Property Appellate Board has held as invalid a Mumbai-based firm’s claim over the
trademark Maggi a world famous brand name that has been popularised by Swiss firm Nestle. More...
Samsung gets a bite on Apple in epic patent war

(Chidanand Rajghatta , 6-Jun-2013 , The Times Of India)
A US trade panel has ruled that homegrown legend Apple has infringed on a patent held by South
Korean giant Samsung, providing a surprising new twist to the ongoing war between the two electronic
majors. More...
Now, an exchange for trading patent rights

(New York Times News Service , 05-Jun-2013 , The Hindu)
Patent rights, which are usually bought and sold in private transactions, are set to be publicly traded on
a new exchange. More...
iPhone 4 imports banned in US patent case

A US trade agency on Tuesday issued a ban on imports of Apple's iPhone 4 and a variant of the iPad 2
after finding the devices violate a patent held by South Korean rival Samsung Electronics. More...
Pfizer's slams India's patent regime, says Indian standards are vague and malleable
(Soma Das , 5-Jun-2013 , The Economic Times)
American drugmaker Pfizer Inc has slammed the patent regime in India telling a domestic industry body
in a letter that all patents that the company has managed to get in the country do not have any
meaning. More...
Apple Inc. infringes Samsung patent on older iPhones, iPads: US agency

(Associated Press , 5-Jun-2013 , The Indian Express)
Samsung Electronics scored a victory over rival Apple Inc in their long-running dispute over mobile
device patents after a US trade agency issued an order banning older but still-popular Apple products
from the US market. More...
iPhone 4 imports banned in US patent case

(AP , 5-Jun-2013 , The Economic Times)
A US trade agency on Tuesday issued a ban on imports of Apple's iPhone 4 and a variant of the iPad 2
after finding the devices violate a patent held by South Korean rival Samsung Electronics. More...
More drug companies join patent pools to aid drug discovery for neglected diseases
(Rema Nagarajan , 04-Jun-2013 , The Times Of India)
As drug pipelines dry up and finding new treatments for diseases afflicting the developing world remains
a challenge, governments, drugs companies, research institutes and donors are forging partnerships to
boost drug discovery. More...
Pfizer gets relief in patent revocation case for anti-cancer drug 'Sutent'
In a relief to pharma major Pfizer, the Intellectual Property Appellate Board here has set aside the
revocation of the patent of the company's anti-cancer drug 'Sutent.' More...
White House issues orders to curb 'patent trolls'

(AFP , 04-Jun-2013 , The Times Of India)
The White House issued a series of executive orders aimed at curbing so called patent trolls who use the
legal system to stifle innovation especially in the tech sector. More...
Commerce Dept bats for pharma exporters

The Commerce Department has come out in strong support of the Indian pharmaceutical industry facing
criticism from the media on quality issues following a series of action taken by the US drug controller
against top Indian companies. More...
Shire, Teva settle generic Intuniv patent infringement lawsuit

(Philadelphia , 03-Jun-2013 , Pharmabiz)
Shire LLC a subsidiary of Shire plc. has settled its litigation against Teva Pharmaceuticals USA Inc. in
connection with Teva’s Abbreviated New Drug Application for a generic version of Shire’s Intuniv
extended release tablets for the treatment of Attention Deficit Hyperactivity Disorder. More...
US drug firm raises red flag over ‘blatant’ patent violation

(Gaurav Choudhury , 02-Jun-2013 , Hindustan Times)
US pharmaceutical giant Merck Sharp and Dohme said it is concerned about the blatant patent violation
in India over two of its blockbuster anti diabetes drugs Januvia and Janumet. More...
Apple Inc vs Samsung group: Panel to review split ruling in patent fight
(Reuters , 31-May-2013 , The Indian Express)
A trade panel that specializes in patent cases will reconsider a split decision made by one of its judges in
a long-running patent battle between Apple Inc and Samsung group. More...
Surti zari set for global presence

(Melvyn Reggie Thomas , 31-May-2013 , The Times Of India)
Surtizari one of the oldest crafts of Gujarat is all set to mark its exclusive presence in the country and
abroad with 21 zari manufacturers from the city getting nod from Chennai based Geographical Indication
Registry to manufacture zari and sell their products using the official logo SuratZari Craft. More...
Can genes be patented?

(Devangshu Datta , 30-May-2013 , Business Standard)
Angelina Jolie has inadvertently highlighted a key question about patenting. More...
Patents that have brought the Everest closer

(Leslie D’monte , 29-May-2013 , Livemint)
Several new products under patent aim to make the climb to world’s highest peaks safer and easier.
More...
Pfizer, pharma sector spar over patent protection issues

(P. T. Jyothi Datta , 29-May-2013 , Business Line)
Multinational drug-maker Pfizer and a key association of the Indian pharmaceutical industry have locked
horns over the protection of intellectual property in India. More...
Apple patent case against Samsung set for additional US review

(Bloomberg , 29-May-2013 , Livemint)
US trade panel seeks more information before deciding whether Samsung should be barred from
entering the US. More...
ndian pharma companies filed 417 DMFs in US during 2012 and 79 in Q1 of 2013
(Sanjay Pingle, Mumbai , 27-May-2013 , Pharmabiz)
ndian pharmaceutical companies filed 417 Drug Master Files with the US FDA during the year 2012 as
against 404 DMFs in the previous year. The DMF filings during the year 2010 and 2009 were at 311 and
271 respectively. More...
Microsoft did not violate Google patent: ITC

Microsoft Corp did not violate a patent owned by Google subsidiary Motorola Mobility when it made its
popular Xbox, the International Trade Commission said on Thursday. More...
Indian pharma under the microscope

( Vidya Krishnan, C.H. Unnikrishnan , 23-May-2013 , Livemint)
The local drug industry also faced intellectual property related issues while exporting drugs. More...
Apple wants to include Samsung Galaxy S4 in patent lawsuit

(AFP , 23-May-2013 , The Times Of India)
Apple has asked a federal judge in Silicon Valley to add Samsung's new flagship Galaxy smartphone to
the list of devices targeted in a patent lawsuit involving Siri personal assistant software. More...
Patent row: Delhi HC to hear diabetes drug case

(CNN-IBN , 23-May-2013 , IBN Live)
The patent battle between US pharmaceuticals major Merck Sharp and Dohme and Indian firm Glenmark
Pharmaceuticals over the sale of diabetes drug Januvia comes up for hearing in the Delhi High Court on
Thursday. More...
Apple wants patent lawsuit to include Samsung Galaxy S4
(AFP , 23-May-2013 , Hindustan Times)
Apple has asked a federal judge in Silicon Valley to add Samsung's new flagship Galaxy smartphone to
the list of devices targeted in a patent lawsuit involving Siri personal assistant software. More...
ICAR moves to patent Goa’s Feni manufacturing process

(PTI , 21-May-2013 , Business Line)
After obtaining Geographical Indication status for the famous Goa Feni researchers and producers in the
coastal State are now trying to patent the process to manufacture this local brew, which is also known
for its medicinal benefits. More...
Japan FTA widening trade deficit, government says

The government on Friday admitted that the trade agreement with Japan was resulting in greater
benefit to exporters from the East Asian giant, reflected in widening trade deficit. More...
When it is right to copy

(Apar Gupta , 18-May-2013 , The Indian Express)
Intellectual property litigation is not a binary battle between the rights-holder and the infringer. More...
Brain League expects developing nations to follow India, may frame tough patent laws
(Nandita Vijay, Bengaluru , 18-May-2013 , Pharmabiz)
Brain League, the Intellectual Property company serving national and global markets, sees that many
developing countries could follow India model in enacting tough drug patent laws. More...
Apple to make Galaxy S4 part of patent battle

(TOI Tech , 15-May-2013 , The Times Of India)
Apple plans to include the newly launched Galaxy S4 in its patent battle against South Korean giant
Samsung. According to Foss Patents, after analyzing. More...
US keenly watching Indian moves on compulsory licensing in pharma sector

Placing India again in the 'Priority Watch List in 2013', the United States has expressed concerns on the
Supreme Court decision on the patent issue in the pharmaceutical sector and said it would be keenly
watching the developments concerning the compulsory licensing. More...
Bangalore Blue Grapes gets Geographical Indication status

(Rhik Kundu , 15-May-2013 , The Times Of India)
Bangalore Blue Grapes, exclusively grown in districts around the city, has been given the Geographical
Indication status. More...
Court dismisses Roche's patent petition against Intas
(BS Reporter , 14-May-2013 , Business Standard)
According to Roche Intas was in the process of selling erlotib the generic version of the drug in TN.
More...
Suven Life gets three patent products for CNS molecules

Life Sciences today said it has received a total of three product patents for CNS molecules, which could
be used for treating various central nervous system disorders. More...
Kebabs from Lucknow may get geographical indication recognition soon

(Rajiv Srivastava , 11-May-2013 , The Times Of India)
Soon after the Lucknow Zardozi was accorded geographical indication recognition, the delicious kebabs
from the city of nawabs, the petha and marble from Agra and dress material and cotton bedsheets from
Mau are next in line to get the GI tag a form of Intellectual Property Right from the Controller General of
Patents Designs and Trademarks. More...
MSF wants newly appointed WTO DG to ensure access to medicines for all WTO member
states
(Our Bureau , 10-May-2013 , Pharmabiz)
Médecins Sans Frontières an international medical humanitarian organisation, wants the incoming
director general Roberto Azevedo of the World Trade Organisation to focus on making access to
affordable medicines a priority. More...
India, EU yet to reach consensus on vexed issues for FTA

(Press Trust of India , 08-May-2013 , Business Standard)
India and the EU, which are negotiating a free trade agreement since 2007, have yet to reach a
consensus on vexed issues including duty cuts in automobile sector, Parliament was informed today.
More...
Top generic drugmakers look to US as patents end

(Reuters , 08-May-2013 , NDTV)
India's top drugmakers, among the world's biggest producers of cheap generic medicines, are looking
beyond their own shores to generate revenue, seeking to profit from big-selling drugs going off-patent
this year in the lucrative U.S. market. More...
Don't link compulsory licensing with price: Pharma companies

(Soma Das , 8-May-2013 , The Economic Times)
Indian drug makers have urged the government to retain the option of compulsory licensing of a
patented drug even as it considers a policy that will allow it to negotiate with drug companies on prices
of patented drugs. More...
German beer company allowed to retain trademark

(Sruthisagar Yamunan , 8-May-2013 , Indian Express)
What could happen if you get a trademark registered and do not use it for a long time? More...
Google files patent for Policy Violation Checker tool

(ANI , 07-May-2013 , The Times Of India)
Google has reportedly filed a patent for a tool that will detect potentially problematic phrases or words
from electronic correspondence which in turn will help companies or individuals avoid lawsuits. More...
Bajaj’s two-wheeler patent not to be revoked

(R. Sivaraman , 06-May-2013 , The Hindu)
The Intellectual Property Appellate Board here on Thursday dismissed an application of LML seeking to
revoke patent granted to Bajaj Auto Ltd. in respect of an improved two-stroke engine for its two-
wheelers. More...
EU regulator takes aim at Google over Apple mobile patent lawsuit

The European Commission said it believed Motorola Mobility, a unit of Google, was abusing its market
position by seeking and enforcing an injunction against Apple in Germany over patents essential to
mobile phone standards. More...
A reflection of tradition
(ANASUYA MENON , 05-May-2013 , The Hindu)
A sale of traditional Aranmula mirrors is on at the Kairali outlet. More...
How patent wars are hurting IT companies

Patent demands are taking a big toll on technology companies, with results that range from forcing
companies to tweak their products to exiting their business altogether, according to a study from the
Santa Clara University School of Law. More...
Bajaj Auto wins 7-year patent spat against LML

(Ashwin Mohan , 2-May-2013 , The Economic Times)
In a boost for India's leading two-wheeler manufacturer Bajaj Auto, the Chennai bench of the IPAB or
the Intellectual Property Appellate Board has dismissed an appeal filed by rival LML Ltd which had
sought the revocation of a patent granted to Bajaj Auto on air & fuel intake systems for engines. More...
US slams patent, trade policies

(Sidhartha , 2-May-2013 , The Times of India)
A United Nations report projected that FDI in Africa will touch $100 billion in 2014 where India trails
France United States United Kingdom, China, Malaysia and Korea. Airtel can look at more in market
acquisitions in Africa while it looks to stabilize the $10.7-billion buyout of Zain's continental unit three
years ago. More...
U.S. trade office hits out at Novartis ruling

(Narayan Lakshman , 2-May-2013 , The Hindu)
Appears to confirm that India’s law creates a special, additional criterion for select technologies More...
Teva settles patent dispute with Orchid Pharma

(C R Sukumar , 1-May-2013 , The Economic Times)
Israeli drugmaker Teva Pharmaceutical Industries has settled patent dispute with the Indian
pharmaceutical firm Orchid Chemicals & Pharmaceuticals pertaining to Parkinsons disease drug Azilect in
the US market. More...
Patented drug entry could be delayed in India: Deloitte

Launch of patented drugs in India could be delayed due to the government’s “thought process on linking
patented drug prices to the country’s per—capita income”, according to a report by consultancy firm
Deloitte. More...
Indian tech start-ups filing patents to get government funding

(Harsimran Julka , 1-May-2013 , The Times Of India)
The Centre has announced a scheme through which it will provide financial support to young technology
companies filing international patents a move that underscores the growing support for emerging
ventures in the country. More...
Motorola buy delivers Google more heartbreak than patent help

Microsoft owes only pennies in royalties per sale of Xbox and Windows instead of billions Google sought
in patent case More...
WTO unimpressed with patent violation charges against India

(Amiti Sen , 26-Apr-2013 , Hindu Business Line)
No country has objected to India issuing compulsory licence or refusing patent for drugs: WTO chief
Pascal Lamy. More...
Ever-greening of patents cannot be permitted: DIPP

Amid concerns expressed by multi-national companies over the Supreme Court's judgement in the
Novartis India today said its laws are WTO compliant and no country could allow "ever-greening" of
patents. More...
An asymmetric deal
(Devashish Mitra , 26-Apr-2013 , The Indian Express)
India has limited bargaining power in negotiating the EU-India FTA. More...
Microsoft gets upper hand in first Google patent trial

(Bill Rigby , 26-Apr-2013 , Reuters)
Microsoft Corp came out on top in the first of two patent trials versus Google Inc's Motorola Mobility unit
on Thursday, as a federal judge in Seattle ruled largely in its favor. More...
Microsoft signs Android patent deal with ZTE

Microsoft has signed a patent deal with China’s smart phones maker ZTE linked to its use of the Android
and Chrome operating systems. More...
Lucknow zardozi gets GI registration

(Virendra Singh Rawat | New Delhi/ Lucknow , 24-Apr-2013 , Business Standard)
The world famous textile embroidery handicraft of ‘Lucknow Zardozi’ is now a brand. More...
German court dismisses Nokia patent claims against HTC

Taiwan's top smartphone maker HTC said Wednesday it was "delighted" after a German court dismissed
another patent infringement complaint brought against it by Finnish phone giant Nokia. More...
IPAB complains lack of manpower, infrastructure as major hurdles

It also complained on the allocation of insufficient funds, which lead the Board to reduce the circuit
sittings in the last quarter of the financial year 2012-13 More...
Apple wins patent case on eve of results

(Bloomberg | Washington , 24-Apr-2013 , Business Standard)
Averts iPhone 4 import ban after Motorola Mobility loses case More...
FTA talks with EU on the fast track, Sharma tells LS

(ENS Economic Bureau - NEW DELHI , 23-Apr-2013 , The New Indian Express)
Commerce and Industry Minister Anand Sharma on Monday informed the Lok Sabha that the
negotiations between India and the European Union (EU) for a free trade agreement (FTA) have been
intensified. More...
Parliamentary panel asks govt to protect dairy sector under India-EU FTA
A Parliamentary panel today urged the government to take adequate steps for protecting the interest of
domestic dairy sector under the proposed India-EU bilateral free trade agreement (FTA). More...
VirnetX sues Microsoft over Skype patent infringement

Internet security software company VirnetX has filed a lawsuit against Microsoft, saying the software
giant’s Skype service violates six of its patents. More...
GI tag to add grandeur to Mamallapuram sculptures
( Express News Service - CHENNAI , 23-Apr-2013 , The New Indian Express)
Efforts are afoot to get the Geographical Indication (GI) tag for the stone sculptures made in
Mamallapuram and wooden sculptures of Thammampatti, the State Assembly was told on Monday.
More...
Copyright organisation asks colleges to buy licence to photocopy book portions

(Soma Das & Urmi Goswami , 22-Apr-2013 , The Economic Times)
This summer, many students cramming for their exams are confused whether their photocopied notes
are legal or not. More...
Madras HC bars Ravikumar Distilleries from using trademark

In response to the petition filed by the IMFL manufacturer Golden Vats Pvt Ltd regarding trademark
violation by the Puducherry-based listed entity Ravikumar Distilleries Ltd, the Madras High Court has
granted an interim injunction restraining the latter from using the brand Golden Vat. More...
India now in position of a thought leader on pharma patents: Kiran Mazumdar Shaw
(Kiran Mazumdar Shaw , 19-Apr-2013 , The Economic Times)
Weeks after the Supreme Court ruling on Novartis AG's cancer drug, Glivec, one thing is clear: India is
now in the position of a thought leader on pharmaceutical patents. More...
Bring down patent walls in pharma, free the knowledge locked up by patent holders
(Rajni Bakshi , 19-Apr-2013 , The Economic Times)
Following the Supreme Court judgment rejecting Novartis' claim for a patent, there has been
impassioned debate about patents versus patients, and profits over people. More...
India, EU eye more sops, fail to clinch trade deal

India and the European Union failed to clinch a deal on the Bilateral Trade and Investment Agreement
that has been in the works for six years as both sides sought more concessions for the deal to go
through. More...
DISALLOW PATENT LINKAGE

(P A Francis , 17-Apr-2013 , Pharmabiz)
The issue of linking grant of marketing approval to the patent status of a drug is being raised by the
multinational drug companies once again in the country. More...
Another India-EU meet in June to thrash out FTA irritants

India and European Union will hold another ministerial meeting in June to trash out the contentious issue
dogging the free trade pact that has been in the works for nearly six years, suggesting that the Brussels
ministerial failed to achieve any significant progress. More...
EU court rejects Spain, Italy challenge to landmark patent law
(AFP , 16-Apr-2013 , Livemint)
Spain and Italy had complained against a provision requiring that a patent be translated into only three
languages—English, French and German More...
Big pharma's uncertain future in India

(Sushmi Dey , 16-Apr-2013 , Business Standard)
Multinationals are worried about the country's patent regime, but India is too big a market to be
ignored. More...
Novartis patent verdict not a problem, other issues pose risks to Indian pharma innovation
(Hari Pulakkat & DIVYA RAJAGOPAL , 16-Apr-2013 , The Economic Times)
The recent Supreme Court judgement against Novartis has reopened old debates on drug patents,
affordable healthcare and India as a destination for pharma innovation. More...
US justices wary of wide human gene patent ruling

US Supreme Court justices on Monday signaled reluctance to issue too broad a ruling about patents on
human genes, and some indicated they might seek a compromise distinguishing between types of
genetic material. More...
Only 3% of patents filed by MNC pharma firms under dispute: Study

(DIVYA RAJAGOPAL , 16-Apr-2013 , The Economic Times)
On April 1, when the Supreme Court rejected Swiss pharmaceutical major Novartis' plea for a patent on
an updated version of its cancer drug Glivec, it evoked different reactions: More...
Delhi HC order on Januvia revives MNCs' clamour for patent linkage

The Delhi High Court's recent interim order in the Merck versus Glenmark case over the diabetes drug
Januvia has once again revived the multinational drug companies' clamour for patent linkage in the
country, for linking marketing approval of a product to its patent status. More...
India, EU talks on FTA expected to make headway

(Press Trust of India , 15-Apr-2013 , Business Standard)
Reduction on import duty in the auto sector & raise in the FDI cap for the insurance sector are high on
EU's demands More...
Why Novartis case will help innovation

(Achal Prabhala, Sudhir Krishnaswamy , 15-Apr-2013 , The Hindu)
The Supreme Court judgment on Glivec is a blow for a patent regime with a higher threshold of
inventiveness More...
With 219 patents, Novartis might have little to complain about
Data contradicts Swiss drug major's claim that India does not respect IPR More...
U.S.Supreme court weighs patentability of human genes

(Reuters , 15-Apr-2013 , The Indian Express)
Soon after learning that his son had autism, Hollywood producer Jon Shestack tried to get researchers
investigating the genetic causes of the disorder to pool their DNA samples, the better to identify genes
most likely to cause that disorder. More...
Indian perfume-maker wins right to ‘Gatsby’ trademark

Who would have thought Scott Fitzgerald’s Gatsby, a fictional character portrayed as a decadent dandy
in the 1920s, will leave an ‘intellectual’ legacy to fight over? More...
Impromptu poet with a trademark headgear

(Rajagopalan Venkataraman , 15-Apr-2013 , The New Indian Express)
There was a special reason why singer P B Sreenivas who passed away on Sunday afternoon was attired
in a headgear, similar to the Mysore Peta. The man with the lilting voice felt he looked infinitely better
when he wore it. More...
Patent expiry hits profitability of top 15 global pharma cos in 2012, Novartis overtakes Pfizer
in sales
(Sanjay Pingle , 15-Apr-2013 , Pharmabiz)
International pharmaceutical companies' are passing through difficult phase and are facing challenging
operating environment with loss of patent exclusivity and limited R&D success. More...
MSD-Glenmark case replay of Bayer-Cipla patent feud

(Jayati Ghose , 13-Apr-2013 , Indian Express)
In the 2010 Bayer-Cipla case on "patent linkage", a single-judge bench of the Delhi High Court and,
subsequently, a division bench had refused to ask the government to link the patent status of a drug to
grant of marketing approval for generic versions. More...
India-EU FTA won't hit generic drugs industry: EU envoy

(Nayanima Basu , 13-Apr-2013 , Business Standard)
EU had demanded an amendment to the Indian patent law, in the wake of a patent being rejected to
Novartis, for its cancer drug, Glivec. More...
A patent victory under threat

(Brook K. Baker , 12-Apr-2013 , Business Line)
Proposed clauses in the EU-India FTA could undo all gains from the Supreme Court’s Glivec ruling.
More...
No patent extension clause in free trade deal: EU
(Vidya Krishnan , 12-Apr-2013 , Livemint)
Pact with India won’t impose data exclusivity, demand anything that goes beyond trade-related IPR,
says EU official More...
Drug patent row: HC seeks Glenmark’s response by May 22

(PTI , 12-Apr-2013 , Business Line)
The Delhi High Court today sought the response of Glenmark Pharmaceuticals on US drug major Merck
Sharp and Dohme’s appeal against the single judge bench order refusing to restrain the Indian firm from
manufacturing and selling anti-diabetes drugs Zita and Zita-Met. More...
India refutes US charges over trade barriers

Commerce ministry says India’s policies are consistent with its international and bilateral obligations
More...
Law change linked to EU's demand for wider patent term

Currently, article 33 of the WTO's agreement on TRIPs provides for 20 years of patent protection from
the date of filing of patent application. More...
Lawyers can be patent agents without clearing exam: HC

A controversial amendment to the Patents Act, 1970, through which a lawyer's automatic right to appear
before tribunals as 'patent agent' was taken away by the Centre and the controller of patents, More...
Patients or patents?
(Vidya Krishnan & Jacob Koshy , 12-Apr-2013 , Livemint)
India’s top court misses an opportunity to answer this question decisively with an all-too-specific
judgement in the contentious Glivec case More...
Should pharma MNCs be peeved?

(Bhupesh Bhandari , 11-Apr-2013 , Business Standard)
In spite of all their complaints, pharma MNCs have been gaining market share in India. More...
After Glivec verdict, India might face patent regime heat

(Sushmi Dey | New Delhi , 10-Apr-2013 , Business Standard)
Stir has already begun with Anand Sharma defending govt's patent regime at WIPO Geneva this week
More...
Drug patent row: U.S. firm files appeal against interim order
(PTI , 10-Apr-2013 , The Hindu)
U.S. pharmaceutical major Merck Sharp and Dohme (MSD) has filed an appeal before the Delhi High
Court, challenging its single bench order refusing to grant interim relief to it on a patent row against
Glenmark Pharmaceuticals. More...
Trade deal with European Union will TRIP patent law

(Dinesh C. Sharma , 10-Apr-2013 , India Today)
When Prime Minister Manmohan Singh meets German Chancellor Angela Markel this week, the long
pending India-EU Broad Based Trade and Investment Agreement will be high on his agenda. More...
SIGNING FTA WITH EU

(P A francis , 10-Apr-2013 , Pharmabiz)
The free trade agreement between Indian government and the European Union is expected to be
finalized by the middle of this month. More...
The Indian way in pharma regulation

(Subir Roy , 9-Apr-2013 , Business Standard)
The Supreme Court verdict denying a patent to Novartis for an updated version of the firm's anti-cancer
drug Glivec may have a far greater impact in India and outside than was earlier realised, when India
became TRIPS compliant by amending its patent Act in 2005. More...
Novartis case: Anand Sharma defends India's patent regime, advocates affordable healthcare
solutions
A week after the Supreme Court rejected Swiss pharma firm Novartis' patent plea for Glivec, commerce
and industry minister Anand Sharma on Monday strongly defended India's decision not to give patent
protection to the drug at the World Intellectual Property Organisation in Geneva. More...
Purdue sues Dr Reddy’s for patent infringement

(ENS Economic Bureau , 9-Apr-2013 , The New Indian Express)
In yet another patent infringment suit, Dr Reddy’s Laboratories Ltd was dragged to court, by Purdue
Pharma LP, which filed a petition in New Jersey Federal Court for alleged infringement of its insomnia
drug — Intermezzo. More...
Global trademark registration: India joins Madrid Protocol

(PTI , 08-Apr-2013 , The Hindu)
India on Monday joined the Madrid Protocol which will enable domestic companies and entrepreneurs to
obtain cost effective global trademark registration. More...
Most big patented drugs skip India

Big pharma may be crying hoarse over India's "weak'' intellectual property environment, but over the
past five years or so, they have introduced only a handful of their patented blockbusters in the country.
More...
Fear in Indian pharma over EU's demand to seize drugs in transit
Indian pharmaceutical firms have faced trouble over IPR-related issues in European ports in the past as
well More...
Pharma verdicts bring major changes in patents

(Niraj Mishra | ENS - NEW DELHI , 8-Apr-2013 , The New Indian Express)
The recent landmark judgements by the Supreme Court and the Delhi High Court in the Novartis and the
Merck cases respectively have brought about largescale changes in the global pharma industry relating
to the manufacture, marketing and even patent protection laws. More...
Patent loss pushes Lipitor to 17th rank in 2012, Abbott's Humira is world's largest selling
drug
(Sanjay Pingle , 8-Apr-2013 , Pharmabiz)
The most significant development in the global pharmaceutical market in 2012 is the displacement of
Lipitor of Pfizer from its number one pharmaceutical product by Humira of Abbott. More...
Indian pharma is high on profit, low on R&D

(Business Standard , 8-Apr-2013 , Business Standard )
The Indian pharmaceutical sector is in the news, with generic makers winning a series of administrative
and judicial victories against patent-holders. More...
Patent industry gets ready with budding agents

(Atul Sethi , 8-Apr-2013 , The Times Of India)
Twenty-three-year-old R Srinivas is a botany graduate who spends most of his time reading up the
Indian Patents Act nowadays. More...
India: pariah or pathbreaker of pharma world?

(8-Apr-2013 , DNA)
The Supreme Court ruling last week dismissing Swiss drug major Novartis AG’s bid for a patent for its
cancer drug Glivec hinged on the interpretation of Section 3(d) of India’s patent law which defines what
are not “inventions” under Indian law, and therefore not patentable. More...
First patent war in India’s diabetes market gets intense

HC has rejected interim relief to Merck against Glenmark saying it had not made a strong case for an
injunction. More...
If you erode patents, where will innovations come from?, asks Dr Brian Druker
(Chidanand Rajghatta , 7-Apr-2013 , The Economic Times)
As a physician I want to see patients get the best treatment at an affordable cost. More...
Patent justice
(Sakthivel Selvaraj , 7-Apr-2013 , The Hindu)
The Supreme Court’s patent denial to Novartis for its anti-cancer drug Gleevec leaves the door open for
Indian pharmaceutical companies to produce their own versions of the drug. More...
And now, patents for genes

(Livemint , 07-Apr-2013 , Livemint)
India must quickly tighten its position on patenting genes and explicitly defining incremental innovation
More...
Is Section 3 (d) of Patents Act good for innovation? - Yes

(Gopakumar G. Nair , 6-Apr-2013 , Business Line)
It is heartening to note that Section 3(d) has so far been largely implemented in India by the office of
the Controller General of Patents, and has now been elegantly upheld by the Supreme Court. More...
System lacuna a bitter pill for patent holders

(Jayati Ghose , 6-Apr-2013 , The Financial Express)
No ‘linkage’ between regulators, patents office More...
Apple's patent claim rejected in Germany

(AFP , 6-Apr-2013 , The Times Of India)
Germany's patent court invalidated on Friday a patent held by Apple and contested by rivals Motorola
and Samsung on its "slide to unlock" function for smartphones, but the ruling can still be appealed.
More...
Glenmark-Merck Patent row: Delhi HC refuses interim relief to Merck

(Harish V Nair , 05-Apr-2013 , Hindustan Times)
Diabetes patients will continue to get cheap medicines manufactured in India thanks to Delhi high court
which for the time being ruled in favour of an Indian company caught in a row over patent rights with a
US pharmaceutical major. More...
Growing brood of patent agents indicator of India’s ready-to-take-off IPR industry

(Atul Sethi , 05-Apr-2013 , The Times Of India)
23-year-old R Srinivas is a Botany graduate who spends most of his time reading up the Indian Patents
Act nowadays. More...
SAIL unit seeks patent cover for its products

(Jaideep Deogharia , 05-Apr-2013 , The Times Of India)
From electrical towers, railway wagons, offshore platforms to nuclear reactors, the 24 steel products
developed by the research and development centre for iron and steel has a wide area of application.
More...
EU, Australia, Canada may follow India's Patent Law
(DIVYA RAJAGOPAL , 4-Apr-2013 , The Times Of India)
India's strong stance on minor drug innovations could reverberate in national parliaments and
courthouses of the developed world as Australia, the EU and Canada get ready to discuss and ban patent
protection for frivolous improvements. More...
Six products from state get geographical indication tag, south tops list
(Daniel P George , 4-Apr-2013 , The Times Of India)
The trademarks and geographical indication authorities on Wednesday awarded the unique tag to 21
products after a spurt in applications for the special status in the first three months of the year. More...
Compulsory licensing could be big business for drug makers

With over 500,000 people dying of cancer every year in India, the argument over compulsory licensing
seems to be headed in one direction in favour of those who can produce inexpensive life-saving drugs.
More...
Leukaemia patients caught in patent war

(Bushra Baseerat , 4-Apr-2013 , The Times Of India)
Blood cancer patient M Srinivas, 38, is battling for life at a city hospital in Tarnaka after a life-saving
drug, Dasatinib, was taken off the shelves recently, thanks to a bitter battle between a multinational and
a Hyderabad-based pharma company over patent rights. More...
US business groups say verdict to impact pharma innovation in India

(Indira Kannan | Toronto , 4-Apr-2013 , Business Standard)
Business groups in the US have sharply criticised the Supreme Court of India judgment against Swiss
drugmaker Novartis in denying patent protection to the company’s anti-cancer drug Glivec. More...
Novartis verdict will encourage genuine innovation: Prathiba M Singh

(03-Apr-2013 , IBN)
Prathiba M Singh, advocate for Ranbaxy and Cipla, fought the Glivec patent case against Novartis.
More...
Indian drugs will now face backlash, warn analysts in US after Novartis ruling
(Namrata Brar , 03-Apr-2013 , NDTV)
Has India's Novartis ruling just killed its own innovation dreams? More...
Cancer patients will get cheaper drugs

(NDTV , 2-Apr-2013 , NDTV/YouTube)
The Supreme Court verdict against Novartis has made sure that the cancer patients will keep getting the
drubgs at cheaper price. (Audio in Hindi)
In Conversation with Dr. Gopakumar G Nair, Mrs. Jyotsna Govil, Advt. Anand Grover, Mrs. Usha Ohari,
Dr. Suresh Advani and Advt. Pratibha Singh More...
Destroying patent model is no solution’

(Raghuvir Srinivasan , 3-Apr-2013 , Business Line)
Cross-subsidy is one solution to make medicines affordable: Novartis MD More...
Glivec lesson for pharma: Patented drugs must be priced smartly

(Kiran Mazumdar Shaw , 3-Apr-2013 , The Economic Times)
To ensure access to healthcare for all, India must harness innovation in discovering drugs, in developing
therapeutics and in delivering affordable healthcare. More...
US trade office reviewing Supreme Court's Novartis patent ruling

The United States said on Tuesday it was considering its response to the Supreme Court ruling that US
drug manufacturers warn is the latest sign of a deteriorating environment for intellectual property rights
in the country. More...
Now, domestic companies in patent war

In a twist in patent wars, a domestic generic company has dragged another to court. More...
Merck unit sues Glenmark Pharmaceuticals for infringing patent on diabetes drugs
(DIVYA RAJAGOPAL , 2-Apr-2013 , The Economic Times)
US-based MSD Pharma, the third-largest pharma company in the world by revenues, has asked the
Delhi High Court to bar Mumbai-based Glenmark from selling two popular anti-diabetic drugs, triggering
yet another legal battle between an Indian generic company and a member of Big Pharma. More...
India's Patent law: Some provisions of the Patents Act 1970

(02-Apr-2013 , The Economic Times)
Patents are a key incentive for any innovator. More...
European Union sets tough conditions under FTA

(Asit Ranjan Mishra, Vidya Krishnan , 02-Apr-2013 , Livemint)
EU has proposed its customs authorities will have the right to seize drugs in transit in case of IPR
infringements More...
Novartis lost patent case on technical ground

The Supreme Court judgment denying Novartis a patent for the beta crystalline form of its leukaemia
wonder drug Imatinib Mesylate (sold as Glivec) is not a blow against research and innovation More...
Apple seeks patent for its wraparound display
Apple is seeking a patent for an iPhone that has a display that wraps around the edges of the device,
expanding the viewable area and eliminating all physical buttons. More...
Stung by landmark Indian patent defeat, western drugmakers will be wary but cannot afford
to quit
(Reuters , 02-Apr-2013 , The Economic Times)
Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in
India, but they cannot afford to quit a country tipped to be the world's eighth largest market for
medicines by 2016. More...
Thumbs up from pro-health groups, domestic drug makers

(Our Bureaus , 1-Apr-2013 , Business Line)
Marks affordable access to medicines in developing countries More...
Glivec patent denial may affect investments to India

(Vidya Krishnan , 1-Apr-2013 , Livemint)
US Chamber of Commerce says decision to hurt businesses’ ability to invest in medical, technological
advancements More...
Novartis India says will continue to file for patents

(Kaustubh Kulkarni , 1-Apr-2013 , Reuters)
Novartis India Ltd a unit of Swiss drugmaker Novartis AG will continue to file for patents in India its vice
chairman said on Monday after the country's top court rejected its plea for patent protection of its drug
Glivec. More...
What is section 3(d) of the Indian Patent Act

(ET Bureau & Agencies , 1-Apr-2013 , The Economic Times)
Swiss pharma major NovartisBSE -0.50 % AG on Monday lost a seven-year long legal battle for getting
its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing
generic drugs, with the Supreme Court rejecting the multinational company's plea. More...
Supreme Court dismisses plea of Novartis for patent of cancer drug

The Supreme Court on Monday dismissed the plea of Swiss pharma giant Novartis AG for getting its
blood cancer drug Glivec patented in India. More...
Novartis wants Indian patent system to improve, compares with China

Novartis India Ltd a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, Ranjit
Shahani its vice chairman said on Monday, after the Supreme Court rejected its plea for patent
protection of its drug Glivec. More...
Novartis wants Indian patent system to improve, compares with China
Novartis India Ltd a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, Ranjit
Shahani its vice chairman said on Monday, after the Supreme Court rejected its plea for patent
protection of its drug Glivec. More...
Patent war over drugs goes chronic

Turf war between Big Pharma and generic companies, which was largely restricted to exorbitantly priced
life-saving drugs for cancer and HIV, is now spilling over to other chronic ailments like diabetes, and
threatening to change dynamics of the nearly Rs 70,000 crore Indian pharma market. More...
Apple seeks patent for an iPhone with 'wraparound' display

(Associated Press , 01-Apr-2013 , NDTV)
Waiving drug patents global trend

(Sidhartha , 01-Apr-2013 , The Times Of India)
For the past several months, Indian officials and ministers have spent a lot of time explaining to their
overseas counterparts that India has only used provisions of an international treaty to waive Bayer
Corporation's patent right on a cancer drug. More...
Novartis warns India over drug patent

( Andrew Jack in London and Amy Kazmin in New Delhi , 31-Mar-2013 , The Financial Times)
Novartis, the Swiss pharmaceuticals group, has threatened to stop supplies of new medicines to India if
the country’s top court refuses on Monday to grant a patent for Glivec, its cancer drug. More...
Innovate at your own risk

(SWATI PIRAMAL , 31-Mar-2013 , Business Line)
With a weak legal system, India’s pharma innovators may not consider it worthwhile to invest in new
inventions. More...
US Patent Office denies 'iPad Mini' trademark

(AFP , 31-Mar-2013 , The Times Of India)
The US patent and trademark office has denied Apple's application for a trademark to safeguard its
widely popular iPad mini tablet, saying the case to own the phrase was too weak. More...
Supreme Court may pronounce final verdict in Glivec case on April 1

The long-drawn patent battle between the Swiss pharma major Novartis and the government of India
over the sustainability of Section 3(d) of India's Patents Act which prohibits 'evergreening' will come to
an end soon as the Indian Supreme Court is all set to the pronounce its much-awaited verdict in the
imatinib mesylate (Glivec) case on April 1, it is learnt. More...
Apple patents iPhone with wraparound display

(AP , 30-Mar-2013 , The Economic Times)
HC dismisses plea challenging probe against Bloomberg Finance

(P Vasanth Kumar , 30-Mar-2013 , The Times Of India)
The Karnataka high court dismissed two petitions challenging investigation against the chairman, the
global head and the legal advisors of New York-based Bloomberg Finance LP on a complaint related to
hacking of two e-mails of a Bangalore -based company. More...
Glivec verdict may decide future course of action for drug makers
(Vidya Krishnan , 28-Mar-2013 , Livemint)
Novartis appeal rejection may hurt India’s reputation, but activists say will boost cause of affordable
drugs. More...
Micromax ordered to pay Ericsson royalty

(Mahesh Sharma , 28-Mar-2013 , ZDNet)
Indian manufacturer agrees to work out a royalty deal with the Swedish network equipment maker,
which had filed a lawsuit--seeking US$18 million in damages--against the company over patent
Drugs for Indian Poor Spark Pfizer Anger at Lost Patents

(Eva von Schaper , 28-Mar-2013 , Bloomberg)
In trying to get sophisticated medicines to its neediest citizens India is increasingly pitting its generic
pharmaceutical industry against international drugmakers threatening their growth in emerging markets
More...
Amul red flag over Europe trade deal

(Nupur Anand , 28-Mar-2013 , DNA)
Amul India’s largest dairy co-operative of India has expressed concerns over the free trade agreement
being negotiated between India and European Union. More...
Big Pharma waits nervously on India drug patent verdict

(Rupali Mukherjee , 27-Mar-2013 , The Economic Times)
The spate of patent defeats and an aggressive generic industry has made Big Pharma jittery. Ahead of a
crucial court ruling on April 1, Swiss major Novartis said on Wednesday that going by the recent
decisions in cases of protecting intellectual property rights, the "most likely" scenario is that the
company may lose patent protection on its blockbuster cancer medicine Glivec. More...
Apple in court in China over 'Siri' claim

(Reuters , 27-Mar-2013 , The Indian Express)
Apple appeared in a Shanghai court today, accused by a Chinese firm of copying software used for the
"Siri" personal assistant on its hugely popular iPhones. More...
Indian pharma sector fears India-European Union FTA could imperil local industry
Drugmakers and healthcare activists are worried that the India European Union Free Trade Agreement
which is in the works, may contain a provision that could imperil local industry and have urged the
government to keep patent infringement issues out of FTAs. More...
Micromax told to pay royalty to Ericsson

(Abhinav Garg & Javed Anwer , 26-Mar-2013 , The Times of India)
The smartphone patent war has finally reached India. More...
BRICS and mortar for India’s global role

(Samir Saran, Daniel Rubin , 26-Mar-2013 , The Hindu)
The grouping’s members can not only learn from each other’s development experiences and understand
views on subjects like climate change but also define new rules for health care, education and
Intellectual Property Rights. More...
Court stops firm from using trademark 'Nautanki'

(Mamta Sharma , 26-Mar-2013 , The Times Of India)
A local court has passed an exparte interim injunction on Saturday against Viacom 18 Media Private Ltd
to the effect that it shall not use the trademark, "Nautanki", and the accompanying logo for the comedy
show, 'Nautanki - The Comedy Theatre', run on their Hindi entertainment channel, Colors. More...
Drugmaker AstraZeneca settles Crestor patent case

(AFP , 25-Mar-2013 , Livemint)
Firm says that the deal will protect its sales of the anti-cholesterol drug until 2016. More...
Nutra Pharma Patent and Trademarks Published in India

(CORAL SPRINGS , 25-Mar-2013 , PRNewswire)
Nutra Pharma has received notification that their patent for their pain drug and their trademarks for
Nyloxin have been published in India's Official Journal. More...
India’s IP growing pains

(Stephen Ezell , 25-Mar-2013 , Reuters)
As it celebrates its 65th year as an independent country, India seems poised for an economic take-off.
More...
Why this royal treatment for MNCs?

(AARATI KRISHNAN , 24-Mar-2013 , Business Line)
MNCs are licensing technology and brands to Indian arms to gain access to a market that is growing
faster than their home markets. More...
Jury orders Cisco to pay $70 million in patent case

(Reuters , 23-Mar-2013 , The Economic Times)
Cisco Systems Inc committed fraud against patent licensor XpertUniverse Inc in an intellectual property
dispute, a jury found on Friday, ordering the networking company to pay $70 million in damages,
according to court filings. More...
Microsoft did not violate Google patent for Xbox: ITC judge
(PTI , 23-Mar-2013 , Indian Express)
Microsoft Corp did not violate a patent owned by Google subsidiary Motorola Mobility when it made its
popular Xbox, an administrative law judge at the International Trade Commission said in a preliminary
decision issued on Friday. More...
Nestle to shell out more in royalty

The company has a General Licence Agreement that allows it to access Nestle Groups intellectual
property rights including access to over 6,000 brands and technologies. More...
India Board Rules against Bayer in Patent Case

(Moneylife Digital Team , 22-Mar-2013 , Moneylife)
An Indian patent appeals board upheld the decision to allow Natco Pharma to sell a generic version of
Bayer AG’s cancer drug, Nexavar. Bayer AG, Germany’s largest drug-maker, said it would continue to
fight to overturn the decision. More...
BDR Pharma lines up more compulsory licences: Sources

(Reporter's Diary , 22-Mar-2013 , Money Control)
Indian generic drug maker BDR Pharma's plans could draw new battles lines over intellectual property
rights. More...
Ericsson confident of winning Samsung patent case

Swedish telecoms gear maker Ericsson said on Wednesday it was confident it would win a dispute over
patents with Samsung after the Korean firm filed a counter-claim in a U.S. court. More...
Winning the intellectual battle for economic liberalization

(Rajeev Mantri | Harsh Gupta , 21-Mar-2013 , Livemint)
That socialist era hasn’t quite passed and may be upon us once again. Citizens should be wary More...
US experiencing real frustration in trade ties with India, says top Obama official
The US is experiencing real "frustration" when it comes to some of the trade and business economic
relationship with India, a top Obama administration official told American Senators today. More...
Nokia wins patent ruling against HTC in Germany

A German court ruled in favour of Finnish mobile phone maker Nokia, saying some devices made by
Taiwan's HTC infringed on its power-saving patent. More...
Pharma MNCs are patently upset

(Amiti Sen , 19-Mar-2013 , Business Line)
They are lobbying abroad to squeeze India’s market access, forcing India to abandon compulsory
licensing. More...
BDR Pharma seeks licence to sell version of Bristol-Myers Squibb cancer drug
(DIVYA RAJAGOPAL , 19-Mar-2013 , The Economic Times)
A small Mumbai-based pharma firm has applied for a compulsory licence (CL) for an anti-cancer drug
owned by American drug giant Bristol-Myers Squibb (BMS), a move that is likely to intensify the battle
between domestic and foreign firms over the controversial facility More...
Bayer Sues in U.S. to Stop India Generic Drug Co.

(Lisa Shuchman , 19-Mar-2013 , Corporate Counsel)
A subsidiary of Bayer AG, the Germany-based pharmaceutical company, has filed suit in federal court in
Wilmington, Delaware, against Glenmark Generics, an international generic drug manufacturer, seeking
to stop the Mumbai-based company from selling a generic form of a medication used to treat a skin
disorder. More...
Glenmark in patent challenge on Bayer skin drug

Drug-maker Glenmark faces legal action in the US from Bayer Healthcare Pharmaceuticals, regarding
the latter’s skin drug Finacea. More...
India undermining intellectual property: Pfizer

Months after its patent for a cancer medication was revoked by India, American firm Pfizer % has told
US lawmakers that New Delhi is undermining intellectual property by misuse of its compulsory licence
provisions. More...
Number of patent applications up nearly 50% this year

Patent applications in India have witnessed a substantial increase over the last five years, D. K. Rahut,
Deputy Controller of Patents and Designs, Intellectual Property Office, Kolkata, said on Thursday. More...
NGOs urge Indian govt to reject EU's demand to sign FTA before April deadline
The IP provisions could potentially block the export of generic medicines from India –a lifeline for
millions of people across the developing world. More...
Nintendo infringed 3D patents: US jury

A federal jury in New York found that video game company Nintendo infringed an inventor's 3D display
technology patent with its handheld 3DS videogame system. More...
Trade panel delays decision on Apple, Samsung patent fight

(Reuters , 14-Mar-2013 , Hindustan Times)
The U.S. International Trade Commission said on Wednesday that it would delay a decision on
allegations that Apple infringed upon patents owned by Samsung Electronics in making the iPod touch,
iPhone and iPad. More...
PATENT DISPUTES & DENIED JUSTICE

(P. A. Francis , 13-Mar-2013 , Pharmabiz)
The amended Indian Patent Act was notified in January 2005 allowing grant of product patent in
pharmaceutical industry under pressure from the World Trade Organization. More...
Nokia Loses "Flagship" Patent Battle Against HTC

( SiliconIndia , 12-Mar-2013 , SiliconIndia )
The Finnish manufacturer, Nokia has lost two patent suits against HTC, including one involving the use
of Google Play on HTC’s Android devices. More...
Leaked IP Chapter Of India-EU FTA Shows TRIPS-Plus Pitfalls For India, Expert Says
(Patralekha Chatterjee , 12-Mar-2013 , Intellectual Property Watch)
Indian negotiators are reportedly under tremendous pressure to give in to the European demands for a
more rigid intellectual property rights regime in the ongoing discussions on EU-India free trade
agreement, suggests a leaked draft text of the chapter on IP which is being negotiated. More...
Abraham Lincoln only US president ever to receive patent

(ANI , 11-Mar-2013 , DNA)
Former US President Abraham Lincoln was the only president ever to have received a patent. More...
Activists want compulsory licence for cancer drug

(Jyotsna Singh , 11-Mar-2013 , Business Standard)
Trastuzumab, used to treat breast cancer, is priced at Rs 6-8 lakh for a full course. More...
US loses race on home turf as patent policy boomerangs

(Subir Ghosh , 11-Mar-2013 , DNA)
The bullying tactics employed by the US in ensuring that it rules the patents regime and therefore the
world, is backfiring badly on itself. US companies, in fact, are losing the race even in the US where
foreign companies have forged ahead in registering patents. More...
India for flexible IP regime for small, medium enterprises in developing countries
At the World Trade Organisation (WTO)'s TRIPS Council meeting, India is arguing for a flexible
Intellectual Property (IP) regime for the small and medium enterprises in developing countries for their
technological progress. More...
Google Maps facing ban in Germany over Microsoft patent case

(ANI , 11-Mar-2013 , The Times Of India)
Web giant Google is facing a ban on its application Google Maps in Germany over a patent dispute with
Microsoft. More...
Nokia's patent claims against HTC dismissed by German court

(Agence France-Presse , 11-Mar-2013 , NDTV)
Taiwan's top smartphone maker HTC said Saturday a German court had dismissed two patent
infringement complaints brought against the company by Finnish phone giant Nokia. More...
US judge will not suspend Apple Siri patent case vs Samsung

A US judge on Friday refused to suspend Apple Inc's patent lawsuit against Samsung Electronics Co Ltd,
a case that includes search technology in Apple's Siri voice assistant. More...
GNA Patent Gurukul submits revisions to norms for processing of patent applications relating
to TK
(Nandita Vijay, Bengaluru , 8-Mar-2013 , Pharmabiz)
GNA Patent Gurukul has submitted the required revisions to the guidelines for processing of Patent
Application relating to Traditional Knowledge to the Controller General of Patents: Design and
Trademarks (CGPDTM). More...
Call for compulsory licensing of breast cancer drug

(P. T. Jyothi Datta , 8-Mar-2013 , Business Standard)
Mark Women’s Day 2013 with a compulsory licensing of breast cancer drug Trastuzumab, so that a less
expensive version of this life-saving medicine can enter the market. More...
Apple granted patent for iPhone 5's integrated touch display

(Anupam Saxena , 08-Mar-2013 , NDTV)
The US Patent and Trademark Office has granted Apple a patent (number 8390582) related to a display
with integrated touch. More...
Bayer to appeal against India's patent ruling on Nexavar

Bayer AG has said it will approach the High Court in Mumbai against a ruling by Intellectual Property
Appellate Board that upheld the compulsory licence issued to India’s Natco Pharma to make and sell a
low-cost generic of the German drug major’s patented cancer drug Nexavar. More...
Samsung loses latest Apple patent suit in UK

Apple won a patent infringement lawsuit on Thursday in an English court, which exonerates the iPhone
maker from charges it unlawfully used Samsung technology. More...
Patients win over patents

(Srividhya Ragavan , 7-Mar-2013 , The Hindu)
Justice Prabha Sridevan’s judgment permitting the production and sale of a generic version of a cancer
drug is a victory for patients. More...
Patent drug pricing to distract from compulsory licences

(Sushmi Dey | New Delhi , 06-Mar-2013 , Business Standard)
The latest recommendations by a government panel on the proposed patented drug pricing policy are
seen as a threat to compulsory licensing, which has just begun in India. More...
India needs a better deal from trade pacts

(Bipul Chatterjee & Purna Chandra Jena , 06-Mar-2013 , Business Standard)
Second, though trade in goods is the first stage in economic integration, services, investment,
competition, government procurement, safeguards, intellectual property rights and dispute-settlement
mechanisms to address non-tariff barriers are essential ingredients for a mutually beneficial international
economic cooperation deal. More...
India needs a better deal from trade pacts

(Bipul Chatterjee & Purna Chandra Jena , 06-Mar-2013 , Business Standard)
Second, though trade in goods is the first stage in economic integration, services, investment,
competition, government procurement, safeguards, intellectual property rights and dispute-settlement
mechanisms to address non-tariff barriers are essential ingredients for a mutually beneficial international
economic cooperation deal. More...
Pfizer painkiller gets longer patent protection

(AP , 6-Mar-2013 , Livemint)
Shares of Pfizer jumps nearly 2% on the news before giving up part of that gain More...
Bayer to move HC to protect patent drug

(Sushmi Dey | New Delhi , 6-Mar-2013 , Business Standard)
A day after the Intellectual Property Appellate Board (IPAB) reinforced the first compulsory licence
granted in India on an anti-cancer medicine, German multinational Bayer said it would approach the
Mumbai High Court with a petition. More...
DPCO not to disturb existing norms on price control of patented drugs

(Joseph Alexander, New Delhi , 06-Mar-2013 , Pharmabiz)
The new Drug Price Control Order (DPCO), being finalized in tune with the new pharmaceutical pricing
policy, may not include any provisions on fixing and monitoring the prices of imported patented drugs,
notwithstanding the recent developments. More...
Bayer plea dismissed, Natco allowed to sell patent cancer drug

The Intellectual Property Appellate Board (IPAB) today upheld a compulsory licence issued by the
Controller of Patents to Hyderabad-based Natco Pharma Ltd, a generic drug maker, to manufacture and
sell a cancer drug of Bayer Corp in India. More...
India’s First Compulsory Licence Upheld, But Legal Fights Likely To Continue
(Patralekha Chatterjee , 4-Mar-2013 , Intellectual Property Watch)
India’s Intellectual Property Appellate Board (IPAB) today upheld the country’s first compulsory licence
on a pharmaceutical product. More...
Stocks to Watch: US court ruling to impact Lupin

(K.S. Badri Narayanan , 3-Mar-2013 , Business Line)
The stock of Lupin is likely to come under pressure as the company failed to get a verdict in its favour in
the US court to prevent Mylan Inc from selling a generic version of the drug Antara, used to treat high
cholesterol levels. More...
Call to amend patenting laws to boost research in Ayurvedic medicines

(Swati Chandra , 28-Feb-2013 , The Times Of India)
The rules and regulations of patenting of traditional knowledge and biological material are affecting the
research activities in the field of Ayurvedic medicines. More...
Fix prices of costly patented drugs: Panel

(Sushmi Dey | New Delhi , 28-Feb-2013 , Business Standard)
The government should start negotiating with pharmaceutical companies for fixing the prices of patented
drugs, an official committee has said. More...
Samsung's claim against Apple rejected by Japan court

(AFP , 28-Feb-2013 , The Times Of India)
A Japanese court Thursday rejected a claim by Samsung that Apple stole its technology, in the latest
round of a global legal battle between the smartphone giants over patents. More...
New compulsory licences policy raises monopoly concerns

(DIVYA RAJAGOPAL , 28-Feb-2013 , The Economic Times)
Public health policy experts, domestic drug makers and aid organisations are concerned over
government's proposal to dilute the provisions of compulsory licences (CL) on the basis of price, a move
they say will encourage monopoly and block access to key life saving drugs for Indians. More...
Suspense as Ipab set to rule on Bayer-Natco row
(KV Ramana , 28-Feb-2013 , DNA)
The Intellectual Property Appellate Board has concluded the hearings (that beganon January 23) on the
issue of the compulsory licensing of Bayer’s anti-cancer generic drug Nexavar (sorafenib tosylate).
More...
Congress to consider bill to stop abusive patent lawsuits

(Reuters , 28-Feb-2013 , Yahoo News)
Two Congressmen introduced a bill on Wednesday that would penalize companies that file frivolous
patent infringement lawsuits, derided by critics as "patent trolls. More...
Congress to consider bill to stop abusive patent lawsuits

(Reuters , 28-Feb-2013 , Yahoo News)
Two Congressmen introduced a bill on Wednesday that would penalize companies that file frivolous
patent infringement lawsuits, derided by critics as "patent trolls. More...
GlaxoSmithKline unit joins patent pool for AIDS drugs

(Ben Hirschler , 27-Feb-2013 , Reuters)
GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine
in a patent pool designed to make treatments more widely available in poor countries. More...
India still lagging in innovation, R&D spend

(Venkatesh Ganesh , 27-Feb-2013 , Business Line)
Despite India having better scientific research institutions, R&D and innovation capabilities are lower
than other BRICS countries, according to the Economic Survey. More...
Link patented drug prices to per capita income: Panel

A government panel has proposed that prices of patented medicines be based on the country's per
capita income, a move that would substantially reduce prices of costly drugs made by global
pharmaceutical firms. More...
India Plans Price Controls for Patented Drugs

(RUMMAN AHMED , 27-Feb-2013 , The Wall Street Journal)
An Indian government panel Wednesday published a set of proposals to control the prices of patented
drugs, a plan which has drawn fire from the pharmaceutical industry. More...
Patents 'spike drug prices'

(KATHARINE CHILD , 27-Feb-2013 , Times Live)
They blame the patenting system, which they say makes it easy to patent new changes to existing
drugs. More...
Music, movie industry to warn copyright infringers

(Associated Press , 27-Feb-2013 , The Indian Express)
Internet users who illegally share music, movies or TV shows online may soon get warning notices from
their service providers that they are violating copyright law. More...
Fix prices of costly patented drugs by negotiated pricing: panel

(Vidya Krishnan , 26-Feb-2013 , Livemint)
Pharma department invites comments from stakeholders on recommendations made by panel. More...
IPAB to pronounce its order in Bayer's appeal against India’s first-ever CL on Nexavar on
March 4
The eagerly-awaited order in the German pharma major Bayer's appeal against India’s first-ever
compulsory licence issued on sorafenib tosylate (Nexavar) will be pronounced by the Intellectual
Property Appellate Board (IPAB), Chennai on March 4. More...
Herbal sector object to draft norms for patenting of traditional knowledge

(Our Bureau, Bengaluru , 23-Feb-2013 , Pharmabiz)
Scientists representing herbal sector have strongly objected to the draft guidelines for patenting
traditional knowledge and biological material issued by the Controller General of Patents Designs and
Trademarks (CGPDTM) for which comments are solicited before March 15, 2013. More...
The best way to expand in India is through partnerships, says Merckâ€™s Schechter
(DIVYA RAJAGOPAL & Satish John , 22-Feb-2013 , The Economic Times)
Merck's executive vicepresident and president, global human health division , says the global pharma
major is committed to India despite the challenges posed by the country's intellectual property rights
regime More...
Apple patent application reveals ‘slap wrap’ iWatch’

(ANI , 22-Feb-2013 , Zee News)
A patent application filed by Apple has revealed that its iWatch could the ‘slap wrap’ mechanism to
mount a flexible touchscreen on a user’s wrist. More...
Jasmine gives regular drink an incredible aromatic lift

(Vikram Doctor , 22-Feb-2013 , The Economic Times)
It is a well-timed book since the Madurai malligai has just received a Geographical Indications tag that
recognises its special characteristics, the second variety to get one after the Mysore jasmine. More...
DIPP seeks details on 3 cancer drugs for compulsory licencing

(PTI , 21-Feb-2013 , The Economic TImes)
Kick starting the process for a possible issuance of compulsory licences for anti-cancer drugs, the DIPP
has sought details from the Health Ministry regarding three medicines sold by multinationals Roche and
Bristol-Myers Squibb in India to make them affordable. More...
Gilead, Teva reach settlement in Viread patent lawsuit
(Sakthi Prasad in Bangalore , 19-Feb-2013 , Reuters)
Gilead Sciences Inc said it has agreed with Israel's Teva Pharmaceuticals Industries Ltd to settle a
lawsuit relating to patents protecting Viread, a treatment for HIV infection and chronic hepatitis B.
More...
Google hits back against BT with patent lawsuits

Google Inc and its Motorola Mobility unit struck back on Wednesday against BT Group Plc, filing patent
lawsuits against the British telecommunications group more than a year after BT launched its own
lawsuit against Google. More...
Apple loses rights to iPhone trademark in Brazil

(Associated Press : Rio De Janeiro , 14-Feb-2013 , The Indian Express)
Brazil's patent authority has bitten Apple. More...
BDR Intl to launch first copy of Pfizer’s Sutent after patent revocation
Firm says its generic version will be priced at least 75% lower than the price of Pfizer’s brand More...
Japanese pharma firms keen on trade and technical tie-ups with Indian companies
(Our Bureau, Mumbai , 13-Feb-2013 , Pharmabiz)
Because of patent expirations of blockbuster drugs, Indian firms are expected to actively participate in
the production of generic version of these products. More...
Pfizer to appeal patent order on cancer drug

The ruling by the Patent Controller is a repeat of an earlier order in response to a post-grant opposition
filed by domestic drug maker Cipla. More...
Meerut's scissor units get Geographical Indicator tag

(Shivendra Kumar Singh , 12-Feb-2013 , The Economic Times)
Now, with a Geographical Indicator status Meeruts scissor industry has got a new lease of life. More...
Indian generics in need of policy tonic

If I win a case and the product is off patent, anyone can market it. More...
Facebook faces lawsuit over infringing ‘Like’ button patent

Facebook has been by the family of a deceased Dutch programmer over the use of the ‘Like’ button on
the social networking site. More...
Cipla gets relief in patent battle with Pfizer
The patent office said Pfizer’s claimed patent for Sutent, a cancer drug, did not involve any inventive
step More...
The 'Rajakumari' of black pepper

(Shenoy Karun , 12-Feb-2013 , The Times Of India)
It seems that Rajakumari pepper can go on claiming a geographical indication tag from Chennai-based
Geographical Indication Registry. More...
Apple and Samsung: frenemies for life?

(Reuters | San Francisco/Seoul , 11-Feb-2013 , Business Standard)
Recent rulings suggest smartphone patent wars are now grinding towards a stalemate More...
An emerging R&D superpower

(Biswajit Dhar , 11-Feb-2013 , Livemint)
Seen from the vantage of patent filings and research output—proxies for innovation—China is outpacing
the US More...
Apple patent filing suggests new take on passwords

(AFP , 11-Feb-2013 , Hindustan Times)
Patent filings published this week show that the technology firm is considering image and object-based
passwords to make their mobile devices more secure and to make pass codes easier to remember but
harder to hack. More...
Indian technology companies sharpen focus on patents

(Leslie D’Monte & | Ruchita Saxena , 10-Feb-2013 , Livemint)
Firms also tap non-linear businesses to shield themselves from risks to traditional offshoring delivery
models More...
Call to establish intellectual property exchange in India

(Our Bureau , 08-Feb-2013 , Business Line)
The country has been falling back in terms of patent filings and protection. More...
Apple applies for patent on use of 'images for authentication'

Tech giant Apple has applied for a patent on the use of images to authenticate the user of a Mac or
some other 'i' product. More...
Microsoft wins latest round in Motorola patent case

(AFP , 8-Feb-2013 , Hindustan Times)
A federal judge on Thursday tossed out more than a dozen patent infringement claims filed against
Microsoft by Google-owned Motorola Mobility. More...
Obama nominates openly gay lawyer for patent appeals court

(Dan Levine | Reuters , 8-Feb-2013 , Yahoo News)
President Barack Obama nominated Thursday an openly gay attorney to serve on the U.S. appeals court
for patent cases after a previous gay nominee for that court stalled. More...
UK court revokes Glaxo patent on malaria drug on Glenmark petition

(C. H. Unnikrishnan , 07-Feb-2013 , Livemint)
After the order to revoke Glaxo’s patent, Glenmark’s generic unit launched a copy of the drug in the UK.
More...
Window of opportunity on FTA closing: EU ambassador

(Elizabeth Roche , 07-Feb-2013 , Livemint)
EU ambassador Joao Cravinho says differences on auto, wine and spirits, services sectors remain to be
resolved More...
Stay on hearing over ‘Financial Times’ trademark

(Utkarsh Anand : New Delhi , 6-Feb-2013 , The Indian Express)
The Supreme Court Tuesday stayed the proceedings before the Karnataka High Court pertaining to
determination of the validity of registration of the trademark Financial Times in India. More...
Organic route to promote Geographical Indications crops

The horticulture department in Mysore is going all out in its efforts to protect Geographical Indications
crops Nanjangud Rasabale Mysore Mallige and Mysore veeledele which are on the verge of extinction.
More...
Financial Times: Whose intellectual property?

(Paranjoy Guha Thakurta , 03-Feb-2013 , Livemint)
The battle could be reaching a conclusion as a bench of the Supreme Court starts hearing the case on 4
Feb More...
US exports may drive top Indian pharma cos to grow 20% in 2013
(Press Trust of India / Mumbai , 03-Feb-2013 , Business Standard)
Patent expiry opportunities, coupled with efforts to contain healthcare spends, are likely to drive the
generic market in developed countries. More...
Opportunities for biosimilars as patent protection drops: report

(Amit Mitra , 01-Feb-2013 , Business Line)
Significant opportunities are expected to open up for pharmaceutical companies in the biosimilar
segment, with biological drugs with a market value of over $50 billion slated to shed their patent
protection in the US alone in the next six years. More...
Microsoft sued over search-related patents

A lawsuit filed on Thursday alleges Microsoft Corp has been infringing patents that allow Internet search
engines to most effectively place advertisements. More...
$19 bn worth biologics to go off patent in US this year

(BS Reporter / Chennai/ Hyderabad , 1-Feb-2013 , Business Standard)
Twenty one biologics with a market value of about $54 billion will be losing patent protection by 2019 in
the US alone. More...
Apple loses a U.S. appeals bid in Samsung patent fight

(Dan Levine , 1-Feb-2013 , Reuters)
A U.S. appeals court on Thursday rejected Apple Inc's request to revive its bid for a sales ban on
Samsung's Galaxy Nexus smartphone dashing the iPhone maker's attempt to recover crucial leverage in
the global patent wars. More...
Patent Gurukul to meet experts to discuss impact of recent patent office notification in
Mumbai
(Our Bureau, Mumbai , 30-Jan-2013 , Pharmabiz)
With a view to get better clarity on the recent notification issued by the Patent office, the Patent Gurukul
will soon be meeting experts from the field to discuss and brainstorm on the concept of traditional
knowledge and biodiversity in Mumbai on February 15. More...
Higher yields & farmer preferences show, Bt cotton detractors spreading patent falsehoods
(Swaminathan S Anklesaria Aiyar , 30-Jan-2013 , The Economic Times)
India's cotton yield was 225 kg per hectare in 1990-91. More...
Glenmark readies to enter one more niche segment in US

(Sushmi Dey / New Delhi , 29-Jan-2013 , Business Standard)
Prodded by patent cliff & increasing competition it files application for foray into injectible oncology
segment. More...
Firms go beyond patent cliff for growth

(Sushmi Dey / New Delhi , 29-Jan-2013 , Business Standard)
Indian pharma companies have depended heavily on drugs coming off patent in the US to fuel their
growth. More...
Free trade pact with EU on verge of completion : Anand Sharma

(Asit Ranjan Mishra, Elizabeth Roche , 28-Jan-2013 , Livemint)
Global economic recovery remained fragile though there was some hope for cautious optimism, Sharma
said More...
India foils US firm bid to patent turmeric

(Vanita Srivastava , 28-Jan-2013 , Hindustan Times)
The claim made by a US multinational company on the usefulness of turmeric apple, basil for the
treatment of inflammation psoriasis and gastritis has been foiled by India thanks to the efforts of the
Traditional Knowledge Digital Library. More...
US panel reviews patent ruling against Samsung

(AFP , 24-Jan-2013 , The Economic )
The US International Trade Commission on Wednesday ordered review of a ruling that Samsung violated
Apple patents for smartphones and tablet computers. More...
US panel reviews patent ruling against Samsung

The US International Trade Commission on Wednesday ordered review of a ruling that Samsung violated
Apple patents for smartphones and tablet computers. More...
Varanasi eyes GI tag for local handicraft

An awareness workshop on Geographical Indications was organised jointly by National Bank for
Agriculture and Rural Development Lucknow Human Welfare Association and GI Registry office Chennai
at Parade Kothi on Wednesday. More...
Pharma MNCs use RTI law to protect market for patented drugs & delay entry of generics
(ET Bureau , 24-Jan-2013 , The Economic Times)
Pharmaceutical multinationals have begun using the Right to Information law to launch pre-emptive
legal action against local generic players to protect the market of patented drugs and delay the entry of
low cost generic medicines in the 60,000-crore domestic drug market. More...
Hindustan Unilever enters into new technology, trademark license agreement with Unilever
(Namrata Singh , 22-Jan-2013 , The Times Of India)
HUL will enter into a new agreement effective February 1 2013 with Unilever for the provision of
technology trade mark license and other services. More...
Global firms turn to ITAG Business Solution for patenting, IP rights issues in India
(Anuradha Himatsingka , 22-Jan-2013 , The Economic Times)
Kolkata based intellectual property firm, ITAG Business Solution has been approached by global as well
as Indian corporate giants for matters as diverse as finding buyers of new technological inventions to
fighting patent issues to filing of new patent of Indian firms seeking markets over-seas with their
exclusive product range. More...
Final hearings in Bayer's appeal against India’s first-ever CL on Nexavar to begin at IPAB
soon
The final hearings in the German pharma major Bayers appeal against Indias first ever compulsory
licence issued on sorafenib tosylate will begin at the Intellectual Property Appellate Board Chennai on
January 23. More...
We must protect traditional Indian products in the international market to boost growth
(21-Jan-2013 , The Times of India)
One such policy is the recognition of geographical indications. More...
India lags behind in applications for patents: Prez

(Press Trust of India / Vidyanagar(WB) , 20-Jan-2013 , Business Standard)
Noting that India "lagged behind" others in applying for patents, President Pranab Mukherjee today said
there is a need to carry out more research and scientific inventions in the country. More...
Naga shawl among 18 handicraft items zeroed in for GI tag status

(Shobha Roy , 20-Jan-2013 , Business Line)
National Institute of Fashion Technology is in the process of registering the well known traditional crafts
of the country’s north-eastern States under the Geographical Indication Act. More...
Meerut scissors may get Geographical Indication (GI) mark

(Pankaj Shah , 17-Jan-2013 , The Times Of India)
The famous Meerut scissors which have 360 year old history are in the process of getting the coveted
Geographical Indication mark enabling artisans get a premium for their unique product and protecting
their age-old tradition against copy-cats. More...
Drug pricing: Govt decides to bypass three patents

(Reghu Balakrishnan / Mumbai , 15-Jan-2013 , Business Standard)
The governments move to issue compulsory licences for three more patented cancer drugs is a jolt to
multinational pharmaceutical companies. More...
Samsung urges U.S. court to keep allowing Galaxy phone sales

(Erin Geiger Smith , 15-Jan-2013 , Reuters)
Samsung Electronics Co Ltd has urged a U.S. appeals court to stand by its denial of Apple Inc's request
to ban sales of the Galaxy Nexus smartphone while Apple challenges its patent, according to a document
filed late last week. More...
India to hit Roche, BMS with compulsory licenses on 3 cancer drugs

(Tracy Staton , 13-Jan-2013 , Fierce Pharma)
Officials aim to usher in cheap copies of Herceptin, Sprycel, Ixempra More...
Compulsory licence likely for three cancer drugs

(Divya Rajagopal , 14-Jan-2013 , The Economic Times.)
The government has appointed a panel to look into issues related to compulsory licensing of drugs and
whether cheaper versions of cancer medicines Trastuzumab, Ixabepilone and Dasatinib can be launched
under the provision, a person with knowledge of the development said. More...
Govt moves to make three key cancer drugs cheaper

( Abantika Ghosh , 12-Jan-2013 , Indian Express)
Compulsory licensing by the government allows a domestic company to manufacture and sell a generic
version of a patented drug with or without the consent of the patent-holder. More...
Kodak patent sale plan gets U.S. bankruptcy court approval

The price is a fraction of the more than $2 billion which Kodak had hoped to fetch for the patents when it
filed for bankruptcy in January 2012. More...
Berhampur charts silk route to recognition

(Hrusikesh Mohanty , 12-Jan-2013 , The Times Of India)
Four products of Ganjam district the Berhampuri patta saree joda or silk dhoti kewda flower and kewda
flower rooh or essence have been registered under the Geographical Indications of Goods Act. More...
IKEA stares at trademark hurdle

(Sounak Mitra & Surajeet Das Gupta / New Delhi , 11-Jan-2013 , Business Standard)
IKEA Home D?cor Pvt. Ltd, registered with the RoC, Chandigarh, since July 2011, has the trade mark
registration for the brand IKEA More...
2012 patent rankings: IBM on top again, Google, Apple surge

(STEVE LOHR , 11-Jan-2013 , The Indian Express)
In the yearly count of patents granted in the United States the corporate front-runner for 2012 is
scarcely a surprise. More...
IBM tops as tech titans scramble for US patents

(AFP , 11-Jan-2013 , Livemint)
The list of the top 50 patent recipients included 17 US firms and 26 that are based in Asia More...
Soon MSMEs can buy, sell licences for patented products online
MSMEs will get concessional rates for trading on the portal More...
Meerut scissors make the cut for GI tag

(Renuka Phadnis , 10-Jan-2013 , Business Line)
For the first time, a handmade tool from micro and small and medium enterprises in India has been
registered for a geographical indicator tag an official of a body promoting this sector said on Wednesday.
More...
Google's Motorola drops patent claims vs Microsoft
Google unit Motorola Mobility has asked a trade panel to drop two key patents from an infringement
complaint that it filed against Microsoft, according to a filing at the International Trade Commission.
More...
Tech patent war: Justice Department against sales bans

The fight has also embroiled Samsung Electronics, HTC and others who use Android technology. More...
Indian court to rule on generic drug industry

(NIRMALA GEORGE AP , 09-Jan-2013 , Daily Finance)
The implications of this case reach far beyond India, and far beyond this particular cancer drug," said
Leena Menghaney, from the aid group Doctors Without Borders. More...
Intellectual property rights to play key role in value-addition to exports

(A. J. Vinayak , 09-Jan-2013 , Business Line)
India should look at intellectual property rights to add value to exports. More...
Indian Patent Office issues draft guidelines on examination of biotech applications

The Indian Patent Office has issued draft guidelines on examination of biotechnology applications.
More...
Ya Allah!! A Dutch artist wants to patent your name for his art
(IANS/RIA Novosti , 09-Jan-2013 , India Today)
A Dutch artist has made a bid to register the name "Allah" as a trademark, saying it is an "incredibly
beautiful name". More...
Patent 'Cliff' a Challenge, but Manageable

(Javier E. David , 08-Jan-2013 , CNBC)
Eli Lilly will be "very challenged" by the loss of exclusivity on several blockbuster drugs, CEO John
Lechleiter told CNBC on Tuesday, but added the company is engaged in other ways to revive growth
next year. More...
Google withdraws ITC patent claims against Microsoft

(Steven Musil , 08-Jan-2013 , cnet)
Motorola Mobility parent drops two patents from its infringement case over video coding patents used in
Xbox and smartphones. More...
Regulatory hurdles dampen MNC appetite for pharma buyouts
(Reghu Balakrishnan / Mumbai , 7-Jan-2013 , Business Standard)
The pharmaceutical sector in India among the fastest growing markets globally in the segment is likely
to witness less demand from multinational corporations for larger buyouts in 2013. More...
MNC R&D centres are now increasing their filing of patents from India
(Chiranjoy Sen , 7-Jan-2013 , The Economic Times)
The Philips R&D centre started in 1996 in a small building at the heart of Bangalore. More...
Google-FTC agreement could impact other patent disputes

While the focus of last week's agreement between the Federal Trade Commission and Google Inc was
search, the deal's restrictions on how Google uses its patents could have a broader impact on the
technology industry. More...
India must expand knowledge base and focus on R&D, says HRD Minister
YDERABAD: There is a need to create intellectual property with proprietary rights by enhancing the
knowledge base and help the country emerge as a major power, Union HRD Minister M M Pallam Raju
said today. More...
RIM settles patent dispute with Nokia

BlackBerry maker Research in Motion paid rival Nokia 50 million euros to settle a patent dispute, the
Financial Times reported on Thursday citing US regulatory filings. More...
The great Indian patent saga

(Shruti Verma Khare , 4-Jan-2013 , mydigitalfc)
The outcome of Novartis & Bayer fights for patents will set new benchmarks for the industry. More...
Need to create intellectual property with proprietary rights: Pallam Raju

(OUR BUREAU , 3-Jan-2013 , Business Standard)
There is a need to create intellectual property with proprietary rights, according to M.M Pallam Raju,
Union Minister for Human Resources. More...
Nestle wins trademark battle against Cadbury over kitkat bar’s shape
(ANI , 3-Jan-2013 , The Indian Express)
Nestle has won a trademark lawsuit against Cadbury over their rights to KitKat chocolate bar's four-
fingered and three-dimensional shape. More...
Suven Life gets three patent approvals for CNS molecules

(Amit Shanbaug , 31-Dec-2012 , The Economic Times)
Suven Life Sciences Ltd announced on Monday that the grant of three product patents two from Eurasia
and one from Canada corresponding to the New Chemical Entities for the treatment of disorders
associated with Neurodegenerative diseases and these Patents are valid through 2027. More...
China patent office world’s biggest India at 7th rank

(Vanita Srivastava, Hindustan Times , 31-Dec-2012 , Hindustan Times)
The Chinese filed the most patent applications in 2011 overtaking the US for the first time says the
World Intellectual Property Indicators 2012 released by the World Intellectual Property Organisation in
December. More...
FDI in pharma, the wrong prescription

(S. Srinivasan , 30-Dec-2012 , Business Line)
FDI in pharma is not what we need. More...
Sylvester Stallone wins copyright infringement case

(PTI , 30-Dec-2012 , Indian Express)
Hollywood action star Sylvester Stallone did not steal the plot for The Expendables from another
screenwriter a federal judge has ruled. More...
Apple to drop patent claims against new Samsung phone

Apple Inc has agreed to withdraw patent claims against a new Samsung phone with a high-end display
after Samsung said it was not offering to sell the product in the crucial U.S. market. More...
Bristol-Myers sues DRL in US for patent infringement

(Press Trust Of India / Hyderabad , 28-Dec-2012 , Business Standard)
US-based drug maker Bristol Myers Squibb Company has filed a patent infringement case against Dr
Reddys Laboratories over the cancer drug Ixempra. More...
Apple fined over $165,000 for copyright violation in China

(Agencies , 28-Dec-2012 , The Indian Express)
Technology major Apple Inc has been fined USD 165,908 by a court here for allegedly selling unlicensed
electronic versions of books online. More...
2012 of Pharma industry ends with debate over patents

(27-Dec-2012 , moneycontrol)
2012 was occupied by Pharma industry bodies & patient groups debated over the contours of the pricing
policy. More...
Nokia signs patent-licensing deal with BlackBerry maker RIM

Nokia the Finnish mobile phone maker struggling to reverse a slide in sales agreed to a patent licensing
deal with BlackBerry maker Research In Motion ending all legal disputes between the companies. More...
Samsung hits back at Ericsson in patent battle
(AFP , 26-Dec-2012 , Hindustan Times)
South Koreas Samsung Electronics said Wednesday it had filed a complaint to seek a US import ban on
some Ericsson products in an escalating patent battle with the Swedish mobile giant. More...
'Patent cliff' forces pharma companies to eye new markets

The drying up of blockbuster drug pipeline and lower R&D productivity of Big Pharma may start
impacting domestic generic companies forcing them to look at alternative research models and focus on
emerging markets for growth. More...
India thwarts US company bid to patent pomegranate

(Vanita Srivastava , 23-Dec-2012 , Hindustan Times)
India has foiled an attempt made by a US company to claim a patent at the United States Patent and
Trademark Office on the use of pomegranate for the treatment of ulcers. More...
Nokia settles Wi-Fi patent dispute with RIM

Struggling Finnish mobile phone maker Nokia has settled its patent dispute with BlackBerry maker
Research in Motion in return for payments, as it tries to exploit its trove of technology patents to boost
its finances. More...
Apple patent case: EU charges Samsung with abuse of sector-essential telecom patent
The European Commission charged Samsung Electronics on Friday with abusing its dominant position in
seeking to bar rival Apple from using a patent deemed essential to mobile phone use. More...
Samsung to face charges from EU in Apple patent case

The European Commission is set to charge South Korean electronics group Samsung in an antitrust
patent case, the European Union's competition chief Joaquin Almunia said. More...
Apple 'pinch-to-zoom' patent deemed invalid

(AFP , 20-Dec-2012 , Hindustan Times)
A filing on Wednesday in a high-stakes legal battle between Samsung and Apple revealed that a "pinch-
to-zoom" patent central to the case has been deemed invalid. More...
Owner of OpenTV slaps Netflix with patent lawsuit

The owner of interactive television pioneer OpenTV sued Netflix Inc on Wednesday, alleging the
company infringed on patents that cover technology underpinning the fast-growing Internet video
sector. More...
Kodak in $525 million patent deal, eyes bankruptcy end
(Agence France Presse , 20-Dec-2012 , NDTV)
US photography giant Eastman Kodak said today it had agreed sell its digital imaging patents for $525
million to help it emerge from bankruptcy protection. More...
ITC judge sides with Apple against Google on phone patent

Googles Motorola Mobility unit cannot assert a patent against Apple Inc which covers a sensor that stops
phone users from dialing wrong numbers on touchscreen devices a US trade judge ruled. More...
Samsung ends 'patent war', withdraws bid to ban Apple devices in Europe
(ANI , 19-Dec-2012 , DNA)
South Korean mobile maker Samsung has withdrawn its bid to get Apple devices banned in Europe.
More...
Microsoft signs new patent deal with German Android device maker
(ANI , 18-Dec-2012 , Zee News)
Software giant Microsoft has negotiated a fresh licensing agreement with the German maker of Android-
based devices. More...
Sun Pharma’s US arm Caraco to buy URL’s generics business

(CH Unnikrishnan , 18-Dec-2012 , Livemint)
Generic assets of URL Pharma will be owned and managed by Sun’s US unit Caraco after deal is
completed More...
Microsoft, Motorola unlikely to reach settlement in patent case

Microsoft Corp and Google Inc's Motorola phone unit remain millions of dollars apart in their respective
valuations of video and wi-fi patents at issue in a pivotal case before a federal judge in Seattle. More...
Pfizers Sutent patent case against Cipla adjourned

Delhi court awaits Patent Controller hearing today More...
Tirur betel farmers scramble for GI tag to secure Pakistan market

(K R Rajeev , 17-Dec-2012 , The Times Of India)
Beeran Kutty is now pinning his hope on the Kerala Agricultural Universitys plan to secure geographical
indications tag for the Tirur betel leaves an attempt by the varsitys Intellectual Property Rights Cell to
help farmers protect their rights over the unique produce. More...
Microsoft, Motorola file to keep patent case details private
(Reuters / Seattle , 16-Dec-2012 , Business Standard)
Microsoft Corp and Google Inc's Motorola Mobility unit have requested a federal judge in Seattle to keep
secret from the public various details from their recent trial concerning the value of technology patents
and the two companies' attempts at a settlement. More...
India revokes patent for Merck asthma drug

(AFP , 12-Dec-2012 , The Economic Times)
India has revoked a patent for an asthma drug held by US based Merck following a challenge from local
pharmaceutical giant Cipla marking a new blow to global drug firms in the Indian market. More...
Goan gets patent for mechanical device invention

(11-Dec-2012 , TImes of India)
In a development that should bring some cheer to the Goan engineering community, a Goan has been
granted a patent from the Indian patent office. More...
UN Climate Change Negotiations 2012: India satisfied at negotiations; manages to retrieve

key issues it lost in Copenhagen & Durban
(Urmi A Goswami , 11-Dec-2012 , The Economic Times)
The lack of an aggressive effort to reduce greenhouse gas emissions and financial support for developing
countries at Doha notwithstanding India has cause not to be dissatisfied with its performance at the
recently concluded negotiations. More...
Essential drug prices may come down

After going through various twists and turns over the years as well as being in the cold storage for
sometime the National Pharmaceutical Pricing Policy 2012 which caps prices of essential drugs has been
finalised, and is expected to be notified over the next few days More...
Google, Apple team up to buy Kodak's 1,100 patents for $500 million
(9-Dec-2012 , Times of India)
Apple and Google have joined forces to offer more than $500 million to buy Eastman Kodak's patents
out of bankruptcy, said people familiar with the situation. More...
Doha climate talks: Rich nations reject India's offer on intellectual property concerns
(Nitin Sethi , 6-Dec-2012 , The Times Of India)
The developed world rejected Indias offer of a diluted reference to concerns about intellectual property
rights in the climate negotiations as the talks in Doha peaked More...
Birla Institute of Technology Patna hosts intellectual property meet

The importance of patents for business houses to avoid litigation was stressed by S K Jain, department
of management studies IIT Delhi, at a workshop on Intellectual Property Rights organized at the Birla
Institute of Technology Patna on Wednesday. More...
Delhi HC asks Cipla to prove its drug doesn’t infringe Roche patent
(C.H. Unnikrishnan , 3-Dec-2012 , Livemint)
A division bench asked Cipla to prove that its anti-lung cancer drug doesn’t infringe a patent belonging
to Roche More...
Global patent filings on the rise

Filing of patents by researchers across the global has increased. More...
CLSA raises target price of Lupin Cipla Sun Pharma

(30-Nov-2012 , The Economic Times)
CLSA has increased target prices of pharmaceutical majors Lupin Cipla and Sun Pharmaceuticals. More...
IPAB dismisses Astra Zeneca’s cancer drug patent appeal

Company was refused patent in 2007 More...
Apple iPad mini infringed patent, claims Samsung

(ANI , 24-Nov-2012 , The Hindu)
Adds the iPad mini to a list of products it claims violate patents on radio signalling technologies More...
Appellate Board sets new ground rule for GI tags

(Vinson Kurian , 23-Nov-2012 , Business Line)
The Intellectual Property Appellate Board has set aside grant of Geographical Indication registration for
Payyannur Pavithra ring. More...
Patent clearance slower in India, says scientist

(Express news service , 24-Nov-2012 , The Indian Express)
A leading Scientist working with the Tata Consultancy Services Dr Hiranmay Ghosh on Friday said that
the pace of clearing patents in India was slower than in developed countries like the US. More...
Ranbaxy shares down over 3% after drug recall in US

Ranbaxy was the first company to launch generic Lipitor in the US market after Pfizers patent expired
last year. More...
Patent paradox
(Staff Writer , 23-Nov-2012 , Livemint)
Patent approvals fall across sectors in 2011. More...

Microsoft files patent for augmented reality smart glasses
(23-Nov-2012 , BBC News)
A patent applied for by the US tech firm describes how the eyewear could be used to bring up statistics
over a wearers view of a baseball game or details of characters in a play. More...
India approves policy to cap prices of 348 drugs

(Reuters / NEW DELHI/ MUMBAI , 22-Nov-2012 , Business Standard)
India approved a new drug pricing policy designed to increase the number of drugs deemed essential
that are subject to price caps two ministers told reporters. More...
CEWiT research may get incorporated into the global standards of 4G

(Sangeetha Kandavel , 22-Nov-2012 , The Economic Times)
India needs to emulate China in creating enough patents to avoid paying royalties. More...
Samsung now accuses iPad Mini, new iPad, iPod Touch of patent infringement
(Tech , 22-Nov-2012 , IBN Live)
Over the last few months Apple and Samsung have been seen including new products in their legal
battles. More...
Samsung gets review in patent case with Apple

(Bloomberg , 21-Nov-2012 , The Times Of India)
Samsung the world's biggest maker of smartphones, will get another chance to convince a US trade
agency that Apple's iPhone and iPad infringe its patents. More...
NSF introduces Atorvastatin Calcium Reference Standard Kits to maintain highest quality
standards for Indian mfrs
(Ann Arbor, Michigan , 21-Nov-2012 , Pharmabiz)
NSF International an independent global public health organization that develops high quality reference
standards has released Atorvastatin Calcium Reference Standard Kits which are traceable to official US
and European pharmacopoeial standards. More...
Microsoft-Google trial ends first phase

A Google expert witness testified on Tuesday that Microsoft will make roughly $94 billion in revenue
through 2017 from its Xbox game console and Surface tablet that use Google's patented wireless
technology. More...
US ITC will review Apple Samsung patent decision

The US International Trade Commission will review a judges decision which found that Apple did not
violate patents owned by Samsung Electronics in making the iPod touch iPhone and iPad. More...
HTC 'happy' with Apple settlement, slams media estimates
Taiwan's HTC Corp is happy with its patent settlement with Apple Inc, but regards media reports on
details of the licensing agreement as "outrageous", chief executive Peter Chou told reporters on
Tuesday. More...
Apple now gets the virtual 'page turn' patent

(IBNLive.com , 19-Nov-2012 , IBN Live)
Apple which was recently granted the design patent on rectangular shape with rounded edges has now
been given the exclusive rights to the page turn in an e-reader app reports The New York Times. More...
WHO meet on fake medicines whips up controversy on NGO participation

(P.T. Jyothi Datta, A.M. Jigeesh , 19-Nov-2012 , Business Line)
A World Health Organisation meet on tackling fake medicines in Buenos Aires has drawn attention of a
different kind involving India. More...
Apple awarded patent for virtual page turn feature for iBooks
(ANI , 18-Nov-2012 , DNA)
Tech giant Apple has awarded a patent this week for a 'page-turn' feature that is used in iBooks. More...
'GMO poses threat to GI tag of crops'

(Kevin Mendonsa , 17-Nov-2012 , The Times of India)
The entering of Genetic Modified Organism crops into the district poses threat to Geographical Indication
crops said K N Ramachandra convener of Southern Action on Genetic Engineering. More...
Hearing in controversial Glivec case between Novartis & Union of India enters crucial stage
Hearing in the controversial imatinib mesylate (Glivec) case between the Swiss pharma major Novartis
AG and the Union of India & Others is continuing in the Supreme Court of India which is expected to
conclude by the end of this month. More...
'Amul' loses trademark battle against US giant in Gujarat HC

(PTI , 16-Nov-2012 , DNA)
The Gujarat High Court has refused to set aside an order which cancelled Amuls registration of its
trademark Trix on which a US firm has claimed its right. More...
Apple quietly acquires 1,024 Nortel patents from own consortium

(NDTV Correspondent , 16-Nov-2012 , NDTV)
Apple may be getting ready to step on the patent offensive once again after acquiring over a 1000
patents from a consortium led by the Cupertino based giant itself. More...
Set up an authority for fast approval of patents: Assocham
Government should set up a National Intellectual Property Right Strategy Authority in order to expedite
clearances of patent applications industry body Assocham has said. More...
iPhone 5, Android 4.1, Galaxy S III, Note 10.1 dragged into patent fight
A US judge on Thursday allowed Samsung Electronics to pursue claims that the iPhone 5 infringes its
patents while also allowing Apple to add claims that the Samsung Galaxy Note 10.1 Galaxy S III and
Android 4.1 operating system violate its patents. More...
Traditional knowledge and limits to GI

(Nitya Nanda, Indrani Barpujari , 15-Nov-2012 , Business Line)
It is often considered that geographical indications can be used to protect traditional knowledge and
communities. More...
Samsung ‘has no intention’ to settle patent suits with Apple

(ANI , 15-Nov-2012 , Zee News)
South Korean electronics maker Samsung has said that it will not follow HTCs lead and settle its patent
lawsuits with Apple. More...
R&D spending of 30 pharma companies surge by19.6% in FY 2011-12

(Sanjay Pingle, Mumbai , 12-Nov-2012 , Pharmabiz)
The Indian pharmaceutical segment has established strong presence in the international market with
higher investments in Research and Development during last decade and launched several new
affordable high quality generic products. More...
Shares of HTC limit up after settling patent issues with Apple

Shares of HTC Corp jumped by their permitted daily limit on Monday after the Taiwanese smartphone
maker and Apple Inc announced a global patent settlement and 10-year licensing agreement. More...
Pharma firms quit AP for greener pastures

(Koride Mahesh , 11-Nov-2012 , The Times Of India)
Thanks to a lack of incentives from its government and the ongoing power crisis in the state the
pharmaceutical sector in Andhra Pradesh is shrinking. More...
Apple to court: Include Android 4.1 in patent suit

A US judge on Wednesday was considering a request by Apple that would pull Google from the sidelines
in a long-running patent war with Samsung over mobile gadgets powered by Android software. More...
Sun Pharma Q2 profit down 46%

Drug maker Sun Pharmaceutical saw a 46 per cent dip in its net profit in the July September quarter
because of Rs 584 crore set aside towards potential damages it may have to pay in a patent
infringement case on heart burn drug Protonix in the United States. More...
Apple violated patents in FaceTime, fined $368 million

Shares of VirnetX Holding jumped 27 percent after a jury asked Apple to pay about $368 million to the
internet security software maker for infringement of four patents. More...
Patent expiration hit sales, profits of top 10 MNCs in 9 months of 2012, Novartis in No1
position
(Sanjay Pingle, Mumbai , 7-Nov-2012 , Pharmabiz)
Financial performances of 10 leading global pharmaceutical companies have received a major setback
during the first nine months of the current year ended September 2012 on account of patent expirations
stiff generic competition austerity measures in regulated markets and US healthcare reform. More...
REVOKING PEGASYS & SUTENT

(P A Francis , 7-Nov-2012 , Pharmabiz)
Indias patent office took two significant decisions of cancelling patents issued to two leading
International pharmaceutical companies namely Pfizer and Roche during the last 30 days. More...
Glenmark settles patent case with Janssen in US

Settlement allows Glenmark to enter the market with a generic version even before the patent expiry of
Janssens drug More...
US judge tosses Apple suit against Motorola

A federal judge has tossed out an Apple lawsuit accusing Google-owned Motorola Mobility of trying to
charge the iPhone maker too much for licenses to essential technology for mobile devices. More...
Pattamadai mats likely to get GI mark soon

(R. Sivaraman , 6-Nov-2012 , The Hindu)
In line of Tirupathi laddu and Kanchipuram silk saris the famous mats Pattamadai pai from Tirunelveli
district and traditional lamps from Nachiarkoil in Thanjavur district are to get the geographical indication
mark very soon. More...
India to be among top 10 pharma markets globally by 2020

Indias pharmaceutical industry is on good growth trajectory and is likely to be among the top 10 global
markets in value terms by 2020 according to a CII PwC report released on Monday. More...
Indias patent fix
(Sushmi Dey / New Delhi , 04-Nov-2012 , Business Standard)
While the government has been battling patents on traditional Indian remedies abroad the Patent Office
back home has granted a handful of such patents causing an embarrassment of sorts More...
PM for early conclusion of trade talks with EU, Asean

(BS Reporter , 3-Nov-2012 , Business Standard)
The two sides also differ on inclusion of intellectual property rights and data security in the agreement.
More...
Patents appeal board revokes patent on Roche hepatitis drug

Patents appeal board has revoked a patent granted to Roches hepatitis C drug Pegasys citing a lack of
evidence the drug is superior to existing treatments and its high price. More...
IPAB order not a healthy signal say drug makers

(P.T.Jyothi Datta , 2-Nov-2012 , Business Line)
The Intellectual Property Appellate Boards decision to set aside Roches patent on its Hepatitis C drug
Pegasys comes even as the amended Patent Act gets tested from several quarters. More...
LG Electronics settles LED patent dispute with Siemens' Osram unit

South Koreas LG Electronics Inc said on Friday it and its component unit LG Innotek Co Ltd had agreed
with Siemens light bulb unit Osram to settle all LED patent suits. More...
Microsoft faces patent infringement lawsuit over live tiles in Windows 8

(ANI , 02-Nov-2012 , Zee News)
A small technology company based in Portland has filed a patent infringement lawsuit against software
Microsoft over the live tiles feature included in its latest operating system Windows 8. More...
UK judges order Apple to apologise again over patent dispute with Samsung
US tech giant Apple has until Saturday to re-write an inaccurate statement relating to its patent dispute
with South Korean rival Samsung British judges have ruled. More...
India EU may go in for partial free trade pact

A day ahead of Prime Minister headed panel taking up the long-pending India-EU free trade agreement,
the two sides today indicated they may open their markets in a gradual way instead of signing a full-
fledged pact in the wake of differences on several key issues. More...
US is in the pink for local drugmakers

(Priyanka Golikeri , 31-Oct-2012 , DNA)
September was at once the best and worst month of the year for local drugmakers according to
analysts. More...
Wait for Indian generic launches gets longer

(Sushmi Dey / New Delhi , 29-Oct-2012 , Business Standard)
USFDA has extended the timeline for granting tentative approval to generic drug applications filed under
Para IV of its rules by 10 months. More...
Gaurav Misra: Pricing drugs, culturally

(Gaurav Misra , 29-Oct-2012 , Business Standard)
The price of life saving drugs is an emotive issue. More...
Venus Remedies gets patent from Mexico for antibiotic drug

(Press Trust of India / Chandigarh , 29-Oct-2012 , Business Standard)
The drug has already received seven patent grants More...
Govt scraps patent for jamun-based diabetes drug

(Sidhartha , 27-Oct-2012 , The Times Of India)
After combating bio piracy of neem and haldi in the US and Europe India has now woken up to the
problem in its own backyard. More...
Samsung infringes on four Apple patents

(Bloomberg , 26-Oct-2012 , The Times Of India)
Samsung Electronics Co lost the first round of a US trade case brought by Apple Inc its second big
defeat this year in America as the companies battle worldwide over smartphone and tablet computer
technology. More...
Samsung violates Apple patents: US judge

South Koreas Samsung Electronics the worlds top maker of smartphones infringed Apple patents to
make its smartphones and tablets a US trade panel judge said in a preliminary decision issued on
Wednesday. More...
Staff shortage dogs patent office as govt sits on compensation plan

More than 100 people recruited as patent examiners declined to join several others may quit More...
Samsung doesn’t infringe Apple patent: Dutch court

(Roberta Cowan , 24-Oct-2012 , Livemint)
The court says Samsung does not infringe an Apples patent by using multi-touch techniques More...
Google considering settlement in patent antitrust case: Report
Google is considering a settlement with the Federal Trade Commission over potential claims it broke
antitrust law in its handling of patents for mobile devices, the Wall Street Journal reported on Friday.
More...
Apple loses tablet copyright appeal against Samsung

Apple lost its appeal of a ruling that its rival Samsungs Galaxy tablet computer did not copy Apples
registered tablet designs in a British court on Thursday More...
The rise of the patent brigade

(VENKATESH GANESH , 19-Oct-2012 , Business Line)
In 2011 the total number of patent applications for in India was estimated to be 37000 according to
controller general of patents designs and trade marks ministry of commerce and industry data. More...
Indian Drugs Manufacturing Association reviewing government directive on drug branding

(DIVYA RAJAGOPALDIVYA RAJAGOPAL , 19-Oct-2012 , The Economic Times)
The government wants to tackle the issue of trademark disputes that comes under their purview when
companies with similar sounding brand names come to them for resolution. More...
India fights to protect its traditional home remedies

(AFP , 18-Oct-2012 , Hindustan Times)
Earlier this year India successfully fought off Nestles attempt at the European Patent Office to secure a
patent saying that using cows milk as a laxative was mentioned in ancient texts and was therefore not
new More...
Indian fashion designers should audit their intellectual property: Safir Anand, Anand and
Anand
(Maulik Vyas , 18-Oct-2012 , The Economic Times)
As the Indian fashion industry gains attention from international brands and labels Indian fashion
designers are also becoming more savvy of their legal rights to protect their designs. More...
Chidambaram asks NABARD to help innovators get patents

(PTI , 17-Oct-2012 , Zee News)
Finance Minister P Chidambaram Wednesday asked NABARD to help innovators in getting patent of their
products and also help them replicate their ideas for benefit of masses. More...
India may win patent claims due to Traditional Knowledge Digital Library: Manmohan Singh
India could win 105 claims on international patents due to its Traditional Knowledge Digital Library Prime
Minister Manmohan Singh said here today, opening the high level segment meeting at the Conference of
Parties to Convention on Biological Diversity. More...
US market to give Indian pharma a booster shot
(Kiran Kabtta Somvanshi , 16-Oct-2012 , The Economic Times)
Pharma companies are expected to continue their strong performance in the September quarter driven
by good performance in the US (aided by certain exclusive launches) and modest growth in the domestic
pharma market. More...
Peoples biodiversity festival rejects IPR regime

The Peoples Biodiversity Festival an event held in the city during the Convention for Biological Diversity
says it rejects Intellectual Property Rights regime over peoples natural resources. More...
Opportunities back home for Indian pharma

(NALINAKANTHI V. , 14-Oct-2012 , Business Line)
Higher affordability, increase in penetration and greater awareness can drive growth. More...
Lupin identifies cancer drugs as focus area in Japan

(Press Trust of India / New Delhi , 14-Oct-2012 , Business Standard)
The company is present in Japan through two wholly owned subsidiaries More...
Microsoft to sue Google with Motorola in German patent row

Microsoft Corp said on Friday it plans to add Google Inc as a defendant in Germany in one of its patent
actions against Googles phone maker Motorola Mobility the first time the two tech giants have come into
direct legal conflict over Google's Android mobile software. More...
Cadila Pharma files for cancer vaccine patent

(Vishal Dutta , 12-Oct-2012 , The Economic Times)
Ahmedabad-based Cadila Pharmaceuticals has developed a cancer vaccine and has filed for its
therapeutic patent with Controller General of Patents Designs and Trademarks Office. More...
Court lifts ban on Samsung Galaxy Nexus in US

A US appeals court Thursday lifted a sales ban on Google branded Samsung smartphones in a patent
fight with Apple saying there was no evidence sales were driven by features copied from the iPhone.
More...
Apple-Samsung patent issue: US appeals court lifts ban on Samsung-Google phone

(AFP , 11-Oct-2012 , The Economic Times)
A US appeals court Thursday lifted a sales ban on Google branded Samsung smartphones in a patent
fight with Apple saying there was no evidence sales were driven by features copied from the iPhone.
More...
Roamware wins patent for its predictive intelligence technology
(Mahesh Kulkarni / Bangalore , 11-Oct-2012 , Business Standard)
Roamware a provider of mobile operator service solutions on Thursday announced that it has won a
patent on Predictive Intelligence a technology that will help operators vastly improve their customer
experience management capabilities and give local and roaming subscribers a much better service usage
experience. More...
SRK to be a trademark!
(Mehul S Thakkar, Mumbai Mirror , 11-Oct-2012 , The Times Of India)
The actor has sent an application to the Trade Mark Registry that his often used initials not be used
without his permission More...
Widening scrutiny of Google’s smartphone patent licensing

(New York Times , 11-Oct-2012 , The Indian Express)
For more than a year the Federal Trade Commission has been conducting a broad antitrust investigation
into the way Google runs its internet search and search advertising businesses. More...
Patently against public health?

(P.T. JYOTHI DATTA , 10-Oct-2012 , Business Line)
The amended Patent Law is in a sense being pushed poked and prodded by drug companies testing its
resilience. More...
Tech fighters in a patent war

(New York Times , 10-Oct-2012 , The Economic Times)
Apple has been involved in 148 smartphone patent lawsuits since 2006. More...
'India needs to work on ensuring intellectual property rights'

(PTI , 09-Oct-2012 , Hindustan Times)
A senior US diplomat has stressed the need for conducting a detailed study on the impact of intellectual
property on Indias economy saying the country should examine ways to ensure IP rights in all
businesses. More...
No decision immediately on controlling prices of imported patented drugs

Though mentioned in the draft pharmaceutical pricing policy 2011 the government is unlikely to rush to
a decision on the price negotiation mechanism of imported patented drugs as it is still examining the
report by an expert panel in this regard. More...
Turf war in the pharma industry

The swadeshi versus videshi battle has broken out afresh in the Rs 67000 cr Indian drug market as
mutinationals step up their efforts to enter the branded generic space to compete with domestic drug
makers. More...
Motorola wins patent case against Microsoft in Germany
(Reuters , 05-Oct-2012 , NDTV)
Mobile phone maker Motorola achieved a rare victory against software giant Microsoft in a patent case
before a German court on Friday the latest in a wave of patent lawsuits by technology firms fighting over
market share. More...
Pfizer to appeal India decision to revoke cancer drug patent

Pfizer Ltd the India unit of US drugmaker Pfizer Inc will challenge the countrys patent office for revoking
a patent for its cancer drug Sutent. More...
Cipla wins patent opposition against Pfizers cancer drug

(Reghu Balakrishnan / Mumbai , 04-Oct-2012 , Business Standard)
The Delhi patent office judged that Pfizers patent of Sutent does not involve any inventive step. More...
Google denied summary judgment in patent dispute with Vringo

Mobile phone software maker Vringo Incs shares jumped 39 percent on Wednesday after a judge denied
Google Inc a motion for summary judgment in a patent dispute. More...
Tata group's Advinus Pharma ties up with Takeda Pharma for drug R&D
(DIVYA RAJAGOPAL , 4-Oct-2012 , The Economic Times)
Tata group promoted Advinus Pharma has entered into a joint drug discovery deal with Japanese
pharma giant Takeda Pharma indicating multinational companies growing interest in Indian drug
research and holding out hope for startup firms engaged in research. More...
Google withdraws US patent complaint against Apple

(Reuters , 4-Oct-2012 , Business Standard)
Google subsidiary Motorola Mobility has dropped a complaint of patent infringement against Apple
without explanation. More...
DLF files five patents on building safety and security

(Ravi Teja Sharma , 03-Oct-2012 , The Economic Times)
Indias largest real estate developer DLF has filed five patents that are related to inventions for safety
and security of its buildings and its residents. More...
European Union wants India to allow extended patent life for drugs
(Amiti Sen , 3-Oct-2012 , The Economic Times)
The European Union is making frantic efforts to convince India to liberalise its patent regime as part of
the proposed bilateral free trade agreement. More...
Drug makers eye M&As to tap markets at home and away
Amid concern multinational companies may buy out Indian drug makers and dominate the
pharmaceutical industry here analysts say it is time domestic companies considered acquisitions and
alliances both at home and abroad. More...
Google backs off patent complaint against Apple

Google owned Motorola Mobility withdrew a patent complaint filed with a US commission but remained
quiet as to the reason for the legal ceasefire. More...
iPhone 5: Samsung files patent lawsuit against Apple

Samsung Electronics said on Tuesday that it filed a new lawsuit against Apple in a US court contending
the iPhone 5 infringed on Samsungs patents. More...
Drug groups eye Indian legal case

(Ft.com , 1-Oct-2012 , MoneyControl)
Chennai may be a long way from the Leverkusen headquarters of Bayer BAY but the German
pharmaceutical group is involved in a legal dispute in the southern Indian city that is being watched by
its peers around the world. More...
Infosys way ahead of Indian peers in patent race

(Bibhu Ranjan Mishra / Bangalore , 30-Sep-2012 , Business Standard)
Accenture the only global IT firm that filed more patents in last five years. More...
Lupin aims to double sales in Japan to $500 mn in next 5 yrs

(Press Trust of India / New Delhi , 30-Sep-2012 , Business Standard)
In order to achieve its desired growth in the Japanese market the company may even consider selective
acquisitions. More...
Whirpool and LG settle refrigerator patent disputes

Whirlpool Corp the worlds largest appliance maker and LG Electronics Inc settled three pending patent
infringement lawsuits involving refrigerators the companies said on Friday. More...
Pharma industry need to look sustaining growth post 2015 when patent expiries stop
(Nandita Vijay, Bengaluru , 29-Sep-2012 , Pharmabiz)
Baring Private Equity Partners India perceives that India pharma will now need to look at sustaining its
growth momentum post 2015 when there will be no major drugs going off patent. More...
Google cant patent injunction against Microsoft in Germany: US court ruling
A US appeals court on Friday ruled that Google Incs Motorola Mobility unit cannot enforce a patent
injunction that it obtained against Microsoft Corp in Germany, diminishing Googles leverage in the
ongoing smartphone patent wars. More...
Essential drug prices to come down by 20%

(Amit Mitra , 28-Sep-2012 , Business Line)
There will be an average reduction of 20 per cent in prices of the 348 essential medicines under the new
pricing mechanism recommended by the Group of Ministers on Thursday. More...
Bayer AG disappointed after losing India patent fight

Pharmaceutical giant Bayer AG on Wednesday said it was disappointed with an Indian ruling that allows
a local firm to produce a cheaper copy of its patented drug Nexavar for liver and kidney cancer. More...
LG: Samsungs Galaxy series phones infringe our patents

South Koreas LG Display, one of the worlds top flat screen TV makers said Thursday it had filed a patent
infringement suit against Samsung Electronics over the use of advanced displays. More...
Ministerial panel recommends price control for 348 essential drugs

(Reuters , 27-Sep-2012 , The Times of India)
Patented drugs are not covered by this policy though India is considering a mechanism to regulate prices
of medicines which are covered by patent protection. More...
Copyright issue gets louder at live concerts

(Kanu Sarda , 27-Sep-2012 , DNA)
In an attempt to protect the interest of music composers and authors the Delhi high court has ruled that
playing music of other composers in live concerts and at disc jockey nights in clubs hotels and
restaurants is illegal and an infringement on the Copyright Act. More...
The booming business in biosimilars

(Sushmi Dey / New Delhi , 27-Sep-2012 , Business Standard)
Various drug makers are set to cash in on the opportunity. More...
LG accuses Samsung of infringing OLED patents

(Agence France-Presse , 27-Sep-2012 , NDTV)
South Koreas LG Display one of the worlds top flat screen TV makers said Thursday it had filed a patent
infringement suit against Samsung Electronics over the use of advanced displays. More...
European Trade Council, German Tea Association uphold Darjeeling tea's authenticity
(Sutanuka Ghosal , 27-Sep-2012 , The Economic Times)
The European Trade Council and the German Tea Association have agreed to confer the protected
geographical indication status on Darjeeling tea the first commodity from India to get such a tag. More...
Googles Eric Schmidt criticises raging mobile patent war

(Agence France Press , 27-Sep-2012 , NDTV)
Google executive chairman Eric Schmidt on Thursday criticised raging patent disputes in the global
mobile industry warning that they stifled innovation and reduced consumer choice. More...
India Courts Drug Disaster

(ROGER BATE , 26-Sep-2012 , The Wall Street Journal)
Not to be outdone by the Supreme Court the India Patent Office also is getting in on the drug-pricing
game too. More...
Madras court allows GSK to resume distribution of biscuits

(Mihir Dalal , 25-Sep-2012 , Livemint)
The Madras high court allowed GlaxoSmithKline Consumer Healthcare Ltd to resume the sales and
distribution of Horlicks Nutribic biscuits after it ordered a halt last month on a complaint of trademark
infringement by Britannia Industries Ltd. More...
Apple loses patent case against Samsung Motorola in Germany

(ANI , 25-Sep-2012 , The Hindu)
A German court has dismissed tech giant Apples claims that Google owned Motorola and Korean firm
Samsung infringed some of its multi touch patents. More...
Orchid Pharma plans entry into therapeutic new segments

(BS Reporter / Chennai , 25-Sep-2012 , Business Standard)
The company has received patents for this and has a niche biotech lab and pilot facility available which
is a kind of 30 people outfit in Sholinganallur near Chennai. More...
Smartphone wars: Patents are the new weapons

(STEVE LOHR, New York Times , 25-Sep-2012 , The Times Of India)
In patent law youre at the cutting edge of everything and thats shifting all the time. More...
Drug patents on the rise: 3,488 in five years

It was in 2005, India changed its patent law and started granting patents in medicines. More...
A bitter pill
(Kaushik Sunder Rajan , 24-Sep-2012 , The Indian Express)
At issue is a key provision in Indias 2005 Patent Amendment Act section 3(d). More...
Discussions essential to influence drug-price policy: P.H. Kurian
(Staff Reporter , 23-Sep-2012 , The Hindu)
Call to oppose lobbying by MNCs to dilute price control order. More...
Italian firm wins trademark case against UK Modi controlled firm

Rolling mill equipment maker Morgardshammar AB a subsidiary of the Italy based Daineli Group won a
trademark case with the Delhi High Court restraining the UK Modi controlled firm from using the trade
name Morgardshammar. More...
Just what the doctor ordered

The Indian pharma industry won an important battle: the Intellectual Property Appellate Board
dismissed German drugmaker Bayer AG's petition seeking a stay on the 'compulsory licence' (CL) issued
to Natco Pharma for selling generic copies of the cancer drug Nexavar in India. More...
Apple has ceded the crown to Samsung in emerging markets: Analyst

(James B Stewart, New York Times , 22-Sep-2012 , The Times Of India)
By many measures Samsung Electronics should be on the ropes. More...
Setback for Apple in German patent case against Samsung

A German court ruled against Apple Inc in two patent cases against Samsung Electronics and Motorola
Mobility owned by Google. More...
Niche plays as patent cliff looms

(Ujjval Jauhari & Ram Prasad Sahu / Mumbai , 20-Sep-2012 , Business Standard)
Efforts of Indian pharma majors in US helped improve share of key cos in US generics prescription mkt.
More...
Dabur sues Amar Remedies for passing off Siwak as Meswak

(ET Bureau , 19-Sep-2012 , The Times of India)
Dabur has filed a case against Amar Remedies for infringing on the intellectual property rights to its
brand Meswak. More...
US probes Apples patent infringement

(IANS , 19-Sep-2012 , DNA)
A US trade panel Tuesday launched a probe after the Motorola company alleged that its patents were
infringed by Apple Inc. More...
HC restrains Indian firm from using Morgardshammar trademark

(PTI , 19-Sep-2012 , Hindustan Times)
Modi groups Morgardshammar India a rolling mill equipment manufacturer was today barred by the
Delhi High Court from using the Morgardshammar trademark and name of Morgardshammar AB a
subsidiary of Danieli group of Italy. More...
Benefits of TRIPS not being utilised by industries

(Express News Service , 19-Sep-2012 , IBN Live)
The benefits and safeguards that have been provided under the Trade Related Intellectual Property
Rights are not being utilised properly by our industries according to P H Kurien Principal Secretary
Department of Information Technology and former Controller General of Patents Designs and
Trademarks India. More...
Benefits of TRIPS not being utilised by industries

(Express News Service , 19-Sep-2012 , IBN Live)
The benefits and safeguards that have been provided under the Trade Related Intellectual Property
Rights are not being utilised properly by our industries according to P H Kurien Principal Secretary
Department of Information Technology and former Controller General of Patents Designs and
Trademarks India. More...
Bayer vows to defend IPR rights on cancer drug

Allellate boardrefuses to stay the compulsory license granted to Natco for its patented cancer drug
Nexavar More...
Intellectual Property Appellate Board dismisses Bayers appeal against Natco

The Intellectual Property Appellate Board has dismissed Bayers request for a stay order against the
compulsory license granted by the Patent Controller to Natco on cancer drug Nexavar earlier this year.
More...
Start-ups fight back as patent wars intensify

(Reuters , 17-Sep-2012 , NDTV)
The patent wars that have embroiled many of the worlds technology giants in recent years are spreading
to a new set of combatants start up companies and their venture capital backers. More...
Bayer plea against Natco on cancer drug dismissed

(R. Sivaraman , 16-Sep-2012 , The Hindu)
Pharma major contested grant of licence to Hyderabad firm for making a drug to treat liver and kidney
cancer More...
Bayers appeal for stay on compulsory licence to Natco Pharma rejected

(R. Sivaraman , 15-Sep-2012 , Business Line)
The Intellectual Property Appellate Board has rejected pharma major Bayer Corporations petition
seeking a stay on the compulsory licence granted to Hyderabad based Natco Pharma Ltd. More...
Apple did not violate Samsung patents: US judge
Apple did not violate patents owned by Samsung Electronics in making the iPod touch iPhone and iPad a
judge at the International Trade Commission said in a preliminary ruling on Friday. More...
Hearing in Glivec patent case to resume on Sept 18 in Supreme Court

Hearing in the controversial Glivec patent case remained inconclusive in the Supreme Court with the
Novartis lawyer Gopal Subramaniam continuing his arguments in the court. More...
Apple wins German patent case against Motorola

(AFP , 15-Sep-2012 , Hindustan Times)
A German court found Google owned IT company Motorola guilty of infringing Apple patents on the
design of smartphones and tablets a court spokesman said on Thursday. More...
DoP to seek public opinion on pricing for patented drugs

The Department of Pharmaceuticals will seek views from stakeholders on how patented drugs must be
priced in the country and will put up draft guidelines in public domain by next week a senior official said
today. More...
With patient welfare pitted against corporate social irresponsibility, lives are at stake
(14-Sep-2012 , The Times Of India)
In doing so the multinational has questioned the applicability of section 3d of the Indian Patent Act
meant to counter abusive patenting practices such as evergreening or the indefinite extension of patent
monopolies through routine modifications of known compounds. More...
Piramal Health set to unveil patented drug in Europe

(Swetha Kannan , 14-Sep-2012 , Business Line)
After 10 years of trials Piramal Healthcare is ready to roll out its first patented product in Europe next
month. More...
Google India should not deprive Consim benefit of trademark policy

The Madras High Court bench on Thursday upheld a single judge order that Google India Private Ltd not
deprive Chennai based Consim Info Pvt Ltd benefit of their trademark policy and protect their
trademarks including Bharat Matrimony, Tamil Matrimony and Telugu Matrimony. More...
Of patients, patents and profits

(Patralekha Chatterjee , 14-Sep-2012 , The Asian Age)
Most Indians depend heavily on local low cost generic drugs. More...
Apple wins German patent case against Motorola
A German court found Google-owned IT company Motorola guilty of infringing Apple patents on the
design of smartphones and tablets a court spokesman said on Thursday. More...
We haven't broken any law: Siddharth Roy Kapur

(Press Trust of India / Gurgaon , 13-Sep-2012 , Business Standard)
Barfi producer Siddharth Roy Kapur who has been sent a legal notice from British manufacturers Murphy
Radio for alleged trademark infringement says they have not broken any law by using it in the film.
More...
Lupin shares drop after US ruling on birth control drug

The ruling could prevent Lupin from launching a generic version although Barclays Capital said that the
drug maker plans to appeal the verdict given the company believes it has a strong basis for invalidating
the patent. More...
As hearing continues in SC on Glivec; health groups & experts ask Novartis to drop the case in
India
Even as the Supreme Court has started hearing the arguments on the controversial Glivec patent case
some health groups and health experts in the world have written an Open letter to Novartis asking the
Swiss drug major to drop the case in India. More...
University of California sues Facebook Wal-mart over patents

The patents for interactive technology including hypermedia display and interaction were issued to the
university and licensed to Eolas a Texas company chaired by Michael Doyle. More...
PRICING PATENTED DRUGS

(P A Francis , 12-Sep-2012 , Pharmabiz)
A fundamental flaw in the current drug pricing policy in India is the absence of regulation on high priced
patented drugs. More...
Salman Khan’s ‘Ek The Tiger’ courts copyright controversy

(Zeenews Bureau , 12-Sep-2012 , ZeeNews)
After a series of Bollywood films embroiled in script cheating controversy, like ‘Jannat 2’, ‘Desi Boyz’ and
others, Salman Khan’s ‘Ek Tha Tiger’ is the latest film to have landed in copyright row More...
Patent expiries: Dr Reddy's, Lupin to foray into specialty pharma Aurobindo Pharma to focus
on services
(Deepika Amirapu , 12-Sep-2012 , The Economic Times)
Indias top pharmaceutical companies are preparing for life after high revenues from expiring patents
drops off at the end of this year. More...
Novartis case opens in SC

(BS Reporter / New Delhi , 12-Sep-2012 , Business Standard)
Company ready to promise assistance scheme for patients will continue even after litigation More...
Neck-deep in debt, Deccan Chronicle Holdings Ltd pledges trademarks too

(Swati Bharadwaj Chand , 12-Sep-2012 , The Times Of India)
Its not just shares movable assets and immovable properties that the promoters of beleaguered Deccan
Chronicle Holdings Ltd have pledged and mortgaged to raise funds. More...
Rice exporting firm seeks patent for parboiling unit

(Express news service , 12-Sep-2012 , Indian Express)
The wheat eating belt of north India likes it raw when it comes to rice. More...
Off-patent pain drug can kill resistant TB

(ANI , 11-Sep-2012 , The Times Of India)
Their findings point to a potential new therapy for the more than 500000 people worldwide whose TB
has become resistant to standard drug treatments. More...
iPhone 5: Samsung to sue Apple over LTE patent

(Zeebiz Bureau , 11-Sep-2012 , ZeeNews)
The persistent battle between tech giants Apple and Samsung takes a new turn almost every day.
More...
Novartis argues for Glivec patent at Supreme Court

Swiss drugmaker Novartis told Indias top court it had demonstrated the improved efficacy of its cancer
drug Glivec as the final hearing began on Tuesday of a patent case that could change the rules for the
countrys healthcare sector. More...
IPAB adjourns hearing on post-grant opposition to Roche's Pegasys to Sept 21

Intellectual Property Appellate Board in Chennai has once again adjourned the hearing in the post grant
opposition case against the patent granted to Roche for Pegasys to September 21. More...
Novartis India share gains 5.5% ahead of Supreme Court hearing on Glivec in patent case
(Reuters , 10-Sep-2012 , The Economic Times )
The Indian unit of Novartis AG has challenged the countrys patent office decision to refuse to grant a
patent for its cancer drug Glivec. More...
Venus bags first patent from Canada for antibiotic drug
(Charanjit Ahuja , 10-Sep-2012 , The Indian Express)
Chandigarh based Venus Remedies Limited a leading research based global pharmaceutical company has
secured its first patent from Canada for its novel antibiotic adjuvant entity Vancoplus. More...
Govt looking at riders for foreign investment in pharma

Some multinational companies operating here are unhappy with tough decisions in recent years by the
patent office and Indian courts in rejecting drug patents recognised in many Western nations. More...
Cipla’s patent win against Roche boosts hopes of generic drugmakers

(DIVYA RAJAGOPAL , 10-Sep-2012 , The Economic Times)
The Delhi High Court ruling favouring Indias second largest drugmaker Cipla has come as a shot in the
arm for other generic makers who are fighting similar patent infringement cases. More...
Venus gets patent from Canada for antibiotic drug

(Press Trust of India / Chandigarh , 10-Sep-2012 , Business Standard)
The company already has a patent for the drug in US South Africa New Zealand Ukraine and Australia.
More...
Could patenting fundamentals be right?

(Raghavendra S. , 09-Sep-2012 , The Hindu)
Ruling upholding Apples design patents may be a setback impacting consumer choice and welfare
More...
Cipla wins patent case over Tarceva

Cipla Ltd won a landmark patent case against Swiss drug maker F Hoffmann-La Roche Ltd in the Delhi
high court on Friday over the Indian companys generic copy of lung cancer drug Tarceva after a four-
year court battle. More...
Patent drug prices to be set in negotiations with pharma companies

A panel set up to look into the pricing mechanism for patented drugs has said that prices have to be
decided after deliberations with manufacturers if the government is to adopt price negotiation model
Fixing of patented drug prices only after negotiating with pharma cos’
A panel set up to look into the pricing mechanism for patented drugs has said that prices have to be
decided after deliberations with manufacturers if the government is to adopt price negotiation model
iPhone 5: Chinese company may sue Apple
(TOI Tech , 07-Sep-2012 , The Times Of India)
It may still be few days for Apples next generation iPhone unveiling however the much awaited phone is
already facing lawsuit threat in China. More...
Move against tiny photocopy shop raises copyright debate

(Aesha Datta , 07-Sep-2012 , Business Line)
The recent crackdown on the Rameshwari Photocopy Service aka the D-School photocopy shop, has
fuelled a debate regarding what’s “unlawful” about photocopying for educational purposes. More...
Slow rise in generics share may hold up pharma cos' plan in Japan
(B Dasarath Reddy / Chennai/ Hyderabad , 7-Sep-2012 , Business Standard)
Drug laws in Japan make it tough for generic makers to enter the country More...
India to hunt for patented technology to bridge innovation gap

(PTI , 06-Sep-2012 , The Times Of India)
Seeking to accelerate innovation India will launch a global hunt for patented technology to fill in the
gaps in its initiatives and hand them over to small industries to speed product development. More...
Hearing on post-grant opposition to Roche's Pegasys to be held by IPAB on Sept 6

The post grant opposition on this case was filed by Sankalp Rehab Trust. More...
Samsung faces probe over Apple's antitrust complaint

South Korean regulators are investigating complaints filed by Apple that Samsung Electronics is abusing
its dominant position in wireless technology the Korea Fair Trade Commission said on Thursday. More...
Will India keep Novartis at bay?

The company wants to patent and sell its anti cancer drug imatinib mesylate known as Glivec in India
but so far its efforts have failed. More...
Exide Industries wins 15 year trademark spat

(Ashwin Mohan , 5-Sep-2012 , The Economic Times)
In a huge relief for leading battery-maker Exide Industries the company averted serious competition as
it won a 15 year old trademark suit against global battery giant Exide Technologies. More...
India Looks To Expand Drug-Price Controls .

(RUMMAN AHMED , 5-Sep-2012 , The Wall Street Journal)
The new proposals would extend price restrictions beyond generic medicines to apply for the first time to
patented drugs. More...
IPAB concludes hearing on Bayer CL appeal

(C H Unnikrishnan , 4-Sep-2012 , Livemint)
The patent office had in February issued a compulsory licence to local drug maker Natco Pharma Ltd to
make and sell a low-cost generic version of Bayer’s cancer drug More...
Pharma manufacturers should understand the principles of intellectual property rights: G

Selvaraj
(Peethaambaran Kunnathoor, Chennai , 4-Sep-2012 , Pharmabiz)
He said under intellectual property law owners are granted certain exclusive rights including
manufacture and distribution of inventions sue in case of unlawful or deceptive copying of their
innovations etc. More...
Intellectual property rights for plants animals by western firms a cause of concern?
(Swati Deshpande , 02-Sep-2012 , The Times Of India)
As emerging trends point to intellectual property rights in plants animals genes found in developing
countries being patented by western firms retired Supreme Court judge Justice B N Srikrishna recently
sounded a warning note for the need to have strong laws to control intellectual property. More...
Patients lose out to patents & profits

(Deepa Kurup , 02-Sep-2012 , The Hindu)
A 2012 WHO study ranks India third behind Myanmar and Bangladesh among countries that fail to
provide health cover to people. More...
The Compulsions and Repercussions of Compulsory Licensing

(Shobhika Puri , 02-Sep-2012 , ZeeNews)
The recent erosion of investor confidence in India that is doing the rounds in corporate circles is due to a
variety of self-defeating strategies that have been adopted by the government. More...
Apple verdict: Days of design innovation over?

In a pre-iPhone age, mobile phones came in all shapes and sizes. More...
Pharma Department proposes negotiating patent drug rates with firms

The Department of Pharmaceuticals is understood to have proposed direct negotiations with companies
for reducing prices of patent drugs to the rate comparable to the lowest available in the global market.
More...
Apple files new Samsung patent action in US

Apple has filed a fresh patent infringement action in the United States against Samsung alleging that the
South Korean company is continuing to steal its technology despite a recent court ruling. More...
Samsung wins patent case against Apple in Japan

(AP , 31-Aug-2012 , The Times Of India)
A Tokyo court on Friday dismissed Apple Incs claim that Samsung had infringed on its patent the latest
ruling in the global legal battle over smartphones that pits the two technology titans against each other.
More...
Google, Apple CEOs in talks on patent issues

Google Inc Chief Executive Larry Page and Apple CEO Tim Cook have been conducting behind the scenes
talks about a range of intellectual property matters including the mobile patent disputes between the
companies people familiar with the matter said. More...
Japanese court to rule on Apple-Samsung patent dispute

A Japanese court today will issue a ruling in a bitter patent dispute between Apple and its South Korean
rival Samsung the latest case in a global war between the two technology giants. More...
'Domestic drug company's need to focus on pharmerging mkts'

This is in the wake of lucrative patent opportunities dying away post 2015, with few blockbuster drugs
losing patent protection in the US. More...
Drug makers may have to tweak domestic business model

Drug makers in India will soon have to restructure their domestic business models to factor in a drop in
margins as prices begin to fall when the country’s new drug pricing policy takes shape. More...
Apple Samsung 'war' overshadows tech show

(AFP , 30-Aug-2012 , The Times Of India)
The repercussions of Apples billion dollar patent victory over Samsung were still being felt at Europes
biggest consumer electronics show as the South Korean firm launched a host of new gadgets. More...
Apple vs Samsung: Keeping patent for 20 years patentee pay renewal fees of $880 after 3.5
years
(Krishnamurthy Subramanian , 30-Aug-2012 , The Economic Times)
The litigation resulted because Apple accused Samsung of ripping off the feel of its iPhone and iPad
among various other patent violations. More...
Sony not worried by Android legal woes

Sony Mobile which uses Google Android software for its smartphones has not seen much impact from
patent problems of the software platform. More...
Indian drug companies like Glenmark, Dr Reddy's, Sun Pharma break into world’s fastest
growing list
(Rupali Mukherjee , 30-Aug-2012 , The Economic Times)
In yet another instance of India Inc occupying a larger seat in the global league tables three out of the
top 10 fastest growing generic companies globally are now from India. More...
Mobile patent case: New York Times leads group defense

The New York Times is girding for a legal battle that many larger organisations have avoided. More...
After patent war, Samsung to take on Apple with 'phablet' & bendable screen smartphones
Samsung Electronics Co unveils the second generation of its popular Galaxy Note phone cum tablet at
Europes biggest electronics show in Berlin later on Wednesday as the South Korean firm comes under
pressure to innovate after losing a US patent battle with Apple Inc. More...
Samsung lawyers find blunders in verdict

The jurys haste takes some of the shine off Apples patent victory. More...
Android’s standard-essential patent hopes hit

But that wasnt Apples only victory. More...
Apple's victory dents Android's patent hopes

Standard essential patents arent providing as much leverage in the smart device wars as Google may
have hoped when it paid $12.5 billion to acquire Motorola Mobility. More...
Hisars Varsity gets patent for pest control technique

Hisar based Chaudhary Charan Singh Haryana Agricultural University today said it has been issued a
patent on a technique useful for controlling the population of an insect Helicoverpa armigera commonly
called sundi. More...
Preserved Apple
(Richard Beales , 28-Aug-2012 , Business Standard)
Apple won big with Fridays $1 billion US patent judgment against Samsung. More...
Desi Boyz makers face trouble over copyright
(Prachi Kadam , 28-Aug-2012 , Mumbai Mirror)
Andheri Magistrate Court issues summons against Rohit Dhawan and an arrest warrant against producer
Krishika Lulla after writer Shyam Devkatte scales up his copyright battle. More...
Apples win dents Androids standard-essential patent hopes

Standard essential patents arent providing as much leverage in the smart device wars as Google may
have hoped when it paid $12.5 billion to acquire Motorola Mobility. More...
Apple patent win may slow Google

Apples decisive victory in a landmark US patent case against Samsung could reshape the hot sector for
mobile devices and slow the momentum of Google and its Android system, analysts say. More...
Punjab National Bank forwards Ind-Swift case for debt recast

(K Ram Kumar , 27-Aug-2012 , Business Line)
But once orders started drying up they ventured on their own to manufacture and market generic drugs
(which are copies of branded drugs whose patent has expired). More...
How Apple overwhelmed Samsung's patent case tactics

But given the extensive business ties between the two companies Samsung is one of Apples key
component suppliers a negotiated solution seemed most likely. More...
Apple patent win may delay Samsung launches

Apple Inc won more than $1 billion after a jury found Samsung Electronics Co infringed six of seven
patents for its mobile devices in a verdict that may lead to a ban on US sales of handheld electronics a
judge deems to violate Apples rights. More...
We don’t want anything to limit choice: Google

Google whose Android platform could be impacted because of the victory of Apple against Samsung has
come up with a guarded reaction on the development. More...
What Apple's $1bn-patent win means for smartphone market

(27-Aug-2012 , The Times Of India)
It was the $1 billion question Saturday: What does Apple Incs victory in an epic patent dispute over its
fiercest rival mean for the US smartphone industry? More...
Apple’s verdict will not impact sales in India, says Samsung
(S. Ronendra Singh , 27-Aug-2012 , Business Line)
Samsung Electronics on Monday said that the verdict in a US court against it on a patent dispute with
Apple will not impact its sales of smartphones and tablet computers in India. More...
Apple patent victory muddies the future of innovation

(New York Times , 27-Aug-2012 , The Economic Times)
Apples victory on Friday in a patent lawsuit against Samsung could if upheld give its rivals a kick in the
pants to create more original products. More...
API market loses out to formulations

(Sushmi Dey / New Delhi , 27-Aug-2012 , Business Standard)
Change in trend attributed to the high-margin business of finished products More...
Apple vs rest: Some kinds of patent protection go against common good

These questions suggest themselves in the wake of a US court finding in favour of Apple in its lawsuit
against Samsung for patent and design violations in smartphones and tablets. More...
Karnataka State Road Transport Corporation files for tagline patent

(Aparajita Ray , 27-Aug-2012 , The Times Of India)
After confirming that it was not a KSRTC bus the transport organization filed a patent for its brand.
More...
Apples victory boosts Microsoft as Asian vendors scramble

(Lee Chyen Yee , 27-Aug-2012 , Livemint)
Interest in alternative from Microsoft may intensify as industry officials fear more patent suits from
Apple More...
Viewpoint: Apples victory over Samsung is patently absurd

(T K Arun,ET Bureau , 27-Aug-2012 , The Economic Times)
Samsung is unlikely to be significantly hurt by the fine of $1.05 billion. More...
Flip-flop in the pharma sector

(Kumkum Sen , 27-Aug-2012 , Business Standard)
The pharma sector is one such where the products are seldom purchased by choice therefore market
forces do not impact prices except for generic drugs. More...
OurView | Users, the ultimate losers

(Shyamal Banerjee , 26-Aug-2012 , Livemint)
While billions of dollars are at stake, it’s thousands of Android users who may have to suffer as prices
increase, while competition and innovation decrease More...
Samsung to contest US court verdict in favour of Apple
(AFP , 25-Aug-2012 , The Economic Times)
South Koreas Samsung Electronics said Saturday it will contest a US court ruling that it must pay rival
technology giant Apple damages of more than $1 billion for patent violations. More...
Indian companies get US FDA approval for generic versions of four blockbuster drugs: Jena
(Our Bureau, New Delhi , 25-Aug-2012 , Pharmabiz)
During the last two years the US Food and Drugs Administration has given approval to the generic
versions of four blockbuster drugs to Indian companies the Parliament was informed. More...
Apple, Samsung infringed each others patents: South Korea court

Samsung Electronics Cos flagship Galaxy smartphone looks very similar to Apples iPhone but the South
Korean firm has not violated the iPhone design a Seoul court ruled on Friday. More...
Kodak to sell retail print, document imaging businesses

The once dominant photography firm already in the midst of auctioning off its digital patent portfolio
hopes to complete the sales by mid-2013 Chief Executive Antonio Perez said in a conference call on
Thursday. More...
Pharmaceuticals: June quarter shows the way

(Malini Bhupta / Mumbai , 24-Aug-2012 , Business Standard)
Also with several blockbuster drugs going off patent globally generics companies are reaping rich
dividends by launching these drugs in the US. More...
Pfizer settles Impax patent suit over generic Detrol LA

(Nate Raymond in New York , 24-Aug-2012 , Reuters)
Pfizer Inc has settled a lawsuit accusing Impax Laboratories Inc of infringing patents covering the
overactive bladder drug Detrol LA. More...
Glenmark gets favourable interim order against Napo Pharma

(P. T. Jyothi Datta/M. Ramesh , 23-Aug-2012 , Business Line)
Dispute over exclusive rights on anti-diarrhoeal drug More...
Madras HC stays GSKs use of Horlicks Nutribic

(Shilpa Phadnis , 23-Aug-2012 , The Times Of India)
The Madras High Court on Thursday passed an interim order restraining directors employees agents
distributors and retailers of GSK Consumer Healthcare makers of brand Horlicks from manufacturing
selling and advertising Horlicks Nutribic brand of biscuits for trademark and copyright violations of
Britannias NutriChoice biscuits. More...
Apple patent infringement case: Jurors to resume deliberations
(AP , 23-Aug-2012 , The Economic Times)
Jurors were set to begin their second day of deliberations Thursday in a multibillion dollar patent
infringement case pitting Apple against Samsung over the design of iPhones and iPads. More...
FDA withdraws nod to 27 Ranbaxy ANDAs

(Priyanka Golikeri , 23-Aug-2012 , DNA)
The US Food and Drug Administration has withdrawn approval given to 27 generic products of Ranbaxy
Laboratories. More...
Apple Samsung make final pitch to US jury

(Reuters / San Jose (California) , 23-Aug-2012 , Business Standard)
Apple and Samsung are going toe to toe in a patents dispute that mirrors the struggle for industry
supremacy between the two companies which control more than half of worldwide smartphone sales.
More...
Supreme Court defers Novartis patent appeal to September 11

(Khomba Singh , 22-Aug-2012 , The Economic Times)
Supreme Court on Wednesday deferred Swiss company Novartis case against Indian government over
the interpretation of Section 3 (d) of the Indian patent laws to September 11. More...
Nearly 6.50 lakh trademarks applications pending with govt

(Press Trust of India / New Delhi , 22-Aug-2012 , Business Standard)
There has been a nearly 100% rise in the number of requests since 2001-02. More...
Copyright violation: Court verdict to provide relief to news channels

In a verdict that will bring relief to news channels the Delhi High Court has said trivial infractions where
a small audio clipping is played in the background cant be termed copyright violation. More...
Apple-Samsung patent case: Alchemy of damages takes the stage

Between the hotshot designers and brainy engineers Apple Inc questioned for three weeks in the
companys bitterly fought patent battle against Samsung Electronics Co Ltd a marketing expert from MIT
took Apples lawyers all of three minutes. More...
Indian campaigners say Novartis’ win in landmark drug patent case would be 'death
sentence' for poor
(Agencies , 22-Aug-2012 , The Financial Express)
Health campaigners in India have warned that granting Swiss pharmaceutical company Novartis an
Indian patent for the cancer drug Glivec would mean handing down a ‘death sentence’ for the poor and
ill in the developing world. More...
All eyes on the Novartis case
(Shishir Asthana / Mumbai , 22-Aug-2012 , Business Standard)
SC judgment will impact business of pharma MNCs in India More...
Maharashtra to adopt South Africa variety of grapes

(Tushar Pawar , 22-Aug-2012 , The Times Of India)
In India grapes do not come under patent crop law. More...
Intellectual Property Appellate Board postpones Bayers compulsory licence appeal

Indias Intellectual Property Appellate Board has postponed German company Bayer AGs appeal against
the grant of a compulsory licence of its patented drug Nexavar to Natco Pharma to September 3 a Natco
official said. More...
Google sues Apple over Siri voice control software

(Daily Telegraph , 21-Aug-2012 , DNA)
Licensing remains the bone of contention; search giant cites violation of as many as seven patents by
Apple More...
Suven Life may tie-up for Alzheimer's drug

(BS Reporter / Chennai/ Hyderabad , 21-Aug-2012 , Business Standard)
Other patented molecules are still at a preclincal stage. More...
Kodak patent auction to be probed

Kodak which filed for bankruptcy in January began selling 1100 digital patents in early August and
extended the auction last week citing ongoing discussions with bidders. More...
Chinas patent targets mask weak innovation, says study

Chinas ambitious drive to produce millions of new patents in the next few years as part of a switch from
a made in China to designed in China economic model will curtail innovation standards a European study
warned on Tuesday. More...
When its about tech its not just Samsung

After three weeks of listening to technology experts patent professionals and company executives
debate the complicated legal claims of Apple and Samsung a jury of nine men and women are set to
decide one of the biggest technology disputes in history. More...
Final hearing on Novartis’ case on Sec 3(d) of Patents Act to begin in Supreme Court on Aug
22
(Ramesh Shankar, Mumbai , 21-Aug-2012 , Pharmabiz)
The controversial imatinib mesylate (Glivec) case between the Swiss pharma major Novartis AG and the
Union of India & Others will be heard by the Supreme Court on August 22. In this long pending case,
Novartis is challenging Section 3(d) of Indias Patents Act which prohibits evergreening the practice of
multinational pharma companies to extend their patent terms by making small and trivial changes to
existing molecules and thereby preventing manufacture of generic drugs. More...
Apple-Samsung patent trial over iPhone technology wraps up

(AP , 21-Aug-2012 , The Economic Times)
The multibillion dollar patent dispute between the worlds biggest smartphone makers is wrapping up.
More...
Apple, Samsung show no progress in patent case

Apple and Samsung Electronics reported they made no progress toward narrowing their dispute over
smartphone and computer tablet patents increasing the chances a jury will decide the matter starting
August 21. More...
Novartis fights India for cancer drug patent

(Kaustubh Kulkarni and Ben Hirschler , 20-Aug-2012 , Livemint)
Apex court will hear final arguments starting this week in a landmark case over drug patents More...
Showdown for Big Pharma in Supreme Court

The Supreme Court will hear final arguments starting this week in a landmark case over drug patents
that could change the rules for the countrys healthcare sector and potentially curb its global role as a
supplier of cut price generic medicines. More...
Apple vs Samsung: Patent verdict to decide future of tab, smartphone industry

This week nine jurors are expected to hunker down in a federal courthouse here to decide a case that
could change how the worlds smartphones and tablet computers look and work. More...
IPAB to hear Bayer’s appeal on granting compulsory license on August 21

(20-Aug-2012 , Contify Banking)
The Intellectual Property Appellate Board is going to hear German drug company Bayers appeal against
granting of compulsory license on its anti-cancer drug Nexavar on August 21 2012 reports Pharmabiz.
More...
Google's list of paid bloggers not sufficient, judge says

Google Inc failed to comply with a court order to disclose the bloggers and other commentators on a
patent and copyright case who might have been influenced by payments from the Web company a judge
said on Monday. More...
Novartis fights India for cancer drug patent
(Kaustubh Kulkarni and Ben Hirschler , 20-Aug-2012 , Livemint)
Indias highest court will hear final arguments starting this week in a landmark case over drug patents
Apple & Samsung not burying the patent hatchet yet

(Bloomberg / San Francisco , 20-Aug-2012 , Business Standard)
Apple and Samsung Electronics reported they made no progress towards narrowing their dispute over
smartphone and computer tablet patents increasing the chances a jury will decide the matter starting
August 21. More...
Novartis patent case up for hearing in the Supreme Court this week judgment to have far
reaching impact
The Supreme Court will hear final arguments starting this week in a landmark case over drug patents
Motorola files new patent case against Apple

(TOI Tech , 18-Aug-2012 , The Times Of India)
Google owned Motorola Mobility has filed a new case against Apple at the US International Trade
Commission claiming patent violation. More...
Cipla bats for automatic compulsory licensing

The Government needs to bring in an automatic system for compulsory licensing if it wants to make
medicines both affordable and accessible said drug maker Ciplas Chairman and Managing Director Y.K.
Hamied. More...
Apple paid $1.4 billion in patent royalties: Samsung

A financial expert said Apple has overstated Samsung Electronics Ltds profit margins for mobile products
an issue that goes to the heart of damages in the high profile patent trial between the two tech
companies. More...
Ranbaxy launches generic diabetes treatment tablets in US

Ranbaxy is among the three companies including Teva and Mylan to have 180 days of marketing
exclusivity for the drug in the US market. More...
Samsung settles global patent case with German firm

South Koreas Samsung Electronics said it has reached a deal with German lighting group Osram to settle
all their global patent lawsuits as it continues a high stakes US court battle with Apple. More...
Linking patented drug price to per capita income may hit generic drug makers: Experts
A government panels proposal to link the price of patented drugs to per capita income is likely to shut
out the option of compulsory licensing for generic drug makers experts and industry executives warn.
More...
Apple Samsung chiefs told to resolve patent spat

(AFP , 16-Aug-2012 , The Times of India)
A US judge today urged the chiefs of Apple and Samsung to negotiate a truce in their high profile patent
trial here saying it was time for peace. More...
Prices of patented medicines may come down by a third if panel's recommendation accepted
An inter ministerial group tasked with regulating prices of patented medicines has recommended using a
per capita income linked reference pricing mechanism a proposal that may reduce prices of several
patented drugs by up to one third but will hit the profitability of foreign companies. More...
Big Pharma lobbies hard to curb generics

Indias tag of pharmacy of the developing world is at a serious threat. More...
India needs umbrella body on telecom standards to foster creation of IPR and develop
indigenous products
(Abhay Karandikar , 16-Aug-2012 , The Economic Times)
Telecom technology development is heavily driven by intellectual property rights innovations patents
and contributions to standards. More...
Watson sues FDA on generic diabetes drug ruling

(Esha Dey in Bangalore and Anna Yukhananov in Washington , 15-Aug-2012 , Reuters)
Generic drugmaker Watson Pharmaceuticals Inc sued the U.S. Food and Drug Administration challenging
a ruling against Watsons generic version of a big selling diabetes drug Actos. More...
Apples iPhone iPad violate three Samsung patents: Samsung expert

(Reuters , 15-Aug-2012 , The times Of India)
A Samsung Electronics Co Ltd expert witness testified that Apple Incs iPhone and iPad violate three of
Samsungs patents as the South Korean electronics company went on offense in the third week of a high
stakes trial. More...
Apples iPhone iPad violate three Samsung patents: Samsung expert

A Samsung Electronics Co Ltd expert witness testified that Apple Incs iPhone and iPad violate three of
Samsungs patents as the South Korean electronics company went on offense in the third week of a high
stakes trial. More...
Santarus sues Dr Reddys over heartburn drug

( Prateek Kumar in Bangalore , 15-Aug-2012 , Reuters)
U.S. drugmaker Santarus Inc said it filed a lawsuit against Dr. Reddys Laboratories accusing the Indian
drugmaker of infringing its patents on heartburn drug Zegerid. More...
Over 12,000 food, pharma patents pending test; Delhi accounts for half
(Our Bureau, Mumbai , 14-Aug-2012 , FnBnews)
As on December 31 2011 12,690 applications seeking patent for food products medicines and
pharmaceutical inventions were pending with the Office of the Controller General of Patents Designs &
Trade Marks. More...
Kodak extends patent auction deadline as talks continue

(Caroline Humer , 14-Aug-2012 , Livemint)
Eastman Kodak extended its patent auction on Monday saying it would not announce a winner as
planned because it was still in discussions with bidders. More...
Apple alleges Samsung sales result of copying

(Reuters , 14-Aug-2012 , IBN Live)
Apple Inc is claiming that more than a quarter of Samsung Electronics $30.4 billion in US smartphone
and tablet sales result from copying of the iPhone and iPad or infringe on other patents a damages
expert for the US company said on Monday. More...
Patent office issues list of pending patent applications deemed as TK

(Suja Nair Shirodkar, Mumbai , 13-Aug-2012 , Pharmabiz)
With a view to foster transparency in the system the Controller General of Patents Designs & Trade
Marks has made available a list of all the pending patent applications that implicate traditional
knowledge. More...
Jobs confronted Samsung over Galaxy: Witness

Steve Jobs Apples late co founder confronted Samsung Electronics executives in 2010 after the South
Korean company introduced its Galaxy smartphone Apples patent licensing director testified. More...
Samsung takes on Apple over value of phone features

An Apple Inc expert witness testified on Friday that consumers would be willing to pay $100 for three
patented smartphone features that are at issue in its high stakes trial against Samsung Electronics Co
Ltd. More...
Kodak receives low bids for patents: WSJ
As Eastman Kodaks patent auction draws to a close the bankrupt photography company has only
received lowball bids for the patents that it believes are worth $2.6 billion the Wall Street Journal
reported citing unnamed sources. More...
CNN Time magazine suspend Fareed Zakaria for plagiarism

Noted Indian American journalist and author Fareed Zakaria has been suspended by his employers CNN
and Time magazine after he admitted to plagiarism and apologised for the ethical lapse. More...
Nokia sells 500 patents, Qt software to counter losses

(Tarmo Virki , 10-Aug-2012 , Livemint)
The patent deal nets Nokia $22 million while still leaving it with one of the strongest portfolios in the
wireless industry More...
RIM off the hook for $147 mn in US patent case

Research In Motion will not have to pay a $147.2 million damages award after an American judge tossed
out a jury verdict in a patent case brought by Mformation Technologies. More...
Apple now sued over FaceTime in China

Within weeks of settling a high profile dispute over its iPad trademark Apple now faces a lawsuit by a
man in Taiwan over its FaceTime application which he claims is a violation of his patent. More...
RIM vs Mformation: Judge overturns jurys decision

Research in Motion said a US judge had ruled the company had not infringed on Mformation
Technologiess patent and overturned an award of $147.2 million that a jury said the Canadian firm
should pay. More...
Alembic enters into license agreement with Accu Break of US

(BS Reporter / Mumbai/ Ahmedabad , 9-Aug-2012 , Business Standard)
ABP patented Accu Break can be split easily by hand into smaller doses to provide maximum flexibility.
More...
Apple faces lawsuit in China over FaceTime

Within weeks of settling a high profile dispute over its iPad trademark Apple now faces a lawsuit by a
man in Taiwan over its FaceTime application which he claims is a violation of his patent. More...
Dr Reddys prescription to stay ahead of the generic pack

(B Dasarath Reddy / Hyderabad , 9-Aug-2012 , Business Standard)
The company has differentiated itself by focusing on internal processes and staying away from costly
acquisitions. More...
Samsung phones confusingly similar to iPhone

The focus of the courtoom battle between Apple and Samsung Electronics shifted to the iPhones iconic
display on Tuesday as the US company called a former employee and award-winning graphic designer to
back up claims that Samsung gadgets look confusingly similar. More...
Must watch: The lighter side of Apple vs Samsung patent trial

(NDTV Correspondent , 08-Aug-2012 , NDTV)
The court proceedings began last Monday in the blockbuster Apple Samsung trial a high stakes legal
contest over infringement of patents for hot selling smartphones and tablet computers. More...
Plea against Tirupati Laddu GI tag rejected

(Vinson Kurian , 8-Aug-2012 , Business Line)
Rectification applicant fails to prove locus standi and interest with registered good More...
Apple faces lawsuit in China over FaceTime application

(Press Trust of India / Beijing , 08-Aug-2012 , Business Standard)
Within weeks of settling a high profile dispute over its iPad trademark US high tech giant Apple now
faces a lawsuit by a man in Taiwan over its FaceTime application which he claims is a violation of his
patent. More...
US STAND ON CL UNFAIR
The grant of compulsory licence by Indias Patent Controller in March this year to Natco for the
manufacture of generic version of Bayers cancer drug Nexavar has attracted severe criticism from the
US Patent and Trademark Office last month. More...
AOL, Vringo reach partial patent settlement

(Associated Press , 08-Aug-2012 , NDTV)
AOL Inc. confirmed Monday that it has reached a partial patent settlement with ringtone company Vringo
Inc. related to online search and advertising. More...
French agency fined for pirating Ray classic

(Debashis Konar , 7-Aug-2012 , The Times Of India)
A French agency that was illegally selling DVDs of the award winning Ashani Sanket has been ordered to
pay a compensation of euro 10000 around Rs 6.8 lakh to producer Sarbani Bhattacharya for infringing
her film rights. More...
Apple, Google bid on Kodak patents: Report

Eastman Kodak which is planning to auction 1,100 digital patents received two bids from investor groups
including Apple Inc and Google Inc of between $150 million and $250 million the Wall Street Journal
reported on Monday. More...
Patent war: iPhones created design crisis for Samsung, says Apple
Apple Inc trotted out a veteran designer to bolster its claims that Samsung Electronics copied the iPhone
after the smartphones 2007 launch triggered a crisis in design for the South Korean electronics giant.
More...
Apple, Samsung take legal battle to hot tub

Apple and Samsung Electronics are embroiled in a high stakes patent battle in several countries around
the world but only in Australia are they also engaged in hot tubbing. More...
Apple reveals origin and history of iOS in Samsung patent trial

(ANI , 06-Aug-2012 , Hindustan Times)
Tech giant Apples Senior Vice President Scott Forstall has revealed all the secrecy hard work and
innovation that went into developing the iOS user interface in its 2.5 billion dollar patent trial with South
Korean mobile maker Samsung. More...
Apple versus Samsung patent trial: World starting to learn how Steve Jobs made the company
successful
Back in the early 1930s a magician by the name of Horace Goldin went to court to defend his signature
illusion: sawing a woman in half. More...
Apple vs Samsung: Can look and feel be patented?

Apple has become the most valuable company by creating products that stand out for design and ease
of use stemming from scores of smaller innovations such as rubberbanding rather than epic underlying
technology breakthroughs. More...
Apple applies for iPad Smart Cover patent

(IANS , 05-Aug-2012 , IBN Live)
Apple has applied for a patent on iPad Smart Cover with an embedded secondary display designed to
enhance the functionality of the tablet computer. More...
Pharma cos set to gain from US nod for asthma drug

Indian drug makers including Aurobindo and Glenmark are set to benefit from a decision by the USFDA
to allow sale of generic Singulair tablets used for treating asthma and allergies in the US market. More...
Judge scolds Samsung, lets patent trial proceed
The judge in a massive smartphone patent dispute reprimanded Samsung Friday for releasing excluded
evidence but denied a bid by Apple to order a verdict in the case. More...
Kodak posts larger 2nd-quarter loss on eve of patent auction

Eastman Kodak Co on Friday posted a wider second quarter loss as it prepares for a crucial auction in
which it hopes to sell more than 1100 patents to help repay its bankruptcy creditors. More...
Google inks patent licensing pact with Rovi

Rovi signed an agreement with Google to allow the technology giant to use its interactive program guide
patent portfolio for set top boxes sending its shares up 4 per cent in premarket trade. More...
IPAB adjourns hearing on post grant opposition against Roches patent for Pegasys
The re hearing in the post grant opposition against the patent granted to Roche for Pegasys a key drug
used for Hepatitis C treatment has been adjourned by the Intellectual Property Appellate Board in
Chennai without fixing any new date for next hearing. More...
Apple asks for verdict after Samsung's 'misconduct'

With a major patent trial barely underway Apple has asked a judge to rule against Samsung saying
lawyers for the South Korean firm improperly disclosed information excluded in court in a bid to sway
jurors. More...
Generic business may hit drug exports of Indian firms like Cipla and Natco
The government is apprehensive that the Indian drug companies strategy of launching generic version of
patented drugs could trigger retaliation from overseas countries that may hit the countrys ambitious
drug export plans. More...
Belgium hopes talks on India-EU FTA will conclude by year end

Belgium today hoped the ongoing negotiations for India EU free trade agreement will conclude by end of
this year as it sought access to the countrys public procurement market. More...
Whirlpool Videocon spar over design infringement

(BS Reporter / Mumbai , 3-Aug-2012 , Business Standard)
The Mumbai High Court in an order dated July 25 restrained consumer durables major Videocon
Industries Ltd from selling its Pebble brand of washing machines which it said was an imitation of rival
Whirlpool of India Ltds Ace brand. More...
Apple applies for iPad Smart Cover patent
(IANS , 3-Aug-2012 , The Times Of India)
Apple has applied for a patent on iPad Smart Cover with an embedded secondary display designed to
enhance the functionality of the tablet computer. More...
Sun Pharma considering buying German drug firm

(Bloomberg / Paris/Mumbai , 3-Aug-2012 , Business Standard)
Sun Pharmaceutical Industries Ltd Indias largest drug maker by market value is looking for acquisitions
in Europe including a possible takeover of German generic drug maker Stada Arzneimittel AG people
familiar with the matter said. More...
Rovi signs patent licensing pact with Google

(Reuters , 3-Aug-2012 , NDTV)
Rovi Corp signed an agreement with Google Inc to allow the technology giant to use its interactive
program guide patent portfolio for set-top boxes sending its shares up 4 percent in premarket trade.
More...
Govt steps up efforts on intellectual property

(Surabhi Agarwal & Asit Ranjan Mishra , 02-Aug-2012 , Livemint)
India has been under international pressure especially from the US to put in place a robust IPR regime
that will not only make multinationals operating in the country more comfortable about their patents but
will also boost domestic innovation. More...
Apple 'bet company' with iPhone launch

(ANI , 02-Aug-2012 , The Times Of India)
In the 2.5 billion dollar patent trial between tech giants Apple and Samsung a US court has heard that
the former was literally betting the company when it introduced the iPhone. More...
U.S. bankruptcy judge lets Kodak sell key patent

(Reuters , 02-Aug-2012 , NDTV)
Eastman Kodak Co can proceed with the sale of a key digital imaging patent a bankruptcy judge ruled on
Wednesday saying that Apple Inc waited too long to raise a claim of infringement. More...
Film ‘Mirattal’ gets copyright cover

Another Tamil film has just prior to its release obtained a John Doe protection order from the Madras
high court barring anyone from uploading the film or any portion of it on websites without the
authorisation of its producers. More...
Apple claims Samsung copied iPhone technology

An attorney for Apple told a jury on Tuesday that bitter rival Samsung faced two options to compete in
the booming cellphone market after Steve Jobs introduced the iPhone to critical acclaim in 2007:
Innovate or copy. More...
Natco in patent war with BMS

Natco which successfully managed to reduce prices of Bayers cancer drug Nexavar by 97% through the
countrys first compulsory licence recently is headed for another major confrontation. More...
Tirupati temple to keep laddu patent

(Maneesh Chhibber , 31-Jul-2012 , The Indian Express)
The Venkateswara temple in Andhra Pradesh Indias richest temple Monday scored a sweet legal victory:
the Geographical Indications Registry upheld its claim of a patent over the famous Tirupati laddu.
More...
Apple vs Samsung trial: Jury selection begins

(AFP , 30-Jul-2012 , The Times Of India)
Jury selection was set to open on Monday in a US federal court in the blockbuster patent case pitting
Apple against Samsung which accuse each other of copying patents for smartphones and tablets. More...
Apple may launch Google Glasses rival reveals patent filing

(ANI , 31-Jul-2012 , The Times Of India)
Tech giant Apple has raked up speculation that it could be creating an augmented reality head mounted
display to compete with Googles Project Glass technology after it reportedly filed for a US patent.
More...
‘Patent’ defect left unattended in truck amounts to negligence: Court

(New Delhi-based chartered accountant , 30-Jul-2012 , Business Line)
A public carrier is liable to compensate the shipper for the losses suffered by it on account of damage of
goods if the reason for the accident is a patent defect a defect that could have been detected and
rectified given reasonable care in the mechanical system of the truck. More...
Taiwan univ sues Apple over Siri patents

Taiwans National Cheng Kung University has filed a suit against US tech giant Apple claiming the
companys Siri intelligent assistant has infringed on two of its patents. More...
Apple to face Samsung over patent trial on Monday

(Agency inputs , 29-Jul-2012 , ZeeBiz)
Samsung and Apple will be at logger heads over a crucial patent trial in US federal court on Monday.
More...
Google asks court to dismiss authors' copyright case

Google asked a US court Friday to dismiss a lawsuit over the internet giants massive book scanning
project saying the effort is not a substitute for books themselves. More...
Price controls ahead for patented drugs

(Kaustubh Kulkarni , 28-Jul-2012 , DNA)
The government is planning to rein in prices of expensive patented drugs to make medicines affordable
to the poor. More...
Indian patenting system needs to improve, says WIPO chief

The Geneva based WIPO an arm of the United Nations Organisation helps member countries in legal and
technical matters pertaining to intellectual property. More...
Kodak Apple patent fight to remain in bankruptcy court

Apple Inc lost on Thursday a bid to transfer its patent dispute with Eastman Kodak Co out of bankruptcy
court a move that could have complicated the photography companys plan to sell the technology.
More...
US doublespeak on patent waiver bared

The United States, which is crying foul over a patent waiver for a cancer drug in India has itself resorted
to similar steps to reduce disruptions in supply of two medicines and that too through an executive
order. More...
Re-hearing on post grant opposition against Roches patent for Pegasys to be held on July 30
at IPAB
The crucial hearing in the post grant opposition against the patent granted to Roche for Pegasys Peg
intergferon alpha 2B a key drug used for Hepatitis-C treatment will be held on July 30-31 by the
Intellectual Property Appellate Board in Chennai. More...
Sudarshan Chemicals wins patent case against Clariant

(BS Reporter / Mumbai/ Pune , 26-Jul-2012 , Business Standard)
The court will now assess damages to be paid by Clariant to Sudarshan as a result of its wrongful
threats. More...
HCL Infosystems acquires educational content provider Edurix

IT firm HCL Infosystems has acquired educational content provider Edurix a move that will help
strengthen its education and learning business. More...
Venus Remedies novel antibiotic product Potentox receives US patent

The United States Patent and Trademark Office has granted 3rd US patent for Venus Remedies Limited a
research based global pharmaceutical company for its novel antibiotic product Potentox. More...
Samsung patent royalty demands unfair: Apple

(Reuters / San Francisco , 26-Jul-2012 , Business Standard)
Apple Inc said Samsung Electronics Co Ltd is demanding from the iPhone maker a far higher patent
royalty than Apple pays to other companies at a rate the South Korean company has never sought from
any other licensee. More...
Manpower shortage hits patents processing

(Shishir Arya , 25-Jul-2012 , The Times Of India)
Though Union Commerce Minister Anand Sharma while inaugurating the National Institute of Intellectual
Property Management in the city last week expressed concern over less number of patents being filed
from the country the government too appears slow when it comes to examining the applications. More...
Indian pharma firms prefer alliance pill

(Ujjval Jauhari & Ram Prasad Sahu / Mumbai , 25-Jul-2012 , Business Standard)
Marketing alliances in emerging markets is at the heart of the expansion strategy. More...
EU members oppose treaty on visually challenged

(Aakshi Magazine , 25-Jul-2012 , DNA)
A historic treaty set to end the book famine faced by the visually challenged is being opposed by EU
members at the 24th meeting of the standing committee for copyright and related rights at the World
Intellectual Property Organisation in Geneva. More...
Patent row: Apple Inc seeks $2.5-bn damages

(Reuters / New York , 25-Jul-2012 , Business Standard)
Apple claims it is entitled to $2.525 billion of damages in its high stake battle against Samsung
Electronics over patents for technology used in smartphones and tablets such as the iPhone and iPad.
More...
EU stalls treaty talks to allow copyright waiver for print disabilities

(Priscilla Jebaraj , 25-Jul-2012 , The Hindu)
India and other developing countries support such a legally binding treaty. More...
Apple Samsung disagree on patent values: Source

Apple Chief Executive Tim Cook and top Samsung Electronic executives disagreed last week on the value
of each others patents at a settlement conference ahead of a high profile US trial according to a source
familiar with the matter. More...
Indian drug firms lobby against EU’s new directive

(Vidya Krishnan , 24-Jul-2012 , Livemint)
Indian drug companies are lobbying against a move by the European Commission to check the import of
counterfeit drugs through a directive that comes into effect in about a year from now. More...
Logistics majors focusing on patents to keep technology edge

(Mamuni Das , 23-Jul-2012 , Business Line)
Players in the highly competitive logistics sector are grappling with protecting innovations through the
use of patents. More...
Apple and Googles Motorola unit file separate patent appeals

(Bloomberg , 23-Jul-2012 , The Economic Times)
Apple and Googles Motorola Mobility unit filed separate appeals of a federal judges June 22 order
dismissing their mutual patent infringement claims. More...
Kodak loses patent case against Apple, RIM

(Reuters , 23-Jul-2012 , Hindustan Times)
Eastman Kodak has lost an appeal of a patent dispute over digital image preview technology with Apple
and Research In Motion, which could set back the onetime photography giants efforts to raise money in
bankruptcy by selling patents. More...
Apple vs Samsung patent trial begins in Australia

Apple and Samsung Electronics began the latest round of their long running global patent war on
Monday as an Australian judge began hearing evidence for an anticipated three month trial. More...
Health Ministry identifying more essential drugs for compulsory licence as debate still rages
on
(Joseph Alexander, New Delhi , 23-Jul-2012 , Pharmabiz)
Even as the debate over India giving compulsory licence heating up with US official too raising
apprehensions Union health ministry made it clear that it is strongly in favour of invoking the provision
of compulsory licences in the case of more essential medicines. More...
Theres an Indian hand in $147-mn patent blow to BlackBerry maker

(Indira Kannan / Toronto , 22-Jul-2012 , Business Standard)
The patents related to wireless mobile device management and the software found to infringe
Mformations patent was RIMs BlackBerry Enterprise Server used by corporate enterprise customers to
manage and secure their BlackBerry devices. More...
42,000 patent applications filed last year: Sharma

(PTI , 21-Jul-2012 , ZeeBiz)
The government Saturday said 42000 patent applications were filed in 2011 indicating the rising trend of
such filings. More...
Pharmexcil to present patent awards to cos during AGM on Sept 26-28

(Our Bureau, Hyderabad , 21-Jul-2012 , Pharmabiz)
The Pharmaceutical Export Promotion Council Of India will present patent awards to the companies who
have shown excellence during the financial year 2011 2012 at its annual general meeting event to be
held from September 26-28 this year. More...
Settlement of Somaxon Pharmaceuticals patent suit in US soon: Zydus

(Vishal Dutta , 20-Jul-2012 , The Economic Times)
Ahmedabad based Zydus Cadila says it agreed to settle a patent litigation suit with US based Somaxon
Pharmaceuticals for insomnia drug Silenor. More...
Growth rates in US markets will decline: Dr Reddy's

(BS Reporter / Hyderabad , 20-Jul-2012 , Business Standard)
Patent expiries which peaked this year will decrease over the next few years says CEO G V Prasad
More...
Natco targets drugs ripe for compulsory licensing

(Viswanath Pilla , 20-Jul-2012 , Livemint)
Natco Pharma Ltd which has started selling a generic version of Bayer AGs patented cancer treatment
Nexavar in India at a fraction of the price charged by the German firm plans to use the so called
compulsory licensing route to try and win the right to copy more patented drugs said vice chairman and
chief executive officer Rajeev Nannapaneni. More...
Apple sued by HTC over patent infringement

Taiwans leading smartphone maker HTC has that it was suing technology giant Apple in the United
States claiming it has infringed on its patents. More...
Apple vs Samsung: Plea to use Steve Jobs’ comments rejected

A US judge on Wednesday approved Apples request to bar disparaging statements by Steve Jobs about
Googles Android operating system from an upcoming patent trial against Samsung Electronics. More...
Apple vs Samsung: Key documents to go public

A US judge rejected several requests by Apple and Samsung Electronics to keep portions of key
documents out of public view in their high stakes patent litigation battle set for trial later this month.
More...
WTO for cheaper drugs in developing countries

(Virendra Singh Rawat / New Delhi/ Lucknow , 18-Jul-2012 , Business Standard)
TRIPS is a WTO-administered international agreement that sets down minimum standards for many
forms of intellectual property regulation on WTO members. More...
18 Motorola phones face ban in US
(Reuters , 18-Jul-2012 , The Times of India)
Google unit Motorola Mobility has said it has taken steps to avert an interruption of US imports and sales
of its smartphones after the devices were found to infringe on a Microsoft patent. More...
Google unit Motorola Mobility says will avoid US import ban on smartphones
Google unit Motorola Mobility said on Tuesday it has taken steps to avert an interruption of US imports
and sales of its smartphones after the devices were found to infringe on a Microsoft patent. More...
Judge rejects secrecy bids in Apple vs. Samsung battle

(Reuters , 18-Jul-2012 , NDTV)
A U.S. judge rejected several requests by Apple Inc and Samsung Electronics Co Ltd to keep portions of
key documents out of public view in their high stakes patent litigation battle set for trial later this
month. More...
Decision on Nexavar not against the law

(Sujay Mehdudia , 17-Jul-2012 , The Hindu)
Asserting that India has not taken any arbitrary decision or gone against the law in issuing compulsory
licence for the generic production of patented anti cancer drug Nexavar Commerce and Industry Minister
Anand Sharma said the U.S. and European companies had done the same on number of occasions.
More...
HTC files counterclaims against Apple with patents from HP

(Steven Musil , 17-Jul-2012 , CNET)
The Taiwanese handset maker is ratcheting up its patent battle with allegations that an array of Apple
products infringe on two recently acquired patents. More...
We re sovereign and progressive: Sharma to Barack Obama

(Press Trust Of India / New Delhi , 17-Jul-2012 , Business Standard)
We are fully compliant when it comes to TRIPS Trade Related Aspects of Intellectual Property Rights.
More...
US steps up lobbying efforts against compulsory licensing

The move has irked activists patent experts and drugmakers in India who have written to the
government protesting the USs campaign. More...
Is pharma steering India's tryst as a major R&D hub?

( Rohit Joshi & Siddharth Tak , 15-Jul-2012 , DNA)
Rather than innovating new drugs our companies replicate branded drugs when their patent expires.
More...
RIM hit with $147.2 million verdict in wireless patent lawsuit
A northern California jury directed Research in Motion Ltd to pay $147.2 million in patent litigation over
a remote management system for wireless devices according to an attorney for the plaintiff Mformation
Technologies Inc. More...
Full confidence in Indian legal system, says Germany

(PTI , 14-Jul-2012 , DNA)
His remarks came in the backdrop of a German company Bayers case in Delhi High Court over a patent
infringement suit against an Indian company on March 15 2010 in response to a decision of the Drug
Controller General of India to grant Cipla marketing authorisation for a generic version of Nexavar a
cancer drug. More...
US pushing India to hike cancer drug price

(IANS , 14-Jul-2012 , IBN Live)
Even as President Barack Obama is plugging his signature law to lower health care costs at home his
administration is pressurising India and other countries to impose higher prices even for lifesaver cancer
drugs. More...
India's patent office calls proposals for a data search system

(Omkar Sapre , 13-Jul-2012 , The Economic Times)
Indias patent authority has called for proposals to provide one point access to databases of patent and
non patent literature of all countries and to develop a customised search platform to enable patent
examiners search through these databases. More...
US accuses India of WTO rules violation over Nexavar: Report

(Press Trust of India / Washington , 13-Jul-2012 , Business Standard)
The US administration has accused India of violating WTO norms by allowing Hyderabad based Natco
Pharma to make generic version of cancer drug Nexavar according to a media report. More...
Worldwide sales of generics to double through 2016

(Ransdell Pierson/Reuters , 13-Jul-2012 , Livemint)
Worldwide sales of generics a mainstay in poorer countries will almost double to between $400 billion
and $430 billion by 2016 driving overall spending growth on pharmaceuticals IMS said More...
We are confident of doubling our US sales in 3-5 years: Glenn Saldanha

Our strategy has never focused on the patent cliff. More...
India refuses to hike cancer drug price

(Narayan Lakshman , 12-Jul-2012 , The Hindu)
Stands up to White Houses strong arm tactics against manufacturers of generic equivalent More...
Laws needed to protect knowledge
(Special Correspondent , 12-Jul-2012 , The Hindu)
M. Ajith, Assistant Controller of Patents and Designs Chennai pointed out that patent was a territorial
right valid for a period of 20 years. More...
All about the patent wars

(Rajni Bakshi , 11-Jul-2012 , Rediff)
The course of the patent wars is almost certain to remain tortuous writes Rajni Bakshi. More...
Locals go FTF to break Big Pharma hold on generics

( Priyanka Golikeri & KV Ramana , 11-Jul-2012 , DNA)
Despite making a significant dent Indian drug makers have been lagging the multinational players in the
lucrative US market but all that is set to change with a lot of off patent opportunities coming up and
companies increasingly going for the first to file status. More...
Alcatel-Lucent files 75 patents from India

(BS Reporter / Chennai , 11-Jul-2012 , Business Standard)
France based Alcatel Lucent has filed 75 patents on various technologies which were developed by its
research and development centre in Chennai. More...
Alcatel-Lucent files 75 patents from India

(BS Reporter / Chennai , 11-Jul-2012 , Business Standard)
France based Alcatel Lucent has filed 75 patents on various technologies which were developed by its
research and development centre in Chennai. More...
Iron grip prised loose

(Deepa Kurup , 10-Jul-2012 , The Hindu)
More compulsory licensing of patent protected medicines coupled with state procurement and
distribution could be a panacea for the healthcare system More...
Ranbaxy planning expansion in US

(Press Trust of India / New Jersey , 10-Jul-2012 , Business Standard)
Despite extra oversight from US regulators over quality questions. More...
Pharma cos may have to shift business strategy due to slow growth: Report
(DIVYA RAJAGOPALDIVYA RAJAGOPAL , 10-Jul-2012 , The Economic Times)
In the last three years Indian drug makers have relished the opportunity emerging from patent expiry of
blockbuster drugs such as Lipitor. More...
Apple loses British suit over Samsung Galaxy Tab

South Koreas Samsung won a patent battle on Monday against US rival Apple with a British judge ruling
that Samsungs Galaxy tablet was not cool enough to be confused with Apples iPad. More...
Cipla Q1 data to reflect generic supply to Teva

(Sushmi Dey / New Delhi , 9-Jul-2012 , Business Standard)
With the expiry of its patent on the blockbuster drug Teva launched its generic version in March and is
currently enjoying a 180-day exclusivity on sales. More...
Indian pharma cos secure approval for 88 ANDAs from US FDA in first half of 2012
(Sanjay Pingle, Mumbai , 9-Jul-2012 , Pharmabiz)
The higher number of approvals from highly regulated markets will help to spread market presence in
the lucrative markets and it will help to en cash upcoming opportunities with the expiration of patents.
More...
Alcatels Chennai centre leads in patent filing

(Staff Reporter , 09-Jul-2012 , The Hindu)
75 patents have been filed over the last six years More...
US retailers sue Pfizer over generic Lipitor delay

(PTI , 08-Jul-2012 , The Business Line)
Five large US drug and grocery chains are suing Pfizer Inc and a second drugmaker alleging they
conspired to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor. More...
Yahoo and Facebook settle patent suits

(Michael J De La Merced , 08-Jul-2012 , Business Standard)
The agreement does not include any cash payout by Facebook seen as a win for the social networking
company. More...
SC to start final hearing on Novartis’ case on Sec 3(d) of Patents Act on August 22
The final hearing on the controversial case on Sec 3(d) of Indian Patents Act will begin in the Supreme
Court on August 22. More...
US retailers sue Pfizer charge generic Lipitor delay

(AP , 7-Jul-2012 , The Economic Times)
Five large US drug and grocery chains are suing Pfizer Inc. and a second drugmaker alleging they
conspired to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor. More...
Yahoo, Facebook have settled patent fight: Source

(AP , 7-Jul-2012 , The Times Of India)
Facebook and Yahoo have agreed to settle a patent dispute and avert a potentially bitter battle over the
technology running two of the Internets most popular destinations according to a person familiar with
the matter. More...
Final hearing on Novartis patent petition put off
(Our Bureau , 06-Jul-2012 , Business Line)
The final hearing on drug maker Novartis petition challenging the rejection of its patent application for
cancer drug Glivec has been adjourned to late next month. More...
Register your trademark or risk losing it altogether

(Omkar Sapre , 06-Jul-2012 , The Economic Times)
Opting for a well-known brand can have its pitfalls particularly if it sounds similar to a big multinational
brand. More...
Patent war: Apple vs Samsung, Motorola & others

Mobile technology has been a hotbed of patent litigation in recent years. More...
US threatens to take India to WTO over Nexavar Generic

The US House of Representatives and the US Patent and Trademark Office have threatened to drag India
to the World Trade Organisations dispute panel for issuing the firstever compulsory licence to a domestic
company to manufacture generic version of Bayers cancer drug Nexavar saying the move violates
international trade laws. More...
European parliament says no global anti-piracy law

The European Parliament rejected a global agreement against copyright theft on Wednesday handing a
victory to protesters who say the legislation would punish people for sharing films and music online.
More...
EU parliament rejects anti-generics ACTA

(Priyanka Golikeri , 05-Jul-2012 , DNA)
In a huge boost to makers of generic medicines the European Union parliament on Wednesday rejected
a treaty agreement that could have given these companies and the patient groups fighting for low cost
medicines a severe migraine. More...
Pureit patent revocation to have minimal impact

(BS Reporter / Mumbai , 5-Jul-2012 , Business Standard)
The recent revocation of a patent granted to Hindustan Unilevers Pureit water filters will have a minimal
impact on the brand according to company executives. More...
US ups the ante on Nexavar Generic threatens to take India to WTO

The US House of Representatives and the US Patent and Trademark Office have threatened to drag India
to the World Trade Organisations dispute panel for issuing the firstever compulsory licence to a domestic
company to manufacture generic version of Bayers cancer drug Nexavar saying the move violates
international trade laws. More...
Last hurdle for EU patent

(T S Vishwanath , 5-Jul-2012 , Business Standard)
A single EU patent regime may trip at its final stage if the Members of European Parliament are not
satisfied More...
Indian pharma: Pricey patented drugs do not seem the norm

There seems considerable policy action in the Indian pharmaceutical scene. More...
Apple planning Google Glass rival?

(ANI , 4-Jul-2012 , The Times Of India)
Software giant Apple has been awarded a patent for a wearable display device by the US Patent and
Trademark Office that sounds similar to Googles Project Glass. More...
Kendriya Vidyalaya set to patent new uniforms for its students

(Hema Rawat , 04-Jul-2012 , Hindustan Times)
The Kendriya Vidyalaya Sanghathan has decided to patent the new school uniforms that it will introduce
for Class 1 students across the country with effect from the current academic session. More...
European Union rejects anti counterfeiting law

The European Parliament on Wednesday rejected the anti counterfeiting trade agreement which if
passed would have limited the access of legitimate generic medicines exported from developing
countries like India. More...
Apples request to ban HTC smartphones rejected

A US trade panel has turned down Apples request to immediately ban some HTC smartphones from
being imported into the United States because of accusations that they infringe on an Apple patent.
More...
Apple suffers UK patent defeat to HTC over technology used in mobile tools
Taiwans HTC on Wednesday won a London court ruling against U.S. tech giant Apple Inc over a series of
patent infringement claims linked to technology used in its mobile devices. More...
Kochiite patents six-stroke engine

Anil Cleetus Chanayil a city based motor mechanic-turned-engine designer has won an Indian patent for
designing a six-stroke engine which he says will be easy on the environment and light on the bike user s
pocket. More...
Samsung Galaxy Nexus sales ban to continue

A US judge on Tuesday rejected a request by Samsung Electronics to lift a pre-trial injunction against
sales of its Galaxy Nexus phone another legal setback for the South Korean firm ahead of an upcoming
court battle with Apple. More...
Kodak wins patent fight with Apple

Beleaguered photography pioneer Kodak has said that a US bankruptcy court has approved its bid to
auction off more than 1,100 patents despite objections by Apple and FlashPoint over a small number of
them. More...
Pharma research to get Rs 2000-cr shot in arm

The Commerce and Industry Minister Mr Anand Sharma said on Tuesday that his Ministry is actively
considering a Rs 2000 crore venture capital fund to be used mostly to boost Research and Development
in the pharmaceutical industry. More...
Apple pays $60m to settle iPad patent row

(Saibal Dasgupta , 3-Jul-2012 , The Times Of India)
Apple paid $60 million to settle a legal dispute with Chinese computer maker Shenzhen Proview
Technology over the iPad trademark. More...
Govt to discuss FDI export barriers in pharma sector

(Arun S , 2-Jul-2012 , Business Line)
The fear is that takeovers of existing companies would increase the prices of many drugs and reduce
generics off patent drug production. More...
Apple wins as Samsung loses bid to lift Galaxy Tab ban in US

(Reuters , 3-Jul-2012 , NDTV)
A U.S. judge on Monday rejected a request by Samsung Electronics Co. to lift a ban on U.S. sales of its
Galaxy Tab 10.1 another setback for the South Korean firm in its tablet patent battle with iPad maker
Apple Inc. More...
Healthcare industry is a rip-off

(Pradeep S Mehta , 2-Jul-2012 , Business Line)
The absence of regulatory oversight in the health industry needs urgent attention. More...
Indian simvastatin makers line up atorva products

(KV Ramana , 02-Jul-2012 , DNA)
Indian generic companies are realigning strategies in the US statin market with atorvastatin the top
selling drug in the category going off patent. More...
USPTO official lambasts issuance of compulsory licensing by Indian patent office

The first ever compulsory licensing issued by the Indian Patent Controller on March 9 2012 to an Indian
generic company to manufacture generic version of Bayers cancer drug Nexavar has come in for severe
criticism by the US Patent and Trademark Office. More...
Apple settles China iPad trademark dispute for $60 mln

(Reuters , 2-Jul-2012 , IBN Live)
Apple Inc has paid $60 million to Chinas Proview Technology to settle a dispute over the iPad trademark
a Chinese provincial court said on Monday. More...
Author alleges copyright violation by US website

G Reghunath Pillai an inspector with Kerala Road Transport Corporation while penning a book on
undesirable truths would not have dreamt that his creation would make him face one in the future.
More...
Indian pharma firms prefer alliance pill for expansion

Marketing alliances in emerging markets continue to be at the heart of the expansion strategy of Indian
generic players. More...
Drug patents expiry to give generic pharma market shot in arm

(PTI , 01-Jul-2012 , IBN Live)
The patent expiry of several major blockbuster drugs coupled with other factors will fuel growth of global
generic pharmaceuticals market by 2017 research firm Frost & Sullivan said. More...
Patent licensing: Google unit under lens in US

(Reuters , 30-Jun-2012 , The Times Of India)
US antitrust regulators are investigating whether Google unit Motorola Mobility is living up to licensing
commitments made when its patents were adopted as industry standards two people familiar with the
probe said on Friday. More...
Pfizer takes Alembic to US court on drug patent

(BS Reporter / Ahmedabad , 30-Jun-2012 , Business Standard)
Pfizer the pharmaceutical giant has gone to a US court to stop or at least delay Gujarat based Alembic
Pharmaceuticals from trying to sell a generic version of the formers anti depressant drug branded
Pristiq. More...
Apple scores second courtroom win vs Samsung

A US judge on Friday granted Apple Incs request for a pre trial injunction against the sale of Samsung
Electronics Co Ltds Galaxy Nexus phone handing the iPhone maker its second legal victory against
Samsung in a week. More...
Obamacare will be good for Indian pharma and IT

(Shishir Asthana / Mumbai , 29-Jun-2012 , Business Standard)
The US Supreme Court passed the landmark ruling dubbed Obamacare thereby upholding the
controversial massive reform of health care coverage which was initiated by President Barack Obama.
More...
Pfizer complains against Zydus on US patent violation

(Sohini Das / Ahmedabad , 29-Jun-2012 , Business Standard)
For the second time in a month a complaint of infringement of patent has been filed against Zydus
Pharmaceuticals a wholly owned subsidiary of Ahmedabad based pharma major Cadila Health care at a
US district court. More...
HC dismisses Sun Pharmas appeal on Acucal trademark

Sun Pharmaceuticals appeal in a trademark suit seeking injunction against Ahmedabad based West
Coast Pharmaceuticals Ltd has been dismissed by the Gujarat High Court. More...
Qualcomm plans new subsidiary to guard patents

Cellphone chip supplier Qualcomm plans to spin off its research and development activities and its
product and services businesses into a wholly owned unit to better protect its patent portfolio. More...
Delhi HC restrains Indian firm from using trademark Maersk

(Soibam Rocky Singh , 28-Jun-2012 , Law et al News)
The Delhi High Court has restrained an Indian mining and exploration firm from using the word Maersk
as part of its corporate name on a plea filed by Danish business conglomerate AP Moller Maersk A/S
claiming exclusive right over the service mark. More...
Indian pharma eyes US generic gold rush

(Sushmi Dey / New Delhi , 27-Jun-2012 , Business Standard)
Bulk drug filings from Indian cos in US have increased significantly. More...
Court bans Samsung Galaxy Tab 10.1 sales in US

A US judge on Tuesday granted Apples bid to stop Samsung Electronics from selling its Galaxy Tab 10.1
tablet in the United States giving the iPhone maker a significant win in the global smartphone and tablet
patent wars. More...
Indian scientist gets U.S. patent for cancer treatment

(M. Sai Gopal , 27-Jun-2012 , The Hindu)
Nano particle carries anti cancer drug and releases it only in the cancerous cell. More...
India to talk retail FDI at EU free-trade meet

(Neeraj Thakur , 26-Jun-2012 , DNA)
India is taking an aggressive stance in the free trade agreement negotiations with the European Union.
More...
Natco, Mylan to appeal against New York district court verdict

(Deepika Amirapu , 25-Jun-2012 , The Economic Times)
Indias Natco Pharma and USAs Mylan are considering to appeal against the judgement by a district court
in New York that dealt the two companies a severe blow denying them permission to make a me too
version of generic giant Teva Pharmaceuticals Copaxone. More...
Natco loses patent case against Teva of anti sclerosis drug

(Press Trust of India / Hyderabad , 25-Jun-2012 , Business Standard)
Natco Pharma Ltd has lost a patent litigation against Israels Teva Pharmaceutical Industries Ltd in the
US over multiple sclerosis treatment drug Copaxone. More...
Now GTU to train its students on filing patent applications

(Bharat Yagnik , 25-Jun-2012 , The Times Of India)
After successful completion a five different training session on Patenting in Engineering and Patenting in
pharmaceuti cals at different places in the state the GTU has decided to train its students on how to file
application for patents. More...
India Brazil & China defend generic drugs at WTO

(Amiti Sen , 25-Jun-2012 , The Economics Times)
India Brazil and China have defended the right of poor countries to access cheap generic medicines at
the World Trade Organisation resisting attempts by the US Japan and some other developed countries to
club counterfeits or copies of patented drugs with fake or spurious ones. More...
Teva shares jump on positive Copaxone patent ruling

(Reuters / By Steven Scheer , 24-Jun-2012 , Business Standard)
Teva Pharmaceutical Industries rose more than 11 percent on Sunday after a U.S. court upheld Tevas
patents for multiple sclerosis drug Copaxone well into 2015. More...
India EU to take stock of proposed free trade pact on Tuesday

(PTI , 24-Jun-2012 , Business Standard)
India and EU are scheduled to take stock of the much delayed negotiations on the proposed free trade
agreement at a meeting here on Tuesday. More...
Apples patent case against Motorola dismissed

A US judge on Friday ruled that Apple cannot pursue an injunction against Googles Motorola Mobility unit
effectively ending a key case for the iPhone maker in the smartphone patent wars. More...
Teva Patents Are Infringed in Sandoz Mylan Patent Suit

(Joel Rosenblatt , 23-Jun-2012 , Bloomberg)
Patent claims that Teva Pharmaceutical Industries Ltd. brought against Novartis AGs Sandoz unit Mylan
Inc. and Momenta Pharmaceuticals Inc. are infringed valid and enforceable a federal judge ruled. More...
Apple filing could delay Kodak patent sale

(Jonathan Stempel REUTERS , 22-Jun-2012 , IBN Live)
Apple Inc on Thursday asked a federal judge to move a lawsuit against it by Eastman Kodak Co to a new
court which could derail the photography pioneers plan to quickly sell a large patent portfolio through
the bankruptcy process. More...
Jay Z in copyright lawsuit

(IANS , 21-Jun-2012 , The Times Of India)
Singer Jay Z has been sued for copyright infringement. More...
Patent war: Apple told to pay damages to Samsung

A Dutch court ordered Apple to pay damages to Samsung Electronics Ltd over a patent violation in the
Netherlands the latest twist in the global legal battle waged by the two rival phone and computer
makers. More...
Microsoft rejects Motorolas patent offer

Microsoft has brushed off an offer by Motorola the phone maker bought by Google to settle patent
disputes with Motorola that are threatening to halt imports of Android devices and Xbox game consoles
into the United States. More...
Big pharma firms may learn to live with compulsory licensing

Taking a cue from India countries have initiated changes in patent laws to lower healthcare costs say
experts. More...
Apple grilled in Google smartphone patent case

A US judge on Wednesday strongly questioned Apples bid for an injunction against Googles Motorola
Mobility unit as the iPhone maker tries to salvage its position on a key front in the smartphone patent
wars. More...
Microsoft demurs at Motorola patent settlement offer

(Reuters , 21-Jun-2012 , NDTV)
Microsoft Corp has brushed off an offer by Motorola the phone maker bought by Google Inc to settle
patent disputes with Motorola that are threatening to halt imports of Android devices and Xbox game
consoles into the United States. More...
Court reserves order against Bhandarkar in copyright case

A Delhi court has reserved its order for June 27 on an authors plea for lodging a first information report
against Bollywood filmmaker Madhur Bhandarkar for copying the plot of his 2008 film Fashion from her
book. More...
Indian drug outlook favourable: ICRA & Moodys

(Ashwin Walunjkar , 20-Jun-2012 , The Economic Times)
Outlook on the Indian pharmaceutical industry remains favourable says ICRA & Moody report released
on Wednesday More...
Patent war: Apple-Google lawsuit hearing to begin today

Apple will try to salvage a high profile lawsuit against Googles Motorola Mobility unit on Wednesday at a
crucial hearing in the smartphone patent wars between the two tech companies. More...
Apple Inc to pay damages to Samsung Electronics over patent violation

(AFP , 20-Jun-2012 , The Economic Times)
A Dutch court ordered Apple Inc to pay damages to Samsung Electronics Co Ltd over a patent violation
in the Netherlands the latest twist in the global legal battle waged by the two rival phone and computer
makers. More...
Kodak sues Apple for interfering in patent sales

Photography pioneer Eastman Kodak sued Apple to stop it from interfering with plans to sell a large
patent portfolio a significant part of its bankruptcy restructuring. More...
Venus Remedies up 38% on winning US patent

(SI Reporter / Mumbai , 19-Jun-2012 , Business Standard)
The company has received patent from the US Patent Office for new antibiotic product CSE 1034 which
targets drug resistant infections. More...
Intel to buy InterDigital patents for $375 million

InterDigital said on Monday it had agreed to sell to Intel about 1700 wireless technology patents for
$375 million sending InterDigital shares up 29 percent. More...
Intel to buy InterDigital patents for $375 million

(Reuters , 19-Jun-2012 , IBN Live)
InterDigital Inc said on Monday it had agreed to sell to Intel Corp about 1,700 wireless technology
patents for $375 million sending InterDigital shares up 27 per cent. More...
We will look at inorganic growth wherever there's a strategic fit

(Sushmi Dey / New Delhi , 18-Jun-2012 , Business Standard)
At a time when most domestic drug companies are looking West in the wake of the number of patents
expiring there Lupin Ltd the Mumbai based transnational drug maker is eyeing a big pie of the Indian
market along with its continued growth strategy in America. More...
Ethnic variety on display

The geographical indication received by the handloom products of Kasaragod Balaramapuram

Chendamangalam and Palakkad have given a boost to the efforts of the institute. More...
Alembic settles patent dispute with Novartis

(BS Reporter / Mumbai/ Ahmedabad , 16-Jun-2012 , Business Standard)
Vadodara based pharmaceuticals products maker Alembic Pharmaceuticals Ltd along with a US based
Breckenridge Pharmaceutical Inc has settled a patent dispute with Novartis AG regarding Rivastigmine
Tartrate Capsules a generic version of Exelon. More...
India, Brazil to set up industry-level working group to sort out hurdles faced by pharma
exporters
(Joseph Alexander, New Delhi , 16-Jun-2012 , Pharmabiz)
Commerce Minister stressed that the provision in TRIPs of invoking the route of compulsory licensing for
making available cheaper drugs though introduced at the behest of developing countries was in fact
used more often by developed countries. More...
Apple Motorola patent lawsuit revived by US judge

A US judge has agreed to hear Apples request for an injunction against the sale of some Motorola
phones giving the iPhone maker a chance to head off a damaging ruling in the smartphone patent wars.
More...
Alembic settles patent case with Novartis for generic capsules

(Press Trust of India , 15-Jun-2012 , Business Line)
Alembic Pharmaceuticals on Friday said it along with US Breckenridge Pharmaceutical Inc has settled
patent case with Novartis for Rivastigmine Tartrate capsules used for treating dementia. More...
India cites WTO accord on drugs patent waiver

India has responded aggressively to protests from developed countries such as the United States over
waiving patent rights on a cancer medicine manufactured by Bayer and Hyderabad based Natco Pharma
to sell the drug at a lower cost. More...
Apple patent bid hints at changeable iPhone lens
(Agence France-Presse , 15-Jun-2012 , NDTV)
A US patent application made public on Thursday hinted that Apple may be toying with the idea of
letting picture loving iPhone users change lenses for the smartphone cameras. More...
Indian drug firms want norms eased in Brazil

The Indian government and pharmaceutical companies have made a strong pitch for easing f norms in
Brazil arguing that they are slow and hamper access to the local market. More...
No WTO violation by issuing licence for Nexavar: Sharma

(Press Trust of India / Sao Paulo , 14-Jun-2012 , Business Standard)
Natco Pharma was allowed to sell the cancer treatment drug at a price 30 times lower than charged by
patent holder Bayer Corp. More...
Apple bid to block Samsung Galaxy SIII in US stalled

(AFP , 14-Jun-2012 , The Economic Times)
Apples effort to stop South Koreas Samsung from launching its newest iPhone challenger in the US has
been derailed by complex maneuvering in the patent war between the companies. More...
China breaks patent barriers on drugs

(Subodh Varma , 14-Jun-2012 , The Times Of India)
In a move full of intriguing possibilities China has changed its patent laws to allow domestic drug makers
to manufacture patent protected drugs in case of state emergencies unusual circumstances or in the
interests of the public. More...
HTC blocked from using Google patents in Apple dispute

(ANI , 13-Jun-2012 , Zee News)
Taiwanese manufacturer of smartphones and tablets HTC has been blocked from using five patents it
secured from Google last year to sue tech giant Apple according to a report. More...
Compulsory pharma licensing, the Indian case of Natco vs Bayer, and the South African
context
(Adams & Adams , 13-Jun-2012 , Biz Community)
Indias controller of patents granted the countrys first compulsory licence in the case of Natco Pharma
Limited vs Bayer Corporation. More...
Indian companies eye $1billion generic opportunity

In the wake of patent expiries on three blockbuster drugs over the last six seven months an opportunity
worth nearly $1.3 billion is up for grabs for domestic generic players. More...
See what is hurting Apple in smartphone wars
Apple has spent nearly three years fighting its rivals in a global smartphone patent war. More...
US firm sues Zydus Cadila subsidary for infringement of patents

(BS Reporter / Mumbai/ Ahmedabad , 12-Jun-2012 , Business Standard)
A complaint for infringement of patents with regard to drug for treatment of acne has been filed against
Zydus Pharmaceuticals USA Inc a fully owned subsidiary of Ahmedabad based pharma major Cadila
Healthcare Ltd in a district court of US. More...
Kodak files for auction of digital imaging patents

Eastman Kodak filed a motion on Monday seeking approval of bidding procedures for bankruptcy auction
of its digital capture and Kodak imaging systems and services patent portfolios which together comprise
more than 1100 patents. More...
Venus Remedies gets US patent for antibiotic product

Drug firm Venus Remedies today said it has received patent from the US Patent Office for new antibiotic
product which targets drug resistant infections. More...
TCS ups patent filing; applies for 460 last year

(T.E. Raja Simhan , 11-Jun-2012 , Business Standard)
Tata Consultancy Services has significantly increased its patent filings in 2011-12. More...
Pharma companies need aggressive R&D and patent filing: Experts

Indian pharmaceutical companies need to go for aggressive research and patent filing like China and
Japan and unless spending on R&D is scaled up it would be difficult to create new molecules industry
experts said. More...
Apples war with Google heats up

(Poornima Gupta , 11-Jun-2012 , Livemint)
When Apple Inc. kicks off its annual conference for software developers on Monday all the power players
in the Apple universe will be on hand save the one that is in many ways driving the agenda: Google Inc.
More...
US body to bring out drug reference standards for biologics

(G. Naga Sridhar , 10-Jun-2012 , Business Line)
The United States Pharmacopeial Convention is working on developing reference standards for biologics
an emerging class of drugs. More...
Copyright amendment: bad, but could have been much worse
(Sunil Abraham , 10-Jun-2012 , Business Standard)
When the Copyright Act 2012 was passed unanimously by the Lok Sabha on May 22 it meant that there
was little reason for celebration some not so great news and a lot of pretty bad news. More...
Action on Nexavar does not violate any treaty: Anand Sharma

India on Friday said it had not violated any multi-lateral trade agreement by issuing compulsory licence
for patented anti cancer drug Nexavar to be produced and sold at a much cheaper cost in the country.
More...
Animal health product: Cipla looking at appeal options against US court order
Cipla is examining options of appealing against a US Federal Circuit order in a patent infringement case
involving the sale of an animal health product. More...
Cipla losses appeal in US court for animal healthcare product

(Reuters , 8-Jun-2012 , Business Standard)
Drugmaker Cipla said on Thursday a US appeals court had upheld a district courts ruling which last year
declared a patent infringement by Cipla over animal healthcare drug PetArmor Plus. More...
Apple may block Samsung Galaxy SIII sales in US

Samsung attorney William Price also said the technology covered by Apples patents such as auto
correcting typed text are not responsible for sales of Galaxy phones. More...
US judge cancels Apple-Google phone patent trial

(Reuters , 08-Jun-2012 , The Economic Times)
A federal judge canceled a scheduled June 11 trial between Apple Inc and Google Incs Motorola Mobility
unit over patents related to mobile phones and tablet computers and expects to dismiss the case
because neither can prove damages. More...
GSK Pharmas pricing strategy may not extend to alliance products

(BUSINESS LINE , 08-Jun-2012 , Myiris)
Two years ago British drug-maker GlaxoSmithKlins Chief Executive Andrew Witty had told an Indian
audience in Nashik the company would pursue customised pricing of its medicines in middle and low
income countries. More...
China amends patent law in fight for cheaper drugs

(Tan Ee Lyn in Hong Kong and Beijing, Ben Hirschler in London , 08-Jun-2012 , CNBC)
China has overhauled parts of its intellectual property laws to allow its drugmakers to make cheap
copies of medicines still under patent protection in a move likely to unnerve foreign pharmaceutical
companies. More...
Dr. Reddys inks drug deal with Merck Serono
(Viswanath Pilla , 7-Jun-2012 , Livemint)
Merck will handle commercialisation in most parts of the world and will pay Dr. Reddy’s royalties More...
Column: Relevance of changes in Indian copyright law

(Pavan Duggal / New Delhi , 06-Jun-2012 , Business Standard)
Copyright (Amendment) Bill 2010 seeks to provide lyricists & artists a level playing field with respect to
music companies and producers. More...
Pfizer job cuts highlight Irish exposure to patent expiries

(Conor Humphries , 06-Jun-2012 , Reuters)
Pfizer Inc will cut 177 jobs in Ireland following the expiration of patents on blockbuster cholesterol drug
Lipitor highlighting the exposure of Irelands export driven economy to the patent cliff facing many in the
pharmaceutical sector. More...
EMC will file 100 patents from India by next year

(Beryl Menezes , 6-Jun-2012 , DNA)
EMC a global IT storage solutions provider is betting big on the Indian data market and has invested $2
billion in the six years of its operations in the country which is the largest investment by an IT multi
national company in India. More...
A mission to defend traditional knowledge

(Sidhartha , 5-Jun-2012 , The Time Of India)
In a few weeks negotiators from the group of like minded countries such as India Columbia Peru and
New Zealand will converge on Bali to decide on what traditional knowledge is. More...
Domestic pharma industry: Emerging growth avenues

The domestic pharma industry may maintain a strong growth momentum spurred by patent expiries of
blockbuster drugs emerging licensing deals and increasing generic penetration in regulated markets over
the next two three years. More...
In search of the right drug pricing formula

(NALINAKANTHI V. , 04-Jun-2012 , Business Line)
The government can make drugs affordable to all without forcing the pharma companies to compromise
either on quality or their profitability. More...
WHO will set generics apart from counterfeits

(Vineeta Pandey , 04-Jun-2012 , DNA)
World Health Organisation has adopted a resolution to clearly define counterfeit medical products so as
to set them apart from genuine generic drugs. More...
Is Sun Pharma getting back on the acquisition track?
(Mark to Market | Ravi Ananthanarayanan , 04-Jun-2012 , Livemint)
If Sun Pharmas base business gets a boost from successful patent challenges and litigation that would
be a plus. More...
Updating our copyright laws

Public discourse on the omnibus copyright law changes approved by Parliament last month has largely
focused on the controversy in the film industry over the provision that gives music composers and
lyricists the right to claim royalties if their music is used in any other form a ring tone for example apart
from the film for which the composition was made and sold. More...
Cisco sues TiVo over DVRs

Cisco Systems Inc has filed a lawsuit to void four TiVo Inc patents related to digital video recorders
escalating a battle over who has the right to profit from sales of the popular machines. More...
Judge won't bar Steve Jobs quotes from patent trial

(Dan Levine SAN FRANCISCO (Reuters) , 2-Jun-2012 , IBN Live)
Steve Jobs gave a lot of juicy quotes before he died and Apple Inc has failed to keep some of them out
of an upcoming patent trial against Googles Motorola Mobility unit according to a court ruling. More...
Steve Jobs quotes set to feature in Apple-Motorola patent trial

Steve Jobs gave a lot of juicy quotes before he died and Apple Inc has failed to keep some of them out
of an upcoming patent trial against Googles Motorola Mobility unit according to a court ruling. More...
Nokia hits back at Google in latest patent war tussle

Nokia struck back at Google on Friday over its accusation that the cellphone maker was colluding with
Microsoft to make money out of their patents. More...
Patents: A prize for inventors will help

(S.MURLIDHARAN , 01-Jun-2012 , Business Line)
A potentially game changing idea is that if an inventor is rewarded with a huge cash award upfront in
exchange for his invention becoming available immediately for public use unseemly patent battles waged
across continents will be a thing of past. More...
Nokia: Android phones have major patent issues

(Reuters , 01-Jun-2012 , The Times of India)
Nokia struck back at Google over its accusation that the cellphone maker was colluding with Microsoft to
make money out of their patents. More...
Google files patent claim against Microsoft Nokia
(AP , 01-Jun-2012 , Hindustan Times)
Google Inc on Thursday accused Microsoft Corp and Nokia of conspiring to use their patents against
smartphone industry rivals and said it has filed a formal complaint with the European Commission.
More...
Patent wars: French co Technicolor dissects smartphones

(Bloomberg , 31-May-2012 , The Times Of India)
When Apples next iPhone hits store shelves Technicolor SAs engineers will rush to get the handset not to
make calls or play games but to rip it apart. More...
Apple-Samsung trials seen solving copycat spat CEOs couldn’t

Apple and Samsung Electronics the worlds top two smartphone makers are heading to trials that may
resolve global patent disputes their chief executive officers couldnt settle on their own. More...
How P H Kurien took on global patents system to make very costly drug affordable for poor
(Arvind Panagariya , 30-May-2012 , The Economic Times)
It is said that only God and a few good men and women run India. More...
HTC phones pass US customs review

Earlier in May HTC had said that US sales of two new smartphones the HTC One X and HTC EVO 4G LTE
would be delayed due to a requirement for customs inspections after the Taiwanese company lost a
patent dispute with Apple. More...
Technicolor dissects iPhones in hunt for patent payoff

(Bloomberg / Paris , 30-May-2012 , Business Standard)
When Apple Incs next iPhone hits store shelves Technicolors engineers will rush to get the handset not
to make calls or play games but to rip it apart. More...
Patent law together with IPR imperative for a democratic market based society
(29-May-2012 , IRIS)
A patent law along with an intellectual property law in various categories of copyright trademark right of
publicity and others are imperative for shaping an open democratic and market based society corporate
affairs minister Dr M Veerappa Moily said while highlighting the importance of a patent system in a
democracy at an Assocham event held here in New Delhi today. More...
Teva Pharmaceuticals not to launch Atorvastatin, generic version of Lipitor

(Khomba Singh , 29-May-2012 , The Economic Times)
Israels Teva Pharmaceuticals will not launch atorvastatin the generic version of the worlds best selling
drug Lipitor that will help Indian companies Ranbaxy Laboratories and Dr Reddys Laboratories garner
larger sales of the medicine in the US. More...
Ranbaxy gets US nod for acne treatment
(Reuters / Mumbai , 29-May-2012 , Business Standard)
The product was jointly developed by Canadian group Cipher Pharmaceuticals and Galephar
Pharmaceutical Research while Ranbaxy holds the US marketing rights. More...
Prize funds: These alternatives to patents might be the way forward to cheaper healthcare
Nobel laureate Joseph Stiglitz advocates a shift from the patents regime to a prize based system for new
drugs. More...
US FDA may impose huge drug user fee on generic imports soon, India to hit badly
(Suja Nair Shirodkar, Mumbai , 28-May-2012 , Pharmabiz)
The US FDA may introduce a Generic Drug User Fee Act soon to curb import of cheap generic drugs into
that country. More...
Proposal to give patent to 'Jugaad' technology on back-burner

Apprehending claims of innovation in frivolous products the government has put on the back burner the
proposal of granting patents to home grown products and technology known as Jugaad. More...
Motorola devices infringe on Microsoft patent: Court

A German regional court ruled in a hearing on Thursday that Motorola Mobility infringed Microsoft
patents by offering the option on its mobile phones to send a longer text in a batch of several messages.
More...
Motorola devices infringe on Microsoft patent: Court

A German regional court ruled in a hearing on Thursday that Motorola Mobility infringed Microsoft
patents by offering the option on its mobile phones to send a longer text in a batch of several messages.
More...
Huawei seeks EU action against InterDigital patent fees

Huawei has called for EU antitrust regulators to intervene in a dispute with InterDigital saying the firm is
demanding exploitative fees for use of its 3G mobile phone patents. More...
Apple-Samsung talks fail

Two days of court directed peace talks between the chiefs of iPhone maker Apple and smartphone giant
Samsung ended with no sign of a truce in the legal battle headed for court in Silicon Valley. More...
Google didn’t infringe Oracle patents: Judge
Google the largest Web search provider didnt infringe Oracles patents in developing Android software a
federal jury found in the second phase of an intellectual property trial in San Francisco. More...
No truce in Apple-Samsung patent war

Two days of court directed peace talks between the chiefs of iPhone maker Apple and smartphone giant
Samsung ended with no sign of a truce in the legal battle headed for court in Silicon Valley. More...
Loopholes in pharma pricing policy

(S. Srinivasan , 24-May-2012 , Business Line)
The list of price-controlled drugs is narrow in scope. More...
Copyrights and wrongs

(M J Antony / New Delhi , 23-May-2012 , Business Standard)
The Supreme Court denies the Copyright Board the power to grant temporary licences More...
Kodak patent deemed invalid in fight with Apple: RIM

(AFP , 22-May-2012 , The Times of India)
A US judge on Monday said a Kodak patent allegedly infringed upon by Apple and Blackberry-maker
Research In Motion (RIM) was not valid, dealing another blow to the struggling photography pioneer.
More...
Bollywood cheers as Lok Sabha passes copyright bill

(Team DNA , 23-May-2012 , DNA)
On the last day of the budget session the UPA government quickly pushed through a few important
social sector Bills including the Copyright Act 2012. More...
Suven Life Sciences gets four patent approvals

(Press Trust of India / New Delhi , 22-May-2012 , Business Standard)
The company has received the approval for molecules which could be used in the treatment of CNS
disorders like Parkinson Alzheimers disease and Schizophrenia. More...
Judge directs truce talks in Apple-Samsung patent fight

The chiefs of iPhone maker Apple and smartphone giant Samsung were to be in patent war truce talks
on Monday at the direction of a judge who asked them sidestep a court battle. More...
Venus Remedies gets patent in South Africa for antibiotic

Venus Remedies today said it has received patent approval in South Africa for an antibiotic combination
to be used for treating bacterial infections. More...
Copyright Amendments: Rendering justice after decades of denial

Broadcasters have welcomed the proposed amendments to the Copyright Act of 1957 pointing out that
this would have a far reaching impact in curbing exploitative practices by the owners of sound
recordings for decades against both artistes and broadcasters. More...
Intellectual Property Appellate Board rules Ayur can’t be trademark

(R. Sivaraman , 22-May-2012 , Business Line)
Can anyone in India the home of Ayurveda claim exclusive intellectual property rights over the word
Ayur for selling a product? Or contend that Ayur a word derived from Ayush is an invented word that can
be used as a trade mark? More...
Patent ruling casts shadow over Kodak

(Richard Waters in San Francisco , 22-May-2012 , The Financial Times)
Eastman Kodak has lost a preliminary ruling in a key patent infringement case against Apple and
Research In Motion casting a cloud over an upcoming patent auction that will help to determine whether
it can emerge intact from bankruptcy. More...
Should drug prices be regulated?

(Patralekha Chatterjee , 21-May-2012 , DNA)
That is good news for those of us who pay for medicines out of our pocket. More...
Indias drug regulation overdose

(The WALL STREET JOURNAL , 21-May-2012 , Livemint)
As a rule India does not allow products to be registered quickly even if they are approved by stringent
foreign agencies such as the US Food and Drug Administration. More...
Glenmarks different route to US drug market

(Sushmi Dey / New Delhi , 21-May-2012 , Business Standard)
At a time when most Indian drug makers are launching generics to monetise patent expiries in the US
Glenmark has chosen to walk a road less travelled. More...
Samsung chief sees settlement with Apple

The chief executives of Apple Inc and Samsung Electronics Ltd are used to running the show at their
global tech empires but they will be in for a different experience when they arrive at a San Francisco
federal courthouse on Monday. More...
Copyright Bill likely to be tabled in Lok Sabha today

(NDTV Correspondent with PTI inputs , 21-May-2012 , NDTV)
The much-delayed Copyright Bill providing for certain important amendments to the Copyright Act is
expected to be tabled in the Lok Sabha today. More...
Google-Motorola deal gets nod in China

Google on Saturday said that Chinese regulators approved its $12.5 billion deal to buy Motorola Mobility
clearing the path for the internet titan to complete the acquisition early next week. More...
Taking copyright law a step too far?

(Karunya Keshav , 20-May-2012 , The Hindu)
Theres confusion as Internet service providers block access to legitimate websites More...
Bayer demands withdrawal of Natco Pharma's compulsory licence

German drugmaker Bayer AG has demanded the withdrawal of the countrys first compulsory licence
given to Natco Pharma arguing that a three-fourth reduction in the price of the anti-cancer drug by
another Indian firm has made the permit redundant and its patent itself is vulnerable to being revoked.
More...
DRL launches Plavix copy in US with exclusivity

DRL will sell the larger dose of the drug known as clopidogrel by its generic name in the US market from
Friday More...
US says will bar some Motorola Mobility phones

Some Motorola Mobility smartphones infringe on a Microsoft patent and will be barred from importation
in to the United States a US trade panel said on Friday. More...
Rajya Sabha nod for Copyright Amendment Bill

The Rajya Sabha on Thursday approved the Copyright Amendment Bill which seeks to remove
operational difficulties and address newer issues related to the digital world and worldwide web. More...
We are focused on drug discovery: Ajay Piramal

(Piyush Pandey , 18-May-2012 , The Times Of India)
Piramal Healthcare chairman Ajay Piramal on Wednesday announced the acquisition of US healthcare
data services firm Decision Resources Group for $653 million. More...
Ind Swift Wockhardt launch Atorvastatin tablets in UK

Drug firm Ind-Swift Laboratories today said it has launched generic formulations of the worlds best
selling drug Atorvastatin in the UK in collaboration with Wockhardt UK on the first day of its patent
expiry. More...
HTC Corp sales delayed due to patent dispute

(Reuters , 16-May-2012 , Hindustan Times)
U.S. sales of two new smartphones from Taiwans HTC Corp will be delayed due to a patent dispute with
Apple Inc a fresh blow to the company as it tries to turn around declining sales in what was once its
largest market. More...
India and China to be a popular outsourcing destinations of choice for CMOs: GBI Research
report
Furthermore the introduction of the new patent regime in India during January 2005 encouraged
multinational pharmaceutical companies looking to outsource their manufacturing of branded drugs with
the protection of Intellectual Property Rights. More...
Oracle patent claims vs. Google sent to jury

(Reuters , 16-May-2012 , IBN Live)
A California jury began another round of deliberations on Tuesday in a high profile trial over allegations
that Googles Android mobile platform violates Oracles intellectual property rights. More...
Kodak seeks expressions of interest for patents

(Bloomberg , 15-May-2012 , The Times of India)
Eastman Kodak the photography pioneer that filed for bankruptcy in January is seeking expressions of
interest in its digital imaging patents by today the first step in an auction of the technology. More...
Apple wins review of tablet patent in Samsung dispute

(Bloomberg, / Washington , 15-May-2012 , Business Standard)
Apple Incmaker of the iPhone and iPad can pursue efforts to win a sales halt of Samsung Electronics Cos
Galaxy Tab 10.1 tablet computer in the US while a patent infringement case is pending a US appeals
court ruled. More...
Protests in US over high pricing of Novartis anti-cancer drug Glivec

(Divya Rajagopal , 15-May-2012 , The Economic Times)
Health activists and cancer patients in the US have pounced on Swiss drug multinational Novartis for the
high price of its famous multi billion dollar anti cancer drug Glivec a development which challenges
pharma MNCs claims of cheap access and affordability for patented drugs. More...
Apple granted patent for iOS steering-wheel remote

(Joe Aimonetti , 15-May-2012 , CNET)
According to a recent patent grant Apple has been interested in solving an awkward issue faced by many
drivers using their iOS devices in their cars. More...
As China opens to basmati imports exporters scout for interpreters

(Sanjay Sharma , 15-May-2012 , The Times Of India)
Rice exporters in Karnal the hub of basmati rice exporters in Haryana are looking for Chinese language
interpreters to explore possibilities of starting exports to China. More...
Too vague patents created the monster

(Mr Joshua Shapiro , 15-May-2012 , The Financial Times)
Sir Global enterprises themselves have created the mess that you detail in “The curse of innovation” by
Richard Waters. More...
Novartis Sues Lupin Torrent Over Blood-Pressure Medicine

(Phil Milford and Sophia Pearson , 15-May-2012 , Bloomberg)
Novartis AG sued Lupin Ltd. and Torrent Pharmaceuticals Ltd. for infringing patents on its Exforge HCT
blood pressure medicine. More...
Over 1 lakh requests pending with patent offices

The government today said more than one lakh patent applications are pending with the Controller
General of Patents Designs and Trade Marks. More...
Good that copyright bill being taken up in Parliament: Akhtar

(PTI , 14-May-2012 , IBN Live)
Veteran lyricist Javed Akhtar says he is happy that the copyright bill of which he has been a strong
advocate has received the governments nod and hopes it will be passed by Parliament soon. More...
Pharma Inc GoM meet to tackle thorny pricing

(Soma Das, MG Arun , 14-May-2012 , The Financial Express)
The meeting assumes significance in the light of the ongoing debate on the high prices of certain
medicines leading to the patent office recently resorting to compulsory licensing a governmental
intervention that allowed domestic drug maker Natco offer a cancer drug at a fraction of the original cost
charged by the innovator Germanys Bayer. More...
India US see differences widen over trade diplomatic issues

(Asit Ranjan Mishra & Elizabeth Roche , 14-May-2012 , Livemint)
India US see differences widen over trade diplomatic issues More...
Ailing Nokia falls back on patents legacy

Desperate for cash to tide it over until sales ramp up of new products Nokia Oyj NOKIV. More...
Biotech body criticises Bayer on cancer drug

The All India Biotech Association Southern Chapter has come out strongly in favour of the Indian Patents
Office order in favour of Natco Pharma Ltd. More...
Saregama Balaji Telefilms spar over The Dirty Picture track

(Arnab Dutta , 12-May-2012 , Livemint)
The question on infringement of IPRs though hasnt yet been answered the appeals courts order from 24
April was only an interim measure to protect the interests of the firm claiming damages. More...
Compulsory licencing of Bayers cancer drug is a triumph

(Dinesh Narayanan, Forbes India , 12-May-2012 , IBN Live)
The third one is the health systems agenda and the changes that are required particularly the universal
healthcare agenda that is currently being debated. More...
Quo Vadis, Indian Pharma?

(RAMESH ADIGE FORMER PHARMA EXECUTIVE , 11-May-2012 , The Economic Times)
The government needs to think out of the box to help pharma grow while keeping medicines affordable
More...
Import of patented goods without IPR authorisation allowed

Imports of goods protected by patent or trademarks are permitted even without authorisation of the
Intellectual Property Rights holder according to the Finance Ministry. More...
Abraham Lincoln tried to patent Facebook-like idea

(ANI , 10-May-2012 , The Times Of India)
In 1845 Abraham Lincoln had tried to patent an idea very similar to Facebook it has been revealed.
More...
Cipla breached patent rights by slashing cancer drug price: Bayer

German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent
rights by slashing the price of a generic version of its patent protected cancer drug Nexavar last week.
More...
Ranbaxy needs to strengthen base business for double-digit growth

Sales from Lipitor generic Atoravastatin helped Ranbaxy to post a stellar performance in the March
quarter. More...
AOL revenues beat forecast

AOL Inc reported better-than-expected quarterly results and said it intends to hand over to shareholders
100 per cent of the proceeds from its patent sales to Microsoft. More...
Lipitor clone delivers for Ranbaxy
(Priyanka Golikeri , 10-May-2012 , DNA)
The generic version of Lipitor atorvastatin the top selling anti cholesterol drug whose global sales once
peaked at $13 billion is turning out to be a money spinner for Ranbaxy in the US. More...
Ranbaxy appears to be making progress, margins likely to rise

(Mark to Market | Mobis Philipose , 10-May-2012 , Livemint)
Reported revenue and profit were higher than Street estimates aided largely by sales of generic Lipitor
More...
Cancer drugs still way too costly

(P.T. JYOTHI DATTA , 10-May-2012 , Business Line)
At Rs 7000-8000 a month after compulsory licence cancer medicines are still very expensive for ordinary
Indians. More...
ACTA as the villain

(T S Vishwanath , 10-May-2012 , Business Standard)
The Anti-Counterfeiting Trade Agreement is finding more detractors than supporters More...
Ranbaxy net jumps on generic Lipitor

(Kaustubh Kulkarni/Reuters , 10-May-2012 , Livemint)
The sales in the north American market more than doubled to Rs. 2093 crore in the period the first full
quarter of sales of its copycat version of blockbuster Lipitor. More...
Patented drugs: No application pending for compulsory license, says government

Amid concerns that more domestic pharma companies could seek compulsory licenses to replicate
patented drugs the government said no such application is pending for approval. More...
India protests USs move to put it on IP rights watch list

(Asit Ranjan Mishra & Vidya Krishnan , 09-May-2012 , Livemint)
The government strongly objected to the US placing India on a priority watch list in its latest trade
representatives report which raises concerns over the countrys enforcement of IP rights. More...
Health panel rap to drug regulator, boost for consumers

(P.T. Jyothi Datta , 9-May-2012 , Business Line)
On an average DCGI is approving one drug every month without trials. More...
Compulsory licensing sets off a wave of price cuts in cancer drugs

In 2010 about 600000 people in the country died of cancer according to a recent joint study by the Tata
Memorial Hospital and the Centre for Global Health Research More...
Google’s Android Infringed Oracle’s Java, Jury Says

(Karen Gullo , 8-May-2012 , Bloomberg)
A federal judge said Oracle Corp. cant seek $1 billion in damages from Google Inc. More...
Inspiration not copying

(KV Lakshmana , 8-May-2012 , Hindustan Times)
Copying is our birthright can well be our motto given how people from all walks of life are getting
inspired by others. More...
Abbott to Pay $1.6 Billion to Settle Depakote Drug Allegations

(Jef Feeley and Margaret Cronin Fisk , 8-May-2012 , Bloomberg)
Abbott Laboratories said it reached an agreement to pay $1.6 billion to settle federal and state claims
resulting from an investigation into its epilepsy medication Depakote the second largest drug marketing
settlement in U.S. history. More...
India has stable IPR regime: Sharma tells U.S.

(Sandeep Dikshit , 8-May-2012 , The Hindu)
Opposes decision to put India on watch list More...
GSK not under compulsion to buy Indian companies: Hasit Joshipura

Global pharma companies have been aggressively looking to buy Indian firms to mitigate revenue loss
due to patent expiry of their top selling brands and also tap the fast growing Indian drug market. More...
Cipla eyes price cuts on more cancer drugs

(Kaustubh Kulkarni and Tony Munroe , 8-May-2012 , Reuters)
Cipla which is engaged in several long-running legal battles with foreign drugmakers will mount a
challenge to a rivals patent only if it believes its chances of winning are at least 75 percent Hamied said.
More...
Biocon-Mylan partnership has a potential of $33 billion from biosimilar drugs

(Divya Rajagopal , 8-May-2012 , The Economic Times)
Biocon will also have to face Roche pharma which has the patent for this drug and recently it tied up
with Pune based Emcure to sell cheaper and locally branded versions. More...
Sorafenib: A tale of moves and counter-moves

Three drug companies and three prices on their respective versions of Sorafenib a medicine used to
treat advanced kidney cancer. More...
Google infringed Oracle Java copyrights - jury
(Reuters Malathi Nayak SAN FRANCISCO , 8-May-2012 , IBN Live)
Inc infringed some of Oracle Corps copyrights on the Java programming language a U.S. jury found on
Monday after days of deliberation. More...
Extend drug patent life to rejuvenate R&D

(Mr Dale A. Frost , 8-May-2012 , Financial Times)
Furthermore it fails to acknowledge the primary problem which is not money. More...
Bayer challenges Nexavar generic licence order

Drugmaker Bayer has filed an appeal against an Indian Patents Offices order which allowed domestic
drug maker Natco Pharma to sell a generic version of the German firms cancer drug Nexavar in India
with the Intellectual Property Appellate Board. More...
Satyamev Jayate in copyright trouble with Euphoria

(IANS , 07-May-2012 , DNA)
Aamir Khans show Satyamev Jayate which has garnered a positive response from TV viewers has got
stuck in a copyright issue filed against Ram Sampath the music composer of the title track by Palash
Sen the lead singer of Euphoria. More...
Indias patent protection regime to be key issue in talks with US

(Vidya Krishnan , 07-May-2012 , Livemint)
Next months dialogue takes place ahead of a hearing in SC on an appeal by Novartis seeking an
extension of its patent on Glivec More...
Patently right
(Business Standard / New Delhi , 07-May-2012 , Business Standard)
Apropos the article The myth of coalition compulsions it is misleading of Ravi Shanker Kapoor to say
compulsory licensing for pharmaceutical products is restrictive. More...
The man who made cancer drugs affordable and made millions
(Patralekha Chatterjee , 07-May-2012 , DNA)
Big Pharma accuses him of exploiting others intellectual property to swell his own coffers undermining
investment in drugs of the future. More...
Apple wins ruling sanctions in Samsung suit

(Bloomberg , 07-May-2012 , Business Standard)
After the Indian government recently lifted a patent license Indian pharma major Cipla has announced a
massive reduction of up to 76 per cent in its cancer drug prices. More...
Infosys patent filings up 50% in FY 2012
(Venkatesh Ganesh , 6-May-2012 , Business Line)
Infosys has increased its patent filings by 50 per cent over FY11. More...
US to keep an eye on Indias compulsory drug licensing move

(Joe C Mathew / New Delhi , 6-May-2012 , Business Standard)
Puts India on priority watch list which means US trade body doubts India over intellectual property
rights More...
Cipla may cut prices of other cancer drugs too

Domestic pharma major Cipla may extend its affordable and humanitarian pricing strategy on other anti
cancer drugs in its portfolio even as domestic generic companies are still trying to grapple with the huge
cuts and evaluate their pricing options. More...
Bayer appeals against compulsory licence order

German drug maker Bayer HealthCare AG has appealed against the compulsory licence granted to Natco
Pharma Ltd to manufacture and market cancer drug Nexavar by Indias Controller General of Patents.
More...
Desi companies dominate US generic space

India is playing a dominant role in the US generic pharma space having cornered over half the certified
dossiers filed globally for active pharmaceutical ingredients. More...
Cipla slashes generic price of Bayers cancer drug Nexavar

Separately Cipla is fighting a patent infringement suit by Bayer over generic Nexavar in an Indian court.
More...
Nokia files patent suit against RIM HTC and Viewsonic

(PTI , 3-May-2012 , ZeeNews)
Finnish telecom giant Nokia has filed a suit against Blackberry maker RIM HTC Corp and Viewsonic Corp
in the US and Germany alleging infringement of its patents by these companies. More...
L&T filed 162 patent applications for its electrical and automation products in 2011-12
(Rachita Prasad , 02-May-2012 , The Economic Times)
Larsen & Toubro filed 162 patent applications for its electrical and automation products during 2011 12
the 11.7 billion engineering and construction conglomerate said Wednesday More...
Pfizer profits solid despite Lipitor loss
(Ransdell Pierson , 2-May-2012 , Livemint)
Pfizer Inc. reported higher than expected quarterly earnings as improved profit margins and strong sales
of its Lyrica nerve-pain drug partly offset plunging demand for its Lipitor cholesterol fighter now facing
cheaper generic rivals. More...
India needs to do more on IPR: US govt report

(HT Correspondent , 2-May-2012 , Hindustan Times)
The United States on Monday said that though India has acted against movie and music piracy it needs
to do more on protection and enforcement of intellectual property rights. More...
Intellectual Property Magic of value creation

(MADHU SOODAN POUDYAL , 01-May-2012 , The Himalayan)
The World Intellectual Property day was observed this year with the slogan Visionary innovators. More...
Misinformed campaign against Glivec

(RANJIT SHAHANI , 01-May-2012 , Business Line)
More than ten years have passed since Digamber Bhalerao walked into my office with his wife looking for
Novartis to support his drug treatment for his CML. More...
US puts India China Pakistan on IPR watch list

The US Government has put India China and Pakistan along with 10 other countries on the intellectual
property watch list for failing to prevent the theft of copyrighted property. More...
In patent wars Apple prefers to settle versus battle

(Bloomberg , 28-Apr-2012 , The Times Of India)
Apple CEO Tim Cook was asked on yesterdays earnings call whether it would be in the companys best
interests to clear the decks of all its various patent suits. More...
Yahoo escalates patent battle with Facebook

(AP , 28-Apr-2012 , Hindustan Times)
Yahoo is bringing out more artillery in its patent battle with Facebook. More...
Indian cheap anti cancer drug gives hope

(Amarnath K. Menon, India Today , 27-Apr-2012 , MSN)
It is the first case of grant of cl in the past seven years since the amended Patents Act came into effect.
More...
Patent laws, IPR should be taken to traditional sectors too

(Staff Reporter , 27-Apr-2012 , Business Line)
The scope and significance of intellectual property rights and patent laws should be taken to and
promoted among the under privileged sections apart from ensuring their application in traditional
systems V.N. Rajasekhara Pillai Principal Secretary has said. More...
Tata Steel plans to license patents to other steel firms

(Aveek Datta , 27-Apr-2012 , Livemint)
The company plans to commercially exploit a few of its over 1200 patents in India and abroad by
licensing them out to other steel manufacturers More...
Patients before patents in healthcare

(P.T. JYOTHI DATTA , 27-Apr-2012 , Business Line)
Close on the heels of the Indian Patent Office issuing a compulsory licence to Natco the Kenyan High
Court ruling on the countrys anti counterfeit law has said that the citizens right to health is supreme.
More...
Affordable health to weigh in health patent regime: Govt

The international IP regime that exists today provides enough flexibility to model a domestic legal
framework to the local conditions that exist within a country says secretary in DIPP Saurabh Chandra
More...
India to have national intellectual property rights strategy

(IANS , 26-Apr-2012 , The Economic Times)
The Indian government has set up a sectoral council to prepare national intellectual property rights
strategy with a view to incentivise innovation a senior official said Thursday. More...
Efforts on for five more Geographical Indication tags for region

(Rajeev Dikshit , 26-Apr-2012 , The Times of India)
Now, five more handicraft items of the region are in the quest for the Geographical Indication. More...
Nokia HTC win European patent ruling

(Bureau Report , 26-Apr-2012 , Zee News)
Helsinki: Finlands Nokia and Taiwans HTC won a key European ruling that a patent of German firm
IPCom which was threatening sales of their phones in Germany was invalid in its current form. More...
Apples iPhone iPad infringes Motorola patents

(Reuters , 25-Apr-2012 , The Times of India)
Apple Inc infringed on a Motorola Mobility Holdings Inc patent in making its popular iPhones iPads and
other products a judge for the International Trade Commission ruled on Tuesday. More...
Microsoft Xbox infringes Motorola patent

Microsoft infringed Motorola Mobilitys patents in making its popular Xbox gaming consoles a judge for
the US International Trade Commission ruled. More...
Facebook pays Microsoft $550 mln for AOL patents
(Reuters , 24-Apr-2012 , IBN Live)
Facebook will pay Microsoft Corp $550 million for hundreds of patents that originated with AOL beefing
up its intellectual property arsenal. More...
Dont shut door on cheap drugs

(P. Bhaskara Narayana , 23-Apr-2012 , Business Line)
Even with patent laws the Government can permit marketing of generics so that patients benefit from
cheaper costs. More...
Future of Indian pharma lies beyond generics

(Ajay Dsouza , 22-Apr-2012 , The Hindu)
The Indian pharmaceutical industrys emergence on the global landscape as a strong generics player was
due in no small measure, to the Indian Patents Act 1970 which allowed only process patents in
pharmaceutical products. More...
Nokia loses IPCom patent case in German court

(Reuters , 21-Apr-2012 , Hindustan Times)
Nokia lost a court case on Friday after a regional court in Mannheim Germany found the Finnish mobile
phone company had violated patents belonging to German patent firm IPCom. More...
AOL patents: Facebook lost to Microsoft on price

(Bloomberg , 20-Apr-2012 , The Economic Times)
Facebook Inc the biggest social networking service made an offer for AOL Incs patent portfolio before
losing out to Microsoft Corps $1.06 billion bid two people with knowledge of the matter said. More...
Nokia loses wireless patent ruling

(Bloomberg , 20-Apr-2012 , The Times of India)
Nokia Oyj lost a ruling in a German court today in a patent lawsuit brought by IPCom GmbH & Co.
More...
MNC drug brands show healthy growth trend in India market

(Joe C Mathew / New Delhi , 20-Apr-2012 , Business standard)
Incidentally Januvia enjoys a product patent and hence has no generic competition in India. More...
Twitter gives peace a chance in patent wars

All we are tweeting is give peace a chance. More...
Nestle wins Nespresso patent battle

Nestle has won a case against rivals including Sara Lee at the European Patent Office concerning its fast
growing Nespresso coffee machines and capsules. More...
IITs start filing patents to safeguard technical innovations

IITs have now started filing patents to safeguard their technological innovations which previously were
published as research and development papers. More...
Sun Pharmaceutical Industries gets favourable US Supreme Court verdict in patent case
Sun Pharmaceutical Industries today said the US Supreme Court has given a favourable verdict in its
patent case against Novo Nordisk over generic Prandin tablets used for treating diabetes. More...
Twitter to limit use of patents in lawsuits

(Reuters , 18-Apr-2012 , IBN Live)
Twitter said on Tuesday that it would structure its patents so they could not be used for offensive
litigation purposes without permission from the people who developed them. More...
Apple and Samsung chiefs to meet to sort patent dispute

(18-Apr-2012 , BBC News)
The chiefs of Apple and Samsung have agreed to meet in a bid to resolve a patent case between the two
in a California court. More...
US top court rules for Sun Pharma unit on patent

The U.S. Supreme Court ruled on Tuesday in favor of a generic drugmaker in a case over how
companies can fight brand-name rivals in an effort to get their cheaper medicines to market. More...
Caraco can sue Novo Nordisk to narrow drug description: US Supreme Court
The US Supreme Court ruled on Tuesday in favor of Caraco a unit of Sun Pharmaceuticals an Indian
generic drugmaker in a case over how companies can fight brand name rivals in an effort to get their
cheaper medicines to market. More...
Drug makers will post 15-34% growth in Q4 revenue, say analysts

(Namrata Nandakumar & C.H. Unnikrishnan , 17-Apr-2012 , Livemint)
Indias drugs sector is heading into a year of fewer patent expiries critical for an industry that thrives on
selling copies of successful medicines but is set to end the previous fiscal year with a strong showing in
the final quarter supported by growth in the domestic market and a favourable rupee movement. More...
Oracle says Googles own emails show its guilt

An Oracle attorney cited emails between top executives at Google as prime evidence that Google took its
intellectual property to gain an edge in the lucrative smartphone market, at the start of a high stakes
trial between the two tech giants. More...
Motorola wins patent war against Apple

A German court on Friday upheld a ban on push emails in Apples iCloud and MobileMe services in
Germany ruling in favor of rival Motorola Mobility. More...
Lenovo, ZTE, Huawei warned of patent disputes in phone market

(IANS , 16-Apr-2012 , The Times Of India)
Chinas smartphone companies are at risk of becoming embroiled in disputes over intellectual property
rights since many important patents are held by international companies like Google and Microsoft
experts have said. More...
Indian competition regulator likely to take hands-off approach to pharma

(Freny Patel , 16-Apr-2012 , Financial Times)
Pharmaceutical acquisitions where there is overseas investment have come under regulatory scrutiny in
India recently to ensure that the existing price control regime is maintained. More...
Ajay Piramal set to buy European drug firm to conduct basic phrmaceutical research
Indian drug companies have now started investing in basic drug research after years of spending money
on a business model which copied patented drugs and relied on litigation and aggressive marketing to
push the product after patent expiry. More...
Chinas smartphone firms warned of patent disputes

(IANS , 15-Apr-2012 , IBN Live)
Chinas smartphone companies are at risk of becoming embroiled in disputes over intellectual property
rights since many important patents are held by international companies like Google and Microsoft
experts have said. More...
Gujaratis patent to rein in blue chip majors

(Bhavesh Shah , 14-Apr-2012 , DNA)
Yogesh Rathod a Mumbai based Gujarati has got an US patent that will force blue chip companies like
Twitter Facebook Apple Oracle and others to shell out billions of dollars as royalty to him every year.
More...
Bhandarkar amused over `Fashion` copyright case

(IANS , 14-Apr-2012 , Zee News)
Filmmaker Madhur Bhandarkar is amused by the copyright infringement case filed against him for 2008
film Fashion. More...
Oracle gets ready to battle Google
Oracle Corp is set to go to trial next week against Google Inc in a high stakes dispute over smartphone
technology the biggest case in what is shaping up to be an intense year in court for the enterprise
software giant. More...
German court rules in Motorolas favour in Apple patent row

Motorola scored a victory in a patent war with rival Apple on Friday when a German court upheld a
decision banning it from offering services for syncrhonising e mails on its devices in Germany. More...
GSK, Teva in talks to buy Micro Labs India business

(Reghu Balakrishnan / Mumbai , 13-Apr-2012 , Business Standard)
Multinational drug majors who are leaving no stone unturned in their efforts to strengthen their India
presence are back in the buyout market scouting for the next big M&A opportunity. More...
Patent case: Microsoft wins ruling against Motorola

Microsoft Corp said on Wednesday it won a ruling in a Seattle court effectively preventing phone
company Motorola Mobility from immediately obtaining an injunction in Germany that could stop
Microsoft from selling its Xbox and other software products there due to a patent disagreement. More...
Pharma leads Indias patent charge as tech telecom lag behind

(Soma Das , 12-Apr-2012 , Financial Express)
Top patent seekers from US Japan and China who file the maximum patent applications hail from IT
telecom and consumer electronics while those from India are from an entirely different field:
Pharmaceuticals. More...
Oracle Google prepares for trial in World Series of IP cases

(Karen Gullo , 12-Apr-2012 , DNA)
Oracle Corp. will ask a jury next week to find that Google Inc. stole its intellectual property to make
Android software in a trial that a federal judge called the World Series of IP cases. More...
US judge backs Microsoft in Motorola patent dispute

A judge in US District Court in Seattle granted Microsoft a preliminary injunction and temporary
restraining order against Motorola in Germany the software company said. More...
Chart of the day | Generic Preference

(Yogesh Kumar , 12-Apr-2012 , Livemint)
In 2011 the spend on generic medicines rose by $5.6 billion Rs28,840 crore today compared with $7.6
billion in 2010 but accounts for nearly half of incremental growth in total spends. More...
Dr Reddys seeks nod for fondaparinux launch in Europe
(KV Ramana , 11-Apr-2012 , DNA)
A drug marketed by GlaxoSmithKline Arixtra has been off-patent since 2002. More...
Nilgiri planters to boost speciality tea output

(Vishwanath Kulkarni , 11-Apr-2012 , Business Line)
Further the NPA plans to leverage the Geographical Indication status granted to the Nilgiris tea and
brand them accordingly in the overseas market. More...
WiLAN: US patent office upholds V-chip claims

The US Patent and Trademark Office has confirmed the validity of WiLAN Incs patent for V chip
technology which enables objectionable television content to be blocked the Canadian company said on
Tuesday. More...
Govt may allow third-party audits for drug quality

(Namrata Nandakumar , 11-Apr-2012 , Livemint)
Third party audits in drug factories a practice accepted in developed countries including the US is likely
to be allowed initially for traditional medicines and may then be extended to modern drugs More...
Copyright case against Madhur Bhandarkar for Fashion

(PTI , 11-Apr-2012 , DNA)
A complaint against Bollywood filmmaker Madhur Bandarkar for allegedly stealing the plot and idea of
his movie Fashion from a book without giving credit to its author was on Wednesday referred to a
designated special court in Delhi dealing with copyright cases. More...
Yahoo files patent applications for e book advert

Internet firm Yahoo has filed applications for two different patents aimed at serving customers
advertisements within e-books. More...
AOL strikes $1.1-bn patent deal with Microsoft Corp

(Michael J. De La Merced , 10-Apr-2012 , Business Standard)
AOL agreed on Monday to sell a portfolio of over 800 patents and license about 300 more to Microsoft
for $1.056 billion amid an arms race within the technology industry over intellectual property. More...
Only strong patent protection can drive investments from West into India: Nobel Laureate
Kurt Wuthrich
(Our Bureau, Bengaluru , 10-Apr-2012 , Pharmabiz)
Patent protection in India would help drive future research initiatives. More...
Venus Remedies gets Australian patent approval for Vancoplus

Drug firm Venus Remedies today said it has received approval from the Australian Patent office for its
product Vancoplus used for treating bacterial infections. More...
Russia seeks details of dilution in Indian tea speciality tag

(Arun S and Vishwa , 09-Apr-2012 , Business Line)
Russia has sought detailed information from India on complaints over alleged dilution of the speciality
tag for Darjeeling Assam and Nilgiris teas. More...
What makes Germany hub of tech patent battles

(Kevin J O'Brien , 09-Apr-2012 , The Times of India)
Is Germanys system of litigating disputes over patents bad for business? More...
Cipla pins hopes on European inhaler market

(Reghu Balakrishnan , 09-Apr-2012 , Business Standard)
Cipla Ltd a domestic pharmaceutical major is set to tap the European inhaler market with generic drug
launches in those markets. More...
AOL to sell 800 patents to Microsoft for $1bn

AOL Inc said it agreed to sell more than 800 of its patents and related patent applications to Microsoft
Corp and grant the software maker a non exclusive license to its retained patent portfolio for about
$1.056 billion in cash. More...
Reverse innovation
(09-Apr-2012 , The Times Of India)
The government policies should strengthen the essential core of eco system for innovations namely the
large and growing markets liberal investment policies and protection of intellectual property rights.
More...
Joe C Mathew: Drug policy gets a dose of reality

(Joe C Mathew , 7-Apr-2012 , Business Standard)
The patent office has shown why India won?t become hostage to high priced multinationals under a
TRIPs compatible regime. More...
Drug prices need to be monitored not controlled

(George Mathew , 7-Apr-2012 , Indian Express)
Ranjit Shahani vice chairman and MD of Novartis India and president of the Organisation of
Pharmaceutical Producers of India the representative body of MNC pharma firms spoke to George
Mathew on the issue of intellectual property rights and public health. Excerpts: More...
Apple drops patent claim against Motorola Mobility

(Bloomberg , 05-Apr-2012 , The Times Of India)
Apple Inc dropped a claim that Motorola Mobility Inc infringed one of its five patents at issue in a federal
lawsuit in Chicago while reserving its rights to revive the case after appealing a pre trial ruling. More...
Facebook launches patent counter-attack

(Reuters / San Francisco , 5-Apr-2012 , Business Standard)
Facebook fired back yesterday in its legal battle with Yahoo by accusing the Web pioneer of infringing 10
of Facebooks patents according to a court filing. More...
US court picks terms in Apple Samsung patent case

A US judge largely sided with Apple on Wednesday over how several technical terms will be defined in
its patent fight against Samsung over smartphones and tablets. More...
UK court rules against Force India in copyright violation case

(P.R. Sanjai , 5-Apr-2012 , Livemint)
A UK court on 30 March dismissed his auto sports company Force Indias three year old plea of copyright
violation against UK based Aerolab SRL the respondent in the case and a former designer of Force India
cars. More...
UK court rules against Force India in copyright violation case

(P.R. Sanjai , 5-Apr-2012 , Livemint)
A UK court on 30 March dismissed his auto sports company Force Indias three year old plea of copyright
violation against UK based Aerolab SRL the respondent in the case and a former designer of Force India
cars. More...
Patent war: Facebook goes against Yahoo

Facebook fired back in its legal battle with Yahoo by accusing the web pioneer of infringing 10 of
Facebooks patents according to a court filing. More...
BlackBerry maker RIM sued by NXP over patents

A Dutch semiconductor company said on Tuesday it had filed a patent infringement suit against
Research In Motion Ltd adding to the BlackBerry makers troubles and sending its shares tumbling.
More...
Patent controller to meet stakeholders today at his office

(Suja Nair Shirodkar, Mumbai , 3-Apr-2012 , Pharmabiz)
With a view to understand the demands of the industry the patents office has organised a high profile
meeting with the stakeholders in Mumbai on April 3. More...
Suven Life gets 4 patent approvals for neuro drug

(Press Trust of India / New Delhi , 03-Apr-2012 , Business Standard)
Drug firm Suven Life Sciences today said it has received four product patents in China and Korea for its
new chemical entities which could be used for treating various central nervous system disorders. More...
EU probes Google's Motorola in Apple, Microsoft patent war

European regulators opened Tuesday two antitrust investigations against Motorola Mobility bought by US
Internet giant Google in the latest chapter of an escalating patent war with Apple and Microsoft. More...
Apple secures 17 patents including wireless sync

(Don Reisinger , 03-Apr-2012 , CNET)
The companys new patents range from a single security model for booting a computing device to a
design patent on its current iPod Shuffle. More...
Settlement talks fail in Google vs Oracle patent case

A federal judge in the heart of Silicon Valley has said that Google and Oracle have failed to settle a
patent dispute out of court and that the case will head to civil trial. More...
Ranbaxy starts generic Lipitor shipments from India

Ranbaxy Laboratories Ltd has started exports of a copycat version of blockbuster cholesterol drug Lipitor
from a new facility in India that has been approved by the US Food and Drug Administration. More...
Twitter to patent refresh page gesture?

Many are trying, thanks to software patents. More...
Microsoft shuts German distribution on patent row

Microsoft is moving its European software distribution to the Netherlands from Germany after being
caught up in legal disputes over patents with Motorola Mobility Inc in Europes biggest economy. More...
Innovation: A journey from the mind to the marketplace

(R A Mashelkar , 02-Apr-2012 , Business Standard)
Going beyond mere research laboratories India must build a powerful national innovation ecosystem
comprising robust physical intellectual and cultural constructs More...
Australia settles patent suit in US wi fi case

Australias scientific research agency has reached a multi million dollar out of court settlement in the
United States over the use of its wireless internet technology which underpins wi fi platforms worldwide.
More...
Licence must for playing music in public places
The Indian Performing Right Society Limited which is authorized by the government to issue public
performance license said gross violation of the Copyright Act 1957 is going on in the state as far as
commercial establishments and playing music in public places are concerned. More...
Tech patents: Touch is forbidden

(Reuters , 01-Apr-2012 , The Times of India)
You can look but you cant touch great advice in most museums and every strip club. More...
EU's Almunia: may probe Motorola, Apple, Microsoft dispute

EU antitrust regulators may open an investigation into a patent dispute between Apple Inc Microsoft
Corp and Motorola Mobility Holdings Inc to ensure patent holders do not thwart rivals the EUs antitrust
chief said on Friday. More...
A Strike against Pharma MNCs

(EDITORIALS , 31-Mar-2012 , Economic & Political Weekly)
The grant of a compulsory licence to Natco Pharma a relatively small Indian pharmaceutical company to
manufacture and sell the cancer drug sorafenib has been rightly hailed as a major step forward for
public health and the wider availability of life saving medicines. More...
Ideal Cures gets US patent for sodium alginate based aqueous film coating technology
Mumbai based Ideal Cures recently secured a US patent for its innovation sodium alginate based
aqueous film coating technology claimed as both cost effective and non toxic. More...
EU antitrust regulators may probe Motorola Apple Microsoft dispute

EU antitrust regulators may open an investigation into a patent dispute between Apple Inc Microsoft
Corp and Motorola Mobility Holdings Inc to ensure patent holders do not thwart rivals the EUs antitrust
chief said on Friday. More...
The new world is about brands and not intellectual property

(Sridhar K. Chari , 31-Mar-2012 , Livemint)
Kapur says the website Qyuki will provide an interactive platform to create media and also bypass
gatekeepers More...
Supreme Court reschedules final hearing on Novartis’ case on Sec 3(d) of Patents Act to July
10, 2012
The Supreme Court has once again rescheduled the final hearing of the much awaited case involving the
Swiss pharma major Novartis and the government of India. More...
Apple mulls settling patent fights with Samsung
(IANS , 30-Mar-2012 , Zee News)
Top executives at Apple and Samsung have met recently about a potential patent settlement a media
report said Thursday. More...
Youngest patent holder on wheelchair

(Ajay Singh , 30-Mar-2012 , The Times Of India)
Drawing inspiration from scientist Stephen Hawking a wheelchair bound nine year old boy here has
invented a game of six player circular chess. More...
White hot rivalry to curb gains from generic Seroquel

(Priyanka Golikeri , 30-Mar-2012 , DNA)
Cut throat competition is seen limiting the opportunity on blockbuster anti psychotic drug Seroquel the
patent on which expired on March 26 in the US. More...
Natco formulates a new opportunity

(B Dasarath Reddy / Hyderabad , 29-Mar-2012 , Business Line)
The drug prices of global pharma companies have no justification whatsoever not just in India but
around the world says V C Nannapaneni chairman of Natco Pharma a Hyderabad based pharma
company. More...
AOL patents valued at $290m

AOL Incs patent portfolio would be valued at about $290 million in a sale less than a third of the amount
that shareholder Starboard Value LP has estimated it could generate according to patent advisory firm M
Cam Inc. More...
AOL patents valued at $290m

AOL Incs patent portfolio would be valued at about $290 million in a sale less than a third of the amount
that shareholder Starboard Value LP has estimated it could generate according to patent advisory firm M
Cam Inc. More...
Kolaveri against piracy

(R. Balaji , 29-Mar-2012 , Business Line)
The order provides for quick action against the offender rather than react after somebody has infringed
on the rights of intellectual property owners. More...
Facebook investors warned of unfavorable outcome in Yahoo patent lawsuit

(ANI , 28-Mar-2012 , The Economic Times)
Social networking giant Facebook has warned investors of an unfavorable outcome in connection with a
patent lawsuit brought against the firm by Yahoo. More...
Apple Sony sued for infringing a patent
Apple Inc Sony Corp and four other companies were sued by Graphics Properties Holdings Inc formerly
known as Silicon Graphics Inc for allegedly infringing a patent through their sale of mobile phones and
other electronic devices. More...
Google proposes Android revenue for Oracle: Report

Google proposed to pay Oracle a per centage of Android revenue if Oracle could prove patent
infringement of the mobile operating technology at an upcoming trial but Oracle rebuffed the offer as too
low according to a court filing late on Tuesday. More...
Patent office may grant CL in future if circumstances demand so Patent Controller

(Suja Nair Shirodkar, Mumbai , 27-Mar-2012 , Pharmabiz)
With respect to safeguarding of public interest and to ensure availability of life saving drugs at affordable
prices Patent office informed that they may certainly consider accepting Compulsory Licence applications
in future also if circumstances demand so. More...
US protests patent issuance to Natco to sell copied versions of Nexaver

(Amiti Sen , 27-Mar-2012 , The Economic Times)
The US has criticised Indias decision to issue its first compulsory licence to domestic drug company
Natco for selling copied versions of Bayers anti cancer drug Nexaver arguing that it would discourage
new investments and dilute the international patent regime but India said it has not broken any rules.
More...
India defends compulsory licensing of patent drugs

Countrys intellectual property rights are in tune with trade related aspects of WTO deal says commerce
minister More...
The international trade climate change interface is emerging as a new issue

In fact the interface between international trade and climate change is fast emerging as a new issue
even though it does not find mention in the originally drafted rules of the General Agreement on Tariffs
and Trade or the World Trade Organization. More...
Novartis challenges patent rejection in India

(26-Mar-2012 , WikiNews)
The Swiss pharmaceutical company Novartis is about to challenge patent rejection in India before the
Supreme Court of India. The court case is to begin on March 28. More...
Natco-Bayer CL judgment: Temper enthusiasm with reality

(P.T. Jyothi Datta , 26-Mar-2012 , Business Line)
Patients in the advanced stage of kidney cancer can take some solace from the fact that a key drug in
their treatment will now be available at a much lower price. More...
Take permission for new Zanjeer Javed Akhtar

(Priya Shahi , 26-Mar-2012 , The Times of India)
After almost 40 years the man who penned the unforgettable dialogue Mere paas maa hai is asking the
producers of the remake of the classic Zanjeer Kya tere paas copyright hai? More...
Hollywood studios body inks IPR deal with Tollywood

The Motion Pictures Association of America the association of all major studios in Hollywood, has signed
an agreement with Tollywood the Telugu film industry to work in the area of protection of intellectual
property rights. More...
Force India to appeal copyright case against Caterham

(Agence France-Presse , 25-Mar-2012 , NDTV)
Force India said Sunday they would appeal for a higher pay out after Caterham were found to have
copied bits of their Formula One car comparing the case to the explosive Spygate scandal. More...
Facebook buys IBM patents

(AFP , 24-Mar-2012 , The Economic Times)
Facebook confirmed Friday that it has added a trove of IBM patents to its arsenal on an increasingly
lawsuit strewn technology battlefield. More...
Google patents environment based ads

(Indo-Asian News Service , 24-Mar-2012 , Hindustan Times)
Google has been awarded a patent on technology that will serve up targeted advertising based on a
smartphone users environment The Telegraph reported Friday. More...
Patent office to undergo major technological up gradation under new Chief

Major technological up gradation is being planned in the patent office to enhance the quality of its
services according to the new controller general of patents who took charge last week in Mumbai.
More...
Move to cut cancer drug price not linked to Bayer case: Roche
(Thomas K. Thomas , 23-Mar-2012 , Business Line)
Pharmaceutical major Roche said that its decision to slash the price of two expensive cancer drugs in
India is not linked to the Bayer Natco case. More...
Microsoft drops patent suits against TiVo

(Bloomberg , 23-Mar-2012 , The Times Of India )
TiVo Inc said Microsoft Corp agreed to drop patent infringement litigation that could have led to a US
import ban on TiVos television set top boxes. More...
Agent Vinod gets HC relief in copyright case

(Express news service , 23-Mar-2012 , The Indian Express)
Saif Ali Khan starrer Agent Vinod will hit theatres on Friday with its popular Pungi baja de number intact
as the Bombay High Court on Thursday granted no relief to Iranian music company Barobax Corp that
alleged a copyright infringement in the use of the song. More...
Roche to slash prices of expensive cancer drugs in India

This development comes close on the heels of India permitting Natco Pharma to manufacture and sell
cancer treatment drug Nexavar at a price over 30 times lower its patent holder Bayer Corporation.
More...
Government probes copyright violation of brands like Onida home appliances Boroplus
antiseptic cream by Chinese firms
India is investigating cases of rogue Chinese companies allegedly copying trusted Indian branded
products including Onida home appliances Boroplus antiseptic cream Raymond suitings and even Kama
Sutra condoms and selling them in China and abroad. More...
Complaints against Chinese companies for counterfeiting Indian products

Several complaints including from leading companies such as Raymond and Boroplus have been received
by the Indian Embassy in Beijing against counterfeiting of their products. More...
Force India slapped with big pay out

(Agencies , 22-Mar-2012 , The Indian Express)
The pay out was demanded by the High Court in London on Wednesday following a copyright
infringement case according to a lawyers statement seen by AFP and media reports. More...
Bharti, Vodafone, RCom, Tata sued over music copyright

(Yogesh Pawar , 21-Mar-2012 , DNA)
The high court order last week restrained the ISPs from reproducing adopting distributing
communicating transmitting disseminating or displaying in any manner infringing the copyright in sound
recordings belonging to the IMI member companies. More...
Apple vs Android: The costly patent war

Before his death Apple Incs Steve Jobs famously promised to go thermonuclear against smartphones
running Googles Android software saying they use technology ripped off from the iPhone. More...
Bitter pill
(Manoj C G , 21-Mar-2012 , The Indian Express)
The Left has expressed concern about the recent spate of mergers and acquisitions of Indian
pharmaceutical companies by foreign multinationals. More...
Cheap generics no panacea for poor

(Reuters / Mumbai , 20-Mar-2012 , Business Standard)
Cheap generic drugs were meant to change the life of Nandakhu Nissar whose mouth is swollen by a
cancerous tumor. More...
India bats for generic drugs seeks Africas support

Commerce Minister Anand Sharma Sunday said that India will resist any attempt made to malign the
countrys generic drugs industry as it provided a means for poor sections of the society to access cheap
medicines. More...
Cheap generics drugs no panacea for Indias poorest

Cheap generic drugs were meant to change the life of Nandakhu Nissar whose mouth is swollen by a
cancerous tumour. More...
Kodak gearing up for robust patent sale sources

Bidders are lining up in earnest now that Eastman Kodaks patent sale is set to resume. More...
MSF asks Indian generic cos to obtain more CLs to make drugs affordable & accessible
Médecins Sans Frontières has urged other Indian generic companies to come forward to apply for
compulsory licenses including on HIV medicines if they cant get appropriate voluntary licenses from the
patent holders to make these life saving patented drugs available to the common people of this country.
More...
Natco examining other drugs to identify compulsory license targets

(Khomba Singh , 15-Mar-2012 , The Economic Times)
Having won a landmark decision Natco Pharma is collecting data to identify other life saving drugs where
they can apply for compulsory licensing. More...
The generics boom in India

(15-Mar-2012 , Livemint)
The year 2012 is turning out to be an uncomfortable year for big pharma. More...
Kodak gearing up for robust patent sale: Sources

Bidders are lining up in earnest now that Eastman Kodaks patent sale is set to resume. More...
Breaking the patent

(Business Standard / New Delhi , 15-Mar-2012 , Business Standard)
Last week India issued its first compulsory licence. More...
Heritage brands big earners in pharma

In an age where billions of dollars are being spent on research for new molecules and drugs it appears
that old is still gold in the Indian pharmaceutical market. More...
Local regulations keep foreign pharma companies on tenterhooks

The grant of the countrys first compulsory drug licence and recent attempts at populist policy initiatives
have raised fears of overseas pharmaceutical firms. More...
Samsung loses bid to ban iPhone iPad in Netherlands

Samsung Electronics Co said on Thursday a Dutch court rejected its 3G patent bid to ban sales of Apples
iPhone and iPad in the Netherlands. More...
A life saver
(Shamnad Basheer , 15-Mar-2012 , The Indian Express)
Compulsory licence can go a long way to ensure access to cheaper drugs. More...
Five GI tags in their kitty state craftsmen close ranks for more
(ADAM HALLIDAY , 14-Mar-2012 , The Indian Express)
As the Kutchi shawl receives a Geographical Indication along the lines of Kancheepuram Silk” and
Darjeeling Tea similar applications for the Patan Patola and Jamnagar Bandhani have also been filed on
behalf of weavers associations over the last few months. More...
Nearly 75000 patent applications pending for review

Inadequate manpower has led to piling up of nearly 75000 patent applications awaiting review by the
designated authority. More...
Natco Pharmas invoking of compulsory licensing could trigger cheaper drug production
(Rupali Mukherjee , 14-Mar-2012 , The Economic Times)
The governments decision to bust the price as well as monopoly of Bayers anti cancer drug through the
process of compulsory licensing now opens up the field for the generic industry to follow suit and could
well pave the way for the availability of cheaper drugs for lifestyle diseases. More...
Sector divided over nod to Natco to sell Bayers drug
(Press Trust Of India / New Delhi , 14-Mar-2012 , Business Standard)
Indias decision to allow Natco Pharma to sell Bayers patented cancer drug Nexavar has divided the
pharmaceutical industry. More...
Older than DRL, little-known Natco comes into limelight

It may be older than Hyderabads most wellknown drug giant Dr Reddys Laboratories but recognition has
come rather belatedly in the day for Hyderabad based Natco Pharma. More...
Pill patents
(Jeff Glekin , 14-Mar-2012 , Business Standard)
India has joined Thailand and Brazil in granting a licence to a local generic drug maker at the expense of
a global player. More...
Apple Motorola discussed patent settlement: EU

(Bloomberg , 14-Mar-2012 , The Economic Times)
Apple Inc held talks with Motorola Mobility Holdings Inc at the end of last year on a potential cross
licensing settlement to end a dispute over smartphone patents according to a European Union
document. More...
Should compulsory licensing be allowed?

(Amit Sengupta , 14-Mar-2012 , The Times of India)
The decision by the Indian Patent Office to issue a compulsory licence to Natco for Bayers anticancer
drug Sorafenib means the drug will now be available at Rs 8800 per month a 97 % reduction from
Bayers Rs 2.8 lakh. More...
At Pfizer signs of priority change

(Priyanka Golikeri & KV Ramana , 14-Mar-2012 , DNA)
Does Pfizers decision to call off its deal with Bangalore based Biocon indicate a change in the US firms
game plan for India? More...
Yahoo! sues Facebook for infringing patents

(Reuters / San Francisco , 14-Mar-2012 , Business Standard)
Yahoo!Inc sued Facebook Inc over 10 patents that include methods and systems for advertising on the
Web opening the first major legal battle among big technology companies in social media. More...
Road to cheaper drugs

(Rupali Mukherjee , 14-Mar-2012 , The Times of India)
More generic companies could invoke the compulsory licensing clause of the Indian Patents Act following
Mondays decision to allow Natco Pharma to sell copycat drugs of Bayers patented cancer drug at 97 %
reduction. More...
A historic move to make drugs affordable
(G. Ananthakrishnan , 14-Mar-2012 , The Hindu)
Compulsory licensing is perfectly legal and built into the patents regime to balance corporate profit and
public interest. More...
Long term damage to future health of world to be dramatic

(Ranjit Shahani , 14-Mar-2012 , The Times of India)
It was with great anticipation that the innovative pharmaceutical industry welcomed the introduction of
product patent laws in 2005. More...
Pharma Street splits not unusual

(Reghu Balakrishnan / Mumbai , 14-Mar-2012 , Business Standatd)
Indian pharmaceutical companies much sought partners for global majors due to the low cost factor
have seen quite a few deals fall apart in the recent past. More...
Patent disregard for patients

(P. Bhaskara Narayana , 14-Mar-2012 , Business Line)
The Glivec case points to the need to go beyond encouraging innovation and providing affordable life
saving medicines. More...
$350-mn Pfizer-Biocon pact off

(BS Reporters / Bangalore/ Mumbai , 14-Mar-2012 , Business Standard)
Indias largest biopharmaceutical company Biocon suffered a severe jolt on Tuesday as its $350 million
pact with global pharmaceutical major Pfizer was called off hardly 18 months after the deal was signed.
More...
Oracle trial against Google set for April

(Bureau Report , 14-Mar-2012 , Zee News)
A US judge scheduled a trial between Oracle Corp and Google Inc for April 16 2012 over claims Google
violated Oracles intellectual property rights relating to the Java programming language according to a
ruling on Tuesday. More...
Indias patent ruling on cancer may open door for cheaper HIV drugs
Indias move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a
precedent that could extend to other treatments including modern HIV AIDS drugs in a major blow to
global pharmaceutical firms experts say. More...
Biocon Pfizer call off $350m insulin deal

Worlds largest drug maker Pfizer has called off a $350 million deal to sell Indian biotech company
Biocons insulin products globally. More...
Indias first compulsory licence granted to Natco for Bayers cancer drug
The countrys first compulsory licence has been granted by the Indian Patent Office to Hyderabad based
drug maker Natco. More...
Litigation clouds Sun Pharmaceutical

(Ujjval Jauhari & Ram Prasad Sahu , 13-Mar-2012 , Business Standard)
Whichever way the judgement in the Protonix case goes it is likely to be a trendsetter for companies
looking to launch generic drugs in the future in prized markets such as the US. More...
Cancer ruling opens door for cheaper drugs in India

(Kaustubh Kulkarni and Henry Foy , 13-Mar-2012 , Reuters)
Indias move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a
precedent that could extend to other treatments including modern HIV AIDS drugs in a major blow to
global pharmaceutical firms experts say. More...
Yahoo points up patent-law failure

(John Shinal , 13-Mar-2012 , MarketWatch)
The patent lawsuit filed by Yahoo Inc. against Facebook Inc. is more than just a desperation move by a
company thats become an also ran in an industry it once helped create. More...
Yahoo sues Facebook over patents

Yahoo Inc sued Facebook Inc over 10 patents that include methods and systems for advertising on the
Web opening the first major legal battle among big technology companies in social media. More...
Health groups hail verdict pharma body disappointed

Natcos baby step may pave the way for a giant leap of sorts where many more drug patents are
subjected to this stick to help bring down highly excessive prices for a country like India says Mr
Shamnad Basheer an intellectual property expert. More...
Is the Pfizer-Biocon deal coming apart?

(DNA Correspondent , 13-Mar-2012 , DNA)
Pfizer stood to gain from greater access to the $14 billion market for insulins used to control diabetes
ahead of 2015 when a number of products are expected to lose patent protection. More...
Geographical indications tag for made in Kutch shawl

The colourful Kutchi shawl has been given the geographical indications tag. More...
Yahoos 10 patents that it claims Facebook infringed
(Dan Farber , 12-Mar-2012 , CNET)
With Facebook on the road to IPO Yahoo has placed ten of its patents in its path. More...
Patent office may give verdict today

(Joe C Mathew / New Delhi , 12-Mar-2012 , Business Standard)
In a move that could set the tone for future pharma patent battles Indias intellectual property rights
watchdog may decide tomorrow the fate of the countrys first compulsory licence application. More...
NGOs reject Novartis claim of no impact on availability of cancer drug because of court
dispute
Public interest groups working in the health sector in the world have pooh poohed the Swiss
pharmaceutical company Novartis argument that there will be no impact on the availability of generic
version of its blood cancer drug Gleevec as a fallout of the on going case in Supreme Court in India.
More...
Glivec ruling to determine India investment: Novartis

Novartis is seeking clarity on whether we can rely on patents in India and whether we as a research
based organisation can continue to invest in the development of better medicines for India. More...
Partnership is better alternative to acquisition

(C.H. Unnikrishnan & Namrata Nandakumar , 11-Mar-2012 , Livemint)
Not having strong patent regime in the country was a barrier in entering India earlier. More...
Copies of patented cancer drugs ahead?

Hope floats for liver and kidney cancer patients who find the available patented medication unaffordable
out of reach. More...
Apple barred from pursuing Kodak patent claims now

(Reuters , 9-Mar-2012 , IBN Live)
The infringement claims center on a Kodak patent that lets consumers preview digital photographs on
LCD screens. More...
No science in 'cut and paste'

(Rahul Siddharthan , 9-Mar-2012 , The Hindu)
There is an urgent need for an institutional mechanism to deal with plagiarism and other violations of
academic ethics. More...
Smartphones tablets and the patent wars

(Sunil Abraham , 08-Mar-2012 , The Economic Times)
Some prefer Steve Jobs patron saint of perfection others prefer Nicholas Negroponte messiah of the
masses. More...
Samsung files fresh patent suit against Apple in South Korea

Samsung Electronics Co said on Wednesday it has filed another lawsuit against Apple Inc in South Korea
claiming the iPhone 4S and iPad2 infringed on three of its patents. More...
Ranbaxy takes Atorvastatin to more countries

Ranbaxy Laboratories Ltd announced that it has launched the generic versions of Atorvastatin tablets in
Italy Sweden and the Netherlands. More...
iPad dispute signals new era in trademark troubles

(AP , 6-Mar-2012 , The Economic Times)
iPotato isock icouch istove i you name-it. More...
Indias Supreme Court to Hear Dispute on Drug Patents

(VIKAS BAJAJ and ANDREW POLLACK , 06-Mar-2012 , The New York Times)
But most of that medicine has been generic copies of brand name drugs protected by patents in Europe
and the United States. More...
Ranbaxy takes Atorvastatin to more countries

Pfizers patent expires in Italy on May 8 and in the Netherlands and Sweden on May 06. More...
Novartis India keeps fingers crossed as SC hears Glivec patent case

(Divya Rajagopal , 5-Mar-2012 , The Economic Times)
Novartis India will take a last shot at protecting its patent for anti cancer drug Glivec in Supreme Court
later this month in a ruling that will have a significant impact on all innovators past and present even as
activists seek affordable drugs in developed countries occupy Novartis offices in the US. More...
2 generics give pharma sector $400 mn boost

(Namrata Nandakumar , 5-Mar-2012 , Livemint)
Foreign pharmaceutical companies may continue to fret over drugs going off patent but drug makers in
India are not only raking in profits selling generic versions of such drugs but are also pushing up the
growth rates of Indias pharma exports. More...
India opposes pharma piracy pact by 10 nations

The ACTA was signed by ten WTO countries including Australia Canada Korea Mexico New Zealand Japan
Morocco Singapore the US and Switzerland in October last year to check global trade of counterfeit
goods and pirated copyright protected works through stricter enforcement laws. More...
India foils Swiss MNCs bio piracy bid

(Kounteya Sinha , 3-Mar-2012 , The Economic Times)
India has successfully foiled a bio piracy bid by a Swiss multi national firm to patent an age old Indian
home remedy milk as a laxative More...
Final hearing on Novartis case on Sec 3(d) of Patents Act to begin in SC on March 28
The Supreme Court has rescheduled the final hearing of the Novartis versus the government of India
case for March 28 2012. More...
Kodak sells online business to Shutterfly patent sale still pending

(Sue Zeidler , 02-Mar-2012 , Reuters)
Eastman Kodak Co has agreed to sell its online photo services business to Shutterfly Inc for $23.8
million kicking off the bankrupt photography pioneers relaunch as a much slimmer company although a
patent sale seen crucial to its turnaround may still be months away. More...
Emcure signs deal to manufacture Roches anti cancer drugs

Instead it has taken Indian generic makers to court for violation of Intellectual Property Rights rather
than signing any voluntary license deals. More...
Biosimilar products development gets a USFDA norms boost

(Rituparna Chatterjee , 1-Mar-2012 , The Economic Times)
Robert Siminski a Detroit based patent attorney specializing in pharmaceuticals and biotech issues
recalls how anxiously biotech experts at Indian firms whom he had met at the India Bio conference in
Bangalore early last month were looking forward to the US Food and Drug Administrations draft
guidelines for biosimilar product development. More...
Patent rights?
(T S Vishwanath , 1-Mar-2012 , Business Standard)
WIPO must protect the developmental needs of countries with genetic resources as it pushes for
inventions and innovation in industry More...
Is Yahoo trying to boost acquisition value by demanding licensing fees from Facebook?
Yahoo could be trying to boost its acquisition value by demanding licensing fees from Facebook for the
use of its technology as the one time Web pioneer considers strategic M&A options according to patent
experts. More...
Big pharma companies must allow generic firms to sell cheap HIV drugs to poor nations
Last month when Emcure Laboratories became the third company to tap an open patent pool it was
more validation of a novel mechanism that seeks to address a conundrum central to the industry:
More...
Price erosion may hit Lipitor sales of Indian firms

(Reghu Balakrishnan / Mumbai , 29-Feb-2012 , Business Standard)
Lipitor has been sold by three players in the US after it lost patent protection in November last year.
More...
Natco ruling is a watershed

(P. T. JYOTHI DATTA , 28-Feb-2012 , Business Line)
The day of the nation wide trade union strike few people are on the roads and in offices in Mumbai.
More...
Bayer-Natco case: Judgment will set benchmark in amended Indian Patent Act
The final patent related hearing on Bayers advanced kidney cancer drug Nexavar following Natcos plea
for a compulsory license on the medicine concluded on Tuesday at the Patent Office. More...
More firms restrained by Delhi court in Aji No Moto trademark infringement case
(Shobha Roy , 28-Feb-2012 , Business Line)
The next time you buy Aji No Moto for cooking your favourite Chinese dish be careful of whether you are
buying the trademark product or monosodium glutamate which some companies have loosely preferred
to call as Aji No Moto. More...
Yahoo threatens Facebook as social media patent war looms

Yahoo has demanded licensing fees from Facebook for use of its technology the companies said on
Monday potentially engulfing social media in the patent battles and lawsuits raging across much of the
tech sector. More...
Hearing on Novartis case on Sec 3(d) of Indias Patents Act in SC to be delayed

The hearing on Novartis case on Section 3(d) of Indias Patents Act in Supreme Court is likely be delayed
from 28 February to sometime in March as the Mumbai terror attack trial is running late in the court.
More...
GENFIT's drug candidate GFT505 gets patent protection from major countries
(Lille, France , 25-Feb-2012 , Pharmabiz)
Following on from GFT505 patents already delivered in the United States Europe China Russia and
Australia the Canadian Japanese and Indian patent offices have granted new patents to GENFIT. More...
Indian Glivec case concerns raised at Novartis AGM at Basel

Drop the legal case in India on Glivec Mr Patrick Durisch with Berne Declaration a Swiss public interest
non government organisation urged the Novartis management. More...
Novartis AGM hit by shareholders protest over continuing litigation against Sec 3(d) of Indias
Patents Act
The Swiss pharmaceutical giant Novartis' Annual General Meeting at Basel in Switzerland on February
23, was hit by protests both inside and outside the AGM on its continuing litigation against the Section
3(d) of Indias Patents Act which prohibits evergreening the practice of multinational pharmaceutical
companies to extend their patent terms by making small trivial changes to existing medicines and
thereby preventing access to generic affordable drugs. More...
Protest against Novartis attempt to obtain patent for Glivec in India

(PTI , 24-Feb-2012 , Business Line)
Several NGOs protested at the annual meeting of Novartis yesterday against the attempt by the Swiss
pharmaceutical groups India company to obtain a patent for its anti cancer drug Glivec. More...
MSF seeks Novartis shareholders to urge company to drop ongoing patent case against India
The international medical humanitarian organization Médecins Sans Frontières has called upon the
shareholders of Swiss pharmaceutical company Novartis to urge the company to drop its ongoing court
case against the Indian government as the case could have a severe impact on access to affordable
medicines for people across the developing world. More...
Kadaknath set to become global brand

(DNA , 26-Feb-2012 , Daily Bhaskar)
The Intellectual Property Facilitation Centre a wing of Confederation of Indian Industries has applied for
Kadaknaths inclusion in the Geographical Indication Registry. More...
Lupin settles patent dispute with 2 US firms

(PTI , 23-Feb-2012 , Business Line)
Lupin has reached a patent litigation settlement agreement with US based firms Santarus Inc and
Depomed Inc involving diabetes drug Glumetza. More...
Sun Pharma shares rise over import of cancer drug Lipodox

(NDTV Correspondent , 23-Feb-2012 , NDTV)
Doxil is a drug innovated by J&J which is facing manufacturing constraints. More...
Sun Pharma may opt for out of court settlement

(Reghu Balakrishnan / Mumbai , 22-Feb-2012 , Business Standard)
The recent patent litigation suit with the highest ever damage claim against an Indian pharmaceutical
company is likely to end in a whimper. More...
Bayer case may set cost precedent
Germanys Bayer HealthCare AG will be forced to disclose cost data for cancer drug Nexavar next week
when Indias patent office holds the second hearing for compulsory licensing of the drug sought by local
drug maker Natco Pharma Ltd likely setting a precedent for similar revelations to be extracted from
other foreign drug makers. More...
Pharmaceutical and healthcare sector to dominate M&As in 2012: Grant Thornton

India will see the largest number of merger and acquisitions in the pharmaceutical and healthcare sector
this year despite stricter regulations according to consulting firm Grant Thornton. More...
Strategy for intellectual property a necessity

With an aim to protect intellectual property industrialists must register patents industrial designs
trademarks copyrights and geographical indices said Karamjit Singh Saluja deputy director federation of
Indian micro small and medium enterprises. More...
Patent office to clear backlog of pending patent applications by 2016

(Suja Nair Shirodkar, Mumbai , 20-Feb-2012 , Pharmabiz)
With a view to safeguard the interest of the patent applicants the Indian Patent office informed that
efforts are being taken to clear the huge backlog of about one lack pending patent applications latest by
2016. More...
AstraZeneca India job cuts likely to hurt drug research

(Jacob P. Koshy , 20-Feb-2012 , Livemint)
Manpower reduction by global pharma firms means loss of potential training experience for Indian
scientists. More...
Patent granted to kit prepared by Haryana Univ for testing urea in milk
(Express news service , 19-Feb-2012 , The Indian Express)
The newly established Lala Lajpat Rai University of Veterinary and Animal Sciences Hisar has been
granted a patent by the Government of India for commercial production for the Urea Detection in Milk
technology developed by its Veterinary Public Health and Epidemiology College of Veterinary Sciences
for testing Urea in milk. More...
India is underperforming in terms of innovation potential

(Staff Correspondent , 18-Feb-2012 , Business Line)
Entrepreneurs having insufficient knowledge of IPR would lose interest in applying for patent rights.
More...
Will India hold on to its status as Pharmacy of the developing world?

(17-Feb-2012 , IBN Live)
Up until year 2000 drugs for HIV AIDS were mostly patented and cost more than $10000 per patient per
year. More...
Wyeth claims $960 mn from Sun Pharma in Protonix case

Wyeth Pharmaceuticals Inc is seeking $960 million in damages from Sun Pharmaceutical Industries for
alleged patent infringement in launching a generic version of acid reflux drug Protonix in the United
States the Indian company said. More...
Apple wins over Motorola in slide to unlock ruling

(16-Feb-2012 , BBC News)
Apple has won a patent dispute against Motorola Mobility regarding a slide to unlock feature on
smartphones. More...
Navara rice farmers seek government support for marketing

(PTI , 15-Feb-2012 , IBN Live)
Navara rice associated with Ayurveda and considered to be an energetic food for people of all ages was
the first farm product that received Geographical Indication Registration in the country considering its
importance. More...
Apple loses iPad copyright battle in China

(Saibal Dasgupta , 15-Feb-2012 , The Times Of India)
A move is afoot to block the worldwide distribution of iPads from their manufacturing base in China after
its maker Apple Inc lost a copyright battle to a Chinese company. More...
Baroda College of Pharmacy files for four patents

(Syed Khalique Ahmed , 15-Feb-2012 , Indian Express)
Baroda College of Pharmacy has filed for four provisional patents for the inventions its faculty and
students are currently working on. More...
Wyeth makes $960 mn claims on Protonix patent case: Sun Pharma

Sun Pharmaceutical Industries on Wednesday said that US based Wyeth Pharmaceuticals has sought
damages worth USD 960 million related to their ongoing patent dispute over a generic version of
Protonix drug. More...
Google gets US EU approval to buy Motorola Mobility

(Reuters / Washington/ Brussels , 15-Feb-2012 , Business Standard)
It was one of a series of approvals on Monday that underscored the scramble by technology companies
to acquire big pools of patents. More...
India can win melon patent

India should invoke provisions of Biodiversity Convention to fight the patent issued by European Patent
Office to Monsanto on virus resistance traits of melons allegedly taken from indigenous varieties in India
according to ecologist S Faizi. More...
Apple launches new legal attack on Samsung phones

(Reuters / New York , 14-Feb-2012 , Business Standard)
Apple Inc raised the stake in an intensifying global patent battle with Samsung Electronics by targeting
the latest model using Googles fast growing Android software a move which may affect other Android
phone makers. More...
Patent office asks industry to engage only sector specialised patent agents for speedy
clearance of applications
The Indian Patent office has asked the industry to appoint only sector specialised patent agents for the
purpose of patent filings to avoid complications while examining the patent cases filed for examination.
More...
Google gets U.S. EU nod to buy Motorola Mobility

(Diane Bartz and Foo Yun Chee , 14-Feb-2012 , Reuters)
It was one of a series of approvals on Monday that underscored the scramble by technology companies
to acquire big pools of patents. More...
TNAU develops ready to cook pearl millet mix

The Tamil Nadu Agricultural University has been granted a patent for producing a ready to cook mix
from pearl millet. More...
Beyonce Jay Z seek to patent daughters name

(ANI , 10-Feb-2012 , Hindustan Times)
Beyonce and Jay Z have reportedly filed an application to trademark their daughter Blue Ivy Carters
name. More...
Compulsory licensing to help patients & players says Natco

Hyderabad based Natco Pharmaceuticals is making a first of its kind effort to get a compulsory licence
for the generic version of Bayers liver and kidney cancer drug Nexavar in India alongside pursuing
opportunities in the generic pharmaceutical markets. More...
No exotic cheese names for Amul if India accepts EU demand

(Joe C Mathew / New Delhi , 10-Feb-2012 , Business Standard)
All this will happen if India accepts an EU demand for high level geographical indication protection for
about 130 products that fall in the agriculture wine and spirit categories. More...
Bandgalas and Jodhpurs patently Rathores: Designer copyrights his two iconic items
(Deepti Jakhar , 10-Feb-2012 , Daily Mail)
In a world where getting inspired and borrowing from each others collections are almost de rigueur
fashion designer Raghavendra Rathore has decided to patent the two styles he revived to life the
Jodhpurs and the bandgalas. More...
Prospects poor for original drug discovery in India finds study

A study attempted to gauge the innovativeness of outsourced pharma and biotech work to India. More...
Protest against EU India free trade agreement swells as summit kicks off in Delhi
Even as the EU India free trade agreement summit kicks off in Delhi the voice against the proposed
agreement is getting louder in the country as there is apprehension among the people that the
agreement will have a negative impact on access to affordable medicines across developing countries.
More...
EU extends special status for Darjeeling tea

Darjeeling tea has become the first product from India to be protected as a geographical indication in
the European Union according to the Tea Board. More...
IP office initiates process to link database to NIIPM for better dissemination of patent info
The Indian Patent office recently initiated the process to link all its database on both published as well as
granted patent applications filed for examination within the country to National Institute of Intellectual
Property Management Nagpur. More...
Opposition to Monsanto patent on Indian melons

(Gargi Parsai , 05-Feb-2012 , The Hindu)
Activist Vandana Shiva and an Europe based NGO have jointly opposed a patent awarded to an
American company on virus resistance traits taken from indigenous melon varieties in India. More...
Patent office appoints 150 patent examiners to expedite process of patent examinations
(Suja Nair-Shirodkar, Mumbai , 3-Feb-2012 , Pharmabiz)
To address the growing pressure from the increasing number of patent applications filed in the country
the Controller General of Patents Designs and Trademarks recently issued an order to appoint 150
examiners of patents. More...
Patent war intensifies as Facebooks IPO approaches

As it prepares for one of the biggest IPOs ever Facebook is coming under the same fierce attacks being
waged against other big technology companies: patent lawsuits. More...
Apple loses bid against Galaxy Tab 10.1N Nexus
(Bloomberg , 2-Feb-2012 , The Times Of India)
The Munich Regional Court rejected the motion today in a case where Apple invoked a patent granted
last year protecting technology related to touchscreens for tablets and smartphones. More...
Ahead of talks with EU concerns remain on drug export seizures

Despite the assurance from European Union authorities that Indian drug consignments would be allowed
to transit Ajanta Pharmas shipment was detained on alleged intellectual property violations in late 2011.
More...
Can Ranbaxy recover from its US debacle?

The generic company that wins a chance to sell its drug by successfully invalidating the patent of
someone elses medicine will have the sole rights to market the low cost version of that drug for six
months immediately after the products goes off patent. More...
Govt planning to patent products manufactured by tribals

Aiming to preserve the indigenous knowledge of tribals and products manufactured by them with the
help of natural resources government is planning to patent some of these under the Intellectual Property
Rights. More...
Raghavendra Rathore to copyright bandhgalas

(Rochelle Pinto , 01-Feb-2012 , Hindustan Times)
Cases of designer copying designer in the fashion industry are too common to count. More...
Indian ideas power US business innovations

(Chitra Unnithan , 1-Feb-2012 , The Economic Times)
Over 50% of total patents filed for industrial innovations in the US have Indian brains behind them says
a study by Indian Institute of Management Ahmedabad. More...
EU antitrust regulators probe Samsung over mobile patents

(Bloomberg / Brussels , 1-Feb-2012 , Business Standard)
Samsung Electronics Co is being probed by European Union antitrust regulators over licensing of patents
to other mobile phone manufacturers. More...
Indian ideas power US business innovations

Patent plaintiffs target Facebook as IPO approaches

(Dan Levine , 1-Feb-2012 , Reuters)
As it prepares for one of the biggest IPOs ever Facebook is coming under the same fierce attacks being
waged against other big technology companies: patent lawsuits. More...
Indian ideas power US business innovations says a study by IIM-Ahmedabad

Strides margin to improve on Ascent sale

(Ujjval Jauhari / Mumbai , 1-Feb-2012 , Business Standard)
Glaxo sources products from Strides for emerging markets while Pfizer is commercialising off patent
products primarily injectibles licensed supplied by Strides for regulated markets like the US. More...
Wake up call for Indian drug makers

(P.T.JYOTHI DATTA , 31-Jan-2012 , Business Line)
India is a huge source for generic drugs or less expensive medicines that are not covered by patent
protection unlike original innovative medicines. More...
Nestle Amul trademark battle is for Re 1 brand

(Vishal Dutta , 30-Jan-2012 , The Economic Times)
The slugfest between diary giants Amul and Nestle for ownership of A PLUS is afterall for a brand that is
worth Re 1. More...
US settlement puts Indias Ranbaxy on the ropes

(Agence France Presse , 29-Jan-2012 , NDTV)
Indian drugs giant Ranbaxy faces a tough road ahead after US authorities imposed stiff conditions to
settle a long legal battle over manufacturing safety violations at its plants analysts say. More...
India EU say making good progress on trade pact

Also the 27 nation bloc has been pressing India to agree for an intellectual property rights regime over
and above what the country has agreed multilaterally in the World Trade Organisation. More...
With GI powers rich pickings for Mysore farmers

(M Raghuram , 28-Jan-2012 , DNA)
Farmers groups of farmers and farmers co operatives in the state will get rights to grow sell and export
and process at least 11 horticultural products so far registered under geographical Indication. More...
Maharashtra leads in filing patents

(Kounteya Sinha , 28-Jan-2012 , The Times Of India)
Maharashtra beats all other states hollow when it comes to filing patents. More...
Ranbaxy stock tanks on court filing in US
(C.H. Unnikrishnan & Bloomberg , 28-Jan-2012 , Livemint)
For 13 of these the company was the first to challenge patents according to a presentation on its
website. More...
Samsung loses again in German patent suit against Apple

(Reuters , 27-Jan-2012 , The Times of India)
Samsung Electronics Co Ltd said on Friday that a German court has ruled against it in a patent suit with
Apple Inc over mobile technology the latest verdict in an intensifying global legal battle between the two
technology giants. More...
Ranbaxy to pay heavily for future US violations

(Joe C Mathew / New Delhi , 27-Jan-2012 , Business Standard)
The 180 day market exclusivity is granted to the first company that challenges the patent of a medicine
in the US. More...
Strides sells Australia SE Asia business to Watson Pharma

(BS Reporter / Bangalore , 25-Jan-2012 , Business Standard)
Rs 1965 cr deal helps it rake in 3.5 times its investment within four years More...
Several knotty issues in trade talks with EU

(Neeraj Thakur , 20-Jan-2012 , DNA)
Trade negotiations at the upcoming India European Union summit have assumed significance as the
euro region caught in an economic maelstrom looks for greater access to Indian markets. More...
Pharma stocks offer safety and upside

(Devangshu Datta / New Delhi , 19-Jan-2012 , Business Standard)
Its global which means an understanding of the complexities of patent law is necessary. More...
Battle set for Kodaks patent portfolio

(Richard Waters and Chris Nuttall , 19-Jan-2012 , Financial Times)
Eastman Kodaks bankruptcy is set to trigger a battle between some of the largest smartphone makers
and other technology groups for control of a patent portfolio that is considered core to digital
photography according to US patent experts. More...
Agra inlay craftsmen seeks Geographical Indication tag for their products
Agra craftsmen practising the marble inlay work found in famous works of architecture such as the Taj
Mahal and Fatehpur Sikri have sought the Geographical Indication tag for their product. More...
Sony to trademark Why this kolaveri di
(Zeebiz Bureau , 18-Jan-2012 , ZeeBiz)
Music label Sony Music Entertainment is planning to trademark the songs first line Why this kolaveri di.
More...
Compulsory license ensures patent rights & public health Expert

Compulsory license specifically under Section 92A of the Patents Amendment Ordinance 2004 for export
of pharmaceutical substances ensures a balance between patent rights and public health is maintained
according to Bindu Sharma Patent Attorney Origiin IP Solutions LLP. More...
Agra inlay craftsmen seeks Geographical Indication tag for their products
A Geographical Indication tag not only certifies a works geographical origin but also confirms adherence
to some production standards. More...
Man gets patent for 22 note harmonium

(Prachi Pinglay , 17-Jan-2012 , Hindustan Times)
The humble harmonium is finally set to get its due. More...
India EU free trade agreement talks at final critical stage

(Elizabeth Roche , 17-Jan-2012 , Livemint)
Indian automobile and wine groups are opposed to major concessions to EU firms More...
Healthcare workers stress need for independent data on medicine prices

(P. T. Jyothi Datta , 16-Jan-2012 , Business Standard)
Patent drugs and their pricing have not been addressed medicines for critical and highly prevalent
conditions in India such as cancer mental illness malaria and diabetes are not covered and the proposed
system of fixing the average of the top three brands as the ceiling price could lead to cartelization the
representative pointed out. More...
GI tag to boost Darjeeling tea exports

(Indrani Dutta , 16-Jan-2012 , The Hindu)
Darjeeling tea exports are set to increase by volume and value following its registration as a protected
geographical indication PGI product from India. More...
Bayer asked to give cost data

(CH Unnikrishnan , 14-Jan-2012 , Livemint)
Natco Pharma had sought compulsory licensing of cancer drug saying most patients found it too
expensive More...
KBL receives trademark registration for Jalverter

(BS Reporter / Mumbai/ Pune , 14-Jan-2012 , Business Standard)
Kirloskar Brothers Limited a fluid management company on Friday announced that it was granted
registration of its trademark Jalverter a patented multipurpose off grid solar inverter by the Office of the
Registrar of Trade Marks India. More...
Novartis cuts 2000 US jobs after patent loss

After cutting 2000 positions in late October mainly in Switzerland and the US the Basel based company
has again downsized its American operation. More...
Sony Music Entertainment files trademark for Kolaveri Di

(Vishal Dutta , 13-Jan-2012 , The Economic Times)
Viral super hit Why this kolaveri di may soon become the first song in India to have its first line
trademarked. More...
Microsoft reaches patent deal with LG

(IANS , 13-Jan-2012 , Zee News)
Microsoft Thursday announced a patent licensing agreement with LG Electronics covering tablets
smartphones and other consumer devices running Googles Android or Chrome operating system. More...
IBM keeps top patent spot for 19th year as Asian rivals gain
(Bloomberg / New York , 12-Jan-2012 , Business Standard)
International Business Machines Corp won a record number of US patents in 2011 its 19th straight year
on top as some Asian competitors advanced in the rankings at the expense of Microsoft Corp and Intel
Corp. More...
Darjeeling Tea tag: EU India meet in February

(Sutanuka Ghosal , 12-Jan-2012 , The Economic Times)
EU has registered the term Darjeeling as a protected geographical indication (PGI) for black tea
originating from the West Bengal region. More...
Scientists follow ancient literature to seek treatment for Parkinsons

(12-Jan-2012 , The Times of India)
But there are other molecules (not being disclosed yet as patent is pending) which are being tried on
human cell lines. More...
Outlook for Indian pharma companies remain stable: CARE

(Divya Rajagopal , 11-Jan-2012 , The Economic Times)
According to Care drugs worth $235 billion are expected to go off patent in the next five years leaving
the market open for off patent or generic drugs. More...
Markets cannot manage a knowledge economy

(Ananya Dutta , 11-Jan-2012 , Business Line)
Citing the example of Trade related Intellectual Property Rights (TRIPS) agreement he said that it was
not developmentally oriented. More...
India US trade talks postponed indefinitely

(Asit Ranjan Mishra & Elizabeth Roche , 10-Jan-2012 , Livemint)
A recent report by the USTR in December identified Nehru Place in New Delhi as among the 30 most
notorious IT markets of the world dealing in goods and services that infringe intellectual property rights.
More...
Indian innovator harnesses sea waves for power

(ANS , 10-Jan-2012 , The Economic Times)
The World Intellectual Property Organisation Geneva a United Nations agency also approved and
published the patent specifications for GPT. More...
Awareness about IPR is important

(Express News Service , The New Indian Express , 9-Jan-2012 , IBN Live)
A proper awareness about intellectual property rights is as important as awareness about land property
rights said Raju Narayana Swamy secretary Department of Youth Affairs. More...
Modi groups firm barred from using Morgardshammar trademark

Modi groups Morgardshammar India a rolling mill equipment manufacturer has been restrained from
using the Morgardshammar trademark by the Delhi High Court. More...
Smartphone battle: Google buys 217 IBM patents

(Reuters , 05-Jan-2012 , The Times of India)
Google confirmed that it has added more IBM patents to its technology arsenal as smartphone rivals
increasingly battle in courts over innovations. More...
Pfizer fastest growing drug MNC in India

Globally the bulk of Pfizer revenues come from exclusive sale of patent protected medicines and not
branded generics. More...
British firms bid to patent ginger foiled

India has foiled an attempt by a British pharmaceutical company to claim a patent on using ginger for
the treatment of cold. More...
A European pill best avoided

(S. Srinivasan , 4-Jan-2012 , Business Line)
The more stringent intellectual property regime under consideration will impact generics producers.
More...
Database helped thwart UK patent bid
India through the Traditional Knowledge Digital Library submitted its prior art evidences on April 25
2011. More...
No surprise that Nehru Place is one of the 30 markets violating IPR

(Shelley Singh , 3-Jan-2012 , The Economic Times)
Nearly half the worlds personal computers use software that is pirated. More...
Complex therapies in US lure pharma firms

(Priyanka Golikeri | Bangalore , 3-Jan-2012 , DNA)
The US market for pharmaceuticals is not just about patent expiries and billion- ollar drugs. More...
Getting your trademark - I

(02-Jan-2012 , Business Line)
With manufacturing costs going up and the value of the money depreciating companies are constantly
competing to gain market share at the expense of the other. More...
Google Apple working on tech to make passwords redundant

Last week Apple applied to the US patent office to register facial recognition software so instead of
sliding to unlock the iPhone iPad or iPod Touch one could simply point it at ones face. More...
HC rules in favour of Indian Co in trademark copyright case

The Bombay High Court has dismissed the Netherlandbased liquor groups plea seeking to restrain
Tilaknagar Industries Ltd here from using trademarks Mansion House and Savoy Club on products sold in
India. More...
Indian pharma companies obtains 144 ANDA approvals from US FDA in 2011
(Sanjay Pingle, Mumbai , 2-Jan-2012 , Pharmabiz)
Research based Indian pharma companies are set to capture a major share of the US domestic market
with increasing number of filing of Abbreviated New Drugs Applications. More...
Bobbili veena gets special GI tag

Now the famed Bobbili veena has earned a Geographical Indication certification from the central
government. More...
Dr Reddys plans Lipitor generic launch in June

(KV Ramana | Hyderabad , 30-Dec-2011 , DNA)
Dr Reddys Laboratories will hit the US market with its much hyped Lipitor generic in the first quarter of
next fiscal. More...
Shasun plans tie up with MNCs

(Gireesh Babu / Chennai , 30-Dec-2011 , Business Standard)
Shasun Pharmaceuticals Ltd is planning to expand its contract manufacturing business by partnering
with multinational companies to manufacture their patented products for Indian and Asian drug markets.
More...
Breaking the deadlock in WTO talks

(30-Dec-2011 , Livemint)
The eighth World Trade Organization ministerial conference concluded on 17 December with the
chairman citing an improved atmosphere but no concrete moves forward on the Doha Round trade talks.
More...
Another Bt cotton variant falls to fraud charges

(Zia Haq , 30-Dec-2011 , Hindustan Times)
Relying on Monsantos technology could have possible because its intellectual property rights protection
of 15 years had ended freeing violators from legal tangles sources said. More...
Patents office appoints 94 examiners to speed up process

(Himanshu Darji & Vishal DuttaHimanshu Darji & Vishal Dutta , 29-Dec-2011 , The Economic Times)
The Indian Patents Office has appointed 94 design examiners to speed up the process of granting
patents and clear a backlog of one lakh applications over the next three years. More...
Patents Bickerings With Rivals May Hurt Apple

(BLOOMBERG BUSINESSWEEK SAN FRANCISCO , 29-Dec-2011 , The Times of India)
Steve Jobs the co founder of Apple Inc. told his biographer that hed rather wage thermonuclear war with
Google than make deals to share its technology with the maker of the Android operating system More...
IP office recast may roll back reforms fear stakeholders

(David Shaftel & C.H. Unnikrishnan , 28-Dec-2011 , Livemint)
Some 400 000 trademark applications are pending and the IP office has resorted to outsourcing or
temporary hiring More...
Yahoos unit Overture Services Inc faces patent roadblock for paid search technology
(Sanjay Vijayakumar & Sangeetha Kandavel , 27-Dec-2011 , The Economic Times)
In a setback to internet major Yahoo the Intellectual Property Appellate Board in Chennai has rejected a
patent filed for a paidsearch technology by its unit Overture Services Inc, after opposition from
Rediff.com India. More...
Soon database on Indian bio resources

(Dipannita Das , 27-Dec-2011 , The Times of India)
The Unit for Research and Development of Information Products here has prepared a database of
patents granted world wide to Indian bio resources including food crops forest trees marine organisms
microbial resources livestock other animals and agro resources. More...
Government eases norms for gold silver mix in Kanchipuram sarees

(SANGEETHA KANDAVEL & SANJAY VIJAYAKUMAR , 27-Dec-2011 , The Economic Times)
Since 2005 Kanchipuram silk sarees have been protected by Geographical Indication label which not only
certifies their geographical origin but also confirms adherence to some production standards. More...
Tilaknagar Industries wins trademark battle in Bombay HC

(India Infoline News Service , 27-Dec-2011 , India Infoline)
TI is a leading player in the IMFL industry with a dominant presence in South India and continues to
successfully extend its footprints on a pan India basis More...
Compliance quality issues cast shadow on pharma deals

(Namrata Nandakumar & C.H. Unnikrishnan , 26-Dec-2011 , Livemint)
Quality and compliance issues over previous deals with Indian firms have hit the revenues of global drug
makers More...
EU ruling on transit goodscase cheers Indian drug cos

May end instances of non member consignments being seized More...
Healthy year for pharma sector on right policy prescriptions

Quality pricing intellectual property issues are challenges in the new year More...
Patent firm sues German retailers over HTC phones

Patent firm IPCom has sued German retailers for patent infringement for continuing to sell phones made
by HTC the No. 4 smartphone maker globally. More...
Roche drags DRL to court over patents

In yet another legal blow to pharma major Dr Reddys Laboratories Swiss healthcare giant Roche Holding
AGs two US based arms have slapped a lawsuit on the Hyderabad based company for infringing on a US
patent for anti viral drug Valcyte. More...
China tops U.S Japan to become top patent filer

( Lee Chyen Yee | Reuters , 22-Dec-2011 , Yahoo News)
China became the worlds top patent filer in 2011 surpassing the United States and Japan as it steps up
innovation to improve its intellectual property rights track record a Thomson Reuters research report
showed on Wednesday. More...
Goan Fenny set to lose its odour for better status

Fenny which is usually brewed from cashew or coconut has already attained Geographical Indication
status following a protracted struggle by its ardent supporters. More...
Negative factors economic slowdown seriously retard growth of Indian pharma: Dr MD Nair
(Our Bureau, Bengaluru , 22-Dec-2011 , Pharmabiz)
Economic downturn reduced investments high costs of R&D and low productivity patent cliffs pressure
on drug prices poor image of the industry and stricter regulatory controls have seriously affected the
pharma sector pointed out Dr MD Nair pharma consultant. More...
The health of nations

(T S Vishwanath , 22-Dec-2011 , Business Standard)
Multilateral forums should address the fear that strong pharma patent protection can affect public health
in developing countries More...
Ranbaxy Laboratories: Settlement takes away gains from Lipitor launch

(Kiran Kabtta Somvanshi , 22-Dec-2011 , The Economic Times)
Drug maker Ranbaxys fortunes have reversed swiftly with the cost of settlement with the USFDA almost
wiping off the gains from the exclusive launch of Lipitor. More...
Android patent rulings signal trouble for Google

(Bloomberg , 21-Dec-2011 , The Times Of India)
Google Inc is facing potential setbacks in its efforts to get smartphone makers to stick with the Android
operating system as legal rulings begin to roll in on patent infringement claims by Apple Inc and
Microsoft Corp. More...
Pharmaceutical stocks to gain on depreciating rupee patents

While the pharma sector has outperformed the broader market valuations have come off the peak
More...
Microsoft wins patent decision against Android

(Bloomberg , 21-Dec-2011 , The Times of India)
Microsoft Corp won a ruling that Motorola Mobility Holdings Incs Android phones violate one of its
smartphone patents while failing to convince a judge that six others are being infringed as well. More...
Apple wins patent row on some HTC phones

(Bloomberg / Washington , 21-Dec-2011 , Business Standard)
Apple Inc won a patent infringement ruling that bans some HTC Corp smartphones from the US starting
next year bolstering efforts to prove that devices running Google Incs Android operating system copy
the iPhone. More...
Delhis Nehru Place among top 30 markets that violate IPR

An official US report has identified Nehru Place in New Delhi among the top 30 notorious IT markets of
the world dealing in goods and services infringing intellectual property rights. More...
Now Mysore Silk too will have fusion labels

(Vinobha K T , 21-Dec-2011 , The Times Of India)
KSIC which has obtained the geographical indication registration for Mysore silk in 2005 is the sole
proprietor of the brand he said adding that traders merchants or unlicensed manufacturers are
prohibited form using the brand name Mysore Silk he added. More...
Kodak patent ruling delayed amid cash worries

(AP , 20-Dec-2011 , The Economic Times)
A US arbiter for trade disputes is delaying a ruling on Eastman Kodak Co.s high stakes patent
infringement claim against smartphone makers Apple Inc. and Research in Motion Ltd. More...
BT sues Google in US over patent infringement

(Reuters / London , 20-Dec-2011 , Business Standard)
British telecoms firm BT has launched legal action against Google in the United States over patent
infringement in a number of key areas for the technology group such as mobile map services. More...
Apple vs Samsung: Samsung files new claims

Samsung Electronics has filed new claims in its patent war with Apple Inc over alleged patent
infringements in Germany a spokesman for the company said on Monday. More...
With new generic rivals Lipitors sales halved

(LINDA A. JOHNSON , 19-Dec-2011 , Business Week)
Two generic versions costing about a third less hit the market right away one made by Indias Ranbaxy
Laboratories Ltd. and the other an authorized generic made by Pfizer and sold by its partner Watson
Pharmaceuticals Inc. More...
Chennai HC rejects Roches patent suit against Matrix in light of lack of jurisdiction
Dr Gopakumar G Nair intellectual property and patent and trade mark attorney pointed out that under
the recent judgement the HC held that Matrix by approaching the IPA Board Chennai did not give rise to
a cause of action from Roche against Matrix as mere filing of an application for revocation in IPA Board
Chennai cannot give rise to a cause of action especially since IPA Board has its headquarters at Chennai.
More...
ITC to review ruling on HTC patent suit vs Apple

The International Trade Commission said on Friday it will revisit in part a decision by an ITC
administrative law judge who had found no violation by Apple of four HTC patents that include
technologies for power management and phone dialing. More...
HC order hits Dunlops brand transfer plan

(Arnab Dutta & Manish Basu , 16-Dec-2011 , Livemint)
Tyre maker Dunlop India Ltds plan to transfer its rights to 100 odd trademarks to private firms owned
by its promoter Pawan Kumar Ruia has been nixed at least for the time being by a Calcutta high court
order. More...
NEW POLICY & PATENTED DRUGS

(P A Francis , 14-Dec-2011 , Pharmabiz)
After almost a decade of preparing notes and drafts officials in the Department of Pharmaceuticals could
come out with a draft proposal for a new drug pricing policy last month. More...
Investors seem to shrug off Glenmarks crofelemer dispute

(Ravi Ananthanarayanan , 14-Dec-2011 , Livemint)
Glenmarks performance is expected to benefit from growing contribution from generic product sales in
the US market similar to that of other Indian firms targeting a number of drugs going off patent. More...
Hoffman La Roche loses patent suit against Matrix Pharmaceuticals

(Divya Rajagopal , 14-Dec-2011 , The Economic Times)
Swiss drug company Hoffman La Roche has lost a patent infringement suit against Matrix
Pharmaceuticals to prohibit the Indian firm from selling its anti cancer drug Tarceva. More...
Glenmark in legal row with Napo Pharma

(Special Correspondent , 14-Dec-2011 , Business Line)
It was a collaboration that would have resulted in a proud first for the Indian pharmaceutical industry
but has landed in a legal tangle instead. More...
Madras HC dismisses Roche case against Intas

(P.T. Jyothi Datta , 13-Dec-2011 , Business Line)
Single sale of cancer drug by a retailer not authorised by Intas More...
India still needs a WTO

(Suman Bery , 13-Dec-2011 , Business Standard)
The Doha Round has been left behind but Indias trade requires a solid institutional structure More...
Kazaa creator sues Internet giants for patent infringement

(ANI , 12-Dec-2011 , The Times Of India)
A US based entrepreneur and a creator of file sharing application Kazaa Kevin Bermeister has sued
several Internet giants including Google and YouTube for infringing their eight patents in their cloud
computing products. More...
NGO asks European Commission not to push India to accept IP provisions in EU India FTA
In a letter to to EC Commissioner for Trade Karel De Gucht the NGO DNP+ has expressed concern over
the ECs alleged secret efforts to bring back intellectual property provisions like data exclusivity and
investment provisions into the negotiations. More...
Eatery wins war to rid patent cover off low sugar sweet
A popular eatery chain in thecity haswon a patent war with an entrepreneur duo who had patented a
lowsugar low glycemic preparation as their own and restrained the food chain from preparing similar
delicacy. More...
Samsung wins round in long legal fight with Apple

Samsung Electronics Co won a round of its bruising global patent fight with Apple Inc on Friday when an
Australian court lifted a ban on the sale of its Galaxy tablet computer in time for the busy Christmas
shopping season. More...
India stands to gain from patent cliff

(Shilpa Kannan , 8-Dec-2011 , BBC News)
The patent cliff has begun. More...
Drug firms to gain from US patent expiries

(Joe C Mathew / New Delhi , 7-Dec-2011 , Business Standard)
Lipitor like exclusivity awaits Indian drug companies as 46 patents expire in 2012-15. More...
Expert calls to set up IPR cells at varsities

(Jaideep Deogharia , 7-Dec-2011 , The Times of India)
Mesra has got seven patents BAU has obtained registration for four varieties of rice from the patent
office. More...
How policies can bypass Indias parliament

(Alam Srinivas , 07-Dec-2011 , BBC News)
The Congress led coalition pushed through critical amendments to the existing patents laws through an
ordinance which was later passed by parliament with many amendments. More...
Bayer Indias Cipla settle trademark suit

(Zeba Siddiqui in Bangalore , 7-Dec-2011 , Reuters)
Bayer AGs healthcare unit said it settled trademark infringement cases with Indian drugmaker Cipla and
Vanuatu based website operator Archipelago Suppliers concerning the German drugmakers pet products.
More...
Amul sues Nestle for copying A+ brand

(Ratna Bhushan , 06-Dec-2011 , The Economic Times)
We own the rights to use a+ as a trademark and therefore do not see why anyone should object to our
using it. More...
Elder Pharma to foray into Japanese market by FY12 end

(Press Trust of India / New Delhi , 06-Dec-2011 , Business Standard)
Drug firm Elder Pharmaceuticals today said it planned to enter the Japanese pharma market during the
current fiscal as it had received accreditation from the Japanese Ministry of Health for its Patalganga
facility. More...
Oranges: India ranks 64th in productivity

(06-Dec-2011 , Business Line)
Coorg orange grown in the Kodagu Hassan and Chikmagalur districts of Karnataka is awarded
Geographical Indication owing to its characteristics such as medium sized fairly tight skinned orange
yellow fruits having dark orange pulp being tender juicy with a rich flavour and excellent blend of acid
and sugar. More...
Richcore Lifesciences launches first ever enzymatic clean technology Ecosol

(Nandita Vijay, Bangalore , 3-Dec-2011 , Pharmabiz)
Richcore currently enjoys a little safety with its patents and first mover advantage in developing traction
for its novel applications he said. More...
Indian yoga guru sues student for copying technique

(Agencies , 02-Dec-2011 , Indian Express)
Kolkata born Bikram Choudhury is the founder of Bikram Yoga and has copyrighted his unique hot yoga
classes. More...
Ranbaxy hits US with Lipitor copy

(C.H. Unnikrishnan & Namrata Nandakumar , 02-Dec-2011 , Livemint)
Ranbaxy and Watson Pharmaceuticals Inc. are the two companies allowed to sell generic versions of
Lipitor for now. More...
NGOs experts to hold national consultation on generic drug production and challenges
(Joseph Alexander, New Delhi , 02-Dec-2011 , Pharmabiz)
A number of public interest groups and health activists will hold a two day national consultation here
from December 6 on Generic drug production and access to medicines: Current challenges and prepare
a roadmap to ensure affordability and accessibility of drugs in the country. More...
Apple vs Samsung suit full of secret combat

(Dan Levine and Carlyn Kolker , 02-Dec-2011 , Reuters)
The biggest legal battle for the technology industry is playing out in a federal court in Silicon Valley
where Apple is trying to stop Samsung from selling Galaxy phones and tablets in the United States.
More...
AU faculty to patent six compounds against HIV

(Rajiv Mani , 1-Dec-2011 , The Times of India)
In a major breakthrough against the dreaded AIDS virus a young faculty from department of Chemistry
Allahabad University along with scientists from National AIDS Research Institute Pune would soon be
patenting six new compounds that have proved patent against the dreaded AIDS spreading HIV. More...
US patents: Ittiam Systems has more than twice that of Infosys

(Hari Pulakkat , 1-Dec-2011 , The Economic Times)
Ittiam has an impressive pipeline of 60 patent applications pending for approval. More...
Jets patent challenge against Virgin dismissed

(P.R. Sanjai & C.H. Unnikrishnan , 01-Dec-2011 , Livemint)
The British carrier can now get the design and technology for its upper class seats patented in India
More...
Civil society groups hold protest demonstration in Mumbai against Novartis

Novartis has taken the Indian government to the Supreme Court challenging the legal interpretation of a
critical public health safeguard in the countrys patent law Section 3d that principally limits the patenting
of new uses and new forms of old medicines in India. More...
Samsung scores win in patent case

Samsung Electronics is set to resume selling its Galaxy tablet computer in Australia as early as Friday
after the South Korean technology firm won a rare legal victory in a long running global patent war with
Apple. More...
Ranbaxy gets USFDA approval for generic Lipitor

(PTI , 01-Dec-2011 , The Hindu)
Ranbaxy and Pfizer had settled all of their litigations worldwide over the Lipitor patent in 2008. More...
Lipitor goes off patent today Pfizer vs Ranbaxy led Indian pharmas war for blockbuster drugs
intensifies
Indian pharma companies quest to make millions from the sale of copycat versions of blockbuster drugs
may turn out to be a flop show as innovative companies raise defences to protect their turf. More...
Samsung wins appeal in Apple tablet battle

The Federal Court granted an interim order against the sale of the Galaxy 10.1 in October ruling that
Apple had established a prima facie case that the South Korean company had breached touchscreen
technology copyrights. More...
Copyright society moves HC against govt circular

(DNA Correspondent , 29-Nov-2011 , DNA)
A non government organisation with over 2500 members which is the sole copyright society in India has
moved the Bombay High Court challenging the circular issued by the state de recognised the society and
directing auditoriums not to pay its fees. More...
Supreme Court set to hear plea on patents

(Menaka Rao , 28-Nov-2011 , Hindustan Times)
The Supreme Court will start hearing in a case that could decide the cost of treating HIV Aids in the
country. More...
Apple wins patent for intelligent dock connector

(Joe Aimonetti , 29-Nov-2011 , cnet)
Apple has just been granted a patent that details an intelligent dock connector able to properly adjust
power levels for multiple connected devices from a single outlet source. More...
Higher US drug sales pep up revenue show

(Ram Prasad Sahu / Mumbai , 28-Nov-2011 , Business Standard)
Going ahead growth is likely to be sustained due to the upcoming launches of cholesterol lowering drug
Lipitor and anti psychotic medicine Geodon among others. More...
Supreme Court to hear Novartis case on Section 3(d) of Indian patent law on Nov 29
The next hearing of Novartis vs Union of India case in Supreme Court regarding interpretation on
Section 3(d) of the Indian patent law will be held on November 29 2011. More...
Patent firm IPCom says to stop HTC German sales

(Reuters , 28-Nov-2011 , IBN Live)
German patent firm IPCom plans to halt as quickly as possible the sale of all HTC smartphones in
Germany another blow to the Taiwanese firm just two days after it shocked markets by cutting its fourth
quarter outlook. More...
PU claims breakthrough in anti ageing research

(Ritu Sharma , 27-Nov-2011 , Indian Express)
For this formulation and research it has already applied for patents with the Indian Patent Application.
More...
THE END OF LIPITOR

(P A francis , 25-Nov-2011 , Pharmabiz)
Worlds top pharmaceutical company Pfizer Inc.stands to lose patent rights for its largest selling drug
Lipitor in the US on November 30. More...
Bayer withdraws writ petition against Natco

In a new twist to the ongoing legal battle between German drug multinational Bayer Healthcare AG and
Hyderabad based cancer drug maker Natco Pharma Ltd over the compulsory licensing of Bayers cancer
drug Nexavar the Delhi high court last week dismissed the foreign companys writ petition as withdrawn.
More...
MNC monopoly mars critical drugs

(Joe C Mathew / New Delhi , 25-Nov-2011 , Business Standard)
Study says formulation for some critical ailments enormously priced. More...
Pfizer fights to retain Lipitor market share

Pfizer has offered to deliver Lipitor at a cut price of $4 directly to patients in its fight to retain market
share of the worlds largest selling drug just days before the US patent for the medicine is due to expire.
More...
Betting on innovation
(T S Vishwanath , 24-Nov-2011 , Business Standard)
A recent report by the World Intellectual Property Rights The Changing Face of Innovation provides
some interesting insights to answer this question. More...
DoP looks to speed up functioning of panel on patented drug pricing ahead of pharma policy
(Joseph Alexander, New Delhi , 23-Nov-2011 , Pharmabiz)
After toying with the idea of fixing the prices of patented drugs through negotiations before marketing
them in the country for nearly five years the Department of Pharmaceuticals now wants to speed up the
working of the expert committee set up to suggest a mechanism in this regard. More...
Abbott Dabur GSK eye Jagdales energy drinks biz

(Boby Kurian & Reeba Zachariah , 23-Nov-2011 , The Times Of India)
The brand a patented fruit-based electrolyte drink competes in the broader energy drinks segment that
include players like Gatorade from PepsiCo. More...
India EU finalise give & take in FTA

(Nayanima Basu / New Delhi , 22-Nov-2011 , Business Standard)
Negotiations for the ambitious India EU free trade agreement is on in full steam and in the final stages
of give and take even as the euro zone crisis has gripped all its 27 member countries. More...
Zydus Cadila faces patent suit in US over drug Asocol

US based Warner Chilcott Plc has moved court against Zydus Cadilas plan to produce a bowel
inflammation drug Asocol. More...
Microsoft seeks patent on employee spy system

(Iain Thomson in San Francisco , 18-Nov-2011 , The Register)
Microsoft has filed a patent for a system that monitors the behavior of employees via computers phone
calls and physical gestures and alerts human resources if anyone is behaving outside of preferred
norms. More...
Lupin set to buy Japanese firm I'rom Pharma

Country is worlds second largest individual drugs market More...
US oral contraceptive mkt draws Indian pharma

(Reghu Balakrishnan / Mumbai , 17-Nov-2011 , Business Standard)
Indian pharmaceutical companies which always wanted a big share in the global copycat drug market
are betting high on the oral contraceptive market in America. More...
Now Hyderabad patent to auto meter tampering

(Rahul Devulapalli , 17-Nov-2011 , The Times Of India)
In the city your auto fare could vary depending on the brand of clothes you wear and not according to
the rates on the fare chart issued by the Road Transport Authority. More...
Music industry to crackdown on copyright violations in Goa

(IANS , 17-Nov-2011 , Zee News)
A music copyright vigilante authority has threatened to launch Halla Bol along Goas coastal belt known
for its music blaring beach shacks scorching raves and techno night party hang outs this year even as
the tourist season is all set to begin in a few days. More...
Bayer to bring innovative products into India

Germany headquartered Bayer AG is committed to bringing more products into India said Chairman Dr
Marijn Dekkers even as he underlined the need to protect intellectual property rights in the country.
More...
Coimbatore man applies for patent to 20 varieties of idlis

(Kumar Chellappan , 16-Nov-2011 , DNA)
If variety is the spice of life then nobody other than Kovai Iniyavan of Coimbatore has truly lived upto
the adage. More...
Pharma brand launches slump this year

The number of new molecules companies could target have come down and drug firms are careful of
new launches due to patent regime restrictions. More...
Look out! Here comes Apples killer location services patent

(Erik Sherman , 16-Nov-2011 , CNET)
Apple has raised bludgeoning competitors with patents on key technologies to a fine art. More...
Intellectual property protection is key for investment in India

(Surabhi Agarwal , 15-Nov-2011 , Livemint)
Is the lack of a strong regime on software piracy and intellectual property hurting the Indian information
technology industry in terms of attracting business? More...
India can boast of a healthy patent pipeline

System to access patent information on cards More...
Utility patenting: Indias next move?

The patent model suggests less stringent intellectual property protection to support incremental
research More...
Gulf turmoil hit Indian tea exports

(Mithun Dasgupta , 13-Nov-2011 , DNA)
But there is some good news for exporters of Darjeeling tea with the European Union registering the
product as a Protected Geographical Indication which aims to protect product names from misuse and
imitation. More...
Ranbaxy Labs posts loss of Rs.465 crore

(Kaustubh Kulkarni/Reuters , 10-Nov-2011 , Livemint)
Lipitors patent protection expires 30 November after which two new versions of the drug are expected to
be sold by Ranbaxy and Watson Pharmaceuticals. More...
Huawei in Android patent talks with Microsoft

(ANI , 08-Nov-2011 , The Times of India)
Chinas leading telecom company Huawei has confirmed that it is in talks with Microsoft over the use of
Android software. More...
Google accuses Microsoft of abusing patents system

(ANI , 08-Nov-2011 , The Economic Times)
A Google lawyer has accused software giant Microsoft of abusing the patent system by using them only
its products stop succeeding. More...
Mango Mazaa producer barred from branding it after Maaza
An Indian soft drink producer has been restrained by the Delhi High Court from naming its product as
Mango Mazaa deceptively similar to multinational Coca Colas mango flavoured drink Maaza. More...
DIPP amends FDI policy on options in equity instruments by deleting Clause 3.3.2.1
(Suja Nair Shirodkar, Mumbai , 7-Nov-2011 , Pharmabiz)
According to Dr Gopakumar G Nair intellectual property and patent and trade mark attorney the real
strength of India over the years have been a strong autonomous and non corrupt RBI. More...
Partnership is the new norm in pharma sector

Eight years earlier Ranbaxy the countrys largest drug company created a stir by challenging the patent
on the worlds highest revenue earning medicine Lipitor in the US. More...
Kodak could run out of US cash in 12 without help - Moodys

(Liana B. Baker , 07-Nov-2011 , Reuters)
Without an infusion of cash from a sale of patents or some hundreds of millions of dollars in additional
financing Eastman Kodak Co would run out of cash in the U.S. in 2012 according to a research note
published on Monday by the credit agency Moodys. More...
Cadbury secures favourable HC order in trademark case

(PTI , 06-Nov-2011 , Business Line)
Cadbury India Ltd the domestic arm of U.S. confectionery major Kraft Foods Inc has secured a relief
from the Delhi High Court which restrained a local garment manufacturer from promoting its apparel
under the phonetically identical trademark Cadbeery. More...
Strong policy support, incentives are better option to pharma sector than FDI cap: Dr G G Nair
(Suja Nair Shirodkar, Mumbai , 5-Nov-2011 , Pharmabiz)
Pharma industry wants the government to give more incentives to this sector so that it would not be
forced to look at the foreign direct investment route for growth. More...
Apple Samsung patent battle worries Brussels

(Alex Barker in Brussels and Richard Waters in San Francisco , 04-Nov-2011 , Financial Times)
Europes competition watchdog is investigating the increasingly aggressive legal tactics being used in
Samsungs patent battle with Apple in what could pave the way for an in depth antitrust probe into the
hotly contested intellectual property agreements that underpin the smartphone technology market.
More...
Ranbaxys plan for Lipitor fuels speculation

With hardly four weeks for patent expiry of the worlds largest revenue earning drug Lipitor in the US
speculation is rife as to how Ranbaxy will exploit this. More...
Kodak may need patent sale new debt to survive
(Liana B. Baker , 4-Nov-2011 , Reuters)
Eastman Kodak Co spooked investors on Thursday by warning it may need to raise new debt or
complete a multibillion dollar patent sale to survive the next 12 months sinking shares by as much as
11.7 percent. More...
Sanofi battles through patent expiries restructuring looms

(Kevin Grogan , 03-Nov-2011 , Pharma Times)
Sanofi has posted financials for the third quarter this morning which show that net profit slipped 3.0% to
2.40 billion euros while sales edged up 5.0% to 8.75 billion euros. More...
Bitter row over Agras trademark sweet

(IANS , 02-Nov-2011 , Zee News)
No trip to Agra is complete without two essentials a glimpse of the Taj Mahal and a sampling of the
famous Agra ka petha. More...
Investors want to see Kodaks cash

Wall Street will be focused on how much cash Eastman Kodak has left on its balance sheet along with
hints of progress on a multibillion dollar patent sale when More...
Pharma sector unlikely to sustain current premium over Sensex

(Nirmal Bang , 02-Nov-2011 , Livemint)
We believe the international growth drivers led by the US generics market which is in a multi year
cyclical upturn given the impending patent cliff and emerging markets owing to favourable demographics
and similarity with the domestic market still hold and would partially cushion any erosion in PE multiple.
More...
Piramals US arm settles case with Baxter on inhaled anesthetic agent

Suprane is Baxters product of Desflurane an anesthetic agent typically used in hospital settings. More...
Can Kodak rescue itself via a patent bonanza?

(Associated Press , 31-Oct-2011 , IBN Live)
Kodak the company that invented the first digital camera in 1975 and developed the photo technology
inside most cellphones and digital devices is in the midst of the worst crisis in its 131 year history.
More...
Civil society groups ask WHO members to drop IMPACT avoid counterfeit term
The term Counterfeit is defined by the WTO TRIPS Agreement as referring to a specific category of
trademark violation1 and in some legislation to all other intellectual property violations as well. More...
Copyright issue: Hearing on Desiboyz adjourned
(PTI , 28-Oct-2011 , DNA)
The lawyer of the Bollywood director Rohit Dhawan today told the Bombay High Court that he would file
reply to the petition by a Latur based script writer claiming copyright on the title and the story of the
Dhawans upcoming film Desiboyz. More...
Lupin gets USFDA nod for oral contraceptive tablets

(PTI , 28-Oct-2011 , Business Line)
The approval for generic version of LoSeasonique tablets is the third approval for the Mumbai
headquartered firm in the oral contraceptives portfolio. More...
Darjeeling tea gets EUs protected tag

The European Union EU has registered Indias Darjeeling tea with a Protected Geographical Indication.
More...
Dr Reddys to push complex products, increase R&D spend

(KV Ramana , 26-Oct-2011 , DNA)
We do not want to limit ourselves just to the opportunities coming up through patent expiries. More...
Govt to give fin support to develop Intellectual Prop Rights

(PTI , 25-Oct-2011 , MSN)
The government will provide financial support to educational institutes and industry associations for
conducting programmes to create awareness on Intellectual Property Rights. More...
Apple wins slide to unlock patent

(Joe Aimonetti , 25-Oct-2011 , cnet)
Many of the patent applications and grants we come across involving Apple relate to theoretical products
that may never see the light of day. More...
Tide Water buys rights to Veedol trademark

(Manish Basu , 25-Oct-2011 , Livemint)
Tide can now expand Veedol sales across the world after buying trademark rights from BP. More...
Desi Boyz title in copyright violation row

(Rosy Sequeira , 25-Oct-2011 , The Times of India)
A scriptwriter has moved the Bombay high court alleging copyright violation in the title of the Akshay
Kumar John Abraham starrer Desi Boyz which is slated for release next month . More...
Health groups ask govt to issue compulsory licenses to make HCV drugs affordable
(Our Bureau, Mumbai , 22-Oct-2011 , Pharmabiz)
A group of health activists in the country demanded to the government to either reject the patents given
to Hepatitis drugs or to issue compulsory licensing to make these drugs accessible to the common
people as Hepatitis C virus is emerging as a growing public health threat in India. More...
BlackBerry maker accused of infringing BBX trademark

(Pav Jordan and Alastair Sharp , 21-Oct-2011 , Reuters)
BBX the operating system that Research In Motion is counting on to revive its floundering BlackBerry
franchise has run into trouble even before the company could install the system in its smartphone line.
More...
Ra.One copyright issue heats up HC reserves order

(DNA Correspondent , 21-Oct-2011 , DNA)
Thus we moved the single bench of the high court which rejected our claim on October 12 and thus we
moved an appeal. More...
How to register a trademark?

(Edlyn G D'Souza , 19-Oct-2011 , The Times Of India)
If youre starting a new business or trade a logo name or signature is the first thing you choose to
separate yourself from the rest. More...
Pharma MNCs pills make Indian rivals sick

(Ram Prasad Sahu / Mumbai , 19-Oct-2011 , Business Standard)
Severe price cuts help multinationals ramp up growth gain market share. More...
After US Dr Reddys eyes Europe for Arixtra play

Dr Reddys Laboratories is looking to take its limited competition candidate fondaparinux sodium generic
Arixtra to the European market. More...
Panel warns on pharma MNC demands

(Soma Das , 18-Oct-2011 , The Financial Express)
The committee acknowledges that prices of medicines have shot up in those countries where such IPR
principles advocated by innovator pharma companies mostly from the US have been introduced. More...
Kodak to license over 1000 patents to Imax

(AP , 17-Oct-2011 , The Economic Times)
Eastman Kodak Co said that it will license thousands of patents to Imax in a deal that will supply the
troubled photography company with millions of dollars. More...
Samsung loses Dutch bid to ban Apple products

(Reuters , 15-Oct-2011 , IBN Live)
A Dutch court on Friday turned down Samsung Electronics request for an injunction against all of Apples
mobile products that use 3G telecommunications technology denying it revenge over a similar move by
Apple. More...
US judge says Samsung tablets infringe Apple patents

(Reuters , 17-Oct-2011 , IBN Live)
A US judge said Samsungs Galaxy tablets infringe Apples iPad patents but also that Apple might have a
problem establishing the validity of its patents. More...
US patent process may turn cheaper for pharma cos

(G. Naga Sridhar , 14-Oct-2011 , Business Line)
Indian pharma companies especially smaller ones can look forward to a cheaper patent filing and
litigation process in the US. More...
Apple must show valid patents in Samsung case: Judge

A US judge said that Samsung Electronics Galaxy tablets infringe Apple Incs iPad patents but added that
Apple has a problem establishing the validity of its patents in the latest courtroom face off between the
technology giants. More...
Public interest groups call for moratorium on pacts by patent pool with Indian generic
companies
A host of public interest organisations have joined this coalition that has written to the UNITAID and the
Medicine Patent Pool. More...
Dangers of FDI in pharma

(S. Srinivasan , 13-Oct-2011 , Business Line)
No matter what the Maira panel would have us believe foreign pharma firms will continue to buy out low
cost domestic manufacturers and raise prices. More...
Four growth drivers beyond patent for pharma companies like Sun Pharma Sanofi
(Gauri Kamath , 13-Oct-2011 , The Economic Times)
It is not just Big Pharma that has to prepare for life after the patent cliff patent expiries on a slew of
blockbuster drugs. More...
Dunlop India transferring trademarks to Ruia flagship

(Aveek Datta , 13-Oct-2011 , Livemint)
Dunlop India Ltd is transferring its rights to around 100 odd trademarks including Dunlop Falcon and
Monotona to Ruia Sons Pvt. Ltd the flagship holding company of Pawan Kumar Ruia an entrepreneur who
controls the beleaguered tyre maker. More...
Pharma brand launches in local market dips

(Khomba Singh , 12-Oct-2011 , The Economic Times)
New brand launches in the local drug market have declined over the last few years as the number of
original drugs going off patent has come down and as Indian companies look at new business models to
boost sales and increase profits. More...
Aurobindo Pharma gets royalty free licence for AIDS drug

(Joe C Mathew / New Delhi , 12-Oct-2011 , Business Standard)
Aurobindo Pharma has become the first major generic drug maker to gain royalty free production and
supply rights for five AIDS medicines through an agreement with Geneva based Medicines Patent Pool.
More...
Aurobindo first major generic drugs maker to tap into Patent Pool
(P.T. Jyothi Datta , 11-Oct-2011 , Business Line)
Generic drugs maker Aurobindo Pharma Ltd has signed an agreement with the global Medicines Patent
Pool for the manufacture of several antiretroviral medicines making it one of the first major generic
companies to tap into the patent pool. More...
Investors to lose from changes in pharmaceutical FDI policy

(Ravi Ananthanarayanan , 11-Oct-2011 , Livemint)
They are launching off patent drugs expanding their field force entering new product categories and
markets and even going to rural markets. More...
Pharma acquisitions to be routed through CCI

(Special Correspondent , 11-Oct-2011 , The Hindu)
Move after concerns raised over acquisitions of Indian pharma companies by multinationals More...
India to retain 100% foreign pharma investment

(Lynne Taylor , 11-Oct-2011 , Pharma Times)
India will continue to permit 100% foreign direct investment in new pharmaceutical industry projects but
foreign takeovers of Indian drugmakers will come under tighter scrutiny the cabinet agreed yesterday.
More...
India pitches for including IPR equitable access in climate talks

(fe Bureau , 11-Oct-2011 , The Financial Express)
Taking a hard stance for the coming climate talks in Durban this December the government has
submitted a proposal to the secretariat of the United Nations Framework Convention on Climate Change
to include three contentious issues of unilateral trade measures intellectual property rights and equitable
access to sustainable development for inclusion in the talks’ provisional agenda. More...
The murky world of intellectual property

(C.GOPINATH , 09-Oct-2011 , Business Line)
Patents are bought and sold through layers of shell companies and people will not talk for fear of being
dragged to court. More...
DIPP moves note on making patents office independent
Indias intellectual property office overseeing patents and trademarks should be granted autonomy to
make it more responsive and effective a government department has suggested. More...
Patent and Trademarks may be split into separate entities

(PTI , 7-Oct-2011 , MoneyControl)
With a pileup of over 4.40 lakh applications for trademarks and 76000 for patents the government is
mulling separate establishments for handling the claims for the two key Intellectual Property Rights
IPRs. More...
Government moves to overhaul patent regime

(HT Correspondent , 07-Oct-2011 , Hindustan Times)
The government has invited comments from the public on reviewing the organisational structure of the
office of the controller general of patents designs trademarks and geographical indications CGPDTM to
make it more responsive to the needs of Intellectual Property holders and users while enhancing the
effectiveness and efficiency of its operations. More...
MSF contends Novartis plea that case against sec 3d will not impact access to medicines
On Novartis statement that Section 3d as it relates to evergreening is not applicable at all to Glivec the
MSF countered that Novartis is seeking a patent in India on the salt form of imatinib Glivec. More...
Hyderabadi biryani looks for GI tag

Well the much relished dish is likely to get a Geographical Indication GI status soon that will have a logo
or hologram to assure foodies that its the original Hyderabadi biryani laid out on the plate. More...
Sanofis acquired companies to retain local indentity

(C. H. Unnikrishnan , 5-Oct-2011 , Livemint)
Sanofi has undergone an impressive transformation over the last two and a half years and it had already
put the bigger threat of patent expiry of some of its blockbuster drugs in the US and other key markets
in the past he said More...
India looking to conclude FTA with EU this year: Anand Sharma

India today said it is looking to conclude the proposed comprehensive free trade pact with the European
Union this year as the negotiations are in advanced stage with the 27 nation bloc. More...
National Pharmaceutical Pricing Authority may get power to verify landed cost of drugs
The drug price watchdog may get powers to verify landed cost of drugs that are under its control.
More...
Kodak weighs options to clear path for sale
Eastman Kodak Co the unprofitable 131 year old camera maker is weighing options including a
bankruptcy filing because of concerns raised by possible buyers of its patent portfolio said three people
with direct knowledge of the process. More...
Branded generics strategy important to drive growth

(Viswanath Pilla & Namrata Nandakumar , 3-Oct-2011 , Livemint)
So most of them are facing the prospect of large revenue producing products coming off patent facing
generics competition and at the same time their late stage pipelines are not adequate to fill the revenue
yet. More...
For pharma MNCs India is an effective pill not a placebo

(D. SAMPATHKUMAR , 02-Oct-2011 , Business Line)
The strategic environment has got murkier for pharma MNCs with fairly new drugs working for fewer
people and litigation problems to contend with too. More...
Khadi cloth still not protected by IPR

Did you know that the popular Darjeeling tea Tirupathi laddu Kancheepuram Silk saree Pochampalli Ikat
and basmati rice are all protected under the Geographical Indications but the Khadi cloth is yet to get
protected in India? More...
Drug makers seek sops to crack off patent opportunity

The much hyped off patent opportunity worth $30 40 billion is likely to remain a tough nut to crack for
the Indian pharmaceutical industry considering the roadblocks in the form of insufficient infrastructure
and lack of proper policy framework at the government level. More...
Intellectual property laws in India suck: Rick Goings Tupperware

(Ratna Bhushan & Bhanu PandeRatna Bhushan & Bhanu Pande , 30-Sep-2011 , The Economic Times)
One thing that irks Goings about the country however is its intellectual property rights laws. More...
Bitter pill for Big Pharma

(Bhupesh Bhandari / New Delhi , 30-Sep-2011 , Business Standard)
There is evidence IPA Secretary General D G Shah says that Indian companies that got acquired by Big
Pharma have scaled down their patent challenges in the West. More...
Microsoft Samsung to share mobile patents

(Bloomberg , 29-Sep-2011 , The Times Of India)
Microsoft Corp the software maker seeking to challenge Apple Inc and Google Incs dominance in
smartphones agreed to share patents with handset maker Samsung Electronics Co. More...
Govt buries plan to empower CCI on IPR disclosures
(Vikas Dhoot , 29-Sep-2011 , The Economic Times)
In a major reprieve for innovation led firms in India the government has quietly dropped a controversial
plan to empower the competition regulator to make intellectual property rights holders share their
knowledge with competitors in specific circumstances. More...
Mosaid: Google is $11m patent buyer

Canadian patent licensing company Mosaid has named Google as the buyer of five non strategic patent
families it said it had sold two week ago for $11 million. More...
Samsung seeks Dutch ban on 3G iPhone iPad

(Roberta Cowan , Reuters , 28-Sep-2011 , Hindustan Times)
Samsung Electronics Co and Apple Inc fought the latest battle of their patent wars on Monday when the
Korean firm urged a Dutch court to ban Apples iPads and iPhones in the Netherlands More...
Glenmark Pharma launches anti malaria drug in the US

The Indian drugmaker had settled a patent litigation with GlaxoSmithKline in April 2010, which allows
Glenmark to launch the generic tablets in the US on royalty bearing licence in the third quarter of
calendar year 2011. More...
GSK open to acquiring reasonably priced company: GSK open to acquiring reasonably priced
company: Andrew Witty CEO
And as these companies stare at their expiring patents emerging markets can no longer be ignored.
More...
Patent office to examine conflict between WIPO guidelines and Patents Act
(Hary M. Pillai , 28-Sep-2011 , Law et al news)
The Delhi High Court recently remanded back to the Controller General of Patents Designs Trademarks
and Geographical Indication a petition in which the court felt existed a conflict between the WIPO
Guidelines and the Patents Act and Rules. More...
Microsoft Samsung Patent Deal: Great News for Windows Phones

(Jared Newman , 28-Sep-2011 , PCWorld )
The success of Samsungs Galaxy S Android phones just became a cash cow for Microsoft thanks to a
patent cross licensing agreement in which Microsoft gets paid for every Android phone or tablet
Samsung sells. More...
Europe threatens to break off India free trade talks

But India and the EU have already been at odds over intellectual property rights involving life saving
generic HIV AIDS drugs and other medicines which are produced by Indian companies. More...
India to be among top 10 pharma markets by 2015: E&Y

Emerging markets India and China will figure in the top 10 pharma markets of the world by 2015 an
Ernst & Young report has said. More...
Patent tribunals admission places question mark against tribunals

The case filed by P PIL questioned the independence of Ipab on the grounds that it was in violation of
the constitutional separation of powers doctrin More...
CCI should clear pharma M&As

(Joe C Mathew & Nayanima Basu / New Delhi , 27-Sep-2011 , Business Standard)
The committee is also of the view that India must desist from any move to dilute the public interest
clauses enshrined in the patent law. More...
Dr Reddys Laboratories abandons deal to buy JB Chemicals brands in Russia CIS

Indian pharmaceutical firm Dr Reddys Laboratories called off a deal to acquire prescription portfolio of JB
Chemicals and Pharmaceuticals in Russia owing to differences over valuation and other operational
issues a senior company official said. More...
Dr Reddys calls off deal to buy JBCPLs Russia business

The changes will result in cost savings in government procurement of drugs and make medicines more
affordable by giving consumers access to generics that are cheaper than patented drugs. More...
India Generics Companies Lead Pharmaceutical Innovation in Asia Pacific According to

Thomson Reuters
(EDT , 26-Sep-2011 , Market Watch)
The change in approach is highlighted by the 72 percent increase in the number of Paragraph IV patent
challenges raised by Indian companies between 2009 and 2010. More...
EU agrees for ambitious comprehensive pact with India

(PTI , 26-Sep-2011 , Zee News)
But India and the EU have been at odds over intellectual property rights in patent areas involving life
saving generic HIV AIDS drugs and other medicines which are produced by Indian companies it added.
More...
India EU trade talks high on Agenda

(Pallavi Aiyar & Nayanima Basu / Brussels/ New Delhi , 26-Sep-2011 , Business Standard)
According to the agenda, apart from tariffs on wines and spirits and automobiles there are wide gaps on
intellectual property rights IPR specifically issues related to geographical indications liberalisation of
services and government procurement. More...
R&D expenditure of 30 cos soars by 19% to Rs.3770 cr in 2011 with no new molecules yet
(Sanjay Pingle, Mumbai , 26-Sep-2011 , Pharmabiz)
The Indian majors like Dr Reddys Labs Lupin Glenmark Pharmaceutical Aurobindo Pharma and Sun
Pharma received higher approvals for ANDAs from US FDA during the first 8 months of 2011. More...
French Cognac gets GI status

(Daniel P George , 24-Sep-2011 , The Times Of India)
The Geographical Indications Registry office in Chennai on Tuesday granted the French Cognac
geographical indication status along with Villianur Teracotta Works and Tirukanur Papier Mache Craft
both handicrafts from Puducherry. More...
Samsung to step up Apple patent war

(Associated Press , 24-Sep-2011 , IBN Live)
A top Samsung executive says the company will take a bolder stance in its patent battle with
smartphone and tablet rival Apple which Samsung claims has been free riding on its patented wireless
Ind Swift set to tap global generic opportunity

Patents are set to see their patents expire in the US over the next four years opening up an opportunity
of about $ 99 billion. More...
US patents from MNCs have shot up while those filed by Indian companies and institutions
are declining
(Hari Pulakkat , 22-Sep-2011 , The Economic Times)
With a global R&D budget of $6 billion it is no surprise that IBM is the worlds largest patent generator.
More...
Eli Lilly scouting for partner to market oncology drugs

( KV Ramana , 22-Sep-2011 , DNA)
There are several products that would go off patent and we are working on them. More...
Speedy Singhs gets copyright protection

(Swati Deshpande , 22-Sep-2011 , The Times Of India)
The producers of the yet to be released Bollywood movie Speedy Singhs starring Akshay Kumar has
landed a speedy relief even before any legal trouble can brew over copyright. More...
Why the world may prefer India to China

(Bala V Balachandran , 22-Sep-2011 , Business Standard)
Although the rate of patenting has been slow in India it hasnt led to unhindered copying of intellectual
property. More...
Google Oracle patent talk makes slow progress

(Bloomberg , 22-Sep-2011 , The Economic Times)
Google and Oracles chief executive officers made little headway this week in negotiations aimed at
resolving a lawsuit accusing the Web search company of patent infringement a person briefed on the
talks said. More...
Bionic boon for the blind

(Durgesh Nandan Jha , 22-Sep-2011 , The Times Of India)
He holds the patent for the device along with his colleagues. More...
DuPont unit accuses Kaveri of gene piracy

Pioneer Overseas Corp. has accused Hyderabad based Kaveri Seeds of copying the gene structure of a
variety of corn developed by the Iowa US based firm. More...
China and India making inroads into biotech drugs

(Gardiner Harris , 21-Sep-2011 , The Hindu)
This could not only transform the care of patients in much of the world but also ignite a counterattack by
major pharmaceutical companies and richer countries. More...
Sharma writes to PM on pharma M&A concerns

(Asit Ranjan Mishra , 21-Sep-2011 , Livemint)
The Indian generic pharma industry has in recent years posed a major challenge to the MNCs through
production and export of low cost high quality medicines as well as patent challenges. More...
Samsung eyes iPhone 5 legal action

(Song Jung-a in Seoul , 21-Sep-2011 , The Financial Times)
Samsung Electronics is considering a legal move to block sales of Apple s long awaited iPhone 5 in some
countries as the patent battle between the two technology companies steps up a gear. More...
Lupin enters oral contraceptives market in the US

A couple of the OC filings would be patent challenges, he said More...
Sun Pharma resolves US units regulatory concerns

(P. T Jyothi Datta , 19-Sep-2011 , Business Line)
Co loses patent case to Sanofi on colon cancer drug More...

Patent trolls cost inventors half a trillion dollars
(David Goldman , 21-Sep-2011 , CNN Money)
Patent trolls companies that license patents but do not actually sell anything have long been looked on
with fiery scorn in Silicon Valley. More...
Godrej Consumer Products wins case against a cybersquatter

Godrej proved that the domain name registered by US based cybersquatter Chris Peri of Illinois was
identical to its trademark and misleading the statement said. More...
China India making inroads in biotech drugs

(Gardiner Harris , 19-Sep-2011 , Hindustan Times)
Already the Obama administration has been trying to stop an effort by poorer nations to strike a new
international bargain that would allow them to get around patent rights and import cheaper Indian and
Chinese knock off drugs for cancer and other diseases as they did to fight Aids. More...
US court rules against Sun Pharma over cancer drug

French drugmaker Sanofi today said a US court has ruled in its favour in a patent litigation against Sun
Pharmaceuticals over Eloxatin oxaliplatin a drug used to treat colon cancer. More...
Sanofi wins U.S. cancer drug patent ruling

(Elena Berton , 19-Sep-2011 , Reuters)
French drugmaker Sanofi has scored an important victory in a patent dispute with Sun Pharmaceuticals
that will keep generic copies of its Eloxatin colon cancer drug off the United States market until August
2012. More...
US terms telecom IT procurement policy against WTO guidelines

(Surajeet Das Gupta / New Delhi , 19-Sep-2011 , Business Standard)
The American government has challenged the protection given to domestic manufacturers by the Indian
government in the areas of information technology and telecom as breaching World Trade Organisation
rules. More...
Evolution of IP valuation
(D. Murali , 19-Sep-2011 , Business Line)
Within the semi conductor industry a lot of patent wars and acquisitions have been fought and survived
reminds Anu. More...
Bristol Myers to launch critical drugs in India

(Joe C Mathew / New Delhi , 18-Sep-2011 , Business Standard)
BMS had reentered India in 2004 after the country changed its patent laws to recognise product patents.
More...
Indian generic drug firms pharma MNC patent fight to determine price of medicines
(Khomba Singh , 18-Sep-2011 , The Economic Times)
Last month former Solicitor General Gopal Subramanium launched an impassioned argument in the
Supreme Court against the rejection of a patent to Glivec a leukemia drug made by pharma MNC
Novartis. More...
GNA Patent Gurukul to conduct seminar on ‘current pharma patent regulatory opportunities
and challenges in Europe’
GNA Patent Gurukul will be organising a one day seminar on current pharma patent regulatory
opportunities and challenges in Europe on October 13 at IDMA Mumbai. More...
Patent issues lack of commitment risk Hulu sale

The auction of online video site Hulu has been slowed by recent developments which could derail it
completely according to sources familiar with the process. More...
Wockhardt Danone deal gets CCI nod

The agreement also involves transfer of nutrition related intellectual property owned by Wockhardt EU a
wholly owned subsidiary that holds intellectual property rights for Wockhardt Group businesses including
pharmaceuticals and healthcare. More...
Apple Microsoft fear: Google buys 1023 IBM patents

Google confirmed that it has added 1023 more IBM patents to its technology arsenal to fend off legal
attacks by rivals such as Apple and Microsoft. More...
India rejects Wests criticism of trade policy

India today rejected the criticism of its trade policy especially by the US at the WTO and asked the
members to judge the country by what it has done over the years. More...
Apple cant take away our leadership in India Samsung

(Pankaj Doval , 16-Sep-2011 , The Economic Times)
Samsung and Apple may be embroiled in numerous patent suits across the globe but the Korean
consumer electronics gianta has said it has a clear edge in India and will retain its stronghold due to its
wider reach and product portfolio and stronger brand profile. More...
Desi cos to gain as Big Pharma goes generic

Faced with losses once its blockbusters start losing patents Big Pharma is now devising strategies to
counter the impact. More...
Patent distribution should be transparent Chandy
(PTI , 15-Sep-2011 , IBN Live)
Kerala Chief Minister Oommen Chandy today said there should be a transparent mechanism to distribute
patents developed by research institutions under government run institutions. More...
Patiala prof gets copyright for his Hindi to Punjabi software

(Jasneet Bindra , 15-Sep-2011 , Indian Express)
The copyright has been granted after more than a year by the Ministry of Human Resources and
Developments Copyright Registrar office. More...
Google AOL Others Sued For Infringing Old Lycos Patents

(Eric Savitz , 15-Sep-2011 , Forbes)
And the great patent wars roll on. More...
Singing a different tune

(Ratnottama Sengupta , 15-Sep-2011 , The Times Of India)
While this comes as relief to the rights owners producers and music companies lyricists and composers
are hoping that the amendment to the Copyright Act of 1957 will retain their rights as first owners.
More...
Bharat Biotech in strategic play with Rotovac vaccine

The company which has 47 global product patents ploughs back 30% of its revenues into R&D. More...
Novartis executive to join Gates foundation

(Andrew Jack in London , 13-Sep-2011 , The Financial Times)
The decision is likely to herald fresh support for the drug companies commitment to tough intellectual
property laws and support further Gates funding of their research including for Novartis which is already
one of the most active in researching drugs and vaccines for diseases of the developing world. More...
Govt not properly briefed on Glivec patent suit: Drugmakers

The case was scheduled to resume hearing on September 6 but has been postponed after one of the
judges recused himself from the case. More...
Wockhardt sees big opportunity in off patent drugs

(Press Trust of India / Mumbai , 12-Sep-2011 , Business Standard)
Troubled pharma player Wockhardt today said it sees huge opportunity in off patent medicines over the
next few years. More...
India EU free trade talks resume today

(Nayanima Basu / New Delhi , 12-Sep-2011 , Business Standard)
India and the European Union are resuming talks on a free trade agreement from tomorrow. More...
Guj share in total Indian patents filed is 0.9%

(Jitendra Dave, DNA , 12-Sep-2011 , dailybhaskar)
For a state that often boasts of its entrepreneurial spirit Gujarat lags behind others when it comes to
research innovation and protecting innovations. More...
Ciplas margin focus likely to yield benefits in the long term

(Ravi Ananthanarayanan , 12-Sep-2011 , Livemint)
The triggers for this change are fewer blockbuster products in the global research pipeline patent expiry
of blockbuster products and a sluggish developed world economy. More...
Is the Google Motorola deal helping Microsoft?

(BALAJI NARASIMHAN , 12-Sep-2011 , Business Line)
The search giant acquired Motorola for patents but if it doesnt move carefully the play may help its
competitor more than itself More...
Banarasi saree glitters in new found demand

(Binay Singh , 10-Sep-2011 , The Times of India)
The benefits of Geographical Indication certification have thus started showing for the handloom industry
of this region. More...
Ranbaxy Laboratories to roll out Lipitor Clone in US on Nov 30

Ranbaxy Laboratories rose more than 4% after a top company executive said the drugmaker is on track
to launch a low cost version of the worlds largest selling drug Lipitor in the United States. More...
Trexime patent: Dr Reddys files appeal in US court

Pharma major Dr Reddys Laboratories Ltd has filed an appeal in the district court of Texas in a patent
infringement case with Pozen Inc on the generic version of Trexime sumatriptan naproxen sodium.
More...
Macleods Novartis settle drug patent row

(Soma Das , 8-Sep-2011 , The Financial Express)
One of the fastest growing Indian drug makers Macleods Pharma has settled a patent dispute with Swiss
pharma giant Novartis over the herpes drug Famvir Famciclovir in the US. More...
Aurobindo Pharma ties up with Russian firm

(Namrata Nandakumar , 8-Sep-2011 , Livemint)
Drug maker Aurobindo Pharma Ltd has formed an equal partnership with OJSC Diod a Russian maker of
healthcare equipment and nutrition supplements to manufacture and market generic or off patent drugs
taking advantage of changes in Russias public healthcare policy that seek to make that country less
dependent on imports. More...
Teva defense of Copaxone starts today

(World News , 7-Sep-2011 , PharmaTimes)
The first trial in Tevas legal action against generic drugmakers seeking to market copycat versions of its
big selling multiple sclerosis drug Copaxone in the USA is due to start later today. More...
Novartis’ case against Section 3(d) of Indias Patents Act enters final stage in Supreme Court
The next hearing in the case will take place on September 6 2011. More...
A victory for Novartis could spell death for millions

(Priscilla Jebaraj , 6-Sep-2011 , The Hindu)
The Swiss pharma giant fighting in Supreme Court for patent on anti cancer drug More...
Suven gets four patent approvals for CNS molecules

Drug firm Suven Life Sciences on Monday said it has received four product patents in Australia and New
Zealand for its new chemical entities which could be used for treating various central nervous disorders.
More...
SC judge under attack from health activists

(Manoj Mitta , 6-Sep-2011 , The Times of India)
Two years ago, Justice Markandeya Katju of the Supreme Court had withdrawn from hearing a patent
dispute vitally concerning pharmaceutical majors. More...
Medicines for all

(5-Sep-2011 , Livemint)
It has been pointed out that between 2011 and 2013 a large number of drugs are likely to go off patent
in the US making it possible for local firms to produce cheaper generic versions. More...
Indians find cancer fighting protein in human body

(Snehal Rebello , 05-Sep-2011 , Hindustan Times)
Last October the team filed a patent for the chemically synthesised protein portion. More...
Removal of parallel imports clause may stir up debate

The provision for importing books without infringing copyrights would have also helped students gain
access to the latest affordable versions of text books from across the world. More...
Legal fraternity slams draft Bill to regulate practice
The government is planning a new accreditation and regulatory mechanism for legal services that has
not been defined under the Advocates Act 1961. More...
Govt alarmed as MNC buyouts set to push up drug prices

(Kounteya Sinha , 04-Sep-2011 , The Times Of India)
The price of India made low cost generic drugs could be sky high soon. More...
Health Ministry wants FDI safeguards to keep drug prices low

(Aarti Dhar , 3-Sep-2011 , The Hindu)
As many as 61 drugs worth $80 billion are likely to go off patent in the U.S. between 2011 and 2013
making it possible for Indian companies to produce cheaper generic versions. More...
Pharmaceutical mega brand buyouts a sweet pill

(Reghu Balakrishnan / Mumbai , 2-Sep-2011 , Business Standard)
It may be Doktor Mom in Russia or Farex in India. More...
Piracy often brings down price of product

(Vivek Kaul , 02-Sep-2011 , The Economic Times)
The story goes that Kumar under his T Series brand initially brought out pirated cassettes of Hindi films
for which HMV had the copyright. More...
DoP to set up NFDC to help SMEs to grab market with many patent expiries expected soon
(Joseph Alexander, New Delhi , 02-Sep-2011 , Pharmabiz)
With large number of drugs losing patents in the near future throwing up huge opportunities for Indian
manufacturers of generic formulations the Department of Pharmaceuticals wants to set up at least one
National Formulation Development Centre to assist the small and medium scale units to grab a decent
pie from the emerging world market. More...
No deal in sight WTO tries to stay relevant

(Sidhartha , 01-Sep-2011 , The Times Of India)
When WTO chief Pascal Lamy comes to Asia next week he will make another pitch to revive the decade
old Doha Round of trade liberalization talks and also seek inputs from India and China on additional work
programme. More...
Kuthampully sarees get an IP address weave history

(Viju B , 01-Sep-2011 , The Times of India)
K Sreedharan got a booking order for 30 Kuthampully sarees from a Non Resident Indian settled in
Canada last year. More...
Strategic Analysis of Indian Biosimilar Market - Impending Patent Expiries Encourage
Companies to Ramp up Biosimilar Manufacturing Capabilities
(Eastern Daylight Time , 01-Sep-2011 , Business Wire)
Impending Patent Expiries Encourage Companies to Ramp up Biosimilar Manufacturing Capabilities

More...
Pollution board chief cashed in on own patent

(Nitin Sethi , 01-Sep-2011 , The Times of India)
Central Pollution Control Board chairman SP Gautam sold a patent he held privately on a technology to
the apex authority on a revenue sharing basis and then passed a directive in his official capacity asking
the leather industry to buy the expensive and untested know how. More...
Pfizer Dr Reddys settle patent suit over Lipitor

Pfizer Inc and Dr Reddys Laboratories have settled a patent infringement suit related to the Indian drug
makers launch of a generic version of the blockbuster drug Lipitor in the US. More...
Venus secures market for anti cancer product

(BS Reporter / New Delhi/ Chandigarh , 31-Aug-2011 , Business Standard)
The molecule patent protection of Sanofi Aventis has recently expired in major European countries while
in rest of the countries the expiry of patent is due in November 2013. More...
Teva Pharma wins 1st round of patent battle against Natco

(Soma Das , 31-Aug-2011 , The Financial Express)
In a setback to Hyderabad based Natco Pharma the Israeli drug giant Teva Pharma claims to have won
the first round of patent battle over the blockbuster multiple sclerosis drug Copaxone Glatiramer Aceatte
in the United States. More...
India EU to renew trade talks in Brussels

(Asit Ranjan Mishra , 30-Aug-2011 , Livemint)
Indian and European Union negotiators will renew talks for a trade and investment agreement in
Brussels on 12 14 September but experts said their differences are too wide to be overcome without a
political push. More...
US patent expiries unlikely to be a big opportunity

In the next four years drugs with sales worth $157 billion will lose patent in the US opening the doors to
generic competitors. More...
Kutchi shawl likely to get GI tag

(PTI , 29-Aug-2011 , IBN Live)
A Geographical Indication tag is on the cards for the colourful Kutchi shawls woven with motifs by
artisan communities for past several generations in Kutch district of Gujarat. More...
India EU to renew trade talks in Brussels
(Asit Ranjan Mishra , 29-Aug-2011 , Livemint)
Differences over services agriculture chemicals intellectual property rights and government procurement
are also yet to be resolved. More...
Payment for copyrighted goods not royalty: ITAT

(M Padmakshan , 29-Aug-2011 , The Economic Times)
However in its ruling a twomember bench of the ITAT said that the payment was not royalty because it
was for the software which was a copyrighted article and not for the copyright itself. More...
Cipla may team up with MNCs

Hamied said that the government should work on three things to address the healthcare concerns of the
country one bring in compulsory licensing when a government allows a pharma company to manufacture
a patented drug without the consent of the patent owner two prevent a monopoly and thirdly prevent
frivolous evergreening and incremental innovations by MNCs. More...
Granules India to augment APIs production expand market share of best sellers
(Deepika Amirapu , 26-Aug-2011 , The Economic Times)
They manufacture several off patent drugs such as Paracetamol Ibuprofen Metformin and Guaifenesin on
a large scale for customers in the regulated and semi regulated markets. More...
Copycat climate
(26-Aug-2011 , Livemint)
Its ironic that Chinas telecom companies are on a patent overdrive. More...
Apple wins ban on 3 Samsung phones in 10 European nations

Apple won an injunction in a Dutch court on Wednesday to stop Samsung Electronics from marketing
three smartphone models in some European countries after alleging a breach of patents. More...
Cipla looking at global alliances to sell its products

On the Unitaids patent pool Dr Hamied said there were issues regarding the markets open to a company
that uses patents from the pool. More...
Cipla Lupin deny report on Takeda talks

(Reuters , 25-Aug-2011 , Livemint)
Emerging markets are set to become the main driver for the global pharmaceuticals industry as patents
run out on many top drugs and sales stall in Western markets but acquisitions in those economies have
not always come easy. More...
Google Motorola could be peak of patent price spike
Now that Google has agreed to a $12.5 billion deal to buy Motorola Mobility scooping up a trove of
17000 phonerelated patents to give itself some ground to defend its Android operating system the most
motivated buyer looks to be off the market. More...
Bharti Airtel Vodafone Essar Reliance communication and BSNL ask Trai to stay out of
dealings with VAS firms
(Joji Thomas Philip , 25-Aug-2011 , The Economic Times)
The telco also pointed out that it would not just be counter productive but also extremely unscientific to
determine a defined revenue percentage share on content because value of such applications were
intellectual property rights driven and not on dry cost basis. More...
Patent ruling clears way for Tatas to market ultra strong steel in Europe
(Vidya Ram, Roudra Bhattacharya , 24-Aug-2011 , Business Line)
Tata Steels plans for marketing a new ultra high strength steel for the automotive industry gained
impetus on Wednesday after a European patent court revoked a rivals patent. More...
Google Motorola and the patent wars

(L Gordon Crovitz , 24-Aug-2011 , Livemint)
The costs of the broken US patent system are often abstract but this month Google put a price tag on it:
$12.5 billion. More...
PM calls for pvt investments in scientific research

Urging the private sector to contribute significantly in spheres of research and development Dr Singh
lamented the fact that the number of patents filed by Indians were very low compared with other
developed nations or developing nations. More...
Cipla Dr Reddys under DCGI scanner for selling banned drugs

The countrys drug regulator has sent show cause notices to Cipla and Dr Reddys Laboratories for selling
drugs banned by the government and is planning similar action against a few other top drug makers.
More...
Suven Life secures four product patents

(BS Reporter / Chennai/ Hyderabad , 19-Aug-2011 , Business Standard)
Hyderabad based Suven Life Sciences has won four product patents for its new chemical entities
designed for treatment of neurodegenerative diseases. More...
In search of the right medicine

Drug price regulation will be better served when the Pharmaceuticals Policy sees the light of day and
takes structural changes in industry into account. More...
Ranbaxy Laboratories may sell Lipitor rights if FDA delays nod

(Bloomberg , 19-Aug-2011 , The Economic Times)
Ranbaxy Laboratories may sell rights to make a generic version of Pfizer Incs Lipitor the worlds best
selling medicine should it fail to win timely US approval for the cholesterol pill Credit Suisse AG said.
More...
WHO disqualifies 3 vaccines of Panacea Biotec

Panacea Biotec scrip fell 20% to Rs 144.90 on Thursday after the biotechnology firm disclosed that WHO
has disqualified its three combination vaccines from supplying to the organisation. More...
UTILITY MODEL PATENTS

Indias commerce ministry is reported to be considering a proposal to introduce a Utility Model for
patents in the country as a new tool for granting intellectual property rights. More...
Lincoln Pharma launches ayurvedic product

(BS Reporter / Mumbai/ Ahmedabad , 18-Aug-2011 , Business Standard)
Ahmedabad based Lincoln Pharmaceuticals Ltd. recently announced the launch of its ayurvedic product
named ISL Granuels that will serve the mother and child healthcare segment. More...
What Motorola India gets from Google deal

Googles takeover of Motorola Mobility is expected to impact the Indian operations of Motorola Mobility.
More...
What Motorola India gets from Google deal

More...
Motorola India may gain from Google deal

More...
Patent search
(Robert Cyran , 17-Aug-2011 , Business )
Google is spending $12.5 billion on insurance for itself but its partners may not feel at ease. More...
India on global R&D map
(Pranav N Desai , 16-Aug-2011 , Express Buzz)
Technological capabilities are enhanced by a learning that is determined not only by codified knowledge
in R&D output such as publications patents and designs but also by interactive learning processes of
international collaboration inward and outward foreign direct investments and by the general socio
economic environment. More...
Motorola buy may not hurt Android partners in India

(Leslie D`Monte / Mumbai , 17-Aug-2011 , Business Standard)
After the completion of the deal Google would own both hardware and software units while
simultaneously acquiring Motorola Mobilitys 17000 patents and an additional 7500 patent applicationsan
arsenal that can help Google fight the Nokia Apple Microsoft trio which recently outbid it in acquiring
Nortels patents. More...
Google Motorola deal more a patents buy say tech analysts

Googles $12.5 billion purchase of Motorola Mobility is more a patents play than a hardware deal say
technology analysts. More...
Monsanto expects a surge in demand for maize

(Nidhi Nath Srinivas , 16-Aug-2011 , The Economic Times)
It is attractive because of well developed intellectual property rights and a robust regulatory process.
More...
Gopal Subramanium to represent Novartis

(Joe C Mathew / New Delhi , 15-Aug-2011 , Business Standard)
Patent case of the Swiss pharma major will be his first private assignment after resigning as Solicitor
General. More...
European Union not keen to relax FTA visa curbs

(Sidhartha , 15-Aug-2011 , The Times of India)
The European Union is pushing for more foreign investment in a slew of sectors banking insurance legal
accounting postal maritime and security services but is unwilling to allow a bigger number of Indian
professionals to work in the 27 member union. More...
Bhalia wheat gets GI tag

Bhalia a long grain wheat variety rich in protein and grown under conserved soil moisture conditions in
Bhal region of Gujarat has received the Geographical Indication tag a move which is likely to benefit
more than 5000 farmers in the State. More...
Novartis imatinib patent battle resumes in Indian Supreme Court

(Article , 15-Aug-2011 , The PharmaLetter)
The controversial Novartis case in which the Swiss major Novartis challenged the manner in which
Section 3(d) of Indias Patents Act is applied is now the subject of hearings at the Indian Supreme Court.
More...
Gandhi Rice as trademark opposed by Indian lawyer

(Hary M. Pillai , 14-Aug-2011 , Law et al)
Lalit Bhasin a leading lawyer in India has taken upon himself to prevent an attempt for commercial
exploitation of the name of father of the nation Mahatma Gandhi. More...
MNCs looking at more global partnerships with Indian cos to launch more products
(A Raju, Hyderabad , 13-Aug-2011 , Pharmabiz)
Global pharma majors are in the midst of a crisis with a decline in the number of blockbuster drugs low
R&D productivity and patent expiries More...
Health ministry goes big on yoga funds studies on its benefits

(Kounteya Sinha , 13-Aug-2011 , The Times of India)
Meanwhile the Traditional Knowledge Digital Library has completed documenting 1300 asanas which will
soon be uploaded making them public knowledge in order to protect them from western pirates. More...
ICARs IPR will be globally showcased through new company AGRINDIA

(Prabha Jagannathan , 12-Aug-2011 , The Economic Times)
The Union Cabinet has approved the proposal of Ministry of Agriculture Department of Agricultural
Research & Education for setting up of a new company called AGRlNDIA. More...
Hindustan Unilever loses trademark case for Sunlight brand to little known Kerala based Thai
Group
(Paramita Chatterjee & Ratna BhushanParamita Chatterjee & Ratna Bhushan , 12-Aug-2011 , The
Economic Times)
The oldest brand in the portfolio of Anglo Dutch consumer products giant Unilever took a bath last week
when its Indian affiliate Hindustan Unilever Ltd lost a trademark case for a 127 year old soap called
Sunlight to a little known southern soap maker. More...
Hearing on Novartis case on Section 3(d) of Indian Patents Act begins in Supreme Court
The Supreme Court has started hearing the controversial Novartis case in which the Swiss multinational
pharmacuetical company has challenged the manner in which Section 3(d) of Indias Patents Act is
applied. More...
Apple blocks Samsung from selling galaxy tablet in EU

(Reuters / Seoul/ San Francisco , 11-Aug-2011 , Business Standard)
The court order comes a week after Samsung was forced to delay the Australian launch of its latest
Galaxy tablet because of a separate lawsuit alleging Samsung infringed on a number of Apples patents.
More...
MSF raises concern over commerce ministrys move to introduce Utility Model for patenting
The Médecins Sans Frontières an independent international medical humanitarian organization has
expressed concern over the union commerce ministrys proposal to introduce Utility Model as an
alternate tool for the protection of Intellectual Property Rights in India. More...
Final hearing in Novartis Glivec case begins in SC

(Nikhil Kanekal , 10-Aug-2011 , Livemint)
Novartis contends that its patent on the drug should be extended as it has increased its efficacy by 30%
meaning that a persons capacity to absorb the newer version of the drug is that much better More...
DoP to convey concerns of industry over proposed FTAs TPPA to commerce ministry
(Joseph Alexander, New Delhi , 10-Aug-2011 , Pharmabiz)
The Department of Pharmaceuticals will take up issues with the Commerce Ministry regarding the
proposed Trans Pacific Partnership Agreement which is likely to have adverse impact on the Indian
pharma products and other such Free Trade Agreements in the pipeline. More...
Digital library to the rescue of traditional patents

(Jaideep Shenoy , 08-Aug-2011 , The Times of India)
Indias resilience in standing up to attempts by powers that be to seek patents for turmeric basmati rice
wheat and all time favourite snack the idli has paid off big time at least for now. More...
EU demanding access to Indian service market is barrier to FTA

(PTI , 07-Aug-2011 , MSN)
The European Unions demand that it be given access to Indian market in services like banking postal
legal and accounting would be a major road block for the India EU free trade pact under negotiations
since June 2007 sources said. More...
Access to affordable generics poses huge challenge in public healthcare: KDPMA chief
(Nandita Vijay, Bangalore , 6-Aug-2011 , Pharmabiz)
While issues like unreliable supply system irrational prescription dispensing usage unfair health financing
mechanism inadequate funding for research in neglected diseases have resulted in the high cost of drugs
the patent regime enforced from 2005 has been one of the key deterrents for drug affordability. More...
Venus Remedies appoints consultants to out license two products

After having got a product patent in the United States on its dry powder injectable antibiotic Vancoplus
the Chandigarh based Venus Remedies expects to out license the product this financial year. More...
Ranbaxy dips 4% on Pfizers Lipitor move

(Rupali Mukherjee , 5-Aug-2011 , The Times of India)
Ranbaxy scrip suffered losses and closed lower on the BSE on Thursday on fears that Pfizer was
reportedly planning to launch an overthe counter version of cholesterol lowering drug Lipitor once the
drug loses patent protection in US in November this year. More...
Copyright judgment garners flak from industry
(Pooja Maheshwary , 04-Aug-2011 , Hindustan Times)
Last week the High Court had stated that the Indian Performing Right Society Limited that safeguards
the copyright of music composers and lyricists is not entitled to demand royalty or licence fees from FM
radio channels for the music they broadcast. More...
Venus Remedies gets US patent nod for research product

Venus Remedies today said it has received its first patent approval from the United States Patent and
Trademark Office for its product Vancoplus used for treating bacterial infections. More...
AstraZeneca Indias Balganesh to head CSIR project

(Jacob P. Koshy , 03-Aug-2011 , Livemint)
None of the entities can claim exclusive patent rights but because companies do not have to make huge
and risky investments in research, they are more likely to agree to non-exclusive marketing licensing
arrangements with CSIR and thus keep the cost of drugs low. More...
Pfizer files patent suit against Hetero

(BV Mahalakshmi , 03-Aug-2011 , The Financial Express)
Pfizer Inc has filed a patent infringement suit against Hyderabad based Hetero Drugs in a US court
raising opposition against Indian pharma firm Heteros attempt to enter the lucrative market of its
blockbuster drug Sildenafil citrate commonly called as Viagra used for treatment of impotence and rare
disease pulmonary arterial hypertension. More...
EU for duty cuts in auto sector in FTA with India

The government today said the European Union had requested India to cut import duties in several
sectors including automobile in the proposed comprehensive market opening pact. More...
Natco Pharma files Indias first compulsory licence plea

Natco Pharma has applied for the countrys first compulsory licence to sell a generic version of Bayers
patented medicine a development whose outcome is expected to determine how global drug makers
price their costly drugs in India. More...
India EU FTA negotiations at advanced stage: Scindia

Negotiations on a comprehensive free trade pact between India and the European Union which began in
June 2007 have reached at an advanced and delicate stage Parliament was informed. More...
Lupin looks to acquire large LatAm firm

Lupin Ltd Indias fifth largest drug maker is planning to acquire a large Latin American pharmaceutical
company to enter a region where cheaper generic drugs outsell medicines sold by patent holders.
More...
EU wants GI protection for 190 products

Anticipating a huge market opportunity once the comprehensive free trade agreement being negotiated
is ratified the European Union has sought geographical indication protection for 190 products in India.
More...
DoP to take up issue of non-tariff barriers by EU with commerce ministry for further actions
In the case of bulk drugs third party audits are being insisted upon as a result the companies are forced
divulge their intellectual property infringing on the right to protect the data. More...
HC decides on own letters patent jurisdiction

In a significant judgment the high court of Bombay at Goa recently held that a letters patent appeal
intra court appeal lies before a division bench of the court from a judgment of a single bench judge in a
civil writ petition under Article 226 of the Constitution. More...
Junagadh Kesar mango gets GI tag as Gir Kesar

The famous saffron coloured Kesar variety of mango largely grown around the foothills of Girnar
mountains in Gujarats Junagadh district has got global recognition as Gir Kesar mango after being
granted the Geographical Indication tag. More...
The Pagadi Unravelled

(Shruti Nambiar , 1-Aug-2011 , Indian Express)
On September 4 2009 Geographical Indication Status a sign used on goods that have a specific
geographical origin was accorded to a traditional Maharashtrian headgear. More...
India Japan implement economic pact aim to double trade

(IANS , 01-Aug-2011 , The Economic Times)
It covers more than 90 percent of trade a vast gamut of services investment intellectual property rights
customs and other trade related issues. More...
Rovio sues Hulu for patent infringement

Rovi Corp sued Hulu, accusing the online video site of infringing patents that cover electronic program
guides. More...
India EU reach understanding on seizure of Indian generic drugs at EU ports

India and the European Union have reached an interim settlement on the long pending issue of seizure
of Indian generic drug shipments at the EU ports en route to Latin American and other countries on
charges of counterfeiting and patents infringement. More...
India EU ink deal to end drug seizure for now

Finally EU has come around and we have agreed on an interim settlement... which means EU will not
make any detention within its territory of pharmaceutical products coming from India. More...
EU agrees to stop confiscation of Indian generic drugs

Indias long drawn dispute with theEuropean Union over confiscation ofIndian generic drugs in transit to
other countries at European airports has been temporarily settled. More...
GI tag for Gir Kesar mango Bhalia wheat

(Daniel P George , 28-Jul-2011 , The Times of India)
Gir Kesar mango and Bhalia wheat from Gujarat have been accorded the geographical indication tag by
the Geographical Indications Registry in Chennai. More...
EUs demand for additional concessions stalls trade talks

The agreement is being opposed by non governmental organizations over concerns that the proposed
trade related aspects of intellectual property rights in the deal will affect Indias ability to produce and
export life saving generic drugs to developing and poor countries. More...
Himalaya Drug positions Liv. 52 HB as safe and cost effective for India’s 4 crore HBV patients
(Nandita Vijay, Bangalore , 28-Jul-2011 , Pharmabiz)
Himalaya Drug Companys Liv. 52 HB is Indias first US patent pending herbal formulation for Hepatitis B
Virus infection. More...
Pharma companies may get tax sops for clinical trials patent filings
(Khomba Singh , 27-Jul-2011 , The Economic Times)
The Department of Pharmaceuticals is planning to recommend extension of tax benefits given to

drugmakers for in house R&D and research work done outside the firm such asclinical trials bio
equivalence studies regulatory approvals and patent filings which could benefit most Indian drug
companies. More...
GI tags sought for M.P.s Nimari chilli Malwi potato

(PTI , 26-Jul-2011 , Business Line)
If things go according to plan Madhya Pradeshs famously bitter Nimari chillis and the Malwi potatoes that
are favoured by potato chip manufacturers will soon get international recognition. More...
Music companies not composers own song rights: Bombay HC

(Shibu Thomas , 27-Jul-2011 , The Times Of India)
The judge however clarified that the owners of the copyright composers and lyricists do not lose all their
rights when they allow it to be recorded. More...
CCSHAU Hisar gets a process patent

(Madhvi Sally , 26-Jul-2011 , The Economic Times)
Chaudhary Charan Singh Haryana Agricultural University CCSHAU Hisar has been issued a patent on a
biotechnological process which enhances in vitro plantlets regeneration inair yarn plant announced the
Vice Chancellor Dr. K.S. Khokhar. More...
Low cost innovations make life easier for rural poor

(T E Narasimhan / Chennai , 26-Jul-2011 , Business Standard)
This water is filtered in a specially designed integrated filtration system including a patented membrane
from NCL which filters out all suspended matter including bacteria and viruses. More...
Lupin settles patent suit with Medicis, signs R&D pact

(Press Trust of India / New Delhi , 25-Jul-2011 , Business Standard)
Drug maker Lupin today said it had settled all patent litigation over Solodyn tablets with Medicis
Pharmaceutical Corp and signed a pact with the US based firm for development of multiple therapeutic
compounds. More...
CSIR keen to revive sick Bengal PSU pharma cos

The CSIR has formed a separate company CSIR Tech to commercialise its patents and knowledge which
will act as a technology business incubator. More...
US to play key role in Dr Reddys generics business

(BS Reporter / Chennai/ Hyderabad , 23-Jul-2011 , Business Standard)
About 63 per cent of the companys new productline in generics pertains to those drugs that would be off
patent by 2013 in the US GV Prasad vice chairman and chief executive officer of the Hyderabad based
pharmaceutical major said at the AGM here. More...
GlaxoSmithKline launches two cancer drugs at reduced prices

Both patent protected products will be imported from the UK. More...
Dr Reddys scouts ally for new chemical entity Balaglitazone

(KV Ramana , 22-Jul-2011 , DNA)
The product pipeline today covers about 63% of patent expiries. More...
Patents Granted in Indian Patent Office Plunge

(Guest Barista , 21-Jul-2011 , Patent Barista)
The Indian patents system having its seeds laid in the British era 1852 and undergoing sporadic
replantations the 1912 1970 2005 Patents Act & amendments was appearing to grow tall and bear fruits
until a noticeable downfall last year. More...
Patents and lawsuits threatening the free world of software

Could something as pesky and well trivial as a patent ruling topple the mighty Android from its perch as
the mostused operating system for smartphones. More...
Focus on pharmaceutical M&As back after Lupin negotiation buzz

(Reghu Balakrishnan / Mumbai , 20-Jul-2011 , Business Standard)
Apart from the lack of strong product pipeline and expiry of patents MNCs were hit by the strong stance
taken by US FDA against innovative product approvals Krishnakumar added. More...
DoP takes steps to assess current status of regulatory matters relating to exports
(Joseph Alexander, New Delhi , 20-Jul-2011 , Pharmabiz)
The DoP has plans to fund IPA to set up a cell to deal with all issues related to IPR regulatory issues and
other trade barriers. More...
Google slogan: Android Asia Action

(Vivek Sinha , 19-Jul-2011 , Hindustan Times)
Schmidt was unfazed by the patent suits filed against the firm by rivals such as Apple Microsoft and
Oracle. More...
Govt to encourage SMEs to go in for patents

The government in collaboration with the UN body World Intellectual Property Organisation has
commissioned a study to ascertain whether Indias small and medium enterprises are prepared to adopt
the global IPR regime. More...
Auto wine duties hold up EU FTA

We have told them that we are unable to offer any concessions since we have not included these two
sectors in our FTAs said a government official. More...
India EU trade deal to benefit textile garment exporters

(Nayanima Basu / New Delhi , 18-Jul-2011 , Business Standard)
European Union negotiators arrive in Delhi today to continue the final leg of talks. More...
Samsung wants Siemens unit banned in US

Samsung LED Co Ltd said it had filed a complaint with the US fair trade commission to ban imports of
LED products from Siemens light bulb unit Osram and affiliates Osram Opto Semiconductors and Osram
Sylvania Inc. More...
India a focus area for patents says GE
(BS Reporter / Chennai/ Hyderabad , 16-Jul-2011 , Business Standard)
US based technology company General Electric is looking to increase patent filings from its research and
development centres in India along with those in China and Brazil as the intellectual property regimes
are strengthened in these countries. More...
ICMR planning to acquire patents of traditional healing techniques for Andaman tribals
(Kounteya Sinha , 16-Jul-2011 , The Times of India)
Traditional healing techniques using indigenous medicinal plants practiced efficiently for hundreds of
years by some of Indias most elusive tribes residing in the Andaman and Nicobar Islands is all set to
become public. More...
Balancing public private interests must in intellectual property issues

A fine balance between protection of private and public interests is vital in intellectual property
management according to Ms Justice Prabha Sridevan Chairman Intellectual Property Appellate Board.
More...
Kootol targets Microsoft Apple others over patent

(Josh Lowensohn , 15-Jul-2011 , cnet News)
More than 30 companies including the likes of Microsoft Apple and IBM have been targeted by India
based Kootol Software for allegedly violating technology covered in a patent application. More...
Hilton loses trademark battle over title in India

(PTI & Nikhil Kanekal , 15-Jul-2011 , Livemint)
Hilton International Corp. which owns the international chain Hilton Hotels and Resorts lost a case in the
Supreme Court on Monday thereby losing the exclusive right over the Hilton trademark in India. More...
Granules India forms JV firm with Belgian company for APIs

(Prabhu Mallikarjunan , 15-Jul-2011 , Livemint)
Belgian chemical company Ajinomoto Omnichem and Indian drug maker Granules India Ltd formed a 50
50 joint venture on Thursday to produce active pharmaceutical ingredients and intermediates for third
parties seeking to tap demand for contract manufacturing in the generic drugs market. More...
Tattoo design registered on SRKs name!

(Meena Iyer , 14-Jul-2011 , The Times of India)
The D tattoo worn by King Khan in the upcoming Don 2 has been registered for copyright protection
against his name. More...
EU not to seize Indian drug despatches using Europe as transit

European Union members will not seize Indian medicines passing through Europe on allegations of
intellectual property right violations as per an understanding reached between India and EU. More...
Roche & Helsinn sue Dr Reddys for patent infringement

(Press Trust of India , 13-Jul-2011 , NDTV)
Roche Palo ALTO and Helsinn Healthcare SA filed a patent infringement litigation against Dr Reddys
Laboratories for antinausea drug Aloxi. More...
Gilead Sciences Inc allows 4 Indian pharmaceutical companies Ranbaxy Laboratories Matrix
Laboratories Hetero Drugs and Strides Arcolab to sell HIV Generics
(OUR BUREAU , 13-Jul-2011 , The Economic Times)
California based Gilead Sciences Inc has allowed four Indian companies to make and sell low cost
versions of three of its new HIV drugs under a firstof its kind agreement between an innovator
pharmaceutical firm and a United Nations backed patent sharing body. More...
EU not to seize Indian drug despatches using Europe as transit

(PTI , 13-Jul-2011 , MSN)
European Union members will not seize Indian medicines passing through Europe on allegations of
intellectual property right violations as per an understanding reached between India and EU. More...
Dr Reddys Labs launches three generic products in USA

(Deepika Amirapu , 13-Jul-2011 , The Economic Times)
Indian drug firm Dr Reddys Laboratories has received the final approval from the USFDA to launch
Fondaparinux Sodium injection used for treating and preventing deep vein thrombosis the company said
in a statement. More...
ComMin for patent protection to Jugaad technology items

(PTI , 13-Jul-2011 , MSN)
The Commerce Ministry has favoured patent protection to low cost innovations like onion seed
transplanter and clay refrigerator mitticool. More...
Why India ranks low in INNOVATION

(Sreelatha Menon , 13-Jul-2011 , Rediff)
Just 200 patent applications were made in 10 years. More...
India China to oppose barriers to affordable drugs

(Ananth Krishnan , 13-Jul-2011 , The Hindu)
India China and other members of the BRICS group of countries have agreed to stand together to
oppose any moves by developed nations to tighten Intellectual Property Rights rules that could threaten
access to affordable drugs in developing countries officials said on Tuesday following two days of talks.
More...
BRIC nations pledge cheaper drugs for developing nations

(Kounteya Sinha , 12-Jul-2011 , The Times Of India)
According to Indian health minister Ghulam Nabi Azad Intellectual Property Right barriers including
patents and data exclusivity cause delays in generic competition in the market which is one of the most
efficient ways to bring prices down. More...
India seeks Polands help for removal of EU trade curbs

India today sought help from Poland which holds the European Union Presidency for resolving trade
obstacles for Indian agri exports to 27 EU countries. More...
Drug makers bet on local biosimilar markets

A recent Standard Chartered Bank report, said By 2015 biologics with an estimated sales value of $60
billion are due to lose patent protection rising to $100 bn by 2020. More...
Industry vehemently objects to the implementation of Utility Models in India

(Suja Nair Shirodkar, Mumbai , 11-Jul-2011 , Pharmabiz)
Objecting strongly to the governments plan to introduce a new IPR in the country in the form of Utility
Models or Petty Patents the Indian pharma industry has urged the government to re consider it as they
fear that it will affect the impact of the well accepted patent laws in India. More...
Trade barriers should not prevent affordable health services

(PTI , 11-Jul-2011 , IBN Live)
India today cautioned against moves to enforce Intellectual Property Rights with the proposed
anticounterfeiting task force saying trade barriers should not prevent equitable and affordable public
health services. More...
Pressing for strong IPR regime in FTA with India: EU tells WTO
The European Union has informed the WTO that it is pressing for inclusion of strong IPR regime in the
free trade agreement under negotiations with India even as the Commerce Ministry has maintained that
New Delhi will not yield to the EU on this issue. More...
Ranbaxy US FDA inch closer to settlement

(Rupali Mukherjee & Partha SinhaRupali Mukherjee & Partha Sinha , 9-Jul-2011 , The Times Of India)
Ranbaxy holds the 180 day exclusivity rights for marketing a generic version of Lipitor in the US through
a deal with current patent holder Pfizer. More...
Lalbaugcha Raja makers get patent for popular idol

(Vinay Dalvi , 8-Jul-2011 , Mumbai Mirror)
In its 77th year the immensely popular Lalbaugcha Raja that attracts millions of devotees each year has
finally been protected by a patent. More...
Indian drug makers bet big on local biosimilar market

By 2015 biologics with an estimated sales value of more than $60 billion are due to lose patent
protection rising to over $100 billion by 2020. More...
Create scalable organisations that last

(Sanjay Anandaram , 8-Jul-2011 , The Financial Express)
Recently India granted geographical indication of origin status to Scotch whisky a legal protection that
will help reinforce the authenticity of the product and enhance the market potential. More...
Government finalises rules of nuclear liability law

Government has finalised the much awaited rules of implementation of the nuclear liability law a move
that could pave way for expansion of the atomic power sector by procuring equipment from foreign
suppliers. More...
Chinas raw deal

The World Trade Organisation is turning into an important platform to target export bans on raw
materials by member countries. More...
A deal still on the drawing board

(Biswajit Dhar , 6-Jul-2011 , Livemint)
The India EU free trade agreement is yet to see daylight. More...
India grants Scotch GI status to check counterfeit

(PTI , 5-Jul-2011 , The Times of India)
India has granted geographical indication of origin status to Scotch whisky a legal protection that will
help prevent the sale of counterfeit products in the Indian market as well as reinforce the authenticity of
the product for the consumer. More...
India has to play a critical role in HIV prevention

Mr. Sidibe hoped India would resist pressure from other countries to place limits of TRIPs trade related
aspects of intellectual property rights flexibilities. More...
Drug cos eye US entry after FDA checks

The US drug regulator has inspected the manufacturing plants of at least half a dozen Indian
drugmakers raising hopes that these companies will be able to export medicines to the worlds largest
drug market reports Khomba Singh from New Delhi. More...
Millions will die if India stops AIDS drugs U.N.

(Nita Bhalla , 05-Jul-2011 , Reuters)
The EU India trade deal includes measures that could delay or restrict competition from generic
medicines by extending patent terms requiring data exclusivity and tightening border enforcement rules.
More...
Google suffers major blow in Nortel patent loss

(IANS , 04-Jul-2011 , The Economic Times)
Google which initiated the bidding war for precious Nortel patents in April has suffered a huge blow with
an Apple led consortium walking away with 6000 patents for $4.5 billion last week. More...
Glenmark settles litigation with Daiichi

Glenmark has settled its litigation with Daiichi Sankyo Inc and Genzyme Corporation over the sale of
Glenmarks generic version of Colesevelam Hydrochloride in the US. More...
Home grown jugaad set for patent cover

(Sidhartha , 4-Jul-2011 , The Times Of India)
Indias spirit of jugaad is finally going to get legal backing. More...
India rejects clause on litigation

India should reject the EUs demand for inclusion of intellectual property in the definition of investment
and the so called investor to state arbitration clause according to Leena Menghaney public health lawyer
and India campaign coordinator for non-profit Medecins Sans Frontieres. More...
Opportunities outweigh risks

(fe Bureau , 4-Jul-2011 , The Financial Express)
Key risks: longer ANDA approval timelines rising FDA scrutiny. More...
The Copyright Amendment Bill 2010: on the death of books and the digital environment
(Aparna Viswanathan , 04-Jul-2011 , The Hindu)
The Copyright Amendment Bill 2010 introduces the parallel importation of books in accordance with
Article 6 of the Trade Related Intellectual Property Rights Agreement a provision intended to provide
readers in developing countries with books at cheaper prices. More...
Scotch Whisky gets GI status in India

(Agencies , 3-Jul-2011 , Indian Express)
India has granted geographical indication of origin status to Scotch Whisky a legal protection that will
help prevent the sale of counterfeit products in the Indian market as well as reinforce the authenticity of
the product for the consumer. More...
DRL haunted by past follies?

(Swati Bharadwaj-Chand , 3-Jul-2011 , The Times Of India)
Over the past two years lawsuits against DRL over alleged patent infringements in US courts have been
piling up as it makes an aggressive play for the US generics market. More...
Pfizer files lawsuit against Aurobindo Pharma

(PBR Staff Writer , 1-Jul-2011 , Pharmaceutical Business Review)
Drug maker Pfizer has filed a lawsuit against India based drug manufacturer Aurobindo Pharma over
generic Lipitor which is indicated as a treatment for cholesterol and for lowering stroke heart attack or
other heart complications in patients type 2 diabetes. More...
Wockhardt gets USFDA nod for generic eye drops

The patent covering this product is under litigation in the US courts and Wockhardt will launch the
product after resolution of the same the company said. More...
Nothing wrong in guarding ones forte

(S. Murlidharan , 30-Jun-2011 , Business Line)
A drug company is normally allowed a 20 year monopoly in most of the countries in the wake of the
WTO norm to this effect when it successfully obtains a patent for its invention. More...
Pfizer sues Aurobindo Pharma over Lipitor

(Press Trust of India / Hyderabad , 30-Jun-2011 , Business Standard)
Global pharma giant Pfizer Inc has sued city based Aurobindo Pharma over the generic version of Lipitor
sources close to the development said today. More...
India needs to nurture culture of innovation

(Rahul Wadke , 30-Jun-2011 , Business Line)
It is one of the top patent producers in the world. More...
Cipla wins pre-grant opposition against Novartis for dispersible tabs containing deferacirox
(Suja Nair Shirodkar, Mumbai , 30-Jun-2011 , Pharmabiz)
The Chennai patent office has granted a pre grant opposition in favour of Cipla for dispersible tablets
containing 'deferacirox'. More...
U.S. Court Orders Seizure of Cipla Pet Drugs

(INTI LANDAURO And ASHUTOSH JOSHI , 30-Jun-2011 , The Wall Street Journal)
A U.S. court ordered the seizure of a pet drug made by pharmaceutical companies Cipla Ltd. and Velcera
Inc. after ruling the drug violated a patent held by a unit of French giant Sanofi SA the French company
said in a statement Thursday. More...
Cookie time
(Rohit Nautiyal , 28-Jun-2011 , The Financial Express)
Cadbury India retaliated and sued Britannia for trademark and copyright infringement of intellectual
Intellectual rights protection forecast: Technical workforce gives India cutting edge in cloud
computing innovation
(Horacio Gutierrez , 27-Jun-2011 , The Economic Times)
There was a time when cloud was nothing more than the result of water droplets suspended above the
surface of the Earth. More...
ICMR to commercialise its patented technology to isolate VSELs from bone marrow cord blood
The Indian Council of Medical Research will soon commercialise its newly developed patent protected
technology in which it has found a simple method to isolate Very Small Embryonic Like stem cells from
bone marrow and cord blood without the use of sophisticated and expensive infrastructure. More...
KSCSTE on a mission to promote IP literacy in Kerala

(T. Nandakumar , 26-Jun-2011 , Business Line)
The Patent Information Centre Kerala an initiative of the Kerala State Council for Science Technology
and Environment has drawn up an ambitious programme aimed to broad base IP literacy in Kerala and
maximize the number of patents filed by universities research institutions grassroots innovators,
educational institutions and individuals. More...
Health groups welcome exclusion of data exclusivity from India EU free trade pact
The NGOs working in the health sector have welcomed Indias formal announcement that it will not
accept data exclusivity as part of a Free Trade Agreement currently being negotiated with the European
Union. More...
Lupin Natco tie up to market generic of GSK cancer drug

Tykerb tablets go off patent in 2017 More...
T S Vishwanath: The grand key to Africa

(T S Vishwanath , 23-Jun-2011 , Business Standard)
Therefore when fully completed this FTA would be a comprehensive agreement covering intellectual
property rights goods and services. More...
India EU agreement may restrict low cost drugs

(Khomba H , 22-Jun-2011 , The Economic Times)
Data exclusivity delays registration of generic versions of a medicine by up to 10 years even for drugs
that do not deserve a patent under Indias law. More...
India pitches for stake in $50 bn pharma mkt in China

(Press Trust of India / Beijing , 22-Jun-2011 , Business Standard)
With China set to open up $50 billion pharmaceutical market India has made a strong pitch saying the
burgeoning Indian pharma sector could step in for supplying affordable life saving medicines to its
neighbour. More...
Strides anti infective gets US nod

The product patent held in the US by Johnson & Johnsons company Ortho McNeil Janssen expired on
June 20. More...
Avesthagen granted US patent

(Press Trust of India / Bangalore , 21-Jun-2011 , Business Standard)
Avesthagen has been granted patent by the US for breakthrough sunflower transformation and eco
friendly safe selection method that can replace the traditional antibiotic marker technology in GM crops.
More...
USFDA approves generic Levofloxacin Indian firms to benefit

(PTI , 21-Jun-2011 , Livemint)
The approval is for the generic tablet oral solution and injectable solution dosage forms of Levofloxacin
US Food and Drug Administration said in a statement More...
Depomed diabetes drug gets another generic threat

Depomed said it would continue to vigorously enforce its intellectual property rights to Glumetza tablets.
More...
Raymond moves HC wants FIR quashed in tech patent case

(Sunil Baghel , 21-Jun-2011 , Mumbai Mirror)
Textile major Raymond Ltd and its Chairman Emeritus have moved the Bombay High Court seeking to
quash an FIR registered against them following a complaint by one Bhogilal Patel last November. More...
Effective intellectual property protections are key to future

(Suresh Sati & Roger Bate , 21-Jun-2011 , DNA)
India is on the brink of finalising a free trade agreement with the European Union. More...
Delhi HC awards punitive damages for infringement of trademark to Pfizer

Creating a benchmark that will help to deter companies from using phonetically and deceptively similar
trademark the Delhi HC recently awarded payment of Rs.1 lakh as punitive damages to a subsidiary of
Pfizer. More...
Europe should be generics global powerhouse - EGA

(Kevin Grogan , 20-Jun-2011 , Pharma Times)
Europes generic drugmakers are in danger of falling behind the likes of India and South Korea if they do
not receive more support from the continents legislators. More...
FTA with Japan holds promise
(C.P. RAVINDRANATHAN , 20-Jun-2011 , Business Line)
Textiles leather products pharmaceuticals and chemicals exports from India could look up as a result.
More...
Confusion abounds in haste to make officials property returns public

Indian Foreign Services IPRs are easy to access More...
Exploring innovation potential in software

(D. Murali , 19-Jun-2011 , Business Line)
They define describe contextualise get IPRs intellectual property rights and then get to the development
part. More...
Piramal Health looks at buyout for expansion

(Reghu Balakrishnan / Mumbai , 17-Jun-2011 , Business Standard)
Increase in outsourcing from developed to developing countries will continue as the innovator companies
will lose patent protection from any of the blockbuster drugs over the next few years thereby forcing
them to look for various alternatives such as cost control and introduction of generics to their portfolio
the report said. More...
Celeb jewellery makers patented designs stolen sold

(Chandrima Pal , 17-Jun-2011 , Mumbai Mirror)
While I dont really care for most of the designs, what I am concerned about is the patented bangle
which I was supposed to unveil at the upcoming gem and jewellery show More...
Nokia loses UK court bid to cancel patent for IPCom

(Bloomberg/New York , 17-Jun-2011 , Business Standard)
Nokia Oyj the worlds biggest maker of mobile phones by volume lost a UK court bid to invalidate a
European patent that Germanys IPCom GmbH & Co claims is vital to the Finnish companys handset
sales. More...
Why copy pasting is a brilliant business strategy

(Vivek Kaul , 17-Jun-2011 , The Economic Times)
The US Patent office had issued Patent 6269361 also known as the 361 patent to Overture in July 2001
More...
Oracle seeks billions in lawsuit against Google

(Reuters / San Francisco , 17-Jun-2011 , Business Standard)
Oracle Corp is seeking damages in the billions of dollars from Google Inc in a patent lawsuit over the
smartphone market according to a court filing. More...
Akhtar takes copyright issue to global platform
Well known Bollywood writer Javed Akhtar has taken his fight for royalty to lyricists to an international
platform. More...
Nortel Delays Mobile Patent Auction One Week As Bidders Get Ready
(Tom Krazit , 17-Jun-2011 , Yahoo)
Nortel will delay the start of a closely watched auction of 6000 mobile patents by a week as it evaluates
what it called a significant level of interest from those hoping to bolster their portfolios More...
Controller general of patents P H Kurian resigns set to return to Kerala

(Our Bureau, Mumbai , 16-Jun-2011 , Pharmabiz)
The controller general of patents designs and trademarks at Indias Intellectual Property office P H Kurian
has resigned from this post and is all set to return to Kerala where he was industries secretary before
moving to the IP office in February 2009. More...
Scientists come up with new molecule that may lead to better drug for TB
After filing for a patent in February the scientists have also sent a 64 page proposal to the ICMR to push
the case for funded research to take the project forward. More...
Limited patents
(Robert Cyran , 16-Jun-2011 , Business Standard)
Nokias innovative past has hitched a ride on Apples future. More...
Kurian quits as patents office chief

Kurian introduced transparency in the process of clearing patent trademark applications and granting IP
rights a function that is becoming increasingly critical as Indias integration with the global economy
More...
Patent office yet to upload information on working patents in India

According to Dr Gopakumar G Nair patent attorney and CEO Gopakumar Nair Associates this step is
taken to ensure that the companies utilise the patents they have been granted rather than keeping it
without use. More...
Patent expiry outsourcing to drive pharma growth: Study

(BV Mahalakshmi , 15-Jun-2011 , The Financial Express)
Patent expiry and outsourcing are expected to be the primary growth drivers for the Indian
pharmaceutical industry a Care research says. More...
Indian regulator calls for central drug pricing
(Lynne Taylor , 15-Jun-2011 , Pharma Times)
Moreover patented drugs should be exempt from all duties and taxes and their marketing approval
should be linked to the pricing negotiations so that import licenses for the product will only be granted
after the price has been agreed, it says according to a report in Indias Business Standard newspaper.
More...
Copyright issue goes global

(Subhash K Jha , 15-Jun-2011 , Mid Day)
Javed Akhtars efforts to secure rights for songwriters composers and authors in India was commended
by Bee Gees singer Robin Gibb More...
Nokia Apple settle patent suits

Nokia Corp on Monday said it has agreed to settle all patent litigations with iPhone maker Apple Inc a
move that will bolster the Finnishs firm profitability in the second quarter. More...
FDA warns Dr Reddys over Mexico plant standards

Indian generic drugmakers including rival Ranbaxy are poised to benefit as drugs worth about $100
billion lose patent protection over the next two years. More...
Country and region-specific Ceylon Tea

(14-Jun-2011 , Daily Mirror)
The tea industry in Sri Lanka is moving closer to protecting the value of Ceylon Tea by initiating action
to obtain a Geographical Indication for the commodity from the World Trade Organization and for
international registration in about 50 markets initially a very costly and time consuming initiative More...
Dr Reddys sees negligible effect of FDA curbs on simvastatin

(KV Ramana , 14-Jun-2011 , DNA)
Dr Reddys Laboratories sees the impact of fresh regulations by the US Foods and Drug Administration on
prescription of 80 mg dose of cholesterol lowering statin drug simvastatin due to risk of muscle injury to
be negligible on overall revenues More...
Some discoveries cant be patented

( Dr David G. Green , 14-Jun-2011 , Financial Times)
Sir The government thinks its patent box scheme under which earnings from patents will be subject to
10 per cent corporation tax will help to make the UK the most competitive tax regime in the Group of
20. More...
Indian scientists develop technology to manage ballast water

(P. Sunderarajan , 13-Jun-2011 , The Hindu)
In the new development that promises to be of far reaching significance the scientists have got a patent
from the United States Patent Office for a treatment technology for the ballast water that is not only
highly effective but is also all more eco friendly as it does not use any chemicals. More...
NPPa: Central agency must decide patented drug prices

(Joe C Mathew / New Delhi , 12-Jun-2011 , Business Standard)
Medicine price regulator National Pharmaceutical Pricing Authority has proposed the formation of a
centralised agency to negotiate the prices of patented medicines. More...
US FDA restricts sale of cholesterol lowering drug Simvastatin

(BS Reporter / Mumbai , 11-Jun-2011 , Business Standard)
The patented version of Simvastatin Zocor manufactured by Merck was approved in 1991 and went off
patent in 2006. More...
Huge opportunities exist in overseas markets for SMEs in pharma sector: Pharmexcil
(Peethaambaran Kunnathoor, Chennai , 11-Jun-2011 , Pharmabiz)
He said in the case of Generic Opportunity 450 molecules worth US$ 350 billion are going off patent in
the coming years. More...
Indian CRAM market to clock $ 7.6 billion by 2012

(Jyothi Datta , 10-Jun-2011 , Business Line)
The growth of the outsourcing opportunity is being propelled by the loss of patent protection to the tune
of $ 97 billion over 2011 2015 steady erosion in new product launches in relation to research spend and
new launches not matching up to the earlier block busters drugs. More...
India calls upon international community to dismantle trade IP barriers to ensure flow of HIV
drugs
(Our Bureau, New Delhi , 10-Jun-2011 , Pharmabiz)
India has called for proactive and collective action from the international community to dismantle trade
and intellectual property right barriers and improve the availability of accessible affordable and quality
drugs for the needy and impoverished across the world. More...
90% of Indian grants are yet to reach the market

Of the 37334 patents granted enforced till Mar 2010 only 4189 have been commercially introduced says
report. More...
State sets up innovation council

(BS Reporter / Chennai/ Bangalore/ Mysore , 9-Jun-2011 , Business Standard)
So far industries and businesses had to make repeated trips to Chennai for obtaining trademark rights
under the Intellectual Property Rights after prolonged procedures. More...
AIDS groups criticise US/EU/Japan for putting profits of MNC drug makers before patients
TRIPS prescribes certain minimum patenting standards that all member organizations have to respect.
More...
India to be firm on IPR at AIDS meet

India is readying to take a zero tolerance position in the ongoing tussle between the developing and the
developed world on a regime for Intellectual Property Rights at a three day United Nations General
Assembly High Level Meeting on AIDS scheduled in New York from Thursday. More...
Health groups call for moratorium on FTAs TRIPS plus measures by developed nations
Even as the global community meets in New York for the United Nations General Assembly High Level
Meeting on HIV and AIDS from 8 to 10 June 2011 networks of People living with HIV health groups and
treatment activists from around the world are calling for an immediate moratorium on all Free Trade
Agreements and TRIPS plus measures. More...
We should increasingly work with China in the field of chemicals

(Promit Mukherjee , 8-Jun-2011 , DNA)
No patented chemicals have ever come under attack because all patented chemicals are held by Europe.
More...
BARCODE FOR EXPORTS

(P A Francis , 8-Jun-2011 , Pharmabiz)
As per a DGFT notification barcoding is going to be mandatory on all pharmaceutical products exported
out of the country from July 1. More...
Eli Lilly to settle dispute over drug copies

(Andrew Jack in London , 08-Jun-2011 , The Financial Times)
Eli Lilly is poised to make a cash payment to settle a long running dispute with Indian generic
drugmakers over low cost copies of the US companys medicines that were impounded within the
European Union. More...
Siemens sues Samsung LG on LED patent breaches

(Reuters , 06-Jun-2011 , The Economic Times)
Siemens lightbulb unit Osram is suing the Samsung and LG groups of companies for alleged
infringement of patents on light emitting diodes technology the German group said on Monday. More...
Troikaa is looking for licensing partner in EU

(Sohini Das / Mumbai/ Ahmedabad , 3-Jun-2011 , Business Standard)
We charge a slight premium of Re 1 per dose as we have developed a patented technology or novel drug
delivery system. More...
Creating an eye capturing business

(K Rajani Kanth / Hyderabad , 3-Jun-2011 , Business Standard)
Professor Daugmans patent will expire in July 2011 post which it will be an open market technology.
More...
IPR rules and their uncertain effects

(Madhukar Sinha , 2-Jun-2011 , Business Line)
If TRIPS has not yielded some of the expected benefits the Anti Counterfeiting Trade Agreement that
seeks cross border IPR protection only gives rise to another set of concerns. More...
Indian pharma ingredient firms in Japanese generics race

(Reghu Balakrishnan / Mumbai , 2-Jun-2011 , Business Standard)
Japan which has a government funded National Health Insurance scheme covering every citizen wanted
to shift from costly patented products to cheaper generic versions. More...
Lupin strengthens biological products pipeline

In licensing pact with Sydney based NeuClone for cell line technology More...
New Indian Express sued over promotion of Sunday Standard

(Anushree Chandran & Abhilasha Ojha , 1-Jun-2011 , Livemint)
Last year we filed a suit against them in the Bombay high court for infringement of the trademark said
the executive. More...
Is Indian pharmaceutical industry losing its sheen? Promoters exit for attractive alternatives
(Gauri Kamath , 1-Jun-2011 , The Economic Times)
For years the Rs 871 crore JB Chemicals and Pharmaceuticals a Mumbai based generics drug company
rode on the success of its cough and cold syrup Doktor Mom in Russia. More...
Drug makers Teva Pfizer settle patent dispute

(ET , 31-May-2011 , CNBC)
Teva Pharmaceutical Industries Ltd. said Tuesday it has settled a patent lawsuit brought by Pfizer Inc.
over a drug for treating seizures and pain caused by shingles. More...
Global Fund calls for clauses in FTA to ensure access to medicines for AIDS malaria TB
Both call for the use of measures to contain costs and foster an open competitive market for health
commodities including the use of TRIPS flexibilities patent pooling and voluntary licence agreements
between patent holders and generic manufacturers. More...
Great job offers to students with campus patents experience

(TV Mahalingam, ET Bureau , 29-May-2011 , The Economic Times)
Swarup credits his blue chip job to both his degree in industrial production and a patent for an invention
a refrigerator cum water purifier that has been filed in his name at the US and Indian patent offices.
More...
Mylan plans direct entry into India

Mylan which acquired the generic business of German drug giant Merck KGaA in 2008 in a global deal is
currently the largest generic or off patent drug maker in the world. More...
Fresenius Kabis India unit now global R&D hub

Fresenius Kabi Oncology has also entered into a contract R&D and manufacturing agreement with its
parent Fresenius Kabi Germany and its affiliates for future products without affecting existing product
business and intellectual property rights, it said in a disclosure to stock exchanges. More...
India for concluding package for LDCs by December under Doha round
(Sujay Mehdudia , 28-May-2011 , The Hindu)
Doha Round would not be concluded this year as planned in Davos More...
Heard on the Street: Suven Life Sciences climbs on Patent acquisitions

Suven Life Sciences Climbs 5% on Foreign Patent Acquisitions More...
Microsoft chief Steve Ballmer says China piracy very costly

It kept the country on this years priority watch list for weak protection of intellectual property rights.
More...
Details of patented drugs to be made public

To increase transparency Indias patent regulator will soon make public details about patented drugs
which include whether domestic demand for these medicines is met at a reasonable price. More...
India EU free trade pact in final stage: Sharma

Indicating that differences persist between India and the European Union over their proposed free trade
agreement the Commerce and Industry Minister Mr Anand Sharma said even the best of astrologers
would not know about the timeline. More...
Takeda to buy Swiss drugmaker Nycomed for $13.6 bn

(James Topham and Ritsuko Shimizu / Reuters , 25-May-2011 , Livemint)
Takeda known for its top selling diabetes drug Actos which faces the upcoming expiry of its US patent
will also gain a portfolio of over the counter consumer products. More...
Suven struggles to find partner to take Alzheimers drug to next stage
(Viswanath Pilla , 25-May-2011 , Livemint)
They still have to learn how to monetize various stages of clinical trials and how to protect their
Levis takes on private labels with Denizen

(Purvita Chatterjee , 24-May-2011 , Business Line)
In fact the decision to change the name of Signature to Denizen came about after Levis started fighting
patent cases across markets for the brand name of Signature. More...
Venus gets European patent for painkiller injection

Drug firm Venus Remedies today said it has received patent from the European Patent Office for ACHNIL
its once a day painkiller injection. More...
Biodiversity of the state needs to be protected

(Express News Service , The New Indian Express , 24-May-2011 , IBNLIVE)
The chairman of Andhra Pradesh State Biodiversity Board R Hampaiah said that several countries have
claimed patents on turmeric garlic basmati and several other agricultural products and animals like the
Ongole Bull. More...
More foreigners than Indians receiving patents in India'

(PTI , 22-May-2011 , MSN)
There are more foreigners than Indians receiving patents in India prompting the government to say
much needs to be done to encourage more domestic innovations. More...
Drug exporters need more time to implement barcode: Pharmexcil

(Peethaambaran Kunnathoor, Chennai , 20-May-2011 , Pharmabiz)
As regards infringement of patent Bhavin said whoever without authority makes or uses or offers to sell
or sells or imports any patented invention during the term of the patent it is infringement. More...
Lincoln Pharma launches anti malarial drug ‘ARH 1’

The company has applied for a patent of ARH 1 in India as well as internationally. More...
Government moots patents for jugaad

If the government has its way the small scale industrys spirit of jugaad could soon be giving competition
to Phunsuk Wangdus Aamir Khans character in the hit movie 3 Idiots 400 patents. More...
Glenmark Pharma in $613 million licensing deal with Sanofi

Mumbais Glenmark Pharmaceuticals has licensed a new biotech drug to Frances Sanofi which has the
potential to generate revenues of $613 million or 2734 crore. More...
Indian American couple pleads guilty for selling fake drugs

(PTI , 17-May-2011 , The Times Of India)
An Indian American couple in New Jersey has pleaded guilty before a US court for selling counterfeit
prescription drugs made in India federal authorities said. More...
Rajkumar Dogra a naval soldier & general manager is now a patent lawyer
(Amit Shanbaug , 16-May-2011 , The Economic Times)
This time as a patent lawyer a profession drastically different from his previous two occupations naval
soldier and general manager. More...
MSN Labs to enter pain management market

The company so far has filed over 100 Indian and over 40 international patents. More...
Commerce min mulls registrar for traditional knowledge

(ENS Economic Bureau , 14-May-2011 , Indian Express)
To protect traditional knowledge in the field of medicine and music the ministry of commerce and
industry today came out with a discussion paper suggesting that a registrar should be appointed to help
knowledge holding community reap benefits of such information and prevent its unauthorised
commercial use. More...
ICMR looks for partners to commercialise herbal composition to treat filariasis

An Indian patent has been filed. More...
Emerging economies: outside in and inside out

(13-May-2011 , Livemint)
China recently filed 977000 domestic patent applications. More...
SC bans production sale and use of Endsosulfan for eight weeks

(PTI , 13-May-2011 , The Hindu)
Endosulfan is an off patent organochlorine insecticide and acaricide. More...
Dr Reddys Q4 net profit doubles tops forecast

Indian generic drug makers including Dr Reddys and rival Ranbaxy are poised to gain as drugs worth
about $100 billion lose patent protection over the next two years but they have to contend with intense
competition rising lawsuits from rivals and a stricter U.S. health regulator. More...
NBRI to scout for commercial partners for herbal innovations
(Virendra Singh Rawat / New Delhi/ Lucknow , 12-May-2011 , Business Standard)
NBRI would apply for national license and patent for the herbal drink before it scouts for suitable private
partner for technology transfer. More...
Border push in EU FTA to hit pharma exports

In the quid pro quo of the free trade agreement currently being negotiated with the European Union
India could end up giving in to a provision which could hamper its exports of pharmaceuticals. More...
No cheer for vodka brand that copied rivals bottle

(Sunil Baghel , 11-May-2011 , Mumbai Mirror)
Two vodka manufacturing companies Gorbatschow Wodka and John Distilleries fought an intellectual
property rights see box case in the Bombay High Court over the design of their products bottles. More...
The push and pull in generic drugs

(10-May-2011 , Livemint)
On the one hand is the crucial process of drug discovery on the other the need to make medicines
affordable More...
Learning with the Times: Endosulfan has chronic adverse effects on humans
Endosulfan is a pesticide which was introduced in the 1950s and soon became a leading chemical to fight
a broad spectrum of insects. More...
Suven Life sued for Ovide patent violation by Taro

(KV Ramana , 7-May-2011 , DNA)
US-based Taro Pharmaceuticals North America has sued Hyderabad based custom research and
manufacturing services major Suven Life Sciences alleging an infringement of patent involving its head
lice killer lotion Ovide. More...
Cultural rights in the digital age

(SHARANYA MANIVANNAN , 7-May-2011 , Business Line)
A pioneering academic in the field of intellectual property Canada based Dr. Mira T. Sundara Rajan is a
polymath with an illustrious lineage. More...
Ranbaxy may pay $1bn to USFDA

Gurgaon based pharma major Ranbaxy Laboratories is said to be negotiating a settlement with US Food
and Drug Administration to clear two of its manufacturing plants from which the US agency had halted
sales. More...
Zydus Cadila aims to be a $3 bn company by 2015
Biosimilars or Follow on biologics are terms used to describe officially approved new versions of
innovator biopharmaceutical products following patent expiry. More...
Sharing the spoils

(6-May-2011 , Mint)
In the lucrative US pharmaceutical market generic and patent holders of drugs have increasingly chosen
to settle patent challenge disputes than to fight them in court More...
Chinese tech giants Huawei Technologies and ZTE in rare mobile phone patent court battle
(AP , 6-May-2011 , The Economic Times)
Two of Chinas biggest technology companies have launched a court battle in Europe over mobile phone
patents in a rare public clash between firms Beijing is promoting as national champions. More...
Himalaya launches Liv.52 HB for treatment of Hepatitis B

(Announcement / Corporate , 05-May-2011 , Business Standard)
The Himalaya Drug Company one of Indias leading herbal health and personal care companies launched
Liv.52 HB the first herbal drug for the effective management of Hepatitis B virus infection. More...
Govt asks exporters to move up the value chain

Indias medium term export strategy is according top priority to changing the value proposition for
pharmaceuticals electronics and auto component exports besides suggesting a plan to get a toehold into
the high technology space. More...
India EU trade pact talks enter final phase

(Nayanima Basu / New Delhi , 05-May-2011 , Business Standard)
Talks to close a broad based comprehensive trade pact with the European Union has reached its final
stage while both sides would be sitting for another round of negotiations by the middle of this month to
agree on crucial areas where there are still some gaps. More...
Regulatory overkill stifling drug discovery: Experts

Lead time was important for getting patents for original drug research she said. More...
Tea Board launches Ozone friendly tea, certification marks

(Athraja de Silva , 05-May-2011 , Daily Mirror)
Sri Lanka Tea Board ceremonially launched the new logo for Ozone Friendly Ceylon Tea together and
Agro climatic regional names logos as Certification Marks under Geographical Indication to protect and
add value to premium Ceylon Tea. More...
No time for copyright say Indian designers
(IANS , 4-May-2011 , The Times of India)
The more the fashion weeks the more the exposure and the more the chances of designs being copied.
More...
Patent suit filed against Dr Reddyâ€™s

(KV Ramana , 4-May-2011 , DNA)
Yet another US drugmaker has sued Dr Reddys Laboratories alleging patent infringement. More...
US court dismisses Mylan challenge on Ranbaxy Lipitor rights

(BS Reporter / New Delhi , 4-May-2011 , Business Standard)
In a major reprieve to Ranbaxy an American court has dismissed a petition from rival pharmaceutical
firm Mylan to challenge the formers exclusive marketing rights over the generic version of Pfizers Lipitor.
More...
ICMR seeks cos to commercialize its two new inventions against cancer dengue vector
The Indian Council of Medical Research has developed an anti neoplastic compound for possible
treatment of cancer and an herbal composition against dengue vector. More...
US puts India Pak and China on IPR violation watch list

United States has placed India Pakistan China and nine other countries on the top priority watch list with
regard to violations of intellectual property rights. More...
IPAB centre likely to come up in Mumbai Delhi and Kolkata

The government may need to set up permanent centres of the countrys nodal body monitoring disputes
related to intellectual property rights and patents in Delhi Mumbai and Kolkata to expedite resolution of
cases. More...
An end to endosulfan?
(Business Standard , 3-May-2011 , Sify)
Those voicing the interests of Indian farmers and the endosulfan industry have alleged that the hue and
cry against it is the handiwork of NGOs funded by European patent holders of newer chemicals. More...
Alkem ties up with Swedens Karo Bio

There will be a royalty payment to Karo once revenues are generated on the patent protected product
Mr Shenoy said without giving details. More...
Technical institutes make beeline for patents
(Vijay C Roy / New Delhi/ Chandigarh , 2-May-2011 , Business Standard)
Realising the importance of Intellectual Property Rights universities technical and educational institutes
in Punjab are getting their innovations patented. More...
India not to dilute stand on intellectual property rights

(IANS , 2-May-2011 , The Economic Times)
India has decided not to dilute its stand or take a position on intellectual property rights especially on
pharmaceuticals beyond its domestic law and the current international commitments. More...
Domestic drug makers set to invoke compulsory licensing route by June

(Joe C Mathew & Nayanima Basu / New Delhi , 2-May-2011 , Business Standard)
Compulsory licensing provisions under the Indian Patent Act will be put to test soon as local drug makers
are planning to use it to make low cost versions of patented drugs. More...
India to launch FTA negotiations with Australia

(The Hindu , 30-Apr-2011 , Business Line)
No IPR obligations beyond domestic laws More...
Glaxos Growth is Not an Accident: Andrew Witty

(Sudeshna Sen , 30-Apr-2011 , The Economic Times)
Andrew Witty global CEO of GlaxoSmithKline is a self confessed Indophile. More...
Nagesh Kumar: An innovation led growth model

(Nagesh Kumar , 30-Apr-2011 , Business Standard)
R&D subsidy to industry and protecting indigenous innovation can give India competitive edge More...
Scientists oppose European stem cell patent ban

Research scientists hit out on Wednesday at a European Court of Justice case they say could block
development of embryonic stem cell based therapies in Europe. More...
PMs Trade and Economic Committee to review trade treaties

(Sujay Mehdudia , 28-Apr-2011 , Business Line)
Even as a large number of consumer and NGO groups have come out in support of more transparency in
sharing information on trade treaties the Prime Ministers Trade and Economic Relations Committee is
meeting on Friday to review various treaties including the India EU free trade agreement. More...
Basmati exporter files two patents on parboiling technology

Method reduces husk splitting; pares brokens range to 4-8% More...

PM to review next month proposed trade pact with EU
(PTI , 27-Apr-2011 , MSN )
Prime Minister Manmohan Singh will review the proposed bilateral trade and investment agreement
between India and the EU at the meeting of the Trade and Economic Relations Committee on May 29.
More...
Intellectual Property Association of South India launched

(PTI , 27-Apr-2011 , IBN Live)
There was a need for creating more awareness about intellectual property rights trademarks and patents
to help the growth of the countrys economy Madras High Court Judge Justice P Jyothimani said today.
More...
TRIPS Plus measures outside WTO framework not acceptable: Anand Sharma
Union commerce and industry minister Anand Sharma has reiterated Indias stand that it will not accept
any Trips plus decision that is taken outside multilateral framework. More...
Purdue Pharma sues Ranbaxy over sale of cheaper pain drug in US

(Khomba Singh , 27-Apr-2011 , The Economic Times)
American drugmaker Purdue Pharma has sued Ranbaxy Laboratories to prevent Indias largest
drugmaker from selling a generic or low priced version of its bestselling medicine pain reliever Oxycontin
in the US. More...
Innovation deficit hurts India Inc

(M. D. Nair , 27-Apr-2011 , Business Line)
In all the surveys on innovations and outcomes India ranks low in the pecking order below even
countries such as Brazil not to speak of China. More...
Suven Life bags seven patents for new molecules

Suven Life Sciences said on Tuesday it has secured seven product patents for its new chemical entities
in different geographies. More...
Lupin In License Pact With Abbott On Cholesterol Drug

(Rumman Ahmed , 26-Apr-2011 , The Wall street Journal)
Indias Lupin Ltd said Tuesday it and its units have agreed to buy licenses from U.S.based Abbott
Laboratories and Frances Laboratoires Fournier S.A. for various patents on anti cholesterol drug
fenofibrate in an attempt to ring fence its Antara brand from generic competition. More...
India should demand review of TRIPS: Isaac

(Express News Service , 26-Apr-2011 , Express Buzz)
India should demand the review of TRIPS a move which will be supported by a large number of countries
especially in the sectors of common property patents and the pharmaceutical sector Finance Minister T M
Thomas Isaac has said. More...
BHU attaches no special significance to day

(Binay Singh , 26-Apr-2011 , The Times of India)
The Banaras Hindu University that has its own Intellectual Property Rights Policy and IPR Cell held no
special programmes to mark the World Intellectual Property Day on Tuesday. More...
GIIP wants govt to make major changes in Patent Act to promote IP in country
(Suja Nair Shirodkar, Mumbai , 26-Apr-2011 , Pharmabiz)
With a view to promote interest in Intellectual Property law and its scope in the country Global Institute
of Intellectual Property wants the government to bring in substantial changes in the present IP law.
More...
Adobe India doles out up to 200% bonus for innovative employees

(Shruti Sabharwal , 26-Apr-2011 , The Economic Times)
A patent is a measure of technical excellence and that probably is the biggest high. More...
The Round that went in circles

(26-Apr-2011 , Livemint)
What Pascal Lamy calls an unbridgeable political gap seems to be the final nail in the Doha trade talks
coffin More...
Ranbaxy launches generic Olanzapine tablets in Spain

Drug major Ranbaxy Laboratories today said it has launched generic Olanzapine tablets used in treating
central nervous system disorders in Spain. More...
Pfizer deal allows Dr Reddys to sell anti depression pill

(Bloomberg / Mumbai , 25-Apr-2011 , Business Standard)
The company has previously settled patent infringement suits regarding Effexor it filed against Teva
Pharmaceutical Industries and Anchen Pharmaceuticals and Impax Laboratories Inc. More...
MNC may need govt nod to buy local pharma firm

The government may approve acquisitions of local drugmakers by global firms on a case by case basis
on certain conditions to ensure availability of medicines at affordable prices, despite calls for restrictions
on such deals in the wake of a spate of takeovers in the last three years. More...

on certain conditions to ensure availability of medicines at affordable prices despite calls for restrictions

on certain conditions to ensure availability of medicines at affordable prices despite calls for restrictions
Google loses Linux patent lawsuit

(Joseph Menn in San Francisco , 23-Apr-2011 , Financial Times)
Google has lost a Texas lawsuit that claims the core of Linux infringes on a privately held patent raising
fears of a wave of similar claims against other users of the open source operating system More...
Dr Reddys reach settlement with Wyeth over Effexor

Dr Reddys Laboratories has reached a deal in New Jersey Federal Court yesterday with Wyeth LLC a
wholly owned subsidiary of US based Pfizer over a patent litigation involving generic version of
blockbuster anti depressant drug Effexor XR sources close to the development said. More...
Halt India EU FTA talks immediately

(Sujay Mehdudia , 22-Apr-2011 , Business Line)
Ska Keller a Green member of the European Parliament has warned that the proposed free trade
agreement between India and European Union will have serious consequences for the Indian people.
More...
Govt to reconstruct 44000 missing trademark files

The Government today said it will issue a public notice by next week to reconstruct 44000 missing files
from the trademarks office. More...
Software firms pin hopes on proposed change in copyright Act to nail piracy
(Yogendra , 21-Apr-2011 , Livemint)
Dont ask for pirated software. More...
India EU FTA talks in crucial phase

(Surojit Gupta , 21-Apr-2011 , The Times of India)
Negotiations between India and the European Union for a Free Trade Agreement have entered a crucial
phase and contours of the deal have started to emerge but there are still some issues which need to be
resolved EU official say. More...
The companys off patent drugs business the cash cow supporting research was facing price
pressures in some key markets.
(Gauri Kamath , 21-Apr-2011 , The Economic Times)
In the 1980s he founded what would become Indias secondlargest generics pharma company. More...
Firms pin hopes on proposed change in Copyright Act to tackle piracy

(Yogendra , 21-Apr-2011 , Livemint)
The anti piracy task force is working on a manual for law enforcement agencies to act against pirates
More...
India videographs 200 yoga postures to prevent patent piracy

(PTI , 20-Apr-2011 , The Times of India)
India has made available a database describing 1300 yoga postures and videography of 200 popular
among these as part of efforts to prevent patent pirates from exploiting it for commercial purposes.
More...
Apple sues Samsung says stop copying us

(Dan Levine & Miyoung Kim / Reuters , 20-Apr-2011 , Livemint)
Samsung phones tablet copy iPhone and iPad lawsuit Apple attacks design interface application icons of
Galaxy models More...
US drug recall not to have big financial impact on Lupin

(P.T.Jyothi Datta , 20-Apr-2011 , Business Line)
Drug maker Lupins recent voluntary recall of a batch of its hypertension drug Lisinopril in the US will not
have a major financial impact on the company. More...
CSIR to ink patent deal with Japan today

Council of Scientific and Industrial Research will on Wednesday sign an access agreement with Japan
Patent Office for Traditional Knowledge Digital Library. More...
Kallam Anji Reddy | We are dominating the generics industry

(Viswanath Pilla & Anil Penna , 20-Apr-2011 , Livemint)
When Big Pharma discovered drugs way back I am talking about 25 years back when someone started
to make generics they first said how can you equate a copycat to us even though the patent has
expired. More...
Indigenous software helps keep global bio pirates at bay

(Kounteya Sinha , 20-Apr-2011 , The Times of India)
Special symbols to denote ancient Indian medicinal formulations are helping identify and catch bio
pirates who are trying to illegally patent existing knowledge. More...
Patenting: India in poor position

Ignorance lack of initiative are among the reasons More...

US Supreme Court hears Microsoft patent case
The US Supreme Court immersed itself in patent rules in a case pitting Microsoft against a Canadian
technology company that claims some versions of Word violated its patent. More...
Orchid Chemicals settles case with Pfizer Inc stock down

Hyderabad based Orchid Chemicals has reached an out of court settlement with world s largest
drugmaker Pfizer Inc to sell a low cost version of the American firms patented anti depressant drug
Effexor XR in the US market this fiscal. More...
India EU FTA to be stitched up within this year

Union Commerce and Industry Minister Anand Sharma on Monday said talks between India and
European Union had been intensified in an attempt to stitch up a free trade agreement within this year.
More...
Pharma MNCs take JV route for India

(Reghu Balakrishnan / Mumbai , 17-Apr-2011 , Business Standard)
With the rising significance of India as one of the largest generic drug markets and escalating valuations
which makes the pharmaceutical space here a tough acquisition target global pharma majors remain
active for entering partnerships joint ventures and alliances with their Indian counterparts. More...
Drug makers may go for more compulsory licences

(P.T. Jyothi Datta , 15-Apr-2011 , Business Line)
The doors seem to have opened for more domestic drug companies to seek compulsory licences say
industry experts after the Centre recently reiterated that it would assess each case for a CL
independently under the Indian Patent Act that is equipped to handle such issues. More...
Pvt pharma firms knock CSIR to develop TB drug

In a first two pharmaceutical companies have expressed their desire to be a part of Council of Scientific
and Industrial Researchs open source drug discovery project for tuberculosis. More...
Innovation Society eyes 3000 patents in 2 yrs

(Express News Service , 15-Apr-2011 , Indian Express)
The Gujarat Innovation Society to be inaugurated on Friday has a target of 3000 patent applications to
be filed from the state in the next two years. More...
Patent office may outsource art searches to IITs

(Soma Das , 15-Apr-2011 , The Financial Express)
Shortly after putting in place a mechanism to outsource prior art searches to Council of Scientific and
Industrial Research the Indian patent office is in talks with premier educational institute IITs for similar
ties. More...
India EU free trade pact talks to conclude by year end

The European Union has exuded confidence that negotiations for the proposed free trade agreement
between the 27 nation block and India would be concluded by the end of this year. More...
Now copyright free maps of States districts panchayats

(S. Anandan , 15-Apr-2011 , The Hindu)
Even as the Malayalam Loves Wikipedia campaign launched to expand the knowledge repositories of
Malayalam Wikipedia with copyright free Malayalam related photographs continues to evoke
overwhelming response from Wiki users and contributors a project meant to make available online free
to use national map and maps of States districts and panchayats is making silent but significant strides.
More...
Now copyright free maps of States districts panchayats

(S. Anandan , 15-Apr-2011 , The Hindu)
Even as the Malayalam Loves Wikipedia campaign launched to expand the knowledge repositories of
Malayalam Wikipedia with copyright free Malayalam related photographs continues to evoke
overwhelming response from Wiki users and contributors a project meant to make available online free
to use national map and maps of States districts and panchayats is making silent but significant strides.
More...
Cos flock to courts to resolve patent suits

(Chitra Unnithan , 14-Apr-2011 , The Times of India)
Mumbai based drugmaker Lupin filed a second suit last week in the US against Ranbaxy Laboratories to
prevent the Gurgaon based drugmaker from launching fenofibrate a generic version of Lupins cholesterol
lowering drug Antara in the US. More...
Govt plans to make public details of patented drugs

The government will make public details of every medicine patented in the country to bring transparency
a move that will also help Indian drugmakers to challenge patent holders and sell low cost version of
high priced patented drugs More...
Dr Reddys launch generic version of Allegra in US

In a bid to tap the $452 million Fexofenadine drug market Dr Reddys Laboratories today announced the
launch of generic version of Allegra Fexofenadine HCl tablets in the US market. More...
Designs on industrial products

(T S Vishwanath / New Delhi , 14-Apr-2011 , Business Standard)
WIPO is mulling a treaty to harmonise protection of industrial designs at all levels More...
Takeda Pharma files patent infringement suit against Dr Reddys
(PTI , 12-Apr-2011 , IBN Live)
Global pharma major Takeda Pharmaceutical Co has filed a patent infringement suit against Indias
second largest drug maker Dr Reddys Laboratories in a New York Court over the latters efforts to
manufacture a generic version of acid reflux treatment drug Dexilant. More...
Indian pharma in tough battle for generic riches

Indian makers of generic drugs have a fight on their hands as they scramble for access to the $100
billion worth of drugs coming off patent over the next two years. More...
No new norms on compulsory licensing

Current guidelines under the TRIPS agreement Indian Patents Act are sufficient to issue such licences
says DIPP More...
PharmaSecure in talks to offer anti counterfeit solutions

(Press Trust of India / Mumbai , 12-Apr-2011 , Business Standard)
PharmaSecure PAS India is in talks with several leading pharma companies to offer its anti counterfeit
solutions of tracking and tracing medicines ahead of the government deadline of July 1. More...
44000 files of trademark registrations missing probe on

(Harish V Nair , 11-Apr-2011 , Hindustan Times)
In what could have a bearing on a large number of trademark disputes more than 44000 files have gone
missing from Mumbai Delhi Chennai and Kolkata branches of the Trade Marks Registry. More...
Sun Pharma Merck venture to target emerging markets

Branded generics are off patent drugs or medicines similar to an innovative drug, but after the exclusive
patent period had lapsed that are nevertheless sold under a brandname. More...
MSF asks EU to confirm it will not push India to accept data exclusivity
Deeply concerned over the new measures Europe is pushing to restrict the production of affordable
generic medicines in India Médecins Sans Frontières has asked the EU to confirm that it will no longer
push for India to accept data exclusivity. More...
Keep off the doodle copycats

(Anu Vaidyanathan , 10-Apr-2011 , Business Line)
What users may not know is that this doodle stands patented. More...
India will not accept any intellectual property talks outside WTO: Anand Sharma
India will not accept any attempt made by groups of countries to discuss intellectual property rights
outside the multilateral forum of the world trade organisation commerce and industry minister Anand
Sharma has said. More...
Ranbaxy stocks up as USFDA opposes Mylans request

The US drug regulator has opposed American firm Mylans request to strip Ranbaxy Laboratories of its six
month exclusive rights to sell a low priced version of the worlds best selling drug Lipitor in the US.
More...
Govt to soon announce manufacturing policy

The government on Friday said it will soon unveil a national manufacturing policy which aims at
attracting overseas investments and increase the share of the sector in the economy. More...
Drug MNCs violating patent law?

Five pharma MNCs including Pfizer Bayer Roche Schering and Bristol Myers Squibb have been accused of
violating patent laws with regard to top selling patented anti cancer and hepatitis drugs sold in the
country. More...
Drug firms may have breached patent norms

Companies required to file information on working status of patents which is key to compulsory licensing
More...
4000 pirated books worth 25 lakh seized 7 arrested

A case under various sections of the Indian Copyright Act has been registered against the suspects at
the Deccan Gymkhana police station. More...
India against inclusion of data exclusivity in any FTA

India today said it was against the inclusion of data exclusivity provision in any of its free trade
agreements as it would hurt the interests of the domestic generic drugs industry. More...
PM led council to deliberate on India Australia FTA

(Sanjeeb Mukherjee / New Delhi , 6-Apr-2011 , Business Standard)
A council headed by Prime Minister Manmohan Singh would deliberate on the feasibility of starting a
dialogue on a Free Trade Agreement between India and Australia besides a more comprehensive
agreement with Indonesia. More...
Amend drug seizure rules to end WTO case: India to EU nations
India today said it will withdraw its case from the WTO against EU on wrongful seizure of drug
consignments of Indian companies only when all the members of the 27 nation bloc amend their rules to
prevent recurrence of such incidents. More...
Reverse Engineering of Off Patent Tech

Tweaking designs of imported technology products that have gone off patent and reselling them in the
local market can turn out to be a money spinner for technopreneurs. More...
Nortel patents: Google bids big

(Indo-Asian News Service , 05-Apr-2011 , Hindustan Times)
Fallen telecom giant Nortel on Monday said that Google is bidding $900 million to buy its patent
portfolio. More...
Tweaking designs of products no longer under patents route to a profitable technology

venture
(Omkar Sapre , 5-Apr-2011 , The Economic Times)
Tweaking designs of imported technology products that have gone off patent and reselling them in the
local market can turn out to be a moneyspinner for technopreneurs. More...
Pharma firms turn to innovative marketing to boost demand

(Priyanka Pulla , 5-Apr-2011 , Livemint)
Drug makers are estimated to lose as much as $140 billion by 2016 because of the expiry of patent
protection according to a 2007 report by market researcher Datamonitor. More...
Panel to address issues of pharma industry

(Nivedita Mookerji / New Delhi , 5-Apr-2011 , Business Standard)
An expert panel comprising top representatives of the health ministry the Department of Industrial
Policy and Promotion, the National Pharmaceutical Pricing Authority various drug industry bodies and
business chambers has been formed to bring out a report on a long term policy for the pharma sector.
More...
Patient info in clinical trial not to be shared: CIC

(PTI , 5-Apr-2011 , MSN )
Data about patients participating in clinical trials cannot be shared the Central Information Commission
has held while dismissing an RTI plea seeking details of stalled Human Papilloma Virus vaccine trials in
the country. More...
PM panel to review India EU free trade pact on Wednesday

(PTI , 04-Apr-2011 , The Times Of India)
Ahead of crucial talks on India EU free trade agreement in Brussels the Prime Ministers Trade and
Economic Relations Committee will review the issue on Wednesday. More...
A big part of HP Unix work happens in India

We encourage all of our engineers to patent any innovation or technology they have. More...
Jasmine fragrance spreads overseas

(KARWAR , 01-Apr-2011 , IBN Live)
Bhatkal jasmine should be included in geographical indication list to safeguard the interest of growers.
More...
Marrying the medicines of the world

(Subir Roy / Bangalore , 1-Apr-2011 , Business Standard)
The patent pipeline particularly for blockbuster drugs that help fund future research is drying up. More...
SPIC urges PM to order inquiry into barcoding being made mandatory for pharma exports
High quality drugs produced by Indian companies earlier have been categorized as counterfeits in the
West if manufactured without approval from Patent holders with the purpose of stalling export of
affordable generics from India. More...
India will not provide data exclusivity: Anand Sharma

(BS Reporter / New Delhi , 30-Mar-2011 , Business Standard)
The government on Tuesday took a firm stand on protection of intellectual property rights and the
aspect of data exclusivity for drug manufacturers saying that the country would not extend data
exclusivity that would hamper the domestic pharma industry. More...
Endosulfan ban: no clear battle lines drawn

(Priyanka Pulla , 30-Mar-2011 , Livemint)
Endosulfan is now off patent and brings in far lower margins. More...
India is big contributor of patents

HPs Bangalore centre has become one of the largest and most diverse sites of HP in the world. More...
GI status to spice up branding of unique crop varieties

(P K Krishnakumar , 29-Mar-2011 , The Economic Times)
The Spices Board under the ministry of commerce has registered pepper cardamom chilli ginger and
turmeric as products that have unique flavour and attributes because they are grown in a specific
geographical region of India. More...
A pill for generic troubles
(Biswajit Dhar , 29-Mar-2011 , Livemint)
Despite positive signals recent trends in the generic pharmaceuticals industry have been most
disheartening More...
Natco Pharmas medicine gets orphan drug designation from USFDA

The drug has been granted patents in nine countries including the US. More...
FTA will enhance R&D in Indias pharma sector

(BV Mahalakshmi , 28-Mar-2011 , The Financial Express)
Brian Ager the Director General of European Federation of Pharmaceutical Industries and Associations
says that its global R&D pharmaceutical industry has no desire to restrict access to essential medicines.
More...
Panel: Apple did not infringe Nokia patents

Apple Inc won a US trade ruling in a patent fight brought by Nokia Oyj over technology used in mobile
telephones. More...
GI tag: Varanasi Bhadohi lead in UP

While Varanasi Bhadohi region takes a lead in Uttar Pradesh by getting two GI tags for its famed
products Banaras brocade and saree and handmade carpet of Bhadohi Karnataka is the leader in
producing maximum number of GI registered products in the country. More...
Free trade pact with four European nations this year

(Sujay Mehdudia , 25-Mar-2011 , The Hindu)
India and the Europe Free Trade Association are likely to conclude a free trade agreement entailing a
comprehensive bilateral trade and investment agreement by this year after fast tracking of the
negotiations between the two groups. More...
Banaras brocade Bhadohi carpets to achieve new height internationally

The Chennai based office of the Geographical Indications Registry Ministry of Commerce and Industry
Government of India organised a seminar cum workshop on awareness about GI and GI authorised
users on Friday. More...
Authorised clones may hit Ranbaxys FTF bet

The proverb all that glitters is not gold seems apt for Ranbaxy Laboratories amid a flurry of patent
expiries that are slated in the US market. More...
Now get live info of your trains position
The Geographical Indication Board which was in stalled at the Charbagh station on a trial basis is now
fully functional. More...
Intellectual property rights need to be propagated

(Our Correspondent , 23-Mar-2011 , Business Line)
Lack of awareness on intellectual property rights is deep in tier II cities and is holding back the growth of
small and medium scale enterprises said Mr N.V. Srinivasan Chairman Indo American Chamber of
Commerce here recently. More...
India EU trade deal threatens access to life saving drugs

(ANI , 23-Mar-2011 , The Economic Times)
An expert has warned that a new trade agreement between India and Europe would block access to life
saving drugs for billions of people living in developing countries. More...
India equipped to protect over 2 lakh formulations under Traditional Knowledge Digital
Library
The Union Minister of Science Technology and Earth Sciences Mr P.K Bansal said on Tuesday that India is
equipped to protect over 2 lakh formulations under the Traditional Knowledge Digital Library. More...
India to help world protect ancient medicines

(fe Bureau , 24-Mar-2011 , The Financial Express)
On Tuesday India offered to share its expertise with other countries on effectively protecting the
commercially valuable traditional systems of medicine such as Ayurveda from being patented by
individuals and companies. More...
India to help world protect ancient medicines

On Tuesday India offered to share its expertise with other countries on effectively protecting the
commercially valuable traditional systems of medicine such as Ayurveda from being patented by
individuals and companies. More...
Ranbaxy: Is the market overreacting to Mylans suit

(Srividhya Sivakumar,BL Research Bureau , 23-Mar-2011 , Business Line)
The stock price of Ranbaxy falling seven per cent on Monday following reports of Mylan suing the US
FDA may be an overreaction More...
Willing to share TKDL model to protect traditional knowledge''

(PTI , 22-Mar-2011 , IBN Live)
India today offered to share its experiences in protecting traditional knowledge from being used to get
patents with countries desirous of doing so. More...
Ranbaxy shares dive 7% as Mylan sues USFDA over Lipitor approval
Ranbaxy Laboratories scrip plunged nearly 7% at around Rs 436 on the Bombay Stock Exchange close
to the months lowest on Monday on speculation that its plans in launching generic Lipitor may hit a
roadblock. More...
India to showcase mission to protect traditional knowledge

(PTI , 22-Mar-2011 , MSN)
India will showcase its unique mission to curb bio piracy and share its experience of protecting
traditional knowledge in front of representatives from 38 countries at an international conference here.
More...
Apple sues Amazon.com over APP STORE trademark

Apple Inc has sued Amazon.com Inc in a bid to stop the online retailer from improperly using Apples APP
STORE trademark according to a court filing. More...
Microsoft sues Barnes & Noble over Nook reader

(Bill Rigby , 21-Mar-2011 , Yahoo News)
Microsoft Corp filed lawsuits for patent infringement on Monday against bookseller Barnes & Noble Inc
over its Nook electronic book reader widening the software companys legal assault on devices running
on Google Incs Android system. More...
The war of generics

(Our Bureau , 21-Mar-2011 , Business Line )
Everyone wants to have his way on any drug that is going off patent. More...
Biocon boost from Optimers patent

Biocons drug development partner Optimer Pharmaceuticals has received a US patent for fidaxomicin an
antibiotic used in the treatment of clostridium difficile infection. More...
Tamiflu patent: Gilead sues Natco Pharma

Gilead Sciences a California based bio pharmaceutical research firm along with its patent partner Roche
Holding AG sued the Indian generic drug maker Natco Pharma here for allegedly infringing a US patent
for Tamiflu a drug used in the treatment of bird and swine-flu infections. More...
Govt for legalising parallel import of copyright works publishers oppose

(Shamnad Basheer , 17-Mar-2011 , The Economic Times)
India is no exception and the industry is now up in arms against a government proposal to legalise the
parallel import of copyright works through Copyright Amendment Bill 2010. More...
Time for European lessons
(T S Vishwanath , 17-Mar-2011 , Business Standard)
The latest matter to hit the headlines is the single patent regime. More...
Indias trade barriers hampering economic ties: EU

(IANS , 17-Mar-2011 , The Economic Times)
Indias restrictive trade policy is hampering the economic ties with the European Union says a report.
More...
Research cost health data key to enforcement

The enforcement of compulsory licence provisions for patented drugs in India will remain a damp squib
in the absence of proper healthcare data available with the government and an accurate account of
patent holders research cost on the drug according to senior officials at the patnt office responsible for
granting such licences. More...
Govt constitutes taskforce to evolve strategy for pharma ind

(PTI , 16-Mar-2011 , MSN)
In order to give a boost to the Indian pharmaceuticals industry the government today constituted a
taskforce to evolve a long term strategy for the sector including addressing issues relating to Intellectual
Property Rights. More...
Health ministry sets up taskforce to address issues of pharma industry

(BS Reporter / New Delhi , 16-Mar-2011 , Business Standard)
Also the committee would evolve strategies to further the interests of Indian pharma industry in the light
of issues related to Intellectual Property Rights and recommend strategies to capitalise the opportunity
of drugs going off patent over the next 5 years a health ministry statement said. More...
Over 83000 patent applications pending for scrutiny

Over 83000 patent applications are pending for examination due to shortage of manpower Parliament
was informed today. More...
India EU settle generics dispute pave way for FTA talks in April
India has sorted out most of its differences with the European Union on production of low cost generic
medicines ahead of a crucial meeting on a proposed free trade pact next month a government official
told ET. More...
Govt will protect interests of drug industry: Scindia

(Press Trust of India / New Delhi , 14-Mar-2011 , Business Standard)
Amid concerns expressed by the Indian industry the government today said in Parliament that it will
protect the interest of the domestic drug industry while finalising the free trade pact with European
Union. More...
Glenmark gets most approvals to sell generic drugs in US

In the first eleven months of the fiscal Glenmark secured nods to sell as many as 21 new generic
medicines or low cost versions of off patent drugs in the US compared to 16 medicines by Aurobindo
Pharma and 12 drugs by Sun Pharma the top Indian generic firm to receive USFDA approvals for the
year ended March 2010. More...
Blockbuster Botoxs India connection

(Sanchita Sharma , 13-Mar-2011 , Hindustan Times)
This prompted Allergan to get a patent for marketing bimatoprost as a eyelash growth cosmetic product.
More...
India patent office head count to jump 170 pc

(PTI , 12-Mar-2011 , MSN)
The India patents design and trade marks office is increasing its head count by 170 per cent to 457 in
the next three months to cope with the growing pressure in number of applications. More...
Cadila Healthcare: Marginal benefits from Taxotere

(Malini Bhupta / Mumbai , 12-Mar-2011 , Business Standard)
Hospira Cadila Healthcares joint venture partner has received the final approval to market the generic
Taxotere an oncology drug that went off the patent in November 2010. More...
SCMS bags patent

(Express News Service , 11-Mar-2011 , Express Buzz)
The SCMS lnstitute of Biotechnology has received the patent from the Government of India for
developing a process for producing stevioside powder a natural remedy for diabetes from stevia leaves
popularly known as honey leaves said Prof Pradeep More...
Efforts on to make patent offices totally transparent: DIPP

With an aim to bring total transparency in the working of Indian patent offices the government is
considering to make reports of examiners on applications public. More...
Compulsory licensing norms soon

Foreign lobby groups oppose allowing govt to order manufacture of drugs without the patent holders
consent More...
Its a tough fight for survival

(Binay Singh , 10-Mar-2011 , The Times of India)
Despite boasting of geographical indication certification the handmade carpet of Bhadohi has not
benefited much. More...
Free trade deal with Europe will help MNCs sue India globally
If India signs the free trade agreement with the European Union in its current form the country would be
opening its doors for getting sued internationally by foreign companies. More...
Popular drugs a waste of money?

(Kounteya Sinha & Mahendra Kumar Singh , 10-Mar-2011 , The Times Of India)
They are some of the most common drugs consumed in India. More...
Ideal Cures wins pre grant opposition against BPSI Holdings

Mumbai based Ideal Cures has won a pre grant opposition under section 25(1) of the Indian Patent Act
against BPSI Holdings Inc parent company of Colorcon. More...
Senate passes America Invents Act

The United States Senate has voted overwhelmingly to approve a legislation to make the first reforms to
its patent system in nearly six decades. More...
Cheap generic drugs eat into pharma cos sales

(News Service , 08-Mar-2011 , The Economic Times)
At the end of November Pfizer stands to lose a $10 billion a year revenue stream when the patent on its
blockbuster cholesterol drug Lipitor expires and cheaper generics begin to cut into the company s huge
sales. More...
Pochampally Ikat hit by triple whammy

(Itishree Samal / Hyderabad , 8-Mar-2011 , Business Standard)
The intricate tie and dye craft of silk and cotton weaving had received geographical indication status in
2005. More...
MNC pharma firms campaigning against Indian cos says govt

The government today said multi national companies are campaigning against domestic pharma industry
as their interests were getting impacted due to increasing global presence of Indian firms in the generic
segment. More...
US to press India for trade opening

(Press Trust of India / Washington , 06-Mar-2011 , Business Standard)
Other barriers range from prohibitions and restrictions on foreign investment in key sectors to
inadequate protection and enforcement of intellectual property rights it said. More...
Dr Reddys eyes $1 bn revenue in next 3 years
The company had filed 141 ANDAs to the US FDA till December 2010. More...
Kraft takes a bite of local biscuit market

Incidentally Oreos launch in India was preceded by Kraft dragging Britannia to court over a trademark
infringement case against the latters Treat O biscuit. More...
Thousands of HIV+ People organise protest march in Delhi against India EU free trade
agreement
The most damaging measure to access to affordable medicines is so called data exclusivity which would
act like a patent and block generic versions from the market even for drugs that are already off patent
or do not merit a patent to begin with under Indias strict patent law. More...
HIV+ patients protest against controversial EU India FTA

Thousands of HIV positive people from India and across Asia marched from Ramlila ground to Jantar
Mantar on Wednesday to protest against the free trade agreement between European Union and India
which has provisions that would restrict access to affordable medicines. More...
Good news for king of fruits

(Paul Fernandes , 02-Mar-2011 , The Times Of India)
While Goas feni has secured geographical indication the registration of plant varieties is on a different
keel. More...
Growth of emerging economies to continue in coming years

The remarkable growth of emerging economies like China India and Brazil has fundamentally changed
the global economic landscape a US trade report has said adding that their growth is projected to
continue in the coming years. More...
India EU kick off fresh talks on free trade agreement

(Pallavi Aiyar / Brussels , 02-Mar-2011 , Business Standard)
The chapter on intellectual property rights has generated some controversy with civil society groups
claiming a deal that would bind India to TRIPS plus commitments would be detrimental to developing
countries and their access to life saving drugs. More...
Google Microsoft join hands on patent

Microsoft Corp and Google Inc rivals in the online search market joined to challenge the validity of a
Texas companys patent on mapping technology. More...
Global health networks urge Novartis to end litigation on Glivec

Novartis had challenged the rejection of its patent application in India. More...
SC dismisses Marico claim to low absorb trademark

The Supreme Court today dismissed the appeal of Marico Industries the maker of cooking oils Saffola
and Sweekar challenging the use of the slogan low absorb by Agro Tech Foods an affiliate of American
foods giant ConAgra Foods. More...
Apex court rejects Maricos claim on low absorb trademark

The Supreme Court has dismissed the appeal of Marico Industries maker of cooking oils Saffola and
Sweekar challenging the use of the slogan low absorb by Agro Tech Foods an affiliate of American foods
giant ConAgra Foods. More...
New forum for IPR attorneys

With a view to better the functioning of various Intellectual Property Rights fora such as patent copyright
trademark and national bio diversity authority a new association was launched here on Friday. More...
Biotech sector to see uptick in M&As: Grant Thornton

(BS Reporter / Chennai/ Hyderabad , 28-Feb-2011 , Business Standard)
Reeling under the pressures of imminent patent expiries the developed markets have relied on the
acquisition or alliance route to sustain the growth. More...
After GI chikankari to get craftmark logo

(Express News Service , 27-Feb-2011 , Indian Express)
After the Geographical Indication registration chikankari craft of Lucknow will now get a distinct identity
by getting a brand name and a logo. More...
Strategic use of IP would aid Indias growth

Against the backdrop of rising number of patent filings in India a top Microsoft official has said that
strategic use of intellectual property would help in supporting the countrys overall growth. More...
Remainders of the day a case for parallel imports

(Guest View | Shamnad Basheer , 26-Feb-2011 , Livemint)
Provided that a copy of a work published in any country outside India with the permission of the author
of the work and imported from that country shall not be deemed to be an infringing copy More...
Novartis asked to end challenge to Indian patent law
(Kevin Grogan , 25-Feb-2011 , Pharma Times)
Novartis has been urged to drop its persistent legal actions in India regarding patent coverage for its
anticancer drug Glivec and a challenge to the countrys patent laws over fears the latter could hinder
access to medicines More...
EUs pharma trade hoax

(Tahir Amin/Priti Radhakrishnan , 25-Feb-2011 , Business Line)
The proposed India EU trade pact is riddled with intellectual property provisions that would harm Indias
2005 Patent Act. More...
Venus Remedies gets patent for anti biotic drug from Mexico
(Press Trust of India / New Delhi , 24-Feb-2011 , Business Standard)
Drug maker Venus Remedies today said it has been granted patent for its anti biotic product
Sulbactomax by the Mexican authorities. More...
Global drug makers making strong comeback in India

(PB Jayakumar / Mumbai , 24-Feb-2011 , Business Standard)
Armed with a product patent regime and a string of large acquisitions multinational drug companies are
making a strong comeback in India. More...
Medicine patents: Drugmakers find find it hard to do business

(Kenji Hall , 24-Feb-2011 , Financial Times)
Among pharmaceutical industry insiders it is known as the patent cliff. More...
Aurobindo gets tentative USFDA nod for generic Venlafaxine

The company claimed that it had filed for the approval under Paragraph IV certification which would
have given it 180 days of marketing exclusivity but it is currently under litigation in the US District Court
of New Jersey. More...
Looking into takeovers of Indian pharma firms by MNCs: Govt

Concerns have been expressed that the recent takeovers of Indian pharmaceuticals companies by multi
national firms would result in their gaining market supremacy affecting the prices of generic off patent
drugs Minister of State for Commerce and Industry Jyotiraditya Scindia said in a written reply to Rajya
Sabha. More...
Looking into takeovers of Indian pharma firms by MNCs: Govt

Concerns have been expressed that the recent takeovers of Indian pharmaceuticals companies by multi
national firms would result in their gaining market supremacy affecting the prices of generic off patent
drugs Minister of State for Commerce and Industry Jyotiraditya Scindia said in a written reply to Rajya
Sabha. More...
CSIR slows down patent filing of its processes discoveries products with few takers
(Joseph Alexander, New Delhi , 23-Feb-2011 , Pharmabiz)
With huge number of patented processes leads discoveries and products developed by its different
institutes relating to pharmaceuticals available but not having many takers the Council of Scientific and
Industrial Research has slowed down the patent filing process. More...
Ind Swift project gets Japan govts nod

(BS Reporter / New Delhi/ Chandigarh , 22-Feb-2011 , Business Standard)
For the first time a large number of drugs patented by Japanese companies are going off patent. More...
Meet the Indian inventor who has 42 patents

(Shobha Warrier , 22-Feb-2011 , Rediff)
In 2005 when Rediff.com met Arvind Thiagarajan he was 25 year old young inventor with a couple of
patents to his credit. More...
Sanofi Aventis plans to buy Generics OTC brands

(Khomba Singh , 21-Feb-2011 , The Economic Times)
French drugmaker Sanofi Aventis plans to buy branded generics and over the counter consumer
healthcare brands in India as part of its strategy to scale up sales from new avenues a top company
Indian bottled water: just the tonic

(Anjli Raval , 21-Feb-2011 , The Financial Times)
Indias Intellectual Property Appellate Board which deals with trademark related issues said in a recent
order that Tatas Mount Everest Mineral Water division could not trademark the term for its products.
More...
India US to discuss trade irritants

(Nayanima Basu / New Delhi , 21-Feb-2011 , Business Standard)
The focus areas are standards anti dumping duties and practices small scale industries and protection
and enforcement of intellectual property rights. More...
GIB to give live into about train positions

(Neha Shukla , 20-Feb-2011 , The Times Of India)
This will be made possible through the geographical indication board which will be installed at the station
in near future. More...
Q&A: Roger L Williams MD & CEO United States Pharmacopeia

(Neha Shukla , 20-Feb-2011 , The Times Of India)
Any company in the US market can get into trouble in terms of good manufacturing practices or
affiliated standards More...
A balanced IPR regime Key to promote technology driven agriculture

(Rana Kapoor , 20-Feb-2011 , Business Line)
As the world moves towards a knowledge driven economy protection of intellectual property rights has
become a key motivator for innovation. More...
2(m) or not 2(m)

(Nilanjana S Roy / New Delhi , 19-Feb-2011 , Business Standard)
How a copyright amendment might change the way we read write and publish in India. More...
Abbott Ranbaxy settle patent suit

Abbott Laboratories has settled a patent litigation case against Ranbaxy Laboratories allowing the Indian
pharmaceutical firm to launch a generic version of the US drugmakers cholesterol lowering medicine
Tricor. More...
Consensus on import duty key to Doha round success

(Namrata Acharya / London , 19-Feb-2011 , Business Standard)
Zeroing in on an agreeable rate of exchange on import duties among member nations was key to
concluding the talks on a global free trade agreement or the Doha round at the World Trade
Organisation a top WTO spokesperson said today. More...
World Cup: Sponsors in fierce off field copyright battles

(Gouri Shah , 19-Feb-2011 , Livemint)
Copyright Integrity International the intellectual property rights firm enlisted by the International Cricket
Council to protect sponsor interest is seeing some fierce rivalry off the field over the tournament that will
kick off on Saturday in Dhaka. More...
Court restores status quo on Maricos trademark Manjal

(Bindu D. Menon , 18-Feb-2011 , Business Line)
The Madras High Court has restored status quo in the dispute regarding the wrongful removal of Maricos
trademark Manjal from the trademarks register. More...
Global consolidation hits Indian contract drug manufacturing cos

Mergers & acquisitions in the global pharmaceutical industry that have led to reduction in outsourced
research work have hit Indian contract drug manufacturing and research services or CRAMS companies.
More...
Problems in trade talks with EU

(KAVALJIT SINGH , 18-Feb-2011 , Business Line)
EU is pushing India to relax controls on capital flows and conditions on investment such as export
obligation and local content requirement. More...
Satyam to pay $125 million to settle US suit

Close on the heels of a settlement of a class action law suit in the US for $125 million Mahindra Satyam
is planning to sue the former Satyam management and the companys erstwhile auditor PriceWaterhouse
for a possible monetary damages claim. More...
Roger L Williams United States Pharmacopeia

(K Rajani Kanth / Hyderabad , 18-Feb-2011 , Business Standard)
Indian manufacturers are critically important for the US market. More...
Controls on MRLs move to bar off patent Endosulfan to impact farmers

(Announcement / Corporate , 17-Feb-2011 , Business Standard)
In a media briefing held in Kolkata today a panel of agronomists and farmers expressed concern over
the mounting pressure exerted on India not to oppose the European Union proposal to list endosulfan as
a Persistent Organic Pollutant. More...
Tatas Mount Everest loses trademark dispute with Bisleri over Himalayan
(Ratna Bhushan , 17-Feb-2011 , The Economic Times)
Tata Groups Mount Everest has no exclusive right on the word Himalayan the countrys trademark
dispute authority said following a petition from Ramesh Chauhans Bisleri International. More...
Ind-Swift Labs gets approvals for two products from PMDA Japan
It is for the first time that a large number of drugs patented by Japanese companies are going off
patent. More...
Textiles pharma sectors to gain most from trade pact with Japan
Indian pharmaceuticals will get access to a highly developed Japanese market and for the first time ever
Japan has committed to give the same treatment for Indian generics off patent drugs as their domestic
industry the statement said More...
Q&A: Brian Ager DG European Federation of Pharmaceutical Industries and Associations

(Pallavi Aiyar / February , 16-Feb-2011 , Business Standard)
India is an important trade partner and growing economic power. More...
Rahul Khullar Trade deficit is still worrying

(Asit Ranjan Mishra & Anil Padmanabhan , 16-Feb-2011 , Livemint)
Next week India plans to sign bilateral trade agreements with Japan and Malaysia to reduce barriers and
increase trade even as the World Trade Organizations Doha round of trade talks make little progress.
More...
Pharma sector injects fresh life into M&A space

When Ajay Piramal promoter and chairman of Piramal Healthcare struck a deal with US based pharma
biggie Abbott Inc for selling assets of the domestic formulation unit at over 9 times its sales little did he
know it will set a benchmark. More...
Ahmedabad gives herbal hues to Levis

The company is certified by Global Organic Textile Standarda leading processing standard for textiles
made from organic fibres worldwide and has a US and India patent for herbal dyeing. More...
Gary Locke US Commerce Secretary

(Nayanima Basu / New Delhi , 14-Feb-2011 , Business Standard)
It is the US Trade Representative that leads on trade negotiations in general. More...
WIPO to organise traditional knowledge meet in March

The World Intellectual Property Organisation a specialised UN agency along with Indian government will
organise a three day meet on traditional knowledge including ayurvedic medicine and unani next month.
More...
Drugmakers rattled by EU austerity moves

(Priyanka Golikeri , 10-Feb-2011 , DNA)
Adithya Bhat manging director of business consulting firm Protiviti Consulting said the pricing pressures
and austerity measures notwithstanding Indian companies can make the most of drugs going off patent
in the EU. More...
China ranks 4th in patent application India lags

India remains a laggard in research and technological innovation as compared to China which has
become the worlds fourth largest filer of patent applications in 2010 according to the data released by
World Intellectual Property Organization today. More...
Natco challenges Gileads patent on Tamiflu

(BS Reporter / New Delhi , 9-Feb-2011 , Business Standard)
Hyderabad based Natco Pharma has challenged the patent for Tamiflu a drug to treat bird flu in the US.
More...
DIPP bats for FDI curbs in pharma

(Surajeet Das Gupta / New Delhi , 9-Feb-2011 , Business Standard)
It said 61 drugs worth over $80 billion are going off patent making it possible for domestic companies to
produce cheaper versions of those drugs. More...
Lincoln Pharma bets big on Pa 2 paracetamol tablets

(BS Reporter / Mumbai/ Ahmedabad , 8-Feb-2011 , Business Standard)
The company received patent for a nasal drug delivery system in India last month. More...
US asks India to lower tariffs remove barriers

(Elizabeth Roche , 8-Feb-2011 , Livemint)
Further changes to US export control policies towards India will continue in the months ahead says
Locke More...
A poetic justice for copyright violations

(Sandhya Soman , 8-Feb-2011 , The Times Of India)
In every lecture that she delivers whether in Rome or Bangalore professor Mira T Sundara Rajan shows
a photo of her great grandfather the poet C Subramania Bharati. More...
Delhi high court stops parasite Chinese company from using L&T logo
(Rakesh Bhatnagar , 7-Feb-2011 , DNA)
The Delhi high court wants Intellectual Property Rights and Enforcement Rules 2007 and Customs Act
1962 implemented in letter and spirit so that overseas sly operators can be stopped from cashing in on
the goodwill and reputation of established Indian brands and duping consumers. More...
Mussels: From delicacy to arthritis cure

(Ullekh N P , 7-Feb-2011 , The Economic Times)
According to the research institute this product made by extracting anti inflammatory ingredients from
green mussels could be a substitute for the regular aspirin containing anti inflammatory arthritis drugs
with undesirable side effects. More...
Nobodys about to kill books

(Rahul Matthan , 7-Feb-2011 , Indian Express)
There is a proposal to amend the Copyright Act that will make it legal to import into India any book that
has been validly published outside India even if an Indian publisher has been granted the exclusive
licence to publish it in India. More...
MSMEs should focus on intellectual property rights

With micro small and medium enterprises in Orissa giving more emphasis on production than on
innovation and intellectual property rights the state government has called for a shift in focus. More...
Move faster on trade barriers US Commerce Secy to tell New Delhi

(Indira Kannan / New York , 5-Feb-2011 , Business Standard)
Answering a question from Business Standard the Secretary said the US had brought up the issue of
tariff and non tariff barriers including restrictions on Foreign Direct Investment and concerns about
Intellectual Property Rights during President Barack Obamas visit to India last November and will raise
these again next week. More...
SC to hear Novartis plea on cancer drug patent

The Supreme Court will start final hearing next month on a plea by Swiss pharma firm Novartis AG
challenging the order of an appellate board, which upheld the governments denial of patent to its blood
cancer drug Glivec. More...
SC to hear Novartis plea on cancer drug patent

The Supreme Court will start final hearing next month on a plea by Swiss pharma firm Novartis AG
challenging the order of an appellate board which upheld the governments denial of patent to its blood
cancer drug Glivec. More...
Indian cos eye $4bn generic opportunity

Around $3 4 billion worth opportunity will be up for grabs in the wake of blockbuster drugs going off
patent losing patent protection in the US over 2011 2012. More...
India is developing good competition policy says WTO official

India is developing an effective competition policy and is also making significant efforts to strengthen its
intellectual property rights regime a top WTO official has said. More...
Natco to take on Bayer on cancer drug Nexavar

Generic pharmaceuticals maker Natco Pharma is gearing up to take on German healthcare giant Bayer
AG. More...
Pirated counterfeit products value to touch $1.78 tn in 2015

A number of G 20 economies may be missing out on higher FDI as a result of concerns over IPR
Intellectual Property Rights enforcement. More...
Artists and musicians told to come together to safeguard their work

(Special Correspondent , 2-Feb-2011 , The Hindu)
A discussion on copyright in Chennai on Tuesday witnessed the forceful articulation of the need for
artists and musicians to come together to safeguard their creative works. More...
India EU free trade pact to be concluded this year: Sharma

(Laxmi Devi , 1-Feb-2011 , MSN)
India today exuded confidence that negotiations for the proposed comprehensive market opening pact
with the 27 nation European Union will conclude in 2011. More...
The decade in science

Over at least the past seven years several multinational firms including Microsoft Corp. and International
Business Machines Corp. have been setting up their key research centres in India often recruiting the
brightest of Indian scientists and researchers to power their patent pipeline. More...
Dr Reddys gets court nod to launch Allegra D 24 tablets in US

(PTI , 31-Jan-2011 , MSN)
In September 2009 AMRI filed a patent infringement lawsuit against Dr Reddys for alleged infringement
of one of AMRIs patents related to the manufacturing process for the active ingredient in Allegra D 24.
More...
Ind Swift net profit up by 83.10%, Exports up 37.87%

(Announcement / Corporate , 31-Jan-2011 , Business Standard)
The Company is now in agreement with global players for the supply of blockbuster drugs like
Clarithromycin Atorvastatin Fexofenadine Letrozole Anastrozole Rosuvastatin Pioglitazone Clopidogrel
etc. to regulated markets on patent expiry. More...
Lupin global ride hinges on the Power of Five

(Priyanka Golikeri , 31-Jan-2011 , DNA)
The Mumbai based company is banking heavily on products belonging to therapeutic areas such as oral
contraceptives ophthalmics dermatology biosimilars off patent versions of biologic drugs and asthma to
be the driving force. More...
Dr Reddys says U.S. court clears generic Allegra sale

(Bharghavi Nagaraju , 31-Jan-2011 , Reuters)
The U.S. District Court of New Jersey lifted an injunction passed last June against the Indian drugmaker
from selling a copycat version of the drug Dr Reddys said in a statement. More...
Vexed issues delaying free trade talks

(Asit Ranjan Mishra , 31-Jan-2011 , Livemint)
A free trade agreement with Australia will provide India access to markets in East Asia, allowing it to
counterbalance the growth of strategic and economic rivals such as China in the region said the
commerce ministry official cited earlier. More...
Hardware and software of innovation

(D. Murali , 29-Jan-2011 , The Hindu)
There is much that is dysfunctional in the US but there is also a great deal to be optimistic about writes
Adam Segal in Advantage How American innovation can overcome the Asian challenge. More...
Cadila Healthcare: Buy

(Srividhya Sivakumar , 29-Jan-2011 , Business Line)
Good results bright prospects in the domestic and export markets and better growth expectations from
its joint venture companies make Cadila Healthcare a good investment bet for the long term. More...
Pharma exports may touch a record Rs 50000 cr in 2010 11

Industry analysts say the growth will be driven by the US revenues where $36.7 billion worth drugs are
expected to go off patent in 2011. More...
HC seeks Centre's response on patent board anomaly plea

The Madras high court has asked the additional solicitor general of South India M Ravindran to ascertain
the Centres response to a public interest writ petition highlighting serious anomalies in the affairs of the
Intellectual Property Appellate Board here. More...
A manufacturing strategy for India

(ARUN MAIRA , 28-Jan-2011 , The Economic Times)
In fact the Chinese government is framing IPR rules to further its own interests suspecting that the rules
being imposed on it have been devised principally to protect foreign companies interests. More...
BJP drags PM into CVC row says govt claim patent lie
BJP on Thursday slammed the government for claiming in the Supreme Court that the committee which
chose P J Thomas as the CVC last year was not aware of corruption charges against him and sought an
answer from Prime Minister Manmohan Singh for the patent lie. More...
IPA concerned over PMO's efforts to destabilize Indias IPR regime at the behest of EU
The Indian Pharmaceutical Alliance an association of leading Indian pharma companies has raised alarm
over the recent media reports that efforts are going on in the Prime Ministers Office to destabilize Indias
IPR regime at the behest of European Union which the IPA cautioned the government will have serious
implications on the public health access to medicines and the domestic generic industry. More...
Plea seeks to expose patent tribunal anomaly

(A Subramani and Pushpa Narayan , 27-Jan-2011 , The Times Of India)
A technical member of the Intellectual Property Appellate Board he was appointed to the post after he
took credit for the cases argued during the British era. More...
Data exclusivity still key hurdle to India EU FTA

(Nayanima Basu & Joe C Mathew / New Delhi , 27-Jan-2011 , Business Standard)
Despite all official assurances the path towards a free trade agreement between India and the European
Union this year remains ambiguous as both sides are unwilling to relax their stand on the biggest
stumbling block the issue of data exclusivity. More...
Dont swallow this pill
(pritiradhakrishnan , 27-Jan-2011 , Indian Express)
Troubling news reports indicate that a newly minted Free Trade Agreement between the European Union
and India would permit companies to circumvent visionary safeguards built into Indias 2005 Patents Act
widely seen as one of the most progressive patent laws in the world. More...
US suggests removal of some key clauses in patent manual

The changes being sought may not be in agreement with the terms of Indias laws on Intellectual
property More...
Quality issues may hit pharma cos US prospects

(P.T. Jyothi Datta , 25-Jan-2011 , Business Line)
Quality concerns could upset the apple cart for Indian generic drug makers exporting to the US even as
they look to tap the $96 billion worth opportunity emerging from drugs going off patent between 2011
and 2013. More...
Punjabs history came in way of GI pleas

(Jasneet Bindra , 25-Jan-2011 , Indian Express)
Punjab suous history has been a major roadblock in its run for geographical indication. More...
India EU negotiators to meet in Kerala to resolve FTA issues

Inclusion of intellectual property rights and social issues like environment and labour standards in the
proposed Bilateral Investment and Trade Agreement are some of the main areas on which a consensus
are yet to be achieved. More...
US generics demand to drive Indian pharma growth: Fitch

(24-Jan-2011 , Rediff)
It said that Indian pharmaceutical companies expect about $ 96 billion worth drugs to go off patent in
the US in 2011 2013. More...
Natco may seek compulsory licence for Bayers cancer drug

(Khomba Singh , 24-Jan-2011 , The Economic Times)
Natco Pharma plans to seek a compulsory licence from the government to make Bayer AGs Nexavar in
India invoking a provision in local laws that allows generic drugmakers to make and sell patented drugs
cheaply if the medicine is unaffordable. More...
Music industry readies copyright database

(Reuters / London , 24-Jan-2011 , Business Standard)
The music industry is working to create a global repertoire database to make it easier and faster for new
online music services to come to market. More...
India raise concern over WHOs failure to replace IMPACT with working group on counterfeit
drugs
(Joseph Alexander, New Delhi , 24-Jan-2011 , Pharmabiz)
India has raised strong concern over the delay in setting up a working group by the World Health
Organisation to address the problems of counterfeit and substandard medicines and adopt changes in
the policy instead of leaving the task with controversial International Medical Products Anti
Counterfeiting Taskforce. More...
The copyright wars

(Satya Prakash , 23-Jan-2011 , The Hindustan Times)
As India emerges as one of the biggest world publishing markets intellectual property rights become a
more contentious issue with authors artists and other creative persons asserting their rights and the
government attempting to bring the industry practices in tune with the international treaties in a more
globalised environment. More...
Maharashtra plans to patent Worli sea link

The Maharashtra State Road Development Corporation is in talks with a few international legal
consultants to patent its iconic Bandra Worli Sea Link project with the intention to generate additional
revenue. More...
Indian movies without songs possible?

(Leena Mulchandani , 22-Jan-2011 , The Economic Times)
Its supposed to amend the copyright laws in India but The Copyright Bill 2010 might just also amend the
way movies are made. More...
EU still pushing data exclusivity through FTA India stands firm

(Joseph Alexander, New Delhi , 22-Jan-2011 , Pharmabiz)
European Union is still pushing India to accept TRIPS plus data exclusivity provisions through the
proposed Free Trade Agreement though India is still firmly against it if the latest draft chapter on
intellectual property rights is any indication. More...
FTA with EU only by year-end

(Special Correspondent , 21-Jan-2011 , Business Standard)
Although negotiations on the much awaited India European Union Free Trade Agreement are likely to be
concluded by summer this year the formal signing will only happen by the end of this year at the India
EU summit. More...
Wockhardt gets USFDA approval to market generic Protonix

Drug firm Wockhardt today said it has received final approval from the US health regulator US Food and
Drug Administration to market generic pantoprazole tablets used for treating ulcers and hyperacidity in
the American market. More...
THE PATENT PRESSURES
(P A Francis , 21-Jan-2011 , Pharmabiz)
India EU Trade and Investment Pact is going to be concluded some time in March this year and the
prime minister is expected to visit Europe for signing the same. More...
Intellectual Property tribunals legality questioned

(P. T. Jyothi Datta , 21-Jan-2011 , Business Standard)
The writ petition alleges that the Board suffers from a lack of relevant IP expertise and that many of its
orders are routinely overturned by High Courts. More...
Writ petition says IP tribunal incompetent

A group of patent lawyers have filed a writ petition challenging the legality of the countrys highest
technical body for intellectual property disputes saying the members are incompetent to hear IP cases.
More...
Signature campaign against copyright Bill

(Abhilasha Ojha , 21-Jan-2011 , Livemint)
The objective of the amendment is that opening up of markets without any boundaries or territories for
films books and music More...
Changing our tune

(Shamnad Basheer , 21-Jan-2011 , Indian Express)
The Copyright Act protects Indian composers at home but not abroad. More...
Glenmark Pharma gets FDA approval to market generic malaria drug

(PBR Staff Writer , 19-Jan-2011 , PBR Regulatory Affairs)
Glenmark Pharmaceuticals has received US Food and Drug Administration approval for marketing
atovaquone amd proguanil hydrochloride tablets to treat malaria. More...
Lincoln Pharma wins patent for NDDS

(BS Reporter / Mumbai/ Ahmedabad , 19-Jan-2011 , Business Standard)
Ahmedabad based Lincoln Pharmaceuticals Limited has received a patent for a Nasal Drug Delivery
System in India that helps in arresting or preventing vomiting and nausea that will particularly help in
chemotherapy induced nausea. More...
Dont swallow this pill

(Unni Karunakara , 19-Jan-2011 , The Times Of India)
But the Indian press now reports that the PMO under pressure to conclude the deal has asked the
concerned government department to reconsider intellectual property provisions it had earlier rejected.
More...
Indian Patents Act Undergoes Changes

(ag-IP-news , 18-Jan-2011 , ag-IP-news)
Abu Ghazaleh Intellectual Property announced in a press release that the Department of Industrial Policy
and Promotion of the Indian Ministry of Commerce and Industry has published a notification in the
official Gazette of India which is a draft of certain rules and does not carry the force of the law as yet
these may be called Draft Patent Rules mendment 2010. More...
Trademark patent seekers get access to database

(Vikas Dhoot , 18-Jan-2011 , The Economic Times)
Patent and trademark seekers will no longer have to wait for weeks to get the go ahead for their
applications from the governments patent registrar . More...
Glenmark loses patent case to Abbott in US

Indian drug firm Glenmark has lost a patent case against US firm Abbott Laboratories over hypertension
drug Tarka. More...
Govt probes irregularities in patent given to B Braun

(Thomas K Thomas , 18-Jan-2011 , Business Line)
The Department of Industrial Policy and Promotion has undertaken disciplinary action against top
officials of the Patents & Designs office in Chennai for alleged irregularities in granting patent to German
medical device maker B Braun for an intravenous device. More...
Indian companies urged to go for IPR

Speakers on Monday said that Intellectual Property Rights could be used as a strategic weapon in the
competitive world to prevent its abuse and urged the Indian companies to go for it. More...
Insurer liable till vehicle owners name is in register

(BS Reporter / New Delhi , 17-Jan-2011 , Business Standard)
The companies entered into a Trade Mark Licence Agreement under which the US firm had granted the
Indian firm licence to use the trademark Penn for use in certain territories for certain products like golf
balls accessories and inflatable balls. More...
Copyright infringements fakes dog FMCG sector

(Viveat Susan Pinto / Mumbai , 14-Jan-2011 , Business Standard)
When US-based Kraft Foods dragged biscuit major Britannia to court last week alleging trademark and
copyright infringement of its Oreo brand of cookies many in the fast moving consumer goods industry
werent surprised. More...
Govt may limit FDI in pharma sector at 49%

(Rupali Mukherjee , 14-Jan-2011 , The Times of India)
The Indian Patent Law allows product patents for all new molecules which have been patented after the
year 1995. More...
Ranbaxy plant a step closer to rehabilitation by US FDA
(Radhieka Pandeya , 14-Jan-2011 , Livemint)
FDA may also want to speed up the process due to the approaching patent expiry of Pfizers blockbuster
statin Lipitor said a Mumbai based analyst who didnt want to be named. More...
US to work with India to crackdown on pirated movies API

Observing that both the pirated Bollywood movies and the counterfeit pharmaceuticals have been
causing huge financial losses Matthew King Deputy Director Homeland Security Investigations National
Intellectual Property Rights Co ordination Center told foreign journalists that such a crackdown would
intensify in 2011. More...
Many artifacts of region await GI status

(Binay Singh , 13-Jan-2011 , The Times of India)
In the days to come eastern UP is going to be a hub of GI tagged properties. More...
India needs robust legal framework in order to advance

(Mr Ranjit Shahani , 13-Jan-2011 , Financial Times)
In India some progress has been made in this area following the amendment to the India Patent Act in
2005. More...
Infosys cash dips by 3.77 pc to Rs 14819 crore in Q3

(PTI , 13-Jan-2011 , The Hindu)
Besides during the third quarter Infosys applied for 17 patent applications in India and US. With this
Infosys has an aggregate of 270 patent applications in India and the US and has been granted 18
patents by the US Patent and Trademark office. More...
Discontent brews over Darjeeling tea label

(Manisha Pande , 12-Jan-2011 , Business Standard)
The Tea Boards control of the GI tag makes small farmers unhappy. More...
India rejects US companys patent for anti HIV drugs

(NDTV Correspondent , 10-Jan-2011 , NDTV India)
What serves as one of the biggest threats against people living with HIV AIDS is multinational drug
companies producing lifesaving drugs pushing for patents so generic companies cannot produce them at
much lower prices. More...
Azad calls upon pharma industry to grab US$ 80 billion off patent opportunity
(Our Bureau, Mumbai , 10-Jan-2011 , Pharmabiz)
Union minister of health and family welfare Gulam Nabi Azad called upon the pharma industry in the
country to grab the opportunity being unfolded in the wake of around 60 products worth more than a
whopping US$ 80 billion going off patent in a couple of years in the US and other regulated markets.
More...
Student gets patent for innovative product
(Nikhila Henry , 8-Jan-2011 , The Times Of India)
Kondamudi Swarnarekha a student of BV Raju Institute of Technology is not just another techie in the
making. More...
Saving yoga from patents

(Uttara Choudhury , 8-Jan-2011 , DNA)
I had taken my son to a birthday party in Manhattan when an Israeli woman in a flowing kurta gave me
a beatific smile and said Yoga is very interesting. More...
Intellectual property
(Madhukar Sabnavis / New Delhi , 7-Jan-2011 , Business Standard)
The film Social Network may be a fictional or realistic account of the creation of Facebook. More...
Dr Reddys to contest Pfizers patent suit

(Press Trust Of India / New Delhi , 6-Jan-2011 , Business Standard)
Dr Reddys Laboratories will contest the patent infringement case filed against it by the global
pharmaceutical giant Pfizer over its cholesterol lowering drug Atorvastatin said a company spokesperson
today. More...
Kraft sues Britannia over Treat O biscuit being a copy of Oreo cookies
(Ratna Bhushan , 05-Jan-2011 , The Economic Times)
US based packaged food maker Kraft Foods on Tuesday sued Nusli Wadia owned Britannia Industries for
trademark and copyright violations of its popular Oreo cookies. More...
Dr Reddys generic version of Lipitor hits Pfizer roadblock in US

Global pharma major Pfizer has filed a petition in a US court against Dr Reddys Laboratories Ltd for
patent infringement on the generic version of atorvastatin which is being sold under the brand Lipitor.
More...
Natco seeks Pfizer nod for drug clone

Pfizer has time till May to reply as Indian patent law allows an innovator company to respond within six
months of receiving a notice for voluntary license. More...
Merck KGaA focuses on diabetes in India lines up five products

While a significantly large population and progressing economy are the key attractions for global drug
makers in India a saturated growth and less number of high value and patent protected products for
launch in the US and European markets are the other compelling factors that drive them into this
market. More...
Microsoft patent to help you date celebrity look alike
(TOI Tech , 04-Jan-2011 , The Times Of India)
Wish you could search for your favourite celebrity look alike on all those online dating sites? More...
Pharma companies are eyeing lucrative biotechnology space

(Debasis Mohapatra & Raghuvir Badrinath / Bangalore , 4-Jan-2011 , Business Standard)
Patent protection on the first batch of biotech drugs that entered regulated markets in the late 1980s is
set to expire. More...
Pfizer drags DRL to court over Lipitor copy launch

Pfizer has taken Dr Reddys Laboratories to court to delay the launch of the Indian drug makers low cost
version of atorvastatin in the US market. More...
Trailer Agreement on employees can protect Patents IPs of cos: Dr KC Kankanala

(Nandita Vijay, Bangalore , 4-Jan-2011 , Pharmabiz)
With Indian companies increasingly getting into knowledge oriented cutting edge work patents and
Intellectual Property are seen as the logical options to protect their interest not only from competition
but also from their own employees. More...
SMEs can benefit from use of IPRs: Expert

(ENS Economic Bureau , 4-Jan-2011 , Finance Buzz)
Intellectual property rights are exclusive legal rights granted to a number of distinct types of intangible
assets such as inventions over which a patent can be obtained and words and symbols over which a
trademark protection can be sought. More...
Govt may cut FDI to 49 per cent in pharma industry

(Sanjay Singh , 4-Jan-2011 , India Today)
Earlier the PMO had also sent a note based on the recommendations submitted by global drugmakers
which seeks key changes such as a legislative review of the Indian patent laws data exclusivity and
implementation of patent linkages. More...
The pitfalls of bilateral deals

(4-Jan-2011 , Livemint)
As regards intellectual property rights negotiations with the EU have also brought concerns about
intellectual property rights arising in particular from the position that Indias intellectual property laws
need to be amended to meet the demands of global pharmaceutical majors. More...
Pharma rides high

(Business Standard / New Delhi , 4-Jan-2011 , Business Standard)
Over the next few years a large number of best selling drugs are going to go off patent in the developed
countries offering a golden opportunity for a generics player like India. More...
Inflicting bitter medicine
(4-Jan-2011 , Livemint)
For one they have the potential to prevent technology and intellectual property rights transfers to Indian
shores from abroad. More...
Elder Pharma gets Japanese approval for API facility

(Press Trust of India / New Delhi , 3-Jan-2011 , Business Standard)
The company has developed two products going off patent in the Japanese market in 2014. More...
Lupin settles litigation with Japanese firm

Drug firm Lupin today said it has settled ongoing litigation over Lunesta tablets used in treating
insomnia with Japan based Dainippon Sumitomo Pharma. More...
India rejects Abbot labs patent application

(Press Trust Of India , 03-Jan-2011 , IBN Live)
India has rejected a drug patent application of a US multi national pharma company paving way for easy
access to an important life saving medication for HIV patients across the globe. More...
Indian pharma remains top in US generics

(P B Jayakumar / Mumbai , 3-Jan-2011 , Business Standard)
Generics are reverse engineered cheap versions of branded patented drugs. More...
Govt explores capping FDI in pharma

DIPP had in September come out with a discussion paper on implementing compulsory licensing
provisions in the country to ensure the availability of low cost versions of patented drugs in the country.
More...
Three sector picks for 2011

(Outperformer , 02-Jan-2011 , Business line)
Expiring patents of global pharma companies More...
Three sector picks for 2011

(Outperformer , 02-Jan-2011 , Business Line)
Expiring patents of global pharma companies More...
Pharma: On a healthy wicket

(Srividhya Sivakumar , 1-Jan-2011 , Business Line)
The year promises to see a higher generic incursion led by expiring patents and receding product
pipelines of global pharma companies. More...
The pharma story: A decade of transition

(P B Jayakumar / Mumbai , 31-Dec-2010 , Business Standard)
India enforced process patent in early 1970 which allowed domestic companies to legally copy and
manufacture patented drugs. More...
Pharma: Walking the tightrope between affordability profits

Also upping the ante of stake holders is a host of FTAs India is getting into and domestic drug industry
representatives and health advocacy workers urge the Government to keep intellectual property out of
trade negotiations More...
Suven Life Sciences gets two patents for their NCEs

(BS Reporter / Mumbai , 30-Dec-2010 , Business Standard)
Suven Life Sciences a biopharmaceutical company was granted patent for two of its products for their
New Chemical Entities for the treatment of disorders associated with Neuro degenerative diseases
according to the press release filed with the BSE. More...
Sony slaps patent violation complaint against LG Electronics

Japanese major Sony Corp has filed a patent infringement complaint against rival and South Korean
conglomerate LG Electronics related to certain mobile phones and modems. More...
Bollywood producers hope to amicably resolve copyright issue

(IANS , 30-Dec-2010 , SpiceZee)
After deferring their Jan 6 strike Bollywood producers Wednesday hoped to soon resolve the raging
controversy over the proposed amendment to the Copyright Act that mandates producers sharing 50
percent of music royalties with lyricists and composers. More...
Innovate or perish
(ET Bureau , 29-Dec-2010 , The Economic Times)
So Indian companies will have to make do with either commoditised tech or proprietary technology that
is not premium enough for the holder of its intellectual property to monetise it on its own. More...
UPA bosses step in to solve copyright dispute

(Report , 29-Dec-2010 , DNA)
The government has assured the Indian film industry that its grievances over the copyright amendment
bill will be addressed and resolved soon. More...
Biocon is at a strong price disadvantage to global players : Kiran Mazumdar Shaw

(ET Now , 29-Dec-2010 , The Economic Times)
That is absolutely the intention and we are reading ourselves for being able to be ready with our product
development upon patent expiration. More...
Clinical drug trials on humans set to become more stringent

(Radhieka Pandeya , 28-Dec-2010 , Livemint)
Thats a big loss of time because the patent clock is already ticking for your product. More...
Pharmexcil urges modern ayurvedic drug units to work together to exploit global markets
(Gireesh P K, Hyderabad , 28-Dec-2010 , Pharmabiz)
The Pharmaceuticals Export Promotion Council has urged the pharmaceutical companies and ayurvedic
units in the country to join hands to reap the opportunities available for the ayurvedic drugs in the
international market. More...
BHEL & Bharat Electronics two PSUs in top R&D spenders in India
(Vivek and Biswarup Gooptu , 28-Dec-2010 , The Economic Times)
Rao is proud of the fact that in the past year BHEL has filed patent and copyright applications at the rate
of one every working day. More...
Markets have a subdued closing

(SI Reporter / Mumbai , 28-Dec-2010 , Business Standard)
And drug firm Venus Remedies gained 1.4% at Rs 269 after receiving patent grants for its antibiotic
drug Sulbactomax from Russian and Ukrainian authorities. More...
Local engineer patents new technology for engine efficiency

(Himanshu Bhatt , 27-Dec-2010 , The Times of India)
In a depressing environment of spiraling fuel prices the news that a new technology increases power
efficiency of two and four stroke engines by 20 to 40 per cent is very inspiring. More...
Venus gets patent for antibiotic drug from Russia Ukraine

Drug firm Venus Remedies today said it has received patent grants for its antibiotic drug Sulbactomax
from Russian and Ukrainian authorities. More...
Patent dissatisfaction
(Business Standard / New Delhi , 27-Dec-2010 , Business Standard)
Indias patent laws allow the patent examiners to delay or reject patent applications if they are satisfied
that the application or any specifications or attached documents do not comply with the requirements of
the Patents Act or Patent Rules. More...
Engineered in India
(D. Murali , 27-Dec-2010 , Business Line)
Indias low R&D spend in fundamental research lack of global product companies and small spend in IP
and patent development need to be addressed to compete with developed markets and China to build
the product ideation ecosystem. More...
Suven Life Sciences gets 4 product patents

Suven Life Sciences Ltd has secured four product patents two each from New Zealand and Eurasia for its
new chemical entities. More...
Takeda settles diabetes drug patent suits with 11 generic firms

Japans Takeda Pharmaceutical Company has settled patent infringement suits out of court with 11
generic drug companies including Ranbaxy Laboratories Torrent Pharmaceuticals Dr Reddys Laboratories
Wockhardt and Aurobindo Pharma over its flagship diabetes drug Actos and its variants. More...
Takeda settles diabetes drug patent suits with 11 generic firms

Japans Takeda Pharmaceutical Company has settled patent infringement suits out of court with 11
generic drug companies including Ranbaxy Laboratories Torrent Pharmaceuticals Dr Reddys Laboratories
Wockhardt and Aurobindo Pharma over its flagship diabetes drug Actos and its variants. More...
Drug panel to recommend some generics have no brand names

Consultative committee wants change to apply to single ingredient generics but move may face legal
challenge More...
Insights caFE
(P. Raghavan, Rakesh Basant , 24-Dec-2010 , The Financial Express)
Intellectual Property Protection Regulation and Innovation in Developing Economies: The Case of Indian
Pharmaceutical Industry More...
Glenmark Generics gets US FDA approvals for three ANDA

Earlier this Glenmark entered into a settlement and license agreement with Sepracor to resolve a United
States patent infringement suit related to Glenmarks filing an ANDA for Eszopiclone with the US FDA.
More...
Protect interest of intellectual property inventors: CSIR

Council of Scientific and Industrial Research Director General Samir K Brahmachari today said the
interest of the intellectual property inventors should be protected and not that of investors. More...
USV looks to monetising US patent on kidney drug

Armed with a patent in the US for its improved version of kidney medicine sevelamer the Rs 1020 crore
drug maker USV is evaluating its options to take the product further. More...
Dilip Chhabria Design violated trademark

The Madras High Court has granted an injunction to Hinduja group flagship company Ashok Leyland
prohibiting two Bangalore and Mumbai based firms from infringing the registered trademark of the
company. More...
First healthcare SEZ to go onstream in Jan 2011

(BS Reporter / Chennai , 23-Dec-2010 , Business Standard)
It has so far bagged two patents along with filings completed for another eight patents with the Indian
Patent Office he added. More...
Copywrong!
(Vickey Lalwani , 23-Dec-2010 , Mumbai Mirror)
The government is amending its copyright laws to protect singers and lyricists. More...
Teva settles diabetes drug patent litigation

(Globes' correspondent , 23-Dec-2010 , Globes)
Teva Pharmaceutical Industries Ltd.said today that it reached a settlement on two Type 2 diabetes
drugs. More...
Ashok Leyland wins LUXURA trademark infringement suit

(Our Legal Correspondent , 22-Dec-2010 , Business Line)
Chennai based commercial vehicles company Ashok Leyland Ltd which has been making and selling
buses and trucks for more than six decades has won a suit filed in the Madras High Court against
infringement of its registered trade mark LUXURA by two firms one in Bangalore and the other in
Mumbai. More...
Unlike generics biosimilars can thwart Indias copycat kings

(Priyanka Golikeri , 21-Dec-2010 , DNA)
While they remain good at the chemistry of molecular tweaking of patented drugs they seem to have
run into a high technology wall when trying to do the same with biologic medicines. More...
Petitions to withdraw GI tags for Darjeeling Tea Tirupathi Laddu

(Vinson Kurian , 20-Dec-2010 , Business Line)
A case for removal of the GI entries seems to have been mounted on the basis of lack of proper
credentials of the applicant as rightful owner of GI. More...
Generics Glitter
(BV Mahalakshmi , 20-Dec-2010 , MSN)
The loss of exclusivity for some iconic pharmaceutical brands is bringing in a new wave of innovation.
More...
Pharma healthcare grew this year on M&As booster dose

(Munish Shekhavat & Ajay Tyagi / PTI , 18-Dec-2010 , Livemint)
Besides hectic activity on the mergers and acquisitions front the Indian pharma firms had to face
hostility from European Union authorities seizing generic drug bound for Africa for alleged patent
violations. More...
Sitar legend hails change in copyright law

Sitar legend Pandit Ravi Shankar has written to the PM congratulating him on amendments to the
copyright law that the government plans to introduce shortly. More...
Patent office to start backlog clearance drive of 3749 pending cases soon
(Suja Nair Shirodkar, Mumbai , 17-Dec-2010 , Pharmabiz)
The Indian patents office has initiated a clearance drive to dispose the backlog of the 3749 applications
pending with it on or before July 3 2009. More...
Embrace open source philosophy Kalam tells scientists researchers

(Deepa Kurup , 17-Dec-2010 , The Hindu)
In the wake of the failure of market forces in this sector the OSDD is exploring new models of drug
discovery and looking at innovative patent regimes Mr. Kalam said. More...
Generex receives Canadian patent for Buccal drug delivery platform technologies
(Worcester, Massachusetts , 17-Dec-2010 , Pharmabiz)
Generex Biotechnology Corporation announced that it has received a new patent for its Buccal drug
delivery platform technologies. More...
New policy for pharma firms

(Special Correspondent , 16-Dec-2010 , Business Line)
Inaugurating a conference on Intellectual Property Right challenges and the way forward for
pharmaceutical industry he said the new policy would address issues faced by pharmaceutical companies
and ensure availability of drugs at the right price. More...
Nokia is suing Apple in Britain Germany and the Netherlands for allegedly infringing its
patents with technology used in the iPhone iPad and iPod Touch.
(Press Association , 16-Dec-2010 , Yahoo News)
The actions add 13 further Nokia patents to the 24 already asserted against Apple in the US
International Trade Commission and the Delaware and Wisconsin Federal courts the worlds largest
handset maker said. More...
Ranbaxy may be on the road to recovery

(Ranju Sarkar / New Delhi , 16-Dec-2010 , Business Standard)
Ranbaxys stock has shot up by more than 50 per cent in a year thanks largely to these off patent
launches. More...
Shah Rukh gets HC go ahead to remake Yeh Jo Hai Zindagi

(Sunil Baghel , 15-Dec-2010 , Mumbai Mirror)
Doordarshans Friday night hit to get a makeover Bombay High Courts interim order rejects copyright
complaint filed by writer Sharad Joshis daughter More...
Now Merck sues Hetero Drugs over Finasteride

(BV Mahalakshmi , 14-Dec-2010 , The Financial Express)
Global research driven pharmaceutical company Merck & Co has filed a patent infringement case over
the active pharmaceutical ingredient Finasteride against Hyderabad based Hetero Drugs in the United
States District Court for the District of New Jersey. More...
Handicrafts of the region aspiring for GI tag

After the world famous Banarasi and brocade and handmade carpet some other products with specific
distinctions of this region of eastern UP are also looking forward to getting the tag of Geographical
Indication. More...
EU pledge to India over generics seizures

(Lynne Taylor , 14-Dec-2010 , Pharma Times)
The European Commission has agreed to amend its customs regulations so that Indian made generic
drugs bound for Third World countries will no longer be seized while they are in transit through European
countries. More...
More than 20,000 patent applications piled up at Chennai office severe shortage of examiners
(Peethaambaran Kunnathoor, Chennai , 13-Dec-2010 , Pharmabiz)
More than 20000 applications scores of them are from abroad for patent registration for pharmaceutical
and biotechnology inventions are pending with the Patent Office in Chennai. More...
Anand Sharma & Karel De Gucht: Partners in trade partners for growth
(Anand Sharma & Karel De Gucht , 13-Dec-2010 , Business Standard)
The EU India Summit last Friday sent a clear signal that the European Union and India are jointly
tackling one of the key challenges facing us all: how to find new sources of economic growth. More...
Merck scouting for Indian partners

(Khomba Singh , 13-Dec-2010 , The Economic Times)
What is new is that the number of products going off patent in next 3 5 years is unprecedented. More...
CPI(M): why this veil of secrecy over FTA with EU

(Special Correspondent , 12-Dec-2010 , The Hindu)
The Communist Party of India on Saturday expressed concern over the veil of secrecy around
negotiations for the India European Union Free Trade Agreement and re emphasised that the Manmohan
Singh government did not have the mandate to conduct parleys on it without discussion within the
country. More...
Experts highlight importance of patents for college students

(Abhinav Malhotra , 12-Dec-2010 , The Times Of India)
Saying that India was lagging behind China in terms of patent applications country manager IBM
Bhooshan Kelkar also pointed out India was on the 20th spot and China ranked sixth on the list of
countries that filed the highest number of patents every year for the innovations made. More...
Farmers’ interest safe in India EU pact says PM

(Sachin Parashar , 11-Dec-2010 , The Economic Times)
Both sides agree that the Intellectual Property Rights chapter will be based on and reflect legislative
developments in the EU and India More...
EU India FTA by March 2011

(Varghese K George , 10-Dec-2010 , Hindustan Times)
Negotiations between India and the European Union for a Free Trade Agreement are on track and
expected to be concluded by March April 2010 said government sources. More...
Pharma cos opt for designer drugs for better brand recall
(Vishal Dutta , 10-Dec-2010 , The Economic Times)
Pharma companies are experimenting with design to distinguish products from round and rectangular
pills sold at drug stores. More...
No compromise on IPR in FTA with EU: Govt

(ENS Economic Bureau , 10-Dec-2010 , Indian Express)
India today made it clear that it will make no compromise on intellectual property rights in the on going
India EU FTA talks and emphasised that it will not accept any TRIPS plus commitments as initially
mooted by the European Union. More...
EU promises to amend norms on seizure of drugs in transit

The European Union has assured India that it will amend its regulations on the seizure of drugs in transit
to Indias satisfaction while ruling out any such confiscation in the meanwhile. More...
Indian generics to be safe from seizure while passing through EU

(Amiti Sen , 10-Dec-2010 , The Economic Times)
Pharmaceutical exporters can breathe easy as the European Union has finally agreed to Indias demand
to amend its Customs regulations to stop confiscation of drugs en route to African and Latin American
countries. More...
FTA will hurt livelihoods in India, Europe: civil society

(Special Correspondent , 10-Dec-2010 , The Hindu)
Halt ongoing negotiations says open letter More...
EU India close to solving dispute over drug seizures

(Pallavi Aiyar / Brussels , 9-Dec-2010 , Business Standard)
In the clearest indication from the European Commission yet that a resolution to the ongoing dispute
between New Delhi and Brussels regarding generic drug seizures had been reached a senior EC official
told reporters on Wednesday that the EU was open to changing the offending regulation. More...
ITPC wants India to remove IP clauses on HIV medicines from EU India trade pact
The current working text of the agreement still contain clauses on intellectual property protection that
go beyond Indias obligations under the WTO TRIPS Agreement. More...
Saldanha hits paydirt with a risky strategy

(PB Jayakumar / Mumbai , 9-Dec-2010 , Business Standard)
Glenmark Generics has first to challenge patent opportunities in the case of about six drugs which are
going off patent before 2015 in the US. More...
US looks to India to strengthen co-operation in Ayurveda-Siddha Unani herbal and botanical

products of global standard
(Nandita Vijay, Bangalore , 9-Dec-2010 , Pharmabiz)
But the reality is that Indian ASU industry is shrugging away from the data generation and protection of
Intellectual Property he added. More...
Generic drugs not on India EU trade talks agenda: Khullar

The Indian Drug Manufacturers Association had told Business Line recently that intellectual property
rights related issues should not form part of the FTA. More...
PM leaves for Brussels tomorrow for India EU summit

The differences broadly relate to social issues like environment and labour standards as well as
Venus completes phase III trials of anti bacterial molecule

The molecule is under patent protection in India China and major markets of the world it added. More...
A powerful push for US firms patent

US commerce secretary writes to Indias Anand Sharma seeking fair consideration of Gileads appeal for
drug patent More...
Mumbai firm wins trademark case against Estee Lauder

Gufic Biosciences a small cap Mumbai based pharmaceutical company has successfully survived a
trademark infringement suit in the Supreme Court filed by US based multinational cosmetic major Estee
Lauder. More...
Bid to browbeat judiciary not a new trend: retired HC judges

Sitting inside a glass bubble we strain every nerve to decipher grievances ranging from common road
problems to complex patent issues. More...
EU pact wont be tighter against drugs

(Asit Ranjan Mishra , 8-Dec-2010 , Livemint)
Indias pharma firms and activist groups have been vociferous opponents of the proposed bilateral pact
on the grounds that it will require India to make a so called TRIPS plus commitment More...
India, EU reach consensus on TRIPS imbroglio

(Nayanima Basu / New Delhi , 8-Dec-2010 , Business Standard)
Decision to be mentioned in the text of the FTA. More...
Oxycodone boost
(Nitin P Shrivastava , 8-Dec-2010 , DNA)
The stock of Glenmark Pharma has been on a roll driven by improving revenue visibility on account of
robust growth in its domestic formulations business and strong product pipeline in the US generic
market. More...
EU pact wont hurt generics

The proposed India EU trade and investment agreement will not curtail Indias right to produce and
export cheap life saving medicines. More...
The Mint Report for 07 December 2010

Generic drug sales may be safe from trade deal with the EU Air India to finally get fresh bailout funding
bank stocks drag down Indian bourses More...
India EU Trade Agreement expected to be ready early 2011

An ambitious Trade and Investment Agreement between India and European Union that could help in
increasing bilateral trade by about 40 per cent to touch 100 billion Euros is expected to be finalised early
next year. More...
Drug cos want IP issues kept out of pact with EU

(P.T.Jyothi Datta , 7-Dec-2010 , Business Line)
Domestic drug makers are worried that Indias proposed Free Trade Agreement with the European Union
would give away more than is beneficial to the country and its pharmaceutical industry. More...
Pharmexcil CIPI to work together to promote pharma exports of SMEs

(Suja Nair Shirodkar, Mumbai , 7-Dec-2010 , Pharmabiz)
The Pharmaceuticals Export Promotion Council of India and Confederation of Indian Pharmaceutical
Industry have decided to join hands to work together on promoting of pharma exports of SMEs. More...
Brain League launches reference manual on Indian Patent Law & its Practice
(Our Bureau Bangalore , 07-Dec-2010 , Pharmabiz)
Brain League has launched a reference manual on Indian Patent Law & its Practice. More...
Protecting trade secrets

(Anurag K Agarwal / New Delhi , 6-Dec-2010 , Business Standard)
Violations of business and intellectual property rights are on the rise and pose a huge challenge to
corporations and innovators. More...
Reduce software piracy to boost economy create new jobs

Lack of awareness about Intellectual Property Rights and threats posed by pirated software as well as
rapid growth of consumer PC markets such as India and China have resulted in increasing software
piracy. More...
India regulators need to inspect Chinese production facilities before imports: Dr G.G Nair
(Peethaambaran Kunnathoor, Chennai , 4-Dec-2010 , Pharmabiz)
Indian regulatory authorities should insist on inspection of Chinese manufacturing premises for GMP GLC
standards as they do in the case of Indian drug manufacturers said Dr Gopakumar G Nair Patent
Attorney & Advisor Pharmexcil. More...
Brainvisa case: Court partly rejects discharge plea

(Ashish Jadhav & Sandip Dighe , 4-Dec-2010 , DNA)
All the five accused are being prosecuted for the offence under section 406 420 to read with 34 of the
Indian Penal Code 1860 and section 65 66 of the Information Technology Act 2000 and section 63 63 B
of the Indian Copyright Act 1957. More...
Complete formalities on Novartis patent claim: SC

The Supreme Court on Friday directed the Centre pharma major Cipla Ranbaxy Lab Hetero Drugs Natco
Pharma and others to complete their pleadings in the matter of Swiss firm Novartis AG challenging
denial of patent for its blood cancer drug Glivec. More...
SC quashes Bayer petition to block Cipla generic drug

The countrys top judicial authority has dismissed German pharmaceutical firm Bayer AGs attempt to
block Indian drug regulator from allowing Mumbai based Cipla Ltd to launch a low cost version of its
patented cancer medicine . More...
Products built on Indian innovations flowing into world markets

(Kala Vijayraghavan, Lijee Philip and N Shivapriya , 2-Dec-2010 , The Economic Times)
Julia Roberts embracing Hinduism may not exactly be the best case study for reverse innovation but 20
years after yoga and ayurveda went global a medley of products built on Indian innovations are slowly
finding their way into world markets. More...
Stay Focussed
(01-Dec-2010 , The Times Of India)
On occasion the issue is patents. More...
EU offers out of WTO settlement on drug seizure row

The Government today said the EU wants to settle the row over seizure of Indian generic drugs by some
European Union members without involving WTO. More...
India to dominate world generic market

India and China are all set to dominate the global generic off patent drugs market as low manufacturing
and R&D cost would prompt key pharma players to set up their base here a report said. More...
Awareness about HIV yes but what of claims?

(Ashish Jadhav , 01-Dec-2010 , DNA)
On May 2 2007 he had advertised in a prominent daily in Pune saying he had a patent for the treatment
in India and Africa. More...
India China set to dominate global generic market: Report

(PTI , 1-Dec-2010 , MSN)
India and China are all set to dominate the global generic off patent drugs market as low manufacturing
and R&D cost would prompt key pharma players to set up their base here a report said. More...
Stepped up talks revive hope of India EU FTA

(Pallavi Aiyar / Brussels , 30-Nov-2010 , Business Standard)
With the pressure on for the European Union and India to come up with a significant announcement at
the upcoming EU India summit on December 10 a flurry of activity surrounding the ongoing negotiations
for a bilateral free trade agreement is giving momentum to the process. More...
Analysts see $250 millon revenues from Ranbaxys Aricept deal

(Our Bureau , 30-Nov-2010 , DNA)
Ranbaxy Laboratories can earn $230-250 million in revenues in the next six months from the US
following approval of its off patent version of Alzheimers medicine Aricept by the US Food and Drug
Administration say analysts. More...
Protecting innovation
(Lalit Bhasin , 29-Nov-2010 , The Economic Times)
The link between economic growth and innovation is by now well established. More...
Pharma pains not over more revamp on anvil

(Report , 29-Nov-2010 , DNA)
In their latest quarter Pfizer AstraZeneca Eli Lilly laxoSmithKline and Roche reported sales that were hurt
by generics and their shares fell signalling their valuations may not have the patent loss impact fully
baked in. More...
Immunitor Awarded the Key U.S. Patent Related to Oral Vaccine Technology Platform
(press release , 29-Nov-2010 , Market Watch)
Immune Network Ltd. advises that its potential acquisition Immunitor USA Inc. has been issued a key
patent by the U.S. Patent and Trademark Office. More...
CEAT Ltd acquires global rights of Brand CEAT from Pirelli

Pirelli is the owner of the Ceat trademark in the rest of the world. More...
Ranbaxy gets nod for Alzheimers drug

(Radhieka Pandeya, , 29-Nov-2010 , Livemint)
Ranbaxy Laboratories Ltd Indias largest pharmaceutical company by revenue has received the US drug
regulators nod to launch its generic version of Pfizer Inc. and Eisai Co. Ltds Alzheimers drug Aricept two
people familiar with the development said. More...
Venus gets patent for Vancoplus in South Africa New Zealand

Drug firm Venus Remedies today said it has received patents in South Africa and New Zealand for its
product Vancoplus used in treatment of bacterial infections. More...
80% Kullu shawls have made in Ludhiana stamp

(Dinker Vashisht , 29-Nov-2010 , Indian Express)
India had argued at the World Trade Organisation forum that since the basmati variety was endemic to
India and Pakistan only these two countries could be allowed a patent it. More...
PhRMA signs cooperation agreement with Chinese pharma assn SINO PhIRDA
After expressing reservations on the regulatory environment and patent laws of India the
Pharmaceutical Research and Manufacturers of America representing the powerful multinationals has
now tied up with Chinese pharma industry by signing a cooperative framework. More...
Free trade pact with EU making good progress

Negotiations for the ambitious free trade agreement between India and the 27 nation economic bloc of
the European Union are likely to be wrapped up by early next year. More...
Time to patent the Kalenjin champagne

(Lotuliangelech Domolina , 29-Nov-2010 , The Standard)
Over the years Kenya has produced excellent athletes who have excelled in global competitions with the
latest being world record holder David Rudisha. More...
Dr Reddys expands horizon

(Ujjval Jauhari / Mumbai , 27-Nov-2010 , Business Standard)
Entry into the penicillin segment would help: the aim is to be further achieved by new launches in low
competition products as well as patent challenge ones. More...
Panel for key changes to copyright Bill

Aparliamentary standing committee headed by Oscar Fernandes which reviewed the proposed Copyright
Bill 2010 has suggested key changes in draft amendments based on the feedback it has received.
More...
The US model of private health insurers is inefficient expensive

(TNN , 26-Nov-2010 , The Times of India)
I am not against intellectual property. More...
India EU pact wont be ready before Dec summit

Negotiations have really not taken speed on crucial issues like government procurement intellectual
property rights labour standard and sustainable development she said. More...
Blockbusters set to witness new order

(Rupali Mukherjee , 26-Nov-2010 , The Times of India)
While some companies such as Dr Reddys Glenmark Pharmaceuticals and Biocon have fast tracked their
research in biosimilars off patent biotech drugs others like Cipla have tied up with Chinese companies to
make a foray in the highly complex but fast growing segment. More...
Facebook to patent the word face?
(AGENCIES , 25-Nov-2010 , The Economic Times)
It may sound ridiculous at first but Facebook is planning to trademark the word face because it wants to
stop other companies using the term in a way which damages its own brand. More...
Tying the Indo US trade knot

(T S Vishwanath / New Delhi , 25-Nov-2010 , Business Standard)
From a US perspective the important issues would be in the area of intellectual property rights besides
other areas such as greater market access in some areas that India may consider sensitive. More...
New GSK plant in US poses multiple challenges to Dr Reddys

GSK has taken a hit on market share and profitability of the brands after they lost patent protection a
few years ago. More...
Oracle wins $1.3 bn from SAP in copyright case

(Bloomberg / San Francisco , 25-Nov-2010 , Business Standard)
Oracle Corp won a $1.3 billion jury verdict against rival SAP AG the worlds largest maker of business
application software for copyright infringement by a now defunct software maintenance unit. More...
Healthy portfolio driving profits

This means that injectables do not face the sharp price erosion as is the case with oraldrugs when
products go off patent thus allowing for better margins. More...
US trade representative finds fault with India China intellectual property regimes
The US trade representative has expressed concern at shortcomings in the intellectual property rights
regimes of both China and India when it comes to investment in pharmaceuticals while noting
improvements put in place by both Asian countries. More...
Film producers get leg up on copyright row

(Charu Sudan Kasturi , 24-Nov-2010 , Hindustan Times)
The HRD ministry should remove a proposed amendment of the Copyright Act allowing film directors to
jointly own movies along with producers the Parliamentary standing committee on HRD has said. More...
Channels get I-T notice over deductingtoo little tax

(Khushboo Narayan & Anushree Chandran , 24-Nov-2010 , Livemint)
Further it is the channel that deducts taxes on IPR intellectual property rights licensed to them and not
YRF. More...
Art of the royalty
(RISHIKESH BAHADUR DESAI , 23-Nov-2010 , The Hindu)
Bidri art has gained the Geographical Indication tag to certify that this product cannot be made
anywhere else except Bidar. More...
Advair Poses Generics Hurdle

(JEANNE WHALEN , 22-Nov-2010 , The Wall Street Journal)
As Patent Nears End Glaxo Blockbuster Asthma Drug Is Proving Tough to Copy More...
Pharmaceutical Industry Is Facing Biological Warfare

(HESTER PLUMRIDGE , 22-Nov-2010 , The Wall Street Journal)
It is a new battle for the drugs industry and it will be hard fought. More...
Surats rich Zari craft gets Geographical Indication status

(Press Trust Of India , 22-Nov-2010 , Hindustan Times)
After Tangaliya the grand and glittering centuries old Zari making craft of Surat district in Gujarat has
been granted Geographical Indication status offering it the much needed succour from infringement.
More...
Claris Lifesciences Rs.300 crore IPO to open on November 24

(Our Bureau, Mumbai , 22-Nov-2010 , Pharmabiz)
All of its products are off patent products a significant majority of which are capable of being directly
injected into the body and are predominantly used in the treatment of critical illnesses. More...
Sun Pharma loses generic challenge in US court

Sun Pharmaceutical Industries has lost an opportunity to launch the generic version of a schizophrenia
drug that had generated revenue of $4 billion in the United States market in 2009. More...
New centre to help city students file patents

(Snehal Rebello , 21-Nov-2010 , Hindustan Times)
When Jayesh Varavadekar and his classmate Prathamesh Wadekar filed their first patent for a biofuel
product last year they spent a month trawling through scientific databases to ensure the product was
indeed a first. More...
Fight against HIV virus to don green hues

(Shimona Kanwar , 22-Nov-2010 , The Times Of India)
A patent has been filed as this is the first such compound which has shown a protection rate of 78.17%
against the HIV virus the standard percentage is 89.75. More...
Dr Reddys gets USFDA nod

(Express news service , 21-Nov-2010 , Indian Express)
Drug firm Dr Reddys Laboratories on Saturday said it has received approval from US health regulator to
launch generic Zafirlukast tablets used for treating asthma in the American market. More...
TVS asked to show it didnt infringe patent

(C.H. Unnikrishnan & Shally Seth , 20-Nov-2010 , Livemint)
A division bench of the Madras high court last week asked TVS Motor Co. Ltd to prove that the
technology used in its Flame brand of motorcycles did not infringe on a patent held by Bajaj Auto Ltd.
More...
Estee Lauder loses Cliniq trademark case

(Indu Bhan , 20-Nov-2010 , The Financial Express)
The Supreme Court on Friday rejected global cosmetics major Estee Lauders trademark infringement
case against Gufic. More...
Karnataka DC cautions SMEs over new regulatory challenges in global markets

(Nandita Vijay, Bangalore , 20-Nov-2010 , Pharmabiz)
Changing dynamics in the global pharma scenario are expected to post serious challenges to the Indian
small & medium enterprises players in future. More...
Hey you copy cat!

(20-Nov-2010 , Deccan Chronicle)
One can charge the accused with regards to the Indian Copyright Act 1957 but there needs to be solid
proof and this is very difficult when it comes to creative fields. More...
Estee Lauder loses Cliniq trademark case

(Indu Bhan , 20-Nov-2010 , The Financial Express)
The Supreme Court on Friday rejected global cosmetics major Estee Lauders trademark infringement
case against Gufic. More...
Indian IT firms look West for patents

(Swati Garg / Kolkata , 17-Nov-2010 , Business Standard)
At a time when the debate on intellectual property rights has taken centre stage globally current Indian
patent laws have ensured an outflow of innovation and ownership registration in the information
technology sector. More...
Hyderabad Haleem gets geographical copyright

(16-Nov-2010 , MSN News)
Haleem a famous and nutritious dish available in Hyderabad during Ramadan has been awarded
geographical copyright. More...
Vidarbha rice innovator gets recognition after 20 long years

(Report , 16-Nov-2010 , DNA)
Experts say the least the government could do now is help him protect his intellectual property. More...
Meet to provide insight into European patenting norms
Experts from European countries will provide their perspectives on the European patenting norms with
reference to information technology and automobile sector at an event at the National Chemical
Laboratory here on Tuesday at 3.30 pm. More...
Copyright and Patent

(Dr Anu Vaidyanathan , 15-Nov-2010 , Business Line)
A look at the tradeoffs in the software context. More...
As of now India not for WTO dispute body on drug row with EU
(Press Trust of India / New Delhi , 15-Nov-2010 , Business Standard)
On an indication that the drug seizure dispute with the European Union would be resolved has not
sought setting up of a settlement body in the World Trade Organisation Parliament was informed today.
More...
Ind Swift Labs registers 74% growth in PAT for Q2 of FY 2010 11

(Announcement / Corporate , 15-Nov-2010 , Business Standard)
Ind Swift Laboratories Limited one of Indias leading pharma company reported growth of 74% in net
profit for the quarter ended September 30 2010. More...
Big pharmas Brazilian prescription

(Andrew Jack , 14-Nov-2010 , Financial Times)
Mr Pedrosa is seeking regulatory approval for seven products combining low cost off patent drugs.
More...
Royalty issue in software

(Mohan R Lavi , 13-Nov-2010 , Business Line)
In a critical judgment the Delhi Tribunal ruled that the income received for supply of software is
assessable as royalty under Section 91 vi in the hands of MSS as a copyright subsists in a computer
programme and it is also a literary as also a scientific work. More...
Workshop on post GI intervention starts

It may be mentioned here that the Banarasi saree and brocade got the GI status on September 4 2009.
More...
Amitabh to move court against copyright infringement

(Indo-Asian News Service , 12-Nov-2010 , Hindustan Times)
Bollywood megastar Amitabh Bachchan seems to be irked by constant copyright infringements and the
illegal use of his name for the promotion of products. More...
Lambretta to seek claim from SCL
(Press Trust of India , 12-Nov-2010 , Indian Express)
Italian two wheeler maker Lambretta Consortium on Thursday said it will seek claim of over euro10
million from Scooters India Ltd following a favourable court order in Europe regarding their trademark
infringement dispute. More...
Ranbaxy Q3 net jumps to Rs.313 cr on surging sales

(AGENCIES , 12-Nov-2010 , The Times of India)
Valacyclovir an anti herpes drug was a first to file has the right to the grant of a patent for the invention
product of the company in the USA. More...
Cong MP cautions govt against more takeovers of Indian pharma cos by MNCs
Dr Mirdha who is a members of the Parliamentary Standing Committee on Health & Family Welfare
reminded the government through her letter that the domestic industry reached the current state of
development due to a variety of policy formulations in early 70s such as FERA drug policy process
patents etc. More...
Climbing Mount Publishable

(Global science , 11-Nov-2010 , The Economist)
They spent the most published the most and patented the most. More...
EU patent talks end in deadlock

(Nikki Tait in Brussels , 11-Nov-2010 , Financial Times)
Europe was urged by senior politicians and officials to break the political deadlock over a single
European Union wide patent regime after ministerial talks failed on Wednesday night. More...
Knowledge on IPR should reach all levels

(Express News Service , 11-Nov-2010 , Express Buzz)
Anyone can create wealth by their own innovations and continuous improvements which will ultimately
improve productivity said N R Madhava Menon while inaugurating the national seminar on IPR in the
Knowledge Era organised jointly by the Institute of Management in Kerala and the Kerala State Council
for Science Technology and Environment at the Science and Technology Museum. More...
CSMCRI in talks with oil companies for manufacturing bio diesel

(Sohini Das / Mumbai/ Ahmedabad , 10-Nov-2010 , Business Standard)
We have recently been granted the US patent for our technology and now we can share our intellectual
property rights with an interested party who can manufacture the jatropha based bio diesel on a larger
scale informed P K Ghosh director of CSMCRI which has been producing bio diesel on a small scale so
far. More...
Green Technology Patent Program Extended for 1 Year by U.S

(Susan Decker , 10-Nov-2010 , Bloomberg)
The U.S. Patent and Trademark Office is extending by one year its program that expedites review of
applications for inventions intended to improve the environment and reduce greenhouse gas emissions.
More...
Cadila Pharma Files For Seventy Patents In The Us

(BUSINESS STANDARD , 10-Nov-2010 , Business Standard)
Cadila Pharmaceuticals Ltd has applied for 70 product patents in the United States. More...
Global regulatory agencies bogged down by staff shortage to oversee patent expiry drugs
With patent expiry drugs expected to reach record levels in the near future global regulators are
expected to vet increased number of applications and their task could only expected to get humongous
as these agencies are unable to hire additional manpower to shoulder sudden surge in workload. More...
Exemption Rules To Be Included In Dpco 2002

(BUSINESS STANDARD , 10-Nov-2010 , Business Standard)
According to the new DPCO a copy of which is with the Business Standard the production of a new drug
patented under the Patents Act 1970 and not produced elsewhere if developed through indigenous
research and development for a period of 15 years from the date of commencement of its commercial
production in the country can be exempted from the Order. More...
DuPont to focus on agri energy saving

(Shubham Mukherjee , 10-Nov-2010 , The Times Of India)
Though Dupont Indias R&D centre is yet to receive a patent it has nine applications in the pipeline.
More...
An Indian Microsoft or Google is inevitable

(Sujit John , 10-Nov-2010 , The Economic Times)
Within global technology enterprises the youth enthusiasm in their India centres is translating into these
centres contributing the most towards potentially patentable ideas. More...
Takeda Pharma says no interest in generic drug mkt

(Ju-min Park , 10-Nov-2010 , Reuters)
In late October Takeda Pharmaceutical reported a 12 percent decline in first half profit as a key drug lost
patent protection but it lifted its full year earnings outlook as a stronger yen helped cut overseas costs.
More...
India to soon ink trade agreements with Japan European Union

(Priyanka Golikeri & Sreejiraj Eluvangal , 09-Nov-2010 , DNA)
Fresh from an exhilarating visit by US president Barack Obama that created much good will on both
sides India seems keen to push its advantage as far as it will go. More...
Corporatised piracy new bug in MS play

(NYT News Service , 9-Nov-2010 , The Economic Times)
As long as intellectual property is the lifeblood of this company we have to go protect it Mr Finn says
More...
Public interest groups ask Centre to reject lobbying by Obama administration against
generics
Public interest groups in India have called upon the Centre to strongly reject the lobbying by the Obama
administration and its industry organisation the US India Business Council against the production of safe
effective and affordable generic medicines in India. More...
Glenmark moves closer to HIV drug launch

Indian drugmakers have mastered developing low cost version of off patent drugs and Crofelemer would
be the countrys first new drug if it is successfully launched. More...
Develop IPR regime for incremental innovation: Pitroda

There is a need to develop a global Intellectual Property Rights regime that encourages incremental
innovation said Mr Sam Pitroda Advisor to the Prime Minister of India on Public Information
Infrastructure and Innovations More...
Glenmark moves closer to HIV drug launch

Indian drugmakers have mastered developing low cost version of off patent drugs and Crofelemer would
be the countrys first new drug if it is successfully launched. More...
EU states to push for single patent regime

(Nikki Tait in Brussels , 08-Nov-2010 , Financial Times)
The push to establish a single European Union wide patent regime is set to gain momentum as a group
of EU countries asks Brussels to consider introducing the measure even if all 27 member states do not
sign up. More...
Patently strategic
(Chitra Narayanan , 8-Nov-2010 , Business Line)
A patent is not just a protective tool but a good business strategy for tech driven or knowledge driven
entrepreneurs. More...
Amitabh Bachchan to get copyright

(Mail Today , 8-Nov-2010 , India Today)
The Bachchan baritone is all set to go exclusive. More...
All eyes on Obamas healthcare resolve

(P.T. Jyothi Datta , 8-Nov-2010 , Business Line)
While patents allow a patent holder exclusive monopoly on the product for 20 years a CL allows
governments to break the patent and allow a third party to make the same medicine. More...
Chasing pirates: Inside Microsofts war room

(Ashlee Vance, New York Times , 07-Nov-2010 , NDTV)
As long as intellectual property is the lifeblood of this company we have to go protect it More...
Legal support to free and open source software projects

(T. Ramachandran , 07-Nov-2010 , The Hindu)
SFLC will bring to notice violations of licence terms More...
CellTrusts Sean Moshir Responds to Indian Government's Plans for Proxy SIM Cards for
Secure Communication
(Lora Friedrichsen , 5-Nov-2010 , PR NewsWire)
CellTrust Corporation the recognized leader in mobile secure messaging and secure applications for
mobile phones responded today to the recent announcement by the Indian government that it plans to
create guidelines and regulations for using proxy SIM cards for secure communication in the country.
More...
Brazil India and South Africa call for flexibility on compulsory drug licensing
(5-Nov-2010 , The Pharma Letter)
Brazil India and South Africa joined forces to reject pressure for the extension of intellectual property
rights and called for effective use of flexibilities such as compulsory licensing. More...
Breaking news: IPO releases revised manual of patent practice & Procedure (MPPP).
(07-Nov-2010 , Indian Patent Office)
The Manual is divided into 21 chapters and 3 schedules which represent areas subject to regulation by
the IPO. More...
EU issues note to address drug seizure concerns of India

(Amiti Sen , 4-Nov-2010 , The Economic Times)
The European Union has offered fresh suggestions to prevent wrongful confiscation of Indian generic
drugs during transit through European countries a move that hints at its seriousness about settling the
issue. More...
The upside of plagiarism and why copying isnt going to die

(R Jagannathan , 4-Nov-2010 , DNA)
IPR intellectual property rights is a relatively recent development probably less a few hundred years old.
More...
Trade grows but hurdles remain

Anwarul Hoda professor at the Indian Council for Research on International Economic Cooperation said
in a probable free trade agreement between the two sides the high standards that the US may demand
in the fields of intellectual property rights labour and environment may be difficult for India to comply
with. More...
Drug research heads to Asia as local markets boom

(Ben Hirschler , 3-Nov-2010 , Reuters)
Asian drugmakers traditionally reliant on manufacturing bulk ingredients and making cheap generic
medicines are these days pouring money into researching their own products as well as mounting risky
patent challenges against brand name drugs. More...
Patent should revert to research firms: Ghulam Nabi Azad

(Vineeta Pandey , 02-Nov-2010 , DNA)
Union health minister Ghulam Nabi Azad feels public funded patents of Indian research organisations
which have been sold to Indian private sector companies should go back to the organisations of these
companies are taken over by multinationals More...
A Singapore sling
(2-Nov-2010 , Hindustan Times)
The government enacted the Indian Patents Act in 1970. More...
Azad for Revisiting FDI Norms in Pharma Sector

(2-Nov-2010 , Outlook)
He said that the Indian Drugs and Cosmetics Act does not recognise data exclusively and patent linkage.
More...
Why European Union seizes Indian drugs

(U S Bhatia , 01-Nov-2010 , Rediff)
Indias status as the pharmacy of the world is at stake says U S Bhatia. More...
Business method patents

(Anu Vaidyanathan , 1-Nov-2010 , Business Line)
Bottom line with innovation is in the patent and IP portfolio.. More...
Parliamentary panel finds 10 to 12 Indian pharma cos seriously into new drug discovery
research
(Our Bureau, New Delhi , 1-Nov-2010 , Pharmabiz)
The Parliamentary Standing Committee on Chemicals and Fertilisers assessed that the research and
development in the Indian pharma industry was picking up and at least 10 to 12 leading companies are
into new drug discovery now. More...
Click through license

(Chanpreet Khurana , 01-Nov-2010 , Indian Express)
But if we are to create a level playing field for Indian technology products companies we need to give
them that intellectual property rights or IPR protection. More...
Old knowledge to get India money

(Chetan Chauhan , 31-Oct-2010 , Hindustan Times)
India has already established Traditional Knowledge Digital Library where over 2000 sources have been
digitised to check patent of this knowledge in the western world. More...
Nagoya Protocol a big victory for India

(Priscilla Jebaraj , 31-Oct-2010 , The Hindu)
In order to bring the American companies into the ramifications of this agreement the U.N.s Convention
on Biological Diversity must be linked to the World Trade Organisations intellectual property agreement.
More...
Micromax loses its Bling brand name

(Gulveen Aulakh & Harsimran Julka , 31-Oct-2010 , The Economic Times)
The Delhi High Court has restrained Indias second largest mobile phone brand Micromax from selling or
advertising one of its largest selling women oriented mobile phones Bling as it acceded to a trademark
violation filed by Delhi based mobile phone maker Bling Telecom. More...
India makes case against ACTA at WTO meet

(BS Reporter / New Delhi , 30-Oct-2010 , Business Standard)
India has made a strong case against Anti Counterfeit Trade Agreement a new international treaty being
framed by a group of developed nations in the annual meeting of the World Trade Organizations Council
for Trade Related Aspects of Intellectual Property Rights held in Geneva on October 27. More...
Biocon to invest $161 mn in Malaysia

Biosimilars are similar acting copies of original biologic medicine and can enter the market when the
originals go off patent they are said to cost much less than the innovator drugs. More...
Poscos patented proposal pipped ArcelorMittal

(Shubhashish / Mumbai , 30-Oct-2010 , Business Standard)
The reason why the Union steel ministry preferred a joint venture between government owned Steel
Authority of India Ltd and Koreas Posco in preference to a similar proposal from ArcelorMittal the worlds
largest producer in the sector was technology. More...
Why EU seizes Indian drugs

(U S Bhatia , 30-Oct-2010 , Business Standard)
Indias status as the pharmacy of the world is at stake More...
The right medicine

(SWATI PIRAMAL , 29-Oct-2010 , The Financial Express)
Many big pharma companies are facing a patent cliff and on the flip side new drug approval by
regulators like USFDA is much more expensive and takes longer. More...
India EFTA FTA likely by year end

(PTI , 29-Oct-2010 , IBN Live)
India and European Free Trade Association comprising Switzerland Iceland Norway and Liechtenstein are
likely to firm up a free trade agreement by end of the year. More...
Curbing broadcast signal piracy

(PN Vasanti , 29-Oct-2010 , Livemint)
The Geneva based World Intellectual Property Organization has for long been grappling with the issue of
signal piracy and the rights of broadcasting organizations to address it. More...
Juicy bites from Washington

(Rasheeda Bhagat , 29-Oct-2010 , Business Line)
In China too weve faced problems but they had to with intellectual property rights people copying our
labels stickers logos More...
Curbing broadcast signal piracy

(MINT , 29-Oct-2010 , IndiaInfoline )
The Geneva based World Intellectual Property Organization has for long been grappling with the issue of
signal piracy and the rights of broadcasting organizations to address it. More...
The great patent battle

(The Economist , 28-Oct-2010 , Indian Express)
History buffs still wax poetic about the brutal patent battles a century ago between the Wright brothers
and Glenn Curtiss another aviation pioneer. More...
New border measures

(T S Vishwanath , 28-Oct-2010 , Business Standard)
The developed worlds new focus on IPR safeguards and fossil fuel subsidies is sparking fresh concerns in
developing nations. More...
India takes lead for guiding developing countries to drive WHO focus on public health instead
of IPR
India has taken the lead to get together a number of generic drug producing nations to call for better
definitions to ensure quality strengthening of regulatory authorities in the respective countries and
bringing focus of the world to public health instead of intellectual property. More...
Glenmark profit rises on India US sales

(C.H Unnikrishnan , 28-Oct-2010 , Livemint)
A first to file generic drug offers market exclusivity for at least six months for a generic company in the
US where the law permits a low cost drug to enter the market soon after the expiry of the inventors
patent protection. More...
Italian luxury brand Canali strikes the Indian chord

(Moinak Mitra , 27-Oct-2010 , The Economic Times)
It could well be the next geographical indication if the Canali family has its way. More...
Rich reluctant to pay for medicines biodiversity deal stuck

(Patent Firm in Pune , 26-Oct-2010 , Sify)
The issue of these firms patenting what has been traditional knowledge in developing countries for
centuries has been an emotive one in India since attempts to patent Basmati rice neem and turmeric hit
the headlines. More...
US lobbying for strong IPR regime in India

The US is lobbying for an intellectual property rights regime in India that protects American patents a
senior official of the Obama Administration said on Tuesday. More...
PhRMA changes stand on generics says generics cannot be termed as spurious

Toning down its earlier stand on counterfeit drugs issue the Pharmaceutical Research and Manufacturers
of America has categorically spelled that the generic medicines cannot be branded as spurious and
intellectual property rights issue cannot be mixed up with generic drugs. More...
Obama aide rosy on Indo US trade

(HT Correspondent , 26-Oct-2010 , Hindustan Times)
Kumar who previously headed the worldwide consumer pharmaceuticals business of Johnson & Johnson
said there were still some gaps in Indias patent regime although India has done a fabulous job
compared to some other countries. More...
Registry moved for removal of GI tag for Tirupati Laddu

(Vinson Kurian , 26-Oct-2010 , Business Line)
An application has been registered with the Geographical Indications Registry seeking removal of the
entry pertaining to Tirupati Laddu GI. More...
Tamil writer claims copyright to Enthiran plot

(Express News Service , 26-Oct-2010 , Express Buzz)
Producing copies of the printed text of both publications as proof Tamilnadan urged the police to file a
criminal complaint under section 63 of the Indian Copyrights Act. More...
With drugs costing Rs9 lakh should govt invoke compulsory licensing?
With patented medicines for treatment of HIV AIDS cancer and hepatitis C beyond the reach of many
patients due to their exorbitant prices some say there is a case for invoking the provision of compulsory
licensing. More...
Cleaning Up the Patent Office

(Nilofer D'Souza , 25-Oct-2010 , Forbes India)
To seed innovation and attract more patent applications India needs an efficient system. More...
Multinationals seeking to control global farming

(Joydeep Gupta , 25-Oct-2010 , Sify)
The gene giants are stockpiling patents that threaten to put a choke hold on the worlds biomass and our
future food supply. More...
Biopiracy the new threat to global food supply

(IANS , 25-Oct-2010 , Zee News)
A handful of multinational corporations are pressuring governments to allow what could become the
broadest and most dangerous patent claims in history warned the group while releasing a report on the
subject at the UN Convention on Biodiversity being held here Oct 18 29. More...
SENSIO Granted Patent in India

(press release , 25-Oct-2010 , MaketWatch)
SENSIO Technologies Inc. today announced that the Indian Patent Office has granted patent no. 242873
covering the SENSIO S2D Switch. More...
Ranbaxy Dr. Reddys Cadila look attractive: Jitendra Sriram HSBC

(ET Now , 25-Oct-2010 , The Economic Times)
The patent expiry cycle is probably going to peak out till another two years out so you will have a lot of
drugs which are coming off patent which offers a wide potential for Indian pharma to actually go out and
sell in the developed world. More...
Hepatitis B patent brings Asia to BigDNA

(Andrew Bolger, Scotland Correspondent , 24-Oct-2010 , The Financial Times)
BigDNA a Scottish developer of vaccines has been granted a patent in Japan to tackle a disease that
could provide access to a huge market in Asia. More...
Obamas visit to Mumbai: Filled with symbolism and business

But business ties between the two countries are not without concerns the recent anti outsourcing
sentiments in the information technology sector and pro Intellectual Property Rights efforts in the
pharmaceutical sector to name a few. More...
Higher margins boost Dr Reddys ne

(Mobis Philipose , 24-Oct-2010 , Livemint)
According to Motilal Oswals estimates the stock trades at 31.1 times core earnings estimated for this
year and 25.5 times FY12 earnings after adjusting for the DCF value of the upsides from patent
challenges low competition opportunities in the US and the impact of bonus debentures. More...
Drug patents
(Govind Diwakar , 23-Oct-2010 , Business Line)
This is with respect to the article on drug patent laws. More...
Trouble ahead as US hints at tighter norms for generics

(ET Bureau & Agencies , 23-Oct-2010 , The Economic Times)
Generic or off patent drugs constitute a major chunk of Indias Rs 40000 crore exports of medicines.
More...
Scaled down Acta will still hurt Indian pharma’

(ENS Economic Bureau , 23-Oct-2010 , Indian Express)
An American expert on intellectual properties conceded that even a scaled down version of the Anti
Counterfeit Trade Act will make Indian pharmaceutical companies presence difficult to maintain in the
international marketplace. More...
Form bloc to oppose new patent regime advises legal guru

India should join forces with other developing countries at the World Trade Organisation to oppose the
stringent intellectual property regime being framed by a number of developed countries which could
affect exports of generic drugs and software from the country a top legal expert has said. More...
Strong IPR rules must to bring funds: Big Pharma

With around a fortnight to go before Presidentbegins his visit to India USbased pharma giants have
warned that New Delhi could lose out in the acute global competition in attracting investment from them
if the country refuses to strengthen regulatory protection for patented drugs. More...
PhRMA objects to compulsory licence idea shows concern over enforcement of patent laws
Expressing concerns on many fronts including pending cases of patents in Indian courts and compulsory
licence issue the Pharmaceutical Research and Manufacturers of America has urged the Government to
create a conducive environment for innovation so that India does not miss out the opportunities in the
global competition. More...
PM to meet Wen in Hanoi amid rising tensions

(Elizabeth Roche , 23-Oct-2010 , Livemint)
It covers almost 90% of trade and a vast gamut of services investment intellectual property rights
customs and other trade related issues. More...
Measures to derive maximum benefits of GI tag discussed

The seminar was on post GI registration of handmade carpet of Bhadohi. More...
Consumer pharmaceuticals
(22-Oct-2010 , Financial Times)
But as many big selling drugs near the end of their lives the patent cliff has made chief executives rush
to diversify away from big name drugs. More...
Rejuvenating Strategic Partnership

(Richard Fontaine , 22-Oct-2010 , The Times Of India)
It should raise its caps on foreign investment enhance its rules for protecting patents and other
intellectual property and reduce barriers to defence and other forms of trade all of which would allow a
major expansion in the bilateral economic relationship. More...
Govt may make registration of drug brands mandatory

Delhi based lawyer Prathiba Singh said the Supreme Court had given an order around ten years ago
asking the national drug regulator and the trademark office to coordinate registration of drug brands to
prevent the confusion. More...
Why drug patents are needed

(Ananda Chakrabarty , 21-Oct-2010 , Business Line)
India has been reluctant to liberalise pharma patent laws losing out on innovation. More...
Indias n bill deviates significantly from global standards

Deal with the problem of intellectual property rights violations Burns said. More...
NGOs, experts seek PM's intervention for imposition of FDI cap of 40% in pharma sector
In an open letter to prime minister Dr Manmohan Singh the health interest groups and experts
expressed the apprehension that the the purpose of the Pharmaceutical Research and Manufacturers of
America visit is to discourage the Indian government from applying a cap on FDI in the pharma sector
and from issuing compulsory licenses for patented medicines. More...
US drug lobby to meet key govt officials this week

In a joint response on September 29 PHRMA and its European counterpart had said that a policy to
encourage compulsory licences on intellectual property would be counter productive for the domestic
drug industry. More...
Attack of the biosimilars

(Pharmaceuticals , 21-Oct-2010 , The Economist)
Although biotech based drugs account for only a fifth or so of global drugs sales they are projected to
grow at double digit rates as sales of many conventional drugs decline especially with a large number of
patent expirations coming. More...
MNCs set to maximize opportunities as Indian pharma gears up to unlock its inherent
strength
(Nandita Vijay, Bangalore , 21-Oct-2010 , Pharmabiz)
In collaboration with Strides Arcolab Pfizer commercializes 40 off patent sterile injectables and oral
products in the regulated markets. More...
Medicis says Genzyme sues for patent infringement

(Krishnakali Sengupta in Bangalore , 20-Oct-2010 , Reuters)
Medicis Pharmaceutical Corp said Genzyme Corp had sued it in a U.S. court over its wrinkle treatments
accusing Medicis of patent violation. More...
India accounts for only 17% of patent applications globally

The total number of patents filed in 2010 is likely to touch 40000 of which only 17 per cent account for
Indian applications. More...
India sees generic drugs row with EU being settled

(Jonathan Lynn , 20-Oct-2010 , Reuters)
India believes a row with the European Union over seizures of generic drugs will be settled without
litigation Trade Minister Anand Sharma said on Wednesday. More...
Indian ayurvedic body slams Colgate for patenting lal dant manjan
(Sagar Malviya & Maulik Vyas , 20-Oct-2010 , The Economic Times)
Lal dant manjan may make many Indians remember the old Dabur commercial featuring a schoolboy
named Raju and his Masterji. More...
Traditional Knowledge Digital Library an effective deterrent against biopiracy

In September 2007 Brazilian firm Ache Laboratories had filed for a patent at the European Patent Office
for using grape to treat diabetes obesity and hypertension. More...
Celgene sues Natco Pharma over cancer drug

Celgene Corporation has filed a lawsuit against Natco Pharma in a US court in connection with the latters
filing of an abbreviated new drug application seeking approval to market Lenalidomide Capsules. More...
Pfizer deal highlights Biocons R&D strength

(Srividhya Sivakumar , 20-Oct-2010 , Business Line)
With leading products in this space lined up for patent expiry from 2015 Biocon would stand to benefit
significantly from the alliance due to Pfizers marketing strength and worldwide reach. More...
Free online trademark search likely from next month

(PTI , 19-Oct-2010 , MSN)
An entrepreneur wanting a trademark now will be able to search the registry online without any cost
whether a particular symbol or design is available and not booked already. More...
PM warns against aping development model of advanced nations

(PTI , 19-Oct-2010 , The Hindu)
Inaugurating the annual meeting of the Academy of Sciences for the Developing World here Singh said
the sharing of intellectual property rights was a major a roadblock in collaborative research efforts for
commercial applications. . More...
Syndax Pharmas Entinostat receives UK patent

(Waltham, Massachusetts , 19-Oct-2010 , Pharmabiz)
The patent covers the polymorph representing a preferred stable form of entinostat with key claims
covering the polymorph form B and the manufacturing process by which it is derived. More...
Biocon Pfizer in $350 million insulin marketing deal

Biocon already sells insulin and Glargine in the country and is developing two more analogues Aspart
and Lispro which go off patent in 2015 and 2017. More...
Pfizer Biocon: Catapulting local alliances into a different league

The deal to commercialise four of Biocons bio similar insulins reflects Pfizers aggressive outsourcing
strategy searching as it is for good bets even as its blockbuster cholesterol drug Lipitor stares at patent
expiry later next year. More...
Venus drug gets patent approval from Australia and Ukraine

(PTI , 18-Oct-2010 , MSN)
Drug firm Venus Remedies today said Australian and Ukrainian patent authorities have granted patents
for its research product Potentox used in treating pneumonia and febrile neutropenia. More...
Safe Trials
(BV Mahalakshmi , 18-Oct-2010 , MSN)
The other issue of focus is on the need to protect intellectual property of companies which is acquired
after years of research. More...
Lupins patent settlement may set new trend in out of court deals
(BS Reporter / Mumbai , 17-Oct-2010 , Business Standard)
Bags right to sell another drug that was not even part of the litigation. More...
Bio drugs a blessing but need regulation
(Shobha John , 17-Oct-2010 , The Times of India)
By 2016 many bio pharmaceuticals will come off patent worldwide and India Brazil and China sense a
huge opportunity to manufacture and sell bio similars which reportedly have similar properties. More...
MNCs coming to India to settle copyright cases : SC Judge

(17-Oct-2010 , Hindustan Times)
Many multi nationals are finding India an attractive destination for initiating legal action in regard to
Intellectual property rights because of reasonable costs of litigation and speedy disposal of cases
according to Supreme Court judge Justice Dalveer Bhandari. More...
India seeks to protect bio diversity at Nagoya meet from October 18

(Urmi Goswami , 17-Oct-2010 , The Economic Times)
As the world faces its worst losses of animal and plant species negotiators from over 190 countries will
be meeting in Nagoya Japan between October 18 to 29 to reach an agreement to protect the diversity of
the earths natural resources. More...
Measures to tackle bio piracy: Safeguards for Indias traditional medicine and knowledge
(Ketki Angre , 16-Oct-2010 , NDTV)
Not too long ago, India almost choked at the thought of our very own basmati being someone elses
patent. More...
India to align copyright norms with global standards

(IANS , 15-Oct-2010 , The Economic Times)
India will align its copyright regulations with international norms to curb rising piracy and violations of
Wockhardt places its French arm under safeguard proceedings

(Press Trust of India / New Delhi , 15-Oct-2010 , Business Standard)
The company also said earlier it had lost patent protection Diacerin an antiinflammatory analgesics and
antipyretic drug through a court challenge it said. More...
India to pitch for comprehensive biodiversity pact

(PTI , 15-Oct-2010 , IBN Live)
India today said it would pitch for a comprehensive protocol to preserve biodiversity and insist on
inclusion of human genetic resource and entire value chain of derivative of bioresource in such a
document. More...
Infosys applies for 18 patent applications in Q2

Domestic IT major Infosys Technologies today said it has applied for 18 patent applications for its
different products and services in India and the US during the second quarter ended September 30
2010. More...
India raises drug seizures issue

(Utpal Bhaskar , 15-Oct-2010 , Livemint)
Proposed EAC legislation does not make a clear distinction between generic and counterfeit drugs
More...
National Innovation Foundation spots innovation award winners

(Kinjal Desai , 15-Oct-2010 , DNA)
This year for the first time during the award ceremony students who are going to receive the awards will
also get a patent form filled for their ideas. More...
GSK to make India a hub for anti parasite drugs

Global drug makers supply select off patent drugs as charity to various WHO programmes against
neglected diseases. More...
MSMEs must innovate to grow: Survey

The survey says in order to achieve the Intellectual Property rights policymakers have to be sensitised.
More...
Knock Out saved the punch by Bombay high court will be released in theatres today
(Mayura Janwalkar , 15-Oct-2010 , DNA)
After a legal battle that stretched beyond court hours Knock Out the Sanjay Dutt starrer which
Hollywood studio 20th Century Fox had charged with copyright infringement will be released in theatres
on Friday. More...
Remixing song doesnt amount to copying: Delhi high court

(Kanu Sarda , 14-Oct-2010 , DNA)
In a major relief to music companies which are often pulled up for copyright issues Delhi high court has
said that the remixed version of a song does not come under the Copyright Act. More...
Warner Chilcott settles patent dispute with Lupin

(The Associated Press , 14-Oct-2010 , Bloomberg)
Warner Chilcott PLC said Thursday they will settle a pending patent lawsuit over Warners birth control
Loestrin 24 and Femcon FE with Lupin Ltd. More...
DIPP paper: Compulsory licence is good for public health say domestic pharma firms
CLs can ensure patent rights do not prevent access to affordable medicine. More...
Judge watches films to decide if rip off slur valid
(Mayura Janwalkar , 14-Oct-2010 , DNA)
In a case of copyright infringement alleged by 20th Century Fox justice Roshan Dalvi asked the
representatives of the litigating parties to be present at the high courts video conference room on
Wednesday evening where she would watch Phone Booth and Knock Out. More...
Enertopia Partially Owned Partner Files Additional Patent Applications

(TheNewswire , 14-Oct-2010 , Market Watch)
Enertopia Corporation is pleased to announce that its partially owned clean energy partner Global Solar
Water Power Systems has filed additional patent applications in order to safeguard certain intellectual
property. More...
Apple gets anti sexting patent

(IANS , 14-Oct-2010 , The Economic Times)
Apple has been granted a patent that allows parents to prevent their children from sending and receiving
sexually explicit text messages. More...
Pfizer sues Lupin on anti epilepsy drug

The US based global pharmaceutical giant Pfizer Inc has filed a second suit against Mumbai based
drumaker Lupin in the US alleging that the latter by attempting to manufacture a generic version of oral
solution with pregabalin is infringing the formers patent coverage on its branded drug Lyrica. More...
India may move WTO as it seeks to resolve EU dispute

Commerce secretary says consultation process is still on but India reserves right to seek settlement
panel More...
Leap from lab idea to business venture NCL paves the way
(Pupul Chatterjee , 13-Oct-2010 , Indian Express)
Apart from starting a company many scientists are also exploring the possibility of possessing
intellectual property rights and patents and then licensing them out to already existing commercial
houses for projects that may have the potential to be converted into business ideas. More...
Some good news on generics

(Biswajit Dhar , 13-Oct-2010 , Livemint)
Two recent instances of international diplomacy provide relief to Indian firms that manufacture generic
drugs More...
GI tag a boost for Uppada sarees

(K Rajani Kanth / Uppada (andhra Pradesh) , 12-Oct-2010 , Business Standard)
The intellectual property right has given weavers a fresh lease of life with the commercial leverage to
enhance their incomes More...
WTO and Indian economy
(U. SANKAR , 12-Oct-2010 , The Hindu)
The World Trade Organisation was created on January 1 1995 to promote world trade. More...
Reviving Doha
(Business Standard / New Delhi , 12-Oct-2010 , Business Standard)
A trade deal can provide a new stimulus More...
Eli Lilly sues Dr Reddys over cancer drug patent

( KV Ramana , 12-Oct-2010 , DNA)
Eli Lilly the US pharma giant has sued Dr Reddys Laboratories over an alleged patent infringement
involving Gemzar. More...
A regressive idea on patents

(11-Oct-2010 , Livemint)
Ideas such as compulsory licensing of patents mooted by the government has the potential to derail
Indias reputation as a market that values and protects innovations More...
India positive on resolution of drug seizure row with EU

India is optimistic about resolution of drug seizure dispute with European Union but reserves the right to
seek redressal from the WTO in case the mutual talks do not yield results a senior official said on
Monday. More...
Nearly 250 NGOs across world urge PM to reject IP provisions in FTA with EU
Hundreds of public interest groups across the world have jointly urged prime minister Manmohan Singh
not to sign the proposed free trade agreement with European Union as the Centres role in medicines
supply is under threat due to the intellectual property provisions included in the pact. More...
HC rejects Fulford plea against United Biotech Oscar Remedies

(Sanjay K Singh , 11-Oct-2010 , The Economic Times)
The Bombay high court has dismissed the plea of US drug giant Schering Plough and its India arm
Fulford India seeking injunction against United Biotech and Oscar Remedies from using the trademark
Netmicin alleging it infringes upon the trademark Netromycin used for its antibacterial drug. More...
Biotechnology stuck in IP warp

(Ananda Chakrabarty , 10-Oct-2010 , Business Standard)
The Indian governments approach to intellectual property rights in the biotechnology sector remains old
fashioned More...
Trouble Stays: 40 nations nearing pact on generics seizure
The drug seizure agreement with the European Union may be an eyewash as another international
treaty will allow 40 countries to seize in transit generic medicines. More...
SME NGOs urge for policy measures to ensure issue of compulsory licences
With the debate on the compulsory licensing gathering momentum after the Department of Industry
Policy and Promotion brought out a concept paper small scale pharma sector and the NGOs reiterated
their demand for policy measures to introduce the same. More...
Build patents regime on fortified law

(Shamnad Basheer & Prashant Reddy , 07-Oct-2010 , The Economic Times)
In a move with significant ramifications for policy making and participatory democracy the ministry of
commerce recently threw open the issue of compulsory licensing for public debate. More...
DIPP rejects MNC firms suggestions on patent law

The Department of Industrial Policy and Promotion has rejected all suggestions made by the
multinational drug majors lobby group Organisation of Pharmaceutical Producers of India before the
Prime Ministers Office in August More...
Motorola sues Apple for patent violation

(Indo-Asian News Service , 07-Oct-2010 , Hindustan Times)
Motorola has sued Apple for allegedly violating 18 of its patents relating to wireless email antenna
design and other technologies used in the companys iPhone and iPod touch devices. More...
India EU dispute on drug seizure resolved

(PTI , 07-Oct-2010 , The Hindu)
India on Thursday said it has resolved a dispute with European Union over seizure of Indian generic
drugs by some European countries and will soon withdraw a complaint filed before the WTO on the
matter. More...
Biocon shares rise on Pfizer drug deal report

(REUTERS , 07-Oct-2010 , The Economic Times)
Emerging markets are a priority for Western drug companies such as Pfizer as they face slowing sales in
their home markets and cheap off patent drugs that can be sold in high volumes under a multinational
brand are an attractive market opportunity. More...
HIV+ people lead protests against India EU negotiations on free trade agreement
With India and European Union moving into the final stages of framing the Free Trade Agreement and
launching the crucial round of negotiations here a group of public interest organisations and the activists
of Delhi Network of Positive People stepped up the campaign against the harmful provisions in the pact.
More...
Pharma protests Indian licensing proposal

(Tracy Staton , 07-Oct-2010 , Fierce Pharma)
The Indian pharmaceutical industry has been shaken up lately worried that multinational drugmakers
will come in and completely take over their drug market. More...
Apple Motorola Google TiVo Rambus Teva MGA: Intellectual Property

(Ellen Rosen , 07-Oct-2010 , Bloomberg)
A Motorola Inc. unit sued Apple Inc. alleging the maker of the iPad computer tablet and iPhone mobile
phone is infringing six of its patents. More...
Activists decry India EU IPR talks

Delhi Network of Positive People is staging a mass demonstration in front of Udyog Bhavan on
Wednesday to protest against the inclusion of intellectual property provisions in the EU India free trade
agreement which they fear will affect peoples access to affordable HIV AIDS drugs. More...
No interim relief to BharatMatrimony owners in claim against Google others

(Legal Correspondent , 6-Oct-2010 , Business Line)
Case relates to complaint on trademark infringement. More...
Google Seeks Dismissal Of Oracle Patent Infringement Suit

(Scott Morrison , 05-Oct-2010 , The Wall Street Journal)
Google Inc. has fired back at Oracle Corp. denying all seven of the software makers claims of
infringement on patents and copyright and arguing that Oracle is now attacking open source licensing
policies it used to support. More...
AstraZeneca sues Torrent for patent violation in US

Global pharma giant AstraZeneca has sued Ahmedabad based Torrent Pharma for allegedly infringing its
patent coverage related to schizophrenia drug Seroquel XR in the US market. More...
For Reddys Zyprexa is a half billion $ opportunity

Dr Reddys Laboratories is likely to see a major upside coming its way in the form of olanzapine a drug to
treat schizophrenia and bipolar disorder. More...
Copycat incentives
(Bibek Debroy , 5-Oct-2010 , Indian Express)
In 2006 we had a Mashelkar Report on patent law issues. More...

ADMA seeks clarification on Rule 158 (B) treating herbal extracts as ayurvedic drugs
(Suja Nair Shirodkar , 5-Oct-2010 , Pharmabiz)
Puranik informed that the amended rule refers that the patent and proprietary drugs would now be
allowed to be registered as either nutraceauticals cosmetics or ayurvedic extracts. More...
Microsoft sues Motorola for alleged patent infringement

(PTI , 03-Oct-2010 , The Times of India)
Microsoft Corp has said that it has sued handset maker Motorola Inc for allegedly infringing on the
software gaints nine patents in its Android smartphones. More...
The time to cross our own Mason Dixon Line has come
(DEAN WILLIAMS , 03-Oct-2010 , DNA)
The fact that it would eventually become a divide that separated the two warring US ideologies of the
abolitionists and slavers was foreseen but only by a fringe. More...
India to move WTO panel against EU

(Nayanima Basu / New Delhi , 1-Oct-2010 , Business Standard)
India may formally approach the World Trade Organizations dispute panel against the European Union
following the seizure of low cost generic medicine consignments in European ports meant for other
developing countries. More...
Tata Steel bags process technology patent may out license to rival cos
(Rakhi Mazumdar , 1-Oct-2010 , The Economic Times)
Tata Steel has bagged a commercial patent on a widely used for developing iron at steel plants. More...
US research funder licenses HIV patent

(Andrew Jack in London , 1-Oct-2010 , Financial Times)
The largest US funder of medical research has licensed the patent rights on an HIV medicine it helped
develop to an international agency a move designed to make treatments more widely available and
affordable in the developing world. More...
Performance enhancing drugs for your portfolio

(Ram Prasad Sahu / Mumbai , 30-Sep-2010 , Business Standard)
Rising share in the US generics market and off patent opportunities should benefit top Indian drug
makers. More...
Copyright society sends notice to malls auditorium

(TNN , 30-Sep-2010 , The Times of India)
Two malls and an auditorium in the city have been served legal notices by the Indian Performing Rights
Society for refusing to pay licence fees before playing music at events to be organised between October
1 and 3. More...
i2india to invest Rs 40 cr in commercialising ideas
(BS Reporter / Mumbai , 30-Sep-2010 , Business Standard)
i2india Holdings Ltd. a company jointly promoted by Tata Sons and Imperial Innovations Plc. of UK
among others will invest over Rs 40 crore in the next few months to create commercial value from IPR in
India. More...
Kunnath Pharma gets patent for its Musli Power X tra

(Our Bureau, Chennai , 30-Sep-2010 , Pharmabiz)
Kunnath Pharmaceuticals of Moovattupuzha in Kerala has been granted a patent by the Patent Controller
of India for its product Musli Power X tra sources from the company informed Pharmabiz. More...
T S Vishwanath: Safeguards against Doha

(T S Vishwanath , 30-Sep-2010 , Business Standard)
The South South trade issue raised by some nations may steer negotiations away from development
objectives More...
Nycomed seeks damages from Sun Pharma Teva

(REUTERS , 29-Sep-2010 , The Economic Times)
Unlisted Swiss drugmaker Nycomed is seeking for a patent infringement of Pantoprazole from Indias Sun
Pharmaceuticals and Tel Aviv listed an official said on Wednesday. More...
Solvay to open research centre in Guj

The centre will focus on high performance polymers organic chemistry nano composite biotechnology
and green chemistry and will also host high level competences in the field of science technology patent
regulation and procurement Solvay groups region general manager Asia Pacific Roger Kearns said on the
ground breaking ceremony of the centre to be worth Rs 45 crore More...
India protests against US trade barriers at WTO

India at today protested against escalating tariff and non tariff barriers imposed by the on Indian goods
and services including enhanced visa fee on Indian short term services providers and the ban in Ohio on
state outsourcing projects. More...
Department expedites recruitment for IP office

The move comes after criticism that the IP office is overloaded with work leading to compromises on
quality More...
1 million HIV patients in India have no access to treatment

(Press Trust Of India , 28-Sep-2010 , Hindustan times)
Compulsory licensing enables a national government to revoke a license issued to a patent holder and
thereby allow other parties to produce and sell a patented product for non commercial purposes. More...
Venus bags contract for anti cancer drug from Thailand
Pharma firm Venus Remedies today said it has bagged a contract from Thailand for an anti cancer drug
Docetaxel under the government policy. More...
Gadwal saree gets GI status

(Express News Service , 28-Sep-2010 , Express Buzz)
Gadwal saree now figures in the patented items list after getting the Geographical Indication certificate.
More...
Pharmexci's Outstanding Export Performance Awards given to 12 pharma majors 24 cos got
patent awards
(Our Bureau, Chennai , 28-Sep-2010 , Pharmabiz)
The Outstanding Export Performance Awards and Patent Awards for 2009 10 instituted by the
Pharmaceuticals Export Promotion Council were presented to leading pharma companies in a ceremony
organized by the Pharmaexcil as part of Pharma CEOs conclave in Hyderabad last week. More...
Pratt & Whitneys case against Rolls

(Jeremy Lemer , 28-Sep-2010 , Financial Times)
Pratt & Whitney the jet engine maker has filed a lawsuit against Rolls Royce claiming that its British rival
has tried to use patent litigation to thwart some of its most critical engine programmes. More...
Punjab Govt warns against unauthorised use of national emblem

The spokesman said that no person shall use the national emblem for the purpose of any trade business
and profession or in the title of any patent or in any trademark or design. More...
US NGO pushes for Eli Lillys second patent for cancer drug
A Washington-based NGO has appealed a US court to reverse its order rejecting Eli Lillys second patent
for its blockbuster cancer drug Gemzar that could delay the launch of Sun Pharmas generic version in
the worlds largest pharma market. More...
CIIs growing proximity with USIBC raises concern among public interest groups
The Confederation of Indian Industry association with US India Business Council in organizing a Round
Table in Delhi on Compulsory Licensing has come in for severe criticism from the public interest groups
and experts as they argue that the USIBC has been a vocal opponent of the health safeguards in Indias
patent law. More...
India EU take another step towards FTA

(Pallavi Aiyar / Brussels , 25-Sep-2010 , Business Standard)
Intellectual property rights is one of these. More...
Indian pharma alive and kicking

Globally the pharma sector is seeing consolidation with generic players growing bigger and companies
driven by patents too getting into generics. More...
Lupin aims for biotech growth; first drug in 2011

(Sachin Kumar , 24-Sep-2010 , Hindustan Times)
Having emerged as a strong player in the global generics market pharmaceuticals major Lupin is now
eyeing the biotechnology sector. More...
YouTube wins Spanish copyright case

(Alan Rappeport in New York , 23-Sep-2010 , Financial Times)
A Spanish federal court has dismissed copyright infringement charges against Googles YouTube that
could have brought the online video service to a halt by forcing it to monitor every piece of content.
More...
Court asks Matrix not to sell generic of Roches cancer drug

The Madras High Court has asked Hyderabad based Matrix Laboratories not to make or sell the generic
version of Swiss major Roches cancer drug erlotinib hydrochloride for the next two months. More...
With the door to Doha closed India opens up windows to the world
(Nayanima Basu / New Delhi , 23-Sep-2010 , Business Standard)
Seeing no progress on the stalled multilateral trade talks potential partners are keen on bilateral pacts
with India. More...
Tuning in to GI Blues
(Bachi Karkaria , 23-Sep-2010 , The Times Of India)
Along with Paithanis and Tellicherry pepper lets patent our peculiar peoples traits? More...
HC rejects BMS plea on sale of hepatitis B generic by Ranbaxy

The Delhi High Court has turned down Bristol Myers Squibbs request to temporarily stop Ranbaxy from
selling its generic version of the American firms patented hepatitis B drug Baraclude in India. More...
Celebrities may soon endorse Banarasi silk

The handwoven Banarasi saree and brocades got the Geographical Indication tag last year. More...
SC asks HC to resolve Montblanc ADD pen dispute in 3 mnths
(PTI , 23-Sep-2010 , MSN News)
The Supreme Court has directed the Delhi High Court to decide the dispute between German luxury
brand Montblanc Simplo GMBH and Mumbai based Add Corporation over trademark infringement within
3 months. More...
Discover the world of IP management

(PATHFINDER , 23-Sep-2010 , Deccan Herald)
Individuals with a degree in physics or any other science subject are at an advantage in the field of
Intellectual Property Rights More...
Ranbaxy drug gets US nod

Ranbaxy Laboratories got the exclusive rights to market a generic version of Japanese firm Eisais
blockbuster Alzheimers drug in the US for six months starting November end which could potentially
earn around $200 million for the company. More...
T Series not affected by copyright royalty

(Ashish Sinha , 22-Sep-2010 , The Financial Express)
T Series is confident to continue generating revenues from the FM radio broadcasters despite the drastic
reduction of the music royalty rates recently. More...
Suven Life Sciences gets 2 new US patents

Suven Life Sciences said on Tuesday it has won U.S. patents for its two new chemical entities pushing its
shares up more than 11 per cent. More...
Merck arm sues Sun over cancer drug

(P B Jayakumar / Mumbai , 21-Sep-2010 , Business Standard)
Schering Corporation part of multinational pharma company Merck & Co and London based Cancer
Research Technology Ltd have sued Sun Pharmaceutical for allegedly infringing patent rights on the
worlds largest selling brain cancer drug Temodar. More...
India EU drug row heading towards long drawn battle in WTO

Row over seizure of Indian generic drugs by several European countries on the high sea appears to be
heading towards a long drawn battle in the WTO as the two sides could not resolve the issue by
consultations. More...
Now Africa siding with India in generics battle

(Amiti Sen , 20-Sep-2010 , The Economic Times)
After a high pitch awareness campaign by India leading African nations Uganda Tanzania and Nigeria are
reconsidering provisions of their proposed stringent anti counterfeit legislations that would have
hampered pharmaceuticals exports to these countries. More...
Drug marketing approvals may be delinked from patent status

(Radhieka Pandeya , 20-Sep-2010 , Livemint)
If the demand is accepted DCGI will issue approvals only on grounds of drug quality and efficacy More...
SC issues notices to Ranbaxy in Capsola trademark case

The Supreme Court on Monday issued notices to Ranbaxy and three others on a petition filed by life
sciences and laboratory solutions firm RFCL in a dispute over the trademark for animal feed supplement
Capsola. More...
Drug problem
(editorial , 20-Sep-2010 , Indian Express)
Over a 16 month period that ended just over a year ago European Union customs officials seized about
20 shipments of Indian generic drugs as they were passing through various European ports especially
Amsterdam and Hamburg while going to Africa and Latin America. More...
Goas Feni gets a makeover marketed abroad

(Smitha Venkateswaran , 17-Sep-2010 , The Economic Times)
Goans now have one more reason to say cheers. More...
When drugs are faked

(P.T. JYOTHI DATTA , 17-Sep-2010 , Business Lines)
There is no escape from implementing anti counterfeiting measures besides hurting the image of the
industry and the country. More...
Commerce Ministry to seek Cabinet nod soon for Indo Japan trade pact
The Commerce Ministry will seek the Cabinets approval soon for the India Japan free trade agreement
likely to be signed during the Prime Minister Manmohan Singhs forthcoming visit to Tokyo in October.
More...
India Brazil to call for dispute settlement panel against EU

(D Ravi Kant , 16-Sep-2010 , MSN News)
India and Brazil are expected to press ahead with a request for establishment of a WTO dispute
settlement panel to adjudicate over the seizure of generic drugs on high seas by EU member countries
that allegedly violated global trade rules trade diplomats said. More...
CEPA with Japan lacks transparency: Farmer groups

A common platform of several farmers groups the Indian Coordination Committee of Farmers
Movements has charged the Central government with complete lack of transparency on the implications
of the proposed Comprehensive Economic Partnership Agreement or CEPA with Japan and the inclusion
of agriculture on its agenda. More...
India sends 80% of AIDS drugs to poor nations

(Rema Nagarajan , 16-Sep-2010 , The Times of India)
A new study published on Tuesday has established that Indian generic manufacturers supplied more
than 80% of donor funded AIDS medicines to developing countries in the last seven years confirming
Indias status as the pharmacy of the Third World. More...
EU awards Venus Remedies patents for anti infection drug

(BS Reporter , 16-Sep-2010 , Sify)
Chandigarh based listed pharma player Venus Remedies has obtained the European Union patent for its
researched anti infection product Sulbactomax. More...
FTA negotiations to boost trade & investment between EU India

(fe Bureau , 16-Sep-2010 , The Financial Express)
India and the European Union are on track to conclude FTA negotiations by early December. More...
Signs of Recovery Emerge after Economic Crisis Hits Innovation & IP Filings
(ag-IP-news , 15-Sep-2010 , ag-IP-news )
A new report by the World Intellectual Property Organization analyzing Intellectual Property trends in
2008 and 2009 shows that innovative activity and demand for IP rights dipped during the global
economic crisis but began to recover this year. More...
Venus Remedies gets EU patent for anti infectant

(Reuters , 15-Sep-2010 , Livemint)
The drugmaker expects Sulbactomax to capture 10% market share of the segment in Europe by 2015
More...
Origin myths
(15-Sep-2010 , The Indian Express )
Would a Mahabaleshwari strawberry by any other name taste as sweet or a Guntur chilli as spicy?
More...
Indian IP examiners have worlds highest workload lowest pay

Quantity linked work assessment system is another reason behind deterioration in the quality of work
More...
Freer trade may hurt access to India generic drugs

(Laura MacInnis , 14-Sep-2010 , Reuters)
UNITAID says 80 percent of its AIDS drugs come from India More...
India Japan trade pact to leave IP laws untouched
The India Japan Comprehensive Economic Partnership Agreement expected to be signed towards the
end of this year will not call for any amendments to the existing intellectual property laws in either of
the partner countries. More...
Dr Reddys sued over patent infringement

Wyeth a wholly owned subsidiary of US based Pfizer Inc has filed a suit against Hyderabad based Dr
Reddys Ltd at the US District Court New Jersey for allegedly infringing formers patent coverage in case
of an anti depressant drug Effexor XR Venlafaxine Hydrochloride. More...
Freer trade may hurt access to India generic drugs

(By Laura MacInnis , 14-Sep-2010 , IBN Live)
Freer trade could harm Indias generic drug business which supplies the bulk of the AIDS medicines sent
to developing countries a study backed by the drug purchasing body UNITAID said on Tuesday. More...
Pot kettle Local pharma in patent rush

(Priyanka Golikeri , 13-Sep-2010 , DNA)
Domestic drugmakers may challenge a Roche or a Novartis patent claim by filing oppositions and crying
hoarse about trivial or evergreening patenting but when it comes to their own molecular or production
process tweaks they havent been shy of laying innovation claims either. More...
Troikaa Pharma gets patent approval for Dynapar AQ in CIS

(BS Reporter / Mumbai/ Ahmedabad , 13-Sep-2010 , Business Standard)
Ahmedabad based mid sized pharmaceutical firm Troikaa Pharmaceuticals Ltd has been granted the
patent for Dynapar AQ a diclofenac or painkiller injection for the CIS block earlier this week. More...
NGOs patient groups alert PMO not to act on behest of OPPI on patent issues
A large number of patient groups, groups working on public health and HIV, public interest
organizations, experts and concerned citizens have demanded to the Prime Ministers Office to
immediately withdraw the biased and one sided notes which the PMO had reportedly circulated to the
union ministries of commerce health legal affairs and chemicals at the urging of OPPI to amend key
public health safeguards in the Patents Act including Section 3d and asking for patent linkages and data
exclusivity. More...
New ventures with foreign partners may get easier

(Asit Ranjan Mishra , 13-Sep-2010 , Livemint)
DIPP now says that the measure patently discriminates against foreign investors who showed confidence
in India by investing prior to 2005 and those who came in later. More...
Natco Pharma open to settle cancer drug patent case with US co

Pharma Ltd on Friday did not rule out a settlement over the patent issue with Celgene Corp which has
said it would file a complaint against the former for alleged infringement of its cancer drug Revlimid.
More...
Copyright suit against top education institution

(Mahesh Buddi , 10-Sep-2010 , The Times Of India )
Police on Thursday night booked criminal cases against the management of a top educational institution
for allegedly copying and publishing textbooks of Intermediate brought out by the Telugu Academy.
More...
Patents drive up treatment costs of Hepatitis C

As board member of the Network of Maharashtra People Living with HIV Manoj Pardesi is confronted
with the twin challenges of helping people fight HIV and Hepatitis C. More...
Famed Bhadohi carpet gets GI tag

(Binay Singh , 9-Sep-2010 , The Times Of India)
The handmade carpet of Bhadohi was finally granted the Geographical Indication on September 4.
More...
Innovation has helped drug firms take on Big Pharma

(Radhieka Pandeya , 9-Sep-2010 , Livemint)
India has also emerged a leader in novel drug delivery systems and custom synthesis of new molecules
More...
Sun closes in on Taro with Israeli SC ruling

Any controlling stake in Taro would help Sun boost generics sales in the US where the market is forecast
to jump with nearly $96 billion worth of drugs going off patent in the next few years and President
Barack Obama pushing for lower healthcare costs. More...
The copyright enforcers

(Samanth Subramanian , 9-Sep-2010 , Livemint)
Extracting copyright fees for music is a tricky business given the unwillingness of establishments to pay
collecting the money requires tact and the ability to endure name calling and sometimes worse More...
FAQs on GI
(09-Sep-2010 , The Times Of India)
A trademark is a sign used by an enterprise to distinguish its goods and services from those of other
enterprises. More...
Suven Life secures patent in Australia Mexico

Suven Life Sciences Ltd has secured product patent in Australia and Mexico for one of their new
chemical entity for the treatment of disorders associated with neurodegenerative diseases. More...
We will continue to sell our patented drugs with India specific pricing
The worlds second largest drugmaker Merck & Co is targeting to occupy one of the top two slots in India
by 2015. More...
Cancer drug prices stay firmly high despite many not being patented
At a time when the government is thinking of ways to regulate the price of cancer medicines a research
paper by a patient group shows that despite many not on patent ones available their prices remain at
stratospheric levels. More...
Revenue of $3 bn by 2013 is a directional target

(Priyanka Pulla and C.R. Sukumar , 8-Sep-2010 , Livemint)
The size of the opportunity remains the same and at the end of it the product does get launched More...
Priyanka Pulla and C.R. Sukumar

(07-Sep-2010 , Sify)
The savoured Haleem dish a mouth watering delicacy of Hyderabad has been awarded the coveted
Geographical Indication status clearing the way for a possible patent in the future. More...
Pharmexcil suggests DGFT to provide sops to exporters to develop norms for non infringing
process for APIs
(Suja Nair Shirodkar, Mumbai , 7-Sep-2010 , Pharmabiz)
The Pharmaceutical Exports Promotion Council has suggested to the director general of foreign trade to
provide incentives to the pharma exporters to develop adhoc norms for non infringing process for bulk
drugs to increase the export of pharmaceutical products in the regulated markets. More...
Reckitt sues copycat Bharti Wal Mart JV

(Ratna Bhushan , 6-Sep-2010 , The Economic Times)
Reckitt Benckiser India the maker of Dettol antiseptic soap and Cherry Blossom shoe polish, has served
a legal notice to Bharti Walmart demanding that the cash and carry joint company withdraw its Great
Value toilet cleaner as it infringes upon the bottle design and cap of Reckitts Harpic brand the domestic
market leader in this category. More...
Govt may cap FDI in pharma at 49%

(Sanjay Singh , 06-Sep-2010 , India Today)
The finance ministry as well as the Planning Commission have advised the concerned ministries to
expedite the process to ensure that 65 per cent of Indians who according to the World Health
Organisation still lack access to essential medicines are not deprived of affordable and high quality
medicines. More...
Bio piracy is biggest concern says Jairam Ramesh
(IANS , 06-Sep-2010 , Sify)
Bio piracy which is gradually robbing India of its precious assets and rich bio diversity has emerged as
one of the biggest concerns before the union environment and forests ministry. More...
The right path

(SUBHA J RAO , 05-Sep-2010 , The Hindu)
Attorney Sanjai Gandhi on the need to go in for a Geographical Indication certificate and how it protects
both manufacturers and consumers. More...
Bull's Eye: Sun Pharma Apollo Tyres Cipla Escorts

Sun announces a final approval to market six dosages of a generic version of Strattera with a 180 day
exclusivity. More...
Govt wishes to market low cost cancer drugs

(Press Trust Of India / New Delhi , 4-Sep-2010 , Business Standard)
The government is in talks with pharmaceutical companies for ensuring availability of cancer drugs at a
minimal price at their low cost pharmacy chain Jan Aushadhi stores across the country. More...
India keen to add remedial clause in trade agreements

(Ronojoy Banerjee , 4-Sep-2010 , The Financial Express)
Wary of third party free trade agreements impinging upon the countrys interests New Delhi is keen on
inserting a remedial clause in all its extant and future FTAs. More...
Celgene seeks to stop Natcos generic Revlimid

(03-Sep-2010 , Reuters)
Celgene Corp said it plans to file a complaint alleging infringement against India's Natco Pharma Ltd
which has submitted a request to the U.S. Food and Drug Administration for authorization to make and
sell generic versions of Celgenes cancer drug Revlimid in the United States. More...
Avesthagen gets process patent for arthritis drug

Bangalore based drugmaker Avesthagen has got the Indian patent for the process to make a biosimilar
drug of Amgens blockbuster medicine Enbrel that is used to treat rheumatoid arthritis a top company
India seeks to insulate FTAs from IP policies of the West

(KARTIKAY MEHROTRA , 3-Sep-2010 , Indian Express)
Prompted by intellectual property agreements among developed economies including the forthcoming
Anti Counterfeiting Trade Agreement Indian agreements will make a point to thwart those trade related
intellectual property rights plus policies being enforced around Europe the US and Japan when it comes
to trade with India. More...
Govt talks to pharma cos for cancer drugs at Jan Aushadhi
The government is in talks with pharmaceutical companies for ensuring availability of cancer drugs at a
minimal price at their low cost pharmacy chain Jan Aushadhi stores across the country. More...
Chidambaram says he doesnt hold patent on saffron terror

Home minister P Chidambaram did not exactly use the phrase saffron terrorism but made it clear it was
not his patent and in the past UPA and Congress leaders have found it quite expedient to refer to
saffronisation of education to target the previous NDA government. More...
The problem with EVMs

(Subramanian Swamy , 02-Sep-2010 , The Hindu)
I have obtained documents from the World Intellectual Property Organisation with its headquarters in
Paris to show that ECIL and BEL had applied for a patent for the EVM in 2002. More...
Industry needs to enhance knowledge across domains to tap burgeoning opportunity in

global arena: Expert
(Nandita Vijay, Bangalore , 02-Sep-2010 , Pharmabiz)
With drugs going off patent over the next three years valued at around a whopping Rs 320000 crore and
also increased penetration of generics in the global market Indian pharmaceutical industry sees a great
opportunity and various stakeholders are gearing up to obtain a share in the pie that appears to be
lucrative. More...
Alkem Lab develops low cost sweetener

We have filed an application to patent the product as well as the process to make it in India two months
back and are in the process of filing for patent in other international markets said Sharad Kasarle vice
president of R&D Nutraceuticals at Alkem More...
Ideal Cures wins patent revocation case against Colorcon Inc. USA
Mumbai based Ideal Cures has won a landmark victory in a patent revocation case against Colorcon Inc.
USA. More...
A modern fold for ancient knowhow

(Biswajit Dhar , 31-Aug-2010 , Livemint)
An October meeting could finally resolve how developing nations get to preserve their traditional
knowledge More...
Rajya Sabha clears nuclear liability Bill

The BJP leader added that inclusion of supplier liability could become a global model pointing out that
this is what had happened in the case of the World Trade Organisation and the global patent regime
where the country had asserted itself. More...
Zydus Natco launch versions of drug facing court battle

Ranbaxy which first launched a generic version of Hepatitis B drug Baraclude was taken to court. More...
Govt speaking in two voices on generic medicines

The governments doublespeak on generic off patent and low cost medicines has the stakeholders in a
tizzy. More...
Cancer drugs may become cheaper after govt study

Dpt of pharma seeks to negotiate patented drug prices before they hit Indian market. More...
Protection of public funded intellectual property bill to be made more transparent

The Ministry of Science and Technology will bring in changes to the Protection and Utilisation of Public
Funded Intellectual Property Bill 2008 to make the process of patenting and commercialisation of
inventions from public funded projects more flexible and transparent in line with the suggestions from
the experts. More...
IPR attorney helps get 10 products GI status

(A Subramani , 29-Aug-2010 , The Times Of India)
Of the 18 Tamil Nadu products enjoying GI security as on date at least 10 of them got the status
because of the efforts of Chennai based advocate and IPR attorney P Sanjai Gandhi. More...
Pharma units await clarity on compulsory licensing

(Ramnathsubbu , 29-Aug-2010 , The Hindu)
When the government initiated discussions last week to lay down norms for the issuance of compulsory
licensing for medicines under the Indian Patent Act 1970 it rekindled the issue facing the Indian
pharmaceutical industry of the affordability of and the access to medicines. More...
Pharma majors pitch for affordable patented drugs

Indian drugmakers have said the price of patented drugs should be fixed based on the cost of
developing and producing the medicine in the country and not in the developed world where it costs
more to make such medicines affordable for patients here. More...
Microsoft co founder starts patent lawsuit

(Richard Waters in San Francisco , 28-Aug-2010 , Financial Times)
Paul Allen co founder of Microsoft on Friday mounted a wide ranging patent case against some of the
best known internet and technology companies including Google Apple and Facebook. More...
T-series: Ruling the Indian music industry

(Nandini Raghavendra and Vinod Mahanta , 28-Aug-2010 , The Economic Times)
That Intellectual Property Rights was the next frontier for the music industry to be conquered was what
son Bhushan Kumar instinctively understood. More...
Indian pharma cos shun EU route goods via SA ports

(KARTIKAY MEHROTRA , 28-Aug-2010 , Indian Express)
Despite Commerce Minister Anand Sharmas assurance that the European Union will amend its laws
ceasing the seizure of generic drugs in transit Indian pharmaceutical giants are taking matters into their
own hands to ensure safe transit. More...
AIPS to organise seminar on precedential patent cases on September 23

The Academy of Intellectual Property Studies an institute that has been set up in affiliation with the
Indian Drug Manufacturers Association is organising a seminar on precedential patent cases on
September 23 at AIPS Goregaon West Mumbai. More...
What is Indian is Indias

(Business Standard , 27-Aug-2010 , Sify)
After successfully contesting a patent dispute with China earlier this year regarding formulations based
on pudina mint and kalamegha Andrographis India last week won another legal battle in Malaysia
against the use of ponni rice as trademark. More...
Panel on drug prices to meet industry today

(Joe C Mathew , 27-Aug-2010 , Sify)
The committee on price negotiation of patented drugs constituted by the Department of Pharmaceuticals
will meet industry representatives on Friday to identify possible negotiation options that can lower the
cost of patent protected and imported medicines for life threatening illnesses in the country. More...
EU to rectify laws stop seizure of off patent drugs says Sharma

(shruti Shrivastav , 27-Aug-2010 , Indian Express)
The European Union has assured India that it will amend its laws to stop the seizure of off patent drugs
shipped to Africa and Latin American countries commerce and industry minister Anand Sharma today
said. More...
Bad medicine
(The Financial Express , 26-Aug-2010 , The Financial Express)
The department of industrial policy and promotion has unveiled a discussion paper on the issue of drug
prices. More...
Ranbaxy settles patent dispute with Roche

Daiichi Sankyo owned Ranbaxy Laboratories has settled its patent dispute with Swiss major Roche for
the latters drug valganciclovir sold under the brand Valcyte. More...
Drug makers drag PMO into dispute over IPR changes

Local industry is critical of the PMOs step that seeks amendments to patent law based on foreign firms
demands More...
ET in the classroom: Compulsory licencing

ET explains Compulsory licensing a provision that allows governments to override Patent rights More...
Patents are granted to ensure people have access to latest technology or drug: Controller
General of Patents
(Our Bureau, Bangalore , 26-Aug-2010 , Pharmabiz)
The Controller General of Patents Designs and Trademarks PH Kurian has said that the key task of
granting a patent is to allow people to have access to the latest technology or drug. More...
Indian ministry for compulsory licensing for 3rd party drug making
(PTI , 26-Aug-2010 , The Financial Express)
The Indian Industry Ministry yesterday suggested that local pharma makers should be allowed to
produce patented drugs to check medicine prices in wake of acquisition of Indian companies by
multinational firms. More...
Allow firms to make patented drugs

The Industry Ministry has suggested putting restrictions on foreign direct investment in the
pharmaceutical sector stating that local pharma makers should be allowed to produce patented drugs to
check medicine prices in the wake of multinational companies acquiring Indian companies. More...
High drug prices a worry: Govt

(Rupali Mukherjee & Prabhakar Sinha , 25-Aug-2010 , The Times Of India)
Government is considering to bring in tighter foreign investment control in the pharmaceutical sector
and to implement compulsory licensing system to check high prices of patented drugs. More...
Compulsory licensing of patented drugs under study

(Bindu D. Menon , 25-Aug-2010 , Business Line)
Recently the Commerce Ministry had raised the issue of acquisition of pharma companies by foreign
multinationals and the resultant concerns over its impact on low cost medicines. More...
Local pharma sellout worries industry ministry

(Siddhartha Singh & Sushmi Dey , 25-Aug-2010 , DNA)
These proposals include compulsory licensing that allows other manufacturers to produce patented drugs
if needed a significant rise in the number of drugs on the essential list and shifting foreign direct
investment in local drug makers from the 100% automatic approval route to the Foreign Investment
Promotion Board for better scrutiny. More...
Pharma FDI checks to shield local companies

This spawned an entire industry of local drugmakers which thrived by making copycat versions of
expensive patent protected medicines by adopting a different manufacturing process. More...
Government starts review of compulsory licensing norms

(BS Reporter / New Delhi , 25-Aug-2010 , Business Standard)
The Department of Industrial Policy and Promotion has started a discussion on various compulsory
licensing provisions enshrined under Indias intellectual property laws. More...
Pill to shield drug makers from MNCs

(Mail Today Bureau , 25-Aug-2010 , India Today)
The department on Industrial Policy & Promotion is in favour of making a provision for allowing Indian
pharmaceutical companies to manufacture patented medicines in case prices of these drugs spiral out of
control due to collusion among multinational companies. More...
Indias first patent tech auction in Ahmedabad this week

(Vishal Dutta , 25-Aug-2010 , The Economic Times)
A herbal drink that tastes like beer a bio insecticide product that attracts and kills mosquitoes using bird
feather a transdermal patch for contraceptives drug delivery and a technology that can make a snake
venom into analgesic that can help cure neuropathic pain: these are a few samples of patented
technologies that will go on auction in Indias first ever Tech Transfer 2010 showcase exclusively for
patented pharma products in Ahmedabad. More...
Lab rats? Drugs for US children tried on Indians

(REUTERS , 24-Aug-2010 , The Times Of India)
A law intended to speed up development of new drugs for US kids has ended up financing clinical trials
in poor countries where the medicines might never become available. More...
Foreign in pharma
(Business Standard , 24-Aug-2010 , Sify)
The takeovers can be seen to be a rather hurried attempt by global drug majors to acquire a generics
portfolio in order to insure themselves for an immediate future in which the patent pipeline will be
running thin and health care cost cutting measures in the developed economies will improve the market
for generics players. More...
Industry Min for compulsory licensing for 3rd party drug making
The Industry Ministry today suggested that local pharma makers should be allowed to produce patented
drugs to check medicine prices in wake of acquisition of Indian companies by multinational firms. More...
Taiwanese LCD maker files second suit against Sony
(Reuters , 24-Aug-2010 , DNA)
Taiwans Chimei Innolux Corp sued Japans Sony Corp for infringing on patents used in PlayStation3 video
game consoles televisions computer notebooks and cameras. More...
Copyright to attract service tax: Govt tells HC

(Vrishti Beniwal / New Delhi , 23-Aug-2010 , Business Standard)
The revenue department has contested the petition filed by PVR Pictures in the Delhi High Court against
the governments decision to levy service tax on copyright services such as sale of music rights sale of
direct to home satellite TV rights and screening in cinemas. More...
Patently wrong
(The Financial Express , 23-Aug-2010 , The Financial Express)
It isnt quite clear why the Prime Ministers Office decided to stir a debate on the Organisation of
Pharmaceutical Producers of India it comprises mostly MNCs operating in India and their partners here
demand to dilute Section 3(d) of the Indian Patent Act. More...
Delhi HCs new age lakshman rekha

(Mukesh Butani / August , 23-Aug-2010 , Business Standard)
Ordinarily marketing intangibles include a bundle of intellectual property rights such brands trademarks
knowhow that surrounds knowledge of distribution channels and customer relationship. More...
Commerce Ministry may step in to check MNC buys in pharma

(P.T. Jyothi Datta , 23-Aug-2010 , Business Line)
Some industry watchers say that the ground realities started becoming difficult for local drug companies
after India implemented the product patent regime in 2005. More...
Man dupes pharmaceutical company to the tune of 96.52 lakhs

The officials from the cyber crime cell of the Pune police on Saturday arrested a technical director of a
company manufacturing herbals products for allegedly duping the company to the tune of Rs 96.52 lakh
on the pretext of providing patent for the companys 15 products with the help of an Indonesia based
pharmaceutical company. More...
Patent law pits MNCs against local drug firms

(HT Correspondent , 22-Aug-2010 , Hindustan Times)
The government is examining a set of proposals by global drug manufacturers seeking changes in Indias
intellectual property rights laws to reward innovation triggering howls of protest from domestic
pharmaceutical companies who said it would keep prices of many critical medicines perpetually high.
More...
Is hybrid model a good long term strategy for drug makers?

(P.T. Jyothi Datta , 21-Aug-2010 , Business Line)
An IMS study reveals an increased pick up in branded innovative products after 2015 as the patent cliff
where drugs go off patent is passed and research pipeline matures. More...
Munna Bhai Circuit head to trademark office

(Rasul Bailay,New Delhi , 21-Aug-2010 , Livemint)
Trademark lawyer Neil Mason said the applications suggest Vinod Chopra Films Pvt. Ltd might be looking
at licensing both the names for businesses More...
Court declines to stay CATs order

According to the petitioner the CATs order was patently illegal and vitiated by errors of law and facts
patent and apparent on the face of the record. More...
Azad takes on PMO over patents?

(Kounteya Sinha , 20-Aug-2010 , The Times Of India)
Dr Gopa Kumar Nair an authority in patents said when a delegation of MNCs meet the PM the latter has
to forward the representation received to various ministries. More...
Need for more stringent anti piracy measures: Kurain

The Patent Office on Thrusday called for more stringent anti piracy measures besides developing a
societal ecosystem that respects intellectual property rights. More...
FICCI launches IPR Facilitation Centre in Delhi to assist MSMEs

In keeping with its commitment to empower Indian businesses FICCI has launched an IPR Facilitation
Centre at Federation House New Delhi in association with the union Ministry of Micro Small and Medium
Enterprises. More...
PMO renews patent debate

The Prime Ministers Office has sought the opinion of various stakeholder departments on the need for
further amendments to the patent law to introduce some of the controversial provisions that were kept
out during the previous amendment to the Indian Patent Act five years ago. More...
Right to health medicine to be protected at all cost: Scindia

India has said that it will not compromise on issues related to health and peoples right to medicine in
the bilateral trade and investment agreement being negotiated with the European Union. More...
Madurai malli Dindigul lock line up for patent

(Express News Service , 19-Aug-2010 , expressbuzz)
Three weeks after it filed an application to patent the Thanjavur veena the Tamil Nadu State Council for
Science and Technology is preparing a list of 10 other indigenous products to make moves for a similar
exercise. More...
Chinese man gets patent for quake proof bed

A retired Chinese man has been granted a patent for his innovative design of a bed that can
automatically turn into a strongbox and help people survive an earthquake the state media reported
today. More...
India wins Ponni rice trademark row in Malaysia

(G. Srinivasan , 18-Aug-2010 , Business Line)
India has won the battle for Ponni rice in a Malaysian court. More...
Biocon CMD refrains from commenting on Biocon Pfizer deal speculation

(Nandita Vijay, Bangalore , 18-Aug-2010 , Pharmabiz)
In fact in 2008 as part of its portfolio development efforts Pfizer set up the Established Product Business
Unit which only deals with off patent products new molecules including generics and injectables to be
marketed globally More...
Nokia Apple Japan Post Faiza Franek Wal Mart: Intellectual Property
(Victoria Slind-Flor , 18-Aug-2010 , Bloomberg)
Nokia Oyj removed one patent from its complaint against Apple Inc. with the U.S. International Trade
Commission company spokesman Mark Durrant said. More...
Satyam wins tax case against Upaid in NY court

(KV Ramana , 17-Aug-2010 , DNA)
Upaid had earlier filed a forgery and fraud case against Satyam involving the issue of patent
Pfizer deal buzz lifts Biocon to 52 wk high

(Bureau , 17-Aug-2010 , The Economic Times)
Lipitor a big Pfizer drug that generates nearly $1.4 billion will go off patent in 2011. More...
Focus on high margin chronic diseases new products to boost Ipcas topline
(Nitin P Shrivastava , 16-Aug-2010 , DNA)
Ipca is looking to increase its abbreviated new drug application filings backed by its own APIs to cash in
on the huge generic opportunity arising out of large scale patent expiries in developed countries. More...
Eli Lilly loses patent case to generics majors

Generic drugmakers including domestic companies like Sun Pharmaceutical and Aurobindo will gain as
Eli Lilly has lost a US court case over its hyperactivity disorder drug Strattera. More...
The purpose of creation
(Pavitra Jayaraman , 14-Aug-2010 , Livemint)
A lawyer an IIT professor a music composer a film maker meet people behind the copy left movement
who champion open licensing More...
Patent war: Oracle sues Google

(REUTERS , 14-Aug-2010 , The Times Of India)
Oracle Corp sued Google Inc alleging patent and copyright infringement in the development of the
popular Android smartphone software. More...
Regulator working on pharma export norms to check fake drug

(Radhieka Pandeya & Asit Ranjan Mishra , 13-Aug-2010 , Livemint)
Indias drug regulator is drafting guidelines for quality control and packaging of pharmaceutical exports
due to concerns about fake medicines. More...
TVS Motor to re start twin spark plug Flame

(M Ramesh , 13-Aug-2010 , Business Line)
In 2008 rival two wheeler manufacturer Bajaj Auto Ltd sued TVS Motor claiming patent infringement
holding that the Flame motorcycle had a twin spark plug a feature that Bajaj said it owned the patent
for. More...
Pfizer Sues Actavis Group Over U.S. Lipitor Patent to Block Generic Copy
(Phil Milford , 12-Aug-2010 , Bloomberg)
Pfizer Inc. the worlds largest drug company sued Icelands Actavis Group hf asking a judge to block sales
of a generic version of the cholesterol drug Lipitor until a patent expires in 2017. More...
Marico Grasim settle trademark case

(Sapna Agarwal , 12-Aug-2010 , Livemint)
Personal care products maker Marico Ltd has settled a trademark infringement case filed against Grasim
Industries Ltd out of court. More...
Pharmexcil to conduct global CEO conclave distribute awards on Sept 14

The Pharmaceutical Exports Promotion Council is planning to organise a global conclave of CEOs of
pharma industry and distribute awards for companies excelled in exports and secured patents
remarkably for their products on its sixth annual day to be held on September 14 2010. More...
Getting global trademark to get easier

(TNN, , 11-Aug-2010 , The Times Of India)
Rajya Sabha on Tuesday passed the Trademarks amendment Bill of 2009 which enables a person or an
enterprise to seek registration of a trademark in any of the 84 member countries of the Madrid Protocol
through a single application. More...
Gufic Biosciences wins trademark infringement suit against Estee Lauder in India
The Mumbai based bioscience company Gufic Biosciences Ltd announced here that it has won a
favourable decision from the division bench of the Delhi High Court on a trademark infringement
litigation against the US based cosmetic major Estee Lauder on a product Skincliniq Stretch Nil. More...
Panel asks health ministry to ensure big domestic pharma cos remain in Indian hands
The Parliamentary standing committee on Health and Family Welfare led by Rajya Sabha MP Amar Singh
has asked the Union Ministry of Health to take up the issue of major Indian pharma companies being
taken over by the multinational pharma companies with the Ministry of Chemicals & Fertilizers without
any delay to come up with policy options to ensure that major Indian pharma companies remain in
Indian hands. More...
IPRI and the retreat from reforms

(Bibek Debroy , 10-Aug-2010 , Indian Express)
There is something called International Property Rights Index. More...
Lupin sues Ranbaxy in US for patent infringement

(P B Jayakumar / Mumbai , 10-Aug-2010 , Business Standard)
In a twist to the tale of drug patent infringement cases in the United States Indian drug company Lupin
has sued Ranbaxy Laboratories which is now controlled by Japanese drug major Daiichi Sankyo in a US
court. More...
Dr Reddys launches cheaper anemia drug

(Priyanka Pulla , 10-Aug-2010 , Livemint)
Dr Reddys Laboratories Ltd launched a biosimilar or off patent version of an anemia drug that it says will
cut treatment costs by about half More...
Glenmark settles patent dispute with Sepracor

(BS Reporter / Mumbai , 10-Aug-2010 , Business Standard)
Glenmark has entered into a settlement agreement with US based Sepracor on a patent litigation suit
related to the generic versions of insomnia drug eszopiclone which Sepracor markets under the brand
name Lunesta. More...
After Tatas Sholay makers to sue Greenpeace

(Kanu Sarda , 10-Aug-2010 , DNA)
The makers of the highest grossing film in India Sholay will take legal action against the international
environmental non governmental organisation Greenpeace for gross violation of copyright and
trademark and for the wrongful use of its characters. More...
Sorry we cant meet you now RIM tells India

(Rishi Raj, Nistula Hebbar , 10-Aug-2010 , The Financial Express)
Even as a possible ban on its BlackBerry services looms officials of Research in Motion the Canada based
patent holders of the push mail service have cited protocol issues to explain their inability to meet Indian
officials. More...
Bhang to trigger new patent war?

(Chidanand Rajghatta , 9-Aug-2010 , The Times Of India)
An ancient Indian high could soon get bhang alored to the United States if the efforts of an American
confectioner prove successful. More...
US firm plans to sell Bhang chocolates seeks trademark

Chocolates as such are considered intoxicating for many and an American entrepreneur now wants to
give it a new high by lacing the bitter sweet dessert with very much an Indian intoxicant Bhang and
trademark it too. More...
Its official: India foiled Chinas bid to patent pudina

The Union health ministry on Friday confirmed a TOI report on how India foiled Chinas bid to patent the
health benefits of pudina. More...
Fortis arm plans full service clinical research foray

The two statutory studies are needed to prove that a generic medicine is equivalent to its originally
discovered and patent protected drug in terms of safety and efficacy. More...
Mexico foreign affairs minister to visit India from Aug 16

(Huma Siddiqui , 6-Aug-2010 , The Financial Express)
The November 8 9 talks are aimed at clarifying rules on sharing future innovations and existing
technologies involving contentious intellectual property rights issues. More...
CWG mess: Gill falls back on God evokes nationalism

I plead that in view of the patent failure of the group of ministers to deliver an untainted and effective
Games could a high level apex committee on the same lines as the special organising committee which
delivered the Asian Games in 1982, be constituted with none other than todays Sardar Dr M S Gill just
like Sardar Buta Singh to chair that committee? More...
Beijing could provide the solution

(Venkatesan Vembu , 6-Aug-2010 , DNA)
According to officials at Huashi Future Parking Equipment a Shenzhen based company whose chairman
Song Youzhou owns the patent on the superbus transport officials from several countries including India
had made enquiries about the project. More...
Military matters
(Aroma Sah, Hindustan Times , 05-Aug-2010 , Hindustan Times)
The military jacket with its trademark button detailing down both sides of the opening is tipped to be a
big trend this autumn. More...
Nihilent develops customer loyalty tool for SMEs

(BS Reporter / Mumbai/ Pune , 5-Aug-2010 , Business Standard)
Pune based business consulting and solutions integration company Nihilent has developed a web based
tool for the Micro Small and Medium Enterprises that incorporates the patented Customer Loyalty
Evaluation methodology and the 14 aspects of customer loyalty. More...
T S Vishwanath So what do NTBs cost?

(T S Vishwanath / August , 5-Aug-2010 , Business Standard)
Interestingly, the issue of slashing tariffs and non tariff barriers under the WTO negotiations is discussed
by the same committee on NAMA which is chaired by Ambassador Luzius Walecha of Switzerland.
More...
MNCs gaining control on Indian drug market

(04-Aug-2010 , Sify)
The parliamentary standing committee on health has asked the government to pay attention to the
selling out of major Indian Pharma companies to multinationals whose increasing hold over the drug
market it says will make essential medicines costlier. More...
Zota targets overseas market for its amino acid combo for alcoholism
The Surat based Zota Healthcare Ltd a pharma manufacturing marketing and exports firm is planning to
grab the overseas market for the first of its kind anti oxidant combination targeting liver psoriasis
caused by alcoholism. More...
Bitter pill for India EU trade ties

(Biswajit Dhar , 3-Aug-2010 , Livemint)
Indias ongoing negotiations with the European Union have seen differences over intellectual property
rights More...
Takeda sues Wockhardt for para IV patent infringement on diabetes drug Actos
The Japanese drug major Takeda Pharmaceuticals and its US subsidiary has filed a Para IV patent
infringement litigation in US against the Mumbai based Wockhardt Ltd and its US subsidiaries Wockhardt
USA LLC and Morton Grove Pharmaceuticals Inc for alleged initiatives to manufacture and market the
generic version of the oral type 2 diabetes drug Actos. More...
Microsoft Wins Patent Lawsuit That Targeted Xbox Game Systems

(Susan Decker , 3-Aug-2010 , Bloomberg)
Microsoft Corp. the worlds biggest software maker won a court ruling that its Xbox video game system
doesnt infringe a patent over multiplayer gaming ending a six year legal battle. More...
About 79k patent applications lying with govt
About 79000 applications are pending before the government for grant of patents with mechanical
engineering and chemicals segment accounting for nearly a third of the requests Parliament was
informed today. More...
Banarasi silk industry again in danger zone

(Binay Singh , 02-Aug-2010 , The Times Of India)
Whatever may be the reason but there is a need to give serious attention to this sector that got the
Geographical Indication tag and joined the league of other GI products like Tirupati laddu and Darjeeling
tea a year back. More...
DRL scouts for partners to tap Japanese mkt

(BV Mahalakshmi , 2-Aug-2010 , The Financial Express)
Currently generic or off patent drugs have only a 17% market share in Japan. More...
WHO echoes Indian view of anti counterfeit laws in Africa hit accessibility of generics
The World Health Organisation has echoed the apprehensions earlier expressed by the developing
countries like India that the anti counterfeit legislation that was adopted or that is under consideration in
some of the East African countries like Kenya and Uganda threatens the accessibility of affordable
generic medicines. More...
Daiichi Sankyo may raise outlook Eisai Q1 jumps

(REUTERS , 30-Jul-2010 , The Economic Times)
Daiichi Sankyo bought a majority stake in Drugmakers including domestic rivals Takeda Pharmaceutical
and Astellas Pharma are struggling to develop strong successors to their mainstay drugs which face
imminent patent expirations. More...
US court rules Gemzar patent invalid says Sun

Sun Pharma said that the US Court of Appeals for the Federal Circuit upheld an earlier judgment by
another court against Eli Lily stating that certain claims made by Lilly on its cancer drug Gemzar were
invalid. More...
First in first out?

(Bhupesh Bhandari / New Delhi , 30-Jul-2010 , Business Standard)
In the United States the worlds largest pharmaceutical market any drug maker who is the first to file an
application with the Food & Drug Administration to launch the generic version of a drug once it goes off
patent gets exclusive rights to sell it for 180 days. More...
Giving Americans Bhang For Their Buck

(Devin Banerjee , 30-Jul-2010 , The Wall Street Journal)
The U.S. Patent office accepts pot related trademark applications but has never granted one according to
a Wall Street Journal report on a short lived medical marijuana specific trademark category. More...
IPR comes in way of Japan FTA

(Amiti Sen , 29-Jul-2010 , The Economic Times)
Negotiations between India and Japan on a pact on trade and investment have got stuck on the issue of
intellectual property rights with both sides refusing to budge from their stated positions though most
other issues have been resolved. More...
AstraZeneca files patent suit against Indian partner Torrent over blockbuster cholesterol drug
Crestor Eli Lilly loses Gemzar patent appeal
(Article , 29-Jul-2010 , The Pharma Letter)
Anglo Swedish drug major AstraZeneca has filed a Para IV patent infringement law suit against the
Gujarat based Torrent Pharmaceuticals and its US subsidiary for its alleged move to manufacture and
sell a generic version of its blockbuster cholesterol lowering drug Crestor before its patent expiry.
More...
Copyright holder can decide on exhibiting movie: Aamir counsel

(Express News Service , 29-Jul-2010 , Indian Express)
Khans counsel said the actors production house is just enforcing its copyright freedom when it comes to
releasing its films and the CCI a central government body has no jurisdiction to initiate any inquiry in
this regard. More...
Facebook beats back patent infringement claim

(AGENCIES , 28-Jul-2010 , The Economic Times)
Facebook Inc won a legal fight on Wednesday over claims its hugely popular social networking website
infringed a patent owned by little known Leader Technologies. More...
Astrazeneca files patent lawsuit against Torrent for blockbuster drug Crestor
The UK based drug major AstraZeneca has filed a Para IV patent infringement law suit against the
Gujarat based Torrent Pharmaceuticals and its US subsidiary for its alleged move to manufacture and
sell the generic version of its blockbuster cholestrol lowering drug Crestor before expiry of its patent.
More...
US Appeals Court Rules Gemzar(R) Patent Invalid

(press release , 28-Jul-2010 , Market Watch)
Sun Pharma Though Not a First Filer Triggered This Successful Patent Challenge More...
Take Tata logo off game: HC advises Greenpeace

(Utkarsh Anand , 28-Jul-2010 , Indian Express)
Justice S Ravinder Bhat granted the NGOs 10 days to file a written reply in the defamation and
trademark infringement suit against a online game Turtle vs Tata modelled on a popular computer game
called Pacman. More...
AstraZeneca Gains After FDA Staff Recommends Brilinta
(Catherine Larkin and Trista Kelley , 27-Jul-2010 , Bloomberg BusinessWeek)
AstraZeneca Plc gained in London trading after U.S. regulatory staff said the blood thinner Brilinta is
approvable if the drugmaker undertakes a study on its effectiveness in Americans once its marketed.
More...
More items to find way into digital library to check biopiracy

India has begun work to include 220 additional Ayurveda Unani and Siddha text in its Traditional
Knowledge Digital Library which will help check rampant biopiracy of the countrys ancient wisdom by
developed countries. More...
Forest Laboratories and Merz Pharma GmbH & Co. KGaA Settle NAMENDA Patent Litigation
(ag-IP-news , 27-Jul-2010 , ag-IP-news )
Forest Laboratories Inc. Forest Laboratories Holdings Ltd. Merz Pharma GmbH & Co. KGaA and Merz
Pharmaceuticals GmbH announced that they have entered into settlement agreements with all remaining
defendants in patent infringement litigation related to Forests NAMENDA immediate release tablets.
More...
Gilead Bayer & Genzyme sue Lupin for alleged Para IV patent infringements in US
The Mumbai based Lupin Ltd and its US subsidiary Lupin Pharmaceuticals Inc have been sued by at least
three firms in United States at various courts in the nation within a week starting from July 14 for Para
IV patent infringement allegedly by the former attempting to manufacture and sell generic version of
products before expiry of patent protection according to reports. More...
Opposition protests disrupt India parliament

(Amy Kazmin in New Delhi , 27-Jul-2010 , Financial Times)
Indias parliament was repeatedly disrupted by opposition protests at high food price inflation on Tuesday
raising concerns about further stalling of the Congress party led governments backlogged reform
agenda. More...
Tech power to farmers

(Surinder Sud / New Delhi , 27-Jul-2010 , Business Standard)
This change in attitude has come about partly because of new economic realities and the intellectual
property rights regime and partly because of the realisation that the old mindset was preventing new
technology from showing its potential impact on agriculture. More...
Skinvisibles Invisicare Patent Portfolio Strengthens

Skinvisible Inc. announced today the Hong Kong Patent Office has issued the Company a patent
covering its unique polymer delivery system Invisicare. More...
Sapience a software thatmeasures productivity

(Shraddha Nair , 27-Jul-2010 , Livemint)
InnovizeTech is seeking a global patent for a product that targets banks and insurance firms as
consumers More...
Several countries join India EU dispute at WTO as interested or affected parties

Several countries such as Brazil Equador Canada China Turkey and Japan have joined as interested or
affected parties in the on going dispute between India and European Union at WTO on the seizure of
generic medicines in transit via ports and airports in EU countries. More...
Head over heart for Singh brothers

(BS Reporter / New Delhi , 27-Jul-2010 , Business Standard)
It was Indias largest pharmaceutical company with an interesting range of patent challenges in the
West. More...
ITC Issues Notice of Final Determination in Rambus Matter Regarding NVIDIA Products
The complaint sought an exclusion order barring the importation sale for importation and sale after
importation of products that infringe nine of Rambus patents. More...
Private labels knock at chemist stores

(BV Mahalakshmi, Sudhir Chowdhary , 26-Jul-2010 , The Financial Express)
The Rs 5000 crore domestic market for common off patent drugs commonly called generic medicines
and over the counter products which are targeted at a wide variety of common ailments and lifestyle
disorders is an obvious enticement for the warring parties. More...
Brain League unveils patent expiry search service

(Madhumathi D.S. , 25-Jul-2010 , Business Line)
Tracking off patent drugs More...
India EU FTA talks begin in Brussels next month

Besides discussions on trade and investment the negotiations would also take up issues concerning
services intellectual property rights competition policy government procurement and geographical
indications among others. More...
Civil Society groups urge State Judicial Academy to restructure agenda for Judges Roundtable
meet
Some of the Civil Society groups in the country have urged the Maharashtra State Judicial Academy to
restructure the agenda for the Judges Roundtable on Intellectual Property Rights Adjudication being held
in Mumbai on July 24 and 25 to promote public interest and a deeper understanding of intellectual
property amongst judicial officers. More...
New hope in stem cell therapy for blindness
(Pushpa Narayan , 23-Jul-2010 , The Times Of India)
The two institutions recently got a patent for the process and are now gearing up for human trials.
More...
Chinese origin Made in India fake medicines seized in Nigeria

(P.T. Jyothi Datta , 23-Jul-2010 , Business Line)
It came as a shocker to V S International founder Mr Vidyut Shah when a fake consignment of his
flagship Ciprotab brand valued at about Rs 1 crore was seized in Nigeria late last month. More...
Forest settles Alzheimers drug patent suits

(Bill Berkrot and Lewis Krauskopf , 22-Jul-2010 , Reuters)
Forest Laboratories Inc said it and Germanys Merz Pharma reached settlement agreements for all patent
litigation over their Namenda Alzheimers drug that will keep cheaper generic versions of the medicine off
the U.S. market until January 2015. More...
T S Vishwanath: Trading on environment

WTO talks on trade in environmental goods are turning into a market access issue for developed
countries More...
NGOs call upon EU to halt aggressive push for higher IP protection enforcement
A string of international NGOs and legal experts who have gathered at the XVIII International AIDS
Conference in Vienna have called upon the European Union to immediately stop their aggressive push
for higher intellectual property protection and enforcement through various bilateral and multilateral
forums that threaten access to safe effective and affordable generic HIV medicines. More...
Bacterial miracle
(Bachi Karkaria , 22-Jul-2010 , The Times Of India)
His Oilzapper fully deserves its formidable reputation its hordes of awards and heaps of patent fees.
More...
Vintage Wear
(RICHA BHATIA , 22-Jul-2010 , Indian Express)
Following allegations of trademark infringement the organisers were forced to change the logo
supporting it with a disclaimer. More...
India EU officials to meet in Sept on drug seizure issue

In an effort to resolve a dispute on seizure of Indian drugs by some European countries officials of the
European Union and the Indian government will meet again at Geneva in September at the instance of
the WTO. More...
India may complain to WTO if Acta is enforced: Khullar
India may complain to the World Trade Organization against the developed nations if they try to enforce
intellectual property regulations that go beyond the terms accepted by WTO and the World Intellectual
Property Rights Organization. More...
Govt cautions pharma industry against harassment by global players

The government on Tuesday cautioned the domestic pharmaceutical industry against attempts by global
giants to harass them through their deep pockets and means outside the WTO. More...
Eisai to cut Aricept costs with move to India

(Tracy Staton , 21-Jul-2010 , Fierce Pharma)
Whats a drugmaker to do when its lead product falls off the patent cliff? More...
Inflation will moderate to 5 6% by year end: Cabinet Secretary

The government said it was readying to split the office of the patents and trademarks controller. More...
India hauls Netherlands to WTO

(P. T. Jyothi Datta , 21-Jul-2010 , Business Line)
Files case over drug export seizures. More...
Govt estimates biotech capacity expansion needs Rs700 crore

Some 48 biopharmaceuticals with a combined sales of $73 billion in 2009 are going off patent in the
next 10 years which provides a competitive opportunity for Indian firms though production of
biopharmaceuticals is more complicated compared with drugs based on conventional chemistry. More...
Japans Eisai to make key drug in India Nikkei

( Ashutosh Joshi in Bangalore , 21-Jul-2010 , Reuters)
Patents for the drug will expire in the United States this November and then in Japan and Europe by
2012. More...
Access to medicine groups call upon WIPO WTO & WHO to reject IP enforcement initiatives
International group of access to medicine groups academics and experts who gathered at the University
of California at Berkeley Law School have called upon policy makers in governments and international
organizations like WIPO WHO and WTO to reject the cynical and dangerous efforts that are being made
through the intellectual property enforcement initiatives to prioritize commercial interests over the right
to health. More...
Konkan Railway has patent on anti crash device
Even as the Konkan Railway Corporation Ltd. was granted an Anti Collision Device patent in the United
States of America for its Track Identification System recently neither the Central nor its counterpart
Western Railway has installed it in any of their trains. More...
US court rules against Sun Pharmas appeal

Sun Pharmaceutical Industries said the US District Court for New Jersey had denied its appeal to reverse
an earlier jury verdict in the patent litigation over the generic version of Wyeths heartburn medicine
Protonix. More...
U.N. urged to probe U.S. trade stance on generic drugs

(Doug Palmer , 20-Jul-2010 , Reuters)
Their ire is directed at an annual report produced by the U.S. Trade Representatives office that ranks
countries with the worst records on protecting U.S. intellectual property rights for goods ranging from
CDs to medicines. More...
Patent for innovative technology crucial Sam Pitroda

(IANS , 20-Jul-2010 , Sify)
Creating an innovative product with new technology is good but to safeguard the patent of such
products is far more important said Sam Pitroda the advisor on Public Information Infrastructure and
Innovations to Prime Minister Manmohan Singh. More...
Punjab to create IPR awareness in 18 clusters

(Vijay C Roy / Chandigarh , 20-Jul-2010 , Business Standard)
Small and medium enterprises face the challenge of extracting the latent value of their intellectual
property and using it effectively in their business strategies. More...
HC asks Singhanias to share Raymond trademark with Chennai pharma co

(Almas Meherally , 19-Jul-2010 , The Economic Times)
Bombay High Court has ordered Raymond the textile company of the Singhania group to share its
trademark Raymond with a Chennai based privately held pharmaceutical company Raymond
Sun Pharma says U.S. court denies motion on Protonix

( Bharghavi Nagaraju , 19-Jul-2010 , Reuters)
Sun Pharmaceutical said a U.S. court had denied its motion to reverse a jury verdict of infringement
against the Indian firm on Pfizers Protonix acid reflux drug patent that the jury had said was valid.
More...
FICCI Maha Judicial Academy to host Judges Roundtable 2010

Federation of Indian Chambers of Commerce and Industry in association with Maharashtra State Judicial
Academy will be organizing Judges Roundtable 2010 at Uttan Bhayander Maharashtra near Mumbai on
July 24 and 25 2010. More...
India has formula to zap oil from BP spill

(Sanjay Dutta , 19-Jul-2010 , The Times Of India)
Lal holds the patent for Oilzapper and heads the joint venture between Teri and state run ONGC that
markets the formulation. More...
Commerce dept seeks cooperation for IP protection

(Joe C Mathew / New Delhi , 18-Jul-2010 , Business Standard)
The Department of Commerce has called for coordination among various ministries for a consensus on
adoption of intellectual property protection measures. More...
Saving yoga from copyright mongers

(Lhendup Gyatso Bhutia , 18-Jul-2010 , DNA)
Somebody in South Korea has filed a patent for baby yoga. More...
Drug dealers venture into production

(PB Jayakumar / Mumbai , 18-Jul-2010 , Business Standard)
Generics are non patented drugs and those without a brand name are referred to as generic generics.
More...
Sun Pharma Says U.S. Court Denies Motion Over Protonix Ruling
(Bloomberg , 17-Jul-2010 , Bloomberg BusinessWeek)
The company continues to believe that the patent is invalid and unenforceable and will pursue all
available legal remedies including appeals it said. More...
HC boost for innovators orders overhaul of patent process

(Nikhil Kanekal , 17-Jul-2010 , Livemint)
In a much needed relief to innovators the Delhi high court on Thursday passed a landmark judgement
which will bring greater transparency to the process of granting patents and crack down on the practice
of filing mischievous pre grant opposition. More...
Sun Pharma gets USFDA nod for Flomaxs generic version

The generic version launched by the company is equivalent to Boehringer Ingelheim Pharmaceuticals
patented Flomax capsules. More...
Discovery says infringement case v Amazon not new

(Tom Hals , 16-Jul-2010 , Reuters)
A patent infringement lawsuit filed on Wednesday against Amazon.com was a procedural move and not
a new lawsuit according to Discovery Communications Inc, which filed the complaint. More...
Time to challenge plus size IPRs
(Prashant Goyal , 15-Jul-2010 , The Economic Times)
In an increasingly competitive world the developed countries are pursuing intellectual property rights
route to retain competitive edge over developing countries. More...
Sun Pharma wins legal battle in US against Taro Pharma

Sun Pharmaceutical Industries Ltd.has received favourable ruling from the United States District Court
for the Southern District of New York against Taro Pharmaceutical Industries. More...
Dr Reddy Laboratories sign MoU with Australian pharma

In the EU Arixtra is protected by data exclusivity which will expire in 2012. More...
IDMA seeks Azads intervention in solving several pending issues

The Indian Drug Manufacturers Association comprising of around 700 drug manufacturers across the
country has sought Union health minister Ghulam Nabi Azads intervention to solve several long pending
issues being faced by the pharma industry in the country. More...
Gilead Sues Lupin In Patent Infringement Case Over Generic Drug

(DOW JONES NEWSWIRES , 14-Jul-2010 , The Wall Street Journal)
Gilead Sciences Inc. sued Lupin Ltd. in federal court in New Jersey accusing the Indian generic drug
maker of infringing its patents for Ranexa an angina treatment. More...
Celgene Novartis sue Sun Pharma on Para IV infringement of its extended release ADHD drug
Focalin
The US based Celgene Corporation and the Swiz pharma major Novartis AG have filed a Para IV patent
infringement suit against the US subsidiary of the Mumbai based Sun Pharmaceuticals Industries Ltd
with the District Court of New Jersey for allegedly attempting to manufacture and sell the generic
version of extended release Focalin used for the treatment of Attention Deficit Hyperactivity Disorder.
More...
Games merchandise to hit market this week

According to Bhanot the IPR for the logo and other Games related designs were registered some years
ago but were again taken out as a public notice because the OC had received several complaints about
copyright infringement. More...
Owner of fake softdrink unit held in Delhi

(PTI , 14-Jul-2010 , Zee News)
A case of infringement of Indian Copyright Act 1957 and Patents Act 1970 has been filed against the
accused. More...
Indias patent regime hurting across Asia Pacific

Sitting in a first floor room of a nondescript school building off Thakurdwar Road at Charni Road in south
Mumbai Eldred Tellis is a picture of frustration and agony. More...
Letters: WIPO reforms

(Business Standard / New Delhi , 12-Jul-2010 , Business Standard)
This refers to Developing nations slam WIPO reform suggestions which talks about discussions at the
most recent session of the Patent Cooperation Treaty Working Group held in Geneva from June 14 to 18.
More...
Tighter import norms: Not just trade use of fakes too a crime
(Deepshikha Sikarwar , 12-Jul-2010 , The Economic Times)
The Central Board of Excise and Customs the apex indirect taxes body has amended a three year old
notification to tighten the norms for import of products that have intellectual property rights protection
said a government official. More...
Music & video piracy up cops blame lax law

We usually book the accused under the Copyright Act and slap 420 IPC for cheating. More...
Rs.3000 crore venture capital fund to drive pharma growth

(12-Jul-2010 , Sify)
The government is also working on priority basis to build Intellectual Property Rights offices for
expeditious approval and rejection of patents. More...
Building an emerging market Bric by Bric

Other methods such as getting listed on foreign stock exchanges making foreign acquisitions seeking
patent protection for innovations in international markets say Khanna and Palepu are other ways for
emerging giants to spread their wings round the globe. More...
India capable of producing lower cost HPV vaccine

(10-Jul-2010 , Sify)
Vaccine manufacturers in India and other developing nations can produce a lower cost HPV vaccine
despite the complicated array of patent protections on the technology according to an Indian origin
scientist at the Duke Institute for Genome Sciences and Policy. More...
NTP files patent suits against technology giants

(9-Jul-2010 , Yahoo News)
NTP a patent holding firm which won a 600 million dollar settlement from Blackberry maker Research in
Motion now has Apple Google HTC Corp. LG Electronics Microsoft and Motorola in its sights. More...
Cipla brass to get new shine CEO to step down

(Kiran Kabtta Somvanshi & Deepali Gupta , 09-Jul-2010 , The Economic Times)
Cipla which makes low cost generic version of patented drugs is Indias second largest drug company by
market share after Abbott Laboratories recently acquired Piramal Healthcares domestic formulations
business to surge ahead of the Indian pharma major. More...
Lupin among top five generic drug companies in US

(P B Jayakumar / Mumbai , 9-Jul-2010 , Business Standard)
A generic drug is one produced and distributed without patent protection. More...
President urges pharmacy sector to get equipped for future

(IANS , 09-Jul-2010 , Sify)
PricewaterhouseCoopers in its recent report has estimated that around $70 billion worth of drugs will go
off patent in the US. More...
SC reprieve for Daiichi Sankyo

Bio similars are low cost versions of patented biotech products. More...
UN body shows a global dream to weavers

(Adam Halliday , 09-Jul-2010 , Indian Express)
Will hold sensitisation programme next Monday to educate them on UN recognised patents that could
turn their products into global brands More...
Shire files patent lawsuit against Cadila

(The Associated Press , 08-Jul-2010 , Bloomberg BusinessWeek)
Irish drugmaker Shire PLC said Thursday it has filed a patent infringement suit against Indian generic
drug developer Cadila Healthcare Ltd. over the bowel disorder drug Lialda. More...
Pfizer launches pneumonia prevention vaccine Prevanar 13

(Archana Shukla , 08-Jul-2010 , NDTV Profit)
Prevenar 13 offers superior protection from pneumococcal diseases and Pfizer in turn is looking at that
vaccine to protect its global revenues which is expected to see a steep fall in the next two years with its
blockbuster drug Lipitor going off patent. More...
Students design device to tackle power theft

(N Dinesh Nayak , 08-Jul-2010 , The Times Of India)
The students have also applied for patent for this first of its kind technology in the country. More...
Ayurvedic drugs too will need to be clinically tested says govt
These are mainly in the nature of confirmatory trials on the safety and efficacy of patent and proprietary
medicines most of which are made by altering approved formulations by adding or removing some
ingredients. More...
Fakes a reality check

(K. Gopinathan , 8-Jul-2010 , Business Line)
Counterfeit phones are thriving as consumers find them a cheap and easy way to possess brands by
paying just a fraction of the cost of a genuine one. More...
Media companies oppose tax on copyright services

(Vrishti Beniwal / New Delhi , 8-Jul-2010 , Business Standard)
PVR Pictures in its petition alleged that copyrights are treated as goods and the transfer of copyrights
are treated as sale of goods which falls within the domain of taxation by states under Article 246 and not
the Union. More...
Online Billfight!
They are all a big fraternity during awards but theres a different side to the family when it comes to the
proposed amendments to the Copyright Act. More...
International experts claim ACTA to threaten global access to affordable medicines

(Our Bureau, New Delhi , 7-Jul-2010 , Pharmabiz)
Akin to the stand taken by India at the international forum a large number of international experts from
across the world have slammed the proposed Anti Counterfeiting Trade Agreement as threat to the
public interests and noted that the claims by the negotiators were wrong footed. More...
Foreign parent need not pay for marketing intangibles

(Deepshikha Sikarwar , 7-Jul-2010 , The Economic Times)
The officer also ruled that SMC failed to compensate MSIL for the use of its trademark Suzuki which
according to him was then a weak brand in India whereas Maruti was a strong brand. More...
Split royalty
(The Financial Express , 7-Jul-2010 , The Financial Express)
The reported decision of the government to split the royalty from publicly funded research projects
between the researchers the institution and the government in the new Protection and Utilisation of
Publicly Funded Intellectual Property Bill which is to be reintroduced in the monsoon session of
Parliament is a welcome step that can help accelerate the pace of innovations and encourage patenting.
More...
Govt expands royalty share in IP Bill to deflect criticism

(Nistula Hebbar , 6-Jul-2010 , The Financial Express)
The Bill to channel more patents from Indian universities for use in industry is now better placed to clear
Parliament. More...
Industry urges govt to remove clause on'Patent status in Form 44 of D&C Rules
The pharmaceutical industry in the country has urged the union health ministry to remove the clause
relating to the Patent status of the drug from the Form 44 of Drugs and Cosmetics Rules on the plea that
the clause on the patent status of the drug only favours the patent holder to delay the entry of a generic
drug in the market. More...
Producers too want rights over film music

(B Ramakrishna / Chennai/ Hyderabad , 6-Jul-2010 , Business Standard)
Telugu film producers have set forth their claim over film music as a piece of intellectual property
arguing that such music is composed in the context of a particular film and so forms part of it. More...
Basmati trademark registration delay to hurt exports: growers

(Shahid Shah , 3-Jul-2010 , The News)
Decision of trademark registration of Basmati rice is pending in the Sindh High Court for over two years
which is likely to have a negative impact on the rice trade of Pakistan a representative rice growers said
on Friday. More...
Fake soft drink unit busted in northeast Delhi

(Indrani Basu , 3-Jul-2010 , The Times Of India)
A case of infringement of Indian Copyright Act 1957 and Patents Act 1970 has been filed against the
accused. More...
One man to run the show at Hubli Spices Board

(Vincent D'Souza , 02-Jul-2010 , The Times Of India)
He said the staff crunch will affect the field offices achievements at a time when it is expecting the
geographical indication tag for Byadagi chilli. More...
Move to better access to drugs a welcome change

(Pillman , 02-Jul-2010 , DNA)
In India Gilead has entered into manufacturing deals with companies like Emcure and Strides but at the
same time it is embroiled in litigations with Cipla over Viread. More...
India foils Danish firms bio piracy bid

After stopping the Chinese from patenting pudinas health benefits India has now foiled a major bio
piracy bid by a Danish company to patent ginger jeera cumin onion and turmerics fat burning properties.
More...
Natco Pharmas earnings on track

(Jwalit Vyas , 2-Jul-2010 , The Economic Times)
However when a drug goes off patent there is a substantial market size erosion due to the lower price
offered for the same drug by several generic manufacturers. More...
AstraZeneca loses ulcer drug appeal

(Nikki Tait in Brussels , 2-Jul-2010 , Financial Times)
On Tuesday the group won an initial court victory in the US in a different patent battle prompting its
shares to rise strongly. More...
Hic! Feni fights to regain turf in Goa

(Chandu Gopalakrishnan , 1-Jul-2010 , The Economic Times)
After a very long campaign feni a beverage distilled out of cashew apple got geographical indication in
2009. More...
Delisting pill yet another time

(Ram Prasad Sahu , 1-Jul-2010 , Business Standard)
The Swedish parent company won an international lawsuit on Tuesday which will help it to keep the
patent on the drug till 2016. More...
Push to launch EU wide patent

(Nikki Tait in Brussels , 01-Jul-2010 , Financial Times)
Top European Union officials and diplomats on Thursday began a new push to introduce a single EU wide
patent a move which could slash costs faced by innovative companies trying to protect their inventions
but which has proved politically elusive for decades. More...
New xxx registry has companies worrying over brand poaching

(Surabhi Agarwal , 1-Jul-2010 , Livemint)
The World Intellectual Property Organization decided in favour of the Tata group Makemytrip.com is still
contesting the decision. More...
AstraZeneca sues Glenmark Generics in US for patent infringement of Crestor

The Anglo Swedish drug maker AstraZeneca Pharmaceuticals has filed a fresh Para IV patent
infringement law suit against Glenmark Generics Inc the North American division of Mumbai based
Glenmark Generics Ltd in the US in June 2010 for attempting to manufacture and sale of generic version
of its blockbuster cholestrol lowering drug Crestor before expiry of patent validity More...
Looking Beyond The Hype

(Sumit Bhaduri , 30-Jun-2010 , The Times Of India)
Low cost labour in the developing world and uniformity in patent rights in more than 100 nations are the
two factors that have had maximum impact on the innovation process. More...
Kotak Mahindra Bank may edge higher on preferential issue to Japans SMFG
(Capital Market , 30-Jun-2010 , NDTV Profit)
Swiss drugmaker AstraZeneca has reportedly sued Glenmark Pharmaceuticals in the US last week
alleging the infringement of its patent on cholesterol lowering drug Crestor. More...
Teva launches generic of AZs breast cancer drug Arimidex

(By Kevin Grogan , 29-Jun-2010 , Pharma Times)
Teva Pharmaceutical Industries says that it has been given the green light by regulators in the USA to
sell its generic version of AstraZenecas cancer blockbuster Arimidex. More...
Pharma research outsourcing faces speed bumps

(PB Jayakumar / Mumbai , 29-Jun-2010 , Business Standard)
Venkat Jasti vice chairman and managing director of Suven Life Sciences is an optimist on new drug
discovery. More...
Mid size drug cos look for angel investors

(P.T.Jyothi Datta , 28-Jun-2010 , Business Line)
Is intellectual property protection still the domain of big fish in the pharmaceutical industry five years
after the country brought in the product patent regime? More...
Venus Remedies gets patent for pneumonia drug in New Zealand

(Press Trust of India / New Delhi , 28-Jun-2010 , Business Standard)
Pharma firm Venus Remedies today said that it has received patent for its anti pneumonia drug in New
Zealand and hopes to generate handsome revenues there following the grant. More...
Animation industry seeks IP fund

(BV Mahalakshmi , 28-Jun-2010 , The Financial Express)
But creating intellectual property was not easy due to a lack of understanding the value of intellectual
Cipla in talks with Centre to share cancer drug know how

(Khomba Singh , 28-Jun-2010 , The Economic Times)
The initial discussions are related to 10 off patented cancer drugs said a person familiar with the matter
adding that the talks centred on the number of drugs and the processes involved in transferring
knowledge. More...
Indian Trademark Rules 2000 Amended

(ag-IP-news , 28-Jun-2010 , ag-IP-news )
Abu Ghazaleh Intellectual Property announced in a press release that the Indian Trademark Rules 2000
have been amended. More...
Indias Sun Pharma to stop selling Eloxatin generic

(Sumeet Chatterjee , 28-Jun-2010 , Reuters)
Sun Pharmaceutical Industries will stop selling generic version of Sanofi Aventis cancer drug Eloxatin in
the United States after June 30 following a court order the Indian drugmaker said. More...
Indias growing CRAMS pie a cause of joy for Jubilant

(Nitin Shrivastava , 28-Jun-2010 , DNA)
The Indian pharmaceutical industry is witnessing lot of interest with huge opportunities in the global
contract manufacturing and generic space for supply of low cost off patent drugs. More...
Rediff wins cybersquatting case against Pakistani individual

(Press Trust Of India , 28-Jun-2010 , Hindustan Times)
Online services major Rediff.com India Ltd has won a cybersquatting dispute against a Pakistani person
who was using an identical domain name and illegally incorporating the Indian firms trademark. More...
India foils Chinese bid to patent pudina

(Kounteya Sinha , 24-Jun-2010 , The Times Of India)
India has foiled a major Chinese bio piracy bid to patent the use of medicinal plants pudina mint and
kalamegha andrographis for the treatment of H5N1 avian influenza or bird flu. More...
Trademarks office ushers in glasnost

Indias Controller General of Patents Designs and Trademarks has placed in the public domain details of
pending trademark applications registered trademarks examination reports copy of applications
opposition to such applications and other information in a move that is certain to increase transparency
into the workings of the department. More...
India asks US to remove ISRO DRDO from banned list

Asked about Kirks calls to India to address longstanding impediments like investment caps agricultural
market access barriers high tariffs and intellectual property rights Sharma said he had conveyed that
India was fully TRIPS compliant. More...
An odd royalty calculus

(Latha Jishnu / New Delhi , 24-Jun-2010 , Business Standard)
For years now at least since India passed amendments to the Patent Act to allow product patents in
2005 patents on drugs have coloured and overwhelmed the debate on health issues in the country.
More...
Mauled Bollywood seeks script change bets on co production

(Nandini Raghavendra , 24-Jun-2010 , The Economic Times)
Depending on deal to deal the intellectual property rights or IPR in a co production could be for
perpetuity or for a number of years. More...
Patent expiry may open $90 bn market for Dr Reddys

(Adi Narayan , 23-Jun-2010 , Livemint)
Dr Reddys Laboratories Ltd may be the biggest beneficiary among Indian generic drug makers as $157
billion of medicines including Eli Lilly and Co.s Zyprexa lose patent protection within five years HDFC
Securities Ltd said. More...
Developing nations slam WIPO reform suggestions

The international patent reform plans pursued by the World Intellectual Property Organization have been
criticised by several developing countries including India after they felt it may have an impact on the
decision making powers of national patent offices More...
Sun Pharmas US outlook improves

(Ravi Ananthanarayanan , 23-Jun-2010 , Livemint)
Sun Pharma received just one approval from the US Food and Drug Administration to market a generic
drug More...
Trademark battles catch city firms off guard

This firm got its name registered as a trademark in India in 2005 and applied for the same with the US
Patent and Trademark Office. More...
India to be battleground for off patent biotech drugs

(Priyanka Golikeri , 23-Jun-2010 , DNA)
Although the growth opportunity for off patent versions of biotech medicines is huge in the developed
world regulatory hurdles there mean India and rest of the developing world could be where the
opportunity lies for biopharmaceutical companies. More...
US asks India to address longstanding impediments to trade

US Trade Representative Ron Kirk also listed intellectual property rights and the need for continuing
regulatory streamlining and transparency among the impediments at a meeting Tuesday with Indian
Commerce and Industry Minister Anand Sharma according to an official US readout. More...
Sun settles patent row over Parkinsons drugs with Orion

Sun Pharmaceutical Industries today said it has settled patent litigation with Finland based Orion over
generic versions of Stalevo and Comtan tablets which are used for the treatment of Parkinsons disease.
More...
Suven looks for global tie ups for new drugs

Hyderabad based drug maker Suven Life Sciences Ltd is looking for partnerships with global pharma
firms to market new drug candidates after winning discovery patents for treatments of some of the
modern worlds most common ailments. More...
Teva execs remark creates furore in Indian pharma
Domestic drugmakers used to frequent India bashing by research driven global pharmaceutical majors
for alleged infringement of patent rights or quality issues were in for a shock last week when the worlds
largest generic company Israels Teva made allegations against the industry practices in India and China.
More...
Draft legislation ready to spin off trademark division

The commerce ministry has prepared a draft law to move the trademark wing of the intellectual property
office out of the purview of the controller general of patents designs and trademarks. More...
Otsuka sues Zydus for Para IV patent infringement of blockbuster drug Abilify
(Gireesh Babu, Mumbai , 22-Jun-2010 , Pharmabiz)
Zydus has filed ANDA with the US FDA to sell generic products containing 5 10 15 20 and 30 mg of
aripiprazole in US market according to the complaint. More...
Lunch with BS: Richard Jefferson

Appalled by the patent thickets that were stifling biotech research Jefferson decided that the basic tools
of biotechnology such as his GUS technology that allowed molecular biologists to monitor exactly what
was going on when they were trying to implant foreign genes into an organism should be freely
available. More...
Scientist uses waste to make biodegradable plastic sheets

(Kautilya Singh , 22-Jun-2010 , expressindia)
On June 14 Mathuria applied for a patent at the Controller of Patent Office in New Delhi. More...
Drugmakers rush for a lift from US hormones mart

Indian drugmakers are queuing up to get a piece of the lucrative hormones market in the US which is
growing at a fast pace. More...
IIT Bombay streamlines technology licensing

(Mihika Basu , 21-Jun-2010 , DNA)
Whats more for the first time IIT B is also advertising all its intellectual property which can be licensed.
More...
Kenyans could soon patent local products

(By MWANIKI WAHOME , 20-Jun-2010 , Daily Nation)
Local producers will for the first time be able to acquire patents for commodities that are unique to their
geographical areas once a Bill at the Attorney Generals office is enacted. More...
Tea fights lingerie in patent row
(Zia Haq , 19-Jun-2010 , Hindustan Times)
India continues to fight off attempts by entities around the world from staking claim to Darjeeling tea
the worlds most expensive variety. More...
Konkan Railway gets patent for anti collision device in the US

(Prakash Kamat , 19-Jun-2010 , Business Line)
Konkan Railway Corporation Ltd has been granted the anti collision device patent in the US for its Track
Identification System recently. More...
US EU cite safety issue in defence of piracy law

(Amiti Sen , 19-Jun-2010 , The Economic Times)
A group of developed nations led by the US and the EU has initiated discussions at the World Trade
Organisation on legitimacy of their proposed anti counterfeit agreement. More...
Developing countries reject WIPOs proposal for increasing reliance of national patent offices
on ISERs
Twenty developing countries including India have rejected the World Intellectual Property Organizations
proposal for increasing the reliance of national patent offices on international search and examination
reports issued by International Search Authorities. More...
US lawmakers rap corporates for preferring China over India

(Lalit K. Jha/PTI / Washington , 19-Jun-2010 , Business Standard)
American corporate giants faced a tough time on the Capitol Hill as lawmakers grilled them as to why
they were opting to do business with communist China over a democratic India. More...
The drug lords

(Anika Gupta , 18-Jun-2010 , Livemint)
Most Indian pharma firms dont even dabble in new drug development. More...
Drug developed by RSS body gets US patent

(STAFF WRITER , 18-Jun-2010 , Press Trust Of India)
An anti cancer drug extracted from cow urine and developed by an affiliate of the RSS has got a US
patent for the third time for its anti genotoxicity properties a senior official has said. More...
Ready for doosra

(Anupama Chandrasekaran , 18-Jun-2010 , Livemint)
But five years after the first prototype was created and the patent was applied for the product is yet to
ring in sales or profits. More...
Glenmark recalls child epilepsy drug in US
Oxcarbazepine is a generic version of Novartis patented drug Trileptal. More...
Big Pharma cuts R&D jobs as generics loom

(REUTERS , 17-Jun-2010 , The Economic Times)
One factor forcing Big Pharma to rethink its business model is the huge number of patents that are set
to expire over the next five years. More...
India EU to hold talks on drug dispute next month

At the instance of the WTO India and the European Union will try to resolve a dispute relating to seizure
of Indian drugs by some European countries for alleged patent violations next month. More...
Wipro to provide legal process outsourcing to Microsoft

(Bangalore , 17-Jun-2010 , Hindustan Times)
The business process outsourcing division of Wipro Technologies will provide legal process outsourcing to
Microsofts intellectual property and licensing group worldwide the Indian IT bellwether said Wednesday.
More...
Suven gets patents for two CNS drugs in Japan

(BS Reporter / Hyderabad , 16-Jun-2010 , Business Standard)
Suven Life Sciences Limited a Hyderabad based biopharmaceutical company has secured two product
patents from the Japanese Patent Office for two of its new chemical entities indicated for the treatment
of disorders associated with the central nervous system. More...
Cipla aims to sell copies of Roche Amgen biotech drugs

(Adi Narayan , 17-Jun-2010 , Livemint)
Biotechnology drugs account for around 10 15% of the global pharmaceutical market and many of them
are off patent or will lose patent protection soon Cipla said. More...
Cipla unveils Rs 300 cr plan to foray into biosimilar space

Cipla the largest domestic drug maker today said it would invest $65 million in three years to acquire a
40 per cent stake in an Indian biotech company and 25 per cent stake in a similar company in Hong
Kong as part of its foray into biosimilars or generics of off patent biotech drugs. More...
Amendment to copyright law opposed by film producers

A move to amend a 53 year old law to give independent rights to writers lyricists and singers thereby
entitling them to royalty today came in for strong opposition from some film producers More...
AMRI Receives Approval of Preliminary Injunction Against Dr. Reddys

(ag-IP-news , 15-Jun-2010 , ag-IP-news )
The positive outcome of this hearing bolsters our belief in the strength of AMRIs intellectual property
rights related to Allegra. More...
Wary investors take refuge in pharma stocks

(Harish Rao , 15-Jun-2010 , The Economic Times)
Mr Jani also says that companies concentrating on the US generics market will see significant price
appreciation because patents on many high potential molecules are going to expire in the coming five
years giving them a huge opportunity to become global generic players. More...
Abbott sues Sun Ranbaxy on cholesterol drug patents

(Soma Das , 15-Jun-2010 , The Financial Express)
The US based pharma company Abbott has sued two top Indian drugmakers Ranbaxy Labs Ltd and Sun
Pharmaceuticals in the US market alleging patent infringement in the cases of two different cholestrol
drugs More...
National Pharmaceutical Pricing Authority may cap cancer drug prices via Para 10
(Vivek Seal , 15-Jun-2010 , DNA)
In a bid to control the high cost of cancer related essential drugs the National Pharmaceutical Pricing
Authority may enact Para 10 B on specific drugs if negotiations with drug makers to reduce prices fail
according to a government official. More...
Bending over backwards to protect Indian yoga

(Hannah Gardner Foreign Correspondent , 14-Jun-2010 , The National)
Foreign countries are trying to patent it. More...
US NGOs urge GWU to stop industry sponsored IP summits in India

A group of nine non governmental organisations working in the field of health sector have appealed to
the George Washington University to stop its industry sponsored intellectual property summits in India
as these summits have become a front for a biased industry agenda. More...
China Equador stand by India at WTO

China and Equador have come out in support of India in its fight against the European Union at the
World Trade Organization for wrongful seizure of its generic or off patent drugs in transit to third
countries. More...
US court injunction stops launch of Dr Reddys drug

(BS Reporters / Mumbai/ Hyderabad , 13-Jun-2010 , Business Standard)
Analysts were expecting Allegra D24 to generate over $150 million in 3 years. More...
India protests regional pact on intellectual property rights

India has protested against the Anti Counterfeit Trade Agreement being negotiated by the United States
the European Union and other countries on the grounds that it will strengthen the holders of intellectual
property rights beyond reasonable measure. More...
India raises concerns on proposed ACTA TRIPS Plus measures at WTO forum
(Joseph Alexander, New Delhi , 12-Jun-2010 , Pharmabiz)
Raising concerns over the efforts by the developed countries to introduce provisions into trade
agreements that go beyond the TRIPS agreement India has strongly raised objection to the proposed
Anti Counterfeiting Trade Agreement which can adversely affect Indian pharma business. More...
RIM Motorola enter into license pact settle all litigations

(Press Trust Of India , 12-Jun-2010 , Hindustan Times)
Blackberry maker Research In Motion and telecom major Motorola have entered into a global settlement
and licensing agreement ending all litigations between them. More...
Venus Remedies gets India patent for painkiller

(Kaustubh Kulkarni & Bharghavi Nagaraju , 11-Jun-2010 , Reuters)
Drug maker Venus Remedies Ltd said on Tuesday it has been granted a patent by Indian authorities for
its once a day painkiller Aceclofenac injection. More...
Ranbaxy to start supply of API formulations to AstraZeneca

(Radhieka Pandeya , 11-Jun-2010 , Livemint)
The agreement between the two companies follows from a manufacturing agreement that was part of a
bigger patent infringement settlement between Ranbaxy and AstraZeneca in April 2008. More...
Grant in aid status for NIF soon

(Vasundhara Vyas Mehta , 11-Jun-2010 , The Times Of India)
NIF has filed 235 patent applications in India and seven patent applications in US. More...
Pfizer recalls 3 drugs made by Indian pharma company

The first glitches in the big pharma generic drug licensing alliance story have surfaced sooner than
expected. More...
Gilead Sciences mulls legal action against Lupin

(Sakthi Prasad in Bangalore , 11-Jun-2010 , Reuters)
U.S. biotechnology firm Gilead Sciences Inc said it may take legal action against Lupin Ltd after the
Indian firm submitted an abbreviated new drug application to manufacture and market a generic version
of its angina drug Ranexa. More...
Publishers plight
(Meethil Momaya , 11-Jun-2010 , Business Standard)
This refers to Copyright copywrong June1. More...
Dream Theatre bags rights for iconic brands

(Bindu D. Menon , 11-Jun-2010 , Business Line)
The licensing industry is set to piggy back on the growth of organised retail with a slew of brands
making inroads in India. More...
Lakhnavi zardozi to get GI tag soon?

(Shailvee Sharda , 10-Jun-2010 , The Times Of India)
Metallic wire kora saadi kinari salma badla sequins and stones... lying scattered these sparkling
trappings may not mean much. More...
Waking up to ACTA
It goes well beyond curbing trade in counterfeit goods and is a brazen attempt to create higher stands of
intellectual property protection than envisaged in the globally mandated TRIPS agreement of the World
Trade Organisation. More...
Glenmark scores over Sanofi Abbott in US patent challenge

Glenmark Pharmaceutical has scored in its patent tussle with Sanofi Aventis and Abbott after the New
Jersey district court upheld the challenge by the Indian company for a hyper tension drug. More...
Global drug makers see big business in anti cancer market

Though patent rights for some of these expensive anti cancer drugs protect the foreign companies from
competition a highly price sensitive market in India and emerging competition from local drug makers
makes it imperative for them to adopt aggressive market development strategies. More...
AIPS to hold seminars on patent opposition in Mumbai on June 25 and 26

Academy of Intellectual Property Studies will organise two back to back seminars on Patent Opposition
and How the Indian Patent Office Decided in 2009 which are to be held on June 25 and 26 2010 in
Mumbai. More...
India China move WTO on Trips plus West agenda

The two countries have asked the WTOs Trips council to include the issue of Trips plus enforcement
trend in the agenda for its meeting this week in order to examine the sanctity of an agreement being
planned by a group of countries that goes beyond what they have agreed to under the WTO. More...
Ericsson claims pole position in patents for 4G technology

(Geeta Nair , 8-Jun-2010 , The Financial Express)
Even though 3G has not yet been launched in many markets telecom companies have already focused
attention on a next generation mobile technology LTE . More...
Weve nothing to lose

(Hindustan Times , 8-Jun-2010 , Hindustan Times)
When an enterprising American wants a patent on the Paschimottanasana we in India say by all means
go and grab that copyright. More...
Differences crop up again at Bonn

(Urmi A Goswami , 8-Jun-2010 , The Economic Times)
The differences over intellectual property regime continue to be hotly contested with the developed
world arguing that intellectual property be protected. More...
EU firm on strong IP provision in free trade

A key provision in the draft of the India European Union free trade agreement may have implications on
the affordability of medicines while also hurting the negotiations between the two trading blocs. More...
PM has failed to outline our priorities

(Bharat Jhunjhunwala , 8-Jun-2010 , expressbuzz)
The international dimension of health problems arises mainly through patent laws which enable
multinational corporations to charge exorbitant prices for patented drugs. More...
Scent of the jasmine

( K Shashidhar Hemmanna , 8-Jun-2010 , Deccan Herald)
Then theres the issue of patenting these flowers. More...
India to patent yoga asanas

(Madan Jaira , 7-Jun-2010 , Hindustan Times)
The Council for Scientific and Industrial Research has prepared patent formats of nearly 900 yoga
asanas to prevent European and American companies involved in fitness related activities from claiming
them as their own. More...
House panel suggests drastic changes to innovation Bill

The new draft proposes to give the government the right to use any invention patented by a state
funded institution More...
Karnataka pharma majors bullish over European export prospects

(Nandita Vijay, Bangalore , 7-Jun-2010 , Pharmabiz)
Liquidity crunch and growing uncertainty in the Euro zone have not deterred the Karnataka based
pharma companies from expanding their operations and also patent filing in Europe. More...
Trademarks section to move out of IP office
India plans to spin off the trademark registry from its intellectual property office which currently deals
with trademarks patents and designs. More...
Fake drugs are a real menace

(Nick Schulz , 04-Jun-2010 , Livemint)
Quality and safety concerns hurt Indias pharmaceutical promise. More...
Glenmark puts IPO of generics arm on hold

(Radhieka Pandeya , 04-Jun-2010 , Livemint)
Glenmark Pharmaceuticals Ltd has deferred the planned initial public offering of its wholly owned
generics arm Glenmark Generics Ltd because it is no longer in desperate need of money. More...
Kenya sees cure in Indian generics now

The Kenyan health ministry has conceded that the country should not have passed the anti counterfeit
law last year and said it would try and make changes to ensure that imports of legitimate generics were
not affected. More...
Takeda drags Dr Reddys to court over diabetic drug

The largest Japanese drug firm Takeda Pharma has sued Hyderabad based Dr Reddys Labs for allegedly
infringing the formers patent coverage on anti diabetic drug Actos by trying to manufacture and market
the same in the US. More...
Zydus arm Irish co in patent dispute

The Rs 3700 crore Zydus Groups US subsidiary Zydus Pharmaceuticals USA has challenged the Irish
company Shire Pharmaceuticals over its patented gastro drug Lialda. More...
Bajaj Auto gets Chinese patent for ExhausTec technology

Two wheeler major Bajaj Auto on Tuesday said its ExhausTec technology used to improve power in
single cylinder four stroke engines has been granted a patent in China. More...
News brief
(Hindustan Times , 01-Jun-2010 , Hindustan Times)
The next batch of nine month postgraduate diploma in Intellectual Property Rights and Patent
Management will commence on June 17 2010. More...
India gets help in drugs piracy fight
A number of developing countries from East Asia Latin America and Africa have extended their support
to India in its fight against an attempt by developed countries to narrow the difference between fake
medicines and counterfeits. More...
GlaxoSmithKline tries a Linux approach to drugs

(Robert A. Guth, The Wall Street Journal , 1-Jun-2010 , Livemint)
Similarly large pharmaceutical companies tightly guard their formulas for drugs and other intellectual
property. More...
India to oppose pact by US Europe on counterfeiting

(1-Jun-2010 , Yahoo News)
The commerce ministry is likely to voice its its opposition to the US and Europe Unions Anti
Counterfeiting Trade Agreement arguing its passage would create non tariff barriers for the trade of
Indian intellectual properties. More...
Copyright copywrong
(Nilanjana S Roy / New Delhi , 1-Jun-2010 , The Economic Times)
The fantasy of any Indian reader whos travelled to countries with bigger and better bookstores is
simple: we want to be able to buy the books we love when they come out. More...
As trade pacts kick in farm fears run high

The objective of UPOV 91 is to protect new plant varieties through intellectual property. More...
Foreign telecom gear cos may get relief

(Joji Thomas Philip , 1-Jun-2010 , The Economic Times)
The review comes after global network vendors and sections of the government including the
communications ministry informed the home ministry that the new rules are inconsistent with Indias
commitments on intellectual property rights in multilateral global forums such as WTO. More...
Lupin set to acquire?second generics firm in Japan

The Japanese government plans to convert at least 30% of the countrys prescription drug market to low
cost generics or off patent drugs by 2012. More...
More generic cos keen on selling out to MNCs

Indian generics companies are an attractive target for overseas multinationals which are faced with loss
of revenues due to the expiry of patents worth $70 billion by 2013 and a squeeze on margins. More...
India Big pharmas new battle field
(BV Mahalakshmi, Sudhir Chowdhary , 31-May-2010 , The Financial Express)
Global pharmaceutical companies are living in an era of change. More...
Not many Indian pharma cos are left for sale

(Vishal Dutta , 31-May-2010 , The Economic Times)
The recent takeovers in the pharma space have raised concerns among Indian players. More...
Legally bound
Going by official reckoning some 2000 patents related to Indian systems of medicine are granted every
year in the US Europe and elsewhere. More...
Union govt ready with draft guidelines for 5th amendment of the D&C Rules 2010 for Ayush
drugs
(Nandita Vijay, Bangalore , 31-May-2010 , Pharmabiz)
For the issue of licenses for patent and proprietary drugs safety study report is not required but
manufacturers will need to submit a pilot study according to the protocol of Ayurveda Siddha and Unani
drugs. More...
Norms for foreign telecom gear cos may be eased

(Joji Thomas Philip , 31-May-2010 , The Economic Times)
The review comes after global network vendors as well as sections of the government including the
communications ministry informed the home ministry that the new rules are inconsistent with Indias
commitments on intellectual property rights in multilateral global forums such as WTO. More...
Much ado on basics of drug policy

(Indira Kannan / New York , 31-May-2010 , Business Standard)
Cipla arm flexing with US university underscores validity concerns on patent issues. More...
Sellout syndrome
(Sanchita Sharma , 31-May-2010 , Hindustan Times)
Medicines worth over $ 80 billion are going off patent at the US Patent and Trademark Office between
2011 and 2013 making it lucrative for global pharma majors to increase their presence in India which is
the largest producer of generic medicines after the US and European Union. More...
India plans front to nip new piracy law

India will strive to forge a united front against an anti counterfeiting agreement being negotiated by
some developed countries which could threaten exports of genuine off patent drugs information
technology and other products from emerging markets. More...
Patent linkage impermissible in India: Cipla
(Indu Bhan , 28-May-2010 , The Financial Express)
The dispute between Indian drug companies and the Big Pharma over patent linkage has reached the
domain of judiciary. More...
Grape seizures at EU port: India sends delegation to sort out

The commerce ministry has sent a delegation to Rotterdam to try and convince officials at the European
port that Indian table grapes were being wrongly seized over the alleged presence of chemical
preservatives More...
Founders of many Indian pharma companies keen to exit: Malvinder

Indian generics companies are an attractive target for overseas multinationals which are faced with loss
of revenues due to the expiry of patents worth $70 billion by 2013 and a squeeze on margins. More...
Whos afraid of Synthia

(Latha Jishnu / New Delhi , 27-May-2010 , Business Standard)
Venters patent application for his synthetic cell creation has set off a frenzied debate on monopolies in
genetic research More...
Piramal to launch own drug by 2012

(By James Fontanella-Khan and Joe Leahy in Mumbai , 27-May-2010 , Financial Times)
The countrys low cost research and production facilities and traditionally weak intellectual property
regime have encouraged the development of a strong generic pharmaceutical industry but local drugs
groups are now keen to formulate their own drugs. More...
Government doctors asked to promote generic drugs

According to the World Health Organisation report prepared for the National Rural Health Mission
Promoting Rational Drug Use under NRHM generic drugs which are usually produced when a branded
drug loses its patent can tremendously increase the availability affordability and efficient use of
medicines. More...
Ranbaxy seeks USFDA approval for new drug

RANBAXY Laboratories has sought the US drug regulators approval to sell a new drug in the worlds
largest pharma market that has been manufactured in a unit of its Indian factory which is under scrutiny
of the US regulator. More...
Should pharma firms sell out?

Two for big pharma firms given the patent laws that came into effect in 2005 and given that they have
already expanded both geographically and across therapeutic areas it is harder to look at growth rates
far in excess of market growth rates. More...
Sun Pharma chief sees more consolidation ahead

Sun Pharma has stopped selling Protonix generic pantaprazole in the US despite being confident on its
litigation due to abundant caution he explained. More...
Novo sues Lupin to block generic in US

Danish company Novo Nordisk has sued Mumbai based drugmaker Lupin to prevent it from launching
the low priced version of its patented diabetes medicine sold under the brand Prandimet in US. More...
Tune in for everything on intellectual property

(Madhumathi D.S. , 25-May-2010 , Business Line)
Its a patently different kind of radio. More...
Pharma MNCs will call the shots soon

Global MNCs lorded over 75% of the countrys drug market before the Indira Gandhi led government
adopted a process of patent regime in 1971. More...
Pharma mergers & acquisition wave has roots in product patent regime
It all began on August 28 2006 when the Pennsylvania US based Mylan Inc bought Hyderabad-based
Matrix Laboratories for $736 million. More...
Winds of change in pharmaceutical industry

(Muralidharan Nair , 25-May-2010 , The Financial Express)
The interest that big pharma firms have evinced in the Indian pharma market has undergone a sea
change over the years More...
Half full half empty

(Business Standard , 25-May-2010 , Sify)
Pharma majors who have a lot of complaints about the patents regime in India nevertheless appear
willing to pay a high price to get in. More...
MNCs back in control of 50% of Indian pharma market

But global MNCs in the face of shrinking revenues and the prospect of further losses when patents of
drugs worth $70 billion expires by 2013 began to amplify their presence in generics from 2008. More...
Discuss FTA talks with EU in Parliament: CPM to govt
On Intellectual Property it said the EU is asking for TRIPS plus provisions and rewriting of Indian patent
and copyright laws. More...
Venus Remedies: Attractive bet among small cap space

(Kiran Kabtta Somvanshi , 24-May-2010 , The Economic Times)
In March 2010 the company got Indian patent for one of its product Sulbactomax and has also filed
patent for this product in another 50 countries including the US Europe Australia Japan and Latin
American countries. More...
Rise of Big Pharma will make drugs dearer

Industry estimates suggest that by 2015 when the Indian pharmaceutical market would be worth $20
billion about 15 per cent of total drugs would be patented molecules. More...
Many Species One Planet One Future

(Narayani Ganesh , 23-May-2010 , The Times Of India)
India is not only being proactive in acknowledging the symbiotic link between biodiversity and climate
change it was also trying to bring together the CBD and TRIPPS agreement of the WTO through pushing
for an amendment of Article 29. More...
EU seizure of Indian drugs improper: WHO

(Sujay Mehdudia , 23-May-2010 , The Hindu)
In a statement issued in Geneva the WHO on Thursday rapped the EU for seizing the Indian generic
drugs in transit for patent violation. More...
India keen to play lead role in Nagoya meet

Besides the Biological Diversity Act 2002 and the national Biodiversity Authority India has also put in
place a traditional knowledge database the Traditional Knowledge Digital Library. More...
Abbott buys Piramals pharma arm for $3.7bn

The India story is an attractive growth story but globally and in emerging markets there is a new way of
selling drugs patented products which we would not have been able to do on our own Ajay Piramal
chairman of the Piramal group told TOI. More...
Dr Reddys launches drug to treat organ rejection in US

(Priyanka Pulla , 22-May-2010 , Livemint)
Dr Reddys can expect an additional $25 million in sales in fiscal 2011 from the tacrolimus capsules
More...
More foreign suitors expected
But acquisitions also likely to get more expensive. More...
Ranbaxy to roll out generic version of Lipitor in Canada

(Press Trust of India , 22-May-2010 , The Financial Express)
Ranbaxy Laboratories on Friday said it has got the approval of Canadian health regulator to market the
generic version of cholesterol lowering medicine Lipitor worlds largest selling drug in Canada. More...
Kites flies into copyright controversy

(DNA Correspondent , 22-May-2010 , DNA)
Of the many controversies threatening to ground Hrithik Roshan starrer Kites this one has leapt right out
of a storyboard. More...
Piramal deal will give Abbott India size

(Ram Prasad Sahu / Mumbai , 22-May-2010 , Business Standard)
As part of its strategy to move beyond the proprietary or patented drugs business Abbott recently set up
the Established Product Business globally. More...
Mango: The King Is Now G.I. Joe

(21-May-2010 , The Times Of India)
According to legend a donkey once walked about a mango tree laden with ripe Dussehris. More...
Gains in crop protection sector stocks may continue

(M.R. Subramani , 21-May-2010 , Business Line)
One of the problems faced by the sector is the lack of patent protection in the country. More...
India asks WHO to drop IMPACT and set up new member driven programme
India has urged World Health Organisation to replace WHOs involvement in the International Medical
Products Anti counterfeiting Taskforce with an effective programme to address the issue of quality safety
and efficacy and to ensure that the new programme avoids conflicts of interests. More...
Why MNCs are keen on data protection for pesticides

(Harish Damodaran , 21-May-2010 , Business Line)
The 20 year protection period in India applies only with respect to product patents filed after January 1
1995. More...
German Court Revokes Glaxos Advair Patent

(By STEN STOVALL , 20-May-2010 , The Wall Street Journal)
GlaxoSmithKline PLC said Thursday that Germanys Federal Patents Court revoked its patent for key
product Advair handing a victory to generic drug makers Mylan dura GmbH Hexal AG Neolab Ltd. and
Ivax International B.V. and highlighting the world wide generic threat to Glaxos blockbuster lung
treatment. More...
India seeks new WHO policy for fake drugs

(Soma Das , 20-May-2010 , The Financial Express)
The government has urged the World Health Organisation to address the issue of spurious substandard
drugs through an effective alternative instead of clubbing it as a counterfeit issue. More...
India EU ready for consultation to resolve drug seizure issue

The seizure of several consignments of medicines was on the patent infringement grounds. More...
India EU consultations on drug seizure to start next week

India and the European Union will, next week start World Trade Organisation-mandated consultations to
resolve a dispute over the seizure of Indian pharmaceutical consignments in Europe. More...
World Health Assembly opens with counterfeit issue as part of agenda

In response to the Director Generals request for information on use of the term counterfeit medicines
and related definitions 55 Member States and the European Commission have so far provided answers
and a preliminary summary was presented to the Member States at an open forum held in Geneva on
March 26 2010. More...
AstraZeneca Teva settle generic budesonide capsules patent litigation

(London , 19-May-2010 , Pharmabiz)
AstraZeneca has entered into an agreement with Teva Pharmaceuticals USA Inc formerly Barr
Laboratories Inc to settle patent litigation regarding Tevas proposed generic version of AstraZenecas
Entocort EC capsules More...
Lupin loses battle to launch antibiotic in US

The district court enjoined Lupin from infringement during the extended term of the patent. More...
Venus Remedies gets India patent for painkiller

(Reuters / Mumbai , 18-May-2010 , Business Standard)
Drug maker Venus Remedies Ltd said on Tuesday it secured an Indian patent for its once a day painkiller
Aceclofenac injection. More...
Indian Patent Office sets aside patent granted to Roche for valganciclovir
In a significant decision the Indian Patent Office at Chennai in its decision on April 30 2010 has set aside
the patent granted to Roche for valganciclovir. More...
Indian pharmas emerging foray

(BV Mahalakshmi , 17-May-2010 , The Financial Express)
They are also improving their intellectual property and regulatory markets. More...
Microsoft settles with VirnetX to pay $200 mn

(Reuters / New York , 17-May-2010 , Business Standard)
Microsoft Corp will pay $200 million to VirnetX Holding Corp and obtain a patent licence to settle
litigation accusing it of infringing two patents for communicating over the Internet. More...
Ranbaxy Lupin to benefit most from Japans push for generics

The firms will have an edge over their Indian counterparts that do not have a Japanese parent or
subsidiary More...
EU confronted on herbal medicines & chemicals ban

(Amiti Sen , 15-May-2010 , The Economic Times)
India has taken up with European Union the issue of its traditional medicine and chemical industries that
are set to face various import restrictions in the European Union. More...
Strategies for growth and survival

This combines with increasing costs and high rates of genericisation drugs going off patent make it a
difficult environment for drug companies. More...
Pharma export council to open offices abroad

(P B Jayakumar / Mumbai , 15-May-2010 , Business Standard)
Indias $12 billion Rs 53500 crore pharmaceutical industry earns 40 per cent of its revenue from exports
of off patent generic drugs. More...
Police to ensure proper investigation

(Express News Service , 15-May-2010 , express buzz)
In the wake of the increasing incidents of infringement on intellectual property rights the state police are
initiating various measures to ensure proper investigation into cases registered under the Copyrights
Act. More...
DCGI associates with commerce ministry to reexamine spurious drugs definition

(Nandita Vijay, Bangalore , 15-May-2010 , Pharmabiz)
Drugs Controller General of India in association with Union Ministry of Commerce & Industry has started
an exercise to reexamine the definition of spurious drugs in the wake of recent seizures of Indian generic
drugs by the EU authorities. More...
A patent shortage
India needs a more efficient patents office More...
FTA? Nothing free about it

(Biraj Patnaik , 14-May-2010 , The Times Of India)
Further over the past few years India has developed a patent regime that gives precedence to patient
rights over the interests of pharma companies emerging as one of the major sources for cheap generics
being used worldwide. More...
Mahabaleshwar strawberry gets GI status

(Hrishikesh Joshi / Mumbai/ Pune , 14-May-2010 , Business Standard)
After Puneri Pagadi Solapurs chadar and towels Yeolas Paithani Alphonso mangoes of Konkan Nashik
grapes and wine now Mahabaleshwars Strawberries has joined the illustrious league of Geographical
Indication status after receiving the registration from the Ministry of Commerce. More...
Authority sets aside patent gives hope to patient groups

(Rema Nagarajan , 14-May-2010 , The Times Of India)
For the first time in the country patient groups have won the right as interested parties to challenge the
patent granted for a medicine. More...
IFPMA defends involvement of IMPACT on counterfeit issue

Patents have nothing to do with counterfeiting and counterfeiting has nothing to do with patents. More...
Balaramapuram Sarees gets IPR protection

(UNI , 14-May-2010 , indlaw news)
Keralas prestigious Balaramapuram Sarees have become the first handloom product in the state to
receive the Intellectual Property Rights protection through Geographical Indications Act. More...
India Brazil drag EU to WTO

(D Ravi Kanth / Geneva , 13-May-2010 , Business Standard)
Raise trade dispute against EU over seizure of generic drugs. More...
Aurobindo gets USFDAs tentative nod for Crestor

Aurobindo Pharma on Thursday said it has received tentative approval of the US Food and Drug
Administration for the generic version of Crestor tablets used in the cardiovascular therapeutic area.
More...
The Roche test
The Valcyte case is vital as it bars incremental innovation and recognises the right of patient groups to
oppose patents More...
Ranbaxy Medicis end drug row

Ranbaxy has reached an out of court settlement with Medicis on acne drug Solodyn minocycline
hydrochloride last week. More...
Suven Life gets Canadian and Eurasian patent for NCE

Suven Life Sciences has received third product patent from the Canadian Patent office and sixth from
Eurasian Patent office corresponding to the New Chemical Entity for treatment of disorders associated
with Neurodegenerative diseases. More...
Big pharma aims for reinvention

(Andrew Jack , 12-May-2010 , Financial Times)
With some of his most profitable medicines going off patent and the uncertainty of replacement drugs
continuing to rise US healthcare reform has been the least of Andrew Wittys recent worries. More...
Microsoft loses as Toronto firm wins claim over Word patent

(Indo-Asian News Service , 12-May-2010 , Hindustan Times)
Ruling against Microsoft the US Patent and Trademark Office on Tuesday confirmed a patent held by
Toronto based i4i Inc. More...
Ranbaxy Labs: Growth strategy fructifies

(Priya Kansara Pandya & Akash Joshi / Mumbai , 12-May-2010 , Business Standard)
The US Food and Drug Administration allows 180 days of exclusive marketing rights to the first company
that successfully challenges a patent on a medicine. More...
Glenmark Merck settle patent row over Zetia

(Sachin Kumar , 11-May-2010 , Hindustan Times)
Glenmark Pharmaceuticals and Merck have agreed to settle their patent litigation on Mercks patent
covering Zetia a cholesterol lowering drug. More...
Ranbaxys US arm to face patent infringement suit

Ranbaxy Pharmaceuticals Inc had applied for marketing approval of a version of Purdues painkiller
Oxycodone. More...
Stocks to watch: Tata Power Fortis Healthcare Jindal Steel MMTC Jubilant Foodworks
Glenmark
Merck and Glenmark Pharmaceuticals Inc. and Glenmark Pharmaceuticals have reached an agreement to
settle their patent litigation involving Glenmarks challenge to Mercks patent covering ZETIA. More...
Google Yum Mattel PepsiCo: Intellectual Property

(Victoria Slind-Flor , 11-May-2010 , Bloomberg)
GreenShift Corp. a New York based company that developed and commercialized clean technologies
sued 15 ethanol producers for patent infringement. More...
Singapore for greater access to Indian generic drugs

(Press Trust of India , 11-May-2010 , NDTV Profit)
India on Tuesday signed a pact with Singapore for greater market access for its generic offpatent drugs
in the South East Asian nation. More...
Merck Settles Patent Infringement Case for Zetia® ezetimibe

(EDT , 10-May-2010 , Yahoo Finance)
Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. USA and Glenmark Pharmaceuticals Ltd. have
reached an agreement to settle their patent litigation involving Glenmarks challenge to Mercks patent
covering ZETIA ® (ezetimibe). More...
MSF welcomes Indias decision to reject drug patent to Roche

Medicins Sans Frontieres an international medical humanitarian group today welcomed Indias decision to
reject a patent granted to Swiss drug multinational Roche for its AIDS related drug Valganciclovir.
More...
US rakes up Indian counterfeit drugs issue wants data protection

Placing India yet again in the priority watch list in 2010 the United States has once again raked up the
issue of counterfeit medicines as a grave concern and has strongly sought protection for undisclosed test
and other data generated for approval of pharma products. More...
Indian Copyright Act: Whose copy is it?

(Sindhu Manjesh , 8-May-2010 , The Times Of India)
The Indian Copyright Act 1957 has seen a few amendments in the past in the 80s and 90s but it is
widely acknowledged that it is far outdated and does not reflect the reality of a rapidly evolving and
interconnected global knowledge economy. More...
Sensitisation workshop organised on Intellectual Property Rights

It targeted Micro Small and Medium Enterprise sectors More...
Digital DImensions
(Sindhu Manjesh , 8-May-2010 , The Times Of India)
Will you be hauled up for making personal copies of your favourite paid for downloads or for converting
them to different formats for private use under the provisions of the proposed Copyright Amendment Bill
More...
Sun Pharma gets US FDA nod for generic Namenda tablets

Sun was amongst the first ANDA applicants to submit a substantially complete ANDA with a paragraph
IV certification to the 703 patent. More...
Pharma cos lose out in patent office judiciary stand off

(Deepali Gupta , 7-May-2010 , The Economic Times)
FOR the patent office the past three years have been like the past three overs of a Twenty20 match.
More...
Abbott Eli Lilly sues Watson Pharma for patent infringement on dyslipidemia drug and SERM
respectively
(Morristown, New Jersey , 07-May-2010 , Pharmabiz)
Watson Pharmaceuticals Inc has confirmed that its subsidiary Watson Laboratories Inc filed Abbreviated
New Drug Applications for two products a generic version of Abbotts dyslipidemia drug Simcor and Eli
Lillys oral selective estrogen receptor modulator Evista with the US Food and Drug Administration.
More...
Orchid to bloom with US deal

(Ravi Ananthanarayanan, Vatsala Kamat and Manas Chakravarty , 6-May-2010 , Livemint)
The real benefits of the Orchids deal with Alvogen Inc. will depend on the rate of success in patent
challenges and the ability to go to get final marketing approvals More...
Sun stops anti ulcer drug sale in US

(Press Trust of India , 6-May-2010 , The Financial Express)
Sun Pharmaceutical Industries on Wednesday said it has stopped the sale of the generic version of
Protonix an antiulcer drug in the US market. More...
Roches patent on HIV drug is dismissed

(Radhieka Pandeya , 6-May-2010 , Livemint)
The Swiss drug maker has the option of filing an appeal against the patent offices decision on Valcyte
with IPAB More...
Glenmark takes patent cover with drug deal

Glenmark Pharmaceuticals issued exclusive marketing rights for cholesterol control ezetimibe to another
generic company Par Pharmaceutical Companies in an effort to strengthen its patent challenge case
against Merck. More...
Medicines bought in bulk by govt can help cut costs
(Subodh Varma , 5-May-2010 , The Times Of India)
Patent rights also give a boost to prices as shown by the case of Glivec an anti cancer drug. More...
Public interest groups urge US president to order inquiry into links between USPTO Pfizer in
India
A slew of public interest groups in India have asked the US president Barak Obama to order a formal
investigation into the links between the United States Patents and Trademark Office in India and the
multinational pharma major Pfizer and to take necessary action against the officials concerned for
misinforming the Indian media and the general public about its own patent laws and public health
safeguards. More...
USTR Releases 2010 Special 301 Report on Intellectual Property Rights

(ag-IP-news , 05-May-2010 , ag-IP-news )
The Office of the United States Trade Representative released its annual Special 301 Report on the
adequacy and effectiveness of US trading partners protection of Intellectual Property Rights. More...
Seizure of drugs cases: India plans to drag EU to WTO independent of Brazil

(Amiti Sen , 4-May-2010 , The Economic Times)
India is planning to drag the European Union to the World Trade Organisation independently of Brazil
despite claims made by the EU that it was changing its customs regulations to prevent seizure of drugs
exported by India while in transit to third countries like Brazil and Nigeria. More...
Non trade issues not to hamper trade talks with EU

In the intellectual property rights chapter of the proposed FTA it will be made clear that there should be
no limit on Indias capacity to produce and export life saving medicines Ms. Danielle Smadja said here.
More...
Pfizer Wyeth sue Ranbaxy over infringement

(fe Bureau , 4-May-2010 , The Financial Express)
US based Pfizer and its subsidiary Wyeth have sued Ranbaxy Laboratories in a US court claiming that
the Daiichi Sankyo owned drugmaker infringed on Wyeths patent coverage of the drug Rapamune.
More...
India EU to hold more discussions tackle FTA hurdles

Both sides resolve to conclude talks before the next India Europe summit in Oct More...
EU assures FTA wont lead to costlier life saving drugs

The European Commission has said the proposed free trade agreement negotiations with India will not
affect production of cheap life saving medicines in the country. More...
SC notice to Pepsi over TM row with Udaipur firm

(PTI , 03-May-2010 , Yahoo News)
The Supreme Court today issued notice to beverages giant PepsiCo India over a petition filed by an
Udaipur based firm challenging the order of the Delhi High Court over a copyright row on the
multinationals popular soft drink brand 7Up. More...
Cipla demands apology from US university

Cipla the countrys leading drug maker has sent a legal notice to George Washington University of the
United States on a recent symposium it had organised in India alleging the meet had attempted to
influence a high court case involving Cipla and one of the event sponsors the US based Gilead Sciences.
More...
Litigation woes could hit sales hard

(Edelweiss , 03-May-2010 , The Financial Express)
The recent jury decision determining that Nycomeds 579 patent on Protonix DR Tablets is not invalid is a
setback to Sun Pharmaceuticalscurrent sales from the product. More...
Counterfeit goods growing problem in India: USTR

US watchdog lauds Indias IPR efforts but picks holes in legal framework. More...
Patent application details now available online

(BS Reporter / New Delhi , 2-May-2010 , Business Standard)
Patent application details are available online for free from this week. More...
Pfizer Wyeth sue Ranbaxy over drug

(P B Jayakumar / Mumbai , 2-May-2010 , Business Standard)
Pfizer the worlds largest drug company and Wyeth have sued Daiichi Sankyo owned Ranbaxy
Laboratories in a US court for infringing the patent rights of Wyeths drug Rapamune. More...
India 10 others on U.S. watch list for inadequate IPR protection

(PTI , 1-May-2010 , The Hindu)
The United States placed India along with 10 other countries on its priority watch list on Friday for not
providing adequate levels of protection or enforcement of Intellectual Property Rights. More...
Keep IPR away from free trade agreements

(P.T.Jyothi Datta , 1-May-2010 , Business Line)
Civil rights groups want the Government to keep Intellectual Property Rights outside the ambit of Free
Trade Agreements being negotiated between India and several other regions including the European
Union and Japan. More...
India on US watch list for inadequate IPR protection

(Lalit K Jha , 1-May-2010 , Press Trust Of India)
The United States placed India along with 10 other countries on its priority watch list on Friday for not
providing adequate levels of protection or enforcement of Intellectual Property Rights. More...
Knowledge library wards off European patents

An electronic facility that India had set up eight years ago to pre empt unfair patenting of the countrys
traditional knowledge on curative potency of various biological resources has come handy. More...
India EU discuss all aspects of proposed FTA

(Pallavi Aiyar / Brussels , 1-May-2010 , Business Standard)
The ninth round of free trade agreement talks between India and the European Union concluded in
Brussels today. More...
India fights patent claims on traditional cures

(Sanchita Sharma , 30-Apr-2010 , Hindustan Times)
India has challenged 36 attempts by international companies to get patents on Indian traditional
knowledge at the European Patents Office over the past one year. More...
Pharma group to oppose patent claims

A group of Indian pharmaceutical firms will collectively oppose as many as 90 drug patent applications
sought by global drugmakers and some local companies terming them as frivolous patent claims. More...
Sanganeri hand block printed textile goods get GI tag

Sanganeri hand block printed textile products will now be protected as a geographical indication under
Geographical Indication of Goods Registration and Protection Act. More...
Orchid Chem settles litigation with Forest Labs

(Kaustubh Kulkarni , 29-Apr-2010 , Reuters)
Orchid Chemicals and Pharmaceuticals Ltd said on Thursday it has settled a patent litigation with Forest
Laboratories Inc regarding its generic drug Memantine tablets. More...
To stop patent fights India gives US UK access to database

(Vineeta Pandey , 29-Apr-2010 , DNA)
Having burnt its fingers on long and expensive litigations to prevent foreign companies from patenting
neem and turmeric the Indian government has developed a unique process to save its AYUSH
knowledge. More...
Strong medicine
(Latha Jishnu / New Delhi , 29-Apr-2010 , Business Standard)
Ecuador is issuing compulsory licences to bring down the cost of patented medicine. More...
Zydus launches Tamsulosin in US

(BS Reporter / Mumbai/ Ahmedabad , 29-Apr-2010 , Business Standard)
Ahmedabad based pharma major Zydus Cadila has launched Tamsulosin capsules in the US following
nod from the US health regulator today. More...
CSIR wing objects to Avesthagen patent claim

(Jacob P. Koshy , 28-Apr-2010 , Livemint)
Records also show that the company had paid application renewal fees every year since 2003 but hadnt
done so for 2009 the deadline for which was 31 August More...
Suven Life gets patent for NCE from India & New Zealand
Suven Life Sciences a bio pharmaceutical company has received patent from New Zealand and Indian
patent office or its New Chemical Entities for the treatment of disorders associated with
Neurodegenerative diseases and these patents are valid until 2024 and 2025 respectively. More...
Special courts planned to clear backlog of IPR cases

The move is part of the ongoing intellectual property rights reforms for which the Centre has set aside
Rs500 cr More...
Ranbaxy to step up head count launch new drugs

It attempted to grow by challenging patents of established drugs such as Pfizers cholesterol curer Lipitor
to make big profits and focused on the western markets. More...
Economy Govt rules out blanket ban on plastic bags

Sanganeri hand block printed textile products from Rajasthan will now be protected as a geographical
indication which prohibits its duplication. More...
Pharma firms see scope in US patent expiry

(Joe C Mathew / New Delhi , 27-Apr-2010 , Business Standard)
Fortune seekers in the Indian pharmaceutical space will find this irresistible. More...
Pharma cos public health groups want patent issue out of FTA talk with EU
Indian pharmaceutical firms and the network of public health groups have separately urged the
government to keep patent related issues out of the ongoing talks for the proposed India EU free trade
agreement. More...
China court rejects Shaolin temple trademark bid: report

(AGENCIES , 27-Apr-2010 , The Economic Times)
Persistent attempts by Chinas famed Shaolin temple to stamp its trademark on instant noodles and
coffee may have hit a brick wall after a court ruled against the move state media said Tuesday. More...
Sun Pharma stocks slip on US court decision

(BS Reporter / Mumbai , 27-Apr-2010 , Business Standard)
In two separate patent cases while a US court asked Sun Pharma to withdraw its version of a cancer
drug Eloxatin from the US market another jury which examined patent validity of heart burn drug
Protonix ruled against the Indian company More...
Apex court rejects Unilever Australasia plea on trademark

(Indu Bhan , 27-Apr-2010 , The Financial Express)
The Supreme Court on Monday has given the go ahead to a cosmetic firm to proceed against Australian
based Unilever Australasia plea in a trademark violation case filed in a Bangalore court. More...
Shire sues Teva over US patent infringement of Intuniv tablet

(Dublin, Ireland , 27-Apr-2010 , Pharmabiz)
Shire LLC subsidiary of Shire plc global specialty biopharmaceutical company has filed a lawsuit in the
US District Court for the District of Delaware against Teva Pharmaceuticals USA Inc and Teva
Pharmaceutical Industries Ltd for the infringement of US Patent Nos. 6287599 and 6811794. More...
India ropes in US UK to protect traditional knowledge

(IANS , 26-Apr-2010 , Sify)
India has joined hands with the US and Britain to protect thousands of medicinal preparations based on
traditional knowledge from piracy and patent controversies. More...
Patent office to hire 500 people this yr: DIPP Secretary

The government will hire about 500 people this fiscal for its intellectual property offices a top official said
today. More...
Bio piracy: India wins case against 15 patents

(sujatha gopal , 26-Apr-2010 , Rediff)
The European Patent Office has rejected 15 patent applications of various international companies during
the past one year after it found they had used Indias traditional medicinal knowledge to prepare certain
products. More...
Emkay reduces Sun Pharmas price target to Rs 1632
In the first case New Jersey jury has ruled that Wyeths patent on Protonix is valid and Sun and Teva
Pharma has infringed the patent by launching the drug at risk. More...
Curing the fear of drug patents

(Ranjit Shahani , 26-Apr-2010 , Business Line)
Intellectual Property Day some home truths to separate myths from facts. More...
Indias tryst with TRIPS

(Shamnad Basheer , 26-Apr-2010 , Livemint)
On World Intellectual Property Day India should remember that it still needs to incentivize innovation
More...
TELCO loses trade mark battle against T SERIES

TELCO has lost its trademark violation case against the Super Cassettes Industries in the Delhi High
Court which allowed the electronics company to use letter T in its T SERIES mark saying it was not its
monopoly. More...
MNC domestic pharma lock horns on patents in India

(STAFF WRITER , 24-Apr-2010 , Press Trust Of India)
MNC durgmakers today hit back at their domestic counterparts over frivolous patent issue and said even
the local firms are engaged in filing for intellectual rights for incremental innovations that merely
improve the safety or efficacy of an already known drug. More...
Low IQ on intellectual property rights

The World Intellectual Property Day has been observed globally on April 26 every year since 2001 but
the knowledge of intellectual property right is still in nascent stage particularly in Varanasi which is one
of the ancient seats of learning. More...
Folk as intellectual property

(PTI , 24-Apr-2010 , ZeeNews.Com)
Everything folk should be considered as intellectual property to ensure that forms of art like music
theatre and dance passed down orally through generations do not vanish feel contemporary folk artists.
More...
Pfizer wins Protonix patent case vs Teva

( Bill Berkrot , 23-Apr-2010 , Reuters)
Jury finds Protonix patent infringed by Teva More...
A $5 billion Indian pharma entity may not be too far away

(23-Apr-2010 , DNA)
In the initial analysis it appears that the nightmares of the patent cliff that the big brand companies are
confronted with may be offset to a large extent by the majestic emergence of the Asian markets like
India and China followed by other growth markets like Mexico Turkey and Brazil. More...
EU approves Novartis Diovan for paediatric use

(Martin de Sa'Pinto , 23-Apr-2010 , Reuters)
Novartis hypertension drug approved for use in EU children More...
IPL cautions Google on copyrighted content

The Indian Premier League has requested Internet search engine Google to discontinue services to
certain Web links that were using its platform to transmit copyrighted content related to the Twenty20
cricket tournament. More...
Like EU Japan FTA also a priority

(Priyanka Golikeri , 22-Apr-2010 , DNA)
Concerns over the Japan FTA include inclusion of strict intellectual property provisions and access to
second hand Japanese goods into the Indian market. More...
Number of patent filings declined in FY'10 due to slowdown

The government on Thursday said filing of patent applications in the country declined by over 6 per cent
to 34,496 in 2009-10 over the year-ago period due to the global economic downturn. More...
Contract manufacturing of drugs to grow 10 15%

(Debasis Mohapatra / Chennai/ Bangalore , 22-Apr-2010 , Business Standard)
Contract manufacturing in pharmaceutical industry is set to grow 10 per cent to 15 per cent in the near
term and is expected to double in the next five years after the approval of US healthcare bill as the bill
has opened up opportunities for the use of more generic drugs in the US market. More...
Ind. engineers receive patent for trailer design

(The Associated Press , 22-Apr-2010 , Business Week)
Two engineers at an Indiana trailer manufacturer have been awarded a patent for a new aerodynamic
trailer designed to save fuel. More...
Piramal Health to buy anaesthetic biz of Pune firm

(Reuters / Mumbai , 22-Apr-2010 , Business Standard)
The acquisition gives Piramal access to key intellectual property developed by BSV for the manufacture
of injectable anaesthetics products including process based intellectual property and business contracts
the filing said. More...
MULTIPLE FILING OF PATENTS

(P A Francis , 21-Apr-2010 , Pharmabiz)
Adoption of the new patent law in 2005 marked the beginning of a new era in the history of
pharmaceutical industry in India. More...
Cipla offers govt low cost drug technology to fight cancer AIDS
Patent holders drugs for the treatment of life threatening diseases such as cancer and AIDS are
expensive and their monopoly in the Indian market will result in denial of treatment for Indian patients
says Amar Lulla joint managing director of Cipla More...
Draft copyright Bill introduced, could transform film, music biz

(Manish Ranjan and Santosh K. Joy , 19-Apr-2010 , Live Mint)
Draft copyright Bill introduced, could transform film, music biz More...
Disability rights activists oppose copyright regime

(Deepa Kurup , 15-Apr-2010 , The Hindu)
The proposed amendments to the Copyright Act 1957 slated to be tabled in the second phase of the
budget session of Parliament that begins on Thursday has disability rights activists up in arms. More...
Beware the EU agenda

Tough intellectual property rights sought by the EU in its free trade agreement with India have set off
global protests More...
US generics to help push Glenmark recovery

US market for the drug company will grow at 32.7% says an analysis More...
Unilever moves SC seeks stay on trademark case

Australia based Unilever Australasia on Tuesday moved the Supreme Court seeking a stay on the
proceedings of a trademark violation case filed against it in a Bangalore court. More...
Hope floats for India EU free trade pact talks

(Pallavi Aiyar / Brussels , 13-Apr-2010 , Business Standard)
Chapters on government procurement and intellectual property rights the EU is pushing for TRIPS plus
protection also remain highly contentious. More...
Infy awaits nod for 224 patent applications

(Press Trust of India , 13-Apr-2010 , NDTV Profit)
IT behemoth Infosys Technologies on Tuesday said it is awaiting approvals for 224 patent applications in
India and in the US. More...
No suo motu powers to review ‘wrongly’ granted patents
(C.H. Unnikrishnan , 13-Apr-2010 , Live Mint)
The first Indian Administrative Service officer to head India’s intellectual property office, P.H. Kurian has
had a tough time since he took charge in 2009—he has had to work towards creating an efficient and
transparent patenting process and reform a system that has previously faced allegations of lack of
transparency, indecision, even corruption. More...
Glenmark settles drug patent row with GSK

(13-Apr-2010 , Financial Express)
Close on the heels of Ranbaxy announcing a patent dispute settlement with Japan's Takeda
Pharmaceuticals for the generic equivalent of Takeda's drug Actos, Mumbai-based Glenmark
Pharmaceuticals said on Monday its US-based group company has settled a patent dispute with
GlaxoSmithKline over the launch of a generic version of anti-malaria drug Malarone. More...
CSIR open-source project for TB democratises research

The average age of scientists on the Council of Scientific and Industrial Research's (CSIR) ‘Connect 2
Decode' project — to map information on the Mycobacterium tuberculosis (Mtb) genome, is “in the 20s”.
Not surprising then, the scientific community explains the project, in lay terms, as a sort of “face-book”
for scientists! More...
Keikaku set to enter India with furniture brand

(Anandita Singh Mankotia, Ronojoy Banerjee , 13-Apr-2010 , The Financial Express )
The $1.7 billion Japanese retailer Ryohin Keikaku is all set to enter the Indian retail market with its
furniture brand Muji. More...
GSK settles malaria drug patent dispute with Glenmark

(Selina McKee , 12-Apr-2010 , Pharma Times)
UK drugmaker GlaxoSmithKline has settled a patent dispute with the US subsidiary of Indias Glenmark
Generics over a copycat formulation of its malaria prophylaxix drug Malarone. More...
Indian drugmakers gear up to challenge frivolous MNC patents

Leading domestic drugmakers have decided to collectively challenge frivolous patent applications filed by
multinationals in India under the aegis of the Indian Pharmaceutical Alliance. More...
Mycobacterium tuberculosis genome mapping released

(Aarti Dhar , 11-Apr-2010 , The Hindu)
Findings may result in development of urgently needed new TB drugs in India. More...
Suns EPS may take a knock if it stops cancer drug sale

(Deepali Gupta , 10-Apr-2010 , The Economic Times)
The stock of Sun Pharma fell for a fourth day in a row as investors are worried about the companys legal
tussle with Sanofi Aventis over cancer drug oxaliplatin. More...
Column : Should drugs be allowed evergreening

(MG Arun , 10-Apr-2010 , The Financial Express)
The issue of evergreening of drugs or obtaining new patents for minor improvements on a product
towards its patent expiry has been a subject of debate in India ever since 2005 when India allowed
patenting of products in pharmaceuticals as opposed to the earlier process patent regime. More...
Will India take EU drug seizures issue to World Trade Organisation

The medicines neither enjoyed patent protection in India nor in the countries that were to import them.
More...
Indian drug exporters to benefit from change in EC norms

It was alleged that the Indian pharmaceutical products had patent violations in Europe. More...
Cipla makes cancer drug cheaper

Cipla has launched a copycat version of German pharma company Bayers cancer medicine Nexavar at
one tenth the price thumbing its nose again at the pharma multinational by selling drugs at a fraction of
the original rates. More...
Malihabadi dussehri is the first branded mango

(DNA Correspondent , 09-Apr-2010 , DNA)
Alphonsos wont be the first mangoes to get a geographical indication. More...
The US healthcare opportunity for India

(Ram Prasad Sahu in Mumbai , 09-Apr-2010 , Rediff)
With larger companies having a pipeline of Abbreviated New Drug Applications some with exclusivity
period and drugs worth $80 billion coming off patent over the next five years investors are betting on
Indian companies garnering a chunk of this generic opportunity. More...
Know the real hapoos by its Ratnagiri brand

(Neeta Kolhatkar , 09-Apr-2010 , DNA)
The registration process of Ratnagiris special alphonso mangoes for a geographical indication is in its
final stages. More...
Through her research MSU student seeks to revive 700 year old craft
(DARSHANA CHATURVEDI , 8-Apr-2010 , The Times Of India)
Her research may or may not fetch her good marks but it will definitely help revive the 700 year old
Tangalia craft which is now among the few Gujarati items to have got geographical indication embedded
in a sarong like garment worn by the Bharwad women from Motabhai Bharwad community of
Saurashtra. More...
MNCs will get market prices for patented drugs only if govt given quota at a discount
(Gireesh Chandra Prasad, KG Narendranath , 08-Apr-2010 , The Financial Express)
The government plans to prevent pharma MNCs from selling their patented drugs which are mostly
expensive in India unless they agree to earmark a portion of their supply for public healthcare system at
negotiated prices. More...
Tatas create intellectual property clusters in Bangalore Pune

(Rakhi Mazumdar , 8-Apr-2010 , The Economic Times)
The Tatas are no slouches in technology as Tata Steel alone owns a bouquet of 850 patents copyrights
and applications. More...
What invalidating breast cancer gene patents implies

(R. PRASAD , 8-Apr-2010 , The Hindu)
Myriad was holding an exclusive licence. More...
LPOs benefit from Microsofts curbs on legal costs

(Adith Charlie , 8-Apr-2010 , Business Line)
Microsofts patent portfolio consistently ranks among the top as it manages nearly 23000 issued and
38000 pending patents worldwide. More...
Court favours Teva in Seasonique patent case against Watson

(Jerusalem , 07-Apr-2010 , Pharmabiz)
The ANDA sought approval to market a generic version of Seasonique in the US before the patent
expires on January 30 2024. More...
Pfizer Novartis and Eli Lilly got bulk of contentious patents

Rules against protection being granted to already known and long ago patented drugs were allegedly
violated More...
US opportunity for pharma

(Business Standard / New Delhi , 7-Apr-2010 , Business Standard)
On the export front as far as the regulated markets are concerned the drug majors that have so far
relied on their patented blockbusters are rapidly changing their business model in several ways. More...
Are industrial zones a good idea

corporate houses mint money by using patents to their advantage. More...

Court denies Lillys request in 2 patents litigation case of Gemzar
(Jerusalem , 07-Apr-2010 , Pharmabiz)
Lilly has appealed that decision and oral argument is scheduled for May 7 2010. More...
Taro Pharma Receives Patent For T2007

(RTT Staff Writer , 06-Apr-2010 , RTT News)
Taro Pharmaceutical Industries Ltd. Tuesday said the U.S. Patent and Trademark Office has issued the
company a patent for its non sedating barbiturate drug T2007 which is under development. More...
Australia pushes for environment labour IPR in trade pact with India
(Amiti Sen , 5-Apr-2010 , The Economic Times)
The proposed free trade agreement between India and Australia has hit rough waters with the latter
insisting that issues including environment labour intellectual property government procurement and
competition policy be part of the negotiations. More...
Fresenius Kabi settles patent dispute with Sanofi Aventis

(Marketing , 05-Apr-2010 , Business Line)
Drug firm Fresenius Kabi Oncology previously know as Dabur Pharma on Monday said that it has settled
the patent litigation with Sanofi Aventis over the cancer drug Eloxatin. More...
SC admits plea against Cipla on modvat refund claim

The Supreme Court has admitted the excise departments plea alleging that pharma major Cipla Ltd is
not entitled to refund modvat credit paid on its destroyed expired medicines. More...
Unfurling a new life for Chamba rumals

(Reshmi R Dasgupta , 5-Apr-2010 , The Economic Times)
The gaining of GI Geographical Indication status has also earned them protection from cheap knock offs
from other regions. More...
The healthcare opportunity

(Ram Prasad Sahu / Mumbai , 5-Apr-2010 , Business Standard)
While generics today have a share just under a fifth in the US market they are likely to grow by over
twice that number by 2013 as many of the innovator drugs go off patent and the healthcare bill comes
into full effec More...
India reasserts its reservations on counterfeit drugs at WHO meeting

(Joseph Alexander, New Delhi , 5-Apr-2010 , Pharmabiz)
These concerns include its association with trademark and the danger that quality safety and efficacy
issues could be viewed through the lens of intellectual property India said terming all this as deliberate
confusion on the part of those seeking to increase IP enforcement regimes. More...
In the pink of health
(IIFL , 5-Apr-2010 , The Financial Express)
n Settlement of patent disputes between an innovator company and a generics company with first to file
status will be banned if such a settlement involves payment in cash or kind. More...
BusinessEurope pushes for stronger intellectual property terms in FTA

Fears of tough intellectual property provisions in Indias free trade agreement with EU are only getting
stronger. More...
Venus Remedies patent on salbactam with ceftrioxane opposed in Delhi patent

The product which is manufactured by several companies under different brand names is indicated for
infections. More...
Microsoft loses appeal on Word patent verdict

(IANS , 02-Apr-2010 , The Economic Times)
Microsoft had filed a review petition in the US federal court of appeals against the ruling as well as fines.
More...
Domestic cos foil global peers rage over patent

Global Pharma Companies Campaigning Against A Key Provision In Indias Patent Act More...
Sanofi Aventis settles patent row over cancer drug

French drugmaker Sanofi Aventis settled its patent row in the US over colon cancer drug Eloxatin with
several generic companies but made no mention of Indian drugmaker Sun Pharmaceutical Industries
that also sells the drug. More...
AstraZeneca ordered to pay attorneys fees to Dr Reddys

Drug major AstraZeneca has been ordered to pay attorneys fees by a US court to Dr Reddys
Laboratories for bringing a frivolous and baseless patent infringement suit against the latter. More...
Ranbaxy to hire 1500 on expansion to push sales

The company has run into a spate of patent battles over generic drugs there and its Indian
manufacturing units have been under the US drug regulators scanner. More...
Not a nice trait to have

MMB is bolstering its argument with a new weapon a patent that it holds in India for its Bt technology.
More...
India prepared to take EU to WTO over drugs

(Matthias Williams and Manoj Kumar , 31-Mar-2010 , Reuters)
India is ready to launch a formal dispute against the European Union at the World Trade Organization
over EU seizures of Indian generic drugs the Indian Trade Secretary said on Wednesday. More...
Drug makers unite to fight frivolous patents

IPA members to challenge patent applications at pre grant stage More...
Teva exclusive on hypertension drugs challenged

(By Jeremy Pelofsky , 31-Mar-2010 , Reuters)
Two generic pharmaceutical manufacturers have challenged the U.S. Food and Drug Administrations
decision to give rival Teva Pharmaceutical Industries Ltd six months of exclusive marketing for generic
versions of widely used blood pressure medicines. More...
US court rejects patents on human genes

(BRIDIE SMITH , 31-Mar-2010 , The Age)
A LANDMARK judgment handed down in the US this week on the contentious practice of patenting
human genes is expected to send a message to Australian policymakers. More...
Will raise penetration of Indian generic

While the period of data exclusivity for innovators is far longer than the generic players would have
wanted the announcements of setting up regulatory pathways in this space is crucial as the value of
biologics starting to go off patent from 2014 will be increasingly larger than conventional oral drugs.
More...
Sanofi moves to block Wockhardt patent challenge

(P B Jayakumar / Mumbai , 30-Mar-2010 , Business Standard)
Battle in US court on anti allergic drug Allegra. More...
Vested interests behind discussion on patents

(Rema Nagarajan , 30-Mar-2010 , The Times Of India)
Several civil society groups have come together to question the commerce and industry ministrys
alleged complicity in allowing meetings and interactions undermining Indias legal position on intellectual
property. More...
Indian Patents Act promotes inventions

(Mail Today Bureau , 30-Mar-2010 , India Today)
Concerns raised by US multinational corporations over the Indian Patents Act discouraging innovation
have been refuted in a study released on Monday. More...
India asks WHO to stay away from counterfeit issues

According to Indian representatives counterfeit is a juridical term and is linked to intellectual property
rights. More...
Suven secures product patent

(Our Bureau , 30-Mar-2010 , Busines Line)
Suven Life Sciences Ltd has secured a product patent from the European Patent Office for its New
Chemical Entity meant for the treatment of neurodegenerative diseases. More...
Indias patent policy is discouraging innovations that can be of help

(Joe C Mathew & Vandana Gombar / Mumbai/ New Delhi , 30-Mar-2010 , Business Standard)
US based Eli Lilly amongst the top 10 global pharmaceutical companies with annual revenues of $21.8
billion in 2009 has planned to continue its focus on innovation driven products instead of opening up to
opportunities in off patent generic drugs being tapped by its larger competitors like GSK and Pfizer.
More...
High risk: trademark cases on the rise in liquor industry

(Poornima Mohandas , 30-Mar-2010 , Livemint)
Cases of trademark violation have been on the rise in the liquor industry in recent years as companies
often copy names bottle and label designs as well as packaging to ride the popularity of other fast
moving brands say two industry experts and a trademark lawyer More...
Indoco Remedies inks drug supply pact with Aspen

(BS Reporter / Mumbai , 30-Mar-2010 , Business Standard)
A dwindling new drug pipeline and drugs losing patent protection are now forcing multinational drug
companies to take up generic drug selling which they had shunned earlier. More...
For both IPR & access to medicines

(TK Arun , 29-Mar-2010 , The Economic Times)
Stefan Oschmann is president Emerging Markets at Merck the worlds second largest pharmaceuticals
company after its 2009 merger with Schering Plough with a combined global revenue in 2009 of $27.4
billion. More...
On course to benefit from patent expiries

(Nitin Shrivastava , 29-Mar-2010 , DNA)
Indian pharmaceutical companies are in for good times with very large generic opportunities awaiting
them in regulated markets and a focus on low cost healthcare globally. More...
Pharma cos take patent route to consolidate ops in US

(Reghu Balakrishnan , 29-Mar-2010 , The Financial Express)
Indian pharma firms seem to be in an upbeat mood as far as strengthening their presence in the US via
the patent litigation route is concerned. More...
Vested interests behind discussion on patents

Several civil society groups have come together to question the commerce and industry ministrys
alleged complicity in allowing meetings and interactions undermining Indias legal position on intellectual
property. More...
Startups look to patenting techs

(K Rajani Kanth / Chennai/ Hyderabad , 29-Mar-2010 , Business Standard)
This patent pending technology has been developed by matrimonial site Coupl.in a Hyderabad based
start up set up in October 2009. More...
Pharma sector: There is room for value buying

(Kiran Kabtta Somvanshi , 29-Mar-2010 , The Economic Times)
Impending patent expiries regulated markets gradually opening their markets for generic products and
the US passing the much awaited Healthcare Bill in order to cut down healthcare costs are turning out to
be a boon for generic companies in India. More...
Bio piracy threats

(Editorial , 29-Mar-2010 , DNA)
Indias successful thwarting of an American firms attempts to patent the well known Indian medicinal
plant ashwagandha must be applauded. More...
US patent office admits to error in judgment

After joining hands with pharma giant Pfizer to campaign against public health safeguard clauses in the
Indian patents law the US Patent and Trademark Office has admitted that they had made a mistake in
co sponsoring a programme on patent law in India along with the pharmaceutical giant. More...
Watchdog Blues
(Sudhir Chowdhary, BV Mahalakshmi , 29-Mar-2010 , The Financial Express)
An effective way to manage these complexities is to assemble a strong resource pool with a good
understanding of the local market conditions intellectual property regulatory pricing and marketing and
distribution. More...
EU MPs oppose corporate interference in FTA talks

David Martin a MEP part of the campaign, says the EU should not push for provisions in bilateral talks
that can impact local manufacturing in developing countries and go beyond what is mandated by the
trade related aspects of intellectual property rights agreement of the World Trade Organisation. More...
Roundtable on controversial Section 3 d of Indian Patents Act to be held in Delhi on March 29
The Federation of Indian Chambers of Commerce and Industry is organizing a Roundtable Conference on
the controversial Section 3d of Indian Patents Act in New Delhi on March 29. More...
India beats back US firms bid to patent Ashwagandha formulations

(Kounteya Sinha , 27-Mar-2010 , The Times Of India)
India has foiled a major bio piracy bid on the use of Ashwagandha Indias wonder plant in the treatment
of a range of illnesses including depression diabetes insomnia convulsions and gastritis. More...
Genentech Biogen sue GSK on cancer drug Arzerra

(Copenhagen, Denmark , 27-Mar-2010 , Pharmabiz)
US patent No 7682612 was issued to GenentechInc. and Biogen Idec Inc. on March 23 2010 and
contains a claim to a method of treating CLL with anti CD20 antibodies wherein the method does not
comprise treatment with radiolabeled anti CD20 antibodies. More...
EU may recall India made generic drug

(Reuters / London , 27-Mar-2010 , Business Standard)
However the medicine is off patent in some European markets where Acino is among the companies that
have been supplying a cheaper generic version. More...
IPR law firms step up fight against fakes

(Manish Ranjan , 26-Mar-2010 , Livemint)
Lawyers and a former police officer among those who have joined the war on piracy as firms try to plug
losses More...
US healthcare bill drives up small pharma

(Apurv Gupta , 26-Mar-2010 , The Economic Times)
The playing field for the domestic pharmaceutical companies changed completely with the advent of
product patent regime. More...
Indian market is important for us looking at the sheer growth potential

However the lack of a strong intellectual property rights regime in a predominantly generics driven
Indian market made the going tough for the firm. More...
We have big R&D plans in the pipeline for India

(Soma Das , 26-Mar-2010 , The Financial Express)
Alpna Seth managing director of Biogen Idec one of the top 10 biotech companies globally with annual
revenues of $4.4 billion talks about special pricing and patent issues More...
NGOs caution govt on designs of EU through on going FTA negotiations
Warning the government about the impact of data exclusivity these groups said that if data exclusivity is
introduced it will create a new patent like monopoly by blocking the registration of generic medicines.
More...
Bayer drags Cipla to court over patent

German drugmaker Bayer has filed a patent infringement case against Cipla the largest domestic drug
seller to stop the Mumbai based company from selling its generic version of controversial cancer
medicine Nexavar. More...
Ranbaxy gets a reprieve in generic case

The Delhi High Court has turned down a plea by US pharma major Bristol Myers Squibb to ban Indias
Ranbaxy Laboratories from launching a generic or copycat version of its patented hepatitis B drug
Baraclude. More...
No trademark infringement by Google: EU court

(Reuters / Luxembourg/ London , 24-Mar-2010 , Business Standard)
Europes highest court ruled Google Inc did not infringe trademark law by selling keywords to trigger ads
after Louis Vuitton and others said the practice undermined their brands. More...
Obamas Health Bill to boost Indian firms

(Bianca Ghose , 24-Mar-2010 , NDTV Profit)
Branded innovators and Indian generic companies often settle patent litigation cases out of court
allowing the generic company to have limited exclusivity on a drug along with the branded company.
More...
Piramal buys Ciplas i Pill for Rs 95 crore

In an announcement to the exchange Piramal Healthcare said the company had signed a definitive
agreement for the purchase of all intellectual property rights in India related to the brand. More...
Albany Molecular seeks injunction against Dr Reddys

( Vidya L Nathan in Bangalore , 23-Mar-2010 , Reuters)
Albany Molecular Research Inc along with Sanofi Aventis SAs U.S. unit sought a preliminary injunction
against Indias Dr Reddys Laboratories Ltd from distributing a copycat version of allergy drug Allegra D.
More...
Skinvisible Granted Patent for South Korea

(ET , 23-Mar-2010 , CNN Money)
Skinvisible Inc. announced today that the South Korean patent office has granted a patent for
Invisicare® the companys polymer delivery system for topical dermatology products. More...
Suven gets patent for Alzheimer Parkinson compound
Suven Life Sciences today said it has received patent from the US Patent Office for a compound used in
the treatment of neuro diseases like Alzheimer and Parkinson. More...
EU trade pact wont hit Indian generic drug cos: Sharma

(Reuters , 23-Mar-2010 , The Financial Express)
The warning highlighted one of the most sensitive issues in trade the extent to which firms intellectual
property rights can be waived to help poor countries and whether that stifles research and innovation.
More...
US Healthcare Law: Indian drug firms are not celebrating yet

(P B Jayakumar / Mumbai , 23-Mar-2010 , Business Standard)
Further the provisions in the legislation to allow 12 year exclusivity to new biologics or patented biotech
drugs would delay plans of Indian companies to launch generic biologics in the US market say industry
circles and analysts. More...
Lupins US arm gets USFDA nod for insomnia tablets

(PTI , 23-Mar-2010 , Livemint)
The company has received a tentative approval for the companys abbreviated new drug application for
Eszopiclone tablets from the USFDA Lupin said in a filing to the BSE More...
Approach to GM foods should be promotional but cautious: Mashelkar

(Express News Service , 23-Mar-2010 , Indian Express)
Speaking on the issue of intellectual property rights Mashelkar who won the IPR battle for India over
Basmati and turmeric which led to the revocation of US patents on these products said that people
understand physical property but intellectual property is a product of the mind and the person whose
idea it is should have a right to exploit the idea for a certain period of time. More...
Dish Big TV wrestle over trademark

(Ashish Sinha , 23-Mar-2010 , The Financial Express)
According to sources recently ADAG applied for the registration of Big Dish TV to the office of the trade
mark registry in Mumbai. More...
Indian pharma patents to surge with US expiries

Between 2010 and 2015 drugs worth a mindboggling $157 billion are set to go off patent in the US
according to industry estimates. More...
Planned EU deal not to hit generic drug cos: Anand Sharma

(REUTERS , 22-Mar-2010 , The Economic Times)
Back in 2005 India granted patents on medicines to respect international trade rules and MSF said a new
free trade agreement now under negotiation would tighten these rules. More...
India ready to move WTO against EU Customs laws
We are very clear that customs officials in the EU countries bent WTO rules when they seized good
quality off patent medicines being shipped from India. More...
Kesar mango from Gir all set to rub shoulders with Darjeeling tea
(Hiral Dave , 22-Mar-2010 , Indian Express)
Is the only agri product from Gujarat to get registered with Geographical Indication Registry More...
FICCI to establish IP Facilitation Centres across the country for MSMEs

The IP Facilitation Centres will be well equipped to offer quality services in all areas of intellectual
property rights and comprises of technical and legal experts having extensive knowledge in the field of
Motherson poised to ride auto boom

(Nitin Shrivastava , 22-Mar-2010 , DNA)
The Visiocorp acquisition lifts Motherson to tier 1 status and arms it with superior technology as
Visiocorp has more than 330 patents in its name. More...
India proposes stringent laws for IP offenders

Audio video piracy to be included under prevention of dangerous activities Act. More...
Weekly News Round Up

(by M J Madhavan , 21-Mar-2010 , Busines Line)
Ranbaxy Laboratories Ltd on Monday said that it has reached an agreement with Japanese pharma
major Takeda Pharmaceutical Company Ltd and Takeda Pharmaceuticals North America resolving
outstanding patent litigation related to generic version of diabetes drug Actos. More...
New process patent granted to IIT Madras and MIN for a drug used in dialysis patients with
chronic kidney disease
Two Indian patents have been filed jointly by IIT Madras and MIN on these new developments in 2006
and one patent has already been granted recently. More...
Teva drags Famy Care to US court over patent infringement

(fe Bureaus , 20-Mar-2010 , The Financial Express)
Mumbai based oral & injectable contraceptive maker Famy Care was sued in a US courtalong with
partner Mylan Labs by the largest generic company Teva last week for alleged infringement of Tevas
patent for oral contraceptive pills Seasonique and LoSeasonique. More...
Celebrities using trademark route to check name misuse
(Rasul Bailay , 20-Mar-2010 , Livemint)
Bollywood actress Kajol was shocked to discover television news channels last month running reports on
derogatory remarks she purportedly made against the Shiv Sena on Twitter. More...
Sales data Obama push healthcare pulse on BSE

(Joe C Mathew & P B Jayakumar / New Delhi/mumbai , 20-Mar-2010 , Business Standard)
Over $86 billion worth of medicines are expected to go off patent in the next two to three years in the
US. More...
DRL gets nod for Allegra D 24 generic

(Radhieka Pandeya , 19-Mar-2010 , Livemint)
Patent litigation over the drug between DRL and Sanofi is still unresolved More...
Malihabad mangoes under bug threat

(Swati Mathur , 19-Mar-2010 , The Times Of India)
With the newly acquired Geographical Indication to the Malihabadi Dussehri coming as a boost to
farmers in the area the expectation of large yields could help the trade even further. More...
Apple patent and trademark skirmishes through the years

(by Erica Ogg , 19-Mar-2010 , cnet news)
Sometimes it doesnt take more than a cease and desist letter or some good backroom negotiating skills
for Apple to get what it wants. More...
Piracy a serious threat to Indian film industry

Strong legislative and enforcement responses are needed to tackle the issue of copyright theft. More...
Indian firms overtake US in FDA drug filings

A significant portion of filings from India has been made since 2008 More...
Commerce Health ministries initiate to delink trademark aspects from quality of drugs
The move in general is to suggest required amendments so that trademark and patent issues do not get
mixed up in the quality aspect of drugs. More...
Column: Astra versus Sun

(VIVEKA ROYCHOWDHRY , 18-Mar-2010 , The Financial Express)
This time AstraZeneca has filed two separate cases against Sun Pharma to block a Para IV filing on
Nexium its best selling drug. More...
Lets hear it for Brazil

(Latha Jishnu / New Delhi , 18-Mar-2010 , Business Standard)
Brazil plans to break IP rights on American drugs music software and movies as retaliation for its cotton
subsidies More...
Idea in soup over paperless ad

(Ratna Bhushan & Joji Thomas Philip , 17-Mar-2010 , The Economic Times)
Ideas trademark Sirji campaign shows Abhishek Bachchans image on a tree advocating the use of
mobiles and saving paper to save the planet. More...
Indian pharma industry should strive to make India number one in volume of production in 5
years Dr Sivathanu Pillai
(Peethaambaran Kunnathoor, Chennai , 17-Mar-2010 , Pharmabiz)
Regarding pharma industrys growth he said the Indian Patent Act of 1970 has helped rapid expansion of
domestic market market development and market orientation research. More...
Pfizer drops Viagra infringement case against Lilly

(Tom Hals in Wilmington and Ransdell Pierson in New York , 17-Mar-2010 , Reuters)
Pfizer Inc agreed to drop an eight year old patent infringement lawsuit against Eli Lilly & Co over Viagra
after a U.S. government agency rejected part of the male impotence drugs patent. More...
SmartMetrics Lawsuit Against Visa and MasterCard

(ET , 17-Mar-2010 , CNN Money)
For an order pursuant to 35 U.S.C. section 271 declaring that each Defendant has infringed one or more
claims of the 464 patent More...
Court bars Cadila from selling drug

(Indu Bhan , 16-Mar-2010 , The Financial Express)
With the Supreme Court refusing to give any relief to Cadila Healthcare Ltd on Monday the pharma
major cannot sell its anti depressant drug Venz OD for another three months. More...
Patent dispute resolution a booster for Ranbaxy

(SI Reporter / Mumbai , 16-Mar-2010 , Business Standard)
Ranbaxy Laboratories has firmed up after settling a patent dispute with Takeda Pharmaceutical
Company regarding a generic version of the Japanese companys diabetes drug Actos in the United
States. More...
Overburdened FDA can scupper a rising bounty

Drugs with sales of $157 billion are going off patent in the next couple of years in the US. More...
Ranbaxy Daiichi combining synergies to boost growth
(Bianca Ghose , 16-Mar-2010 , NDTV Profit)
What Ranbaxy gets is access to Daiichis patent protected products. More...
Ranbaxy settles spat with Takeda over Actos

Ranbaxy Labs has resolved its patent litigation with Takeda Pharma related to its generic version of
Actos. More...
Setback for Zydus Cadila in trademark case

In a setback to Ahmedabad based drug maker Zydus Cadila the Supreme Court on Monday declined to
interfere with a Madras High Court order which prevented the company from selling its anti depressant
drug Venz. More...
Venus Remedies gets patent for Sulbactomax

(Corporate , 15-Mar-2010 , Busines Line)
Pharma Company Venus Remedies Ltd on Monday said it has received a product patent for its antibiotic
drug Sulbactomax in the country. More...
Column: Against Tide but at what cost to Rin

(Latha R Nair , 13-Mar-2010 , The Financial Express)
An audacious advertisement campaign for Rin started by Hindustan Unilever Limited by pitching and
comparing it with Tide Naturals a Procter & Gamble product has become a hot topic of discussion for
intellectual property rights enthusiasts. More...
AstraZeneca in deal with generic drugs maker

(Rhys Blakely , 12-Mar-2010 , Times Online)
The deal with Torrent Pharmaceuticals gives the Anglo Swedish group access to a fresh portfolio of
cheap medicines to sell in developing markets at a time when it faces the loss of patents on several of
its blockbuster brands. More...
Indian pharma eyes $60B in lost patents

(Tracy Staton , 12-Mar-2010 , FiercePharma)
While Big Pharma bewails the forthcoming loss of patent protection on many top selling drugs the knock
off drug business is rubbing its hands in anticipation. More...
LG infringed Whirlpool patent jury finds

(Dhanya Skariachan , 12-Mar-2010 , Reuters)
A U.S. jury found that LG Electronics infringed on a Whirlpool patent for ice storage bins in some of its
refrigerators Whirlpool said on Friday. More...
Pharma drools as US patent expiries
After a brief lull caused by the slowdown the US has once again emerged as El Dorado for Indian drug
makers. More...
Medicines for all

(Business Standard / New Delhi , 11-Mar-2010 , Business Standard)
This is difficult to understand as there is no intellectual property to guard against foreign takeover the
Indian industry being entirely generic. More...
Climate change
(by Atty. Adrian S. Cristobal Jr. , 11-Mar-2010 , BusinessMirror)
One concern especially of developing countries is that the intellectual property system may hinder
access to these technologies. More...
GlaxoSmithKline stays confident on patent regime

(Reghu Balakrishnan , 10-Mar-2010 , The Financial Express)
At a time when multinational innovator drug companies and global pharma associations cry hoarse over
the intellectual property regime in India GlaxoSmithKline the second largest pharma firm in the world
remains confident over the countrys patent scenario. More...
IPR is tool for wealth creation

(BS Reporter , 10-Mar-2010 , Sify)
The Uttar Pradesh government has advocated preparing a blueprint of not only creating awareness
towards Intellectual Property Rights but also wealth creation by the stakeholders. More...
Natco Pharma looks to relaunch breast cancer drug in India

Natco said it has tied up with Dr Reddys Laboratories Ltd to take this product to the US market where
they are looking to challenge Abraxis patent. More...
Culinary manifesto
One recent occasion was the donning of geographical indication protection by the venerable Tirupati
ladoo. More...
Bidding War Pits Pfizer Against Teva

(Mergers & Acquisitions , 10-Mar-2010 , The New York Times)
In 2008 it created a division called the established products business unit to sell medications that have
lost their patent protection. More...
Our Indian operations are a great success story
(P B Jayakumar / Mumbai , 10-Mar-2010 , The Economic Times)
The patent pool is a good option for finding a cure for these diseases as drugs can be made available to
people in least developed countries. More...
Sun wins first roundover Wyeths Protonix

The case was filed by US based Wyeth Pharmaceuticals which had sued Sun and Caraco for claiming that
their heartburn drug was a generic version of its Protonix drug More...
AstraZeneca Sues Sun Pharma For Patent Infringement

(Pharmaceutical Business Review , 9-Mar-2010 , Pharmaceutical Business Review)
AstraZeneca has filed a patent infringement complaint against India based Sun Pharma for planning to
market a generic formulation of its intravenous acid reflux disease treatment Nexium IV. More...
$280000 a year job offer for Chennai patent holder

(IANS , 9-Mar-2010 , The Economic Times)
Patent under the US law is awaited Shivaraman told IANS talking about his innovative polymer
templated lithography process which allows fabrication of patterned magnetic media with density of
around 30 TB. More...
Glaxo chief Witty says ready to ramp up play

Experts feel depleting new molecule pipelines and impending patent expiries are increasing the
desperation of pharma biggies such as Pfizer and GSK to rapidly expand their presence in India. More...
FICCI to organise Roundtable on controversial section 3 d of Indian Patents Act

Even as the multinational pharma companies are making an orchestrated efforts to remove the
controversial section 3d of the Indian Patents Act which prevents incremental pharmaceutical
innovations from receiving patent protection the Federation of Indian Chambers of Commerce and
Industry is organizing a Roundtable Conference on the issue in New Delhi on March 22. More...
AstraZeneca takes Sun Pharma to court

A generic company files an abbreviated new drug application with a Para IV certification before a
patented product goes off patent. More...
Glaxo chief Witty says ready to ramp up play

Experts feel depleting new molecule pipelines and impending patent expiries are increasing the
desperation of pharma biggies such as Pfizer and GSK to rapidly expand their presence in India. More...
Dept of pharma wants review of FDI rules
(Surajeet Das Gupta & Joe Mathew / New Delhi , 8-Mar-2010 , Business Standard)
The Alliance has also pointed out that there are serious new entry barriers in the international market
such as seizure in transit ever growing intellectual property rights enforcement and protection and
attacks on Indias brand equity. More...
Public interest groups object to disguised lobbying with judges policymakers by GWU and CII
Several public interest groups in the country have asked the central government to take immediate
steps to put a stop to the industry sponsored lobbying with judges and policymakers in the country as
part of the of Summits on Intellectual Property being organised in different cities in India jointly by the
US based George Washington University and the Confederation of Indian Industry with funding from
multinational pharmaceutical companies industry associations and corporate law firms. More...
India to submit IPR report to US trade representative

India will submit a status report on the progress it has made on intellectual property rights protection
and enforcement during the last year to the United States Trade Representative. More...
India-US to sign key trade pact on Mar 17

(STAFF WRITER , 07-Mar-2010 , Press Trust Of India)
The US has been seeking greater market access in India and raising concern over protection of the
India tops exporting generic medicines

(Nageshwar Patnaik , 07-Mar-2010 , The Economic Times)
The word generic is used to describe a product particularly a drug which does not have a trademark.
More...
UP slack in claiming its intellectual rights

Despite being a repository of rich biodiversity Uttar Pradesh is one of the poorest performers when it
comes to protecting their traditional knowledge. More...
AstraZeneca sues Sun Pharma in us court

(BS Reporter / Mumbai , 5-Mar-2010 , Business Standard)
Sun had challenged the patent on Nexium IV in the US market. More...
Ranbaxy may still gain from Flomax

The company may get a one time payment for enabling the launchof its generic versionin the US market
More...
Natco moves SC against Novartis drug
(Indu Bhan , 5-Mar-2010 , The Financial Express)
Natco Pharma has approached the Supreme Court challenging a part of the Intellectual Property
Appellate Boards decision that said Swiss drug maker Novartis blood cancer drug Glivec was novel and
inventive. More...
Pharma cos filing multiple patents for same drug

In September 2009 a patent application for AIDS drug darunavir was rejected as it did not meet
patentability criteria laid down in the Indian Patent Act. More...
How pharma can use deduction as addition

(Gireesh Chandra Prasad , 5-Mar-2010 , The Financial Express)
The US allows a six month exclusive marketing right to the first generic copy that enters the market
without infringing the patent protecting the original drug or by proving that the patent was invalid.
More...
Strides buys Aspen unit for $75 m

The acquisition is believed to facilitate the contract that Strides signed with US behemoth Pfizer in
January 2010 whereby the two companies struck a deal to deliver 40 off patent products mainly
injectable cancer medicines and oral medicines to patients in the US. More...
Kolhapuri chappals scale new heights

(Sujata Reddy , 04-Mar-2010 , Hindustan Times)
In an effort to protect intellectual property rights of the popular Kolhapuri Chappals Shivaji University
Kolhapur had decided to apply for Intellectual Property Rights close to five years back. More...
Ranbaxy faces more trouble in US

Local arm faces lawsuit for alleged marketing of products with false patent claims. More...
IIT drug to treat kidney diseases gets patent

An indigenous drug, developed by scientists at the Indian Institute of Technology Madras which can
remove toxic phosphorous from the body of a patient with chronic kidney failure has been awarded a
process patent. More...
Insidious India project

MNC backed IP summits try to influence sitting judges on patent law enforcement issues pending in
Indian courts More...
EU trade chief sees progress in India FTA talks
(by Bate Felix , 04-Mar-2010 , Reuters)
Disagreements over market access intellectual property rights a dispute over generic drugs and the EUs
desire to include issues such as climate change and child labour have stalled the talks. More...
Copyright content to pinch pockets of FM TV channels

(Pradipta Mukherjee & Swarup Chakraborty / Kolkata/mumbai , 4-Mar-2010 , Business Standard)
According to the Bill service tax will be levied on any temporary transfer of copyright or permitting the
use or enjoyment of any copyright defined in the Copyright Act 1957 except the following: original
literary dramatic musical and artistic works Section 13 a of the Copyright Act 1957]. More...
Ranbaxy loses out on FDA delay

Ranbaxy the Indian unit of Japanese drugmaker Daiichi Sankyo was to launch the generic version of the
Japan based Astellas Flomax on March 2 in the US eight weeks before the drugs patent expires in the US
following an out of court settlement in 2007. More...
Apple sues rival HTC as phone competition rises

(Corporate News , 3-Mar-2010 , Livemint)
Apple said HTC has infringed on 20 of its patents covering aspects of the iPhones user interface and
hardware More...
Supreme Court admits Bayer patent linkage plea

The Supreme Court has admitted a special leave petition filed by Bayer seeking introduction of patent
linkage system in India. More...
A Passage to India
(Bhupesh Bhandari / New Delhi , 2-Mar-2010 , Business Standard)
The absence of product patents had made them experts in reverse engineering. More...
A few extramural research projects under ICMR get patents set for commercialisation
A number of extramural research projects going on in different institutes under the Indian Council for
Medical Research and in Universities with the support of ICMR have reached laboratory scale stage and
in the process of being commercialized after having granted patents. More...
FM injects new life into pharma

From this year on companies will also be allowed to claim the weighted deduction benefit on expenses
incurred on clinical trials and product patent registrations. More...
Budget could push R&D spend by 25 50%: pharma players

(Sohini Das / Mumbai/ Ahmedabad , 01-Mar-2010 , Business Standard)
Troikaa Pharma is in the process of getting patent approvals for its novel drug delivery system for
Diclofenac injections Dynapar AQ from several countries. More...
No interim stay on Ciplas Nexavar clone

The Supreme Court on Friday turned down a request by German drugmaker Bayer AG to stop Mumbai
based Cipla from launching the low cost version of Bayers patented cancer medicine Nexavar while
admitting the case. More...
Bayh Dole in India: Not a great idea

(Dwijen Rangnekar , 28-Feb-2010 , Business Standard)
In recent times the making of intellectual property law in India has been ironically tarnished by claims of
plagiarism. More...
Copyright panel cancels meet

(Bharati Dubey , 28-Feb-2010 , The Times Of India)
The joint committee of producers and writers formed by the HRD ministry has cancelled its meeting
scheduled for Sunday after Bollywood producers abstained from attending it. More...
No interim relief for Bayer: Supreme Court

(Manish Ranjan , 27-Feb-2010 , Livemint)
The apex court refused to stay a Delhi HC order of 10 Feb which rejected Bayers attempt to block the
DCGI from allowing Cipla to market its generic version of Nexavar More...
Pharma sector gets booster dose for innovation

For instance a biotech company must file international patents in order to protect its IP and to conduct
clinical trials which are all legitimate R&D expenses that would need to be covered under the weighted
deduction scheme. More...
Desi Viagra likely to roll out of Kerala institute

(IANS , 26-Feb-2010 , The Times Of India)
TBGRI director A. Subramonian principal investigator of the project undertaken for the past three years
said they were in the process of applying for a patent. More...
Customs duty move to help media gaming firms in India

( by Shilpa Jamkhandikar and Bharghavi Nagaraju , 26-Feb-2010 , Reuters)
The governments move to simplify the customs duty on imported films will help the entertainment
industry cut costs but imposing service tax on intellectual property rights could be a dampener officials
said. More...
Big Pharma starts believing in outside innovation

(Pillman , 25-Feb-2010 , DNA)
One business development executive felt that the approvals from the FDA are coming at a faster speed
now and so there could be big drugs in the offing but another remained skeptical saying that newer
approaches to research like patent pools and collaborative work may fetch better dividends. More...
Bayer drags Cipla to SC over anti cancer drug patent

(Indu Bhan , 25-Feb-2010 , The Financial Express)
German drug major Bayer AG on Wednesday approached the Supreme Court seeking protection for its
drug Nexavar even as Ciplas plea for marketing approval for Sorafenib the generic version of its kidney
cancer drug is pending with the regulatory authorities. More...
More delay in supplies to AstraZeneca may hit Ranbaxy revenue

(Radhieka Pandeya , 25-Feb-2010 , Livemint)
The accord between the two companies follows from a manufacturing agreement that was part of a
bigger patent infringement settlement between Ranbaxy and AstraZeneca in April 2008. More...
Patent office to recruit 257 new examiners to clear huge backlog of applications
(Suja Nair-Shirodkar, Mumbai , 25-Feb-2010 , Pharmabiz)
Faced with a huge backlog of more than 70000 patent applications that are in the pipeline for process
and examination in the country the government has decided to recruit another 257 patent examiners to
expedite the process of patent scrutiny and its disposal. More...
Ambanis now fighting over trademarks

(rasul.b , 24-Feb-2010 , Livemint)
Rival Reliance groups that had turned a blind eye to conflicting names in the past spar over Finance and
Financial More...
Infosys expects increase in patent filings

(Kirtika Suneja / New Delhi , 24-Feb-2010 , Business Standard)
Infosys Technologies expects an increase in its patent filings on the back of new technologies like cloud
computing analytics and emerging information and communication technologies. More...
Polymed gets to sell IV device in Germany

Indian law allow patent holders to have exclusive marketing rights for 20 years. More...
Host Analytics expands presence in India to support rapid product innovation

(Businesswire India , 24-Feb-2010 , The Financial Express)
Host Analytics Indian engineering team has made important contributions to the companys intellectual
property and patent portfolio as well as its industry leading analyst recommended financial performance
solutions. More...
Pharma sector wants govt to cut excise duty on bulk drugs to 4%

(Rediff Business , 23-Feb-2010 , Rediff)
At the same time they are also entering into generic business segment by tie up with low manufacturing
countries as block buster drugs worth of USD 100 billion are expected to come out of patent in the next
five years. More...
Govt considers liberalizing merger and acquisition norms

(Sangeeta Singh , 23-Feb-2010 , Livemint)
Industry has also suggested that acquisition of dead or dormant companies of intangibles such as
intellectual property rights and companies primarily into exports be exempt from CCI ratification. More...
Indian FTAs may hit SE Asian ryots

While India mulls another free trade agreement with Australia and New Zealand its FTAs with European
Union and Japan remains shrouded in uncertainty with its decisions regarding intellectual property rights
likely to impact not just India but other developing South East Asian countries as well. More...
Indian exporters breathe easy as East African nations reject draft

The new legislation in East Africa was mainly aimed at stopping affordable generic drugs from India
More...
Copyright ya wrong
(M Suganth , 22-Feb-2010 , The Times Of India)
Now that Aamir Khan is back on the HRD ministrys copyright panel which is debating the amendment to
copyright laws it is time to step away from the brouhaha and focus on the matter at hand amending our
archaic copyright laws governed by the Copyright Act 1957. More...
Protecting pharma patents

(Ronald A. Cass / WSJ , 22-Feb-2010 , Livemint)
Degrading patents has serious side effects. More...
Poly Medicure gets Germany nod for safety IV Cannula

(fe Bureaus , 22-Feb-2010 , The Financial Express)
In these preliminary injunctions the German court had found that the attacked products infringed the
German part of the European Patent 1 911 486. More...
We should do R&D in India

Medical technology is not like pharmaceuticals where a single chemical has been patented and no one
can come out with that product. More...
GI marker of Tirupati laddus gets nod

(Express News Service , 20-Feb-2010 , express buzz)
The Geographical Indication Registry has not committed any illegality by registering Tirupati laddus as a
geographical indication the Registry has submitted in its counter affidavit filed in the Madras High Court
on Friday. More...
Does Cong have a patent in visiting Dalit homes asks BJP

(PTI , 20-Feb-2010 , The Hindu)
Taking strong exception to Congress remark that its chief Nitin Gadkari was aping Rahul Gandhi by
visiting Dalit households BJP today asked if any particular party has a patent to do so. More...
Biogen to bring its global drug portfolio to India

We have sought patents for these drugs in India and the country will be part of future global launches of
all our drugs Ms Seth added. More...
Sun Pharmas cancer drug application gets EMA backing

The development comes at a time when Sun is up against a suit by Sanofi Aventis in the US alleging
patent infringement and asking the US Food and Drug Administration not to grant approval to market it
in America. More...
Does India Want Drug Innovation or Not?

(By RONALD A. CASS , 18-Feb-2010 , The Wall Street Journal)
A string of recent court decisions degrading patent rights suggests the answer is no. More...
Book building worries

(Latha Jishnu / New Delhi , 18-Feb-2010 , Business Standard)
Googles project to digitise the worlds books raises complex issues of copyright fair use and fears of
monopoly power. More...
Patent offices need more staff

(Special Correspondent , 18-Feb-2010 , The Hindu)
70000 patent applications in the pipeline for process: Controller General of Patents More...
Berry enterprising
(By Siddharth Gadkari , 18-Feb-2010 , Mumbai Mirror)
Not wanting to let farmers from other regions fool consumers into buying their strawberries by saying
they are from Mahabaleshwar producers of the original fruit have applied for a patent More...
Experts NGOs oppose CII GWU summit on IP for strong patent regime in India
Even as the Confederation of Indian Industry two day Summit on IP in association with the George
Washington University has got underway in Mumbai several public interest groups and experts have
raised eyebrows expressing apprehensions that the one sided focus of IP Summit is detrimental to
Indian interests. More...
Patents weapon of biopirates of the West

(Gokul Chandrasekar , 18-Feb-2010 , express buzz)
Biodiversity is in the air: 2010 is being observed as its international year and an international
biodiversity summit will be held in Nagoya in October. More...
Industry can handle todays problem but need us for tomorrows science
(Joe C Mathew & Vandana Gombar , 18-Feb-2010 , Business Standard)
CSIR gets patents but doesnt sell these exclusively exclusivity reaches only the rich. More...
70000 patent applications lying due to shortage of examiners

(PTI , 17-Feb-2010 , The Hindu)
Over 70000 patent applications are in the pipeline for examination and may need at least 3 4 years for
approval under the Intellectual Property Rights Act due to shortage of examiners a senior government
official said. More...
Drug induced speculation in India

(By HARSH JOSHI , 17-Feb-2010 , The Wall Street Journal)
For blockbuster drugs like Lipitor and Plavix the patent expiration schedule is even more front loaded.
More...
Delhi HC dismisses B Brauns appeal for interim injunction against Poly Medicure
(Gireesh Babu, Mumbai , 17-Feb-2010 , Pharmabiz)
A division bench of the High Court of Delhi has dismissed an appeal filed by the Germany based B Braun
Melsungen AG and its Indian subsidiary against the New Delhi based Poly Medicure Ltd seeking an
interim injunction restraining the latter from manufacturing and selling a needle guard product for which
the company claims to have an Indian patent. More...
Northern SMEs gear up to file for patents

(Komal Amit Gera / Chandigarh , 16-Feb-2010 , Business Standard)
Taking inspiration from their bigger brothers small and medium units in the northern region are gearing
up to seek patents for their products in the international market. More...
GSK to increase headcount introduce more products

(P.T. Jyothi Datta , 16-Feb-2010 , Busines Line)
Two of the drugs are patented and the medicines will be priced differently in the local market he said
adding that the price had not yet been decided. More...
While Bayer pushes patent EU parliamentary group opposes

While German firm Bayer has adopted a try till you succeed stance on pursuing patent linkage in India
on the other hand a European parliamentary group is planning to call on the EU and European
Commission the executive arm of the EU to not push for provisions such as patent linkage in developing
countries. More...
Biotech industry pushes for fiscal sops, duty exemption

(K Ramnath Shenoy/PTI / Bangalore , 16-Feb-2010 , Business Standard)
This is short sighted in view of the fact that international patent filings are key to the biotech sector she
said. More...
Indian drug makers worried by East Africas legal proposals

Countries such as Uganda and Tanzania are taking their cue from a Kenyan law against fakes More...
India EU FTA gets flak in Europe

Intellectual property in trade agreements could endanger the poor mans access to affordable medicines
according to a veteran member of the European Parliament. More...
Drug trials begin for cancer Alzheimers

(IANS , 14-Feb-2010 , The Times Of India)
We re into research that can give us patents. More...
Indian cotton products may soon carry US trademark seal

(Amit Mitra , 13-Feb-2010 , Busines Line)
Indian consumers of cotton apparel and home furnishings may soon have an additional point of interest
to pick up their favourite products from retail stores. More...
Indian pharma in midst of corporate transformation

(P B Jayakumar / Mumbai , 13-Feb-2010 , Business Standard)
Industry sources also said Ahmedabad based Cadila Pharmaceuticals is also planning to appoint a CEO
with strong background in biological drug development as the company is planning to develop a large
portfolio of copycat off patent biologic drugs. More...
IPR policy resolves issues in knowledge sharing

(Vinson Kurian , 13-Feb-2010 , Busines Line)
Proposes commons licence for traditional knowledge. More...
US patent for Avanir Pharmas low dose quinidine formulations of Zeniva

(Aliso Viejo, California , 13-Feb-2010 , Pharmabiz)
Avanir Pharmaceuticals Inc announced that the United States Patent and Trademark Office has issued
the company a new patent for its lead drug candidate Zenvia extending the period of patent protection
in the United States into late 2025. More...
Market flooded with Smartphone look-alikes
(Writankar Mukherjee & Debjoy Sengupta , 13-Feb-2010 , The Economic Times)
While it is a conscious business decision to launch models which are look alike of bigger brands we do
make certain design modifications to ensure that there are no IPR or legal issues. More...
Drug Makers Decry Indian Patent Law

(GEETA ANAND , 12-Feb-2010 , The Wall Street Journal)
Multinational drug companies have pushed big time into India in recent years after the country agreed to
respect intellectual property rights for pharmaceutical products. More...
Renault likely to take charge of Logan revival

(Murali Gopalan , 12-Feb-2010 , Busines Line)
Sources say that the most likely solution will result in M&M divesting its 51 per cent stake in favour of
Renault which by the end of the day holds the intellectual property rights for the Logan. More...
Indian pharma cos to grow 12% will witness more deals

The pharmaceutical industry globally is facing a period of significant drug patent expiries which expands
the addressable market for generics companies. More...
Glaxo Voltas in brand war

Volmax vs Voltas dispute back with Intellectual Property Board More...
Every generic drug is not spurious says court

(P.T. Jyothi Datta , 11-Feb-2010 , Busines Line)
Observations made in Bayer patent link case. More...
Book famine
(Atty. Adrian S. Cristobal Jr. , 11-Feb-2010 , BusinessMirror)
In one of the committee hearings concerning amendments to the copyright laws at the House of
Representatives there was a contingent of blind people led by an advocate who participated in the
discussions on House Bill 4217 sponsored by Rep. Irwin Tieng. More...
HC rejects Bayers patent plea on cancer drug

A bench of the High Court here today dismissed an appeal by Bayer the German pharmaceutical
company on an earlier decision to allow marketing of generic versions of its patented drug. More...
US pharma cos sue Lupin for patent infringement

US based Purdue Pharma Products LP and UK based Napp Pharmaceutical Group have sued Lupin Ltd
and its US subsidiary Lupin Pharma Inc claiming that their attempt to manufacture and market the
generic version of the analgesic tramadol ER infringes patent coverage of the innovator. More...
Parliament panel wants govt review on Innovation Bill

Critics say there is a disconnect between its objectives and the efficacy of a Bayh Dole structure More...
Danone begins marketing flavoured milk

(Ratna Bhushan , 10-Feb-2010 , The Economic Times)
The Wadia Group had sued Groupe Danone in a Singapore court claiming violation of its intellectual
property rights of the Tiger brand. More...
HC rejects petition of UCB Franchim

(STAFF WRITER , 10-Feb-2010 , Press Trust Of India)
The Delhi High Court has rejected the petition of global biopharma major UCB Farchim against the
Indian drugmaker Cipla and the countrys patent authority over rejection of its patent of a new anti
allergic drug and directed it to approach sectoral tribunal IPAB. More...
Everyones connected
(Manju Menon and Kanchi Kohli Manju Menon and Kanchi Kohli , 09-Feb-2010 , Hindustan Times)
In one of the meetings in 2007 126 approvals for Intellectual Property Rights from the Council for
Scientific and Industrial Research were approved. More...
UK court overturns GSK patent for lupus drug

(By Andrew Jack in London , 09-Feb-2010 , Financial Times)
The UK courts on Tuesday overturned a patent on belimumab a treatment for the auto immune disease
lupus under joint development by GlaxoSmithKline and Human Genome Sciences. More...
Approach patents body first: HC to pharma firms

Delhi High Court dismisses six petitions of drug majors. More...
Court throws out pharma cos patent claim

The patents authority had rejected the claim saying The claimed invention covered by the subject
application lacks inventive steps More...
Sambalpuri Bastralaya moves for patenting

Sambalpuri Bastralaya Handloom Co operative Society Limited has filed a patent application on textile
weaving technology and design application on wall hanging made by it using the new technology.
More...
China fifth in UN patent filings India way behind

(D Ravi Kanth / Geneva , 9-Feb-2010 , Business Standard)
China is on its way to become a global leader in scientific research while India has a long way to go
according to data issued by a Geneva based organisation on international patent filings. More...
Dispute on patent adds to Toyotas problems

(By Bernard Simon in Toronto , 09-Feb-2010 , Financial Times)
As if Toyota did not have enough on its plate with a series of damaging recalls the Japanese carmaker is
embroiled in a long running patent infringement dispute in the US involving a key part of the technology
that drives its hybrid petrol electric vehicles. More...
Purdue Pharma sues Lupin following Para IV filing on controlled release painkiller drug
The US based Purdue Pharma Products LP and its UK based partner Napp Pharmaceutical Group Ltd has
filed a para IV patent infringement suit against the Mumbai based Lupin Ltd and its US subsidiary for the
latters move to manufacture and market the generic version of the narcotic painkiller drug Ultram ER.
More...
CRISIL assigns IPO grade 4/5 to Glenmark Generics

According to estimates by CRISIL Research drugs worth an estimated $137 billion is scheduled to go off
patent in the US and Europe over the next five years which implies significant generics opportunity for
India. More...
Lupin goes all out to make up for lost chances

(Satish John & , 8-Feb-2010 , Livemint)
An ANDA filing is an application with the US Food and Drug Administration for permission to introduce a
generic version of an already patented drug in the market. More...
Troikaa drug to get US patent

(Press Trust of India , 8-Feb-2010 , The Financial Express)
Troikaa Pharmaceuticals a Gujarat based fast growing healthcare company is likely to get US patent for
its novel drug delivery form of Diclofenac injections Dyanapar AQ. More...
Google book project US stance firm but not enough for Indian writers
(Lison Joseph , 8-Feb-2010 , Livemint)
In its Friday submission the department told the court the US government believes that the court lacks
authority to approve a proposed settlement agreement as it involved the rights of many foreign
copyright owners too. More...
Indian SMEs keep pharma prices under check: Study

A global study by Health Action International a non government body on the price variations of
Ciproflaxin a commonly used medicine in 93 countries found the price charged by Bayer the originator of
the drug to be the lowest in India. More...
Scientists want changes in innovation Bill

(Anika Gupta , 8-Feb-2010 , Livemint)
The scientists presented complaints regarding the proposed Protection and Utilization of Public Funded
Intellectual Property Bill 2008. More...
Jaggi Vasudev hits out at Bt brinjal

Pointing out that the Western multinational companies hold patent for these GM foods he said, when the
farmers in the country tend to use these genetically engineered seeds the royalties for it would go to the
European countries. More...
Fears regarding amendments to Copyright Act will diminish

HRD Minister Kapil Sibal in an interview with ET says talks at length about the proposed amendments to
Copyright Act. More...
Zari industry set to regain lost lustre

(Melvyn Thomas , 05-Feb-2010 , The Times Of India)
The industry is likely to be registered under the Geographical Indication Act of Government of India
which stipulates protection of the market of the producers and safeguards the interests of the
consumers of the unique product by mid 2010. More...
China tops India comes in third in IPR violations

(T.E. Raja Simhan , 5-Feb-2010 , Busines Line)
For the US China remains the top trading partner for IPR violations followed by Hong Kong in the second
place and India third during 2009 according to the US Customs and Border Protection and the
Immigration and Customs Enforcement. More...
Foreign drug makers may lose monopoly

Patent office can revoke monopoly rights if firms cannot prove obligations were met within their 3 year
window More...
Swedens generic drive to help Indian pharma cos

(Soma Das , 5-Feb-2010 , The Financial Express)
If buyers choose to pay the difference between the cheapest available option and the brand prescribed
in case of an off patent drug they could buy the latter. More...
IPL: SET Max & organisers to check ambush marketing
(Monica Behura , 5-Feb-2010 , The Economic Times)
Six IPL franchisee teams have also protected their Intellectual Property Rights and Trademark rights in
India and eight other cricket playing nations for their merchandise and logos. More...
India reluctant to relent on greater market access to EU

(Asit Ranjan Mishra , 5-Feb-2010 , Livemint)
Leena Menghaney campaign coordinator for access to essential medicines Medecins Sans Frontieres
raised concerns about the EUs insistence on stringent TRIPS plus trade related aspects of intellectual
property rights measures. More...
Kiris market pie gets bigger but debt weighs

(Ramkrishna Kashelkar , 5-Feb-2010 , The Economic Times)
The buyout entailed purchase of 17 manufacturing facilities out of Dystars 19 along with all brands
patents and intellectual property rights. More...
BlackBerry wins patent battle with Motorola in Britain

(IANS , 04-Feb-2010 , The Economic Times)
BlackBerry maker Research In Motion Wednesday won its patent battle in Britain with Motorola when a
court in London ruled in favour of the Canadian wireless giant based at Waterloo near here. More...
Wed restrict filings to those of high quality

The chief patent counsel for Microsoft Corp. Bart Eppenauer spoke in an interview about his companys
growing engagement with Indian patent offices and law firms to strengthen its intellectual property
portfolio in the country More...
Cautionary tale of trolls

Patent trolls and not patent holders are raking in money from lawsuits and firms are desperately seeking
a way out More...
Governments move to relax Copyright Act lacks vision

People with visual handicaps can read printed material only when it is converted into older formats such
as Braille or newer and more flexible audio and electronic formats More...
Delhi HC stays patent revocation of Abbotts drug

The Delhi High Court has stayed a decision to revoke the patent granted to Abbott Laboratories
blockbuster rheumatoid arthritis drug Humira adalimumab. More...
Informatica reports record quarterly revenues of $151 mn and 25 pct license revenue growth
(Businesswire India , 2-Feb-2010 , The Financial Express)
This compares to $39.5 million in income from operations in the fourth quarter of 2008 which included
the one time benefit of $11.5 million from patent related litigation proceeds net of patent contingency
accruals. More...
Court relief for city firm in copyright case

(Kartikeya , 01-Feb-2010 , The Times Of India)
In a significant judicial order aimed at protecting intellectual property rights of internet driven and
telephonic services the Delhi high court has restrained a website from using a directory of telephone
numbers originally compiled by a Mumbai based dial up firm. More...
Sun gets a boost as FDA rejects rival Osmoticas plea

As Sun and Osmoticas drugs are in the form of tablets and therefore not replicas of Wyeths drug
capsulesthese companies do not have to wait for the Pfizer group companys patent to expire later this
year. More...
FE Editorial: Google booked

(The Financial Express , 1-Feb-2010 , The Financial Express)
After all intellectual property issues didnt really gain global traction till the last part of the twentieth
century at which point they exploded all across a host of commerce verticals ranging from
pharmaceutical to artistic works. More...
Boston Scientific reaches $1.73 bn patent settlement with J&J

(Press Trust of India / New York , 01-Feb-2010 , Business Standard)
US medical devices maker Boston Scientific Corp today said it will pay $1.73 billion to settle three patent
disputes with healthcare firm Johnson & Johnson. More...
Secretly India talked free trade agreement with EU again

There is absolutely no word on how Indias concerns on intellectual property tariffs on agriculture second
hand goods etc would get addressed said a source closely associated with the government. More...
Apeda initiates registration process of basmati under GI

(Sandip Das , 1-Feb-2010 , The Financial Express)
After much delay the process of registration of basmati rice famaous across the globe for aroma and
long grain under the geographical indications certification has started in the country. More...
Drugs companies face deeper cuts in research

(Carl Mortished, World Business Editor , 1-Feb-2010 , Times Online)
The extent to which the recession has cut into high value research and development jobs in the
pharmaceutical industry will be laid bare this week as job losses in the industry climb to 12000. More...
Eco labelling norms for ornamental fish formulated
The task force also looked in to the geographical indications of each species and requirements needed
for import of exotic species. More...
Frivolous patents make drugs costly

Many pharma companies are making huge money just by making minor changes over existing
technologies or drugs a patent expert said More...
Indian authors publishers take Google to court on book deal

(Our Bureau , 30-Jan-2010 , Busines Line)
Claim violation of copyright laws. More...
Strong patent law may lead to rise in costs

(Express News Service , 30-Jan-2010 , express buzz)
A strong patent law may lead to increase in the costs of essential supplies including the inputs for
improved agricultural and industrial production thereby raising the cost of living of the poor and the
marganilised said N R Madhava Menon member of the Commission on Centre State Relations. More...
A journey without maps

(Pratik Kanjilal , 30-Jan-2010 , Hindustan Times)
Any cultural nationalist can tell you that like all good things multiculturalism originated in India and we
have a patent on it. More...
Farmers chip in against Bt Brinjal

(Swati Mathur , 30-Jan-2010 , The Times Of India)
Even as scientists and farmers cry foul over the ill effects of genetically modified crops an equally large
community of scientists and patent holders are making a strong case in favour of Bt brinjal. More...
HC to hear pharma patent issue on Monday

(Indu Bhan , 29-Jan-2010 , The Financial Express)
The Delhi High Court will hear on Monday a batch of petitions filed by global pharma majors seeking
quashing of the patent offices decision that rejected their applications for grant of patents for their
respective drugs. More...
Pharma research: Pool of skills and low costs fosters growth

(By Amy Kazmin in Bangalore , 28-Jan-2010 , Financial Times)
Indias pharmaceutical industry cut its teeth in the 1970s fostered by local patent laws that only
protected the unique processes of synthesising a drug molecule rather than the molecules themselves.
More...
India asks Kenya to change law making generics illegal

(Amiti Sen & Khomba Singh , 28-Jan-2010 , The Economic Times)
The Kenyan legislation lays down that all generics will be treated as counterfeits and rejected in case a
patent holder in a third country files a dispute. More...
Merck loses temozolomide patent infringement suit against Teva in US court

(Whitehouse Station, New Jersey , 28-Jan-2010 , Pharmabiz)
Merck & Co Inc announced that the US District Court for the District of Delaware ruled against the
company in a patent infringement suit against Teva Pharmaceuticals USA Inc. More...
Microsoft joins network designed to counter patent trolls

(By John Letzing , 27-Jan-2010 , MarketWatch)
Microsoft Corp. a technology giant that wins thousands of patents every year has joined RPX Corp. a
start up network aimed at aggregating intellectual property to shield its members from what are known
as patent trolls. More...
Drug patent regime has led to high prices: US Study

Other reasons include transfer of marketing rights to larger companies and mergers and acquisitions
among drug companies. More...
Cipla asks UNITAID to address all related issues to make patent pool workable & realistic
Indian pharma major Cipla has expressed apprehensions on achieving the goal of the UNITAIDs patent
pool initiative which was recently created for HIV AIDS drugs unless and until the terms and reference
objectives and all issues of patent pool are spelt out clearly. More...
The problem with patents

(Shamnad Basheer , 27-Jan-2010 , Livemint)
The 2008 Protection and Utilization of Public Funded Intellectual Property Bill popularly called the Indian
Bayh Dole Bill since it draws inspiration from the US Bayh Dole Act of 1980 is currently undergoing
scrutiny by a parliamentary select committee. More...
Claris talking to 3 more pharma majors for Pfizer type deal

Claris and Pfizer had entered into a deal in May last year for supply of sterile injectable drugs that are off
patent and have lost exclusivity in the US Canada Australia New Zealand and Europe. More...
Virgin Atlantic files case in UK against Jet

(P.R. Sanjai , 27-Jan-2010 , Livemint)
Virgin founded by Richard Branson holds the patent and design rights for the flatbed seating system in
several countries including in the UK More...
New vaccine may help cure multiple diseases

(Sohini Das & Maulik Pathak / Ahmedabad , 27-Jan-2010 , Business Standard)
A brainchild of Pawan Saharan chairman of Mumbai based Biomix Network the active pharmaceutical
ingredient is patented in India as Radha 108. More...
Bajaj Auto gets European patent for ExhausTEC

(Corporate , 25-Jan-2010 , Busines Line)
Leading auto maker Bajaj Auto on Monday said its technology ExhausTEC which help improve
performance of a two wheeler has been granted a patent by the Munich headquartered European Patent
Office. More...
Traditional knowledge: Concern on access pact

(Vinson Kurian , 25-Jan-2010 , Busines Line)
The access agreement that India has signed with foreign patent offices to share Traditional Knowledge
Digital Library in the form of a prior art could undermine its confidentiality. More...
DIPP in mysterious pact on patents with Wipo

(Latha Jishnu / New Delhi , 25-Jan-2010 , Business Standard)
Agreement mentions Indias IP strategy and action plan but govt declines to reveal what these contain.
More...
We need to step up research in IPR regime

(VR Kaundinya , 25-Jan-2010 , The Financial Express)
The use of technology is helping breeders around the world to maximise the potential for crops to
become a source of renewable energy food and feed while minimising the environmental impact. More...
Still in the trial phase

(Ram Prasad Sahu / Mumbai , 25-Jan-2010 , Business Standard)
The company wants to set up an unit at the SEZ get the clearances from European and US federal
authorities and market off patent drugs in those geographies. More...
Student innovations have no takers in India

Around six lakh students graduate from technical institutes every year in our country and none of their
innovative project works is considered worthy of a patent. More...
Google wins domain name dispute against Indian cybersquatter

Internet search engine Google has won a domain name dispute against an Indian cybersquatter at the
World Intellectual Property Organisation. More...
Lawsuit against Salman in HC seeks stay on screening of Veer

(PTI , 23-Jan-2010 , DNA)
Choudary has sought damages of Rs20 lakh from the producer and the director of the film for alleged
violation of his copyright for making illegal gains by lifting a portion from his book Trilogy of Wisdom.
More...
Anand Sharma pins hopes on concluding Doha Round

CIIs two day 16th partnership summit began in Chennai on Saturday under the theme global
partnerships: More...
Immigrants in US see better prospects back home

(Vivek Wadhwa , 23-Jan-2010 , The Economic Times)
My research teams at Duke University calculated that foreign nationals were named as inventors or co
inventors in one quarter of WIPO patent applications filed from the US in 2006. More...
Domestic pharma cos fare well in patent litigation tests

(Soma Das , 22-Jan-2010 , The Financial Express)
In the legal mesh of pharma patent litigations in the largest drug market the US Lupin Pharma Sun
Pharma Ranbaxy Labs Ltd and Dr Reddys Ltd top the list of domestic pharma companies which have
best battled the court cases in the last decade. More...
Scientists fume over new patent bill

(Rema Nagarajan , 22-Jan-2010 , The Times Of India)
Thousands of scientists working in government supported research institutes and labs in India are
seething over a proposed law which makes it mandatory to patent all new innovations generated by
public funded research. More...
The curious case of patent agents

(FEROZ ALI , 21-Jan-2010 , The Hindu)
Patent Agents are hybrid professionals whose area of practice is at the intersection of law and science.
More...
India issues demarche to China on trade barriers

(Dhiraj Nayyar , 21-Jan-2010 , The Financial Express)
The demarche also demands the removal of local content requirement and recognition of the
international IPR registration regime in order to create a favourable investment environment in wind non
conventional energy. More...
Perils of the US model

Copying the Bayh Dole legislation to promote the culture of innovation in India can be counterproductive
More...
Flexible pricing pays off for drugs groups

(By Andrew Jack in London , 22-Jan-2010 , Financial Times)
GSK which also has a significant presence in China remained in India when many of its foreign peers cut
back during the nationalisations and weakening of patent rules in the 1970s. More...
US to curb delay in entry of generic drugs

(Joe C Mathew & P B Jayakumar / New Delhi/mumbai , 20-Jan-2010 , Business Standard)
Indian pharmaceutical companies which are increasingly choosing to settle patent litigation with global
drug majors in the US would have to be more cautious now. More...
With 219 patents pending Infosys awaits a non linear push

(Amit Tripathi , 20-Jan-2010 , DNA)
Infosys Technologies which surprised analysts with a 6.1% volume growth for the quarter ended
December is betting on its 219 pending patent applications in India and the US for a sustained non
linear growth. More...
4 brokerages predict strong growth for top drug makers

(C.H. Unnikrishnan and Radhieka Pandeya , 20-Jan-2010 , Livemint)
The Rs90000 crore drug industry sells more than one third of its production in the international market
More...
Ranbaxy to buy biotech firm Biovel Lifesciences

(Press Trust of India , 20-Jan-2010 , The Financial Express)
Ranbaxy Laboratories on Tuesday said it would acquire Bangalore based Biovel Lifesciences for an
undisclosed amount. More...
Lupin cant sell pill in US Teva files patent suit

(Khomba Singh & Vishal Dutta , 20-Jan-2010 , The Economic Times)
Israeli drugmaker Teva Pharma has filed a patent infringement suit in the US against Lupin that
prevents the Indian pharma company from selling the generic or copycat version of Tevas birth control
drug LoSeasonique for 30 months in a key market. More...
Pharma tops in patent suits

(Joe C Mathew in New Delhi , 19-Jan-2010 , Rediff, Business Standard)
Pharmaceutical patents are just over a fourth of all patents granted in the country but domestic drug
makers account for almost all post grant patent opposition filed official data reveals. More...
Nokia victory in IPCom patent suit

(By Andrew Ward in Stockholm and Jane Croft in London , 19-Jan-2010 , Financial Times)
Nokia the worlds largest maker of mobile phones yesterday won an important court victory in a
longrunning patent dispute with German based IPCom as it braced itself for fresh legal conflict with
Apple of the US. More...
Fake mineral water plant unearthed in Lodhika

(Express News Service , 19-Jan-2010 , Indian Express)
In a joint operation officers of the local police and Enforcers of Intellectual Property Rights unearthed a
duplicate manufacturing plant of a standard mineral water company at Lodhika in Rajkot district on
Monday. More...
Pharma sector looks at inventory correction gradual restocking

(Reghu Balakrishnan , 19-Jan-2010 , The Financial Express)
Aventis Pharma Ltd will be one of the key beneficiaries of the patent regime as the parent company has
a strong R&D pipeline. More...
Could copyright be wrong?

(V. Raghunathan , 18-Jan-2010 , Livemint)
Much media attention has gone into how much Vidhu Vinod Chopras movie 3 Idiots has borrowed from
Chetan Bhagats novel Five Point Someone. More...
Torrent has reach product mix edge

(Nitin Shrivastava , 18-Jan-2010 , DNA)
Torrentd revenues would be driven by steady growth in its domestic formulation segment increasing
presence in developing markets and huge opportunities on account of newer product introduction and
expiry of patents on large number of products in developed markets. More...
Indian cos grab 32% of total ANDAs approved by US FDA in 2009

(Sanjay Pingle, Mumbai , 18-Jan-2010 , Pharmabiz)
Research based Indian pharmaceutical companies and their subsidiaries are increasingly cornering a
large percentage of approvals for ANDAs from the US FDA during the last three years as per a
compilation did by Pharmabiz. More...
For a new approach to China

(Nick Schulz , 18-Jan-2010 , Livemint)
Life for innovation intensive businesses is difficult in countries where there is scant respect for liberty
More...
McSuppiahs Uttapam
(Saritha Rai , 17-Jan-2010 , Indian Express)
McDonalds sued him for trademark violation. More...
Intellectual bottlenecks
(AMIT SHOVON RAY, SABYASACHI SAHA , 16-Jan-2010 , The Financial Express)
Indias strive towards self reliance shaped its post independence policy agenda in all spheres. More...
Pharma tops in patent suits

Pharmaceutical patents are just over a fourth of all patents granted in the country but domestic drug
makers account for almost all post grant patent opposition filed official data reveals. More...
Drug cos patent settlements to cost Americans $3.5 bn annually

Under such deals innovator companies have entered into agreements with the generic firms to delay the
launch of generic version of patented drugs. More...
Bharti Walmart flagship brand faces opposition

(Rasul Bailay , 14-Jan-2010 , Livemint)
The management will fight to protect intellectual property of its Great Value label applications filed in 08.
More...
Dr Reddys Nexium plan faces hurdle

(KV Ramana , 14-Jan-2010 , DNA)
Dr Reddys Laboratories plans to get a pie of the $4 billion market of generic Nexium are likely to be cut
short by the patent holder of the drug AstraZeneca. More...
Wockhardt gets US FDA tentative nod for Levofloxacin tablets

The Mumbai based pharmaceutical firm will launch the product immediately upon expiration of the
patent on June 20 2011 it said. More...
Copenhagen to Nagoya
(Business Standard / New Delhi , 13-Jan-2010 , Business Standard)
India being one of the worlds most biodiversity rich countries has been a victim of bio piracy despite the
existence of the CBD and agreement on trade related intellectual property rights. More...
A generic giant juggernaut called Teva Pharma

(Pillman , 14-Jan-2010 , DNA)
Within the biosimilars sphere Teva has said $115 billion worth of products will go off patent by 2015.
More...
IBM May Not Be the Patent King After All

(By Steve LeVine , 13-Jan-2010 , Business Week)
No one beats IBM on patents. More...
Drug patent settlements to come under EU scanner

(Pallavi Aiyar / Brussels , 13-Jan-2010 , Business Standard)
Patent settlements between pharmaceutical companies that make original drugs and their generic
manufacturing rivals are to come under renewed scrutiny from the European Unions competition
regulation authority as part of an ongoing probe into the sector. More...
Suven Life gets two patents
(Our bureau , 13-Jan-2010 , Busines Line)
Suven Life Sciences Ltd has been granted two product patents for its New Chemical Entities in China and
Russia. More...
Pharmas Govt join for $80 bn off patent market

(Sanchita Sharma , 13-Jan-2010 , Hindustan Times)
Pfizers Viagra will be among 61 drugs worth over US $ 80 billion that will go off patent at the US Patent
and Trademark Office between 2011 and 2013 and the Indian pharmaceutical industry is gearing to
make the most of it. More...
Patent office begins data compilation on working patents in India

For the first time in the history of patents in the country the government has started the gargantuan
process of compilation of data regarding the status of the valid patents granted during the last over 20
years in the country. More...
Ministers in retreat over copyright law

(By Jean Eaglesham, Chief Political Correspondent , 13-Jan-2010 , Financial Times)
Ministers last night retreated from a proposed sweeping power to change copyright law amid increased
political wrangling over digital piracy and internet regulation. More...
Infosys awaits nod for 219 patent applications in India US

IT behemoth Infosys Technologies which today came out with its third quarter earnings is awaiting
approval for 219 patent applications in India and the US. More...
Pharma looks up to fresh opportunities in generics market

(Venkata Ramana , 12-Jan-2010 , DNA)
Several drugs going off patent some markets such as Japan trying to encourage generics penetration
and the agreements the global pharma companies are forging with the Indian pharmaceutical companies
are expected to add strength to the Indian generic pharma story a chief operating officer of a pharma
company said on condition of anonymity. More...
Spurious drugmakers harm countrys image says Azad

(Staff Reporter , 11-Jan-2010 , The Hindu)
In the event of drugs worth $80 billion going off patent Mr. Azad urged industry heads to seize the day
and harness the fullest benefit from this opportunity to the advantage of the Indian economy. More...
Patent expiries set to knock drug group profits

(By Andrew Jack in London , 11-Jan-2010 , Financial Times)
Patent expiries in the coming years on some of the worlds top selling medicines will have an
unexpectedly large impact on profits because of margins which can reach nearly 90 per cent a US
investment analyst has warned. More...
Biodiversity Forum expresses concern over biopiracy

(Roy Mathew , 11-Jan-2010 , The Hindu)
According to an official release of the Union Ministry for Environment and Forests about 2000 patents
related to the Indian Systems of Medicine are granted every year in the U.S. Patent and Trademark
Office the European Patent Office and other overseas patent offices. More...
Novartis gains on getting patent right

(BS Reporter / Mumbai , 11-Jan-2010 , Business Standard)
Novartis finally ended with a Rs 21 or 3.6% gain at Rs 590. More...
Dr. Reddys AstraZeneca may settle patent case out of court

(PTI , 11-Jan-2010 , The Hindu)
Dr Reddys Laboratories long standing patent dispute with Europes AstraZeneca over a drug to treat
heartburn may be resolved out of court following a similar settlement between the European drug maker
and Israels Teva feel market watchers. More...
Novartis gets patent for cancer drug

(PB Jayakumar / Mumbai , 11-Jan-2010 , Business Standard)
Swiss drug manufacturer Novartis AG has been granted patent protection in India for Nilotinib a superior
version of blood cancer drug Gleevec. More...
Trademarks and their licensing to preserve the distinctiveness of the brand

(AZB and Partners , 11-Jan-2010 , Livemint)
A major criterion for choosing a specific brand is the goodwill that the brand has More...
Natco to launch cancer drug as min stays DCGI order

Natco has filed a pre grant opposition on Abraxis patent for its drug in India. More...
Mahableshwar strawberry awaits its special status

(Anuradha Mane, Gitesh Shelke , 11-Jan-2010 , DNA)
Nearly 1500 strawberry farmers from Mahabaleshwar and surrounding areas have applied for a
geographical indication status for their strawberries. More...
Japan may open up to Indian generics

(Amiti Sen & Khomba Singh , 11-Jan-2010 , The Economic Times)
Japan has veered round to considering Indias demand to open up its over $100 billion pharmaceutical
market to Indian generic or off patent drug producers after four years of dogged resistance a
government official involved in the talks said. More...
NSE seeks trademark for currency derivatives label
The National Stock Exchange has applied before authorities for registration of trademark for its Currency
Derivatives label. More...
India: A nation develops

(By Joe Leahy , 10-Jan-2010 , The Financial Times)
During the same decade the number of patent applications soared to 500 a year by 2007 the study
found. More...
Rush begins to become patent agents

There has been a sharp increase in the number of graduates who want to qualify as patent agents the
intermediates between patent applicants and the patent office. More...
NRIs invited to invest in pharmaceutical sector

Azad points to drugs worth $80 going off patent. More...
Delhi HC rejects B Brauns plea

The German company was granted patent for manufacturing and marketing safety IV cannula in India in
September 2007. More...
Roches cancer drug loses protection

Likely test case with courts yet to rule on patent challenge from generic manufacturers. More...
Creative rights v/s copyright

(Subhash K Jha , 9-Jan-2010 , The Times Of India)
Its about creative rights copyright the relationship between cinema and literature and between the world
of words and visuals. More...
Counterfeiting piracy leave deep holes in firms pockets

(BS Reporter / Chennai/ Bangalore , 9-Jan-2010 , Business Standard)
The industry estimates that 20 per cent of the drugs available in the market today are spurious. More...
AstraZeneca heads off Nexium threat with Teva deal

(Ben Hirschler , 8-Jan-2010 , Livemint)
Anglo Swedish drug maker AstraZeneca Plc settled a US patent row over Nexium with Israels Teva
Pharmaceutical Industries Ltd on Thursday protecting its top selling heartburn drug from immediate
generic competition. More...
Microsoft appeals Word patent case once more

( by Bill Rigby , 08-Jan-2010 , Reuters)
Microsoft asks full panel of judges to review case. More...
Pfizer Strides Arcolab enter pact to sell generic drugs in US

The move would further bolster Pfizers stake in the generics market 40 off patent products expected to
be delivered. More...
Challenges to domestic drug patents grow

Domestic drug companies who have been challenging drug patents in the US and Europe are now taking
the first steps to challenge patents granted in India to companies based there. More...
Robust growth in auto sales may fuel fake components market

(Aveek Datta and Tarun Shukla , 8-Jan-2010 , Livemint)
Pankaj Chadha director of automotive practice at Ernst and Young India says the spread of fake parts is
the biggest disincentive for a multinational to step into India because it loses control over its intellectual
Government creates patent watchdog

(By Jonathan Moules , 08-Jan-2010 , The Financial Times)
The government has created an intellectual property regulator to ensure that those using lawyers to set
up patent and trade mark protection get a fair service and appropriate redress when things go wrong.
More...
Stay awake drugs second act focus on battling jet lag

(Andrew Pollack , 8-Jan-2010 , Livemint)
For Cephalon a drug company in Frazer Pennsylvania with a reputation for aggressive business tactics
the approval for jet lag is part of a plan to extend the patent protection for its core franchise in stay
awake drugs. More...
Wockhardt gets tentative nod from US FDA

The patent covering this product is under litigation in the US courts. More...
Pharma industry urges govt to withdraw WHO study on data exclusivity

This the industry feels is an attempt on the part of the multinational companies to get monopoly by
creating a new IP Right. More...
Copyrights and wrongs
The 3 Idiots spat is not really about violation of authors rights by filmmakers moral or otherwise. More...
We dont want MNCs to patent Indian traditional knowledge

(Rediff , 07-Jan-2010 , Rediff Business)
Multinational companies will now find it very difficult to patent products made by using Indian traditional
knowledge of science. More...
Pfizer to source 40 off patent cancer care drugs from Strides

(BS Reporter / Bangalore , 7-Jan-2010 , Business Standard)
Global pharma major Pfizer is to source source 40 off patent cancer care products from Bangalore based
Strides Arcolab and sell the products in the United States. More...
India for one binding deal on use of bio resources

Bio piracy is going to be the new battle ground for the rich and poor countries. More...
Dr Reddys poised to gain from new drug

(Ravi Ananthanarayanan and Manas Chakravarty , 6-Jan-2010 , Livemint)
The drug will lose patent protection in the US in 2011. More...
SC rejects Pernod Ricards plea in trademark violation case

(Indu Bhan , 6-Jan-2010 , The Financial Express)
In a set back to global alcoholic giant Pernod Ricard SA France the Supreme Court has rejected its claim
of exclusivity over usage of the word Imperial thus allowing other liquor manufacturers to use it in their
respective brands. More...
Free copyright control to help blind students: Xaviers Resource Centre

(Mayura Janwalkar , 6-Jan-2010 , DNA)
An amendment in copyright laws is needed to bring about this awareness. More...
Why piling eye drops high can make a lot of sense to Novartis
(Dominic Walsh: Tempus , 5-Jan-2010 , TimesOnline)
However a quick glance at the likely patent expiries among the leading pharmaceutical companies in
2010 explains why Novartis may pay top dollar for eye drops. More...
Novartis to get leg up in India with Alcon buy

(P B Jayakumar & Praveen Bose / Mumbai/ Bangalore , 5-Jan-2010 , Business Standard)
Will get access to large distribution network in eyecare segment. More...
India documents traditional formulations yoga postures

(STAFF WRITER , 5-Jan-2010 , Press Trust Of India)
TKDL is an effort to protect our traditional knowledge mainly traditional medicine and yoga postures
from misappropriation through patents granted abroad as had happened with the use of neem and haldi
Environment Minister Jairam Ramesh told reporters. More...
CA rules in PALs favor in infringement case

(Joel R. San Juan / Reporter , 05-Jan-2010 , Business Mirror)
THE Court of Appeals has ordered the dismissal of the 18 year old infringement case filed against flag
carrier Philippine Airlines by a textile manufacturer for the alleged illegal use of her patented shell
designs on table linens and placemats in its commercial flights. More...
Marico acquires Malaysian hair care brand Code 10 from Colgate

The acquisition by Maricos Malaysian unit estimated to be about Rs 25 crore by analysts also gets
intellectual property rights related to the brand from Colgate Palmolive. More...
Rich & poor countries now dont agree on biodiversity

Some 2000 patents related to the Indian system of medicine are granted every year by the US Trade
and Patents Office European Patents Office and other overseas patent offices. More...
Indias Cipla in drug supply talks with GSK Teva

(By Farah Master , 04-Jan-2010 , Reuters)
But Hamied said that WTO regulations which since 2005 have prevented Indian generic drug firms from
copying patented drugs mean Indian generic companies have to change their business model or risk
being swallowed up by multinational firms. More...
Ranbaxy launches dermatological product Lulifin

It is well recognised that in the post patent era licensing would be the key strategy to bring new
chemical entities to India. More...
Web portal owner held for uploading Jaggubai

(Express News Service , 4-Jan-2010 , Express Buzz)
The CCC deleted the film from all from the websites and arrested the owner of www.cine-
entertainment.com Shankerganesh in Coimbatore on Saturday and booked him under the Indian
Information Technology Act and the Indian Copyright Act. More...
Indian drug makers maintain pace of US marketing approvals

Twenty five Indian generic drug makers got a little over 200 approvals from the US Food and Drug
Administration in 2009 half a dozen more than the number approved in 2008. More...
Copyrights mired in grey

(Alisha Coelho , 03-Jan-2010 , Mid-Day)
3 Idiots controversy has opened the intellectual property rights can of worms. Lifting plots or tunes is
punishable... but its still only on paper say lawyers More...
Puneri Pagdi obtains geographical indication status

(By Shivaji (ANI) , 03-Jan-2010 , Yahoo News)
Shree Puneri Pagdi Sangha recently managed to obtain geographical indication status for the famed
Puneri Pagadi the traditional headgear of Maharashtrians and thus ensure its conservation. More...
A prescription for soul

(Jumana Shah & Himansh Dhomse , 03-Jan-2010 , DNA)
Now I have a vision that India and particularly Cadila should work on new molecules and patent them.
More...
Patent regime set for fresh changes

Quality of applications to improve as most old applications have been cleared. More...
Pharma cos see opportunity in India

(P.T. Jyothi Datta , 2-Jan-2010 , Business Line)
This year marks five years since the Patent Law was amended to respect product patents. More...
News on Royalty payment brings cheer in new year

(Kumkum Sen / New Delhi , 2-Jan-2010 , Business Standard)
The Patent Act 1970 was conducive to methods such as reverse engineering and incremental adaptation
leading to inefficient and unrealistic self reliance. More...
A new prescription
(Radhieka Pandeya , 01-Jan-2010 , Livemint)
In what is referred to as the patent cliff starting in 2010 and running up to 2012 innovator
pharmaceutical companies are set to lose billions of dollars from patent expiries of some of their hottest
drugs. More...
Paris Hilton sued by shoe company

(ANI , 31-Dec-2009 , DNA)
According to documents filed last week New York based firm Gwyneth Shoes are suing Hilton for
trademark and patent infringement. More...
Innovation culture still absent
(P.T. JYOTHI DATTA , 31-Dec-2009 , Business Line)
Protecting intellectual property can be an incentive to spur innovative work which helps drive research in
areas where few others tread. More...
U.S. panel to probe Richtek patent charges

(by Diane Bartz , 31-Dec-2009 , Reuters)
A U.S. trade court has agreed to investigate Richtek Technology Corps charges that Advanced Micro
Devices and other companies violated its patents for power supply regulating devices. More...
India EU free trade talks enter key phase

(Asit Ranjan Mishra , 31-Dec-2009 , Livemint)
Small groups have already met on sanitary and phyto sanitary measures investment and intellectual
property rights he said. More...
Google plays games after patent application

(Martin Waller: City Diary , 31-Dec-2009 , TimesOnline)
Is YouTube the worlds biggest online video portal also planning on setting up some sort of gaming
service? More...
Top grosser 3 Idiots to fund real life inventors

(Samar Halarnkar , 31-Dec-2009 , The Hindustan Times)
Its generated 220 patent applications in India and one in the US. More...
Reliance Life ups stake in GeneMedix to 79%

(Sreejiraj Eluvangal , 31-Dec-2009 , DNA)
GeneMedix is primarily into making biosimilars biopharmaceutical drugs that have emerged out of their
patent period and was acquired by Mukesh Ambani in 2007 with an eye to on two of its products EPO
and GCSF. More...
No copyright music without licence this year

(Amit Sharma , 30-Dec-2009 , The Economic Times)
Pubs and discotheques will have to dance to the tune of the music industry to go ahead with their high
voltage New Year parties thanks to a Bombay High Court order on Wednesday that barred hotels and
other commercial establishments in the city from playing copyright music without licence. More...
Geographical Indication move to boost Ceylon Tea

(By Nizla Naizer , 30-Dec-2009 , Daily Mirror)
The tea industry in Sri Lanka is moving one step closer to protecting the value of Ceylon Tea by deciding
to obtain a Geographical Indication for the commodity from the World Trade Organisation. More...
Nokias latest patent strike on Apple a risk but may pay off
(Brett Young , 30-Dec-2009 , Reuters)
Nokias latest patent strike against Apple underscores the changing dynamics of the cell phone market
with the sector leader no longer holding the whip hand over rivals in terms of product development.
More...
South Korean trade pact with India going into effect

(IANS , 30-Dec-2009 , Sify News)
The agreement which is similar to a free trade agreement and covers trade in goods and services and
investments along with chapters on competition and intellectual property rights also includes phased
eliminations of other tariffs most notably in the car industry. More...
Drugmaker has unique model to compete with rivals

(By John O'Doherty , 30-Dec-2009 , The Financial Times)
But Jordan based Hikma has managed to create a business from selling both generic medicines and
drugs that are still under patent to other pharma groups. More...
Industry flays IPR pact with WIPO

(Gireesh Chandra Prasad, KG Narendranath , 30-Dec-2009 , The Financial Express)
The governments plan to take the help of the World Intellectual Property Organisation a UN arm to put
into action an intellectual property rights strategy has met with strong disapproval from a section of the
local pharma industry which suspects the arrangement would benefit only multinational patent holders.
More...
Nokia steps up smartphone patent battle

(By Joseph Menn in San Francisco and Maija Palmer in,London , 30-Dec-2009 , The Financial Times)
Nokia escalated its patent dispute with rival Apple over smartphone technology yesterday filing a
complaint with the US International Trade Commission. More...
US Bill a challenge for Indian generic firms

(Manas Chakravarty, Ravi Ananthanarayanan and Vatsala Kamat , 30-Dec-2009 , Livemint)
Initially companies were fighting the patent challenge battles in court. More...
Depomed files second Para IV infringement suit against Lupin on Glumetza patent
(Gireesh Babu, Mumbai , 30-Dec-2009 , Pharmabiz)
The US based Depomed Inc has filed one more Para IV patent infringement suit against the Mumbai
based Lupin Pharmaceuticals and its US subsidiary alleging infringement of four patents on its anti
diabetic pill Glumetza in the District Court of Maryland. More...
Indian sweets drinks and clothes get copyrights

(Siddharth Kumar/PTI / New Delhi , 29-Dec-2009 , Business Standard)
Places famous for their food drink or clothes like Tirupati Ladu Goa Feni and Banarsi Saree from much
before the days of copyrights and trademarks won the exclusive right to use these names in 2009.
More...
Music industry cheers royalty bonanza
(Indo Asian News Service , 29-Dec-2009 , Yahoo News)
The Rs.740 crore Rs.7.4 billion Indian music industry is cheering the cabinets decision to amend the
Copyright Act of 1957 that will fetch royalty to composers singers lyricists et al. More...
Lupin eyes acquisitions to gain market share

We will get there through the organic and inorganic growth route and in licensing products especially
patented products that have no presence in India said Chakraborty. More...
Global mobile market turns into a legal battleground

(New York Times , 29-Dec-2009 , The Economic Times)
When Nokia the worlds largest maker of mobile phones sued Apple Samsung LG and eight other
competitors within six weeks beginning in October it said it was conducting a routine defense of its
intellectual property. More...
CSIR set to recruit patent examiners

The patent office had been so far relying on govt agencies for recruitment More...
Spreadsheet
(fe Bureau , 29-Dec-2009 , The Financial Express)
This is because the patent law has limited the number of patented medicines which has reduced the
scope of import of formulations. More...
Fairchild Infineon settle patent lawsuits

(by Divya Sharma in Bangalore , 29-Dec-2009 , Reuters)
Fairchild Semiconductor International Inc said it reached a patent settlement deal with Infineon
Technologies and that it entered into a cross license deal with the company. More...
Emerging Middle Class Nations

(Sanjaya Baru / New Delhi , 28-Dec-2009 , Business Standard)
Goldman Sachs may want to patent its term BRIC for Brazil Russia India and China that lie at the core of
the new middle. More...
Pharma PSUs: Caught between public interest and commercial goals

(Gireesh Chandra Prasad , 28-Dec-2009 , The Financial Express)
Secondly if the government has to break a patent held by a private company that refuses to sell a drug
at an affordable price it should have a state entity to rely on for making a copy of the costly private
sector brand. More...
Roche eyes acquisitions in India
What holds us back is the patent protection system in the country which needs improvement Agarwal
points out. More...
India gives EU another chance to settle drug seizure case

These seizures violate the international patent agreement Trips as the drugs being confiscated are off
patent both in India and the countries it was being exported to the official said. More...
Generics cos in the cold as big pharma has its way in US

(REUTERS , 26-Dec-2009 , The Economic Times)
The massive US Senate healthcare reform measure passed on Thursday with support from the
multibillion drug industry but makers of cheaper generic rivals are feeling left out in the cold. More...
Amgen wins recombinant erythropoietin patent dispute against Roche

(Thousand Oaks, California , 26-Dec-2009 , Pharmabiz)
Amgen announced that the United States District Court in Boston has entered final judgment and a
permanent injunction against Roche prohibiting Roche from infringing Amgens patents on recombinant
erythropoietin thus bringing the five year patent infringement dispute to an end. More...
Two GM varieties of wheat developed by Indian co registered

(Prabha Jagannathan , 26-Dec-2009 , The Economic Times)
The new wheat varieties are being registered under the Protection of Plant Varieties and Farmers Rights
Act which meets all the requirements under the TRIPS agreement for intellectual property rights for
plants. More...
Govt in pre Xmas reforms drive

(BS Reporter / New Delhi , 25-Dec-2009 , Business Standard)
The amendments to the domestic Copyright Act would bring it in conformity with the World Intellectual
Property Organisation Internet Treaties WIPO Copyright Treaty and WIPO Performances and
Phonograms Treaty which have set the international standards in these spheres. More...
New bill to amend copyright laws music to creators ears

(Indo Asian News Service , 24-Dec-2009 , Yahoo News)
Musicians writers and film directors who were earlier exploited by producers and music companies can
now hope to reclaim commercial rights to their works and earn royalty from them. More...
Indoco eyes US Europe markets; will sign four contract research treaties soon
(Reghu Balakrishnan , 24-Dec-2009 , The Financial Express)
The company is in the process of submitting abbreviated new drug applications ANDAs with the USFDA
for the products proposed for marketing. More...
Patent office braces for surge in applications
The Indian Patent Office is set to address the shortage in patent examiners and the standardised
implementation of the Patents Amendment Act 2005 as it braces for the increasing flood of patent
applications. More...
Eisai bets big on India

Incidentally the companys flagship product Aricept used for treating Alzheimers diseases and
contributing close to $3.2 billion of the total revenue of $8.6 billion is going off patent in 2010. More...
AFDIL sues Fizikem Labs for trademark infringement of its Beplex Forte
(Our Bureau, Bangalore , 24-Dec-2009 , Pharmabiz)
Anglo French Drugs & Industries Limited has resorted to legal proceedings against the Baddi based
Fizikem Laboratories for trademark infringement of its flagship brand Beplex Forte. More...
Copyright aggression
(Latha Jishnu / New Delhi , 24-Dec-2009 , Business Standard)
Microsofts methods of protecting copyright have been slammed by the court as abuse of its money
power. More...
Citys top pubs hotels served notices for not paying music licence fee
Under the statutory sanction of section 35 of the Indian Copyright Act playing commercial music in
public without paying the requisite licence fee is liable to contempt of court. More...
Top drug firms take in licensing route to up sales

Most of the in licensed products by Indian companies are niche innovative patented drugs that are
selling well in the US and Europe and are made by medium scale players in those countries. More...
Indian American works new way to save refineries billions

(IANS , 23-Dec-2009 , The Economic Times)
Purdue has filed a patent application for the new crude distillation sequences. More...
Do drug prices need control?

(BS Bureau , 23-Dec-2009 , Rediff)
This is essential for the proper implementation of Indian patent law safeguards that facilitate the local
production of low cost generic versions of patented medicines and vaccines through government use
licences. More...
Troikaa Pharma to put Sanand plan on hold till December 2010

(Sohini Das / Mumbai/ Ahmedabad , 23-Dec-2009 , Business Standard)
Expects to get patent approvals for Dynapar AQ in 99 countries in six months More...
Opposition slams government on Copenhagen Accord

(Gargi Parsai , 23-Dec-2009 , The Hindu)
Mr. Yechury described the financial commitments under the accord as woolly and said the Intellectual
Property Rights regime on transfer technology was effectively negated in the accord. More...
WTO rules against China; Victory for US

(Press Trust Of India / Washington , 23-Dec-2009 , Business Standard)
The WTO Appellate Body yesterday held that China was obstructing trade by forcing foreign suppliers to
distribute certain copyright intensive products through state owned companies which is inconsistent with
the Beijings obligations with the WTO. More...
Pharma cos want govt to question European seizure statistics

(Soma Das , 23-Dec-2009 , The Financial Express)
Apart from goading the Centre to move the WTO against the recent drug seizures in Europe the
domestic pharma industry is also urging the government to officially question the statistical claims of the
European Commission that project India as a major source of counterfeit drugs. More...
Lupin settles litigation with Forest Labs for Alzheimers drug

Lupin Ltd has settled all its ongoing patent litigation with US based Forest Laboratories on the
Alzheimers disease treatment drug Namenda memantine tablets. More...
Microsoft Loses Lawsuit But Word Likely to Stay

(David Coursey , 22-Dec-2009 , Yahoo News)
First the good news: No you won have to turn in your copies of Office 2007 even now that Microsoft has
lost its appeal of a lawsuit brought by the Canadian company i4i. More...
Pharma 2009: No medicine to cure adversity

Indian pharma industry found that it had no medicine to cure adversities that came its way in 2009
when it battled shipment seizures by EU authorities tightened US regulations Chinese drug piracy and
currency fluctuations. More...
Sanofi to acquire Chattem expand presence in US

Hes also looking beyond branded drugs and the search for new blockbusters to businesses that are less
subject to patent expirations More...
Five years on patent regime implementation still needs work

(P.T.Jyothi Datta , 22-Dec-2009 , Business Line)
It was on the eve of January 2005 that an Ordinance was issued to amend the Patent Act 1970 and
bring in a regime that would honour product patents. More...
Abbott Sues Sandoz Over Patent for Muscle Relaxant Nimbex

(By Phil Milford , 22-Dec-2009 , Bloomberg)
Abbott Laboratories a diversified healthcare product maker accused Sandoz Inc. of infringing a patent for
the muscle relaxant Nimbex by seeking approval to market a generic copy of the drug in the U.S.
More...
Outsourcing steroid for Indian pharma firms

(B G Shirsat & P B Jayakumar / Mumbai , 21-Dec-2009 , Business Standard)
Daiichi Sankyo owned Ranbaxy Laboratories struggling with its US business due to manufacturing
discrepancies at two of its Indian units is also likely to recover in future with drug supply deals and
exclusivities as part of patent case settlements with drug majors said analysts. More...
India to be part of patent pool for HIV drugs clarifies UNITAID

(Joseph Alexander, New Delhi , 21-Dec-2009 , Pharmabiz)
UNITAID which hast just voted to create a patent pool for HIV AIDS drugs with the aim of bringing down
the prices of medicines for this dreaded disease has clarified that India will also be included in the pool.
More...
Dr Reddys plans to launch Lipitors generic version in US

(Press Trust Of India / Hyderabad , 21-Dec-2009 , Business Standard)
Under the new drug application submitted to the US drug regulators approval Para IV filing are those
which seeks nod for launching the drug before expiry of patent. More...
HC permits Madras Fertilizers agent to use trade name Vijay Agro

(Our Legal Correspondent , 19-Dec-2009 , Business Line)
The Madras High Court in its interim order on an original application of the State owned Madras
Fertilizers Ltd has permitted a firm in Erode district of Tamil Nadu to use the trade name Vijay Agro from
February 1 2010 in selling its product mixture fertiliser. More...
Lok Sabha nod to amended trademark law

A person seeking global trade mark now need not apply for it in several countries incurring a big cost as
Lok Sabha today amended the trade mark law to simplify the procedures. More...
U.S. Patents Take a Fall

(By Michael Arndt , 17-Dec-2009 , BusinessWeek)
Hurt by smaller R&D budgets and offshoring U.S. patent applications fell this year and Yankees are
winning fewer grants than non residents More...
The Indian Dream

(Vivek Wadhwa , 16-Dec-2009 , Hindustan Times)
We calculated that foreign nationals residing in the US were named as inventors or co inventors in one
quarter of WIPO patent applications filed from the US in 2006. More...
Cipla in talks to supply drugs to Germanys BI

Global innovator pharma majors are expected to see a drop in sales in the next 2 3 years because the
patent on their top selling drugs would expire and they dont have a strong research pipeline to
supplement the revenue loss. More...
Patent pool for AIDS gets UNITAIDs approval

In a relief for civil society and stakeholders from India Unitaid the international facility for the purchase
of drugs against HIV AIDS has included middle income countries such as India in the pool More...
HUL to pay 1% of net sales as trademark royalty

(TNN , 16-Dec-2009 , The Time Of India)
Hindustan Unilever Ltd has entered into a fresh trademark licence agreement with its parent company
Unilever under which the Indian subsidiary will pay royalty of 1% on net sales of specific brands whose
trademark is owned by the Anglo Dutch parent company. More...
Health Ministrys nod to WHO for a study on data exclusivity raises concern
The union health ministrys move has raised eyebrows among the patient community and the public
interest groups in the country as they view that data exclusivity could prevent the registration of low
cost quality generic versions of medicines even when there is no patent on a medicine when a drug does
not meet the standards for patentability. More...
Trademark case: Interim injunction favours Witco

Witco a multi-brand travel accessories retailer with stores in Chennai Bangalore and Kerala has got a
breather from the Madras High Court in a trademark infringement case. More...
India fourth largest illegal downloader

(IANS , 15-Dec-2009 , The Economic Times)
According to their findings India trails only the US Britain and Canada in online copyright infringement.
More...
Glenmark may settle with Merck on cholesterol drug

Glenmark Pharmaceuticals Ltd may settle with US firm Merck Schering Plough Pharmaceuticals Llc
resulting in the withdrawal of patent litigations related to the launch of a copy of the latters $1.6 billion
in sales drug ezetimibe in the US market next year according to a report released by First Global
Securities Ltd last week. More...
FM III may say whats not news
(Nivedita Mookerji , 15-Dec-2009 , DNA)
The HRD ministry was late in giving its input over issues related to copyright and intellectual property
rights a source pointed out. More...
Court pulls up Microsoft for forum hiring

The Delhi High Court has asked software major Microsoft to shell out Rs 8 lakh as cost security for
deliberately choosing Delhi to file copyright violation cases despite having offices in cities where the
offences were allegedly committed by opposite parties. More...
Suven Life gets patent in Canada for two new chemical entities
Drug maker Suven Life Sciences today said it has recieved patent for two new chemical entities used in
the treatment of diseases like Parkinson and schizophrenia from the Canadian Intellectual Property
Office. More...
Technology transfer development pact to be feather on Indias cap

(Urmi A Goswami , 14-Dec-2009 , The Economics Times)
The poorer countries will also get support for the deployment and diffusion of environmentally safe and
sound technologies efforts to leverage public and private investment in technology incremental costs of
soft and hard technologies for implementation of adaptation and mitigation purchasing of licences and
other intellectual property rights issues. More...
Consideration for use of copyright is not royalty

(HP Agarwal / New Delhi , 14-Dec-2009 , Business Standard)
In many cases foreign companies grant access to Indian companies for using their data base and other
copyrighted material. More...
Bangalore scores an A in Biotech

(Kiran Mazumdar-Shaw , 14-Dec-2009 , DNA)
Offering fiscal incentives to the tune of Rs400 crore and benefits such as investment promotion subsidy
interest free loan on VAT and financial support for patent registration the policy goes to show the strong
support the sector receives from the government. More...
Wipo goes green for domain name dispute resolution

(PTI , 14-Dec-2009 , The Economics Times)
Amid the ongoing global debate on climate change the World Intellectual Property Organisation has said
it will launch paperless procedures in matters relating to domain name dispute from Monday. More...
India to maintain edge in generics

(BS Reporter / Chennai/ Hyderabad , 14-Dec-2009 , Business Standard)
Bad reputation on quality of medicines exported from India and weak combat mechanisms from the
government to weed out counterfeit medicines in the international society are the bottlenecks for the
Indian pharmaceutical companies to grow in Japan according to Kenji Toda chairman Japan
Pharmaceutical Manufacturers Association. More...
Indian drugs face EU music

Indian medicine accounted for over 50 per cent of all drug seizures in Europe for intellectual property
rights violation last year. More...
NGOs slam move to keep India out of patent pool

(BS Reporter / New Delhi , 13-Dec-2009 , Business Standard)
Indian civil society organisations have opposed a reported move by global drug procurement agency
UNITAID to exclude countries such as China Brazil and India from a proposed patent pool for AIDS
drugs. More...
Indian pharma industry can improve share in global market

The Indian pharmaceutical companies are already lining up the US FDA office to get patent on the first
to file basis of the drugs which will get off patented in 2012. More...
Recession hits patent filings in US fall 2.3% in 09

The financial crisis has not only rattled the US economy but seems to have also choked innovations
among the Americans with patent filings declining for the first time in over a decade in 2009. More...
Apple hits back at Nokia in patent war

(By Joseph Menn in San Francisco and Andrew Parker in,London , 12-Dec-2009 , The Financial Times)
Applefiled a countersuit against Nokia yesterday claiming that the Finnish company has pursued anti
competitive practices and infringed 13 of its patents. More...
History of Jeans Modi'fied Denim Denim ka Bandhan

(TNN , TOI Crest , 12-Dec-2009 , The Times Of India)
He teamed up with Strauss and the two received US Patent 139121 for their rivetted and rivetting
product. More...
Pfizer sues Dr Reddys over Lipitor patent

(Phil Milford / Bloomberg , 11-Dec-2009 , Livemint)
Dr Reddys had notified Pfizer in October that it was seeking US Food and Drug Administration permission
to sell copies of Lipitor and that the patent wasnt infringed according to the lawsuit More...
IT firms focus on patents to widen revenue window

(Surabhi Agarwal , 11-Dec-2009 , The Financial Express)
This is a game changer for the companies showing how far they have traveled from just adapting
software off the shelves as they aggressively try to acquire intellectual property rights to fuel future
revenue growth. More...
FTAs could hurt farmers too

After generic drugmakers its the farmers who are feeling the heat of the intellectual property regime.
More...
Who owns the eggplant?

(Latha Jishnu / New Delhi , 10-Dec-2009 , Business Standard)
What would be the nature of intellectual property rights that the developers would enjoy given that the
technology is owned by Mahyco a company in which Monsanto has a 26 per cent stake and how soon
would the universities be allowed to release their seeds? More...
Satyam Upaid in $70 million settlement Deloitte is auditor

(Lison Joseph , 10-Dec-2009 , Livemint)
The settlement requires the British firm to give Mahindra Satyam a worldwide royalty free licence to all
its patents besides withdrawing all pending legal actions initiated by it. More...
Ranbaxy admits to infringement of Purdues Oxcontin patent in US

(Gireesh Babu, Mumbai , 10-Dec-2009 , Pharmabiz)
Ranbaxy Pharmaceuticals Inc the US subsidiary of the Gurgaon based Ranbaxy Laboratories has
reportedly admitted infringement of the US based Purdue Pharmas patent for the blockbuster drug
Oxycontin in the District Court for the Southern District of New York US. More...
Do we need data exclusivity ?

(Business Standard / New Delhi , 9-Dec-2009 , Business Standard)
The term DE is new to India as it does not figure in the Trade Related Intellectual Property Rights
Agreement of the WTO. More...
HIV patent pool hobbles as drug firms want India China excluded
Efforts to bring together nine global drugmakers to pool their HIV patents in order to make available
treatment to millions living with HIV AIDS in the developing world seem to have faltered over a crucial
issue the inclusion of middle income countries such as India and China in the list of beneficiaries. More...
Indian IP firm adjudged best in Asia Pacific

J Trivedi & Co an Ahmedabad based law firm specialising in intellectual property rights and patent
related issues has emerged the Highly Commended Law Firm of the Year in the Asia Pacific region at the
2009 World Leaders International IP Awards. More...
US Gilead appeals against patent rejection of AIDS drug Viread

(Khomba Singh , 8-Dec-2009 , The Economics Times)
US drug company Gilead Sciences has filed an appeal in the Indian Intellectual Property Appellate Board
to challenge a recent order by an Indian Patent Office that rejected two patent claims for its best seller
drug Viread tenofovir disoproxil fumarate. More...
Trademarks sans borders

(Editorial , 8-Dec-2009 , Business Line)
It is only logical that countries that adhere to a philosophy of open trade must also recognise
trademarks registered in one country to be universally applicable across markets. More...
Our growth does not depend on acquisitions’

Established products are medicines that have lost patent exclusivity or are close to losing exclusivity.
More...
Bill seeks to make trademark registrations easier

A Bill seeking to amend the Trade Marks Act 1999 with a view to enabling Indian nationals as well as
foreign nationals to secure simultaneous protection of trademarks in other countries was tabled in
Parliament on Friday. More...
India to take on EU over drug seizures

The seizures were made for alleged patent law violations as some of these drugs are still under
protection in European countries. More...
Column : Buzz in pharma biz

(MG Arun , 7-Dec-2009 , The Financial Express)
Their profitability is under pressure owing to patent expiries challenges in pricing and falling R&D
productivity. More...
Intellectual Property Right is a social crime

(DNA,Ahmedabad , 06-Dec-2009 , DNA)
There was a time when knowledge was imparted freely. More...
Data exclusivity study draws flak from Indian drug industry

A WHO official asking not be named as he is not the authorised spokesman said: Neither the TRIPs or
the Doha declaration mention data exclusivity. More...
Cephalon files patent lawsuit against Teva for armodafinil tabs

(Frazer, Pennsylvania , 5-Dec-2009 , Pharmabiz)
Cephalon Inc has filed a lawsuit in US District Court in Delaware against Teva Pharmaceuticals USA Inc
for infringement of US Patent Nos. 7132570 the 570 Patent 7297346 the 346 Patent and RE37516 the
516 Patent for the Cephalon product Nuvigil armodafinil Tablets. More...
News broadcasters oppose amendment of copyright laws

(Ashish Sinha / New Delhi , 5-Dec-2009 , Business Standard)
The issue of proposed amendments to the existing Copyright Act 1957 is becoming a flash point
between broadcasters and the Ministry of Human Resource Development with news broadcasters asking
the government to take them into confidence before undertaking any amendment to the law. More...
Our negotiating position has strengthened: Jairam

(Nitin Sethi , 5-Dec-2009 , The Times Of India)
The same IPR issues that dominated the pharmaceutical debate are now coming to dominate the climate
change debate. More...
Drug trial data issue invites pharma fire

The controversial issue of exclusivity of drug trial data which saw overseas multinational companies and
Indian pharma companies taking opposite positions is back on the table. More...
Data exclusivity study draws flak from Indian drug industry

The industrys main objection is the fact that the study is being carried out by the Delhi based law firm
Anand and Anand who has regularly represented global pharma companies in patent disputes besides
being a member of the Satwant Committee an industry excessive said. More...
Kodak Sells OLED Business To LG, Cos Will Share Patents

(DOW JONES NEWSWIRES , 04-Dec-2009 , CNN Money)
Eastman Kodak Co. agreed to sell its organic light emitting diode business to a group of South Koreas LG
companies and also said it has an agreement with LG Electronics Inc. that will allow each company
broad access to the others patent portfolio. More...
Bata drags Relaxo to court over brand infringement

Footwear major Bata today dragged its rival Relaxo Footwear before the Delhi High Court alleging
infringement of one of its popular brand Sparx. More...
Bridging the gap on clean technology

(Padmaparna Ghosh , 04-Dec-2009 , Livemint)
Developed nations say it will destroy the incentive for innovation. More...
Commerce ministry plans to add booster dose to border scrutiny to check spurious drug
exports
(Soma Das , 04-Dec-2009 , The Financial Express)
After the health ministry declared the domestic pharma market largely free of spurious and substandard
drugs the commerce ministry now wants to step up the vigil at the checkpoints to scrutinise pharma
export consignments and assess the quantum of spurious drugs that could be leaving the country and
ascertain whether such channels of spurious drugs exist. More...
Technology Of Hope
(Kiran Mazumdar-Shaw , 3-Dec-2009 , The Times Of India)
A large number of blockbuster drugs are also set to go off patent giving the sector here tremendous
opportunities. More...
Pfizer Cipla in Aurobindo redux plan

(K V Ramana , 2-Dec-2009 , DNA)
Drug maker Cipla could soon be supporting the strategies of global pharma giant Pfizer for expanding its
footprint and protecting its business interests as many of its drugs go off patent. More...
Doha progress only with new market access: US

(D Ravi Kanth / Geneva , 2-Dec-2009 , Business Standard)
Meanwhile India Brazil and South Africa yesterday decided to pool their energies for adopting common
positions on all issues pertaining to WTO and World Intellectual Properties Organization. More...
Japans top pharma comes calling

(MG Arun , 2-Dec-2009 , The Financial Express)
In March this year Pfizer entered into an agreement with Aurobindo Pharma to market drugs that are no
longer patent protected and dont have market exclusivity in the US and Europe. More...
Copyright draft is tough on covers

(Nivedita Mookerji , 2-Dec-2009 , DNA)
Broadcasting organisations will have to give prior notice to the Copyright Board for airing published
literary or musical work. More...
Japans largest drug maker Takeda plans India foray

Besides Takedas best selling anti diabetic anti diabetic medicine Actos will lose patent protection in
2011. More...
Sunny re rating of pharma companies

(B G Shirsat & Ashok Divase / Mumbai , 2-Dec-2009 , Business Standard)
It is aiming at entering the market with a new biotech product off patent and with a market size of $5
billion. More...
Gilead set to benefit from HIV guidelines

(By Andrew Jack in London , 02-Dec-2009 , The Financial Times)
Yusuf Hamied head of Cipla the Indian generics company that is one of the largest providers of
stavudine and other HIV treatments dismissed the financial impact pointing out that he could also sell
Gileads principal drug in developing countries after overturning the US companys patent on tenofovir in
India. More...
Cipla in drug supply talks with Pfizer

Pfizer after sluggish growth in its speciality and patented pharmaceutical business in the developed
markets has been aggressive on the generic or off patented drugs business. More...
Troikaa Pharma gets patent in Australia for Diclofenac painkiller injections

Troikaa Pharmaceuticals Ltd a fast growing healthcare company has been granted patent in Australia for
its novel drug delivery form of Diclofenac injections Dynapar AQ the worlds first painless painkiller
injection. More...
Fake medicine sale rampant cops helpless

Fake drugs are sold rampantly in the state. More...
Suven gets patents from EPO for 3 drugs

(Press Trust of India / Mumbai , 30-Nov-2009 , Business Standard)
Pharmaceutical firm Suven Life Sciences today said the European Patent Office has issued three patents
to its chemical entities which are used in treating nerve disorders. More...
Depomed sues Indias Lupin for patent infringement

(Esha Dey in Bangalore , 30-Nov-2009 , Reuters)
Drug developer Depomed Inc said it filed a lawsuit in a U.S. federal court against Indias Lupin Ltd
alleging that Lupins application to market a generic version of Depomeds diabetes drug Glumetza
infringed its patents. More...
Abbott gives Teva TriCor rights as early as 2011

( The Associated Press , 30-Nov-2009 , CNBC)
Pharmaceutical and medical products maker Abbott Laboratories and Laboratories Fournier SA granted
intellectual property rights for the cholesterol medication TriCor to Teva Pharmaceutical Laboratories Ltd.
according to a Securities and Exchange Commission filing Monday. More...
Revised Copyright Act to pinch broadcasters pockets

(Ashish Sinha / New Delhi , 30-Nov-2009 , Business Standard)
These included tinkering with the fair use provisions of Section 52 insertion of Section 33A and changes
in Section 31 among others. More...
City techie receives patent for anti virus software

(SiddharthKelkar , 30-Nov-2009 , Indian Express)
A system that can curtail virus attacks on computer networks as well as minimise false alerts of attacks
invented by city based computer expert received central government patent recently. More...
The reality of free

(Rajan Anandan , 30-Nov-2009 , The Economics Times)
The company is the worlds largest holder of IP rights with 13400 patents worldwide but it also spends
billions on its open innovation efforts under which it is working with the open source software
community to facilitate faster and easier access to Microsoft technologies and IP. More...
Avon to gain from nod to Ranbaxys drug

(P B Jayakumar / Mumbai , 29-Nov-2009 , Business Standard)
The company will supply the main active pharmaceutical ingredient for Valtrex. More...
Many ills in draft Copyright Act

(ET Bureau , 28-Nov-2009 , The Economics Times)
The HRD ministrys proposals for amending the Copyright Act which are slated to be discussed by the
Cabinet shortly contain provisos that will hurt the interests of artists and reduce the accountability of
copyright societies. More...
The fall of the worlds best selling drug

(By Andrew Jack , 28-Nov-2009 , The Financial Times)
Once its patents expire in 2011 generic drug manufacturers will be able to sell it far more cheaply.
More...
Patent worries
(Business Standard / New Delhi , 27-Nov-2009 , Business Standard)
Few people in this country understand how seriously Indias development as those of other Third World
countries would be impacted by a stifling intellectual property regime. More...
Supply of fake drugs grossly overstated

(Radhieka Pandeya , 27-Nov-2009 , Livemint)
Two intellectual property right issues are not involved. More...
Ranbaxy set for Rs 1000 cr boost from Valtrex clone

(K V Ramana , 27-Nov-2009 , DNA)
Gurgaon based Ranbaxy Laboratories has launched generic Valtrex tablets in the US over two years
after it settled a patent dispute with GlaxoSmithKline and secured a 180 day sales exclusivity for it.
More...
Pfizer pins hopes on Aurobindo does not rule out Indian buys
(C.R. Sukumar , 27-Nov-2009 , Livemint)
To counter competition from generic drugs and impact of patent expiry Pfizer is implementing a three
pronged strategy. More...
Broadcasters protest move to amend Copyright Act
Indian broadcasters have demanded immediate consultation on proposed amendments in the Copyright
Act which they feel will completely skew the field against television and radio industries in fact could
even jeopardise their survival while spelling windfall gains for monopolistic music companies and
copyright societies. More...
The WIPO knife edge

(Latha Jishnu , 26-Nov-2009 , Business Standard)
For well over a decade the chirpy sounding acronym for the WTOs agreement on intellectual property
rights TRIPS has rolled familiarly off tongues albeit with fear and loathing in the developing world.
More...
Govt may give sops to drug exports avoiding Europe

The European Union has been seizing Indian generic drugs en route Latin America and Africa citing
patent violations. More...
Glenmark signs licensing deal with US firm

A Glenmark official said on condition of anonymity that the company is exploring opportunities to licence
out the newly patented acne treating antibiotic to firms in the European market. More...
Chennai HC records 17 issues on Bajaj TVS dispute

(T E Narasimhan / Chennai , 25-Nov-2009 , Business Standard)
Some of the issues raised by TVS include whether they infringe Bajajs patent if TVS is entitled to
question the patent and if so, whether Bajajs patent is valid if Bajaj is entitled to claim damages
whether a lean air fuel mixture combustion constitutes an essential element in the patent and so on.
More...
Increased trade okay but FTA a difficult task

(fe Bureaus , 25-Nov-2009 , The Financial Express)
The US has very high expectations on compliance of intellectual property rights which goes beyond the
prevision of the TRIPS agreement said RS Ratna professor Indian Institute of Foreign Trade. More...
EU ends four year probe into Qualcomm

(By Nikki Tait in Brussels , 25-Nov-2009 , Financial Times)
Europes top competition regulator has ended a four year inquiry into patent royalty rates charged by
Qualcomm after the remaining companies that had brought a complaint against the US mobile
chipmaker withdrew. More...
Tread cautiously on bilateral investment treaties

(PRABHASH RANJAN , 25-Nov-2009 , Business Line)
For example most BITs and this includes BITs entered by India bind the host nation not to discriminate
between foreign and national investments allow full repatriation of income in foreign exchange to the
home country of the investor provide an extremely wide definition of foreign investment which includes
portfolio investment and intellectual property rights and provide very high compensation criteria for both
direct and indirect expropriations with very limited manoeuvrability to the host state. More...
Lupin moves to block rival generics

(K V Ramana , 25-Nov-2009 , DNA)
However after expiry of the patent that year the company took the drug off the market following which
Lupin started selling its generic version. More...
Novo Nordisk to launch range of insulin products in India

(Sohini Das / Mumbai/ Ahmedabad , 25-Nov-2009 , Business Standard)
Denmark based Novo Nordisk a world leader in diabetes care is bullish on setting up robust clinical
research functions and also leveraging the India opportunity in related fields such as data management
and studying the patent situation of the medicines under development as well as shared services.
More...
Pharmexcils 2nd Patent Facilitation Centre to be set up at NIPER Mohali

(Gireesh Babu, Mumbai , 25-Nov-2009 , Pharmabiz)
The Pharmaceuticals Export Promotion Council will launch its second Patent Facilitation Centre at
National Institute of Pharmaceutical Education and Research Mohali by the end of the month to provide
patent related information for the exporters in Northern Region. More...
India US ink pacts on Intellectual Property Rights

(Betwa Sharma in Washington , 24-Nov-2009 , Rediff Business)
India and United States on Monday signed two inter governmental agreements on Intellectual Property
Rights to help prevent misappropriation of traditional knowledge through mistaken issuance of patents.
More...
Spencer Stuart Perspectives Leadership challenge looms for generics firms

(Filomena Leonardi, Sachin Rajan and Claudia Schütz , 23-Nov-2009 , Livemint)
With generic medicines already representing a large and growing share of the pharmaceutical market
these companies are looking ahead to the patent expirations of tens of billions of dollars of branded
drugs over the next several years. More...
In the mesh of FTAs whither generics?

(Priyanka Golikeri , 23-Nov-2009 , DNA)
All the three blocs are pressing for a measure called data exclusivity a period during which the innovator
drug companys clinical trial data cannot be relied upon to register a generic exact off patent version of
the innovator drug which is 40 80% cheaper. More...
Medicis takes Lupin to US court on patent charge

Alleges infringement of patent for dermatology medicine. More...

Drug seizure Govt to drag EU to WTO
(Amiti Sen , 23-Nov-2009 , The Economics Times)
India is preparing to file a case against the European Union at the World Trade Organisation for wrongful
seizure of high quality Indian drugs at its ports while in transit to other destinations a commerce
department official has said. More...
AYUSH to take home remedies out to market

(Aditya Dev , 23-Nov-2009 , The Times Of India)
If those are found effective in subsequent trials the department will try to get the person forwarding it
the methods patent and also devise ways to market the idea. More...
Fake Chinese drugs deluge mkt with Made in India tag

(Soma Das , 23-Nov-2009 , The Financial Express)
Barely four months after China made fake drugs with deceptive Made in India labels were seized in
Nigeria more cases of spurious drugs are surfacing in the Indian market with alleged links to China.
More...
Experts confirm that RP had not reneged on its IP commitments

(Economy , 23-Nov-2009 , Business Mirror)
THE recently enacted Intellectual Property Code of the Philippines and the Quality and Affordable
Medicine Act passed into law late last year are compliant with the countrys commitments to the World
Trade Organization. More...
Fake Vicks Vaporabs tablets worth Rs 30L seized from medical stores in Karanj Shahpur
The Enforcers of Intellectual Property Rights officials working against copyright and trademark violations
had got a tip off about infringement of the P&G products in Ahmedabad. More...
Patent Volume Isnt the Best Innovation Gauge

(Michael Arndt , 22-Nov-2009 , BusinessWeek)
Patent volume based on new analysis isnt necessarily a valid proxy for innovation. More...
In healthcare we can at best play catch up with China

(Pillman , 20-Nov-2009 , DNA)
Dan Vasella the chief executive of Swiss firm Novartis which has been struggling for the last five years to
secure the patent rights in India on Glivec its therapy for a rare form of blood cancer called chronic
myeloid leukemia has spoken again on the alleged gaps in the Indian patent system. More...
Dabur accuses US firm of infringing on its trademark

(Press Trust Of India / New Delhi , 19-Nov-2009 , Business Standard)
FMCG major Dabur has alleged that US based company Aveda which manufactures and sells Ayurvedic
cosmetic products is infringing on the trademark of its skincare range. More...
EU blamed for breaking Doha Declaration denying access to cheaper medicines to poor
nations
Alleging that the European Unions trade agenda has taken a wrong turn and charging the EU with
breaking its commitment under the Doha Declaration on TRIPS three leading international organizations
have sought corrections in the existing policies and a new approach towards the issue. More...
Wockhardt Sun get US okay for generic drug

(BS Reporter / Mumbai , 19-Nov-2009 , Business Standard)
The patents covering this product had expired yesterday. More...
90% of local patents applied for and granted come from nonresidents
(Max V. de Leon / Reporter , 18-Nov-2009 , Business Mirror)
THE countrys patent landscape continues to be dominated by foreign owners with data both from the
World Intellectual Property Organization and the Intellectual Property Office of the Philippines indicating
that over 90 percent of the patents applied for and granted here were from nonresidents. More...
Supreme Court: When Do Ideas Deserve Patents

(By Adi Narayan , 18-Nov-2009 , TIME)
It all started in 1997 when a little known company wanted to patent a method for letting customers of
utility companies pay a fixed predictable sum each month. More...
Bayers patent case hearing in HC today

Drug multinational Bayers appeal against rejection of its petition in the Delhi high court indirectly
seeking patent linkages will come up for hearing on November 18. More...
Mahindra Satyam could service M&M

(Shweta Bhanot, Rachana Khanzode , 18-Nov-2009 , The Financial Express)
According to Natarajan the firm currently helps its clients in the intellectual property IP space for
designing products working out new regulations industrial products for emission fuel efficiency & fuel
cost reduction and safety aspects in aerospace area. More...
Protectionism by another name

The India European Union Joint Customs Cooperation Committee has met in New Delhi and failed to
resolve the issue over Indian generic drugs being seized when they are in transit through European
ports. More...
Suven Life Sciences plans to raise funds for clinical trials

(C.R. Sukumar , 18-Nov-2009 , livemint)
Its chairman and CEO Venkat Jasti said SUVN 502 is intended for the symptomatic treatment of
Alzheimers disease schizophrenia and other disorders of memory and cognition More...
NGOs warn against proposal to link marketing approval with patent status
The public interest groups have again warned the Health Ministry against any attempt to link marketing
approval with patent status as being pushed by the multinational companies saying that it would turn
the drug regulator into Indias patent police. More...
Intel withdraws suit against govt

The worlds largest chip maker Intel Corporation today withdrew its suit before the Delhi High Court
against the government trademark registry and the two small firms which have got registered its
trademark till 2017. More...
TRIPS flexibilities sacred no plans to touch them

(KG Narendranath , 17-Nov-2009 , The Financial Express)
Francis Gurry the director general of the World Intellectual Property Organisation was in the capital
recently amid the controversies over multilateral bodys plans to reform the Patent Cooperation Treaty
which some quarters allege would lead to infringing upon the powers of national governments in matters
of patent examination and grant. More...
Medicis deal generic biz to boost financials

( Kiran Kabtta Somvanshi , 17-Nov-2009 , The Economic Times)
Glenmark has also settled a patent litigation with the same company over the latters two products.
More...
Plea to protect intellectual property rights

(LESLEY STONES , 17-Nov-2009 , Business Day)
SA NEEDS to protect the intellectual property rights of companies more vigorously to spark greater
innovations that will benefit the economy says the Free Market Foundation. More...
Purdue Pharma sues Sun Pharma following Para IV patent filing on pain killer drug
The US based Purdue Pharma products LP and its partner Napp Pharmaceutical Group Ltd have filed a
patent infringement petition against Sun Pharmaceuticals and its US arms following a para IV
certification filed by the latter to manufacture and market generic version of the formers pain killer
Ryzolt tramadol hydrochloride extended release drug. More...
Tangaliya gets GI status

(Rupam Singh Gupta , 16-Nov-2009 , The Times Of India)
The Tangaliya shawl which uses a unique weaving technique and was almost on the verge of extinction
has been given GI recognition by the Central government. More...
TVS Bajaj case adjourned to Wednesday
Barely days after TVS Motor re launched the contentious TVS Flame 125 cc motorcycle fitted with twin
spark plug on the back of a Supreme Court order the battle between the company and Bajaj Auto made
a comeback to the Madras High Court. More...
Garmin says has not infringed Pioneers patents

(by Savio D'Souza in Bangalore , 16-Nov-2009 , Reuters)
U.S. navigation device maker Garmin denied it infringed any patents and said it intended to defend itself
against a patent suit filed by Japanese consumer electronics maker Pioneer Corp a Garmin spokesperson
told Reuters. More...
Now Zydus moves court against Sun

The battle lines have been drawn between Mumbai based Sun Pharmaceutical and its Ahmedabad based
rival Zydus Cadila. More...
Glenmark Generics settles litigation with Medicis

(REUTERS , 16-Nov-2009 , The Economic Times)
Glenmark Generics Inc the US unit of Glenmark Generics Ltd on Monday said that it has settled all
pending litigation with Medicis Pharmaceutical Corp relating to patent actions regarding Fluocinonide.
More...
Govt to free tech tie ups trademark use

(Anindita Dey / Mumbai , 16-Nov-2009 , Business Standard)
In a move that would help Indian companies access technology and trademarks more freely the
government has decided to free the pricing for import of technology and use of trademark. More...
Affordable innovation in healthcare

(Kiran Mazumdar-Shaw , 16-Nov-2009 , The Economic Times)
Perhaps the most poignant present day paradox is that even as medical knowledge advances and global
wealth grows health inequity between the rich and the poor is widening. More...
Drug Makers Raise Prices in Face of Health Care Reform

(By DUFF WILSON , 15-Nov-2009 , The New York Times)
But drug companies say they are having to raise prices to maintain the profits necessary to invest in
research and development of new drugs as the patents on many of their most popular drugs are set to
expire over the next few years. More...
Cash crunch hits intellectual property office reforms

(Gunjan Sharma , 14-Nov-2009 , The Financial Express)
The Controller General of Patents Design and Trademarks PH Kurian has said that budget constraints are
hindering the reforms in the functioning of the Intellectual Property Office. More...
Endo Pharma to pay US$ 23 mn to LecTec to settle patent litigation
(Chadds Ford, Pennsylvania , 14-Nov-2009 , Pharmabiz)
Endo Pharmaceuticals has reached a settlement with LecTec Corporation on outstanding patent litigation
related to LecTecs US Patent Nos. 5536263 and 5741510. More...
No cure in sight for India EU drug seizure controversy

(Pallavi Aiyar / Brussels , 14-Nov-2009 , Business Standard)
Last month the Indian mission to the World Trade Organization in Geneva informed a TRIPS council
meeting that widespread and repeated seizures were having an adverse impact on the legitimate trade
of generic medicines universal access to medicines in developing countries and national public health
budgets. More...
Top drug firms growth to come from Russia Brazil and India
(C.H. Unnikrishnan , 13-Nov-2009 , livemint)
In the past half a decade big pharmaceutical firms havent developed any new blockbuster drugs the
lifeblood for them. More...
Venus bags another product patent for Potentox from South Africa
Venus Remedies a research based pharma company has received fifth product patent in the current
year. More...
Now cosmetics from cow

(Ramu Bhagwat , 13-Nov-2009 , The Times Of India)
The research centre situated at Deolapar 65 km from here has already won patents from the United
States and China for its cow urine distillate. More...
Astellas Pharma set to launch Prograf in India works on marketing strategy

The product has been enjoying the top ranks in the segment in the US market till it lost the patent
protection. More...
WIPO Director General Pledges Support for Indias Visually Impaired Community
(ag-IP-news ,GENEVA , 12-Nov-2009 , ag-IP-news)
The World Intellectual Property Organization Director General Francis Gurry met representatives of
Indias visually impaired community at a conference on the Right to Read of persons with print
disabilities and copyright challenges. More...
Valuing intangible property

(By Anuradha Salhotra , 12-Nov-2009 , Indian Express Finance )
Over the past few years businesses have given more and more prominence to intellectual property.
More...
Cipla offers to step up swine flu drug supplies
Cipla has offered to sell generic Oseltamivir the generic version of Roches anti viral drug Tamiflu to the
US said Cipla Chairman and Managing Director Dr Y.K. Hamied adding however that at present it does
not sell to the US and Europe because the drug is patent protected in these markets. More...
Method mania
(Latha Jishnu / New Delhi , 12-Nov-2009 , Business Standard)
A US Supreme Court case on the patenting of business methods draws pharma and software giants into
the battle. More...
Rs 55k cr domestic drug mkt largely spurious free claims health ministry
(By Soma Das , 12-Nov-2009 , Indian Express Finance )
The much awaited official word of the government on the penetration of counterfeit drug in the domestic
market is out. More...
Novartis puts R&D activities in India on hold

(Nina Mehta , 12-Nov-2009 , The Economic Times)
Frustrated with patent challenges Swiss pharma giant Novartis has put its research and development
activities in India on the back burner its CEO Daniel Vasella said. Mr Vasella who was in town to attend
the Pepsico board meet said the intellectual property protection was not up to the mark in India. More...
E7 the new El Dorado for pharma

Even for biosimilars off patent versions of biopharmaceutical drugs potential lies in Latin America and
Asia says Kiran Mazumdar Shaw CMD of Bangalore based biotechnology player Biocon. More...
Outsourcing arm of Dr Reddys expects 10 15% revenue growth

(Sumeet Chatterjee , 12-Nov-2009 , livemint)
Analysts say growth in the sector will also be boosted by the biggest loss of patent protection in history
in the next couple of years depriving global pharma firms of exclusivity on some of the worlds most
famous and profitable medicines. More...
MNCs working against Indian drug firms Anand Sharma tells WIPO chief
India on Wednesday complained to the UN intellectual property rights body WIPO that some
multinational firms have launched campaign against countrys pharmaceutical industry which has broken
their cartel in the generic drugs. More...
Daiichi to leverage Ranbaxy abroad

(Mohit Bhalla & Khomba Singh , 11-Nov-2009 , The Economic Times)
Japans Daiichi Sankyo which controls Ranbaxy Laboratories will use the Indian company as a launch pad
to sell its patented drugs in Europe China and the US and will work together in developing new products
a senior company official said. More...
AstraZeneca sues Lupin for infringing on drug patent

(fe Bureau , 11-Nov-2009 , The Financial Express)
Anglo Swedish drug giant AstraZeneca has sued the Mumbai based pharma company Lupin Ltd in the US
District Court of New Jersey charging it of infringing the innovators patent coverage by attempting to
manufacture and market anti ulcer drug Nexium one of the top five blockbuster drugs globally. More...
Lupin issues notice to Depomed Inc relating to Glumetza patent

Lupin Ltd a Rs 3775 crore fifth largest Indian pharma major has issued a Paragraph IV certification
notice to Depomed Inc regarding filing of an ANDA with the US FDA for a generic version of Glumetza
500 mg and 1000 mg strengths. More...
Mahabaleshwar seeks GI tag for its strawberries

After the Puneri pagdi Tirupati laddoo basmati rice the Mahabaleshwar strawberry is seeking
geographical identification status. More...
Medicis files another patent infringement suit against Glenmark

The US based Medicis Pharmaceutical Corp the specialty pharmaceutical company focusing on
dermatological and aesthetic products has sued the Mumbai based Glenmark Generics Ltd and its US
subsidiary in the District Court of New Jersey for alleged infringement of its patent rights on antifungal
agent Loprox Gel. More...
HC stops Zydus drug sale on Sun petition

(BS Reporters / Mumbai/chennai , 11-Nov-2009 , Business Standard)
Unlike patent litigation trademark cases can be filed anywhere in India where the company sells the
drug explained Gopakumar Nair an expert on patents and managing director of Patent Gurukul. More...
Dr Reddys unit rev to grow 10 15pct in FY10

(By Sumeet Chatterjee , 11-Nov-2009 , Reuters)
Analysts say growth in the sector will also be boosted by the biggest loss of patent protection in history
in the next couple of years depriving global pharma majors of exclusivity on some of the worlds most
famous and profitable medicines. More...
Patent disputes give global biggies the jitters

(Bloomberg , 10-Nov-2009 , The Economic Times)
The US Supreme Court on Monday considers a patent dispute that will determine how much legal
protection is afforded abstract business innovations and has drawn in companies including Microsoft
Google and Novartis. More...
Access to US biosimilars market set to get tougher
The US is considering a measure that would prevent the US Food and Drug Administration from
approving a biosimilar off patent version of a biopharmaceutical drug until 12 years have passed since
the innovator biologic was first approved. More...
Indian generic firms to gain from Obamas healthcare bill

(Khomba Singh , 10-Nov-2009 , The Economic Times)
In return for patents which are valid for 20 years innovator companies have to share the research work
of their new drugs so that other companies can use the knowledge to develop copies of the drug when
the original drugs patent expires. More...
AstraZeneca sues Lupin to protect patent rights of anti ulcer drug Nexium
AstraZeneca the Anglo Swedish drug major has filed a patent infringement lawsuit at the US District
Court of New Jersey against the Mumbai based Lupin Ltd and its US subsidiary to curb the latters move
to manufacture and market the generic version of its blockbuster acid reflux drug Nexium. More...
IP rights create a secure environment for investment in innovation

(Francis Gurry , 9-Nov-2009 , The Hindu)
The sustained growth of Indias IT sector is a further example of what can be achieved through strategic
use of IP. More...
Generics Gateway
(BV Mahalakshmi, Sudhir Chowdhary , 9-Nov-2009 , The Financial Express)
The global generics market driven by a series of growth factors such as increasing genericisation
favourable government support significant patent expiries and an ageing population is projected to grow
at an attractive rate. More...
Brain League set to tap start up

BrainLeague a knowledge management and Intellectual Property consultancy company has now started
a special service for pharma biotech start ups where it will offer IP generation protection management
and commercialization advise. More...
Centre protests copyright violation by Google Books

(Rituparna Bhuyan , 9-Nov-2009 , The Financial Express)
The portal has led to numerous class action suites by authors and publishers in the US France and
Germany for offering this facility in alleged violation of copyrights laws. More...
Barkha Dutt wins domain dispute against Hyderabad based entity

(STAFF WRITER , 08-Nov-2009 , Press Trust Of India)
Barkha Dutt a noted journalist and Group Editor of NDTV news channel has won an internet domain
dispute at the World Intellectual Property Organisation against a Hyderabad based entity. More...
Generic drug cos see a bitter pill in counterfeit label
(Soma Das , 7-Nov-2009 , The Financial Express)
The fear of generic drugs coming under the definition of counterfeit drugs is haunting the Indian pharma
industry yet again. More...
Dr Reddys develops generic version of Pfizers Lipitor

With this the Indian drug maker has joined the club of only a few generic companies hoping to grab a
share of the cholesterol lowering drugs market when its patent expires from next year. More...
Biocon hums with plans pitches for global top 3 slot

About $25 billion worth of biological drugs are losing patent protection by 2016 and it is predicted that
seven of the 10 top selling drugs will be biologics by 2020. More...
India EU to resolve generic drugs exports tangle

These shipments were for third countries so they did not violate either TRIPS Trade Related Intellectual
Property Rights agreement or other existing laws. More...
Indian drug cos need to focus on niche segments in US generic market: Pharmexcil Study
The Indian pharma companies should focus more on complex chemistry biotech based medicines and
advance formulations to tap the lucrative US generic market in future suggests a study conducted by
Pharmaceuticals Exports Promotion Council the apex body governing pharma exports under the Union
Ministry of Commerce. More...
EU to resolve drugs seizure issue soon

Since the beginning of the year the EU have been confiscating Indian generic drugs that are on transit to
Africa and Latin America on the ground that it violated the EUs patent regime. More...
Salix Pharma gets US patent for Rifaximin

(Raleigh, North Carolina , 06-Nov-2009 , Pharmabiz)
Salix Pharmaceuticals Ltd announced that the US Patent and Trademark Office has issued US Patent No.
7612199 entitled Polymorphic Forms Alpha Beta and Gamma of Rifaximin. More...
FTA negotiation tops agenda at India EU bilateral summit

(fe Bureaus , 5-Nov-2009 , The Financial Express)
It is at a critical phase as it will involve bargaining on duty cuts market access on services sector IPR as
well as toning down non tariff barriers. More...
EU review mechanism on customs laws not likely to cover drug seizure issue
Even as the repeated seizure of drugs by the European authorities raised resentment and the EU claimed
to be reviewing the contentious regulatory clause relating to the issue India has expressed apprehension
about the review and its chances of resolving the matter permanently. More...
Core group for promoting local mfg of telecom infra

The meeting also discussed issues such as investments manufacturing and Indian intellectual property
rights. More...
India takes drug seizure issue to WTO council

The seizure of another consignment of Indian generic drugs in transit has pushed India to drag the issue
to the TRIPS Council a high level body of the World Trade Organization dealing with intellectual property
issues. More...
Pharma firms now need to shift focus to marketing: PwCs Friend

(C.H. Unnikrishnan , 4-Nov-2009 , livemint)
Big pharmaceutical companies such as Pfizer Inc. Novartis AG and GlaxoSmithKline Plc have followed a
strategy to invest in the research and development of new drugs to feed their market needs driven by
speciality and patent protected products. More...
Quick fix solution

(M J Antony / New Delhi , 4-Nov-2009 , Business Standard)
Two judgments of the Supreme Court delivered in recent weeks are significant as they highlight the
problem of long delays in cases involving intellectual property rights and the quick fix solution suggested
by the court. More...
Indian drugs may get safe EU passage

(Amiti Sen , 4-Nov-2009 , The Economic Times)
Pharma exports from India are likely to be promised safe passage by the European Union after India
took up the issue following seizure of two consignments while in transit through the region. More...
Share tech to manage climate change

(Urmi Goswami , 3-Nov-2009 , The Economic Times)
The failure to arrive at a consensus on the issue of sharing IPRs could well be one of the hurdles to an
outcome at the Copenhagen summit. More...
Not the right medicine

Big global pharmaceutical firms seeking to buy into prominent Indian generic players is in fact a
vindication of the Indian pharmaceutical story which began with the decision by Indira Gandhi to rein in
the cost of medicines and allow process and not product patents. More...
No fair play in pharma industry

(MM Sharma Head , 3-Nov-2009 , The Economic Times)
These drugs contain same active ingredients as the original formulations invented by the originator
companies mostly from Europe or United States and in most cases the usual life 20 years of the patents
have expired or are about to expire. More...
ABLEs fourth biotech investor forum to kick off in Mumbai on Nov 5

(Our Bureau, Bangalore , 3-Nov-2009 , Pharmabiz)
The deliberation will focus on partnering & alliances opportunities from Intellectual Property sharing risk
and explore other avenues to generate revenues which include monetizing assets licensing opportunities
& services. More...
EU seizes another generic package

In yet another instance of attacks on Indian generics in the European Union a consignment of 1.74
million tablets of anti platelet drug clopidogrel from Mumbai based Macleods Pharma to Venezuela is
learnt to have been seized at the Paris airport in October on grounds of patent violation. More...
ICFAI told to pay $1 million for infringing trademark in US

(Kalpana Pathak / Mumbai , 3-Nov-2009 , Business Standard)
The Hyderabad based Institute of Chartered Financial Analysts of India has been asked to pay over $1
million to the US based Chartered Financial Analyst Institute in damages for using the CFA trademark in
the US. More...
Experts suspect Cotonou Declaration another attempt by developed nations to push

counterfeit agenda
(Ramesh Shankar , 3-Nov-2009 , Pharmabiz)
Recently the WHO South East Asia Regional Office passed a resolution stressing the need to separate
issues related to intellectual property enforcement from the safety quality and efficacy of medicines.
More...
Novartis Venture Funds looking at innovative India opportunities

Also working in favour of target companies was strong intellectual property and capital efficiency he
added. More...
India ready to face WTO over wines spirits duties

Negotiations to create a trade and investment agreement were initiated on June 2007 covering trade in
goods services investment intellectual property rights competition policy and geographical indications
among others. More...
India in talks with US PTO for granting access to TKDL data to curb bio piracy
After sharing the database of Traditional Knowledge Digital Library with European countries India is now
in talks with more countries including the US for similar agreement to grant access to the details in a bid
to prevent wrong patents across the world on Indian medicinal plants. More...
Popular cold pain drugs face ban

(Rupali Mukherjee , 31-Oct-2009 , The Times Of India)
Popular and widely used medicines like phenylpropanolamine or PPA found in cough and cold remedies
like Vicks Action 500 Solvin Wincold gastrointestinal tegaserod anti bacterial gatifloxacin and painkiller
nimesulide are under government scanner on concerns raised about their adverse reactions. More...
Sanofi sues Sandoz for infringing cancer drug patent

(Tom Hals , 31-Oct-2009 , Reuters)
French drugmaker Sanofi Aventis SA asked a U.S. federal court to block a Novartis unit from selling a
generic version of its cancer drug in the United States because it infringes a patent according to court
documents. More...
Bumpy road ahead for India EU FTA

(Nirmala Ganapathy , 31-Oct-2009 , The Economic Times)
Though Ms Smadja said the priority in the negotiations remained issues like tariff market access non
tariff barriers government procurement and IPR she also maintained that non trade issues were also
important. More...
Takeda holds forecast drugs outlook still tough

(by Nobuhiro Kubo , 30-Oct-2009 , Reuters)
Takedas sales may drop from next year on as patents of some drugs will expire and most investors are
wondering how Takeda will deal with the problem. More...
Sun Pharma net profit dips 11.5%

Analysts said despite regulatory issues in the US for its subsidiary Caraco growth in domestic business
Caracos better sales than what was clocked in the immediate previous quarter and the patent settlement
with Forest Laboratories during the recent quarter helped the company post better than expected
profits. More...
Prof Baker too finds fault with Mashelkars revised report after Correas objections
Close on the heels of international patent expert professor Carlos Correas criticism of the revised
Mashelkar Committee report another international patent expert professor Brook K Baker has lambasted
the Mashelkar Committee report stating that the revised version underestimates Indias right to define
patentability. More...
Seeds of trouble
(Latha Jishnu / New Delhi , 29-Oct-2009 , Business Standard)
Last week the debate on intellectual property rights on seeds became more contentious when Olivier de
Schutter the UNs Special Rapporteur on the Right to Food warned that the increasing dependency on
commercial seed varieties controlled by a handful of very powerful multinational companies could have a
severe impact on small farmers in developing countries. More...
Music industry wins Indias biggest plea bargaining case: IMI

(Chitra Unnithan / Mumbai/ Ahmedabad , 29-Oct-2009 , Business Standard)
In a significant case of copyright infringement under the concept of plea bargaining the Indian Music
Industry won a compensation amount of Rs 12 lakhs in a copyright case. More...
Watson and Barr Settle Lawsuit Over Oxytrol

(CORONA, Calif , 29-Oct-2009 , PRNewswire)
Watson Pharmaceuticals Inc. a leading specialty pharmaceutical company announced today that its
subsidiary Watson Laboratories Inc. has reached a settlement with Barr Laboratories Inc. on outstanding
patent litigation related to Watsons Oxytrol® product. More...
Proposed PCT II revisions in WIPO against developing countries: IDMA

Now WIPO proposes a new treaty for a Global Patenting Order. More...
India may ask exporters to boycott KLM to deter EU for holding up drug cargo
Even as the Indian government is planning to file a complaint with World Trade Organisation against the
European Union on the issue of seizure of Indian drug shipments at EU ports the government is also
exploring other options to pressurise the EU nations to change the patent laws amended some time back
to make them more stringent. More...
Allergan wins brimonidine patent infringement case against Exela PharmSci & Apotex
(Irvine, California , 27-Oct-2009 , Pharmabiz)
Innovation in medicine has improved lives reduced suffering and advanced the quality of patient care
and our intellectual property embodies our commitment to and investment in medical innovation said
Douglas S Ingram Allergans executive vice president chief administrative officer and secretary. More...
Pfizers Handa is new MD of Wyeth India

(fe Bureaus , 27-Oct-2009 , The Financial Express)
Pfizer has launched five patented products in India since 2005 Vfend Viagra Lyrica Caduet and Macugen.
More...
Glenmark Generics launches first four products in UK market

Of the four products launched Topiramate Tablets 25mg 50mg 100mg 200mg was launched on
September 24 2009 which was day 1 of patent expiry in the UK market. More...
India seeks help from global NGOs to dissuade African nations enacting anti counterfeit laws
The Indian government has asked the NGOs about the need to segregate twin issues of Intellectual
Property and counterfeit drugs. More...
Nokia may seek up to$1 billion from Apple

(Tarmo Virki , 26-Oct-2009 , livemint)
Apple a latecomer to the cellphone industry has won a considerable share of the higher end of the
market but it has limited intellectual property assets compared with rivals when all vendors work under
cross licensing agreements. More...
Govt gives overt & covert support to US stand on climate CPI M

(Press Trust Of India , 25-Oct-2009 , Hindustan Times)
It also said India should work for freeing of technology transfers from restrictions of Intellectual Property
Rights regime. More...
Biocon starts reaping benefits of Mylan pact

Under the partnership Biocon is to develop four biosimilar products low cost versions of patented
biotechnology products and supply them to Mylan for selling globally. More...
Allergan wins ruling in patent case against 2 drugmakers

(By Robert Daniel , 25-Oct-2009 , MarketWatch)
Allergan Inc. won a ruling in federal court that its patents on Alphagan which lowers pressure in the eye
in patients with open angle glaucoma and ocular hypertension were infringed. More...
Sun to stop making Alzheimers drug after losing patent battle

Sun Pharmaceuticals has agreed not to manufacture and market the generic version of Alzheimers drug
of Forest Laboratories after it lost patent battle with the US drugmaker on Thursday. More...
Pfizer scans India for shopping options

Pfizer has approached several Indian drugmakers for possible alliances as part of moves to try and
bolster revenues threatened by the expiry of patents on key blockbuster drugs in the next three years
three persons with direct knowledge of the matter said. More...
The new pharmaceutical order

(Bhupesh Bhandari / New Delhi , 23-Oct-2009 , Business Standard)
All of them not so long ago shared a common dream quickly capture the market for drugs that have
gone off patent in the west. More...
BJP may soon claim patent on poll defeat
(Devesh Kumar , 23-Oct-2009 , The Economic Times)
For BJP tasting defeats in electoral battles has by now become routine. More...
It was only growth that eluded us

(Business Standard / New Delhi , 23-Oct-2009 , Business Standard)
We at Nasscom are looking at monitoring of patents as many companies now have to declare their
patents in India. More...
Biocon banks on biosimilars novel drugs

Estimates suggest that by 2016 about $25 billion worth of biologics would lose patent protection. More...
India rejects draft WTO services schedule by US

(D Ravi Kanth / Geneva , 23-Oct-2009 , Business Standard)
India along with other countries today shot down a concerted move by the United States Australia and
Canada to prepare draft scheduling of commitments in Doha services negotiations based on signals
made by trade ministers during the failed ministerial meeting last year a trade envoy told Business
Standard. More...
Nokia sues Apple for patent infringement

(REUTERS , 22-Oct-2009 , The Economic Times)
The worlds top cellphone maker Nokia Oyj on Thursday charged Apple with infringing Nokia patents in
its iPhone. More...
India need to develop strong legal system against bio piracy Prof. K V Krishnamurthy
(Peethaambaran Kunnathoor, Chennai , 22-Oct-2009 , Pharmabiz)
The usurping of indigenous knowledge or traditional knowledge including medical knowledge without any
benefit to the owner society is called bio piracy or gene robbing. More...
RA Mashelkar For me its national interest that comes first

(C.H. Unnikrishnan , 22-Oct-2009 , livemint)
Former director general of the Council of Scientific and Industrial Research R. A. Mashelkar who chaired
the technical experts group on patent law constituted by the government has been dragged into a fresh
controversy. More...
Indias patent progress

(Science|Business reporting , 22-Oct-2009 , Science|Business )
The reform of Indias patent system has given foreign companies the confidence that they can protect
their intellectual property rights but the economic boom is yet to translate through to a surge in home
grown innovation according to the latest research from the market analyst Evalueserve. More...
ImmunoCellular seeks US patent protection for intellectual property relating to novel
glycosylated epitopes
(Los Angeles, California , 21-Oct-2009 , Pharmabiz)
ImmunoCellular Therapeutics Ltd a clinical stage biotechnology company that is developing immune
based therapies for the treatment of brain and other cancers has filed a provisional patent application at
US Patent Office seeking protection of intellectual property relating to novel glycosylated epitopes
present in lung cancer pancreatic cancer and colon cancer that are targeted by the Companys ICT 109
monoclonal antibody product candidate. More...
Patenting Landscape in India

( Stephen Albainy-Jenei , 21-Oct-2009 , Patent Barista)
In recent years India has witnessed rapid changes in its patenting landscape as a result of the growing
economic activity and reforms. More...
International public interest groups slam EU on double standards on drug laws

International public interest organizations have charged the European Union with adopting double
standards vis à vis poor and developed countries and blocking the access to essential medicines across
the world especially in the underdeveloped countries. More...
FDA seizes spurious drugs worth Rs10 lakh

(Ninad Siddhaye , 21-Oct-2009 , DNA)
Drug inspectors of the state Food and Drug Administration have seized a huge stock of spurious drugs
from a godown in MIDC Turbhe. More...
GI protection Gain for some pain for others

(Vandana Gombar & Ch Prashanth Reddy / New Delhi/hyderabad , 21-Oct-2009 , Business Standard)
Early next month the Madras High Court will hear a unique case a petition challenging the geographical
indications protection given to the famous Tirupati laddu produced by the Tirumala Tirupati
Devasthanam. More...
Dont dilute Right To Information Act with amendments

(Ashutosh Shukla , 21-Oct-2009 , DNA)
The amendments to the RTI Act proposed by the central government have made activists as well as the
public information commissioners increasingly unhappy. More...
Bisleri told to stop using Maaza trademark

(Press Trust Of India / New Delhi , 21-Oct-2009 , Business Standard)
The Delhi High Court today asked Bisleri International not to sell its mango flavoured soft drink under
the trade name Maaza in India. More...
India to lodge complaint with WTO against seizure of drug exports at EU ports
The government so far failed to cut much ice with the EU authorities in relaxing regulations on patent
and trade mark issues so that at least the drug shipments on transit cannot be seized at the EU ports on
charges of counterfeiting and patents infringement. More...
Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance
to Its Intellectual Property Portfolio
(Matthew Swetonic , 19-Oct-2009 , Reuters)
Health Discovery Corporation is pleased to announce numerous additional issued patents and Notices of
Allowance since its last press release describing its intellectual property portfolio. More...
Generics face uniform patent norms threat

Patients suffering from swine flu in India have a choice of buying the medicine oseltamivir from Natco
Pharma Hetero Drugs and Strides Arcolab etc all of whose brands are available in the market. More...
Teva sues Mylan alleging Copaxone patent infringement

(Esha Dey in Bangalore , 17-Oct-2009 , Reuters)
Generic drugmaker Teva Pharmaceutical Industries Ltd sued rival Mylan Inc alleging that Mylans
application to market a copycat version of Tevas multiple sclerosis drug Copaxone was infringing certain
patents. More...
Made in India dominates US AIDS scheme

(P B Jayakumar / Mumbai , 16-Oct-2009 , Business Standard)
Even patent protected drugs are procured for supply with a tentative approval in the countries covered
under the programme. More...
US Court rules Ranbaxys generic valganciclovir does not infringe Roches Valcyte patent
(Gireesh Babu, Mumbai , 16-Oct-2009 , Pharmabiz)
The verdict is on a complaint filed by Roche alleging Ranbaxy of patent infringement of the formers US
Patent No 6083953 following an Abbreviated New Drug Application filed by Ranbaxy on amorphous form
of valganciclovir with the US Food and Drug Administration in 2006. More...
Darjeeling tea closes in on Europe

(Sachin P Mampatta , 16-Oct-2009 , DNA)
The Indian application for a Geographical Indication mark for Darjeeling tea has entered a crucial six
month period after which it would be given the same status as products such as Roquefort cheese and
Napa Valley wines. More...
EUs latest moves on counterfeit drugs cause fresh concerns to Indian pharma
The recent moves by the developed countries especially the European Union on the counterfeit
medicines issue have caused fresh worries among the Indian generic exporters prompting them to take
recourse with the authorities for renewed efforts including international intervention along with other
USFDA tells Glenmark to withdraw drug
The US Food and Drug Administration has directed Glenmarks US arm Glenmark Generics Inc and three
other manufacturers to stop the marketing of unapproved codeine sulphate tablets in the US market.
More...
EC seeks views on Darjeeling tea patent

The European Commission has invited public comments on a proposal from India seeking protection for
Darjeeling tea against grant of patent for the beverage leaves grown in the hilly region of West Bengal.
More...
Better monitoring of clinical research an imperative

(Pillman , 15-Oct-2009 , DNA)
In truth the largest benefit of globalised trials comes from faster time to market reducing development
time by half results in nearly two thirds reduction in overall development cost and provides a longer post
approval patent term in which to recoup the investment. More...
Suven Lifes Alzheimers Drug Gets Patents

(By RUMMAN AHMED , 14-Oct-2009 , The Wall Street Journal)
Suven Life Sciences Ltd. said Wednesday it has secured product patents in nine regions for its
experimental drug for treating Alzheimers disease and schizophrenia. More...
Pharma industry seeks new technical committee in place of Mashelkar panel

Pharma industry has called for further amendment to the Patents Act to strengthen the criteria of patent
protection and constitution of a fresh technical expert committee on the scope of patentability of pharma
products as the earlier panel headed by Dr R A Mashelkar has run into controversy yet again. More...
The campaign against that pesky 3 d

(Latha Jishnu / New Delhi , 14-Oct-2009 , Business Standard)
Section 3 d is a singular provision aimed at preventing the evergreening of patents by drug inventors.
More...
Sun acquisitions on hold will resume

Dilip Shanghvi Suns chairman and managing director has put the companys new expansion plans on
hold as he battles over Taro and tries to sort out US subsidiary Caraco Pharmaceutical Laboratories Ltd.
which has had operations halted by the US FDA. More...
Indian excipients market expected to grow 15 to 18% in near future say experts
Owing to the large chunk of drugs going off patent in the coming years the experts expect a growth rate
of Indian excipients market at around 15 to 18 per cent annum as against the global growth rate.
More...
We dont have space for more partnerships

(Joe C Mathew & Vandana Gombar / New Delhi , 14-Oct-2009 , Business Standard)
Piramal Healthcare Ltd the countrys fourth largest drug company has been focusing on international
partnerships and collaborations instead of following the high risk route of patent challenges to grow
revenues. More...
EMPOWERING SMEs
(P A Francis , 14-Oct-2009 , Pharmabiz)
With the amendment of Indian Patent Act in 2005 allowing product patent Indian pharmaceutical market
has become very attractive to MNCs. More...
Glenmark Pharma plans to list its generics subsidiary

(Nina Mehta , 14-Oct-2009 , The Economic Times)
Glenmark Pharmaceuticals is planning to list its generics subsidiary Glenmark Generics and has filed a
draft red herring prospectus with SEBI. More...
Phytogen develops a range of modified dosage nutraceuticals scouts for marketing par
(Nandita Vijay, Bangalore , 14-Oct-2009 , Pharmabiz)
All the products have gone in for trademark clearances. More...
Mashelkar clarifies on patent report conclusions

Nearly two months after Argentine patent expert Carlos M Correa complained about the
misinterpretation of his observations to conclude an expert group report on Indian patent laws the
chairman of the Technical Expert Group R A Mashelkar clarified that the reports conclusions were not
based on Correas views but on TEGs own interpretations. More...
Panel on pricing of patented drugs undecided on formula with no data on imported drugs
The panel set up by the chemicals ministry in February 2007 to suggest a framework to fix prices of
imported drugs through negotiations still could not muster enough support for its formula. More...
Outlook for pharmaceutical companies looks good

(Manas chakravarty, Ravi Ananthanarayanan and Vatsala Kama , 12-Oct-2009 , livemint)
IMS Health a global pharmaceutical market research company has released its latest forecast for 2010 in
which it projects the global pharmaceutical market to grow by 4 6%. More...
US District Court approves sanofi aventis Sun Pharma patent settlement on Eloxatin
The District Court has now ruled that since the terms of the agreement were explained in both the letter
of intent and the term sheets the agreement is enforceable without considering whether all the required
signatures are obtained or not. More...
Storm over drug patent linkage after court rejects Bayer petition
(AZB and Partners , 12-Oct-2009 , livemint)
Bayer contended DCGI should not approve any application for a generic drug if the original has been
patented. More...
Big Pharma targets emerging mkts

(Joe C Mathew /New Delhi , 12-Oct-2009 , Business Standard)
According to a recent KPMG study drugs worth $65 70 billion are expected to go off patent in five years
while there are very few new drugs that can generate similar revenues. More...
The end of a drug alliance

(Shamnad Basheer , 12-Oct-2009 , livemint)
Recent alliances such as Ranbaxy Daiichi Indian generics firms are now acquiring dual personalities and
speaking the language of patents and innovation. More...
Improved product mix margins make Atul a good long term bet
(Ujjval Jauharri , 12-Oct-2009 , DNA)
Atul also plans to introduce new products coming off patent. More...
Carlos Correa accuses Mashelkar for misinterpreting his quotes in revised report
The government had set up a technical expert group with Dr R A Mashelkar as its chairman and four
other members on April 5 2005 on the twin issues of evergreening of patents and excluding micro
organism from patentability. More...
Lupin eyes $200 mn opportunity in US contraceptives market

Mumbai based pharmaceutical firm Lupin is gearing to tap opportunities to the tune of up to $200 million
in the US oral contraceptives market despite patent litigation from rivals on its plans to sell generic
drugs there. More...
Lupin pills hit legal wall in United States

(PB Jayakumar / Mumbai , 11-Oct-2009 , Business Standard)
Teva Womens Health of Israel and Warner Chilcott of Puerto Rico have sued Indias Lupin in separate
patent infringement cases in the US. More...
Indian scientists develop sulphur free sugar

(Shivani Vig , 10-Oct-2009 , The Times Of India)
Before this we would be filing a patent for the developed sugar within a month and once through it
would be the biggest achievement for the sugar industry and for NSI as well concluded Prof Narendra
Mohan. More...
Court directive to Texmo on trade mark issue

(Our Legal Correspondent , 10-Oct-2009 , Business Line)
The Madras High Court has directed the Madhya Pradesh based Texmo Pipes & Products Ltd to print or
project in its publication advertisement pertaining to public issue of 50 lakh equity shares of Rs 10 each
that its right to use the trade mark Texmo had nothing to do with the plaintiffs firm viz. Aqua Pump
Industries or its trade mark Texmo Aqua. More...
Scanner at shops multi coloured pills to detect counterfeit medicines

(Nina Mehta & Prashant Mahesh , 09-Oct-2009 , The Economic Times)
The company has filed several patent applications for this technology which it says can be easily
integrated into a pharma companys manufacturing process. More...
Uganda Tanzania Zambia too planning anticounterfeit legislations despite Indias caution
In the World Trade Organization Agreement on Trade Related Aspects of Intellectual Property Rights
TRIPS counterfeit is defined as pertaining to trademark infringement. More...
Pharma cos build immunity against counterfeiters

(Nina Mehta & Prashant Mahesh , 9-Oct-2009 , The Economic Times)
The company has filed several patent applications for this technology which it says can be easily
integrated into a pharma companys manufacturing process. More...
Basic Research Loses Some Allure

(By DON CLARK and CHRISTOPHER RHOADS , 08-Oct-2009 , The Wall Street Journal)
Last year 70% of its patents were for software and services reflecting its shift away from computers and
semiconductors where pure science plays a bigger role. More...
Brazil may team up with India against EC

(Asit Ranjan Mishra , 8-Oct-2009 , livemint)
India is appealing against EC at WTO for seizure of in transit consignments citing patent infringement.
More...
EU officials raid Ranbaxy French unit

Generic companies make the low cost version of original drugs and they challenge the patent of original
drugmakers so that they are able to launch their drugs before patent expiry. More...
Patent experts pool being set up to advise courts

Move to assist the judiciary which is not yet fully conversant with the technical aspects of patent cases.
More...
Developing nations gain victory at WIPO against patent harmonization agenda

The member states of the WIPO have reached an agreement on a renewed and strengthened mandate
for the Intergovernmental Committee on IP on Genetic Resources Traditional Knowledge and Folklore
which would now undertake text based negotiations on an international legal instrument aimed at
protecting these resources. More...
Glaxo eyes Dr Reddys as Big Pharma hunts in India

(By Ben Hirschler and Quentin Webb , 07-Oct-2009 , Reuters)
But attitudes are changing fast as slowing markets at home and a cliff of patent expiries has forced Big
Pharma to explore new business models. More...
Lupin outlicences drug delivery tech to Salix

According to the agreement Lupin and Salix have also entered into an exclusive agreement in the US for
supply of Rifaximin active pharmaceutical ingredient. More...
Astellas US sues Wockhardt for alleged patent infringement of Adenoscan

Astellas US LLC the US subsidiary of the Japanese drug major Astellas Pharma has sued the Mumbai
based Wockhardt Ltd and its US subsidiary for alleged infringement of its patent on pharmacological
stress agent Adenoscan adenosine injection as the latter has filed an abbreviated new drug application
for generic version of the product. More...
Glenmark Generics listing unlocks value for parent

(Ravi Ananthanarayanan , 6-Oct-2009 , livemint)
GGL has also focused on niche segments where there is lower competition and on drugs where there are
patent challenge opportunities. More...
India may file case against EU at WTO

(Amiti Sen , 5-Oct-2009 , The Economic Times)
Its illegal as it not only violated the international intellectual property agreement but was also against
the GATT provisions on transit a commerce department official told ET requesting anonymity. More...
PCT reforms at WIPO will benefit Indian innovators exporters OPPI

The Organisation of Pharmaceutical Producers of India which represents multinational pharma

companies in the country has joined issue with the forces who are opposing the efforts of the developed
nations at WIPO for the patent harmonization which is feared to undermine the flexibilities available
under TRIPS. More...
Indian formulation mkt to cross $13.7 billion by 2013
(R Ravichandran , 5-Oct-2009 , The Financial Express)
Global investors are under pressure due to growing patent expiries of major blockbuster drugs price
restrictions and slowdown in new product approvals and launches. More...
Cordis enters pact with Boston to settle selected stent litigation cases
(3-Oct-2009 , Pharmabiz)
Cordis Corporation has reached an agreement with Boston Scientific resolving its Palmaz infringement
suit relating to Bostons NIR stent settling several other cardiology related cases relating to patents in
the Ding Kastenhofer Palmaz and Fontirroche patent families and exchanging paid up licenses for certain
intellectual properties. More...
Plea filed in apex court against GI tag for Tirupati Laddu

(Vinson Kurian , 3-Oct-2009 , Business Line)
A public interest petition has been filed in the Supreme Court seeking suo motu action against the grant
of intellectual property right protection to Tirupati Laddu which is a temple offering. More...
Big Pharma urged to pool HIV patents

Médecins Sans Frontières an international humanitarian organisation has called upon nine global pharma
giants to pool their HIV patents in order to make available treatment to millions living with HIV AIDS.
More...
Geographical indicators and beyond

(RAJESH HALDIPUR , 3-Oct-2009 , Business Line)
GIs are just one stop in a long journey to strengthen the intellectual property rights of traditional and
artisan products. More...
Actavis launches generic Lipitor in Spain

(By Kevin Grogan , 02-Oct-2009 , PharmaTimes)
Actavis said that atorvastatin tablets are subject to widely varying patent situations around the world
which is why Medis has invested significantly in different forms of the molecule. More...
China way ahead of India in patent filings

The Indian Patent Office ranks 9th in the number of patents filed and 12th in the number of patents
granted according to the World Intellectual Property Organisations latest data. More...
The promise of WIPOs development plan

(By John Tarpey , 1-Oct-2009 , The Economic Times)
A group of states known as the Friends of Development launched a far reaching proposal in 2004 to put
development at the heart of the activities of the World Intellectual Property Organization. More...
Taro files new lawsuit against Sun Pharma
(BS Reporters / New Delhi/mumbai , 1-Oct-2009 , Business Standard)
Recent action by the USFDA against Suns majority owned US subsidiary Caraco Laboratories Inc. More...
Developing IPR is not a zero sum scenario

The Geneva based World Intellectual Property Organization a specialised agency of the United Nations
aims at developing a balanced and accessible international intellectual property system among its 184
member countries. More...
Bharat Biotech gets patent for Lysostaphin

(BS Reporter / Hyderabad , 30-Sep-2009 , Business Standard)
Hyderabad based vaccines and biotherapeutics manufacturer Bharat Biotech International announced on
Wednesday that its anti staphylococcal molecule Lysostaphin had secured patent rights in US Europe
China Australia and other nations. More...
Reverse innovation isnt optional. It is oxygen

(Vivek Kaul , 30-Sep-2009 , DNA)
Multinational companies need to change the very way they conduct business suggests Vijay
Govindarajan noted expert on strategy & innovation and author of the international bestseller Ten Rules
for Strategic Innovators. More...
Recession and the global patent effect

(Latha Jishnu / New Delhi , 30-Sep-2009 , Business Standard)
What happens when the apex patents organisation brings an economist sorry a chief economist on board
More...
Encourage innovation in pharma and healthcare

Participating at a panel discussion on pharma and biotech industry the Chairman and Managing Director
Bharat Biotech Dr Krishna M. Ella said the absence of laws protecting intellectual property rights was
discouraging innovation. More...
Public interest groups urge India to oppose moves at WIPO to harmonise patent
administration
A number of public interest organizations mainly in the health sector have urged the Centre to oppose
any effort at WIPO General Assembly on harmonization of patent administration as it can fundamentally
change the way in which substantive decisions about granting patents are taken by the patent offices in
Lunch with BS Anand Burman

(Bhupesh Bhandari / New Delhi , 29-Sep-2009 , Business Standard)
Burman 57 is a scientist his father and the grand old man of Dabur A C Burman never got to finish
college with over 40 patents against his name. More...
Indo Jap FTA Data exclusivity threat to generics
According to intellectual property experts keeping close tabs on the FTA Japan is pressing amongst other
thing for data exclusivity which could increase costs and delay the process of bringing low cost generic
drugs to the market if it is granted. More...
D Ravi Kanth Doha drifts again

(D Ravi Kanth / New Delhi , 29-Sep-2009 , Business Standard)
We sail within a vast sphere ever drifting in uncertainty driven from end to end is what the G20 leaders
conveyed to their trade negotiators at the Pittsburgh summit last Friday. More...
Lupin buys cholesterol drug for $39 million

(PB Jayakumar & Joe C Mathew / Mumbai/delhi , 29-Sep-2009 , Business Standard)
The drug has strong brand equity with primary care physicians and has patent protection till 2020.
More...
Indian drug market to triple to $ 20 bn by 2015 Report

The report notes that In 2015 India could be a potential USD 8 billion market for MNCs with patented
drugs accounting for nearly 8 10 % of the total market. More...
Not such a patent misfit

(Shyam Sunder,S. Subramanyan,Karan Thakur , 27-Sep-2009 , livemint)
Commercialization of patents in India remains weak is because the enforcement mechanism. More...
Ideal Cures bags Pharmexcil awards

Bagging the Government of India Patents Ideal Cures was honoured with the prestigious Government of
India Patents Award and the Outstanding Export Performance Award in Drugs and Pharmaceuticals for
the year 2008 09 by the Pharmexcil apex body under Ministry of Commerce and Industry Government of
India on Friday September 25 2009 at the Indo Africa Pharma Business Meet at the Convention Centre
Hotel Marriot in Hyderabad. More...
Orchid wins US court battle against Wyeth

(fe Bureaus , 26-Sep-2009 , The Financial Express)
Wyeths plea for a TRO was in connection with its lawsuit against the USFDA as it challenged the
regulators approval of Orchids abbreviated new drug applications for its generic products Piperacillin and
Tazobactam for injections. More...
India objects efforts of developed nations to undermine flexibilities in TRIPS at WIPO

India has taken strong objection to the efforts being made by the developed nations through the World
Intellectual Property Organization to undermine the flexibilities available under TRIPS by stretching the
definition of counterfeiting. More...
Pharmaceutical exports up 17%

(BS Reporter / Chennai/ Hyderabad , 26-Sep-2009 , Business Standard)
The government is working to provide a conducive policy environment through flexible patent legislation
to make the sector self reliant he said. More...
Sanofi Aventis scans India for acquisitions

(Nina Mehta & George Smith Alexander , 26-Sep-2009 , The Economic Times)
The absence of blockbuster patented drugs is forcing these companies to increase their revenues by
buying up generic companies in developing markets which are growing exponentially because of
economic prosperity. More...
Merck vaccine move signals shift in Big Pharma

(Pillman , 25-Sep-2009 , DNA)
We have come a long way since the days when vaccines were considered a business of marginal interest
for multinational companies. More...
TVS set to make twin spark plug Flame

The company statement added that in the patent dispute between Bajaj Auto Limited vs TVS Motor
Company Limited the Supreme Court in its order dated September 16 has allowed TVS to sell the twin
spark plug TVS Flame. More...
Consolidation will happen in the domestic drug industry

(P B Jayakumar / Mumbai , 25-Sep-2009 , Business Standard)
India has moved to product patents has a huge middle class its healthcare and insurance systems are
improving and it has a good branded generics market. More...
Pharma M&As sounding death knell for low cost drugs

Indian companies which have been actively pursuing pre grant and post grant oppositions against the
patents of MNCs would become less aggressive after being acquired by Big Pharma and their focus
would shift more towards the generic markets in the US and the EU from India say healthcare and legal
experts working in the area of access to medicines. More...
Wockhardt gets award for patents

Drug maker Wockhardt today said it has been chosen as the pharmaceutical company for the maximum
number of patent filings and grants from India. More...
Eli Lilly Wins Ruling on Evista Patent Validity in Teva Case

(By Edvard Pettersson , 24-Sep-2009 , Bloomberg)
Eli Lilly & Co. won a ruling on the validity of patents for its Evista osteoporosis treatment blocking an
attempt by Teva Pharmaceutical Industries Ltd. to sell a generic version of the bone loss drug. More...
Venus Remedies Korean firm sign out licensing deal

(Press Trust of India / Mumbai , 23-Sep-2009 , Business Standard)
The company has also received patent for Sulbactomax from South African authorities and is scouting
for partner to market the drug in the country. More...
Glaxo eyes Piramal Dr Reddys Labs

(C.H. Unnikrishnan and Baiju Kalesh , 23-Sep-2009 , livemint)
At least $70 billion worth of patented drugs will go off patent by 2012. More...
GSK drug deal talk lifts DRL scrip

Shares of Dr Reddys Laboratories touched an intra day high of Rs 878.70 amid speculation that the
Indian drug maker is in preliminary talks with UK based GlaxoSmithKline to market Red Heart Pill used
to treat those with heart ailments. More...
An idea thats a patent misfit

(Views , 23-Sep-2009 , livemint)
Indias intellectual property rights regime can barely be improved by blindly transplanting a three decade
old US law. More...
Resolvyx gets US patent for first Resolvin therapeutic to enter human trials
(Bedford, Maryland , 22-Sep-2009 , Pharmabiz)
Resolvyx Pharmaceuticals Inc. the leading Resolvin therapeutics company announced that the US Patent
and Trademark Office has granted a patent covering composition of matter for RX 10045 the first
Resolvin therapeutic to enter clinical trials. More...
Growing pharma market makes India a clinical trial destination Report

By 2015 MNCs with patented drugs could account for $8 billion in the domestic pharmaceutical market
nearly 8 10 per cent of the total market. More...
When patenting is in question

(K M Gopakumar , 22-Sep-2009 , The Economic Times)
The report of the Technical Expert Group on Patent Law Issues also known as the Mashelkar Committee
Report has once again created controversy. More...
SC order on IPR violations may have left door open for misuse
(Manish Ranjan , 22-Sep-2009 , livemint)
Analysts say in some cases especially those with evidence of literal copying temporary relief may be
required. More...
Brazil India to oppose EU at WTO

(D Ravi Kanth / Geneva , 22-Sep-2009 , Business Standard)
Indian generic drug companies have been charged with violating EUs patent laws. More...
Govt begins efforts to establish Indian pharmacy chains in Africa to counter issue of fake
drugs with made in India label by China
In an effort to effectively counter the complex issue of spurious drugs with made in India label but were
produced by Chinese companies to tarnish the image of Indian generic drugs in the African countries the
Indian government has started initiatives to establish a chain of pharmacies in African countries by the
reputed Indian pharmacy chains like Apollo Group and Hetero Group. More...
Proposed patent Bill is flawed say experts

(C.H. Unnikrishnan , 21-Sep-2009 , livemint)
A patent and intellectual property rights Bill modelled on a 1980 Act of the US Congress and due to be
tabled in the Parliaments December session is drawing criticism from researchers and academics for not
addressing key issues and jeopardizing public interest. More...
OSI Pharma receives reissued patent for Tarceva

(Melville, New York , 21-Sep-2009 , Pharmabiz)
OSI Pharmaceuticals Inc announced that the US Patent & Trademark Office has issued a Notice of
Allowance in OSIs reissue application for US Patent No.5747498 composition of matter patent for
Tarceva. More...
Pharma market may touch $20 billion by 2015

Patent products may capture 8 10% share of the total market by 2015 the report said. More...
Developing countries express concern over WIPOs hidden agenda of pushing patent
harmonization
Even as the World Intellectual Property Organisations two day Global Symposium of IP Authorities is
underway in Geneva the developing countries are expressing concern on the larger agenda of the
organisation controlled by US EU and Japan on pushing a patent harmonization agenda. More...
Indian global pharma firms find it worthwhile to join hands

(Ravi Anathanarayanan , 21-Sep-2009 , livemint)
Companies began by selling generic drugs in India and other non regulated markets also invested in the
US branded generic drugs market targeting drugs that went off patent and also challenging some
patents. More...
Pharma market in global top 10 by 2015 Report
A report by the Federation of Indian Chambers of Commerce and Industry with Ernst and Young states
that India could be a potential $8 billion market for multinational companies with patented drugs
accounting for 8 10 per cent of the total market. More...
Sun Pharma to file 30 applications for generic drugs

(PTI , 21-Sep-2009 , livemint)
The company would file these applications along with its US based subsidiary Caraco which is facing
trouble due to non compliance of current good manufacturing practice of the US drug regulator. More...
Innovation the key for winning organisations

Innovation is all about research and development turned into an application and needs to come from all
levels within an organisation. More...
Now an Invention Inventors Will Like

(By STEVE LOHR , 20-Sep-2009 , The New York Times)
The world can be a rough place for independent inventors. More...
Patented drugs market in India to touch $8 bn by 2015 Report

(Press Trust Of India , 20-Sep-2009 , Hindustan Times)
The increasing population of higher income group in the country will open a potential $ 8 billion market
for multi national companies selling costly patented drugs by 2015 a FICCI Ernst & Young study said.
More...
Merck to launch 13 innovator drugs here

Besides the drugs launch we would go to smaller towns and cities where nobody has gone.Our growth
will be driven by patented drugs. More...
Glaxo seen eyeing 5% stake in Dr Reddys

Dr Reddys will get a lot of mileage in terms of selling their products in new markets while Glaxo will get
access to a basket of generics at a time when a large numbers of drugs are going off patent. More...
Banarasi silk sarees get copyright cover

(Binay Singh , 18-Sep-2009 , The Times Of India)
Banarasi silk products have now joined the league of Pochampalli Tirupati laddu and Darjeeling tea
under the registered name of Banaras Brocades and Sarees by securing Geographical Indication rights.
More...
Reliance Life trims pharma plans to keep cash in hand

The pharma arm will now focus on selected high value but low volume specialty drugs. More...
Skype founders file a copyright suit against eBay

(New York Times , 18-Sep-2009 , The Economic Times)
The founders of Skype are escalating their legal battle with eBay. More...
Appeals court affirms patent infringement rulings against Roches peg EPO product
(Thousand Oaks, California , 18-Sep-2009 , Pharmabiz)
Amgen announced that the Court of Appeals for the Federal Circuit affirmed the Massachusetts District
Courts decision that Roches peg EPO product Mircera infringes four Amgen patents relating to
recombinant erythropoietin and processes for making it. More...
The Apex Court of India Sets Guidelines for All IP Litigation in Lower Courts
(ag-IP-news Agency , 17-Sep-2009 , ag-IP-news )
A landmark Judgment has been passed by the Supreme Court of India which could change the course of
Intellectual Property litigation in India. More...
Dr Reddys Promoter exit wont come cheap

The one off windfall gains through patent challenges of the last few years are also not so much talked
about as more and more companies increasingly shake hands and call truce to save spiralling litigation
costs. More...
View Good candidate for GI status

(Amrith Lal , 17-Sep-2009 , The Times Of India)
After Darjeeling tea champagne and Florida oranges its the turn of Tirupati laddus to get a geographical
indications patent. More...
Counterview A laddu is a laddu is a laddu

(Amrith Lal , 17-Sep-2009 , The Times Of India)
But these are not convincing reasons to claim that the Tirupati laddu is an exceptional item like the
Darjeeling tea or Goan feni to have geographical indications patent rights. More...
TVS can sell Flame with twin spark plug

A Supreme Court Bench asks the Madras High Court to decide the matter before November 30. More...
Sun Pharma Caraco plan to file 30 patent pleas for generics

(BS Reporter / Mumbai , 17-Sep-2009 , Business Standard)
Sun Pharmaceutical Industries and its troubled US subsidiary Caraco Pharmaceuticals plan to together
file 30 Abbreviated New Drug Applications with the US Food and Drug Administration to market generic
drugs despite regulatory issues for the US company. More...
India has immense potential to take on global pharma markets

Primary problems faced by the Indian pharma sector today are issues of intangibles namely lack of
skilled manpower lack of consistency and quality lack of clarity on IPR and patenting regulatory failures
and a highly fragmented sector it said. More...
Centre plans action against EU customs rules

(Amiti Sen , 16-Sep-2009 , The Economic Times)
India is not willing to take the European Commissions verbal assurances on sorting out the issue of
seizure of Indian drugs at European ports. More...
SC reserves judgement on Bajaj TVS patent case

(Legal , 16-Sep-2009 , Business Line)
The Supreme Court on Tuesday reserved its judgement on the patent case between two wheeler rivals
Bajaj Auto and TVS Motor. More...
Tirupati laddu gets global patent

Temple sources said the Tirupati laddu got the patent rights under the Geographical Indications of Goods
Registration and Protection Act on Tuesday. More...
Vedi asked not to use Le Passage trademark

Delhi high court on Tuesday restrained Vedis International Tours and Travels from infringing on the
registered trademark and the domain name of another tour operator Le Passage to India Tours and
Travels. More...
The IPR icing on Brazils cotton victory

The more significant aspect of the arbitration panels ruling is that it allows cross retaliation by Brazil
against intellectual property rights which is protected by the WTOs Agreement on Trade Related Aspects
of Intellectual Property Rights TRIPS or on services. More...
India Wins European Patent Battle For Jute

(FE Reporter , 15-Sep-2009 , The Financial Express)
In a major victory for the ailing jute industry Jute Manufacturers Development Council successfully
fought to revoke a UK based firms patent for use of hessian cloth to cover waste and dumping grounds.
More...
DRL faces patent suit in US over allergy generic

NYSE listed Dr Reddys Laboratories is embroiled in a fresh patent infringement row with US based drug
discovery firm Albany Molecular Research. More...
Mega deals boost pharma in crisis

With the so called patent cliff and stagnating pipelines of big pharma companies are trying to augment
their portfolios and revenues like Pfizer gets the biotech and OTC business of Wyeth to augment
revenues. More...
Patent expiry to open huge opportunity for Indian pharma

Patent expiry will be a major avenue of growth for the Indian pharmaceutical industry as products worth
$235 billion are going off patent within horizon of five years from 2009 to 2014 a top pharma company
official said here today. More...
Major growth will come from generics business

(C.R. Sukumar , 15-Sep-2009 , livemint)
Dr. Reddys Laboratories Ltds vice chairman and chief executive G.V. Prasad shares the drug makers
future ambitions. More...
WHO SEARO rejects counterfeit agenda of pharma MNCs

The meeting noted that the term and definition of counterfeit relates to infringement of intellectual
property rights and should not be equated with substandard medical products. More...
Suven gets two US patents for neurodegenerative disorder drugs

Suven Life Sciences Ltd announced that the US Patent Office has issued two Patents US 7507835 and US
7388024 corresponding to two New Chemical Entities for the treatment of disorders associated with
Neurodegenerative diseases and these Patents are valid until 2022 & 2024 respectively. More...
Lupin Novartis end patent row for Lotrel

(Khomba Singh, , 12-Sep-2009 , The Economic Times)
Mumbai based pharma firm Lupin has reached an out of court settlement with Swiss pharma major
Novartis for the latters hypertension drug sold under the brand name Lotrel which will allow the Indian
firm to launch the generic version of the drug ahead of its patent expiry in 2017 and get a one time
revenue upside said a person familiar with the development. More...
Fake drugs WHO body rejects MNC argument

The World Health Organisation regional committee has rejected the counterfeit drugs agenda propagated
by developed countries and pharma MNCs which is already threatening the entry of legitimate generics
exported from India. More...
Biocon joins hands with US co Amylin for diabetes drug
(ET Now , 12-Sep-2009 , The Economic Times)
Even as Amylin will own the intellectual property rights to the molecule and phybrid technology Biocon
will hold the IP for manufacturing. More...
SC issues notices in Novartis patent case

The apex court sought replies from the commerce ministry the comptroller general of patents the Cancer
Patient Aid Association and the four pharma firms that state their objections on why the patent should
not be granted to Novartis. More...
IPRS issues notices to hotels mall for copyright violation

(BS Reporter / Mumbai/ Ahmedabad , 12-Sep-2009 , Business Standard)
We have sent legal notices to the hotels and the mall for violating copyright under Section 33 of the
Copyright Act 1957. More...
Pfizer Indias new strategy for emerging markets

(Manas Chakravarty and Ravi Ananthanarayan , 12-Sep-2009 , livemint)
Profitability improvements would come from a higher share of products that have patent protection.
More...
IPA calls for amendment to D&C Act to exclude IPR issues from Sec 17
In a recent meeting jointly held by different departments including health pharma and commerce on the
issue the IPA has suggested that the terms of counterfeit and spurious be defined separately and the
IPR related issues e.g misbranded should be removed from Section 17 of the Drugs and Cosmetic Act.
More...
SC notices to Centre pharma companies on Novartis petition

(PTI , 11-Sep-2009 , The Times Of India)
The Supreme Court on Friday issued notices to the Centre pharma major Cipla Ranbaxy Lab Hetero
Drugs Natco Pharma and others on a pettion filed by Swiss firm Novartis AG challenging the denial of
patent for its blood cancer drug Glivec in beta crystal form. More...
Mid cap pharma firms focus on LatAm market

(Nina Mehta , 11-Sep-2009 , The Economic Times)
Indian companies faced with increased competition in developed markets and stiff standards set by the
US Food and Drug Administration are looking to markets where rules are less stringent as governments
focus on affordability of healthcare rather than defending patents on billions of dollars of drugs. More...
Pfizer plans major push into generics

Pfizer Ltd the Indian subsidiary of the worlds largest drug maker Pfizer Inc. is making an aggressive play
in the Indian generics or off patent drugs market. More...
Marico Agro Tech in trademark tussle

( T Knight Ridder/Tribune , 09-Sep-2009 , BusinessWeek)
Marico India the maker of cooking oils Saffola and Sweekar has sued Agro Tech Foods an affiliate of
American foods giant ConAgra Foods over what it believes is trademark violation by the latter. More...
India patent rejections welcomed by HIV AIDS groups

(By Bappa Majumdar , 09-Sep-2009 , Reuters)
Indias rejection of patent applications on two life saving HIV AIDS drugs last week has been welcomed
by health officials who say it will ensure wider access to the medicines. More...
Suven gets milestone payment from Eli Lilly

(KV Ramana , 8-Sep-2009 , DNA)
Once it is launched we will keep getting the royalty till the drug is covered by the patent he said. More...
DCGI asks states to effect fake drug norms

(Sushmi Dey , 8-Sep-2009 , The Economic Times)
The recent amendments in the Drugs & Cosmetics Act prescribes stricter punishment for companies
guilty of manufacturing adulterated or spurious drugs. More...
Cipla to produce biotech drugs

Cipla the countrys second largest drug company will foray into the production of biotechnology
medicines soon. More...
McDonalds loses trademark fight against McCurry

(The Associated Press , 8-Sep-2009 , CNBC)
U.S. fast food giant McDonalds lost an eight year trademark battle to prevent local restaurant McCurry
from using the Mc prefix in a precedent setting judgment by Malaysias highest court. More...
3 provisions helped India cull frivolous patents study

Three patent provisions that have come under flak from foreign companies and governments for not
being compliant with global intellecutual property regimes have actually helped India weed out frivolous
patents since 2005 when the country moved to a new patent regime. More...
Venus Remedies gets Indian patent for Potentox

Venus Remedies a mid cap Rs 260 crore plus Chandigarh based pharma company has received first ever
injectable FDC product patent for Potentox a research product of the company from the Indian Patent
Office Government of India. More...
U.S. court backs Synthes in U.S. patent case
(by Lisa Jucca , 07-Sep-2009 , Reuters)
Switzerland based medical device maker Synthes Inc has won a key ruling in an ongoing U.S. patent
case against U.S. competitor Medtronic the Swiss company said on Monday. More...
Innovation can benefit Indian drug industry

(ENS Economic Bureau , 07-Sep-2009 , express buzz)
Extending patent protection to incremental pharmaceutical innovation should encourage Indian

pharmaceutical companies to expand further their investment in innovation and ultimately become
major sources of new products for both the Indian and global markets. More...
Pfizer India arm to launch 2 3 generic drugs by Dec

(MUMBAI (Reuters) , 07-Sep-2009 , Reuters)
Drug maker Pfizer Ltd plans to launch two or three generic drugs in India by December as part of its
efforts to widen its portfolio and market share its managing director said late on Friday. More...
IT dept takes drug companies to court

(Khushboo Narayan and C.H. Unnikrishnan , 7-Sep-2009 , livemint)
Barring the top 300 pharma firms most of the 15000 drug units operating in India are engaged in
contract manufacturing. More...
EU will take steps to resolve drug seizure cases says Ashton

The EU has assured India that it will take steps to resolve the issue related to the recent cases of life
saving generic or off patent medicines exported from India to other countries being seized at European
ports. More...
Process Ciplas licence for Soranib HC

The Delhi High Court today directed the Drug Controller General of India to process the licence
application of Cipla for production and sale of the generic version of global pharma major Bayer
Corporations liver and kidney cancer drug Nexavar. More...
Bayers bid to stay Cipla cancer drug foiled next hearing on Oct 6
Germanys largest drug maker Bayer failed to get a court stay on Cipla from seeking permission to
launch the European companys copycat of cancer treating drug Nexavar in India. More...
Toyota patent trade case

(Bloomberg / Washington , 5-Sep-2009 , Business Standard)
Toyota Motor Corp the world’ biggest seller of autos powered by a combination of gasoline and electricity
faces a patent infringement claim that may result in a US import ban on its Prius and other hybrid
models. More...
Process Ciplas licence for Soranib HC

The Delhi High Court today directed the Drug Controller General of India to process the licence
application of Cipla for production and sale of the generic version of global pharma major Bayer
Corporations liver and kidney cancer drug Nexavar. More...
Ayurvedic remedies gain ground in India

(Saikat Chatterjee and Arush Chopra / Bloomberg , 4-Sep-2009 , livemint)
Residents have switched to traditional Ayurvedic healing used for hundreds of years to boost immunity
as well as unproven remedies being sold to take advantage of the outbreak More...
Revamping legal mechanism alone cant stop spurious drug makers

Excessive pressure from global agencies pushed India to make significant changes in the Drugs and
Cosmetics Act that will now subject perpetrators of spurious drugs to harsher punishments. More...
India rejects patent claims on two HIV AIDS drugs

(R. Prasad , 04-Sep-2009 , The Hindu)
The Indian Patent Office has rejected applications from two US pharmaceutical companies on grounds of
evergreening raising hopes of a further lowering of prices of two life saving drugs used by HIV AIDS
patients in the country. More...
Protecting the Patent System for Entrepreneurs

(By Scott A. Shane , 04-Sep-2009 , The New York Times)
Recently a number of companies from the information technology and financial services sectors have
been pushing Congress to change the patent system. More...
HC asks DGCI to grant licence to Ciplas anti cancer drug

The Delhi High Court today directed the drug regulator of the country to go ahead with the process of
granting a licence to Cipla for producing a generic version of the anti cancer medication Nexavar against
which global drug maker Bayer Corp is fighting a legal battle. More...
NGO asks govt to further amend Patent Act to avoid frivolous patent filings
The National Working Group on Patent Law an NGO working on patent issues in the country has asked
the government to further amend the Amended Patent Act 1970 to avoid frivolous and questionable
patent claims being filed by the industry and are being granted by the Patent Offices. More...
Govt may move WTO on EU drug seizures

The government plans to file a complaint to the World Trade Organisation against seizures of its
legitimate low cost generic drugs by the European Union according to people in the know. More...
Setting aside Bayers spurious claims

Two weeks ago Justice S Ravindra Bhat of the Delhi High Court dismissed with costs the writ petition
filed by the German pharmaceuticals giant Bayer Corporation against the Union of India the Drug
Controller General of India and Cipla. More...
India refuses patent protection for AIDS drug of US company

More appeals pending domestic manufacturing some way off. More...
Bayer CropScience Wins Patent Litigation

(By Staff Reporter , 01-Sep-2009 , Pharmaceutical Business Review)
Under the settlement Tian Rong and Hua Dong to cease the infringing acts. More...
Novartis Glivec case to be heard by another Bench

Swiss drug maker Novartis challenge in the Supreme Court on being denied a patent for its cancer drug
Glivec will now be re assigned to another Bench by the Chief Justice of India. More...
Britannia to sharpen focus on global biz

(BS Reporter / Kolkata , 01-Sep-2009 , Business Standard)
Biscuits major Britannia Industries plans to focus on strengthening its international business and expand
its brand presence in the aftermath of its settlement with Danone on the intellectual property rights
issue over the Tiger brand. More...
Swiss NGO flays Novartis Glivec appeal

A Switzerland based NGO has come out strongly against Swiss pharma giant Novartis appeal to the
Supreme Court last week over the rejection of its patent for cancer drug Glivec. More...
SC to hear Novartis case next week

The Supreme Court will hear Swiss drug maker Novartis AGs plea against denial of patent for its blood
cancer drug Glivec next week. More...
Britannia settles Tiger brand tangle with US firm

(IANS , 31-Aug-2009 , sifynews)
The Nusli Wadia led Britannia was embroiled in a bitter intellectual property right violation litigation with
its partner Groupe Danone after the Indian company charged the French dairy major with using its Tiger
trademark a key intellectual property in the overseas market without prior consent. More...
Big multinationals dumping excess vendor baggage

(Shelley Singh , 31-Aug-2009 , The Economic Times)
Companies doing R&D remotely also try to limit the number of third party vendors to protect intellectual
property and any infringements of patents. More...
GSK plans to launch H1N1 drug in India

(Press Trust Of India / New Delhi , 31-Aug-2009 , Business Standard)
UK based drug maker GlaxoSmithKline is in talks with the Indian government for introducing its
patented drug Relenza which is used for the treatment of Influenza A H1N1. More...
DRL seeks USFDA help to make cancer drug clone

(Sai Deepika Amirapu , 31-Aug-2009 , The Economic Times)
Dr Reddys Laboratories Indias second largest drug maker by sales has approached the US Food and
Drug Administration to overcome impediments in making the generic version of Revlimid an expensive
drug used to treat blood cancer. More...
Insurance firm told to pay up

The Supreme Court will on Monday hear Swiss drug maker Novartis AGs plea against denial of patent for
its blood cancer drug Glivec in its beta crystal form. More...
Lack of clarity in drugs Act may hit generic companies

(Nina Mehta , 31-Aug-2009 , The Economic Times)
Ambiguity in the amended Drugs and Cosmetics Act over the definition of the terms adulterated and
spurious drugs could affect Indian generic drug players. More...
Tata Sons wins trademark case against MakeMyTrip

(Shubhra Tandon , 30-Aug-2009 , Business Line)
Tata Sons recently won a trademark case at the World Intellectual Property Organisation against New
Delhi based travel portal MakeMyTrip for the use of the word TATA in the latters sister Web site
okaytatabyebye.com an online networking forum for the travel community. More...
Govt curbs sale of flu drug Zanamivir

The government is set to put Zanamivir the only swine flu drug that is freely available in the market
currently under restricted sale category. More...
Cipla calls off marketing alliance with Avesthagen

Cipla has terminated its marketing agreement with Avesthagen and is looking at selling its 5.8% stake in
the Bangalore based company. More...
Novartis moves SC in Glivec patent case

Swiss major Novartis AG has moved the Supreme Court challenging Intellectual Property Appellate
Board decision to reject its patent application of blood cancer drug Glivec in India. More...
Sharma to take up drug seizures issue with EU commissioner

(Asit Ranjan Mishra and Radhieka Pandeya , 29-Aug-2009 , livemint)
According to European Commission laws if a consignment of drugs is not patented either in the country
of origin or its final destination it could be seized. More...
Cipla gets relief as SC rejects Roche plea

The Supreme Court on Friday rejected Swiss drugmaker Roches petition to stop Indian firm Cipla from
selling the generic version of its cancer drug Tarceva to ensure that Indians have access to the medicine
at a lower cost till the Delhi High Court decides on Ciplas patent challenge plea. More...
Encouraging drug innovation

(Shamnad Basheer , 28-Aug-2009 , livemint)
The Mashelkar committee report on drug patent law may have stirred controversy but it sets the right
tone More...
GSK to launch promecta in India by 2009 end

Glaxo SmithKline Pharmaceutical said it is looking at launching its patented medicine promecta used in
treatment of depleted platelet count in India by this year end or early next year. More...
Patent regime poses new challenges for health Minister

(IANS , 27-Aug-2009 , SamayLive)
Minister of State for Health Dinesh Trivedi Thursday called for taking a serious look at the intellectual
property rights regime so that Indian patients are not adversely affected. More...
Even European Union doesnt link regulatory approval for generics to innovator patent
German healthcare giant Bayer is determined to introduce in India a system that can prevent early entry
of low cost generics despite the Delhi High Court quashing its plea to link regulatory approval to last
week saying the company was trying to tweak public policy. More...
Incremental pharma innovation in patent regime to benefit local firms

(fe Bureaus , 27-Aug-2009 , The Financial Express)
Expanding the scope of Indias current patent regime to include incremental pharma innovation would
benefit the domestic pharma players according to a study commissioned by the US India Business
Council which was released on Wednesday. More...
Drug Biotech Research Spending Hangs Tough

(By Emily Thornton and Frederick Jespersen , 27-Aug-2009 , BusinessWeek)
With billions of dollars worth of branded drugs losing their patent protection the pharmaceutical industry
is under pressure to boost its pipeline of innovative new drugs. More...
Indian patent laws not conducive to domestic R&D OPPI

The countrys pharmaceutical industry today said the present patent laws do not value incremental
innovations and are not conducive to the research and development activities of domestic firms. More...
Biocon mulls listing of two of its arms by next yr

(Press Trust of India / Chennai , 26-Aug-2009 , Business Standard)
Biocons patent portfolio totals close to 942 applications worldwide with over 182 granted patents.
More...
Stringent IP enforcement will limit access to generic drugs

(fe Bureaus , 26-Aug-2009 , The Financial Express)
Civil society organisations led by Centre for Trade and Development have sent a strong missive to the
Confederation of Indian Industry urging it to be careful about associating with multinational corporations
and developed countries that are keen to push more stringent intellectual property enforcement laws in
India . More...
US pharma association disapproves Customs seizure of generics

The response comes after 17 consignments of genuine generic medicines from India were recently
seized at various European ports alleging intellectual property violations. More...
Sanofi sues Sun Pharma over Taxotere generic

(Bloomberg , 26-Aug-2009 , livemint)
Sun is pursuing approval from the US FDA to market two dosage forms of the drug before the patents
expire in 2012 according to the complaint filed by Sanofi Aventis SA. More...
Concerns of WIPOs members and its customers differ

(D G Shah , 25-Aug-2009 , The Economic Times)
WIPO like other UN organisations is a member driven organisation. More...
The treaty is a cornerstone of multilateral cooperation

(Claus Matthes , 25-Aug-2009 , The Economic Times)
Recently articles have surfaced in the Indian press about international efforts to reform the Patent
Cooperation Treaty an agreement that binds 141 countries in a pact that facilitates the process of
seeking protection for an invention in multiple countries. More...
Govt should not succumb to the WIPO pressure

(Dr.Y.K.Hamied , 25-Aug-2009 , The Economic Times)
I strongly subscribe to the view that the ongoing reform of the Patent Cooperation Treaty at the behest
of WIPO is an attempt to undermine the sovereign rights of the Indian government to make laws to suit
its domestic needs. More...
Verva licenses FGFR intellectual property rights to Isis Pharma to treat obesity & other
diseases
(Geelong, Australia , 24-Aug-2009 , Pharmabiz)
Verva Pharmaceuticals Ltd and Isis Pharmaceuticals Inc announced the completion of an agreement
providing Isis an exclusive license to Vervas intellectual property rights targeting the Fibroblast Growth
Factor Receptor with antisense technology for the treatment of diseases including obesity and other
metabolic disorders. More...
Stem cell therapy market picking up as 4 new firms look to expand

(C.H. Unnikrishnan , 24-Aug-2009 , livemint)
The recent government decision to allow patenting of micro organisms and its processes and increased
awareness about cord blood cell banking are giving a boost to the new therapy. More...
The R&D debacle

(Ram Prasad Sahu / Mumbai , 24-Aug-2009 , Business Standard)
One of the four is the anti malarial drug Malarone on which the company is facing a patent infringement
suit by Smithkline Beecham. More...
India Infoline maintains Reduce rating on Sun Pharma

The company received US FDA approval for Eloxatin only to be suspended soon after on account of
continuing patent litigation. More...
Dump the Mashelkar report

(Business Standard / New Delhi , 24-Aug-2009 , Business Standard)
Even as the government accepts the revised report of the technical expert group on patent law issues
headed by RA Mashelkar a key conclusion of the group has run into fresh controversy over the reasoning
on which it is based. More...
North Indian pharma Focusing on R&D and tie ups to meet challenging conditions
(Sanjay Pingle, Mumbai , 24-Aug-2009 , Pharmabiz)
It has set up five R&D centers and got 24 product patents valid in more than 60 countries worldwide.
More...
We must look to avoid grant of frivolous patents at all costs

With the government accepting the Mashelkar Committee Report on pharmaceutical patents the stage is
now set for a new battle over patents and public health. More...
Hetero bags deal for 10 m Tamiflu

Roches application seeking patent for Tamiflu in India was rejected in March allowing Indian companies
to market the generic versions in India and other countries where Roche does not hold the patent.
More...
Govt plans retail clamp on Ciplas Tamiflu substitute

(Joe C Mathew & Pb Jayakumar / New Delhi , 22-Aug-2009 , Business Standard)
Relenza a pre 1995 molecule lacks patent protection in India and legally Cipla can manufacture and sell
the drug. More...
Drug makers face penalty for overcharging

(Sushmi Dey , 21-Aug-2009 , The Economic Times)
Drug manufacturing companies such as Cipla Ranbaxy Johnson & Johnson and Dr Reddys Laboratories
may have to pay over Rs 2038 crore to the government for overcharging consumers on price controlled
medicines. More...
Merck wins Singulair patent infringement suit against Teva

(Whitehouse Station, New Jersey , 21-Aug-2009 , Pharmabiz)
Merck & Co Inc announced that the US District Court for the District of New Jersey has ruled in Mercks
favour in a patent infringement suit against Teva Pharmaceuticals USA Inc. More...
Mashelkar report runs into fresh controversy

Patent expert says his views were misinterpreted to support conclusion that Indias patent laws could not
be tightened. More...
Bayer beaten in Indian court over patent law

(By Kevin Grogan , 20-Aug-2009 , Pharma Times)
Bayer has suffered a setback after a court in India dismissed the German firms attempt to prevent the
countrys regulator from approving a generic version of its kidney and liver cancer drug Nexavar that is
being prepared by Cipla. More...
Sun Pharma wins Gemzar patent case

(NewsWire18 , 20-Aug-2009 , livemint)
The US district court for the eastern district of Michigan delivered a partial summary judgement on
Monday invalidating Eli Lillys patent for method of use for Gemzar. More...
Sun wins US court ruling in Eli Lilly patent challenge

Clears way for low cost cancer drug launch in 2010. More...
Incremental innovations
It is hard to quibble with the Mashelkar Committees report on patenting of pharmaceutical substances
for its main theme that it is wrong to deny patents to incremental innovations if they have significantly
better safety and efficacy standards over the known molecule. More...
M&M wins disputed internet site case at WIPO

(Press Trust Of India / New Delhi , 20-Aug-2009 , Business Standard)
Mahindra & Mahindra has won a cybersquatting case at the World Intellectual Property Organisation
against a US based person who was using the name Mahindra in an internet domain. More...
Big Pharma must mend its ways to succeed in India

(Pillman , 20-Aug-2009 , DNA)
Close on the heels of the Intellectual Property Appellate Board halting Novartis Glivec patent application
and linking it to threatening public disorder on account of its high prices, the Delhi High Court has dealt
a body blow to German drug maker Bayers ambitions to monopolise the Indian market with its kidney
cancer drug Nexavar. More...
Bayers attempt to stop Cipla drug sale fails

Court rejects bid to introduce a linkage between regulatory approval of a medicine and its patent status
More...
Glenmark faces patent infringement case in US

(Press Trust Of India / Mumbai , 19-Aug-2009 , Business Standard)
Drug maker Glenmark Pharmaceuticals today said it was facing a lawsuit in a US District Court for a
patent infringement case of an anti malaria product. More...
Govt in talks with Roche for cheaper Tamiflu

(Soma Das , 19-Aug-2009 , The Financial Express)
Last month Roche the patent holder of Tamiflu not in India started a new initiative to supply the anti
viral drug to select developing countries at a reduced cost of $2.80 and $8.50 in consultation with the
WHO. More...
Courts being used to stifle generic challengers

Patent fights are becoming more difficult for domestic pharmaceutical companies as multinational drug
giants which obtain patent protection for medicines that are vulnerable to post grant oppositions are
increasingly approaching Indian courts to stall competition from low cost local manufacturers. More...
Microsofts Patent Dust Ups
(Aaron Ricadela , 19-Aug-2009 , Business Week)
For the past half dozen years Microsoft has been busily getting its patent house in order. More...
Daiichi Sankyo Lupin in talks for marketing tie up

(Radhieka Pandeya , 19-Aug-2009 , livemint)
Today MNCs are looking at how they can create opportunities after patent expiry and joining hands with
generic companies. More...
Lilly shares fall after court invalidates patent

(by Toni Clarke , 18-Aug-2009 , Reutres)
Shares of Eli Lilly & Co fell 1.4 percent in premarket trading on Tuesday after a court invalidated a key
patent governing its cancer drug Gemzar. More...
Major win for Indian pharma cos as HC dismisses Bayer petition

In a major win for Indian pharmaceutical companies the Delhi High Court on Tuesday dismissed German
drug major Bayer Healthcares attempt to stop Drug Controller General of India from giving marketing
approval to Indian company Cipla for the generic version of Bayers patented kidney cancer drug
Nexavar. More...
We have filed a world patent for a new energy saving technology

(Business Standard / New Delhi , 18-Aug-2009 , Business Standard)
Deepak Pahwa Managing Director of Pahwa Enterprises Indias largest private sector SME in the HVAC&R
heating ventilation air conditioning and refrigeration industry tells Business Standard that some of his
key customers are pharma units and since dehumidification machines are at the heart of pharma units
his company was unaffected by the downturn. More...
Govt accepts panel report against narrowing of Indian patent law

The central government has accepted the recommendations of an expert committee headed by former
Council of Scientific and Industrial Research chief R A Mashelkar on patent laws. More...
Govt wont tweak drug patent rules

(Khomba Singh & Sushmi Dey , 18-Aug-2009 , The Economic Times)
The commerce ministrys decision to accept the Mashelkar committees revised report that recommends
not to restrict patenting to new drugs has come in for strong criticism from health activists and some
generic drugmakers even as patent experts supported the move thats in line with international norms.
More...
Indian generics profit from Glaxo patent expiry

(P B Jayakumar / Mumbai , 18-Aug-2009 , Business Standard)
GlaxoSmithKline Plcs anti migraine drug brand Imitrex is turning out to be a good revenue earner for
Indian generic companies as the US Food and Drug Administration has given almost half of the final
approvals for the reverse engineered or generic versions of the drug made by Indian pharmaceutical
companies following its patent expiry. More...
Patently right
(The Indian Express ,Mashelkar report , 17-Aug-2009 , Indian Express)
Should patents be granted to incremental changes on existing drugs not just to completely new medical
and chemical entities Yes said the government appointed Mashelkar Committee report and yes says the
Centre by accepting the reports findings. More...
Maker of fake drugs has fled to Hong Kong

(S Balakrishnan , 17-Aug-2009 , The Times Of India)
Chairman and MD of Phikon Biotech Pvt Ltd D J Vaidya who is allegedly involved in the manufacture of
fake drugs for heart ailments and cancer has fled to Hong Kong. More...
Big pharma companies join outsourcing queue

(PB Jayakumar / Mumbai , 17-Aug-2009 , Business Standard)
Diminishing numbers of new drugs as against existing drugs going off patent high research and
development costs and pressure to reduce healthcare costs are forcing Big Pharma to rope in strategic
partners to contain manufacturing and drug development expenses. More...
Pharma patents Mashelkar report gets Centre approval

(Amitabh Sinha , 16-Aug-2009 , Indian Express)
Mashelkar as head of a Technical Expert Group that had four other members had been asked by the
government in 2005 to examine whether the grant of patents for pharmaceutical substances could be
limited only to new chemical entities and new medical entities involving one or more inventive steps or
they could be granted to incremental innovations on existing drugs as well. More...
Novartis reportedly sues GlaxoSmithKline over patent

(By Polya Lesova , 16-Aug-2009 , MarketWatch)
Swiss drugmaker Novartis AG has filed a legal action against rival GlaxoSmithKline over a vaccine patent
according to a media report Sunday. More...
Remedy for a malady

(By Andrew Jack , 14-Aug-2009 , Financial Times)
He cites as symptomatic the large scale takeovers this year of Wyeth by Pfizer and Schering Plough by
Merck which he argues were primarily designed to defer patent expiries and cut costs rather than
provide a solution to falling research productivity. More...
Allow retail sale of drug say domestic pharma players

(P B Jayakumar & Joe C Mathew / Mumbai & New Delhi , 14-Aug-2009 , Business Standard)
The central governments decision to continue controlling supply of the swine flu drug oseltamivir will
help the drug innovator Swiss multinational Hoffmann La Roche and its Indian licencee Hetero Drugs
maintain their effective monopoly in the country even as the drug lacks patent protection in India fear
domestic industry circles. More...
Macro gain for ASEAN micro pain for India
(G. Srinivasan , 14-Aug-2009 , Business Line)
Effectively this implies that India has less than 50 60 items in its negative list for each ASEAN country a
patent asymmetric pact from negotiation angle leaving legions of domestic industries vulnerable to
dumping and material injury. More...
Sun Pharmas US arm reliant on generic launches

(Manas Chakravarty and Mobis Philipose , 13-Aug-2009 , livemint)
In the previous year two such Para IV filings for abbreviated new drug applications which challenge an
existing patent in order to launch a slightly different generic version of the same product with one off
revenue potential accounting for 57% of revenues. More...
Orchid settles Schering lawsuit

Orchid Chemicals and Pharmaceuticals has reached an out of court settlement with the US based
Schering Plough Corporation on a 2006 patent lawsuit regarding allergy medicines Clarinex and Clarinex
Reditabs. More...
IDMA urges law makers to initiate measures to save Indian generic drugs
The products had no Patent or Trade Mark problem either in India origin country or the destination
country. More...
Stricter law on fake drugs now in force

(Radhieka Pandeya , 13-Aug-2009 , livemint)
India finally has a law to combat the menace of fake and adulterated drugs and not all pharma
companies are happy with it. More...
Information on Swine Flu - I

(12-Aug-2009)
Government Authorized Hospitals For Treatment Of Swine Flu
Courtesy: Mr. Amit Didwania, Drishya Holidays Pvt. Ltd. More...
Information on Swine Flu - II

(12-Aug-2009)
Important Information on Swine Flu H1N1.
Courtesy: Mr. Amit Didwania, Drishya Holidays Pvt. Ltd. More...
Swine Flu H1N1- Prevention & Treatment

(12-Aug-2009)
There is no vaccine available right now to protect against novel H1N1 virus. However, a novel H1N1
vaccine is currently in production and may be ready for the public in the fall. As always, a vaccine will be
available to protect against seasonal influenza. There are everyday actions that can help prevent the
spread of germs that cause respiratory illnesses like influenza.
Courtesy: Jimmy George More...
India emerging global pharma outsourcing hub Study

Of the total global outsourcing custom manufacturing phase IIb to the off patent stage including
intermediates API and formulations contributes almost 65 per cent of the $51 billion market in 2008.
More...
Sun Pharma gets US nod for two generic drugs

(REUTERS , 12-Aug-2009 , The Economic Times)
Sun Pharmaceutical Industries has got the US Food and Drug Administrations approval to launch its
generic version of GlaxoSmithKlines Imitrex tablets to treat migraine the Indian drugmaker said. More...
Ranbaxy gets USFDA nod for Sumatriptan Succinate Tablets

The office of generic drugs USFDA has determined that the Ranbaxy formulations to be bio equivalence
and have same therapeutic effect as that of GlaxoSmithKlines patented drug Imitrex Ranbaxy said.
More...
China admits its companies involvement in fake drugs case

China has admitted that its pharmaceutical companies were involved in shipping fake drugs labeled
Made In India to Nigeria. More...
Novartis hits Astellas with transplant drug generic

(Yumiko Nishitani , 11-Aug-2009 , Reutres)
Astellas lost U.S. patent protection for Prograf in April 2008 but until now has not faced any generic
competition. More...
Strides Arcolab ready to supply Swine Flu drug

Oseltamivir Capsules are the generic version of Roches patented drug Tamiflu. More...
Schering settles final Clarinex patent litigation

(LOS ANGELES , 11-Aug-2009 , Reutres)
Drugmaker Schering Plough Corp SGP.N said on Tuesday it settled patent litigation with Orchid
Chemicals & Pharmaceuticals Ltd related to generic versions of its allergy medication Clarinex. More...
Swiss firm moves apex court against Cipla

Swiss drug maker F. Hoffmann La Roche Ltd has petitioned the Supreme Court against a Delhi high
court order in a patent violation lawsuit regarding its cancer drug Tarceva with Indian pharma firm Cipla
Ltd. More...
immatics gets European patent for IMA901 product & US patent for MUC 1 peptide
(Martinsried, Munich , 11-Aug-2009 , Pharmabiz)
immatics biotechnologies GmbH has obtained European patent protection for the composition of matter
for its drug candidate IMA901. More...
HC returns appeal on dual SIM card case

The Madras high court on Friday returned an appeal filed by Madurai Tamil Nadu based electronics
engineer S. Ramkumar to the Customs Appellate Tribunal in a case related to his patent on dual SIM
card mobile phones. More...
India warned on moving WTO over drug seizures

Even as India considers the European Union directive that allows seizure of goods in transit by its
member countries as violative of the World Trade Organizations TRIPS trade related aspects of
intellectual property rights agreement legal experts caution against the central governments plans to
approach the dispute settlement body of WTO. More...
Azad says wont wait for desi swine flu vaccine will import
(Kounteya Sinha , 11-Aug-2009 , The Times Of India)
At present only one US based company Biosystem has the patent of the real time PCR kits for detection
of H1N1 being used globally. More...
US Patent and Trademark Office Issues Key Patent For OncoGenexs OGX 011
(By Staff Reporter , 10-Aug-2009 , Pharmaceutical Business Review)
US Patent and Trademark Office has issued US Patent Number 7569551 entitled Chemo and Radiation
sensitization of Cancer by Antisense TRPM 2 Oligodeoxynucleotides on the method of using OncoGenexs
OGX 011 to treat certain cancers. More...
Indian companies may pitch in with generic version of Tamiflu

(Khomba Singh & Sushmi Dey , 10-Aug-2009 , The Economic Times)
Cipla and other Indian pharma majors can now legally manufacture generic versions of Tamiflu after the
patent office in Delhi last month rejected a patent application by Swiss company Roche which markets
the antiviral in India. More...
GI tags sought for veena lock

(Our Correspondent , 10-Aug-2009 , Business Line)
The Tamil Nadu State Council has taken steps to get Geographical Indication Tags of Thanjavur Veena
and Dindigul Lock establishing their place of origin. More...
Human clinical trials for stem cell research on cards
(Vishal Dutta , 10-Aug-2009 , The Economic Times)
StemCyte has patented the plasma depletion technology that helps in collecting higher volume of stem
cells and better cell counts resulting in successful therapeutic applications for over 70 diseases. More...
Low costs a draw for foreign drug makers

Low costs high technical capabilities and a skilled work force are making India an attractive destination
for research and contract manufacturing of drugs. More...
Old medicine new patents

(Gaurav Choudhury , 08-Aug-2009 , Hindustan Times)
Slowly but surely India Inc is waking up to the virtues of traditional wisdom. More...
HC bans MNS Pharma from lipid control drug sale

Rosuva is a registered trademark of Ranbaxy. More...
Oppn to officials taking up plum posts in WTO WIPO

Civil society groups have complained against the practice of senior commerce ministry officials taking up
plum posts with international agencies such as the World Trade Organization and World Intellectual
Property Organisation with whom they have been involved in direct negotiations on issues of national
interest. More...
Top Article Log On To The Power Of Ideas

(R A Mashelkar , 8-Aug-2009 , The Times Of India)
Due to the limitations in Indias patent laws the phytopharmaceutical breakthrough medicine on psoriasis
by an Indian company will be commercialised first in the West not in India. More...
US court to hear Glenmarks patent dispute on Aug 19

Glenmark Pharmaceuticals patent challenge against Schering Ploughs cholesterol lowering drug Zetia will
come up for hearing in the US district court of New Jersey on August 19. More...
Pfizer agrees to cut price of TB drug

(By Andrew Jack in London , 7-Aug-2009 , Financial Times)
Mylan will reduce the price of four HIV drugs that are off patent atazanavir ritonavir tenofovir and
lamivudine to $475 a year falling to $425 a year from 2010 which is 28 per cent less than current prices.
More...
GSK to up output of inhaler drug
GSK and Biota which invented the drug and holds the patent till the end of 2014 are not the only ones
who have been approached to supply the drug. More...
Roche will only help itself by making drugs affordable

(Pillman , 7-Aug-2009 , DNA)
In a recent judgment by the Intellectual Property Appellate Board on Novartis Glivec the need to make
the drug affordable was emphasised. More...
BR Films pays up Rs1 crore in copycat case

(Anshika Misra, Mumbai , 6-Aug-2009 , DNA)
Bollywood will now think twice before getting inspired by Hollywood again. BR Films,which was dragged
to court by Twentieth Century Fox for alleged plagiarism, on Wednesday agreed to pay a settlement
amount of $200,000 (a little less than Rs1 crore)to the American studio. More...
Ailing drugmakers may seek foreign cure

(By Pratish Narayanan , 6-Aug-2009 , Reutres)
Global heavyweight Pfizer is seen as the most likely suitor of Indian rivals as it looks to replace revenue
lost from the lapse of key patents while Merck and Sanofi Aventis may also seek to shake hands with
Indian producers analysts said. More...
Lupin to launch more branded generics in US

Branded generics are rip off versions of off patent drugs but since they incorporate added advantages
such as lower dosages the US drug regulator allows them to be sold under a brand. More...
India may get its first novel drug by 2014

From the last few years almost every Indian company worth its name is talking of having novel
molecules new chemicals entities and a few new biological entities in its kitty. More...
US exclusivity law may hit Indian biotech cos

These companies will have to choose their products carefully and focus on those products which are
already off patent or scheduled to go off patent soon said Sanjay Singh associate director KPMG. More...
Nigerian drug regulator to open Indian offices

Reacting to the seizure of fake Chinese drugs carrying a made in India tag the Nigerian drug regulator
has decided to set up its offices in India. More...
A singular victory for open innovation

(Latha Jishnu / New Delhi , 5-Aug-2009 , Business Standard)
At the conference sponsored by the World Intellectual Property Organisation on July 13 and 14 he would
launch his Initiative for Open Innovation globally to promote transparency in the patent system a
disruptive democratising cyber infrastructure to make it possible to turn the patent system into a
transparent fixable part of society as he called it in his letter. More...
MNCs eye Indian pharma

Till a few years ago it was believed Indian pharma companies highly profitable generic business model
they were able to corner a large share of market for drugs going off patent and occasionally challenged
patents through Para IV filings in the US would allow them to build financial muscle. More...
Interpol scans fake drugs with Made in India label

(PTI,New Delhi , 04-Aug-2009 , livemint)
Recently fake drugs carrying the Made in India label were seized in Nigeria but were allegedly
manufactured in China. More...
India may move WTO to protest drug seizures

The government is planning to approach the dispute settlement body of the World Trade Organization
against frequent seizure of Indian medicines at various European ports. More...
Roche prepares to defend local patent for Valcyte

Firm facing at least five post grant oppositions at Chennai patent office it has cut price of the drug by
35% More...
Combating spurious drugs

(Pharmaceutical , 4-Aug-2009 , Business Line)
The whistle blower scheme outlined by the Union Health Minister is a workable idea but only a consistent
multi level approach can snuff out spurious drug makers. More...
India grants 3500 pharma patents in three yrs

The Indian Patent Office has granted 3506 patents relating to pharmaceutical innovations over the last
three years the government said today. More...
A patent case for invention

(P. V. INDIRESAN , 3-Aug-2009 , Business Line)
India needs improved patent laws that will protect genuine inventors better and minimise disputes on
trivial grounds. More...
Daiichi wins court battle against Mylan Matrix

(Press Trust of India / Tokyo/ New Delhi , 03-Aug-2009 , Business Standard)
Japanese drug major Daiichi Sankyo said today a US Court has ruled in its favour in a patent litigation
related to the anti hypertensive drug Benicar against Mylan Inc and its Indian subsidiary Matrix
Laboratories. More...
India set to sign pharma export deal with Nigeria

(Sushmi Dey & Gireesh Chandra Prasad , 3-Aug-2009 , The Economic Times)
The government is set to sign an exhaustive deal with Nigeria to boost pharmaceutical exports to its
eighth largest global consumer where the reputation of Indian drugs was recently dented by fake drugs
from China bearing Made in India labels. More...
Indias Sun Pharma MedImmune settle on ethyol

(by Bharghavi Nagaraju , 3-Aug-2009 , Reutres)
Indias Sun Pharmaceutical Industries Ltd said on Monday it has settled a patent dispute with
AstraZenecas MedImmune unit for generic version of Ethyol resolving all litigation between them.
More...
Copycat Indian drug cos turn MNC partners

This seems to be the strategy of multinational pharmaceutical companies vis a vis the highly Top 10
Drugmakers by sales successful Indian drug industry that makes a living out of copying off patent
blockbuster drugs. More...
The French connection

(BV Mahalakshmi, Sudhir Chowdhary , 3-Aug-2009 , The Financial Express)
The fact that Shantha Biotech was able to attract Sanofi with its intellectual property and good
manufacturing facilities is a sign of the maturity of the Indian vaccine industry. More...
$70 bn worth drugs to go off patent benefiting India Report

The Indian drug industry would make huge gains as over $70 billion worth of drugs are expected to go
off patent in the US the worlds largest pharma market in the next three years according to a report.
More...
Takeda swings back to profit keeps forecast

(By Yumiko Nishitani , 31-Jul-2009 , Reutres)
Takeda launched Kapidex ahead of the patent expiration in November for its predecessor drug Prevacid
in the United States but analysts expect competition to keep Kapidex from compensating fully for a likely
drop in Prevacid sales. More...
SemBioSys shares soar after insulin patent granted

(by Nina Lex , 30-Jul-2009 , Reutres)
Shares of SemBioSys Genetics Inc soared as much as 74 percent on Thursday morning after the
company announced it had been granted a U.S. patent for commercial production of insulin by using oil
from the seeds of safflower plants. More...
India Patent Rights and Wrongs
(By ROGER BATE , 29-Jul-2009 , The Wall Street Journal)
India promised to protect intellectual property when it signed up to the World Trade Organizations rules
in 2005. More...
Sanofi profits soar prepared for Plavix Taxotere patent losses

(By Kevin Grogan , 29-Jul-2009 , Pharma Times)
Sanofi Aventis has posted a strong set of figures for the second quarter this morning and says it has laid
the groundwork to cope with patent expiries. More...
Right and wrong medicines

(Business Standard / New Delhi , 29-Jul-2009 , Business Standard)
One recent step has been to hire more inspectors another to float the idea of a quality mark for generic
medicines which have no patent cover. More...
GITAM varsity plans IPR cell

The GITAM Institute of International Business is setting up an intellectual property rights IPR cell with
the assistance of the National Research and Development Corporation according to Prof V.K Kumar the
Director. More...
Drug sector fears bias in Tamiflu sourcing

(P.T.Jyothi Datta , 28-Jul-2009 , Business Line)
India did not grant a patent to innovator Gilead on Oseltamivir. More...
Lunch with BS Malvinder Mohan Singh

(Bhupesh Bhandari / New Delhi , 28-Jul-2009 , Business Standard)
What made you sell I ask Malavs friends say the patent litigations switched him off pharmaceuticals such
litigation can be expensive and nerve wracking. More...
IT firms speed up patent filing

(Vishwanath Kulkarni,Shamik Paul , 28-Jul-2009 , Business Line)
Stepping up efforts to commercialise their intellectual property IP Indian IT services firms have
accelerated their patent filing process. More...
An incubator that takes care of everything

(Deepti Chaudhary , 27-Jul-2009 , livemint)
In India i2india has signed patent agreements with institutions such as Indian Institutes of Technology
and Indian Institute of Science. More...
Sanofi Aventis to acquire Indian vaccine company
(PARIS , 27-Jul-2009 , Business Week)
It aims to refill a development pipeline that analysts see as woefully light on new drugs to replace those
that will soon go off patent and face competition from cheaper copies. More...
Global drug cos set sights on Indias veterinary market

(Nina Mehta , 27-Jul-2009 , The Economic Times)
Animal healthcare in India is no longer an afterthought as global pharmaceutical companies facing loss
in revenues due to expiring drug patents are looking for new growth markets. More...
Anna University IPR centre files 53 patents

(D Suresh Kumar , 27-Jul-2009 , The Times Of India)
Inventors and innovators including college students who are keen on getting their work patented no
longer need to spend time and money undertaking a taxing documentation process or familiarising
themselves with legal jargons. More...
How pharma companies can be better long term bets

(Kiran Kabtta Somvanshi and Santanu Mishra , 27-Jul-2009 , The Economic Times)
Over dependence on cost competitiveness however comes with its own set of risks increased scrutiny
and clamps from drug regulators legal risks in challenging patented drugs and rising pricing pressure as
regulated markets overhaul their healthcare systems. More...
Quality stamp for drugs in works

(Sushmi Dey , 27-Jul-2009 , The Economic Times)
A generic drug is not protected by patents and can be manufactured without paying royalty. More...
Ranbaxy net jumps 30 fold to Rs 693 cr

FTFs are the main growth drivers for most leading Indian companies that make generic versions of
expensive drugs that have gone off patent. More...
Teva J&J settle oral contraceptive patent case

(By Lewis Krauskopf , 24-Jul-2009 , Reutres)
Teva Pharmaceutical Industries Ltd said on Friday it settled a patent infringement lawsuit with Johnson &
Johnson over Tevas U.S. generic version of J&Js Ortho Tri Cyclen Lo birth control pill. More...
Non market strategies making a comeback in West

(Dibeyendu Ganguly , 24-Jul-2009 , The Economic Times)
A blood cancer drug called Glivec has been a money spinner for Novartis all over the world except in
India where the patent authorities have turned down the Swiss companys application for a product
patent on the grounds that it does not offer sufficient improved efficacy over its predecessor. More...
Give info on counterfeit drugs get rewarded

Informing the government about spurious drugs could soon earn you big money. More...
Moser Baer Philips settle patent dispute

Global technology company Moser Baer has settled a patent and licence dispute with global electronics
giant Philips. More...
Costly drugs prompt exclusivity debate

(Andrew Pollack , 23-Jul-2009 , livemint)
For starters whatever the exclusivity period biologic drugs would also continue to be protected from
copycats by patents. More...
Sun Pharma arm faces class action suit in US

(Khomba Singh and Nina Mehta , 23-Jul-2009 , The Economic Times)
Caraco Pharmaceuticals the US arm of Sun Pharma has been slapped with a class action suit in the
United States for allegedly Top 10 Drugmakers by sale not disclosing adequate information about US
regulatory action that hurt its shares rendering Indias most valuable drugmaker vulnerable to the
prospect of hefty payouts as damages. More...
Barking up the wrong tree

(By René B. Azurin , 23-Jul-2009 , BusinessWorld)
For the pharmaceutical companies that own patents to various drugs this meant that they are deemed to
have no further legal claims insofar as the resale of their products is concerned. More...
DSM in talks to supply Lipitor ingredient

Pfizers patent for Lipitor in the US expires in 2011. More...
Cadila loses Mexate trademark case

(BS Reporter / Mumbai/ Ahmedabad , 21-Jul-2009 , Business Standard)
Ahmedabad based Cadila Healthcare Ltd has lost the case in a civil suit which it had filed for its brand
Mexate against Wallace Pharmaceuticals Pvt Ltd. More...
Incidence high in countries where access to medicines is poor

(Tapan Ray , 21-Jul-2009 , The Economic Times)
Incidents like recent detention in transit of DRL shipment of the generic version of Losartan in the
Netherlands or a consignment of Amoxicillin at the Frankfurt airport on the ground of patent
infringement cannot be considered as attempts of MNCs to brand Indian generic drugs as counterfeit
medicines. More...
18230 patents granted in 2008 09

The Indian Patent Office has granted 18230 new patents in 2008 09 Lok Sabha was informed today.
More...
Its an MNC agenda to prevent competition

(Anand Grover , 21-Jul-2009 , The Economic Times)
The recent anti counterfeiting measures worldwide seizures of generic drugs in Holland the proposals in
the WHO the moves in the East African Anand Grover Director Lawyers Collective HIV AIDS Unit region
and in the Andean community to criminalise patent infringements etc. More...
A Trips plus agenda at WIPO

(D Ravi Kanth , 21-Jul-2009 , Business Standard)
Those who cannot remember the past are condemned to repeat it is a timely reminder for key actors
who are bent on pushing failed agendas. More...
Earnings Preview: Pfizer preps for Wyeth deal

(By LINDA A. JOHNSON , 20-Jul-2009 , Forbes)
It also broadened its partnership with an Indian generic drugmaker and started a new one with an
Indian maker of injected medicines part of an effort to boost sales of off patent drugs and of products in
Dual SIM dispute highlights flaws in Indias patent process

(C.H. Unnikrishnan , 20-Jul-2009 , livemint)
Patent experts expressed surprise that Ipab passed an interim order instead of deciding the patents
validity More...
Novartis to challenge IPABs patent decision on Glivec

The Indian subsidiary of Swiss drugmaker Novartis will challenge a decision by the Intellectual Property
Appellate Board IPAB that said its cancer drug Glivec was not patentable. More...
Novartis set to appeal move on Glivec

Novartis looks set to appeal the recent decision by the Intellectual Property Appellate Board IPAB against
its cancer drug Glivec. More...
IT firms push for IPR multiple standards for e gov projects

(Vivek Seal , 18-Jul-2009 , DNA)
There are a couple of points in the policy that I think needs further debate one is single standard versus
multiple standard and the role of intellectual property rights IPR. More...
Govt orders recall as Natco cancer drug fails toxin test

Natco has filed pre grant opposition on the patents in India which are yet to be granted. More...
Pvt equity venture capital cos turning to healthcare Report

Another issue is the high risk of failure especially in new drug discovery competition from within and
outside India as well as patent related issues. More...
Patents will only benefit patients claim drug cos

As the issue of patent protection assumes centrestage not only in India but also in the countrys free
trade agreements with different countries multinationals are dredging up a number of reasons to support
their demand for patent protection. More...
Roche set to move SC against high court ruling on Tarceva

Roche had appealed against a ruling that allowed Cipla to continue selling a generic version of the
cancer drug Tarceva despite having a patent of it in India. More...
Madras HC stays appellate board order on dual SIM patent

(Niranjana Ramesh , 16-Jul-2009 , The Economic Times)
The Madras High Court on Wednesday set aside an interim order passed by the Intellectual Property
Appellate Board suspending the patent held by Madurai based engineer Somasundaram Ramkumar for
the technology that enables usage of more than one SIM card in mobile handsets popularly called a dual
SIM. More...
IPL teams to now bat for trademark rights

(Monica Behura , 16-Jul-2009 , The Economic Times)
All eight franchises of the Indian Premier League including Shahrukh Khans Knight Riders Deccan
Chargers and Delhi Daredevils have filed applications before government authorities in 12 13 cricket
playing countries seeking exclusive trademark rights for their names. More...
US amendment may leave Indian biopharma cos shaken & stirred

Once a patent is filed it takes a company almost 10 years to develop the product and reach the market.
More...
Indian pharma firms swallow bitter pill in US Europe

Regulators tighten net on safety grounds More...
Bisleri Coke may smoke peace pipe

(Monica Behura , 16-Jul-2009 , The Economic Times)
Last year the Delhi High Court was prima facie of the view that Coca Cola was the owner of the Maaza
trademark in India. More...
R&D gets a boost

In tandem whats required is to promptly update the norms on royalty payment for use of trademark or
brand and fees for technology transfer. More...
Retailer Knockoffs Abound in India

(By HEATHER TIMMONS , 15-Jul-2009 , The New York Times)
The United States has long tussled over intellectual property rights with China where counterfeiters
crank out knockoffs of designer bags and iPhones and manufacturers have even made entire vehicles
that look just like foreign cars. More...
Kenya gives clean chit to imported drugs from India

The legislation recognises intellectual property rights registered in any country of the world and not
necessarily in Kenya. More...
Sun Pharma A dose of good news

(Shobhana Subramanian / Mumbai , 14-Jul-2009 , Business Standard)
The US authorities still need to bless the settlement that Sun Pharma has entered into with Forest
Laboratories Holdings over the patent litigation for Lexapro an anti depressant. More...
PE & VC firms bullish on Healthcare investments

In the Life Sciences segment investors concerns are focused on the high risk of failure especially in new
drug R&D stiff competition from inside and outside India as well as patent related issues. More...
Merck to revise labelling on cervical cancer vaccine

(P.T. Jyothi Datta , 14-Jul-2009 , Business Line)
Multinational drug major Merck Sharp & Dohme will revise the labelling on its cervical cancer vaccine
Gardasil after it informs the Indian drug regulatory authority later this month. More...
Sun Pharma up on patent deal with Forest Labs

Sun Pharma rose 2.6 per cent to Rs 1149.75 after the company and its subsidiary Caraco Pharma
entered into agreement with Forest Labs and H Lundbeck over Lexapro. More...
West uses Africa in war against generic drugs

Now the developed world is using this vulnerability and turning it into a campaign against legitimate
generics by branding them counterfeits which has to do more with IPR and patent violations than
quality. More...
India Inc finds stem cells a healthy business

The company already owns seven patents. More...
Sun Pharmaceutical Rises Most in Three Weeks on Suit Settlement

(By Rajhkumar K Shaaw , 13-Jul-2009 , Bloomberg)
Sun Pharmaceutical Industries Ltd. rose the most in three weeks after it reached an agreement with
Forest Laboratories Inc. to drop a lawsuit challenging patents on the antidepressant Lexapro. More...
We have a conservative generic policy

We do make generic versions of our previously patented products. More...
Delhi HC rejects German pharma cos plea

(Legal,NEW DELHI , 13-Jul-2009 , Business Line)
The Delhi High Court has rejected the plea of German pharma company B Braun Melsungen AG claiming
patent rights to an item sold by healthcare products manufacturer Eastern Medikit. More...
Team heads to Africa on quality mission

Africa accounts for over 15% of Indias total generic off patent drugs exports worth Rs 30000 crore
annually. More...
Foreign copycats rattle Gujarat brands

(Vishal Dutta , 11-Jul-2009 , The Economic Times)
The US trademark office turned down the Patel familys request for registration. More...
Efficacy point in Glivec ruling impractical

The controversy over patent to Novartis magic bullet Glivec continues to deepen. More...
Ranbaxy plans to launch growth hormone drug

(Mohit Bhalla , 11-Jul-2009 , The Economic Times)
Ranbaxy Laboratories is planning a new growth hormone product to target the emerging global market
for new versions of patent expired biotech drugs a person familiar with the development said. More...
Dark clouds loom on Big Pharma horizon

(By Sam Cage , 10-Jul-2009 , Reuters)
Consolidation was the major theme of early 2009 as some companies tried to escape the patent crunch
by splashing the cash aiming for synergies to offset the depressed outlook for growth over the next few
years. More...
Pfizer CEO Braces For Changes

(Arlene Weintraub , 10-Jul-2009 , Business Week)
Thats particularly a challenge in light of drugs going off patent. More...
STOCKS TO WATCH Infosys Matrix Labs Ranbaxy

Matrix Laboratories has filed an application against Israeli drugmaker Teva Pharmaceuticals Industries
challenging a process patent used to make Tevas blockbuster drug Copaxone. More...
Forest Lundbeck settle patent row over Lexapro

(by Lewis Krauskopf , 10-Jul-2009 , Reuters)
Forest Laboratories Inc and H Lundbeck AS have settled patent infringement litigation with two generic
drugmakers on their blockbuster Lexapro anti depressant the companies said on Friday. More...
Ranbaxy recalls drug in US

Industry experts say consumer litigation are unlikely for such drug recalls. More...
Cipla gets notices for alleged overcharging

The issue has been under litigation for over five years and the total alleged overcharging amount on
Cipla at present is over Rs 1000 crore. More...
Matrix drags Israeli co Teva to court over patent issue

(Chandra Ranganathan & Sai Deepika Amirapu , 10-Jul-2009 , The Economic Times)
The dust hasnt settled yet on the Novartis case and another patent dispute has emerged in the pharma
space. More...
Lupin 2 others face Europe anti trust probe

The investigation is still at an early stage and the EC has said that the publication of its statement does
not imply it has proof of an infringement of the competition rules Lupin told the media. More...
Europe Is Studying Delays in Access to Generic Drugs

(By JAMES KANTER , 09-Jul-2009 , The New York Times)
Commission officials said that generic versions of drugs often were unavailable for at least seven months
after the patent on the original version expired a factor that drove costs up by at least 3 billion euros
from 2000 to 2007 in 17 European Union countries. More...
3 Indian pharma cos face EU anti trust probe
(fe Bureau, Agencies , 09-Jul-2009 , The Financial Express)
In April 2007 Lupin had sold certain patent and intellectual property rights of perindopril to French firm
Laboratories Servier for Rs 115.31 crore euro 20 million. More...
Drug firms come under EU lens over antitrust practices

(Foo Yun Chee / Reuters , 09-Jul-2009 , livemint)
The EU executive said it would examine current EU rules on price and reimbursement urged European
countries to introduce legislation to facilitate the entry of generics and stress the need for a Europe wide
patent. More...
Knotted patent litigations inflict medical devices mkt

(Soma Das , 9-Jul-2009 , The Financial Express)
The lucrative domestic medical devices industry estimated to touch $1.7 billion in 2010 and expected to
grow at an annual growth rate of around 23% is getting mired in entangled patent litigation cases with
companies dragging each other to courts. More...
Teva Servier Face EU Antitrust Probe for Drug Delays

(By Matthew Newman and Naomi Kresge , 9-Jul-2009 , Bloomberg)
The commission called for a community patent that would be valid in all of the EUs 27 member states.
More...
Lupin Matrix face antitrust probe in EU

The Commission said it would continue to probe whether use of patents to delay generics violated
antitrust rules as companies used a variety of techniques to delay introduction of generics. More...
EU raps Big Pharma Indian copycat kings boosted

Though it does not actually mention the term evergreening it details the primary patents and secondary
patents which Big Pharma seek said an intellectual property expert based in New Delhi who is closely
monitoring the report. More...
Nestle Takeda sue Lupin Torrent over patents

Cases aimed at stopping approval of new generics More...
Ranbaxy faces new legal trouble in US

(Radhieka Pandeya , 9-Jul-2009 , livemint)
Ranbaxy Laboratories Ltd whose share price has been roiled by its troubles with the US drug regulator
suffered a further blow with Canadian generic or off patent drug maker Apotex Inc. questioning in court
the companys ability to launch two generic drugs on schedule. More...
Dilemma on traditional knowledge
(Latha Jishnu / New Delhi , 8-Jul-2009 , Business Standard)
Last Friday the World Intellectual Property Organisation ended a five day meeting of the Inter
governmental Committee on Intellectual Property and Genetic Resources Traditional Knowledge and
Folklore without Indias participation. More...
Alnylam Joins GSK in Donating IP to Patent Pool

(CAMBRIDGE, MASS & LONDON , 08-Jul-2009 , ag-IP-news )
GlaxoSmithKline and Alnylam Pharmaceuticals Inc. announced on July 8 2009 that Alnylam will
contribute more than 1500 issued or pending patents on its RNA interference technology patent estate
to the patent pool established by GSK earlier this year according to Alnylam. More...
Alnylam Joins GSK In Patent Pool For Neglected Tropical Diseases

(By Staff Reporter , 8-Jul-2009 , Pharmaceutical Business Review)
Alnylam shall contribute more than 1500 issued or pending patents on its RNA interference technology
patent estate to the patent pool established by GlaxoSmithKline. More...
Glivec patent ruling a welcome turn for Novartis

(Priyanka Golikeri & KV Ramana , 8-Jul-2009 , DNA)
The rejection of Novartis patent application for the beta crystalline version of cancer drug Glivec by the
Intellectual Property Appellate Board on the ground that it is priced beyond the reach of the common
man may have given the company new ground to challenge Indian patent rules. More...
Teva stops shipping generic birth control pill

(The Associated Press , 7-Jul-2009 , Business Week)
The worlds largest generic drug maker said it agreed to stop shipping the drug pending a preliminary
injunction hearing in a patent infringement lawsuit from Johnson & Johnson. More...
DOJ Shifts Policy on Generic Drug Patent Settlements

(By BRENT KENDALL , 7-Jul-2009 , The Wall Street Journal)
The U.S. Department of Justice on Monday took a skeptical view on the legality of pharmaceutical patent
settlements that delay the introduction of generic drugs the latest change in antitrust policy under the
Obama administration. More...
Star Scientific seeks to overturn Reynolds verdict

(By Ian Sherr , 07-Jul-2009 , Reuters)
Tobacco company Star Scientific Inc is seeking reversal of a jury ruling that cleared a Reynolds American
Inc unit of violating a Star patent for reducing cancer causing agents in tobacco. More...
U.S. court to rehear spat over patent office rules

(by Diane Bartz , 07-Jul-2009 , Reuters)
A U.S. appeals court has said it would rehear a fight between drugmaker GlaxoSmithKline Plc and the
patent office over new rules aimed at cutting a backlog of patent applications. More...
Astellas wins OK for broader use of key drug in Japan

(by Yumiko Nishitani , 07-Jul-2009 , Reuters)
In the United States where Prograf lost patent protection in April last year Astellas expects competition
from a generic rival in the financial year ending in March 2010. More...
Dor BioPharma Receives European Patent For Drug Delivery Technology

Dor BioPharma has received a European patent for its Lipid Polymer Micelle technology for the improved
oral delivery of drugs. More...
A Prescription for Saving Big Drugmakers

(By Mark Schneider , 6-Jul-2009 , Business Week)
But concerns over patent expirations of blockbuster drugs generic drug competition regulatory problems
and a lack of promising new products are giving investors caution. More...
Takeda Sues Torrent to Stop Generic Copy of Actos Diabetes Pill

(By Susan Decker , 06-Jul-2009 , Bloomberg)
Takeda Pharmaceutical Co. sued Indias Torrent Pharmaceuticals Ltd. to prevent it from selling a copy of
the Actos diabetes pill in the U.S. until 2016. More...
Precision BioSciences Issues Update Regarding Recent U.S. Patent Office Action Concerning
Cellectis Patents
(RESEARCH TRIANGLE PARK, N.C (BUSINESS WIRE) , 06-Jul-2009 , Biocompare)
The United States Patent and Trademark Office is reexamining two currently issued U.S. patents owned
by the Institut Pasteur and the Universite Pierre et Marie Curie and licensed to Cellectis SA. More...
Fake drugs reach Kenya now

Africa is an important market for Indian drug producers as it accounts for over 15% of Indias total
generic off patent drugs exports worth Rs 30000 crore annually. More...
Novartis may challenge verdict denying patent for cancer drug

The Indian tribunal had cited non compatibility with domestic patent laws and unaffordable pricing as
reasons More...
Emami plans to make 50 Ayurvedic drugs from Zandu stable

(Aveek Datta , 6-Jul-2009 , livemint)
The company had even tried to secure patent for some of its formulations but couldnt because of
unfriendly patent offices Bhatt added. More...
Bitter Pill Novartis patent plea for cancer drug Gilvec rejected
(REUTERS , 05-Jul-2009 , The Economic Times)
Novartis Indias application to patent its cancer drug Glivec has been rejected by the Intellectual Property
Appellate Board IPAB. More...
Ayurveda drug for cancer Experts

(Minati Singha , 03-Jul-2009 , The Times of India)
Lavekar said they have the credit of obtaining as many as 22 patents including one international patent
right on drugs. More...
Biotechnology can be the next big driver for the pharma sector
The authors of the study noted The fact that a biotech product will assume Lipitors crown in 2012 after
the cholesterol lowering drug phenomenon goes off patent is indicative of the increasing dominance of
biotech products and specifically cancer antibodies. More...
Glenmark gets first to file status for 3 drugs in US

First to file status typically recognises a generic company as being the first to file a para IV application
challenging a particular patent and seeking to manufacture generic versions of a drug which at present
does not have generic competition. More...
Bayer Files Lawsuit Against Teva

Bayer Schering and Bayer HealthCare together with Schering have filed a patent infringement lawsuit in
the US Federal Court in the District of Delaware against Teva Pharmaceuticals and Teva Pharmaceutical
Industries. More...
Dish wins stay in TiVo patent fight

(The Associated Press , 02-Jul-2009 , Business Week)
Dish Network satellite TV customers can keep using their digital video recorders while a court battle
continues with TiVo Inc. More...
Pharma not IT is Indias next big thing

(Pallavi Aiyar , 2-Jul-2009 , Business Standard)
Indian companies know they cant survive on the generic model alone forever. So once they have a
serious self interest in protecting patents that will be the tipping point. More...
LG and Hitachi Settle Patent Fights Over TVs and Servers

(By Susan Decker , 2-Jul-2009 , Bloomberg)
Hitachi Ltd Japans largest electronics maker and South Koreas LG Electronics Inc. have settled their U.S.
patent disputes over plasma televisions computer servers and car radio and navigation systems. More...
U.S. group questions AstraZenecas Crestor patent
(by Diane Bartz , 1-Jul-2009 , Reuters)
A U.S. patent research group says it has uncovered evidence that could be used to declare AstraZeneca
Plcs patent for its cholesterol fighter Crestor invalid. More...
Abbott Loses Drug Patent Suit

(By THE ASSOCIATED PRESS , 30-Jun-2009 , New York Times)
A unit of Johnson & Johnson said Monday that a jury has ordered Abbott Laboratories to pay $1.67
billion in a patent infringement suit over rheumatoid arthritis drugs. More...
Collegium Pharmaceutical Announces the Sale of AllerNaze to Lupin

(CUMBERLAND, R.I. , 30-Jun-2009 , Business Wire)
COL 003 is a tamper resistant formulation of extended release oxycodone that utilizes the Companys
patented DETERx™ delivery technology. More...
Biocon Mylan team up for global biogenerics play

(C Chitti Pantulu , 30-Jun-2009 , DNA)
An initial list of products has been identified that includes a basket of biologics that will go off patent by
2016 he said. More...
Sun Pharma Inclement weather

(Shobhana Subramanian / Mumbai , 30-Jun-2009 , Business Standard)
Sales of Para IV products those abbreviated new drug applications that face a patent challenge fetch a
larger amount estimated at $150 million. More...
Aurobindo Pharma sues SA govt over AIDS drug bids

(BV Mahalakshmi , 30-Jun-2009 , Indian Express)
The balance was awarded to the patent holding companies. More...
Jury returns $1.67B drug verdict against Abbott

(by Ransdell Pierson and Jonathan Spicer , 29-Jun-2009 , Reuters)
A U.S. federal jury returned a $1.67 billion verdict against Abbott Laboratories in a patent suit brought
by Johnson & Johnson related to arthritis treatments the drug companies said on Monday. More...
Indian firm sues South Africa after losing AIDS drug contract
(AGENCIES,JOHANNESBURG , 29-Jun-2009 , The Economic Times)
An Indian manufacturer of drugs to treat HIV AIDS is suing the South African government after failing to
clinch a $400 million tender South African media reported on Monday. More...
Make it a criminal violation Japan

But a bigger demand from Japan is stringent enforcement of intellectual property laws including criminal
procedures against patent infringement. More...
14 years of data exclusivity is crazy

(Nina Mehta , 29-Jun-2009 , The Economic Times)
Founder of the generic trade association in the US William Haddad chairman and CEO of Biogenerics
initiated and negotiated the Drug Price Competition and Patent Restoration Act Hatch Waxman. More...
US study wants India to allow frivolous patenting

Multinational drug makers seem hell bent upon forcing the government to alter the patent regulations in
their favour. More...
India needs a brilliant wave of entrepreneurs

Koshy has been working towards his dream for seven years now and had applied for a patent as well.
More...
Glenmark banks on new drugs to recover losses

(C.H. Unnikrishnan , 29-Jun-2009 , livemint)
While the generics or off patent drug business of Glenmark has been growing it had to write off in the
March quarter at least Rs130 crore on account of stock withdrawals following delayed US market
approvals and Rs117 crore for price erosion of distributor stock after the expiry of US market exclusivity
of its anti epilepsy drug oxcarbazapine. More...
Now Kinnauri shawl to get a patent

(Pratibha Chauhan , 28-Jun-2009 , Tribune News Service )
After the Kullu shawl Kangra tea and the Chamba rumaal it is now the turn of the Kinnauri shawl to
acquire a patent and a GI Geographical Indication stamp a hallmark for quality and authenticity. More...
Takeda shares down on diabetes drug setback

(by Mayumi Negishi , 28-Jun-2009 , Reuters)
Actos patent expires in 2011. More...
Takeda fails to get US approval for diabetes drug

(by Leika Kihara , 27-Jun-2009 , Reuters)
Takeda Pharmaceutical Japans largest drugmaker said on Saturday a key diabetes drug had failed to get
approval from U.S. regulators who had asked for additional safety tests a process the company predicts
could take at least two years. More...
The Real Reason Big Pharma Mergers Are Wise

(Charles Farkas and Tim van Biesen , 26-Jun-2009 , Forbes)
Thats important because of the looming patent cliff as blockbuster drugs lose their patent protection
faster than new ones can emerge. More...
Irish court invalidates patent on Glaxos top drug

(by Ben Hirschler , 26-Jun-2009 , Reuters)
An Irish court has ruled that a key patent protecting GlaxoSmithKlines biggest selling medicine is invalid
the British based drugmaker said on Friday. More...
Japan approves first generic biotech drug

(Reuters , 25-Jun-2009 , The Financial Express)
Biosimilars are viewed as a promising new market given the pent up demand for cheaper versions of
extremely expensive biotech drugs some of which are coming to the end of their patent life. More...
Sharp may appeal ruling in patent row with Samsung

(by Mayumi Negishi in TOKYO and Diane Bartz in WASHINGTON , 25-Jun-2009 , Reuters)
Sharp Corp said it may appeal a ruling by a US trade panel that said the Japanese electronics maker had
violated an LCD patent held by South Koreas Samsung Electronics. More...
Drug patent pool proposal gets a push

(P. T. Jyothi Datta , 25-Jun-2009 , Business Line)
Concerned over the changing intellectual property environment where medicines are getting patented
across the world UNITAID had proposed a patent pool to make drugs more accessible. More...
Vicious sting in the tail of FTAs

Because FTAs have more stringent provisions than those mandated by the World Trade Organisation
under the TRIPS for protecting the intellectual property rights IPRs of the developed world such
agreements can directly impact access to affordable medicines More...
DRDO records jump in patents filing

(General , 24-Jun-2009 , Business Line)
The Defence Research and Development Organisation DRDO has registered a substantial jump in filing
patents and set a 10 per cent growth target for the current year. More...
Actavis Launches Finasteride As Patent Expires In France

(By Staff Reporter , 24-Jun-2009 , Pharmaceutical Business Review)
Actavis has launched Finasteride in France just one day before the patent expired. More...
CEL SCI Files Patent Application For LEAPS Immune Therapy Drugs
CEL SCI has filed a provisional US patent application covering its LEAPS immune therapy drugs vaccines.
More...
A global patenting model for India
(PK Vasudeva , 24-Jun-2009 , The Financial Express)
The United Nations arm on intellectual property is planning to implement a global patenting model which
will pave the way for global firms to obtain patents in India easily. More...
UNITAID to meet Indian drug manufacturers

(Press Trust of India / New Delhi , 23-Jun-2009 , Business Standard)
The UNITAID patent pool initiative seeks to ensure that patents do not prevent the production of generic
ARVs particularly the development and production of fixed dose combinations and AIDS medicines for
children. More...
U.S. Patent Infringement Lawsuit Filed by Aperio Technologies Inc.

(David A. Leinwand , 23-Jun-2009 , Biocompare)
A U.S. patent infringement lawsuit was filed on June 10 2009 against Hamamatsu Photonics K.K.
Hamamatsu Corporation and Olympus America Inc. More...
Ericsson signs LTE patent deals

(by Sven Nordenstam , 22-Jun-2009 , Reuters)
Swedish telecom equipment maker Ericsson has signed its first license agreements for LTE technology
patents allowing other companies to use the technology an Ericsson official said on Monday. More...
ION sues WesternGeco for patent infringement

(by Arup Roychoudhury in Bangalore , 22-Jun-2009 , Reuters)
ION Geophysical Corp said it filed a patent infringement lawsuit against privately held WesternGeco LLC
over technology related to steering devices and control systems for marine seismic streamers. More...
A Scholar Activist Challenges US Patent Law

(By Michael Orey , 22-Jun-2009 , Business Week)
John Duffy wants courts to rethink what can be patented and how to calculate damages. More...
Intellectual property issues in school franchising

(Anuradha Salhotra , 22-Jun-2009 , The Financial Express)
Emergence of school franchises bodes well for the several thousand students all over the country who
scramble to study in well known schools. More...
i2india hopes to bridge industry academia gap

(L.N. Revathy , 22-Jun-2009 , Business Line)
i2india an IPR Intellectual Property Rights commercialisation and investment company is striving to
bridge the gap between the industry and academia by providing the nucleus for growing such companies
in India. More...
Pharma sector told to focus on improving HR quality
(22-Jun-2009 , Business Line)
Finishing schools in the information technology industry are creating more awareness towards the
Intellectual Property Rights environment and the pharma industry should emulate it said panellists at
the Bangalore Bio 2009 here Saturday. More...
Pfizer charges Sun with another patent violation

A legal battle between US pharma giant Pfizer and Indian company Sun Pharmaceutical has escalated
with the worlds largest maker of medicines alleging in court filings that in addition to the original patent
that it claims Sun violated it infringed another patent when it sought approval for its generic version of
Lyrica a blockbuster drug used to treat seizures. More...
Chavez may end patents on medicine in Venezuela

(by Frank Jack Daniel , 21-Jun-2009 , Reuters)
President Hugo Chavez has vowed to shake up the rules governing intellectual property rights on
medicines and other products in Venezuela the socialists latest move against the private sector. More...
Cannabis Science To File Patent For Cannabis Processing and Drug Delivery Systems
Cannabis Science has announced that patent filings are expected for two of its key innovations. More...
Advinus seeks approval for trials of new diabetes molecule

Advinus Therapeutics has filed its first investigational new drug application with the Drugs Controller
General of India to start clinical trials on humans for a new diabetes type 2 molecule. More...
Prices of essential drugs may drop by 30 70%

(Gireesh Chandra Prasad & Sushmi Dey , 19-Jun-2009 , The Economic Times)
The government is likely to revise the plan to have a comprehensive new drug policy which would
extend a milder form of price control to 354 essential medicines. More...
Madras HC stays customs order on dual SIM phones

The leading parties in the legal case were Samsung India Electronics Ltd and Hansum India Ltd which
were arguing against Madurai based engineer S. Ramkumar who holds a patent for dual SIM phones in
India. More...
Elder signs deal with US co for human trials of anti cancer drug
(Sushmi Dey , 19-Jun-2009 , The Economic Times)
The company follows the non infringing business model of either in licensing products of innovator
companies or manufacturing off patented drugs. More...
Generic cos board biosimilars wagon
Move over off patent chemical drugs. More...
Pfizer Wins Canadian Patent Protection for Viagra

(By Joe Schneider , 19-Jun-2009 , Bloomberg)
Pfizer Inc the worlds biggest drugmaker has a valid Canadian patent on the impotence pill Viagra a
federal judge ruled dismissing a bid by Novopharm Ltd to introduce a generic version of the drug.
More...
Big Pharma comes calling to India

(P B Jayakumar / Mumbai , 19-Jun-2009 , Business Standard)
Thanks to the favourable patent regime in India till 2005 his team of scientists and he worked in small
research and development laboratories in Hyderabad and successfully reverse engineered patented
drugs of multinationals to make low cost generic drugs. More...
Novartiss Sandoz Sued by J&J Over Contraceptive Pill Patent

(By Susan Decker , 19-Jun-2009 , Bloomberg)
J&Js Ortho McNeil Janssen Pharmaceuticals unit wants a federal judge to prevent Sandoz from getting
regulatory approval until a patent expires in 2019. More...
Sanofi says US court ruled against it on Eloxatin

(by Deena Beasley , 18-Jun-2009 , Reuters)
Sanofi Aventi SA on Thursday said a US court ruled against the French pharmaceutical company by
granting summary judgment motions brought by generic drugmakers in patent litigation over the cancer
drug Eloxatin. More...
US firm files patent infringement case against Ranbaxy

(18-Jun-2009 , Business Standard)
Medicis Pharmaceutical Corporation, a US-based skincare drug manufacturer, has filed a lawsuit against
Daiichi Sankyo-owned Ranbaxy Pharmaceuticals for alleged infringement of its patent on Solodyn, a
minocycline hydrochloride extended-release tablet used to treat acne. More...
Drug industry expects final EU probe report July 8

(By Ben Hirschler , 17-Jun-2009 , Reuters)
There could also be a couple of positive recommendations he added such as backing for a common
European patent applicable in all EU countries and the introduction of a specialised patent litigation
system. More...
India losing 2,000 patents every year: Jairam Ramesh

India is losing about 2,000 patents every year in the US and Europe on traditional formulations as the
knowledge on these is not documented, said union minister of state for environment and forests Jairam
Ramesh More...
MicroFluidic Systems Receives Patent for Method to Selectively Process Different Biological
Cell Types for Analysis.
(M. Allen Northrup,MicroFluidic Systems , 16-Jun-2009 , Biocompare)
Microfluidic Systems a privately held company announced today that they received patent number
7541166 entitled Sonication to Selectively Lyse Different Cell Types. More...
DuPont fires back at Monsantos patent lawsuit

(By ERNEST SCHEYDER , 16-Jun-2009 , Forbes)
DuPont fired back at Monsantos patent lawsuit Tuesday telling a federal court it did not err in combining
its genetically modified soybeans with Monsantos herbicide product. More...
Martek European regulator upholds patent with narrower claims

(by Jennifer Robin Raj in Bangalore , 16-Jun-2009 , Reuters)
Martek Biosciences Corp a health and nutritional supplements maker said the European Patent Office
upheld its arachidonic patent granted in 2007 but with narrower claims. More...
Report on pharma innovation to be released at USIBC meet

(Lalit K Jha , 16-Jun-2009 , Business Standard)
A report identifying a broad range of potential benefits of incremental pharmaceutical innovation for
India would be released later this week by the US India Business Council (USIBC). Commissioned by the
USIBC and Coalition for Healthy India (CHI), and funded by the US Chamber of Commerce's Innovation,
Development and Employment Alliance, the report 'The Value of Incremental Pharmaceutical Innovation:
Benefits for Indian Patients and Indian Business' was produced by White & Case LLP and Dua Consulting.
More...
US Patent Office Provides Re Examination Office Action for US Patent No 5735844

(press release , 15-Jun-2009 , MarketWatch)
Palomar also added 27 new claims to the 844 patent and the PTO confirmed these new claims as
patentable. More...
Sharp wins US patent fight with Samsung

(by Diane Bartz , 15-Jun-2009 , Reuters)
Japanese electronics maker Sharp Corp has won a fight with South Koreas Samsung Electronics Co over
patented technology for liquid crystal displays according to an administrative law judges ruling from the
US International Trade Commission. More...
Apex Court overrules HC order favouring Gufic Ltd

The Supreme Court today set aside the Delhi high court order which had allowed the Indian company,
Gufic Ltd, to use the name ‘Cliniq’ in its skin care product. The bench headed by Justice B Sudershan
Reddy vacated the order on the appeal of Clinique Laboratories against the high court order. More...
RPT Pfizer eyes deals to raise emerging markets presence
(By John Irish , 14-Jun-2009 , Reuters)
Pfizer which posted $48 billion in revenue last year faces severe sales declines in the coming years from
patent expirations to its own products including its blockbuster Lipitor cholesterol treatment. More...
Satoris Receives Patent Allowance for Use of Plasma Biomarkers in Alzheimers Disease
Detection
(PRWeb , 12-Jun-2009 , Biocompare)
Patent acknowledges utility of blood biomarkers in diagnosing Alzheimers. More...
Take strong action against fake drugs India to China

(BS Reporter , 12-Jun-2009 , Business Standard)
India has asked China to take strong action against Chinese pharma manufacturers who are exporting
fake drugs under Made in India label. More...
EU seeks greater commitment on IPR

(Radhieka Pandeya and Asit Ranjan Mishra , 12-Jun-2009 , livemint)
The EU is also demanding that India should extend the monopoly accorded by a patent for up to 5
additional years in order to compensate for the time required for the marketing approval of a medicinal
product More...
Watson Files ANDA For Generic Mucinex D

Watson has filed an Abbreviated New Drug Application with the FDA seeking approval to market its
guaifenesin pseudoephedrine HCI extended release 600mg 60mg and 1200mg 120mg tablets prior to
the expiration of patents owned by Reckitt Benckiser. More...
India to prepare case on drug confiscations at European ports

(Amiti Sen & Deepshikha Sikarwar , 11-Jun-2009 , The Economic Times)
India is preparing its case on the repeated seizures at European ports of its consignments containing off
patent drugs meant for other developing nations before it moves the European Union and the World
Trade Organisation according to a commerce ministry official. More...
Collegium Pharmaceutical Inc Announces Submission of a Request for Special Protocol

Assessment to FDA for Pivotal Trial for Tamper Resistant Extended Release Opioid COL 003
(CUMBERLAND, R.I , 10-Jun-2009 , Business Wire)
COL 003 is a tamper resistant formulation of extended release oxycodone that incorporates the
Companys patented DETERx™ delivery technology. More...
Solvay challenged in US on male hormone therapy

(Aaron Gray-Block , 10-Jun-2009 , Reuters)
Solvay said Perrigo Israels application with the US Food and Drug Administration challenged a United
States patent relating to its treatment Androgel which runs through the next decade. More...
Vitro Obtains US Adult Stem Cell Patent
Vitro declared that it has received US Patent number 7527971 entitled Generation and Differentiation of
Adult Stem Cells. More...
BUY OR SELL Daiichi Sankyo to rebound from rocky Ranbaxy ride

(By Yumiko Nishitani , 10-Jun-2009 , Reuters)
Analysts reckon Daiichi Sankyo is the top long term pick among Japans drug stocks with Takeda
Pharmaceutical and Astellas Pharma more exposed to the impact of patent expirations on key drugs.
More...
Access Pharmaceuticals Receives Two US Patents For MuGard

Access Pharmaceuticals has announced that the company has received issue notifications from the US
Patent and Trademark Office that two US patents relating to MuGard the companys approved oral rinse
product for the management of mucositis will issue in June as US Patent numbers 7544348 and
7547433. More...
Pfizer exec reinforces companys generic drug plancos

(Associated Press , 10-Jun-2009 , Forbes)
Dave Simmons Pfizers president of established products told analysts at Goldman Sachs Healthcare
Conference in New York that part of the companys strategy includes focusing on the off patent
marketplace. More...
New Mashelkar report has well little new

The Mashelkar committee report on pharmaceutical and micro organism patents has reared its
controversial head again. More...
India can become a global pharma innovation hub experts say

(PTI,WASHINGTON , 09-Jun-2009 , The Economic Times)
William Chin Vice President Discovery Research & Clinical Investigation Eli Lilly felt the pharma industry
is under siege with flood of patent expiries higher safety hurdles and pricing pressure. More...
Impliant granted two new US patents successfully defends European patent

(Medical Patent News , 09-Jun-2009 , News-Medical.Net)
Impliant Inc a developer of novel spine arthroplasty alternatives to fusion surgery today announced that
the European Patent Office has confirmed the validity of one of its key patents following an Opposition
by Archus Orthopedics Inc that concluded with oral proceedings on May 12 2009 in Munich Germany.
More...
Purdue KV settle OxyContin drug patent dispute

(Edwin Chan , 09-Jun-2009 , Reuters)
Purdue Pharma LP has settled a patent dispute over OxyContin with KV Pharmaceutical agreeing to let
KV sell generic versions of the popular painkiller on a limited basis in the United States. More...
Bulk pharma imports to go under DCGI scanner

(Radhieka Pandeya , 9-Jun-2009 , livemint)
Regulator acts after evidence of attempts to evade import duty and bring in spurious drugs to Mumbai
Chennai More...
Pharma firms continue to face patent violation charges in Europe

(Rupali Mukherjee , 8-Jun-2009 , The Economic Times)
Even after India raised concerns with EU troubles of generic companies which export drugs to developing
countries through Europe are far from over as seizures by Dutch customs still continue. More...
IITs to market patents with help from investment firms

(Kalpana Pathak & Shivani Shinde / Mumbai , 8-Jun-2009 , Business Standard)
Sitting on a pool of close to 900 patents the Indian Institutes of Technology are for the first time
planning to monetise these intellectual properties by exploring tie ups with firms that invest in
inventions. More...
Row over generic drugs intensifies after seizure in Germany

(Khomba Singh , 8-Jun-2009 , The Economic Times)
German authorities last month seized a large consignment of antibiotic Amoxicillin made by Chennai
based Medopharm during transit at Frankfurt over alleged trademark infringement in the latest incident
of European Union nations interfering in legitimate trade of generic medicine. More...
16 out of 17 drug consignment seizures in the Dutch were from India

(P.T. Jyothi Datta , 8-Jun-2009 , Business Line)
There were 17 incidents of drug seizure last year in the Netherlands on the grounds of patent
infringement and 16 of them were Indian medicine exports says Health Action International a Dutch
network that works on increasing access to medicines. More...
Vizio files TV patent suit against LG in US

(by Rhee So-eui , 07-Jun-2009 , Reuters)
US TV brand Vizio Inc has filed a patent infringement suit against South Koreas LG Electronics Inc
seeking an injunction to ban LG from importing and selling certain TVs in the United States. More...
Playing defense on patents

(By Kenneth Klee , 5-Jun-2009 , Reuters)
The idea of developing patents as a kind of asset class is still new and controversial. More...
Neuralstem Receives Patent Allowance for Compounds That Promote Neurogenesis

(ROCKVILLE, Md.(BUSINESS WIRE) , 05-Jun-2009 , Biocompare)
Neuralstem Inc announced today it received a notice of allowance from the US Patent and Trademark
Office for a patent on four new chemical entities that boost the generation of new neurons. More...
Curbs on Amul Vadilal to use American Dry Fruits trade name for their products
(Virendra Pandit , 5-Jun-2009 , Business Line)
About Vadilals argument that the plaintiff had not obtained registration of trademark till date Mr Sheikh
observed that evidence proved that the company had obtained proprietary rights to use trade name and
it cannot be termed as pirator of trade name. More...
Takeda to delay European application for key drug

(By Yumiko Nishitani , 04-Jun-2009 , Reuters)
Actos accounts for roughly a quarter of Takedas revenues and will lose US patent protection in 2011.
More...
Crash boom bax the rise & fall of Ranbaxy

(Radhieka Pandeya , 4-Jun-2009 , livemint)
And the Ranbaxy story is as characteristic of what happens in most family owned and run businesses in
India as it is of the Indian pharma industrys evolution from makers of cheap illegal copycat drugs and
suppliers of raw material to respected manufacturers of generics legal copies of off patent drugs and
ultimately to research driven firms. More...
J&J upbeat on drugs business cites new medicines

(By Ransdell Pierson , 04-Jun-2009 , Reuters)
J&J whose first quarter earnings fell slightly due to generic competition for its Risperdal schizophrenia
drug and waning demand for its anemia medicines is now under even greater pressure due to the
expiration in March of the US patent on its $2.5 billion a year Topamax epilepsy drug. More...
German market for Indian drugs shrinks

Orchid is currently focusing on products that enjoy patent protection but once they go off patent the
company will be affected. More...
Agilent wins patent fight with Affymetrix

(by Maggie Fox and Diane Bartz , 04-Jun-2009 , Reuters)
A US patent appeals court ruled on Thursday in favor of Agilent Technologies which had been involved in
a patent fight with Affymetrix Inc. More...
Vical Receives US Patent For Universal Influenza Vaccine Approach

Vical has received US Patent No 7537768 covering the use of influenza virus gene sequences in a
universal vaccine that could provide protection against circulating seasonal strains as well as emerging
pandemic strains of influenza viruses. More...
Mylan Again Calls for an End to Authorized Generics During 180 Day Exclusivity Period
(PITTSBURGH , 3-Jun-2009 , PRNewswire)
The committees hearing Pay to Delay Are Patent Settlements That Delay Generic Drug Market Entry
Anticompetitive was called to gather information about the effects of settlements. More...
Almirall gets FDA approval for migraine drug

(by Tracy Rucinski , 3-Jun-2009 , Reuters)
Almiralls patent on Almotriptan in the United States has been extended to November 2015. More...
Novocell Obtains US Patent for Drug Screening Human Embryonic Cell Derived Endoderm Cells
(SAN DIEGO , 3-Jun-2009 , Business Wire)
Novocell Inc a stem cell engineering company today announced that it has received US Patent No
7541185 with method claims covering the use of endoderm cells derived from human embryonic stem
cells for drug discovery. More...
Rallis India seeks patent for three new biomolecules

In a move that could help extend its presence in the global crop protection market Rallis India Ltd a Tata
group agrochemical company has developed at least three new biomolecules for use in fungicides
More...
ARIAD Announces Updates On NF kB Patent Appeals

(CAMBRIDGE, MASS , 03-Jun-2009 , ag-IP-news )
ARIAD Pharmaceuticals Inc and its co plaintiffs announced that they are filing a petition for an en banc
rehearing of an April decision by the US Court of Appeals for the Federal Circuit in its patent
infringement case against Eli Lilly and Company. More...
Echostar To Pay TiVo Another $103 Million In Patent Case

(By Rory Maher , 03-Jun-2009 , Reuters)
In the latest chaper of a patent infringement case on its DVR technology that dates back to 2004 TiVo
was awarded an additional $103 million by the United States District Court in Texas after a failed appeal
by Echostar. More...
Vical Announces Issuance of US Patent for Universal Influenza Vaccine Approach

(SAN DIEGO , 03-Jun-2009 , ag-IP-news )
Vical Incorporated announced in a Wednesday press release the issuance of US Patent No 7537768
covering the use of influenza virus gene sequences in a universal vaccine that could provide protection
against circulating seasonal strains as well as emerging pandemic strains of influenza viruses. More...
Denial of patent to Gilead beneficial for Indian firms

The Indian Patent Offices decision to reject a product patent for Gilead Sciences Incs adefovir dipivoxil
variant a new form of its Hepatitis B drug Hepsera has come as a boon for Indian copy cat drug makers
such as Ranbaxy Cipla and Sun Pharma. More...
Top court to hear business method patent case
(By Diane Bartz , 2-Jun-2009 , Reuters)
The Supreme Court said on Monday that it would hear the Bilski patent case which will tell high tech and
software companies how far they can go in patenting software financial strategies and other abstract
processes. More...
Nvidia US patent office rejects Rambus claims

(SANTA CLARA, Calif. , 2-Jun-2009 , Business Week)
Nvidia Corp said Tuesday the US Patent and Trademark Office has rejected 41 claims against the chip
maker brought by Rambus Inc a company that licenses semiconductor technology. More...
They opposed Novartis on Glivec but now seek patent

If you thought only multinational drugmakers were monopolistic and fought fiercely to secure patents for
new forms of known molecules you are so wrong. More...
InterDigital Nokia finish patent fight hearing

(By Diane Bartz , 02-Jun-2009 , Reuters)
Wireless technology firm InterDigital and the worlds top cellphone maker Nokia wrapped up hearings on
Tuesday at the International Trade Commission in a battle over four patents said InterDigital spokesman
Jack Indekeu. More...
Zydus Teva end patent disputes

Ahmedabad based ZydusCadila and Israeli generic major Teva have settled their patent disputes over
active pharmaceutical ingredients used to make generic versions of GlaxoSmithKlines heart drug and
Johnson & Johnsons anti psychotic drug. More...
Microsoft Lucent battle in huge patent case

Microsoft Corp argued before an appeals court on Tuesday that its Outlook calendar date picker tool did
not infringe an Alcatel Lucent patent and asked for a $358 million jury verdict to be overturned. More...
GraphOn Announces Settlement Resolving Legal Dispute with Google

(SANTA CRUZ, Calif , 1-Jun-2009 , Business Wire)
GraphOn Corporation today announced a settlement that resolves the legal dispute between GraphOn
and Google Inc. More...
BASF Sues DuPont for Patent Infringement

(Mark Stephenson, BASF Corporation , 1-Jun-2009 , Biocompare)
BASF Plant Science GmbH seeks an injunction and damages against DuPont and its subsidiary Pioneer Hi
Bred International for this unlawful use of BASFs patented technology. More...
Sanofi has winning cancer drug but short patent
(By Ben Hirschler , 1-Jun-2009 , Reuters)
Sanofi Aventis may have bagged a winning cancer drug when it agreed to buy privately held BiPar
Sciences for up to $500 million in April but a short patent could limit the French groups scope to cash in
on sales. More...
First Product Patent Granted to Venus Remedies in South Korea

(ag-IP-news ,HARYANA , 1-Jun-2009 , ag-IP-news )
The Korean Intellectual Property Office has granted a Product Patent to one of the research products of
Venus used for the treatment of pneumonia. More...
Top court to hear business method patent case

The Supreme Court said on Monday it would hear the Bilski patent case which would tell high tech and
software companies how far they could go in patenting software financial strategies and other abstract
processes. More...
Medtronic announces appeal decision in patent case with DePuy Spine

(Medical Patent News , 01-Jun-2009 , News-Medical.Net)
Medtronic Inc has announced results from a Federal Circuit Court review of a December 2007 patent
infringement verdict regarding the Vertex line of multiaxial screws which are no longer on the market.
More...
Supreme Court to Review Business Method Patents

(By Michael Orey , 01-Jun-2009 , Business Week)
The high court will decide if such things as financial products and Internet commerce systems deserve
intellectual property protection More...
Venus Remedies gets patent for anti pneumonia drug

(Corporate,NEW DELHI , 01-Jun-2009 , Business Line)
Pharmaceutical firm Venus Remedies on Monday said it has received a patent right in South Korea for its
drug which is used for the treatment pneumonia. More...
Unigen's First Site Directed Bone Growth Patent Issues

(BOONTON, NJ , 30-May-2009 , ag-IP-news )
Unigene Laboratories Inc reported that its first patent covering its Site Directed Bone Growth technology
has been issued a press release by Unigene stated. More...
Citigroup upgrades Sanofi Aventis to buy

(By Sarah Turner , 29-May-2009 , MarketWatch)
They noted that data at the upcoming ASCO meeting could be significant and that patent challenges are
not insurmountable. More...
Indian court uses blog reference to solve TVS Bajaj patent issue
(Soumya Shanker & Malathi Nayak , 29-May-2009 , livemint)
Ablog post by a student was instrumental in TVS Motor Co Ltds victory over Bajaj Auto Ltd in their
recent legal skirmish over patent infringement issues setting a precedent for the use of blog content by
the countrys courts. More...
Osteologix Receives Key US Patent Allowance for Novel Osteoporosis Drug

(GLEN ALLEN, Va. BUSINESS WIRE , 28-May-2009 , Biocompare)
Osteologix Inc today announced that is has received a Notice of Allowance from the US Patent and
Trademark Office for its US Patent Application Number 11269289 titled Water Soluble Strontium Salts
for Use in Treatment of Cartilage and or Bone Conditions reporting allowance of claims covering the
treatment of osteoporosis and related bone conditions using NB S101 the Companys lead osteoporosis
drug candidate. More...
US reexamines Mercks Singulair patent

(By Ransdell Pierson , 28-May-2009 , Reuters)
Merck & Co said on Thursday the US Patent Office is reexamining the patent on its biggest product $4.5
billion a year asthma treatment Singulair. More...
New US patent issued for Limbrel in osteoarthritis

(Medical Patent News , 27-May-2009 , News-Medical.Net)
Primus Pharmaceuticals Inc has announced the issuance of a new composition of matter patent for
Limbrel the first prescription medical food product to safely meet the distinctive nutritional requirements
of patients with osteoarthritis. More...
Your genes Not on your life

In a first of its kind a motley group of interests from cancer patients and civil liberties activists to clinic
pathologists and researchers have challenged the gene patents granted to a US biopharmaceutical
company. More...
Bajaj Auto to move SC on TVS issue

(T E Narasimhan & Swaraj Baggonkar / Chennai/mumbai , 27-May-2009 , Business Standard)
The High Courts ruling had come as a big relief for TVS Motor which was restricted by an earlier verdict
from the same court that did not allow the company to produce or sell the disputed motorcycle Flame a
125cc bike sporting twin spark plugs as Bajaj Auto held patent rights for the same. More...
Medicis Announces New Patents for SOLODYN

(SCOTTSDALE, ARIZ , 26-May-2009 , ag-IP-news )
Medicis announced in a Tuesday press release that the United States Patent and Trademark Office has
advised the company that US Patent No 7541347 directed to the use of SOLODYN in 90mg tablet form
will issue on June 2 2009 and that US Patent No 7544373 directed to SOLODYN in 90mg tablet form will
issue on June 9 2009. More...
US District Court Orders Hynix to Post Security for Infringing Rambus Patents
(LOS ALTOS, Calif , 26-May-2009 , Business Wire)
Rambus Inc today announced that the US District Court for the Northern District of California has
ordered Hynix Semiconductor to secure the judgment amount of approximately $397 million through a
combination of a bond and a lien on a Hynix property in South Korea for infringing Rambus patents.
More...
Samsung may win dual SIM patent case

(C.H. Unnikrishnan , 26-May-2009 , livemint)
The Chennai patent office had in January 2008 granted a patent to Ramkumar for mobile phones with
the capability of using two SIM cards. More...
Ranbaxy shares spurt 20% on BSE

(BS Reporter / Mumbai , 26-May-2009 , Business Standard)
Daiichi Sankyo has strength in developing patented products for lifestyle diseases such as hypertension
diabetes mellitus autoimmune disorders hyperlipidemia or atherosclerosis and bacterial infections More...
Advaxis Receives US Patent and Trademark Office Approval on Act A Protein Patent Pending
Rights
(NORTH BRUNSWICK, N.J , 26-May-2009 , Business Wire)
The US Patent and Trademark office approved Advaxis Incorporated patent application Compositions and
Methods for Enhancing the Immunogenicity of Antigens Application US20050118184 A1. More...
Supplies delay Ranbaxy may take $50 mn hit

(Radhieka Pandeya , 26-May-2009 , livemint)
This follows from a manufacturing agreement that was part of a bigger patent infringement settlement
between Ranbaxy and AstraZeneca in April 2008. More...
Fake drugs
(Sudhir Chowdhary , 25-May-2009 , The Financial Express)
Recently enforcement officials of the European Union seized a consignment of fake drugs which included
not just Viagra but also other serious medicines such as anti cholesterols anti osteoporosis and anti
hypertensives. More...
Television brands turn tangible

(Shuchi Bansal / New Delhi , 25-May-2009 , Business Standard)
Piracy that is infringement of IPR is our other challenge in the market place adds Jibi George. More...
AAU for patent of mechanised production of basundi

(Shubhlakshmi Shukla , 25-May-2009 , Indian Express)
Anand Agriculture University authorities plan to patent the mechanised production of basundi. More...
Epistar Soars to 16 Month High After Winning Patent Appeal

(By Weiyi Lim , 25-May-2009 , Bloomberg)
Epistar Corp. jumped to its highest in 16 months after winning its appeal in a patent infringement case
in which Royal Philips Electronics NV s Lumileds unit was trying to block the Taiwanese companys chips
from US markets. More...
Amsterdam authorities release Ind Swift exports

Diplomacy and legal channels have helped the Chandigarh based Ind Swift get its export consignment
released from customs authorities in Amsterdam about six months after it was seized. More...
Viral Genetics issued patent for novel cancer therapies

Biotechnology firm Viral Genetics Inc has been issued a patent for novel cancer therapies. More...
Conceptus files patent suit against Hologic

(by Anand Basu , 22-May-2009 , Reuters)
Conceptus Inc a maker of contraception devices filed a lawsuit against Hologic Inc alleging that the
medical diagnostics companys sterilization system will infringe several US patents owned by Conceptus.
More...
Drug regulator to expand survey on fake medicines

(Thomas K. Thomas , 22-May-2009 , Business Line)
The Drug Controller General of India plans to widen the survey to map the prevalence of counterfeit
drugs in the country with larger number of samples. More...
We do not foresee much implication of Toshiba suit Moser Baer

The Moser Baer India Chairman Mr Deepak Puri said Thursday that he does not foresee much implication
of the Toshiba lawsuit and that as per his preliminary reading the infringement allegations pertain to
optical media disk drives whereas his company is into manufacturing of optical storage media. More...
Pfizer to market off patent injectables with Claris

(BS Reporter / Ahmedabad , 21-May-2009 , Business Standard)
Leading pharmaceutical company Pfizer Inc has entered into a partnership with Ahmedabad based Claris
Lifesciences Ltd to commercialise sterile injectible drugs that are off patent and have lost exclusivity in
the United States Canada Australia New Zealand and Europe. More...
Pfizer strikes deals in generics emerging markets

(By Lewis Krauskopf , 20-May-2009 , Reuters)
The deals announced by Pfizer on Wednesday with Aurobindo Pharma Ltd and Claris Lifesciences Ltd
substantially increase Pfizers offerings in medicines that have lost patent protection in markets around
the world. More...
Qualcomm others found to infringe Tessera patents
(By Diane Bartz , 20-May-2009 , Reuters)
Qualcomm and others infringed Tessera Technologies patents for methods to package semiconductor
chips so they are protected inside portable devices the US International Trade Commission said on
Wednesday. More...
Indian pharma players to benefit from generic drugs in US

(Nina Mehta , 20-May-2009 , The Economic Times)
According to GPhAs analysis high growth rates were driven by factors such as increase in the overall
percentage of generic utilisation and loss of patent protection by several brand name blockbusters such
as Pravachol Ambien Fosamax Zoloft and Zocor. More...
Microsoft ordered to pay $200 million in patent case

(by Bill Rigby , 20-May-2009 , Reuters)
Microsoft Corp said on Wednesday a Texas federal jury ordered the company to pay Canadian software
firm i4i Ltd $200 million in damages for infringing a patent. More...
GenVault Receives Four Critical US and EU Patent Allowances for Key Biosample Management
Technologies
(Bret Dash , 20-May-2009 , Biocompare)
GenVault Corporation is pleased to announce notice of allowance for four key patents in its growing
portfolio. More...
Court grants AstraZeneca preliminary injunction against Apotex in PULMICORT RESPULES

patent litigation
(Wilmington, DE , 20-May-2009 , AstraZeneca )
No trial date for the patent litigation has been set. More...
HC lifts stay against TVS on Flame

(Agencies, fe Bureau , 20-May-2009 , The Financial Express)
TVS has been a licencee of patent dated May 25 2000 and Bajaj held the patent as of July 1 2002.
More...
Avigen Granted AV411 Patent for Neuropathic Pain

(ALAMEDA, CA - , 20-May-2009 , ag-IP-news )
Avigen Inc announced in a press release that it has been granted United States Patent No 7534806
entitled Method for Treating Neuropathic Pain and Associated Syndromes. More...
Resverlogix files two patents on compounds for inflammatory diseases

Two new patent applications have been filed for novel compounds and their use in regulating
inflammatory markers. More...
SanDisk Samsung talking over patents
(By Anupreeta Das , 19-May-2009 , Reuters)
SanDisk Corp continues to negotiate with rival Samsung Electronics Co Ltd over renewing their patent
licensing agreement that is set to expire this August SanDisk Chief Executive Eli Harari said. More...
DVD patent violation Toshiba sues Moser Baer

(Corporate,NEW DELHI , 19-May-2009 , Business Line)
Japanese electronics major Toshiba Corporation has filed a lawsuit against optical storage device maker
Moser Baer India for alleged DVD patents infringement. More...
Bulk drug firms want pollution norms relaxed

(B Krishna Mohan / Hyderabad , 19-May-2009 , Business Standard)
Bulk drug manufacturers see a business opportunity arising when many drug patents expire next year.
More...
Intradigm Announces Issuance of RNA Interference Patent Covering Potent siRNA Sequence
(Intradigm Corporation , 19-May-2009 , Biocompare)
Intradigm Corporation a leading developer of targeted systemic RNA interference therapeutics today
announced the issuance of United States patent 7534878 titled Composition and Methods of RNAi
Therapeutics for Treatment of Cancer and Other Neovascularization Diseases. More...
A patent attempt at cultural sensitivity

(Leslie D`Monte / New Delhi , 19-May-2009 , Business Standard)
You may soon get an email with a colour that suits your culture and nerves now that IBM the over $100
billion IT giant which has a current active portfolio of about 26000 patents in the US and over 40000
patents worldwide has applied for a patent to cover a method for customising colour in an email
message based on the cultural perspective of each recipient. More...
Atherotech receives patent for ApoB measurement for determining heart disease risk
(Medicinal Patent News , 19-May-2009 , News-Medical.Net)
Atherotech Inc developer of the VAP Cholesterol Test has announced it has received a patent on its
method to derive and report apolipoprotein B100 using the Vertical Auto Profile technology. More...
Madras HC allows TVS to use Bajajs patented tech

(T E Narsimhan & Swaraj Baggonkar / Chennai/mumbai , 19-May-2009 , Business Standard)
The Madras High Court today set aside its earlier order restraining countrys third largest two wheeler
manufacturer TVS Motors from manufacturing and marketing vehicles with twin spark technology.
More...
US firm sues Lupin over patent infringement

(By fe Bureau , 19-May-2009 , Indian Express Finance )
Lupin Pharmaceuticals the US subsidiary of Indian pharma major Lupin has been sued by US firm
Genzyme. More...
Wealth of microbes
(Surinder Sud / New Delhi , 19-May-2009 , Business Standard)
Many feel that microbes being live forms should not be patented as these are the creations of nature
and not of man. More...
Calcutta HC Bench admits ITC appeal

ITC had moved the High Court against Godfrey Phillips alleging infringement of copyright and illegal use
of a registered trademark of ITC products. More...
22 patent department officers transferred

(C.H. Unnikrishnan , 18-May-2009 , livemint)
However the transfers have drawn criticism from within the office on the grounds that some of the
officials are wrong targets More...
USPTO Upholds StemCells Patents

(PALO ALTO, CA , 16-May-2009 , ag-IP-news )
StemCells Inc announced in a press release that the US Patent and Trademark Office has upheld the
validity of the remaining two neural stem cell patents which were subjected to reexamination
proceedings commenced by Neuralstem Inc. More...
Indian drug seizure by EU may force firms to change routes

(Press Trust Of India / New Delhi , 16-May-2009 , Business Standard)
Frequent seizure of Indian drug consignments in Europe may force domestic pharmaceutical firms to
avoid the European sea routes to destinations in Africa and Latin America Commerce Secretary G K Pillai
said. More...
Competitive Technologies wins new patent for nanoparticle bone biomaterial

(By Staff Reporter , 15-May-2009 , Pharmaceutical Business Review)
Third patent supports first two patents and provides additional claims regarding the preparation of the
primary components of bone cement More...
UCB stock rises as US clears arthritis drug

(By Philip Blenkinsop and Antonia van de Velde , 14-May-2009 , Reuters)
The news will reduce UCBs reliance on older drugs some of which have lost patent protection and is a
vindication of its investment in biotechnology. More...
Gilead sues Teva in Atripla patent dispute

(Associated Press , 14-May-2009 , Forbes)
Gilead Sciences Inc said Thursday it is suing Teva Pharmaceuticals Industries Ltd over the drugmakers
plans to make a generic version of the blockbuster HIV treatment Atripla. More...
Piramal Healthcare launches ActiPatch for pain therapy
Its unique delivery system using patented technology provides a cost effective patient friendly method
to reduce soft tissue pain and swelling Piramal said. More...
Teva wins a round in court in Protonix fight

(by Diane Bartz , 14-May-2009 , Reuters)
A US appeals court refused on Thursday to give drugmakers Altana AG and Wyeth a preliminary
injunction in a patent fight with Teva Pharmaceutical Industries over the ulcer drug Protonix. More...
Indian group to sell copy of Tamiflu

(By Andrew Jack in London , 14-May-2009 , Financial Times)
An Indian pharmaceutical company is gearing up to sell a cheap version of Tamiflu the leading patented
antiviral flu drug to emerging economies in a move that will pit intellectual property rights against
affordable access to drugs. More...
Bajaj gets patent for multi spring shock absorbers

Pune based Bajaj Auto today said it has received patent for its invention multi spring vehicle shock
absorber used in its motorcycles with which it hopes to counter cheap Chinese copycats. More...
Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel
(The Procter & Gamble Company , 13-May-2009 , Biocompare)
Today the United States Court of Appeals for the Federal Circuit ruled in favor of The Procter & Gamble
Company in the patent infringement lawsuit filed by P&G against Teva Pharmaceuticals USA Inc. More...
ACLU and PUBPAT Challenge Patents on Breast Cancer Genes

(ag-IP-news Agency , 13-May-2009 , ag-IP-news )
The American Civil Liberties Union and the Public Patent Foundation at Benjamin N Cardozo School of
Law filed a lawsuit charging that patents on two human genes associated with breast and ovarian cancer
stifle research that could lead to cures and limit womens options regarding their medical care. More...
OMAX Announces Settlement in Patent Litigation

(KENT, Wash , 13-May-2009 , PRNewswire)
OMAX has announced the settlement of the outstanding patent litigation with Flow Corporation along
with the cessation of merger negotiations with the company. More...
Satyam Upaid get chance to try out of court settlement

(Andy Mukherjee & Jessica Mehroin Irani , 13-May-2009 , The Economic Times)
Satyam Computer Services and UK based mobile solutions company Upaid have been offered a chance
to settle their dispute out of court. More...
Global HIV AIDS initiative to help Indian pharma
(PB Jayakumar / Mumbai , 13-May-2009 , Business Standard)
Global healthcare aid agencies such as UNITAID and Medicines Sans Frontieres have begun to lobby for
a patent pool of HIV AIDS drugs. More...
Cancer Patients Challenge the Patenting of a Gene

(By JOHN SCHWARTZ , 12-May-2009 , The New York Times)
On Tuesday Ms Girard 39 who lives in the Austin Tex area filed a lawsuit against Myriad and the Patent
Office challenging the decision to grant a patent on a gene to Myriad and companies like it. More...
Japans Daiichi says deep in red due to Ranbaxy deal

(REUTERS , 12-May-2009 , The Economic Times)
Ranbaxy which derives 80 percent of its sales from abroad has grown by selling cheap copies of branded
drugs that have gone off patent and through successful challenges to patents owned by Western
companies. More...
Lupin settles antidepressant drug litigation with Wyeth

Lupin a generic drug maker has settled all patent litigation with US drug maker Wyeth for Effexor XR
capsules the US firms branded anti depressant. More...
Concert Pharmaceuticals Granted Patents on Deuterium Modified Compounds

(LEXINGTON, Mass , 11-May-2009 , Business Wire)
Concert Pharmaceuticals Inc announced today that its first patents have been granted by the US Patent
and Trademark Office. More...
WIPO clarifies
(IST,NEW DELHI , 11-May-2009 , The Economic Times)
This is with reference to the story Global model to give instant patent relief to drug cos which purports
to relate to matters under discussion this week in the Patent Cooperation Treaty Working Group at
WIPO. More...
AstraZeneca shares jump on blood thinner drug study

(Val Brickates Kennedy , 11-May-2009 , MarketWatch)
Plavix is due to lose patent protection in late 2011. More...
Nanosys Licenses Nanowire Technology to QuantuMDx Group for Next Generation Diagnostic
and Sequencing Technologies
(PALO ALTO, Calif. and LONDON,PRNewswire , 11-May-2009 , Biocompare)
Nanosys Inc and QuantuMDx Group today announced that QMDx has signed a non exclusive license
agreement with Nanosys for several patents and patent applications related to the use of nanowires for
biosensors. More...
SISVEL Patent Pool for 3G Long Term Evolution LTE
(TURIN, Italy , 11-May-2009 , Business Wire)
Following talks with the stakeholders in the LTE field worldwide that began last year and culminated in
April 2009 in a presentation on the benefits of an LTE patent pool delivered to the IPR Plenary Assembly
of the Next Generation Mobile Network Alliance today SISVEL issued a call for patents and patent
applications that are essential to the LTE standard. More...
Takeda Q4 profit more than doubles sees growth ahead

(by Yumiko Nishitani , 11-May-2009 , Reuters)
Joining other drugmakers using acquisitions to stave off earnings declines on patent expirations Takeda
bought US biotech firm Millennium Pharmaceuticals and absorbed its part of former US joint venture TAP
Pharma cos seek rise in prices of regulated drugs

( Khomba Singh & Sushmi Dey , 11-May-2009 , The Economic Times)
The domestic pharma industry is going to seek an upward revision in drug prices by submitting a report
on the increase in conversion and packaging costs to the Indian drug price regulator National
Pharmaceutical Pricing Authority. More...
Drug to curb Diabetes gets patent rights

(KAKINADA,TNN , 11-May-2009 , The Times of India)
Chintaluru village in East Godavari district which had become a popular place in the state for the
manufacture of ayurvedic drugs for several decades has earned a rare distinction of getting patent rights
for one of its product meant for curbing diabetes. More...
India asks Africa to keep doors open to generic drug imports

(Addis Ababa (IANS) , 10-May-2009 , The Hindu)
India has urged African countries not to put barriers on the production and import of generic drugs to
the continent especially in the current economic slowdown which could adversely affect the purchasing
power of patients. More...
The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against
Oxford BioMedica
(Bavarian Nordic , 9-May-2009 , Biocompare)
Oxford Biomedicas second attempt to dismiss Bavarian Nordics patent infringement suit in the United
States has failed. More...
Cadila expects Rs 100 cr revenue from Policap

(PTI,NEW DELHI , 9-May-2009 , The Economic Times)
Ahmedabad based Cadila Pharmaceuticals on Saturday said it is expecting a revenue of Rs 100 crore
from the sale of its patented combination drug Policap which it expects to launch by the middle of next
month. More...
Pfizer counters Dr Reddys claims against its anti smoking drug

Pfizer has responded to the post grant opposition filed by Dr Reddys Laboratories against its anti
smoking drug Champix. More...
The war for intellectual property

At the Geneva headquarters of the World Intellectual Property Organisation skirmishes between rich
nations and the developing world take place with predictable regularity. More...
Gene Network Sciences wins new US patent

(By Datamonitor staff writer , 08-May-2009 , Pharmaceutical Business Review)
Gene Network Sciences a biotechnology company has received a US patent that covers the companys
core model learning and simulation platform REFS. More...
Gucci sues Guess for trademark infringement

(Bloomberg / New York , 8-May-2009 , Business Standard)
Guess Inc was sued by Gucci Groups US unit for trademark infringement over allegations the Los
Angeles based apparel company uses a network of wholesale buyers to sell imitations of Guccis best
selling designs. More...
Wyeth sues Sun and its US subsidiary over Protonix drug

(Radhieka Pandeya , 8-May-2009 , livemint)
US based Wyeth Pharmaceuticals has sued Mumbai based Sun Pharmaceutical Industries Ltd and its US
subsidiary Caraco Pharmaceutical Laboratories Ltd for claiming that their heartburn drug was a generic
version of its Protonix drug. More...
Indian pharma cos upbeat on biogenerics

(Joe C Mathew / Bangalore , 8-May-2009 , Business Standard)
Even as the substitutability of biogeneric or biosimilar medicines with their original patented
counterparts continues to be a matter of debate world over Indian drug companies which have
introduced biogeneric products or copies of biotechnology drugs in the country are bullish over the
marketing prospects of biogenerics after patents expire in developed markets. More...
India pips US UK in IP laws enforcement practices

(PTI , 7-May-2009 , DNA)
Indian has been ranked top globally for enforcing intellectual property laws ahead of some of the most
advanced nations like the United States and the United Kingdom a survey says. More...
China drug maker Zensun eyes Nasdaq listing in 2011

(by David Lin , 7-May-2009 , Reuters)
Zhou also the chief executive of the firm said that he is in talks with several US pharmaceutical firms to
sell the patent of Neuregulin and hopefully to gain the Food and Drug Administrations approval to sell it
in the United States. More...
IL wins patent infringement lawsuit against Diagnostica Stago
Instrumentation Laboratory and its parent company Instrumentation Laboratory SpA or IL have reported
that the Paris First Level Civil Court has determined that Diagnostica Stago infringed the French
counterparts of two European patents licensed exclusively to IL and committed acts of unfair competition
due to denigrating advertisements. More...
Wi LAN settles patent litigation with Infineon

(by Krishna Chaithanya , 07-May-2009 , Reuters)
Technology licensing firm Wi LAN Inc said it settled a patent litigation with German chipmaker Infineon
Technologies AG for an undisclosed amount. More...
Wockhardt seeks to sell animal healthcare biz

Wockhardt has one of the largest number of off patent biotech drugs under development in India.
More...
10 Q PAR PHARMACEUTICAL COMPANIES INC

(EDGAR Online via COMTEX , 6-May-2009 , MarketWatch)
Certain statements in this Report constitute forward looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995 including those concerning managements expectations
with respect to future financial performance trends and future events particularly relating to sales of
current products and the development approval and introduction of new products. More...
Teva says Parkinsons drug patent extended to 2017

(Associated Press , 06-May-2009 , Forbes)
Drugmaker Teva Pharmaceutical Industries Ltd said Wednesday that one of the patents on Azilect its
Parkinsons disease drug has been extended by five years into 2017. More...
Pharma cos seek retail opening for swine flu drug

(Nina Mehta & Khomba Singh, , 6-May-2009 , The Economic Times)
This time though the timely rejection of Roches patent in March has allowed Indian companies to
manufacture the product and sell it in India and the countries where Roche does not have patent
protection. More...
Pfizer sues Sun Wockhardt Lupin in US

(Joe C Mathew / Bangalore , 6-May-2009 , Business Standard)
Files patent infringement suits against generic versions of best selling nerve drug. More...
Global model to give instant patent relief to drug cos

In what will pave the way for global pharma firms to obtain patents in India easily the United Nations
arm on intellectual property is planning to implement a global patenting model that will mandate all
member countries including India to grant patent to drugs approved by any two international patent
offices. More...
Patent law again

The revised report of the technical expert group on patent law issues is not very different from the one
that the group had to withdraw in 2007. More...
Biotech Pharma Docket

(By Suresh Pillai , 5-May-2009 , Patent Docs)
In the lawsuit filed in July 2008 Norvartis alleges that Roxane infringed Novartis patents covering Famvir
a treatment for genital and oral herpes. More...
Warner Chilcott files new patent infringement lawsuit against Mylan

Warner Chilcott a Bermuda based specialty pharmaceutical company has reported that one of its
subsidiaries and Mayne Pharma International have filed a second lawsuit against Mylan Pharmaceuticals
Inc and Mylan Inc in the District Court of New Jersey for infringement of Maynes US patent which covers
Doryx a tetracycline class oral antibiotic. More...
NanoLogix Inc to Exhibit at The American Society for Microbiology General Meeting in
Philadelphia Announces Two New Patents
(Carol Surrena , 05-May-2009 , Biocompare)
NanoLogix recently received two patents. More...
3 Monsanto DuPont bicker over herbicide tolerant tech

(By Steve James , 05-May-2009 , Reuters)
This violates Monsantos contract rights and US patents it said in the suit demanding DuPont honor its
agreements and respect patented technologies. More...
Takeda Lilly Lead $28.5 Billion in Biotech Deals Report Says

(By Lisa Rapaport , 05-May-2009 , Bloomberg)
Drugs with about $24 billion in annual sales are set to lose patent protection this year according to IMS
Health Inc the Norwalk Connecticut based research firm. More...
India may ask Kenya to review drug law

(Amiti Sen & Sushmi Dey, , 05-May-2009 , The Economic Times)
India is likely to ask Kenya to make amendments in its recent anti counterfeit law to protect Indian
pharmaceutical exports. More...
Hetero bags mega chunk of govts anti flu drug deal

Roche does not hold a patent for Tamiflu in India. More...

Indian drugmakers facing takeover threat says Govt panel
With a large number of drugs going off patent in developed markets like the US and Europe Indian
companies are expected to garner a lions share in the segment. More...
Acclarent Inc Granted Key Patent Covering Balloon Sinuplasty Technologies

(MENLO PARK, Calif , 04-May-2009 , PRNewswire)
Acclarent Inc the pioneer of Balloon Sinuplasty technologies for use in the treatment of chronic sinusitis
announced today that the US Patent and Trademark Office awarded US Patent Number 7500971 entitled
Devices Systems and Methods for Treating Disorders of the Ear Nose and Throat to the company.
More...
Hetero Drugs close to receiving orders for its swine flu medicines
Its patent application was rejected by the India patent office in March 2009 which paved the way for
Indian companies to legally manufacture and sell their generic version of the drug. More...
Pharma The 10 Most Promising New Drugs

(By Arthur Wong , 04-May-2009 , Business Week)
The pharmaceutical industry continues to march toward the patent cliff in 2010 2012 when a record
amount of drug sales will lose patent protection in the US. More...
IPL brands work on intellectual property bouquets

(Malathi Nayak , 04-May-2009 , livemint)
Rodney D Ryder partner at law firm Kochhar and Co refers to the Indian Premier League the popular
Twenty20 cricket tournament as the intellectual property league. More...
20th Century Fox sues B R Films for plagiarism

(Press Trust of India / Mumbai , 3-May-2009 , Business Standard)
Hollywoods famous studio Twentieth Century Fox has moved the Bombay High Court against B R Chopra
Films seeking Rs 7 crore damages and an injunction against the release of the Hindi film Banda Yeh
Bindaas Hai alleging it was a remake of Oscar winning My Cousin Vinny. More...
Google and other firms sued over use of Android name

(TEL AVIV , 3-May-2009 , MarketWatch)
An Illinois software developer sued some four dozen companies including Google Inc claiming that they
infringed his trademark on the word Android weekend media reports said. More...
India to move WTO against EU MNCs blocking its generics

(Sushmi Dey , 02-May-2009 , The Economic Times)
India along with Brazil will lodge a complaint with the World Trade Organisation against the European
Union alleging that Europe based multinational pharmaceutical firms are persuading African nations to
enact anti counterfeit laws. More...
Patent office lets Roche keep Hepatitis C drug

According to the World Health Organisation as many as 180 million people worldwide have been infected
by the hepatitis C virus with 3 4 million being added to the list every year. More...
Ranbaxy recalls Nitrofurantoin capsules from US market

(ET Bureau,NEW DELHI , 2-May-2009 , The Economic Times)
Indias largest drug company by sales Ranbaxy Laboratories is voluntarily recalling its entire lots of
Nitrofurantoin 100 mg capsules from the US retail market after it was discovered that the drugs did not
meet the US drug manufacturing standards. More...
Indian pharma emerges big player in Japan

(PB Jayakumar / Mumbai , 2-May-2009 , Business Standard)
Leading Indian drug makers such as Ranbaxy Lupin Zydus Cadila and Dishman which forayed into Japan
in the past three years have emerged as important players in the generic or copycat drug business of
patented medicines in that market the second largest in the world. More...
Gileads Hepatitis patent plea rejected

(Khomba Singh, , 2-May-2009 , The Economic Times)
The Delhi Patent Office has rejected American company Gilead Sciences plea to patent its Hepatitis B
drug adefovir dipivoxil sold under the brand name Hepsera. More...
ImmunoCellular Therapeutics wins new patent for monoclonal antibody technology

ImmunoCellular Therapeutics a biotechnology company has received a new US patent relating to the
companys monoclonal antibody therapeutics. More...
New Delhi rejects American firms plea to patent Hepatitis B drug

The Delhi Patent Office has rejected American company Gilead Sciences plea to patent its Hepatitis B
drug adefovir dipivoxil sold under the brand name Hepsera. More...
Warner Chilcott Files New Lawsuit for Infringement of DORYX Patent

(HAMILTON, Bermuda , 01-May-2009 , PRNewswire)
Warner Chilcott Limited announced today that one of its subsidiaries and Mayne Pharma International
Pty Ltd have filed a second lawsuit against Mylan Pharmaceuticals Inc and Mylan Inc in the District Court
for the District of New Jersey for infringement of Maynes US Patent No 6958161 which covers DORYX a
tetracycline class oral antibiotic. More...
Ready to supply anti flu drug at short notice says Ranbaxy

The timely rejection of Gileads other patent application for Tamiflu in India has come as a shot in the
arm for Indian generic players. More...
Wockhardt may get rights for two Parkinsons drugs

(BS Reporter / Mumbai April 30 , 30-Apr-2009 , Business Standard)
Settles 3 patent infringement cases out of court. More...
The Patent Reform Act Means Progress

(by Senator Patrick Leahy , 30-Apr-2009 , BusinessWeek)
Ingenuity and innovation have been cornerstones of the American economy from the time Thomas
Jefferson issued the first patent. More...
FDAs Tamiflu move to spur generics mkt

(Reghu Balakrishnan , 30-Apr-2009 , The Financial Express)
Earlier this month the Delhi patent office had rejected the patent application for Tamiflu filed by Gilead
Sciences while considering the pre grant opposition of Cipla. More...
The Patent Reform Act Means Progress

(by Senator Patrick Leahy , 29-Apr-2009 , Business Week)
Ingenuity and innovation have been cornerstones of the American economy from the time Thomas
Jefferson issued the first patent. More...
McCurry beats McDonald in Malaysia lawsuit

(David Chance, Kuala Lumpur , 29-May-2009 , Reuters)
Fast food chain McDonald's lost a lawsuit in Malaysia on Wednesday after an appeals court overruled a
decision that its trademark had been infringed by a local restaurant called McCurry. More...
i2 Files Intellectual Property Lawsuit

(DALLAS--(BUSINESS WIRE) , 29-Apr-2009 , StreetInsider )
i2 Technologies Inc announced today that it has filed a suit for patent infringement against Oracle
Corporation. More...
Watson Confirms Filing of Abbreviated New Drug Application for Generic Enablex
(CORONA, Calif , 28-Apr-2009 , PRNewswire)
Watson Pharmaceuticals Inc a leading specialty pharmaceutical company today confirmed that it has
filed an Abbreviated New Drug Application with the US Food and Drug Administration seeking approval
to market its darifenacin hydrobromide extendedrelease 7.5 mg and 15 mg product prior to the
expiration of a patent owned by Novartis AG. More...
Dr Reddy launches anti acne drug Nexret in India

(Agencies , 28-Apr-2009 , The Financial Express)
Pharmaceutical firm Dr Reddy said it has launched a variety of gel Nexret used in the treatment of skin
diseases. More...
NicOx to acquire NO donating patents from Nitromed

(By Datamonitor staff writer , 28-Apr-2009 , Pharmaceutical Business Review)
France based NicOx has agreed to purchase US based Nitromeds unlicensed patent estate covering nitric
oxide donating compounds. More...
AVI BioPharma Receives Key Patents

(PORTLAND, OR , 28-Apr-2009 , ag-IP-news )
AVI BioPharma Inc a developer of RNA based drugs announced in a Tuesday press release the issuance
of the second of two key US patents covering the companys candidate drug for the treatment of Ebola
Zaire infection. More...
Watson and Novartis battle over Enablex patent

(Associated Press , 28-Apr-2009 , Forbes)
Watson Pharmaceuticals Inc is disputing the patent on Novartis AGs extended release overactive bladder
treatment Enablex Watson said Tuesday. More...
US approval for Glenmark cholesterol drug

Sources said Zetia had sales of $1.5 billion in 2008 and the main patent for this drug would expire in
2014. More...
US watch list on patents irks India

(PTI ,New Delhi , 28-Apr-2009 , The Financial Express)
India has conveyed its big disappointment to the US for retaining New Delhi on the Priority Watch List
which binds Washington to exert pressure on Americas trade partners to improve their copyright and
patent regimes. More...
Local drug cos may chip in to treat swine flu

(Khomba Singh & Sushmi Dey , 28-Apr-2009 , The Economic Times)
Cipla and other Indian pharma majors can now legally manufacture generic versions of Tamiflu after the
patent office in Delhi last month rejected a patent application by Swiss company Roche which markets
the antiviral in India. More...
Cipla ready to supply generic drug to West

(Corporate Bureau , 28-Apr-2009 , The Financial Express)
Early this month the Delhi patent office had rejected the application of Gilead Sciences the manufacturer
of Tamiflu for a patent considering Ciplas arguments that the drug lacked inventiveness. More...
L&T unit files for 108 patents in 2008 09

Mumbai April 27 Larsen and Toubros Electrical and Electronics Division has filed 108 patents applications
in 2008 09 for its electrical and electronic products. More...
Sinobiopharma Secures Rights to Seven Key Patents

(NANJING, China , 27-Apr-2009 , PRNewswire)
The patents that will significantly enhance Sinobiopharmas ability to execute on its mission of bringing
safe low cost high efficacy biopharmaceuticals to market. More...
FTC focused on drug pay for delay settlements

(By Diane Bartz , 27-Apr-2009 , Reuters)
The FTC while watching legislative efforts to ban the practice of big drug companies paying off generics
as part of patent lawsuits has challenged the deals in court with mixed success. More...
Qualcomm and Broadcom Settle Patent

(Corporate News , 27-Apr-2009 , StreetInsider)
Qualcomm Incorporated and Broadcom Corporation entered into a settlement and multi year patent
agreement with Qualcomm paying Broadcom $891 million over a four year period. More...
Not too enticing

(Ram Prasad Sahu / Mumbai , 27-Apr-2009 , Business Standard)
Going ahead although there are issues pertaining to patent registration and pricing if the company does
manage to sort out these and use the listed arm for new launches sales could witness a jump
considering its presence in high growth areas of anti diabetic cardiovascular gynaecology and anti
ulcerants. More...
Sanofi Rebuffed by US High Court on Lovenox Patent

(By Greg Stohr and Susan Decker , 27-Apr-2009 , Bloomberg.com)
The US Supreme Court rejected an appeal by two Sanofi Aventis SA units refusing to reinstate a patent
that prevented generic competition to the companys top selling product the blood thinner Lovenox.
More...
Govt to create 1380 patent examiners posts

The Centre plans to create 1380 patent examiners posts during the 11th Plan period of which 414 will be
filled up this year alone. More...
Govt gives diplomatic push to pharma exports to Africa

(Amiti Sen & Sushmi Dey , 25-Apr-2009 , The Economic Times)
India has started a diplomatic exercise to counter a propaganda by multinational pharmaceutical

companies against Indian generics or off patent drugs exported to Africa. More...
Cipla gets HC relief in Roche case

(Radhieka Pandeya , 25-Apr-2009 , livemint)
In a ruling that could encourage more generic or off patent drug makers here to challenge patents held
my multinational pharma firms the Delhi high court dismissed a patent infringement suit filed by Swiss
pharma company Hoffman La Roche Ltd for its lung cancer drug Tarceva thereby allowing Indian drug
maker Cipla Ltd to continue marketing the generic version of the drug. More...
J&J Wins Approval to Sell Arthritis Drug in US

(By Shannon Pettypiece and Alex Nussbaum , 24-Apr-2009 , Bloomberg.com)
Remicades patent will expire in 2018 said Brian Kenney a spokesman for J&Js Centocor Ortho Biotech
unit. More...
Delhi High Court dismisses Roche plea on patent

The Delhi High Court on Friday allowed Indian pharmaceutical company Cipla to manufacture and sell
the generic version of patented lung cancer drug Erlotinid of Swiss pharma firm Hoffman La Roche Ltd.
More...
Intellectual property report favours conditional patenting of micro organisms

Mumbai April 23 Without much ado the Technical Expert Group on Patent Law Issues headed by Dr R A
Mashelkar has resubmitted its report to the Union Ministry of Commerce. More...
Teva to appeal against preliminary injunction for Generic Evista update

(by RTT Staff Writer , 23-Apr-2009 , RTT News)
Teva Pharmaceutical Industries Ltd said Thursday that it plans to appeal the Courts order in the litigation
with Eli Lilly & Co. More...
Gilead to challenge Tamiflu verdict

The patent office had recently rejected Gileads patent application owing to lack of inventiveness in the
drug. More...
Teva Glenmark call an end to patent dispute

(Nina Mehta , 23-Apr-2009 , The Economic Times)
Israeli generic major Teva and Mumbai based Glenmark Pharmaceuticals have settled a patent dispute
over various generic versions of Corega drug used for treating congestive heart failure out of court.
More...
NicOx acquires Nitromeds NO donating patents

(SOPHIA ANTIPOLIS, FRANCE, MARKET WIRE , 23-Apr-2009 , StreetInsider)
NicOx SA today announced it has agreed to purchase Nitromeds unlicensed patent estate covering nitric
oxide donating compounds. More...
Lilly says judge prevents launch of generic Evista

(by Deena Beasley , 22-Apr-2009 , Reuters)
Eli Lilly and Co said on Wednesday that a federal judge issued a preliminary injunction preventing the
launch of a generic version of osteoporosis drug Evista. More...
Piramal Health eyes acquisitions in US Europe

(Reuters , 22-Apr-2009 , livemint)
Piramal Healthcare and a related firm Piramal Life Sciences Ltd would together invest about Rs1 billion
during the 12 months to March 2010 mostly on new drug development and research. More...
IMS Health Cuts Pharma Growth Forecast

(By Catherine Arnst , 22-Apr-2009 , BusinessWeek)
Big Pharma isnt so immune to the recession after all. More...
Dr Reddys launches Redispar in India

(Press Trust of India / Mumbai , 22-Apr-2009 , Business Standard)
Pharmaceutical firm Dr Reddys Laboratories today said it has launched Redispar drugs used in the
treatment of chronic kidney diseases in the country. More...
The US Is Losing Its Lead in Patents

(By Michael Arndt , 22-Apr-2009 , BusinessWeek)
Innovation is coming from abroad these days and foreign applications are coming faster and faster.
More...
ACTA to fight copyright infringement

(PK Vasudeva , 22-Apr-2009 , The Financial Express)
The US is considering bringing an Anti Counterfeiting Trade Agreement. More...
Glaxo Pfizers patent claims turned down

Indian authorities have rejected the patent applications of GlaxoSmithklines anti diabetic drug Avandia
and Pfizers cholesterol lowering drug Caduet allowing other companies to sell generic versions of these
drugs. More...
Big Pharma evergreening nixed

Introducing highly expensive patented drugs that show little or no improvement over existing ones or
attempts to evergreen patents is getting tougher for multinationals. More...
Glaxo Pfizer HIV research JV may harm generic cos

(Nina Mehta , 22-Apr-2009 , The Economic Times)
Ranjit Kapadia a pharma analyst with HDFC Securities said that the formation of the new firm will affect
Indian companies if they are violating or challenging patents. More...
Par Pharma settles patent dispute with Reliant
Generic drug developer Par Pharmaceutical Cos said Tuesday it settled a patent dispute with Reliant
Pharmaceuticals Inc over the abnormal heart rhythm treatment Rythmol SR. More...
Covidien Files Patent Infringement Lawsuit over Davols Mesh Fixation Device and Applier
(NORTH HAVEN, Conn , 21-Apr-2009 , Business Wire)
The lawsuit contends that Davols recently released Sorbafix device infringes multiple claims of Covidiens
US Patent Number 6562051. More...
Expert committee suggests patenting microorganisms too

(C.H. Unnikrishnan , 21-Apr-2009 , livemint)
An expert group has suggested significant changes to Indias patent regime that will address contentious
provisions that barred the issue of patents to anything that isnt a new chemical or medical entity and to
drugs built around microorganisms. More...
Glaxo to buy skin care firm for at least $2.9 billion

(By Steve Goldstein , 20-Apr-2009 , MarketWatch)
Companies in the sector have been looking for deals to boost their stable of new products as the patent
protection for older medications expire. More...
Achillion wins new US patent

Achillion Pharmaceuticals a US based biopharmaceutical company has announced that the US Patent &
Trademark Office has granted Achillion a US patent related to the companys NS4A antagonists to treat
the hepatitis C virus. More...
IPR course for women

(STAFF REPORTER , 20-Apr-2009 , The Hindu)
The training is aimed at having a pool of resources trained in scientific and technical aspects of
Indian lawyer turns IPR into a board game

(Malathi Nayak , 20-Apr-2009 , livemint)
The game is the brainchild of Pravin Anand one of Indias best known IPR lawyers. More...
Drug firms may exceed growth targets

(PB Jayakumar / Mumbai , 20-Apr-2009 , Business Standard)
Despite forex losses and currency fluctuations impacting profitability leading Indian drug companies such
as Cipla Sun Pharma Dr Reddys Laboratories and Wockhardt are likely to exceed revenue growth targets
set for financial year 2008 09. More...
Scope to improve in big markets where the firm is already present
Russia has been a good market for us. It is a branded generics market and we have been in the market
for long More...
Govt protests as generic drugs get bitter pill in Africa

(Arun S , 20-Apr-2009 , The Financial Express)
India has called an extraordinary meeting of the ambassadors of all African countries in the Capital this
week to register its strong protest against a recently passed Anti Counterfeit Act in Kenya that could
severely restrict the market for Indian generic drugs into Africa. More...
Pharma companies headed for slower earnings growth analysts

(C.H. Unnikrishnan and Radhieka Pandeya , 20-Apr-2009 , livemint)
Average growth in sales for the quarter likely to be less than 11% compared with 14% in the year ago
period More...
Pharma MNCs ask DCGI to liaison with patent offices

In the backdrop of Wednesdays Delhi High Court verdict that allowed Cipla to manufacture and sell a
patented cancer drug in India multinational pharma companies plan to urge the Drug Controller General
of India to improve its co ordination with patent offices across the country. More...
Indian pharma industry may gain $18.4 bn from global mkt

(PTI,NEW DELHI , 19-Apr-2009 , The Economic Times)
With the global pharmaceutical market likely to witness products worth 123 billion dollars loosing
patents by 2012 the generics driven Indian drugs industry could get benefit of around 18.4 billion dollars
about Rs 91576 crore from those products. More...
Sepracor Announces Patent Interference Proceedings Against Wyeth

(MARLBOROUGH, MASS , 18-Apr-2009 , ag-IP-news )
Sepracor Inc announced that the Board of Patent Appeals and Interferences of the US Patent and
Trademark Office has combined three patent interferences into a single interference between Sepracor
and Wyeth and set a date for oral arguments. More...
Adcocks plan to buy Medpro hits Cipla hurdle

South African company Adcock Ingrams plans to buy Cipla Medpro with whom Indian pharma major
Cipla has a 20 year drugsupply agreement has run into trouble with the Mumbai based company
opposing the $228 million takeover. More...
Drug patents India to take EU to WTO

(Arun S , 18-Apr-2009 , The Financial Express)
The patents battle between India and the European Union in the pharmaceutical space will soon reach
the dispute settlement body of the World Trade Organisation. More...
Glaxo Pfizer to merge HIV drug units in challenge to Gilead

(Bloomberg / London , 18-Apr-2009 , Business Standard)
GlaxoSmithKline Plc once the worlds biggest maker of AIDS drugs will form a new company with rival
Pfizer Inc to increase its share of the $12.3 billion HIV market now dominated by Gilead Sciences Inc.
More...
Nobel Biocare wins patent ruling in Germany

(Katie Reid , 17-Apr-2009 , Reuters)
Swiss dental implant maker Nobel Biocare said on Friday it had won a German court ruling in a patent
infringement case brought by Materialise Dental in relation to Nobel Biocares NobelGuide software.
More...
Patentholder asks Noida excise dept to cancel Samsung licence

A Madurai based engineer has asked authorities to cancel Samsungs licence to manufacture dual SIM
mobile phones as he holds the local patent for such mobiles More...
Sepracor disputes patent on Wyeths Pristiq

Sepracor Inc on Friday took a step toward a potential challenge of patents supporting Pristiq an
antidepressant marketed by Wyeth. More...
Roches Hepatitis drug patent upheld

(Joe C Mathew / Bangalore , 17-Apr-2009 , Business Standard)
The patent office has upheld the validity of Roches patent rights over Pegasys pegylated interferon
alfa2a a Hepatitis C medicine. More...
Rib X granted patent for novel oxazolidinone in China

(Medical Patent News , 16-Apr-2009 , News-Medical.Net)
Pharmaceuticals Inc has announced the issuance of a key antibiotic patent in China. More...
Court Grants AstraZeneca Temporary Restraining Order Against Apotex in PULMICORT

RESPULES Patent Litigation
(AstraZeneca , 16-Apr-2009 , Biocompare)
On 16 April 2009 the US District Court for the District of New Jersey granted AstraZenecas request for a
temporary restraining order barring Apotex from launching a generic version of AstraZenecas
PULMICORT RESPULES until further order of the court. More...
Pig patent row upsets top EU producer Germany

(By Brian Rohan , 16-Apr-2009 , Reuters)
A test to check pigs for a gene that makes them produce more meat has sparked a row in Germany
where farmers ecologists and politicians filed objections to its patent before an appeals deadline on
Thursday. More...
Piramal gets injunction in drug trademark case

(C.H. UnnikRishnan , 16-Apr-2009 , livemint)
The injunction temporarily restrains these companies from using brand names similar to Esgipyrin for
marketing the same drug combination More...
AstraZeneca India announces CRESTOR tablets launch

(Sushmi , 16-Apr-2009 , The Economic Times)
AstraZeneca India announced the launch of CRESTOR rosuvastatin 5 10 20 and 40 mg tablets today.
More...
Troikaa Pharma launches cancer drug

The lozenges and their holders are indigenously designed and patented. More...
New drug research is a high risk game

(P B Jayakumar / Mumbai , 16-Apr-2009 , Business Standard)
Lupin Ltd one of the top five drug companies in India grew over 30 per cent yearly in the past four years
and maintained 38 per cent growth in turnover and 49 per cent growth in profits in the first nine months
of 2008 09. More...
India rejects patent to Glivecs second variant

(Joe C Mathew / Bangalore , 15-Apr-2009 , Business Standard)
Ruling intended to prevent patenting of inventions known earlier. More...
CORRECT Sales forecast haunts Abbott shares

(By Val Brickates Kennedy , 15-Apr-2009 , MarketWatch)
Abbott Laboratory shares moved notably lower Wednesday as investors reacted negatively to news that
sales growth for the companys popular rheumatoid arthritis drug Humira might not be as robust as
previously expected. More...
Peregrine wins new US patent

Peregrine Pharmaceuticals a biopharmaceutical company has received a new US patent that is expected
to strengthen the companys intellectual property in the field of phospholipid targeting agents for the
treatment of life threatening diseases. More...
Rib X Granted Key Antibiotic Patent in China

(NEW HAVEN, Conn. , 15-Apr-2009 , PRNewswire)
Rib X Pharmaceuticals Inc a development stage company focused on the discovery and development of
novel antibiotics for the treatment of antibiotic resistant infections today announced the issuance of a
key antibiotic patent in China. More...
Samsung files appeal against dual SIM

(Bettina Wassener , 15-Apr-2009 , livemint)
Prateek Garg a 26 year old software engineer who lives in Delhi has been unemployed since September
and has had only two job interviews since then. More...
Mylan Confirms First To File Patent Challenge Relating To Xeloda Cancer Treatment
(Mylan Inc. , 14-Apr-2009 , Biocompare)
Mylan Inc today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc have been
sued by Hoffmann La Roche Inc in connection with the filing of an Abbreviated New Drug Application
with the US Food and Drug Administration for Capecitabine Tablets 150 mg and 500 mg the generic
version of Xeloda Tablets a chemotherapy treatment for breast and colorectal cancer. More...
Mylan challenges patent sued by Roche

Mylan Inc said Tuesday it is being sued by Roche after challenging the Swiss drug developers patent on
the cancer treatment Xeloda. More...
Zydus Pharma sued in US over anti depressant

Zydus Pharma Inc the US subsidiary of the Ahmedabad based pharma major Zydus Cadila has been
sued by US major Wyeth following the latters paragraph IV ANDA submission for the marketing approval
of Effexor a leading anti depressant drug with $4 billion sales revenue owned by Wyeth in the US
market. More...
We should properly evaluate these combination drugs

(M Venkateswarlu, , 14-Apr-2009 , The Economic Times)
Any drug before being permitted for marketing in the country for the first time undergoes a series of
scientific studies pre clinical studies or M Venkateswarlu Former Drugs Controller General of India animal
model studies and clinical trials carried out in three phases. More...
These are quality medicines Indias success formula

(Daara B Patel, , 14-Apr-2009 , The Economic Times)
Fixed Dose Combinations have been manufactured successfully in India and abroad for many years.
More...
Alcatel Patent in $358 Million Suit Rejected by US

(By Susan Decker , 14-Apr-2009 , Bloomberg.com)
An Alcatel Lucent SA patent that resulted in a $358 million jury verdict against Microsoft Corp was
rejected by the US Patent and Trademark Office after the agency took a second look at the invention.
More...
US rejects Alcatel patent could affect award
(Bill Rigby , 13-Apr-2009 , Reuters)
The US Patent and Trademark Office has rejected two patents claimed by French telecoms equipment
Alcatel Lucent which could end up nullifying a multi million dollar damages award against software
maker Microsoft Corp. More...
CoolTouch Inc Settles Diomed Lawsuit Files Re examination Request for Cynosure 873 Patent
(CoolTouch Inc. , 13-Apr-2009 , Biocompare)
ROSEVILLE Calif PRNewswire On April 7 2009 the Boston District Court dismissed the Diomed lawsuit
between Endolaser Associates LLC and CoolTouch Inc after CoolTouch signed a settlement agreement
with Dr Luis Navarro. More...
Indias Sun Pharma gets FDA nod for generic Roxicodone

(Prashant Mehra , 13-Apr-2009 , Reuters)
The generic oxycodone hydrochloride tablets are used as a painkiller. More...
Cadila looking at global tie ups for Polycap

(Press Trust Of India / New Delhi , 13-Apr-2009 , Business Standard)
Ahmedabad based Cadila Pharmaceuticals is looking for global tie ups to market its new patented
product Polycap a combination of five medicines that prevents heart attack. More...
HC to hear dual SIM patent case today

(Niranjana Ramesh, , 13-Apr-2009 , The Economic Times)
The Madras High Court will hear a petition filed by a Madurai based engineer Somasundaram Ramkumar
seeking the enforcement of patent protection for his invention the dual SIM card technology used in
mobile phones. More...
Sun loses US patent case for lucrative drug

Sun Pharmaceutical Industries has lost a patent infringement case in the US on Cardene a drug for
controlling high blood pressure. More...
Defensive pharma promises solid Q1 results

(Ben Hirschler and Lewis Krauskopf , 12-Apr-2009 , Reuters)
A looming cliff of patent expiries growing political pressure in the United States and elsewhere and a lack
of new drugs coming out of research labs mean drug companies are struggling with over capacity just
like other industries. More...
J&J expected to report lower earnings

(Val Brickates Kennedy , 12-Apr-2009 , MarketWatch)
J&Js pharmaceutical division once its core business has been hit in recent quarters by the loss of patent
exclusivity on such brand names as Risperdal and Topamax. More...
HP Files Appeal in Patent Dispute with Cornell University
(PALO ALTO, CA , 12-Apr-2009 , ag-IP-news )
HP announced in a press release that it has filed an appeal in its patent dispute with Cornell University
and the Cornell Research Foundation Cornell. More...
Daiichi Sankyo Files Patent Infringement Actions Against 11 Generics Companies

(ag-IP-news , 11-Apr-2009 , ag-IP-news )
Daiichi Sankyo Ltd announced in a press release that it has brought patent infringement litigations
against 11 generics companies for the substance patent 2008845 and usage patent 1659502 for
Levofloxacin Hydrate brand name Cravit tablets and Cravit fine granules. More...
United Treatment Centers Inc Acquires a Stake in Bel Ea Co and Its Trademarks
(ASTORIA, NEW YORK -- (MARKET WIRE) , 10-Apr-2009 , StreetInsider)
United Treatment Centers Inc today announced it has acquired a 50% stake of Bel Ea Co from an
existing shareholder. More...
We will be back to normal soon

(P. T. Jyothi Datta , 10-Apr-2009 , Business Line)
Wockhardt watchers also observe that the company like many corporates in and outside the
pharmaceutical segment went on an acquisition over kill and worse funded it through debt when the
going was good. More...
Wockhardt to foray into biosimilar market

(Nina Mehta,MUMBAI , 10-Apr-2009 , The Economic Times)
Wockhardt is planning to tap the $33 billion biosimilar market and focus on products that lose patent
protection in 2013 2015. More...
Natco Lupin tie up for generic drug to treat kidney failure

Natco Pharma Ltd has tied up with Lupin Ltd to jointly commercialise generic equivalents of Lanthanum
Carbonate tablets used to treat kidney failure. More...
Samsung files appeal with board against dual SIM patent

The firm filed a petition with IPAB asking it to revoke the existing patent for issued toan Indian inventor
More...
Novartis retailers lock horns over direct sales

(Khomba Singh, , 10-Apr-2009 , The Economic Times)
An open battle has erupted between drug retailers in Mumbai and Novartis a Swiss company and its
subsidiary Sandoz. More...
Cipla can benefit if Medpro acquisition goes through

Mumbai based drug maker Cipla Ltd can look to expand its presence in South Africa and indeed other
parts of the region if South Africa s Adcock Ingram Healthcare Ltds $233 million proposal to acquire
generic drugs player Cipla Medro goes through. More...
Takeda takes back Actos rights from Lilly

(Yumiko Nishitani , 9-Apr-2009 , Reuters)
Like its peers Takeda Japans largest drugmaker faces pressure from the economic slowdown in the
United States the biggest market for Actos and it will lose patent protection on the drug there in 2011.
More...
Wockhardt to hive off biotech division

(P B Jayakumar / Mumbai , 9-Apr-2009 , Business Standard)
Wockhardt has one of the largest off patent biotech drugs under development in India. More...
Aurobindo gets nod from Swissmedic

(Agencies , 8-Apr-2009 , The Financial Express)
Drug maker Aurobindo Pharma on Wednesday said it has received approval from the Switzerland
government for marketing Finasteride APL a drug used for treating enlarged prostate in men. More...
Mylan Announces Clarinex Settlement Agreement

(Mylan Inc. , 8-Apr-2009 , Biocompare)
Mylan Inc today announced the settlement of all patent litigation relating to Desloratadine Tablets 5 mg
the generic version of Schering Ploughs Clarinex allergy medication. More...
Microsoft ordered to pay Uniloc $388 million

(SEATTLE , 08-Apr-2009 , BusinessWeek)
A federal judge on Monday ordered Microsoft Corp to pay $388 million in damages after finding the
worlds largest software maker infringed on a patent held by Uniloc Inc. More...
Are Patent Problems Stifling US Innovation

(Damian Joseph. , 08-Apr-2009 , BusinessWeek)
The US Patent and Trademark Office is drowning in applications while its budget shrinks. More...
Affitech wins new European patent for antibody screening technology

Affitech an antibody R&D company has reported that the European Patent Office has granted a European
patent on the use of phagemid particles having an antibody coliphage pIII fusion protein to identify
tumor associated antigens on cells by negative selection. More...
Many Drug Prescriptions are Now Going Unfilled

(By JONATHAN D. ROCKOFF , 08-Apr-2009 , The Wall Street Journal)
That isnt good news for drug makers already struggling to replace the sales of top selling medicines
losing patent protection over the next several years. More...
Pfizer reorganizes units for Wyeth buy

(Shannon Pettypiece , 8-Apr-2009 , livemint)
Pfizer the worlds biggest drug maker needs to ramp up new drug development as it braces to lose $10
billion in annual sales in 2011 when patent protection ends for its cholesterol pill Lipitor analysts said.
More...
Re evaluating pharma
The last avenue has been opened up with patent protection taking root in India. More...
Indian drug makers welcome to join patent pool prog GSK

Global drug major GlaxoSmithKline has said Indian drug makers and research firms can join its patent
pool programme aimed at developing low cost drugs for 16 neglected tropical diseases. More...
AstraZeneca Files Suit Against Apotex

(LONDON , 07-Apr-2009 , ag-IP-news )
AstraZeneca has filed a lawsuit in the US District Court for the District of New Jersey against Apotex
seeking a declaration of patent infringement a press release by AstraZeneca stated. More...
Gilead Sciences Announces Notification of ANDA Filing for Atripla

(BUSINESS WIRE , 07-Apr-2009 , Biocompare)
Gilead Sciences Inc today announced receipt of a Paragraph IV Certification Notice Letter advising that
Teva Pharmaceuticals submitted an Abbreviated New Drug Application to the US Food and Drug
Administration requesting permission to manufacture and market a generic version of Atripla. More...
Rambus Buys Inapac Patents

(Corporate News , 07-Apr-2009 , StreetInsider)
Rambus Inc announced it has acquired a number of patents from Inapac Technology Inc to broaden its
offerings for the mobile memory market. More...
Impax Confirms Patent Challenge Relating to Renvela

(HAYWARD, CA , 07-Apr-2009 , ag-IP-news )
Impax Laboratories Inc confirmed that it has initiated a challenge of the patents listed by Genzyme
Corporation in connection with its Renvela 800 mg tablets a press release by Impax stated. More...
Ex Bristol Myers Executive Pleads Guilty In Plavix Patent Case

(DOW JONES NEWSWIRES , 6-Apr-2009 , CNNMoney.com)
Andrew Bodnar a former executive of Bristol Myers Squibb Co pleaded guilty Monday to a charge related
to his role in a patent deal the drug maker struck to keep a generic competitor to its popular blood
thinning drug Plavix off the market. More...
Teva Pharma A Safe Prescription

(RTTNews , 6-Apr-2009 , RTT News)
Hit by a triple whammy of pipeline woes an onslaught of blockbuster patent expiries and regulatory
stringency the once invincible branded drugs giants are engulfed in a fog of uncertainty. More...
Arrow Coated Products gets patent for specialised films

Arrow Coated Products Ltd one of Indias leading and pioneering manufacturers of pressure sensitive
adhesive coated films has been granted patent for Embedded Water Soluble Films by Australian Patent
office Patent Grant No 2002356417 till October 07 2022 the company said in a BSE filing. More...
Sepracor files NDA for seizure drug

Sepracor a research based pharmaceutical company has submitted a new drug application to the FDA for
the use of eslicarbazepine acetate as adjunctive therapy in the treatment of partial onset seizures in
adults with epilepsy. More...
Impax sued by Genzyme in patent challenge

Drug developer Impax Laboratories Inc said Monday it is being sued by Genzyme Corp over a patent
challenge to that companys kidney condition drug Renvela. More...
Gilead Reviews Tevas Generic Application May File Suit

(DOW JONES NEWSWIRES , 06-Apr-2009 , CNNMoney.com)
Gilead Sciences Inc said it is reviewing a notice letter and has 45 days to file a patent infringement
lawsuit against Teva Pharmaceutical Industries Ltd following Tevas submission to manufacture and
market a generic version of HIV drug Atripla. More...
Five Indian inventions win US patent

(NEW DELHI (Xinhua) , 5-Apr-2009 , The Hindu)
Five inventions by a New Delhi resident named Anadish Pal have won patent from the United States
government Navbharat Times reported on Sunday. More...
Nomadix Wins Patent Enforcement Action Against Second Rule LLC

(NEWBURY PARK, CA , 4-Apr-2009 , ag-IP-news )
DOCOMO interTouch announced that its subsidiary Nomadix Inc has won a patent enforcement action
against Second Rule LLC the maker of the IP3 NetAccess gateway a press release by Nomadix stated.
More...
Patent to Bajaj will not affect us TVS Motor

Mumbai April 3 TVS Motor Company has stated that the grant of the ExhausTEC patent to Bajaj Auto
does not in any way impact its products in the market. More...
AstraZeneca sues Apotex over generic asthma drug

(Bill Berkrot , 03-Apr-2009 , Reuters)
Pulmicort had US sales of $982 million in 2008 with about 90 percent of that coming from the form of
the medicine that is being disputed in the patent case. More...
Boston Scientific announces key rulings in stent litigation with J&J

Boston Scientific a developer manufacturer and marketer of medical devices has reported that the Court
of Appeals for the Federal Circuit has issued a positive ruling in the companys stent litigation with
Johnson and Johnson or J&J. More...
Court rules for Lilly in patent fight with Ariad

( Diane Bartz , 03-Apr-2009 , Reuters)
Eli Lilly did not infringe a patent owned by Ariad Pharmaceuticals when it made its Evista osteoporosis
drug and Xigris sepsis treatment a US appeals court said on Friday. More...
Acquisition overdose Worries over future of pharma industry

Challenges are in store for local drug companies also in the form of patent related challenges in India
and abroad. More...
What is the Satyam Upaid case about

(Raghuvir Srinivasan , 3-Apr-2009 , Business Line)
Armed with the patent Upaid filed a suit against Qualcomm and Verizon Wireless in 2005 alleging that
they were using the patented technology. More...
Patent to Bajaj could mean trouble for TVS

(Shally Seth , 3-Apr-2009 , livemint)
Indias patents office has granted exclusive rights to an engine technology Bajaj Auto Ltd uses in all its
motorcycles which could land its rival TVS Motor Co Ltd into trouble since it also uses the same
technology in some of its bikes. More...
Better protection of intellectual property to boost indigenous innovation

(Ayushman Baruah , 3-Apr-2009 , The Financial Express)
According to a BSA IDC global software piracy study the Indian software industry lost around $2 billion
due to software piracy last year. More...
MNC drug makers eye generics in India other emerging countries

Multinational drug makers such as Pfizer and GlaxoSmithkline are planning large scale forays into
generic manufacturing or the reverse engineered cheap drugs business threatening the growth prospects
and survival of Indian generic companies such as Ranbaxy Laboratories Dr Reddys Laboratories and Sun
Pharma and global generic leaders like Teva Sandoz and Mylan. More...
Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL Patents
(Shire Plc , 2-Apr-2009 , Biocompare)
Shire plc announces that it has filed a lawsuit in the US District Court for the Southern District of New
York against Natco Pharma Limited for infringement of two of Shires patents US Patent No 5968976 and
US Patent No 7381428. More...
Watson Does Not Infringe Patent Related to Generic Version of Concerta

(CORONA, CA , 2-Apr-2009 , ag-IP-news )
Watson Pharmaceuticals Inc announced in a press release that the United States District Court for the
District of Delaware has ruled that Watsons generic version of Concerta does not infringe United States
Patent No 6919373 and that the 373 Patent is invalid. More...
US Senate panel approves patent reform

The Senate Judiciary Committee voted on Thursday to approve a patent reform bill that has had drug
high tech and other industries at loggerheads for several years. More...
US senators agree on patent changes

Leaders of the US Senate Judiciary Committee said on Wednesday they had reached agreement on key
elements of a bill to revise US patent law. More...
Mylan confirms four first to file ANDA lawsuits

Believes it to be the first to have filed substantially complete ANDAs containing Paragraph IV
certification. More...
District Court decision received in Concerta patent sase

(Medical Patent News , 01-Apr-2009 , News-Medical.Net)
The US has rendered a decision in the patent litigation between Alza Corporation McNeil PPC Inc and
Andrx Pharmaceuticals LLC McNeil Pediatrics Division of Ortho McNeil Janssen Pharmaceuticals Inc which
markets Concerta Extended Release Tablets CII said the court held that the patent in suit is not valid or
infringed by the filing of Andrxs Abbreviated New Drug Application. More...
Glenmark to stop sale of its pain killer in US

Glenmark Pharmaceuticals Ltd said it will stop selling its morphine sulfate drug in the US complying with
a warning by that countrys drugs regulator More...
Clearance for only one Ranbaxy site
Information provided by Ranbaxy Laboratories Ltd in filings to the stock exchanges and a press release
issued on 23 March has led some analysts and at least one international news agency into assuming that
the companys Paonta Sahib facility censured by the US Food and Drug Administration had been
subsequently given the all clear by the drug regulators of the UK and Australia. More...
Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of
Concerta and Declares Patent Invalid
(Patty Eisenhaur , 31-Mar-2009 , Biocompare)
Watson Pharmaceuticals Inc a leading specialty pharmaceutical company announced today that the
United States District Court for the District of Delaware has ruled that Watsons generic version of
Concerta does not infringe United States Patent No 6919373 and that the 373 Patent is invalid. More...
Eli Lilly looks to make more deals

(INDIANAPOLIS , 31-Mar-2009 , BusinessWeek)
Lilly will lose patent protection for its best selling drug the antipsychotic Zyprexa in 2011. More...
Matrix Labs gets USFDA nod for HIV infection tablets

(PTI,MUMBAI , 31-Mar-2009 , The Economic Times)
Drug manufacturer Matrix Laboratories on Tuesday said it has received US regulators approval for
Emtricitabine and Tenofovir Disoproxil Fumarate Tablets used in controlling HIV infection. More...
US FDA warns firms selling unapproved narcotics

(Lisa Richwine , 31-Mar-2009 , Reuters)
US regulators warned nine companies on Tuesday to stop selling 14 unapproved narcotic pain medicines
part of an ongoing effort to rid the market of drugs without proper clearance. More...
Aurobindo Pharma gets tentative US nod for HIV drug

Drug maker Aurobindo Pharma said on Tuesday it secured a tentative approval from the US Food and
Drug Administration to sell its emtricitabine and tenofovir disproxil fumarate combination drug in tablet
form. More...
Amicus Therapeutics wins new US patent

(By Datamonitor staff writer , 31-Mar-2009 , Pharmaceutical Business Review)
Amicus Therapeutics a biopharmaceutical company has received a new US patent isofagomine the active
ingredient in the companys investigational drug Plicera and its use for the treatment of Gaucher disease.
More...
New Cadila combo pill may cut risk of stroke by half

(Sangeeta Singh,New Delhi , 31-Mar-2009 , livemint)
Medical professionals have long theorized on the benefits of a combination pill in cardiac disorders but it
wasnt known if such a drug could be formulated and at the same time be effective More...
Eli Lilly eyes acquisitions WSJ
(Ajay Kamalakaran , 31-Mar-2009 , Reuters)
Lillys best selling drug the antipsychotic Zyprexa loses patent protection in 2011. More...
Unichem Lab gets FDA nod for Topiramate tablets

(Agencies ,Mumbai , 30-Mar-2009 , The Financial Express)
Pharma company Unichem Laboratories on Monday said it has received US regulatory approval for
Topiramate tablets used for the treatment of epilepsy. More...
Ranbaxy Aurobindo get US FDA nod for epilepsy drug

Pharma firm Ranbaxy on Monday said it has received US regulatory approval for Topiramate tablets used
in the treatment of epilepsy. More...
Cadila Pharma to launch product to curb sudden cardiac death

(BS Reporter / Mumbai/ Ahmedabad , 30-Mar-2009 , Business Standard)
Leading pharma company Cadila Pharmaceuticals in collaboration with McMaster University of Hamilton
Canada has announced its plans to launch a product worldwide to bring down cardiovascular morbidity
and mortality. More...
US FDA approves Suns new drug to market Topamax topiramate

(PTI,MUMBAI , 29-Mar-2009 , The Economic Times)
Sun Pharma today said the US Food and Drug Administration has granted an approval for its abbreviated
new drug application to market generic Topamax topiramate tablets. More...
Local companies blocked from selling cheap lifesaving drug

(Janet Silvera , 29-Mar-2009 , The Gleaner)
JAMAICAN pharmaceutical company Indies Pharma is gearing up for a court battle with international
drug manufacturing giant Pfizer USA over local distribution of hypertension medication used by
thousands of Jamaicans living with the debilitating illness. More...
BCCI Zee fight over Twenty20 trademarks

(Rasul Bailay & , 28-Mar-2009 , livemint)
Over the past 15 months the Essel Group popularly referred to as Zee Group after the television
channels it runs has filed at least four dozen applications with the countrys trademark office seeking
registration of various combinations of Twenty20. More...
Teva gets FDA approval on version of J&Js Topamax

(Associated Press , 27-Mar-2009 , BusinessWeek)
The drugs key patents expired in March. More...

UK discovers counterfeit Novo Nordisk insulin pens
(Ben Hirschler , 27-Mar-2009 , Reuters)
Britains medicines watchdog said on Friday it had discovered a batch of counterfeit Novo Nordisk insulin
pen needles circulating in the country and urged diabetics not to use them. More...
Pantaloon 1 a or 2 the names mine

(Rasul Bailay , 26-Mar-2009 , livemint)
Firm seeks cancellation of registrations granted to R Adag for using the Reliance Big Bazar trademark
More...
India may drag EU to WTO on seizure of drugs in transit

EU authorities have been seizing cargoes of drugs from India because they believe these medicines
infringe local patent laws while transiting from its customs. More...
New diabetes drug approved without trial

(Radhieka Pandeya , 26-Mar-2009 , livemint)
A new drug to combat diabetes which is administered orally and not injected was given a marketing
approval by the Drugs Controller General of India without being put through the mandatory human
clinical trials highlighting a possible lapse in Indian laws dealing with the testing and approval of drugs.
More...
Ranbaxy gets Australia nod for antipsychotic drug

( Devidutta Tripathy , 25-Mar-2009 , Reuters)
Indian drug maker Ranbaxy Laboratories said on Wednesday it had received the Australian drug
regulators approval to market a generic version of Johnson & Johnsons antipsychotic drug Risperdal.
More...
Foreign drug companies gain sales muscle following mergers

(C.H. Unnikrishnan , 25-Mar-2009 , livemint)
The growth of local drug firms had actually begun in the 1970s following the abolition of the product
patent regime.Coincidentally foreign drug makers are set to gain market share after the reversal of the
patent regime in 2005. More...
Patent for Making Combination Chemotherapy Work Better

(NexGen Biomedical, Inc , 24-Mar-2009 , Biocompare)
Patent 7507704 issued on 03 24 09 to NexGen Biomedical Inc founder Mark Zamoyski of San Jose
California discloses an improved method of treating lung brain pancreatic breast and colon cancers that
are driven by a mutation known as HER1 overexpression. More...
Allergan soars on Glaxo takeover speculation

(Val Brickates Kennedy , 24-Mar-2009 , MarketWatch)
An Allergan buy would immediately bolster Glaxos lucrative migraine headache franchise as a key patent
for Imitrex is set to expire this year. More...
Plexxikon wins key patents for new drug compounds
Plexxikon a developer of small molecule pharmaceuticals has received key composition of matter patents
covering novel compounds discovered through the companys Scaffold based Drug Discovery platform.
More...
Glaxo pools 800 patents cuts drug prices for poor

GlaxoSmithKline Plc will share more than 800 of its patents with others seeking to develop new
medicines for neglected tropical diseases and slash the cost of many of its drugs in poor countries from
next week. More...
Court Denies Wyeth Bid For Patent Extension On Cydectin

(By Brent Kendall , 24-Mar-2009 , CNNMoney.com)
A US trial judge on Monday denied Wyeths bid for a 10 month extension on its patent rights to Cydectin
an animal health drug. More...
Lillys Zyprexa Prozac combo wins expanded use

(Lewis Krauskopf , 23-Mar-2009 , Reuters)
US regulators have expanded the approval of Eli Lilly and Cos Symbyax which combines the active
ingredients of its Zyprexa antipsychotic and Prozac antidepressant for treatment resistant depression the
company said on Monday. More...
American Bio Medica to receive two new US patents

American Bio Medica a biotechnology company has received notification from the US Patent &
Trademark office that it will be granted two new patents one for its oral fluid drug testing product line
and the other for its all inclusive urine point of collection drug test cup product line. More...
Cubist Pharma Files Patent Infringement Lawsuit Against Teva Update

(by RTT Staff Writer , 23-Mar-2009 , RTT News)
Monday drug maker Cubist Pharmaceuticals Inc said it filed a patent infringement lawsuit against Teva
Parenteral Medicines Inc or TPM Teva Pharmaceuticals USA Inc alleging violation of its US patents
related to daptomycin. More...
Patent filing facility soon

(Shastry V. Mallady , 23-Mar-2009 , The Hindu)
Micro Small and Medium Enterprises in the State will soon have a patent filing facility as the Tamil Nadu
State Council for Science and Technology is launching an initiative in this direction. More...
Drug makers get ready to work on vaccine for cervical cancer

Gennovas patent team had given the research team the go ahead Dr Singh said responding to whether
their vaccines could infringe the innovators patents. More...
Ricoh and Taisei Join Eco Patent Commons

(Press Releases , 23-Mar-2009 , StreetInsider)
Ricoh Company Ltd a global leader in office solutions and Taisei Corporation a leading engineering
construction company have joined the Eco Patent Commons a first of a kind business effort coordinated
by the World Business Council for Sustainable Development to help the environment by pledging
environmentally beneficial patents to the public domain. More...
Pharma lobby wants a probe into delayed orders

(C.H. Unnikrishnan, , 23-Mar-2009 , livemint)
The Indian Pharmaceutical Alliance or IPA has sought an investigation into several delayed orders in
patent opposition cases. More...
Sepracor sues to suppress generic copies of Lunesta

(Bloomberg News , 21-Mar-2009 , boston.com)
Sepracor Inc said it filed a lawsuit to prevent companies from selling generic versions of its top selling
sleep drug Lunesta. More...
Appeals Court Revives Some Patent Rules Attacked By Glaxo

(Dow Jones,WASHINGTON , 20-Mar-2009 , CNNMoney.com)
GlaxoSmithKline PLC and an independent inventor challenged the rules before they went into effect
arguing that Congress had not given the patent office the authority to make substantive changes to the
patent process. More...
US court rules largely for patent office on Glaxo

(By Diane Bartz , 20-Mar-2009 , Reuters)
A US appeals court largely overturned on Friday GlaxoSmithKline Plcs summary judgment win in a fight
against new patent office rules. More...
Epix Pharmaceuticals wins new US patent

(Datamonitor staff writer , 20-Mar-2009 , Pharmaceutical Business Review)
The granted claims of this patent are directed to the highly selective 5HT4 small molecule agonist,
PRX03140, and to compositions that include PRX03140 as one of the active ingredients. Epix also has
pending patent applications relating to compositions and methods of using PRX03140. More...
Global pharma consolidates

Big pharma is set to lose nearly $100 billion in sales as many blockbuster drugs are set to lose patent
protection over the next five years. More...
Dr Reddys to exit small generic drug markets abroad

Dr Reddys Laboratories Ltd has decided to exit from the small distributor driven markets in its global
generics business. More...
OSI Pharma files suit against Teva Mylan

(Helen Chernikoff , 19-Mar-2009 , Reuters)
OSI Pharmaceuticals Inc on Thursday announced that it filed two lawsuits against rival drug companies
regarding patents associated with Tarceva OSIs cancer drug the company said in a statement. More...
Warner Chilcott sues Impax over acne drug Doryx

(NEW YORK , 19-Mar-2009 , Associated Press)
Warner Chilcott Ltd said Thursday it is suing Impax Laboratories Inc accusing Impax of infringing a
patent supporting 150 milligram tablets of Warner Chilcotts acne medication Doryx. More...
Chennai tops in filing of trademarks

In India the Chennai branch of the Patent and Trademark Office has the highest number of trademarks
filed and Bangalore stands first in the e filing of trademarks More...
US bill may dent Dr Reddys growth plans

(Amriteshwar Mathur , 19-Mar-2009 , The Economic Times)
Dr Reddys Laboratories could be affected if a recent US bill that seeks ban on MNC pharma companies
from transferring authorised generics to third parties becomes a law. More...
Strides Acrolab receives US FDA approval

Amidst stringent US Food & Drug Administration compliance Bangalore based Strides Acrolab has
reasons to cheer. More...
EU Patent Court drug rulings must consider public interest

(By Lynne Taylor , 18-Mar-2009 , PharmaTimes)
The European Union Patent Court proposed by the European Commission must crucially take due care of
the public interest in its considerations regarding pharmaceutical patents say generic drugmakers.
More...
Merck gives malaria drug to non profit group

Last month GlaxoSmithKlines chief executive urged the creation of a voluntary patent pool to spark
development of new treatments for neglected diseases including malaria. More...
Cadila moves SC against Dabur Baidyanath on trademark

Pharma major Cadila Healthcare has moved the Supreme Court seeking to restrain Dabur India and
Shree Baidyanath Ayurved from using its trademark Sugar free used for artificial sweeteners. More...
Medicis Teva end dispute relating to Solodyn

(Helen Chernikoff , 18-Mar-2009 , Reuters)
Israels Teva the worlds largest generic drugmaker confirmed that Medicis patents relating to Solodyn
Extended Release Tablets are valid and enforceable and has agreed to stop all further shipments of its
generic version of the drug. More...
Genzyme sues Impax in patent fight

(Bloomberg News ,WASHINGTON , 18-Mar-2009 , boston.com)
Genzyme Corp the worlds largest maker of drugs for rare genetic disorders sued Impax Laboratories Inc
for allegedly infringing a patent used for its Renagel kidney medicine. More...
Hope is a patent troll for IIT Bombay

The patent trolls main activity is seen as litigation and thus the reason for its unsavoury reputation.
More...
Samsung to file fresh petition in dual SIM case

The firm is challenging a law that linked a patent enforcement provision in import rules under which
Samsung mobile phones that use double SIM were seized in Mumbai and Chennai More...
First to file Para IV suits on steady rise along with patent settlements
A latest study conducted in US by Stanford Group Company a member of the Stanford Financial Group
shows that patent challenges as well as settlements continue to be on the rise. More...
Warner Chilcott faces new patent dispute

(Associated Press , 17-Mar-2009 , Forbes)
Warner Chilcott Ltd said Tuesday Impax Laboratories has challenged the drug developers patent on
another dose of the antibiotic Doryx. More...
Shire Files Lawsuit Against Barr for Infringement of FOSRENOL Patents

(WASHINGTON, DC , 17-Mar-2009 , ag-IP-news )
Shire plc announced in a press release that it has filed a lawsuit in the US District Court of the Southern
District of New York against Barr Laboratories Inc for infringement of three of Shires patents US Patent
No 5968976 US Patent No 7381428 and US Patent No 7465465. More...
Drug Firms Bet Big on High Risk Deals

(By RON WINSLOW and AVERY JOHNSON , 17-Mar-2009 , The Wall Street Journal)
Amid the biggest financial crisis since the Great Depression drug giants Pfizer Inc Merck & Co and Roche
Holding AG are pulling off an impressive feat More...
USPTO Grants Reissue Patent Relating to Lipitor

(NEW YORK , 17-Mar-2009 , ag-IP-news )
Pfizer Inc announced in a press release that the US Patent and Trademark Office has granted reissue
patent RE40667 relating to Lipitor. More...
IIT B to encash its intellectual bonds

(Mumbai , 17-Mar-2009 , DNA)
Converting their ideas into monetary value will now become easier for the IIT Bombay faculty thanks to
a partnership between the institute and Intellectual Ventures IV. More...
Patent offices asked to clear opposition cases by 31 March

The new controller general of patents designs and trademarks has ordered the heads of all four regional
offices to issue final orders in some 600 patent and trademark opposition cases by 31 March. More...
Natco successfully opposes patent application

(BS Reporter / Hyderabad , 16-Mar-2009 , Business Standard)
Hyderabad based Natco Pharma limited said that it had successfully opposed a patent application in
India that covers the composition of Glatiramer Acetate the generic version of Teva Pharmaceutical
Industries Copaxone. More...
Tatas seek patent security for Nano against copycats

(Kala Vijayraghavan & Lijee Philip , 16-Mar-2009 , The Economic Times)
Tata Motors has applied for patent protection for over 37 inventions and innovations linked to its high
profile affordable car Nano aggressive move to protect the brand against imitation in the ultra
competitive car industry. More...
Pfizer to give data on smoking cessation drug impact in India

Indian drug regulator has askedPfizer Ltd the Indian arm of the worlds largest drug maker Pfizer Inc to
submit data of a compulsory post sales study on its smoking cessation drug Champix More...
Glaxo proposes patent pool for new treatment of neglected diseases

GlaxoSmithKline Plcs chief executive urged creation of a voluntary patent pool to spark development of
new treatments for neglected diseases in the worlds poorest countries. More...
Dr Reddys wins drug patent case in US

Hyderabad March 13 A US District Court has granted a summary judgment that pharma major Dr
Reddys Laboratories Ltd does not infringe the patents in its Abbreviated New Drug Application for
Omeprazole. More...
Govt to spend $2 b annually till 20 on drug discovery

(ET Bureau,AHMEDABAD , 14-Mar-2009 , The Economic Times)
We have ability of backward engineering but we lack innovation he added Mr Kumar said about $103
billion worth of patented drugs will go off patent in the years to come. More...
Pfizer says CEOs 2008 pay over $13 mln

(By Ransdell Pierson , 13-Mar-2009 , Reuters)
Pfizers biggest challenge comes in 2011 when its $12 billion a year Lipitor cholesterol fighter loses US
patent protection and confronts cheaper generic competition. More...
Strides Arcolab to launch over 25 products this year

(Dow Jones , 13-Mar-2009 , Business Line)
Bangalore Mumbai 12 Pharmaceutical company Strides Arcolab Ltd expects new product launches mainly
in the US and Europe to drive its revenue growth this year its Vice Chairman and Chief Executive said.
More...
Pharma MNCs want to take a shot at Indias vaccine market

(Nina Mehta,MUMBAI , 12-Mar-2009 , The Economic Times)
MSD Pharmaceuticals GlaxoSmithKline Novartis and Pfizer are some of the companies that want to be a
part of this story. More...
Sepracor Inc Reaches Xopenex Deal with Teva Pharmaceutical Industries Limited
(MARLBOROUGH, Mass,BUSINESS WIRE , 12-Mar-2009 , Biocompare)
Sepracor Inc today announced that it has entered into a Settlement and License Agreement with Teva
Pharmaceuticals USA Inc and Barr Laboratories Inc a wholly owned subsidiary of Teva to resolve the
patent litigation against Barr involving Sepracors XOPENEX brand levalbuterol HCl Inhalation Solution
products and to grant a license to Barr and Teva. More...
Mercks Schering Plough buy is a win win deal

(Pillman,Mumbai , 12-Mar-2009 , DNA)
To make the going tough patent expiries burnt a major hole into Mercks revenues. More...
India Brazil protest seizure of generic drugs by Dutch

(Sheila Mathrani,GENEVA , 11-Mar-2009 , The Economic Times)
India and Brazil have expressed their deep concern over the public health implications of the seizure of
generic drugs in transit by European nations and its systemic implications. More...
Moodys cuts Pfizer as Lipitor patent nears expiry

(Karen Brettell,NEW YORK , 13-Mar-2009 , Reuters)
Moodys Investors Service on Wednesday cut its ratings on Pfizer citing declining credit quality at the
pharmaceutical company due to the upcoming expiration of its patent for cholesterol drug Lipitor.
More...
Merck deal puts pressure on drugmakers AstraZeneca Sanofi J&J

(Bloomberg / New Delhi , 11-Mar-2009 , Business Standard)
The worlds biggest drugmakers armed with about $100 billion in cash and short term investments are
seeking acquisitions to replace $84 billion in sales from products nearing the end of their patent life.
More...
USPTO Issues Notice of Final Determination for Patent Term Extension for NAMENDA
(Forest Laboratories , 10-Mar-2009 , Biocompare)
Forest Laboratories Inc Forest Laboratories Holdings Ltd Merz Pharma GmbH & Co KGaA and Merz
Pharmaceuticals GmbH announced today that the US Patent and Trademark Office has issued a Notice of
Final Determination granting the full five years of patent term extension for US Patent No 5061703
which is listed in the US Food and Drug Administration Orange Book for NAMENDA. More...
Cordex files patent application for anti arrhythmic drug

Cordex Pharma a developer of cardiovascular medicines has filed a formulation patent covering its lead
product ATPace. More...
Tax free bonds to fund drug research venture

(Sushmi Dey & Gireesh Chandra Prasad , 10-Mar-2009 , The Economic Times)
Much of Indias strengths in this sector are in making copycat versions of popular drugs discovered
abroad and making medicines whose patents have expired. More...
Pfizer Aurobindo pact may expand to CIS Asian markets

Pfizer the worlds largest drug maker which announced a licensing and supply pact on March 3 with
Aurobindo Pharma to source over 50 generic medicines for sale in the US and Europe will expand this to
about 30 countries in Asia and the CIS region soon. More...
Ranbaxy gets USFDA nod for heart drug

(Our Bureau ,New Delhi , 09-Mar-2009 , Business Line)
Ranbaxy Laboratories Ltd announced on Monday that it has received an approval from the US Food and
Drug Administration to market and manufacture cardiovascular drug Ramipril Capsules More...
Drug Mergers Killers for Research

(By Catherine Arnst , 09-Mar-2009 , BusinessWeek)
Further out however Merck may find itself in the same wobbly boat its in now No big drugs to replace
the best sellers that are on the verge of losing patent protection. More...
Merck Schering Plough deal What happens to subsidiaries

Early days yet to map how the acquisition will pan out in India. More...
For Big Pharma the playfields here

(Priyanka Golikeri & C Chitti Pantulu , 9-Mar-2009 , DNA)
Multinational drugmakers are taking Masefield a little too seriously. They are fast moving eastward with
India in the periscope. More...
Indias Ranbaxy gets US FDA nod for ramipril

(Janaki Krishnan , 9-Mar-2009 , Reuters)
Indian drug maker Ranbaxy Laboratories Ltd said on Monday it had received approval from the US Food
and Drug Administration to manufacture and market ramipril capsules. More...
Takeda stock sold off on key drug approval concerns

(Nathan Layne , 9-Mar-2009 , Reuters)
Shares of Japanese drugmaker Takeda Pharmaceutical Co were untraded due to a glut of sell orders on
news that US regulators have asked for more data to complete a review of a key diabetes drug
candidate. More...
Watson to pay $18 million to Elan to settle patent suit

(By Kathy Shwiff , 7-Mar-2009 , MarketWatch)
Watson Pharmaceuticals Inc will pay $18 million to Elan Corp PLC to settle patent litigation related to
Watsons generic version of Naprelan or naproxen sodium tablets. More...
UN agency protests Dutch seizure of Indian HIV drugs

(Radhieka Pandeya , 7-Mar-2009 , livemint)
The purchase by the Clinton Foundation through UNITAID was confiscated at Amsterdams Schiphol
airport on 12 November on grounds that it contained counterfeit goods and infringed IPRs More...
New drug regulatory norms on cards

(Gireesh Chandra Prasad , 7-Mar-2009 , The Economic Times)
The government is putting finishing touches on a new regulatory regime for the countrys pharmaceutical
sector that will seek to catapult domestic drug makers into the global league of inventors from being
successful copiers of expensive multinational brands. More...
Ranbaxy gets approval to market anti fungal drugs in Australia

(PTI,NEW DELHI , 6-Mar-2009 , The Economic Times)
Drug major Ranbaxy Laboratories on Friday said it has received approval from the Australian health
regulator to market its anti fungaltablets Serbifin Terbinafine in that country. More...
Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium

(CORONA, Calif. , 6-Mar-2009 , PRNewswire)
Watson Pharmaceuticals Inc a leading specialty pharmaceutical company announced today that it has
reached a settlement with Elan Corporation Plc on outstanding patent litigation related to Watsons
generic version of Naprelan tablets. More...
Indian firms expect US FDAs local office to speed up approvals

(Nina Mehta , 6-Mar-2009 , The Economic Times)
The US Food and Drugs Administrations new office in India could likely boost local pharma companies
efforts to process their applications and speed up approvals for marketing in the global market. More...
Slowdown pill chokes Reliance Pharma

Reliance Pharmaceuticals Pvt Ltd a generics or off patent drug manufacturing and exporting firm that is
being set up at a cost of at least Rs1000 crore may start functioning later than originally envisaged.
More...
USFDA door wide open for Indian pharma cos

The trend is likely to continue as Indian companies account for 35 per cent of all ANDA approvals given
by the FDA in the first two months of 2009. ANDA is an application for a generic drug approval for an
existing licensed medication or an approved drug. More...
Pharma to get new regulatory regime

(Gireesh Chandra Prasad , 05-Mar-2009 , The Economic Times)
Drug makers in the country will get a new regulatory regime that is more friendly for investing heavily
into high risk research testing experimental drugs on animals protecting the costly research data shared
with the regulators and everything needed to lead them to the global league of drug inventors. More...
Aussie regulator puts Ranbaxy under scanner

(ET Bureau,NEW DELHI , 5-Mar-2009 , The Economic Times)
The Australian drug regulator Therapeutic Goods Administration said it is reviewing 62 drugs sold in the
country which are made by Ranbaxy at its Paonta Sahib plant. More...
Cordex Pharma Files ATPace Formulation Patent

(LA JOLLA, Calif , 04-Mar-2009 , PRNewswire)
Cordex Pharma Inc announced today that it has filed a formulation patent covering its lead product
ATPace. More...
Way to go New patents for old drugs

It is one of the great ironies of this country that regulations put together after careful thought and
debate to prevent their misuse by smart companies are carelessly flouted by the implementing agency.
More...
Aurobindo gets USFDA nod for anti depressant

(ET Bureau,MUMBAI , 04-Mar-2009 , The Economic Times)
Drug major Aurobindo Pharma on Wednesday said it has got tentative USFDA approval to market
escitalopram oxalate tablets. More...
Pfizer to license 50 generics from Aurobindo

(BS Reporter / New York , 4-Mar-2009 , Business Standard)
Pfizer Inc has agreed to license an array of generic pills and injectable medicines from Indias Aurobindo
Pharma Ltd as the worlds largest drugmaker looks to off patent medicines for growth. More...
Congress takes up patent redo damages fight looms

(WASHINGTON , 3-Mar-2009 , Reuters)
Senior US lawmakers launched a new patent reform attempt on Tuesday with controversial legislation
that would reduce damages paid for infringement. More...
Basilea Pharmaceutica files claims against Johnson & Johnson

Basilea Pharmaceutica has filed claims in arbitration against Johnson & Johnson and affiliated companies
related to delays in approval of ceftobiprole. More...
Pfizer Expands Portfolio of Generic Medicines in the US and Europe

(NEW YORK , 03-Mar-2009 , ag-IP-news )
Pfizer Inc announced that it has entered into a series of agreements with Aurobindo Pharma Ltd a
pharmaceutical company based in India to commercialize medicines that are no longer patent protected
and have lost market exclusivity in the United States and Europe further progressing its Established
Products Business Unit strategy. More...
Jubilant gets Canadian nod for anti heart disease generic

(Agencies ,Mumbai , 02-Mar-2009 , The Financial Express)
Drug maker Jubilant Organosys on Monday said its Canadian subsidiary has received approval from
Canadian health regulator for its anti heart disease generic Sestamibi in that country. More...
SC asks Chennai patent office to hear Roche

The Supreme Court on Monday asked the Chennai patent office to hear and take a final view for all post
grant oppositions for a patent it had granted to Swiss company Roche for its anti infection drug Valcyte .
More...
SC asks Roche not to pursue Cipla case until patent examination

The Supreme Court has asked Swiss company Roche not to pursue the patent violation case against the
generic version of Ciplas anti infection drug Valcept until the Chennai patent office re examines the
patent granted to Roche. More...
DoJ files suit against KV Pharma

(BANGALORE , 02-Mar-2009 , Reuters)
The US Department of Justice said it sued KV Pharmaceutical Co to block the drugmaker from making
and distributing adulterated and unapproved drugs. More...
AstraZeneca FDA approves Symbicort

(Edited Press Release , 02-Mar-2009 , MarketWatch)
AstraZeneca Monday announced that the US Food and Drug Administration has approved SYMBICORT
160 45 mcg for the twice daily maintenance treatment of airflow obstruction in patients with chronic
obstructive pulmonary disease including chronic bronchitis and emphysema. More...
Another jolt for Ranbaxy Labs

(BS Reporter / Mumbai , 28-Feb-2009 , Business Standard)
Ranbaxy Laboratories which has been charged by the US Food and Drug Administration with falsifying
data has agreed to a Canadian governments request to quarantine all drugs coming into Canada from its
drug making facility in Himachal Pradesh. More...
Pfizer generics chief eyes licensing injectables

(By Lewis Krauskopf , 27-Feb-2009 , Reuters)
Pfizer Inc is seeking licensing deals to help turn its burgeoning business focused on generic drugs into a
growth engine for the worlds largest drug maker over the next several years. More...
Kissei and Takeda win Japanese approval for diabetes treatment

(By Datamonitor staff writer , 27-Feb-2009 , Pharmaceutical Business Review)
Japan based Kissei Pharmaceutical and Takeda Pharmaceutical Company have announced that an
additional indication of combination therapy with insulin sensitizer for Glufast 5mg tablet and 10mg
tablet which is being co marketed by both the companies was approved by the regulatory authorities in
Japan. More...
Obama calls for generic biotech drugs

(By RICARDO ALONSO-ZALDIVAR, , 27-Feb-2009 , Associated Press)
President Barack Obamas budget aims to foster generic competition for costly biotech drugs used to
treat cancer and other intractable ailments. More...
USFDA action against Ranbaxy based on false drug stability data

The action by the US Food and Drug Administration against Ranbaxy on Wednesday was triggered after
it was found out that the company had given incorrect data to prove drugs are stable over a certain time
period. More...
Suit against Amgen for drug marketing unsealed

(LOS ANGELES,Reuters , 27-Feb-2009 , Reuters)
A whistle blower lawsuit accusing Amgen Inc of illegally marketing its blockbuster drugs Enbrel and
Aranesp has been unsealed a company spokesman said on Friday. More...
Daiichi Ranbaxy form joint team to counter FDA charges
(BS Reporters / New Delhi/mumbai , 27-Feb-2009 , Business Standard)
Daiichi Sankyo which owns Indias biggest drug maker said it had formed a team with Ranbaxy
Laboratories to address the data falsification charges levied by the US Food and Drug
Administrationeven as analysts foresaw more trouble for the drug maker. More...
Pfizer close to deal with Nigeria in drug lawsuit

(By Mike Oboh , 27-Feb-2009 , Reuters)
Nigeria is close to a settlement in a multi billion dollar lawsuit against Pfizer Inc over a 1996 drug trial it
says caused the death of 11 children and left dozens more disabled lawyers said on Friday. More...
Ranbaxy to isolate Canada bound drugs from HP unit

(Press Trust of India / Toronto , 27-Feb-2009 , Business Standard)
Indian pharmaceutical firm Ranbaxy has agreed to a Health Canada request to quarantine all drugs
coming into the North American country from the Paonta Sahib manufacturing facility in Himachal
Pradesh Canadian Press reported on Thursday quoting the company. More...
Genentech Receives Final Notification Upholding Cabilly Patent in Reexamination Proceeding

(SOUTH SAN FRANCISCO, Calif.(BUSINESS WIRE) , 26-Feb-2009 , Biocompare)
Genentech Inc today announced that the US Patent and Trademark Office has issued a Notice of Intent
to Issue a Reexamination Certificate confirming the patentability of all claims of the Cabilly et al patent
US Patent No 6331415 of which claims 21 through 32 were amended in a manner that does not affect
the commercial importance of the patent. More...
VIA Pharmaceuticals Announces Grant of New Patent

(SAN FRANCISCO, CA , 26-Feb-2009 , ag-IP-news )
VIA Pharmaceuticals Inc announced the issuance of United States Patent No 7495024 entitled
Phenylalkyl N Hydroxyureas for Combating Atherosclerotic Plaque covering the use of VIAs lead
compound VIA 2291 for the treatment of atherosclerosis. More...
Will continue to cooperate with USFDA Ranbaxy

Ranbaxy has just received a letter and information indicating that all pending and approved ANDAs from
Ranbaxys Paonta Sahib facility have been added to a list maintained under a policy entitled Application
Integrity Policy or AIP. More...
Cipla opposes GSKs patent on Tykerb in India

(Anju Ghangurde , 25-Feb-2009 , SCRIP)
Cipla has filed a post grant opposition against GlaxoSmithKline s patent on the breast cancer drug
Tykerb in India. More...
Endo and Penwest settle litigation with Actavis

Endo and Penwest have agreed to dismiss their suit with prejudice and Actavis has agreed to dismiss its
counterclaims with prejudice. More...
Genentech says US patent office upholds key patent

(Bill Berkrot, New York , 24-Feb-2009 , Reuters)
Genentech Inc said on Tuesday that the US Patent and Trademark Office has confirmed its claims of the
validity of a key patent that governs the biotechnology company's method of producing some of its
drugs. More...
US companies get Cuba trademarks wait for change

(Esteban Israel, Havana , 24-Feb-2009 , Reuters)
As recently as December the Cuban Office of Intellectual Property registered trademarks for new
products for Coca-Cola, Google and Ford Motor Co. More...
Pharma cos may face penalties for overpricing

(Sushmi Dey,NEW DELHI , 24-Feb-2009 , The Economic Times)
Drugmakers such as Dr Reddys Laboratories Wyeth GlaxoSmithKline Pharmaceuticals and Alkem

Laboratories may now have to face state officials for failing to pay up penalties for overpricing. More...
Sun Taro chiefs meet for out of court settlement

Sun Pharmaceutical Industries and Israel based Taro Pharmaceutical have started fresh rounds of
negotiations to settle their differences over a takeover by the Indian company out of court. More...
LG Electronics asks for patent suit against Kodak

(Diane Bartz, Washington , 23-Feb-2009 , Reuters)
LG Electronics has asked a trade panel to investigate possible digital camera patent infringement by
Eastman Kodak, the International Trade Commission announced. More...
Cordex files amended SPA for tachycardia drug to FDA

Cordex Pharma a developer of new cardiovascular medicines has submitted to the FDA an amended
Phase III protocol for ATPace to be reviewed as a special protocol assessment. More...
Gen Next turns its back on small medium pharma companies

India was import dependent on drugs till 1970 when Indira Gandhi the then prime minister decided to
amend the Patent Act to legalise process patenting or copying of drugs innovated by multinationals.
More...
Merck girds to battle Tevas generic Singulair

(By Ransdell Pierson , 22-Feb-2009 , Reuters)
Although many analysts expect the larger Merck to prevail in the trial at federal court in Trenton New
Jersey a victory by Teva could allow the Israeli company to launch its generic well before Singulairs US
patent lapses in August 2012. More...
Daiichi Sankyo to launch flu preventive drug

(Nikkei,TOKYO , 22-Feb-2009 , Reuters)
Japans Daiichi Sankyo Co plans to launch as early as 2011 a new influenza preventive drug that could be
effective against a strain unresponsive to widely used Tamiflu of Roche the Nikkei business daily said.
More...
Aurobindo gets nod for HIV drug

Aurobindo Pharma Ltd has received tentative approval for Tenofovir Disoproxil Fumarate tablets in 300
mg dosage from the US Food & Drug Administration. More...
Pharma companies eye new markets to drive sales

Indian pharmaceutical companies whose global revenues were affected by their exposure to foreign
currencies and slump in the US sales have seen significant revenue growth in the newer or emerging
markets across continents. More...
Patent office to dispose of all pending cases by March end

(PTI, New Delhi , 20-Feb-2009 , Live Mint)
Though the all India numbers of the pending cases were not disclosed but an official said that in Delhi
alone there are roughly 154 cases More...
USV to sell generic version of cancer drug bicalutamide in US

(P.T. Jyothi Datta , 20-Feb-2009 , Business Line)
USV Ltd will be able to see its generic version of bicalutamide the active pharmaceutical ingredient in
Astra Zenecas prostate cancer drug Casodex when the patent on this drug expires in the US in April.
More...
Endo and Penwest Pharmaceuticals Settle Opana ER Litigation with Actavis South Atlantic LLC
(Corporate News , 20-Feb-2009 , StreetInsider)
Endo Pharmaceuticals and Penwest Pharmaceuticals have settled litigation with Actavis South Atlantic
LLC regarding the production and sale of generic formulations of Opana ER Extended Release Tablets
CII. More...
Tweaking inputs no ground for raising drug prices NPPA

(Sushmi Dey & Khomba Singh , 20-Feb-2009 , The Economic Times)
The drug price regulator has ruled that pharma companies cannot unilaterally increase prices of
medicines that are under price control by merely tweaking their composition. More...
Schering Takeda Unit Sue Teva Over Snake Drug Patent

(By Phil Milford , 19-Feb-2009 , Bloomberg.com)
Schering Corp and Takeda Pharmaceutical Cos Millennium unit accused Israels Teva Pharmaceutical
Industries Ltd of infringing their US patent for Integrilin anti clotting agent made from rattlesnake
venom. More...
Pharma industry may see more consolidation

(C.H. Unnikrishnan & Nesil Staney , 19-Feb-2009 , livemint)
3 multinationals said to be looking to expand India businesses GlaxoSmithKline Sanofi Aventis Merck
More...
Vion files new drug application for leukemia drug

Onrigin injection a single agent for remission induction treatment for acute leukemia More...
GSK Pharma scouts for domestic buys

GlaxoSmithKline Pharmaceuticals the Indian arm of global drug major GlaxoSmithKline is scouting for
acquisitions in the domestic market to consolidate its Indian business. More...
Most trials conducted under strict FDA European rules

(C.H. Unnikrishnan , 19-Feb-2009 , livemint)
India has been a preferred destination for clinical trials ever since pharmaceutical outsourcing picked up
at the start of the decade. More...
To GSK with awe and some scepticism

Pharmaceutical giant GlaxoSmithKline appears to have knocked almost everyone into a cocked hat with
its announcement last week of slashing prices of drugs for the poorest countries and sharing part of the
profits with these countries to beef up health facilities. More...
Teva to seek US approval for Neupogen biosimilar

(By Lewis Krauskopf , 18-Feb-2009 , Reuters)
Teva Pharmaceutical Industries Ltd hopes to seek US approval for its version of Amgen Incs Neupogen
this year company officials said on Wednesday as it seeks to establish leadership in the emerging field of
generic biotech medicines. More...
Gilead Receives Response From US FDA on Companys Request for Formal Dispute Resolution
for Aztreonam for Inhalation Solution
(FOSTER CITY, Calif , 18-Feb-2009 , StreetInsider)
Gilead Sciences Inc today announced that the company has received a response from the US Food and
Drug Administrationto its appeal submitted under the formal Dispute Resolution process regarding the
Agencys Complete Response Letter for its New Drug Application for aztreonam for inhalation solution.
More...
Pirate Bay copyright test case begins in Sweden
(Simon Johnson, Stockholm , 19-Feb-2009 , Reuters)
A copyright test case involving one of the world's biggest free file-sharing websites that could help music
and film companies recoup millions of dollars in lost revenues started on Monday in Stockholm. More...
Alnylam wins new patent for RNAi therapeutics

Alnylam Pharmaceuticals an RNAi therapeutics company has announced the first grant for the Kay &
McCaffrey patent an early fundamental patent in the RNAi therapeutics field. More...
New norms for MNC drug prices

(Sushmi Dey , 16-Feb-2009 , The Economic Times)
In a move that would prevent MNCs such as GlaxoSmithKline Eli Lilly Roche and Pfizer from selling their
drugs at a huge premium in India the government may soon finalise norms for monitoring prices of
costly imported patented medicines for diseases such as diabetes arthritis obesity cancer and heart
diseases. More...
Piramal Glaxo deal may trigger top level exits

(Mahima Puri , 16-Feb-2009 , The Economic Times)
Many top executives of Mumbai based generic drug maker Piramal Healthcare and the Indian arm of
British pharma company GlaxoSmithKline Formula for successful business are exploring exit options
following reports of a possible acquisition of the Indian firm according to head hunters. More...
As valuations dip Sun Pharma is in M&A mode

(Ruchita Saxena , 16-Feb-2009 , The Economic Times)
With valuations in the Indian pharmaceutical sector correcting in the last few months Sun
Pharmaceutical is aggressively looking for an acquisition. More...
FDA nod key to drug cos US growth

Ranbaxy Dr Reddys and other Indian drug makers which earn a third of their earnings from selling
products in the US need higher drug approvals from the Food and Drug Administration of that country in
the next financial year to maintain 20 per cent sales growth. More...
GlaxoSmithKline vows cheap medicine for the poor

(AFP,LONDON , 14-Feb-2009 , The Times of India)
The head of British drugs giant GlaxoSmithKline said in a British newspaper Saturday he would cut
prices for medication in developing countries and share knowledge of patented treatments. More...
Glaxo proposes patent pool for neglected diseases

(By Lisa Richwine , 13-Feb-2009 , Reuters)
GlaxoSmithKline Plcs chief executive urged creation of a voluntary patent pool to spark development of
new treatments for neglected diseases in the worlds poorest countries. More...
Cubist plans to file patent infringement lawsuit against Teva
Cubist Pharmaceuticals a biopharmaceutical company has said that it intends to file a patent
infringement lawsuit against Teva Parenteral Medicines in response to the abbreviated new drug
application filing that TPM had submitted to the FDA for approval to market a generic version of Cubicin.
More...
Teijin Pharma and Takeda Announces ULORIC Received FDA Approval for the Chronic
Management of Hyperuricemia in Patients with Gout
(TOKYO & OSAKA, Japan , 13-Feb-2009 , StreetInsider)
Teijin Pharma Limited and Takeda Pharmaceutical Company Limited announced today that on February
13 2009 Teijin Pharmas US licensee for febuxostat and Takedas wholly owned subsidiary Takeda
Pharmaceuticals North America Inc received FDA marketing approval for ULORIC for the chronic
management of hyperuricemia in patients with gout. More...
Dr Reddys Losing the edge

(Shobhana Subramanian & Varun Sharma , 12-Feb-2009 , Business Standard)
The upside from generic Imitrex will be lower with Ranbaxy also selling the 100mg dosage in the US
market. More...
Global drug majors slow R&D offshoring to India

(P B Jayakumar , 12-Feb-2009 , Business Standard)
New drug discovery and contract research have taken a back seat as global drug majors have slowed
down their research and development offshoring to India. More...
OSI Pharmaceuticals Announces Notification of ANDA Filing for Tarceva

(MELVILLE, NY , 11-Feb-2009 , ag-IP-news )
OSI Pharmaceuticals Inc announced the receipt of a Paragraph IV Certification Notice Letter advising
that Teva Pharmaceuticals USA Inc submitted an Abbreviated New Drug Application to the US Food and
Drug Administration requesting permission to manufacture and market a generic version of Tarceva.
More...
Ranbaxy gets USFDA approval for migraine drug

The company had earlier missed its December 2008 launch date as it did not get approval from the US
drug regulator. More...
Wockhardt launches Sanofis Lantus generic in India

(REUTERS , 10-Feb-2009 , The Economic Times)
Drugmaker Wockhardt Ltd said on Tuesday it has launched a new insulin Glaritus in India for the
treatment of diabetes. More...
Geneart wins European patent for new screening system

Geneart a provider for DNA engineering and processing services has received a patent from European
patent office for a new screening system based on synthesized virus like reporter genes with which a
new class of antiviral drug candidates may be identified. More...
Wockhardt launches Sanofis Lantus generic in India

(REUTERS , 10-Feb-2009 , The Economic Times)
Drugmaker Wockhardt Ltd said on Tuesday it has launched a new insulin Glaritus in India for the
treatment of diabetes. More...
Antarctic patents strain goals of shared science

(Alister Doyle, Environment Correspondent, Rothera Base, Antarctica , 05-Feb-2009 , Reuters)
An increasing number of companies developing new products through biological discovery or

"bioprospecting" are trying to file patents on Antarctic organisms or molecules for items from cosmetics
to medicines, putting new strains on the treaty. More...
EpiCept receives permission to file leukemia drug NDA

EpiCept a specialty pharmaceutical company has announced that the FDA indicated that the company
has the necessary pivotal data to file a new drug application for Ceplene in conjunction with interleukin-
2 as a remission maintenance treatment of acute myeloid leukemia. More...
Cipla export consignment too seized at Amsterdam

(P.T. Jyothi Datta , 04-Feb-2009 , Business Line)
It is not just drug makers Ind-Swift and Dr Reddy’s Laboratories’ export consignments that were
confiscated by Customs authorities in Amsterdam in the last three-odd months on the grounds of patent
The IAS grabs the patent office too

(Latha Jishnu , 04-Feb-2009 , Business Standard)
India’s patents office, or the Office of the Controller General of Patents, Designs and Trademarks to give
its full title, was one of those dreary government departments, badly-equipped and poorly-staffed, its
decrepit state of little interest to officialdom — or to the media — till January 1, 2005. More...
India, Brazil slam Dutch govt for seizing drugs

(D Ravi Kanth , 04-Feb-2009 , Business Standard)
India and Brazil today strongly denounced the Netherlands Customs authorities at the World Trade
Organization for seizing several consignments of generic medicines from the two countries. More...
Intellectual property rights issues stall Bhel-NTPC project

(Utpal Bhaskar , 04-Feb-2009 , livemint)
New Delhi: An alleged dispute over intellectual property rights has stalled a joint initiative between
Bharat Heavy Electricals Ltd (Bhel) and NTPC Ltd to build less-polluting power generation plants. More...
US lawmakers propose bill to stop generic drug patent deals
(Diane Bartz, Washington , 3-Feb-2009 , Reuters)
Two senior senators have introduced a bill that would make it illegal for pharmaceutical companies to
pay generic drugmakers to keep lower priced alternatives off the market. More...
New Trademarks Act in Force in Dominica

(ROSEAU , 3-Feb-2009 , ag-IP-news )
The final deadline by which granted UK marks can be registered in Dominica will expire on February 1,
2010 - one year from the date of entry into force of the new legislation. More...
FTC challenges Par Solvay patent settlement

(Vidya L Nathan, Bangalore , 2-Feb-2009 , Reuters)
Par Pharmaceutical Cos Inc said federal and state regulators filed an antitrust lawsuit against it related
to its patent settlement over Belgian drugmaker Solvay's testosterone gel, AndroGel. More...
India to move WTO on Dutch drug seizure

(New Delhi , 31-Jan-2009 , The Economic Times)
India and Brazil have decided to mount a joint offensive at the World Trade Organisation against the
Netherlands for seizing a consignment in transit, which was on its way from India to Brazil. More...
Shah Rukh in legal soup over copyright

(Vignesh Iyer, Mumbai , 31-Jan-2009 , Hindustan Times)
A petition has been filed against Shah Rukh Khans Red Chillies Private Ltd, TV channel NDTV Imagine
and Sunanda Oberai by Neha Joshi for making a serial Ghar Ki Baat, based on the script written by her
father, Sharad, for a comedy serial called Yeh Jo Hai Zindagi, without obtaining any prior permission and
violating the Copyright Act More...
Warner Chilcott files patent suit against Actavis

(Hamilton, Bermuda , 30-Jan-2009 , News Release Warner Chilcott )
Pty. Ltd. ("Mayne") have filed a lawsuit against Actavis Elizabeth LLC ("Actavis") in the District Court for
the District of New Jersey for infringement of Mayne's U.S. Patent No. 6,958,161 (the "'161 Patent")
which covers DORYX, a tetracycline-class oral antibiotic. More...
Pfizer pancreatic cancer drug fails, trial halted

(NEW YORK , 30-Jan-2009 , Reuters)
Pfizer Inc (PFE.N), in its latest research setback, said on Friday it stopped a late stage study of an
experimental drug to treat advanced pancreatic cancer after an independent monitoring board found no
evidence that it prolongs survival. More...
Seattle Genetics's lymphoma drug wins orphan designation

(By Datamonitor staff writer , 30-Jan-2009 , Pharmaceutical Business Review)
Seattle Genetics, a clinical stage biotechnology company, has announced that its antibody-drug
conjugate SGN-35 has received the orphan drug designation from the European Medicines Agency for
the treatment of Hodgkin lymphoma and anaplastic large cell lymphoma, or ALCL, and from the FDA for
the treatment of ALCL. More...
Patents grant for mere change under scanner

(C.H. Unnikrishnan , 30-Jan-2009 , livemint)
Mumbai: The Mumbai patent office has initiated an inquiry into alleged violations in granting patents for
modified forms of existing drugs, even as newly available documents related to these present evidence
of negligence. More...
Pfizer's acquisition of Wyeth brings scale but will fail to deliver sustainable sales growth
(By Datamonitor staff writer , 30-Jan-2009 , Pharmaceutical Business Review)
The Pfizer-Wyeth merger will create a prescription pharmaceutical company of unprecedented scale. The
combined entity would have recorded total company sales in excess of $70 billion and prescription
pharmaceutical sales of over $60 billion in 2008. More...
Merck eyes Indian drug biggie, brands

Germany-based Merck KGaA, the world’s oldest multinational pharmaceutical company, is eyeing to
acquire a prominent Indian pharmaceutical company and established drug brands. More...
Cadila to strengthen US reach with fresh approvals

(BS Reporter / Mumbai/ Ahmedabad , 30-Jan-2009 , Business Standard)
Ahmedabad based pharma major Zydus Cadila has got a shot in the arm as it has received three product
approvals from the United States Food and Drug Administration (USFDA) in quick succession. More...
Medarex announces allowance of IND application for antibody-drug conjugate, MDX-1203

(Pharmaceutical News , 29-Jan-2009 , News-Medical.Net)
Medarex, Inc. has announced the allowance of an investigational new drug (IND) application filed with
the U.S. Food & Drug Administration (FDA) for MDX-1203, the Company's first Antibody-Drug Conjugate
(ADC) candidate generated from its proprietary technology. More...
Mylan receives final FDA approvals for generic Lamictal tablets

Mylan Inc has announced that its subsidiaries Mylan Pharmaceuticals Inc. and Genpharm ULC received
final approvals from the U.S. Food and Drug Administration (FDA) for their Abbreviated New Drug
Applications (ANDAs) for Lamotrigine Tablets. More...
Drug prices increased

(Our Bureau ,New Delhi , 28-Jan-2009 , Business Line)
Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has revised the price of 174
formulation packs and three bulk drugs. Prices of most of the drugs have been revised upward. More...
Jannssen-Cilag's Stelara approved in EU for psoriasis

(Katie McQue- Reporter , 28-Jan-2009 , SCRIP)
The European Commission has approved Janssen-Cilag's (Johnson & Johnson) novel human monoclonal
antibody drug Stelara (ustekinumab) for the treatment of moderate-to-severe plaque psoriasis in adults
who have failed to respond to, are intolerant to, or have a contraindication to other systemic therapies
including ciclosporin, methotrexate and psoralen plus ultraviolet light (PUVA). More...
Pfizer-Wyeth may climb to No 2 spot

The merger of Pfizer and Wyeth is expected to create the second-biggest drug maker among
multinational companies in India. The world's largest drug maker Pfizer yesterday announced a $68-
billion acquisition of US-based Wyeth. More...
WHO won't redefine fake drugs

(Sushmi Dey & Khomba Singh , 27-Jan-2009 , The Economic Times)
NEW DELHI: In a major victory for India's cheap but high quality generic drug industry, the World Health
Organisation (WHO) has decided to shelve its plans of redefining counterfeit medicines-a move that
could have posed a threat to sale and export of legitimate generic medicines, a government official said.
More...
Indian arms of Pfizer, Wyeth to merge soon

The decision of Pfizer to acquire rival drugmaker Wyeth in a $68-billion cash-and-stock deal will also see
merger of the listed Indian subsidiaries of both US multinationals soon. More...
'Ranbaxy's investments in Indian drug cos yet to pay off'

NEW DELHI: Ranbaxy Laboratories' strategic investments in Indian drug companies have so far not
delivered desired results, feel industry analysts. More...
Stromedix awarded U.S. patent for antibody-based therapeutics

(Medical Patent News , 26-Jan-2009 , News-Medical.Net)
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ
failure, has announced that the U.S. Patent Office has granted patent number US 7,465,449, which
broadly covers monoclonal antibodies to integrin ávβ6, including compositions related to its lead
product, STX-100. More...
Pfizer, Wyeth close to deal: reports

(AP / PTI / New York , 26-Jan-2009 , Business Standard)
Drugmakers Pfizer and Wyeth are closing in on a deal worth $68 billion that could be announced before
the markets open today, according to published reports. More...
A Pfizer-Wyeth Merger Isn't the Cure-All

(By Catherine Arnst , 24-Jan-2009 , BusinessWeek)
Buying Wyeth would boost Pfizer's revenues, but it won't help with the litany of marketing challenges
and other problems plaguing Big Pharma More...
GeoPharma settles patent litigation with Schering and Sepracor
(Datamonitor staff writer , 23-Jan-2009 , Pharmaceutical Business Review)
GeoPharma has reached an agreement with Schering, Sepracor and the University of Massachusetts
settling all Hatch-Waxman litigation relating to desloratadine tablets 5mg, with the company receiving a
license under all relevant patents. More...
GSK wins European positive opinion for pneumococcal vaccine

(By Staff Writer , 23-Jan-2009 , Pharmaceutical Business Review)
GlaxoSmithKline has announced that the European Medicines Agency's Committee for Medicinal Products
for Human Use has issued a positive opinion and recommended the approval of GSK's pediatric
pneumococcal candidate vaccine Synflorix. More...
Lilly, Bristol withdraw FDA Erbitux lung cancer application

(By Wallace Witkowski , 23-Jan-2009 , MarketWatch)
SAN FRANCISCO (MarketWatch) -- ImClone Systems, which was recently acquired by Eli Lilly & Co.and
Bristol-Myers Squibb Co. said Friday they decided to withdraw a Food and Drug Administration
application to market cancer drug Erbitux for a type of advanced lung cancer. More...
Ranbaxy losses mount on forex hit

Ranbaxy Laboratories, India’s biggest drug maker, posted a loss for the second straight quarter on
adverse foreign exchange fluctuations. More...
Alnylam Provides Update on Kreutzer-Limmer Patent Family

(CAMBRIDGE, MASS , 22-Jan-2009 , ag-IP-news )
Alnylam Pharmaceuticals Inc., a leading RNAi therapeutics company, announced in a press release that
the European Patent Office (EPO) has ruled in favor of the opposing parties in oral proceedings before
the European Opposition Board related to the '945 (EP 1214945) patent in its Kreutzer-Limmer patent
estate. More...
GSK wins European approval for weight loss drug

GlaxoSmithKline has received a non-prescription license for alli, a drug indicated for weight loss in
adults, with a BMI 28kg/m2 or more, when used along with a reduced calorie, lower-fat diet. More...
Drugs regulator issues warning letters to Wyeth pharma, GVK

(Radhieka Pandeya , 22-Jan-2009 , livemint)
Office of the drugs controller general of India issued warning letters asking for explanations, based on
the audit findings More...
Silence Therapeutics announces favorable ruling in European patent lawsuit

Silence Therapeutics, a UK-based RNAi-focused biotechnology company, has announced that a second
member of the Kreutzer-Limmer patent family has been revoked in its entirety. More...
HC allows CPAA to join Bayer-Cipla case

(Khomba Singh & Sushmi Dey , 21-Jan-2009 , The Economic Times)
NEW DELHI: The Delhi High Court (HC) has allowed cancer patient group Cancer Patients Aid Association
(CPAA) to join the Bayer AG and Cipla case. The German drugmaker Bayer AG had sued the Indian
government, its drug regulator and domestic drug company Cipla for giving marketing approval to Cipla
for Bayer's patented cancer drug Nexavar. More...
GeoPharma Announces Settlement of Clarinex ANDA Patent Litigation

(LARGO, FLA , 21-Jan-2009 , ag-IP-news )
GeoPharma, Inc. announced in a Wednesday press release that it has reached agreement with the
Schering Corporation, and Sepracor Inc. and the University of Massachusetts settling all Hatch-Waxman
litigation relating to Desloratadine tablets (5 mg), with the Company receiving a license under all
relevant patents. More...
King Pharma Has A Patent Problem

(Lisa LaMotta , 21-Jan-2009 , Market Scan,Forbes.com)
King Pharmaceuticals was looking a little less than regal Wednesday when a court invalidated two
patents for its best-selling drug. More...
Dr Reddy's Labs back in the black

Dr Reddy’s Laboratories, India’s biggest drug maker by sales, said it turned to profit in the third-quarter,
helped by higher sales of an authorised generic drug in the US, even as it set aside money for foreign
exchange losses. More...
Geneart wins new European patent

Geneart, a provider of DNA engineering and processing solutions, has received a new patent for
selective evolution of proteins from the European Patent Office. More...
Corgenix Receives Two Additional Patents on AtherOx® Technology

(Corgenix Medical Corporation , 20-Jan-2009 , Biocompare)
Corgenix Medical Corporation , a worldwide developer and marketer of diagnostic test kits, has received
notification of two new patents for technology to which Corgenix holds exclusive worldwide licensing
rights outside of Japan. More...
Alexza Pharmaceuticals (ALXA) Initiates AZ-104 Phase 2b Clinical Trial in Patients With
Migraine Headaches
(Corporate News , 20-Jan-2009 , StreetInsider)
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it has initiated a Phase 2b clinical trial with
AZ-104 (Staccato loxapine) in patients with migraine headaches. More...
CSL Behring's bleeding disorder drug RiaSTAP gets US FDA marketing nod
(King of Prussia, Pennsylvania , 20-Jan-2009 , Pharmabiz)
US Food and Drug Administration (FDA) has granted marketing approval to CSL Behring for RiaSTAP,
the first and only treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency,
including afibrinogenemia and hypofibrinogenemia. More...
Oscient and Ethypharm file lawsuit against Lupin

(Datamonitor staff writer , 19-Jan-2009 , Pharmaceutical Business Review)
Oscient Pharmaceuticals, a commercial-stage pharmaceutical company, has announced that the

company, its wholly owned subsidiary Guardian II Acquisition, and its licensor, Ethypharm, have filed a
lawsuit against Lupin Limited and its subsidiary Lupin Pharmaceuticals in the US District Court of
Maryland for the infringement of a US patent which covers Antara (fenofibrate) capsules. More...
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent

(HAMILTON, Bermuda , 19-Jan-2009 , PRNewswire,Biocompare)
Pty. Ltd. ("Mayne"), a subsidiary of Hospira, Inc., have filed a lawsuit against Sandoz Inc. ("Sandoz") in
the District Court for the District of New Jersey for infringement of Mayne's U.S. Patent No. 6,958,161
(the "'161 Patent") which covers DORYX, a tetracycline-class oral antibiotic. More...
'Uniform patent policy needed for cheaper drugs'

(AHMEDABAD , 18-Jan-2009 , The Times of India)
Chief justice of Gujarat High Court, KS Radhakrishnan has called for a uniform patenting policy in order
to curtail price rise of life saving drugs. More...
Drug cos concerned over definition of counterfeits

(P.T. Jyothi Datta,Mumbai , 18-Jan-2009 , Business Line)
The seizure of a transiting export consignment belonging to Dr Reddy’s Laboratories by customs

authorities in Netherlands, barely two months after another local drug-maker Ind-Swift faced a similar
situation, has the domestic pharmaceutical industry concerned about what they say are efforts to block
the movement of generic drugs. More...
No antidote to stop copies of patented drugs: Health min

(Khomba Singh & Sushmi Dey , 17-Jan-2009 , The Economic Times)
NEW DELHI: The health ministry has said it is not equipped with technical expertise to stop domestic
pharmaceutical companies from copying patented drugs. More...
India to drag EU to WTO over the issue of patents

NEW DELHI: The tussle between Indian generic drug industry and western innovative pharmaceutical
firms is set to get stronger as India is considering dragging the European Union to WTO on the issue.
More...
Oscient files patent lawsuit against another drug firm

(Boston Globe Business Team , 15-Jan-2009 , boston.com)
Oscient Pharmaceuticals Corp. of Waltham said it has filed a patent infringement lawsuit against Lupin
Pharmaceuticals Inc., which is seeking to market a generic version of one of Oscient's drugs. More...
Dr Reddy’s consignment of drugs to Brazil seized

(Radhieka Pandeya , 15-Jan-2009 , livemint.com)
This is the first time a shipment of a large Indian company has been held on charges of patent
infringement More...
Not a patent process

(New Delhi , 15-Jan-2009 , Business Standard)
Our patent regime is yet to gain full credibility although the patent law conforms to global norms More...
Eli Lilly Said to Be Near $1.4 Billion U.S. Settlement

(By GARDINER HARRIS and ALEX BERENSON , 14-Jan-2009 , The New York Times)
Eli Lilly, the drug company, is expected to agree as soon as Thursday to pay $1.4 billion to settle
criminal and civil charges that it illegally marketed its blockbuster antipsychotic drug Zyprexa for
unauthorized use in patients particularly vulnerable to its risky side effects. More...
China Pharma wins approval for Tiopronin enteric-coated capsules

China Pharma Holdings, a developer, manufacturer and marketer of specialty pharmaceuticals, has
received approval from China's State Food and Drug Administration for the production of Tiopronin
enteric-coated capsules. Tiopronin is listed in the National Medical Insurance Program, thus allowing
patients to obtain reimbursement. More...
Vical Announces Issuance of New US Patent

(SAN DIEGO , 14-Jan-2009 , ag-IP-news )
Vical Incorporated announced in a Wednesday press release the issuance of US Patent No. 7,470,675
covering the composition, delivery and use of gene-based interferon-omega. More...
Oncolytics Biotech issued new U.S. patent "Reovirus for the Treatment of Neoplasia"
Oncolytics Biotech Inc. has announced that it has been granted its 31st U.S. Patent, # 7,476,382,
entitled "Reovirus for the Treatment of Neoplasia." More...
Bavarian Nordic's patent infringement suit against Oxford BioMedica

Bavarian Nordic owns several United States patents relating to an attenuated strain of the company's
core technology, MVA-BN(R), which is the basis for its smallpox vaccine, IMVAMUNE(R). More...
Dey L.P. Granted Three Additional US Patents

(PITTSBURGH , 13-Jan-2009 , ag-IP-news )
Mylan Inc. announced in a Tuesday press release that its subsidiary Dey L.P. has been issued several
additional US patents protecting the company's Perforomist Inhalation Solution, a chronic obstructive
pulmonary disease (COPD) treatment. More...
VIVUS Announces Issuance of Key European Patent for Qnexa

(MOUNTAIN VIEW, CA , 13-Jan-2009 , ag-IP-news )
VIVUS Inc.announced in a Tuesday press release that the European Patent Office has granted a patent
for Qnexa, an investigational, oral weight loss product for the treatment of obesity and related
conditions. More...
Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin® 24 and

Femcon® Fe Patent Litigation
(Watson Pharmaceuticals, Inc.; Warner Chilcott Limited , 12-Jan-2009 , Biocompare)
Watson Pharmaceuticals, Inc. and Warner Chilcott Limited announced today that they have entered into
Settlement and License Agreements to resolve pending patent litigation related to Warner Chilcott's oral
contraceptive products, Loestrin® 24 and Femcon® Fe. Separately, Warner Chilcott and Watson have
entered into a Co-Promotion Agreement relating to Warner Chilcott's Femring® product and License and
Supply Agreements relating to a Warner Chilcott development-stage oral contraceptive product. More...
Genta Announces Issuance of Two Key US Patents

(BERKELEY HEIGHTS, NJ , 10-Jan-2009 , ag-IP-news )
Genta Incorporated announced in a press release that two new patents related to the company's
franchise in gallium-containing products have issued in the United States. More...
Silence Therapeutics Granted New Patent

(LONDON , 10-Jan-2009 , ag-IP-news )
Silence Therapeutics plc, the leading European biopharmaceutical company focused on RNA interference,
announced that the European Patent Office (EPO) has granted a patent to Silence that covers the
company‘s lead product candidate, Atu027, a press release by the company stated. More...
Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand

Zingo(TM) Indication
(SOUTH SAN FRANCISCO , 9-Jan-2009 , PRNewswire)
Anesiva, Inc. (Nasdaq: ANSV) today announced that the U.S. Food and Drug Administration (FDA) has
approved Anesiva's supplemental New Drug Application (sNDA) to expand the indication for Zingo(TM)
to treat the pain associated with blood draws to include adults. Zingo (lidocaine hydrochloride
monohydrate) powder intradermal injection system was previously approved to treat the pain associated
with peripheral IV insertions and blood draws in children three to 18 years of age. The notification was
received according to PDUFA deadlines. More...
Adhezion wins FDA clearance for SurgiSeal topical skin adhesive

Adhezion Biomedical, a medical device company, has announced that the FDA has provided marketing
clearance for its SurgiSeal topical skin adhesive. More...
Marshall Edwards wins IND approval for cancer drug

Marshall Edwards, an oncology company, has received an investigative new drug approval from the FDA
to undertake clinical studies with triphendiol as a chemosensitizing agent in combination with
gemcitabine. More...
Sun Pharmaceutical receives FDA approvals for 4 generics

Pharmaceutical Industries Ltd. announced that together with its subsidiaries, it has received final
approval from U.S. FDA for several Abbreviated New Drug Applications (ANDA). More...
Pfizer Wins New Lipitor Patent Expiring in June 2011

(Susan Decker , 6-Jan-2009 , Bloomberg)
Pfizer Inc. won new protection on the cholesterol pill Lipitor, the world's best-selling drug, after the U.S.
agreed to reissue a patent on the drug's key ingredient that had been invalidated by an appeals court.
The U.S. Patent and Trademark Office today said it would reissue a patent that expires in June 2011
after the company altered what an appeals court had called inconsistent language that made the patent
invalid. More...
Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment
(Warner Chilcott Limited , 06-Jan-2009 , Biocompare)
Warner Chilcott Limited today announced that it has signed an agreement with Dong-A PharmTech Co.
Ltd., based in Korea, to develop and market their orally-administered udenafil product, a
phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED) in the United
States. Dong-A has successfully completed Phase 2 studies of the product in the United States. More...
Pronova BioPharma ASA Files a Terminal Disclaimer

(LYSAKER, NORWAY , 06-Jan-2009 , ag-IP-news)
Pronova BioPharma ASA announced in a Tuesday press release that it has filed a Terminal Disclaimer in
US Patent No. 5,656,667 ('667 Patent) with the US Patent and Trademark Office. More...
Alexion and PDL BioPharma Resolve Patent Dispute

(NCLINE VILLAGE, NEV., and CHESHIRE, CONN , 05-Jan-2009 , ag-IP-news )
PDL BioPharma Inc. and Alexion Pharmaceuticals Inc. today jointly announced that the companies have
entered into a definitive license agreement and settlement agreement that resolve the legal disputes
between them relating to Alexion's humanized antibody, Soliris (eculizumab) and PDL's patents known
as the Queen et al. patents. More...
Orexigen Therapeutics Issued a Key Fourth US Patent

(SAN DIEGO , 05-Jan-2009 , ag-IP-news )
Orexigen Therapeutics Inc. announced in a Monday press release that the United States Patent and
Trademark Office (USPTO) has issued a patent for what the company refers to as the "Weber/Cowley
methods patent" (US Patent No. 7,462,626), which provides coverage for Contrave, the company's lead
obesity product candidate now in Phase 3 clinical trials. More...
Acura and King Pharmaceuticals file NDA for pain drug

Acura Pharmaceuticals and King Pharmaceuticals have submitted a new drug application for Acurox
tablets to the FDA including a request for priority review. More...
Imitrex delay: Ranbaxy's loss may be Dr Reddy's gain

(Press Trust Of India / New Delhi , 5-Jan-2009 , Business Standard)
The delay in Ranbaxy Laboratories getting approval from the USFDA for launching the generic version of
GlaxoSmithKline’s (GSK) migraine and headache drug Imitrex could turn out to be a gain for Dr Reddy’s
Laboratories, which has already launched the drug in the United States. More...
FDA extends review of King Pharmaceuticals

King Pharmaceuticals has announced that the FDA is continuing its review of the company's new drug
application for Embeda extended release capsules. It is likely that this review will extend into early
2009. More...
FDA extends review of King Pharmaceuticals's Embeda extended release capsules

King Pharmaceuticals has announced that the FDA is continuing its review of the company's new drug
application for Embeda extended release capsules. It is likely that this review will extend into early
2009. More...
Labopharm wins FDA approval for pain drug

Labopharm, a Canadian specialty pharmaceutical company, has announced that the FDA has approved
Ryzolt, the company's once-daily formulation of the analgesic tramadol. More...
Ranbaxy misses deadline for migraine drug launch

( Khomba Singh, ET Bureau , 2-Jan-2009 , The Economic Times)
NEW DELHI: India's largest drugmaker, Ranbaxy Laboratories, has missed its December 2008 deadline
to launch an anti-migraine drug as the US regulator has yet to give its approval. Ranbaxy was expecting
to earn almost $100 mn from the drug, a low-cost version of GlaxoSmithKine-owned Imitrex. More...
Cipla pips Ranbaxy in domestic market

(P B Jayakumar , 2-Jan-2009 , Business Standard)
Veteran industrialist Y K Hamied-led Cipla has edged out Daiichi-Sankyo-owned Ranbaxy Laboratories as
the largest player in the domestic pharmaceutical market in the January-November period, according to
data compiled by ORG-IMS.. More...
IMPAX Sued Based on ANDA for Generic Doryx®

(HAYWARD, Calif.(BUSINESS WIRE) , 01-Jan-2009 , Biocompare)
IMPAX Laboratories, Inc. today announced that Warner Chilcott Laboratories Ireland Limited, Warner
Chilcott Company, Inc., Warner Chilcott (US) LLC, and Mayne Pharma International PTY. LTD have filed
suit for patent infringement in the United States District Court for the District of New Jersey based on
the Company’s submission of Abbreviated New Drug Application (“ANDA”) for doxycycline hyclate
delayed-release tablets (75 and 100 mg), generic of Doryx®, to the Food and Drug Administration. In
connection with this ANDA, IMPAX provided notice that its submission includes a Paragraph IV
certification stating the Company believes its product does not infringe U.S. Patent No. 6,958,161, or the
patent is invalid or unenforceable. More...
Akorn-Strides, LLC Announces FDA Approvals for Sterile Vancomycin HCl USP, 500 mg/Vial; 1
g/Vial and Sterile Vancomycin HCl USP, 5 g/Vial Pharmacy Bulk Package
(LAKE FOREST, Ill.(BUSINESS WIRE) , 31-Dec-2008 , StreetInsider)
Akorn-Strides, LLC today announced that the U.S. Food and Drug Administration has granted approvals
for two Abbreviated New Drug Applications (ANDAs) for Sterile Vancomycin HCl USP, 500 mg/vial, 1
g/vial and Sterile Vancomycin HCl USP, 5 g/vial Pharmacy Bulk Package. Akorn-Strides, LLC is a Joint
Venture that was formed in 2004 by Akorn, Inc. (NASDAQ: AKRX) and Strides Arcolab Limited (NSE:
STAR) (BSE: 532531). The primary mission for the Joint Venture is to develop liquid, lyophilized and dry
powder formulations of generic injectable products targeting several therapeutic markets with a major
focus on anti-infectives, analgesics and CNS medicines. More...
Novartis Girds for the Day Blockbuster Loses Patent

(LONDON , 31-Dec-2008 , The Wall Street Journal)
Sales of Novartis's blockbuster drug, Diovan, are expected to tumble when the high-blood-pressure pill's
patent expires in four years More...
Bayer sues Abbott, alleging patent infringement

(By LINDA A. JOHNSON , 31-Dec-2008 , Associated Press)
Pharmaceutical and chemical maker Bayer AG has filed a federal lawsuit alleging that drugmaker Abbott
Laboratories' best-selling drug, Humira, infringes on a decade-old Bayer patent. More...
Aurobindo Pharma gets US nod for Stavudine

(Reuters,Mumbai , 31-Dec-2008 , The Financial Express)
Drug firm Aurobindo Pharma said on Wednesday it received the final nod from the US Food and Drug
Administration for its stavudine tablets and oral solution. More...
Apeda moves Sindh HC against basmati trademark

(Chennai , 30-Dec-2008 , The Hindu Business Line)
The Agricultural and Processed Food Products’ Export Development Authority (Apeda) has moved the
Sindh High Court in Pakistan against the trademark right given by the Registrar of Trademark, Karachi,
to Basmati Growers’ Association, Lahore, for basmati rice. The registrar, in fact, has allowed only the
growers to use the trademark. The case is slated to come up for hearing in January. More...
Cree Settles Patent Litigation with Bridgelux

(DURHAM, NC , 30-Dec-2008 , ag-IP-news)
Cree Inc. announced in a press release that the company and Boston University have agreed with
Bridgelux Inc. to settle the parties’ patent infringement litigation and to dismiss all claims and
counterclaims in the suits. More...
US’ Alcon wins case against Ajanta Pharma

(Paramita Chatterjee & Khomba Singh, ET Bureau , 29-Dec-2008 , The Economic Times)
US’ Alcon wins case against Ajanta Pharma 29 Dec 2008, 0022 hrs IST, Paramita Chatterjee & Khomba
Singh, ET Bureau Print EMail Discuss Share Save Comment Text: NEW DELHI: US-based drugmaker
Alcon has won a trademark case against its Indian counterpart Ajanta Pharma preventing the latter from
selling its popular eyedrop under the brand ‘Travaxo’ here. The Bombay High Court (HC) granted an
injunction in favour of Alcon, restricting Ajanta Pharma from using its product Travaxo on grounds of
trademark infringement. The medicine directly competes with Alcon’s Travatan in the highly competitive
Rs 33,000-crore drug retail market. More...
Dr Reddy's resolves patent litigation with Schering and Sepracor

(Datamonitor staff writer , 28-Dec-2008 , Pharmaceutical Business Review)
Dr Reddy's Laboratories has entered into agreements with Schering and Sepracor which is expected to
allow Dr Reddy's to manufacture and market generic versions of the Clarinex-D 12 hour and Clarinex-D
24 hour products, with six months marketing exclusivity, and the Clarinex Reditabs product, with six
months marketing co-exclusivity, starting in 2012. More...
Bristol-Myers to pay $1.1 million as settlement charges in Plavix case

(By Staff Writer , 26-Dec-2008 , Pharmaceutical Business Review)
Bristol-Myers Squibb has agreed to pay $1.1 million as part of settlement charges in the Plavix case,
which was being investigated by the New York State Attorney General's Office, reported Reuters More...
Bill to change Apeda Act to protect trade mark interests

(G. Srinivasan, New Delhi , 25-Dec-2008 , The Hindu Business Line)
Indias case for safeguarding its specified agricultural and processed food products such as basmati rice,
Darjeeling tea or Alfonso mango which have been increasingly challenged by other countries would get a
real booster dose once the Agricultural and Processed Food Products Export Development Authority
(Amendment) Bill introduced in the just-ended Parliament session gets into the statute More...
Teva wins approval for generic Seroquel tablets

Teva Pharmaceutical Industries has announced that the FDA has granted tentative approval for the
company's abbreviated new drug application to market its generic version of AstraZeneca's antipsychotic
agent Seroquel tablets, equivalent to 25mg base, 50mg base, 100mg base, 150mg base, 200mg base,
300mg base and 400mg base. More...
Warner Chilcott Files Lawsuits for Infringement of DORYX Patent

(ST. DAVID'S, BERMUDA , 24-Dec-2008 , ag-IP-news )
Warner Chilcott Limited (WCRX) announced in a press release that one of its subsidiaries and Mayne
Pharma International Pty. Ltd. ("Mayne"), a subsidiary of Hospira, Inc., have filed lawsuits against each
of Mutual Pharmaceutical Company Inc. (Mutual), Mylan Pharmaceuticals Inc. (Mylan) and Impax
Laboratories Inc. (Impax). More...
Aurobindo Pharma gets Canada nod for Terbinafine

(Reuters,Mumbai , 24-Dec-2008 , The Financial Express)
Drug maker Aurobindo Pharma said on Wednesday it received the Canadian regulatory approval to sell
terbinafine hydrochloride tablets in multiple strengths. More...
Bill to amend Apeda Act in LS

(New Delhi , 23-Dec-2008 , The Hindu Business Line)
A Bill seeking to amend the Agricultural and Processed Food Products Export Development Authority
(Apeda) Act 1985 to empower the Authority to undertake steps for registration and protection of
intellectual property rights in respect of specified agricultural and processed food products, including
basmati rice, was introduced in the Lok Sabha on Monday. More...
Sun Pharmaceutical extends tender offer for Taro

India-based Sun Pharmaceutical Industries has announced that its subsidiary Alkaloida Chemical
Company Exclusive Group has extended the expiration date of the tender offer for the purchase of all
outstanding ordinary shares of US-based Taro Pharmaceutical Industries. More...
AVI BioPharma Strengthens Its Patent Position in RNA Therapeutics

(PORTLAND, OR - AVI BioPharma Inc. , 23-Dec-2008 , ag-IP-news )
PORTLAND, OR - AVI BioPharma Inc. (AVII), a developer of RNA–based drugs, announced the issuance
of a US patent protecting the composition of matter of its RNA–based therapeutic agent AVI–5126.
More...
Glenmark may beat rivals in novel chemical entity sale

Glenmark Pharmaceuticals, India’s 11th biggest drug maker by sales, may beat bigger rivals, including
Ranbaxy, Dr Reddy’s and Nicholas Piramal, in selling an original drug, or novel chemical entity (NCE), by
2010. More...
AstraZeneca submits sNDA for NEXIUM (esomeprazole magnesium)

(Pharmaceutical News , 22-Dec-2008 , News-Medical.Net)
AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S.
Food and Drug Administration (FDA) for NEXIUM(R) (esomeprazole magnesium) to seek approval for the
short-term (up to 6 weeks) treatment of gastroesophageal reflux disease (GERD) in pediatric patients
ages 0 to 1 year old. More...
AstraZeneca and MAP Pharmaceuticals announce collaboration on Unit Dose Budesonide

AstraZeneca and MAP Pharmaceuticals, Inc. have announced an exclusive worldwide agreement to
develop and commercialize Unit Dose Budesonide (UDB), MAP Pharmaceuticals' proprietary nebulized
formulation of budesonide. More...
Pressure BioSciences, Inc. And Battelle Memorial Institute Sign Exclusive Patent License
Agreement
(Pressure BioSciences, Inc. , 22-Dec-2008 , Pressure BioSciences, Inc.)
Pressure BioSciences, Inc. ("PBI" or the "Company") today announced that they have entered into an
exclusive patent license agreement with the Battelle Memorial Institute ("Battelle"). The licensed
technology is described in the patent application filed by Battelle on July 31, 2008 (US serial number
12/183,219). This application includes subject matter related to a method and a system for improving
the analysis of protein samples, including through an automated, in-line system utilizing pressure and a
pre-selected agent to obtain a digested sample in a significantly shorter period of time than current
methods, while maintaining the integrity of the sample throughout the preparatory process. More...
FDA approves Gleevec (imatinib mesylate) to prevent gastrointestinal stromal tumor
The U.S. Food and Drug Administration has approved Gleevec (imatinib mesylate) for a new indication -
keeping cancer from growing in patients following surgical removal of a gastrointestinal stromal tumor or
GIST. More...
Transcept: Intermezzo accepted for review by the FDA

(By Charlotte Dumezy , 18-Dec-2008 , Pharmaceutical Business Review)
Transcept's insomnia drug, Intermezzo, has been accepted for review by the FDA. This sublingual
reformulation of zolpidem, designed for the treatment of middle-of-the-night awakenings, provides a
fast onset of action and maintains sleep for only four hours. It is not clear that Intermezzo fulfils a
significant unmet need and Datamonitor believes the market for such a treatment will be limited. More...
Gilead Sciences Files Patent Infringement Lawsuit Against Teva Pharmaceuticals

(FOSTER CITY, Calif , 15-Dec-2008 , BUSINESS WIRE)
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that it has filed a lawsuit in U.S. District Court in
New York against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. for
infringement of U.S. Patent Numbers 6,642,245 and 6,703,396. Both patents are associated with
emtricitabine, a component of Truvada(R) (emtricitabine and tenofovir disoproxil fumarate), and are
licensed exclusively to Gilead Sciences by Emory University. Truvada is indicated in combination with
other antiretroviral agents for the treatment of HIV-1 infection in adults. More...
Sanofi-Aventis (France) (SASY.PA) And Bristol-Myers Squibb Company (BMY) Prevail Before
the U.S. Court of Appeals for the Federal Circuit in the U.S Plavix(R) Patent Infringement Case
(PARIS & NEW YORK , 14-Dec-2008 , BUSINESS WIRE)
Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY) and Bristol-Myers Squibb
(New York: NYSE: BMY) announced today that the U.S. Court of Appeals for the Federal Circuit has
upheld the June 19, 2007 decision by the U.S. District Court for the Southern District of New York
holding the U.S. patent 4,847,265 covering clopidogrel bisulphate, the active ingredient in Plavix®, valid
and enforceable. As a result of this ruling, the ‘265 patent protection for this product is maintained in
the United States until November 2011. More...
Gilead accuses Teva of patent infringement

(Foster City-based Gilead , 12-Dec-2008 , Silicon Valley / San Jose Business Journal)
Foster City-based Gilead (NASDAQ:GILD) said the suit, filed in U.S. District Court in New York, centers
on patents associated with emtricitabine, a component of Truvada and licensed exclusively to Gilead by
Emory University. More...
Alnylam Pharmaceuticals (ALNY) Strengthens Intellectual Property Estate through

Acquisition of Nucleonics Inc. Patent Assets
(CAMBRIDGE, Mass , 8-Dec-2008 , BUSINESS WIRE)
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News), a leading RNAi therapeutics company,
announced today that it has acquired the intellectual property (IP) assets of Nucleonics, Inc., a privately
held biotechnology company. The Nucleonics IP estate includes over 100 active patent filings, including
16 that have granted worldwide and 6 that have been granted in the U.S., Europe, or Japan – the
world’s largest pharmaceutical markets. More...
Roche wins European approval for hepatitis drug
Roche has announced that the European Commission has approved Pegasys plus Copegus for the re-
treatment of hepatitis C patients who were not successfully treated with an initial course of interferon
alpha, either alone or in combination with ribavirin. More...
Cephalon, Inc. (CEPH) and Eurand File Patent Infringement Lawsuit Against Mylan
Pharmaceuticals, Inc. (MYL) and Barr Pharmaceuticals, Inc. (BRL)
(FRAZER, Pa. and PHILADELPHIA , 26-Nov-2008 , PRNewswire)
FRAZER, Pa. and PHILADELPHIA, Nov. 26 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH -
News) and Eurand, Inc. (Nasdaq: EURX - News) today announced that they have filed a lawsuit in U.S.
District Court in Delaware against Mylan Pharmaceuticals, Inc. and its subsidiary, Mylan, Inc., and Barr
Pharmaceuticals, Inc. and its subsidiary, Barr Laboratories, Inc., for infringement of Eurand's U.S. Patent
Number 7,387,793. More...
 News Room
 GNAs - Case Laws
 General Case Laws
 Links
 Notices & Notifications
 Login Here
 Indian Patents Database
 Patent Bazar™
 Patent Gurukul®
w w w .gnaipr.com
Enter your search terms
Web www.gnaipr.com
Google Search pub-7295600775 1 6260410312
Submit search form
ISO-8859-1 ISO-8859-1 active GALT:#002E3F;G en
News Feed
Patent firms in India | Licensing & Technology Transfer in India | Patent Drafting Filing & Prosecution
Patent Search & Landscapping | Trademark Registration in India | Sitemap | Sitemap XML | Contact GNAIPR
Copyright © 2008 Gopakumar Nair Associates. All Rights Reserved.
Technology Partners :Plus91

Contact Us

Uploaded by

Document Informationclick to expand document information

Document Informationclick to expand document information

Copyright:

Available Formats

Contact Us

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Contact Us

Uploaded by

Copyright:

Available Formats

 Contact Us

Patent lawyer held in Goa for duping film writer of Rs 45 lakh

Patent applications by female innovators to get faster clearance: Draft rules

N-E varsity researchers patent process to treat industrial waste

DIPP floats draft patent rules

India granted 86 per cent of total patents to foreigners in 2017: UN

Number of patents granted by India shot up by 50% in 2017: UN

Opinion | Incentivizing private sector R&D in India

Activists irked by RCEP talks over pharma patents

'Simmba' movie infringes its trademark, claims a beverage co in HC

Suven Life gets product patents from Australia, Hong Kong

LG files patent for a phone with four rear cameras

LG is likely to retain the 3.5mm jack in its upcoming smartphone More...

Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga More...

Universities and patents

ShareChat drags Bytedance to court over copyright row

No copyright on Patel community: Court

Number of GI registrations from T.N. dwindles

KAU embarks on a mission to rejuvenate hill garlic

326 products registered as geographical indication so far

ZEE patents immersive tech platform for home entertainment

'Take patent to avoid wastage of resource’

Bihar's 'Shahi Litchi' Gets Geographical Indication Tag

Walmart seeks patent for drones to deliver products

Study shows low IPR awareness in India

Protect intellectual property rights: V-C

Alphonso mangoes get Geographical Indication tag

IPR policy reduces pendency of intellectual property applications: DIPP Secy

After a slump, IIT-B witnesses 8 per cent hike in patent application

Funding for research and innovation is improving: Clarivate Analytics

Say cheers to Kutchhi dates wine!

Sohan Lal Commodity Management applies for a patent

Study shows low IPR awareness in India

GI tag fails to boost Kalamkari sales

Government seeks Geographical Indication tag for ‘Odisha Rasagola’

Mumbai: Andhericha Raja gets a trademark certificate, finally

Storm in a coffee mug: Starbucks versus Sardarbuksh

Ever been to a Sardarbuksh for a coffee? More...

Patent infringement complaint filed by Fiat in US: M&M

A withering climate for agricultural innovation

Patent Applications: Bigger team, faster processing on the cards

Patent Applications: Bigger team, faster processing on the cards

Ministry, HUL clash over use of Ayush trademark

August 14, 1968: Patents Bill to Joint Select Committee

Public health TRIPS at WTO

Kerala Agriculture University to pitch cases of a gram, bean for GI tag

HC restrains firm from using ‘Limeroad’ trademark

DowDuPont ‘defers’ field trials to seek sale of GM corn seed in India

Govt’s drug price caps may trigger showdown with US

Flautist designs hybrid musical instrument; applies for patent

KitKat’s four-finger shape can’t be trademarked, rules E.U. court

AstraZeneca sues DRL on patent

SC restrains educational institute from using DPS trademark

Maharashtra gets 474 patents, highest in India

Awareness on patent rights among scholars in govt varsities stressed

Philips wins patent battle in Delhi HC

Meril may get relief on price cap for its stent